Details of Disease

General Information of Disease (ID: DISC7DFA)

• Disease Name: Discovery agent
• Disease Class: N.A.: Discovery agent
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISC7DFA: Discovery agent
• ICD Code: ICD-11: ICD-11: N.A.

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 5 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Desoxycorticosterone Acetate	DMS0AFE	Approved	Small molecular drug	[1]
Lactoferrin	DMA7QTC	Approved	Small molecular drug	[2]
RAUWOLFIA SERPENTINA ROOT	DMWTVAN	Approved	Small molecular drug	[3]
Tenofovir disoproxil fumarate	DMSY4ZG	Approved	Small molecular drug	[1]
Trospium chloride	DM32XZT	Approved	Small molecular drug	[1]

This Disease is Treated as An Indication in 18 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BAY 794980	DMA75FG	Phase 2	NA	[4]
Interferon beta 1a	DMQSA7H	Phase 2	NA	[5]
MK-866	DMQHS6B	Phase 2	NA	[6]
Z 360	DM2M80G	Phase 2	Small molecular drug	[7]
ALXN1910	DMDXTAE	Phase 1	Enzyme replacement	[8]
ALXN2030	DMXT6YT	Phase 1	Small interfering RNA	[9]
ALXN2080	DMQPZQB	Phase 1	NA	[10]
Bile acid	DM9UZD7	Phase 1	NA	[11]
Lactose	DMO4GPK	Phase 1	NA	[12]
rAAV1.tMCK.human-alpha-sarcoglycan	DM1N8PZ	Phase 1	NA	[5]
RG6163	DMZ40ZY	Phase 1	NA	[13]
RG6209	DMLSKA6	Phase 1	NA	[13]
RG6315	DMFHGCC	Phase 1	NA	[13]
RG6351	DM0T74D	Phase 1	NA	[13]
RG7637	DMWW830	Phase 1	NA	[13]
RH 1	DMDM85L	Phase 1	Small molecular drug	[14]
SAR443809	DMSUQTW	Phase 1	Antibody	[15]
TEV-53408	DMI7M5C	Phase 1	NA	[16]

This Disease is Treated as An Indication in 14 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
4-hydroxybenzaldehyde	DM471P5	Patented	Small molecular drug	[17]
BUTAPROST	DMVYNJZ	Patented	Small molecular drug	[18]
CAMBINOL	DMW46GY	Patented	Small molecular drug	[19]
EUGENOL	DM7US1H	Patented	Small molecular drug	[20]
FERULIC ACID	DMJC7NF	Patented	Small molecular drug	[21]
Harmine	DMPA5WD	Patented	Small molecular drug	[22]
Jte 013	DMS3HNM	Patented	Small molecular drug	[23]
KENPAULLONE	DMAGVXW	Patented	Small molecular drug	[24]
MRL20	DMNGQ3I	Patented	Small molecular drug	[25]
MRL24	DM8NS7U	Patented	Small molecular drug	[25]
NSC-87877	DMEYKXL	Patented	Small molecular drug	[26]
T83193	DMHO29Y	Patented	Small molecular drug	[27]
T863	DMX41ZF	Patented	Small molecular drug	[28]
TG003	DMP4HR2	Patented	Small molecular drug	[29]

This Disease is Treated as An Indication in 1 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Trenonacog alfa	DM7RNPJ	Discontinued in Phase 3	NA	[30]

This Disease is Treated as An Indication in 12 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
A-196	DMFP316	Preclinical	Small molecular drug	[31]
BAY 598	DMWH19X	Preclinical	Small molecular drug	[31]
MK6-83	DMI3E0Y	Preclinical	Small molecular drug	[32]
SCF-I2	DMQMA3O	Preclinical	Small molecular drug	[33]
TEV-54142	DMZ15N6	Preclinical	NA	[16]
TEV-56191	DMCI1U6	Preclinical	NA	[16]
TEV-56261	DMHPKLM	Preclinical	NA	[16]
TEV-56278	DMTVD7E	Preclinical	NA	[16]
TEV-56284	DMY0U5K	Preclinical	NA	[16]
TEV-56285	DMHXH2B	Preclinical	NA	[16]
TEV-56288	DMPIBPH	Preclinical	NA	[16]
YM-201636	DMU86XT	Preclinical	Small molecular drug	[32]

This Disease is Treated as An Indication in 15017 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine	DM2TIU3	Investigative	Small molecular drug	[34]
((E)-3-Amino-propenyl)-methyl-phosphinic acid	DMEJRVW	Investigative	NA	[35]
((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine	DMCW65Q	Investigative	Small molecular drug	[36]
((Z)-3-Amino-propenyl)-methyl-phosphinic acid	DM6H0FW	Investigative	Small molecular drug	[37]
(+)-(1R,1'S)-berbamunine hydrochloride	DMF62GN	Investigative	Small molecular drug	[38]
(+)-(1R,1'S)-thaligrisine hydrochloride	DM521S4	Investigative	Small molecular drug	[38]
(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol	DMLDQWT	Investigative	Small molecular drug	[39]
(+)-(5S,8S,10S)-20-methoxypuupehenol	DMU7BJA	Investigative	Small molecular drug	[39]
(+)-(5S,8S,9R,10S)-20-methoxypuupehenone	DMD4YPO	Investigative	Small molecular drug	[39]
(+)-3,3'-bisdemethyltanegool	DMNUWVB	Investigative	Small molecular drug	[40]
(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid	DM2CHX8	Investigative	Small molecular drug	[41]
(+)-5-deoxyadeenophorine	DMF8C50	Investigative	Small molecular drug	[42]
(+)-ADTN	DMXWCVY	Investigative	Small molecular drug	[43]
(+)-AJ76	DMEDMC0	Investigative	Small molecular drug	[44]
(+)-BHFF	DM1K2SC	Investigative	Small molecular drug	[45]
(+)-BUTACLAMOL	DMX6UYN	Investigative	Small molecular drug	[46]
(+)-cis-H2-PAT	DMDFR59	Investigative	Small molecular drug	[47]
(+)-HA966	DMKWEAJ	Investigative	Small molecular drug	[48]
(+)-MCPG	DMG5QJB	Investigative	Small molecular drug	[49]
(+)-Myristinin A	DM7FZHI	Investigative	Small molecular drug	[50]
(+)-Myristinin D	DMEK07T	Investigative	Small molecular drug	[50]
(+)-norfenfluramine	DMOZJA5	Investigative	Small molecular drug	[51]
(+)-S-14297	DMX7ECD	Investigative	Small molecular drug	[52]
(+)-SK&F10047	DM1QPA4	Investigative	Small molecular drug	[53]
(+)-trans-H2-PAT	DMAN63P	Investigative	Small molecular drug	[54]
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one	DMDXKQ6	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	DMCB74T	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	DM1WCJV	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	DMG3MF2	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	DM1YBJ2	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	DMKPX7W	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	DM7BY4T	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	DMKFSQ8	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	DMY1W20	Investigative	Small molecular drug	[55]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	DMUPYN1	Investigative	Small molecular drug	[55]
(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DMGY5WB	Investigative	Small molecular drug	[56]
(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one	DMHL7BC	Investigative	Small molecular drug	[56]
(+/-)-2-(4-fluorophenyl)chroman-4-one	DMXK4HR	Investigative	Small molecular drug	[56]
(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one	DMTUFOE	Investigative	Small molecular drug	[56]
(+/-)-2-Amino-1,2,3,4-tetrahydro-2-naphthoic acid	DMX768L	Investigative	Small molecular drug	[57]
(+/-)-2-Aminoindane-2-carboxylic acid	DML5URN	Investigative	Small molecular drug	[57]
(+/-)-2-Methyl-1-(1-phenylethyl)-1H-imidazole	DMJ6MPO	Investigative	Small molecular drug	[58]
(+/-)-2-p-tolylchroman-4-one	DMYJGZ4	Investigative	Small molecular drug	[56]
(+/-)-2-Phenylthiomorpholin-5-one	DMSHDNO	Investigative	Small molecular drug	[55]
(+/-)-2-Phenylthiomorpholine	DMNR3YL	Investigative	Small molecular drug	[55]
(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine	DML68KX	Investigative	Small molecular drug	[59]
(+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one	DM9AJSU	Investigative	Small molecular drug	[60]
(+/-)-3-(pent-4-enyl)azetidin-2-one	DMWIABE	Investigative	Small molecular drug	[60]
(+/-)-3-allyl-1-pent-4-enoylazetidin-2-one	DMS5AWP	Investigative	Small molecular drug	[60]
(+/-)-3-allylazetidin-2-one	DMK42RU	Investigative	Small molecular drug	[60]
(+/-)-5'-deoxy-4'-fluoro-5'-methylthio-DADMe-ImmH	DMQP5U9	Investigative	Small molecular drug	[61]
(+/-)-5-amino-2-(mercaptomethyl)pentanoic acid	DMSNWA6	Investigative	Small molecular drug	[62]
(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine	DM23W58	Investigative	Small molecular drug	[63]
(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DMKWBY8	Investigative	Small molecular drug	[56]
(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one	DMYHV9P	Investigative	Small molecular drug	[56]
(+/-)-7-fluoro-2-p-tolylchroman-4-one	DM4H1JO	Investigative	Small molecular drug	[56]
(+/-)-7-fluoro-2-phenylchroman-4-one	DMJEBXA	Investigative	Small molecular drug	[56]
(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one	DMYJGDK	Investigative	NA	[56]
(+/-)-7-methoxy-2-p-tolylchroman-4-one	DMJMTVQ	Investigative	Small molecular drug	[56]
(+/-)-7-methoxy-2-phenylchroman-4-one	DMC0OKA	Investigative	NA	[56]
(+/-)-7-methyl-2-p-tolylchroman-4-one	DMBN3WE	Investigative	Small molecular drug	[56]
(+/-)-7-methyl-2-phenylchroman-4-one	DMI3URD	Investigative	Small molecular drug	[56]
(+/-)-cis-2-CAMP	DMY3J0B	Investigative	Small molecular drug	[64]
(+/-)-cis-H2-PAT	DMAHO9M	Investigative	Small molecular drug	[65]
(+/-)-Daedalin A	DMBSH5L	Investigative	Small molecular drug	[66]
(+/-)-nantenine	DM0L3GE	Investigative	NA	[67]
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate	DM8023E	Investigative	Small molecular drug	[68]
(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate	DMI5R3E	Investigative	Small molecular drug	[68]
(+/-)-threo-3',4'-Dichloromethylphenidate amide	DMFSZ8H	Investigative	Small molecular drug	[69]
(+/-)-threo-3',4'-Dichlororitalinol methyl ether	DM5MLZ0	Investigative	Small molecular drug	[69]
(+/-)-threo-3',5'-Dichloromethylphenidate	DM4UQBI	Investigative	Small molecular drug	[69]
(+/-)-threo-3',5'-Dimethylmethylphenidate	DMUWKNX	Investigative	Small molecular drug	[69]
(+/-)-threo-3-Fluororitalinol	DM3O4FI	Investigative	Small molecular drug	[69]
(+/-)-threo-4'-Ethylmethylphenidate	DMU5T28	Investigative	Small molecular drug	[69]
(+/-)-threo-Benzylphenidate	DM9TSW0	Investigative	Small molecular drug	[69]
(+/-)-threo-Methylphenidate amide	DMRZOVP	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Chlorobenzyl)methylphenidate	DM80JOH	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Methylfuran)methylphenidate	DM6CWBO	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Methylpyridine)methylphenidate	DMN6ZX9	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Methylthiopene)methylphenidate	DMWUGSV	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Phenylethyl)methylphenidate	DM2WRED	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(2-Phenylethyl)ritalinol	DM9Y3MT	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Chlorobenzyl)methylphenidate	DMU08WO	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Methylfuran)methylphenidate	DMHPE4L	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Methylpyridine)methylphenidate	DMDMTZK	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Methylthiopene)methylphenidate	DMIJ7PC	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Phenylpropyl)methylphenidate	DMD926H	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(3-Phenylpropyl)ritalinol	DMVP183	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate	DM3HWQY	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate	DMHIKD2	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Methylpyridine)methylphenidate	DM9QIAL	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate	DMB3JY8	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Phenylbutyl)methylphenidate	DMK6IJW	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(4-Phenylbutyl)ritalinol	DMG3FA1	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(5-Phenylpentyl)methylphenidate	DMHNQO9	Investigative	Small molecular drug	[69]
(+/-)-threo-N-(6-Phenylhexyl)methylphenidate	DMG1K5H	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Allylmethylphenidate	DMYNO71	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Benzyl-3',4'-dichlororitalinol	DMOJXCK	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Benzyl-3'-chloromethylphenidate	DM15LE0	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Benzylmethylphenidate amide	DMUACDH	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Methyl-30-methylmethylphenidate	DM6D18M	Investigative	Small molecular drug	[69]
(+/-)-threo-N-Propargylmethylphenidate	DMYE0MZ	Investigative	Small molecular drug	[69]
(+/-)-TRANS-U-50488 METHANESULFONATE	DMM2QOX	Investigative	Small molecular drug	[70]
(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid	DMSN7GJ	Investigative	Small molecular drug	[71]
(-)-(1S,1'R)-O,O-dimethylgrisbine hydrochloride	DM974LP	Investigative	Small molecular drug	[38]
(-)-(R)-efonidipine	DMV6EMN	Investigative	Small molecular drug	[72]
(-)-(S)-BayK8644	DMEA9KH	Investigative	Small molecular drug	[73]
(-)-3,3'-bisdemethylpinoresinol	DMGC7F5	Investigative	Small molecular drug	[40]
(-)-3-(1-Propyl-piperidin-3-yl)-benzonitrile	DME5TIR	Investigative	Small molecular drug	[74]
(-)-3-O-acetylspectaline	DMKRTBM	Investigative	Small molecular drug	[75]
(-)-7-N-methyldibromophakellin	DM396OK	Investigative	Small molecular drug	[76]
(-)-alpha-thujone	DMBTIY7	Investigative	Small molecular drug	[77]
(-)-CATECHINGALLATE	DMZOGSK	Investigative	Small molecular drug	[78]
(-)-Cercosporamide	DMJ249P	Investigative	Small molecular drug	[79]
(-)-clusin	DMPGJE6	Investigative	Small molecular drug	[80]
(-)-cubebin	DM57LVW	Investigative	Small molecular drug	[80]
(-)-cubebinin	DMSTZF9	Investigative	Small molecular drug	[80]
(-)-cubebininolide	DM8Q6I0	Investigative	Small molecular drug	[80]
(-)-cyclorphan	DMC8WS4	Investigative	Small molecular drug	[81]
(-)-DEBROMOFLUSTRAMINE B	DM6LGHU	Investigative	Small molecular drug	[82]
(-)-dihydroclusin	DMNYH3X	Investigative	Small molecular drug	[80]
(-)-Discorhabdin Z	DMWG2ZG	Investigative	Small molecular drug	[83]
(-)-englerin A	DMPQBWY	Investigative	Small molecular drug	[84]
(-)-eseroline	DMJD34Q	Investigative	Small molecular drug	[70]
(-)-HIP-A	DM8WBIQ	Investigative	Small molecular drug	[85]
(-)-huperzine B	DMBO9J3	Investigative	Small molecular drug	[86]
(-)-hydroxycitrate	DMJVNQB	Investigative	Small molecular drug	[87]
(-)-isoelaeocarpiline	DMJS6IZ	Investigative	Small molecular drug	[88]
(-)-norfenfluramine	DMOY9J8	Investigative	Small molecular drug	[89]
(-)-Phenethylcymserine	DMVUEW5	Investigative	Small molecular drug	[90]
(-)-pinoresinol	DM4INSG	Investigative	Small molecular drug	[40]
(-)-Ro 363	DMH6EVM	Investigative	Small molecular drug	[91]
(-)-SNAP-5399	DMFE3YK	Investigative	Small molecular drug	[92]
(-)-thujaplicatintrimethyl ether	DMKWIYP	Investigative	Small molecular drug	[80]
(-)-Tolserine	DMAT58Z	Investigative	Small molecular drug	[90]
(-)-trans-H2-PAT	DMITWZ7	Investigative	Small molecular drug	[93]
(-)-uniflorine A	DMRGVNJ	Investigative	Small molecular drug	[94]
(-)-yatein	DMDHGIR	Investigative	Small molecular drug	[80]
(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone	DMHEYOK	Investigative	Small molecular drug	[95]
(1,1-Difluoro-pentadecyl)-phosphonic acid	DMDK59X	Investigative	Small molecular drug	[96]
(1,2,3,4-Tetrahydro-isoquinolin-3-yl)-methanol	DMF6WHC	Investigative	Small molecular drug	[97]
(1-Amino-2-phenyl-ethyl)-phosphinic acid	DMXD8H1	Investigative	Small molecular drug	[98]
(1-Amino-3-methyl-butyl)-phosphinic acid	DMNUO79	Investigative	Small molecular drug	[98]
(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid	DMJL8QZ	Investigative	Small molecular drug	[98]
(1-Amino-3-phenyl-propyl)-phosphinic acid	DMXD697	Investigative	Small molecular drug	[98]
(1-Amino-ethyl)-phosphinic acid	DMUACZF	Investigative	Small molecular drug	[98]
(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine	DMNIP7J	Investigative	Small molecular drug	[99]
(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine	DM0SCW9	Investigative	Small molecular drug	[99]
(1-Benzyl-2-oxo-ethyl)-carbamic acid benzyl ester	DMWK3RO	Investigative	Small molecular drug	[100]
(1-hydroxy-1-phosphono-heptyl)-phosphonic acid	DM5L8WX	Investigative	Small molecular drug	[101]
(1-Phenethyl-piperidin-4-yl)-phenyl-methanone	DMXY9R5	Investigative	Small molecular drug	[102]
(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine	DMECH9W	Investigative	Small molecular drug	[103]
(1-Phenyl-propyl)-(9-phenyl-9H-purin-6-yl)-amine	DMZU2VG	Investigative	Small molecular drug	[104]
(1-phenylcyclopentyl)methanamine	DM0TUKZ	Investigative	Small molecular drug	[22]
(10H-phenothiazin-10-yl)(m-tolyl)methanone	DM2J9RI	Investigative	Small molecular drug	[105]
(10H-phenothiazin-10-yl)(o-tolyl)methanone	DM8BKTV	Investigative	Small molecular drug	[105]
(10H-phenothiazin-10-yl)(p-tolyl)methanone	DMRQ0ZF	Investigative	Small molecular drug	[105]
(10H-phenothiazin-10-yl)(phenyl)methanone	DMT3GAD	Investigative	Small molecular drug	[105]
(10r)-10-Formyl-5,8,10-Trideazafolic Acid	DMVTLF9	Investigative	Small molecular drug	[12]
(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE	DMTPQ84	Investigative	Small molecular drug	[106]
(11E)-OCTADEC-11-ENOIC ACID	DMZ5YMH	Investigative	Small molecular drug	[107]
(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid	DMSUPVE	Investigative	Small molecular drug	[108]
(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid	DM5ZTXL	Investigative	Small molecular drug	[108]
(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid	DMBY623	Investigative	Small molecular drug	[108]
(12E,20Z,18S)-8-hydroxyvariabilin	DMJNLQ5	Investigative	Small molecular drug	[109]
(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine	DMPKM9B	Investigative	Small molecular drug	[110]
(1H-Imidazol-2-yl)-quinoxalin-6-yl-amine	DMRDHL2	Investigative	Small molecular drug	[110]
(1H-Imidazo[4,5-c]quinolin-4-yl)-phenyl-amine HCl	DM4FSTL	Investigative	Small molecular drug	[111]
(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	DM21CXZ	Investigative	Small molecular drug	[112]
(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	DM94XJ2	Investigative	Small molecular drug	[112]
(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	DM7KDNM	Investigative	Small molecular drug	[112]
(1H-indol-2-yl)(piperazin-1-yl)methanone	DMW15DS	Investigative	Small molecular drug	[113]
(1H-pyrazol-1-yl)(o-tolyl)methanone	DMACN68	Investigative	Small molecular drug	[114]
(1r)-1,2,2-trimethylpropyl (r)-methylphosphinate	DMVE34H	Investigative	Small molecular drug	[22]
(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE	DMCVKTB	Investigative	Small molecular drug	[22]
(1R)-MENTHYL HEXYL PHOSPHONATE GROUP	DMGAJYW	Investigative	Small molecular drug	[22]
(1R,2R)-1,2-diphenylethane-1,2-diamine	DM18E9D	Investigative	Small molecular drug	[115]
(1R,2R)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine	DM5ROS1	Investigative	Small molecular drug	[116]
(1R,2R)-N-Arachidonoylcyclopropanolamide	DMYLPV1	Investigative	Small molecular drug	[117]
(1R,2S)-1,2-diphenylethane-1,2-diamine	DM28D9E	Investigative	Small molecular drug	[115]
(1R,2S)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine	DMZ3DMX	Investigative	Small molecular drug	[116]
(1R,2S)-N-Arachidonoylcyclopropanolamide	DM39AFU	Investigative	Small molecular drug	[117]
(1R,2S)-N-Oleoylcyclopropanolamide	DMITW5P	Investigative	Small molecular drug	[117]
(1R,5R)-30-OXO-19-OXA-2,6,10,12-TETRAAZAHEXACYCLO[18.6.2.1^{2,5}.1^{14,18}.0^{8,12}.0^{23,27}]TRIACONTA-8,10,14(29),15,17,20(28),21,23(27)-OCTAENE-17-CARBONITRILE (STRUCTURAL MIX)	DMUJ7ZE	Investigative	Small molecular drug	[118]
(1S)-MENTHYL HEXYL PHOSPHONATE GROUP	DMJ2WD5	Investigative	Small molecular drug	[22]
(1S,2S)-2-(1H-Imidazol-4-yl)-cyclopentylamine	DMZCS2K	Investigative	Small molecular drug	[116]
(1S,2S)-N-Arachidonoylcyclopropanolamide	DMKA0ON	Investigative	Small molecular drug	[117]
(1S,2S)-N-Oleoylcyclopropanolamide	DMIV2OY	Investigative	Small molecular drug	[117]
(1S,3R)-ACPD	DM5DOAF	Investigative	Small molecular drug	[119]
(2'Z,3'E)-5-Chloro-5'-chloro-indirubin-3'-oxime	DMGXRSZ	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Chloro-5'-fluoro-indirubin-3'-oxime	DM6AUHR	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Chloro-5'-hydroxy-indirubin-3'-oxime	DMD7WGM	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Chloro-5'-methyl-indirubin-3'-oxime	DMZ0V6G	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Fluoro-5'-chloro-indirubin-3'-oxime	DMO7RFL	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Fluoro-5'-fluoro-indirubin-3'-oxime	DMJ4ABD	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Fluoro-5'-hydroxy-indirubin-3'-oxime	DM9LQH1	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Fluoro-5'-methoxy-indirubin-3'-oxime	DMQDH3N	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Fluoro-5'-methyl-indirubin-3'-oxime	DMAS3JC	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Nitro-5'-chloro-indirubin-3'-oxime	DMYLX0U	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Nitro-5'-fluoro-indirubin-3'-oxime	DMXZ2UC	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Nitro-5'-hydroxy-indirubin-3'-oxime	DM0S82C	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Nitro-5'-methoxy-indirubin-3'-oxime	DMLOIUK	Investigative	Small molecular drug	[120]
(2'Z,3'E)-5-Nitro-5'-methyl-indirubin-3'-oxime	DM6BA5L	Investigative	Small molecular drug	[120]
(2'Z,3'E)-7-Azaindirubin-3'-oxime	DMUIOAP	Investigative	Small molecular drug	[121]
(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate	DM2ATRC	Investigative	Small molecular drug	[122]
(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine	DMNGEFS	Investigative	Small molecular drug	[123]
(2,5-Diphenyl-furan-3-yl)-phenyl-methanone	DM97GFB	Investigative	Small molecular drug	[124]
(2,6-Diamino-pyridin-3-yl)-phenyl-methanone	DMWRCM1	Investigative	Small molecular drug	[125]
(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine	DM27TH9	Investigative	Small molecular drug	[110]
(2-(2-chlorophenyl)pyridin-3-yl)methanamine	DMYOTMP	Investigative	Small molecular drug	[115]
(2-(4-chlorobenzyloxy)-5-bromophenyl)methanamine	DMA15WU	Investigative	Small molecular drug	[126]
(2-Amino-4,5-dihydro-thiazol-4-yl)-acetic acid	DMLEZKJ	Investigative	Small molecular drug	[127]
(2-Benzyl-phenyl)-(2-pyrrolidin-1-yl-ethyl)-amine	DMFRPGX	Investigative	Small molecular drug	[128]
(2-biphenyl-3-yl-ethyl)-dimethyl-amine	DMTW0GD	Investigative	Small molecular drug	[129]
(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine	DM8N79M	Investigative	Small molecular drug	[110]
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE	DMZSP7F	Investigative	Small molecular drug	[22]
(2-bromophenyl)difluoromethanesulfonamide	DMFX9H8	Investigative	Small molecular drug	[130]
(2-Butyryloxy-ethyl)-trimethyl-ammonium iodide	DMLTMPC	Investigative	NA	[131]
(2-chloro-6-phenoxyphenyl)methanamine	DMOS864	Investigative	Small molecular drug	[115]
(2-Chloro-9-methyl-9H-purin-6-yl)-phenyl-amine	DMCE1SU	Investigative	Small molecular drug	[104]
(2-Chloro-ethyl)-trimethyl-ammonium chloride	DM6DH15	Investigative	NA	[131]
(2-Ethoxy-ethyl)-trimethyl-ammonium iodide	DMN7XT9	Investigative	NA	[131]
(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide	DMFV76H	Investigative	Small molecular drug	[132]
(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine	DMCHJL1	Investigative	Small molecular drug	[133]
(2-hydroxyphenyl)(4-hydroxyphenyl)methanone	DMEZNXS	Investigative	Small molecular drug	[134]
(2-Indol-1-yl-ethyl)-dimethyl-amine	DM24E08	Investigative	Small molecular drug	[135]
(2-Mercapto-ethyl)-trimethyl-ammonium iodide	DMCJKOQ	Investigative	NA	[131]
(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	DMQWD75	Investigative	Small molecular drug	[136]
(2-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine	DME6MYZ	Investigative	Small molecular drug	[137]
(24E)-3beta-hydroxy-7,24-euphadien-26-oic acid	DM1RYH9	Investigative	Small molecular drug	[138]
(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol	DMPL80G	Investigative	Small molecular drug	[139]
(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	DMKWRFA	Investigative	Small molecular drug	[22]
(2E, 6E)-farnesylbisphosphonate	DM3ST2Y	Investigative	Small molecular drug	[140]
(2E,4S)-4-ammoniopent-2-enoate	DMA9RIS	Investigative	Small molecular drug	[141]
(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	DMQ2XUE	Investigative	Small molecular drug	[22]
(2R)-2-Methyl-4,5-dideoxy	DM3K2TI	Investigative	Small molecular drug	[142]
(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	DMXPQU6	Investigative	Small molecular drug	[143]
(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	DMX0YIV	Investigative	Small molecular drug	[143]
(2R,3R)-iodoreboxetine	DMYRHFI	Investigative	Small molecular drug	[144]
(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine	DMY2FX8	Investigative	Small molecular drug	[145]
(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine	DM260TI	Investigative	Small molecular drug	[145]
(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine	DMKM8E2	Investigative	Small molecular drug	[145]
(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol	DM852Z6	Investigative	NA	[146]
(2R,3S,4S,5R)-2-hexylpiperidine-3,4,5-triol	DMDS8AN	Investigative	Small molecular drug	[147]
(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol	DMIQNX9	Investigative	Small molecular drug	[147]
(2R,3S,4S,5R)-2-propylpiperidine-3,4,5-triol	DM7GI94	Investigative	Small molecular drug	[147]
(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate	DMYW40T	Investigative	Small molecular drug	[148]
(2R,5R)-delta-methyl-alpha-acetylenic putrescine	DMSFXEO	Investigative	Small molecular drug	[149]
(2S)-1-(1H-furo[2,3-g]indazol-1-yl)propan-2-amine	DMIS39C	Investigative	Small molecular drug	[150]
(2S)-1-(5-fluoro-1H-indazol-1-yl)propan-2-amine	DMW4ARM	Investigative	Small molecular drug	[150]
(2S)-1-(6-fluoro-1H-indazol-1-yl)propan-2-amine	DM31SNW	Investigative	Small molecular drug	[150]
(2S)-1-(6-methoxy-1H-indazol-1-yl)propan-2-amine	DMYALON	Investigative	NA	[150]
(2S)-2'-methoxy kurarinone	DMZOX43	Investigative	Small molecular drug	[151]
(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	DMNKEUG	Investigative	Small molecular drug	[22]
(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	DMYBXHF	Investigative	Small molecular drug	[22]
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	DM73TPQ	Investigative	Small molecular drug	[22]
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE	DMMP8TR	Investigative	Small molecular drug	[22]
(2S)-5,7,2',4'-tetrahydroxyflavanone	DMYVBHT	Investigative	Small molecular drug	[152]
(2S)-abyssinone II	DM5V3M1	Investigative	Small molecular drug	[152]
(2S)-aminobutyryl-(R)-pipecolinic acid amide	DMWQK86	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-prolinamide	DMG0QKL	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline (R)-sec-butylamide	DMTFP0Z	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline isobutylamide	DMO5ZEK	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline n-butylamide	DM12Q9O	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline n-pentylamide	DM1DJX2	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline n-propylamide	DM6WXJO	Investigative	Small molecular drug	[153]
(2S)-aminobutyryl-L-proline-(2S)-methylbutylamide	DMEWU6Z	Investigative	Small molecular drug	[153]
(2S)-euchrenone a7	DM6L0KZ	Investigative	Small molecular drug	[152]
(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	DMRCMIT	Investigative	Small molecular drug	[143]
(2s)-Pyrrolidin-2-Ylmethylamine	DMZON3T	Investigative	Small molecular drug	[107]
(2S,1'R,2'S)-2-(2'-phosphonocyclopropyl)glycine	DMLS29E	Investigative	Small molecular drug	[154]
(2S,3R)-2-(benzyloxy)-3-methoxycyclohexanone	DMJE83O	Investigative	Small molecular drug	[155]
(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	DM4JQCR	Investigative	Small molecular drug	[22]
(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol	DMDUI8R	Investigative	Small molecular drug	[156]
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol	DMDUGZS	Investigative	Small molecular drug	[156]
(2S,3S)-iodoreboxetine	DMBEOIQ	Investigative	Small molecular drug	[144]
(2S,4R)-4-(3-Methoxy-3-oxopropyl)glutamic Acid	DMTQF2G	Investigative	Small molecular drug	[157]
(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone	DMNVDLI	Investigative	Small molecular drug	[114]
(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	DMTB41W	Investigative	Small molecular drug	[22]
(3,4-dimethylphenyl)(4-phenoxyphenyl)methanone	DMAF43E	Investigative	Small molecular drug	[158]
(3,5-Dibromo-4-butoxy-phenyl)-acetic acid	DM9PDCA	Investigative	Small molecular drug	[159]
(3,5-Dibromo-4-hexyloxy-phenyl)-acetic acid	DM5GN46	Investigative	Small molecular drug	[159]
(3,5-Dibromo-4-pentyloxy-phenyl)-acetic acid	DMB5KVZ	Investigative	Small molecular drug	[159]
(3-((1H-imidazol-1-yl)methyl)phenyl)methanol	DMBZJT5	Investigative	Small molecular drug	[160]
(3-(2-methylquinolin-7-yl)phenyl)methanol	DMR6JTQ	Investigative	Small molecular drug	[161]
(3-Amino-1-ethyl-propyl)-methyl-phosphinic acid	DMPHCX7	Investigative	Small molecular drug	[37]
(3-Amino-1-hydroxy-propyl)-methyl-phosphinic acid	DM7HF4I	Investigative	Small molecular drug	[37]
(3-amino-5-bromobenzofuran-2-yl)(phenyl)methanone	DMP2G5W	Investigative	Small molecular drug	[162]
(3-Amino-phenyl)-phosphonic acid diphenyl ester	DMDGFS0	Investigative	Small molecular drug	[163]
(3-Amino-propyl)-hexyl-phosphinic acid	DMBJYTD	Investigative	Small molecular drug	[164]
(3-Amino-propyl)-hydroxymethyl-phosphinic acid	DMGFIJV	Investigative	Small molecular drug	[37]
(3-Amino-propyl)-phosphonic acid	DMK3JZS	Investigative	Small molecular drug	[163]
(3-Bromo-phenyl)-(5-nitro-quinazolin-4-yl)-amine	DMHLF2S	Investigative	Small molecular drug	[165]
(3-Bromo-phenyl)-quinazolin-4-yl-amine	DMMIPZ8	Investigative	Small molecular drug	[166]
(3-Bromo-propyl)-trimethyl-ammonium	DMUJ18K	Investigative	Small molecular drug	[131]
(3-Bromobenzoylpyridine)thiosemicarbazone	DMHF01G	Investigative	Small molecular drug	[167]
(3-bromophenyl)(10H-phenothiazin-10-yl)methanone	DMIJH7W	Investigative	Small molecular drug	[105]
(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	DMHODXG	Investigative	Small molecular drug	[22]
(3-Chloro-phenyl)-piperazin-1-yl-methanone	DM7U02R	Investigative	Small molecular drug	[168]
(3-Ethoxy-pyridin-2-yl)-pyridin-2-yl-amine	DMG1KIJ	Investigative	Small molecular drug	[169]
(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine	DM5WJBH	Investigative	Small molecular drug	[137]
(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid	DMPHM23	Investigative	Small molecular drug	[170]
(3-Hydroxy-2-methyl-phenyl)-trimethyl-ammonium	DM08UQF	Investigative	Small molecular drug	[131]
(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid	DMX5CY3	Investigative	Small molecular drug	[170]
(3-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine	DMHED9G	Investigative	Small molecular drug	[137]
(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone	DMT9FZD	Investigative	Small molecular drug	[114]
(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone	DMD4Z6H	Investigative	Small molecular drug	[114]
(3-Phenoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	DMGYAP7	Investigative	Small molecular drug	[136]
(3-Phenyl-propyl)-quinazolin-4-yl-amine	DM1C90Y	Investigative	Small molecular drug	[171]
(3-Tetradecylamino-cyclohexyl)-phosphonic acid	DM6P35D	Investigative	Small molecular drug	[172]
(3-Tetradecylamino-cyclopentyl)-phosphonic acid	DMFMBPT	Investigative	Small molecular drug	[172]
(35)S-labeled oligonucleotide	DM3OPNE	Investigative	Antisense drug	[173]
(3r)-1-Acetyl-3-Methylpiperidine	DM49YTN	Investigative	Small molecular drug	[12]
(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine	DMEUBGY	Investigative	Small molecular drug	[174]
(3R,4S)-293B	DM47BEG	Investigative	Small molecular drug	[175]
(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol	DMET6IS	Investigative	Small molecular drug	[176]
(3S,4R)-3-butyl-1-phenylpiperidin-4-amine	DMAEXO3	Investigative	Small molecular drug	[177]
(3Z)-1H-indole-2,3-dione 3-thiosemicarbazone	DMI9N8G	Investigative	Small molecular drug	[178]
(4-((1H-imidazol-1-yl)methyl)phenyl)methanol	DMWS35F	Investigative	Small molecular drug	[160]
(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol	DMUOFW8	Investigative	Small molecular drug	[179]
(4-(thiophen-2-yl)phenyl)methanamine	DMV2CKN	Investigative	Small molecular drug	[22]
(4-benzhydrylpiperazin-1-yl)(cyclohexyl)methanone	DM1XY7C	Investigative	Small molecular drug	[180]
(4-benzylpiperidin-1-yl)(2-fluorophenyl)methanone	DMGVDEL	Investigative	Small molecular drug	[181]
(4-benzylpiperidin-1-yl)(3-chlorophenyl)methanone	DMEQZ5M	Investigative	Small molecular drug	[181]
(4-benzylpiperidin-1-yl)(m-tolyl)methanone	DMS16CO	Investigative	Small molecular drug	[181]
(4-benzylpiperidin-1-yl)(p-tolyl)methanone	DMJ81M3	Investigative	Small molecular drug	[22]
(4-bromo-1H-pyrazol-1-yl)(m-tolyl)methanone	DMS9125	Investigative	Small molecular drug	[114]
(4-bromo-1H-pyrazol-1-yl)(o-tolyl)methanone	DM5QDK9	Investigative	Small molecular drug	[114]
(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone	DM31OSD	Investigative	Small molecular drug	[114]
(4-Bromo-butyl)-trimethyl-ammonium	DMU1HFM	Investigative	Small molecular drug	[131]
(4-bromophenyl)(10H-phenothiazin-10-yl)methanone	DMLAEPF	Investigative	Small molecular drug	[105]
(4-bromophenyl)difluoromethanesulfonamide	DMOCYZJ	Investigative	Small molecular drug	[130]
(4-chloro-1H-pyrazol-1-yl)(o-tolyl)methanone	DM4MAZ1	Investigative	Small molecular drug	[114]
(4-Dipropylamino-cyclohexylidene)-acetonitrile	DMRIWH2	Investigative	Small molecular drug	[182]
(4-Ethynyl-cyclohex-3-enyl)-dipropyl-amine	DMHQCRU	Investigative	NA	[182]
(4-Fluoro-phenyl)-(9-methyl-9H-purin-6-yl)-amine	DMYAJQU	Investigative	Small molecular drug	[183]
(4-Fluoro-phenyl)-(9H-purin-6-yl)-amine	DM75EAT	Investigative	Small molecular drug	[183]
(4-fluorophenyl)(pyridin-4-yl)methanone	DMOS68D	Investigative	Small molecular drug	[22]
(4-guanidino-benzyl)-carbamic acid benzyl ester	DM0KXP1	Investigative	Small molecular drug	[184]
(4-hexylphenyl)(oxiran-2-yl)methanone	DM1WZXL	Investigative	Small molecular drug	[185]
(4-Hydroxy-phenoxy)-acetic acid	DMRCM5O	Investigative	Small molecular drug	[186]
(4-Iodo-butyl)-trimethyl-ammonium iodide	DMOWFE5	Investigative	NA	[131]
(4-methoxyphenyl)(4-phenylazepan-1-yl)methanone	DMZD0KG	Investigative	Small molecular drug	[187]
(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid	DMPU7KE	Investigative	Small molecular drug	[188]
(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone	DMBPL3J	Investigative	Small molecular drug	[114]
(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone	DMIDUO9	Investigative	Small molecular drug	[114]
(4-nitrophenyl)(10H-phenothiazin-10-yl)methanone	DM1YC0B	Investigative	Small molecular drug	[105]
(4-Phenoxy-phenyl)-quinazolin-4-yl-amine	DMFO8DR	Investigative	Small molecular drug	[189]
(4-Phenylethynyl-cyclohex-3-enyl)-dipropyl-amine	DMQM8O5	Investigative	Small molecular drug	[182]
(4-phenylpiperazin-1-yl)(p-tolyl)methanone	DM0NTA3	Investigative	Small molecular drug	[181]
(4-Quinolin-2-ylpiperazin-1-yl)acetic Acid	DMKF3U6	Investigative	Small molecular drug	[190]
(4-sulfamoylphenylethylthioureido)fluorescein	DMGCZOI	Investigative	Small molecular drug	[191]
(4e)-4-Aminohex-4-Enoic Acid	DMG27K1	Investigative	Small molecular drug	[12]
(4R)-4-ammoniopentanoate	DMZFTI4	Investigative	Small molecular drug	[141]
(4S)-4-ammoniopentanoate	DMBLAY1	Investigative	Small molecular drug	[141]
(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine	DMM6QV5	Investigative	Small molecular drug	[192]
(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine	DM0V9HB	Investigative	Small molecular drug	[192]
(4S,5R)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine	DMDC84U	Investigative	Small molecular drug	[192]
(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine	DM1VJUZ	Investigative	Small molecular drug	[192]
(4S,5S)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine	DM5EKF4	Investigative	Small molecular drug	[192]
(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol	DM15P2G	Investigative	Small molecular drug	[193]
(5-(pyridin-3-yl)furan-2-yl)methanamine	DMTC5VF	Investigative	Small molecular drug	[194]
(5-amino-1-phenyl-1H-pyrazol-4-yl)phenylmethanone	DMF0YJ3	Investigative	Small molecular drug	[195]
(5-Bromo-pentyl)-trimethyl-ammonium	DM4EH2J	Investigative	Small molecular drug	[131]
(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	DMIV4BU	Investigative	Small molecular drug	[112]
(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	DMPBNYM	Investigative	Small molecular drug	[112]
(5-Imino-[1,4]thiazepan-3-yl)-methanol	DMBKZDJ	Investigative	Small molecular drug	[196]
(5-methoxy-1H-indol-3-yl)methanamine	DMOPMNC	Investigative	Small molecular drug	[197]
(5-Methoxy-chroman-3-yl)-dipropyl-amine	DM4FJHO	Investigative	Small molecular drug	[198]
(5-phenyl-3H-benzo[d]imidazol-4-yl)methanamine	DM2HCUK	Investigative	Small molecular drug	[199]
(5-Phenyl-oxazol-2-yl)-m-tolyl-amine	DM1R5SF	Investigative	Small molecular drug	[136]
(5-phenylfuran-2-yl)methanamine	DMORD8S	Investigative	Small molecular drug	[194]
(5-pyridin-3-yl-furan-2-yl)methanethiol	DMKC2BE	Investigative	Small molecular drug	[194]
(5BETA)-PREGNANE-3,20-DIONE	DMVQ6RN	Investigative	Small molecular drug	[200]
(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenal	DM8JHWS	Investigative	Small molecular drug	[201]
(5R,6S)-5,6-bis(benzyloxy)cyclohex-2-enone	DMREVX9	Investigative	Small molecular drug	[155]
(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone	DMHG7MU	Investigative	Small molecular drug	[155]
(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	DMA5DO2	Investigative	Small molecular drug	[12]
(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine	DMT9CXD	Investigative	Small molecular drug	[202]
(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine	DMP4UC1	Investigative	Small molecular drug	[202]
(5Z,9Z)-5,9-heptacosadienoic acid	DMA97CS	Investigative	Small molecular drug	[203]
(6-Benzylamino-9H-beta-carbolin-3-yl)-methanol	DMAXS9H	Investigative	Small molecular drug	[204]
(6-Benzyloxy-2-naphthyl)-2-aminopropane	DMF7LST	Investigative	Small molecular drug	[205]
(6-Butoxy-2-naphthyl)-2-aminopropane	DM7BK9A	Investigative	Small molecular drug	[205]
(6-Ethoxy-2-naphthyl)-2-aminopropane	DMM2EX6	Investigative	Small molecular drug	[205]
(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	DMQJ5RU	Investigative	Small molecular drug	[188]
(6-Methoxy-2-naphthyl)-2-aminopropane	DM6YGQ3	Investigative	Small molecular drug	[205]
(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid	DMTYXFU	Investigative	Small molecular drug	[188]
(6-methylthio-2-naphthyl)isopropylamine	DM39W5K	Investigative	Small molecular drug	[205]
(6-Propoxy-2-naphthyl)-2-aminopropane	DMIFL3V	Investigative	Small molecular drug	[205]
(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	DMOD9R7	Investigative	Small molecular drug	[12]
(6s)-5,6,7,8-Tetrahydrofolate	DMRAC6T	Investigative	Small molecular drug	[12]
(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	DMB9YAO	Investigative	Small molecular drug	[206]
(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	DMRU0IB	Investigative	Small molecular drug	[188]
(8R,8'R)-4-hydroxycubebinone	DM1UGQN	Investigative	Small molecular drug	[80]
(8R,8'R,9'S)-5-methoxyclusin	DMVIHTF	Investigative	Small molecular drug	[80]
(9-Benzyl-9H-purin-6-yl)-cyclopropyl-amine	DMHJG5N	Investigative	Small molecular drug	[207]
(9-Methyl-9H-purin-6-yl)-phenyl-amine	DMWJNFC	Investigative	Small molecular drug	[104]
(9H-beta-Carbolin-3-yl)-carbamic acid ethyl ester	DMKI2Y9	Investigative	Small molecular drug	[208]
(9H-beta-Carbolin-3-yl)-ethyl-amine	DMVHMPC	Investigative	Small molecular drug	[208]
(9H-beta-Carbolin-3-yl)-methanol	DMUF16A	Investigative	Small molecular drug	[204]
(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	DM12GHQ	Investigative	Small molecular drug	[22]
(9Z,12E)-12-nitrooctadeca-9,12-dienoic acid	DM2REIN	Investigative	Small molecular drug	[209]
(Amino-phenyl-methyl)-phosphinic acid	DMS4ZVK	Investigative	Small molecular drug	[98]
(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone	DME80RK	Investigative	Small molecular drug	[210]
(beta-CCE)9H-beta-Carboline-3-carboxylic acid	DMVWQ26	Investigative	Small molecular drug	[211]
(biphenyl-3-ylamino)methylenediphosphonic acid	DMGB97I	Investigative	Small molecular drug	[212]
(C8-R)-Hydantocidin 5'-Phosphate	DM5WH6R	Investigative	Small molecular drug	[12]
(C8-S)-Hydantocidin 5'-Phosphate	DMMH179	Investigative	Small molecular drug	[12]
(Carboxyhydroxyamino)Ethanoic Acid	DMZB0C3	Investigative	Small molecular drug	[12]
(CH3)CCO-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2	DMD0P4G	Investigative	NA	[213]
(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane	DMMC139	Investigative	Small molecular drug	[214]
(D)-Ala-Pro-Glu	DMGXTSB	Investigative	Small molecular drug	[215]
(D)-Phe-(D)-Phe-NH2	DM5ZIUW	Investigative	Small molecular drug	[216]
(D)-Phe-(L)-Phe-NH2	DMS32YA	Investigative	Small molecular drug	[216]
(D)Arg-Arg-Pro-Hyp-Gly-Phe-Ser-(d)Phe-Phe-Arg	DMWE42T	Investigative	NA	[217]
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Cys-(D)Phe-Phe-Cys-Arg	DMYSE3O	Investigative	NA	[217]
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Aoc-Arg	DMLSJKM	Investigative	NA	[217]
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Tic-Arg	DMP0627	Investigative	NA	[217]
(D)Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2	DMQN14X	Investigative	NA	[218]
(D-Arg)(9)-p19(ARF) 26-44 peptide	DMI39LV	Investigative	NA	[219]
(E)-(thiophen-2-ylmethylidene)amino benzoate	DMHSJAT	Investigative	Small molecular drug	[220]
(E)-1-(4-heptylphenyl)but-2-en-1-one	DMBXK5L	Investigative	Small molecular drug	[185]
(E)-1-(4-Nitro-phenyl)-3-pyridin-2-yl-propenone	DMEP903	Investigative	Small molecular drug	[221]
(E)-1-Adamantan-1-yl-3-quinolin-3-yl-propenone	DMQ9TWD	Investigative	Small molecular drug	[158]
(E)-10-Nitrohexadec-9-enoic Acid	DMO38CP	Investigative	Small molecular drug	[209]
(E)-10-nitrooctadec-9-enoic acid	DMTF7JA	Investigative	Small molecular drug	[209]
(E)-12-Nitrooctadec-12-enoic Acid	DMBQTZL	Investigative	Small molecular drug	[209]
(E)-13-Nitrooctadec-12-enoic Acid	DMF74GJ	Investigative	Small molecular drug	[209]
(E)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid	DMI146O	Investigative	Small molecular drug	[222]
(E)-2-(4-(methylsulfonyl)styryl)furan	DMH2U4Z	Investigative	Small molecular drug	[223]
(E)-2-(4-(methylsulfonyl)styryl)thiophene	DMDFE1R	Investigative	Small molecular drug	[223]
(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine	DMTJI4F	Investigative	Small molecular drug	[224]
(E)-2-(4-fluorostyryl)-5-(phenylsulfonyl)pyridine	DM7P5VM	Investigative	Small molecular drug	[224]
(E)-3-(2,3-dichlorophenylimino)indolin-2-one	DM1LG27	Investigative	Small molecular drug	[225]
(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid	DMOWGT3	Investigative	Small molecular drug	[170]
(E)-3-(4-(methylsulfonyl)styryl)thiophene	DMUS0D8	Investigative	Small molecular drug	[223]
(E)-3-(4-chlorophenylimino)indolin-2-one	DMPOYK2	Investigative	Small molecular drug	[225]
(E)-3-(4-hydroxybenzylidene)indolin-2-one	DMX4U9L	Investigative	Small molecular drug	[226]
(E)-3-(4-tert-Butyl-phenyl)-N-phenyl-acrylamide	DMTKCAL	Investigative	Small molecular drug	[227]
(E)-3-[2-(2-methyl-4-thiazolyl)vinyl]pyridine	DMITXKJ	Investigative	Small molecular drug	[228]
(E)-4,4-Dimethyl-1-quinolin-3-yl-pent-1-en-3-one	DMJGAFV	Investigative	Small molecular drug	[158]
(E)-4-(2-(furan-2-yl)vinyl)benzenesulfonamide	DMDF7M4	Investigative	Small molecular drug	[223]
(E)-4-(2-(thiophen-2-yl)vinyl)benzenesulfonamide	DM7204O	Investigative	Small molecular drug	[223]
(E)-4-(2-(thiophen-3-yl)vinyl)benzenesulfonamide	DMTAB8W	Investigative	Small molecular drug	[223]
(E)-4-(3,5-dimethoxystyryl)phenol	DMYXI2V	Investigative	Small molecular drug	[229]
(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine	DM75OHG	Investigative	Small molecular drug	[230]
(E)-5-(3-Chlorostyryl)isatin	DMLIQUA	Investigative	Small molecular drug	[231]
(E)-5-(3-Fluorostyryl)isatin	DMP4T9Z	Investigative	Small molecular drug	[231]
(E)-5-(4-Hydroxybenzylidene)-1-phenethylhydantoin	DM81JRF	Investigative	Small molecular drug	[232]
(E)-5-Nitrooctadec-5-enoic Acid	DMJKOFW	Investigative	Small molecular drug	[209]
(E)-5-octadecen-7,9-diynoic acid	DMIPY3W	Investigative	Small molecular drug	[233]
(E)-5-Styrylisatin	DM1PCIX	Investigative	Small molecular drug	[231]
(E)-6-Nitrooctadec-5-enoic Acid	DMACVNM	Investigative	Small molecular drug	[209]
(E)-6-Styrylisatin	DMG47QU	Investigative	Small molecular drug	[231]
(E)-8-(3-chlorostyryl)-caffeine	DMQT15Z	Investigative	Small molecular drug	[234]
(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one	DM5LSY9	Investigative	Small molecular drug	[235]
(E)-9-Nitrohexadec-9-enoicAcid	DMULW35	Investigative	Small molecular drug	[209]
(E)-9-nitrooctadec-9-enoic acid	DMWC2F9	Investigative	Small molecular drug	[209]
(E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide	DM9WHD2	Investigative	Small molecular drug	[236]
(E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n	DMW3RJL	Investigative	NA	[237]
(E)-N-(4-methoxyphenethyl)undec-2-enamide	DML6PJD	Investigative	Small molecular drug	[236]
(E)-N-(4-methoxyphenyl)undec-2-enamide	DM1PCEM	Investigative	Small molecular drug	[236]
(E)-N-(4-Phenylthiazol-2-yl) cinnamamide	DM7XIH3	Investigative	Small molecular drug	[238]
(E)-N-(6-(prop-1-enyl)-1H-indazol-3-yl)butyramide	DMHKXPM	Investigative	Small molecular drug	[239]
(E)-Octadec-9-enal	DMXYAIQ	Investigative	Small molecular drug	[201]
(E)-Octadec-9-enoic acid phenylamide	DMP7TK0	Investigative	Small molecular drug	[240]
(E)-octadecan-9-ynoic acid	DMBLGF6	Investigative	Small molecular drug	[233]
(E,E)-1,7-Diphenyl-4,6-heptadien-3-one	DMWU17O	Investigative	Small molecular drug	[241]
(E,E)-5-Hydroxy-1,7-diphenyl-4,6-heptadien-3-one	DMBIV6M	Investigative	Small molecular drug	[241]
(E,E)-8-(4-Phenylbutadien-1-yl)caffeine	DMPIUKZ	Investigative	Small molecular drug	[242]
(E,E)-8-[4-(3-Bromophenyl)butadien-1-yl]caffeine	DMPEV7S	Investigative	Small molecular drug	[242]
(E,E)-8-[4-(3-Chlorophenyl)butadien-1-yl]caffeine	DMY4W25	Investigative	Small molecular drug	[242]
(E,E)-8-[4-(3-Fluorophenyl)butadien-1-yl]caffeine	DMPHJO2	Investigative	Small molecular drug	[242]
(H-261)Boc-His-Pro-Phe-His-Leu(OH)-Val-Ile-His-OH	DMVKJ0H	Investigative	NA	[243]
(H-Dmt-Tic-Glu-NH-(CH(2))(5)-CO-Dap(6DMN)-NH(2)	DMSCQ64	Investigative	Small molecular drug	[244]
(Hydroxyethyloxy)Tri(Ethyloxy)Octane	DMY6FUD	Investigative	Small molecular drug	[12]
(hydroxymethylphenyl)agomelatine	DMOJUEC	Investigative	Small molecular drug	[245]
(L)-Phe-(D)-Phe-NH2	DMP9ZVQ	Investigative	Small molecular drug	[216]
(L-)-S-adenosyl-L-homocysteine	DMDUN83	Investigative	Small molecular drug	[12]
(LTB4-(Csa)4)2-Glu-H Conjugate	DMRGIF3	Investigative	NA	[246]
(N)methanocarba-UTP	DM6SV7I	Investigative	Small molecular drug	[247]
(N-(3-phenoxycinnamyl)-acetohydroxamic acid	DM9ATZ8	Investigative	Small molecular drug	[248]
(O10eq)-Benzyloxycarbonyl-beta-alanylryanodine	DMPYK1T	Investigative	Small molecular drug	[249]
(O10eq)-beta-alanyl-anhydro-ryanodine	DMRSZGB	Investigative	Small molecular drug	[249]
(O10eq)-beta-alanylryanodine	DMVGARN	Investigative	Small molecular drug	[249]
(O10eq)-beta-guanidinopropionylryanodine	DMSV8XM	Investigative	Small molecular drug	[249]
(O10eq)-guanidino acetylryanodine	DM97W5T	Investigative	Small molecular drug	[249]
(P-Iodophenylacetylamino)Methylphosphinic Acid	DMB8NWI	Investigative	Small molecular drug	[12]
(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DM5UOFY	Investigative	Small molecular drug	[56]
(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DM6WTLZ	Investigative	Small molecular drug	[56]
(R)(+)-7-fluoro-2-p-tolylchroman-4-one	DMHNKWR	Investigative	Small molecular drug	[56]
(R)(+)-7-fluoro-2-phenylchroman-4-one	DMJCN0Y	Investigative	Small molecular drug	[56]
(R)(+)-7-methyl-2-p-tolylchroman-4-one	DMVN50D	Investigative	Small molecular drug	[56]
(R)(+)-7-methyl-2-phenylchroman-4-one	DM8ZHYR	Investigative	Small molecular drug	[56]
(R)-(+)-(4,5,6-trimethoxyindan-1-yl)methanamine	DM9DBHU	Investigative	Small molecular drug	[250]
(R)-(+)-coclaurine	DM7C148	Investigative	Small molecular drug	[251]
(R)-(-)-10-methyl-11-hydroxyaporphine	DMYJAM5	Investigative	Small molecular drug	[252]
(R)-(-)-11-hydroxy-N-n-propylnoraporphine	DMKB621	Investigative	NA	[253]
(R)-(-)-2-methoxy-11-hydroxyaporphine	DMQ2INJ	Investigative	Small molecular drug	[253]
(R)-(-)-2-methoxy-N-npropylnorapomorphine	DMLXB62	Investigative	Small molecular drug	[253]
(R)-(-)-2-Methyl-apomorphine hydrochloride	DMAYEJL	Investigative	Small molecular drug	[254]
(R)-(-)-2-Phenyl-apomorphine hydrochloride	DME62U0	Investigative	Small molecular drug	[254]
(R)-(-)-N-ethyl-2-methoxy-11-hydroxynoraporphine	DMPSEZV	Investigative	Small molecular drug	[253]
(R)-(-)-N-propyl-2-methoxy-11-hydroxynoraporphine	DM48SML	Investigative	Small molecular drug	[253]
(R)-1-((S)-morpholin-2-yl)-1,2-diphenylethanol	DMBXRKS	Investigative	Small molecular drug	[255]
(R)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea	DMYBC24	Investigative	Small molecular drug	[256]
(R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid	DMGD026	Investigative	Small molecular drug	[257]
(R)-1-(2-methoxyphenethyl)-2-methylpyrrolidine	DMMY0NF	Investigative	Small molecular drug	[258]
(R)-1-(3-methoxyphenethyl)-2-methylpyrrolidine	DM76SZK	Investigative	Small molecular drug	[258]
(R)-1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine	DMDC297	Investigative	Small molecular drug	[259]
(R)-1-(4-methoxyphenethyl)-2-methylpyrrolidine	DMR3DSG	Investigative	Small molecular drug	[258]
(R)-1-(4-nitrophenethyl)-2-methylpyrrolidine	DMNROUV	Investigative	Small molecular drug	[258]
(R)-11-Amino-2-methoxyaporphine	DMKJWMC	Investigative	Small molecular drug	[260]
(R)-2,11-Diaminoaporphine	DM70ZIF	Investigative	Small molecular drug	[260]
(R)-2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol	DMRO9C7	Investigative	Small molecular drug	[261]
(R)-2-((4-benzylphenoxy)methyl)piperidine	DMXUHV3	Investigative	Small molecular drug	[262]
(R)-2-((4-phenoxyphenoxy)methyl)piperidine	DM6KJ3D	Investigative	Small molecular drug	[262]
(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol	DMFDW4C	Investigative	Small molecular drug	[258]
(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	DM0L6ES	Investigative	Small molecular drug	[258]
(R)-2-(2-naphthamido)-3-m-tolylpropanoic acid	DMVEMNA	Investigative	Small molecular drug	[263]
(R)-2-(2-naphthamido)-3-p-tolylpropanoic acid	DMXGCYZ	Investigative	Small molecular drug	[263]
(R)-2-(2-naphthamido)-5-phenylpent-4-ynoic acid	DM9WL6O	Investigative	Small molecular drug	[263]
(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol	DM74IWX	Investigative	Small molecular drug	[264]
(R)-2-(4-Benzylphenoxymethyl)pyrrolidine	DM1GCV3	Investigative	Small molecular drug	[265]
(R)-2-(4-Isobutyl-phenyl)-N-methoxy-propionamide	DMR8E0G	Investigative	Small molecular drug	[266]
(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide	DMAD4JY	Investigative	Small molecular drug	[266]
(R)-2-(4-Isobutyl-phenyl)-propionamide	DMBQ0PR	Investigative	Small molecular drug	[266]
(R)-2-(Benzylamino-methyl)-chroman-7-ol	DMJVQN8	Investigative	Small molecular drug	[267]
(R)-2-(biphenyl-4-sulfonylamino)-propionic acid	DM16JFS	Investigative	Small molecular drug	[268]
(R)-2-amino-3-(4-octylphenylamino)propan-1-ol	DMZXT34	Investigative	Small molecular drug	[269]
(R)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide	DMA1EFL	Investigative	Small molecular drug	[269]
(R)-2-Amino-5-phosphono-pentanoic acid	DMSY4CK	Investigative	Small molecular drug	[270]
(R)-2-Amino-7-phosphono-heptanoic acid	DM4XEHR	Investigative	Small molecular drug	[270]
(R)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine	DMT8HP1	Investigative	Small molecular drug	[258]
(R)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine	DMA1FUH	Investigative	Small molecular drug	[258]
(R)-3-(1'-Adamantanecarbonyl)amino-caprolactam	DMRZDM0	Investigative	Small molecular drug	[271]
(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate	DMCSHI3	Investigative	Small molecular drug	[272]
(R)-3-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	DMUFP7W	Investigative	Small molecular drug	[258]
(R)-3-(2-naphthamido)-4-m-tolylbutanoic acid	DM5TH2W	Investigative	Small molecular drug	[263]
(R)-3-(4-Isobutyl-phenyl)-butan-2-one	DMQ2KF8	Investigative	Small molecular drug	[266]
(R)-3-(4-propylmorpholin-2-yl)phenol	DMC73DY	Investigative	Small molecular drug	[273]
(R)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DM2DVNT	Investigative	Small molecular drug	[274]
(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine	DM94B12	Investigative	Small molecular drug	[59]
(R)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline	DM98L2X	Investigative	Small molecular drug	[275]
(R)-3-Prop-2-ynylamino-indan-5-ol	DMPEV2W	Investigative	Small molecular drug	[22]
(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	DM1Y9MZ	Investigative	Small molecular drug	[196]
(R)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	DM5CL8B	Investigative	Small molecular drug	[258]
(R)-4-amino-2-methylbutanoic acid	DM3F56O	Investigative	Small molecular drug	[276]
(R)-4-[2-[3-(4-methoxy-benzoylamino)-benzyl]-piperidin-1-ylmethyl]piperidine-1-carboxylic acid amide (Ro-320-6206)	DMRVOLN	Investigative	NA	[277]
(R)-5-Amino-3-(4-chloro-phenyl)-pentanoic acid	DMW87OE	Investigative	Small molecular drug	[278]
(R)-5-diphosphomevalonate	DMOESL1	Investigative	Small molecular drug	[279]
(R)-5-phosphomevalonate	DMFGMM2	Investigative	Small molecular drug	[280]
(R)-6-(2-(2-methylpyrrolidin-1-yl)ethyl)quinoline	DM3LQFK	Investigative	Small molecular drug	[281]
(R)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile	DM134UV	Investigative	Small molecular drug	[59]
(R)-8-phenyl-N,N-dipropylchroman-3-amine	DMCY76E	Investigative	Small molecular drug	[282]
(R)-alpha-methylhistamine	DMKAW4P	Investigative	Small molecular drug	[283]
(R)-DULOXETINE	DMECK7H	Investigative	Small molecular drug	[284]
(R)-EF-1520	DM297MU	Investigative	Small molecular drug	[285]
(R)-flurocarazolol	DM2KBOU	Investigative	Small molecular drug	[286]
(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	DMKFPMC	Investigative	NA	[287]
(R)-Mevalonate	DMEXLUR	Investigative	Small molecular drug	[288]
(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline	DMM8TE0	Investigative	Small molecular drug	[22]
(R)-N-Hydroxy-2-(4-isobutyl-phenyl)-propionamide	DMWRIQG	Investigative	Small molecular drug	[266]
(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide	DMJFH97	Investigative	Small molecular drug	[289]
(R)-N-isopropyl-N-(pyrrolidin-3-yl)-2-naphthamide	DMQIUOB	Investigative	Small molecular drug	[289]
(R)-N-oleoyltyrosinol	DMIHR14	Investigative	Small molecular drug	[290]
(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	DMPKWIN	Investigative	Small molecular drug	[291]
(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	DMEVM6G	Investigative	Small molecular drug	[291]
(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide	DMU49JN	Investigative	Small molecular drug	[291]
(R)-nipecotic acid	DMWGB40	Investigative	Small molecular drug	[292]
(R)-Norfluoxetine	DMS30KU	Investigative	Small molecular drug	[293]
(R)-ONDANSETRON	DMCYD8Q	Investigative	Small molecular drug	[294]
(R)-Rolipram	DM95Z4Q	Investigative	Small molecular drug	[295]
(R)-sirtinol	DMV1IS8	Investigative	Small molecular drug	[296]
(R)-tacrine(10)-hupyridone	DMSFA2D	Investigative	Small molecular drug	[22]
(R)-zacopride	DMT6J51	Investigative	Small molecular drug	[297]
(R)PK-11195	DM03N5V	Investigative	Small molecular drug	[298]
(R,)-2-(2-naphthamido)-5-phenylpent-4-enoic acid	DMCW5A9	Investigative	Small molecular drug	[263]
(R,R)-(-)-fenoterol	DM3FQYS	Investigative	Small molecular drug	[299]
(R,S)-(-)-fenoterol	DMETQBI	Investigative	Small molecular drug	[299]
(R,S)-1-(5-bromo-1H-indol-1-yl)propan-2-amine	DMKZ4C6	Investigative	Small molecular drug	[300]
(R,S)-1-(5-chloro-1H-indol-1-yl)propan-2-amine	DMTZDAJ	Investigative	Small molecular drug	[300]
(R,S)-1-(5-fluoro-1H-indol-1-yl)propan-2-amine	DMAU1M5	Investigative	Small molecular drug	[300]
(R,S)-1-(5-methyl-1H-indol-1-yl)propan-2-amine	DMS2DI9	Investigative	Small molecular drug	[300]
(R,S)-1-(6-fluoro-1H-indol-1-yl)propan-2-amine	DM0YELX	Investigative	Small molecular drug	[300]
(R,S)-4-phosphonophenylglycine	DM7COSH	Investigative	Small molecular drug	[301]
(R,S)-homoaromaline hydrochloride	DMUG451	Investigative	Small molecular drug	[38]
(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide	DMPDO43	Investigative	Small molecular drug	[302]
(R,S)-PHPNECA	DMQO71C	Investigative	Small molecular drug	[303]
(R/R)BEFLOXATONE	DM8I6MG	Investigative	Small molecular drug	[304]
(R/S) EF-1500	DMYDG27	Investigative	Small molecular drug	[305]
(R/S)-2-((4-benzylphenoxy)methyl)piperazine	DM3MEQB	Investigative	Small molecular drug	[262]
(R/S)-2-((4-benzylphenoxy)methyl)piperidine	DMRXD82	Investigative	Small molecular drug	[262]
(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine	DMDA285	Investigative	Small molecular drug	[262]
(RS)-(tetrazol-5-yl)glycine	DMYZCRF	Investigative	Small molecular drug	[306]
(RS)-5-diphosphomevalonate	DMCPEBF	Investigative	Small molecular drug	[307]
(RS)-mevalonate	DMLQJQ5	Investigative	Small molecular drug	[308]
(RS)-PPCC	DMA8DEG	Investigative	Small molecular drug	[309]
(RS)-tacrine(10)-hupyridone	DMCN6WR	Investigative	Small molecular drug	[86]
(RS/SR)-2-[1-(3,4-dichlorophenyl)butyl]piperidine	DM6EYQ2	Investigative	Small molecular drug	[310]
(RS/SR)-2-[1-(4-chlorophenyl)butyl]piperidine	DMGHWJ5	Investigative	Small molecular drug	[310]
(RS/SR)-2-[1-(4-chlorophenyl)ethyl]piperidine	DMAIGM2	Investigative	Small molecular drug	[310]
(RS/SR)-2-[1-(4-chlorophenyl)hexyl]piperidine	DMDVMSP	Investigative	Small molecular drug	[310]
(RS/SR)-2-[1-(4-chlorophenyl)pentyl]piperidine	DMMUV7R	Investigative	Small molecular drug	[310]
(RS/SR)-2-[1-(4-chlorophenyl)propyl]piperidine	DMPQAGL	Investigative	Small molecular drug	[310]
(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	DMC5Z2I	Investigative	Small molecular drug	[56]
(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	DMILWE7	Investigative	Small molecular drug	[56]
(S)(+)-7-fluoro-2-p-tolylchroman-4-one	DMTFZBQ	Investigative	Small molecular drug	[56]
(S)(+)-7-fluoro-2-phenylchroman-4-one	DMHR1IB	Investigative	Small molecular drug	[56]
(S)(+)-7-methyl-2-p-tolylchroman-4-one	DMVBD6H	Investigative	Small molecular drug	[56]
(S)(+)-7-methyl-2-phenylchroman-4-one	DMBG4KN	Investigative	Small molecular drug	[56]
(S)-(+)-CBPG	DMPDOY8	Investigative	Small molecular drug	[311]
(S)-(-)-(4,5,6-trimethoxyindan-1-yl)methanamine	DMUNQY7	Investigative	Small molecular drug	[250]
(S)-1,7-Diphenyl-6(E)-hepten-3-ol	DM1U7MC	Investigative	Small molecular drug	[241]
(S)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea	DMF2IY8	Investigative	Small molecular drug	[256]
(S)-1-(2-methoxyphenethyl)-2-methylpyrrolidine	DMF9YLR	Investigative	Small molecular drug	[258]
(S)-1-(3-methoxyphenethyl)-2-methylpyrrolidine	DM8UWT9	Investigative	Small molecular drug	[258]
(S)-1-(4-methoxyphenethyl)-2-methylpyrrolidine	DMDBHY1	Investigative	Small molecular drug	[258]
(S)-1-(4-nitrophenethyl)-2-methylpyrrolidine	DMG7XL5	Investigative	Small molecular drug	[258]
(S)-1-(5,6-difluoro-1H-indol-1-yl)propan-2-amine	DMEIB8F	Investigative	Small molecular drug	[300]
(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate	DMICUQK	Investigative	Small molecular drug	[312]
(S)-2,3-epoxysqualene	DMWL97T	Investigative	Small molecular drug	[313]
(S)-2-((4-phenoxyphenoxy)methyl)piperidine	DM2VOAS	Investigative	Small molecular drug	[262]
(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol	DMQGCKX	Investigative	Small molecular drug	[258]
(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	DMVKL84	Investigative	Small molecular drug	[258]
(S)-2-amino-1-(4-butylthiophenyl)-propane	DMPQ53V	Investigative	Small molecular drug	[314]
(S)-2-amino-1-(4-ethylthiophenyl)-propane	DMFK7O1	Investigative	Small molecular drug	[314]
(S)-2-amino-1-(4-methylthiophenyl)-propane	DM06NUM	Investigative	Small molecular drug	[314]
(S)-2-amino-1-(4-propylthiophenyl)-propane	DMAN7YJ	Investigative	Small molecular drug	[314]
(S)-2-Amino-1-azetidin-1-yl-2-cyclohexyl-ethanone	DMWBH9N	Investigative	Small molecular drug	[315]
(S)-2-Amino-1-thiazolidin-3-yl-propane-1-thione	DMORFZE	Investigative	Small molecular drug	[316]
(S)-2-amino-2-cyclohexylacetic acid	DMVD05E	Investigative	Small molecular drug	[317]
(S)-2-amino-2-o-tolylacetic acid	DMG9KMN	Investigative	Small molecular drug	[317]
(S)-2-amino-2-p-tolylacetic acid	DMCDZ8A	Investigative	Small molecular drug	[317]
(S)-2-Amino-2-phenyl-ethanethiol	DMFEGPX	Investigative	Small molecular drug	[98]
(S)-2-amino-2-phenylpropanoic acid	DM2104G	Investigative	Small molecular drug	[317]
(S)-2-amino-3-(benzylthio)propanoic acid	DM6OUW0	Investigative	Small molecular drug	[317]
(S)-2-amino-3-cyclohexylpropanoic acid	DM1GBX8	Investigative	Small molecular drug	[317]
(S)-2-Amino-3-phenyl-propane-1-thiol	DMMAUKO	Investigative	Small molecular drug	[98]
(S)-2-amino-4-(benzylthio)butanoic acid	DMF8I2W	Investigative	Small molecular drug	[317]
(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide	DM8A1HG	Investigative	Small molecular drug	[269]
(S)-2-Amino-4-methyl-pentane-1-thiol	DM96XYI	Investigative	Small molecular drug	[98]
(S)-2-Amino-4-methylsulfanyl-butane-1-thiol	DMOVQ1T	Investigative	Small molecular drug	[98]
(S)-2-Amino-4-phenyl-butane-1-thiol	DMJEGMI	Investigative	Small molecular drug	[98]
(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid	DMZSWDM	Investigative	Small molecular drug	[318]
(S)-2-amino-6-hydroxy-N-(4-octylphenyl)hexanamide	DMG0CSZ	Investigative	Small molecular drug	[269]
(S)-2-Amino-6-[(E)-ethylimino]-hexanoic acid	DMRG80O	Investigative	Small molecular drug	[318]
(S)-2-amino-N-(1-cyano-2-phenylethyl)acetamide	DMN1G8L	Investigative	Small molecular drug	[319]
(S)-2-Amino-N-cyclopentyl-7-mercaptoheptanamide	DMDWFHV	Investigative	Small molecular drug	[320]
(S)-2-Amino-propane-1-thiol	DMYG8EV	Investigative	Small molecular drug	[98]
(S)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine	DMQGCM3	Investigative	Small molecular drug	[258]
(S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine	DMJFI75	Investigative	Small molecular drug	[258]
(S)-3,4-DCPG	DMG5BUA	Investigative	Small molecular drug	[321]
(S)-3-(1'-Adamantanecarbonyl)amino-caprolactam	DMS5IHX	Investigative	Small molecular drug	[271]
(S)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate	DM435QN	Investigative	Small molecular drug	[272]
(S)-3-(2',2'-Dimethyl-propionyl)amino-caprolactam	DMANICH	Investigative	Small molecular drug	[271]
(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DMTBG57	Investigative	Small molecular drug	[274]
(S)-3-(azetidin-2-ylmethoxy)-2-fluoropyridine	DMB9CQL	Investigative	Small molecular drug	[322]
(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine	DM5ILK1	Investigative	Small molecular drug	[59]
(S)-3-amino-2-methylpropanoate	DML05XZ	Investigative	Small molecular drug	[323]
(S)-3-hydroxy-3-methylglutaryl-CoA	DM3TW9V	Investigative	Small molecular drug	[324]
(S)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline	DMS4JAG	Investigative	Small molecular drug	[275]
(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	DMIG9H3	Investigative	Small molecular drug	[196]
(S)-3HPG	DMQ0FVJ	Investigative	Small molecular drug	[325]
(S)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine	DMLZBJT	Investigative	Small molecular drug	[258]
(S)-4-AHCP	DMN9YXL	Investigative	Small molecular drug	[326]
(S)-4-CMTB	DMI12X9	Investigative	Small molecular drug	[327]
(S)-4C3HPG	DMQK4I2	Investigative	Small molecular drug	[328]
(S)-4CPG	DMZ9UIL	Investigative	Small molecular drug	[329]
(S)-5-fluorowillardiine	DMCIZ7P	Investigative	Small molecular drug	[330]
(S)-5-iodowillardiine	DM1DNRP	Investigative	Small molecular drug	[331]
(S)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile	DM32PJ5	Investigative	Small molecular drug	[59]
(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid	DMG58HM	Investigative	Small molecular drug	[196]
(S)-alpha-methylhistamine	DMTUZIN	Investigative	Small molecular drug	[332]
(S)-AMPA	DMNJSTM	Investigative	Small molecular drug	[333]
(S)-benzyl 4-chloro-3-oxobutan-2-ylcarbamate	DMA43NY	Investigative	Small molecular drug	[334]
(S)-BULBOCAPNINE	DMPI0AX	Investigative	Small molecular drug	[335]
(S)-cetirizine	DMJN659	Investigative	Small molecular drug	[336]
(S)-crizotinib	DMFACXL	Investigative	Small molecular drug	[337]
(S)-DHPA	DMQSC21	Investigative	Small molecular drug	[338]
(S)-dimethylenastron	DM0SEYN	Investigative	Small molecular drug	[339]
(S)-EF-1520	DM0EQTM	Investigative	Small molecular drug	[340]
(S)-enastron	DMWNEA1	Investigative	Small molecular drug	[339]
(S)-Ethyl 6-(2-oxohexadecanamido)decanoate	DMFSXTJ	Investigative	Small molecular drug	[341]
(S)-flurocarazolol	DM715AS	Investigative	Small molecular drug	[342]
(S)-hexylhomoibotenic acid	DMALBAK	Investigative	Small molecular drug	[343]
(S)-Methyl 4-(2-oxohexadecanamido)octanoate	DM8H0ND	Investigative	Small molecular drug	[341]
(S)-N-(1-phenylethyl)acetimidamide hydrobromide	DMLR0N3	Investigative	Small molecular drug	[58]
(S)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide	DMUAYZJ	Investigative	Small molecular drug	[289]
(S)-N-oleoyltyrosinol	DMNOWZ2	Investigative	Small molecular drug	[344]
(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide	DMGFOQJ	Investigative	Small molecular drug	[345]
(S)-N2-[4-(benzyloxy)benzyl]alaninamide	DMGMAPB	Investigative	Small molecular drug	[291]
(S)-N2-[4-(benzyloxy)benzyl]serinamide	DMW5ZK7	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	DMKMJBL	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	DMINLCJ	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide	DMSC8ZW	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide	DMU3F7H	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide	DMLFOPV	Investigative	Small molecular drug	[291]
(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide	DMLP63J	Investigative	Small molecular drug	[291]
(S)-NORDULOXETINE	DMULFYA	Investigative	Small molecular drug	[346]
(S)-Norfluoxetine	DM8ZTPF	Investigative	Small molecular drug	[293]
(S)-phenylglycine	DMAI1HU	Investigative	Small molecular drug	[317]
(S)-PIA	DM04BHI	Investigative	Small molecular drug	[347]
(S)-Piperidine-3-carboxylic acid	DMST89H	Investigative	Small molecular drug	[348]
(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone	DMXVQJI	Investigative	Small molecular drug	[349]
(S)-pyrrolidin-2-yl(thiazolidin-3-yl)methanone	DM16N7Z	Investigative	Small molecular drug	[350]
(S)-Rolipram	DM1SJZ3	Investigative	Small molecular drug	[295]
(S)-secoantioquine hydrochloride	DMG4KIU	Investigative	Small molecular drug	[38]
(S)-sirtinol	DMS8WG3	Investigative	Small molecular drug	[296]
(S)-tacrine(10)-hupyridone	DMH7QZ2	Investigative	Small molecular drug	[22]
(S)-TBPG	DM68XFZ	Investigative	Small molecular drug	[351]
(S)-tert-butyl 1-oxohexan-2-ylcarbamate	DMAQX4K	Investigative	Small molecular drug	[312]
(S)-tert-Butyl 4-(2-oxohexadecanamido)pentanoate	DMLG8Q2	Investigative	Small molecular drug	[341]
(S)-tert-butyl 4-methyl-1-oxopentan-2-ylcarbamate	DMR1HQ3	Investigative	Small molecular drug	[312]
(S)-WILLARDIINE	DMXQ47M	Investigative	Small molecular drug	[352]
(S)-zacopride	DM6BON2	Investigative	Small molecular drug	[353]
(S)APOMORPHINE	DMEKGIX	Investigative	Small molecular drug	[354]
(S,R)-(+)-fenoterol	DMA30RW	Investigative	Small molecular drug	[299]
(S,R)-antioquine hydrochloride	DMIV0MT	Investigative	Small molecular drug	[38]
(S,R)-isotetrandrine hydrochloride	DMZV52W	Investigative	Small molecular drug	[38]
(S,R)-pseudoxandrine hydrochloride	DMMRUVF	Investigative	Small molecular drug	[38]
(S,S)-(-)-bis(10)-hupyridone	DMBR1JS	Investigative	Small molecular drug	[86]
(S,S)-(-)-bis(12)-hupyridone	DM6PQ8D	Investigative	Small molecular drug	[86]
(S,S)-oxandrine hydrochloride	DMYDS6F	Investigative	Small molecular drug	[38]
(S-(2-oxo)pentadecyl-CoA)	DML1GP5	Investigative	Small molecular drug	[355]
(Sar)WTLNSAGYLLGPKK(Lys-decanoyl)K	DMJL8SE	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-lauroyl)K	DMPZHIE	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-MPEG4)K	DMQIHZU	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-myristoyl)K	DMVHDF4	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-octanoyl)K	DMX3K4E	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-palmitoyl)K	DMSVMI8	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKK(Lys-stearoyl)K	DMO6N7C	Investigative	NA	[356]
(Sar)WTLNSAGYLLGPKKKK	DMT2NVG	Investigative	NA	[356]
(South)-Methanocarba-Thymidine	DMT3S72	Investigative	Small molecular drug	[12]
(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	DMLW7TV	Investigative	Small molecular drug	[12]
(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one	DMSVBZO	Investigative	Small molecular drug	[357]
(Z)-1,1,1-Trifluoro-nonadec-10-en-2-one	DMBTMDG	Investigative	Small molecular drug	[358]
(Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one	DMVZYNH	Investigative	Small molecular drug	[359]
(Z)-1-(benzo[d]oxazol-2-yl)octadec-9-en-1-one	DMNBDGH	Investigative	Small molecular drug	[359]
(Z)-1-(pyridazin-3-yl)octadec-9-en-1-one	DMMTXKO	Investigative	Small molecular drug	[359]
(Z)-2'-des-methyl sulindac sulfide	DM0OEQJ	Investigative	Small molecular drug	[360]
(Z)-2,2-Dimethyl-1-oxazol-2-yl-octadec-9-en-1-one	DM2HZX8	Investigative	Small molecular drug	[361]
(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide	DMFLDPU	Investigative	Small molecular drug	[362]
(Z)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid	DMKQ679	Investigative	Small molecular drug	[222]
(Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one	DMYH9BC	Investigative	Small molecular drug	[361]
(Z)-2-Methyl-3-tetradecyl-but-2-enedioic acid	DM18R6J	Investigative	Small molecular drug	[363]
(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one	DM27WDP	Investigative	Small molecular drug	[364]
(Z)-3-[2-(9H-fluoren-2-yloxy)ethylidene]-quinuclidine hydrochloride 31	DMIQ14F	Investigative	Small molecular drug	[365]
(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid	DM30YQF	Investigative	Small molecular drug	[185]
(Z)-5-Amino-3-(4-methoxybenzylidene)indolin-2-one	DMPJAKL	Investigative	Small molecular drug	[226]
(Z)-5-Benzylidene-2-thioxothiazolidin-4-one	DM3ALJD	Investigative	Small molecular drug	[366]
(Z)-5-Butylidene-2-thioxothiazolidin-4-one	DMLRWAF	Investigative	Small molecular drug	[366]
(Z)-5-Decylidene-2-thioxothiazolidin-4-one	DM5U1M8	Investigative	Small molecular drug	[366]
(Z)-5-Hexylidene-2-thioxothiazolidin-4-one	DMV70YA	Investigative	Small molecular drug	[366]
(Z)-5-octadecen-7,9-diynoic acid	DM4X9GW	Investigative	Small molecular drug	[233]
(Z)-5-Octylidene-2-thioxothiazolidin-4-one	DMEJNFS	Investigative	Small molecular drug	[366]
(Z)-7-octedecan-9-ynoic acid	DMKWLSB	Investigative	Small molecular drug	[233]
(Z)-8-(3-chlorostyryl)caffeine	DMOB9E4	Investigative	Small molecular drug	[242]
1',2',3',6'-Tetrahydro-[2,4']bipyridinyl	DMFDK4N	Investigative	Small molecular drug	[367]
1'-(4-Methyl-benzyl)-[1,4']bipiperidinyl	DMNDJTL	Investigative	Small molecular drug	[368]
1'-acetoxychavicol acetate	DMMP7HU	Investigative	Small molecular drug	[369]
1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione	DMMNH4K	Investigative	Small molecular drug	[370]
1'-tosylspiro[indene-1,4'-piperidine]	DM9SYEP	Investigative	Small molecular drug	[371]
1(beta)-O-galloylpedunculagin	DMA15X9	Investigative	Small molecular drug	[372]
1,1':4',1''-terphenyl-3,3''-diol	DMGHAC7	Investigative	Small molecular drug	[373]
1,1':4',1''-terphenyl-3,4''-diol	DMA3LZ9	Investigative	Small molecular drug	[373]
1,1,1,2,2,3,3,5-octafluoro-8-phenyloctan-4-one	DMWHN2J	Investigative	Small molecular drug	[357]
1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol	DM45NF1	Investigative	Small molecular drug	[357]
1,1,1,2,2,4-hexafluoro-7-phenylheptan-3-one	DMN68K4	Investigative	Small molecular drug	[357]
1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one	DM7U8LD	Investigative	Small molecular drug	[374]
1,1,1,2,2-Pentafluoro-9-phenyl-nonan-3-one	DMSEHNV	Investigative	Small molecular drug	[374]
1,1,1,3-Tetrafluoro-6-phenylhexan-2-one	DMLDH4Z	Investigative	Small molecular drug	[357]
1,1,1,3-Tetrafluoro-7-phenylheptan-2-one	DMV0CXN	Investigative	Small molecular drug	[357]
1,1,1,3-Tetrafluoro-heptadecan-2-one	DMD36WS	Investigative	Small molecular drug	[374]
1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one	DMJ0ZMT	Investigative	Small molecular drug	[375]
1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one	DMWDUCH	Investigative	Small molecular drug	[375]
1,1,1-trifluoro-3-(hexylthio)propan-2-one	DMWGSP6	Investigative	Small molecular drug	[375]
1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one	DMLBT0E	Investigative	Small molecular drug	[375]
1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one	DMT29SN	Investigative	Small molecular drug	[375]
1,1,1-trifluoro-3-(octylthio)propan-2-one	DMU4EJW	Investigative	Small molecular drug	[375]
1,1,1-Trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one	DMODCAM	Investigative	Small molecular drug	[374]
1,1,1-Trifluoro-5-(4-octylphenoxy)pentan-2-one	DMI2XWY	Investigative	Small molecular drug	[357]
1,1,1-Trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one	DMCAQ5T	Investigative	Small molecular drug	[374]
1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one	DMZ2VE3	Investigative	Small molecular drug	[357]
1,1,1-Trifluoro-7-phenylheptan-2-one	DMLHVWP	Investigative	Small molecular drug	[374]
1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one	DM6GI4Z	Investigative	Small molecular drug	[376]
1,1,1-Trifluoro-8-phenoxy-octan-2-one	DM41R2O	Investigative	Small molecular drug	[376]
1,1,1-Trifluoro-8-phenyl-octan-2-one	DMYENI7	Investigative	NA	[374]
1,1,1-Trifluoro-9-phenyl-nonan-2-one	DM7DWVL	Investigative	Small molecular drug	[358]
1,1,1-Trifluoro-nonadecan-2-one	DM8TWY7	Investigative	Small molecular drug	[358]
1,1,1-Trifluoro-tridecan-2-one	DM4CEQP	Investigative	Small molecular drug	[358]
1,1,1-Trifluoro-undecan-2-one	DMX2SFW	Investigative	Small molecular drug	[358]
1,1,1-trifluorododecan-2-one	DMW6CQV	Investigative	Small molecular drug	[375]
1,1,1-trifluoroheptadecan-2-one	DMB5U3P	Investigative	Small molecular drug	[374]
1,1-bisphosphonate esters	DMG362U	Investigative	NA	[377]
1,1-Dimethyl-4-phenyl-piperazin-1-ium iodide	DM9XTY7	Investigative	NA	[378]
1,1-Dimethyl-5-oxa-spiro[2.4]heptan-4-one	DMOGHRS	Investigative	Small molecular drug	[379]
1,1-diphenyl-2-(3-tropanyl)ethanol	DMZDUSA	Investigative	Small molecular drug	[380]
1,1-diphenyl-3-(phenylsulfonyl)propan-2-one	DM7SQ4H	Investigative	Small molecular drug	[381]
1,10-(methylenedi-4,1-phenylene)bismaleimide	DMYVBD2	Investigative	Small molecular drug	[382]
1,10-bis(pyridinium)-decane dibromide	DM6VCI3	Investigative	Small molecular drug	[383]
1,10-bis-(Dmt-Tic-amino)decane	DM9UGFQ	Investigative	Small molecular drug	[384]
1,10-phenanthroline-5,6-dione	DM5LVD2	Investigative	Small molecular drug	[385]
1,11-bis(pyridinium)-undecane dibromide	DMVXYZL	Investigative	Small molecular drug	[383]
1,2,3,4,4a,5,10,10a-Octahydro-benzo[g]quinoline	DMDYX7P	Investigative	Small molecular drug	[386]
1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one	DM7JMCI	Investigative	Small molecular drug	[238]
1,2,3,4,5,6-Hexahydro-benzo[c]azocine	DMTKYFE	Investigative	Small molecular drug	[275]
1,2,3,4,6-penta-O-galloyl-beta-D-glucose	DMTK650	Investigative	Small molecular drug	[387]
1,2,3,4,6-penta-O-galloyl-D-glucopyranose	DM9ICSA	Investigative	Small molecular drug	[388]
1,2,3,4-Tetrahydro-benzo[h]isoquinolin-8-ol	DMHKANE	Investigative	Small molecular drug	[389]
1,2,3,4-Tetrahydro-isoquinolin-7-ol	DM5VLIE	Investigative	Small molecular drug	[389]
1,2,3,4-Tetrahydro-naphthalen-1-ylamine	DMNXQ7Z	Investigative	Small molecular drug	[390]
1,2,3,4-Tetrahydro-naphthalen-2-ylamine	DMP4DLV	Investigative	Small molecular drug	[391]
1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	DM3JGVF	Investigative	Small molecular drug	[392]
1,2,3,4-tetrahydroisoquinoline	DMZGCEQ	Investigative	Small molecular drug	[393]
1,2,3,7,12,12a-hexahydro-1-aza-pleiaden-5-ol	DMYDGAZ	Investigative	Small molecular drug	[335]
1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol	DMAJ0B4	Investigative	Small molecular drug	[335]
1,2,3-benzenetricarboxylic acid	DMXL5R7	Investigative	Small molecular drug	[394]
1,2,4-Triazole	DM73F5A	Investigative	Small molecular drug	[12]
1,2,4-Triazole-Carboxamidine	DMOXLHT	Investigative	Small molecular drug	[12]
1,2,5,6-tetrahydro pyrido[1,2-a]quinolin-3-one	DM7BAU2	Investigative	Small molecular drug	[395]
1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	DM9VYOI	Investigative	Small molecular drug	[22]
1,2,6-tri-O-galloyl-beta-D-glucose	DMWGN3F	Investigative	Small molecular drug	[372]
1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone	DMZSL7H	Investigative	Small molecular drug	[396]
1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione	DML5ECR	Investigative	Small molecular drug	[396]
1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone	DMD9HP8	Investigative	Small molecular drug	[396]
1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione	DMZHWAV	Investigative	Small molecular drug	[396]
1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione	DMWS2HL	Investigative	Small molecular drug	[396]
1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone	DMZ0D5W	Investigative	Small molecular drug	[396]
1,2-bis(2,3-fluorophenyl)ethane-1,2-dione	DM9Z1NY	Investigative	Small molecular drug	[396]
1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone	DMLMCBW	Investigative	Small molecular drug	[396]
1,2-bis(2,4-difluorophenyl)ethane-1,2-dione	DMUZHPS	Investigative	Small molecular drug	[396]
1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone	DM9EW2F	Investigative	Small molecular drug	[396]
1,2-bis(2,5-difluorophenyl)ethane-1,2-dione	DMVLMBQ	Investigative	Small molecular drug	[396]
1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone	DMSMVCH	Investigative	Small molecular drug	[396]
1,2-bis(2,6-difluorophenyl)ethane-1,2-dione	DM351EA	Investigative	Small molecular drug	[396]
1,2-bis(2-fluorophenyl)-2-hydroxyethanone	DMNWM5S	Investigative	Small molecular drug	[396]
1,2-bis(2-fluorophenyl)ethane-1,2-dione	DM9FMUE	Investigative	Small molecular drug	[396]
1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone	DM0LWAV	Investigative	Small molecular drug	[396]
1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione	DMPJT3V	Investigative	Small molecular drug	[396]
1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone	DMRCUKJ	Investigative	Small molecular drug	[396]
1,2-bis(3,4-difluorophenyl)ethane-1,2-dione	DMBZ5RN	Investigative	Small molecular drug	[396]
1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone	DMQTPX2	Investigative	Small molecular drug	[396]
1,2-bis(3,5-difluorophenyl)ethane-1,2-dione	DM3K5RI	Investigative	Small molecular drug	[396]
1,2-bis(3-fluorophenyl)-2-hydroxyethanon	DM8XGD0	Investigative	Small molecular drug	[396]
1,2-bis(3-fluorophenyl)ethane-1,2-dione	DMM3I1P	Investigative	Small molecular drug	[396]
1,2-bis(4-fluorophenyl)ethane-1,2-dione	DM38Q7W	Investigative	Small molecular drug	[396]
1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione	DMZF4IC	Investigative	Small molecular drug	[397]
1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione	DMWY1QN	Investigative	Small molecular drug	[397]
1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione	DMGSTKZ	Investigative	Small molecular drug	[397]
1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione	DMUW2EJ	Investigative	Small molecular drug	[397]
1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione	DM0E5FH	Investigative	Small molecular drug	[397]
1,2-Bis-(4-hydroxy-phenyl)-3H-inden-5-ol	DM9RF1T	Investigative	Small molecular drug	[398]
1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione	DMCGRV7	Investigative	Small molecular drug	[397]
1,2-Bis-[R-(-)-apomorphine-2'-oxy]ethane	DM9ENXO	Investigative	Small molecular drug	[399]
1,2-di(10H-phenothiazin-10-yl)ethane-1,2-dione	DMJAK0E	Investigative	Small molecular drug	[105]
1,2-Di(berberine-9-O-yl)ethane dibromide	DM7S1D5	Investigative	Small molecular drug	[400]
1,2-Di-naphthalen-2-yl-ethane-1,2-dione	DMGXMF0	Investigative	Small molecular drug	[401]
1,2-Di-p-tolyl-ethane-1,2-dione	DMFXB21	Investigative	Small molecular drug	[397]
1,2-Diacetoxylycorine	DMBAX2L	Investigative	Small molecular drug	[402]
1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane	DMDJYHK	Investigative	Small molecular drug	[403]
1,2-dicyclohexylethane-1,2-dione	DM75OR8	Investigative	Small molecular drug	[385]
1,2-dihydro-2-oxoquinazoline-4-carboxyanilide	DM542I9	Investigative	Small molecular drug	[404]
1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene	DMST60D	Investigative	Small molecular drug	[405]
1,2-Dihydro-indazol-3-one	DM9G7DT	Investigative	Small molecular drug	[406]
1,2-Dihydroxy-10H-anthracen-9-one	DMASC8K	Investigative	Small molecular drug	[407]
1,2-dioctanoyl-sn-glycerol	DMEAB03	Investigative	Small molecular drug	[408]
1,2-indanedione	DMV275G	Investigative	Small molecular drug	[385]
1,2-NAPHTHOQUINONE	DMYXELH	Investigative	Small molecular drug	[385]
1,3,5-BENZENETRICARBOXYLIC ACID	DMNCWXZ	Investigative	Small molecular drug	[22]
1,3,5-triphenylimidazolidine-2,4-dione	DM7U6S0	Investigative	Small molecular drug	[409]
1,3,5-tris(4-chlorophenyl)imidazolidine-2,4-dione	DMDNM05	Investigative	Small molecular drug	[409]
1,3,7-trihydroxyacridone	DMFA8CW	Investigative	NA	[410]
1,3,7-Tripropyl-3,7-dihydro-purine-2,6-dione	DMNCJ5R	Investigative	Small molecular drug	[411]
1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one	DMRP03X	Investigative	Small molecular drug	[407]
1,3,8-Trimethyl-3,7-dihydro-purine-2,6-dione	DMOZEKU	Investigative	Small molecular drug	[412]
1,3,9,9a-Tetrahydro-imidazo[4,5-b]quinolin-2-one	DM7U31Q	Investigative	Small molecular drug	[413]
1,3-bis(3,4-dihydroxyphenyl)prop-2-en-1-one	DMELSV1	Investigative	Small molecular drug	[414]
1,3-bis(nitrooxy)propan-2-yl 2-acetoxybenzoate	DMIK7XV	Investigative	Small molecular drug	[415]
1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea	DM78UPQ	Investigative	Small molecular drug	[416]
1,3-Di(berberine-9-O-yl)ethane dibromide	DMZKUOX	Investigative	Small molecular drug	[400]
1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione	DMHNUWG	Investigative	Small molecular drug	[417]
1,3-Diallyl-3,7-dihydro-purine-2,6-dione	DMEV8G2	Investigative	Small molecular drug	[418]
1,3-Diallyl-7-methyl-3,7-dihydro-purine-2,6-dione	DM4G2IE	Investigative	Small molecular drug	[411]
1,3-dibenzyl urea	DMMOBPN	Investigative	Small molecular drug	[419]
1,3-Dibenzyl-3,7-dihydro-purine-2,6-dione	DM2WSG5	Investigative	Small molecular drug	[411]
1,3-Dibenzyl-[1,3]diazetidine-2,4-dione	DM8NARQ	Investigative	Small molecular drug	[417]
1,3-Diethyl-3,7-dihydro-purine-2,6-dione	DMKYE16	Investigative	Small molecular drug	[418]
1,3-Dihydro-imidazo[4,5-b]quinolin-2-one	DMB9XR5	Investigative	Small molecular drug	[413]
1,3-Dihydro-naphtho[2,3-d]imidazol-2-one	DM8CYOP	Investigative	Small molecular drug	[413]
1,3-Diisobutyl-3,7-dihydro-purine-2,6-dione	DMZ80CT	Investigative	Small molecular drug	[418]
1,3-Diphenyl-1H-chromeno[4,3-c]pyrazol-4-one	DM1KND6	Investigative	Small molecular drug	[420]
1,3-DIPHENYLUREA	DMI4H05	Investigative	Small molecular drug	[22]
1,3-Dipropyl-3,7-dihydro-purine-2,6-dione	DMUL2B3	Investigative	Small molecular drug	[418]
1,3-ditolylguanidine	DM04KS1	Investigative	Small molecular drug	[421]
1,3-propanediphosphonic acid	DMVBI2C	Investigative	Small molecular drug	[422]
1,4,-IP2	DMGUXDB	Investigative	Small molecular drug	[423]
1,4-bis(malimido)xylene	DMC4LMT	Investigative	Small molecular drug	[382]
1,4-bis-(Dmt-Tic-amino)butane	DMLBHXN	Investigative	Small molecular drug	[384]
1,4-Butanediol	DMVHKZT	Investigative	Small molecular drug	[424]
1,4-Di(berberine-9-O-yl)ethane dibromide	DM87MWN	Investigative	Small molecular drug	[400]
1,4-diaminoanthracene-9,10-dione	DMIHYKG	Investigative	Small molecular drug	[162]
1,4-dideoxy-1,4-imino-D-arabinito	DMB5VQK	Investigative	Small molecular drug	[425]
1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	DM4RD2S	Investigative	Small molecular drug	[12]
1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	DM9KUQZ	Investigative	Small molecular drug	[12]
1,4-Diethylene Dioxide	DMI36WC	Investigative	Small molecular drug	[107]
1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide	DMNHGVD	Investigative	Small molecular drug	[426]
1,4-dihydroindeno[1,2-c]-pyrazole	DMMGP9X	Investigative	Small molecular drug	[427]
1,4-Dimethylquinolin-2(1H)-one	DMRT13B	Investigative	Small molecular drug	[428]
1,4-diphenyl-(1E,3E)-1,3-butadiene	DMFY3VS	Investigative	Small molecular drug	[429]
1,4-Dithiothreitol	DMIFOXE	Investigative	Small molecular drug	[12]
1,4-Naphthoquinone	DMTCMH7	Investigative	Small molecular drug	[430]
1,4-phenylene disulfamate	DMEDBO2	Investigative	Small molecular drug	[431]
1,5,-IP2	DMJXC5G	Investigative	Small molecular drug	[432]
1,5-bis(4-chlorophenyl)-1H-1,2,3-triazole	DMF0RXK	Investigative	Small molecular drug	[433]
1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one	DMPOAB7	Investigative	Small molecular drug	[434]
1,5-Dideoxy-1,5-imino-D-xylitol	DMZU1GD	Investigative	Small molecular drug	[435]
1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one	DMYA25G	Investigative	Small molecular drug	[436]
1,5-Dihydroxy-10H-anthracen-9-one	DMC7FLT	Investigative	Small molecular drug	[407]
1,6-bis(4'-aminophenyl)-hexa-1,3,5-triene	DM70ODN	Investigative	Small molecular drug	[437]
1,6-bis(4'-dimethylaminophenyl)-hexa-1,3,5-triene	DMBCU6W	Investigative	Small molecular drug	[437]
1,6-Bis(4'-hydroxyphenyl)-hexa-1,3,5-triene	DMEU3MN	Investigative	Small molecular drug	[437]
1,6-bis(4'-methylaminophenyl)-hexa-1,3,5-triene	DM0D6JN	Investigative	Small molecular drug	[437]
1,6-bis(4'-nitrophenyl)-hexa-1,3,5-triene	DMQY75B	Investigative	Small molecular drug	[437]
1,6-bis(4-(3-chlorophenyl)piperazin-1-yl)hexane	DMDFU6S	Investigative	Small molecular drug	[438]
1,6-bis(4-(3-methoxyphenyl)piperazin-1-yl)hexane	DMNLUKS	Investigative	Small molecular drug	[438]
1,6-bis(4-(pyridin-2-yl)piperazin-1-yl)hexane	DM0GRMD	Investigative	Small molecular drug	[438]
1,6-bis(4-m-tolylpiperazin-1-yl)hexane	DM5Z6XG	Investigative	Small molecular drug	[438]
1,6-bis(4-phenylpiperazin-1-yl)hexane	DMD3EUI	Investigative	Small molecular drug	[438]
1,6-bis-(Dmt-Tic-amino)hexane	DMRG2CU	Investigative	Small molecular drug	[384]
1,6-bis-(N,N-dimethyl-Dmt-Tic-NH)hexane	DMMUZK9	Investigative	Small molecular drug	[384]
1,6-hexamethylene diisocyanate	DMLB3RT	Investigative	Small molecular drug	[439]
1,7,8,9-tetrahydro-1,5-diaza-trindene-4,6-dione	DMBU796	Investigative	Small molecular drug	[440]
1,8,9-Trimethoxy-9,10-dihydro-anthracene	DMVHE1P	Investigative	Small molecular drug	[407]
1,8-bis-maleimidodiethyleneglycol	DMKJGTH	Investigative	Small molecular drug	[382]
1,8-Dichloro-10H-anthracen-9-one	DMZK4DL	Investigative	Small molecular drug	[407]
1,8-Dichloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	DMKJBRZ	Investigative	Small molecular drug	[441]
1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one	DMDFBSX	Investigative	Small molecular drug	[407]
1,9-bis(pyridinium)-nonane dibromide	DMWC7QE	Investigative	Small molecular drug	[383]
1,9-dideoxyforskolin	DMW613U	Investigative	Small molecular drug	[442]
1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole	DMGRV8U	Investigative	Small molecular drug	[443]
1-((9H-Fluoren-2-yl)methyl)-1H-imidazole	DMPBJ9L	Investigative	Small molecular drug	[443]
1-((R)-2-aminopropyl)-1H-indazol-6-ol	DM74R0E	Investigative	Small molecular drug	[444]
1-((S)-2-aminopropyl)-1H-indazol-6-ol	DMU83KP	Investigative	Small molecular drug	[444]
1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol	DMRFJNC	Investigative	Small molecular drug	[444]
1-((S)-2-aminopropyl)-7-fluoro-1H-indazol-6-ol	DM76JVB	Investigative	Small molecular drug	[444]
1-((S)-2-aminopropyl)-7-iodo-1H-indazol-6-ol	DMR2SXL	Investigative	Small molecular drug	[444]
1-((S)-2-aminopropyl)-7-methyl-1H-indazol-6-ol	DM8MNZG	Investigative	Small molecular drug	[444]
1-(1,2,4-Oxadiazol-3-yl)-7-phenylheptan-1-one	DMPMLZF	Investigative	Small molecular drug	[445]
1-(1,2,4-Oxadiazol-5-yl)-7-phenylheptan-1-one	DMBS90M	Investigative	Small molecular drug	[445]
1-(1,2-diphenylethyl)-4-phenylpiperidin-4-ol	DMOR9EK	Investigative	Small molecular drug	[446]
1-(1,2-diphenylethyl)piperazine	DM0ARKB	Investigative	Small molecular drug	[447]
1-(1,3,4-Oxadiazol-2-yl)-7-phenylheptan-1-one	DMHIYB3	Investigative	Small molecular drug	[445]
1-(1,3,4-oxadiazol-2-yl)octadec-9-en-1-one	DMZ1GH0	Investigative	Small molecular drug	[445]
1-(1,3,4-thiadiazol-2-yl)octadec-9-en-1-one	DM6B14Q	Investigative	Small molecular drug	[445]
1-(1,3-diphenylpropyl)piperazine	DMTC98X	Investigative	Small molecular drug	[448]
1-(1,3-diphenylpropylidene)thiosemicarbazide	DMYI3F5	Investigative	Small molecular drug	[449]
1-(1,4-diacetylphenyl)dithiosemicarbazide	DMHNOLA	Investigative	Small molecular drug	[450]
1-(1,4-diphenylbutan-2-yl)piperazine	DM8Z1QU	Investigative	Small molecular drug	[448]
1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)	DMCSOAV	Investigative	Small molecular drug	[264]
1-(1-(3-nitrophenyl)propylidene)thiosemicarbazide	DM0XNMP	Investigative	Small molecular drug	[451]
1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole	DMOQPKT	Investigative	Small molecular drug	[443]
1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide	DMXJ58Z	Investigative	Small molecular drug	[450]
1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX)	DMS9PZ7	Investigative	Small molecular drug	[264]
1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide	DMQBHGK	Investigative	Small molecular drug	[450]
1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole	DMQF2N5	Investigative	Small molecular drug	[452]
1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole	DMEIH5N	Investigative	Small molecular drug	[452]
1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine	DMPGM0V	Investigative	Small molecular drug	[453]
1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole	DMLJ7WA	Investigative	Small molecular drug	[443]
1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide	DM7WJOY	Investigative	Small molecular drug	[450]
1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide	DMJ21XT	Investigative	Small molecular drug	[450]
1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide	DMQSEF6	Investigative	Small molecular drug	[450]
1-(1-Adamantyl)-3-(1-propionylpiperidin-4-yl)urea	DM7G2AB	Investigative	Small molecular drug	[454]
1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane	DM2T1CD	Investigative	Small molecular drug	[455]
1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane	DMEFP15	Investigative	Small molecular drug	[455]
1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane	DM1Q36W	Investigative	Small molecular drug	[455]
1-(1-Benzyl-2-biphenyl-4-yl-ethyl)-1H-imidazole	DMLBCE5	Investigative	Small molecular drug	[456]
1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole	DMPEIQT	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole	DMCTF8X	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole	DMWME7I	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-butyl)-1H-imidazole	DM4XILF	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole	DMW85CH	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole	DM3AD7E	Investigative	Small molecular drug	[443]
1-(1-Biphenyl-4-yl-propyl)-1H-imidazole	DMGVE3F	Investigative	Small molecular drug	[443]
1-(1-Naphthyl)-2-aminopropane	DM6X9J3	Investigative	Small molecular drug	[205]
1-(1-p-tolylethylidene)thiosemicarbazide	DM2PQFE	Investigative	Small molecular drug	[450]
1-(1-phenyl-1H-tetrazol-5-ylthio)propan-2-one	DMSUC85	Investigative	Small molecular drug	[457]
1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine	DM54ZKU	Investigative	Small molecular drug	[264]
1-(1-phenyl-2-(pyridin-2-yl)ethyl)piperazine	DMIZBP6	Investigative	Small molecular drug	[448]
1-(1-phenyl-2-(pyridin-4-yl)ethyl)piperazine	DMTVPZC	Investigative	Small molecular drug	[448]
1-(1-phenyl-2-o-tolylethyl)piperazine	DMZ6QX0	Investigative	Small molecular drug	[447]
1-(1-Phenyl-propyl)-3-thiazol-2-yl-thiourea	DMER0IY	Investigative	Small molecular drug	[458]
1-(1-phenylethylidene)thiosemicarbazide	DMN5SL6	Investigative	Small molecular drug	[450]
1-(1-Propionylpiperidin-4-yl)-3-m-tolylurea	DMAZR9C	Investigative	Small molecular drug	[454]
1-(1-Propionylpiperidin-4-yl)-3-o-tolylurea	DMUH59X	Investigative	Small molecular drug	[454]
1-(1-Propionylpiperidin-4-yl)-3-p-tolylurea	DMWUBI4	Investigative	Small molecular drug	[454]
1-(10-Bromoanthracen-9-yl)-2-aminopropane	DM2AEO0	Investigative	Small molecular drug	[459]
1-(10H-phenothiazin-10-yl)-2-phenylbutan-1-one	DMKIWBT	Investigative	Small molecular drug	[105]
1-(10H-phenothiazin-10-yl)-2-phenylethanone	DM5WBMY	Investigative	Small molecular drug	[105]
1-(10H-phenothiazin-10-yl)-2-phenylpropan-1-one	DMYWG7D	Investigative	Small molecular drug	[105]
1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one	DMZCPAQ	Investigative	Small molecular drug	[105]
1-(10H-phenothiazin-10-yl)-3-phenylpropan-1-one	DMJQNLR	Investigative	Small molecular drug	[105]
1-(10H-phenothiazin-10-yl)-4-phenylbutan-1-one	DMGY32O	Investigative	Small molecular drug	[105]
1-(1H-Indazol-6-yl)-3-pyridin-2-yl-urea	DM9MCAU	Investigative	Small molecular drug	[460]
1-(1H-Indol-4-yloxy)-3-phenethylamino-propan-2-ol	DMSUPCD	Investigative	Small molecular drug	[461]
1-(2'-chlorophenyl)penta-1,4-dien-3-one	DMKTZSY	Investigative	Small molecular drug	[462]
1-(2,2'-bithiophen-5-yl)methanamine	DMNX6CE	Investigative	Small molecular drug	[22]
1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)	DM1Q0TM	Investigative	Small molecular drug	[463]
1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine	DM0URSE	Investigative	Small molecular drug	[464]
1-(2,5-Dimethoxy-4-methyl-phenyl)-piperazine	DM31CVR	Investigative	Small molecular drug	[168]
1-(2,5-Dimethoxy-phenyl)-piperazine	DMNETHQ	Investigative	Small molecular drug	[168]
1-(2,5-dimethoxyphenyl)propan-2-amine	DM043N8	Investigative	Small molecular drug	[465]
1-(2,5-Dimethyl-1H-pyrrol-1-yl)thiourea	DM3FHJK	Investigative	Small molecular drug	[466]
1-(2,6-dimethoxy-4-methylphenyl)propan-2-amine	DMV0C6F	Investigative	Small molecular drug	[459]
1-(2-((3-fluorophenoxy)methyl)phenyl)piperazine	DMJXKOF	Investigative	Small molecular drug	[467]
1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)	DMUJ2WB	Investigative	Small molecular drug	[264]
1-(2-(2-bromophenyl)-1-phenylethyl)piperazine	DMPRALC	Investigative	Small molecular drug	[447]
1-(2-(2-chlorophenoxy)pyridin-3-yl)piperazine	DM9CVX5	Investigative	Small molecular drug	[468]
1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine	DMUM4YQ	Investigative	Small molecular drug	[447]
1-(2-(2-ethoxyphenyl)-1-phenylethyl)piperazine	DMBRS3D	Investigative	Small molecular drug	[447]
1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine	DMKWRCD	Investigative	Small molecular drug	[447]
1-(2-(2-fluorobenzyloxy)phenyl)piperazine	DM6XCPV	Investigative	Small molecular drug	[467]
1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine	DM2H38V	Investigative	Small molecular drug	[447]
1-(2-(3-chlorophenyl)-1-phenylethyl)piperazine	DM4WEGM	Investigative	Small molecular drug	[447]
1-(2-(3-fluorophenoxy)phenyl)piperazine	DMXV2KQ	Investigative	Small molecular drug	[467]
1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine	DM8V5IH	Investigative	Small molecular drug	[447]
1-(2-(4-fluorophenoxy)phenyl)piperazine	DMU082P	Investigative	Small molecular drug	[467]
1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine	DMR4DJ1	Investigative	Small molecular drug	[59]
1-(2-(benzo[b]thiophen-4-yl)ethyl)-1H-imidazole	DMB3HI4	Investigative	Small molecular drug	[469]
1-(2-(benzyloxy)phenyl)piperazine	DM0UZHL	Investigative	Small molecular drug	[467]
1-(2-(diethylamino)quinazolin-4-yl)-3-phenylurea	DMU5BOW	Investigative	Small molecular drug	[470]
1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine	DMXL7Z5	Investigative	Small molecular drug	[448]
1-(2-(naphthalen-2-yl)-1-phenylethyl)piperazine	DMTEBP0	Investigative	Small molecular drug	[448]
1-(2-(naphthalen-2-yl)ethyl)piperazine	DMS7YF6	Investigative	Small molecular drug	[59]
1-(2-(naphthalen-2-yl)ethyl)pyrrolidine	DMYFKID	Investigative	Small molecular drug	[258]
1-(2-(phenoxymethyl)phenyl)piperazine	DM7Z19T	Investigative	Small molecular drug	[467]
1-(2-adamantyl)-3-benzylpyrrolidin-2-one	DMRHY2M	Investigative	Small molecular drug	[471]
1-(2-allylphenoxy)-3-morpholinopropan-2-ol	DMLV0PQ	Investigative	Small molecular drug	[472]
1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea	DMAE8BF	Investigative	Small molecular drug	[473]
1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea	DMCSHRL	Investigative	Small molecular drug	[473]
1-(2-aminoethyl)-1H-indazol-6-ol	DMKWO6A	Investigative	Small molecular drug	[444]
1-(2-Bromo-phenyl)-3-(2,4-dihydroxy-phenyl)-urea	DMUSEOW	Investigative	Small molecular drug	[474]
1-(2-bromoethyl)-1H-indole-2,3-dione	DMYF8ES	Investigative	Small molecular drug	[475]
1-(2-bromophenyl)-3-(4-cyano-2-hydroxyphenyl)urea	DMU9T3A	Investigative	Small molecular drug	[476]
1-(2-Butoxy-phenyl)-piperazine	DMT5S2O	Investigative	Small molecular drug	[477]
1-(2-Chloro-phenyl)-piperazine	DM5RE71	Investigative	Small molecular drug	[478]
1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea	DMGSKAO	Investigative	Small molecular drug	[479]
1-(2-Dimethylamino-ethyl)-1H-indol-4-ol	DMM3LET	Investigative	Small molecular drug	[480]
1-(2-ethoxy-1-phenylethyl)-4-phenylpiperidin-4-ol	DMV3FSH	Investigative	Small molecular drug	[446]
1-(2-Ethoxy-phenyl)-piperazine	DM2P7YX	Investigative	Small molecular drug	[477]
1-(2-Fluoro-phenyl)-piperazine	DM94LID	Investigative	Small molecular drug	[477]
1-(2-Furan-2-yl-ethyl)-3-thiazol-2-yl-thiourea	DM0K2T1	Investigative	Small molecular drug	[481]
1-(2-Hydroxy-3-nitro-phenyl)-3-phenyl-urea	DM3WXET	Investigative	Small molecular drug	[482]
1-(2-hydroxy-4-nitrophenyl)-3-phenylurea	DMN4G7U	Investigative	Small molecular drug	[483]
1-(2-Hydroxy-5-nitro-phenyl)-3-phenyl-urea	DMPLHEY	Investigative	Small molecular drug	[482]
1-(2-hydroxyphenyl)-3-p-tolylprop-2-en-1-one	DMAFS7J	Investigative	Small molecular drug	[484]
1-(2-iodoethyl)-1H-indole-2,3-dione	DM1MSAC	Investigative	Small molecular drug	[475]
1-(2-Isopropoxy-phenyl)-piperazine	DM5KAH6	Investigative	Small molecular drug	[477]
1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol	DMK209P	Investigative	Small molecular drug	[472]
1-(2-m-tolyl-ethyl)-pyrrolidine	DMKITY6	Investigative	Small molecular drug	[258]
1-(2-mercaptoethyl)-3-(m-tolylsulfonyl)urea	DMIPAMW	Investigative	Small molecular drug	[485]
1-(2-Methoxy-phenyl)-4-propyl-piperazine	DMCADRI	Investigative	Small molecular drug	[486]
1-(2-Methoxy-phenyl)-piperazine	DM3M4RA	Investigative	Small molecular drug	[487]
1-(2-methoxyphenethyl)pyrrolidine	DMDQVSU	Investigative	Small molecular drug	[258]
1-(2-methoxyphenyl)-4-pentylpiperazine	DM0EZSR	Investigative	Small molecular drug	[488]
1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMBWCOZ	Investigative	Small molecular drug	[489]
1-(2-morpholinoethyl)-1H-indol-3-yl acetate	DMZF0D3	Investigative	Small molecular drug	[490]
1-(2-Naphthyl)-2-aminopropane	DMBNZKH	Investigative	Small molecular drug	[205]
1-(2-nitrophenethyl)-1H-pyrrolo[3,2-b]pyridine	DMR12KP	Investigative	Small molecular drug	[491]
1-(2-Oxo-2-p-tolyl-ethyl)-1H-indole-2,3-dione	DM69T3A	Investigative	Small molecular drug	[492]
1-(2-p-tolyl-ethyl)-pyrrolidine	DMDLKPI	Investigative	Small molecular drug	[258]
1-(2-Phenoxy-ethyl)-1H-imidazole	DMOMAXJ	Investigative	Small molecular drug	[493]
1-(2-Phenoxy-ethyl)-3-thiazol-2-yl-thiourea	DMC1IKP	Investigative	Small molecular drug	[458]
1-(2-phenoxybenzyl)-1H-imidazole	DMLY4ER	Investigative	Small molecular drug	[494]
1-(2-phenoxyphenyl)piperazine	DMWFCYN	Investigative	Small molecular drug	[467]
1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea	DMXG10E	Investigative	Small molecular drug	[481]
1-(2-Pyridin-2-yl-ethyl)-3-thiazol-2-yl-thiourea	DM4B2EN	Investigative	Small molecular drug	[481]
1-(3,3-Dimethyl-2-oxo-butyl)-1H-indole-2,3-dione	DMNZYWR	Investigative	Small molecular drug	[492]
1-(3,3-Diphenyl-allyl)-3-m-tolyl-urea	DM6RO2L	Investigative	Small molecular drug	[495]
1-(3,3-diphenylpropyl)-4-phenylpiperidin-4-ol	DMJDK7Z	Investigative	Small molecular drug	[446]
1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol	DMN4JU0	Investigative	Small molecular drug	[496]
1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol	DMWIEDN	Investigative	Small molecular drug	[496]
1-(3,4-dichlorobenzyl)-1H-imidazole	DMX6PKO	Investigative	Small molecular drug	[497]
1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione	DMX71K9	Investigative	Small molecular drug	[475]
1-(3,4-dichlorophenyl)-2-(phenylsulfonyl)ethanone	DM4YWEL	Investigative	Small molecular drug	[381]
1-(3,4-dichlorophenyl)-3-(3,5-dichlorophenyl)urea	DMNOQ49	Investigative	Small molecular drug	[498]
1-(3,4-dichlorophenyl)-3-hydroxyurea	DMVOJ7K	Investigative	Small molecular drug	[499]
1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMYZ548	Investigative	Small molecular drug	[500]
1-(3,4-difluorobenzyl)-1H-imidazole	DMRXD2P	Investigative	Small molecular drug	[497]
1-(3,4-dihydronaphthalen-1-yl)ethanone	DM5C7I8	Investigative	Small molecular drug	[451]
1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole	DMP93HZ	Investigative	Small molecular drug	[501]
1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone	DM9M5D1	Investigative	Small molecular drug	[502]
1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone	DMKI719	Investigative	Small molecular drug	[503]
1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione	DMCHILK	Investigative	Small molecular drug	[397]
1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole	DM5WOK8	Investigative	Small molecular drug	[497]
1-(3,5-dibromobenzyl)-1H-imidazole	DMNRCM0	Investigative	Small molecular drug	[497]
1-(3,5-dichlorobenzyl)-1H-imidazole	DMLSWHP	Investigative	Small molecular drug	[497]
1-(3,5-difluorobenzyl)-1H-imidazole	DMEAI6V	Investigative	Small molecular drug	[497]
1-(3,5-dimethylphenyl)-2-(phenylsulfonyl)ethanone	DMYJ4EG	Investigative	Small molecular drug	[381]
1-(3-(2-(3-methoxyphenoxy)ethoxy)propyl)azepane	DMEDSLZ	Investigative	Small molecular drug	[504]
1-(3-(2-methylquinolin-7-yl)phenyl)ethanone	DMD25N9	Investigative	Small molecular drug	[161]
1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea	DM3EBFS	Investigative	Small molecular drug	[505]
1-(3-(3-phenylpropoxy)propyl)piperidine	DM3EYOL	Investigative	Small molecular drug	[506]
1-(3-(4-(2-fluoroethyl)phenoxy)propyl)piperidine	DMHEIKQ	Investigative	Small molecular drug	[507]
1-(3-(4-(fluoromethyl)phenoxy)propyl)piperidine	DMVXCPE	Investigative	Small molecular drug	[507]
1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine	DMM36DE	Investigative	Small molecular drug	[508]
1-(3-(4-chlorophenyl)propyl)-1H-imidazole	DMIFARP	Investigative	Small molecular drug	[509]
1-(3-(4-fluorophenyl)propyl)-1H-imidazole	DMWKXZ2	Investigative	Small molecular drug	[509]
1-(3-(benzyloxy)-2-methylphenyl)piperazine	DMQ4MUF	Investigative	Small molecular drug	[510]
1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine	DMX5N3V	Investigative	Small molecular drug	[511]
1-(3-(phenylthio)propyl)-4-m-tolylpiperazine	DMXUNMW	Investigative	Small molecular drug	[512]
1-(3-Amino-benzyl)-1H-indole-5-carboxamidine	DMEJZAC	Investigative	Small molecular drug	[513]
1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine	DMTY41F	Investigative	Small molecular drug	[508]
1-(3-benzyloxy-pyridin-2-yl)-3-phenyl-urea	DMDZAVU	Investigative	Small molecular drug	[514]
1-(3-benzylquinoxalin-2-yl)hydrazine	DMJCVQN	Investigative	Small molecular drug	[508]
1-(3-Bromobenzyl)-1H-imidazole	DMA59TP	Investigative	Small molecular drug	[160]
1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone	DM58S47	Investigative	Small molecular drug	[515]
1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one	DM2SEXH	Investigative	Small molecular drug	[516]
1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)	DMJXOUK	Investigative	Small molecular drug	[463]
1-(3-Chloro-phenyl)-3-(4-hydroxy-decyl)-urea	DMC5PI4	Investigative	Small molecular drug	[517]
1-(3-Chloro-phenyl)-3-cyclohexyl-urea	DM1VLMC	Investigative	Small molecular drug	[517]
1-(3-Chlorobenzyl)-1H-imidazole	DM3SQBH	Investigative	Small molecular drug	[160]
1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one	DMFYJ5V	Investigative	Small molecular drug	[516]
1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one	DMPOVUY	Investigative	NA	[516]
1-(3-chloropyridin-2-yl)-4-tosylpiperazine	DM6LWR2	Investigative	Small molecular drug	[518]
1-(3-cyano-1-methyl-1H-indol-6-yl)-3-phenylurea	DM8DR1B	Investigative	Small molecular drug	[519]
1-(3-cyano-2-hydroxyphenyl)-3-phenylurea	DM9KTH6	Investigative	Small molecular drug	[476]
1-(3-Cyano-phenyl)-1H-pyrazole-4-carboxylic acid	DMVTCGP	Investigative	Small molecular drug	[520]
1-(3-Fluoro-phenyl)-piperazine	DM2SNR0	Investigative	Small molecular drug	[477]
1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine	DMWFU3T	Investigative	Small molecular drug	[367]
1-(3-Fluorobenzyl)-1H-imidazole	DM18DB3	Investigative	Small molecular drug	[160]
1-(3-Hydroxyphenyl)-4-propylpiperazine	DMQHFOX	Investigative	Small molecular drug	[521]
1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMPEZ1V	Investigative	Small molecular drug	[489]
1-(3-Methoxy-benzyl)-5-methyl-1H-indole-2,3-dione	DM30M9H	Investigative	Small molecular drug	[178]
1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole	DM16U5F	Investigative	Small molecular drug	[522]
1-(3-methoxyphenethyl)pyrrolidine	DMGU7MO	Investigative	Small molecular drug	[258]
1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone	DMR0ICB	Investigative	Small molecular drug	[381]
1-(3-Methylbutylidene)thiosemicarbazide	DMI15LJ	Investigative	Small molecular drug	[466]
1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMB9T6F	Investigative	Small molecular drug	[489]
1-(3-methylpyridin-2-yl)-4-tosylpiperazine	DMYH9M0	Investigative	Small molecular drug	[518]
1-(3-Nitro-benzyl)-1H-indole-5-carboxamidine	DM3RGLE	Investigative	Small molecular drug	[513]
1-(3-Nitro-phenyl)-piperazine	DMMJC5E	Investigative	Small molecular drug	[477]
1-(3-nitropyridin-2-yl)-4-tosylpiperazine	DM3FP6J	Investigative	Small molecular drug	[518]
1-(3-Oxocyclohexylidene)thiosemicarbazide	DMEMHIF	Investigative	Small molecular drug	[466]
1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine	DMG8DLM	Investigative	Small molecular drug	[368]
1-(3-Phenyl-propyl)-3-thiazol-2-yl-thiourea	DM37RI9	Investigative	Small molecular drug	[481]
1-(3-Phenylallylidene)thiosemicarbazide	DMFPUGV	Investigative	Small molecular drug	[466]
1-(3-phenylpropyl)-1H-imidazole	DMPAWFJ	Investigative	Small molecular drug	[509]
1-(3-tritylaminopropyl)uracil	DMZPJM4	Investigative	Small molecular drug	[523]
1-(4-(1H-pyrazol-1-yl)benzyl)-4-phenylpiperazine	DMUDVRM	Investigative	Small molecular drug	[524]
1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea	DMYIK9W	Investigative	Small molecular drug	[505]
1-(4-(4-phenyl-1-piperazinyl)butyl)indolin-2-one	DMM18AQ	Investigative	Small molecular drug	[525]
1-(4-(benzyloxy)phenethyl)pyrrolidine	DMT3H0K	Investigative	Small molecular drug	[258]
1-(4-(benzyloxy)phenyl)-3-hydroxyurea	DM7FWK8	Investigative	Small molecular drug	[526]
1-(4-(benzyloxy)phenyl)propan-2-amine	DMT81N3	Investigative	Small molecular drug	[205]
1-(4-(Hexyloxy)phenyl)-3-morpholinopropan-1-one	DMLODAM	Investigative	Small molecular drug	[527]
1-(4-(methylsulfonyl)phenyl)-1H-indole	DMCE7G0	Investigative	Small molecular drug	[528]
1-(4-(methylsulfonyl)phenyl)-1H-pyrrole	DMYFBRQ	Investigative	Small molecular drug	[528]
1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea	DMMSQLC	Investigative	Small molecular drug	[529]
1-(4-(methylsulfonyl)phenyl)-3-phenylurea	DMH7RY0	Investigative	Small molecular drug	[529]
1-(4-acetyloxazol-2-yl)-7-phenylheptan-1-one	DM170BV	Investigative	Small molecular drug	[530]
1-(4-Aminobenzyl)-1H-imidazole	DMOZAM6	Investigative	Small molecular drug	[160]
1-(4-Aminophenyl)-2-(1H-imidazol-1-yl)ethanone	DMMYT4W	Investigative	Small molecular drug	[531]
1-(4-aminophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMY7TDZ	Investigative	Small molecular drug	[532]
1-(4-aminophenylsulfonyl)-3-(2-mercaptoethyl)urea	DM4G0NH	Investigative	Small molecular drug	[485]
1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene	DMWA6G1	Investigative	Small molecular drug	[533]
1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene	DMP93E2	Investigative	Small molecular drug	[533]
1-(4-Benzylsulfanyl-phenyl)-propylamine	DMXV9S7	Investigative	Small molecular drug	[534]
1-(4-Bromo-2,5-difluorophenyl)-2-aminopropane	DMMLCSG	Investigative	Small molecular drug	[459]
1-(4-Bromo-2,5-dimethoxy-phenyl)-piperazine	DMCH6R1	Investigative	Small molecular drug	[168]
1-(4-Bromo-benzyl)-3-quinazolin-8-yl-urea	DMTPD4R	Investigative	Small molecular drug	[535]
1-(4-Bromobenzyl)-1H-imidazole	DM2C7U0	Investigative	Small molecular drug	[509]
1-(4-Bromobenzyl)-5-phenyl-1H-imidazole	DMCW8RT	Investigative	Small molecular drug	[160]
1-(4-bromooxazol-2-yl)-7-phenylheptan-1-one	DMUMNYZ	Investigative	Small molecular drug	[530]
1-(4-bromophenethyl)-1H-imidazole	DME8B15	Investigative	Small molecular drug	[509]
1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one	DMW6YDK	Investigative	Small molecular drug	[516]
1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMPLEC0	Investigative	Small molecular drug	[489]
1-(4-bromophenyl)-3-hydroxyurea	DMEUHDL	Investigative	Small molecular drug	[526]
1-(4-Butoxy-phenyl)-1H-imidazole	DMOEGZV	Investigative	Small molecular drug	[536]
1-(4-butoxyphenyl)propan-2-amine	DM7GIZL	Investigative	Small molecular drug	[205]
1-(4-Butyl-thiazol-2-yl)-3-phenethyl-thiourea	DMIGDCK	Investigative	Small molecular drug	[481]
1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione	DMOGVZ2	Investigative	Small molecular drug	[397]
1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione	DMCDV1O	Investigative	Small molecular drug	[397]
1-(4-Chloro-phenyl)-3-(3,3-diphenyl-allyl)-urea	DM3YI5G	Investigative	Small molecular drug	[495]
1-(4-Chloro-phenyl)-3-(3-pentyl-oct-2-enyl)-urea	DMUW1GI	Investigative	Small molecular drug	[495]
1-(4-chlorobenzyl)-1H-imidazole	DMBR9TQ	Investigative	Small molecular drug	[509]
1-(4-chlorobenzyl)-1H-indole-2,3-dione	DMOUPNT	Investigative	Small molecular drug	[475]
1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole	DMASLUF	Investigative	Small molecular drug	[160]
1-(4-chlorooxazol-2-yl)-7-phenylheptan-1-one	DMXGB38	Investigative	Small molecular drug	[530]
1-(4-chlorophenethyl)-1H-imidazole	DM9MDZG	Investigative	Small molecular drug	[509]
1-(4-CHLOROPHENYL)-2-(2,4-DICHLOROPHENYL)-5-(METHYLSULFINYL)-N-(PIPERIDIN-1-YL)-1H-IMIDAZOLE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	DMV8C7I	Investigative	Small molecular drug	[537]
1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone	DMQHTR4	Investigative	Small molecular drug	[381]
1-(4-chlorophenyl)-4-phenyl-1H-imidazole	DMVCHSI	Investigative	Small molecular drug	[538]
1-(4-chlorophenylsulfonyl)-4-phenylazepan-4-ol	DMEJXWG	Investigative	Small molecular drug	[187]
1-(4-cyano-2-hydroxyphenyl)-3-phenylurea	DMIU3C8	Investigative	Small molecular drug	[476]
1-(4-Cyano-thiazol-2-yl)-3-phenethyl-thiourea	DM9EK3T	Investigative	Small molecular drug	[481]
1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole	DMKDAJ2	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole	DMAJXYO	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole	DMVS4D5	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole	DMI8UC7	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole	DM7C3VD	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole	DMQX37R	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole	DM372EG	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-bromo-1H-imidazole	DMBUMDG	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-formyl-1H-imidazole	DM2THVK	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole	DMCUE25	Investigative	Small molecular drug	[160]
1-(4-Cyanobenzyl)-5-methyl-1H-imidazole	DMKC52N	Investigative	NA	[160]
1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole	DMQF8DY	Investigative	Small molecular drug	[160]
1-(4-ethoxyphenyl)propan-2-amine	DMZR94D	Investigative	Small molecular drug	[205]
1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine	DMIYLXU	Investigative	Small molecular drug	[459]
1-(4-ethylphenylsulfonyl)-4-phenylazepan-4-ol	DMXUIS2	Investigative	Small molecular drug	[187]
1-(4-ethylpiperazin-1-yl)-2-phenylethanone	DMRK0Z1	Investigative	Small molecular drug	[539]
1-(4-fluorobenzyl)-1H-imidazole	DMBJCGA	Investigative	Small molecular drug	[509]
1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole	DMT2ZSV	Investigative	Small molecular drug	[160]
1-(4-fluorophenyl)-2-(phenylsulfonyl)ethanone	DMZLNAP	Investigative	Small molecular drug	[381]
1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DM6ARQF	Investigative	Small molecular drug	[489]
1-(4-fluorophenyl)-3-(phenylsulfonyl)propan-1-one	DMKATOJ	Investigative	Small molecular drug	[381]
1-(4-heptylphenyl)prop-2-en-1-one	DMIQ0VA	Investigative	Small molecular drug	[185]
1-(4-hexylphenyl)-3-(propylamino)propan-1-one	DM5QLGH	Investigative	Small molecular drug	[185]
1-(4-hexylphenyl)-3-morpholinopropan-1-one	DMFN8T6	Investigative	Small molecular drug	[185]
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE	DMX7PJH	Investigative	Small molecular drug	[22]
1-(4-hydroxyphenyl)prop-2-en-1-one	DM145QS	Investigative	Small molecular drug	[540]
1-(4-iodobenzyl)-1H-imidazole	DMM17I0	Investigative	Small molecular drug	[541]
1-(4-iodooxazol-2-yl)-7-phenylheptan-1-one	DMDY93H	Investigative	Small molecular drug	[530]
1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DMBV8PT	Investigative	Small molecular drug	[489]
1-(4-Methoxy-benzenesulfonyl)-heptane-3-thiol	DMZWRU7	Investigative	Small molecular drug	[542]
1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione	DM5R8KU	Investigative	Small molecular drug	[397]
1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole	DMSWJKZ	Investigative	Small molecular drug	[160]
1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one	DMEPJRD	Investigative	Small molecular drug	[530]
1-(4-methoxyphenethyl)pyrrolidine	DMAW78K	Investigative	Small molecular drug	[258]
1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone	DMRC7V8	Investigative	Small molecular drug	[381]
1-(4-methoxyphenyl)-3-(1,3,4-thiadiazol-2-yl)urea	DMNJ2CS	Investigative	Small molecular drug	[543]
1-(4-methoxyphenyl)-3-(4-methylthiazol-2-yl)urea	DMYPC0W	Investigative	Small molecular drug	[543]
1-(4-methoxyphenyl)-3-(5-methylthiazol-2-yl)urea	DMVWIE5	Investigative	Small molecular drug	[543]
1-(4-methoxyphenylsulfonyl)-4-phenylazepan-4-ol	DMG7PKA	Investigative	Small molecular drug	[187]
1-(4-methyl-benzyl)-1H-imidazole	DM48ISZ	Investigative	Small molecular drug	[497]
1-(4-methyloxazol-2-yl)-7-phenylheptan-1-one	DMVI2PM	Investigative	Small molecular drug	[530]
1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide	DM3NVLB	Investigative	Small molecular drug	[466]
1-(4-nitro-2-phenoxybenzyl)-1H-imidazole	DMSRBUE	Investigative	Small molecular drug	[494]
1-(4-Nitro-2-phenylsulfanylbenzyl)-1H-imidazole	DMCP089	Investigative	Small molecular drug	[494]
1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione	DMOC67J	Investigative	Small molecular drug	[397]
1-(4-nitrobenzyl)-1H-imidazole	DMKT2MB	Investigative	Small molecular drug	[497]
1-(4-nitrophenethyl)pyrrolidine	DMKR8BI	Investigative	Small molecular drug	[258]
1-(4-nitrophenyl)-2-(phenylsulfonyl)ethanone	DM1M67Q	Investigative	Small molecular drug	[381]
1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one	DME435S	Investigative	Small molecular drug	[489]
1-(4-nonylbenzyl)azetidine-3-carboxylic acid	DMQKMCG	Investigative	Small molecular drug	[544]
1-(4-nonylbenzyl)pyrrolidin-3-ylphosphonic acid	DM8U2HP	Investigative	Small molecular drug	[544]
1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid	DMAR39L	Investigative	Small molecular drug	[544]
1-(4-octylphenyl)prop-2-en-1-one	DM9KVBJ	Investigative	Small molecular drug	[185]
1-(4-p-Tolyl-butyl)-piperidine	DMFYK6T	Investigative	Small molecular drug	[545]
1-(4-Phenoxyphenyl)piperazine	DMVCM0I	Investigative	Small molecular drug	[265]
1-(4-propoxyphenyl)propan-2-amine	DMKNA5U	Investigative	Small molecular drug	[205]
1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane	DMM7IJZ	Investigative	Small molecular drug	[187]
1-(4-tert-butylphenylsulfonyl)azepan-4-ol	DMQECWT	Investigative	Small molecular drug	[187]
1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one	DMPL3UZ	Investigative	Small molecular drug	[445]
1-(5-(pyridin-2-yl)oxazol-2-yl)dodecan-1-one	DM4V9IB	Investigative	Small molecular drug	[359]
1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one	DMICZK0	Investigative	Small molecular drug	[445]
1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one	DMZNEIB	Investigative	Small molecular drug	[359]
1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one	DM6FDAY	Investigative	Small molecular drug	[359]
1-(5-chloro-2-hydroxy-4-nitrophenyl)-3-phenylurea	DMDTYAF	Investigative	Small molecular drug	[476]
1-(5-fluorooxazol-2-yl)-7-phenylheptan-1-one	DMD8IYZ	Investigative	Small molecular drug	[359]
1-(5-methyloxazol-2-yl)-7-phenylheptan-1-one	DMWQ9ZP	Investigative	Small molecular drug	[359]
1-(5-phenyloxazol-2-yl)octadec-9-en-1-one	DMRITHA	Investigative	Small molecular drug	[445]
1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-yn-1-one	DM4IMON	Investigative	Small molecular drug	[358]
1-(6-Amino-4-methylpyridin-2-yl)propan-2-ol	DMUS9Z3	Investigative	Small molecular drug	[230]
1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole	DMEHK4F	Investigative	Small molecular drug	[522]
1-(7-Hydroxy-naphthalen-1-yl)-3-pyridin-2-yl-urea	DM7OGLI	Investigative	Small molecular drug	[460]
1-(7-Methoxy-2-phenyl-chroman-4-yl)-1H-imidazole	DMLHDE3	Investigative	Small molecular drug	[546]
1-(7-Methoxy-naphthalen-2-yl)-piperazine	DM1MJCE	Investigative	Small molecular drug	[547]
1-(7-methyl-9H-carbazol-3-yl)ethanone	DMKHJBI	Investigative	Small molecular drug	[548]
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	DMC3PYM	Investigative	Small molecular drug	[22]
1-(9-Oxo-9H-fluoren-4-yl)-3-pyridin-2-yl-urea	DM30FNL	Investigative	Small molecular drug	[460]
1-(9-phenyl-9H-fluoren-9-yl)-1H-1,2,4-triazole	DMVJZ0C	Investigative	Small molecular drug	[469]
1-(9-Phenyl-9H-fluoren-9-yl)1H-imidazole	DMLIJYS	Investigative	Small molecular drug	[549]
1-(9H-beta-Carbolin-3-yl)-butan-1-one	DMA96U5	Investigative	Small molecular drug	[550]
1-(9H-beta-Carbolin-3-yl)-ethanone	DMFOD2L	Investigative	Small molecular drug	[204]
1-(9H-fluoren-9-yl)-1H-imidazole	DMH49OD	Investigative	Small molecular drug	[469]
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	DMOTJWZ	Investigative	Small molecular drug	[22]
1-(Benzhydrylamino)ethaniminium bromide	DMOJC9Z	Investigative	Small molecular drug	[58]
1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane	DMGNL2A	Investigative	Small molecular drug	[214]
1-(benzyloxy)-2-(2-phenylethyl)benzene	DMVSC3O	Investigative	Small molecular drug	[551]
1-(benzyloxy)-2-[2-(3-methoxyphenyl)ethyl]benzene	DMVB7P3	Investigative	Small molecular drug	[551]
1-(biphenyl-3-ylmethyl)-1H-1,2,4-triazole	DMGVPMT	Investigative	Small molecular drug	[552]
1-(biphenyl-4-yl)-3-(4-(piperidin-1-yl)butyl)urea	DM5KZ74	Investigative	Small molecular drug	[553]
1-(bis(3-bromophenyl)methylene)thiosemicarbazide	DMTZ71K	Investigative	Small molecular drug	[451]
1-(bis(4-bromophenyl)methyl)-3-phenylurea	DMYO8D3	Investigative	Small molecular drug	[554]
1-(bis(4-chlorophenyl)methyl)-3-phenylurea	DMTVNO3	Investigative	Small molecular drug	[554]
1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole	DMF3D5R	Investigative	Small molecular drug	[443]
1-(But-2-enylidene)thiosemicarbazide	DMEULBF	Investigative	Small molecular drug	[466]
1-(but-2-ylamino)ethyl 1,I-bisphosphonic acid	DMTMZAJ	Investigative	Small molecular drug	[101]
1-(Butan-2-ylidene)thiosemicarbazide	DMXU1EF	Investigative	Small molecular drug	[466]
1-(cyclohexyl)methyl-5'-O-tritylinosine	DMS3XUC	Investigative	Small molecular drug	[555]
1-(cyclopropyl)methyl-5'-O-tritylinosine	DMDU3X7	Investigative	Small molecular drug	[555]
1-(dio-tolylmethyl)-4-phenylpiperidin-4-ol	DMLYO8P	Investigative	Small molecular drug	[446]
1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	DMBTLIJ	Investigative	Small molecular drug	[22]
1-(isoquinolin-5-yl)-3-(1-phenylpropyl)urea	DMOTICP	Investigative	Small molecular drug	[256]
1-(isoquinolin-5-yl)-3-(4-morpholinobenzyl)urea	DMHWITR	Investigative	Small molecular drug	[556]
1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMI479T	Investigative	Small molecular drug	[500]
1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane	DMUEQC8	Investigative	Small molecular drug	[214]
1-(oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one	DMXT2ZL	Investigative	Small molecular drug	[557]
1-(oxazol-2-yl)-4-(piperidin-4-yl)butan-1-one	DMEOS8P	Investigative	Small molecular drug	[558]
1-(oxazol-2-yl)-7-phenylheptan-1-one	DMLKA5O	Investigative	Small molecular drug	[530]
1-(oxazol-2-yl)octadec-9-en-1-one	DM1ATS3	Investigative	Small molecular drug	[445]
1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one	DMT7P2Z	Investigative	Small molecular drug	[359]
1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one	DMFGUXZ	Investigative	Small molecular drug	[359]
1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one	DMH2G13	Investigative	Small molecular drug	[359]
1-(pentyloxy)-4-phenoxybenzene	DMJQ7T0	Investigative	Small molecular drug	[559]
1-(phenyl(p-tolyl)methylene)thiosemicarbazide	DMU10CY	Investigative	Small molecular drug	[449]
1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine	DM8APLN	Investigative	Small molecular drug	[491]
1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole	DM7W25U	Investigative	Small molecular drug	[560]
1-(phenylsulfonyl)butan-2-one	DMRGD8W	Investigative	Small molecular drug	[381]
1-(piperazin-1-yl)isoquinoline	DMEP80C	Investigative	Small molecular drug	[561]
1-(piperidin-3-ylmethyl)pyridin-2(1H)-one	DMVRN0I	Investigative	Small molecular drug	[562]
1-(piperidin-4-ylmethyl)pyridin-2(1H)-one	DMKQZB7	Investigative	Small molecular drug	[562]
1-(Propan-2-ylidene)thiosemicarbazide	DMO10FD	Investigative	Small molecular drug	[466]
1-(pyridin-2-yl)piperazine	DMKE7FG	Investigative	Small molecular drug	[367]
1-(pyridin-4-yl)piperazine	DM78AJ1	Investigative	Small molecular drug	[563]
1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane	DM6J1AK	Investigative	Small molecular drug	[214]
1-(trifluoromethyl)-9H-carbazole	DMD6CHB	Investigative	Small molecular drug	[548]
1-1-1-trichloroethane	DM7PE73	Investigative	Small molecular drug	[564]
1-3 Sugar Ring of Pentamannosyl 6-Phosphate	DMRO1IU	Investigative	Small molecular drug	[12]
1-acetamido-5-sulfonamidoindane	DM92ZCU	Investigative	NA	[565]
1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine	DM7DL03	Investigative	Small molecular drug	[402]
1-Acetoxylycorine	DMQH1MS	Investigative	Small molecular drug	[402]
1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea	DMRJSG7	Investigative	Small molecular drug	[566]
1-adamantan-1-yl-3-(1-benzyl-piperidin-4-yl)-urea	DMNXU1O	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea	DMAJC42	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea	DMY1Z2X	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea	DM2K7TX	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-(2-heptyloxyethyl)urea	DMRIYX9	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-(2-hydroxy-phenyl)-urea	DMJ8ZS6	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-(2-hydroxyethyl)urea	DMDO9YM	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-(2-methoxy-phenyl)-urea	DMRBVFO	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-(3-hexyloxypropyl)urea	DMGEXOZ	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-(3-hydroxy-phenyl)-urea	DM8SEJP	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-(3-hydroxypropyl)urea	DMZX72E	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-(3-methoxy-phenyl)-urea	DMHAS3G	Investigative	Small molecular drug	[569]
1-Adamantan-1-yl-3-(4-hydroxy-decyl)-urea	DMHKG89	Investigative	Small molecular drug	[517]
1-Adamantan-1-yl-3-(4-hydroxy-phenyl)-urea	DMUPAR1	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-(4-hydroxybutyl)urea	DM53G1V	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-(4-methoxy-phenyl)-urea	DMMBYOD	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-(4-pentyloxybutyl)urea	DM3RE2D	Investigative	Small molecular drug	[568]
1-adamantan-1-yl-3-(4-pentyloxycylclohexyl)urea	DMUZ3OS	Investigative	Small molecular drug	[568]
1-adamantan-1-yl-3-(5-butoxypentyl)urea	DMEDQVX	Investigative	Small molecular drug	[568]
1-adamantan-1-yl-3-(5-hydroxypentyl)urea	DMV6824	Investigative	Small molecular drug	[568]
1-adamantan-1-yl-3-(6-hydroxyhexyl)urea	DMOX5MC	Investigative	Small molecular drug	[568]
1-adamantan-1-yl-3-(6-propyloxyhexyl)urea	DMO1L3I	Investigative	Small molecular drug	[568]
1-Adamantan-1-yl-3-decyl-urea	DMLD2G3	Investigative	Small molecular drug	[517]
1-Adamantan-1-yl-3-phenyl-urea	DMCFKX0	Investigative	Small molecular drug	[569]
1-adamantan-1-yl-3-piperidin-4-yl-urea	DMTNPBH	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea	DMGPIL0	Investigative	Small molecular drug	[567]
1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea	DMXRHKQ	Investigative	Small molecular drug	[570]
1-Adamantan-1-ylmethyl-3-thiazol-2-yl-thiourea	DM60Y8M	Investigative	Small molecular drug	[458]
1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole	DMQJ9RZ	Investigative	Small molecular drug	[571]
1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one	DMNDW4J	Investigative	Small molecular drug	[572]
1-Allyl-3,7-dihydro-purine-2,6-dione	DML54H2	Investigative	Small molecular drug	[573]
1-Allyl-3,7-dimethyl-3,7-dihydro-purine-2,6-dione	DMZE5GX	Investigative	Small molecular drug	[411]
1-allyl-5'-O-tritylinosine	DM2J5WH	Investigative	Small molecular drug	[555]
1-amino-2,4-bis(phenylthio)anthracene-9,10-dione	DMRAN9T	Investigative	Small molecular drug	[162]
1-amino-2-phenoxyanthracene-9,10-dione	DMWCXM4	Investigative	Small molecular drug	[162]
1-Amino-3-(aminoxy)-2-propanol Dihydrochloride	DMOAQC4	Investigative	Small molecular drug	[574]
1-amino-4-chloroanthracene-9,10-dione	DMJMDNX	Investigative	Small molecular drug	[162]
1-amino-4-methoxyanthracene-9,10-dione	DM7X5BP	Investigative	Small molecular drug	[162]
1-Amino-6-Cyclohex-3-Enylmethyloxypurine	DM6AV2S	Investigative	Small molecular drug	[12]
1-aminoanthracene-9,10-dione	DMGU76I	Investigative	Small molecular drug	[162]
1-aminobutylphosphonic acid	DM4TFN6	Investigative	Small molecular drug	[575]
1-aminohexylphosphonic acid	DMFUABI	Investigative	Small molecular drug	[575]
1-aminohexylphosphonic acid monophenyl ester	DML6UJM	Investigative	Small molecular drug	[575]
1-Aminomethyl-3-cyclohexyl-isochroman-5,6-diol	DMBWNL6	Investigative	Small molecular drug	[576]
1-Aminomethyl-3-phenyl-isochroman-5,6-diol	DMJNG8A	Investigative	Small molecular drug	[577]
1-Aminomethyl-isochroman-5,6-diol	DM50GS7	Investigative	Small molecular drug	[577]
1-aminopentylphosphonic acid monophenyl ester	DMMV30B	Investigative	Small molecular drug	[575]
1-Aminopropane-1,2,3-tricarboxylic acid	DMPYCK5	Investigative	Small molecular drug	[578]
1-arylmethylpyrrolidin-2-yl ethanol amine	DMJD1QF	Investigative	Small molecular drug	[579]
1-benzene sulfonyl-cis-2,6-dimethyl piperidine	DMQ1EVT	Investigative	Small molecular drug	[580]
1-Benzenesulfonyl-2-nitro-benzene	DM781L6	Investigative	Small molecular drug	[581]
1-Benzenesulfonyl-3-piperidin-3-yl-1H-indole	DM1N4LK	Investigative	Small molecular drug	[582]
1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole	DMRA9VG	Investigative	Small molecular drug	[583]
1-benzhydryl-3-(isoquinolin-5-yl)urea	DMQSK3H	Investigative	Small molecular drug	[256]
1-benzhydryl-3-butylpiperidin-4-amine	DMBAZG3	Investigative	Small molecular drug	[177]
1-benzhydryl-4-(2-fluorophenyl)piperidin-4-ol	DMTANPG	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(2-methoxyphenyl)piperidin-4-ol	DMWHMNY	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(3,3-diphenylpropyl)piperazine	DMTYKMR	Investigative	Small molecular drug	[585]
1-benzhydryl-4-(3-fluorophenyl)piperidin-4-ol	DMXZFPB	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(3-methoxyphenyl)piperidin-4-ol	DM1QYS8	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(3-phenylpropyl)piperidin-4-ol	DMIT7SH	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4,4-diphenylbutyl)piperazine	DM5SWL7	Investigative	Small molecular drug	[585]
1-benzhydryl-4-(4-bromophenyl)piperidin-4-ol	DM0BQYX	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-butylphenyl)piperidin-4-ol	DMMAJW9	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-chlorophenyl)piperidin-4-ol	DMWYG8K	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-ethylphenyl)piperidin-4-ol	DME0BJD	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-fluorophenyl)piperidin-4-ol	DMRNZD6	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-methoxyphenyl)piperidin-4-ol	DMXT894	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(4-propylphenyl)piperidin-4-ol	DMJDUM5	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(benzyloxy)-4-phenylpiperidine	DMDRUBL	Investigative	Small molecular drug	[446]
1-benzhydryl-4-(furan-2-yl)piperidin-4-ol	DMMB2GV	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(pyridin-2-yl)piperidin-4-ol	DMJ8F60	Investigative	Small molecular drug	[584]
1-benzhydryl-4-(thiophen-2-yl)piperidin-4-ol	DMNOZR2	Investigative	Small molecular drug	[584]
1-benzhydryl-4-benzylpiperidin-4-ol	DMVBR36	Investigative	Small molecular drug	[584]
1-benzhydryl-4-butylpiperidin-4-ol	DMRN7SC	Investigative	Small molecular drug	[584]
1-benzhydryl-4-cyclohexylpiperidin-4-ol	DMZVSYD	Investigative	Small molecular drug	[584]
1-benzhydryl-4-cyclopropylpiperidin-4-ol	DMM94Y2	Investigative	Small molecular drug	[584]
1-benzhydryl-4-ethoxy-4-phenylpiperidine	DM6PIL2	Investigative	Small molecular drug	[446]
1-benzhydryl-4-hexylpiperidin-4-ol	DMUK95S	Investigative	Small molecular drug	[584]
1-benzhydryl-4-isopropylpiperidin-4-ol	DMGYCQ3	Investigative	Small molecular drug	[584]
1-benzhydryl-4-m-tolylpiperidin-4-ol	DMVJH1S	Investigative	Small molecular drug	[584]
1-benzhydryl-4-methoxy-4-phenylpiperidine	DMBG0N8	Investigative	Small molecular drug	[446]
1-benzhydryl-4-o-tolylpiperidin-4-ol	DMVUMSF	Investigative	Small molecular drug	[584]
1-benzhydryl-4-p-tolylpiperidin-4-ol	DM679RC	Investigative	Small molecular drug	[584]
1-benzhydryl-4-phenyl-4-propoxypiperidine	DMEB968	Investigative	Small molecular drug	[446]
1-benzhydryl-4-phenylpiperidin-4-ol	DM7KU1X	Investigative	Small molecular drug	[586]
1-benzhydryl-4-tert-butylpiperidin-4-ol	DMM5DTF	Investigative	Small molecular drug	[584]
1-Benzooxazol-2-yl-6-phenyl-hexan-1-one	DM153Y8	Investigative	Small molecular drug	[358]
1-Benzothiazol-2-yl-3-phenethyl-thiourea	DMEZPC8	Investigative	Small molecular drug	[481]
1-benzoyl-2-benzyl-1,2-dihydropyridin-3(6H)-one	DMF9X2T	Investigative	Small molecular drug	[155]
1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide	DMG5MNZ	Investigative	Small molecular drug	[114]
1-Benzo[b]thiophen-2-yl-cycloheptylamine	DMMN5TA	Investigative	Small molecular drug	[455]
1-Benzo[b]thiophen-2-yl-cyclohexylamine	DMR97FU	Investigative	Small molecular drug	[455]
1-Benzo[b]thiophen-2-yl-cyclopentylamine	DM6EF1L	Investigative	Small molecular drug	[455]
1-Benzyl-1,2-dihydro-indazol-3-one	DM17TIX	Investigative	Small molecular drug	[406]
1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide	DMUXSH5	Investigative	Small molecular drug	[426]
1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione	DMYGZ8V	Investigative	Small molecular drug	[587]
1-benzyl-1H-indole-2,3-dione	DM2UFXE	Investigative	Small molecular drug	[475]
1-Benzyl-1H-indole-5-carboxamidine	DMW0Y92	Investigative	Small molecular drug	[513]
1-benzyl-1H-pyrrolo[3,2-b]pyridine	DMEVSFY	Investigative	Small molecular drug	[491]
1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid	DMQFS2D	Investigative	Small molecular drug	[588]
1-Benzyl-2-methyl-1H-imidazole	DMEVO6M	Investigative	Small molecular drug	[58]
1-benzyl-3,3-diethylazetidine-2,4-dione	DMPTMKU	Investigative	Small molecular drug	[589]
1-benzyl-3,3-dimethylazetidine-2,4-dione	DMW59XA	Investigative	Small molecular drug	[589]
1-Benzyl-3-methyl-3,7-dihydro-purine-2,6-dione	DMMRV21	Investigative	Small molecular drug	[573]
1-Benzyl-3-phenylquinazoline-2,4(1H,3H)-dione	DMV7UC0	Investigative	Small molecular drug	[590]
1-Benzyl-3-thiazol-2-yl-thiourea	DMNWGOE	Investigative	Small molecular drug	[481]
1-benzyl-4-(2,4-dichlorophenyl)pyrrolidin-3-amine	DMGDY4X	Investigative	Small molecular drug	[591]
1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine	DMF0GXD	Investigative	Small molecular drug	[592]
1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine	DMBRJ5S	Investigative	Small molecular drug	[592]
1-Benzyl-4-(2-oxazol-5-yl-pyrrol-1-yl)-piperidine	DMSBNY8	Investigative	Small molecular drug	[592]
1-Benzyl-4-(3-hydroxyphenyl)piperidine	DMCO0JU	Investigative	Small molecular drug	[521]
1-Benzyl-4-(3-oxazol-5-yl-pyrrol-1-yl)-piperidine	DMCJZVA	Investigative	Small molecular drug	[592]
1-Benzyl-4-(4-phenylpiperazin-1-yl)phthalazine	DM4NGUL	Investigative	Small molecular drug	[593]
1-Benzyl-4-chroman-2-ylmethyl-piperazine	DMAQSBV	Investigative	Small molecular drug	[594]
1-Benzyl-4-methyl-piperazine	DMETDQC	Investigative	Small molecular drug	[595]
1-benzyl-4-phenylpiperidin-4-ol	DMNTELW	Investigative	Small molecular drug	[446]
1-Benzyl-4-pyrrol-1-yl-piperidine	DMNWEC9	Investigative	Small molecular drug	[592]
1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperazine	DMOF07G	Investigative	Small molecular drug	[521]
1-Benzyl-4-[3-(methylsulfonyl)phenyl]piperidine	DME0MDL	Investigative	Small molecular drug	[521]
1-benzyl-5'-O-tritylinosine	DMH0ZVR	Investigative	Small molecular drug	[555]
1-Benzyl-5-phenyl-1H-imidazole	DM8GUN9	Investigative	Small molecular drug	[160]
1-Benzyl-7-chloro-4-hexyloxy-quinolinium	DMCX3N1	Investigative	Small molecular drug	[596]
1-benzyl-APDC	DMJHXMY	Investigative	Small molecular drug	[597]
1-benzylpiperidine hydrochloride	DM7GDEK	Investigative	Small molecular drug	[598]
1-biphenyl-2-ylmethanamine	DMKJYCU	Investigative	Small molecular drug	[22]
1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane	DM6E7TA	Investigative	Small molecular drug	[214]
1-Biphenyl-4-ylmaleimide	DM9QTWB	Investigative	Small molecular drug	[382]
1-Biphenyl-4-ylmethylmaleimide	DMKL201	Investigative	Small molecular drug	[382]
1-Bromo-4-imidazol-1-ylmethyl-xanthen-9-one	DMGL4MJ	Investigative	Small molecular drug	[599]
1-Bromo-6-(3-hydroxyphenyl)-2-naphthol	DMU2PSQ	Investigative	Small molecular drug	[600]
1-Bromo-6-(4-hydroxy-phenyl)-naphthalen-2-ol	DM2T4NL	Investigative	Small molecular drug	[441]
1-butoxy-4-phenoxybenzene	DMXMATS	Investigative	Small molecular drug	[559]
1-Butyl-3,7-dihydro-purine-2,6-dione	DMOE2ZV	Investigative	Small molecular drug	[573]
1-Butyl-3-(2-dimethylamino-ethyl)-1H-indol-4-ol	DMO7NXE	Investigative	Small molecular drug	[480]
1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione	DM9GRN8	Investigative	Small molecular drug	[601]
1-Butyl-4-(2-methoxy-phenyl)-piperazine	DM6QULO	Investigative	Small molecular drug	[486]
1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione	DMSNK98	Investigative	Small molecular drug	[602]
1-butyryl-1H-indole-2,3-dione	DMVFCLO	Investigative	Small molecular drug	[475]
1-Chloro-4-(1-phenyl-cyclohexanesulfonyl)-benzene	DM13HGN	Investigative	Small molecular drug	[603]
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	DM0MGFQ	Investigative	Small molecular drug	[22]
1-Cycloheptyl-3-(1-propionylpiperidin-4-yl)urea	DMA2607	Investigative	Small molecular drug	[454]
1-cyclohexyl-1-isopropyl-3,3-dimethylselenourea	DMS10LE	Investigative	Small molecular drug	[604]
1-Cyclohexyl-3-(1-propionylpiperidin-4-yl)urea	DMAZYCD	Investigative	Small molecular drug	[454]
1-Cyclohexyl-3-(4-methoxy-phenyl)-urea	DMESUD7	Investigative	Small molecular drug	[517]
1-Cyclohexyl-3-phenethyl-urea	DMH9O6V	Investigative	Small molecular drug	[517]
1-Cyclohexyl-3-phenyl-urea	DM9K8HA	Investigative	Small molecular drug	[517]
1-cyclohexylamido-5-sulfonamidoindane	DMFPQME	Investigative	Small molecular drug	[565]
1-Cyclohexylidenethiosemicarbazide	DM7A50Z	Investigative	Small molecular drug	[466]
1-Cyclopentyl-3,7-dihydro-purine-2,6-dione	DMEMQFH	Investigative	Small molecular drug	[573]
1-Cyclopentylidenethiosemicarbazide	DMDGWAY	Investigative	Small molecular drug	[466]
1-D-glucopyranosyl cytosine	DM4NBUH	Investigative	Small molecular drug	[605]
1-D-glucopyranosyl uracil	DM90ULM	Investigative	Small molecular drug	[605]
1-Deaza-Adenosine	DMG0VN6	Investigative	Small molecular drug	[12]
1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	DMOEQDP	Investigative	Small molecular drug	[12]
1-Deoxy-1-Thio-Heptaethylene Glycol	DMAEWHB	Investigative	Small molecular drug	[22]
1-Deoxy-D-Xylulose-5-Phosphate	DMCSPU4	Investigative	Small molecular drug	[12]
1-Deoxy-Ribofuranose-5'-Phosphate	DMH9WFD	Investigative	Small molecular drug	[12]
1-deoxynojirimycin-1-sulfonic acid	DM6VZJY	Investigative	Small molecular drug	[606]
1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine	DMOL2Y0	Investigative	Small molecular drug	[607]
1-DODECANOL	DM7P3N5	Investigative	Small molecular drug	[22]
1-dodecyl-1H-indole-2,3-dione	DMK6BWV	Investigative	Small molecular drug	[475]
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	DMJBFN0	Investigative	Small molecular drug	[22]
1-Ethyl-3-imidazol-1-ylmethyl-1H-indole	DM5UWH9	Investigative	Small molecular drug	[608]
1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione	DMSFINY	Investigative	Small molecular drug	[411]
1-Ethyl-4-(2-methoxy-phenyl)-piperazine	DMGKP9Y	Investigative	Small molecular drug	[486]
1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole	DMUOSJG	Investigative	Small molecular drug	[609]
1-Ethylidenethiosemicarbazide	DMQRKZO	Investigative	Small molecular drug	[466]
1-fluoro-5-phenyl-3-aza-bicyclo[3.1.0]hexane	DM0Q46C	Investigative	Small molecular drug	[214]
1-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	DM8BC1M	Investigative	Small molecular drug	[441]
1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3)	DM7UK56	Investigative	Small molecular drug	[610]
1-Furan-2-ylmethyl-3-thiazol-2-yl-thiourea	DMF4BCP	Investigative	Small molecular drug	[458]
1-Guanidinium-7-Aminoheptane	DM42IY7	Investigative	Small molecular drug	[12]
1-guanidino-7-isoquinolinesulphonamide	DM48TIN	Investigative	Small molecular drug	[611]
1-guanidino-N-phenyl-7-isoquinolinesulphonamide	DMTF1HL	Investigative	Small molecular drug	[611]
1-hexadecyl-1H-indole-2,3-dione	DM4OWM6	Investigative	Small molecular drug	[475]
1-Hydroxy-1-Thio-Glycerol	DMIOTQ8	Investigative	Small molecular drug	[12]
1-Hydroxy-10H-anthracen-9-one	DM235CQ	Investigative	Small molecular drug	[407]
1-Hydroxy-2-Amino-3-Cyclohexylpropane	DM9EWN8	Investigative	Small molecular drug	[12]
1-hydroxy-2-dodecyl-4(1H)quinolone	DMGBSWP	Investigative	Small molecular drug	[612]
1-hydroxy-3-(4-(trifluoromethyl)phenyl)urea	DMGNVEF	Investigative	Small molecular drug	[526]
1-hydroxy-3-(4-nitrophenyl)urea	DMZ7GUP	Investigative	Small molecular drug	[526]
1-Hydroxy-3-Methylbutane	DMZ8IL9	Investigative	Small molecular drug	[12]
1-hydroxy-3-phenylurea	DM4TSVC	Investigative	Small molecular drug	[526]
1-Hydroxy-8-methoxy-10H-anthracen-9-one	DMRNO5U	Investigative	Small molecular drug	[407]
1-Hydroxyamine-2-Isobutylmalonic Acid	DM6FLXW	Investigative	Small molecular drug	[12]
1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one	DM3JHVL	Investigative	Small molecular drug	[613]
1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one	DMN7KHS	Investigative	Small molecular drug	[599]
1-Imidazol-1-ylmethylxanthen-9-one	DMIDX7P	Investigative	Small molecular drug	[494]
1-Iodyl-3-nitro-benzene	DMYIQDE	Investigative	Small molecular drug	[614]
1-Iodyl-4-nitro-benzene	DMF1WA6	Investigative	Small molecular drug	[614]
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	DMD7WNV	Investigative	Small molecular drug	[12]
1-methoxy-3-(3-(pyridin-4-yl)-1H-indol-6-yl)urea	DM7DTRM	Investigative	Small molecular drug	[519]
1-Methoxy-3-(oxiran-2-ylmethoxy)-9H-xanthen-9-one	DMFVSBK	Investigative	Small molecular drug	[615]
1-Methoxy-6-phenyl-6H-benzo[c]chromen-8-ylamine	DM8YQ2O	Investigative	Small molecular drug	[616]
1-Methoxy-6-phenyl-6H-benzo[c]chromene	DM2D5HB	Investigative	Small molecular drug	[616]
1-methoxy-9-aminomethyl-9,10-dihydroanthracene	DMAUZHJ	Investigative	Small molecular drug	[617]
1-Methyl-1,2,3,4-tetrahydro-isoquinoline-6,7-diol	DMI6P91	Investigative	Small molecular drug	[618]
1-Methyl-1,2-dihydro-indazol-3-one	DM1BGQN	Investigative	Small molecular drug	[406]
1-Methyl-1,3-dihydro-indol-2-one	DMMX7V8	Investigative	NA	[619]
1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea	DM9KCXI	Investigative	Small molecular drug	[620]
1-methyl-1H-indole-2,3-dione	DMPW75L	Investigative	Small molecular drug	[475]
1-methyl-1H-indole-3-carbaldehyde	DMDZ1FR	Investigative	Small molecular drug	[621]
1-methyl-1H-indole-3-carbonitrile	DML5FQT	Investigative	Small molecular drug	[519]
1-methyl-1H-indole-3-carboxamide	DMUKAH6	Investigative	Small molecular drug	[621]
1-Methyl-2-(4-phenylsulfanyl-phenyl)-ethylamine	DMYU348	Investigative	Small molecular drug	[534]
1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	DM5GELS	Investigative	Small molecular drug	[12]
1-methyl-3-(phenylcarbamoyloxy)pyridinium bromide	DMC3IGK	Investigative	Small molecular drug	[90]
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID	DMICQWN	Investigative	Small molecular drug	[107]
1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione	DM90LWT	Investigative	Small molecular drug	[601]
1-Methyl-4-(1-phenyl-ethyl)-piperazine	DMBWSCR	Investigative	Small molecular drug	[595]
1-Methyl-4-p-tolyl-piperidine-4-carbonitrile	DM6XFMT	Investigative	Small molecular drug	[622]
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	DMPWB8G	Investigative	Small molecular drug	[623]
1-Methyl-5-(4-phenylazo-phenyl)-piperidin-2-one	DM4HS92	Investigative	Small molecular drug	[624]
1-Methyl-5-oxa-spiro[2.4]heptan-4-one	DMX2FWN	Investigative	Small molecular drug	[379]
1-Methyl-5-phenyl-piperidin-2-one	DMB3JO2	Investigative	Small molecular drug	[624]
1-Methyl-8-phenyl-3,7-dihydro-purine-2,6-dione	DMSTH24	Investigative	Small molecular drug	[625]
1-methylcyclopropanecarboxylic acid	DMDIH07	Investigative	Small molecular drug	[626]
1-Methyloxy-4-Sulfone-Benzene	DMFR7JW	Investigative	Small molecular drug	[12]
1-METHYLXANTHINE	DM2WQ1E	Investigative	Small molecular drug	[418]
1-Morpholin-4-yl-benzo[f]chromen-3-one	DMYOJ01	Investigative	Small molecular drug	[627]
1-N-Acetyl-Beta-D-Glucosamine	DMF87Z5	Investigative	Small molecular drug	[12]
1-Naphthalen-2-yl-1H-imidazole	DMTBZJL	Investigative	Small molecular drug	[522]
1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one	DMU04ZQ	Investigative	Small molecular drug	[489]
1-Naphthalen-2-yl-piperazine	DMJK0MF	Investigative	Small molecular drug	[391]
1-naphthylpiperazine	DM6BIWK	Investigative	Small molecular drug	[628]
1-nitro-2-(2-nitrophenylsulfonyl)benzene	DMP6VOK	Investigative	Small molecular drug	[581]
1-Octyl-3-(1-propionylpiperidin-4-yl)urea	DM9OJ7T	Investigative	Small molecular drug	[454]
1-OH-PGE1	DMYHMEK	Investigative	Small molecular drug	[629]
1-oleoyl glycerol	DM5KU8S	Investigative	Small molecular drug	[630]
1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one	DMPMGLO	Investigative	Small molecular drug	[631]
1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one	DM9BY8D	Investigative	Small molecular drug	[358]
1-palmitoyl-lysophosphatidylcholine	DM9ZK0M	Investigative	Small molecular drug	[632]
1-pentafluorophenylamido-5-sulfonamidoindane	DM9PNTQ	Investigative	Small molecular drug	[565]
1-pentenyl-4-(aminosulfonyl)benzoate	DMNUAB9	Investigative	Small molecular drug	[633]
1-Phenethyl-3,7-dihydro-purine-2,6-dione	DMA29SX	Investigative	Small molecular drug	[573]
1-Phenethyl-3-[1,3,4]thiadiazol-2-yl-thiourea	DM32WSM	Investigative	Small molecular drug	[481]
1-phenyl-1-(piperidin-2-yl)propan-2-one	DM0DH98	Investigative	Small molecular drug	[310]
1-Phenyl-1H-benzoimidazol-5-ol	DMGV6BI	Investigative	Small molecular drug	[634]
1-Phenyl-1H-benzoimidazole	DM8YPH0	Investigative	Small molecular drug	[634]
1-phenyl-1H-indole-2,3-dione	DM74RMP	Investigative	Small molecular drug	[475]
1-phenyl-2-(1-phenyl-1H-tetrazol-5-yloxy)ethanone	DMZM9AI	Investigative	Small molecular drug	[457]
1-Phenyl-2-p-tolyl-ethane-1,2-dione	DMW9CRT	Investigative	Small molecular drug	[397]
1-Phenyl-2-pyridin-3-yl-propan-1-one	DM8EDI7	Investigative	Small molecular drug	[635]
1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea	DM6QU5B	Investigative	Small molecular drug	[479]
1-Phenyl-3-(1-propionylpiperidin-4-yl)urea	DMCHOFK	Investigative	Small molecular drug	[454]
1-phenyl-3-(2-(pyridin-2-yl)quinazolin-4-yl)urea	DM9SKYC	Investigative	Small molecular drug	[470]
1-phenyl-3-(2-(pyridin-3-yl)quinazolin-4-yl)urea	DMQKB6W	Investigative	Small molecular drug	[470]
1-phenyl-3-(2-(pyridin-4-yl)thiazol-4-yl)urea	DMJVITG	Investigative	Small molecular drug	[636]
1-phenyl-3-(3-(pyridin-2-yl)isoquinolin-1-yl)urea	DMJNAX5	Investigative	Small molecular drug	[470]
1-Phenyl-3-(4-pyridin-2-yl-thiazol-2-yl)-urea	DMJ723D	Investigative	Small molecular drug	[637]
1-phenyl-3-(phenylsulfonyl)propan-1-one	DM8ZBHF	Investigative	Small molecular drug	[381]
1-phenyl-3-(quinazolin-4-yl)urea	DMZOEQY	Investigative	Small molecular drug	[470]
1-phenyl-3-aza-bicyclo[3.1.0]hexane	DMUA72F	Investigative	Small molecular drug	[214]
1-phenyl-4-(1-phenyl-1H-tetrazol-5-yl)butan-2-one	DMKV17L	Investigative	Small molecular drug	[457]
1-Phenyl-propane-1,2-dione	DM04SWY	Investigative	Small molecular drug	[397]
1-phenylbiguanide	DMA4XGL	Investigative	Small molecular drug	[638]
1-phenylthio-N,N-dimethyltryptamine	DM5REQ9	Investigative	Small molecular drug	[639]
1-Prop-2-ynyl-3,7-dihydro-purine-2,6-dione	DMCBX7R	Investigative	Small molecular drug	[573]
1-propionyl-1H-indole-2,3-dione	DM1TNWG	Investigative	Small molecular drug	[475]
1-Propyl-3,7-dihydro-purine-2,6-dione	DML5J94	Investigative	Small molecular drug	[573]
1-Propyl-3-(3-trifluoromethyl-phenyl)-pyrrolidine	DMOCAUL	Investigative	Small molecular drug	[640]
1-Propyl-3-m-tolyl-piperidine hydrochloride	DM1387P	Investigative	NA	[641]
1-Propyl-3-o-tolyl-piperidine hydrochloride	DM1O6KQ	Investigative	NA	[641]
1-Propyl-3-p-tolyl-piperidine hydrochloride	DMPMIN9	Investigative	NA	[641]
1-propyl-5'-O-tritylinosine	DM5P01L	Investigative	Small molecular drug	[555]
1-Propylidenethiosemicarbazide	DMXOUFI	Investigative	Small molecular drug	[466]
1-Pyridin-2-yl-3-quinolin-5-yl-urea	DMTMXN4	Investigative	Small molecular drug	[460]
1-stearoyl-lysophosphatidylcholine	DM7K0B3	Investigative	Small molecular drug	[642]
1-tert-butyl-9H-carbazole	DMPSM4O	Investigative	Small molecular drug	[548]
1-Thiazol-2-yl-3-(2-o-tolyl-ethyl)-thiourea	DMAQKO1	Investigative	Small molecular drug	[481]
1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea	DMCIA40	Investigative	Small molecular drug	[458]
1-valproylamido-5-sulfonamidoindane	DM9ZRU2	Investigative	Small molecular drug	[565]
1-[(3-Methoxybenzyl)amino]ethaniminium chloride	DM7U0XW	Investigative	Small molecular drug	[58]
1-[(3-methoxybenzyl)oxy]-2-(2-phenylethyl)benzene	DM3UHDW	Investigative	Small molecular drug	[551]
1-[(7-Fluoronaphth-2-yl)methyl]-1H-imidazole	DMNJMGK	Investigative	Small molecular drug	[549]
1-[(cyclohexylamino)ethyl]-1,1-bisphosphonicacid	DM1JQPW	Investigative	Small molecular drug	[101]
1-[(Furan-2(5H)-one)-4-methyl]-desloratadine	DMQPFT3	Investigative	Small molecular drug	[643]
1-[(n-but-1-ylamino)ethyl]-1,1-bisphosphonic acid	DM8VNYA	Investigative	Small molecular drug	[101]
1-[(n-hex-1-ylamino)ethyl]-1,1-bisphosphonic acid	DM4ABTN	Investigative	Small molecular drug	[101]
1-[(n-oct-1-ylamino)ethyl]-1,1-bisphosphonic acid	DM9ZK0D	Investigative	Small molecular drug	[101]
1-[(prop-1-ylamino)ethyl]-1,1-bisphosphonic acid	DMCRHVI	Investigative	Small molecular drug	[101]
1-[(prop-2-ylamino)ethyl]-1,1-bisphosphonicacid	DMSCN8J	Investigative	Small molecular drug	[101]
1-[(tert-butylamino)ethyl]-1,1-bisphosphonicacid	DMLDY3H	Investigative	Small molecular drug	[101]
1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine	DMU3VWA	Investigative	Small molecular drug	[644]
1-[(Z)-4-trityloxy-2-butenyl]uracil	DMIHBFO	Investigative	Small molecular drug	[523]
1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine	DMEHP8M	Investigative	Small molecular drug	[258]
1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine	DMTNRG7	Investigative	Small molecular drug	[128]
1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine	DMLSU30	Investigative	Small molecular drug	[128]
1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine	DMDZA83	Investigative	Small molecular drug	[644]
1-[2-(trityloxy)ethoxymethyl]uracil	DM98F0U	Investigative	Small molecular drug	[523]
1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine	DMD2NXL	Investigative	Small molecular drug	[128]
1-[3-(3-biphenyl)-(1,2,4-triazol-4-yl) ]-3-phenol	DMLRS8I	Investigative	Small molecular drug	[645]
1-[3-(4-biphenyl)-(1,2,4-triazol-4-yl) ]-3-phenol	DMB1NF0	Investigative	Small molecular drug	[645]
1-[3-(Methylsulfonyl)phenyl]-4-propylpiperazine	DMS192I	Investigative	Small molecular drug	[521]
1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	DME1R96	Investigative	Small molecular drug	[22]
1-[4-(4-Iodophenoxy)phenyl]piperazine	DM0I2RH	Investigative	Small molecular drug	[265]
1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol	DM4F1GJ	Investigative	Small molecular drug	[453]
1-[4-hydroxy-3-(tritylaminomethyl)butyl]uracil	DMHXAMR	Investigative	Small molecular drug	[523]
1-[5-(4-Chlorophenyl)-2-furoyl]piperazine	DM8NMAV	Investigative	Small molecular drug	[646]
1-[5-(triphenylmethoxy)pentyl]thymine	DMFHBJM	Investigative	Small molecular drug	[644]
1-[6-(triphenylmethoxy)hexyl]thymine	DM5NVHO	Investigative	Small molecular drug	[644]
1-[7-(triphenylmethoxy)heptyl]thymine	DMQ05F2	Investigative	Small molecular drug	[644]
1-[bis(4-bromophenyl)methyl]-3-phenylthiourea	DM13D4E	Investigative	Small molecular drug	[554]
1-[bis(4-chlorophenyl)methyl]-3-(4-chlorophenyl)-	DMN2LHM	Investigative	Small molecular drug	[554]
1-[bis(4-chlorophenyl)methyl]-3-phenylthiourea	DMFMR2N	Investigative	Small molecular drug	[554]
1-[bis(4-iodophenyl)methyl]-3-(4-bromophenyl)urea	DMJT7VI	Investigative	Small molecular drug	[554]
10,10-difluoro TXA2	DML745Y	Investigative	Small molecular drug	[647]
10,11-dihydro-5H-dibenzo[b,f]azepine	DMS5ICY	Investigative	Small molecular drug	[648]
10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one	DM5BUXZ	Investigative	Small molecular drug	[407]
10-Allyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	DM1JLUV	Investigative	Small molecular drug	[649]
10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one	DM4M2VU	Investigative	Small molecular drug	[407]
10-CF3C(OH)2-DDACTHF	DMQOUJ7	Investigative	Small molecular drug	[12]
10-EPI-8-DEOXY-CUMAMBRIN B	DMDQ7Z9	Investigative	Small molecular drug	[549]
10-Ethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	DMGT82V	Investigative	Small molecular drug	[649]
10-Formyl-5,8,10-Trideazafolic Acid	DMEBHML	Investigative	Small molecular drug	[12]
10-hydroxy-18-methoxybetaenone	DM4R7X8	Investigative	Small molecular drug	[650]
10-Hydroxy-infractopicrin	DM5H73W	Investigative	Small molecular drug	[651]
10-hydroxycamptothecin	DM9WLN4	Investigative	Small molecular drug	[652]
10-Isopropyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	DMCXA1Y	Investigative	Small molecular drug	[649]
10-methoxy-ginkgolide C	DM2H6KD	Investigative	Small molecular drug	[653]
10-methoxy-N(1)-methylburnamine-17-O-veratrate	DMJW25X	Investigative	Small molecular drug	[654]
10-OBn-7alpha-F-gingkolide B	DMM9GEA	Investigative	Small molecular drug	[655]
10-OBn-epi-ginkgolide C	DMAM5WJ	Investigative	Small molecular drug	[656]
10-OBn-ginkgolide B	DMS0I5V	Investigative	Small molecular drug	[657]
10-OBn-ginkgolide C	DMOXKLH	Investigative	Small molecular drug	[658]
10-Propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one	DMD1258	Investigative	Small molecular drug	[649]
10-Propyl-10H-dibenzo[b,f][1,4]thiazepin-11-one	DMZ3N8A	Investigative	Small molecular drug	[649]
10-trifluoroacetyl-DDACTHF	DMEAGI6	Investigative	Small molecular drug	[659]
10R-hydroxylobel-7-ene	DM8XRCT	Investigative	Small molecular drug	[660]
10R-hydroxylobelane	DMN93QT	Investigative	Small molecular drug	[660]
10S-hydroxylobel-7-ene	DMN1YQ6	Investigative	Small molecular drug	[660]
10S-hydroxylobelane	DM54AKV	Investigative	Small molecular drug	[660]
10Z-Hymenialdisine	DMIRSA5	Investigative	Small molecular drug	[661]
11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione	DME0OGM	Investigative	Small molecular drug	[385]
11-Butyryloxy-N-n-propylnoraporphine	DMH5QEA	Investigative	Small molecular drug	[662]
11-cis-retinal	DMLV9A2	Investigative	Small molecular drug	[663]
11-cis-retinol	DMKL5AL	Investigative	Small molecular drug	[664]
11-dehydro-thromboxane B2	DMLYFFB	Investigative	Small molecular drug	[665]
11-deoxy-PGE1	DM1ERJC	Investigative	Small molecular drug	[666]
11-deoxy-PGE2	DMXLWOK	Investigative	Small molecular drug	[667]
11-deoxycortisol	DMFWYTO	Investigative	Small molecular drug	[668]
11-Heptanoyloxy-N-n-propylnoraporphine	DMX4I9D	Investigative	Small molecular drug	[662]
11-Hexanoyloxy-N-n-propylnoraporphine	DMRYV9E	Investigative	Small molecular drug	[662]
11-keto-beta-boswellicacid	DMM6CJI	Investigative	Small molecular drug	[669]
11-keto-ursolic acid	DM1WPE3	Investigative	Small molecular drug	[669]
11-methyl-6,11-dihydro-5H-benzo[a]carbazol-9-ol	DM9IHFY	Investigative	Small molecular drug	[670]
11-Propionyloxy-N-n-propylnoraporphine	DM62FEH	Investigative	Small molecular drug	[662]
11-valeryloxynoraporphine	DMM91WE	Investigative	Small molecular drug	[662]
11BETA,13-DIHYDRO-10-EPI-8-DEOXYCUMAM-BRIN B	DM0EPJT	Investigative	Small molecular drug	[549]
11C-PBR-170	DMYGE3K	Investigative	NA	[671]
11H-benzo[a]carbazole	DMK41DJ	Investigative	Small molecular drug	[548]
12,13-DEHYDRO-8-O-ACETYLMANZAMINE A	DMVP39I	Investigative	Small molecular drug	[672]
12,13-DEHYDROMANZAMINE A	DM8XAWU	Investigative	Small molecular drug	[672]
12,17-dehydroxyriccardin C	DMAUPQR	Investigative	Small molecular drug	[673]
12-(3-Adamantan-1-yl-ureido)-dodeca noic acid	DM84YCI	Investigative	Small molecular drug	[674]
12-(3-n-Hexylureido)dodec-8(Z)-enoic acid	DM0F3SR	Investigative	Small molecular drug	[675]
12-(3-n-Pentylureidooxy)dodec-8(Z)-enoic acid	DMAFNXZ	Investigative	Small molecular drug	[675]
12-dehydroxyriccardin C	DMTOSXF	Investigative	Small molecular drug	[673]
12-epi LTB4	DM9JI8C	Investigative	Small molecular drug	[676]
12-EPI-SALVINORIN A	DMZ9PW3	Investigative	Small molecular drug	[677]
12-hydroxyheptadecatrienoic acid	DMA2EIK	Investigative	Small molecular drug	[678]
12-hydroxylauric acid	DMBFVDY	Investigative	Small molecular drug	[679]
12-O-deacetyl-12-epi-19-deoxy-21-hydroxyscalarin	DMKH0OC	Investigative	Small molecular drug	[680]
12-Phenylheme	DMLR2FB	Investigative	Small molecular drug	[12]
12R-HETE	DMK0GJ3	Investigative	Small molecular drug	[681]
12R-HPETE	DMR72PC	Investigative	Small molecular drug	[682]
12S-HETE	DMBEZ09	Investigative	Small molecular drug	[683]
12S-HPETE	DM6ZX1O	Investigative	Small molecular drug	[684]
13,14-dihydro-15-keto-PGD2	DMZVWCG	Investigative	Small molecular drug	[685]
13,14-dihydro-15-keto-PGF2alpha	DMNT1XI	Investigative	Small molecular drug	[686]
13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF1alpha	DMNRMTX	Investigative	Small molecular drug	[687]
13,14-dihydro-PGE1	DMTEACQ	Investigative	Small molecular drug	[688]
13-(3-n-Pentylthioureido)tridec-8(Z)-enoic Acid	DMIY9DB	Investigative	Small molecular drug	[675]
13-(3-n-Pentylureido)tridec-5(Z)-enoic acid	DM0NRJG	Investigative	Small molecular drug	[675]
13-(3-n-Pentylureido)tridec-8(E)-enoic acid	DM17DY6	Investigative	Small molecular drug	[675]
13-(3-n-Pentylureido)tridec-8-ynoic acid	DM9VDOG	Investigative	Small molecular drug	[675]
13-(3-Pentyluredo)tridec-8(Z)-enoic acid	DM3I6PS	Investigative	Small molecular drug	[675]
13-(5-n-Pentylfuran-2-yl)tridec-8(Z)-enoic acid	DM8HRTC	Investigative	Small molecular drug	[675]
13-(N-Isopropylheptanamido)tridec-8(Z)-enoic acid	DMXK6D2	Investigative	Small molecular drug	[675]
13-(N-Methyl-n-heptnamido)tridec-8(Z)-enoic acid	DM689TH	Investigative	Small molecular drug	[675]
13-(n-Pentylcarbamoyloxy)tridec-8(Z)-enoic acid	DMSF3C8	Investigative	Small molecular drug	[675]
13-Acetylphorbol	DMJ2T7P	Investigative	Small molecular drug	[22]
13-cis-retinal	DM2PXWY	Investigative	Small molecular drug	[689]
13-cis-retinol	DM9G5GD	Investigative	Small molecular drug	[690]
13-HODE	DM57MIW	Investigative	Small molecular drug	[691]
13-n-Heptanamidotridec-5-ynoic acid	DMRVQCB	Investigative	Small molecular drug	[675]
13-n-Heptanamidotridec-8(Z)-enoic acid	DM0LGWJ	Investigative	Small molecular drug	[675]
135PAM1	DMMTPK3	Investigative	Small molecular drug	[692]
14-(n-Hexylamino)-14-oxotetradec-8(Z)-enoic acid	DM5NFB6	Investigative	Small molecular drug	[675]
14-O-phenylpropylnaltrexone	DMI7LXH	Investigative	Small molecular drug	[693]
1400W	DMLZT64	Investigative	Small molecular drug	[694]
15(R)-15-methyl-PGD2	DMY9ZT8	Investigative	Small molecular drug	[695]
15(S)-15-methyl-PGD2	DMG273T	Investigative	Small molecular drug	[696]
15-ACETOXY-EREMANTHOLIDE B	DMLSZW2	Investigative	Small molecular drug	[697]
15-deoxy-Delta(12, 14)-prostaglandin J(2)	DM8VUX3	Investigative	Small molecular drug	[698]
15-deoxy-Delta12,14-PGD2	DMJ27QT	Investigative	Small molecular drug	[699]
15-deoxy-Delta12,14-PGJ2	DMNDECA	Investigative	Small molecular drug	[700]
15-deoxy-LXA4	DM1QVQI	Investigative	Small molecular drug	[701]
15-deoxy-TIC	DMDXTW4	Investigative	Small molecular drug	[702]
15-DEOXYBUDLEIN A	DMJC0NQ	Investigative	Small molecular drug	[697]
15-deoxygoiazensolide	DMR9SFM	Investigative	Small molecular drug	[703]
15-hydroxyeicosatetraenoic acid	DMEML8B	Investigative	Small molecular drug	[704]
15-isobutyrylmiguanin	DMQCRUG	Investigative	Small molecular drug	[703]
15-nor-18-Methoxycornaridine	DMDKFGX	Investigative	Small molecular drug	[705]
15R-TIC	DMAXEWJ	Investigative	Small molecular drug	[706]
15S-HPETE	DM41LV6	Investigative	Small molecular drug	[707]
16-(2',2'-Dimethyl)-propylidene-estradiol	DMK4N2F	Investigative	Small molecular drug	[708]
16-(2',2'-Dimethyl)-propylidene-estrone	DMQYJB1	Investigative	Small molecular drug	[708]
16-(3-Ethylureido)hexadec-11(Z)-enoic acid	DMCHMNF	Investigative	Small molecular drug	[675]
16-(4-cyano-benzylidene)-estradiol	DMTAXZI	Investigative	Small molecular drug	[708]
16-(4-dimethylamino-benzylidene)-estradiol	DMEH8I0	Investigative	Small molecular drug	[708]
16-(4-dimethylamino-benzylidene)-estrone	DMX8YCK	Investigative	Small molecular drug	[708]
16-(pyridin-2-yl)methyl-estradiol	DMSXFG0	Investigative	Small molecular drug	[708]
16-(pyridin-2-yl)methylene-estradiol	DMIC0OU	Investigative	Small molecular drug	[708]
16-(pyridin-3-yl)methyl-estradiol	DMTD5AO	Investigative	Small molecular drug	[708]
16-(pyridin-3-yl)methylene-estradiol	DMIMZ21	Investigative	Small molecular drug	[708]
16-(pyridin-4-yl)methyl-estradiol	DM7NSRI	Investigative	Small molecular drug	[708]
16-(pyridin-4-yl)methylene-estradiol	DMOTNPC	Investigative	Small molecular drug	[708]
16-(thiophen-2-yl)methylene-estrone	DME3XS4	Investigative	Small molecular drug	[708]
16-alphaH,17-isovaleryloxy-ent-kauran-19-oic acid	DMI49D0	Investigative	Small molecular drug	[709]
16-beta-ethoxymethyl-estrone	DMWJNV5	Investigative	Small molecular drug	[708]
16-beta-hydroxymethyl-estradiol	DMUW07J	Investigative	Small molecular drug	[708]
16-HETE	DMWT83Z	Investigative	Small molecular drug	[710]
16-isobutylidene-estradiol	DMTZG68	Investigative	Small molecular drug	[708]
16-isobutylidene-estrone	DMS7PL3	Investigative	Small molecular drug	[708]
16beta-cyano-estradiol	DMCMP9B	Investigative	Small molecular drug	[708]
17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one (4MA)	DMDR1M6	Investigative	NA	[711]
17-(Cyclobutylmethyl)-N-phenylmorphinan-3-amine	DMUQWPZ	Investigative	Small molecular drug	[712]
17-(Cyclopropylmethyl)-N-phenylmorphinan-3-amine	DM174HN	Investigative	Small molecular drug	[712]
17-dehydroxyriccardin C	DM7UHJS	Investigative	Small molecular drug	[673]
17-desmethoxy-17-aminogeldanamycin	DMCALYO	Investigative	Small molecular drug	[713]
17-METHYL-17-ALPHA-DIHYDROEQUILENIN	DMKUGH1	Investigative	Small molecular drug	[22]
17-methyl-4'-methyldihydromorphinone	DMMEB64	Investigative	Small molecular drug	[714]
17-Methylmorphinan-3-yl 4-Iodophenyl Carbamate	DMI4WCQ	Investigative	Small molecular drug	[712]
17-phenyl-omega-trinor-PGE2	DM9OMI3	Investigative	Small molecular drug	[715]
17alpha-hydroxypregnenolone	DMT2EPG	Investigative	Small molecular drug	[716]
18-Dimethylaminocoronaridine	DM0JEQ6	Investigative	Small molecular drug	[705]
18-HETE	DMCR4D1	Investigative	Small molecular drug	[717]
18-methoxycoronaridinate 2-Hydroxyethylamide	DMBG9Z3	Investigative	Small molecular drug	[705]
18-methoxycoronaridinate 2-methoxyethylamide	DMSBAC0	Investigative	Small molecular drug	[705]
18-Methylaminocoronaridine	DMOYC0U	Investigative	Small molecular drug	[705]
18alpha-Glycyrrhetic acid	DMYS6DB	Investigative	Small molecular drug	[718]
18beta-Glycyrrhetic acid	DMFMRN8	Investigative	Small molecular drug	[718]
18R-HEPE	DMK3DDL	Investigative	Small molecular drug	[719]
18S-HEPE	DM0PK6E	Investigative	Small molecular drug	[720]
19(R)-OH-PGE2	DMGUKCF	Investigative	Small molecular drug	[721]
19alpha,24-dihydroxyurs-12-en-3-on-28-oic acid	DMP168O	Investigative	Small molecular drug	[722]
1beta-methoxy-miller-9Z-enolide	DMHR90S	Investigative	Small molecular drug	[703]
1DMe	DMOSRET	Investigative	Small molecular drug	[723]
1G244	DMEB8CG	Investigative	Small molecular drug	[724]
1H-1,2,3-benzotriazol-1-amine	DM9KAI5	Investigative	Small molecular drug	[725]
1h-Benoximidazole-2-Carboxylic Acid	DMNZAVE	Investigative	Small molecular drug	[12]
1H-Imidazo[4,5-c]quinolin-4-ylamine HCl	DMME09C	Investigative	Small molecular drug	[111]
1H-Indole-2,3-dione	DMOZ91H	Investigative	Small molecular drug	[107]
1H-indole-4,7-dione	DMNDVMH	Investigative	Small molecular drug	[726]
1H-Pyrazole-3-carboxylic acid	DM4V6JE	Investigative	Small molecular drug	[727]
1na	DM0A1YI	Investigative	Small molecular drug	[12]
1S,2R-milnacipran	DM7Y5AN	Investigative	Small molecular drug	[728]
2',3'-ddATP	DMOB7P6	Investigative	Small molecular drug	[729]
2',3'-Dideoxycytidine-5'-Monophosphate	DMCXR4M	Investigative	Small molecular drug	[12]
2',3'-Dideoxythymidine-5'-Monophosphate	DMEQXUD	Investigative	Small molecular drug	[12]
2',4'-dicyanobiphenyl-4-yl sulfamate	DM4QDZV	Investigative	Small molecular drug	[552]
2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	DM5OYWF	Investigative	Small molecular drug	[22]
2',5'-dideoxyadenosine	DM83H0Z	Investigative	Small molecular drug	[730]
2'-3'-dideoxy-7-deaza-guaninetriphosphate	DM74X5O	Investigative	Small molecular drug	[731]
2'-5'dideoxyuridine	DM6P3Z8	Investigative	Small molecular drug	[107]
2'-amino-3,4,4',5-tetramethoxy-(Z)-stillbene	DMUYZA8	Investigative	Small molecular drug	[732]
2'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	DMTP3LD	Investigative	Small molecular drug	[733]
2'-aminoimidazolylmethyluracils	DMUJC2E	Investigative	Small molecular drug	[734]
2'-Deoxycytidine-5'-Monophosphate	DMG7CAU	Investigative	Small molecular drug	[12]
2'-Deoxyguanosine-5'-Monophosphate	DMY9FDT	Investigative	Small molecular drug	[735]
2'-deoxyinosine	DMJQPGY	Investigative	Small molecular drug	[736]
2'-deoxythymidine triphosphate	DM9OEJT	Investigative	Small molecular drug	[737]
2'-Deoxyuridine	DM1HMWA	Investigative	Small molecular drug	[12]
2'-deoxyuridine 5'-alpha,beta-imido-diphosphate	DMXV27U	Investigative	Small molecular drug	[107]
2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate	DMOHABR	Investigative	Small molecular drug	[12]
2'-deoxyuridylic acid	DMPV1LU	Investigative	Small molecular drug	[12]
2'-epi-guianin	DMNVJY0	Investigative	Small molecular drug	[738]
2'-hydroxy-3,4,5-trimethoxychalcone	DM5ACNU	Investigative	Small molecular drug	[484]
2'-Hydroxy-3-methoxy-biphenyl-4-carbonitrile	DM5QV19	Investigative	Small molecular drug	[739]
2'-Hydroxychalcone	DM8RTBS	Investigative	Small molecular drug	[484]
2'-Me-CCPA	DMDFPGB	Investigative	Small molecular drug	[740]
2'-Me-tecadenoson	DMY2GXT	Investigative	Small molecular drug	[741]
2'-Monophosphoadenosine 5'-Diphosphoribose	DME9S8M	Investigative	Small molecular drug	[12]
2'-Monophosphoadenosine-5'-Diphosphate	DMDYRNF	Investigative	Small molecular drug	[12]
2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide	DM2NX4K	Investigative	Small molecular drug	[742]
2'-O-Methyl G-Clamp Containing Oligonucleotides	DMO6JRW	Investigative	NA	[743]
2(S)-amino-6-boronohexanoic acid	DMYG2BL	Investigative	Small molecular drug	[744]
2,2',3-Tribromo-4,4',5,5'-tetrahydroxybibenzyl	DMG7EPF	Investigative	Small molecular drug	[745]
2,2',4,4',6'-pentahydroxychalcone	DMAYXUR	Investigative	Small molecular drug	[746]
2,2',4,4'-tetrahydroxy-6'-methoxychalcone	DMMJ613	Investigative	Small molecular drug	[746]
2,2',4,4'-tetrahydroxychalcone	DMM6KBD	Investigative	Small molecular drug	[746]
2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione	DMPMOHQ	Investigative	Small molecular drug	[747]
2,2'-pyridylisatogen tosylate	DMOQDBA	Investigative	Small molecular drug	[748]
2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (DIASTEREOMERIC MIX)	DMBLXOG	Investigative	Small molecular drug	[463]
2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide	DMG4ITB	Investigative	Small molecular drug	[749]
2,2,2-tris-(3-fluorophenyl)-acetamide	DMJXAF7	Investigative	Small molecular drug	[132]
2,2,2-tris-(4-fluorophenyl)-acetamide	DMCZHEN	Investigative	Small molecular drug	[132]
2,2,4-Trimethyl-6-phenyl-1,2-dihydro-quinoline	DMP9ECK	Investigative	Small molecular drug	[750]
2,2-bis(3-fluorophenyl)-N-hydroxyacetamide	DMTODR2	Investigative	Small molecular drug	[751]
2,2-bis(4-chlorophenyl)-N-hydroxyacetamide	DM2RKD6	Investigative	Small molecular drug	[751]
2,2-bis(4-fluorophenyl)-N-hydroxyacetamide	DM5PWQM	Investigative	Small molecular drug	[751]
2,2-bis-(2-fluorophenyl)-2-phenylacetamide	DMDIX40	Investigative	Small molecular drug	[132]
2,2-bis-(3-fluorophenyl)-2-phenylacetamide	DM6ICRJ	Investigative	Small molecular drug	[132]
2,2-Dibenzylcyclopentanol	DMFPYU8	Investigative	Small molecular drug	[752]
2,2-difluoromevalonate 5-diphosphate	DMKXFDA	Investigative	Small molecular drug	[753]
2,2-diMeBut-RYYRIK-NH2	DMPX642	Investigative	Small molecular drug	[754]
2,2-Dimethoxy-1,2-diphenyl-ethanone	DM34IX5	Investigative	Small molecular drug	[397]
2,2-dimethyl-2H-benzo[g]chromene-5,10-dione	DMQYCFI	Investigative	Small molecular drug	[755]
2,2-dimethyl-3-methyleneheptadecane	DM7BL04	Investigative	Small molecular drug	[375]
2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide	DMATB8H	Investigative	Small molecular drug	[749]
2,2-Diphenyl-ethylamine	DMTBAUG	Investigative	Small molecular drug	[756]
2,3'-diamino-3,4,4',5-tetramethoxy-(Z)-stillbene	DM2UWDR	Investigative	Small molecular drug	[732]
2,3,3-Triphenyl-acrylonitrile	DM7H34U	Investigative	Small molecular drug	[757]
2,3,4,11-tetrahydro-1H-benzo[a]carbazole	DMV1CX0	Investigative	Small molecular drug	[548]
2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol	DMK4LTB	Investigative	Small molecular drug	[758]
2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol	DMGQE4B	Investigative	Small molecular drug	[759]
2,3,4,5-Tetrahydro-1H-benzo[c]azepine	DM1RE9Q	Investigative	Small molecular drug	[275]
2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine	DM4EZOB	Investigative	Small molecular drug	[275]
2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	DMX8NYD	Investigative	Small molecular drug	[760]
2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine	DMOFG4M	Investigative	Small molecular drug	[275]
2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	DMXAS25	Investigative	Small molecular drug	[761]
2,3,4-tribromo-6-(2,4-dibromophenoxy)phenol	DMQYEZP	Investigative	Small molecular drug	[762]
2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide	DMCAZ32	Investigative	Small molecular drug	[763]
2,3,4-trihydroxybenzoic acid	DMWHK35	Investigative	Small molecular drug	[764]
2,3,4-Trimethoxy-4'-amino-trans-stilbene	DMPRF1X	Investigative	Small molecular drug	[531]
2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	DM592YS	Investigative	Small molecular drug	[12]
2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol	DMRVYKQ	Investigative	Small molecular drug	[759]
2,3,5-Trimethoxy-4'-amino-trans-stilbene	DMLI5UT	Investigative	Small molecular drug	[531]
2,3,7-trichloro-5-nitroquinoxaline (TNQX)	DMCKO6T	Investigative	Small molecular drug	[765]
2,3-dichloro-1,4-naphthoquinone	DMPCGSD	Investigative	Small molecular drug	[755]
2,3-Didehydroalanine	DM6SBPI	Investigative	Small molecular drug	[107]
2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide	DMJB7W1	Investigative	Small molecular drug	[766]
2,3-dihydro-1H-benzo[de]isoquinolin-1-one	DMB3WI8	Investigative	Small molecular drug	[767]
2,3-dihydro-1H-indene-5-sulfonamide	DM46MKY	Investigative	Small molecular drug	[22]
2,3-Dihydro-1H-indol-5-ol	DM3URJG	Investigative	Small molecular drug	[618]
2,3-Dihydro-1H-isoindole	DMWI9XS	Investigative	Small molecular drug	[275]
2,3-dihydrobenzo[d]thiazole-2-thiol	DMUW94S	Investigative	Small molecular drug	[768]
2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine	DMYHFUO	Investigative	Small molecular drug	[769]
2,3-dihydroxypropanal	DMOWNB4	Investigative	Small molecular drug	[770]
2,3-dimethoxy-2'-hydroxychalcone	DML92OK	Investigative	Small molecular drug	[484]
2,3-Dimethoxy-4'-amino-trans-stilbene	DM9C0YZ	Investigative	Small molecular drug	[531]
2,3-Dimethoxybenzo[i]phenanthridines	DMEB47J	Investigative	Small molecular drug	[771]
2,3-DIMETHYL-1,4-NAPHTHOQUINONE	DMGXVBA	Investigative	Small molecular drug	[22]
2,3-Dimethylnaphtho[2,3-f]quinoxaline-7,12-dione	DMKV9EZ	Investigative	Small molecular drug	[772]
2,3-dioxoindoline-7-carboxylic acid	DM8C43L	Investigative	Small molecular drug	[134]
2,3-diphenyl-1H-indole	DMC3UYH	Investigative	Small molecular drug	[773]
2,4'-Diacetoxy-5,3'-di-(2-propenyl)-biphenyl	DMVPWML	Investigative	Small molecular drug	[774]
2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl	DMWNJ84	Investigative	Small molecular drug	[774]
2,4'-Dimethoxy-5,3'-dipropyl-biphenyl	DM94NM7	Investigative	Small molecular drug	[774]
2,4,3',5'-tetrahydroxybibenzyl	DMI2PY7	Investigative	Small molecular drug	[775]
2,4,4-triphenylimidazoline	DMS8I1E	Investigative	Small molecular drug	[776]
2,4,5-Triarylimidazole analogue	DMSJBEH	Investigative	Small molecular drug	[777]
2,4,6 trinitrobenzene sulfonate 1,3-bis (2-chlorethyl)-1-nitrosourea	DMTA152	Investigative	Small molecular drug	[778]
2,4,6-Trihydroxy-3-nitro-N-tridecyl-benzamide	DMTVL9N	Investigative	Small molecular drug	[779]
2,4-bis-docosanoylamino-benzenesulfonate	DM90TSI	Investigative	Small molecular drug	[780]
2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid	DMZO0EI	Investigative	Small molecular drug	[107]
2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	DMQPKWM	Investigative	Small molecular drug	[22]
2,4-Diamino-butyric acid(GABA)	DMAOGBP	Investigative	Small molecular drug	[781]
2,4-diaminoquinozalines and quinoxaline-2,3-diones	DMS1YXL	Investigative	NA	[782]
2,4-Dibenzylamino-6-isopentylpyrimidine	DMQ385U	Investigative	Small molecular drug	[783]
2,4-dichloro-5-sulfamoylbenzoic acid	DM4EY5S	Investigative	Small molecular drug	[784]
2,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	DMO4FSH	Investigative	Small molecular drug	[785]
2,4-Dichlorobenzenemethanethiol	DMR5DYK	Investigative	Small molecular drug	[786]
2,4-difluorophenyl 4-butoxybenzylcarbamate	DM75TJ1	Investigative	Small molecular drug	[787]
2,4-diisobutylamino-6-isopentylpyrimidine	DM0URFY	Investigative	Small molecular drug	[783]
2,4-dimethoxy-2'-hydroxychalcone	DMP9BZU	Investigative	Small molecular drug	[484]
2,4-Dimethoxy-3'-amino-trans-stilbene	DMHSLXI	Investigative	Small molecular drug	[531]
2,4-Dimethoxy-4'-amino-trans-stilbene	DMMZ643	Investigative	Small molecular drug	[531]
2,4-Disulfamyltrifluoromethylaniline	DM2AW0Z	Investigative	Small molecular drug	[788]
2,4-epi-neodysiherbaine	DMZRY0Q	Investigative	Small molecular drug	[789]
2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine	DMMESIU	Investigative	Small molecular drug	[790]
2,5-Anhydroglucitol-1,6-Biphosphate	DMLDHMB	Investigative	Small molecular drug	[12]
2,5-bis(2-methoxyphenyl)thiophene	DMU5GKN	Investigative	Small molecular drug	[791]
2,5-bis(4-hydroxybenzylidene)cyclopentanone	DMOQPHK	Investigative	Small molecular drug	[434]
2,5-bis(4-Hydroxyphenyl)thiophene	DMNQIGZ	Investigative	Small molecular drug	[791]
2,5-bis(4-methoxyphenyl)thiophene	DM30RNY	Investigative	Small molecular drug	[791]
2,5-bis(4-nitrophenyl)thiophene	DM3USOR	Investigative	Small molecular drug	[791]
2,5-Bis-(3,4-dimethoxy-phenyl)-furan	DMH6RDL	Investigative	Small molecular drug	[124]
2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan	DM28GQS	Investigative	Small molecular drug	[124]
2,5-dichloro-N-p-tolylthiophene-3-sulfonamide	DMU5J8Y	Investigative	Small molecular drug	[792]
2,5-dichloro-N-phenylthiophene-3-sulfonamide	DM9PK1R	Investigative	Small molecular drug	[792]
2,5-dideoxy-2,5-imino-D-altritol	DMI1O54	Investigative	Small molecular drug	[793]
2,5-Dideoxy-2,5-imino-D-mannitol	DMGQVF5	Investigative	Small molecular drug	[425]
2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol	DMKP7O0	Investigative	Small molecular drug	[794]
2,5-didesoxy-3-ATP	DM5CWM0	Investigative	Small molecular drug	[795]
2,5-difluorophenol	DMIGFX6	Investigative	Small molecular drug	[796]
2,5-Dimethoxy-4'-amino-trans-stilbene	DMV0UIR	Investigative	Small molecular drug	[531]
2,5-dimethoxy-4-bromophenethylamine	DM50ZQP	Investigative	Small molecular drug	[797]
2,5-imino-2,5,6-trideoxy-D-manno-heptitol	DM5IJSW	Investigative	Small molecular drug	[794]
2,6,8-triphenyl-9H-purine	DM4IFPQ	Investigative	Small molecular drug	[798]
2,6-bis(4-chlorophenyl)-9H-purine	DMYQNK0	Investigative	Small molecular drug	[798]
2,6-bis(4-methoxyphenyl)-9H-purine	DMC2N80	Investigative	Small molecular drug	[798]
2,6-bis(4-tolyl)-9H-purine	DM41RZX	Investigative	Small molecular drug	[798]
2,6-di-t-butylphenol	DMY8LDT	Investigative	Small molecular drug	[799]
2,6-di-tert-butyl-4-methoxyphenol	DMFO1H2	Investigative	Small molecular drug	[799]
2,6-diamino-5-nitropyrimidin-4(3H)-one	DMREF31	Investigative	Small molecular drug	[800]
2,6-diamino-5-nitrosopyrimidin-4(3H)-one	DM4RS9N	Investigative	Small molecular drug	[800]
2,6-DICARBOXYNAPHTHALENE	DM8JFNU	Investigative	Small molecular drug	[22]
2,6-Difluorobenzenesulfonamide	DMGEYAK	Investigative	Small molecular drug	[107]
2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	DMDN12L	Investigative	Small molecular drug	[12]
2,6-dihydroxy-1,7-dimethoxyxanthone	DM5QEUC	Investigative	Small molecular drug	[801]
2,6-Diisopropyl-4-nitro-phenol	DMD51I4	Investigative	Small molecular drug	[802]
2,6-dimethyl-8-ethyl-1-deazapurine	DMRZJU5	Investigative	Small molecular drug	[803]
2,6-diphenyl-1-deazapurine	DMW2VZ1	Investigative	Small molecular drug	[803]
2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine	DMY3C78	Investigative	Small molecular drug	[803]
2,6-diphenyl-8-ethyl-1-deazapurine	DM0C8BW	Investigative	Small molecular drug	[803]
2,6-diphenyl-8-methyl-1-deazapurine	DMI79FV	Investigative	Small molecular drug	[803]
2,6-diphenyl-8-tButyl-1-deazapurine	DM6D1BQ	Investigative	Small molecular drug	[803]
2,6-diphenyl-9H-purine	DM5SXYI	Investigative	Small molecular drug	[798]
2,6-Diphenyl-pyrimidin-4-ylamine	DM3JURW	Investigative	Small molecular drug	[804]
2,6-dphenyl-8-propyl-1-deazapurine	DM8F9KO	Investigative	Small molecular drug	[803]
2,7-Bis(3-chloropropionamido)anthraquinone	DMT9JHV	Investigative	Small molecular drug	[805]
2,7-Bis(4-chlorobutyramido)anthraquinone	DM8VWQ2	Investigative	Small molecular drug	[805]
2,7-Bis(acetamido)anthraquinone	DM2EPM4	Investigative	Small molecular drug	[805]
2,7-Bis(benzoamido)anthraquinone	DMEQC4X	Investigative	Small molecular drug	[805]
2,7-Bis(butyramido)anthraquinone	DM9S8LY	Investigative	Small molecular drug	[805]
2,7-Bis(chloroacetamido)anthraquinone	DM4MYAR	Investigative	Small molecular drug	[805]
2,7-Bis(cyclohexanecarbonamido)anthraquinone	DMTPZ8D	Investigative	Small molecular drug	[805]
2,7-Bis(cyclopentanecarbonamido)anthraquinone	DMP3EZ8	Investigative	Small molecular drug	[805]
2,7-Bis(cyclopropanecarbonamido)anthraquinone	DMY3V2B	Investigative	Small molecular drug	[805]
2,7-Bis(phenylacetamido)anthraquinone	DMEVIBT	Investigative	Small molecular drug	[805]
2,7-Bis(phenylpropionamido)anthraquinone	DMDKXEY	Investigative	Small molecular drug	[805]
2,7-Bis(propionamido)anthraquinone	DM2D1EJ	Investigative	Small molecular drug	[805]
2,7-Bis[2-(butylamino)acetamido]anthraquinone	DM3GTV0	Investigative	Small molecular drug	[805]
2,7-Bis[2-(diethylamino)acetamido]anthraquinone	DMKDSGE	Investigative	Small molecular drug	[805]
2,7-Bis[2-(dimethylamino)acetamido]anthraquinone	DMNW5PL	Investigative	Small molecular drug	[805]
2,7-Bis[2-(ethylamino)acetamido]anthraquinone	DMZ7EAC	Investigative	Small molecular drug	[805]
2,7-Bis[2-(isobutylamino)acetamido]anthraquinone	DMM4T1Q	Investigative	Small molecular drug	[805]
2,7-Bis[2-(isopropylamino)acetamido]anthraquinone	DMRQGWX	Investigative	Small molecular drug	[805]
2,7-Bis[2-(piperazino)acetamido]anthraquinone	DMPE8GX	Investigative	Small molecular drug	[805]
2,7-Bis[2-(piperidino)acetamido]anthraquinone	DMITF0P	Investigative	Small molecular drug	[805]
2,7-Bis[2-(propylamino)acetamido]anthraquinone	DMH89TO	Investigative	Small molecular drug	[805]
2,7-Bis[2-(pyrrolidino)acetamido]anthraquinone	DMHVKIJ	Investigative	Small molecular drug	[805]
2,7-Bis[3-(butylamino)propionamido]anthraquinone	DM4V63W	Investigative	Small molecular drug	[805]
2,7-Bis[3-(ethylamino)propionamido]anthraquinone	DMC537F	Investigative	Small molecular drug	[805]
2,7-Bis[3-(piperazino)propionamido]anthraquinone	DMOZEKQ	Investigative	Small molecular drug	[805]
2,7-Bis[3-(piperidino)propionamido]anthraquinone	DMET693	Investigative	Small molecular drug	[805]
2,7-Bis[3-(propylamino)propionamido]anthraquinone	DM6I90F	Investigative	Small molecular drug	[805]
2,7-Bis[3-(pyrrolidino)propionamido]anthraquinone	DMD6ZV5	Investigative	Small molecular drug	[805]
2,7-diaminoanthraquinone	DME0TZU	Investigative	Small molecular drug	[805]
2,7-Dinitroantraquinone	DMN56VM	Investigative	Small molecular drug	[805]
2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one	DMAKZ43	Investigative	Small molecular drug	[806]
2,8-Dimethyl-3H-quinazolin-4-one	DMU2EFH	Investigative	Small molecular drug	[807]
2-((1H-imidazol-4-yl)methyl)pyridine	DM1TK45	Investigative	Small molecular drug	[808]
2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine	DM91PA5	Investigative	Small molecular drug	[809]
2-((2-iodophenoxy)(phenyl)methyl)morpholine	DMS1AOK	Investigative	Small molecular drug	[810]
2-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol	DM1BI65	Investigative	Small molecular drug	[811]
2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine	DMS21CR	Investigative	Small molecular drug	[810]
2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	DMUE0D6	Investigative	Small molecular drug	[22]
2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-b]pyridine	DMZ83G9	Investigative	Small molecular drug	[812]
2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-c]pyridine	DMEKSAZ	Investigative	Small molecular drug	[812]
2-(1-(aminomethyl)-3-butylcyclopentyl)acetic acid	DMFXDY3	Investigative	Small molecular drug	[813]
2-(1-(aminomethyl)-3-ethylcyclopentyl)acetic acid	DM1ASK6	Investigative	Small molecular drug	[813]
2-(1-(phenylsulfonyl)-1H-indol-3-yl)ethanamine	DM3D8WI	Investigative	Small molecular drug	[814]
2-(1-adamantyl) piperidine	DM05OJD	Investigative	Small molecular drug	[815]
2-(1-adamantyl) pyrrolidine	DMMSFEU	Investigative	Small molecular drug	[815]
2-(1-adamantyl)-2-methyl-pyrrolidine	DMIGRMV	Investigative	Small molecular drug	[815]
2-(1-benzyl-1H-inden-3-yl)-N,N-dimethylethanamine	DMB5LHA	Investigative	Small molecular drug	[816]
2-(1-benzyl-1H-indol-3-yl)-N,N-dimethylethanamine	DMML3XI	Investigative	Small molecular drug	[816]
2-(1-dodecyl-1H-indol-3-yl)acetic acid	DMF2XHZ	Investigative	Small molecular drug	[222]
2-(1-Imidazol-1-yl-ethyl)-9H-carbazole	DM4MIXK	Investigative	Small molecular drug	[443]
2-(1-o-tolyl-1H-pyrrol-3-yl)ethanamine	DMY35HG	Investigative	Small molecular drug	[129]
2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole	DMR0HDF	Investigative	Small molecular drug	[817]
2-(1-tosyl-1H-indol-3-yl)ethanamine	DMXCID6	Investigative	Small molecular drug	[814]
2-(10-Imidazol-1-yl-decyl)-isoindole-1,3-dione	DMVXN01	Investigative	Small molecular drug	[818]
2-(1H-benzo[d]imidazol-2-yl)quinoxaline	DM0Y2P1	Investigative	Small molecular drug	[819]
2-(1H-Imidazol-1-yl)-1-(4-nitrophenyl)ethanone	DMFK9GA	Investigative	Small molecular drug	[531]
2-(1H-Imidazol-4-yl)benzene-1,3-diol	DM2PZ1B	Investigative	Small molecular drug	[820]
2-(1H-Imidazol-4-yl)phenol	DM6MR82	Investigative	Small molecular drug	[820]
2-(1H-Imidazol-4-ylmethyl)-4-phenyl-thiazole	DMCG1HE	Investigative	Small molecular drug	[821]
2-(1H-imidazo[4,5-c]pyridin-2-yl)quinoxaline	DMXA20E	Investigative	Small molecular drug	[822]
2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	DM0CSH8	Investigative	Small molecular drug	[22]
2-(1H-Indol-3-yl)-2-oxo-N-phenethyl-acetamide	DMFAME4	Investigative	Small molecular drug	[211]
2-(1H-indol-3-yl)-N,N-dimethylethanamine	DMR9Q4Y	Investigative	Small molecular drug	[823]
2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one	DMB7AU5	Investigative	Small molecular drug	[406]
2-(1H-indol-5-yl)-6-morpholino-4H-pyran-4-one	DMZNML4	Investigative	Small molecular drug	[824]
2-(1H-pyrazol-3-yl)-1H-benzimidazole	DMHSORL	Investigative	Small molecular drug	[22]
2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	DMUY75A	Investigative	Small molecular drug	[22]
2-(2''-indolylethyloxy)adenosine	DMCLIN8	Investigative	Small molecular drug	[825]
2-(2'-Aminoethyl)-5-benzyltetrahydrofuran	DMVTD1F	Investigative	Small molecular drug	[826]
2-(2'-methyl-biphenyl-3-yl)-ethylamine	DM7HN4Z	Investigative	Small molecular drug	[129]
2-(2,3,4-trimethoxyphenyl)-1H-indene	DMFU1PK	Investigative	Small molecular drug	[405]
2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid	DM1T8IP	Investigative	Small molecular drug	[827]
2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine	DM56NK4	Investigative	Small molecular drug	[464]
2-(2,4-dichlorophenoxy)-5-(2-methylbutyl)phenol	DM4XL8Z	Investigative	Small molecular drug	[828]
2-(2,4-dichlorophenoxy)-5-(3-phenylpropyl)phenol	DME3FUD	Investigative	Small molecular drug	[829]
2-(2,4-dichlorophenoxy)-5-ethylphenol	DMPSR1O	Investigative	Small molecular drug	[829]
2-(2,4-dichlorophenoxy)-5-isobutylphenol	DMKOFRE	Investigative	Small molecular drug	[828]
2-(2,4-dichlorophenoxy)-5-isopentylphenol	DME0LZ2	Investigative	Small molecular drug	[828]
2-(2,4-dichlorophenoxy)-5-methylphenol	DM1L3US	Investigative	Small molecular drug	[829]
2-(2,4-dichlorophenoxy)-5-phenethylphenol	DM6ZNR3	Investigative	Small molecular drug	[828]
2-(2,4-dichlorophenoxy)-5-propylphenol	DMKP974	Investigative	Small molecular drug	[829]
2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole	DMDUF21	Investigative	Small molecular drug	[830]
2-(2,4-difluorophenyl)-2,2-diphenylacetamide	DMSND8U	Investigative	Small molecular drug	[132]
2-(2,4-diphenylthiazol-5-yl)acetic acid	DMG49N2	Investigative	Small molecular drug	[831]
2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole	DM7JUK0	Investigative	Small molecular drug	[832]
2-(2-((benzylamino)methyl)phenoxy)-5-chlorophenol	DMGZKCT	Investigative	NA	[833]
2-(2-(2,5-dichlorophenylamino)phenyl)acetic acid	DM54M6C	Investigative	Small molecular drug	[834]
2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid	DMJ2DE4	Investigative	Small molecular drug	[835]
2-(2-(2-chlorophenoxy)phenyl)acetic acid	DMBP1TQ	Investigative	Small molecular drug	[834]
2-(2-(2-chlorophenylamino)phenyl)acetic acid	DMPLV3A	Investigative	Small molecular drug	[834]
2-(2-(2-fluorophenoxy)phenyl)acetic acid	DMDSUR2	Investigative	Small molecular drug	[834]
2-(2-(2-fluorophenylamino)phenyl)acetic acid	DMVQ68F	Investigative	Small molecular drug	[834]
2-(2-(4-tert-butylphenoxy)acetamido)benzoic acid	DMKT51Z	Investigative	Small molecular drug	[836]
2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole	DMZVBPG	Investigative	NA	[808]
2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid	DMDR50V	Investigative	Small molecular drug	[71]
2-(2-(biphenyl-4-yl)ethylsulfonyl)acetic acid	DM95B4J	Investigative	Small molecular drug	[71]
2-(2-(biphenyl-4-yl)ethylthio)acetic acid	DMBZIUC	Investigative	Small molecular drug	[71]
2-(2-(butylamino)pyrimidin-4-ylamino)benzoic acid	DMZA8M7	Investigative	Small molecular drug	[837]
2-(2-(pentyloxy)pyrimidin-4-ylamino)benzoic acid	DM4KS27	Investigative	Small molecular drug	[837]
2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide	DM5GAOZ	Investigative	Small molecular drug	[837]
2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole	DMCHZ8J	Investigative	Small molecular drug	[258]
2-(2-(pyrrolidin-1-yl)ethyl)phenol	DMQ0WKA	Investigative	Small molecular drug	[258]
2-(2-(pyrrolidin-1-yl)ethyl)pyridine	DMGQC2F	Investigative	Small molecular drug	[258]
2-(2-acetyl-4-bromophenoxy)acetic acid	DMITKZY	Investigative	Small molecular drug	[838]
2-(2-adamantyl) piperidine	DMP1KZW	Investigative	Small molecular drug	[815]
2-(2-allyl-4-chlorophenoxy)acetic acid	DMXDGEF	Investigative	Small molecular drug	[839]
2-(2-Amino-ethyl)-7-imino-azepane	DM3JM7V	Investigative	Small molecular drug	[36]
2-(2-Amino-phenyl)-6-methyl-chromen-4-one	DM0CWHT	Investigative	Small molecular drug	[840]
2-(2-Amino-propyl)-5-bromo-4-methoxy-phenol	DMZNRFG	Investigative	Small molecular drug	[465]
2-(2-Aminoethyl)anthra[1,9-cd]pyrazol-6(2H)-one	DMDFYJR	Investigative	Small molecular drug	[841]
2-(2-aminophenoxy)-5-hexylphenol	DMM9A8G	Investigative	Small molecular drug	[842]
2-(2-aminophenyl)-6-morpholino-4H-pyran-4-one	DMCLSJZ	Investigative	Small molecular drug	[824]
2-(2-benzhydryl-4-phenylthiazol-5-yl)acetic acid	DMN6IV2	Investigative	Small molecular drug	[843]
2-(2-benzoyl-4-bromophenoxy)acetic acid	DMLOD2Y	Investigative	Small molecular drug	[838]
2-(2-bromo-2-naphthamido)benzoic acid	DMFK0GM	Investigative	Small molecular drug	[844]
2-(2-Bromo-benzoyl)-cyclohexane-1,3-dione	DM3VH7F	Investigative	Small molecular drug	[845]
2-(2-Bromophenoxy)-N,N-dimethylethanamine	DMHBE0X	Investigative	Small molecular drug	[282]
2-(2-Bromophenylthio)-N,N-dimethylethanamine	DMHJMUX	Investigative	Small molecular drug	[282]
2-(2-butoxypyrimidin-4-ylamino)benzoic acid	DMLTU3J	Investigative	Small molecular drug	[837]
2-(2-carboxy-5-mercaptopentyl)benzoic acid	DMEGY0T	Investigative	Small molecular drug	[846]
2-(2-carboxy-7-mercaptoheptyl)benzoic acid	DMR98ML	Investigative	Small molecular drug	[846]
2-(2-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	DMWDV71	Investigative	Small molecular drug	[847]
2-(2-Chloro-benzoyl)-cyclohexane-1,3-dione	DMG6ABE	Investigative	Small molecular drug	[845]
2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine	DM1ULEX	Investigative	Small molecular drug	[468]
2-(2-chlorophenyl)-2,2-diphenylethanamide	DM60RWZ	Investigative	Small molecular drug	[132]
2-(2-chlorophenyl)-2-morpholinoethanamine	DMFG2S5	Investigative	Small molecular drug	[115]
2-(2-Chlorophenyl)-2H-indazole-7-carboxamide	DMTYDX2	Investigative	Small molecular drug	[848]
2-(2-chlorophenylamino)-5-methylthiazol-4(5H)-one	DMJ38LE	Investigative	Small molecular drug	[849]
2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	DM187UQ	Investigative	Small molecular drug	[850]
2-(2-cyclohexyl-4-fluorophenoxy)acetic acid	DMUN2CS	Investigative	Small molecular drug	[839]
2-(2-cyclohexyl-4-methoxyphenoxy)acetic acid	DMSI07M	Investigative	Small molecular drug	[839]
2-(2-cyclohexyl-4-methylphenoxy)acetic acid	DMVCY42	Investigative	Small molecular drug	[839]
2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole	DMTFWAQ	Investigative	Small molecular drug	[850]
2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole	DMPNGXE	Investigative	Small molecular drug	[850]
2-(2-cyclohexylphenoxy)acetic acid	DM81WJK	Investigative	Small molecular drug	[839]
2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	DMH1VCE	Investigative	Small molecular drug	[850]
2-(2-Fluoro-phenyl)-benzo[h]chromen-4-one	DMDUG9M	Investigative	Small molecular drug	[627]
2-(2-fluorophenoxy)-3-(piperidin-4-yl)pyridine	DM1SN37	Investigative	Small molecular drug	[468]
2-(2-formylphenoxy)acetic acid	DMMEBH3	Investigative	Small molecular drug	[838]
2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine	DMXGWOT	Investigative	Small molecular drug	[851]
2-(2-hexylphenyl)isoindoline-1,3-dione	DMSI41E	Investigative	Small molecular drug	[673]
2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	DM3UMYD	Investigative	Small molecular drug	[852]
2-(2-Hydroxy-phenyl)-6-methyl-chromen-4-one	DMOANXP	Investigative	Small molecular drug	[840]
2-(2-Hydroxycarbamoyl-ethyl)-pentanedioic acid	DMMEL39	Investigative	Small molecular drug	[853]
2-(2-Hydroxyethyl)anthra[1,9-cd]pyrazol-6(2H)-one	DMRPCL7	Investigative	Small molecular drug	[841]
2-(2-Iodo-benzoyl)-cyclohexane-1,3-dione	DMSVHU9	Investigative	Small molecular drug	[845]
2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one	DMPA4S0	Investigative	Small molecular drug	[854]
2-(2-Mercapto-ethyl)-pentanedioic acid	DMGELY0	Investigative	Small molecular drug	[855]
2-(2-Methoxy-benzoyl)-cyclohexane-1,3-dione	DMESMBO	Investigative	Small molecular drug	[845]
2-(2-Methoxy-phenyl)-1-methyl-ethylamine	DMDI98B	Investigative	Small molecular drug	[465]
2-(2-Methoxy-phenyl)-6-methyl-chromen-4-one	DMPVCDN	Investigative	Small molecular drug	[840]
2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one	DM9Z8V5	Investigative	Small molecular drug	[856]
2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine	DMYVDJQ	Investigative	Small molecular drug	[468]
2-(2-methoxyphenyl)-1H-indene	DMXFYN8	Investigative	Small molecular drug	[405]
2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one	DMXVCL0	Investigative	Small molecular drug	[824]
2-(2-Methyl-benzoyl)-cyclohexane-1,3-dione	DM4GN0E	Investigative	Small molecular drug	[845]
2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one	DMAHZR9	Investigative	Small molecular drug	[857]
2-(2-Methyl-thiazol-4-ylethynyl)-pyridine	DMIHTL0	Investigative	Small molecular drug	[858]
2-(2-Methylpropanoyl)-1,3,5-benzenetriol	DMPH63G	Investigative	Small molecular drug	[859]
2-(2-methylquinolin-4-ylamino)-N-phenylacetamide	DMW75IF	Investigative	Small molecular drug	[860]
2-(2-methylquinolin-7-yl)benzonitrile	DMENUIH	Investigative	Small molecular drug	[161]
2-(2-naphthamido)benzoic acid	DMN176Y	Investigative	Small molecular drug	[844]
2-(2-Nitro-benzoyl)-cyclohexane-1,3-dione	DMUJQX1	Investigative	Small molecular drug	[845]
2-(2-phenethylphenyl)isoindoline-1,3-dione	DM5NLQE	Investigative	Small molecular drug	[861]
2-(2-phenoxypyrimidin-4-ylamino)benzoic acid	DME0HPA	Investigative	Small molecular drug	[837]
2-(2-Phenyl-1H-indol-3-yl)-N,N-dipropyl-acetamide	DM1K0U5	Investigative	Small molecular drug	[862]
2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile	DMO9SP1	Investigative	Small molecular drug	[447]
2-(2-Phosphonooxy-ethyl)-pentanedioic acid	DMQM6IA	Investigative	Small molecular drug	[855]
2-(2-propoxypyrimidin-4-ylamino)benzoic acid	DMGVCKZ	Investigative	Small molecular drug	[837]
2-(2-sec-butoxypyrimidin-4-ylamino)benzoic acid	DMB4W68	Investigative	Small molecular drug	[837]
2-(2-thiazolyl)ethanamine	DMRL65E	Investigative	Small molecular drug	[863]
2-(3''(5''-chloro-indolyl)ethyloxy)adenosine	DMD8Q3E	Investigative	Small molecular drug	[825]
2-(3''(7''-bromo-indolyl)ethyloxy)adenosine	DMITEND	Investigative	Small molecular drug	[825]
2-(3''-(4''-bromo-indolyl)ethyloxy)adenosine	DMXRHOY	Investigative	Small molecular drug	[825]
2-(3''-(5''-bromo-indolyl)ethyloxy)adenosine	DMR8PGZ	Investigative	Small molecular drug	[825]
2-(3''-(5''-fluoro-indolyl)ethyloxy)adenosine	DME3IN1	Investigative	Small molecular drug	[825]
2-(3''-(5''-hydroxyindolyl)ethyloxy)adenosine	DM6BIOP	Investigative	Small molecular drug	[825]
2-(3''-(5''-iodo-indolyl)ethyloxy)adenosine	DMFP0IW	Investigative	Small molecular drug	[825]
2-(3''-(5''-methoxy-indolyl)ethyloxy)adenosine	DMWA0MN	Investigative	Small molecular drug	[825]
2-(3''-(6''-bromo-indolyl)ethyloxy)adenosine	DMGRC24	Investigative	Small molecular drug	[825]
2-(3''-(6''-chloro-indolyl)ethyloxy)adenosine	DML39UW	Investigative	Small molecular drug	[825]
2-(3''-(benzoimidazole-1''-yl)ethyloxy)adenosine	DMLDOH6	Investigative	Small molecular drug	[825]
2-(3''-(benzotriazole-1''-yl)ethyloxy)adenosine	DM1KCUV	Investigative	Small molecular drug	[825]
2-(3''-indolylethyloxy)adenosine	DMXRAE3	Investigative	Small molecular drug	[825]
2-(3''-pyrrolylethyloxy)adenosine	DMNCP8Y	Investigative	Small molecular drug	[825]
2-(3'-Allyl-biphenyl-4-yl)-propionic acid	DMAGFUH	Investigative	Small molecular drug	[864]
2-(3'-Ethyl-biphenyl-4-yl)-propionic acid	DMPLN58	Investigative	Small molecular drug	[864]
2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid	DMPGYDA	Investigative	Small molecular drug	[864]
2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	DMCDGAU	Investigative	Small molecular drug	[22]
2-(3'-Vinyl-biphenyl-4-yl)-propionic acid	DM7NGV1	Investigative	Small molecular drug	[864]
2-(3,4,5-Trihydroxy-benzylidene)-malononitrile	DM1I6SO	Investigative	Small molecular drug	[865]
2-(3,4-Difluorophenyl)-2,2-diphenylacetamide	DMJKVZ3	Investigative	Small molecular drug	[132]
2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one	DMAOD0K	Investigative	Small molecular drug	[866]
2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one	DM5MKEI	Investigative	Small molecular drug	[866]
2-(3,4-Dihydroxyphenyl)Acetic Acid	DMSZ0H9	Investigative	Small molecular drug	[12]
2-(3,4-dimethoxybenzamido)thiophene-3-carboxamide	DM3S26I	Investigative	Small molecular drug	[867]
2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole	DMLOX0Y	Investigative	Small molecular drug	[830]
2-(3,4-dimethylphenyl)-1,8-naphthyridine	DMDGRWM	Investigative	Small molecular drug	[868]
2-(3,5-dichlorophenyl)pyrido[2,3-d]pyrimidine	DM8KM1Q	Investigative	Small molecular drug	[869]
2-(3,5-difluorophenyl)-7-methyl-1,8-naphthyridine	DMGJPYO	Investigative	Small molecular drug	[868]
2-(3,5-dimethoxy-4-phenethoxyphenyl)ethanamine	DMIEB8R	Investigative	Small molecular drug	[459]
2-(3,5-dimethoxyphenyl)-1,8-naphthyridine	DMKND0T	Investigative	Small molecular drug	[868]
2-(3-(2-methylquinolin-7-yl)phenyl)acetonitrile	DMLJH92	Investigative	Small molecular drug	[161]
2-(3-(3,5-dichlorophenyl)ureido)benzoic acid	DMM9WB0	Investigative	Small molecular drug	[870]
2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid	DMRX4HM	Investigative	Small molecular drug	[871]
2-(3-(3-methoxyphenoxy)prop-1-ynyl)pyridine	DM1VSOK	Investigative	Small molecular drug	[872]
2-(3-(benzyloxy)phenyl)isoindoline-1,3-dione	DM0R5U6	Investigative	Small molecular drug	[873]
2-(3-(naphthalen-2-yl)propanamido)benzoic acid	DMKEY9V	Investigative	Small molecular drug	[836]
2-(3-(phenylsulfonyl)-1H-indol-1-yl)ethanamine	DM94B7N	Investigative	Small molecular drug	[874]
2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one	DMJ2NPY	Investigative	Small molecular drug	[824]
2-(3-Amino-phenyl)-6-methyl-chromen-4-one	DMAP37I	Investigative	Small molecular drug	[840]
2-(3-aminophenoxy)-5-hexylphenol	DMC6E8R	Investigative	Small molecular drug	[842]
2-(3-aminophenyl)-3-mercaptopropanoic acid	DMQB9SC	Investigative	Small molecular drug	[875]
2-(3-benzenesulfonyl)phenyl-1-aminoethane	DM3FBLT	Investigative	Small molecular drug	[876]
2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid	DMDB4LZ	Investigative	Small molecular drug	[877]
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	DMWMFTJ	Investigative	Small molecular drug	[22]
2-(3-benzylquinoxalin-2-ylamino)ethanol	DM6V91D	Investigative	Small molecular drug	[508]
2-(3-biphenyl-4-yl-propionylamino)-benzoic acid	DMY60K3	Investigative	Small molecular drug	[878]
2-(3-Bromo-phenyl)-6-methyl-chromen-4-one	DM9G7B6	Investigative	Small molecular drug	[840]
2-(3-Bromo-phenyl)-6-nitro-chromen-4-one	DM9RAYC	Investigative	Small molecular drug	[879]
2-(3-Bromo-phenyl)-chromen-4-one	DM7XDLO	Investigative	Small molecular drug	[879]
2-(3-bromobenzoylamino)-4-chlorobenzoic acid	DMX4DUR	Investigative	Small molecular drug	[871]
2-(3-bromophenyl)-7-methyl-1,8-naphthyridine	DMYSM9L	Investigative	Small molecular drug	[868]
2-(3-bromophenyl)-7-methylpyrido[2,3-d]pyrimidine	DMANS5X	Investigative	Small molecular drug	[869]
2-(3-bromophenyl)histamine	DM260RG	Investigative	Small molecular drug	[880]
2-(3-bromophenyl)pyrido[2,3-d]pyrimidine	DMVA4XC	Investigative	Small molecular drug	[869]
2-(3-Bromophenylthio)-N,N-dimethylethanamine	DMFETRH	Investigative	Small molecular drug	[282]
2-(3-Butoxy-4-hydroxy-phenyl)-benzooxazol-6-ol	DMJM5VW	Investigative	Small molecular drug	[847]
2-(3-Butoxy-phenyl)-6-methyl-chromen-4-one	DMSZT9G	Investigative	Small molecular drug	[840]
2-(3-carbamoylbenzyl)-5-mercaptopentanoic acid	DMHXVNZ	Investigative	Small molecular drug	[846]
2-(3-carboxybenzyl)succinic acid	DMI6AZ5	Investigative	Small molecular drug	[846]
2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	DMBONUV	Investigative	Small molecular drug	[847]
2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-6-ol	DM3B6IN	Investigative	Small molecular drug	[847]
2-(3-Chloro-phenyl)-1H-[1,8]naphthyridin-4-one	DMK6CD9	Investigative	Small molecular drug	[881]
2-(3-Chloro-phenyl)-chromen-4-one	DML83DM	Investigative	Small molecular drug	[879]
2-(3-chlorobenzyloxy)-6-chloroisonicotinonitrile	DM1VDC3	Investigative	Small molecular drug	[873]
2-(3-Chlorophenyl)-2H-indazole-7-carboxamide	DMYQBSV	Investigative	Small molecular drug	[848]
2-(3-chlorophenyl)-7-methyl-1,8-naphthyridine	DM7BC50	Investigative	Small molecular drug	[868]
2-(3-chlorophenyl)histamine	DMO0Y79	Investigative	Small molecular drug	[882]
2-(3-cyanobenzyl)-5-mercaptopentanoic acid	DMVB5U0	Investigative	Small molecular drug	[846]
2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-5-ol	DMNTHK5	Investigative	Small molecular drug	[847]
2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-6-ol	DM50FW1	Investigative	Small molecular drug	[847]
2-(3-Fluoro-phenyl)-benzo[h]chromen-4-one	DMNYWAT	Investigative	Small molecular drug	[627]
2-(3-guanidinophenyl)-3-mercaptopropanoic acid	DMZX2GE	Investigative	Small molecular drug	[875]
2-(3-Hydroxy-phenyl)-6-methyl-chromen-4-one	DM40RS3	Investigative	Small molecular drug	[840]
2-(3-Hydroxycarbamoyl-propyl)-pentanedioic acid	DMFVITM	Investigative	Small molecular drug	[853]
2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	DMZCE18	Investigative	Small molecular drug	[883]
2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-6-ol	DMIGXRJ	Investigative	Small molecular drug	[883]
2-(3-hydroxyphenyl)-7-methoxychroman-4-one	DMAH0ZG	Investigative	Small molecular drug	[884]
2-(3-hydroxyphenyl)quinolin-6-ol	DMV9M57	Investigative	Small molecular drug	[885]
2-(3-iodophenyl)histamine	DMML0VP	Investigative	Small molecular drug	[886]
2-(3-Isobutyl-phenyl)-propionic acid	DM59VBG	Investigative	Small molecular drug	[266]
2-(3-Isopropyl-phenyl)-propionic acid	DMUOWNE	Investigative	Small molecular drug	[266]
2-(3-Mercapto-propyl)-pentanedioic acid	DMMDNA8	Investigative	Small molecular drug	[855]
2-(3-Methoxy-phenyl)-1-methyl-ethylamine	DM4C9H2	Investigative	Small molecular drug	[465]
2-(3-Methoxy-phenyl)-6-methyl-chromen-4-one	DMBGVEK	Investigative	Small molecular drug	[840]
2-(3-methoxybenzylthio)-2-phenylacetic acid	DM21MAU	Investigative	Small molecular drug	[887]
2-(3-methoxyphenyl)-6-morpholino-4H-pyran-4-one	DMASH36	Investigative	Small molecular drug	[824]
2-(3-Methyl-3H-imidazol-4-yl)-ethylamine	DME09J2	Investigative	Small molecular drug	[888]
2-(3-Methyl-indole-1-sulfonyl)-benzoic acid	DMFOA6R	Investigative	Small molecular drug	[889]
2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline	DM1J4MT	Investigative	Small molecular drug	[890]
2-(3-Methylsulfanyl-propyl)-pentanedioic acid	DM4D1UT	Investigative	Small molecular drug	[855]
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole	DMMYQ9R	Investigative	Small molecular drug	[830]
2-(3-Phenoxy-benzoylamino)-benzoic acid	DM6GLEA	Investigative	Small molecular drug	[891]
2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one	DMIQBXD	Investigative	Small molecular drug	[406]
2-(3-phenylthio)phenyl)-1-aminoethane	DM4WOT6	Investigative	Small molecular drug	[876]
2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one	DMZ5H8O	Investigative	Small molecular drug	[892]
2-(4'-chloro-biphenyl-4-sulfonyl)-pentanoic acid	DMQAVM4	Investigative	Small molecular drug	[893]
2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	DM4X0SJ	Investigative	Small molecular drug	[830]
2-(4,5-Dihydroxy-indan-1-ylidene)-malononitrile	DM4BFHR	Investigative	Small molecular drug	[894]
2-(4,6-dimethoxypyrimidin-2-yloxy)-5-hexylphenol	DM1UBGQ	Investigative	Small molecular drug	[842]
2-(4-(3-chlorophenyl)but-1-ynyl)-6-methylpyridine	DM27CQJ	Investigative	Small molecular drug	[895]
2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol	DMOYT8I	Investigative	Small molecular drug	[896]
2-(4-(benzenesulfonyl)phenyl)-1-aminoethane	DMDAO5T	Investigative	Small molecular drug	[876]
2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol	DMFNQZS	Investigative	Small molecular drug	[437]
2-(4-(methylsulfonyl)phenyl)-3-phenylquinoline	DMVD6HE	Investigative	Small molecular drug	[897]
2-(4-(methylsulfonyl)phenyl)pyridine	DM1TZNK	Investigative	Small molecular drug	[528]
2-(4-amino-2-chlorophenoxy)-5-chlorophenol	DMUANX1	Investigative	Small molecular drug	[898]
2-(4-Amino-3'-chloro-biphenyl-3-yl)-propan-2-ol	DMSHPCW	Investigative	Small molecular drug	[899]
2-(4-Amino-phenyl)-6-methyl-chromen-4-one	DMGQHBU	Investigative	Small molecular drug	[840]
2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one	DM7LBEG	Investigative	Small molecular drug	[807]
2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one	DMJRDAQ	Investigative	Small molecular drug	[807]
2-(4-Amino-phenyl)-benzo[h]chromen-4-one	DM2P9L5	Investigative	Small molecular drug	[627]
2-(4-aminophenoxy)-5-hexylphenol	DMP0GI8	Investigative	Small molecular drug	[842]
2-(4-aminophenylsulfonamido)acetic acid	DMMU2BZ	Investigative	Small molecular drug	[900]
2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one	DM2JG49	Investigative	Small molecular drug	[807]
2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide	DMJA5Y4	Investigative	Small molecular drug	[901]
2-(4-benzoylpiperidine-1-carbonyl)benzoic acid	DMGMZV9	Investigative	Small molecular drug	[902]
2-(4-Benzyl-piperazin-1-yl)-benzothiazole	DM1V7EF	Investigative	Small molecular drug	[903]
2-(4-benzyl-piperidin-1-ylmethyl)-1H-indol-6-ol	DMFGCS1	Investigative	Small molecular drug	[904]
2-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one	DMID9YA	Investigative	Small molecular drug	[594]
2-(4-benzylphenoxy)ethanamine	DM6R4MG	Investigative	Small molecular drug	[559]
2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid	DM7QK5C	Investigative	Small molecular drug	[838]
2-(4-bromo-2-cyclohexylphenoxy)acetic acid	DM6I1NQ	Investigative	Small molecular drug	[839]
2-(4-bromo-2-formylphenoxy)acetic acid	DMQVUZP	Investigative	Small molecular drug	[838]
2-(4-Bromo-2-methoxy-phenyl)-1-methyl-ethylamine	DM79JVK	Investigative	Small molecular drug	[465]
2-(4-bromo-2-tert-butylphenoxy)acetic acid	DMXAQZ0	Investigative	Small molecular drug	[838]
2-(4-Bromo-3-phenoxy-benzoylamino)-benzoic acid	DMY8GZP	Investigative	Small molecular drug	[891]
2-(4-Bromo-phenyl)-1-methyl-ethylamine	DMB49UP	Investigative	Small molecular drug	[465]
2-(4-bromophenylsulfonamido)-N-hydroxyacetamide	DMY5STK	Investigative	Small molecular drug	[905]
2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide	DMG32HQ	Investigative	Small molecular drug	[742]
2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide	DMEKNZW	Investigative	Small molecular drug	[742]
2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide	DMO5IM0	Investigative	Small molecular drug	[742]
2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide	DMP7CF8	Investigative	Small molecular drug	[742]
2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	DM2XFGJ	Investigative	Small molecular drug	[22]
2-(4-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline	DM7BHYS	Investigative	Small molecular drug	[822]
2-(4-chloro-2-cycloheptylphenoxy)acetic acid	DM15YM7	Investigative	Small molecular drug	[906]
2-(4-chloro-2-cyclohexylphenoxy)acetic acid	DMGYZ8D	Investigative	Small molecular drug	[839]
2-(4-chloro-2-cyclopentylphenoxy)acetic acid	DMA6KQU	Investigative	Small molecular drug	[839]
2-(4-chloro-2-hydroxyphenoxy)benzenaminium	DMBHFIM	Investigative	Small molecular drug	[828]
2-(4-Chloro-phenyl)-3H-imidazo[4,5-c]quinoline	DMSB0JA	Investigative	Small molecular drug	[907]
2-(4-Chlorobenzylidene)cyclopentanone	DMOH2YC	Investigative	Small molecular drug	[752]
2-(4-chlorobenzylidene)cyclopentyl ethyl ether	DMFE93N	Investigative	Small molecular drug	[752]
2-(4-chlorobenzylidene)cyclopentylmethyl ether	DMTW9B7	Investigative	Small molecular drug	[752]
2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide	DM1JKWL	Investigative	Small molecular drug	[908]
2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide	DMFGQ7K	Investigative	Small molecular drug	[908]
2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide	DMRADWB	Investigative	Small molecular drug	[908]
2-(4-Chlorophenyl)-2H-indazole-7-carboxamide	DM6Z9U4	Investigative	Small molecular drug	[848]
2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole	DMFQI4C	Investigative	Small molecular drug	[830]
2-(4-chlorophenyl)-5-phenyl-4-isoxazolin-3-one	DMYGRS9	Investigative	Small molecular drug	[538]
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	DM9SGBO	Investigative	Small molecular drug	[12]
2-(4-chlorophenyl)-6-morpholino-4H-pyran-4-one	DM7EUOX	Investigative	Small molecular drug	[824]
2-(4-chlorophenyl)-6-phenyl-9H-purine	DMAPWNR	Investigative	Small molecular drug	[798]
2-(4-chlorophenylsulfonyl)naphthalene-1,4-diol	DMJORCV	Investigative	Small molecular drug	[909]
2-(4-cyano-2-cyclohexylphenoxy)acetic acid	DM4XFJI	Investigative	Small molecular drug	[839]
2-(4-cyclohexylthiosemicarbazono)methyl-phenol	DMOH46C	Investigative	Small molecular drug	[910]
2-(4-Cyclopentyl-piperazin-1-yl)-quinoline	DM6VQEO	Investigative	Small molecular drug	[911]
2-(4-Cyclopropyl-piperazin-1-yl)-quinoline	DMPU90E	Investigative	Small molecular drug	[911]
2-(4-Diethylamino-but-2-ynyl)-isoindole-1,3-dione	DM823CD	Investigative	Small molecular drug	[912]
2-(4-Dipropylamino-cyclohexylidene)-malononitrile	DMXH0FO	Investigative	Small molecular drug	[182]
2-(4-ethylthiobenzimidazol-2-yl)quinoxaline	DMTAVU5	Investigative	Small molecular drug	[822]
2-(4-Fluoro-3-phenoxy-benzoylamino)-benzoic acid	DMGLEX5	Investigative	Small molecular drug	[891]
2-(4-fluoro-benzyl)isoquinoline-1,3,4-trione	DMZSHDR	Investigative	Small molecular drug	[913]
2-(4-Fluoro-indole-1-sulfonyl)-benzoic acid	DMKFIEY	Investigative	Small molecular drug	[889]
2-(4-fluorophenyl)-6-morpholino-4H-pyran-4-one	DMECX8S	Investigative	Small molecular drug	[824]
2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one	DMZDGB3	Investigative	Small molecular drug	[56]
2-(4-fluorophenylsulfonamido)-1-naphthoic acid	DM0CDRP	Investigative	Small molecular drug	[914]
2-(4-hexyl-2-methoxyphenoxy)pyrimidine	DM05HBC	Investigative	Small molecular drug	[842]
2-(4-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	DMUGHF6	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-1-p-tolyl-3H-inden-5-ol	DMBIV8F	Investigative	Small molecular drug	[398]
2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile	DMNGW1A	Investigative	Small molecular drug	[757]
2-(4-Hydroxy-phenyl)-4-methoxy-quinolin-6-ol	DM4N0LB	Investigative	Small molecular drug	[915]
2-(4-Hydroxy-phenyl)-4-vinyl-quinolin-6-ol	DM81G2U	Investigative	NA	[915]
2-(4-Hydroxy-phenyl)-7-isopropyl-benzooxazol-5-ol	DMFWOMY	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-7-methoxy-benzofuran-5-ol	DMY0I8P	Investigative	Small molecular drug	[916]
2-(4-Hydroxy-phenyl)-7-methoxy-benzooxazol-5-ol	DMCNITS	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-7-methyl-benzofuran-5-ol	DMQ2KPI	Investigative	Small molecular drug	[916]
2-(4-Hydroxy-phenyl)-7-phenyl-benzooxazol-5-ol	DMUB7KH	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-7-propenyl-benzooxazol-5-ol	DMND63Z	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-7-propyl-benzooxazol-5-ol	DMONT2D	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-7-vinyl-benzooxazol-5-ol	DM2F6U3	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one	DMVHQM9	Investigative	Small molecular drug	[807]
2-(4-Hydroxy-phenyl)-benzooxazol-5-ol	DMMUNA7	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-benzooxazol-6-ol	DM31MY0	Investigative	Small molecular drug	[847]
2-(4-Hydroxy-phenyl)-quinolin-6-ol	DMCWFUZ	Investigative	Small molecular drug	[915]
2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	DMN6S3F	Investigative	Small molecular drug	[22]
2-(4-hydroxybenzylideneamino)ethanesulfonamide	DMCPN7V	Investigative	Small molecular drug	[917]
2-(4-hydroxylphenyl)-3-(3,5-dihydroxylphenyl) propenoic acid (NNU-hdpa)	DMM4S1R	Investigative	Small molecular drug	[918]
2-(4-hydroxypent-1-yl)-N6-methoxyadenosine	DM1C864	Investigative	Small molecular drug	[919]
2-(4-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	DMW6L38	Investigative	Small molecular drug	[883]
2-(4-hydroxyphenyl)-7-methoxychroman-4-one	DMT847Y	Investigative	Small molecular drug	[884]
2-(4-hydroxystyryl)quinolin-8-ol	DM8GBH4	Investigative	Small molecular drug	[920]
2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine	DMUIVS9	Investigative	Small molecular drug	[536]
2-(4-Isopropyl-piperazin-1-yl)-quinoline	DMSH4WP	Investigative	Small molecular drug	[911]
2-(4-Mercapto-butyl)-pentanedioic acid	DMXPJF3	Investigative	Small molecular drug	[855]
2-(4-methoxy-benzyl)isoquinoline-1,3,4-trione	DMHAE31	Investigative	Small molecular drug	[913]
2-(4-Methoxy-phenyl)-1H-indole-3-carbaldehyde	DMTEQU8	Investigative	Small molecular drug	[921]
2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol	DMZ9A6U	Investigative	Small molecular drug	[922]
2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one	DMS572H	Investigative	Small molecular drug	[807]
2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol	DMZNPMQ	Investigative	Small molecular drug	[923]
2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole	DM0KUMX	Investigative	Small molecular drug	[830]
2-(4-methoxyphenyl)-4H-chromene-4-thione	DMIDXTR	Investigative	Small molecular drug	[56]
2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one	DMVQU1M	Investigative	Small molecular drug	[824]
2-(4-methoxyphenyl)-6-phenyl-9H-purine	DMXTHOV	Investigative	Small molecular drug	[798]
2-(4-methoxyphenyl)-N-(thiazol-2-yl)acetamide	DM1N08O	Investigative	Small molecular drug	[543]
2-(4-methoxyphenyl)quinoline-8-carboxamide	DMBRETS	Investigative	Small molecular drug	[924]
2-(4-methyl-1H-benzo[d]imidazol-2-yl)quinoxaline	DMDXIN1	Investigative	Small molecular drug	[819]
2-(4-Methyl-indole-1-sulfonyl)-benzoic acid	DM943YL	Investigative	Small molecular drug	[889]
2-(4-Methyl-piperazin-1-yl)-4-phenyl-pyrimidine	DMDHFU9	Investigative	Small molecular drug	[925]
2-(4-Methyl-piperazin-1-yl)-quinoline	DMB8OY6	Investigative	Small molecular drug	[911]
2-(4-nitro-1H-benzo[d]imidazol-2-yl)quinoxaline	DMBJICP	Investigative	Small molecular drug	[822]
2-(4-nitrophenyl)-5-(4-methoxyphenyl)thiophene	DMX8U32	Investigative	Small molecular drug	[791]
2-(4-pentylphenyl)-N-(pyridin-3-yl)acetamide	DMR54SW	Investigative	Small molecular drug	[926]
2-(4-Phenoxy-benzyl)-1H-benzoimidazole	DM65IF1	Investigative	Small molecular drug	[927]
2-(4-Phenoxy-benzyl)-3H-benzoimidazol-4-ol	DM3HANW	Investigative	Small molecular drug	[927]
2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ol	DMFO19B	Investigative	Small molecular drug	[927]
2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ylamine	DMJSBFU	Investigative	Small molecular drug	[927]
2-(4-Phenoxy-phenyl)-1H-benzoimidazol-5-ylamine	DMSPOAT	Investigative	Small molecular drug	[928]
2-(4-phenoxyphenoxy)ethanamine	DM7TBUJ	Investigative	Small molecular drug	[929]
2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one	DMEQ063	Investigative	Small molecular drug	[406]
2-(4-phenylbutyl)pyrido[2,3-d]pyrimidin-4(3H)-one	DMNJAV1	Investigative	Small molecular drug	[930]
2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole	DM98WVL	Investigative	Small molecular drug	[453]
2-(4-Propyl-piperazin-1-yl)-quinoline	DMWPM9L	Investigative	Small molecular drug	[911]
2-(4-propylphenylsulfonyl)naphthalene-1,4-diol	DMXC20R	Investigative	Small molecular drug	[909]
2-(4-tert-Butyl-phenyl)-4,5-dihydro-1H-imidazole	DM1A4BS	Investigative	Small molecular drug	[832]
2-(4-tert-butylbenzylideneamino)ethanesulfonamide	DMIOW3D	Investigative	Small molecular drug	[917]
2-(4-tosylpiperazin-1-yl)nicotinonitrile	DMED9FL	Investigative	Small molecular drug	[518]
2-(5,6-Dihydroxy-indan-1-ylidene)-malononitrile	DMTC5Y9	Investigative	Small molecular drug	[894]
2-(5-Bromo-indole-1-sulfonyl)-benzoic acid	DMXRYDL	Investigative	Small molecular drug	[889]
2-(5-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline	DM0ZB89	Investigative	Small molecular drug	[822]
2-(5-cyano-1-pent-1-ynyl)-N6-methoxyadenosine	DMSIJ17	Investigative	Small molecular drug	[919]
2-(5-fluoro-1H-indol-3-yl)ethanamine	DMHW5FT	Investigative	Small molecular drug	[931]
2-(5-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	DMB3JG0	Investigative	Small molecular drug	[847]
2-(5-Mercapto-pentyl)-pentanedioic acid	DM0P6A3	Investigative	Small molecular drug	[855]
2-(5-Methoxy-1H-indol-3-yl)-1-methyl-ethylamine	DM1O0JD	Investigative	NA	[444]
2-(5-Nonyloxy-1H-indol-3-yl)-ethylamine	DM2TU6W	Investigative	Small molecular drug	[932]
2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	DMDZ9RK	Investigative	Small molecular drug	[933]
2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	DMX6QMT	Investigative	Small molecular drug	[136]
2-(5-Thiophen-2-yl-1H-indol-3-yl)-ethylamine	DM1AEK4	Investigative	Small molecular drug	[934]
2-(6-amino-8-bromo-9H-purin-9-yl)ethanol	DMRBX1D	Investigative	Small molecular drug	[935]
2-(6-Cyclopentylamino-purin-9-yl)-ethanol	DMTI1VO	Investigative	Small molecular drug	[104]
2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-5-ol	DMXAVHT	Investigative	Small molecular drug	[847]
2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	DM3GQN2	Investigative	Small molecular drug	[847]
2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-5-ol	DM715EC	Investigative	Small molecular drug	[847]
2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-6-ol	DMANHOT	Investigative	Small molecular drug	[847]
2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione	DMKI6GQ	Investigative	Small molecular drug	[818]
2-(6-Methoxy-indole-1-sulfonyl)-benzoic acid	DM41UYN	Investigative	Small molecular drug	[889]
2-(6-morpholino-9H-purin-2-yl)phenol	DMZDNHQ	Investigative	Small molecular drug	[179]
2-(6-phenylhexyl)pyrido[2,3-d]pyrimidin-4(3H)-one	DMR3Z1D	Investigative	Small molecular drug	[930]
2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine	DMD2QVO	Investigative	Small molecular drug	[936]
2-(7-phenylheptanoyl)oxazole-4-carbaldehyde	DMJAEZ8	Investigative	Small molecular drug	[530]
2-(7-phenylheptanoyl)oxazole-4-carbonitrile	DMVSL49	Investigative	Small molecular drug	[530]
2-(7-phenylheptanoyl)oxazole-4-carboxamide	DM9JMF2	Investigative	Small molecular drug	[530]
2-(7-phenylheptanoyl)oxazole-4-carboxylic acid	DM9BE2S	Investigative	Small molecular drug	[530]
2-(7-phenylheptanoyl)oxazole-5-carbonitrile	DM89RYN	Investigative	Small molecular drug	[530]
2-(7-phenylheptanoyl)oxazole-5-carboxylic acid	DMB53ML	Investigative	Small molecular drug	[530]
2-(8-Imidazol-1-yl-octyl)-isoindole-1,3-dione	DMLQ9WD	Investigative	Small molecular drug	[818]
2-(9,10-dihydroanthracen-9-yl)-N-methylethanamine	DMRW475	Investigative	Small molecular drug	[937]
2-(9-Benzyl-9H-purin-6-ylamino)-ethanol	DMPJ0O6	Investigative	Small molecular drug	[207]
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose	DMOUG6Y	Investigative	Small molecular drug	[12]
2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one	DMB3YXG	Investigative	Small molecular drug	[938]
2-(allyloxy)-N8-hydroxy-N1-phenyloctanediamide	DM6P20R	Investigative	Small molecular drug	[939]
2-(Aminomethyl)-5-(1'-naphthethyl)tetrahydrofuran	DMU4MIC	Investigative	Small molecular drug	[826]
2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran	DMCUTY9	Investigative	Small molecular drug	[826]
2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran	DM157SO	Investigative	Small molecular drug	[826]
2-(Aminomethyl)-5-phenethyltetrahydrofuran	DMEZ7O2	Investigative	Small molecular drug	[826]
2-(benzofuran-2-yl)-6-morpholino-4H-pyran-4-one	DMO3G6Q	Investigative	Small molecular drug	[824]
2-(benzylamino)-5,5-diethyloxazol-4(5H)-one	DMW27AC	Investigative	Small molecular drug	[938]
2-(Benzylamino)-6-(3-acetamidophenyl)pyrazine	DM4X6I9	Investigative	Small molecular drug	[940]
2-(benzylideneamino)ethanesulfonamide	DM3VJLZ	Investigative	Small molecular drug	[917]
2-(benzyloxy)-N7-hydroxy-N1-phenylheptanediamide	DM48C7G	Investigative	Small molecular drug	[939]
2-(benzyloxy)naphthalene	DME50RZ	Investigative	Small molecular drug	[941]
2-(benzyloxyamino)-N-hydroxy-3-methylpentanamide	DMSNCOW	Investigative	Small molecular drug	[908]
2-(benzyloxyamino)-N-hydroxyacetamide	DMHZJXG	Investigative	Small molecular drug	[908]
2-(benzyloxyamino)-N-hydroxyhexanamide	DMOUKTH	Investigative	Small molecular drug	[908]
2-(Biphenyl-2-yloxy)-N,N-dimethylethanamine	DM0C5O3	Investigative	Small molecular drug	[282]
2-(Biphenyl-2-ylthio)-N,N-dimethylethanamine	DM9XZSC	Investigative	Small molecular drug	[282]
2-(Biphenyl-3-ylthio)-N,N-dimethylethanamine	DMU0GDY	Investigative	Small molecular drug	[282]
2-(biphenyl-4-yl)vinylboronic acid	DMRQOKB	Investigative	Small molecular drug	[942]
2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide	DM3PWK7	Investigative	Small molecular drug	[905]
2-(biphenyl-4-ylsulfonamido)pentanedioic acid	DMH3YBR	Investigative	Small molecular drug	[923]
2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide	DMCNV5J	Investigative	Small molecular drug	[943]
2-(butylthiomethyl)-5-hydroxy-4H-pyran-4-one	DMFO7CH	Investigative	Small molecular drug	[944]
2-(Carbazole-9-sulfonyl)-benzoic acid	DMA6P4J	Investigative	Small molecular drug	[889]
2-(carboxymethylamino)-2-oxoacetic acid	DMQ2SNL	Investigative	Small molecular drug	[945]
2-(cinnamyloxy)pyrido[2,3-d]pyrimidin-4(3H)-one	DM0PA6I	Investigative	Small molecular drug	[930]
2-(cycloheptylamino)-2-oxoethyl 2-aminonicotinate	DMQ9ODG	Investigative	Small molecular drug	[946]
2-(cyclohexylamino)benzoic acid	DMPT0MB	Investigative	Small molecular drug	[22]
2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one	DM2CAI1	Investigative	Small molecular drug	[944]
2-(cyclooctylamino)-5,5-diethyloxazol-4(5H)-one	DMAPW5K	Investigative	Small molecular drug	[938]
2-(difluoromethyl)-9H-carbazole	DMZVMDO	Investigative	Small molecular drug	[548]
2-(ethoxycarbonyl)-1H-indole-5-carboxylic acid	DMS7WQD	Investigative	Small molecular drug	[947]
2-(ethylthiomethyl)-5-hydroxy-4H-pyran-4-one	DM8GJCU	Investigative	Small molecular drug	[944]
2-(furan-2-yl)-6-morpholino-4H-pyran-4-one	DM6BHUF	Investigative	Small molecular drug	[824]
2-(heptylthiomethyl)-5-hydroxy-4H-pyran-4-one	DM490BL	Investigative	Small molecular drug	[944]
2-(hex-1-ynyl)-N6-methoxyadenosine	DM7YLTS	Investigative	Small molecular drug	[919]
2-(hexylthiomethyl)-5-hydroxy-4H-pyran-4-one	DM235Q4	Investigative	Small molecular drug	[944]
2-(indolin-1yl)-melatonin	DMOVYXT	Investigative	Small molecular drug	[948]
2-(m-tolylethynyl)pyrimidine	DM15BA7	Investigative	Small molecular drug	[949]
2-(methylsulfonyl)naphthalene-1,4-diol	DM1SIQD	Investigative	Small molecular drug	[909]
2-(methylsulfonylthio)ethyl 2-propylpentanoate	DMM52D3	Investigative	Small molecular drug	[950]
2-(N''-Acetyl-hydrazino)-benzenesulfonamide	DMHYKR8	Investigative	Small molecular drug	[951]
2-(N,N-Diethylamino)-3'-chloropropiophenone	DMVR248	Investigative	Small molecular drug	[952]
2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid	DMRNOM6	Investigative	Small molecular drug	[953]
2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid	DMCL9E6	Investigative	Small molecular drug	[953]
2-(N-Cyclopentylamino)-3'-bromopropiophenone	DML4GHA	Investigative	Small molecular drug	[516]
2-(N-Cyclopentylamino)-3'-chloropropiophenone	DMP68CE	Investigative	Small molecular drug	[952]
2-(N-Cyclopentylamino)-3'-fluoropropiophenone	DMH6FKX	Investigative	Small molecular drug	[516]
2-(N-Cyclopentylamino)-3'-methoxypropiophenone	DMVN1UI	Investigative	Small molecular drug	[516]
2-(N-Cyclopentylamino)-3'-methylpropiophenone	DMG87RK	Investigative	Small molecular drug	[516]
2-(N-Cyclopropylamino)-3-chloropropiophenone	DMNMES3	Investigative	Small molecular drug	[952]
2-(N-Isopropylamino)-3'-chloropropiophenone	DMCK7SV	Investigative	Small molecular drug	[952]
2-(N-Morpholino)-Ethanesulfonic Acid	DMZVHSB	Investigative	Small molecular drug	[12]
2-(N-Pyrrolidinyl)-3'-bromopropiophenone	DM85ZCW	Investigative	Small molecular drug	[516]
2-(N-Pyrrolidinyl)-3'-fluoropropiophenone	DMYPOC5	Investigative	Small molecular drug	[516]
2-(N-Pyrrolidinyl)-3'-methoxypropiophenone	DM1W3L9	Investigative	Small molecular drug	[516]
2-(N-Pyrrolidinyl)-3'-methylpropiophenone	DMGKXOI	Investigative	Small molecular drug	[516]
2-(N-Pyrrolidinyl)-3'-nitropropiophenone	DM1I9LQ	Investigative	Small molecular drug	[516]
2-(N-tert-Butylamino)-3',4'-dichloropropiophenone	DMKIEVP	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)-3'-chloroheptanophenone	DMY2PBO	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)-3'-chlorohexanophenone	DMPO3CJ	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)-3'-chlorooctanophenone	DMW47VA	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)-3'-chloropentanophenone	DMTZ540	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)-4'-chloropropiophenone	DME1SP4	Investigative	Small molecular drug	[952]
2-(N-tert-Butylamino)propiophenone	DM9E5LT	Investigative	Small molecular drug	[952]
2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	DMKY71Z	Investigative	Small molecular drug	[830]
2-(naphthalen-2-ylsulfonyl)naphthalene-1,4-diol	DMEXBUF	Investigative	Small molecular drug	[909]
2-(o-toluidino)-5-ethylthiazol-4(5H)-one	DM3RCA9	Investigative	Small molecular drug	[954]
2-(o-toluidino)-5-isopropylthiazol-4(5H)-one	DMYTJX4	Investigative	Small molecular drug	[849]
2-(Oxalyl-Amino)-Benzoic Acid	DM7LOHK	Investigative	Small molecular drug	[12]
2-(p-Methylsulfonylbenzoyl)furan	DMLT635	Investigative	Small molecular drug	[528]
2-(p-toluidino)-4-phenylpyrimidine-5-carbonitrile	DM27YTF	Investigative	Small molecular drug	[955]
2-(p-tolylthio)naphthalene-1,4-dione	DMON1A5	Investigative	Small molecular drug	[909]
2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine	DMPUARE	Investigative	Small molecular drug	[940]
2-(phenylethynyl)pyrimidine	DMRIFCW	Investigative	Small molecular drug	[949]
2-(phenylsulfonamido)-1-naphthoic acid	DMFBTM2	Investigative	Small molecular drug	[914]
2-(phenylsulfonamido)-5-propylbenzoic acid	DMDGAHO	Investigative	Small molecular drug	[914]
2-(Phenylsulfonamido)acetic Acid	DMMSI67	Investigative	Small molecular drug	[956]
2-(phenylsulfonyl)-1-(thiophen-3-yl)ethanone	DMCF75U	Investigative	Small molecular drug	[381]
2-(phenylsulfonyl)-1-p-tolylethanone	DM93XJT	Investigative	Small molecular drug	[381]
2-(phenylsulfonyl)naphthalene-1,4-diol	DMAKR2E	Investigative	Small molecular drug	[909]
2-(Phosphonooxy)Butanoic Acid	DM4V2ZO	Investigative	Small molecular drug	[107]
2-(piperazin-1-yl)-5,6,7,8-tetrahydroquinoline	DML6HSE	Investigative	Small molecular drug	[561]
2-(piperidin-1-yl)-4H-benzo[h]chromen-4-one	DMGQX1I	Investigative	Small molecular drug	[957]
2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine	DMST2LX	Investigative	Small molecular drug	[958]
2-(pyridin-2-yl)-1H-benzo[d]imidazole	DMRUTDY	Investigative	Small molecular drug	[958]
2-(pyridin-2-yl)-1H-imidazo[4,5-c]pyridine	DMHFGMQ	Investigative	Small molecular drug	[958]
2-(pyridin-2-yl)-4-(m-tolylthio)pyrimidine	DM3EBYD	Investigative	Small molecular drug	[959]
2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile	DMET46L	Investigative	Small molecular drug	[960]
2-(Sulfanylmethyl)phenylphosphonic acid	DM5CEG8	Investigative	Small molecular drug	[961]
2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one	DMI457Y	Investigative	Small molecular drug	[516]
2-(tert-butylamino)-1-m-tolylpropan-1-one	DM6PV4W	Investigative	Small molecular drug	[516]
2-(tert-butylamino)-1-p-tolylpropan-1-one	DMYFQDT	Investigative	Small molecular drug	[516]
2-(tert-Butylamino)-3',4'-dichlorobutyrophenone	DMOJK8Y	Investigative	Small molecular drug	[952]
2-(tert-Butylamino)-3',4'-dichloropentanophenone	DMMUDQ7	Investigative	Small molecular drug	[952]
2-(tert-Butylamino)-3',5'-difluoropropiophenone	DMH3QLF	Investigative	Small molecular drug	[952]
2-(tert-Butylamino)-3'-fluoropropiophenone	DM5YJP3	Investigative	Small molecular drug	[952]
2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-amine	DMH4IRP	Investigative	Small molecular drug	[958]
2-(trifluoromethoxy)-9H-carbazole	DMDL8KY	Investigative	Small molecular drug	[548]
2-(trifluoromethyl)-9H-carbazole	DM7M6T3	Investigative	Small molecular drug	[548]
2-(trifluoromethyl)benzaldehyde thiosemicarbazone	DMWAKFM	Investigative	Small molecular drug	[962]
2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid	DMIQM4O	Investigative	Small molecular drug	[963]
2-acetamido-5-sulfonamidoindane	DMPKBVR	Investigative	Small molecular drug	[565]
2-acetyl-3-hydroxycyclohex-2-enone	DMRKYD6	Investigative	Small molecular drug	[964]
2-Acetyl-cyclohexane-1,3-dione	DMN8TVB	Investigative	Small molecular drug	[845]
2-Acetylamino-indan-5-sulfonic acid hydrate	DMEQKIU	Investigative	NA	[965]
2-Acetylaminoethyl 18-methoxycoronaridinate	DM9ZOX4	Investigative	Small molecular drug	[705]
2-acetylaminoquinazoline-4-carboxyanilide	DM0NJYZ	Investigative	Small molecular drug	[404]
2-Adamantan-1-yl-N-decyl-acetamide	DMJAUH0	Investigative	Small molecular drug	[517]
2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol	DMXG029	Investigative	Small molecular drug	[966]
2-allylisoquinoline-1,3,4-trione	DM3DE9Z	Investigative	Small molecular drug	[913]
2-Allylthio-3-benzyl-6-nitro-quinazolin-4(3H)-one	DMTO1EJ	Investigative	Small molecular drug	[967]
2-Allylthio-6-amino-3-benzyl-quinazolin-4(3H)-one	DMBWGCX	Investigative	Small molecular drug	[967]
2-Amino-1-(4-ethylthiophenyl)butane	DM73FWA	Investigative	Small molecular drug	[534]
2-Amino-1-(4-ethylthiophenyl)propane	DMS5LKR	Investigative	Small molecular drug	[534]
2-Amino-1-(4-methylthiophenyl)butane	DMW7N3H	Investigative	Small molecular drug	[534]
2-Amino-1-(4-methylthiophenyl)propane	DMJ2Z9G	Investigative	Small molecular drug	[205]
2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	DMNQL17	Investigative	Small molecular drug	[22]
2-amino-2,3-dihydro-1H-indene-5-sulfonamide	DMQOCAY	Investigative	Small molecular drug	[963]
2-amino-2-(2,3-difluorophenyl)acetic acid	DMWDENZ	Investigative	Small molecular drug	[317]
2-amino-2-(2,4-difluorophenyl)acetic acid	DMSAFUK	Investigative	Small molecular drug	[317]
2-amino-2-(2-fluorophenyl)acetic acid	DMLXOHE	Investigative	Small molecular drug	[317]
2-amino-2-(3-bromophenyl)acetic acid	DMEX6AM	Investigative	Small molecular drug	[317]
2-amino-2-(3-chloro-4-fluorophenyl)acetic acid	DMMU1CQ	Investigative	Small molecular drug	[317]
2-amino-2-(3-chlorophenyl)acetic acid	DMPZX8U	Investigative	Small molecular drug	[317]
2-amino-2-(thiophen-2-yl)acetic acid	DMHQNZD	Investigative	Small molecular drug	[317]
2-amino-2-phenyl-1,1-di(pyridin-3-yl)ethanol	DM14HCY	Investigative	Small molecular drug	[968]
2-amino-3,4',5-trimethoxy-(Z)-stillbene	DMMZ2LI	Investigative	Small molecular drug	[732]
2-AMINO-3-(4-HYDROXY-1,2,5-OXADIAZOL-3-YL)PROPIONIC ACID (STRUCTURAL MIX)	DMQKGL3	Investigative	Small molecular drug	[969]
2-amino-3-(m-tolylamino)naphthalene-1,4-dione	DM2GJZE	Investigative	Small molecular drug	[162]
2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	DM6AYDL	Investigative	Small molecular drug	[12]
2-Amino-3-Oxo-4-Sulfo-Butyric Acid	DMXLZUA	Investigative	Small molecular drug	[12]
2-Amino-4,6-di-furan-2-yl-nicotinonitrile	DMVN0EC	Investigative	Small molecular drug	[970]
2-Amino-4,6-di-thiophen-2-yl-nicotinonitrile	DM53T8Q	Investigative	Small molecular drug	[970]
2-amino-4,6-dimethylpyridine	DMVJXQ9	Investigative	Small molecular drug	[971]
2-Amino-4,6-diphenyl-nicotinonitrile	DMO69TS	Investigative	Small molecular drug	[970]
2-Amino-4,6-diphenyl-pyrimidin-5-carbonitrile	DM1MOB9	Investigative	Small molecular drug	[804]
2-Amino-4,6-diphenyl-pyrimidine	DMI9YGU	Investigative	Small molecular drug	[804]
2-amino-4-(2-methyl-benzylsulfanyl)-butyric acid	DMULSNQ	Investigative	Small molecular drug	[317]
2-Amino-4-furan-2-yl-6-phenyl-nicotinonitrile	DMP4NHD	Investigative	Small molecular drug	[970]
2-amino-4-methylpyridine	DM1OED2	Investigative	Small molecular drug	[972]
2-Amino-4-phenyl-6-thiophen-2-yl-nicotinonitrile	DMRVTJ1	Investigative	Small molecular drug	[970]
2-Amino-4-phosphono-butyric acid	DMOIZY1	Investigative	Small molecular drug	[973]
2-Amino-5-(N-nitro-guanidino)-pentanoic acid	DMDUZ2H	Investigative	Small molecular drug	[318]
2-Amino-5-Hydroxy-Benzimidazole	DMA7ZOW	Investigative	Small molecular drug	[12]
2-amino-5-phenylthiophene-3-carboxamide	DMOQ2R8	Investigative	Small molecular drug	[974]
2-Amino-6-(2-bromo-benzenesulfonyl)-benzonitrile	DM3VJEZ	Investigative	Small molecular drug	[581]
2-Amino-6-(2-chloro-benzenesulfonyl)-benzonitrile	DMFW9D3	Investigative	Small molecular drug	[581]
2-Amino-6-(2-chloro-phenylsulfanyl)-benzonitrile	DM7391H	Investigative	Small molecular drug	[581]
2-Amino-6-(2-cyano-benzenesulfinyl)-benzonitrile	DM8O6AC	Investigative	Small molecular drug	[581]
2-Amino-6-(2-cyano-benzenesulfonyl)-benzonitrile	DMRKQLV	Investigative	Small molecular drug	[581]
2-Amino-6-(2-cyano-phenylsulfanyl)-benzonitrile	DM8UQD5	Investigative	Small molecular drug	[581]
2-Amino-6-(2-fluoro-benzenesulfonyl)-benzonitrile	DMBMK8S	Investigative	Small molecular drug	[581]
2-Amino-6-(2-methoxy-phenylsulfanyl)-benzonitrile	DM0N5J4	Investigative	Small molecular drug	[581]
2-Amino-6-(3-bromo-benzenesulfinyl)-benzonitrile	DM6R98Y	Investigative	Small molecular drug	[581]
2-Amino-6-(3-bromo-benzenesulfonyl)-benzonitrile	DMTUM78	Investigative	Small molecular drug	[581]
2-Amino-6-(3-bromo-phenylsulfanyl)-benzonitrile	DMH4TRD	Investigative	Small molecular drug	[581]
2-Amino-6-(3-chloro-benzenesulfonyl)-benzonitrile	DM9XKJQ	Investigative	Small molecular drug	[581]
2-Amino-6-(3-chloro-phenylsulfanyl)-benzonitrile	DMT3KP0	Investigative	Small molecular drug	[581]
2-Amino-6-(3-cyano-benzenesulfonyl)-benzonitrile	DM9GQ1U	Investigative	Small molecular drug	[581]
2-Amino-6-(3-cyano-phenylsulfanyl)-benzonitrile	DM2MCK1	Investigative	Small molecular drug	[581]
2-Amino-6-(3-fluoro-phenylsulfanyl)-benzonitrile	DMG7HP2	Investigative	Small molecular drug	[581]
2-Amino-6-(3-methoxy-phenylsulfanyl)-benzonitrile	DMACYWZ	Investigative	Small molecular drug	[581]
2-Amino-6-(4-chloro-phenylsulfanyl)-benzonitrile	DML6EFV	Investigative	Small molecular drug	[581]
2-Amino-6-(indan-5-ylamino)-3H-pyrimidin-4-one	DMECHD0	Investigative	Small molecular drug	[975]
2-Amino-6-(naphthalene-1-sulfonyl)-benzonitrile	DMXPWHF	Investigative	Small molecular drug	[581]
2-Amino-6-(naphthalene-2-sulfonyl)-benzonitrile	DMMKJYG	Investigative	Small molecular drug	[581]
2-Amino-6-(toluene-2-sulfonyl)-benzonitrile	DMWGE3U	Investigative	Small molecular drug	[581]
2-Amino-6-(toluene-3-sulfinyl)-benzonitrile	DMJXWH0	Investigative	Small molecular drug	[581]
2-Amino-6-(toluene-3-sulfonyl)-benzonitrile	DM1EGP9	Investigative	Small molecular drug	[581]
2-Amino-6-(toluene-4-sulfonyl)-benzonitrile	DMB7415	Investigative	Small molecular drug	[581]
2-Amino-6-benzenesulfonyl-benzonitrile	DMJ4H9F	Investigative	Small molecular drug	[581]
2-Amino-6-Chloropyrazine	DMJVG30	Investigative	Small molecular drug	[12]
2-Amino-6-furan-2-yl-4-phenyl-nicotinonitrile	DMUYTXS	Investigative	Small molecular drug	[970]
2-Amino-6-m-tolylsulfanyl-benzonitrile	DMQF9H1	Investigative	Small molecular drug	[581]
2-Amino-6-p-tolylsulfanyl-benzonitrile	DM4BQ1W	Investigative	Small molecular drug	[581]
2-amino-6-phenyl-4-p-tolylnicotinonitrile	DMAXESK	Investigative	Small molecular drug	[976]
2-Amino-6-phenyl-4-thiophen-2-yl-nicotinonitrile	DM7M9CL	Investigative	Small molecular drug	[970]
2-Amino-6-phenylsulfanyl-benzonitrile	DMMBGK0	Investigative	Small molecular drug	[581]
2-amino-8-methyl-7,8-dihydropteridin-4(3H)-one	DMRSGC5	Investigative	NA	[800]
2-Amino-benzenesulfonamide	DMEMANH	Investigative	Small molecular drug	[788]
2-Amino-indan-5-sulfonic acid	DMCUSH1	Investigative	NA	[963]
2-Amino-N,3,3-Trimethylbutanamide	DM3YI9P	Investigative	Small molecular drug	[12]
2-amino-N-(quinolin-8-yl)benzenesulfonamide	DMESFTW	Investigative	Small molecular drug	[977]
2-amino-N-benzyl-6-phenyl-9H-purine-9-carboxamide	DM320RW	Investigative	Small molecular drug	[978]
2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide	DMRY06D	Investigative	Small molecular drug	[22]
2-amino-N1-benzyl-N3-hydroxymalonamide	DMQ30UY	Investigative	Small molecular drug	[979]
2-amino-quinoline-3-carboxylic acid amide	DME4856	Investigative	Small molecular drug	[974]
2-amino-uridine-5'-monophosphate	DMO792L	Investigative	Small molecular drug	[980]
2-Aminoethanimidic Acid	DM2OE1W	Investigative	Small molecular drug	[12]
2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran	DMCJUWK	Investigative	Small molecular drug	[826]
2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran	DM3OTZY	Investigative	Small molecular drug	[826]
2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran	DMDG8FL	Investigative	Small molecular drug	[826]
2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran	DME4P7K	Investigative	Small molecular drug	[826]
2-Aminomethyl-5-(phenyl)tetrahydrofuran	DM413ZB	Investigative	Small molecular drug	[826]
2-Aminomethyl-pyrrolidine-3,4-diol	DMAN8EH	Investigative	Small molecular drug	[981]
2-aminopyridine	DMQIC3L	Investigative	Small molecular drug	[971]
2-aminoquinazoline-4-carboxy-(4-bromophenyl)amide	DMJW4CS	Investigative	Small molecular drug	[404]
2-aminoquinazoline-4-carboxyanilide	DMQJYX7	Investigative	Small molecular drug	[404]
2-Aminothiazoline	DM9YCAH	Investigative	Small molecular drug	[12]
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	DMFNEZW	Investigative	Small molecular drug	[22]
2-APB	DM9AKVR	Investigative	Small molecular drug	[982]
2-arachidonoylglycerol	DMM0KOJ	Investigative	Small molecular drug	[983]
2-arachidonoylglycerolphosphoinositol	DMICOL3	Investigative	Small molecular drug	[984]
2-arachidonyl glyceryl ether	DM2H8TV	Investigative	Small molecular drug	[985]
2-azido-N6-methyl-9-(beta-D-ribofuranosyl)adenine	DMBSDIV	Investigative	Small molecular drug	[986]
2-Benzhydryl-7-hydroxy-chromen-4-one	DMXZ1HL	Investigative	Small molecular drug	[866]
2-Benzoxy-5-(2-methylquinolin-7-yl)benzonitrile	DMQX9PD	Investigative	Small molecular drug	[987]
2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile	DMO97FR	Investigative	Small molecular drug	[334]
2-benzoylaminoquinazoline-4-carboxyanilide	DMGEFQP	Investigative	Small molecular drug	[404]
2-Benzyl-1,2-dihydro-indazol-3-one	DM1CB5J	Investigative	Small molecular drug	[406]
2-Benzyl-1-hydroxy-3H-benzo[f]chromen-3-one	DMV7IWE	Investigative	Small molecular drug	[988]
2-Benzyl-2H-indazole-7-carboxamide	DMPYB93	Investigative	Small molecular drug	[848]
2-benzyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	DM6E04T	Investigative	Small molecular drug	[989]
2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole	DMANTCY	Investigative	Small molecular drug	[990]
2-benzyl-4,5,6,7-tetrachloroisoindoline-1,3-dione	DMH76SO	Investigative	Small molecular drug	[991]
2-Benzyl-4-piperazin-1-yl-1H-benzimidazole	DMYGKW5	Investigative	Small molecular drug	[992]
2-benzyl-5-mercaptopentanoic acid	DM3I7EL	Investigative	Small molecular drug	[846]
2-Benzyl-6-methoxy-5-oxazol-5-yl-1H-indole	DMGWRID	Investigative	Small molecular drug	[993]
2-Benzyl-7-hydroxy-chromen-4-one	DMAX5TC	Investigative	Small molecular drug	[866]
2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide	DMF5MGQ	Investigative	Small molecular drug	[979]
2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide	DMRVA94	Investigative	Small molecular drug	[979]
2-benzyl-N1-hydroxy-N3-phenethylmalonamide	DM2BPIN	Investigative	Small molecular drug	[979]
2-Benzylaminomethyl-3-hydroxymorphinan	DM6EMGJ	Investigative	Small molecular drug	[712]
2-Benzylbenzo[f]chromen-3-one	DMM48L6	Investigative	Small molecular drug	[856]
2-benzylisoquinoline-1,3,4-trione	DME7SAV	Investigative	Small molecular drug	[913]
2-benzyloxy-7,8-dihydro-6H-quinolin-5-one	DMCLAXG	Investigative	Small molecular drug	[994]
2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine	DM6F0C4	Investigative	Small molecular drug	[995]
2-BFi	DMFAW4R	Investigative	Small molecular drug	[996]
2-biphenyl-4-yl-1-phenothiazin-10-yl-ethanone	DMHS3N6	Investigative	Small molecular drug	[105]
2-biphenyl-4-yl-6-morpholin-4-yl-pyran-4-one	DML1W5Z	Investigative	Small molecular drug	[824]
2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide	DMWOJ5N	Investigative	Small molecular drug	[742]
2-bromo-4-(3-fluorophenylethynyl)thiazole	DMCM01R	Investigative	Small molecular drug	[228]
2-bromo-4-methylphenyl 2-nitrobenzoate	DMJ0368	Investigative	Small molecular drug	[997]
2-bromo-LSD	DMOYCWU	Investigative	Small molecular drug	[998]
2-Bromo-N-(2-morpholinoethyl)nicotinamide	DMYCENM	Investigative	Small molecular drug	[999]
2-Bromo-N-(3-morpholinopropyl)nicotinamide	DM9NMIO	Investigative	Small molecular drug	[999]
2-Bromoacetyl Group	DMIHJSA	Investigative	Small molecular drug	[12]
2-bromophenol	DM6JDIY	Investigative	Small molecular drug	[107]
2-Butyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione	DMY7RM8	Investigative	Small molecular drug	[772]
2-butylamido-5-sulfonamidoindane	DML9MCU	Investigative	Small molecular drug	[565]
2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone	DMG5SAQ	Investigative	Small molecular drug	[1000]
2-chloro-2'-C-methyl-tecadenoson	DMD3ZNP	Investigative	Small molecular drug	[741]
2-chloro-4-(o-tolyloxy)benzonitrile	DMTPKU8	Investigative	Small molecular drug	[1001]
2-chloro-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	DMPCRLY	Investigative	Small molecular drug	[1002]
2-chloro-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	DMC5OQ3	Investigative	Small molecular drug	[1002]
2-Chloro-5-(2-methylquinolin-7-yl)nicotinonitrile	DM5KR4B	Investigative	Small molecular drug	[987]
2-chloro-5-nitro-N-phenylbenzamide	DMUGQIV	Investigative	Small molecular drug	[22]
2-chloro-6(methylamino)purine	DML0S8M	Investigative	Small molecular drug	[1003]
2-Chloro-N-(2-morpholinoethyl)nicotinamide	DMR8M36	Investigative	Small molecular drug	[999]
2-chloro-N-(3-(3-chlorobenzamido)phenyl)benzamide	DM2W71L	Investigative	Small molecular drug	[1004]
2-Chloro-N-(3-morpholinopropyl)nicotinamide	DM5S1DW	Investigative	Small molecular drug	[999]
2-chloro-N-(6-cyanopyridin-3-yl)propanamide	DMBKVM4	Investigative	Small molecular drug	[1005]
2-chloro-N-(o-tolylcarbamoyl)benzamide	DMLDQ6I	Investigative	Small molecular drug	[792]
2-chloroadenosine	DMYPQEW	Investigative	Small molecular drug	[1006]
2-chloroadenosine-5-triphosphate	DMQUDA9	Investigative	Small molecular drug	[1007]
2-Chlorobenzenemethanethiol	DMI89RL	Investigative	Small molecular drug	[786]
2-Chlorophenol	DM2E3X5	Investigative	Small molecular drug	[12]
2-Cinnamamido-N1-hydroxy-N4-octylsuccinamide	DMXYTGU	Investigative	Small molecular drug	[1008]
2-Cinnamamido-N1-hydroxy-N4-pentylsuccinamide	DMI6FZN	Investigative	Small molecular drug	[1008]
2-Cinnamamido-N4-hexyl-N1-hydroxysuccinamide	DMRNGK7	Investigative	Small molecular drug	[1008]
2-Cl-ADP(alpha-BH3)	DM4235F	Investigative	Small molecular drug	[1009]
2-cyano-3-(3,4-dihydroxyphenyl)acrylamide	DMCN6PY	Investigative	Small molecular drug	[334]
2-Cyclohex-1-enylethynyl-pyridine	DM2U1N5	Investigative	Small molecular drug	[1010]
2-Cyclohexyl-N-(4-methoxy-phenyl)-acetamide	DMF6PMU	Investigative	Small molecular drug	[517]
2-Cyclohexyl-N-phenethyl-acetamide	DM89CLH	Investigative	Small molecular drug	[517]
2-Cyclohexyl-N-phenyl-acetamide	DMBJUP5	Investigative	Small molecular drug	[517]
2-Cyclohexylacetic acidbiphenyl-3-yl ester	DMS1T0V	Investigative	Small molecular drug	[1011]
2-cyclohexylamido-5-sulfonamidoindane	DMFBD3K	Investigative	Small molecular drug	[565]
2-cyclohexylamino-pyridine-2-carbonitrile	DMFMZRB	Investigative	Small molecular drug	[1012]
2-cyclohexylamino-pyrimidine-4-carbonitrile	DMMIGXO	Investigative	Small molecular drug	[1012]
2-Cyclohexylethynyl-pyridine	DM2JZ84	Investigative	Small molecular drug	[1010]
2-Cyclopent-1-enylethynyl-pyridine	DMVP6CW	Investigative	Small molecular drug	[1010]
2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine	DM6CZAN	Investigative	Small molecular drug	[111]
2-Cyclopentylaminomethyl-pyrrolidine-3,4-diol	DMS947W	Investigative	Small molecular drug	[981]
2-Cyclopropanecarbonyl-cyclohexane-1,3-dione	DMRS6LH	Investigative	Small molecular drug	[845]
2-Cyclopropylmethylenepropanal	DM0W2QB	Investigative	Small molecular drug	[12]
2-Deoxy-2-Amino Glucitol-6-Phosphate	DMBMK4T	Investigative	Small molecular drug	[12]
2-Deoxy-2fluoro-Glucose	DMMC8IG	Investigative	Small molecular drug	[12]
2-Deoxy-Glucose-6-Phosphate	DMMPL3D	Investigative	Small molecular drug	[12]
2-dibenzofuran-4-yl-6-morpholin-4-yl-pyran-4-one	DM4A527	Investigative	Small molecular drug	[824]
2-Dipropylamino-1,2,3,4-tetrahydro-anthracen-9-ol	DMF50YH	Investigative	Small molecular drug	[1013]
2-EPI-2-THIOSALVINORIN A	DM2PDGO	Investigative	Small molecular drug	[1014]
2-EPI-2-THIOSALVINORIN B	DMZXIW0	Investigative	Small molecular drug	[1014]
2-ethoxy-5-(m-tolylethynyl)pyrimidine	DMGRA3T	Investigative	Small molecular drug	[949]
2-ethyl-4-(furan-2-yl)thieno[3,2-d]pyrimidine	DM0BHKM	Investigative	Small molecular drug	[1002]
2-ethyl-4-(furan-3-yl)thieno[3,2-d]pyrimidine	DMR0IEK	Investigative	Small molecular drug	[1002]
2-ethyl-4-(pyridin-2-yl)thieno[3,2-d]pyrimidine	DMWFR16	Investigative	Small molecular drug	[1002]
2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	DMWCGE8	Investigative	Small molecular drug	[1002]
2-ethyl-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	DMIRSQO	Investigative	Small molecular drug	[1002]
2-Ethyl-5-methoxy-3-piperidin-4-yl-1H-indole	DMLC8OB	Investigative	Small molecular drug	[1015]
2-ethyl-9H-carbazole	DMN8W1H	Investigative	Small molecular drug	[548]
2-ethylamido-5-sulfonamidoindane	DMDY3JQ	Investigative	Small molecular drug	[565]
2-ethylestradiol 3,17-O,O-bis-sulfamate	DMC10DR	Investigative	Small molecular drug	[1016]
2-ethylquinoline-8-carboxamide	DMKR47X	Investigative	Small molecular drug	[924]
2-ethynyl-4-(3-fluorophenylethynyl)thiazole	DME6VKS	Investigative	Small molecular drug	[228]
2-ethynyl-N6-methoxyadenosine	DM2D78W	Investigative	Small molecular drug	[919]
2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol	DMUGAT8	Investigative	Small molecular drug	[373]
2-Fluoro-4-[5-(3-hydroxyphenyl)-3-thienyl]phenol	DMGBEFY	Investigative	Small molecular drug	[373]
2-fluoro-5-(3-methylthiophen-2-yl)pyridine	DMCGI1S	Investigative	Small molecular drug	[194]
2-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol	DMKOUCM	Investigative	Small molecular drug	[373]
2-Fluoro-6-(3-phenoxy-benzoylamino)-benzoic acid	DMP8OXL	Investigative	Small molecular drug	[891]
2-fluoromevalonate 5-diphosphate	DMEQRHY	Investigative	Small molecular drug	[1017]
2-fluoronorepinehprine	DMX34TL	Investigative	Small molecular drug	[1018]
2-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate	DM5OW91	Investigative	Small molecular drug	[787]
2-fluorophenyl 4'-ethylbiphenyl-4-ylcarbamate	DMGIKWA	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(decyloxy)phenylcarbamate	DMSFQAZ	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(dodecyloxy)phenylcarbamate	DMCEGZU	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(heptyloxy)phenylcarbamate	DMLM2WU	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(hexyloxy)phenylcarbamate	DM854ED	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(octyloxy)phenylcarbamate	DM81J0O	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-(undecyloxy)phenylcarbamate	DMTYX5G	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-butoxybenzylcarbamate	DM4EIQ3	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-butoxyphenylcarbamate	DMYJ1M4	Investigative	Small molecular drug	[787]
2-fluorophenyl 4-phenoxyphenylcarbamate	DMSMDQC	Investigative	Small molecular drug	[787]
2-fluorophenyl-2,2-diphenylacetamide	DMNPGXA	Investigative	Small molecular drug	[132]
2-fluorophenylboronic acid	DMXPFYZ	Investigative	Small molecular drug	[1019]
2-Furan-2-yl-3-phenethyl-3H-quinazolin-4-one	DM28XTE	Investigative	Small molecular drug	[1020]
2-Furan-2-yl-4,5-dihydro-1H-imidazole	DMQIFJ9	Investigative	Small molecular drug	[1021]
2-Furan-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMHT80R	Investigative	Small molecular drug	[1022]
2-Furan-2-yl-7-methyl-1H-[1,8]naphthyridin-4-one	DMD8ZUH	Investigative	Small molecular drug	[1023]
2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one	DMQIRY7	Investigative	Small molecular drug	[406]
2-Heptyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione	DMX45WE	Investigative	Small molecular drug	[772]
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	DMJ3ATL	Investigative	Small molecular drug	[22]
2-Hex-5-enyl-5-non-8-enyl-3,4-dihydro-2H-pyrrole	DMRXW3U	Investigative	Small molecular drug	[1024]
2-Hex-5-enyl-5-non-8-enyl-pyrrolidine	DM7KDQV	Investigative	Small molecular drug	[1024]
2-Hex-5-enyl-5-nonyl-pyrrolidine	DMIBRYM	Investigative	Small molecular drug	[1024]
2-Hexadecynoic acid	DMTFIPZ	Investigative	Small molecular drug	[1025]
2-Hexyl-4-(4-isobutyl-phenyl)-1H-imidazole	DM94PBL	Investigative	Small molecular drug	[817]
2-Hexyloxy-5-imidazol-1-yl-pyridine	DMKORTS	Investigative	Small molecular drug	[536]
2-hexylphenyl acrylate	DMTD0IG	Investigative	Small molecular drug	[185]
2-Hydrazino-3-methyl-4(3H)-quinazolinone	DMOT1LQ	Investigative	Small molecular drug	[1026]
2-Hydrazinocarbonyl-benzenesulfonamide	DMG78U2	Investigative	Small molecular drug	[951]
2-hydrazinylbenzenesulfonamide	DMCNXZM	Investigative	Small molecular drug	[788]
2-hydroxy capric acid	DMJAN52	Investigative	Small molecular drug	[1027]
2-hydroxy-17beta-estradiol	DMM9Z0B	Investigative	Small molecular drug	[795]
2-Hydroxy-2-phenyl-nonanoic acid amide	DM2GPF6	Investigative	Small molecular drug	[1028]
2-HYDROXY-3,5-DIIODOBENZOIC ACID	DMDOHRF	Investigative	Small molecular drug	[1029]
2-hydroxy-3-isopropyl-2,4,6-cycloheptatrien-1-one	DMK8WUR	Investigative	Small molecular drug	[1030]
2-hydroxy-5-isopropyl-2,4,6-cycloheptatrien-1-one	DMSDYZQ	Investigative	Small molecular drug	[1030]
2-Hydroxy-6-(3-phenoxy-benzoylamino)-benzoic acid	DMB3Y8H	Investigative	Small molecular drug	[891]
2-Hydroxy-N,6-bis(3-hydroxyphenyl)-1-naphthamide	DMQ0F96	Investigative	Small molecular drug	[600]
2-Hydroxy-N-(3-phenyl-propyl)-benzamide	DMWSR13	Investigative	Small molecular drug	[171]
2-hydroxy-saclofen	DMHO8KQ	Investigative	Small molecular drug	[1031]
2-HYDROXYCARBAMOYL-4-METHYL-PENTANOIC ACID	DMOT6V7	Investigative	Small molecular drug	[22]
2-Hydroxycarbamoyl-pentanedioic acid	DM412RI	Investigative	Small molecular drug	[853]
2-Hydroxycarbamoylmethyl-pentanedioic acid	DMA8DZT	Investigative	Small molecular drug	[853]
2-Hydroxycinnamic acid	DM86HTZ	Investigative	Small molecular drug	[1032]
2-Hydroxyethyl 18-methoxycoronaridinate	DMT6APV	Investigative	Small molecular drug	[705]
2-hydroxygarveatin E	DM5E1DC	Investigative	Small molecular drug	[1033]
2-HYDROXYGARVIN A	DMK96BL	Investigative	Small molecular drug	[1033]
2-Hydroxyiminoolean-12-en-28-oic acid	DMNXV2I	Investigative	Small molecular drug	[1034]
2-Hydroxyiminours-12-en-28-oic acid	DMDKF03	Investigative	Small molecular drug	[1034]
2-hydroxyisoquinoline-1,3(2H,4H)-dione	DMTLYDS	Investigative	Small molecular drug	[1035]
2-hydroxylauric acid	DMCNW3M	Investigative	Small molecular drug	[1036]
2-Hydroxymethyl-3-hydroxymorphinan	DM4LMPD	Investigative	Small molecular drug	[712]
2-Hydroxymethyl-Pyrrolidine-3,4-Diol	DM7MUZ1	Investigative	Small molecular drug	[107]
2-hydroxyoctanoic acid	DMMILJS	Investigative	Small molecular drug	[1037]
2-hydroxyphenethyl 3,4,5-trihydroxybenzoate	DMHK2NQ	Investigative	Small molecular drug	[1038]
2-Imidazol-1-yl-7-methoxy-3-phenyl-chromen-4-one	DM261B0	Investigative	Small molecular drug	[1039]
2-Imidazol-1-ylmethylxanthen-9-one	DM2GUDZ	Investigative	Small molecular drug	[494]
2-iodo-melatonin	DMSEIUP	Investigative	Small molecular drug	[1040]
2-iodo-[125I]5MCA-NAT	DMJSLS5	Investigative	Small molecular drug	[1041]
2-isooleanolic acid	DMOVRX7	Investigative	Small molecular drug	[1034]
2-isopropyl-9H-carbazole	DMSLMAN	Investigative	Small molecular drug	[548]
2-isoursolic acid	DMEZFKS	Investigative	Small molecular drug	[1034]
2-Isoxazol-3-yl-3H-imidazo[4,5-c]quinoline	DM1F4TN	Investigative	Small molecular drug	[907]
2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline	DMD2ZNA	Investigative	Small molecular drug	[907]
2-m-tolyl-1,8-naphthyridine	DMBWDXH	Investigative	Small molecular drug	[868]
2-m-Tolyl-1H-[1,8]naphthyridin-4-one	DM9ZVHJ	Investigative	Small molecular drug	[881]
2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	DM3AFXM	Investigative	Small molecular drug	[989]
2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	DMIMRCH	Investigative	Small molecular drug	[989]
2-MePen-RYYRIK-NH2	DMDZTU3	Investigative	Small molecular drug	[754]
2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide	DMXEUDM	Investigative	Small molecular drug	[22]
2-Mercapto-pentanedioic acid	DMRVBCI	Investigative	Small molecular drug	[855]
2-Mercaptomethyl-pentanedioic acid	DMHK25N	Investigative	Small molecular drug	[855]
2-mercaptophenylphosphonic acid	DM8HSBT	Investigative	Small molecular drug	[961]
2-methoxy-1,4-naphthoquinone	DMA5Q4T	Investigative	Small molecular drug	[755]
2-methoxy-1-naphthaldehyde thiosemicarbazone	DMH76C5	Investigative	Small molecular drug	[962]
2-methoxy-3,4-methylenedioxybenzophenone	DM93DYT	Investigative	Small molecular drug	[1042]
2-methoxy-4-(2-methoxyphenylthio)benzonitrile	DMF8E5L	Investigative	Small molecular drug	[1043]
2-methoxy-4-(2-nitrovinyl)phenol	DMEAVD2	Investigative	Small molecular drug	[334]
2-methoxy-4-(m-tolyloxy)benzonitrile	DM1MGQ6	Investigative	Small molecular drug	[1043]
2-methoxy-4-(o-tolyloxy)benzonitrile	DMT7YR3	Investigative	Small molecular drug	[1043]
2-methoxy-4-(p-tolyloxy)benzonitrile	DMR5YZG	Investigative	Small molecular drug	[1043]
2-methoxy-4-(propylthio)benzonitrile	DMXGP2I	Investigative	Small molecular drug	[1043]
2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol	DMCGID6	Investigative	Small molecular drug	[1044]
2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol	DM6CAYV	Investigative	Small molecular drug	[1045]
2-Methoxy-5-(5,6,7-trimethoxy-indan-1-yl)-phenol	DM9LY0Z	Investigative	Small molecular drug	[1046]
2-methoxy-9-aminomethyl-9,10-dihydroanthracene	DMXCAKO	Investigative	Small molecular drug	[617]
2-methoxy-alpha,beta-didehydro-agomelatine	DM4G3FS	Investigative	Small molecular drug	[1047]
2-Methoxy-N-(3-methyl-2-phenyl-butyl)-benzamide	DM31E6J	Investigative	Small molecular drug	[1048]
2-methoxyapomorphine	DMPG0V7	Investigative	Small molecular drug	[399]
2-methoxyestradiol-17-O-sulfamate	DMIBKNZ	Investigative	Small molecular drug	[1049]
2-methoxyestrrone-3-O-sulfamate	DMD6L7C	Investigative	Small molecular drug	[1049]
2-Methoxyethyl 18-methoxycoronaridinate	DM6X8GN	Investigative	Small molecular drug	[705]
2-methoxyphenyl 10H-phenothiazine-10-carboxylate	DMQS8VE	Investigative	Small molecular drug	[1050]
2-methoxyphenylboronic acid	DML5PE9	Investigative	Small molecular drug	[1019]
2-Methyl-1(3)H-anthrasimidazole-6,11-dione	DMKTQB2	Investigative	Small molecular drug	[772]
2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane	DMIWX21	Investigative	Small molecular drug	[635]
2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime	DMB0NEL	Investigative	Small molecular drug	[635]
2-Methyl-1,2-di-pyridin-3-yl-propane	DMC3ET2	Investigative	Small molecular drug	[635]
2-Methyl-1,2-di-pyridin-3-yl-propylchloride	DMQHM7R	Investigative	Small molecular drug	[635]
2-Methyl-1,2-di-pyridin-3-yl-propyliodide	DM561MH	Investigative	Small molecular drug	[635]
2-Methyl-1,2-dihydro-indazol-3-one	DMDJHFQ	Investigative	Small molecular drug	[406]
2-methyl-1-(pyridin-3-yl)pent-1-en-3-one oxime	DMRWOQH	Investigative	Small molecular drug	[1051]
2-methyl-1-(pyridin-4-yl)pent-1-en-3-one oxime	DMTQ4FV	Investigative	Small molecular drug	[1051]
2-methyl-1-(thiophen-2-yl)pent-1-en-3-one oxime	DMLTJDR	Investigative	Small molecular drug	[1051]
2-methyl-1-(thiophen-3-yl)pent-1-en-3-one oxime	DMQJKSV	Investigative	Small molecular drug	[1051]
2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol	DMLX9RG	Investigative	Small molecular drug	[635]
2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one	DMZY72I	Investigative	Small molecular drug	[635]
2-Methyl-2,4-Pentanediol	DMD45CU	Investigative	Small molecular drug	[12]
2-Methyl-2-Propanol	DMHM5GJ	Investigative	Small molecular drug	[12]
2-Methyl-3-(2-Aminothiazolo)Propanal	DM3DNFQ	Investigative	Small molecular drug	[22]
2-methyl-3-(pyridin-4-yl)-1H-indol-6-amine	DMV8YIZ	Investigative	Small molecular drug	[621]
2-methyl-3-(pyridin-4-yl)-1H-indole	DM8N54C	Investigative	Small molecular drug	[621]
2-methyl-3-oxopropanoate	DMTADLZ	Investigative	Small molecular drug	[1052]
2-methyl-3-phenethyl-3H-pyrimidin-4-one	DMHYA7G	Investigative	Small molecular drug	[1020]
2-methyl-4-(2-thienylethynyl)thiazole	DMAFPE7	Investigative	Small molecular drug	[228]
2-methyl-4-(3-thienylethynyl)thiazole	DMK4A0J	Investigative	Small molecular drug	[228]
2-methyl-4-(m-tolylethynyl)thiazole	DM4P3CW	Investigative	Small molecular drug	[228]
2-Methyl-4-o-tolylethynyl-thiazole	DMKFBVS	Investigative	Small molecular drug	[858]
2-Methyl-4-p-tolylethynyl-thiazole	DMWRCFY	Investigative	Small molecular drug	[858]
2-Methyl-4-phenylethynyl-thiazole	DMRC60A	Investigative	Small molecular drug	[858]
2-methyl-6-(3-(p-tolyloxy)prop-1-ynyl)pyridine	DMGPDYE	Investigative	Small molecular drug	[872]
2-methyl-6-(3-(phenylthio)prop-1-ynyl)pyridine	DM536IA	Investigative	Small molecular drug	[895]
2-methyl-6-(4-phenylbut-1-ynyl)pyridine	DM1YK7M	Investigative	Small molecular drug	[895]
2-methyl-6-(4-phenylpent-1-ynyl)pyridine	DM0UNM1	Investigative	Small molecular drug	[895]
2-methyl-6-(5-phenylpent-1-ynyl)pyridine	DMDVO7Z	Investigative	Small molecular drug	[895]
2-methyl-6-(phenylethynyl)pyridine	DMVQK4Y	Investigative	Small molecular drug	[1053]
2-methyl-6-(trifluoromethyl)-9H-carbazole	DMJYSF3	Investigative	Small molecular drug	[548]
2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime	DM8EV4A	Investigative	Small molecular drug	[1054]
2-methyl-7-(pyridin-3-yl)quinoline	DM9FZ0B	Investigative	Small molecular drug	[161]
2-methyl-7-m-tolyl-1,6-naphthyridine	DMMFKOH	Investigative	Small molecular drug	[868]
2-methyl-7-m-tolyl-1,8-naphthyridine	DMZFK4R	Investigative	Small molecular drug	[868]
2-methyl-7-m-tolylquinoline	DMC02TI	Investigative	Small molecular drug	[161]
2-methyl-7-phenyl-1,8-naphthyridine	DM8RV5X	Investigative	Small molecular drug	[868]
2-methyl-7-phenylquinoline	DMT7MVD	Investigative	Small molecular drug	[161]
2-Methyl-8-phenyl-1,2,3,4-tetrahydro-isoquinoline	DMY65CX	Investigative	Small molecular drug	[1055]
2-methyl-9H-carbazole	DM06TZN	Investigative	Small molecular drug	[548]
2-methyl-9H-indeno[2,1-d]pyrimidin-9-one	DMEVFJW	Investigative	Small molecular drug	[1056]
2-Methyl-beta-carboline-2-ium iodide	DMQBF7J	Investigative	Small molecular drug	[1057]
2-Methyl-[1,4]thiazepan-(5E)-ylideneamine	DMX1IC4	Investigative	Small molecular drug	[196]
2-Methylamino-succinic acid(NMDA)	DMKP6BM	Investigative	Small molecular drug	[1058]
2-methylbut-3-yn-2-yl 4-methoxybenzoate	DMKB2P8	Investigative	Small molecular drug	[114]
2-methylhistamine	DMD8CQS	Investigative	Small molecular drug	[1059]
2-methylisoquinoline-1,3,4-trione	DMHW9GL	Investigative	Small molecular drug	[913]
2-Methylquinoline-8-carboxamide	DMUN3LV	Investigative	Small molecular drug	[924]
2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate	DMM4HXK	Investigative	Small molecular drug	[1016]
2-morpholin-4-yl-6-phenyl-4H-thiopyran-4-one	DMCVF7R	Investigative	Small molecular drug	[824]
2-Morpholin-4-yl-6-phenyl-chromen-4-one	DMTB1KV	Investigative	Small molecular drug	[627]
2-morpholin-4-yl-8-naphthalen-2-ylchromen-4-one	DMC1TWI	Investigative	Small molecular drug	[957]
2-morpholin-4-yl-8-phenoxathiin-4-ylchromen-4-one	DMVN38H	Investigative	Small molecular drug	[957]
2-Morpholin-4-yl-8-phenylethynyl-chromen-4-one	DMNKHOI	Investigative	NA	[1060]
2-morpholin-4-yl-8-styrylchromen-4-one	DMNHYQ0	Investigative	Small molecular drug	[957]
2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one	DM5JHT6	Investigative	Small molecular drug	[957]
2-morpholin-4-yl-8-thiophen-3-ylchromen-4-one	DMCY4EP	Investigative	Small molecular drug	[957]
2-Morpholin-4-yl-benzo[h]chromene-4-thione	DM3ZWNI	Investigative	Small molecular drug	[627]
2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide	DMDTRZ2	Investigative	Small molecular drug	[1061]
2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one	DMCKSX7	Investigative	Small molecular drug	[627]
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one	DM79ZOV	Investigative	Small molecular drug	[627]
2-morpholino-1,1,2-triphenylethanol	DMFHTEG	Investigative	Small molecular drug	[968]
2-morpholino-1,1-di(pyridin-3-yl)hexan-1-ol	DMH89O5	Investigative	Small molecular drug	[968]
2-morpholino-1,1-di(pyridin-3-yl)octan-1-ol	DMDMVA1	Investigative	Small molecular drug	[968]
2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol	DM3V5AB	Investigative	Small molecular drug	[968]
2-morpholino-4H-benzo[g]chromen-4-one	DM5J6IT	Investigative	Small molecular drug	[957]
2-morpholino-6-(naphthalen-1-yl)-4H-chromen-4-one	DMZL6Q1	Investigative	Small molecular drug	[957]
2-morpholino-6-(naphthalen-1-yl)-4H-pyran-4-one	DMEOI0V	Investigative	Small molecular drug	[824]
2-morpholino-6-(naphthalen-2-yl)-4H-pyran-4-one	DMO7QCN	Investigative	Small molecular drug	[824]
2-morpholino-6-(quinolin-8-yl)-4H-pyran-4-one	DMTBRLK	Investigative	Small molecular drug	[824]
2-morpholino-6-(thianthren-1-yl)-4H-chromen-4-one	DMATVZB	Investigative	Small molecular drug	[957]
2-morpholino-6-(thiophen-2-yl)-4H-pyran-4-one	DMTWJMN	Investigative	Small molecular drug	[824]
2-morpholino-6-(thiophen-3-yl)-4H-pyran-4-one	DMF3NPW	Investigative	Small molecular drug	[824]
2-morpholino-6-phenyl-4H-pyran-4-one	DMMC0ZP	Investigative	Small molecular drug	[824]
2-morpholino-6-styryl-4H-pyran-4-one	DM8ZPJI	Investigative	Small molecular drug	[824]
2-morpholino-7-(2-phenylethynyl)-4H-chromen-4-one	DM4XKYN	Investigative	Small molecular drug	[1060]
2-morpholino-7-phenyl-4H-chromen-4-one	DMK7WON	Investigative	Small molecular drug	[1060]
2-morpholino-N-phenethylpyrimidin-4-amine	DMIQYWM	Investigative	Small molecular drug	[1062]
2-morpholinobenzo[h]quinolin-4(1H)-one	DMYP0UI	Investigative	Small molecular drug	[957]
2-N,N-Dimethylamino-1-(4-methylthiophenyl)propane	DMKSUVH	Investigative	Small molecular drug	[534]
2-N-(Isopropyl)amino-1-(4-methylthiophenyl)butane	DM0PT8R	Investigative	Small molecular drug	[534]
2-N-(n-Propyl)amino-1-(4-methylthiophenyl)butane	DMLJ30O	Investigative	Small molecular drug	[534]
2-N-Allylamino-1-(4-methylthiophenyl)propan	DM5S0BY	Investigative	Small molecular drug	[534]
2-N-Cyclopropylamino-1-(4-methylthiophenyl)butane	DMS0NW3	Investigative	Small molecular drug	[534]
2-N-Ethylamino-1-(4-ethylthiophenyl)butane	DMCYVS0	Investigative	Small molecular drug	[534]
2-N-Ethylamino-1-(4-ethylthiophenyl)propane	DM64093	Investigative	Small molecular drug	[534]
2-N-Ethylamino-1-(4-methylthiophenyl)butane	DMKA3V2	Investigative	Small molecular drug	[534]
2-N-Ethylamino-1-(4-methylthiophenyl)propane	DM6O1SY	Investigative	Small molecular drug	[534]
2-N-Hydroxyamino-1-(4-ethylthiophenyl)butane	DM2MH6J	Investigative	Small molecular drug	[534]
2-N-Hydroxyamino-1-(4-ethylthiophenyl)propane	DMIQGWK	Investigative	Small molecular drug	[534]
2-N-Hydroxyamino-1-(4-methylthiophenyl)butane	DME41NR	Investigative	Small molecular drug	[534]
2-N-Hydroxyamino-1-(4-methylthiophenyl)propane	DMZDYCW	Investigative	Small molecular drug	[534]
2-N-Methoxyamino-1-(4-methylthiophenyl)propane	DMHCVKJ	Investigative	Small molecular drug	[534]
2-N-Methylamino-1-(4-ethylthiophenyl)propane	DM1X5RY	Investigative	Small molecular drug	[534]
2-N-Methylamino-1-(4-methylthiophenyl)butane	DMCR49K	Investigative	Small molecular drug	[534]
2-N-Methylamino-1-(4-methylthiophenyl)propane	DMVLX1T	Investigative	Small molecular drug	[534]
2-N-Propargylamino-1-(4-methylthiophenyl)butane	DMLZCOU	Investigative	Small molecular drug	[534]
2-N-Propargylamino-1-(4-methylthiophenyl)propane	DM9HPG1	Investigative	Small molecular drug	[534]
2-Naphthalen-1-yl-1H-[1,8]naphthyridin-4-one	DMTSF6A	Investigative	Small molecular drug	[881]
2-Naphthalen-1-yl-benzooxazol-6-ol	DMBI6U9	Investigative	Small molecular drug	[847]
2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one	DMIDGNB	Investigative	Small molecular drug	[406]
2-Naphthalen-2-yl-1H-[1,8]naphthyridin-4-one	DM12YH4	Investigative	Small molecular drug	[881]
2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one	DM1EJ6W	Investigative	Small molecular drug	[406]
2-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole	DMNMEPB	Investigative	Small molecular drug	[1063]
2-NAPHTHALENESULFONIC ACID	DMZ4LJ7	Investigative	Small molecular drug	[22]
2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine	DMFXKN1	Investigative	Small molecular drug	[1064]
2-nitro-N-(2,4,5-trichlorophenyl)benzamide	DMRZK9A	Investigative	Small molecular drug	[997]
2-nitro-N-(quinolin-8-yl)benzenesulfonamide	DM4Z56O	Investigative	Small molecular drug	[977]
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	DMQWR69	Investigative	Small molecular drug	[22]
2-nonylamido-5-sulfonamidoindane	DMOGWIK	Investigative	Small molecular drug	[565]
2-O-ethyl-PAF C-16	DMZK0JV	Investigative	Small molecular drug	[1065]
2-O-methyl-PAF C-18	DME7K64	Investigative	Small molecular drug	[1066]
2-oleoyl glycerol	DM5PXQU	Investigative	Small molecular drug	[1067]
2-oleoyl-LPA	DMN9OS1	Investigative	Small molecular drug	[1068]
2-Oxa-spiro[4.4]nonan-1-one	DM2NEX4	Investigative	Small molecular drug	[379]
2-oxo-2H-chromene-3-carboxylic acid	DMFN769	Investigative	Small molecular drug	[1069]
2-oxo-2H-thiochromene-3-carboxylic acid	DMZTCOM	Investigative	Small molecular drug	[1069]
2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	DMDKSZ0	Investigative	Small molecular drug	[1070]
2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	DMWXI6C	Investigative	Small molecular drug	[1070]
2-oxo-N-phenyl-2H-chromene-3-carboxamide	DMH8QWY	Investigative	Small molecular drug	[1070]
2-oxoguaia-1,4(15), 11(13)-trien-12,8beta-olide	DM3UY74	Investigative	Small molecular drug	[703]
2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide	DM23WOV	Investigative	Small molecular drug	[703]
2-Oxoolean-12-en-28-oic acid	DMDMK81	Investigative	Small molecular drug	[1034]
2-oxothiazolidine-4-carboxylate	DMXC9U7	Investigative	Small molecular drug	[1071]
2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	DM1NK2M	Investigative	Small molecular drug	[989]
2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	DM9MIC5	Investigative	Small molecular drug	[989]
2-p-tolyl-4,5-dihydro-1H-imidazole	DM37S5C	Investigative	NA	[830]
2-p-tolyl-4H-chromen-4-one	DMFWA9Y	Investigative	Small molecular drug	[56]
2-p-tolyl-4H-chromene-4-thione	DM2HKCM	Investigative	Small molecular drug	[56]
2-p-Tolyl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMJIVL3	Investigative	Small molecular drug	[1022]
2-pentafluorophenylamido-5-sulfonamidoindane	DMZ9NCA	Investigative	Small molecular drug	[565]
2-pentenal	DM032YM	Investigative	Small molecular drug	[1072]
2-Phenethyl-1,2-dihydro-indazol-3-one	DM0WMBC	Investigative	Small molecular drug	[406]
2-Phenethyl-4,5-dihydro-1H-imidazole	DM4H6PC	Investigative	Small molecular drug	[1021]
2-phenethylisoquinoline-1,3,4-trione	DMPWG21	Investigative	Small molecular drug	[913]
2-phenoxy-1-(2-p-tolylthiazolidin-3-yl)ethanone	DMQX7FW	Investigative	Small molecular drug	[1073]
2-phenoxy-3-(piperidin-4-yl)pyridine	DM6JNT5	Investigative	Small molecular drug	[468]
2-Phenoxymethyl-4,5-dihydro-1H-imidazole	DM5E74G	Investigative	Small molecular drug	[1021]
2-phenyl-1,1-di(pyridin-3-yl)ethanol	DMERNSK	Investigative	Small molecular drug	[968]
2-phenyl-1,2'-spirobi[1H-indene]-5'-ol	DMP8G3C	Investigative	Small molecular drug	[883]
2-Phenyl-1,2-dihydro-indazol-3-one	DM28CLZ	Investigative	Small molecular drug	[406]
2-phenyl-1,8-naphthyridine	DM3WOHI	Investigative	Small molecular drug	[868]
2-phenyl-1H-imidazole-4-carboxylic acid	DMZI7O1	Investigative	Small molecular drug	[22]
2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine	DMDC6XP	Investigative	Small molecular drug	[111]
2-phenyl-2,3-dihydrobenzo[h]chromen-4-one	DMRNZ4X	Investigative	Small molecular drug	[884]
2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide	DMTSBJL	Investigative	Small molecular drug	[848]
2-phenyl-2H-indazole-7-carboxamide	DM8HSMU	Investigative	Small molecular drug	[848]
2-phenyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	DMFE2R1	Investigative	Small molecular drug	[989]
2-phenyl-2H-pyrazolo[3,4-c]quinolin-4-amine	DM5WOSM	Investigative	Small molecular drug	[989]
2-Phenyl-2H-pyrazolo[4,3-c]quinoline	DMAHI7G	Investigative	Small molecular drug	[1074]
2-phenyl-2H-pyrazolo[4,3-d]pyrimidin-7(6H)-one	DMQXCIK	Investigative	Small molecular drug	[1075]
2-Phenyl-3-(1-phenyl-ethoxy)-piperidine	DMNXI6D	Investigative	Small molecular drug	[1076]
2-Phenyl-3-(2-piperidin-1-yl-ethyl)-1H-indole	DM5YC2K	Investigative	Small molecular drug	[1077]
2-Phenyl-3-piperidin-3-yl-1H-indole	DMY6NIT	Investigative	Small molecular drug	[1078]
2-Phenyl-3-piperidin-4-yl-1H-indole	DMEXZQ5	Investigative	Small molecular drug	[1077]
2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one	DMKCOS2	Investigative	Small molecular drug	[1079]
2-Phenyl-3H-imidazo[4,5-c]quinoline	DML9DJP	Investigative	Small molecular drug	[907]
2-Phenyl-4-[1,2,4]triazol-1-yl-chroman-7-ol	DMEXYSP	Investigative	Small molecular drug	[546]
2-Phenyl-5,6-dihydro-pyrazolo[1,5-c]quinazoline	DMUIYZB	Investigative	Small molecular drug	[1022]
2-Phenyl-5-(2-methylthiazol-4ylethynyl)pyridine	DM7A3GO	Investigative	Small molecular drug	[1080]
2-phenyl-5H-indeno[1,2-d]pyrimidine	DMMDS2T	Investigative	Small molecular drug	[1056]
2-Phenyl-6-propyl-chromen-4-one	DMY9ERA	Investigative	Small molecular drug	[840]
2-Phenyl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMA1RHE	Investigative	Small molecular drug	[1022]
2-phenyl-9H-indeno[2,1-d]pyrimidine	DMMHSYV	Investigative	Small molecular drug	[1056]
2-Phenyl-cyclopropylamine hydrochloride	DMUGH6J	Investigative	NA	[1081]
2-phenyl-N,N-bis(o-tolylthiomethyl)ethanamine	DMMJENF	Investigative	Small molecular drug	[1082]
2-phenyl-N-(1,3,4-thiadiazol-2-yl)acetamide	DMFC3B5	Investigative	Small molecular drug	[543]
2-phenyl-N-(1-phenylethyl)quinoline-4-carboxamide	DMNOE0V	Investigative	Small molecular drug	[1083]
2-phenyl-N-(pyridin-4-yl)quinazolin-4-amine	DMEFOV6	Investigative	Small molecular drug	[1084]
2-phenyl-N-(thiazol-2-yl)acetamide	DMP0NW3	Investigative	Small molecular drug	[543]
2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	DM60AJ2	Investigative	Small molecular drug	[22]
2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine	DMW0M14	Investigative	Small molecular drug	[1085]
2-phenylethylyl-adenosine derivative	DMW3F5C	Investigative	Small molecular drug	[1086]
2-phenylethynyl-5,6,7,8-tetrahydro-quinolin-5-ol	DMNYOH5	Investigative	Small molecular drug	[994]
2-phenylethynyl-5,6,7,8-tetrahydro-quinoline	DM4LCRS	Investigative	Small molecular drug	[994]
2-phenylethynyl-7,8-dihydro-6H-quinolin-5-one	DMFRQJ3	Investigative	Small molecular drug	[994]
2-Phenylheme	DMPIQTE	Investigative	Small molecular drug	[12]
2-phenylpiperidine hydrochloride	DM7OHSX	Investigative	Small molecular drug	[598]
2-phenylpropoxyadenosine	DMZQCEP	Investigative	Small molecular drug	[825]
2-phenylpyrazolo-[1,5-a]pyridine-7-carboxamide	DM64JE8	Investigative	Small molecular drug	[848]
2-phenylquinoline-8-carboxamide	DMAENRQ	Investigative	Small molecular drug	[924]
2-Phosphoglyceric Acid	DMX6GH5	Investigative	Small molecular drug	[12]
2-Phosphoglycolic Acid	DMO14NH	Investigative	Small molecular drug	[12]
2-Phosphonooxy-pentanedioic acid	DMM05AO	Investigative	Small molecular drug	[855]
2-Piperazin-1-yl-benzonitrile	DM742IJ	Investigative	Small molecular drug	[477]
2-Piperazin-1-yl-phenol	DMQT9OK	Investigative	Small molecular drug	[168]
2-PMPA	DM27GZC	Investigative	Small molecular drug	[1087]
2-Propanol, Isopropanol	DML5O0H	Investigative	Small molecular drug	[12]
2-Propionyl-1H-indole-6-carboxamidine	DMORG3D	Investigative	Small molecular drug	[513]
2-Propionyl-cyclohexane-1,3-dione	DMP8J7E	Investigative	Small molecular drug	[845]
2-Propyl-beta-carboline-2-ium iodide	DMBW6GA	Investigative	Small molecular drug	[1057]
2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester	DM1L7PN	Investigative	Small molecular drug	[1088]
2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide	DMVWUME	Investigative	Small molecular drug	[1088]
2-propylamido-5-sulfonamidoindane	DMG0I25	Investigative	Small molecular drug	[565]
2-Pyridin-2-yl-6H-pyrazolo[1,5-c]quinazolin-5-one	DMLCDZN	Investigative	Small molecular drug	[1022]
2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one	DMAS46B	Investigative	Small molecular drug	[406]
2-Pyridin-3-yl-7-aza-bicyclo[2.2.1]heptane	DM7RUNT	Investigative	Small molecular drug	[1089]
2-Pyridin-3-yl-benzo[h]chromen-4-one	DMT21UX	Investigative	Small molecular drug	[627]
2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one	DMJYI0P	Investigative	Small molecular drug	[1090]
2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline	DM5D09Q	Investigative	Small molecular drug	[1091]
2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one	DMGB1QU	Investigative	Small molecular drug	[406]
2-Pyridinethiol	DMVAQOZ	Investigative	Small molecular drug	[107]
2-pyridylethylamine	DMN516S	Investigative	Small molecular drug	[1092]
2-Pyrrolidin-1-yl-benzo[h]chromen-4-one	DMGPI0C	Investigative	Small molecular drug	[627]
2-Sulfamoyl-benzoic acid methyl ester	DMAO7DS	Investigative	Small molecular drug	[951]
2-Sulfhydryl-Ethanol	DMJBO3D	Investigative	Small molecular drug	[12]
2-tert-butoxy-9H-carbazole	DM26NKG	Investigative	Small molecular drug	[548]
2-tert-butyl-7-(trifluoromethyl)-9H-carbazole	DMJBQD8	Investigative	Small molecular drug	[548]
2-tert-butyl-9H-carbazole	DM6M8Y3	Investigative	Small molecular drug	[548]
2-tert-butylbenzene-1,4-diol	DMNXI1E	Investigative	Small molecular drug	[1093]
2-tert-Butyldimethylsilyloxylycorine	DMFAV5R	Investigative	Small molecular drug	[402]
2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one	DM35JQS	Investigative	Small molecular drug	[406]
2-thio-UDP	DM84R6C	Investigative	Small molecular drug	[1094]
2-Thioethenamine	DMEY9T2	Investigative	Small molecular drug	[107]
2-Thiomethyl-3-Phenylpropanoic Acid	DMCEK6N	Investigative	Small molecular drug	[12]
2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one	DMSKNBA	Investigative	Small molecular drug	[627]
2-thiomorpholino-4H-benzo[h]chromen-4-one	DMFXG2E	Investigative	Small molecular drug	[957]
2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline	DMPF598	Investigative	Small molecular drug	[907]
2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one	DM4J8B9	Investigative	Small molecular drug	[406]
2-THIOSALVINORIN B	DMIEGF4	Investigative	Small molecular drug	[1014]
2-thioUTP	DMJZ5V0	Investigative	Small molecular drug	[1095]
2-tolyl-6-phenyl-9H-purine	DM1HABS	Investigative	Small molecular drug	[798]
2-tosylanthracene-1,4-diol	DMOFDVE	Investigative	Small molecular drug	[909]
2-tosylbenzene-1,4-diol	DM8LS6H	Investigative	Small molecular drug	[909]
2-tosylnaphthalene	DM2OUG0	Investigative	Small molecular drug	[909]
2-Tosylnaphthalene-1,4-diol	DM5FHO4	Investigative	Small molecular drug	[909]
2-tosylnaphthalene-1,4-dione	DMK9OYM	Investigative	Small molecular drug	[909]
2-trityl-4,5-dihydrooxazole	DMVJORE	Investigative	Small molecular drug	[132]
2-valproylamido-5-sulfonamidoindane	DM8XSE3	Investigative	Small molecular drug	[565]
2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL	DMR4LJY	Investigative	Small molecular drug	[22]
2-[(2,2-diphenylacetyl)amino]benzoic acid	DMVSTG7	Investigative	Small molecular drug	[1096]
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	DMXA1LK	Investigative	Small molecular drug	[22]
2-[(2-methyl-4-thiazolyl)ethynyl]pyrazine	DM75WN4	Investigative	Small molecular drug	[228]
2-[(4-acetylphenyl)ethynyl]-N6-methoxyadenosine	DMKC1GI	Investigative	Small molecular drug	[919]
2-[(4-fluorophenyl)ethynyl]-N6-methoxyadenosine	DMTNQZU	Investigative	Small molecular drug	[919]
2-[(biphenyl-4-carbonyl)-amino]-benzoic acid	DMDT7SK	Investigative	Small molecular drug	[844]
2-[(Dioxidophosphino)Oxy]Benzoate	DMVSI6R	Investigative	Small molecular drug	[12]
2-[1,4]Diazepan-1-yl-6-nitro-quinoline	DMEA2SR	Investigative	Small molecular drug	[890]
2-[1,4]Oxazepan-4-yl-benzo[h]chromen-4-one	DMC8IEM	Investigative	Small molecular drug	[627]
2-[1-(2-Chloro-phenyl)-1H-pyrrol-2-yl]-ethylamine	DMSW89U	Investigative	Small molecular drug	[1097]
2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	DMUZDSC	Investigative	Small molecular drug	[22]
2-[125I]melatonin	DMFJOHG	Investigative	Small molecular drug	[1098]
2-[2-(1H-Imidazol-4-yl)-cyclopropyl]-ethylamine	DMKEZ5G	Investigative	Small molecular drug	[1099]
2-[2-(3,5-Dimethoxy-phenyl)-vinyl]-thiophene	DMX1TIU	Investigative	Small molecular drug	[1100]
2-[3-(1-Hydroxy-propyl)-phenyl]-propionic acid	DMDT9KG	Investigative	Small molecular drug	[266]
2-[3-(1-Phenyl-ethyl)-phenyl]-propionic acid	DMWIUR0	Investigative	Small molecular drug	[266]
2-[3-(2-Methyl-butyl)-phenyl]-propionic acid	DMKSDT4	Investigative	Small molecular drug	[266]
2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM8A3NI	Investigative	Small molecular drug	[536]
2-[3-(Pyridin-4-yloxy)-benzoylamino]-benzoic acid	DM5ETL9	Investigative	Small molecular drug	[891]
2-[4-(1-Ethyl-propyl)-piperazin-1-yl]-quinoline	DMUH526	Investigative	Small molecular drug	[911]
2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid	DMUHECR	Investigative	Small molecular drug	[864]
2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	DMWXI06	Investigative	Small molecular drug	[22]
2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole	DMDMK5V	Investigative	Small molecular drug	[453]
2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole	DM923WK	Investigative	Small molecular drug	[453]
2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole	DMECQB4	Investigative	Small molecular drug	[453]
2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole	DMMYJ3R	Investigative	Small molecular drug	[453]
2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol	DM6R1XH	Investigative	Small molecular drug	[1101]
2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	DMZFKDW	Investigative	Small molecular drug	[206]
2-{[2-(2-phenylethyl)phenoxy]methyl}pyridine	DM1PSRQ	Investigative	Small molecular drug	[551]
2-{[R-(-)-Apomorphine-2'-oxy]ethoxy}-ethanol	DM9TCWA	Investigative	Small molecular drug	[399]
20-HETE	DM5BAJ9	Investigative	Small molecular drug	[1102]
20-hydroxy-LTB4	DM84GAQ	Investigative	Small molecular drug	[1103]
20S-hydroxycholesterol	DMXRVJS	Investigative	Small molecular drug	[1104]
22R-hydroxycholesterol	DME8273	Investigative	Small molecular drug	[1105]
23-hydroxybetulinic acid	DM27GH0	Investigative	Small molecular drug	[1106]
24(S), 25-epoxycholesterol	DMW2KI5	Investigative	Small molecular drug	[1107]
24(S)-hydroxycholesterol	DMGMWA6	Investigative	Small molecular drug	[1108]
24-ethyl-cholest-7-ene-3,5,6-triol	DMQSTYZ	Investigative	Small molecular drug	[139]
24-ethylcholest-6-ene-3,5-diol	DMZIQ56	Investigative	Small molecular drug	[139]
24-hydroxyursolic acid	DMVY271	Investigative	Small molecular drug	[722]
24-thiacycloartanol	DM90IRW	Investigative	Small molecular drug	[1109]
25-hydroxycholesterol	DMCHAQ7	Investigative	Small molecular drug	[1110]
27-hydroxycholesterol	DM2L6OZ	Investigative	Small molecular drug	[1111]
29-methylidene-2,3-oxidosqualene	DMUQAP7	Investigative	Small molecular drug	[1112]
2alpha-Hydroxyolean-12-en-28-oic acid	DMHY2RA	Investigative	Small molecular drug	[1034]
2alpha-Hydroxyurs-12-en-28-oic acid	DM1RSCP	Investigative	Small molecular drug	[1034]
2beta,3alpha-dihydroxyolean-12-en-28-oic acid	DMV4OY2	Investigative	Small molecular drug	[1113]
2beta,3alpha-dihydroxyurs-12-en-28-oic acid	DMU4Q8C	Investigative	Small molecular drug	[1113]
2beta-methoxy-2-deethoxyphantomolin	DMWZ4KN	Investigative	Small molecular drug	[703]
2ewy	DMNOAJG	Investigative	Small molecular drug	[1114]
2H-chromeno[2,3-d]pyrimidine-2,4(3H)-dione	DMET6FO	Investigative	Small molecular drug	[1115]
2H-Isoquinolin-1-one	DMHR1UE	Investigative	Small molecular drug	[807]
2MD	DMPJT1C	Investigative	Small molecular drug	[1116]
2MeSADP	DMGADQ1	Investigative	Small molecular drug	[1117]
2MeSAMP	DMBO2DC	Investigative	Small molecular drug	[1118]
2MeSATP	DMUE0W6	Investigative	Small molecular drug	[1119]
2np8	DMRXDS2	Investigative	Small molecular drug	[1120]
2pyrrolidin-1-yl-1-phenylpentan-1-one	DMBJXCF	Investigative	Small molecular drug	[489]
2S,4R-4-METHYLGLUTAMATE	DMNU1YR	Investigative	Small molecular drug	[157]
3 9-DIHYDRO-N-DESMETHYL-N-ISOPROPYLERYTHROMYCIN A	DMOAY8R	Investigative	Small molecular drug	[1121]
3 beta-O-acetyloleanolic acid	DM1L5IJ	Investigative	Small molecular drug	[1122]
3'',5''-dimethoxy-[1,1':2',1'']-terphenyl-4-ol	DMRY2ZC	Investigative	Small molecular drug	[1123]
3'',5''-dimethoxy-[1,1':3',1'']-terphenyl-4-ol	DMXCZAK	Investigative	Small molecular drug	[1123]
3',4'-dichloroacetophenonethiosemicarbazone	DMS1QIJ	Investigative	Small molecular drug	[1124]
3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine	DM5UL3F	Investigative	Small molecular drug	[1125]
3'-(1-Benzothien-2-yl)biphenyl-3-ol	DMSZLNE	Investigative	Small molecular drug	[1126]
3'-(5-Chloro-2-thienyl)biphenyl-3-ol	DMM4HF8	Investigative	Small molecular drug	[1126]
3'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	DMJ7Y3H	Investigative	Small molecular drug	[733]
3'-Azido-3'-Deoxythymidine-5'-Monophosphate	DMU08MN	Investigative	Small molecular drug	[12]
3'-bromopropiophenonethiosemicarbazone	DMK7D8N	Investigative	Small molecular drug	[1124]
3'-carbamoylbiphenyl-3-yl 6-phenylhexylcarbamate	DM530OW	Investigative	Small molecular drug	[1127]
3'-Methoxy-4'Hydroxyclomiphene	DMG1T6H	Investigative	Small molecular drug	[1128]
3'-Oxo-Adenosine	DM47ZWK	Investigative	Small molecular drug	[107]
3'-THIO-THYMIDINE-5'-PHOSPHATE	DM5SM8X	Investigative	Small molecular drug	[22]
3'thiacytidine	DM2K59V	Investigative	Small molecular drug	[1129]
3,14-DIDEHYDROGINKGOLIDE A	DMR9WF7	Investigative	Small molecular drug	[653]
3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile	DMD0Z3U	Investigative	Small molecular drug	[1130]
3,3',3''-Thiene-2,3,5-triyltriphenol	DMH7A32	Investigative	Small molecular drug	[373]
3,3'-(1,2,4,5-tetrazine-3,6-diyl)diphenol	DM9GO8Y	Investigative	Small molecular drug	[1131]
3,3'-(1,2,4-Thiadiazol-2,5-diyl)diphenol	DM4O2VC	Investigative	Small molecular drug	[1131]
3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol	DMC34UW	Investigative	Small molecular drug	[1131]
3,3'-(1,3-Thiazol-2,4-diyl)diphenol	DM9AJNW	Investigative	Small molecular drug	[1131]
3,3'-(3-Methylthiene-2,5-diyl]diphenol	DM40SNY	Investigative	Small molecular drug	[373]
3,3'-(3-Phenylthiene-2,5-diyl)diphenol	DMUK1VX	Investigative	Small molecular drug	[373]
3,3'-(4-phenylpyridine-2,6-diyl)diphenol	DMJVKMO	Investigative	Small molecular drug	[1132]
3,3'-difluorobenzaldazine	DMGMJWL	Investigative	Small molecular drug	[1133]
3,3'-pyrazine-2,5-diyldiphenol	DMZTIPJ	Investigative	Small molecular drug	[1131]
3,3'-Pyridine-2,5-diyldiphenol	DMZILNC	Investigative	Small molecular drug	[1131]
3,3'-Thiene-2,4-diyldiphenol	DMW7XFQ	Investigative	Small molecular drug	[1131]
3,3'-thiene-2,5-diyldiphenol	DMWH0ER	Investigative	Small molecular drug	[373]
3,3,3-tris(4-chlorophenyl)propanoic acid	DMBFY4H	Investigative	Small molecular drug	[1134]
3,3-(1,3-Thiazole-2,5-diyl)diphenol	DMQY50A	Investigative	Small molecular drug	[1131]
3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile	DMO51QG	Investigative	Small molecular drug	[757]
3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile	DMZPYN2	Investigative	Small molecular drug	[757]
3,3-di(pent-4-enyl)azetidin-2-one	DMK9BN0	Investigative	Small molecular drug	[60]
3,3-Diethyl-1-(pyridin-3-yl)azetidine-2,4-dione	DMWFD5C	Investigative	Small molecular drug	[589]
3,3-Diethyl-1-o-tolylazetidine-2,4-dione	DMY8S94	Investigative	Small molecular drug	[589]
3,3-diethyl-1-phenylazetidine-2,4-dione	DMCFJIP	Investigative	Small molecular drug	[589]
3,3-Diethyl-dihydro-furan-2-one	DMFJ9N0	Investigative	Small molecular drug	[379]
3,3-Diisopropyl-dihydro-furan-2-one	DMIFUDG	Investigative	Small molecular drug	[379]
3,3-dimethyl-5-m-tolyl-2,3-dihydro-1H-inden-1-one	DMUS0A4	Investigative	Small molecular drug	[1135]
3,3-Dimethyl-dihydro-furan-2-one	DM09LY4	Investigative	Small molecular drug	[379]
3,3-diphenylpropan-1-amine	DMNOUSV	Investigative	Small molecular drug	[937]
3,4',5-trimethoxy-(Z)-stilbene	DMYHC3S	Investigative	Small molecular drug	[732]
3,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine	DMQDKYI	Investigative	Small molecular drug	[1136]
3,4'-(Ethane-1,2-diyl)dibenzenamine	DMFM60H	Investigative	Small molecular drug	[531]
3,4'-(thiophene-2,4-diyl)diphenol	DMEN9T4	Investigative	Small molecular drug	[373]
3,4,4',5-tetramethoxy-(Z)-stilbene	DMSN814	Investigative	Small molecular drug	[732]
3,4,5,6-Tetrachloro-[1,2]benzoquinone	DMSV6K5	Investigative	Small molecular drug	[397]
3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one	DMKOE9I	Investigative	Small molecular drug	[395]
3,4,5-tribromo-2-(2', 4'-dibromo-phenoxy)phenol	DMS42CA	Investigative	Small molecular drug	[762]
3,4,5-Trimethoxy-3'-amino-trans-stilbene	DMCA7XU	Investigative	Small molecular drug	[531]
3,4,5-Trimethoxy-4'-amino-trans-stilbene	DMDBOJ5	Investigative	Small molecular drug	[531]
3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide	DMU5NRA	Investigative	Small molecular drug	[543]
3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol	DMO34LJ	Investigative	Small molecular drug	[758]
3,4,6-Trihydroxy-2-(4-hydroxy-phenyl)-inden-1-one	DM3MAEQ	Investigative	Small molecular drug	[1137]
3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	DMN4Z27	Investigative	Small molecular drug	[1138]
3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	DM1MC06	Investigative	Small molecular drug	[1138]
3,4-Benzo-7-acetonyloxy-8-methylcoumarin	DMKC6L8	Investigative	Small molecular drug	[1138]
3,4-bis(3,4-dimethoxyphenyl)furan-2(5H)-one	DM91W2K	Investigative	Small molecular drug	[549]
3,4-bis(indol-3-yl)maleimide derivative	DMEQ1HC	Investigative	Small molecular drug	[1139]
3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	DMDO175	Investigative	Small molecular drug	[1140]
3,4-diarylpyrazoline derivative	DM8R03D	Investigative	NA	[1141]
3,4-dibenzyloxy-2'-hydroxychalcone	DMBUT8A	Investigative	Small molecular drug	[484]
3,4-Dibromo-2-(5-bromo-2-hydroxy-phenoxy)-phenol	DMXQVRD	Investigative	Small molecular drug	[758]
3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMMZURL	Investigative	Small molecular drug	[1142]
3,4-Dichloro-N-(3,3-diphenyl-allyl)-benzamide	DMWOMVF	Investigative	Small molecular drug	[495]
3,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	DM4RNOE	Investigative	Small molecular drug	[785]
3,4-dichlorobenzaldehyde thiosemicarbazone	DMUSPIC	Investigative	Small molecular drug	[962]
3,4-dichlorobenzamil	DMA5XY6	Investigative	Small molecular drug	[1143]
3,4-Dichlorobenzenemethanethiol	DMN61Q5	Investigative	Small molecular drug	[786]
3,4-dichloroisocoumarin	DMOZCDK	Investigative	Small molecular drug	[1144]
3,4-difluorobenzaldehyde O-benzoyloxime	DMFV3Y9	Investigative	Small molecular drug	[1145]
3,4-Dihydro-1H-quinolin-(2E)-ylideneamine	DM0I6UT	Investigative	Small molecular drug	[202]
3,4-dihydroquinazolin-2-amine hydrobromide	DMUOXHP	Investigative	Small molecular drug	[1146]
3,4-Dihydroxy-10H-anthracen-9-one	DMG4NR3	Investigative	Small molecular drug	[407]
3,4-dihydroxybenzaldehyde-O-ethyloxime	DMZJ4VL	Investigative	Small molecular drug	[1147]
3,4-dihydroxymandelic acid	DMYNOMZ	Investigative	Small molecular drug	[1148]
3,4-dihydroxyphenylacetaldehyde	DM7N3MX	Investigative	Small molecular drug	[1149]
3,4-dihydroxyxanthone	DMTQX92	Investigative	Small molecular drug	[801]
3,4-Dimethoxy-4'-amino-trans-stilbene	DMVDZCE	Investigative	Small molecular drug	[531]
3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine	DMMO6QI	Investigative	Small molecular drug	[1150]
3,4-diphenyl-1H-pyrrole-2,5-dione	DMPK6YT	Investigative	Small molecular drug	[1140]
3,4-epoxydehydroleucodin	DM8BJPU	Investigative	Small molecular drug	[703]
3,5 DIBROMOTYROSINE	DMLIG3X	Investigative	Small molecular drug	[22]
3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	DMAU80W	Investigative	Small molecular drug	[12]
3,5-bis(2-methylpyridin-4-yl)-1H-1,2,4-triazole	DMV859W	Investigative	Small molecular drug	[1136]
3,5-DHPG	DMFEQ6S	Investigative	Small molecular drug	[1151]
3,5-di(pyridin-4-yl)-1H-1,2,4-triazole	DM6CBTE	Investigative	Small molecular drug	[1136]
3,5-Di-tert-butyl-[1,2]benzoquinone	DMWOB7Q	Investigative	Small molecular drug	[397]
3,5-Diacetoxy-4'-amino-trans-stilbene	DMEXPIJ	Investigative	Small molecular drug	[531]
3,5-Diamino-4'-amino-trans-stilbene	DMK9JCA	Investigative	Small molecular drug	[531]
3,5-dibromo-2-(2,4-dibromophenoxy)phenol	DMCEY6O	Investigative	Small molecular drug	[762]
3,5-dichlorobenzaldehyde thiosemicarbazone	DMPVI9W	Investigative	Small molecular drug	[962]
3,5-dichlorosalicylic acid	DMQ45WH	Investigative	Small molecular drug	[1152]
3,5-Difluorobenzenesulfonamide	DMET46F	Investigative	Small molecular drug	[12]
3,5-difluorophenol	DM4VT0Q	Investigative	Small molecular drug	[1153]
3,5-dihydroxybenzoic acid	DM04N7I	Investigative	Small molecular drug	[1154]
3,5-Dihydroxyl-4'-amino-trans-stilbene	DMQ9TNB	Investigative	Small molecular drug	[531]
3,5-diiodo-L-tyrosine	DMT7DZ7	Investigative	Small molecular drug	[1155]
3,5-Dimethoxy-4'-amino-trans-stilbene	DMC3917	Investigative	Small molecular drug	[531]
3,5-dimethyl PPP	DM3E98I	Investigative	Small molecular drug	[1156]
3,5-dimethyl-2-(phenylsulfonamido)benzoic acid	DMAQ6OM	Investigative	Small molecular drug	[914]
3,5-Dinitrocatechol	DMBGSHD	Investigative	Small molecular drug	[12]
3,6,8-Tribromo-dibenzo[1,4]dioxin-1-ol	DMM632N	Investigative	Small molecular drug	[758]
3,6,9,12,15,18-HEXAOXAICOSANE	DMY26JI	Investigative	Small molecular drug	[22]
3,6,9,12,15-Pentaoxaheptadecane	DMY8IOP	Investigative	Small molecular drug	[22]
3,6,9,12,15-PENTAOXATRICOSAN-1-OL	DMMVL5P	Investigative	Small molecular drug	[22]
3,6-bis(Dmt-Tic-NH-butyl)-2(1H)-pyrazinone	DMWTP7Y	Investigative	Small molecular drug	[384]
3,6-bis(Dmt-Tic-NH-ethyl)-2(1H)-pyrazinone	DM2Y4A6	Investigative	Small molecular drug	[384]
3,6-bis(Dmt-Tic-NH-methyl)-2(1H)-pyrazinone	DMJR983	Investigative	Small molecular drug	[384]
3,6-bis(Dmt-Tic-NH-propyl)-2(1H)-pyrazinone	DMEQBS3	Investigative	Small molecular drug	[384]
3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine	DMNV0EZ	Investigative	Small molecular drug	[1157]
3,6-Dihydroxy-2-(4-hydroxy-phenyl)-inden-1-one	DMUH4OV	Investigative	Small molecular drug	[1137]
3,6-Dihydroxy-Xanthene-9-Propionic Acid	DM7AORH	Investigative	Small molecular drug	[12]
3,6-Diphenyl-1-oxa-7-aza-spiro[4.5]decane	DMEOBNJ	Investigative	Small molecular drug	[1158]
3,7,3',4'-TETRAHYDROXYFLAVONE	DMES906	Investigative	Small molecular drug	[22]
3,7-Bis(2-hydroxyethyl)icaritin	DMQADXL	Investigative	Small molecular drug	[1159]
3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM	DMBIRC6	Investigative	Small molecular drug	[22]
3,7-dihydroxy-flavone	DMH04P7	Investigative	Small molecular drug	[1160]
3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID	DMJ0654	Investigative	Small molecular drug	[107]
3,8-dibromoboldine	DM23CEI	Investigative	Small molecular drug	[1161]
3,8-dihydroxy-4-methyl-6H-benzo[c]chromen-6-one	DMIFJRS	Investigative	Small molecular drug	[1162]
3,8-dihydroxy-7-methyl-6H-benzo[c]chromen-6-one	DMW0B4H	Investigative	Small molecular drug	[1162]
3,9-dihydroxy-2,10-diprenylpterocap-6a-ene	DMXZ8RJ	Investigative	Small molecular drug	[1163]
3,9-Dihydroxy-4-prenyl-[6aR,11aR]pterocarpan	DMK53AT	Investigative	Small molecular drug	[1164]
3-((1H-imidazol-1-yl)methyl)-9H-xanthen-9-one	DM491YV	Investigative	Small molecular drug	[494]
3-((1H-imidazol-1-yl)methyl)aniline	DMZ9L6Q	Investigative	Small molecular drug	[160]
3-((1H-imidazol-4-yl)methyl)pyridine	DMJ6O43	Investigative	Small molecular drug	[808]
3-((2-Pyrrolidine-1-yl)-ethyl)uracil	DMSGX7V	Investigative	Small molecular drug	[1165]
3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol	DMJZK40	Investigative	Small molecular drug	[811]
3-((3-bromothiophen-2-yl)methylene)indolin-2-one	DME3079	Investigative	Small molecular drug	[1166]
3-((4-aminophenyl)diazenyl)benzenesulfonamide	DM37X04	Investigative	Small molecular drug	[1167]
3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	DMAPZQW	Investigative	Small molecular drug	[1167]
3-((E)-Styryl)-quinoline	DMAO64J	Investigative	Small molecular drug	[1168]
3-((S)-Azetidin-2-yloxy)-5-iodo-pyridine	DMZU74I	Investigative	Small molecular drug	[378]
3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine	DM57ZMJ	Investigative	Small molecular drug	[635]
3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indole	DMTDB62	Investigative	Small molecular drug	[1169]
3-(1,2-dihydroacenaphthylen-3-yl)pyridine	DMXZBQL	Investigative	Small molecular drug	[1170]
3-(1,2-dihydroacenaphthylen-5-yl)pyridine	DMHB4PA	Investigative	Small molecular drug	[1170]
3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid	DMQC168	Investigative	Small molecular drug	[233]
3-(1,5-naphthyridin-3-yl)benzonitrile	DM24BG6	Investigative	Small molecular drug	[868]
3-(1,8-naphthyridin-2-yl)benzonitrile	DMSP4N5	Investigative	Small molecular drug	[868]
3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol	DMGYDEK	Investigative	Small molecular drug	[160]
3-(1-Benzyl-piperidin-3-yl)-2-phenyl-1H-indole	DMGDN93	Investigative	Small molecular drug	[1078]
3-(1-Benzyl-piperidin-4-yl)-2-phenyl-1H-indole	DMWP0VK	Investigative	Small molecular drug	[1077]
3-(1-benzylpiperidin-4-yl)-5-chloro-1H-indole	DM2YKHI	Investigative	Small molecular drug	[1171]
3-(1-benzylpiperidin-4-yloxy)benzamide	DMG3A4Z	Investigative	Small molecular drug	[1172]
3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP)	DMOMSTN	Investigative	NA	[277]
3-(1-carboxy-4-mercaptobutoxy)benzoic acid	DMHPYWM	Investigative	Small molecular drug	[846]
3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine	DMLH7YI	Investigative	Small molecular drug	[522]
3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine	DMR7M82	Investigative	Small molecular drug	[501]
3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine	DMU5HMC	Investigative	Small molecular drug	[501]
3-(1-Methyl-piperidin-2-yl)-2-phenyl-1H-indole	DMK8LHB	Investigative	Small molecular drug	[1078]
3-(1-Methyl-piperidin-3-yl)-2-phenyl-1H-indole	DM4UD8C	Investigative	Small molecular drug	[1078]
3-(1-Methyl-piperidin-4-yl)-2-phenyl-1H-indole	DM6R5HU	Investigative	Small molecular drug	[1077]
3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	DMXMBEF	Investigative	Small molecular drug	[22]
3-(1-Phenethyl-piperidin-3-yl)-2-phenyl-1H-indole	DMOQ4ER	Investigative	Small molecular drug	[1078]
3-(1-Phenethyl-piperidin-4-yl)-2-phenyl-1H-indole	DM8TH2N	Investigative	Small molecular drug	[1077]
3-(1-Propyl-pyrrolidin-3-yl)-phenol	DM4QRV9	Investigative	Small molecular drug	[640]
3-(1-Pyridin-2-yl-1H-pyrazol-3-yl)-benzonitrile	DMTD7VE	Investigative	Small molecular drug	[1173]
3-(1-Pyridin-2-yl-1H-pyrazol-4-yl)-benzonitrile	DMWI37C	Investigative	Small molecular drug	[1173]
3-(1-Pyridin-2-yl-1H-pyrrol-3-yl)-benzonitrile	DMJ9LRE	Investigative	Small molecular drug	[1173]
3-(1H-Imidazol-4-yl)benzenethiol	DMERZHK	Investigative	Small molecular drug	[820]
3-(1H-inden-2-yl)pyridine	DM9ZDIK	Investigative	Small molecular drug	[501]
3-(1H-indol-1-yl)-N-methyl-3-phenylpropan-1-amine	DMLV80B	Investigative	Small molecular drug	[1174]
3-(1H-Indol-2-yl)-1H-quinolin-2-one	DMS3JCN	Investigative	Small molecular drug	[1175]
3-(1H-Indol-3-yl)-4-phenylamino-pyrrole-2,5-dione	DMP0RYB	Investigative	Small molecular drug	[1176]
3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline	DMSGCKU	Investigative	Small molecular drug	[1168]
3-(1H-indol-3-yl)-N,N-dimethylpropan-1-amine	DM6Y2XK	Investigative	Small molecular drug	[1177]
3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine	DMEV6Q2	Investigative	Small molecular drug	[1178]
3-(1H-Indol-3-yl)-quinoline	DMW7XN5	Investigative	Small molecular drug	[1168]
3-(1H-pyrazol-3-yl)benzoic acid	DMKFGDI	Investigative	Small molecular drug	[920]
3-(1H-Pyrrol-3-yl)-propionamide	DMCKJ27	Investigative	Small molecular drug	[1179]
3-(2,2-Dimethyl-propoxy)-9H-beta-carboline	DMSCIP2	Investigative	Small molecular drug	[550]
3-(2,2-Diphenyl-vinyl)-pyridine	DMCPOQ9	Investigative	Small molecular drug	[1180]
3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine	DMTS4YD	Investigative	Small molecular drug	[1181]
3-(2,3-Dimethyl-phenyl)-1-propyl-piperidine	DM0ZRDV	Investigative	Small molecular drug	[1182]
3-(2,3-Dimethyl-phenyl)-piperidine	DMEFKJD	Investigative	Small molecular drug	[1182]
3-(2,4-dihydroxyphenyl)propionic acid	DMXQROU	Investigative	Small molecular drug	[1183]
3-(2,4-Dimethyl-phenyl)-1-propyl-piperidine	DMB71FZ	Investigative	Small molecular drug	[1182]
3-(2,5-dimethyl-1H-pyrrol-1-yl)benzoic acid	DMUDW1J	Investigative	Small molecular drug	[1184]
3-(2,5-Dimethyl-phenyl)-1-propyl-piperidine	DM974E5	Investigative	Small molecular drug	[1182]
3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid	DM6JTNW	Investigative	Small molecular drug	[1185]
3-(2,6-Dimethyl-phenyl)-1-propyl-piperidine	DMPSAQW	Investigative	Small molecular drug	[1182]
3-(2,6-diphenylpyridin-4-yl)phenol	DMDYW4J	Investigative	Small molecular drug	[1132]
3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid	DM8P26J	Investigative	Small molecular drug	[1186]
3-(2-(4-methoxycinnamyl)phenyl)acrylic acid	DM61CHU	Investigative	Small molecular drug	[1186]
3-(2-(naphthalen-2-ylmethyl)phenyl)acrylic acid	DM9O5CH	Investigative	Small molecular drug	[1186]
3-(2-adamantyl) pyrrolidine	DMS98WA	Investigative	Small molecular drug	[815]
3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane	DM95R6O	Investigative	Small molecular drug	[36]
3-(2-Amino-propyl)-1H-indol-5-ol	DMQPNUM	Investigative	NA	[444]
3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	DMQXPM3	Investigative	Small molecular drug	[12]
3-(2-Benzylamino-ethoxy)-phenol	DMZCTGF	Investigative	Small molecular drug	[1187]
3-(2-Bromophenyl)-2-thioxo-(1H )-quinazolin-4-one	DMH6I4E	Investigative	Small molecular drug	[1188]
3-(2-Bromophenyl)-6-methylcoumarin	DMDM0R6	Investigative	Small molecular drug	[1189]
3-(2-carbamoyl-5-mercaptopentyl)benzoic acid	DMNOKR3	Investigative	Small molecular drug	[846]
3-(2-carboxy-3-mercaptopropyl)benzoic acid	DM67B8S	Investigative	Small molecular drug	[846]
3-(2-carboxy-3-phosphonopropyl)benzoic acid	DMG5R0N	Investigative	Small molecular drug	[846]
3-(2-carboxy-4-mercaptobutyl)benzoic acid	DM6HPYN	Investigative	Small molecular drug	[846]
3-(2-carboxy-5-mercaptopentyl)benzoic acid	DM6H52B	Investigative	Small molecular drug	[846]
3-(2-carboxy-6-mercaptohexyl)benzoic acid	DM870W1	Investigative	Small molecular drug	[846]
3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine	DMDS4Q0	Investigative	Small molecular drug	[635]
3-(2-cinnamylphenyl)acrylic acid	DM4XWME	Investigative	Small molecular drug	[1186]
3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline	DMVUK96	Investigative	Small molecular drug	[1168]
3-(2-Diethylamino-acetamino)-rutaecarpine	DM08GRF	Investigative	Small molecular drug	[1190]
3-(2-Diethylamino-propionamino)-rutaecarpine	DM1FOIZ	Investigative	Small molecular drug	[1190]
3-(2-Dimethylamino-ethyl)-1-methyl-1H-indol-4-ol	DMKYZGD	Investigative	Small molecular drug	[480]
3-(2-Dimethylamino-ethyl)-1H-indol-6-ol	DM32MIE	Investigative	Small molecular drug	[480]
3-(2-Dimethylamino-ethyl)-2-methyl-1H-indol-4-ol	DM9BTLC	Investigative	Small molecular drug	[480]
3-(2-Dimethylamino-propyl)-1H-indol-4-ol	DMMJP9D	Investigative	Small molecular drug	[480]
3-(2-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	DMD24EW	Investigative	Small molecular drug	[847]
3-(2-Methyl-2-aza-bicyclo[3.3.1]non-5-yl)-phenol	DM1DQGJ	Investigative	Small molecular drug	[1191]
3-(2-methylbenzo[d]thiazol-5-yl)benzonitrile	DMY782R	Investigative	Small molecular drug	[1192]
3-(2-methylquinolin-7-yl)benzonitrile	DMUPB9H	Investigative	Small molecular drug	[161]
3-(2-methylquinolin-7-yl)phenol	DM41HMZ	Investigative	Small molecular drug	[161]
3-(2-N-Piperidyl-acetamino)-rutaecarpine	DM3BQO0	Investigative	Small molecular drug	[1190]
3-(2-N-Piperidyl-propionamino)-rutaecarpine	DMFEHDY	Investigative	Small molecular drug	[1190]
3-(2-N-Pyrrolyl-acetamino)-rutaecarpine	DMQ0A8W	Investigative	Small molecular drug	[1190]
3-(2-N-Pyrrolyl-propionamino)-rutaecarpine	DM9MRTW	Investigative	Small molecular drug	[1190]
3-(2-naphthyl)phenol	DM27HSO	Investigative	Small molecular drug	[885]
3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine	DMYXQ7L	Investigative	Small molecular drug	[36]
3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzamide	DM0YEGM	Investigative	Small molecular drug	[447]
3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile	DM6YJOU	Investigative	Small molecular drug	[447]
3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol	DM6QZTB	Investigative	Small molecular drug	[447]
3-(2-phenyl-6-(thiophen-2-yl)pyridin-4-yl)-phenol	DM63T9D	Investigative	Small molecular drug	[1132]
3-(2-phenyl-6-(thiophen-3-yl)pyridin-4-yl)-phenol	DMF369N	Investigative	Small molecular drug	[1132]
3-(2-phenylthiazol-4-yl)quinolin-2(1H)-one	DMQC9WV	Investigative	Small molecular drug	[1193]
3-(2-propyn-1-yl)thymidine	DM2IYAP	Investigative	Small molecular drug	[1194]
3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile	DMPWEL8	Investigative	Small molecular drug	[1173]
3-(2-Pyrrolidin-1-yl-ethyl)-1H-indol-4-ol	DM7VJPX	Investigative	Small molecular drug	[480]
3-(3'-furyl)-aniline	DM7FQVC	Investigative	Small molecular drug	[1195]
3-(3,3-dimethyl-2-oxoindolin-5-yl)benzonitrile	DMSHORK	Investigative	Small molecular drug	[1196]
3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline	DMEJH13	Investigative	Small molecular drug	[1168]
3-(3,4-dichlorophenyl)-2-nortropene	DMT3AW8	Investigative	Small molecular drug	[1197]
3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline	DMX3AMB	Investigative	Small molecular drug	[1168]
3-(3,4-dihydronaphthalen-2-yl)pyridine	DM0VL17	Investigative	Small molecular drug	[501]
3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline	DMDU10A	Investigative	Small molecular drug	[1168]
3-(3,4-Dimethyl-phenyl)-1-propyl-piperidine	DM8W9EO	Investigative	Small molecular drug	[1182]
3-(3,4-Dimethyl-phenyl)-piperidine	DMOW0L9	Investigative	Small molecular drug	[1182]
3-(3,4-Dimethylbenzyl)-4-hydroxy-2H-chromen-2-one	DM9BYVL	Investigative	Small molecular drug	[988]
3-(3,4-dimethylphenyl)-1,5-naphthyridine	DMULX9O	Investigative	Small molecular drug	[868]
3-(3,5-Dibromo-4-hexyloxy-phenyl)-propionic acid	DMDFHCU	Investigative	Small molecular drug	[159]
3-(3,5-Dimethyl-phenyl)-1-propyl-piperidine	DMSI3V4	Investigative	Small molecular drug	[1182]
3-(3,5-Dimethyl-phenyl)-piperidine	DMUWKMN	Investigative	Small molecular drug	[1182]
3-(3-(3-chlorobenzyloxy)-5-methylphenyl)pyridine	DMKAEUD	Investigative	Small molecular drug	[873]
3-(3-(benzamido)-5-nitrobenzamido)propanoic acid	DMY4VX2	Investigative	Small molecular drug	[1198]
3-(3-(carbamoyl)benzamido)-3-phenylpropanoic acid	DM2K51S	Investigative	Small molecular drug	[1198]
3-(3-(carbamoyl)benzamido)propanoic acid	DM31JAZ	Investigative	Small molecular drug	[1198]
3-(3-Adamantan-1-yl-ureido)-benzoic acid	DMT0M94	Investigative	Small molecular drug	[569]
3-(3-aminobenzo[e][1,2,4]triazin-7-yl)phenol	DMLYVPH	Investigative	Small molecular drug	[1199]
3-(3-aminocyclopentyl)-1H-indole-5-carbonitrile	DMB6SP8	Investigative	Small molecular drug	[1200]
3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid	DMXKL75	Investigative	Small molecular drug	[877]
3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine	DM1325C	Investigative	Small molecular drug	[1201]
3-(3-benzylamino)-piperidin-2-one	DMYN6Z9	Investigative	Small molecular drug	[1195]
3-(3-Benzylnaphthalen-2-yl)pyridine	DM9S36A	Investigative	Small molecular drug	[1201]
3-(3-bromophenylethynyl)-5-methyl[1,2,4]triazine	DMFPTXO	Investigative	Small molecular drug	[1202]
3-(3-Carboxy-propionylamino)-benzoic acid	DMSJGQE	Investigative	Small molecular drug	[1185]
3-(3-chloro-1H-pyrazol-5-yl)quinoxalin-2(1H)-one	DMI2RH1	Investigative	Small molecular drug	[819]
3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one	DMD4O6V	Investigative	Small molecular drug	[1203]
3-(3-cyano-1H-indol-6-yl)-1-methyl-1-phenylurea	DMGJS9N	Investigative	Small molecular drug	[519]
3-(3-Dimethylamino-propyl)-1H-indol-4-ol	DM0O2ZB	Investigative	Small molecular drug	[480]
3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline	DM0ZHJQ	Investigative	Small molecular drug	[1168]
3-(3-hydroxyphenyl)quinolin-7-ol	DMP0DQE	Investigative	Small molecular drug	[885]
3-(3-Methanesulfonyl-phenyl)-1-propyl-pyrrolidine	DMRDS1U	Investigative	Small molecular drug	[640]
3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	DMU53NZ	Investigative	Small molecular drug	[22]
3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one	DMZQ2CJ	Investigative	Small molecular drug	[1204]
3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine	DM2YLBD	Investigative	Small molecular drug	[501]
3-(3-Methyl-butoxy)-9H-beta-carboline	DMTNCXP	Investigative	Small molecular drug	[550]
3-(3-methylphenylethynyl)-5-methyl[1,2,4]triazine	DMXAD0R	Investigative	Small molecular drug	[1202]
3-(3-methylthiophen-2-yl)pyridine	DMHU9V5	Investigative	Small molecular drug	[194]
3-(3-Phenyl-ureido)-benzenesulfonamide	DM314ZE	Investigative	Small molecular drug	[749]
3-(3-Pyridin-2-yl-pyrazol-1-yl)-benzonitrile	DMU52WA	Investigative	Small molecular drug	[1173]
3-(3-Pyridin-2-yl-pyrrol-1-yl)-benzonitrile	DMZLT24	Investigative	Small molecular drug	[1173]
3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide	DM18MOH	Investigative	Small molecular drug	[1167]
3-(4,5-Bis-biphenyl-4-yl-1H-imidazol-2-yl)-phenol	DMGXPJV	Investigative	Small molecular drug	[1205]
3-(4,5-Dihydrooxazol-2-yl)phenyl propylcarbamate	DMONSM1	Investigative	Small molecular drug	[1206]
3-(4-(2-phenylethynyl)benzoyl)pentanoic acid	DMQDPHT	Investigative	Small molecular drug	[1207]
3-(4-(4-hydroxyphenyl)phthalazin-1-ylamino)phenol	DM1GVE8	Investigative	Small molecular drug	[1208]
3-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol	DM8EH07	Investigative	Small molecular drug	[896]
3-(4-(benzyloxy)-3,5-dibromophenyl)propanoic acid	DM36VA0	Investigative	Small molecular drug	[1209]
3-(4-(o-toluidino)pyrimidin-2-ylamino)benzamide	DMX6ZHQ	Investigative	Small molecular drug	[1210]
3-(4-Amino-phenyl)-1-methyl-pyrrolidine-2,5-dione	DMS1LDH	Investigative	Small molecular drug	[1211]
3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione	DMD5YKO	Investigative	Small molecular drug	[1212]
3-(4-Amino-phenyl)-3-ethyl-pyrrolidine-2,5-dione	DM3I15D	Investigative	Small molecular drug	[1211]
3-(4-Amino-phenyl)-3-heptyl-piperidine-2,6-dione	DMZ86CS	Investigative	Small molecular drug	[1212]
3-(4-Amino-phenyl)-3-hexyl-piperidine-2,6-dione	DMW62U8	Investigative	Small molecular drug	[1212]
3-(4-Amino-phenyl)-3-methyl-pyrrolidine-2,5-dione	DMITHX5	Investigative	Small molecular drug	[1211]
3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione	DM20DXS	Investigative	Small molecular drug	[1212]
3-(4-Amino-phenyl)-3-propyl-piperidine-2,6-dione	DM39XMT	Investigative	Small molecular drug	[1212]
3-(4-Amino-phenyl)-pyrrolidine-2,5-dione	DMVN0O5	Investigative	Small molecular drug	[1211]
3-(4-aminophenyl)quinoxaline-5-carboxamide	DM6XTBI	Investigative	Small molecular drug	[238]
3-(4-aminophenyl)thieno[3,2-c]pyridin-4-amine	DM30GV2	Investigative	Small molecular drug	[1213]
3-(4-Benzoylpiperazine-1-carbonyl)coumarin	DMAT7VN	Investigative	Small molecular drug	[1214]
3-(4-Benzyl-piperazin-1-yl)-phenol	DMWPB0G	Investigative	Small molecular drug	[1215]
3-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one	DMFVCOP	Investigative	Small molecular drug	[594]
3-(4-Benzyl-piperidin-1-ylmethyl)-chromen-4-one	DM7LMD6	Investigative	Small molecular drug	[594]
3-(4-bromobenzyl)-1,1-dimethylselenourea	DMAKMIJ	Investigative	Small molecular drug	[604]
3-(4-bromophenyl)-1,1-dimethylthiourea	DMXMZRE	Investigative	Small molecular drug	[604]
3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide	DM8W3GC	Investigative	Small molecular drug	[742]
3-(4-chloro-2-cyclohexylphenoxy)propanoic acid	DMQ2D09	Investigative	Small molecular drug	[839]
3-(4-Chlorophenyl)-2-nortropene	DM71EUO	Investigative	Small molecular drug	[1197]
3-(4-cyanophenyl)quinoxaline-5-carboxamide	DM23JIY	Investigative	Small molecular drug	[238]
3-(4-cyclohexylthiosemicarbazono)methyl-phenol	DMGQE8D	Investigative	Small molecular drug	[910]
3-(4-dimethylamino-benzylidenyl)-2-indolinone	DM6XC0M	Investigative	Small molecular drug	[1216]
3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine	DMM7BQP	Investigative	Small molecular drug	[501]
3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline	DM0POH2	Investigative	Small molecular drug	[1168]
3-(4-Fluorophenyl)-2-nortropene	DM8CK9M	Investigative	Small molecular drug	[1197]
3-(4-hexylthiosemicarbazono)methyl-benzoic acid	DMDYS7Q	Investigative	Small molecular drug	[910]
3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile	DME5238	Investigative	Small molecular drug	[757]
3-(4-Hydroxy-phenyl)-4H-chromen-7-ol	DMN01PI	Investigative	Small molecular drug	[1217]
3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-5-ol	DMXZ9T6	Investigative	Small molecular drug	[847]
3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	DMYLDFG	Investigative	Small molecular drug	[847]
3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one	DM3XOVL	Investigative	Small molecular drug	[1204]
3-(4-Hydroxyphenyl)-7-isobutoxychromen-4-one	DMS5N6Y	Investigative	Small molecular drug	[1218]
3-(4-Hydroxyphenyl)-7-isopropoxychromen-4-one	DMH75AO	Investigative	Small molecular drug	[1218]
3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone	DMSR2O3	Investigative	Small molecular drug	[1219]
3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol	DM206M1	Investigative	Small molecular drug	[1220]
3-(4-Methoxy-benzenesulfonyl)-cyclopentanethiol	DMK79U1	Investigative	Small molecular drug	[1220]
3-(4-Methoxy-benzenesulfonyl)-hexane-1-thiol	DMRLAX8	Investigative	Small molecular drug	[542]
3-(4-Methoxy-benzenesulfonyl)-pentane-1-thiol	DM854IG	Investigative	Small molecular drug	[542]
3-(4-Methoxy-benzenesulfonyl)-propane-1-thiol	DM7B1VT	Investigative	Small molecular drug	[542]
3-(4-methoxybenzyloxy)-2-phenylthiazolidin-4-one	DMFRZGS	Investigative	Small molecular drug	[1073]
3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	DMGC7RY	Investigative	Small molecular drug	[1140]
3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one	DMXKJOC	Investigative	Small molecular drug	[1204]
3-(4-methoxyphenyl)quinoxaline-5-carboxamide	DM7WPQC	Investigative	Small molecular drug	[238]
3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine	DMDR20P	Investigative	Small molecular drug	[501]
3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole	DM0HYDZ	Investigative	Small molecular drug	[1221]
3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol	DM54MDH	Investigative	Small molecular drug	[1222]
3-(4-o-Tolylpiperazine-1-carbonyl)coumarin	DMIBAM2	Investigative	Small molecular drug	[1214]
3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol	DMBKDZ3	Investigative	Small molecular drug	[1220]
3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol	DM2HBGL	Investigative	Small molecular drug	[542]
3-(4-Phenoxy-phenyl)-1H-pyrazole	DMO6LID	Investigative	Small molecular drug	[1223]
3-(4-phenyl-2,4'-bipyridin-6-yl)phenol	DMSZ1VC	Investigative	Small molecular drug	[1132]
3-(4-phenyl-6-(thiophen-2-yl)pyridin-2-yl)-phenol	DM0OF64	Investigative	Small molecular drug	[1132]
3-(4-phenyl-6-(thiophen-3-yl)pyridin-2-yl)-phenol	DMTR8SZ	Investigative	Small molecular drug	[1132]
3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole	DM17SNR	Investigative	Small molecular drug	[1221]
3-(4-Phenyl-piperidin-1-ylmethyl)-1H-indole	DMM0WGI	Investigative	Small molecular drug	[1221]
3-(4-Phenylethynylbenzoyl)nonanoic acid	DMXL0J5	Investigative	Small molecular drug	[1207]
3-(4-Phenylpiperazin-1-carbonyl)coumarin	DMH27E0	Investigative	Small molecular drug	[1214]
3-(4-Pyridin-2-yl-imidazol-1-yl)-benzonitrile	DMDYVA7	Investigative	Small molecular drug	[1173]
3-(4-Pyridin-2-yl-pyrazol-1-yl)-benzonitrile	DMTD16H	Investigative	Small molecular drug	[1173]
3-(4-sulfamoylphenyl)propanoic acid	DMBDW8P	Investigative	Small molecular drug	[22]
3-(4-Trifluoromethylphenyl)-2-nortropene	DMZB804	Investigative	Small molecular drug	[1197]
3-(4H-Imidazol-4-yl)benzenethiol	DMPS1GW	Investigative	NA	[820]
3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine	DMTVYLM	Investigative	Small molecular drug	[1181]
3-(5-((methylthio)methyl)furan-2-yl)pyridine	DM6S28U	Investigative	Small molecular drug	[194]
3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine	DMUIXNS	Investigative	Small molecular drug	[522]
3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine	DM67DVU	Investigative	Small molecular drug	[522]
3-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	DMPRBLH	Investigative	Small molecular drug	[847]
3-(5-methoxy-1H-inden-2-yl)pyridine	DMTJXOU	Investigative	Small molecular drug	[501]
3-(5-methoxy-1H-indol-3-yl)propanoic acid	DMXLVG6	Investigative	Small molecular drug	[22]
3-(5-phenyl-2-thienyl)phenol	DM5NIE7	Investigative	Small molecular drug	[373]
3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	DMPBLM2	Investigative	Small molecular drug	[136]
3-(5-Pyridin-2-yl-tetrazol-2-yl)-benzonitrile	DMM1CKZ	Investigative	Small molecular drug	[1173]
3-(5-Thiophen-3-yl-pyridin-3-yl)-1H-indole	DM9LVR5	Investigative	Small molecular drug	[1224]
3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine	DMOUNPH	Investigative	Small molecular drug	[194]
3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenol	DM4DFUS	Investigative	Small molecular drug	[1225]
3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine	DMAWXV6	Investigative	Small molecular drug	[1225]
3-(6-(furan-2-yl)-4-phenylpyridin-2-yl)-phenol	DMADQCW	Investigative	Small molecular drug	[1132]
3-(6-(phenylamino)-9H-purin-8-yl)benzonitrile	DM8WL21	Investigative	Small molecular drug	[1226]
3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol	DMISL9R	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-4-p-tolyl-butan-2-ol	DMU08A4	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-4-phenethyloxy-butan-2-ol	DMMTU78	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-5-m-tolyl-pentan-2-ol	DMHXI21	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-6-o-tolyl-hexan-2-ol	DMYIZBK	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-6-phenyl-hexan-2-ol	DMZT8QX	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-7-phenyl-heptan-2-ol	DMUYELJ	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-8-phenyl-octan-2-ol	DMAIS1D	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-non-5-en-2-ol	DM6FHWZ	Investigative	Small molecular drug	[1227]
3-(6-Amino-purin-9-yl)-non-5-yn-2-ol	DM0YOZJ	Investigative	Small molecular drug	[1227]
3-(6-Bromo-naphthalen-2-yl)-pyridine	DM63BI9	Investigative	Small molecular drug	[522]
3-(6-Ethoxy-naphthalen-2-yl)-pyridine	DMUQ0WI	Investigative	Small molecular drug	[522]
3-(6-fluoroquinazolin-4-ylamino)benzonitrile	DMHJ0SV	Investigative	Small molecular drug	[1228]
3-(6-hydroxy-2-naphthyl)benzoic acid	DMTIKF7	Investigative	Small molecular drug	[885]
3-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	DM5H9QT	Investigative	Small molecular drug	[847]
3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	DMAJHXO	Investigative	Small molecular drug	[501]
3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine	DMISLV4	Investigative	Small molecular drug	[1229]
3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine	DM0GXFB	Investigative	Small molecular drug	[1229]
3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine	DM704R5	Investigative	Small molecular drug	[1229]
3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine	DMN75RD	Investigative	Small molecular drug	[1229]
3-(6-methoxynaphthalen-2-yl)pyridine	DMYRJAB	Investigative	Small molecular drug	[1181]
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzaldehyde	DMS9DPO	Investigative	Small molecular drug	[824]
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzoic acid	DM2VNLK	Investigative	Small molecular drug	[824]
3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile	DM2J63V	Investigative	Small molecular drug	[824]
3-(6-morpholino-9H-purin-2-yl)phenol	DMS2OY9	Investigative	Small molecular drug	[179]
3-(6-phenyl-2,4'-bipyridin-4-yl)phenol	DM8ZUBY	Investigative	Small molecular drug	[1132]
3-(7-methyl-1,8-naphthyridin-2-yl)benzonitrile	DMZ53N4	Investigative	Small molecular drug	[868]
3-(9-Acridinylamino)-5-(hydroxymethyl)aniline (AHMA)	DMDIQ7H	Investigative	Small molecular drug	[1230]
3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DM5497S	Investigative	Small molecular drug	[274]
3-(aminomethyl)-4-(furan-3-yl)butanoic acid	DMG3FPJ	Investigative	Small molecular drug	[274]
3-(aminomethyl)-4-(thiophen-2-yl)butanoic acid	DMT72FB	Investigative	Small molecular drug	[274]
3-(aminomethyl)-4-(thiophen-3-yl)butanoic acid	DMWO1Z7	Investigative	Small molecular drug	[274]
3-(Aminooxy)propan-1-amine hydrochloride	DMPFH15	Investigative	Small molecular drug	[574]
3-(benzo[b]thiophen-5-yl)-3-benzylpyrrolidine	DM58GRA	Investigative	Small molecular drug	[1178]
3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate	DMPFH8U	Investigative	Small molecular drug	[1206]
3-(benzyloxy)-2-(4-chlorophenyl)thiazolidin-4-one	DMD4WHN	Investigative	Small molecular drug	[1073]
3-(benzyloxy)-9H-pyrido[3,4-b]indole	DMDNEKR	Investigative	Small molecular drug	[1231]
3-(Benzyloxy)Pyridin-2-Amine	DM35VEI	Investigative	Small molecular drug	[12]
3-(biphenyl-4-yl)-1-(oxazol-2-yl)propan-1-one	DM4GWJO	Investigative	Small molecular drug	[557]
3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one	DM8PM0E	Investigative	Small molecular drug	[375]
3-(butylthio)-1,1,1-trifluoropropan-2-one	DM8T2OX	Investigative	Small molecular drug	[375]
3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one	DMWJ6UD	Investigative	Small molecular drug	[375]
3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one	DMF27YT	Investigative	Small molecular drug	[375]
3-(decylthio)-1,1,1-trifluoropropan-2-one	DM1Y6L8	Investigative	Small molecular drug	[375]
3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one	DM2JBQI	Investigative	Small molecular drug	[185]
3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one	DMG5VMH	Investigative	Small molecular drug	[527]
3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one	DMJYCHG	Investigative	Small molecular drug	[185]
3-(dimethylamino)phenyl phenylcarbamate	DMM05G2	Investigative	Small molecular drug	[90]
3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one	DM7AG6Y	Investigative	Small molecular drug	[375]
3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one	DMPRCS0	Investigative	Small molecular drug	[375]
3-(ethoxycarbonyl)phenylboronic acid	DM71EMN	Investigative	Small molecular drug	[1019]
3-(furan-3-yl)-1-methyl-1H-indole	DM6L4J8	Investigative	Small molecular drug	[621]
3-(furan-3-yl)-1H-indole	DMM2AR3	Investigative	Small molecular drug	[621]
3-(heptyloxy)benzoic acid	DMQZU9G	Investigative	Small molecular drug	[22]
3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole	DMKHNTY	Investigative	Small molecular drug	[1231]
3-(imidazolylmethyl)-4'-methoxyflavone	DMM52LC	Investigative	Small molecular drug	[1232]
3-(imidazolylmethyl)-4'-nitroflavone	DMX2LT5	Investigative	Small molecular drug	[1232]
3-(imidazolylmethyl)-7-methoxy-4'-nitroflavone	DML63MX	Investigative	Small molecular drug	[1232]
3-(imidazolylmethyl)flavone	DMLI7F4	Investigative	Small molecular drug	[1232]
3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	DM3EV9N	Investigative	Small molecular drug	[1140]
3-(N-alkylamino) propylphosphonic acid derivative	DMJDG9C	Investigative	Small molecular drug	[172]
3-(N-propylpiperidin-4-yl)phenol	DM6OCU5	Investigative	Small molecular drug	[521]
3-(naphthalen-2-yl)pyridine	DMJRBT1	Investigative	Small molecular drug	[1201]
3-(Octahydro-indolizin-8-yl)-phenol	DMJRNI7	Investigative	Small molecular drug	[1233]
3-(Octahydro-quinolizin-1-yl)-phenol	DMU1SGX	Investigative	Small molecular drug	[1233]
3-(Octahydro-quinolizin-3-yl)-phenol	DM01BKR	Investigative	Small molecular drug	[1233]
3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	DMMRV1N	Investigative	Small molecular drug	[12]
3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one	DM2UPQG	Investigative	Small molecular drug	[1056]
3-(phenylsulfonyl)-1-(piperidin-3-yl)-1H-indole	DMSRHLC	Investigative	Small molecular drug	[1234]
3-(phenylsulfonyl)-1-(piperidin-4-yl)-1H-indole	DM9QB0X	Investigative	Small molecular drug	[1234]
3-(phenylsulfonyl)-1-(pyrrolidin-3-yl)-1H-indole	DMVKO5N	Investigative	Small molecular drug	[1234]
3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine	DMN1DWF	Investigative	Small molecular drug	[491]
3-(piperidin-4-yl)-2-(o-tolyloxy)pyridine	DM2ETXB	Investigative	Small molecular drug	[468]
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	DMMOE40	Investigative	Small molecular drug	[12]
3-(pyridin-3-yl)prop-2-yn-1-amine	DM3EDQ1	Investigative	Small molecular drug	[194]
3-(pyridin-4-yl)-1H-indol-6-amine	DMZARSD	Investigative	Small molecular drug	[621]
3-(pyridin-4-yl)-1H-indol-7-amine	DMRFPNE	Investigative	Small molecular drug	[621]
3-(tetradecylamino)propylphosphonic acid	DMNA6LF	Investigative	Small molecular drug	[544]
3-(thiophen-3-yl)-1H-indol-6-amine	DMMI0UC	Investigative	Small molecular drug	[621]
3-(trifluoromethyl)-9H-carbazole	DMWX4L5	Investigative	Small molecular drug	[548]
3-(trifluoromethyl)benzaldehyde thiosemicarbazone	DM2YVA1	Investigative	Small molecular drug	[962]
3-(trifluoromethyl)phenyl 4-butoxybenzylcarbamate	DMH7K0N	Investigative	Small molecular drug	[787]
3-(trifluoromethyl)phenylboronic acid	DM4B5JY	Investigative	Small molecular drug	[1019]
3-acetyl-11-keto-beta-boswellic acid	DMGO2D7	Investigative	Small molecular drug	[669]
3-acetyl-11-keto-ursolic acid	DMHRZ2V	Investigative	Small molecular drug	[669]
3-acetyl-7-hydroxy-2H-chromen-2-one	DM01WBD	Investigative	Small molecular drug	[920]
3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane	DMO5IJA	Investigative	Small molecular drug	[1197]
3-Amino-1-(2-amino-5-methoxy-phenyl)-propan-1-one	DMKGIQ1	Investigative	Small molecular drug	[168]
3-amino-2-(benzylideneamino)-5-mercaptophenol	DMF3DBE	Investigative	Small molecular drug	[134]
3-Amino-3-(methoxycarbonyl)-1,5-pentandioic acid	DMV4XGT	Investigative	Small molecular drug	[578]
3-amino-3-demethoxythiocolchicine	DM60K7H	Investigative	Small molecular drug	[1235]
3-Amino-4'-amino-trans-stilbene	DMIS3LN	Investigative	Small molecular drug	[531]
3-Amino-4-Oxybenzyl-2-Butanone	DM5Z0O6	Investigative	Small molecular drug	[12]
3-Amino-5,6-dihydro-2H-benzo[f]quinazolin-1-one	DMP2K1A	Investigative	Small molecular drug	[1236]
3-amino-5-(4-chlorophenyl)thiophene-2-carboxamide	DM2U9RY	Investigative	Small molecular drug	[974]
3-amino-5-(4-octylphenyl)pentanoic acid	DMONHFR	Investigative	Small molecular drug	[1237]
3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile	DM6Y2KW	Investigative	Small molecular drug	[1238]
3-Amino-5-Phenylpentane	DMHDFZE	Investigative	Small molecular drug	[12]
3-AMINO-AZACYCLOTRIDECAN-2-ONE	DM5073T	Investigative	Small molecular drug	[22]
3-Amino-benzenesulfonamide	DME0TNA	Investigative	Small molecular drug	[1239]
3-amino-benzo[b]thiophene-2-carboxylic acid amide	DMWOTD3	Investigative	Small molecular drug	[974]
3-aminoacetamido-4'-methylfuro[3,2-g]coumarin	DM0GJZM	Investigative	Small molecular drug	[1240]
3-aminobenzamide	DM7P3IZ	Investigative	Small molecular drug	[1241]
3-aminobenzo[c][1,5]naphthyridin-6(5H)-one	DML2UCP	Investigative	Small molecular drug	[238]
3-Aminomethyl-5-methyl-hexanoic acid	DMTYXH1	Investigative	Small molecular drug	[1242]
3-ammoniopropane-1-sulfinate	DM5SQVC	Investigative	Small molecular drug	[1243]
3-anilino-5-benzylthio-1,2,4-triazole	DM3VYNJ	Investigative	Small molecular drug	[1244]
3-azageranylgeranyl diphosphate	DM6KNMB	Investigative	Small molecular drug	[1245]
3-Benzenesulfinyl-heptanoic acid hydroxyamide	DMQXD0N	Investigative	Small molecular drug	[1246]
3-Benzenesulfonyl-heptanoic acid hydroxyamide	DM7XDCF	Investigative	Small molecular drug	[1246]
3-Benzimidazol-2-ylhydroquinolin-2-one	DMQXJA1	Investigative	Small molecular drug	[1247]
3-benzoyl-1-pentyl-1,4-dihydroquinolin-4-one	DMHXRQL	Investigative	Small molecular drug	[1248]
3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one	DMAH4DG	Investigative	Small molecular drug	[1249]
3-Benzoyl-N-hydroxy-benzamide	DM25K86	Investigative	Small molecular drug	[742]
3-benzyl-1-cyclohexylpyrrolidin-2-one	DMNG0TY	Investigative	Small molecular drug	[471]
3-Benzyl-2-ethylthio-6-nitro-quinazolin-4(3H)-one	DMQ13Z8	Investigative	Small molecular drug	[967]
3-benzyl-2-mercapto-6-nitroquinazolin-4(3H)-one	DM4GWAH	Investigative	Small molecular drug	[967]
3-Benzyl-3-ethyl-1-phenylazetidine-2,4-dione	DMDAO28	Investigative	Small molecular drug	[589]
3-Benzyl-3-methyl-1-phenylazetidine-2,4-dione	DMHINWF	Investigative	Small molecular drug	[589]
3-Benzyl-4-hydroxy-2H-benzo[h]chromen-2-one	DMA5EHC	Investigative	Small molecular drug	[988]
3-Benzyl-4-hydroxy-2H-chromen-2-one	DM3BFX0	Investigative	Small molecular drug	[988]
3-Benzyl-4-hydroxy-6,7-dimethyl-2H-chromen-2-one	DML0ME9	Investigative	Small molecular drug	[988]
3-benzyl-5-fluorobenzo[d]oxazol-2(3H)-one	DMZ85NC	Investigative	Small molecular drug	[1250]
3-Benzyl-5-isopropyl-8-methylchromen-2-one	DMKZDYP	Investigative	Small molecular drug	[856]
3-Benzyl-5-methoxy-7-methylchromen-2-one	DMF04YH	Investigative	Small molecular drug	[856]
3-Benzyl-5-methoxychromen-2-one	DMSIAMN	Investigative	Small molecular drug	[856]
3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one	DMHYQ3Z	Investigative	Small molecular drug	[1250]
3-benzyl-6-methylbenzo[d]oxazol-2(3H)-one	DMGPKIY	Investigative	Small molecular drug	[1250]
3-Benzyl-7-methyl-[1,8]naphthyridin-4-ol	DMHQ467	Investigative	Small molecular drug	[1251]
3-Benzyl-7-methyl-[1,8]naphthyridine-4-thiol	DM12RH3	Investigative	Small molecular drug	[1251]
3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine	DMZIOJS	Investigative	Small molecular drug	[508]
3-Benzylamino-5-ethyl-6-methyl-1H-pyridin-2-one	DMB4WP5	Investigative	Small molecular drug	[1252]
3-Benzyloxy-2-phenyl-piperidine	DM94K83	Investigative	Small molecular drug	[1076]
3-benzyloxy-4-methoxy-2'-hydroxychalcone	DMKD874	Investigative	Small molecular drug	[484]
3-Benzyloxy-6,7-dimethoxy-quinoline	DMPG315	Investigative	Small molecular drug	[1168]
3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol	DMZ8WMA	Investigative	Small molecular drug	[1253]
3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide	DMHSAOQ	Investigative	Small molecular drug	[742]
3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide	DMKBRIM	Investigative	Small molecular drug	[742]
3-biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine	DMMC2Q9	Investigative	Small molecular drug	[1202]
3-boronobenzoic acid	DMRCJW0	Investigative	Small molecular drug	[1254]
3-bromo-1-(4-hexylphenyl)propan-1-one	DM03ROH	Investigative	Small molecular drug	[185]
3-Bromo-1H-indazole-7-carbonitrile	DMZGWL2	Investigative	Small molecular drug	[1255]
3-Bromo-2'-hydroxy-4-methoxychalcone	DM1BALV	Investigative	Small molecular drug	[484]
3-bromo-4,4',5-trimethoxy-(Z)-stilbene	DMPZ4M8	Investigative	Small molecular drug	[732]
3-bromo-5-(2-methylquinolin-7-yl)benzonitrile	DMPQOS2	Investigative	Small molecular drug	[161]
3-Bromo-5-phenylsalicylc acid	DMZTDCL	Investigative	Small molecular drug	[1256]
3-bromo-5-[(2-methyl-4-thiazolyl)ethynyl]pyridine	DMOXY78	Investigative	Small molecular drug	[228]
3-Bromo-6-nitro-2-piperazin-1-yl-quinoline	DMXZB5C	Investigative	Small molecular drug	[890]
3-bromo-7-nitro-1H-indazole	DMM7DHB	Investigative	Small molecular drug	[1257]
3-bromo-N-(6-methylpyridin-2-yl)benzamide	DM62Y1S	Investigative	Small molecular drug	[1258]
3-bromoboldine	DMPF7O2	Investigative	Small molecular drug	[1161]
3-bromophenyl-difluoromethanesulfonamide	DMXZW3R	Investigative	Small molecular drug	[130]
3-bromopyruvate	DMYL3ST	Investigative	Small molecular drug	[1259]
3-Butoxy-9H-beta-carboline	DMQ8H74	Investigative	Small molecular drug	[550]
3-butoxycarbonyl-4-quinolone	DMRF2Q8	Investigative	Small molecular drug	[1260]
3-butoxycarbonyl-6-ethyl-4-quinolone	DMD6PMZ	Investigative	Small molecular drug	[1260]
3-butyl-1-(naphthalen-1-yl)piperidin-4-amine	DMXF8M0	Investigative	Small molecular drug	[177]
3-Butyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ol	DMDOPVM	Investigative	Small molecular drug	[1261]
3-butyl-3-ethyl-1-phenylazetidine-2,4-dione	DMOGZUK	Investigative	Small molecular drug	[589]
3-Butyl-[1,4]oxazepan-(5Z)-ylideneamine	DMRI503	Investigative	Small molecular drug	[36]
3-Butyl-[1,4]thiazepan-(5E)-ylideneamine	DM6A80U	Investigative	Small molecular drug	[196]
3-butylaminocarbonyl-6-ethyl-4-quinolone	DM95XWR	Investigative	Small molecular drug	[1260]
3-Carbamoyl-6-chloro-1H-indole-2-carboxylic acid	DMP6TLY	Investigative	Small molecular drug	[1262]
3-Carbazol-9-yl-propionic acid	DMHUBT5	Investigative	Small molecular drug	[889]
3-carboxy-6-ethyl-4-quinolone	DMRUX93	Investigative	Small molecular drug	[1260]
3-chloro-1-(4-hydroxyphenyl)propan-1-one	DM9OGNE	Investigative	Small molecular drug	[17]
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	DM3R8OM	Investigative	Small molecular drug	[22]
3-chloro-4-(4-chloro-2-hydroxyphenoxy)benzamide	DMZ5JFG	Investigative	Small molecular drug	[898]
3-chloro-4-(4-hydroxyphenyl)salicylaldoxime	DMER4U1	Investigative	Small molecular drug	[1263]
3-chloro-4-(o-tolyloxy)benzonitrile	DMNQF03	Investigative	Small molecular drug	[1001]
3-chloro-4-(o-tolylthio)benzonitrile	DM6Z3I8	Investigative	Small molecular drug	[1043]
3-Chloro-4-hydrazino-benzenesulfonamide	DMSB5IQ	Investigative	Small molecular drug	[951]
3-chloro-5-(2-methylquinolin-7-yl)benzonitrile	DMBMH96	Investigative	Small molecular drug	[161]
3-Chloro-9H-beta-carboline	DMCD901	Investigative	Small molecular drug	[1264]
3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMIEZGD	Investigative	Small molecular drug	[1142]
3-chloro-N-(3-isobutyramidophenyl)benzamide	DMV8TNO	Investigative	Small molecular drug	[1004]
3-chloro-N-(4-(phenyldiazenyl)phenyl)benzamide	DMBVCLY	Investigative	Small molecular drug	[1238]
3-chloro-N-(4-methylthiazol-2-yl)benzamide	DM4EL6M	Investigative	Small molecular drug	[1258]
3-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	DMAWC7S	Investigative	Small molecular drug	[785]
3-chloro-N-(6-chloropyridin-2-yl)benzamide	DMLC2I6	Investigative	Small molecular drug	[1258]
3-chloro-N-(6-methylpyridin-2-yl)benzamide	DMLJGF1	Investigative	Small molecular drug	[1080]
3-Chloroboldine	DM5J1TX	Investigative	Small molecular drug	[1161]
3-chlorophenyl 10H-phenothiazine-10-carboxylate	DMQCVKO	Investigative	Small molecular drug	[1050]
3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate	DMZ0F7E	Investigative	Small molecular drug	[1265]
3-chlorophenyl 4-butoxybenzylcarbamate	DMJ2SZ1	Investigative	Small molecular drug	[787]
3-chlorotyrosine	DMJ4SDM	Investigative	Small molecular drug	[1266]
3-cis-p-coumaroyl maslinic acid	DM78FWG	Investigative	Small molecular drug	[1267]
3-cyano-5-fluoro-N-(3-fluorophenyl)benzamide	DMF1PIW	Investigative	Small molecular drug	[1268]
3-cyano-5-fluoro-N-(pyridin-2-yl)benzamide	DMBA4XN	Investigative	Small molecular drug	[1268]
3-cyano-5-fluoro-N-m-tolylbenzamide	DMF097H	Investigative	Small molecular drug	[1268]
3-cyano-5-fluoro-N-phenylbenzamide	DMIZ8RC	Investigative	Small molecular drug	[1268]
3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	DMH7FC9	Investigative	Small molecular drug	[1269]
3-cyano-N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide	DM3EIWC	Investigative	Small molecular drug	[1270]
3-cyano-N-(3-cyanophenyl)-5-fluorobenzamide	DMRD8VM	Investigative	Small molecular drug	[1268]
3-cyano-N-(3-ethylphenyl)-5-fluorobenzamide	DMFUT57	Investigative	Small molecular drug	[1268]
3-cyano-N-(3-ethynylphenyl)-5-fluorobenzamide	DM9FEMV	Investigative	Small molecular drug	[1268]
3-cyano-N-(6-ethylpyridin-2-yl)-5-fluorobenzamide	DMUB9XW	Investigative	Small molecular drug	[1268]
3-cyano-N-(6-methylpyridin-2-yl)benzamide	DMTDEYL	Investigative	Small molecular drug	[1080]
3-cyanophenylboronic acid	DMPWR90	Investigative	Small molecular drug	[1019]
3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide	DMJSOTE	Investigative	Small molecular drug	[1246]
3-Cyclohexyl-1-propyl-piperidine hydrochloride	DMWMFZ3	Investigative	NA	[641]
3-Cyclohexylethynyl-6,7-dimethoxy-quinoline	DMCQ6J8	Investigative	Small molecular drug	[1168]
3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline	DM1FSZM	Investigative	Small molecular drug	[1168]
3-cyclopentoxycarbonyl-6-ethyl-4-quinolone	DMEL8S5	Investigative	Small molecular drug	[1260]
3-Cyclopentyl-6,7-dimethoxy-quinoline	DMS7B6T	Investigative	Small molecular drug	[1168]
3-Decanoyl-4-hydroxy-6-nonyl-pyran-2-one	DMLQJ64	Investigative	Small molecular drug	[1271]
3-demethoxy-3-D-lyxopyranosylaminothiocolchicine	DME8VPC	Investigative	Small molecular drug	[1235]
3-demethoxy-3-D-mannopyranosylaminothiocolchicine	DMALMGH	Investigative	Small molecular drug	[1235]
3-demethoxy-3-D-xylopyranosylaminothiocolchicine	DMXFVD1	Investigative	Small molecular drug	[1235]
3-demethoxy-3-L-fucopyranosylaminothiocolchicine	DM4ERYF	Investigative	Small molecular drug	[1235]
3-demethoxy-3D-glucopyranosylaminothiocolchicine	DMID7TC	Investigative	Small molecular drug	[1235]
3-Deoxyguanosine	DMFQUGE	Investigative	Small molecular drug	[12]
3-desoxy-3-carboxamidonaltrexone	DMBNA0V	Investigative	Small molecular drug	[1272]
3-Dimethylaminomethyl-1-methyl-1H-indol-4-ol	DMDOIJM	Investigative	Small molecular drug	[480]
3-Dimethylaminomethyl-1H-indol-4-ol	DMSJUOH	Investigative	Small molecular drug	[480]
3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	DMVHQB8	Investigative	Small molecular drug	[22]
3-dodecyl-1,1-dimethylthiourea	DMO5EBI	Investigative	Small molecular drug	[604]
3-epi-masilinic acid	DM1UOWB	Investigative	Small molecular drug	[1273]
3-epicorosolic acid methyl ester	DMQ8VIU	Investigative	Small molecular drug	[669]
3-Ethenylquinoline-8-carboxamide	DMTKQNU	Investigative	Small molecular drug	[924]
3-ethoxy-5-(2-methylquinolin-7-yl)benzonitrile	DMSK6EM	Investigative	Small molecular drug	[161]
3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine	DMWZDA1	Investigative	Small molecular drug	[1229]
3-Ethoxy-9H-beta-carboline	DM6K7BI	Investigative	Small molecular drug	[1274]
3-ethoxycarbonyl-4-quinolone	DMY4VOI	Investigative	Small molecular drug	[1260]
3-ethoxycarbonyl-6-ethyl-2-methyl-4-quinolone	DMMDOI4	Investigative	Small molecular drug	[1260]
3-ethoxycarbonyl-6-propyl-4-quinolone	DM1E5QZ	Investigative	Small molecular drug	[1260]
3-ethoxycarbonylpyroglutamate	DM4YL5Q	Investigative	Small molecular drug	[578]
3-Ethyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-6-ol	DMN8C93	Investigative	Small molecular drug	[1261]
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	DMEWAVM	Investigative	Small molecular drug	[22]
3-Ethyl-3-isobutyl-1-phenylazetidine-2,4-dione	DMB8Q7T	Investigative	Small molecular drug	[589]
3-Ethyl-3-isopropyl-dihydro-furan-2-one	DMZK13I	Investigative	Small molecular drug	[379]
3-Ethyl-3-methyl-dihydro-furan-2-one	DM1VTFU	Investigative	Small molecular drug	[379]
3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine	DMX2JKQ	Investigative	Small molecular drug	[196]
3-Ethylquinoline-8-carboxamide	DMGPRBE	Investigative	Small molecular drug	[924]
3-Ethynylquinoline-8-carboxamide	DMS4JGT	Investigative	Small molecular drug	[924]
3-Fluoren-9-ylidenemethyl-pyridine	DMR29IQ	Investigative	Small molecular drug	[1180]
3-Fluoro-2-(Phosphonooxy)Propanoic Acid	DMTY92S	Investigative	Small molecular drug	[12]
3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol	DM4PLSU	Investigative	Small molecular drug	[1275]
3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol	DMJ3WNP	Investigative	Small molecular drug	[1276]
3-Fluoro-4-hydrazino-benzenesulfonamide	DMLG69R	Investigative	Small molecular drug	[951]
3-fluoro-5-(1,6-naphthyridin-7-yl)benzonitrile	DMH9VLF	Investigative	Small molecular drug	[868]
3-fluoro-5-(2-methylquinolin-7-yl)benzonitrile	DM2V45Z	Investigative	Small molecular drug	[161]
3-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol	DMDPY9N	Investigative	Small molecular drug	[373]
3-Fluoromethyl-1,2,3,4-tetrahydro-isoquinoline	DMDPUC7	Investigative	Small molecular drug	[1277]
3-fluorovinylglycine	DMECBLA	Investigative	Small molecular drug	[1278]
3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide	DM8RY7G	Investigative	Small molecular drug	[1279]
3-hydroxy capric acid	DMC70P1	Investigative	Small molecular drug	[1280]
3-Hydroxy-1H-benzo[b]azepine-2,5-dione	DMZSOPU	Investigative	Small molecular drug	[1281]
3-hydroxy-2-methoxybenzaldehyde	DMI785L	Investigative	Small molecular drug	[799]
3-hydroxy-2-phenylquinoline-4-carboxylic acid	DMIVDFW	Investigative	Small molecular drug	[1282]
3-hydroxy-2-propionylcyclohex-2-enone	DMEK9DH	Investigative	Small molecular drug	[964]
3-hydroxy-3-methyl-6-phosphohexanoic acid	DM3YO72	Investigative	Small molecular drug	[1283]
3-Hydroxy-3-Methyl-Glutaric Acid	DMJD0UV	Investigative	Small molecular drug	[12]
3-hydroxy-4,10-dimethyl-6H-benzo[c]chromen-6-one	DMEJQTA	Investigative	Small molecular drug	[1162]
3-hydroxy-4,7-dimethyl-6H-benzo[c]chromen-6-one	DMUME74	Investigative	Small molecular drug	[1162]
3-hydroxy-4-methyl-6H-benzo[c]chromen-6-one	DMDBJCY	Investigative	Small molecular drug	[1162]
3-Hydroxy-4-phenyl-5H-furan-2-one	DM5QZDL	Investigative	Small molecular drug	[186]
3-hydroxy-5-(2-methylquinolin-7-yl)benzonitrile	DMZS4P7	Investigative	Small molecular drug	[161]
3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione	DMYR350	Investigative	Small molecular drug	[1281]
3-Hydroxy-7-(3-hydroxyphenyl)-1-naphthonitrile	DM3SOFX	Investigative	Small molecular drug	[600]
3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione	DMTEJOY	Investigative	Small molecular drug	[1281]
3-hydroxy-8,10-dimethyl-6H-benzo[c]chromen-6-one	DM3H56L	Investigative	Small molecular drug	[1162]
3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione	DM7HKIF	Investigative	Small molecular drug	[1281]
3-Hydroxy-benzamide	DMNV1P3	Investigative	Small molecular drug	[807]
3-Hydroxy-Myristic Acid	DMFJLWO	Investigative	Small molecular drug	[12]
3-hydroxy-N,N,N-trimethylbenzenaminium iodide	DMXO98C	Investigative	Small molecular drug	[1284]
3-Hydroxy-piperidine-4-carboxylic acid	DM5OR96	Investigative	Small molecular drug	[1285]
3-hydroxybenzylhydrazine	DMNUM4K	Investigative	Small molecular drug	[1286]
3-hydroxydesaminokynurenine	DM5T6AM	Investigative	Small molecular drug	[1287]
3-Hydroxyhippuric acid	DM2LBFW	Investigative	Small molecular drug	[22]
3-Hydroxyisoxazole-4-Carboxylic Acid	DMKLZXV	Investigative	Small molecular drug	[12]
3-hydroxylauric acid	DMNMB6V	Investigative	Small molecular drug	[1288]
3-hydroxyoctanoic acid	DMS658R	Investigative	Small molecular drug	[1289]
3-hydroxyphenethyl 3,4,5-trihydroxybenzoate	DMMAK83	Investigative	Small molecular drug	[1038]
3-Hydroxypyruvic Acid	DM67QDT	Investigative	Small molecular drug	[12]
3-hydroxyquinazoline-2,4(1H,3H)-dione	DMCXZ9L	Investigative	Small molecular drug	[1035]
3-Imidazol-1-yl-quinoline	DMVF6OQ	Investigative	Small molecular drug	[522]
3-Imidazol-1-ylmethyl-1H-indole	DMBZ60O	Investigative	Small molecular drug	[608]
3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole	DMAQOL0	Investigative	Small molecular drug	[608]
3-Indan-(1E)-ylidenemethyl-pyridine	DMYH6A2	Investigative	Small molecular drug	[1180]
3-Indan-(1Z)-ylidenemethyl-pyridine	DMTQERW	Investigative	Small molecular drug	[1180]
3-iodo-N-(6-methylpyridin-2-yl)benzamide	DMDSJ0O	Investigative	Small molecular drug	[1258]
3-Iodoboldine	DM890WJ	Investigative	Small molecular drug	[1161]
3-iodothyronamine	DM3L0F8	Investigative	Small molecular drug	[1290]
3-iodotyrosine	DMNZMH6	Investigative	Small molecular drug	[1291]
3-Iodyl-benzoic acid	DMJSLVT	Investigative	Small molecular drug	[614]
3-isobutoxy-5-(2-methylquinolin-7-yl)benzonitrile	DMWP0LZ	Investigative	Small molecular drug	[161]
3-Isobutoxy-9H-beta-carboline	DM6X5TZ	Investigative	Small molecular drug	[550]
3-isobutyl-8-pyrrolidinoxanthine	DM9GM1H	Investigative	Small molecular drug	[1292]
3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine	DMQXP7C	Investigative	Small molecular drug	[196]
3-isopr-sal-cyclosal-d4TMP	DMZPGBT	Investigative	Small molecular drug	[1293]
3-Isopropoxy-9H-beta-carboline	DM7PHO4	Investigative	Small molecular drug	[550]
3-Isopropyl-1-methyl-3,7-dihydro-purine-2,6-dione	DMYKVRF	Investigative	Small molecular drug	[411]
3-Isopropyl-3-methyl-dihydro-furan-2-one	DMSLPGZ	Investigative	Small molecular drug	[379]
3-isopropyl-4-(phenylamino)naphthalene-1,2-dione	DMHAJ6W	Investigative	Small molecular drug	[1294]
3-isopropyl-4-(phenylthio)naphthalene-1,2-dione	DMJZEMB	Investigative	Small molecular drug	[1294]
3-isopropyl-4-phenylnaphthalene-1,2-dione	DMYZCWX	Investigative	Small molecular drug	[1294]
3-isopropylnaphthalene-1,2-dione	DM46ID2	Investigative	Small molecular drug	[1294]
3-Isothiocyanato-9H-beta-carboline	DM9LEWH	Investigative	Small molecular drug	[1295]
3-keto-lithocholic acid	DM5LUED	Investigative	Small molecular drug	[1296]
3-ketosphinganine	DMWPNSV	Investigative	Small molecular drug	[1297]
3-m-tolyl-1,5-naphthyridine	DMMFA4N	Investigative	Small molecular drug	[868]
3-MATIDA	DMRMF13	Investigative	Small molecular drug	[1298]
3-mercapto-2-(piperidin-3-yl)propanoic acid	DMPJBNC	Investigative	Small molecular drug	[875]
3-mercapto-2-(piperidin-4-yl)propanoic acid	DMYQG7A	Investigative	Small molecular drug	[875]
3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide	DMQ09J8	Investigative	Small molecular drug	[1299]
3-mercaptopyruvic acid	DMLF1W3	Investigative	Small molecular drug	[1300]
3-Mercuri-4-Aminobenzenesulfonamide	DMX3ANZ	Investigative	Small molecular drug	[12]
3-MeSO2-DDE	DMAWEQH	Investigative	Small molecular drug	[1301]
3-methoxy-4-(m-tolyloxy)benzonitrile	DM2QD45	Investigative	Small molecular drug	[1043]
3-methoxy-4-(o-tolyloxy)benzonitrile	DMEGF58	Investigative	Small molecular drug	[1043]
3-methoxy-4-(oxazol-5-yl)aniline	DMKUM4L	Investigative	Small molecular drug	[621]
3-methoxy-4-(p-tolyloxy)benzonitrile	DM37QE8	Investigative	Small molecular drug	[1043]
3-methoxy-4-hydroxylonchocarpin	DMAL1CP	Investigative	Small molecular drug	[1302]
3-methoxy-5-(1,5-naphthyridin-3-yl)benzonitrile	DMHYRES	Investigative	Small molecular drug	[868]
3-methoxy-5-(1,6-naphthyridin-7-yl)benzonitrile	DMKHJ8G	Investigative	Small molecular drug	[868]
3-methoxy-5-(2-methylquinolin-7-yl)benzonitrile	DMRMZLV	Investigative	Small molecular drug	[161]
3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine	DMF2IW8	Investigative	Small molecular drug	[1229]
3-methoxy-9-aminomethyl-9,10-dihydroanthracene	DMO2N56	Investigative	Small molecular drug	[617]
3-Methoxy-9H-beta-carboline	DMTBX0D	Investigative	Small molecular drug	[1264]
3-methoxy-N',2-diphenylquinoline-4-carbohydrazide	DMZ9MQ5	Investigative	Small molecular drug	[1303]
3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide	DMFEL39	Investigative	Small molecular drug	[543]
3-methoxy-N-(4-methylthiazol-2-yl)benzamide	DM4WJX3	Investigative	Small molecular drug	[1258]
3-methoxy-N-(6-methylpyridin-2-yl)benzamide	DMSFJNE	Investigative	Small molecular drug	[1258]
3-Methoxybenzamide	DM245AB	Investigative	Small molecular drug	[12]
3-Methoxycarbonyl-2-methyl-9H-beta-carbolin-2-ium	DMQMT1A	Investigative	Small molecular drug	[1304]
3-methoxydesaminokynurenine	DMHVIK3	Investigative	Small molecular drug	[1287]
3-Methoxyl-4'-amino-trans-stilbene	DMWNO4D	Investigative	Small molecular drug	[531]
3-Methoxymethyl-1,2,3,4-tetrahydro-isoquinoline	DMH1RX6	Investigative	Small molecular drug	[97]
3-methoxyphenyl 10H-phenothiazine-10-carboxylate	DMKHVGJ	Investigative	Small molecular drug	[1050]
3-methoxyphenylboronic acid	DMHJTLW	Investigative	Small molecular drug	[1019]
3-methoxytyramine	DMAMNWQ	Investigative	Small molecular drug	[1305]
3-Methyl-1,2,3,4-tetrahydro-isoquinoline	DMIWQ7G	Investigative	Small molecular drug	[275]
3-Methyl-1-phenethyl-3,7-dihydro-purine-2,6-dione	DMKYPUW	Investigative	Small molecular drug	[573]
3-Methyl-1-phenyl-1H-chromeno[4,3-c]pyrazol-4-one	DMTM6B0	Investigative	Small molecular drug	[420]
3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide	DMKOX0N	Investigative	Small molecular drug	[1306]
3-methyl-2(1H)-thioxo-4(3H)-quinazolinone	DMHVNQM	Investigative	Small molecular drug	[1026]
3-methyl-2-morpholino-1,1-diphenylbutan-1-ol	DMKWAV6	Investigative	Small molecular drug	[968]
3-Methyl-2-phenyl-2H-chromeno[4,3-c]pyrazol-4-one	DM870UV	Investigative	Small molecular drug	[420]
3-Methyl-2H-benzo[f]quinazolin-1-one	DMFC0H5	Investigative	Small molecular drug	[1236]
3-Methyl-4-phenylbut-3-en-2-one oxime	DM0WVTF	Investigative	Small molecular drug	[1307]
3-methyl-5-(2-methylquinolin-7-yl)benzonitrile	DMM3RNV	Investigative	Small molecular drug	[161]
3-methyl-6-(trifluoromethyl)-9H-carbazole	DM3BL45	Investigative	Small molecular drug	[548]
3-Methyl-7-nitro-1,2,3,4-tetrahydro-isoquinoline	DMZY6VX	Investigative	Small molecular drug	[1308]
3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one	DME81U3	Investigative	Small molecular drug	[1054]
3-Methyl-9H-beta-carboline	DMEJKZN	Investigative	Small molecular drug	[1309]
3-methyl-N-(6-methylpyridin-2-yl)benzamide	DMRNMKG	Investigative	Small molecular drug	[1258]
3-Methyl-pyrrolidin-(2Z)-ylideneamine	DMHVUF8	Investigative	Small molecular drug	[1150]
3-Methyl-[1,4]thiazepan-(5E)-ylideneamine	DMCOH46	Investigative	Small molecular drug	[196]
3-Methylfentanyl	DMX71N9	Investigative	Small molecular drug	[1310]
3-Methylphenylalanine	DMQOI5X	Investigative	Small molecular drug	[12]
3-Methylpyridine	DMF3JHM	Investigative	Small molecular drug	[12]
3-Methylquinoline-8-carboxamide	DMQZULR	Investigative	Small molecular drug	[924]
3-Methylthiofentanyl	DMC153X	Investigative	Small molecular drug	[1311]
3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one	DM0YS25	Investigative	Small molecular drug	[1312]
3-morpholino-1H-benzo[f]chromen-1-one	DMGWH0E	Investigative	Small molecular drug	[824]
3-MPPTS	DMCDLG4	Investigative	Small molecular drug	[1313]
3-Naphthalen-1-yl-1-propyl-pyrrolidine	DMNZI9R	Investigative	Small molecular drug	[640]
3-Naphthalen-1-yl-pyrrolidine	DMCW7F5	Investigative	Small molecular drug	[640]
3-Nitro-4'-nitro-trans-stilbene	DMZRNOT	Investigative	Small molecular drug	[531]
3-Nitro-9H-beta-carboline	DM08V9W	Investigative	Small molecular drug	[1264]
3-Nitro-benzenesulfonamide	DMAY4OZ	Investigative	Small molecular drug	[1314]
3-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	DMIZJ9G	Investigative	Small molecular drug	[1270]
3-Nitrophenylboronic Acid	DMPMX8R	Investigative	Small molecular drug	[12]
3-nitropropionate	DMH798G	Investigative	Small molecular drug	[1315]
3-noradamantyl-1,3-dipropylxanthine	DMFHYAE	Investigative	Small molecular drug	[1316]
3-O-METHYLQUERCETIN	DMVIZ1S	Investigative	Small molecular drug	[1317]
3-Oximo-olean-12-en-29-oic acid	DMVIRLX	Investigative	Small molecular drug	[1318]
3-oxoolean-12-en-27-oic acid	DM6JYWQ	Investigative	Small molecular drug	[718]
3-p-Tolyl-8-aza-bicyclo[3.2.1]octane	DM0872E	Investigative	Small molecular drug	[1319]
3-phenacyl-UDP	DMOLZ65	Investigative	Small molecular drug	[1320]
3-Phenanthren-9-yl-pyridine	DM7RWQT	Investigative	Small molecular drug	[522]
3-Phenethyl-2-phenyl-3H-quinazolin-4-one	DMVSQFI	Investigative	Small molecular drug	[1321]
3-Phenyl-1,2-Propandiol	DMU9WGT	Investigative	Small molecular drug	[12]
3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole	DMD0OZ8	Investigative	Small molecular drug	[1322]
3-Phenyl-1-(2-methylthiazol-4-ylethynyl)benzene	DMGPOZE	Investigative	Small molecular drug	[1080]
3-Phenyl-1-propyl-piperidine hydrochloride	DM568CK	Investigative	NA	[641]
3-Phenyl-1-propyl-pyrrolidine	DMJ0SVB	Investigative	Small molecular drug	[640]
3-Phenyl-1-propylquinazoline-2,4(1H,3H)-dione	DMEG3YX	Investigative	Small molecular drug	[590]
3-Phenyl-2-nortropene	DMAJMU6	Investigative	Small molecular drug	[1197]
3-phenyl-4-(phenylamino)-1H-pyrrole-2,5-dione	DM6T5K4	Investigative	Small molecular drug	[1323]
3-phenyl-4-hydroxyquinolin-2(1H)-one	DM2C9X8	Investigative	Small molecular drug	[1324]
3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide	DM43CIK	Investigative	Small molecular drug	[1325]
3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one	DM830FW	Investigative	Small molecular drug	[1056]
3-phenyl-CPP	DMQZJYS	Investigative	Small molecular drug	[1326]
3-phenyl-cyclosal-d4TMP	DM3LM6B	Investigative	Small molecular drug	[1293]
3-Phenyl-pyrrolidine	DMBTDZL	Investigative	Small molecular drug	[640]
3-Phenylcyclopentanecarboxylic acid	DMJOD1T	Investigative	Small molecular drug	[752]
3-phenylprop-1-enylboronic acid	DMIJN9E	Investigative	Small molecular drug	[942]
3-Phenylquinoline-8-carboxamide	DM12SKU	Investigative	Small molecular drug	[924]
3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine	DMRNHXE	Investigative	Small molecular drug	[1327]
3-Phosphoglyceric Acid	DMIK9VO	Investigative	Small molecular drug	[12]
3-Phosphoglycerol	DM9BDV2	Investigative	Small molecular drug	[12]
3-Prop-1-ynylquinoline-8-carboxamide	DM23I8E	Investigative	Small molecular drug	[924]
3-Propoxy-9H-beta-carboline	DMDEV64	Investigative	Small molecular drug	[1264]
3-Propyl-[1,4]thiazepan-(5E)-ylideneamine	DMYACO7	Investigative	Small molecular drug	[196]
3-Pyridin-3-yl-quinoline-6,7-diol	DM60Q1B	Investigative	Small molecular drug	[1168]
3-Pyridin-4-yl-quinolin-7-ol	DM0SEL5	Investigative	Small molecular drug	[1328]
3-Pyridin-4-yl-quinoline	DM6U074	Investigative	Small molecular drug	[1328]
3-Pyridin-4-yl-quinoline-5,7-diol	DMPCT0A	Investigative	Small molecular drug	[1328]
3-Pyridin-4-yl-quinoline-6,7-diol	DME1TUK	Investigative	Small molecular drug	[1328]
3-pyridine-acetic acid	DMAGXMJ	Investigative	Small molecular drug	[1329]
3-sal-cyclosal-d4TMP	DMCD4GR	Investigative	Small molecular drug	[1293]
3-sec-Butoxy-9H-beta-carboline	DMNP8DQ	Investigative	Small molecular drug	[550]
3-tapap	DMKSUV9	Investigative	Small molecular drug	[1064]
3-tert-Butyl-3-ethyl-dihydro-furan-2-one	DMGDT8V	Investigative	Small molecular drug	[379]
3-tert-butyl-9H-carbazole	DMY57CV	Investigative	Small molecular drug	[548]
3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane	DMIH6JU	Investigative	Small molecular drug	[1330]
3-Thiophen-3-yl-quinoline	DM9MFZ1	Investigative	Small molecular drug	[1168]
3-trans-p-coumaroyl maslinic acid	DMOQWDS	Investigative	Small molecular drug	[1267]
3-[(1-carboxy-4-mercaptobutyl)thio]benzoic acid	DMLSET4	Investigative	Small molecular drug	[846]
3-[(1s)-1-(Dimethylamino)Ethyl]Phenol	DM2KXFS	Investigative	Small molecular drug	[22]
3-[(2,5-dimethyl-4-thiazolyl)ethynyl]pyridine	DMBAHRJ	Investigative	Small molecular drug	[228]
3-[(2-methyl-4-thiazolyl)ethynyl]-5-vinylpyridine	DMZ78WB	Investigative	Small molecular drug	[228]
3-[(2-methyl-4-thiazolyl)ethynyl]benzamide	DMMLDOZ	Investigative	Small molecular drug	[228]
3-[(2-methyl-4-thiazolyl)ethynyl]benzonitrile	DMQUDR1	Investigative	Small molecular drug	[1331]
3-[(2-methyl-4-thiazolyl)ethynyl]phenol	DMF0QM2	Investigative	Small molecular drug	[228]
3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	DMHISM2	Investigative	Small molecular drug	[1276]
3-[(5-ethyl-2-methyl-4-thiazolyl)ethynyl]pyridine	DM9OI2R	Investigative	Small molecular drug	[228]
3-[(6-Methylpyridin-2-yl)ethynyl]benzonitrile	DMH5329	Investigative	Small molecular drug	[1080]
3-[(Z)-2-phenylvinyl]pyridine	DMNPKZ6	Investigative	Small molecular drug	[501]
3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene	DMIHWAJ	Investigative	Small molecular drug	[1332]
3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol	DM7URMW	Investigative	Small molecular drug	[160]
3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol	DM63IKF	Investigative	Small molecular drug	[160]
3-[1-ethyl-2-(3-hydroxyphenyl)butyl]phenol	DMPTI1Z	Investigative	Small molecular drug	[1333]
3-[10-(benzylmethylamino)decyloxy]xanthen-9-one	DMBHUP3	Investigative	Small molecular drug	[1334]
3-[11-(benzylmethylamino)undecyloxy]xanthen-9-one	DM287UO	Investigative	Small molecular drug	[1334]
3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one	DM9KVHQ	Investigative	Small molecular drug	[1334]
3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole	DME1UNY	Investigative	Small molecular drug	[1335]
3-[2-(3,5-Dimethoxy-phenyl)-vinyl]-furan	DMXE1LC	Investigative	Small molecular drug	[1100]
3-[2-(5-Chloro-2-thienyl)pyridin-4-yl]phenol	DM5EJLD	Investigative	Small molecular drug	[1126]
3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine	DMJB1KL	Investigative	Small molecular drug	[1336]
3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one	DMLX9SI	Investigative	Small molecular drug	[221]
3-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide	DM60YGF	Investigative	Small molecular drug	[514]
3-[3-(4-hydroxyphenyl)isoxazol-5-yl]phenol	DMNC6W9	Investigative	Small molecular drug	[1337]
3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DMTLJMF	Investigative	Small molecular drug	[536]
3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine	DM8NRJQ	Investigative	Small molecular drug	[1201]
3-[3-(benzylmethylamino)propoxy]xanthen-9-one	DMPVXTB	Investigative	Small molecular drug	[1334]
3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine	DMDS8UJ	Investigative	Small molecular drug	[1180]
3-[3-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	DMTF520	Investigative	Small molecular drug	[1180]
3-[3-Phenyl-indan-(1E)-ylidenemethyl]-pyridine	DMYEWA4	Investigative	Small molecular drug	[1180]
3-[4-(4-Fluoro-phenoxy)-phenyl]-1H-pyrazole	DME86OK	Investigative	Small molecular drug	[1223]
3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol	DMIM5WE	Investigative	Small molecular drug	[1337]
3-[4-(4-phenoxybenzoyl)phenyl]propanoic acid	DM75F1Q	Investigative	Small molecular drug	[170]
3-[4-(5-Chloro-2-thienyl)pyridin-2-yl]phenol	DMZCO83	Investigative	Small molecular drug	[1126]
3-[4-(benzylmethylamino)butoxy]xanthen-9-one	DMZPULH	Investigative	Small molecular drug	[1334]
3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine	DM0XD6T	Investigative	Small molecular drug	[1180]
3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	DMMDIB9	Investigative	Small molecular drug	[1180]
3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	DMZS20Y	Investigative	Small molecular drug	[1180]
3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	DMPS340	Investigative	Small molecular drug	[1180]
3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine	DMJN93U	Investigative	Small molecular drug	[1180]
3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	DMNILXG	Investigative	Small molecular drug	[1180]
3-[5-(3,4-Difluorophenyl)-2-thienyl]phenol	DMYZIG3	Investigative	Small molecular drug	[373]
3-[5-(3-Fluorophenyl)-2-thienyl]phenol	DMD5QOW	Investigative	Small molecular drug	[373]
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	DM1QKNU	Investigative	Small molecular drug	[22]
3-[5-(4-Fluorophenyl)-2-thienyl]phenol	DMYZ2U0	Investigative	Small molecular drug	[373]
3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol	DM4TFMA	Investigative	Small molecular drug	[1131]
3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol	DM2IXO0	Investigative	Small molecular drug	[373]
3-[5-(4-Hydroxyphenyl)-2-thienyl]-5-methylphenol	DMAMOJE	Investigative	Small molecular drug	[373]
3-[5-(4-hydroxyphenyl)-2-thienyl]phenol	DMSFW9T	Investigative	Small molecular drug	[373]
3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol	DM40GJ8	Investigative	Small molecular drug	[1131]
3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one	DMQZ0A7	Investigative	Small molecular drug	[1334]
3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	DMUEVAQ	Investigative	Small molecular drug	[1180]
3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	DMCXSIH	Investigative	Small molecular drug	[1180]
3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	DM8TWLO	Investigative	Small molecular drug	[1180]
3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	DMN60YG	Investigative	Small molecular drug	[1180]
3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine	DMLJQZS	Investigative	Small molecular drug	[1180]
3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine	DMMTUON	Investigative	Small molecular drug	[1180]
3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	DMWSFIR	Investigative	Small molecular drug	[1180]
3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	DMN42I5	Investigative	Small molecular drug	[1180]
3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	DM9AW5U	Investigative	Small molecular drug	[1180]
3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	DMB3XYE	Investigative	Small molecular drug	[1180]
3-[6-(5-Chloro-2-thienyl)pyridin-2-yl]phenol	DMLTZ5F	Investigative	Small molecular drug	[1126]
3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one	DM89RN3	Investigative	Small molecular drug	[1334]
3-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	DMHT6FX	Investigative	Small molecular drug	[1180]
3-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	DMG76LS	Investigative	Small molecular drug	[1180]
3-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	DMKOB2T	Investigative	Small molecular drug	[1180]
3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene	DM7IHUK	Investigative	Small molecular drug	[1332]
3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one	DMMD3G6	Investigative	Small molecular drug	[1334]
3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	DMVWIQ2	Investigative	Small molecular drug	[1180]
3-[8-(benzylmethylamino)octyloxy]xanthen-9-one	DM31WYF	Investigative	Small molecular drug	[1334]
3-[9-(benzylmethylamino)nonyloxy]xanthen-9-one	DMZSBU5	Investigative	Small molecular drug	[1334]
3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	DMUH9PF	Investigative	Small molecular drug	[1338]
3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	DMGS2X7	Investigative	Small molecular drug	[1338]
3-{[2-(2-phenylethyl)phenoxy]methyl}pyridine	DMLZ5F1	Investigative	Small molecular drug	[551]
3570-0208	DMT80IF	Investigative	Small molecular drug	[1339]
3alpha,24-dihydroxyolean-12-en-27-oic acid	DM3ZR7A	Investigative	Small molecular drug	[718]
3alpha-(1'-Methyl-2'-Indolecarbonyloxy)-tropane	DMCNX34	Investigative	Small molecular drug	[1340]
3alpha-(2'-Indolecarbonyloxy)-nortropane	DM3BRYJ	Investigative	Small molecular drug	[1340]
3alpha-(bis-chloro-phenylmethoxy)tropane	DMBUZWQ	Investigative	Small molecular drug	[1341]
3alpha-Hydroxyurs-12-en-28-oic Acid	DMV6OPB	Investigative	Small molecular drug	[1106]
3alpha-O-trans-p-coumaroyl-7-labden-15-oic acid	DM4M6LR	Investigative	Small molecular drug	[1342]
3beta,6beta-dihydroxyolean-12-en-27-oic acid	DMLEXWC	Investigative	Small molecular drug	[718]
3beta-acetoxyolean-12-en-27-oic acid	DMOZAHB	Investigative	Small molecular drug	[718]
3beta-hydroxyolean-12-en-27-oic acid	DMF6VGK	Investigative	Small molecular drug	[718]
3beta-hydroxyrus-12,19(29)-dien-28-oic acid	DML8NY0	Investigative	Small molecular drug	[1343]
3beta-hydroxyrus-18,20(30)-dien-28-oic acid	DMKL59W	Investigative	Small molecular drug	[1343]
3beta-hydroxyurs-12-en-27-oic acid	DM6NFO0	Investigative	Small molecular drug	[718]
3h-Indole-5,6-Diol	DMBFCTZ	Investigative	Small molecular drug	[12]
3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	DMLB2W5	Investigative	Small molecular drug	[12]
3hydroxy-1-methyl-1-phenylurea	DM4758S	Investigative	Small molecular drug	[526]
3r-Hydroxydecanoyl-Coa	DMV1HMX	Investigative	Small molecular drug	[107]
3R14S-OCHRATOXIN A	DM2KEW6	Investigative	Small molecular drug	[1344]
3S,4R-293B	DMVGDSM	Investigative	Small molecular drug	[175]
4',4-Dihydroxychalcone	DMFPO16	Investigative	Small molecular drug	[1345]
4',5,7-trihydroxy-6,8-dimethylisoflavone	DM1RM3H	Investigative	Small molecular drug	[1346]
4'-((2-butylbenzofuran-3-yl)methyl)biphenyl-4-ol	DMCRWTH	Investigative	Small molecular drug	[1347]
4'-(1,1-dimethyl-heptyl)-3,5-dimethyl-biphenyl	DMUMD8L	Investigative	Small molecular drug	[733]
4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol	DMEW1CP	Investigative	Small molecular drug	[1275]
4'-(2-butylbenzofuran-3-yl)biphenyl-4-ol	DM2MSEF	Investigative	Small molecular drug	[1347]
4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol	DM6DSNI	Investigative	Small molecular drug	[1275]
4'-(4-Aminobenzensulfonamide)-4-hydroxychalcone	DMGOTYC	Investigative	Small molecular drug	[1345]
4'-(4-Fluorobenzensulfonamide)-4-hydroxychalcone	DMA6E28	Investigative	Small molecular drug	[1345]
4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone	DMHB1N6	Investigative	Small molecular drug	[1345]
4'-(5-Chloro-2-thienyl)biphenyl-3-ol	DMDYBIC	Investigative	Small molecular drug	[1126]
4'-(6-Methoxypyridin-3-yl)biphenyl-3-ol	DM4B73F	Investigative	Small molecular drug	[1126]
4'-(Benzensulfonamide)-4-hydroxychalcone	DML2EF4	Investigative	Small molecular drug	[1345]
4'-(p-toluenesulfonamide)-3,4-dihydroxy chalcone	DM8M0N9	Investigative	Small molecular drug	[1348]
4'-(p-Toluenesulfonamide)-4-hydroxychalcone	DMRFWE1	Investigative	Small molecular drug	[1345]
4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine	DMZ0H5X	Investigative	Small molecular drug	[1276]
4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol	DM6Z5EK	Investigative	Small molecular drug	[1276]
4'-(Pyridin-4-ylmethyl)biphenyl-3-amine	DMR8O1B	Investigative	Small molecular drug	[1276]
4'-(Pyridin-4-ylmethyl)biphenyl-4-amine	DM8HXYS	Investigative	Small molecular drug	[1276]
4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide	DMYXMT6	Investigative	Small molecular drug	[1276]
4'-(trifluoromethyl)-4-biphenylol	DMMWZLC	Investigative	Small molecular drug	[1349]
4'-(trifluoromethyl)-4-biphenylsulfonamide	DMLP67R	Investigative	Small molecular drug	[1349]
4'-(trifluoromethyl)-4-biphenylyl carbamate	DMT3BX9	Investigative	Small molecular drug	[1349]
4'-(trifluoromethyl)-4-biphenylyl sulfamate	DM8PTNR	Investigative	Small molecular drug	[1349]
4'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	DMQ6EBR	Investigative	Small molecular drug	[733]
4'-Amino-4-hydroxychalcone	DM9S5V0	Investigative	Small molecular drug	[1345]
4'-bromo-3-(imidazolylmethyl)-7-methoxyflavone	DMK2PBJ	Investigative	Small molecular drug	[1232]
4'-bromo-3-(imidazolylmethyl)flavone	DM2V3S8	Investigative	Small molecular drug	[1232]
4'-cyano-3-(imidazolylmethyl)-7-methoxyflavone	DMWGF9R	Investigative	Small molecular drug	[1232]
4'-cyano-3-(imidazolylmethyl)flavone	DMUJS4R	Investigative	Small molecular drug	[1232]
4'-Demethyl-4beta-amino-4-desoxypodophyllotoxin	DMQWHLM	Investigative	Small molecular drug	[1350]
4'-Demethyl-epipodophyllotoxin	DMIWX3B	Investigative	Small molecular drug	[1350]
4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	DMQ1D9A	Investigative	Small molecular drug	[22]
4'-hydroxy-6,3',5'-triprenylisoflavonone	DM7PWOL	Investigative	Small molecular drug	[1163]
4'-Methoxy-5,3'-dipropyl-biphenyl-2ol	DM5FRV2	Investigative	Small molecular drug	[774]
4'-Phosphopantetheine	DMJ0A4Z	Investigative	Small molecular drug	[12]
4'-trifluoromethyl-biphenyl-4-ylamine	DMT81SD	Investigative	Small molecular drug	[1349]
4(Z)-(5'-Deoxyadenosin-5'-ylidene)butanoic acid	DM2YAUX	Investigative	Small molecular drug	[1351]
4,10-dimethyl-6H-benzo[c]chromene-3,8-diol	DMB5RJK	Investigative	Small molecular drug	[1162]
4,12,17-dehydroxyriccardin C	DM1XTJC	Investigative	Small molecular drug	[673]
4,17-dehydroxyriccardin C	DMIZ0GO	Investigative	Small molecular drug	[673]
4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl	DMBN4G6	Investigative	Small molecular drug	[1123]
4,3'',5''-trimethoxy-[1,1':3',1'']-terphenyl	DM40E1T	Investigative	Small molecular drug	[1123]
4,4'-(4-phenylpyridine-2,6-diyl)diphenol	DMJKWFI	Investigative	Small molecular drug	[1132]
4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol	DM1NVEI	Investigative	Small molecular drug	[1352]
4,4'-Biphenyldiboronic Acid	DMFGQ02	Investigative	Small molecular drug	[12]
4,4'-dihydroxyoctafluoroazobenzene	DM1ONBT	Investigative	Small molecular drug	[759]
4,4'-thiodipyridine-3-sulfonamide	DM0K5JM	Investigative	Small molecular drug	[1353]
4,4-Diphenyl-N-(pyridin-3-yl)-butyramide	DMM0H9Y	Investigative	Small molecular drug	[1354]
4,4-Diphenylbutan-1-amine	DMQ0TBX	Investigative	Small molecular drug	[937]
4,5,-IP2	DMFW3XP	Investigative	Small molecular drug	[1355]
4,5,6,7-tetrabromo-1H-benzimidazole	DMUE4K3	Investigative	Small molecular drug	[1356]
4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole	DMN9YOB	Investigative	Small molecular drug	[1357]
4,5,6,7-tetrafluoro-3-methyl-1H-indazole	DMTC7J2	Investigative	Small molecular drug	[1358]
4,5,6,7-tetrafluoro-3-perfluorophenyl-1H-indazole	DMZEY31	Investigative	Small molecular drug	[1358]
4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid	DMDQL24	Investigative	Small molecular drug	[727]
4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol	DMO91EH	Investigative	Small molecular drug	[1359]
4,5,6-trihydroxy-3-methylphthalide	DMQFTJ7	Investigative	Small molecular drug	[1360]
4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one	DMXZ9PI	Investigative	Small molecular drug	[1361]
4,5-Bis(4-chlorophenyl)-1,2-selenazole	DMIO254	Investigative	Small molecular drug	[1362]
4,5-Bis(4-chlorophenyl)isothiazole	DMENLFY	Investigative	Small molecular drug	[1363]
4,5-Bis(4-methoxyphenyl)-1,2-selenazole	DMKHD1M	Investigative	Small molecular drug	[1362]
4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one	DMI39QT	Investigative	Small molecular drug	[1363]
4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione	DMPW145	Investigative	Small molecular drug	[1363]
4,5-Bis(4-methoxyphenyl)isothiazole	DM90DV6	Investigative	Small molecular drug	[1363]
4,5-dibenzylbenzene-1,2-diol	DMHURXY	Investigative	Small molecular drug	[1364]
4,5-Dibromo-1H-pyrrole-2-carboxylic acid amide	DMDM9UV	Investigative	Small molecular drug	[1365]
4,5-dichloro-1H-indole-2,3-dione	DMX94EK	Investigative	Small molecular drug	[475]
4,5-Dihydroxy-10H-anthracen-9-one	DMG8KRN	Investigative	Small molecular drug	[407]
4,5-Dimethoxy-10H-anthracen-9-one	DM34L89	Investigative	Small molecular drug	[407]
4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine	DMB9CJM	Investigative	Small molecular drug	[1150]
4,5-ISOBUDLEIN A	DMXNP2W	Investigative	Small molecular drug	[703]
4,6,10-trimethyl-6H-benzo[c]chromene-3,8-diol	DM6N98E	Investigative	Small molecular drug	[1162]
4,6,6,7-tetramethyl-6H-benzo[c]chromene-3,8-diol	DM14VI3	Investigative	Small molecular drug	[1162]
4,6,7,10-tetramethyl-6H-benzo[c]chromene-3,8-diol	DMYN25U	Investigative	Small molecular drug	[1162]
4,6,7-trimethyl-6H-benzo[c]chromene-3,8-diol	DMFECXI	Investigative	Small molecular drug	[1162]
4,6-dichloro-1H-indole-2,3-dione	DMHBO17	Investigative	Small molecular drug	[475]
4,6-Dichloro-1H-indole-2-carboxylic acid	DM62XC3	Investigative	Small molecular drug	[22]
4,6-Dideoxy-4-Amino-Alpha-D-Glucose	DMBZIG7	Investigative	Small molecular drug	[12]
4,6-Dideoxyglucose	DMP5M9E	Investigative	Small molecular drug	[12]
4,6-Dinitro salicylic acid	DMIJ4VZ	Investigative	Small molecular drug	[1366]
4,6-dinitrobenzo[c][1,2,5]thiadiazole	DMWDYLR	Investigative	Small molecular drug	[1367]
4,7-dichloro-1H-indole-2,3-dione	DMEVK5F	Investigative	Small molecular drug	[475]
4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	DM67Z81	Investigative	Small molecular drug	[1162]
4,7-Dioxosebacic Acid	DML5302	Investigative	NA	[12]
4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	DMQNXL1	Investigative	Small molecular drug	[1138]
4,9-anhydro-tetrodotoxin	DMEKI1B	Investigative	Small molecular drug	[1368]
4,9-Dihydro-3H-beta-carboline	DM27HMT	Investigative	Small molecular drug	[392]
4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate	DMI15VQ	Investigative	Small molecular drug	[1369]
4-((+/-)-(1H-imidazol-1-yl)-(E)-retinoic acid	DMKYB4D	Investigative	Small molecular drug	[1369]
4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	DMDHV0N	Investigative	Small molecular drug	[469]
4-((1H-imidazol-1-yl)methyl)benzonitrile	DMFUBRC	Investigative	NA	[497]
4-((1H-imidazol-1-yl)methyl)phenol	DMYDGH4	Investigative	Small molecular drug	[541]
4-((1H-imidazol-4-yl)methyl)-1-heptylpiperidine	DMX2QD5	Investigative	Small molecular drug	[1370]
4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine	DMRYWSN	Investigative	Small molecular drug	[1371]
4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol	DMLV59R	Investigative	Small molecular drug	[1372]
4-((1H-indol-1-yl)methyl)benzenamine	DMRWZ6T	Investigative	Small molecular drug	[1373]
4-((2R,3S)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole	DMJN2OW	Investigative	Small molecular drug	[116]
4-((2S,3R)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole	DM8WCJK	Investigative	Small molecular drug	[116]
4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine	DMHN5OL	Investigative	Small molecular drug	[1276]
4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	DM5EP3V	Investigative	Small molecular drug	[1167]
4-((4-methoxyphenyl)diazenyl)benzenesulfonamide	DMNAT1D	Investigative	Small molecular drug	[1374]
4-((benzylideneamino)methyl)benzenesulfonamide	DM6R43J	Investigative	Small molecular drug	[917]
4-((E)-1-Naphthalen-1-yl-propenyl)-1H-imidazole	DMDOJ4E	Investigative	Small molecular drug	[1375]
4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol	DM52Y3Q	Investigative	Small molecular drug	[1372]
4-((naphthalen-2-yloxy)methyl)piperidine	DMIQHYZ	Investigative	Small molecular drug	[59]
4-((pyridin-4-ylthio)methyl)benzene-1,2-diol	DM7X2AY	Investigative	Small molecular drug	[1134]
4-((Z)-1-Naphthalen-1-yl-propenyl)-1H-imidazole	DM1UK3G	Investigative	Small molecular drug	[1375]
4-(1,1-dimethyl-heptyl)-2'-methoxy-biphenyl-2-ol	DMV4QRF	Investigative	Small molecular drug	[733]
4-(1,1-dimethyl-heptyl)-3'-methoxy-biphenyl-2-ol	DM5BN41	Investigative	Small molecular drug	[733]
4-(1,2,3-thiadiazol-4-yl)phenyl butylcarbamate	DMG4HO3	Investigative	Small molecular drug	[1376]
4-(1,2,3-thiadiazol-4-yl)phenyl hexylcarbamate	DMSFGRI	Investigative	Small molecular drug	[1376]
4-(1,2-Diphenyl-but-1-enyl)-phenol	DMJDW50	Investigative	Small molecular drug	[1377]
4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol	DMNV9H5	Investigative	Small molecular drug	[1378]
4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol	DMS1OYA	Investigative	Small molecular drug	[1378]
4-(1-cyclopentyl-7-fluoro-1H-indazol-3-yl)phenol	DM3NEYB	Investigative	Small molecular drug	[1378]
4-(1-Imidazol-1-yl-vinyl)-benzonitrile	DM08963	Investigative	Small molecular drug	[1379]
4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole	DMFYBLH	Investigative	Small molecular drug	[1380]
4-(1-Naphthalen-1-yl-propyl)-1H-imidazole	DM64THP	Investigative	Small molecular drug	[1375]
4-(1-Naphthalen-1-yl-vinyl)-1H-imidazole	DM49PR1	Investigative	Small molecular drug	[1375]
4-(10H-Anthracen-9-ylidene)-1-methyl-piperidine	DM1SP36	Investigative	Small molecular drug	[756]
4-(1H-1,2,3-triazol-5-yl)pyridine	DMFWVJI	Investigative	Small molecular drug	[768]
4-(1H-IMIDAZOL-1-YL)PHENOL	DM5JDYO	Investigative	Small molecular drug	[22]
4-(1H-Inden-1-ylmethyl)-phenylamine	DMMJI4R	Investigative	Small molecular drug	[1381]
4-(1H-indol-1-ylsulfonyl)benzenamine	DMY5QBF	Investigative	Small molecular drug	[560]
4-(1H-indol-3-yl)-1-morpholinobutan-1-one	DM9FKSM	Investigative	Small molecular drug	[1382]
4-(1H-indol-3-yl)-N,N-dimethylcyclohex-3-enamine	DM7Y1ZD	Investigative	Small molecular drug	[1383]
4-(1H-Indol-3-ylmethyl)-phenylamine	DMK5CJO	Investigative	Small molecular drug	[1381]
4-(1H-indol-4-yloxy)-1-(isopropylamino)butan-2-ol	DMQVOSU	Investigative	Small molecular drug	[1384]
4-(1H-indol-5-ylamino)-5-styrylnicotinonitrile	DMAU0SF	Investigative	Small molecular drug	[1385]
4-(1H-indol-5-yloxy)-5-styrylnicotinonitrile	DMH360U	Investigative	Small molecular drug	[1385]
4-(1H-indol-6-ylamino)-5-styrylnicotinonitrile	DMB07TU	Investigative	Small molecular drug	[1385]
4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	DM9MPHF	Investigative	Small molecular drug	[1386]
4-(2'-(trifluoromethoxy)biphenyl-3-yl)oxazole	DMIL45X	Investigative	Small molecular drug	[1387]
4-(2'-(trifluoromethoxy)biphenyl-3-yl)thiazole	DM3R2D1	Investigative	Small molecular drug	[1387]
4-(2'-(trifluoromethyl)biphenyl-3-yl)oxazole	DMXC5S0	Investigative	Small molecular drug	[1387]
4-(2,2'-bithiophen-5-ylmethyleneamino)phenol	DMRZY0B	Investigative	Small molecular drug	[1388]
4-(2,2-Diphenyl-vinyl)-pyridine	DMI638K	Investigative	Small molecular drug	[1180]
4-(2,3-dichlorobenzylthio)-2-aminobutanoic acid	DMGOHSF	Investigative	Small molecular drug	[317]
4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole	DMVIQ7F	Investigative	Small molecular drug	[1375]
4-(2,3-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DM6PMFJ	Investigative	Small molecular drug	[1225]
4-(2,4-dichloro-phenoxy)-2'-methyl-biphenyl-3-ol	DMPKE6G	Investigative	Small molecular drug	[829]
4-(2,4-dichloro-phenoxy)-4'-fluoro-biphenyl-3-ol	DMAK789	Investigative	Small molecular drug	[829]
4-(2,4-dichloro-phenoxy)-biphenyl-3-ol	DMB96SY	Investigative	Small molecular drug	[829]
4-(2,4-dichlorophenoxy)-3'-methylbiphenyl-3-ol	DMY6GWF	Investigative	Small molecular drug	[828]
4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile	DMS7POY	Investigative	Small molecular drug	[829]
4-(2,4-dichlorophenoxy)-4'-methylbiphenyl-3-ol	DMRPVO3	Investigative	Small molecular drug	[828]
4-(2,4-dichlorophenyl)-1-phenylpyrrolidin-3-amine	DMCGOPQ	Investigative	Small molecular drug	[591]
4-(2,4-dichlorophenyl)-1-tosylpyrrolidin-3-amine	DMRMAOI	Investigative	Small molecular drug	[591]
4-(2,4-diethyl-1H-pyrrol-3-yloxy)benzonitrile	DMBLAI1	Investigative	Small molecular drug	[1389]
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	DME8BLW	Investigative	Small molecular drug	[12]
4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	DM3D8OK	Investigative	Small molecular drug	[22]
4-(2,5-dichlorobenzylthio)-2-aminobutanoic acid	DMKVH90	Investigative	Small molecular drug	[317]
4-(2,5-Diphenyl-furan-3-yl)-morpholine	DMVYALJ	Investigative	Small molecular drug	[124]
4-(2,6-diamino-9H-purin-8-yl)-2,6-dimethoxyphenol	DMH3TBQ	Investigative	Small molecular drug	[1390]
4-(2,6-dimethylphenylthio)-2-methoxybenzonitrile	DMPLG9Q	Investigative	Small molecular drug	[1043]
4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine	DMJ9CNA	Investigative	Small molecular drug	[467]
4-(2-((dimethylamino)methyl)phenoxy)benzonitrile	DM0MWVU	Investigative	Small molecular drug	[1391]
4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	DM1043B	Investigative	Small molecular drug	[469]
4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine	DMTJGBL	Investigative	Small molecular drug	[179]
4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine	DM9UA0N	Investigative	Small molecular drug	[467]
4-(2-(2-fluorobenzyloxy)phenyl)piperidine	DMCR3VM	Investigative	Small molecular drug	[467]
4-(2-(3,4-Dimethylphenylamino)ethyl)-1H-imidazole	DMKZ6JW	Investigative	Small molecular drug	[1392]
4-(2-(3-chlorophenoxy)phenyl)piperidine	DM0IT5E	Investigative	Small molecular drug	[467]
4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine	DMEPB9L	Investigative	Small molecular drug	[467]
4-(2-(3-fluorophenoxy)phenyl)piperidine	DMZMEOG	Investigative	Small molecular drug	[467]
4-(2-(3-fluorophenyl)ethynyl)-2-methylthiazole	DMRDWUT	Investigative	Small molecular drug	[228]
4-(2-(3-tert-Butylphenylamino)ethyl)-1H-imidazole	DMP1LY4	Investigative	Small molecular drug	[1392]
4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine	DMN97TC	Investigative	Small molecular drug	[1393]
4-(2-(4-Cyclohexylphenylamino)ethyl)-1H-imidazole	DMM8CU2	Investigative	Small molecular drug	[1392]
4-(2-(4-fluorobenzyloxy)phenyl)piperidine	DM29QLG	Investigative	Small molecular drug	[467]
4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine	DMJNB8C	Investigative	Small molecular drug	[467]
4-(2-(4-fluorophenoxy)phenyl)piperidine	DMFQT9O	Investigative	Small molecular drug	[467]
4-(2-(4-fluorophenyl)ethynyl)-2-methylthiazole	DMOX40J	Investigative	Small molecular drug	[228]
4-(2-(4-Methoxyphenylamino)ethyl)-1H-imidazole	DMFCS8G	Investigative	Small molecular drug	[1392]
4-(2-(4-Methylphenylamino)ethyl)-1H-imidazole	DMYM72T	Investigative	Small molecular drug	[1392]
4-(2-(4-tert-Butylphenylamino)ethyl)-1H-imidazole	DMK8ROX	Investigative	Small molecular drug	[1392]
4-(2-(aminomethyl)phenyl)-1-benzylpiperidin-4-ol	DMUYPMO	Investigative	Small molecular drug	[584]
4-(2-(benzyloxy)-3-fluorophenyl)piperidine	DMM2NHZ	Investigative	Small molecular drug	[467]
4-(2-(benzyloxy)-6-fluorophenyl)piperidine	DMF3S50	Investigative	Small molecular drug	[467]
4-(2-(benzyloxy)phenyl)piperidine	DMOC7PY	Investigative	Small molecular drug	[467]
4-(2-(Cyclohexylamino)ethyl)-1H-imidazole	DM1MP96	Investigative	Small molecular drug	[1392]
4-(2-(diethylamino)ethylamino)-1-naphthol	DMRQ8T9	Investigative	Small molecular drug	[768]
4-(2-(phenoxymethyl)phenyl)piperidine	DM0OFRQ	Investigative	Small molecular drug	[467]
4-(2-(Phenylamino)ethyl)-1H-imidazole	DMX1HKU	Investigative	Small molecular drug	[1392]
4-(2-(pyrrolidin-1-yl)ethyl)pyridine	DMHWD2C	Investigative	Small molecular drug	[258]
4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine	DMWN1CM	Investigative	Small molecular drug	[179]
4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine	DMAO6X9	Investigative	Small molecular drug	[179]
4-(2-amino-1,3-thiazol-4-yl)phenol	DMH5CAQ	Investigative	Small molecular drug	[22]
4-(2-aminoethyl)-1,2,5-oxadiazol-3-ol	DMCS538	Investigative	Small molecular drug	[1394]
4-(2-aminoethyl)-2-cyclohexylphenol	DMZSN1Y	Investigative	Small molecular drug	[22]
4-(2-aminoethyl)-2-ethylphenol	DMF8D5S	Investigative	Small molecular drug	[22]
4-(2-AMINOETHYL)BENZENESULFONAMIDE	DMEK6WX	Investigative	Small molecular drug	[22]
4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide	DMWG706	Investigative	Small molecular drug	[788]
4-(2-benzenesulfonylphenyl)piperazine	DMAZ0LV	Investigative	Small molecular drug	[876]
4-(2-Benzylamino-ethoxy)-1,3-dihydro-indol-2-one	DMYVD2E	Investigative	Small molecular drug	[1395]
4-(2-bromobenzylthio)-2-aminobutanoic acid	DMZ9TSR	Investigative	Small molecular drug	[317]
4-(2-Butyl-benzoimidazol-1-ylmethyl)-phenol	DM8HLEP	Investigative	Small molecular drug	[1396]
4-(2-carboxy-5-mercaptopentyl)benzoic acid	DM5L4WP	Investigative	Small molecular drug	[846]
4-(2-cyanobenzylthio)-2-aminobutanoic acid	DM82D9N	Investigative	Small molecular drug	[317]
4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine	DMFJW2E	Investigative	Small molecular drug	[1397]
4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine	DMQUAP2	Investigative	Small molecular drug	[468]
4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine	DMUBHRF	Investigative	Small molecular drug	[467]
4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine	DMJ2GW0	Investigative	Small molecular drug	[467]
4-(2-fluoro-6-phenoxyphenyl)piperidine	DMXIGWC	Investigative	Small molecular drug	[467]
4-(2-fluorophenylethynyl)-2-methylthiazole	DMCWZF6	Investigative	Small molecular drug	[228]
4-(2-Hydroxy-ethyl)-benzenesulfonamide	DM1C5U6	Investigative	NA	[788]
4-(2-Hydroxyethoxy)-1-naphthol	DM17QG8	Investigative	Small molecular drug	[768]
4-(2-Imidazol-1-yl-ethoxy)-benzamide	DMB6SNE	Investigative	Small molecular drug	[493]
4-(2-methoxybenzylthio)-2-aminobutanoic acid	DMNSKXR	Investigative	Small molecular drug	[317]
4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	DM9WQOJ	Investigative	Small molecular drug	[22]
4-(2-methoxyphenylethynyl)-2-methylthiazole	DMFVYHI	Investigative	Small molecular drug	[228]
4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide	DME6DHX	Investigative	Small molecular drug	[1353]
4-(2-Methyl-thiazol-4-ylethynyl)-pyridine	DMEAV9Q	Investigative	Small molecular drug	[858]
4-(2-nitrobenzylthio)-2-aminobutanoic acid	DMC1KEG	Investigative	Small molecular drug	[317]
4-(2-nitroprop-1-enyl)benzene-1,2-diol	DMCHTI0	Investigative	Small molecular drug	[334]
4-(2-nitrovinyl)benzene-1,2-diol	DM62ZRE	Investigative	Small molecular drug	[334]
4-(2-nitrovinyl)phenol	DMPTVR2	Investigative	Small molecular drug	[334]
4-(2-Oxo-2-phenyl-acetyl)-benzoic acid	DMFPNQ9	Investigative	Small molecular drug	[397]
4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	DMWIALU	Investigative	Small molecular drug	[1070]
4-(2-oxohexadecanamido)butanoic acid	DMBMJC5	Investigative	Small molecular drug	[1398]
4-(2-phenoxyphenyl)piperidine	DMB5IFA	Investigative	Small molecular drug	[467]
4-(2-phenyl-1H-benzo[d]imidazol-1-yl)phenol	DMFQZOI	Investigative	Small molecular drug	[773]
4-(2-phenyl-1H-indol-3-yl)phenol	DMCPSE9	Investigative	Small molecular drug	[773]
4-(2-Phenylacetamido)-3-bromobenzenesulfonamide	DMZ62L3	Investigative	Small molecular drug	[1399]
4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide	DM9GOTA	Investigative	Small molecular drug	[1399]
4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide	DMCOD4N	Investigative	Small molecular drug	[1399]
4-(2-Phenylacetamido)benzenesulfonamide	DMFYR6H	Investigative	Small molecular drug	[1399]
4-(2-Phenylacetamidoethyl)benzenesulfonamide	DM1JL03	Investigative	Small molecular drug	[1399]
4-(2-Phenylacetamidomethyl)benzenesulfonamide	DMDYHXE	Investigative	Small molecular drug	[1399]
4-(2-Propynylthio)pyridine-3-sulfonamide	DMT9RAC	Investigative	Small molecular drug	[1353]
4-(2-Pyridin-2-ylacetamido)benzenesulfonamide	DM9LKMP	Investigative	Small molecular drug	[1399]
4-(2-Pyridin-4-ylacetamido)benzenesulfonamide	DMD6AYQ	Investigative	Small molecular drug	[1399]
4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile	DMOSDAN	Investigative	Small molecular drug	[489]
4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	DMX681M	Investigative	Small molecular drug	[12]
4-(2-thienyl)benzene-1,2-diamine	DM4YWQN	Investigative	Small molecular drug	[1400]
4-(3'-furyl)-aniline	DMZ1TNM	Investigative	Small molecular drug	[1195]
4-(3,4,5-Trimethoxyphenethyl)aniline	DMNUWK2	Investigative	Small molecular drug	[531]
4-(3,4-dichlorobenzylthio)-2-aminobutanoic acid	DMBEA23	Investigative	Small molecular drug	[317]
4-(3,4-Diethoxy-benzylamino)-benzamidine	DMIZXYM	Investigative	Small molecular drug	[1401]
4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline	DMCOJIL	Investigative	Small molecular drug	[1091]
4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DMW1H6C	Investigative	Small molecular drug	[1225]
4-(3,4-Dimethoxyphenethyl)aniline	DMBI7MS	Investigative	Small molecular drug	[531]
4-(3,4-dimethylbenzylthio)-2-aminobutanoic acid	DM5ZTXO	Investigative	Small molecular drug	[317]
4-(3,5-dichlorobenzylthio)-2-aminobutanoic acid	DMM3F9K	Investigative	Small molecular drug	[317]
4-(3,5-difluorophenylethynyl)-2-methylthiazole	DM48Z5Y	Investigative	Small molecular drug	[228]
4-(3,5-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DM5279R	Investigative	Small molecular drug	[1225]
4-(3,5-Dimethoxyphenethyl)benzenamine	DM4FC9O	Investigative	Small molecular drug	[531]
4-(3,5-dimethylbenzylthio)-2-aminobutanoic acid	DM9MIQB	Investigative	Small molecular drug	[317]
4-(3-(4-hydroxyphenyl)-1H-indol-2-yl)phenol	DMR3T2D	Investigative	Small molecular drug	[773]
4-(3-(Dimethylamino)propanoyl)-N-hexylbenzamide	DMX5V9T	Investigative	Small molecular drug	[527]
4-(3-Adamantan-1-yl-ureido)-benzoic acid	DMKUAEY	Investigative	Small molecular drug	[569]
4-(3-benzenesulfonamidophenyl)piperazine	DMLVZ6O	Investigative	Small molecular drug	[876]
4-(3-benzenesulfonylphenyl)piperazine	DMG4X13	Investigative	Small molecular drug	[876]
4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid	DMT0EK8	Investigative	Small molecular drug	[877]
4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	DMNBLQ8	Investigative	Small molecular drug	[1225]
4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	DMK6JV7	Investigative	Small molecular drug	[1225]
4-(3-Bromo-phenylamino)-quinazoline-6,7-diol	DM1Q5KV	Investigative	Small molecular drug	[166]
4-(3-bromobenzylthio)-2-aminobutanoic acid	DML3VB7	Investigative	Small molecular drug	[317]
4-(3-bromophenoxy)-6-chloroquinazoline	DM3LGOT	Investigative	Small molecular drug	[1228]
4-(3-bromophenylthio)-2-(pyridin-2-yl)pyrimidine	DMQBHF2	Investigative	Small molecular drug	[959]
4-(3-bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol	DML5NF6	Investigative	Small molecular drug	[1402]
4-(3-Chloro-phenoxy)-6,7-dimethoxy-quinazoline	DMDS2LZ	Investigative	Small molecular drug	[1403]
4-(3-chlorobenzylthio)-2-aminobutanoic acid	DMQVXMZ	Investigative	Small molecular drug	[317]
4-(3-chlorophenylethynyl)-2-methylthiazole	DMDTFKL	Investigative	Small molecular drug	[228]
4-(3-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine	DMJH2OE	Investigative	Small molecular drug	[959]
4-(3-cyanobenzylthio)-2-aminobutanoic acid	DMSUB8D	Investigative	Small molecular drug	[317]
4-(3-cyclohexylureido)butanoic acid	DMXFLMK	Investigative	Small molecular drug	[22]
4-(3-Ethoxy-phenoxy)-6,7-dimethoxy-quinoline	DMOQE5W	Investigative	Small molecular drug	[1225]
4-(3-Ethyl-phenoxy)-6,7-dimethoxy-quinoline	DMFM9SH	Investigative	Small molecular drug	[1225]
4-(3-fluoro-2-phenoxyphenyl)piperidine	DM1C3NZ	Investigative	Small molecular drug	[467]
4-(3-Fluoro-phenoxy)-6,7-dimethoxy-quinoline	DMER3D9	Investigative	Small molecular drug	[1225]
4-(3-fluorobenzylthio)-2-aminobutanoic acid	DMXLC94	Investigative	Small molecular drug	[317]
4-(3-fluorophenylethynyl)-2-thiazolylamine	DM6RV9L	Investigative	Small molecular drug	[228]
4-(3-hexylureido)-N-phenylbenzenesulfonamide	DMC5GAW	Investigative	Small molecular drug	[1404]
4-(3-hydroxy-benzylideneamino)-benzenesulfonamide	DMY2OVL	Investigative	Small molecular drug	[1405]
4-(3-Hydroxy-piperidin-3-yl)-benzene-1,2-diol	DMUQWJZ	Investigative	Small molecular drug	[1406]
4-(3-methoxy-benzylideneamino)-benzenesulfonamide	DMO8SQA	Investigative	Small molecular drug	[1405]
4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione	DMSUFJZ	Investigative	Small molecular drug	[1407]
4-(3-methoxybenzylthio)-2-aminobutanoic acid	DMTPL0C	Investigative	Small molecular drug	[317]
4-(3-methoxyphenylethynyl)-2-methylthiazole	DMGCPKU	Investigative	Small molecular drug	[228]
4-(3-Methyl-indole-1-sulfonyl)-phenylamine	DM67A4U	Investigative	Small molecular drug	[1408]
4-(3-methylpyridin-2-yl)-N-p-tolylbenzamide	DM5I6O2	Investigative	Small molecular drug	[1409]
4-(3-nitro-benzylideneamino)-benzenesulfonamide	DMD94OB	Investigative	Small molecular drug	[1405]
4-(3-nitrobenzylthio)-2-aminobutanoic acid	DM4WI0Y	Investigative	Small molecular drug	[317]
4-(3-Pent-1-ynyl-benzyl)-1H-imidazole	DMEYV1B	Investigative	Small molecular drug	[1410]
4-(3-Phenoxy-propyl)-1H-imidazole	DM5F13I	Investigative	Small molecular drug	[1411]
4-(3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole	DMSXG23	Investigative	Small molecular drug	[1412]
4-(3-phenyl-1H-indol-2-yl)phenol	DMEJF6V	Investigative	Small molecular drug	[773]
4-(3-Phenylethynyl-benzyl)-1H-imidazole	DMS4JVT	Investigative	Small molecular drug	[1410]
4-(3-pyridylethynyl)-2-thiazolylamine	DMRXKMP	Investigative	Small molecular drug	[228]
4-(3-thienyl)benzene-1,2-diamine)	DML4NJU	Investigative	Small molecular drug	[1400]
4-(3H-Inden-1-ylmethyl)-phenylamine	DM3QJVT	Investigative	Small molecular drug	[1381]
4-(3H-indol-4-ylamino)-5-styrylnicotinonitrile	DMM8AY5	Investigative	Small molecular drug	[1385]
4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine	DM52NMU	Investigative	Small molecular drug	[1276]
4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide	DMGVNE3	Investigative	Small molecular drug	[1167]
4-(4,5-dihydrothiazol-2-yl)phenyl butylcarbamate	DMOF0J1	Investigative	Small molecular drug	[1376]
4-(4,6-dinitro-1H-indol-1-ylsulfonyl)benzenamine	DMI1598	Investigative	Small molecular drug	[560]
4-(4,6-diphenylpyridin-2-yl)phenol	DMETK18	Investigative	Small molecular drug	[1132]
4-(4-((phenethylamino)methyl)phenoxy)benzamide	DM0QRJ3	Investigative	Small molecular drug	[1413]
4-(4-(2-nitrovinyl)phenoxysulfonyl)benzoic acid	DMWBVMH	Investigative	Small molecular drug	[334]
4-(4-(4-Nitrophenyl)thiazol-2-ylamino)phenol	DMA9TCD	Investigative	Small molecular drug	[896]
4-(4-(dec-1-ynyl)phenyl)-4-oxobutanoic acid	DM6KIG0	Investigative	Small molecular drug	[1207]
4-(4-(pentyloxy)phenoxy)phenol	DMYXHUO	Investigative	Small molecular drug	[559]
4-(4-(thiophen-2-yl)benzyl)pyridine	DMVXJU6	Investigative	Small molecular drug	[1276]
4-(4-(thiophen-3-yl)benzyl)pyridine	DM7I21V	Investigative	Small molecular drug	[1276]
4-(4-aminophenyl)-1H-indazol-3yl-amine	DMK1IWD	Investigative	Small molecular drug	[1414]
4-(4-benzenesulfonamidophenyl)piperazine	DMP0G1W	Investigative	Small molecular drug	[876]
4-(4-benzenesulfonylphenyl)piperazine	DM0DZFX	Investigative	Small molecular drug	[876]
4-(4-benzyl-1H-1,2,3-triazol-1-yl)phenol	DMT2S9U	Investigative	Small molecular drug	[1415]
4-(4-Benzyl-piperazin-1-yl)-1H-benzoimidazole	DMXAEW9	Investigative	Small molecular drug	[1215]
4-(4-Benzyl-piperazin-1-yl)-1H-indole	DMWR0AS	Investigative	Small molecular drug	[1215]
4-(4-Benzyl-piperazin-1-yl)-5-chloro-1H-indole	DMZ4237	Investigative	Small molecular drug	[1215]
4-(4-Benzyl-piperazin-1-yl)-7-bromo-1H-indole	DMVAB7U	Investigative	Small molecular drug	[1215]
4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	DME3PUT	Investigative	Small molecular drug	[1401]
4-(4-bromobenzylthio)-2-aminobutanoic acid	DMHWIMO	Investigative	Small molecular drug	[317]
4-(4-bromophenyl)-5-cyano-2H-1,2,3-triazole	DMFEBCO	Investigative	Small molecular drug	[1412]
4-(4-Butoxy-phenyl)-N-hydroxy-4-oxo-butyramide	DMNGDOM	Investigative	Small molecular drug	[1416]
4-(4-butoxyphenoxy)phenol	DMI2EM5	Investigative	Small molecular drug	[559]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	DMM9X0G	Investigative	Small molecular drug	[1417]
4-(4-chloro-2-cyclohexylphenoxy)butanoic acid	DM14I6C	Investigative	Small molecular drug	[839]
4-(4-chlorobenzyl)-2-allylphthalazin-1(2H)-one	DMRBEZD	Investigative	Small molecular drug	[1418]
4-(4-chlorobenzyl)-2-methylphthalazin-1(2H)-one	DMNYQGV	Investigative	Small molecular drug	[1418]
4-(4-chlorobenzyl)phthalazin-1(2H)-one	DM9AEF0	Investigative	Small molecular drug	[1418]
4-(4-chlorobenzylthio)-2-aminobutanoic acid	DMENLUP	Investigative	Small molecular drug	[317]
4-(4-chlorophenyl)-1-pyrid-2-yl-pyrazole	DMJI6QH	Investigative	Small molecular drug	[538]
4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole	DMODVGN	Investigative	Small molecular drug	[1363]
4-(4-chlorophenyl)-5-cyano-2H-1,2,3-triazole	DMVN7GC	Investigative	Small molecular drug	[1412]
4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole	DMZBEYO	Investigative	Small molecular drug	[1362]
4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one	DMVDF9Q	Investigative	Small molecular drug	[1363]
4-(4-Chlorophenyl)-5-p-tolylisothiazole	DMMK9RC	Investigative	Small molecular drug	[1363]
4-(4-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine	DM9YRHW	Investigative	Small molecular drug	[959]
4-(4-Cyanophenoxy)-3-pyridinesulfonamide	DMNEAJH	Investigative	Small molecular drug	[1353]
4-(4-cyclohexylthiosemicarbazono)methyl-phenol	DMSYH8R	Investigative	Small molecular drug	[910]
4-(4-Decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one	DMCDKHJ	Investigative	Small molecular drug	[374]
4-(4-Fluoro-benzyl)-piperidine hydrochloride	DM4NEOU	Investigative	Small molecular drug	[1419]
4-(4-fluoro-benzylideneamino)-benzenesulfonamide	DMRJD75	Investigative	Small molecular drug	[1405]
4-(4-fluoro-phenyliminomethyl)-benzenesulfonamide	DMK8DCF	Investigative	Small molecular drug	[1405]
4-(4-FLUOROBENZYL)PIPERIDINE	DMW8IN3	Investigative	Small molecular drug	[22]
4-(4-Fluorophenoxy)-3-pyridinesulfonamide	DMRJLAP	Investigative	Small molecular drug	[1353]
4-(4-hexylphenyl)-4-oxobut-2-enoic acid	DMR9TBW	Investigative	Small molecular drug	[185]
4-(4-hydroxy-benzylideneamino)-benzenesulfonamide	DMNY0I5	Investigative	NA	[1405]
4-(4-hydroxybenzylideneamino)benzoic acid	DML357W	Investigative	Small molecular drug	[917]
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	DMZT6HL	Investigative	Small molecular drug	[22]
4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol	DMC9Z45	Investigative	Small molecular drug	[1406]
4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole	DMRGM21	Investigative	Small molecular drug	[1412]
4-(4-m-Tolylamino-phthalazin-1-yl)-benzamide	DM3KCL1	Investigative	Small molecular drug	[1420]
4-(4-methoxy-1H-indol-1-ylsulfonyl)benzenamine	DMA7LEO	Investigative	Small molecular drug	[1421]
4-(4-Methoxy-benzenesulfonyl)-butane-2-thiol	DM5PTB9	Investigative	Small molecular drug	[542]
4-(4-methoxy-benzylideneamino)-benzenesulfonamide	DM2OR8E	Investigative	Small molecular drug	[1405]
4-(4-methyl-benzylideneamino)-benzenesulfonamide	DMZSQ04	Investigative	Small molecular drug	[1405]
4-(4-Methyl-indan-1-yl)-1H-imidazole	DMYZHXR	Investigative	Small molecular drug	[1422]
4-(4-methyl-phenyliminomethyl)-benzenesulfonamide	DMV0S4U	Investigative	Small molecular drug	[1405]
4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one	DMS74F2	Investigative	Small molecular drug	[1312]
4-(4-nitro-benzylideneamino)-benzenesulfonamide	DMM86YK	Investigative	Small molecular drug	[1405]
4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide	DM6ESXB	Investigative	Small molecular drug	[1420]
4-(4-phenoxybenzoyl)benzoic acid	DMOHB6U	Investigative	Small molecular drug	[170]
4-(4-phenoxybenzoyl)phenylacetic acid	DMQ0JWZ	Investigative	Small molecular drug	[170]
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one	DMKMH5L	Investigative	Small molecular drug	[1423]
4-(4-propoxyphenoxy)phenol	DMBZHUA	Investigative	Small molecular drug	[559]
4-(4-tert-butylbenzylideneamino)benzoic acid	DMFLH2G	Investigative	Small molecular drug	[917]
4-(4-tert-butylbenzylthio)-2-aminobutanoic acid	DMG6DV9	Investigative	Small molecular drug	[317]
4-(5-(4-(methylamino)phenyl)thiophen-2-yl)phenol	DMGHVW7	Investigative	Small molecular drug	[791]
4-(5-(4-aminophenyl)thiophen-2-yl)benzenamine	DMOGMJ9	Investigative	Small molecular drug	[791]
4-(5-(4-aminophenyl)thiophen-2-yl)phenol	DM1UX89	Investigative	Small molecular drug	[791]
4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol	DMK1ZF2	Investigative	Small molecular drug	[1363]
4-(5-(4-methoxyphenyl)thiophen-2-yl)benzenamine	DMO9YH0	Investigative	Small molecular drug	[791]
4-(5-(4-methoxyphenyl)thiophen-2-yl)phenol	DMCNLBZ	Investigative	Small molecular drug	[791]
4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine	DMJKUQI	Investigative	Small molecular drug	[1424]
4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline	DMLSGU1	Investigative	Small molecular drug	[1425]
4-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	DM1EANV	Investigative	Small molecular drug	[847]
4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	DMIWT60	Investigative	Small molecular drug	[1426]
4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide	DMKT20Q	Investigative	Small molecular drug	[1353]
4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one	DMXHIK5	Investigative	Small molecular drug	[1312]
4-(5-Nitro-indol-1-ylmethyl)-benzamidine	DMUHQ0J	Investigative	Small molecular drug	[513]
4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide	DM3N9O5	Investigative	Small molecular drug	[136]
4-(5-tert-Butyl-[1,3]dithian-2-yl)-benzonitrile	DMZ1DW0	Investigative	Small molecular drug	[1427]
4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid	DM8A6UH	Investigative	Small molecular drug	[1168]
4-(6,7-Dimethoxy-quinolin-3-yl)-phenol	DM9RNUX	Investigative	Small molecular drug	[1168]
4-(6-Cyclohexyl-hex-3-ynyl)-1H-imidazole	DMPD9GE	Investigative	Small molecular drug	[888]
4-(6-Cyclopentyl-hex-3-ynyl)-1H-imidazole	DM4EC0J	Investigative	Small molecular drug	[888]
4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	DMHGRPB	Investigative	Small molecular drug	[22]
4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	DM38YZ4	Investigative	Small molecular drug	[847]
4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	DM07NT9	Investigative	Small molecular drug	[847]
4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol	DM4SPV7	Investigative	Small molecular drug	[1428]
4-(6-methoxy-1H-indol-1-ylsulfonyl)benzenamine	DM3L5I6	Investigative	Small molecular drug	[1421]
4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	DM3ACVD	Investigative	Small molecular drug	[501]
4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline	DMRPU0V	Investigative	Small molecular drug	[1229]
4-(6-Methoxynaphthalen-2-yl)isoquinoline	DM51XDA	Investigative	Small molecular drug	[1229]
4-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile	DM9O8VY	Investigative	Small molecular drug	[824]
4-(6-morpholino-9H-purin-2-yl)phenol	DM1Z3N6	Investigative	Small molecular drug	[179]
4-(6-phenyl-2,4'-bipyridin-4-yl)phenol	DMJ81IL	Investigative	Small molecular drug	[1132]
4-(7,7-Dimethyl-oct-3-ynyl)-1H-imidazole	DMIY5QU	Investigative	Small molecular drug	[888]
4-(7-chloro-1-cyclohexyl-1H-indazol-3-yl)phenol	DMUXZOM	Investigative	Small molecular drug	[1378]
4-(7-chloro-1-cyclopentyl-1H-indazol-3-yl)phenol	DM0X5SY	Investigative	Small molecular drug	[1378]
4-(7-chloro-1-propyl-1H-indazol-3-yl)phenol	DMEYUH0	Investigative	Small molecular drug	[1378]
4-(7-methyl-1-propyl-1H-indazol-3-yl)phenol	DMX2K8R	Investigative	Small molecular drug	[1378]
4-(7-Methyl-oct-3-ynyl)-1H-imidazole	DMJ86OS	Investigative	Small molecular drug	[888]
4-(8-Phenyl-oct-3-ynyl)-1H-imidazole	DM27OGL	Investigative	Small molecular drug	[888]
4-(Acetylamino)-3-Amino Benzoic Acid	DMR37FN	Investigative	Small molecular drug	[12]
4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID	DM8F0N5	Investigative	Small molecular drug	[22]
4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID	DM1DKSV	Investigative	Small molecular drug	[22]
4-(Allylamino)-3-pyridinesulfonamide	DM6MQCI	Investigative	Small molecular drug	[1353]
4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	DMTB80W	Investigative	Small molecular drug	[206]
4-(Benzylamino)-1-naphthol	DMF6S3X	Investigative	Small molecular drug	[768]
4-(benzylideneamino)benzenesulfonamide	DM03BQD	Investigative	Small molecular drug	[1405]
4-(benzylideneamino)benzoic acid	DMJM2H1	Investigative	Small molecular drug	[917]
4-(biphenyl-3-yl)-5-(piperidin-4-yl)isoxazol-3-ol	DM1T95Y	Investigative	Small molecular drug	[1429]
4-(Bis(2-chloroethyl)amino)-N-p-tolylbenzamide	DMNE5H7	Investigative	Small molecular drug	[1430]
4-(butyl(methyl)amino)-N-(quinolin-3-yl)benzamide	DM3GUFI	Investigative	Small molecular drug	[926]
4-(butylthio)-2-(trifluoromethyl)benzonitrile	DM6SIA4	Investigative	Small molecular drug	[1043]
4-(butylthio)-2-methoxybenzonitrile	DMH1AZV	Investigative	Small molecular drug	[1043]
4-(Carbamolymethylthio)pyridine-3-sulfonamide	DM12R4M	Investigative	Small molecular drug	[1353]
4-(Carboxyvin-2-Yl)Phenylboronic Acid	DMSG9LV	Investigative	Small molecular drug	[12]
4-(Cyanomethylthio)pyridine-3-sulfonamide	DMZP20H	Investigative	Small molecular drug	[1353]
4-(cyclobutylmethylthio)-2-methoxybenzonitrile	DMR69K2	Investigative	Small molecular drug	[1043]
4-(Cyclohexylamino)-1-naphthol	DMUOQN7	Investigative	Small molecular drug	[768]
4-(cyclohexylamino)-N-(quinolin-3-yl)benzamide	DMWELVK	Investigative	Small molecular drug	[926]
4-(cyclohexylmethylcarbamoyloxy)benzoic acid	DMWYESB	Investigative	Small molecular drug	[1127]
4-(cyclohexyloxy)quinazoline	DMCDZ7E	Investigative	Small molecular drug	[1431]
4-(cyclopropylmethylthio)-2-methoxybenzonitrile	DM43Z2J	Investigative	Small molecular drug	[1043]
4-(dimethylamino)-N-(thiazol-2-yl)benzamide	DMJP5YH	Investigative	Small molecular drug	[543]
4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE	DM68S9F	Investigative	Small molecular drug	[22]
4-(ethylamino)naphthalen-1-ol	DM14C9V	Investigative	Small molecular drug	[768]
4-(ethylthio)-6-phenyl-1,3,5-triazin-2-amine	DM0GCEK	Investigative	Small molecular drug	[976]
4-(furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine	DMY7035	Investigative	Small molecular drug	[1432]
4-(furan-2-yl)thieno[3,2-d]pyrimidin-2-amine	DM7LVKP	Investigative	Small molecular drug	[978]
4-(furan-3-yl)-2,6-di(thiophen-2-yl)pyridine	DMW4O31	Investigative	Small molecular drug	[1433]
4-(hexyl(methyl)amino)-N-(quinolin-3-yl)benzamide	DM70MRZ	Investigative	Small molecular drug	[926]
4-(Hydroxymercury)Benzoic Acid	DMWJN73	Investigative	Small molecular drug	[12]
4-(hydroxymethyl)benzenesulfonamide	DMR6VWL	Investigative	Small molecular drug	[788]
4-(Indan-1-ylsulfanyl)-phenylamine	DMHI50W	Investigative	Small molecular drug	[1381]
4-(Indane-1-sulfonyl)-phenylamine	DM201UM	Investigative	Small molecular drug	[1381]
4-(isopentylthio)-2-(trifluoromethyl)benzonitrile	DMGSZB2	Investigative	Small molecular drug	[1043]
4-(isopentylthio)-2-methoxybenzonitrile	DML1G9S	Investigative	Small molecular drug	[1043]
4-(Isopropylamino)-1-naphthol	DMJFSTX	Investigative	Small molecular drug	[768]
4-(isopropylthio)-2-(trifluoromethyl)benzonitrile	DMVDHX1	Investigative	Small molecular drug	[1043]
4-(isopropylthio)-2-methoxybenzonitrile	DMR5HNI	Investigative	Small molecular drug	[1043]
4-(isoquinolin-5-yl)-N-m-tolylphthalazin-1-amine	DM8LODU	Investigative	Small molecular drug	[1434]
4-(isoquinolin-5-yl)-N-o-tolylphthalazin-1-amine	DMS30HQ	Investigative	Small molecular drug	[1434]
4-(m-tolyloxy)-2-(trifluoromethyl)benzonitrile	DM8BWZO	Investigative	Small molecular drug	[1001]
4-(mesityloxy)-2-(trifluoromethyl)benzonitrile	DMQG57D	Investigative	Small molecular drug	[1001]
4-(mesitylthio)-2-(trifluoromethyl)benzonitrile	DMAI3NZ	Investigative	Small molecular drug	[1043]
4-(mesitylthio)-2-methoxybenzonitrile	DM1XK68	Investigative	Small molecular drug	[1043]
4-(methyl(4-phenylthiazol-2-yl)amino)phenol	DMQCMFU	Investigative	Small molecular drug	[1388]
4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide	DM3TF9Y	Investigative	Small molecular drug	[926]
4-(methyl(octyl)amino)-N-(quinolin-3-yl)benzamide	DM1I0TA	Investigative	Small molecular drug	[926]
4-(methylamino)naphthalen-1-ol	DMF3O10	Investigative	Small molecular drug	[768]
4-(Methylhydrazino)-3-pyridinesulfonamide	DM4BPL1	Investigative	Small molecular drug	[1353]
4-(N-Methyl-hydrazino)-benzenesulfonamide	DMADWTI	Investigative	Small molecular drug	[1435]
4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide	DMYCV8E	Investigative	Small molecular drug	[1353]
4-(n-propyl)amino-3-nitrobenzoic acid	DMP43HI	Investigative	Small molecular drug	[1436]
4-(Naphthalene-1-sulfonyl)-phenylamine	DMI5XB1	Investigative	Small molecular drug	[1408]
4-(o-tolyloxy)-2-(trifluoromethyl)benzonitrile	DM8I4B9	Investigative	Small molecular drug	[1001]
4-(o-tolylthio)-2-(trifluoromethyl)benzonitrile	DM85XP6	Investigative	Small molecular drug	[1043]
4-(p-toluidino)-3-isopropylnaphthalene-1,2-dione	DMQA0EJ	Investigative	Small molecular drug	[1294]
4-(p-Tolyl)spiro[chromene-2,4'-piperidine]	DMIOQJD	Investigative	Small molecular drug	[1437]
4-(p-tolyloxy)-2-(trifluoromethyl)benzonitrile	DMXK56P	Investigative	Small molecular drug	[1001]
4-(Pent-3-ylamino)-1-naphthol	DMHIDY6	Investigative	Small molecular drug	[768]
4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine	DM54MOP	Investigative	Small molecular drug	[811]
4-(piperazin-1-yl)-1H-indole	DMM1RCS	Investigative	Small molecular drug	[560]
4-(piperazin-1-yl)-3-tosyl-1H-indazole	DM1HM3F	Investigative	Small molecular drug	[1438]
4-(piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine	DMTNVFZ	Investigative	Small molecular drug	[561]
4-(piperazin-1-yl)furo[3,2-c]pyridine	DMNM8VY	Investigative	Small molecular drug	[561]
4-(piperazin-1-yl)thieno[2,3-d]pyrimidine	DMNU2RM	Investigative	Small molecular drug	[561]
4-(piperazin-1-yl)thieno[3,2-c]pyridine	DMJGTS7	Investigative	Small molecular drug	[561]
4-(piperazin-1-yl)thieno[3,2-d]pyrimidine	DM2KAG5	Investigative	Small molecular drug	[561]
4-(propylamino)naphthalen-1-ol	DMEAZFJ	Investigative	Small molecular drug	[768]
4-(propylthio)-2-(trifluoromethyl)benzonitrile	DM8BZQ3	Investigative	Small molecular drug	[1043]
4-(Quinolin-3-yl)-N-p-tolylpyrimidin-2-amine	DM4YFU5	Investigative	Small molecular drug	[1439]
4-(Quinolin-4-yl)-N-p-tolylpyrimidin-2-amine	DMDW3SX	Investigative	Small molecular drug	[1439]
4-(Quinolinoxy)-3-pyridinesulfonamide	DMPNXFA	Investigative	Small molecular drug	[1353]
4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide	DM0XDG6	Investigative	Small molecular drug	[1440]
4-(Spiro[chromene-2,4'-piperidine]-4-yl)phenol	DM8ZRAE	Investigative	Small molecular drug	[1437]
4-(tert-butylamino)naphthalen-1-ol	DMU5A2B	Investigative	Small molecular drug	[768]
4-(thiazol-2-yl)phenyl butylcarbamate	DMSUM3C	Investigative	Small molecular drug	[1441]
4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine	DMK3J8Q	Investigative	Small molecular drug	[1002]
4-(trifluoromethyl)biphenyl	DMZ0AKP	Investigative	Small molecular drug	[1349]
4-(trifluoromethyl)phenylboronic acid	DMADZQ9	Investigative	Small molecular drug	[1019]
4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	DMN2TMS	Investigative	Small molecular drug	[1442]
4-adamantyl resorcinol	DME24LV	Investigative	Small molecular drug	[1443]
4-Allyl-6-nitro-2-piperazin-1-yl-quinoline	DM9WT8M	Investigative	Small molecular drug	[1444]
4-AMBA	DMYNASR	Investigative	Small molecular drug	[1445]
4-Amino Hexanoic Acid	DMYX34S	Investigative	Small molecular drug	[12]
4-amino-1,2,5-oxadiazole-3-carboximidamide	DMNXSM2	Investigative	Small molecular drug	[1446]
4-amino-1,8-naphthalimide	DMU49H6	Investigative	Small molecular drug	[22]
4-Amino-2,6-diphenyl-pyrimidine-5-carbonitrile	DM7X59V	Investigative	Small molecular drug	[804]
4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid	DMINUHD	Investigative	Small molecular drug	[107]
4-amino-2-p-tolylisoindoline-1,3-dione	DMOJTZD	Investigative	Small molecular drug	[162]
4-amino-2H-chromen-2-one	DM3MUF1	Investigative	Small molecular drug	[1447]
4-amino-3,5-dibromobenzenesulfonamide	DMDCQAX	Investigative	Small molecular drug	[1448]
4-Amino-3-(2-chloro-phenyl)-butyric acid	DMIX81A	Investigative	Small molecular drug	[1449]
4-amino-3-(4-(hexyloxy)phenyl)-4-oxobutanoic acid	DMGI0YV	Investigative	Small molecular drug	[923]
4-Amino-3-(4-fluoro-phenyl)-butyric acid	DMVKPF1	Investigative	Small molecular drug	[1449]
4-Amino-3-(5-bromo-thiophen-2-yl)-butyric acid	DMTO8NV	Investigative	Small molecular drug	[1449]
4-Amino-3-(5-chloro-thiophen-2-yl)-butyric acid	DM415DB	Investigative	Small molecular drug	[1449]
4-Amino-3-(5-methyl-thiophen-2-yl)-butyric acid	DMEDRAX	Investigative	Small molecular drug	[1449]
4-Amino-3-benzofuran-2-yl-butyric acid	DM1IHCV	Investigative	Small molecular drug	[1450]
4-Amino-3-bromo-benzenesulfonamide	DMVUCZK	Investigative	NA	[788]
4-Amino-3-chloro-benzenesulfonamide	DMERTQ4	Investigative	Small molecular drug	[788]
4-amino-3-fluoro-5-iodobenzenesulfonamide	DMR9M6H	Investigative	Small molecular drug	[1448]
4-Amino-3-fluoro-benzenesulfonamide	DMIQ3VR	Investigative	NA	[788]
4-Amino-3-hydroxy-butyric acid	DMPY8D3	Investigative	Small molecular drug	[1451]
4-Amino-3-iodo-benzenesulfonamide	DMCOYHR	Investigative	NA	[788]
4-Amino-3-thiophen-2-yl-butyric acid	DMZJS2E	Investigative	Small molecular drug	[1449]
4-amino-6-(4-octylphenyl)hexanoic acid	DMZRM0Q	Investigative	Small molecular drug	[1237]
4-amino-6-chlorobenzene-1,3-disulfonamide	DMIWGZS	Investigative	Small molecular drug	[788]
4-amino-biphenyl-3-carboxylic acid amide	DMHDB70	Investigative	Small molecular drug	[974]
4-amino-N-(2-chlorophenyl)benzenesulfonamide	DM6PQ5V	Investigative	Small molecular drug	[1452]
4-amino-N-(4-chlorophenyl)benzenesulfonamide	DMCUSD4	Investigative	Small molecular drug	[1452]
4-amino-N-(4-iodophenyl)benzenesulfonamide	DMN19QP	Investigative	Small molecular drug	[1452]
4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide	DMJZNX6	Investigative	Small molecular drug	[788]
4-amino-N-p-tolylbenzenesulfonamide	DMLW651	Investigative	Small molecular drug	[1452]
4-amino-N-[4-(benzyloxy)phenyl]butanamide	DMDX0VP	Investigative	Small molecular drug	[22]
4-aminobenzoic acid hydrazide	DMP2GN7	Investigative	Small molecular drug	[1453]
4-aminobutanal	DMH1DGQ	Investigative	Small molecular drug	[1454]
4-aminonaphthalen-1-ol	DMIG82P	Investigative	Small molecular drug	[768]
4-AMINOPHENOL	DMYC1T6	Investigative	Small molecular drug	[796]
4-ANDROSTENE-3-17-DIONE	DMSE8NU	Investigative	Small molecular drug	[22]
4-APPES	DM1UXHE	Investigative	Small molecular drug	[1455]
4-arylphthalazin-1(2H)-3,4-Di-F	DM3UE42	Investigative	Small molecular drug	[1456]
4-azidobenzenesulfonamide	DM7EQ06	Investigative	Small molecular drug	[1457]
4-Benzenesulfonyl-1-(3-phenyl-propyl)-piperidine	DMACRHS	Investigative	Small molecular drug	[1458]
4-Benzenesulfonyl-1-phenethyl-piperidine	DMCKT3Q	Investigative	Small molecular drug	[1458]
4-Benzenesulfonylamino-benzenesulfonamide	DMC7HKA	Investigative	Small molecular drug	[749]
4-Benzenesulfonylamino-N-hydroxy-benzamide	DMM6UPD	Investigative	Small molecular drug	[1459]
4-benzhydryl-N-butylpiperazine-1-carboxamide	DMVSNPB	Investigative	Small molecular drug	[180]
4-benzhydryl-N-cyclohexylpiperazine-1-carboxamide	DMASO86	Investigative	Small molecular drug	[180]
4-Benzoimidazol-1-yl-phenylamine	DM7AOGD	Investigative	Small molecular drug	[634]
4-Benzoxazo-2-yl-1,4-diazabicyclo[3.2.2]nonane	DMA9DHE	Investigative	Small molecular drug	[1460]
4-Benzoylamino-N-hydroxy-benzamide	DMYBPFS	Investigative	Small molecular drug	[1461]
4-Benzo[b]thiophen-4-yl-1H-imidazole	DM02Q8N	Investigative	Small molecular drug	[1462]
4-Benzo[d]isoxazol-3-yl-benzene-1,3-diol	DM1UG2A	Investigative	Small molecular drug	[847]
4-Benzyl-1-(2-phenoxy-ethyl)-piperidine	DMQZ0D6	Investigative	Small molecular drug	[1463]
4-Benzyl-1-chroman-2-ylmethyl-piperidine	DM6XLZ0	Investigative	Small molecular drug	[594]
4-Benzyl-1-chroman-3-ylmethyl-piperidine	DMAZMPF	Investigative	Small molecular drug	[594]
4-Benzyl-1-indan-2-ylmethyl-piperidine	DMES9AJ	Investigative	Small molecular drug	[594]
4-Benzyl-1-methyl-piperidine hydrochloride	DMQKCGI	Investigative	NA	[1419]
4-Benzyl-1-phenethyl-piperidine hydrochloride	DMAI6X2	Investigative	NA	[1464]
4-Benzyl-1-[3-phenylpropoxy)propyl]piperidine	DMIX6RG	Investigative	Small molecular drug	[506]
4-benzyl-2,6-diisobutylamino-pyrimidine	DM2Q0VB	Investigative	Small molecular drug	[783]
4-benzyl-2-methylphthalazin-1(2H)-one	DM8MVU4	Investigative	Small molecular drug	[1418]
4-benzyl-5-(4-piperidyl)isothiazol-3-ol	DMZ18OJ	Investigative	Small molecular drug	[1465]
4-Benzyl-5-piperidin-4-yl-isoxazol-3-ol	DMA4CZK	Investigative	Small molecular drug	[1466]
4-Benzyl-6-nitro-2-piperazin-1-yl-quinoline	DMOBC0F	Investigative	Small molecular drug	[1444]
4-benzyloxy-2'-hydroxychalcone	DMDC7TL	Investigative	Small molecular drug	[484]
4-Benzyloxybenzo[b]thiophene-2-carboxamidine	DM0T1NZ	Investigative	Small molecular drug	[1467]
4-benzylphthalazin-1(2H)-one	DMA5FEM	Investigative	Small molecular drug	[238]
4-Benzythiopyridine-3-sulfonamide	DMI1EFY	Investigative	Small molecular drug	[1353]
4-Biphenyl-2-ylethynyl-2-methyl-thiazole	DM3B2TG	Investigative	Small molecular drug	[858]
4-biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline	DMYUL9J	Investigative	Small molecular drug	[1468]
4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole	DML6PTX	Investigative	Small molecular drug	[817]
4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole	DM2I13S	Investigative	Small molecular drug	[817]
4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole	DMLSUXD	Investigative	Small molecular drug	[817]
4-Biphenyl-4-yl-2-hexyl-1H-imidazole	DMPIH4L	Investigative	Small molecular drug	[817]
4-Biphenyl-4-yl-2-methyl-1H-imidazole	DMNLC2Y	Investigative	Small molecular drug	[817]
4-Biphenyl-4-ylethynyl-2-methyl-thiazole	DMCQYKO	Investigative	Small molecular drug	[858]
4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one	DMMVASI	Investigative	Small molecular drug	[599]
4-bromo-1H-indazole	DM81D90	Investigative	Small molecular drug	[1469]
4-Bromo-2,6-diisopropyl-phenol	DMY8TLO	Investigative	Small molecular drug	[802]
4-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	DMPSRAC	Investigative	NA	[915]
4-Bromo-3-hydroxy-1H-quinolin-2-one	DMYOCFX	Investigative	Small molecular drug	[1361]
4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one	DM2QJ5A	Investigative	Small molecular drug	[1361]
4-Bromo-6-nitro-2-piperazin-1-yl-quinoline	DMH6OPI	Investigative	Small molecular drug	[1444]
4-Bromo-N-(4-phenyl-thiazol-2-yl)-benzamide	DMJFY9Z	Investigative	Small molecular drug	[785]
4-Bromo-N-hydroxy-benzamide	DMF38M5	Investigative	Small molecular drug	[742]
4-bromophenylboronic acid	DM2YN37	Investigative	Small molecular drug	[942]
4-Butoxy-N-hydroxy-N-methyl-benzamide	DMFCB7L	Investigative	Small molecular drug	[742]
4-Butoxy-N-hydroxycarbamoylmethyl-benzamide	DMMGK2B	Investigative	Small molecular drug	[1416]
4-Butyl-1-[3-(phenylpropoxy)propyl]piperidine	DM6ADJM	Investigative	Small molecular drug	[506]
4-butyl-N-(7-hydroxynaphthalen-1-yl)benzamide	DMZHGP6	Investigative	Small molecular drug	[926]
4-butyl-N-(isoquinolin-5-yl)benzamide	DMHLQSE	Investigative	Small molecular drug	[926]
4-butyl-N-(pyridin-3-yl)benzamide	DMGW9XJ	Investigative	Small molecular drug	[926]
4-butyl-N-(quinolin-3-yl)benzamide	DMRMGWF	Investigative	Small molecular drug	[926]
4-butyl-N-phenylbenzamide	DMIMW1E	Investigative	Small molecular drug	[926]
4-Butyl-thiazolidin-(2E)-ylideneamine	DMKU4TR	Investigative	Small molecular drug	[1150]
4-butylphenylboronic acid	DMD9FZW	Investigative	Small molecular drug	[942]
4-Butyrylamino-N-hydroxy-benzamide	DMRY6B4	Investigative	Small molecular drug	[1470]
4-Carbazol-9-yl-butyric acid	DM74GWO	Investigative	Small molecular drug	[889]
4-Carboxycinnamic Acid	DMBIQV3	Investigative	NA	[22]
4-Carboxyphenylboronic Acid	DM8A2QO	Investigative	Small molecular drug	[12]
4-chloro-1-guanidino-7-isoquinolinesulphonamide	DMMIA36	Investigative	Small molecular drug	[611]
4-chloro-1H-indazole	DMHNSXP	Investigative	Small molecular drug	[1469]
4-chloro-1H-indole-2,3-dione	DM9HXPR	Investigative	Small molecular drug	[475]
4-Chloro-2,6-diisopropyl-phenol	DM9VN21	Investigative	Small molecular drug	[802]
4-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	DMKJ18X	Investigative	NA	[915]
4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	DMIYVJX	Investigative	Small molecular drug	[107]
4-Chloro-3-hydroxy-1H-quinolin-2-one	DMMALY3	Investigative	NA	[1361]
4-Chloro-5,7-diphenyl-7H-pyrrolo[2,3-d]pyrimidine	DMI580M	Investigative	Small molecular drug	[1471]
4-Chloro-6-nitro-2-piperazin-1-yl-quinoline	DM04OFE	Investigative	Small molecular drug	[1444]
4-chloro-7-methyl-1H-indole-2,3-dione	DM16P3N	Investigative	Small molecular drug	[475]
4-Chloro-7-methyl-2-phenyl-[1,8]naphthyridine	DM9SVEB	Investigative	Small molecular drug	[1472]
4-chloro-N-(2,5-dichlorophenyl)-3-nitrobenzamide	DMHL9V3	Investigative	Small molecular drug	[997]
4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide	DMVJ61A	Investigative	Small molecular drug	[1473]
4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide	DM6SI78	Investigative	Small molecular drug	[1473]
4-Chloro-N-(2-morpholinoethyl)nicotinamide	DMVCLP8	Investigative	Small molecular drug	[999]
4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide	DMI3OR9	Investigative	Small molecular drug	[1473]
4-Chloro-N-(3-morpholinopropyl)nicotinamide	DMM8G6H	Investigative	Small molecular drug	[999]
4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide	DMTDX2S	Investigative	Small molecular drug	[1473]
4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide	DMM0TL6	Investigative	Small molecular drug	[1473]
4-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	DMVKU4L	Investigative	Small molecular drug	[785]
4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide	DM5AVG3	Investigative	Small molecular drug	[1474]
4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide	DM2UYCS	Investigative	Small molecular drug	[965]
4-Chlorobenzenemethanethiol	DMKTSPM	Investigative	Small molecular drug	[786]
4-chlorophenyl 10H-phenothiazine-10-carboxylate	DMPINBR	Investigative	Small molecular drug	[1050]
4-CMTB	DM3QVDI	Investigative	Small molecular drug	[1475]
4-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	DMJ610E	Investigative	Small molecular drug	[1270]
4-CYANOPHENOL	DMN12EX	Investigative	Small molecular drug	[796]
4-cyanophenyl ethyl dodecylphosphonate	DMEP80Q	Investigative	Small molecular drug	[1476]
4-cyanophenylboronic acid	DMOLFHZ	Investigative	Small molecular drug	[1019]
4-cycloheptyl-6-propylpyrimidine-2-carbonitrile	DMNT5BF	Investigative	Small molecular drug	[1477]
4-cycloheptyliden(4-hydroxyphenyl)methylphenol	DM4LIUC	Investigative	Small molecular drug	[757]
4-Cyclohexyl-4-hydroxy-but-2-enoic acid	DMTFL5J	Investigative	Small molecular drug	[1478]
4-cyclohexyl-6-propylpyrimidine-2-carbonitrile	DM10U6S	Investigative	Small molecular drug	[1477]
4-cyclohexylamino-pyrimidine-2-carbonitrile	DMGVIXW	Investigative	Small molecular drug	[1012]
4-cyclohexyliden(4-hydroxyphenyl)methylphenol	DM8BLK2	Investigative	Small molecular drug	[757]
4-cyclooctyl-6-propylpyrimidine-2-carbonitrile	DMS42TN	Investigative	Small molecular drug	[1477]
4-cyclopentyliden(4-hydroxyphenyl)methylphenol	DM7LN53	Investigative	Small molecular drug	[757]
4-DAMP	DMZIUQ2	Investigative	Small molecular drug	[1479]
4-decyl-N-(pyridin-3-yl)benzamide	DMGQTF9	Investigative	Small molecular drug	[926]
4-dehydroxyriccardin C	DM93DQG	Investigative	Small molecular drug	[673]
4-Dimethylamino-2,6-diisopropyl-phenol	DMEC1PS	Investigative	Small molecular drug	[802]
4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide	DM0M8G5	Investigative	Small molecular drug	[1480]
4-Dipropylamino-cyclohex-1-enecarbonitrile	DMKEHLD	Investigative	Small molecular drug	[182]
4-Ethoxy-3-pyridinesulfonamide	DM8WAOR	Investigative	Small molecular drug	[1353]
4-Ethoxy-7-((E)-styryl)-furo[3,2-g]chromen-5-one	DM8642Z	Investigative	Small molecular drug	[1481]
4-ethoxynaphthalene-1,2-dione	DMUN7KC	Investigative	Small molecular drug	[1482]
4-Ethyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	DMTIY89	Investigative	NA	[915]
4-ethyl-3,4-dihydroquinazolin-2-amine	DMHDN25	Investigative	Small molecular drug	[1146]
4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine	DM5G3NU	Investigative	Small molecular drug	[1150]
4-Ethyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine	DMTM1VD	Investigative	Small molecular drug	[1483]
4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine	DMOAQ1E	Investigative	Small molecular drug	[1150]
4-Ethyl-5-piperidin-4-yl-isoxazol-3-ol	DMYO2GP	Investigative	Small molecular drug	[1484]
4-Ethyl-oxazolidin-(2Z)-ylideneamine	DMG0Y3W	Investigative	Small molecular drug	[192]
4-Ethyl-pyrrolidin-(2Z)-ylideneamine	DMYIWAH	Investigative	Small molecular drug	[1150]
4-ethynyl benzene sulfonamide	DMIF1D6	Investigative	Small molecular drug	[1485]
4-Ethynyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	DMXLZAT	Investigative	NA	[915]
4-Flourobenzenesulfonamide	DMNDS19	Investigative	Small molecular drug	[12]
4-Fluoren-9-ylidenemethyl-pyridine	DMW9I1X	Investigative	Small molecular drug	[1180]
4-Fluoro-1,1':4',1''-terphenyl-3,3''-diol	DM0INZX	Investigative	Small molecular drug	[373]
4-fluoro-N-(4-(methylsulfonyl)phenyl)aniline	DMV6M5U	Investigative	Small molecular drug	[528]
4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide	DMGBKN7	Investigative	Small molecular drug	[431]
4-fluorobenzaldehyde O-benzoyloxime	DM2N4BJ	Investigative	Small molecular drug	[1145]
4-Fluorobenzenemethanethiol	DMS6RHD	Investigative	Small molecular drug	[786]
4-fluorobenzoyl-Phe-Gly-Leu-Arg-Trp-NH2	DMWD42N	Investigative	Small molecular drug	[1486]
4-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate	DMZV3MD	Investigative	Small molecular drug	[787]
4-fluorophenyl 4-butoxybenzylcarbamate	DMCRJ54	Investigative	Small molecular drug	[787]
4-fluorophenyl-2,2-diphenylacetamide	DMI03KV	Investigative	Small molecular drug	[132]
4-fluorophenylboronic acid	DMD5LXQ	Investigative	Small molecular drug	[1019]
4-formylphenyl-O-beta-D-ribopyranoside	DM7DW0G	Investigative	Small molecular drug	[1487]
4-formylphenyl-O-beta-Dglucopyranoside	DM1VNEF	Investigative	Small molecular drug	[1487]
4-Furan-2-yl-6-nitro-2-piperazin-1-yl-quinoline	DMKT915	Investigative	Small molecular drug	[1444]
4-Hept-3-ynyl-1H-imidazole	DM5MHO6	Investigative	Small molecular drug	[888]
4-heptyl-N-(pyridin-3-yl)benzamide	DMA3MX5	Investigative	Small molecular drug	[926]
4-heptyl-N-(quinolin-3-yl)benzamide	DMAHLF6	Investigative	Small molecular drug	[926]
4-Hex-3-ynyl-1H-imidazole	DMYNTJ0	Investigative	Small molecular drug	[888]
4-hexyl resorcinol	DM36JUD	Investigative	Small molecular drug	[1488]
4-hexyl-N-(quinolin-3-yl)benzamide	DM5E03C	Investigative	Small molecular drug	[926]
4-hexylphenyl propiolate	DMONZ0Y	Investigative	Small molecular drug	[185]
4-Hydrazino-3-pyridinesulfonamide	DMSZMQU	Investigative	Small molecular drug	[1353]
4-Hydrazino-benzenesulfonamide	DM49B18	Investigative	Small molecular drug	[788]
4-Hydrazinocarbonyl-benzenesulfonamide	DM8PBEJ	Investigative	Small molecular drug	[951]
4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid	DM6WJ4K	Investigative	Small molecular drug	[12]
4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid	DME29PX	Investigative	Small molecular drug	[12]
4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone	DMTZ9G3	Investigative	NA	[1489]
4-Hydroxy-2-Butanone	DM7BQ65	Investigative	Small molecular drug	[12]
4-hydroxy-2-nonenal	DM2LJFZ	Investigative	Small molecular drug	[1490]
4-Hydroxy-3,5-diisopropyl-benzaldehyde	DM2PS89	Investigative	Small molecular drug	[802]
4-Hydroxy-3-(1-naphthylmethyl)-2H-chromen-2-one	DMY3OHK	Investigative	Small molecular drug	[988]
4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one	DMM3QPL	Investigative	Small molecular drug	[988]
4-Hydroxy-3-methyl-but-2-enoic acid	DMWDBHC	Investigative	Small molecular drug	[1478]
4-Hydroxy-3-methyl-butyric acid	DM6AHO4	Investigative	Small molecular drug	[1478]
4-hydroxy-3-nitrobenzaldehyde	DMR0S8X	Investigative	Small molecular drug	[540]
4-Hydroxy-3-nonanoyl-6-octyl-pyran-2-one	DMDEMV8	Investigative	Small molecular drug	[1271]
4-Hydroxy-4-phenyl-but-2-enoic acid	DMIVQGW	Investigative	Small molecular drug	[1478]
4-Hydroxy-4-phenyl-butyric acid	DMDWGS9	Investigative	Small molecular drug	[1478]
4-Hydroxy-5-methoxy-10H-anthracen-9-one	DMVFKSX	Investigative	Small molecular drug	[407]
4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one	DMT3H2X	Investigative	Small molecular drug	[1324]
4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one	DMH78QU	Investigative	Small molecular drug	[1491]
4-hydroxy-8-nitro-3-phenylquinolin-2(1H)-one	DMD3OV8	Investigative	Small molecular drug	[1491]
4-Hydroxy-Aconitate Ion	DMT8L5R	Investigative	Small molecular drug	[12]
4-hydroxy-but-2-enoate	DMCA2XQ	Investigative	Small molecular drug	[1478]
4-hydroxy-N,N-diphenylbenzenesulfonamide	DMXPQ5H	Investigative	Small molecular drug	[1492]
4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide	DMULOHZ	Investigative	Small molecular drug	[1474]
4-hydroxy-N-isopropyl-N-phenylbenzenesulfonamide	DMVAP9U	Investigative	Small molecular drug	[1492]
4-hydroxy-N-neopentyl-N-phenylbenzenesulfonamide	DM8XOJC	Investigative	Small molecular drug	[1492]
4-hydroxy-N-phenyl-N-propylbenzenesulfonamide	DM5TU98	Investigative	Small molecular drug	[1492]
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	DMNMJDL	Investigative	Small molecular drug	[22]
4-Hydroxy-pent-2-enoic acid	DM5ZQK1	Investigative	Small molecular drug	[1478]
4-Hydroxy-pentanoic acid	DMDGKFV	Investigative	Small molecular drug	[1478]
4-Hydroxy-piperidine-3-carboxylic acid	DM9VQ0T	Investigative	Small molecular drug	[1285]
4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	DM7WPGN	Investigative	Small molecular drug	[22]
4-hydroxybenzylamine	DMJVPF0	Investigative	Small molecular drug	[540]
4-hydroxylonchocarpin	DM36PHM	Investigative	Small molecular drug	[1302]
4-hydroxyphenethyl 3,4,5-trihydroxybenzoate	DMJ7G0E	Investigative	Small molecular drug	[1038]
4-hydroxyphenyl acetaldehyde	DM3CWHS	Investigative	Small molecular drug	[1493]
4-hydroxyphenylpyruvic acid	DM0564K	Investigative	Small molecular drug	[1494]
4-hydroxysaprothoquinone	DMPIV6J	Investigative	Small molecular drug	[1495]
4-Imidazol-1-yl-2-phenyl-chroman-7-ol	DMJKF17	Investigative	Small molecular drug	[546]
4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one	DMZLVIF	Investigative	Small molecular drug	[599]
4-Imidazol-1-ylmethyl-1-nitrothioxanthen-9-one	DM28DEU	Investigative	Small molecular drug	[494]
4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one	DM6FMO1	Investigative	Small molecular drug	[494]
4-Imidazol-1-ylmethyl-3-nitroxanthen-9-one	DM8KZQN	Investigative	Small molecular drug	[494]
4-Imidazol-1-ylmethylthioxanthen-9-one	DMVUSMP	Investigative	Small molecular drug	[494]
4-Imidazol-1-ylmethylxanthen-9-one	DMM8HK0	Investigative	Small molecular drug	[494]
4-Indan-(1E)-ylidenemethyl-pyridine	DMFRCQS	Investigative	Small molecular drug	[1180]
4-Indan-(1Z)-ylidenemethyl-pyridine	DM25DR7	Investigative	Small molecular drug	[1180]
4-Indan-1-ylmethyl-phenylamine	DM6YON7	Investigative	Small molecular drug	[1381]
4-Inden-(1E)-ylidenemethyl-phenylamine	DM23E0R	Investigative	Small molecular drug	[1381]
4-Indol-1-ylmethyl-benzamidine	DMG9JSK	Investigative	Small molecular drug	[513]
4-iodo-1H-indazole	DMKZQ3I	Investigative	Small molecular drug	[1469]
4-Iodo-2,6-diisopropyl-phenol	DMIPENJ	Investigative	Small molecular drug	[802]
4-Iodo-6-nitro-2-piperazin-1-yl-quinoline	DMC8D4R	Investigative	Small molecular drug	[1444]
4-iodo-acetamido phenylboronic acid	DMFSH2I	Investigative	Small molecular drug	[12]
4-iodophenyl-alaninyl-(S)-2-cyano-pyrrolidine	DMJMOAI	Investigative	Small molecular drug	[1496]
4-Iodopyrazole	DMF3CLX	Investigative	Small molecular drug	[12]
4-Iodyl-benzoic acid	DMQ95EG	Investigative	Small molecular drug	[614]
4-isopropyl-2-(phenoxymethyl)morpholine	DM7F38J	Investigative	Small molecular drug	[809]
4-isopropyl-N-(naphthalen-1-yl)thiazol-2-amine	DMW1T93	Investigative	Small molecular drug	[1497]
4-Isopropyl-pyrrolidin-(2Z)-ylideneamine	DMVTEOQ	Investigative	Small molecular drug	[1150]
4-ISOPROPYLPHENSERINE	DMMDGR2	Investigative	Small molecular drug	[1498]
4-isothiocyanatobenzenesulfonamide	DMBK67H	Investigative	Small molecular drug	[1499]
4-MA	DMNCVIP	Investigative	Small molecular drug	[1500]
4-Methanesulfonylamino-benzenesulfonamide	DMPH4C8	Investigative	Small molecular drug	[749]
4-Methoxy-2-phenyl-2H-pyrazolo[4,3-c]quinoline	DM97B2G	Investigative	Small molecular drug	[1074]
4-Methoxy-3-pyridinesulfonamide	DMJIX7H	Investigative	Small molecular drug	[1353]
4-Methoxy-5-phenyl-6-thia-10b-aza-benzo[e]azulene	DMID40H	Investigative	Small molecular drug	[1501]
4-methoxy-9-aminomethyl-9,10-dihydroanthracene	DM54A3W	Investigative	Small molecular drug	[617]
4-methoxy-N'-(2-phenylacetyl)benzohydrazide	DMF079L	Investigative	Small molecular drug	[114]
4-Methoxy-N-(3-phenyl-isoquinolin-1-yl)-benzamide	DMFKN1M	Investigative	Small molecular drug	[785]
4-methoxy-N-(thiazol-2-yl)benzamide	DMPQKGY	Investigative	Small molecular drug	[543]
4-Methoxybenzenemethanethiol	DMVFLCM	Investigative	Small molecular drug	[786]
4-Methoxymethyl-3,6-dipropoxy-9H-beta-carboline	DMCS83F	Investigative	Small molecular drug	[1274]
4-methoxynaphthalen-1-amine	DMBS61O	Investigative	Small molecular drug	[768]
4-methoxyphenyl 1-(4-butoxyphenyl)propylcarbamate	DM739SQ	Investigative	Small molecular drug	[787]
4-methoxyphenyl 10H-phenothiazine-10-carboxylate	DM3L76R	Investigative	Small molecular drug	[1050]
4-methoxyphenylboronic acid	DMP5YFQ	Investigative	Small molecular drug	[942]
4-methoxyphenylsulfamide	DMVW8KN	Investigative	Small molecular drug	[122]
4-Methyl-1,1':4',1''-terphenyl-3,4''-diol	DM2IZA3	Investigative	Small molecular drug	[373]
4-methyl-2H-benzofuro[3,2-g]chromen-2-one	DMKRHQ3	Investigative	Small molecular drug	[1240]
4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine	DM5FWYG	Investigative	Small molecular drug	[1483]
4-Methyl-3-(2-oxo-azetidin-1-yl)-benzoic acid	DMH6QZO	Investigative	Small molecular drug	[1502]
4-Methyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine	DMUP8NS	Investigative	Small molecular drug	[1483]
4-Methyl-5,6-dihydro-pyrido[1,2-a]quinolin-3-one	DM7LPON	Investigative	Small molecular drug	[395]
4-Methyl-5-(4-piperidyl)isothiazol-3-ol	DMV19HC	Investigative	Small molecular drug	[1465]
4-Methyl-5-piperidin-4-yl-isoxazol-3-ol	DM0ZA7T	Investigative	Small molecular drug	[1484]
4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine	DMN8Z3C	Investigative	Small molecular drug	[1150]
4-Methyl-6-(2-methylprop-1-enyl)pyridin-2-amine	DMW7YHS	Investigative	Small molecular drug	[230]
4-methyl-6-propylpyridin-2-amine	DMY04D1	Investigative	Small molecular drug	[1503]
4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	DM9K7CQ	Investigative	Small molecular drug	[1138]
4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide	DMSF5DR	Investigative	Small molecular drug	[785]
4-methyl-N-(naphthalen-1-yl)thiazol-2-amine	DMFRASQ	Investigative	Small molecular drug	[1497]
4-methyl-N-propyl-3,4-dihydroquinazolin-2-amine	DMN45EH	Investigative	Small molecular drug	[1504]
4-Methyl-oxazolidin-(2Z)-ylideneamine	DME7W0Q	Investigative	Small molecular drug	[192]
4-Methyl-piperidin-(2E)-ylideneamine	DMNMXCE	Investigative	Small molecular drug	[202]
4-Methyl-pyridine	DME6UOM	Investigative	Small molecular drug	[1505]
4-Methyl-pyrrolidin-(2Z)-ylideneamine	DM0YS36	Investigative	Small molecular drug	[1150]
4-Methylamino-benzenesulfonamide	DM5XMI9	Investigative	Small molecular drug	[1435]
4-methylaminomethyl-7-methoxycoumarin	DMI1L6Q	Investigative	Small molecular drug	[1506]
4-Methylbenzenemethanethiol	DM3S2P8	Investigative	Small molecular drug	[786]
4-methylhistamine	DMABMPQ	Investigative	Small molecular drug	[1507]
4-methylhomoibotenic acid	DMRAVVV	Investigative	Small molecular drug	[1508]
4-Methylimidazole	DM45N6U	Investigative	Small molecular drug	[107]
4-methylphenyl-difluoromethanesulfonamide	DMR5NLM	Investigative	Small molecular drug	[130]
4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	DMVMHBL	Investigative	Small molecular drug	[440]
4-methylstyrylboronic acid	DMW0Y29	Investigative	Small molecular drug	[942]
4-Methylthiopyridine-3-sulfonamide	DMEB5XP	Investigative	Small molecular drug	[1353]
4-Morpholin-2-yl-benzene-1,2-diol	DM049QO	Investigative	Small molecular drug	[1406]
4-Morpholin-4-yl-benzo[g]chromen-2-one	DMEJ6G9	Investigative	Small molecular drug	[627]
4-Morpholin-4-yl-benzo[h]chromen-2-one	DMW2MRP	Investigative	Small molecular drug	[627]
4-Morpholin-4-yl-chromen-2-one	DM7T3CU	Investigative	Small molecular drug	[627]
4-morpholino-6-phenyl-2H-pyran-2-one	DM8QPTJ	Investigative	Small molecular drug	[824]
4-MPPTS	DM4E6HW	Investigative	Small molecular drug	[1509]
4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol	DMEIA3L	Investigative	Small molecular drug	[1466]
4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol	DM9O8UM	Investigative	Small molecular drug	[1466]
4-Naphthalen-2-yl-phenol	DMKPNSH	Investigative	Small molecular drug	[441]
4-Nitro-benzenesulfonamide	DMZY8UW	Investigative	Small molecular drug	[1314]
4-Nitro-N-(4-phenyl-thiazol-2-yl)-benzamide	DMKZUWY	Investigative	Small molecular drug	[785]
4-nitro-N-(quinolin-8-yl)benzenesulfonamide	DMLJDU5	Investigative	Small molecular drug	[977]
4-nitrobenzo[c][1,2,5]thiadiazole	DMKZJ1V	Investigative	Small molecular drug	[1367]
4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate	DMTJ3F9	Investigative	Small molecular drug	[1510]
4-nitrophenyl phosphate	DMBX4UJ	Investigative	Small molecular drug	[1511]
4-nitrophenyl-difluoromethanesulfonamide	DM9ETMD	Investigative	Small molecular drug	[130]
4-nitrophenylboronic acid	DMO6XK2	Investigative	Small molecular drug	[1019]
4-nitrophenylsulfamide	DM47IFL	Investigative	Small molecular drug	[122]
4-nonyl-N-(quinolin-3-yl)benzamide	DMOW8TM	Investigative	Small molecular drug	[926]
4-nonylphenylboronic acid	DMBF5KW	Investigative	Small molecular drug	[1019]
4-octyl-N-(pyridin-3-yl)benzamide	DMNSU1H	Investigative	Small molecular drug	[926]
4-octyl-N-(quinolin-3-yl)benzamide	DMOGM3H	Investigative	Small molecular drug	[926]
4-oxo-4H-chromene-3-carboxylic acid	DM7GW4P	Investigative	Small molecular drug	[1512]
4-oxo-nonenal	DMPX1J9	Investigative	Small molecular drug	[1513]
4-oxobutanoate	DM8BVD3	Investigative	Small molecular drug	[1514]
4-Oxosebacic Acid	DMADSUY	Investigative	Small molecular drug	[12]
4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid	DMN1XMK	Investigative	Small molecular drug	[1515]
4-pentyl-N-pyridin-3-yl benzamide	DMW198G	Investigative	Small molecular drug	[926]
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	DMIPQTW	Investigative	Small molecular drug	[22]
4-phenoxyphenylboronic acid	DMMWYI9	Investigative	Small molecular drug	[942]
4-phenyl-1,2,3,6-tetrahydropyridine	DMV6WC4	Investigative	Small molecular drug	[623]
4-phenyl-1-(1-phenylbutyl)piperidin-4-ol	DMVCIJB	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylethyl)piperidin-4-ol	DM6EFLV	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylheptyl)piperidin-4-ol	DMISTXQ	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylhexyl)piperidin-4-ol	DM1GRWY	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylpentyl)piperidin-4-ol	DMZQ7DP	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylpropan-2-yl)piperidin-4-ol	DM491FJ	Investigative	Small molecular drug	[446]
4-phenyl-1-(1-phenylpropyl)piperidin-4-ol	DMALIQ8	Investigative	Small molecular drug	[446]
4-phenyl-1-(3-phenylpropyl)piperidin-4-ol	DMM8O1X	Investigative	Small molecular drug	[446]
4-phenyl-1-(phenyl(m-tolyl)methyl)piperidin-4-ol	DMFV0JC	Investigative	Small molecular drug	[446]
4-phenyl-1-(phenyl(o-tolyl)methyl)piperidin-4-ol	DM2MPWC	Investigative	Small molecular drug	[446]
4-phenyl-1-(phenyl(p-tolyl)methyl)piperidin-4-ol	DM5R6T4	Investigative	Small molecular drug	[446]
4-phenyl-2-(phenylamino)pyrimidine-5-carbonitrile	DMONKDQ	Investigative	Small molecular drug	[955]
4-phenyl-4-[1H-imidazol-2-yl]-piperidine	DMPY4G1	Investigative	Small molecular drug	[1516]
4-Phenyl-5-piperidin-4-yl-isoxazol-3-ol	DM7E4JU	Investigative	NA	[1466]
4-phenyl-6-propylpyrimidine-2-carbonitrile	DMMIB0R	Investigative	Small molecular drug	[1517]
4-Phenyl-benzo[b]thiophene-2-carboxamidine	DMLZSH1	Investigative	Small molecular drug	[1467]
4-Phenylbutylcarbamic Acid Biphenyl-3-yl Ester	DM871ZE	Investigative	Small molecular drug	[1011]
4-Phenylbutyrohydroxamic acid	DMCZKN7	Investigative	Small molecular drug	[1518]
4-Phenylimidazole	DM5UNBW	Investigative	Small molecular drug	[820]
4-phenyliminomethyl-benzenesulfonamide	DM9J5TZ	Investigative	Small molecular drug	[1405]
4-Phenylspiro[chromene-2,4'-piperidine]	DMW46K7	Investigative	Small molecular drug	[1437]
4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine	DMHANXD	Investigative	Small molecular drug	[183]
4-phenylthiazole-2-thiol	DM3B1CE	Investigative	Small molecular drug	[768]
4-phospho-D-erythronate	DMW4KXQ	Investigative	Small molecular drug	[1519]
4-Piperidin-1-yl-chromen-2-one	DMOHDRS	Investigative	Small molecular drug	[627]
4-Piperidino-Piperidine	DMONGDX	Investigative	Small molecular drug	[22]
4-Propyl-1-[3-(phenylpropoxy)propyl]piperidine	DMDBC1K	Investigative	Small molecular drug	[506]
4-propyl-3,4-dihydroquinazolin-2-amine	DMRYCL6	Investigative	Small molecular drug	[1146]
4-propyl-6-m-tolylpyrimidine-2-carbonitrile	DMNM4GE	Investigative	Small molecular drug	[1517]
4-propyl-N-(quinolin-3-yl)benzamide	DM4FLK6	Investigative	Small molecular drug	[926]
4-Pyridin-2-yl-5-quinolin-2-yl-thiazol-2-ylamine	DMY8ZLM	Investigative	Small molecular drug	[1520]
4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine	DM6RVB3	Investigative	Small molecular drug	[1520]
4-Pyridin-2-yl-piperazine-1-carboxylic acid amide	DMFC8Q4	Investigative	Small molecular drug	[1521]
4-Pyridin-3-yl-5-quinolin-4-yl-thiazol-2-ylamine	DM06AV8	Investigative	Small molecular drug	[1520]
4-substituted 2,4-dioxobutanoic acids	DMELGKY	Investigative	Small molecular drug	[1522]
4-Sulfamoyloxy-benzoic acid butyl ester	DMWH2NT	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid cycloheptyl ester	DMDNRCU	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid cyclohexyl ester	DMIX0UN	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid cyclooctyl ester	DMG4LD9	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid cyclopentyl ester	DMF3C71	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid heptyl ester	DMTC25W	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid hexyl ester	DMU784M	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid nonyl ester	DM4Z7TU	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid octyl ester	DMQMSW3	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid pentyl ester	DMZIFW7	Investigative	Small molecular drug	[1523]
4-Sulfamoyloxy-benzoic acid propyl ester	DMRILJC	Investigative	Small molecular drug	[1523]
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	DM61CJK	Investigative	Small molecular drug	[12]
4-tert-butyl-N-(2-isopropylphenyl)thiazol-2-amine	DMDWRE5	Investigative	Small molecular drug	[1497]
4-tert-Butyl-N-(4-phenyl-thiazol-2-yl)-benzamide	DMLFZ6Q	Investigative	Small molecular drug	[785]
4-tert-butyl-N-(naphthalen-1-yl)oxazol-2-amine	DM5U6ZW	Investigative	Small molecular drug	[1497]
4-tert-butyl-N-(naphthalen-1-yl)thiazol-2-amine	DMBUZ75	Investigative	Small molecular drug	[1497]
4-tert-butyl-N-(quinolin-3-yl)benzamide	DM1OBHQ	Investigative	Small molecular drug	[926]
4-tert-butyl-N-hydroxybenzamide	DMUWTPX	Investigative	Small molecular drug	[1524]
4-tert-butyl-N-m-tolylthiazol-2-amine	DM9K27Q	Investigative	Small molecular drug	[1497]
4-tert-butyl-N-o-tolylthiazol-2-amine	DMJQFD5	Investigative	Small molecular drug	[1497]
4-tert-butyl-N-phenylthiazol-2-amine	DM5CPBK	Investigative	Small molecular drug	[1497]
4-TERT-BUTYLBENZENESULFONIC ACID	DMGCYS1	Investigative	Small molecular drug	[22]
4-thio-UTP	DM7YOXW	Investigative	Small molecular drug	[1525]
4-Thiocyanato-benzenesulfonamide	DMUGMVI	Investigative	Small molecular drug	[1314]
4-Thiomorpholin-4-yl-benzo[g]chromen-2-one	DMA8SHN	Investigative	Small molecular drug	[627]
4-trimethylammoniobutanal	DMMTKBM	Investigative	Small molecular drug	[1526]
4-trimethylammoniobutanoate	DMQYGUT	Investigative	Small molecular drug	[1527]
4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine	DM8BPTQ	Investigative	Small molecular drug	[58]
4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine	DM04MK7	Investigative	Small molecular drug	[1276]
4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol	DMSKJ1X	Investigative	Small molecular drug	[811]
4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	DMIEMWA	Investigative	Small molecular drug	[1276]
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	DMNMC9O	Investigative	Small molecular drug	[22]
4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	DMGRWEU	Investigative	Small molecular drug	[22]
4-[(diphenylmethyl)amino]-2-phenylquinazoline	DMT1PM4	Investigative	Small molecular drug	[103]
4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	DMXKT6M	Investigative	Small molecular drug	[22]
4-[1,2-bis(4-hydroxyphenyl)but-1-enyl]phenol	DMW1IXY	Investigative	Small molecular drug	[1528]
4-[1,2-bis(4-hydroxyphenyl)hex-1-enyl]phenol	DMTL6ES	Investigative	Small molecular drug	[1528]
4-[1,2-bis(4-hydroxyphenyl)pent-1-enyl]phenol	DMTHG0Y	Investigative	Small molecular drug	[1528]
4-[1,2-bis(4-hydroxyphenyl)vinyl]phenol	DMR7GP6	Investigative	Small molecular drug	[1528]
4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine	DMCEABJ	Investigative	Small molecular drug	[1276]
4-[1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenol	DMTMLXU	Investigative	Small molecular drug	[1377]
4-[1-(4-hydroxyphenyl)-2-phenylhex-1-enyl]phenol	DM30421	Investigative	Small molecular drug	[1377]
4-[1-(4-hydroxyphenyl)-2-phenylpent-1-enyl]phenol	DMWHKLA	Investigative	Small molecular drug	[1377]
4-[1-(4-hydroxyphenyl)-2-phenylprop-1-enyl]phenol	DMH1I32	Investigative	Small molecular drug	[1377]
4-[1-(4-hydroxyphenyl)-2-phenylvinyl]phenol	DM4BFPE	Investigative	Small molecular drug	[1377]
4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol	DM8IYG1	Investigative	Small molecular drug	[757]
4-[2,2-bis(4-hydroxyphenyl)-1-methylvinyl]phenol	DMS0HV6	Investigative	Small molecular drug	[1528]
4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine	DM08CG7	Investigative	Small molecular drug	[128]
4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide	DMH3UPO	Investigative	Small molecular drug	[1399]
4-[2-(2-Thienyl)acetamido]benzenesulfonamide	DMYESXB	Investigative	Small molecular drug	[1399]
4-[2-(3,5-Dimethoxy-phenyl)-vinyl]-pyridine	DM4ENGI	Investigative	Small molecular drug	[1100]
4-[2-(3-Phenyl-propylamino)-ethyl]-phenol	DM64WSV	Investigative	Small molecular drug	[1464]
4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide	DMGXM9C	Investigative	Small molecular drug	[749]
4-[2-(4-Benzyl-piperidin-1-yl)-ethoxy]-phenol	DM74G6Q	Investigative	Small molecular drug	[1463]
4-[2-(4-Benzylphenoxy)ethyl]pyridine	DMDI32S	Investigative	Small molecular drug	[265]
4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine	DM9UGO0	Investigative	Small molecular drug	[536]
4-[2-(4-Phenyl-butoxy)-ethyl]-phenol	DML8B3T	Investigative	Small molecular drug	[1464]
4-[2-(4-Phenyl-butylamino)-ethyl]-phenol	DMXLVJW	Investigative	Small molecular drug	[1464]
4-[2-(4-Phenyl-piperidin-1-yl)-ethoxy]-phenol	DM8JM4Q	Investigative	Small molecular drug	[1463]
4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol	DM5J7O8	Investigative	Small molecular drug	[1464]
4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol	DMLCIJX	Investigative	Small molecular drug	[1464]
4-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide	DMOPRQ7	Investigative	Small molecular drug	[514]
4-[3-(4-Butyl-phenoxy)-propyl]-1H-imidazole	DMFKRMG	Investigative	Small molecular drug	[1529]
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	DMJI6AM	Investigative	Small molecular drug	[22]
4-[3-(4-Ethynyl-phenoxy)-propyl]-1H-imidazole	DMXBEYQ	Investigative	Small molecular drug	[1529]
4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM7LV5A	Investigative	Small molecular drug	[536]
4-[3-(4-Methoxy-phenoxy)-propyl]-1H-imidazole	DM4GU29	Investigative	Small molecular drug	[1411]
4-[3-(4-Phenyl-butylamino)-propyl]-phenol	DMOF9YN	Investigative	Small molecular drug	[1530]
4-[3-(5-Phenyl-pentylamino)-propyl]-phenol	DMKDBHN	Investigative	Small molecular drug	[1464]
4-[3-(benzyloxy)benzoyl]benzoic acid	DMZU23D	Investigative	Small molecular drug	[170]
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	DMTIA27	Investigative	Small molecular drug	[107]
4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine	DM62351	Investigative	Small molecular drug	[1276]
4-[4-(benzhydryloxy)benzoyl]benzoic acid	DM8MVE9	Investigative	Small molecular drug	[170]
4-[4-(benzhydryloxy)piperidino]butyl benzoate	DM5Z64L	Investigative	Small molecular drug	[1531]
4-[4-(benzoylamino)benzoyl]benzoic acid	DM9VPFL	Investigative	Small molecular drug	[170]
4-[4-(benzylamino)benzoyl]benzoic acid	DMQC5EH	Investigative	Small molecular drug	[170]
4-[4-(benzyloxy)piperidino]butyl benzoate	DMTDYHE	Investigative	Small molecular drug	[1531]
4-[4-(benzyloxy)piperidino]butyl-3-chlorobenzoate	DMIXRCS	Investigative	Small molecular drug	[1531]
4-[4-(benzyloxy)piperidino]butyl-3-fluorobenzoate	DM87AYP	Investigative	Small molecular drug	[1531]
4-[4-(benzyloxy)piperidino]butyl-4-chlorobenzoate	DM0V8MA	Investigative	Small molecular drug	[1531]
4-[4-(benzyloxy)piperidino]butyl-4-fluorobenzoate	DML7UQ1	Investigative	Small molecular drug	[1531]
4-[4-(benzyloxy)piperidino]butyl-4-nitrobenzoate	DMNOD2Q	Investigative	Small molecular drug	[1531]
4-[4-benzyloxy)benzoyl]benzoic acid	DMQ9IN4	Investigative	Small molecular drug	[170]
4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol	DMK4ICB	Investigative	Small molecular drug	[373]
4-[5-(3-Hydroxyphenyl)-2-thienyl]benzene-1,2-diol	DMZHVFO	Investigative	Small molecular drug	[373]
4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol	DM7ERYJ	Investigative	Small molecular drug	[373]
4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	DMI7YAQ	Investigative	Small molecular drug	[1180]
4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	DMQKHXN	Investigative	Small molecular drug	[1180]
4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	DMZL8KN	Investigative	Small molecular drug	[1180]
4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	DM1Z3DG	Investigative	Small molecular drug	[1180]
4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	DMY08FE	Investigative	Small molecular drug	[1180]
4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	DMHDZUO	Investigative	Small molecular drug	[1180]
4-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	DM25GS6	Investigative	Small molecular drug	[1180]
4-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	DMLBX4Q	Investigative	Small molecular drug	[1180]
4-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	DM3IR8Y	Investigative	Small molecular drug	[1180]
4-[6-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	DMIBZJC	Investigative	Small molecular drug	[1180]
4-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	DMYGN1K	Investigative	Small molecular drug	[1180]
4-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	DM5VN3D	Investigative	Small molecular drug	[1180]
4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	DMMGHNA	Investigative	Small molecular drug	[22]
4-{2-[Ethyl-(4-phenyl-butyl)-amino]-ethyl}-phenol	DMA21GM	Investigative	Small molecular drug	[1464]
4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	DMZUM95	Investigative	Small molecular drug	[1532]
4557W	DMLE0I7	Investigative	Small molecular drug	[99]
4ALPHA-(HYDROXYMETHYL)-4ALPHA-DEMETHYLTERRITREM B	DMGYK25	Investigative	Small molecular drug	[1533]
4alpha-PDD	DMTSPLX	Investigative	Small molecular drug	[1534]
4alpha-PDH	DMUOLES	Investigative	Small molecular drug	[1535]
4beta,15-epoxy-miller-9E-enolide	DMDF3KJ	Investigative	Small molecular drug	[703]
4beta,15-epoxy-miller-9Z-enolide	DMZ01SV	Investigative	Small molecular drug	[703]
4BP-TQS	DMS0JVE	Investigative	Small molecular drug	[1536]
4P-PDOT	DMEMN0W	Investigative	Small molecular drug	[1537]
4r-Fluoro-N6-Ethanimidoyl-L-Lysine	DMUGFS3	Investigative	Small molecular drug	[12]
4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide	DMQNT8D	Investigative	Small molecular drug	[1538]
5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine	DMNYQGS	Investigative	Small molecular drug	[1520]
5'-(N-ethyl-N-isopropyl)amiloride	DM3TPMO	Investigative	Small molecular drug	[1539]
5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine	DMT6D5V	Investigative	Small molecular drug	[1540]
5'-amino-5'-deoxy-alpha-D-thymidine	DMBF42W	Investigative	Small molecular drug	[1541]
5'-dAMP	DMUPEJG	Investigative	Small molecular drug	[1542]
5'-deoxy-4'-hydroxy-5'-methylthio-DADMe-ImmH	DMRFH9U	Investigative	Small molecular drug	[61]
5'-Deoxy-5'-(Methylthio)-Tubercidin	DMR28HG	Investigative	Small molecular drug	[12]
5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine	DMOHSY0	Investigative	Small molecular drug	[1543]
5'-Deoxy-5'-(N,N-dimethylamino)adenosine	DMF7JPO	Investigative	Small molecular drug	[1543]
5'-Deoxy-5'-dimethylsulfonioadenosine chloride	DM1NAMK	Investigative	Small molecular drug	[1543]
5'-Deoxy-5'-phenyladenophostin A	DMU4MCK	Investigative	Small molecular drug	[1544]
5'-deoxy-5'-ureidoadenosine	DM8IQX4	Investigative	Small molecular drug	[1545]
5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine	DM6HGUL	Investigative	Small molecular drug	[1540]
5'-deoxythymidine	DMR48NG	Investigative	Small molecular drug	[1546]
5'-fluoroindirubinoxime	DMF2GXR	Investigative	Small molecular drug	[1547]
5'-Guanosine-Diphosphate-Monothiophosphate	DMIARG7	Investigative	Small molecular drug	[12]
5'-iodoresiniferatoxin	DMQINY5	Investigative	Small molecular drug	[1548]
5'-iodotubercidin	DML5ZEJ	Investigative	Small molecular drug	[1549]
5'-Methylthio-ImmH	DM3LY0Q	Investigative	Small molecular drug	[61]
5'-methylthio-immucillin-H	DMK52UH	Investigative	NA	[1165]
5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine	DM20X8C	Investigative	Small molecular drug	[12]
5'-phenylthio-ImmH	DMQMZ0Y	Investigative	Small molecular drug	[61]
5'-S-ethyl-5'-thioadenosine	DM0PQH1	Investigative	Small molecular drug	[22]
5(E)-(5'-Deoxyadenosin-5'-ylidene)pentanoic acid	DM1IGOD	Investigative	Small molecular drug	[1351]
5,10-Dioxy-2-phenyl-benzo[g]pteridin-4-ylamine	DMM7N6K	Investigative	Small molecular drug	[1550]
5,10-Methylene-6-Hydrofolic Acid	DMAQDK9	Investigative	Small molecular drug	[12]
5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol	DMWSLTB	Investigative	Small molecular drug	[1551]
5,3'-Dipropyl-biphenyl-2,4'-diol	DMJRXLD	Investigative	Small molecular drug	[774]
5,5'-methylenebis(1,3,4-oxadiazole-2(3H)-thione)	DMPVBC2	Investigative	Small molecular drug	[747]
5,5'-methylenebis(1,3,4-thiadiazole-2(3H)-thione)	DMW13SO	Investigative	Small molecular drug	[747]
5,5'-methylenebis(3,4-dibromobenzene-1,2-diol)	DMZ693W	Investigative	Small molecular drug	[745]
5,5-diethyl-2-(phenethylamino)oxazol-4(5H)-one	DMWL1UY	Investigative	Small molecular drug	[938]
5,5-Diphenyl-2-iminohydantoin	DM28LNV	Investigative	Small molecular drug	[1552]
5,6,7,8-tetrahydroanthracene-1,4-dione	DMIQAO9	Investigative	Small molecular drug	[1482]
5,6,7-Trichloro-1,4-dihydro-quinoxaline-2,3-dione	DMTL4S9	Investigative	Small molecular drug	[1553]
5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline	DM53CLY	Investigative	Small molecular drug	[1328]
5,6,7-Trimethyl-2-p-tolyl-chromen-4-one	DM6VPF4	Investigative	Small molecular drug	[1554]
5,6,8-trichloroquinoline-4-one-3-carboxylic acid	DMDCE1M	Investigative	Small molecular drug	[1555]
5,6,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one	DMNHT7Q	Investigative	Small molecular drug	[428]
5,6,8-Trimethoxy-4-methylquinolin-2(1H)-one	DM97XZ1	Investigative	Small molecular drug	[428]
5,6-Bis-p-tolylamino-isoindole-1,3-dione	DM6A4LM	Investigative	Small molecular drug	[1556]
5,6-Cyclic-Tetrahydropteridine	DMDE7XJ	Investigative	Small molecular drug	[107]
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole	DM3JB6S	Investigative	Small molecular drug	[1557]
5,6-dichloro-3,4-dihydroquinazolin-2-amine	DMN1S35	Investigative	Small molecular drug	[1146]
5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide	DMR2OMU	Investigative	Small molecular drug	[999]
5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide	DMZL87A	Investigative	Small molecular drug	[999]
5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one	DM94V8D	Investigative	Small molecular drug	[502]
5,6-dinitroacenaphthoquinone	DM07HYA	Investigative	Small molecular drug	[385]
5,6-epoxyeicosatrienoic acid	DMXTYCU	Investigative	Small molecular drug	[1558]
5,7-Dibromo-1,4-dihydro-quinoxaline-2,3-dione	DMA50BQ	Investigative	Small molecular drug	[1553]
5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol	DMZLOVB	Investigative	Small molecular drug	[1559]
5,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione	DMOJ5LM	Investigative	Small molecular drug	[1553]
5,7-dichloro-1H-indole-2,3-dione	DMFHDWG	Investigative	Small molecular drug	[475]
5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione	DMUADN4	Investigative	NA	[1560]
5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one	DMZJKIU	Investigative	Small molecular drug	[1249]
5,7-Dichlorokynurenic Acid	DMHKQ1L	Investigative	Small molecular drug	[1561]
5,7-dihydroxy-3-phenyl-3H-quinazolin-4-one	DMA61I2	Investigative	Small molecular drug	[1562]
5,7-Dimethoxy-3-pyridin-4-yl-quinoline	DM724JF	Investigative	Small molecular drug	[1328]
5,7-Dimethoxy-3-thiophen-3-yl-quinoline	DMJAQ41	Investigative	Small molecular drug	[1168]
5,7-Dimethyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	DMU618S	Investigative	Small molecular drug	[881]
5,7-Dimethyl-3-thiophen-3-yl-quinoline	DM3P79O	Investigative	Small molecular drug	[1168]
5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione	DMG4UCX	Investigative	Small molecular drug	[1249]
5,7-diphenyl-3H-imidazo[4,5-b]pyridin-2-ol	DM4TIXY	Investigative	Small molecular drug	[803]
5,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol	DMKXIWQ	Investigative	Small molecular drug	[1471]
5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one	DMJ1IRO	Investigative	Small molecular drug	[22]
5,8-Dimethoxy-4-methylquinolin-2(1H)-one	DMEMBKW	Investigative	Small molecular drug	[428]
5,8-hydroxy-naphthoquinone	DM1SO62	Investigative	NA	[430]
5,N-Dihydroxythalidomide	DM3MSZN	Investigative	Small molecular drug	[590]
5-((1H-imidazol-1-yl)methyl)-7,8-dihydroquinoline	DML4DSG	Investigative	Small molecular drug	[469]
5-((6-Methylpyridin-2-yl)ethynyl)nicotinonitrile	DMBSFLW	Investigative	Small molecular drug	[987]
5-((E)-Styryl)-quinazoline-2,4-diamine	DMH0QA7	Investigative	Small molecular drug	[1563]
5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol	DMS31H9	Investigative	Small molecular drug	[733]
5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine	DMMSK9W	Investigative	Small molecular drug	[1564]
5-(2-(1H-imidazol-1-yl)ethyl)quinoline	DMA2GIE	Investigative	Small molecular drug	[469]
5-(2-(2,5-dimethylphenyl)ethynyl)pyrimidine	DMCFKGW	Investigative	Small molecular drug	[1565]
5-(2-(3,5-difluorophenyl)ethynyl)pyrimidine	DM3XMKJ	Investigative	Small molecular drug	[1565]
5-(2-(3-chlorophenyl)ethynyl)pyrimidine	DM37KG6	Investigative	Small molecular drug	[1565]
5-(2-(4-fluoro-3-methylphenyl)ethynyl)pyrimidine	DMRS1Q5	Investigative	Small molecular drug	[1565]
5-(2-(pyrrolidin-1-yl)ethyl)isothiazole	DMXAF7Y	Investigative	Small molecular drug	[258]
5-(2-1H-indenyl)-1,3-benzodioxole	DM149IX	Investigative	Small molecular drug	[405]
5-(2-Amino-ethyl)-2-chloro-phenol hydrobromide	DMJXI65	Investigative	NA	[1566]
5-(2-fluorobenzyloxy)quinazoline-2,4-diamine	DMQCYEK	Investigative	Small molecular drug	[1567]
5-(2-hydroxyethyl)nonane-1,9-diol	DMHBD1T	Investigative	Small molecular drug	[22]
5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline	DMCP5U8	Investigative	Small molecular drug	[1568]
5-(2-m-tolylethynyl)pyrimidine	DMO5WG8	Investigative	Small molecular drug	[1565]
5-(2-methylpiperazin-1-ylsulfonyl)isoquinoline	DMV3KBE	Investigative	Small molecular drug	[1569]
5-(2-Methylquinolin-7-yl)-2-phenylbenzonitrile	DMIQJM4	Investigative	Small molecular drug	[987]
5-(2-Methylquinolin-7-yl)-2-phenylnicotinonitrile	DMO74HX	Investigative	Small molecular drug	[987]
5-(2-methylquinolin-7-yl)isophthalonitrile	DMMX69H	Investigative	Small molecular drug	[161]
5-(2-methylquinolin-7-yl)nicotinonitrile	DM8LN2X	Investigative	Small molecular drug	[161]
5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile	DMR7OHB	Investigative	Small molecular drug	[1196]
5-(2-phenethylpiperazin-1-yl)-1H-indazole	DM07P5E	Investigative	Small molecular drug	[1570]
5-(3'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid	DMPC9DV	Investigative	Small molecular drug	[71]
5-(3,4-dichlorophenyl)-1H-pyrazol-3-ol	DMRF0PS	Investigative	Small molecular drug	[1238]
5-(3-(4-fluorobenzyl)pyrrolidin-3-yl)-1H-indole	DMR35OM	Investigative	Small molecular drug	[1178]
5-(3-benzylpyrrolidin-3-yl)-1-methyl-1H-indole	DM2ZUFO	Investigative	Small molecular drug	[1178]
5-(3-benzylpyrrolidin-3-yl)-1h-indole (structural mix)	DMZK4AH	Investigative	Small molecular drug	[1178]
5-(3-butylpyrrolidin-3-yl)-1H-indole	DMPKGJC	Investigative	Small molecular drug	[1178]
5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid	DMCR9KX	Investigative	Small molecular drug	[727]
5-(3-chlorophenylethynyl)-5-methyl[1,2,4]triazine	DMABSOC	Investigative	Small molecular drug	[1202]
5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione	DM2H9ND	Investigative	Small molecular drug	[747]
5-(3-Phenyl-propyl)-1H-pyrazole-3-carboxylic acid	DMPCFA6	Investigative	Small molecular drug	[727]
5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid	DM6KSN9	Investigative	Small molecular drug	[1571]
5-(4'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid	DMTDNX3	Investigative	Small molecular drug	[71]
5-(4-((phenethylamino)methyl)phenoxy)picolinamide	DMZYE8W	Investigative	Small molecular drug	[1413]
5-(4-bromophenyl)-2-furaldehyde thiosemicarbazone	DMT4856	Investigative	Small molecular drug	[962]
5-(4-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid	DMDCNZE	Investigative	Small molecular drug	[727]
5-(4-Chloro-phenyl)-1-methyl-piperidin-2-one	DMJKAF0	Investigative	Small molecular drug	[624]
5-(4-Chloro-phenyl)-1-methyl-piperidine-2-thione	DMQB1UI	Investigative	Small molecular drug	[624]
5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide	DM6CRVS	Investigative	Small molecular drug	[1572]
5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole	DMSTG03	Investigative	Small molecular drug	[1363]
5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole	DMY0P86	Investigative	Small molecular drug	[1362]
5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one	DMFYEL8	Investigative	Small molecular drug	[1363]
5-(4-Chlorophenyl)-4-p-tolylisothiazole	DMA1N75	Investigative	Small molecular drug	[1363]
5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide	DMV7HA1	Investigative	Small molecular drug	[1573]
5-(4-hydroxy-2,6-dimethylstyryl)nicotinic acid	DMISOLU	Investigative	Small molecular drug	[1574]
5-(4-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione	DMB2GLE	Investigative	Small molecular drug	[747]
5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione	DM7KQXL	Investigative	Small molecular drug	[950]
5-(4-Methoxy-phenyl)-1-phenyl-1H-benzoimidazole	DMCMNKA	Investigative	Small molecular drug	[1575]
5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	DM3SQEY	Investigative	Small molecular drug	[12]
5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole	DMEV8WS	Investigative	Small molecular drug	[1362]
5-(4-Methoxyphenyl)-4-p-tolylisothiazole	DMJSTCK	Investigative	Small molecular drug	[1363]
5-(4-Methylpiperazin-1-yl)-3-tosyl-1H-indazole	DMNSIF2	Investigative	Small molecular drug	[1438]
5-(4-Phenoxy-phenyl)-pyrimidine-2,4,6-trione	DM05OMF	Investigative	Small molecular drug	[1576]
5-(4-Phenylbutoxy)psoralen	DM3QFCV	Investigative	Small molecular drug	[1577]
5-(4-piperidyl)-4-propylisothiazol-3-ol	DMZ7K5G	Investigative	Small molecular drug	[1465]
5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one	DMVMBG0	Investigative	Small molecular drug	[1168]
5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid	DM0K7U5	Investigative	Small molecular drug	[1578]
5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol	DMIB9AX	Investigative	Small molecular drug	[1579]
5-(6-hydroxy-2-naphthyl)pyridin-3-ol	DMJWIPS	Investigative	Small molecular drug	[885]
5-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol	DMJRBKO	Investigative	Small molecular drug	[1428]
5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol	DMMPAWD	Investigative	Small molecular drug	[1229]
5-(azepan-1-ylsulfonyl)indoline-2,3-dione	DMGIO3R	Investigative	Small molecular drug	[1580]
5-(azetidin-1-ylsulfonyl)indoline-2,3-dione	DMJIVLY	Investigative	Small molecular drug	[1580]
5-(biphenyl-4-yl)-3-methoxypentanoic acid	DMJAG7M	Investigative	Small molecular drug	[71]
5-(biphenyl-4-yl)-3-oxopentanoic acid	DMQKU9H	Investigative	Small molecular drug	[71]
5-(Biphenyl-4-yl)-pentanoic acid N-hydroxyamide	DMPQSZN	Investigative	Small molecular drug	[1581]
5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID	DMPFX0S	Investigative	Small molecular drug	[22]
5-(isopropylamino)quinolin-8-ol	DM45VRX	Investigative	Small molecular drug	[768]
5-(methylthio)thiophene-2-carboxylic acid	DMYLIX9	Investigative	Small molecular drug	[134]
5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol	DMG2VQB	Investigative	Small molecular drug	[1582]
5-(phenylethynyl)pyrimidine	DMP4RO3	Investigative	Small molecular drug	[1565]
5-(piperidin-1-ylsulfonyl)indoline-2,3-dione	DMT60AM	Investigative	Small molecular drug	[1580]
5-(piperidin-4-yl)isothiazol-3-ol	DM4XGFW	Investigative	Small molecular drug	[1465]
5-(piperidin-4-yl)isoxazol-3-ol	DM6GO2I	Investigative	Small molecular drug	[1466]
5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione	DM93MAX	Investigative	Small molecular drug	[747]
5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione	DMEL8XU	Investigative	Small molecular drug	[747]
5-(pyrrolidin-1-ylsulfonyl)indoline-2,3-dione	DMJBK7F	Investigative	Small molecular drug	[1580]
5-(trifluoromethoxy)-1H-indole-2,3-dione	DMK3TEV	Investigative	Small molecular drug	[475]
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	DMX0EAK	Investigative	Small molecular drug	[12]
5-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	DMB7R95	Investigative	Small molecular drug	[1442]
5-amino-2-p-tolyl-oxazole-4-carboxylic acid amide	DM4SWJ7	Investigative	Small molecular drug	[974]
5-amino-2-phenyl-oxazole-4-carboxylic acid amide	DMX37ZC	Investigative	Small molecular drug	[974]
5-amino-3,4-dihydroisoquinolin-1(2H)-one	DMR853M	Investigative	Small molecular drug	[767]
5-amino-3-(N-methylpiperidin-4-yl)-1H-indole	DMJKQ5I	Investigative	Small molecular drug	[1583]
5-AMINO-NAPHTALENE-2-MONOSULFONATE	DMYTUNE	Investigative	Small molecular drug	[22]
5-Amino-[1,3,4]thiadiazole-2-thiol	DMGA47N	Investigative	Small molecular drug	[1584]
5-aminoisoquinolin-1(2H)-one	DMVPSXW	Investigative	Small molecular drug	[924]
5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMWDUVC	Investigative	Small molecular drug	[304]
5-Aminomethyl-4,5-dihydro-isoxazol-3-ol	DMZK8V5	Investigative	Small molecular drug	[1451]
5-Aminomethyl-naphthalen-2-ol	DMTP9DB	Investigative	Small molecular drug	[389]
5-aminoquinolin-8-ol	DMIBHP5	Investigative	Small molecular drug	[768]
5-Azido-6-benzyl-2-methyl-[1,8]naphthyridine	DMURTHE	Investigative	Small molecular drug	[1251]
5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one	DM0HO6C	Investigative	Small molecular drug	[304]
5-benzhydryl-1,3,4-oxadiazole-2(3H)-thione	DM65WZ7	Investigative	Small molecular drug	[747]
5-benzhydryl-1,3,4-thiadiazole-2(3H)-thione	DMBQ5HV	Investigative	Small molecular drug	[747]
5-benzyl-1,3,4-oxadiazole-2(3H)-thione	DM8QK2O	Investigative	Small molecular drug	[747]
5-Benzyl-1H-pyrazole-3-carboxylic acid	DMJVGUZ	Investigative	Small molecular drug	[727]
5-benzyl-2-(2,4-dichlorophenoxy)phenol	DM5MJ3I	Investigative	Small molecular drug	[828]
5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione	DMCKODQ	Investigative	Small molecular drug	[1585]
5-Benzyloxy-benzo[b]thiophene-2-carboxamidine	DM8WB96	Investigative	Small molecular drug	[1467]
5-Benzyloxytryptamine	DMOM35G	Investigative	Small molecular drug	[1586]
5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione	DMFAITE	Investigative	Small molecular drug	[1576]
5-Biphenyl-4-yl-5-hexyl-pyrimidine-2,4,6-trione	DMI2PXO	Investigative	Small molecular drug	[1576]
5-Biphenyl-4-ylethynyl-pyrimidine	DMMG9PV	Investigative	Small molecular drug	[1565]
5-Biphenyl-4-ylmethyl-1-isobutyl-1H-tetrazole	DM6W0QI	Investigative	Small molecular drug	[1587]
5-Biphenyl-4-ylmethyl-2-isobutyl-2H-tetrazole	DMCPIK5	Investigative	Small molecular drug	[1587]
5-BODMT	DM7BWG5	Investigative	Small molecular drug	[1588]
5-boronothiophene-2-carboxylic acid	DMPITR9	Investigative	Small molecular drug	[1254]
5-bromo orotate	DM0HCG6	Investigative	NA	[1589]
5-bromo-1H-indazole	DM2QPHE	Investigative	Small molecular drug	[1469]
5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMMI4H3	Investigative	Small molecular drug	[760]
5-bromo-2-(4-chlorophenylsulfonamido)benzoic acid	DM4WVSB	Investigative	Small molecular drug	[914]
5-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	DM2YL0T	Investigative	Small molecular drug	[915]
5-Bromo-4,9-dihydro-3H-beta-carboline	DM2SEFR	Investigative	Small molecular drug	[760]
5-bromo-6-(cyclopropylamino)uracil hydrochloride	DMRY0OL	Investigative	Small molecular drug	[1590]
5-bromo-6-hydrazinouracil hydrochloride	DMZJE6M	Investigative	Small molecular drug	[1590]
5-Bromo-6-methoxy-9H-beta-carboline	DM157OQ	Investigative	Small molecular drug	[1591]
5-Bromo-6-p-tolylamino-1H-pyrimidine-2,4-dione	DMTPRIW	Investigative	Small molecular drug	[975]
5-Bromo-8-imidazol-1-ylmethyl-chromen-4-one	DM09Y72	Investigative	Small molecular drug	[599]
5-Bromo-8-piperazin-1-yl-imidazo[1,2-a]pyrazine	DMSVCJM	Investigative	Small molecular drug	[1592]
5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide	DM37T5L	Investigative	Small molecular drug	[977]
5-Bromomethyl-oxazolidin-(2Z)-ylideneamine	DMH908V	Investigative	Small molecular drug	[192]
5-Bromothienyldeoxyuridine	DMZ8X3H	Investigative	Small molecular drug	[12]
5-Butyl-1H-pyrazole-3-carboxylic acid	DMXKQFM	Investigative	Small molecular drug	[1593]
5-butyl-2-(2,4-dichlorophenoxy)phenol	DMCNU6I	Investigative	Small molecular drug	[828]
5-butyl-2-(phenylsulfonamido)benzoic acid	DMI7DSM	Investigative	Small molecular drug	[914]
5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione	DMFKMYV	Investigative	Small molecular drug	[1585]
5-Butyl-8-phenyl-3H-[1,2,4]triazolo[5,1-i]purine	DM2EPFZ	Investigative	Small molecular drug	[1594]
5-butyl-methyl immidazole carboxylate 30	DM0VGCX	Investigative	Small molecular drug	[1595]
5-Carbazol-9-yl-pentanoic acid	DM04WVH	Investigative	Small molecular drug	[889]
5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	DMTJNY0	Investigative	Small molecular drug	[1596]
5-Chloro-1-(4-chloro-benzyl)-1H-indole-2,3-dione	DMIH7W1	Investigative	Small molecular drug	[178]
5-chloro-1H-indazole	DMOCYDU	Investigative	Small molecular drug	[1469]
5-chloro-1H-indole-2,3-dione	DMQ350F	Investigative	Small molecular drug	[475]
5-chloro-2-(2-chloro-4-hydroxyphenoxy)phenol	DMDZ8NA	Investigative	Small molecular drug	[898]
5-chloro-2-(2-chloro-4-nitrophenoxy)phenol	DMAJ8BS	Investigative	Small molecular drug	[898]
5-Chloro-2-(2-methylquinolin-7-yl)benzonitrile	DMH4SLZ	Investigative	Small molecular drug	[987]
5-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-6-ol	DMCFIZN	Investigative	Small molecular drug	[847]
5-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	DMXNPSB	Investigative	Small molecular drug	[915]
5-chloro-2-(4-phenylbutyl)isoindoline-1,3-dione	DM9QBAZ	Investigative	Small molecular drug	[991]
5-chloro-2-(pyridin-2-yl)-1H-benzo[d]imidazole	DMJBHR9	Investigative	Small molecular drug	[958]
5-Chloro-2-methyl-3H-quinazolin-4-one	DM6YBZR	Investigative	Small molecular drug	[892]
5-chloro-3,4-dihydroquinazolin-2-amine	DMKEFJ0	Investigative	Small molecular drug	[1146]
5-Chloro-3-ethyl-1-(4-fluoro-phenyl)-1H-indole	DM207CQ	Investigative	Small molecular drug	[1597]
5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine	DMGDTNI	Investigative	Small molecular drug	[1146]
5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine	DM7FZU2	Investigative	Small molecular drug	[1146]
5-chloro-4-nitrothiophene-2-sulfonamide	DMRS82Q	Investigative	Small molecular drug	[792]
5-chloro-6-hydrazinouracil hydrochloride	DMMT7WO	Investigative	Small molecular drug	[1590]
5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine	DM2SKP7	Investigative	Small molecular drug	[1598]
5-chloro-N-(pyridin-3-yl)indoline-1-carboxamide	DMZ5MDY	Investigative	Small molecular drug	[300]
5-chloro-N-(quinolin-8-yl)thiophene-2-sulfonamide	DMMV931	Investigative	Small molecular drug	[977]
5-Chloro-N-phenylbenzo[d]oxazol-2-amine	DMVQLFB	Investigative	Small molecular drug	[1598]
5-Chlorosalicylic Acid	DMH397E	Investigative	Small molecular drug	[1366]
5-Chloryl-2,4,6-Quinazolinetriamine	DMWS3D6	Investigative	Small molecular drug	[12]
5-Cl-5-deoxy-(+/-)-ENBA	DM109IL	Investigative	Small molecular drug	[1599]
5-CT	DM260KD	Investigative	Small molecular drug	[1600]
5-cyclohexyl-1,3,4-oxadiazole-2(3H)-thione	DMMYENH	Investigative	Small molecular drug	[747]
5-deoxy-5-phosphono-D-arabinonate	DM65XZJ	Investigative	Small molecular drug	[1601]
5-deoxyabyssinin II	DM1Q0BF	Investigative	Small molecular drug	[1602]
5-desgalloylstachyurin	DM6TM1L	Investigative	Small molecular drug	[387]
5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine	DMX64E3	Investigative	Small molecular drug	[258]
5-ethyl-2-(phenylsulfonamido)benzoic acid	DM0E9O1	Investigative	Small molecular drug	[914]
5-Ethyl-3,4-diphenyl-isoxazole	DMRIGXA	Investigative	Small molecular drug	[1603]
5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole	DMK57W2	Investigative	Small molecular drug	[1604]
5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione	DMYD8GP	Investigative	Small molecular drug	[1605]
5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine	DMS9TFC	Investigative	Small molecular drug	[1150]
5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine	DMQWOIG	Investigative	Small molecular drug	[1150]
5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine	DMSA8X2	Investigative	Small molecular drug	[1150]
5-Ethyl-oxazolidin-(2Z)-ylideneamine	DM8Y4G5	Investigative	Small molecular drug	[192]
5-Fluoro orotate	DMLSC10	Investigative	Small molecular drug	[1589]
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	DME1AGO	Investigative	Small molecular drug	[12]
5-fluoro-2-(pyridin-2-yl)-1H-benzo[d]imidazole	DMEA8WP	Investigative	Small molecular drug	[958]
5-Fluoro-2-hydroxy-N-isopropyl-benzamide	DMOI7ME	Investigative	Small molecular drug	[1606]
5-Fluoro-2-sulfanyl-phenylphosphonic acid	DMUCLAV	Investigative	Small molecular drug	[961]
5-Fluoro-3-thiophen-3-yl-quinoline	DM0OQTJ	Investigative	Small molecular drug	[1168]
5-fluoro-6-amino-UMP	DM6QHIA	Investigative	Small molecular drug	[1607]
5-fluoro-6-azido-UMP	DMZLJRS	Investigative	Small molecular drug	[1607]
5-Fluoro-6-ethyluridine-5'-O-monophosphate	DMTAZ71	Investigative	Small molecular drug	[1607]
5-fluoro-6-iodo-UMP	DM3LMIS	Investigative	Small molecular drug	[1607]
5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil	DMEV0GO	Investigative	Small molecular drug	[1608]
5-Fluorolevulinic Acid	DMDV48S	Investigative	Small molecular drug	[12]
5-fluorouridine	DM9KPL5	Investigative	Small molecular drug	[1609]
5-Formyl-6-Hydrofolic Acid	DM371WE	Investigative	Small molecular drug	[12]
5-HEAT	DMKUT6A	Investigative	Small molecular drug	[1610]
5-Heptyl-5-phenyl-imidazolidine-2,4-dione	DMICKOU	Investigative	Small molecular drug	[1028]
5-heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione	DM49F6Z	Investigative	Small molecular drug	[22]
5-Hex-5-enyl-2-nonyl-3,4-dihydro-2H-pyrrole	DMHGQRF	Investigative	Small molecular drug	[1024]
5-hexyl-2-(2-nitrophenoxy)phenol	DM0OJZF	Investigative	Small molecular drug	[842]
5-hexyl-2-(3-nitrophenoxy)phenol	DM7EBQL	Investigative	Small molecular drug	[842]
5-hexyl-2-(4-nitrophenoxy)phenol	DMNBLPA	Investigative	Small molecular drug	[842]
5-hexyl-2-(pyrazin-2-yloxy)phenol	DM9263J	Investigative	Small molecular drug	[842]
5-hexyl-2-(pyridin-2-yloxy)phenol	DMLIMOP	Investigative	Small molecular drug	[842]
5-hexyl-2-(pyridin-3-yloxy)phenol	DMHZT1S	Investigative	Small molecular drug	[842]
5-hexyl-2-(pyridin-4-yloxy)phenol	DMP6U3L	Investigative	Small molecular drug	[842]
5-hexyl-2-(pyrimidin-2-yloxy)phenol	DMNYOV3	Investigative	Small molecular drug	[842]
5-hexyl-2-phenoxyphenol	DMHNRXT	Investigative	Small molecular drug	[842]
5-Hexyl-5-phenyl-imidazolidine-2,4-dione	DMCDUO1	Investigative	Small molecular drug	[1028]
5-Hexyl-5-phenyl-pyrimidine-2,4,6-trione	DM4S86L	Investigative	Small molecular drug	[1576]
5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one	DM5RI4H	Investigative	Small molecular drug	[1611]
5-hydroxy-1H-indole-3-acetic acid	DM98OEQ	Investigative	Small molecular drug	[1612]
5-hydroxy-2-(4-aminophenyl)benzofuran	DM8KON3	Investigative	Small molecular drug	[1613]
5-hydroxy-2-(4-dimethylaminophenyl)benzofuran	DMYL0ZF	Investigative	Small molecular drug	[1613]
5-hydroxy-2-(4-methylaminophenyl)benzofuran	DM4QC0R	Investigative	Small molecular drug	[1613]
5-hydroxy-2-(pentylthiomethyl)-4H-pyran-4-one	DMTO2L3	Investigative	Small molecular drug	[944]
5-hydroxy-2-(propylthiomethyl)-4H-pyran-4-one	DM7M1RZ	Investigative	Small molecular drug	[944]
5-hydroxy-2-phenylisoindoline-1,3-dione	DMLZKNF	Investigative	Small molecular drug	[1614]
5-hydroxy-L-tryptophan	DMDWZGJ	Investigative	Small molecular drug	[1615]
5-hydroxy-pentanoate	DMJQFZH	Investigative	Small molecular drug	[1478]
5-hydroxyindole	DMI0GMB	Investigative	Small molecular drug	[1616]
5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMT9FQN	Investigative	Small molecular drug	[304]
5-Hydroxymethyl-Chonduritol	DMZHVRW	Investigative	Small molecular drug	[12]
5-hydroxymethylbenzo[b]thiophen-2-ylboronic acid	DMN9FPV	Investigative	Small molecular drug	[1617]
5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate	DMWVCJ1	Investigative	Small molecular drug	[12]
5-hydroxynaphthalene-1-sulfonamide	DMMF57V	Investigative	Small molecular drug	[22]
5-hydroxyvaleric acid	DMIXQG6	Investigative	Small molecular drug	[1618]
5-Imidazol-1-yl-5,6,7,8-tetrahydro-quinoline	DMVSBHU	Investigative	Small molecular drug	[1568]
5-Indan-(1E)-ylidenemethyl-1H-imidazole	DMW8AOM	Investigative	Small molecular drug	[1619]
5-Indan-(1Z)-ylidenemethyl-1H-imidazole	DMKLY20	Investigative	Small molecular drug	[1619]
5-iodo orotate	DMDKFIO	Investigative	NA	[1589]
5-iodo,5'-deoxytubercidin	DMVT2LW	Investigative	Small molecular drug	[1620]
5-iodo-1H-indazole	DM4NQY6	Investigative	Small molecular drug	[1469]
5-Iodo-2'-Deoxyuridine-5'-Monophosphate	DMZACXG	Investigative	Small molecular drug	[12]
5-Iodouracil	DM4O6I5	Investigative	Small molecular drug	[12]
5-Isopropyl-1H-pyrazole-3-carboxylic acid	DME6BX5	Investigative	Small molecular drug	[727]
5-isopropyl-2-(phenylamino)thiazol-4(5H)-one	DM2TNWO	Investigative	Small molecular drug	[849]
5-Isopropyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole	DMXGRMB	Investigative	Small molecular drug	[1604]
5-ketodihydromevinolin	DMXVPL1	Investigative	Small molecular drug	[1621]
5-Me-IAA	DMFZN7J	Investigative	Small molecular drug	[1622]
5-MEO-DMT	DMG0EL7	Investigative	Small molecular drug	[1623]
5-Mercapto-pentanoic acid	DM7YGJO	Investigative	Small molecular drug	[855]
5-Mercapto-pentanoic acid phenylamide	DMET3OJ	Investigative	Small molecular drug	[1480]
5-Methoxy-1-phenyl-1H-benzoimidazole	DMPEKWD	Investigative	Small molecular drug	[634]
5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMNRSYA	Investigative	Small molecular drug	[760]
5-methoxy-2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole	DMX1LY3	Investigative	Small molecular drug	[258]
5-methoxy-2-(4-(methylsulfonyl)phenyl)-1H-indole	DMG2HSU	Investigative	Small molecular drug	[1624]
5-methoxy-2-(4-aminophenyl)benzofuran	DMW7IXL	Investigative	Small molecular drug	[1613]
5-methoxy-2-(4-dimethylaminophenyl)benzofuran	DM3NUMG	Investigative	Small molecular drug	[1613]
5-methoxy-2-(4-methylaminophenyl)benzofuran	DM5N1JX	Investigative	Small molecular drug	[1613]
5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one	DMW9D30	Investigative	Small molecular drug	[856]
5-Methoxy-4,9-dihydro-3H-beta-carboline	DMBOMZE	Investigative	Small molecular drug	[760]
5-methoxy-luzindole	DMUXTWC	Investigative	Small molecular drug	[1625]
5-Methoxy-N-phenylbenzo[d]oxazol-2-amine	DM98EQX	Investigative	Small molecular drug	[1598]
5-methoxycarbonylamino-N-acetyltryptamine	DMCZSP3	Investigative	Small molecular drug	[1626]
5-Methoxyflavone	DMQX3V9	Investigative	Small molecular drug	[1627]
5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMJ1HX2	Investigative	Small molecular drug	[304]
5-METHOXYTRYPTAMINE	DMARCKD	Investigative	Small molecular drug	[1628]
5-methyl nicotinic acid	DM0AIOW	Investigative	Small molecular drug	[1629]
5-methyl orotate	DMYNFIP	Investigative	Small molecular drug	[1589]
5-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DM0E1Y9	Investigative	Small molecular drug	[413]
5-methyl-2-(phenylsulfonamido)benzoic acid	DMC10HG	Investigative	Small molecular drug	[22]
5-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole	DMAR4ZF	Investigative	Small molecular drug	[958]
5-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	DMH1IVN	Investigative	Small molecular drug	[881]
5-Methyl-2-p-tolyl-thiazol-4-ol	DMIE9BG	Investigative	Small molecular drug	[922]
5-Methyl-3,4-diphenyl-isoxazole	DM0G2N5	Investigative	Small molecular drug	[1603]
5-methyl-3-phenylethynyl[1,2,4]triazine	DMF0IJ2	Investigative	Small molecular drug	[1202]
5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine	DM6DEOC	Investigative	Small molecular drug	[1150]
5-methyl-5-(5-methylthiophen-3-yl)-4-oxo-4,5-dihydrofuran-2-carboxylic acid	DMO37W4	Investigative	Small molecular drug	[1630]
5-Methyl-5-phenyl-pyrimidine-2,4,6-trione	DMRMKXD	Investigative	Small molecular drug	[1576]
5-methyl-benzo[b]thiophen-2-ylboronic acid	DMLJVB7	Investigative	Small molecular drug	[1617]
5-methyl-cyclosal-d4TMP	DMRC8SO	Investigative	Small molecular drug	[1293]
5-Methyl-N-phenylbenzo[d]oxazol-2-amine	DMNJ0XZ	Investigative	Small molecular drug	[1598]
5-Methyl-oxazolidin-(2Z)-ylideneamine	DMBQS31	Investigative	Small molecular drug	[192]
5-Methyl-pyrrolidin-(2Z)-ylideneamine	DM4QB3G	Investigative	Small molecular drug	[1150]
5-methylenearisteromycin	DMIQ1X3	Investigative	Small molecular drug	[1631]
5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	DMYERNM	Investigative	Small molecular drug	[440]
5-Methylsulfanyl-thiophene-2-carboxamidine	DM3MVSD	Investigative	Small molecular drug	[1632]
5-methylurapidil	DMCX9WN	Investigative	Small molecular drug	[1633]
5-MPEP	DMSRGTI	Investigative	Small molecular drug	[1634]
5-N-Allyl-Arginine	DMOSKJ8	Investigative	Small molecular drug	[12]
5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	DM74JL8	Investigative	Small molecular drug	[22]
5-Naphthalen-2-yl-1H-imidazole	DMK0PAL	Investigative	Small molecular drug	[522]
5-Naphthalen-2-yl-oxazole	DMTH3BW	Investigative	Small molecular drug	[522]
5-Nitro-1H-indole-2,3-dione	DMTS06Z	Investigative	Small molecular drug	[221]
5-Nitro-2-(4-phenoxy-phenyl)-1H-benzoimidazole	DM26MIC	Investigative	Small molecular drug	[928]
5-Nitroindazole	DMH7SIX	Investigative	Small molecular drug	[12]
5-nitroindirubin-3'-oxime	DM4K8N2	Investigative	Small molecular drug	[120]
5-Nonyl-5-phenyl-imidazolidine-2,4-dione	DM2DWUQ	Investigative	Small molecular drug	[1028]
5-octyl-2-phenoxyphenol	DMAXHEU	Investigative	Small molecular drug	[1635]
5-OH-DPAT	DMZT6JR	Investigative	Small molecular drug	[1636]
5-oxo-1-2-4-oxadiazol biphenyl	DME62OQ	Investigative	Small molecular drug	[1637]
5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate	DMQ94BX	Investigative	Small molecular drug	[1611]
5-oxo-12-HETE	DMLABR9	Investigative	Small molecular drug	[1638]
5-oxo-15-HETE	DM9ZC7B	Investigative	Small molecular drug	[1639]
5-oxo-20-HETE	DM493GU	Investigative	Small molecular drug	[1640]
5-oxo-C20:3	DM6FSUW	Investigative	Small molecular drug	[1641]
5-oxo-ODE	DM56TVA	Investigative	Small molecular drug	[1642]
5-p-Tolyl-1H-[1,2,3]triazole	DM2W0AD	Investigative	Small molecular drug	[1643]
5-p-Tolylsulfanyl-quinazoline-2,4-diamine	DMV4ICS	Investigative	Small molecular drug	[1644]
5-PENTYL-2-PHENOXYPHENOL	DMKHFV4	Investigative	Small molecular drug	[22]
5-Phenethyl-1H-pyrazole-3-carboxylic acid	DMZKJF8	Investigative	Small molecular drug	[727]
5-Phenethyl-quinazoline-2,4-diamine	DMWI7XJ	Investigative	Small molecular drug	[1563]
5-phenyl-1,3,4-oxadiazole-2(3H)-thione	DMZ6TRV	Investigative	Small molecular drug	[747]
5-phenyl-1,3,4-thiadiazole-2(3H)-thione	DMCKBQY	Investigative	Small molecular drug	[747]
5-phenyl-1H-1,2,3-triazole	DMWF4HX	Investigative	Small molecular drug	[768]
5-phenyl-1H-indazol-3-amine	DMJBEIF	Investigative	Small molecular drug	[22]
5-phenyl-2-(4-(piperidin-1-yl)butyl)oxazole	DMQHU0J	Investigative	Small molecular drug	[1645]
5-Phenyl-6-thia-10b-aza-benzo[e]azulen-4-one	DMLK2VT	Investigative	Small molecular drug	[1646]
5-Phenyl-6-thia-10b-aza-benzo[e]azulene	DMUBCVL	Investigative	Small molecular drug	[1501]
5-Phenyl-pentanoic acid benzyl-hydroxy-amide	DM3B6A8	Investigative	Small molecular drug	[1647]
5-phenylamino-4-cyano-3-hydroxy-isothiazole	DMX6R0H	Investigative	Small molecular drug	[1648]
5-Phenylsulfanyl-2,4-Quinazolinediamine	DMMWYFR	Investigative	Small molecular drug	[12]
5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate	DMGK05W	Investigative	Small molecular drug	[12]
5-propenyl-2'-deoxyuridine triphosphate	DM6A902	Investigative	NA	[1649]
5-propenyl-arabinofuranosyluracil 5'-triphosphate	DM762FY	Investigative	Small molecular drug	[1649]
5-Propyl-1H-pyrazole-3-carboxylic acid	DMSPVXM	Investigative	Small molecular drug	[727]
5-propyl-2'-deoxyuridine	DM9IHV6	Investigative	Small molecular drug	[1085]
5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one	DMLRM9Z	Investigative	Small molecular drug	[1181]
5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one	DMQYIBC	Investigative	Small molecular drug	[1181]
5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime	DMZQPTU	Investigative	Small molecular drug	[1650]
5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	DMVX063	Investigative	Small molecular drug	[22]
5-tert-Butyl-2-(4-ethynyl-phenyl)-[1,3]dithiane	DMCG6EK	Investigative	Small molecular drug	[1427]
5-tert-Butyl-2-(4-fluoro-phenyl)-[1,3]dithiane	DMQK32F	Investigative	Small molecular drug	[1427]
5-thia-8,11,14,17-eicosatetraenoic acid	DMF4RGW	Investigative	Small molecular drug	[1651]
5-tosyl-5H-dibenzo[b,d]azepin-7(6H)-one	DMTB91D	Investigative	Small molecular drug	[1652]
5-[(1R)-1-ammonioethyl]isoxazol-3-olate	DM23PL4	Investigative	Small molecular drug	[141]
5-[(1S)-1-ammonioethyl]isoxazol-3-olate	DMYAPLT	Investigative	Small molecular drug	[141]
5-[(2-methyl-4-thiazolyl)ethynyl]pyrimidine	DMM9GCA	Investigative	Small molecular drug	[228]
5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	DMLFY2T	Investigative	Small molecular drug	[22]
5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	DM1KO7U	Investigative	Small molecular drug	[22]
5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole	DMW8RLN	Investigative	Small molecular drug	[1276]
5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole	DMV7QU3	Investigative	Small molecular drug	[1619]
5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole	DMZICL8	Investigative	Small molecular drug	[1619]
5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine	DM2RIHT	Investigative	Small molecular drug	[1180]
5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine	DMQGX2Z	Investigative	Small molecular drug	[1180]
5-[5-Methoxy-indan-(1E)-ylidenemethyl]-thiazole	DM5FA74	Investigative	Small molecular drug	[1180]
5-[5-Methoxy-indan-(1Z)-ylidenemethyl]-thiazole	DMPDN63	Investigative	Small molecular drug	[1180]
5-{8(Z),-pentadecenyl}resorcinol	DMNRWEV	Investigative	Small molecular drug	[1653]
5-{8(Z),11(Z),14-pentadecatrienyl}resorcinol	DMSZ3T6	Investigative	Small molecular drug	[1653]
5-{8(Z),11(Z)-pentadecadienyl}resorcinol	DM0EBWR	Investigative	Small molecular drug	[1653]
5alpha-Androstan-3,17-Dione	DMHI7Y2	Investigative	Small molecular drug	[12]
5BrUTP	DMEVRH4	Investigative	Small molecular drug	[1654]
5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	DM1SON5	Investigative	Small molecular drug	[977]
5PAM523	DMPLB3S	Investigative	Small molecular drug	[1655]
5S-HETE	DM3Z6G4	Investigative	Small molecular drug	[1656]
5S-HPETE	DME1304	Investigative	Small molecular drug	[1657]
6'-Iodononivamide	DM0GSRL	Investigative	Small molecular drug	[1658]
6'-methylepibatidine	DMTG8D0	Investigative	Small molecular drug	[1659]
6,11-dihydro-5H-benzo[a]carbazole	DMSB8WQ	Investigative	Small molecular drug	[1056]
6,11-dihydrothiochromeno[4,3-b]indol-8-ol	DM0RB53	Investigative	Small molecular drug	[670]
6,6-dimethyl-1-phenyl-3-aza-bicyclo[3.1.0]hexane	DMMZTE3	Investigative	Small molecular drug	[214]
6,6-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	DMOIFAP	Investigative	Small molecular drug	[379]
6,7'-oxybis(2-phenyl-4H-chromen-4-one)	DMT09YC	Investigative	Small molecular drug	[1660]
6,7,8,9-Tetrahydro-5-thia-8-aza-benzocycloheptene	DMNOI7B	Investigative	Small molecular drug	[275]
6,7,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one	DMAMD87	Investigative	Small molecular drug	[428]
6,7,8-Trimethoxy-4-methylquinolin-2(1H)-one	DMJX9NQ	Investigative	Small molecular drug	[428]
6,7-dibromoquinoline-5,8-dione	DMDO083	Investigative	Small molecular drug	[1661]
6,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione	DMMX1QJ	Investigative	Small molecular drug	[1553]
6,7-dichloro-1H-indole-2,3-dione	DMZHDFM	Investigative	Small molecular drug	[475]
6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine	DM592FB	Investigative	Small molecular drug	[1662]
6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione	DMNEJ8W	Investigative	Small molecular drug	[1560]
6,7-Dichloro-3-thiophen-3-yl-quinoline	DMJNHSL	Investigative	Small molecular drug	[1168]
6,7-diethoxy-4-(4-phenylbut-1-enyl)quinazoline	DMI7FVJ	Investigative	Small molecular drug	[1468]
6,7-diethoxy-4-(5-phenylpent-1-enyl)quinazoline	DMFVT8A	Investigative	Small molecular drug	[1468]
6,7-diethoxy-4-styrylquinazoline	DMVR4OW	Investigative	Small molecular drug	[1468]
6,7-Difluoro-3-thiophen-3-yl-quinoline	DMUZYXQ	Investigative	Small molecular drug	[1168]
6,7-Dihydroxy-2-phenyl-chromen-4-one	DMF08UT	Investigative	Small molecular drug	[866]
6,7-dihydroxy-8-nitro-1-tetralone	DM9JLUS	Investigative	Small molecular drug	[502]
6,7-Dimethoxy-3-((E)-styryl)-quinoline	DMSM0QV	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-(2-methoxy-phenyl)-quinoline	DMPYGK9	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline	DMDENVF	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline	DM12DVT	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline	DMM7NHI	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-p-tolyl-quinoline	DMM7IAK	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-phenyl-quinoline	DM516B4	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-phenylethynyl-quinoline	DMFRXDT	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-pyridin-3-yl-quinoline	DMSG1AY	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-3-pyridin-4-yl-quinoline	DMW7K5P	Investigative	Small molecular drug	[1328]
6,7-Dimethoxy-3-thiophen-2-yl-quinoline	DM6WD8T	Investigative	Small molecular drug	[1168]
6,7-Dimethoxy-4-(2-methoxy-phenoxy)-quinoline	DMU15YV	Investigative	Small molecular drug	[1225]
6,7-dimethoxy-4-(2-phenylethynyl)quinazoline	DMQTHV7	Investigative	Small molecular drug	[1468]
6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline	DMPS2GX	Investigative	Small molecular drug	[1225]
6,7-Dimethoxy-4-(3-nitro-phenoxy)-quinoline	DM3YSNX	Investigative	Small molecular drug	[1225]
6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline	DMKO8QT	Investigative	Small molecular drug	[1468]
6,7-Dimethoxy-4-(4-methoxy-phenoxy)-quinoline	DMX2VFP	Investigative	Small molecular drug	[1225]
6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline	DMBI40Y	Investigative	Small molecular drug	[1468]
6,7-Dimethoxy-4-m-tolyloxy-quinoline	DMEMGPU	Investigative	Small molecular drug	[1225]
6,7-Dimethoxy-4-phenoxy-quinoline	DMBZP3I	Investigative	Small molecular drug	[1225]
6,7-dimethoxy-N-m-tolylquinazolin-4-amine	DMP8LXB	Investigative	Small molecular drug	[1663]
6,7-Diphenyl-pteridine-2,4-diamine	DM7U8ID	Investigative	Small molecular drug	[1664]
6,8-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine	DMUEFDM	Investigative	Small molecular drug	[1665]
6,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one	DMAFP18	Investigative	Small molecular drug	[428]
6,8-Dimethoxy-4-methylquinolin-2(1H)-one	DMYKSTZ	Investigative	Small molecular drug	[428]
6,8-Dinitro-2-piperazin-1-yl-quinoline	DME4193	Investigative	Small molecular drug	[890]
6,9-Dimethyl-2-oxa-spiro[4.4]nonan-1-one	DM7FMWS	Investigative	Small molecular drug	[379]
6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione	DMOR04W	Investigative	NA	[469]
6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one	DM5RX0K	Investigative	Small molecular drug	[1175]
6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one	DM1TOFD	Investigative	Small molecular drug	[1666]
6-(2,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	DMRU963	Investigative	Small molecular drug	[441]
6-(2,6-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	DMFALTY	Investigative	Small molecular drug	[441]
6-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one	DMA9LFR	Investigative	Small molecular drug	[957]
6-(2-Amino-ethyl)-biphenyl-2,3,4'-triol	DMO724D	Investigative	Small molecular drug	[1667]
6-(2-Amino-ethyl)-biphenyl-2,3-diol	DMI8KOF	Investigative	Small molecular drug	[1667]
6-(2-aminophenoxy)benzo[d]isothiazol-3-amine	DMXFRW9	Investigative	Small molecular drug	[1668]
6-(2-benzylisoindolin-5-yloxy)nicotinamide	DMUD2R9	Investigative	Small molecular drug	[1669]
6-(2-Bromo-acetylamino)-hexanoic acid phenylamide	DM9LKXD	Investigative	Small molecular drug	[1480]
6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	DMYDHLN	Investigative	Small molecular drug	[1666]
6-(2-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	DMTPAMS	Investigative	Small molecular drug	[441]
6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	DM2Y9O4	Investigative	Small molecular drug	[1666]
6-(2-Dipropylamino-ethyl)-biphenyl-2,3,4'-triol	DM3VME7	Investigative	Small molecular drug	[1667]
6-(2-Dipropylamino-ethyl)-biphenyl-2,3-diol	DMNQWZO	Investigative	Small molecular drug	[1667]
6-(2-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	DM6Q3M7	Investigative	Small molecular drug	[441]
6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	DMQKR2W	Investigative	Small molecular drug	[1666]
6-(2-Fluoropropyl)-4-methylpyridin-2-amine	DME1JLM	Investigative	Small molecular drug	[230]
6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	DMA2CPG	Investigative	Small molecular drug	[22]
6-(2-Hydroxy-phenyl)-naphthalen-2-ol	DMM3798	Investigative	Small molecular drug	[441]
6-(2-Imidazol-1-yl-vinyl)-1H-quinolin-2-one	DMXZWOA	Investigative	Small molecular drug	[1670]
6-(2-mercaptoacetamido)-N-phenylhexanamide	DM9P4LB	Investigative	Small molecular drug	[1671]
6-(2-phenethylisoindolin-5-yloxy)nicotinamide	DMQOJBN	Investigative	Small molecular drug	[1669]
6-(2-Phenylsulfanyl-ethyl)-pteridine-2,4-diamine	DMKXNP0	Investigative	Small molecular drug	[1664]
6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)	DMZHFWX	Investigative	Small molecular drug	[500]
6-(3,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	DMKJOL6	Investigative	Small molecular drug	[441]
6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol	DMIXT2L	Investigative	Small molecular drug	[1123]
6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol	DMA8TWC	Investigative	Small molecular drug	[1672]
6-(3-(trifluoromethyl)phenyl)picolinonitrile	DMDYQE2	Investigative	Small molecular drug	[1673]
6-(3-Amino-benzyloxy)-9H-purin-2-ylamine	DMJ92W0	Investigative	Small molecular drug	[1674]
6-(3-aminopropyl)benzo[h]isoquinolin-1(2H)-one	DMYA4D2	Investigative	Small molecular drug	[1675]
6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline	DMKFDQ7	Investigative	Small molecular drug	[214]
6-(3-Benzoyl-ureido)-hexanoic acid hydroxyamide	DMQZTS3	Investigative	Small molecular drug	[1676]
6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	DM89LF5	Investigative	Small molecular drug	[22]
6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione	DMMFWYX	Investigative	Small molecular drug	[1677]
6-(3-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	DM4YP3Q	Investigative	Small molecular drug	[441]
6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	DMJO4I7	Investigative	Small molecular drug	[1666]
6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione	DMKUHN9	Investigative	Small molecular drug	[1677]
6-(3-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	DMAJEDG	Investigative	Small molecular drug	[441]
6-(3-Fluoropropyl)-4-methylpyridin-2-amine	DMTJPZU	Investigative	Small molecular drug	[230]
6-(3-Hydroxy-phenyl)-naphthalen-1-ol	DMMHRVO	Investigative	Small molecular drug	[441]
6-(3-Hydroxy-phenyl)-naphthalen-2-ol	DMH8WA2	Investigative	NA	[1428]
6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol	DMMZENV	Investigative	Small molecular drug	[600]
6-(3-hydroxyphenyl)-2-morpholino-4H-chromen-4-one	DM28DPY	Investigative	Small molecular drug	[957]
6-(3-Iodo-phenylamino)-1H-pyrimidine-2,4-dione	DMISV5A	Investigative	Small molecular drug	[1677]
6-(3-Methyl-benzyloxy)-9H-purin-2-ylamine	DMSW3KN	Investigative	Small molecular drug	[1674]
6-(3-Nitro-phenyl)-3H-benzothiazol-2-one	DM83VN6	Investigative	Small molecular drug	[1678]
6-(4-((benzylamino)methyl)phenoxy)nicotinamide	DMEM1BA	Investigative	Small molecular drug	[1413]
6-(4-((phenethylamino)methyl)phenoxy)nicotinamide	DM9VD4W	Investigative	Small molecular drug	[1669]
6-(4-(2-(benzylamino)ethyl)phenoxy)nicotinamide	DMDKOWP	Investigative	Small molecular drug	[1669]
6-(4-(2-(benzylamino)ethyl)phenoxy)picolinamide	DMOSDM2	Investigative	Small molecular drug	[1413]
6-(4-(3-(benzylamino)propyl)phenoxy)nicotinamide	DMDTMB7	Investigative	Small molecular drug	[1413]
6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	DM9K8DY	Investigative	Small molecular drug	[1666]
6-(4-Bromo-phenylamino)-1H-pyrimidine-2,4-dione	DMCYQDU	Investigative	Small molecular drug	[1677]
6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	DMNAHVB	Investigative	Small molecular drug	[1666]
6-(4-Chloro-phenylamino)-1H-pyrimidine-2,4-dione	DM5LUF4	Investigative	Small molecular drug	[1677]
6-(4-chlorophenyl)-2-morpholin-4-ylpyridin-4-ol	DMSO2JW	Investigative	Small molecular drug	[824]
6-(4-chlorophenyl)-4-morpholino-2H-pyran-2-one	DMMTG7L	Investigative	Small molecular drug	[824]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	DM0C1FX	Investigative	Small molecular drug	[143]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	DM1N46J	Investigative	Small molecular drug	[143]
6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	DM5H4KE	Investigative	Small molecular drug	[143]
6-(4-chlorophenylamino)-N,N-diethylnicotinamide	DMOZFU5	Investigative	Small molecular drug	[1679]
6-(4-Decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one	DMYQB5R	Investigative	Small molecular drug	[374]
6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	DM7WYNT	Investigative	Small molecular drug	[1666]
6-(4-Fluoro-phenylsulfanyl)-9H-purine	DM5JWEY	Investigative	Small molecular drug	[183]
6-(4-Fluorobutyl)-4-methylpyridin-2-amine	DM3EDBO	Investigative	Small molecular drug	[230]
6-(4-fluorostyryl)-2-morpholino-4H-chromen-4-one	DMKGTRF	Investigative	Small molecular drug	[957]
6-(4-Hydroxy-2-methoxy-phenyl)-naphthalen-2-ol	DMYM3EW	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-2-methyl-phenyl)-naphthalen-2-ol	DMYEIRH	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-phenyl)-1-methoxy-naphthalen-2-ol	DMBG5Y8	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-phenyl)-1-methyl-naphthalen-2-ol	DMGLT0N	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-phenyl)-1-nitro-naphthalen-2-ol	DMGC84U	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-phenyl)-1-phenyl-naphthalen-2-ol	DMI6UVN	Investigative	Small molecular drug	[441]
6-(4-Hydroxy-phenyl)-naphthalen-1-ol	DM2V9XI	Investigative	NA	[441]
6-(4-Hydroxy-phenyl)-naphthalen-2-ol	DM3L2OI	Investigative	Small molecular drug	[915]
6-(4-hydroxyphenyl)-2-morpholino-4H-chromen-4-one	DMTYWCS	Investigative	Small molecular drug	[957]
6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one	DM5LBCH	Investigative	Small molecular drug	[1666]
6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one	DMUHCO8	Investigative	Small molecular drug	[824]
6-(4-Methyl-piperazin-1-yl)-phenanthridine	DM1HAWR	Investigative	Small molecular drug	[1680]
6-(4-Methylpiperazin-1-yl)-9H-purin-2-amine	DMWITYU	Investigative	Small molecular drug	[1681]
6-(4-methylpiperazin-1-yl)-9Hpurine	DMA3FQP	Investigative	Small molecular drug	[1681]
6-(4-Methylpiperazin-1-yl)pyrimidine-2,4-diamine	DMYAS2V	Investigative	Small molecular drug	[1681]
6-(4-Methylpyridin-3-yl)-2-naphthonitrile	DMTV753	Investigative	Small molecular drug	[1229]
6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine	DMPL5XV	Investigative	Small molecular drug	[1682]
6-(9H-carbazol-9-yl)-N-hydroxyhexanamide	DMVMDJ3	Investigative	Small molecular drug	[1683]
6-(Allyl-methyl-amino)-4,4-diphenyl-heptan-3-ol	DMYMJHF	Investigative	Small molecular drug	[1684]
6-(aminomethyl)-2H-chromen-2-one	DMJU9TG	Investigative	Small molecular drug	[1069]
6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one	DM2GFI3	Investigative	Small molecular drug	[1666]
6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one	DMXLDHR	Investigative	Small molecular drug	[1666]
6-(benzylamino)-9-butyl-9H-purine-2-carbonitrile	DM7BIJH	Investigative	Small molecular drug	[1685]
6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one	DM4KMDB	Investigative	Small molecular drug	[1666]
6-(Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine	DMAYWIN	Investigative	Small molecular drug	[1674]
6-(Dihydroxy-Isobutyl)-Thymine	DMQPTL5	Investigative	Small molecular drug	[12]
6-(furan-2-yl)-9H-purin-2-amine	DMOYCBH	Investigative	Small molecular drug	[1432]
6-(hydroxymethyl)-2H-chromen-2-one	DM5TOX2	Investigative	Small molecular drug	[1069]
6-(Indan-5-ylamino)-1H-pyrimidine-2,4-dione	DMSH107	Investigative	Small molecular drug	[1677]
6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	DMHM0RW	Investigative	Small molecular drug	[12]
6-(Naphthalen-2-ylamino)-1H-pyrimidine-2,4-dione	DMM2TFX	Investigative	Small molecular drug	[1677]
6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one	DMXSCQE	Investigative	Small molecular drug	[1666]
6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one	DMCIA63	Investigative	Small molecular drug	[1666]
6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	DM1LY0S	Investigative	Small molecular drug	[12]
6-(piperazin-1-yl)-3-tosyl-1H-indazole	DMM9G0J	Investigative	Small molecular drug	[1438]
6-(piperazin-1-yl)-9-propyl-9H-purine	DMUNWJR	Investigative	Small molecular drug	[561]
6-(piperidin-4-ylmethoxy)-2-naphthonitrile	DMBQKGY	Investigative	Small molecular drug	[59]
6-(pyridin-3-yl)-2-naphthonitrile	DMC3SJI	Investigative	Small molecular drug	[1181]
6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one	DMV3MF4	Investigative	Small molecular drug	[1666]
6-Acetyl-7-ethoxy-2H-chromen-2-one	DMERKGH	Investigative	Small molecular drug	[1686]
6-Acetyl-7-hydroxy-2H-chromen-2-one	DM1K0E2	Investigative	Small molecular drug	[1686]
6-acetyl-7-methoxy-2H-chromen-2-one	DMXOB2K	Investigative	Small molecular drug	[1686]
6-acetyl-7-propoxy-2H-chromen-2-one	DMCG8BJ	Investigative	Small molecular drug	[1686]
6-Allyloxy-9H-purin-2-ylamine	DMI2XUQ	Investigative	Small molecular drug	[1687]
6-Amino-2-(1H-imidazol-4-yl)-hexanoic acid	DMMUE05	Investigative	Small molecular drug	[1688]
6-amino-4-trifluoromethylquinolin-2(1H)-one	DMC5M76	Investigative	Small molecular drug	[1689]
6-amino-5-bromouracil	DM5SZHR	Investigative	Small molecular drug	[1690]
6-amino-5-chlorouracil hydrochloride	DMFPCSJ	Investigative	Small molecular drug	[1590]
6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	DMU1CV4	Investigative	Small molecular drug	[1138]
6-Amino-benzothiazole-2-sulfonic acid amide	DMWPELS	Investigative	Small molecular drug	[1691]
6-amino-N-(2,4-dichlorobenzyl)nicotinamide	DMEHG2F	Investigative	Small molecular drug	[1692]
6-amino-N-(3,3-diphenylpropyl)nicotinamide	DMYI5GU	Investigative	Small molecular drug	[1692]
6-amino-uridine monophosphate	DMUZOYN	Investigative	Small molecular drug	[1693]
6-aza-uridine monophosphate	DM7WYCM	Investigative	Small molecular drug	[1693]
6-Azido-8-(3-iodo-phenyl)-quinoline	DM8BNWH	Investigative	Small molecular drug	[1694]
6-benzenesulfinylhexanoic acid hydroxamide	DM2I95Z	Investigative	Small molecular drug	[1695]
6-Benzenesulfonyl-2H-pyridazin-3-one	DM81DTC	Investigative	Small molecular drug	[1666]
6-benzenesulfonylhexanoic acid hydroxamide	DMY9IK8	Investigative	Small molecular drug	[1695]
6-Benzyl-2-cyclohexylsulfanyl-3H-pyrimidin-4-one	DM0CZ1F	Investigative	Small molecular drug	[1696]
6-Benzyl-2-cyclopentylsulfanyl-3H-pyrimidin-4-one	DMZRQEF	Investigative	Small molecular drug	[1697]
6-Benzyl-2-isobutylsulfanyl-3H-pyrimidin-4-one	DMI5RNJ	Investigative	Small molecular drug	[1696]
6-Benzyl-2-sec-butylsulfanyl-3H-pyrimidin-4-one	DM7ANE3	Investigative	Small molecular drug	[1697]
6-benzyl-3-ethoxycarbonyl-4-quinolone	DMICRFQ	Investigative	Small molecular drug	[1260]
6-benzyl-3-propoxycarbonyl-4-quinolone	DMXMI5E	Investigative	Small molecular drug	[1260]
6-benzyl-3-propylaminocarbonyl-4-quinolone	DM7HNPJ	Investigative	Small molecular drug	[1260]
6-Benzylamino-1H-pyrimidine-2,4-dione	DM8FUZL	Investigative	Small molecular drug	[975]
6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione	DMGJYWF	Investigative	Small molecular drug	[975]
6-Benzylamino-5-iodo-1H-pyrimidine-2,4-dione	DM8FTNC	Investigative	Small molecular drug	[975]
6-Benzyloxy-5-nitro-pyrimidine-2,4-diamine	DMK8XIO	Investigative	Small molecular drug	[1698]
6-Benzyloxy-5-nitroso-pyrimidine-2,4-diamine	DMUFSE2	Investigative	Small molecular drug	[1698]
6-Benzyloxy-9H-purin-2-ylamine	DMFI7A8	Investigative	Small molecular drug	[1698]
6-Benzyloxybenzo[b]thiophene-2-carboxamidine	DMARP3M	Investigative	Small molecular drug	[1467]
6-Benzylsulfanyl-9H-purine	DMI7FNZ	Investigative	Small molecular drug	[183]
6-Benzylthioinosine	DMNXGZP	Investigative	Small molecular drug	[1699]
6-biphenyl-2-yl-2-morpholin-4-yl-chromen-4-one	DMZPY69	Investigative	Small molecular drug	[957]
6-bromo-1-methyl-3-(pyridin-4-yl)-1H-indole	DMM9GOR	Investigative	Small molecular drug	[621]
6-bromo-1H-indazole	DMU9WG0	Investigative	Small molecular drug	[1469]
6-bromo-2'-de-N-methylaplysinopsin	DM39VT6	Investigative	Small molecular drug	[1700]
6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMXQ8K1	Investigative	Small molecular drug	[760]
6-Bromo-2-(2-nitro-phenyl)-chromen-4-one	DM7U58O	Investigative	Small molecular drug	[1701]
6-Bromo-2-(3-bromo-phenyl)-chromen-4-one	DMTJRF3	Investigative	Small molecular drug	[879]
6-Bromo-2-(3-nitro-phenyl)-chromen-4-one	DMP8ZVS	Investigative	Small molecular drug	[1701]
6-Bromo-2-(4-nitro-phenyl)-chromen-4-one	DMCX3TM	Investigative	Small molecular drug	[1701]
6-Bromo-2-phenyl-chromen-4-one	DMMCNQI	Investigative	Small molecular drug	[879]
6-Bromo-2-piperazin-1-yl-quinoline	DMLT01H	Investigative	Small molecular drug	[890]
6-bromo-3-(pyridin-4-yl)-1H-indole	DMVWX62	Investigative	Small molecular drug	[621]
6-bromo-3-ethoxycarbonyl-2-methyl-4-quinolone	DM4HRIX	Investigative	Small molecular drug	[1260]
6-bromo-3-ethoxycarbonyl-4-quinolone	DM0MQHP	Investigative	Small molecular drug	[1260]
6-Bromo-4,9-dihydro-3H-beta-carboline	DM64KOZ	Investigative	Small molecular drug	[760]
6-bromo-5-methyl-1H-indole-2,3-dione	DMFZ2PI	Investigative	Small molecular drug	[475]
6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione	DM8A1ZU	Investigative	Small molecular drug	[1585]
6-bromo-8-(piperazin-1-yl)imidazo[1,2-a]pyrazine	DMZJ6M8	Investigative	Small molecular drug	[561]
6-bromo-N-(3-bromophenyl)quinazolin-4-amine	DMP9O7G	Investigative	Small molecular drug	[1228]
6-bromo-N-(3-chlorophenyl)quinazolin-4-amine	DM0A3DB	Investigative	Small molecular drug	[1228]
6-bromo-N-(3-fluorophenyl)quinazolin-4-amine	DM2IP5F	Investigative	Small molecular drug	[1228]
6-bromo-N-m-tolylquinazolin-4-amine	DM2MJ9F	Investigative	Small molecular drug	[1228]
6-bromoaplysinopsin	DMQGB70	Investigative	Small molecular drug	[1700]
6-bromoindirubin-3-oxime	DM12WYV	Investigative	Small molecular drug	[1702]
6-butyl-2,4-dipropylaminopyrimidine	DM46GLQ	Investigative	Small molecular drug	[783]
6-Carboxymethyluracil	DM9MPDK	Investigative	Small molecular drug	[12]
6-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	DMW6320	Investigative	Small molecular drug	[135]
6-Chloro-1,4-dihydro-quinoxaline-2,3-dione	DMURJ34	Investigative	Small molecular drug	[1703]
6-chloro-1H-indazole	DMKCBIL	Investigative	Small molecular drug	[1469]
6-Chloro-2-(3-nitro-phenyl)-chromen-4-one	DMTWBOV	Investigative	Small molecular drug	[879]
6-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	DMLMOC0	Investigative	Small molecular drug	[847]
6-Chloro-2-phenyl-chromen-4-one	DM5FZDI	Investigative	Small molecular drug	[879]
6-Chloro-2-piperazin-1-yl-quinoline	DMM41AQ	Investigative	Small molecular drug	[890]
6-Chloro-4-morpholin-4-yl-chromen-2-one	DMHJIN0	Investigative	Small molecular drug	[627]
6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione	DMSZML2	Investigative	Small molecular drug	[1585]
6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione	DMASFR6	Investigative	Small molecular drug	[1585]
6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione	DMP4V8Y	Investigative	Small molecular drug	[1585]
6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione	DMUJSP7	Investigative	Small molecular drug	[1585]
6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione	DM90JMN	Investigative	Small molecular drug	[1585]
6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione	DMB24LJ	Investigative	Small molecular drug	[1585]
6-Chloro-N-(2-morpholinoethyl)nicotinamide	DM10A9S	Investigative	Small molecular drug	[999]
6-chloro-N-(3-chlorophenyl)quinazolin-4-amine	DMPIFLA	Investigative	Small molecular drug	[1228]
6-Chloro-N-(3-morpholinopropyl)nicotinamide	DM78I4P	Investigative	Small molecular drug	[999]
6-chloro-N-(pyridin-3-yl)indoline-1-carboxamide	DMUY9TF	Investigative	Small molecular drug	[300]
6-Chloropurine Riboside, 5'-Monophosphate	DMWB43U	Investigative	Small molecular drug	[12]
6-chlorotacrine hydrochloride	DMV0C69	Investigative	Small molecular drug	[1704]
6-cinnamoyl-N-methylstephasunoline	DMPXS9F	Investigative	Small molecular drug	[1705]
6-cinnamoylhernandine	DMPULH3	Investigative	Small molecular drug	[1705]
6-Cl-IMP	DMNTDFV	Investigative	Small molecular drug	[1706]
6-Cl-MLT	DMKNOLV	Investigative	Small molecular drug	[1707]
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	DMACTDZ	Investigative	Small molecular drug	[22]
6-Cyclohexylmethoxy-pyrimidine-2,4,5-triamine	DM9IHYS	Investigative	Small molecular drug	[1708]
6-cyclohexylmethyloxy-2-(4'-hydroxyanilino)purine	DM6UP25	Investigative	Small molecular drug	[22]
6-Deoxy-Alpha-D-Glucose	DM9HBY5	Investigative	Small molecular drug	[12]
6-deoxymanzamine X	DMKPWN0	Investigative	Small molecular drug	[672]
6-desoxonaltrexone	DMGZQNS	Investigative	Small molecular drug	[1272]
6-Dimethylamino-2-methyl-hex-4-ynal oxime	DML2AC1	Investigative	Small molecular drug	[1054]
6-ethyl-2,4-diisobutylaminopyrimidine	DMBMRUI	Investigative	Small molecular drug	[783]
6-Ethyl-2-phenyl-chromen-4-one	DMUHOF4	Investigative	Small molecular drug	[840]
6-ethyl-3-(2-ethylbutoxycarbonyl)-4-quinolone	DMLEUP2	Investigative	Small molecular drug	[1260]
6-ethyl-3-(2-methylbutoxycarbonyl)-4-quinolone	DMESU53	Investigative	Small molecular drug	[1260]
6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone	DM1POEA	Investigative	Small molecular drug	[1260]
6-ethyl-3-(3-pentoxycarbonyl)-4-quinolone	DMG05V1	Investigative	Small molecular drug	[1260]
6-ethyl-3-i-propoxycarbonyl-4-quinolone	DML9EU7	Investigative	Small molecular drug	[1260]
6-ethyl-3-pentoxycarbonyl-4-quinolone	DMSGJM6	Investigative	Small molecular drug	[1260]
6-ethyl-3-propoxycarbonyl-4-quinolone	DMGVI08	Investigative	Small molecular drug	[1260]
6-ethyl-3-propylaminocarbonyl-4-quinolone	DMC1F2E	Investigative	Small molecular drug	[1260]
6-ethyl-4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	DMOGETD	Investigative	Small molecular drug	[1162]
6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE	DM9OD7U	Investigative	Small molecular drug	[22]
6-ethylamino-2-(3''-indolyl)ethyloxy)adenosine	DME4GBS	Investigative	Small molecular drug	[825]
6-Fluoro-2-(3-nitro-phenyl)-chromen-4-one	DMPZIV0	Investigative	Small molecular drug	[879]
6-fluoro-2-methyl-9H-carbazole	DM2DTHV	Investigative	Small molecular drug	[548]
6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione	DM4Q5TX	Investigative	Small molecular drug	[1585]
6-Fluoro-N-(2-morpholinoethyl)nicotinamide	DMA1QH0	Investigative	Small molecular drug	[999]
6-fluoro-N-m-tolylquinazolin-4-amine	DMVADTP	Investigative	Small molecular drug	[1228]
6-fluoro-noradrenaline	DMF2RGY	Investigative	Small molecular drug	[1709]
6-Fluoromelatonin	DMKFUO0	Investigative	Small molecular drug	[197]
6-fluoromevalonate 5-diphosphate	DMPZ92X	Investigative	Small molecular drug	[1710]
6-fluoromevalonate pyrophosphate	DMZ26LS	Investigative	Small molecular drug	[1711]
6-fluoronorepinehprine	DMPWXI8	Investigative	Small molecular drug	[1018]
6-fluoropyridin-3-ylboronic acid	DMS325C	Investigative	Small molecular drug	[1019]
6-fluorotryptophan	DM6YD3U	Investigative	Small molecular drug	[1712]
6-Furan-2-yl-9-phenethyl-9H-purin-2-ylamine	DMOLIW4	Investigative	Small molecular drug	[1713]
6-Furan-2-yl-9-phenyl-9H-purin-2-ylamine	DMSJP6T	Investigative	Small molecular drug	[1713]
6-guanidino-2-(3''-indolylethyloxy)adenosine	DMM86PK	Investigative	Small molecular drug	[825]
6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one	DMF3W15	Investigative	Small molecular drug	[1271]
6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium	DMWLN2Y	Investigative	Small molecular drug	[1714]
6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium	DM20DAG	Investigative	Small molecular drug	[1714]
6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	DMPSOIF	Investigative	Small molecular drug	[22]
6-Hydroxy-1,6-Dihydro Purine Nucleoside	DMUD1CG	Investigative	Small molecular drug	[12]
6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium	DMNA2M6	Investigative	Small molecular drug	[1714]
6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	DMU1CGD	Investigative	Small molecular drug	[866]
6-hydroxy-2-methyl-9H-beta-carbolin-2-ium	DMAK35M	Investigative	Small molecular drug	[1714]
6-hydroxy-3-(3',5'-dihydroxyphenyl)coumarin	DM4F5OG	Investigative	Small molecular drug	[1715]
6-Hydroxy-5,7-dimethyl-beta-carboline	DM0CVTI	Investigative	Small molecular drug	[1559]
6-Hydroxy-7,8-Dihydro Purine Nucleoside	DMNM1EZ	Investigative	Small molecular drug	[12]
6-hydroxy-7,9-octadecadiynoic acid	DMPQTNK	Investigative	Small molecular drug	[233]
6-Hydroxy-benzothiazole-2-sulfonic acid amide	DM2B4S5	Investigative	NA	[788]
6-Hydroxy-N-(2-morpholinoethyl)nicotinamide	DM6KVO0	Investigative	Small molecular drug	[999]
6-hydroxybenzo[d][1,3]oxathiol-2-one	DMDRSNH	Investigative	Small molecular drug	[1716]
6-hydroxydopa quinone	DM7M58P	Investigative	Small molecular drug	[12]
6-Hydroxyflavanone	DM6FNVC	Investigative	Small molecular drug	[1627]
6-hydroxymelatonin	DM89YV7	Investigative	Small molecular drug	[1717]
6-Hydroxymethyl-7,8-Dihydropterin	DMYF60K	Investigative	Small molecular drug	[12]
6-Hydroxymethylpterin	DM7EWDN	Investigative	Small molecular drug	[107]
6-Hydroxypropylthymine	DMVRFU5	Investigative	Small molecular drug	[12]
6-Hydroxyuridine-5'-Phosphate	DMDMNQV	Investigative	Small molecular drug	[12]
6-ile-ustiloxin	DMQF8JG	Investigative	Small molecular drug	[1718]
6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one	DMRMSU5	Investigative	Small molecular drug	[1670]
6-Imidazol-1-yl-isoquinoline	DMQXL1Y	Investigative	Small molecular drug	[1568]
6-Imidazol-1-ylmethyl-8-phenyl-quinoline	DMBQ3HV	Investigative	Small molecular drug	[1694]
6-Iodo-2-piperazin-1-yl-quinoline	DM31VLA	Investigative	Small molecular drug	[890]
6-iodo-4'-dimethyaminoflavone	DMAL1UH	Investigative	Small molecular drug	[1719]
6-iodo-4'-hydroxyflavone	DM5FZBI	Investigative	Small molecular drug	[1719]
6-iodo-4'-methoxyflavone	DM6U9CY	Investigative	Small molecular drug	[1719]
6-iodo-4'-methylaminoflavone	DM9GJAY	Investigative	Small molecular drug	[1719]
6-iodo-nordihydrocapsaicin	DM1S9DB	Investigative	Small molecular drug	[1720]
6-isobutyl-4-methylpyridin-2-amine	DM2XB68	Investigative	Small molecular drug	[230]
6-isopropyl-2-morpholin-4-yl-4H-thiopyran-4-one	DMGXMZL	Investigative	Small molecular drug	[824]
6-Isopropyl-2-phenyl-chromen-4-one	DMO2F8L	Investigative	Small molecular drug	[840]
6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one	DM2WUZP	Investigative	Small molecular drug	[1181]
6-m-Tolyl-pteridine-2,4,7-triamine	DMHU78R	Investigative	Small molecular drug	[1664]
6-Mercapto-hexanoic acid phenylamide	DMD2FW9	Investigative	Small molecular drug	[1480]
6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium	DMJUT70	Investigative	Small molecular drug	[1714]
6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole	DMOHWPD	Investigative	Small molecular drug	[1714]
6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMSA367	Investigative	Small molecular drug	[392]
6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium	DMG3F7D	Investigative	Small molecular drug	[1714]
6-Methoxy-2-(4-phenoxy-benzyl)-1H-benzoimidazole	DMZP3XJ	Investigative	Small molecular drug	[927]
6-methoxy-2-methyl-9H-beta-carbolin-2-ium	DMHITF8	Investigative	Small molecular drug	[1714]
6-methoxy-2-oxo-2H-chromene-3-carboxylic acid	DM7WH82	Investigative	Small molecular drug	[1069]
6-Methoxy-3-pyridin-4-yl-quinoline	DM52SDO	Investigative	Small molecular drug	[1328]
6-Methoxy-3-thiophen-3-yl-quinoline	DMOYL71	Investigative	Small molecular drug	[1168]
6-Methoxy-4,9-dihydro-3H-beta-carboline	DM98FQO	Investigative	Small molecular drug	[392]
6-Methoxy-4-morpholin-4-yl-chromen-2-one	DMPB9MY	Investigative	Small molecular drug	[627]
6-Methoxy-5-oxazol-5-yl-2-phenyl-1H-indole	DMHO7TZ	Investigative	Small molecular drug	[993]
6-methoxykaempferol 3-O-beta-D-robinobioside	DM5JB9D	Investigative	Small molecular drug	[1721]
6-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	DMAQGZR	Investigative	Small molecular drug	[881]
6-Methyl-2-oxa-spiro[4.4]nonan-1-one	DMNJRFP	Investigative	Small molecular drug	[379]
6-methyl-2-oxo-2H-chromene-3-carboxylic acid	DMZ6HQL	Investigative	Small molecular drug	[1069]
6-Methyl-2-p-tolyl-chromen-4-one	DM8KMEG	Investigative	Small molecular drug	[840]
6-Methyl-2-phenyl-chromen-4-one	DMAXBOU	Investigative	Small molecular drug	[840]
6-Methyl-2-pyridin-3-yl-chromen-4-one	DMFMK6Y	Investigative	Small molecular drug	[840]
6-Methyl-4-(4-benzoylpiperazin-1-yl)coumarin	DMOVUP2	Investigative	Small molecular drug	[1214]
6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin	DMN0SYW	Investigative	Small molecular drug	[1214]
6-Methyl-4-(4-phenylpiperazin-1-yl)coumarin	DMU7E3O	Investigative	Small molecular drug	[1214]
6-methyl-4-(piperazin-1-yl)furo[2,3-d]pyrimidine	DM1LW62	Investigative	Small molecular drug	[561]
6-Methyl-4-morpholin-4-yl-chromen-2-one	DMO7RPW	Investigative	Small molecular drug	[627]
6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine	DMSLT3I	Investigative	Small molecular drug	[1660]
6-Methyl-[1,3]dioxolo[4,5-h]quinolin-8(9H)-one	DMOIC64	Investigative	Small molecular drug	[428]
6-Methylamino-5-Nitroisocytosine	DMN6IDK	Investigative	Small molecular drug	[107]
6-MORPHOLIN-4-YL-9H-PURINE	DMTNZKU	Investigative	Small molecular drug	[22]
6-n-octylaminouracil	DMXJFCQ	Investigative	Small molecular drug	[1722]
6-N-propyl -4-trifluoromethylquinolin-2(1H)-one	DMDPA2T	Investigative	Small molecular drug	[1689]
6-Nitro-1,4-dihydro-quinoxaline-2,3-dione	DM84CTA	Investigative	Small molecular drug	[1703]
6-Nitro-2-(3-nitro-phenyl)-chromen-4-one	DMRCTBA	Investigative	Small molecular drug	[1723]
6-Nitro-2-(4-nitro-phenyl)-chromen-4-one	DMM635K	Investigative	Small molecular drug	[1723]
6-Nitro-2-(4-phenoxy-benzyl)-1H-benzoimidazole	DMZTXDV	Investigative	Small molecular drug	[927]
6-Nitro-2-phenyl-chromen-4-one	DMVLID9	Investigative	Small molecular drug	[879]
6-Nitro-2-piperazin-1-yl-4-vinyl-quinoline	DMAOUQI	Investigative	Small molecular drug	[1444]
6-Nitro-4-phenyl-2-piperazin-1-yl-quinoline	DMCEG6V	Investigative	Small molecular drug	[1444]
6-Nitro-benzothiazole-2-sulfonic acid amide	DMYP7UG	Investigative	Small molecular drug	[1314]
6-Nitroindazole	DM2WZCX	Investigative	Small molecular drug	[12]
6-O-Cyclohexylmethyl Guanine	DMDIW08	Investigative	Small molecular drug	[12]
6-O-Phosphoryl Inosine Monophosphate	DM6YHBR	Investigative	Small molecular drug	[12]
6-o-tolylquinazolin-2-amine	DM4TX9O	Investigative	Small molecular drug	[1724]
6-oxo-16-formyl-estrone	DMPBE5H	Investigative	Small molecular drug	[708]
6-oxo-estrone	DMKMYAJ	Investigative	Small molecular drug	[708]
6-p-Tolylamino-1H-pyrimidine-2,4-dione	DMIAQUC	Investigative	Small molecular drug	[1677]
6-Phenoxy-hexane-1-thiol	DMVYIN2	Investigative	Small molecular drug	[1480]
6-phenyl-3-(pyridin-4-yl)-1H-indole	DM3UBR5	Investigative	Small molecular drug	[519]
6-Phenyl-naphthalen-2-ol	DMEYOF7	Investigative	Small molecular drug	[441]
6-phenyl-thieno[3,2-d]pyrimidin-4-ylamine	DME230I	Investigative	Small molecular drug	[974]
6-Phenylaminomethyl-quinazoline-2,4-diamine	DMG6PZT	Investigative	Small molecular drug	[1725]
6-phenylethynyl-nicotinic acid methyl ester	DMIKRP6	Investigative	Small molecular drug	[994]
6-Phenylhexylcarbamic Acid Biphenyl-3-yl Ester	DMLJN8Z	Investigative	Small molecular drug	[1011]
6-Phenylmethanesulfonyl-2H-pyridazin-3-one	DMPA534	Investigative	Small molecular drug	[1666]
6-phenylpyridazin-3-yl thiophene-2-carboxylate	DMXTV1B	Investigative	Small molecular drug	[479]
6-Phenylsulfanyl-9H-purine	DMZ76NQ	Investigative	Small molecular drug	[183]
6-phenylsulfanylhexanoic acid hydroxamide	DM3OLM6	Investigative	Small molecular drug	[1695]
6-Phenylsulfanylmethyl-pteridine-2,4-diamine	DM6GWRB	Investigative	Small molecular drug	[1726]
6-Phosphogluconic Acid	DMB1QCY	Investigative	Small molecular drug	[12]
6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol	DM86XG5	Investigative	Small molecular drug	[1181]
6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one	DMG5ABT	Investigative	NA	[1670]
6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one	DMIM5DL	Investigative	Small molecular drug	[1181]
6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione	DMHAS2B	Investigative	Small molecular drug	[1181]
6-Pyridin-3-yl-naphthalen-2-ol	DMGWNDB	Investigative	Small molecular drug	[522]
6-Styryl-naphthalene-2-carboxamidine	DMDO13Y	Investigative	Small molecular drug	[1727]
6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one	DMQAG1B	Investigative	Small molecular drug	[824]
6-tert-butyl-m-cresol	DM9EA3C	Investigative	Small molecular drug	[1728]
6-Thia-10b-aza-benzo[e]azulen-4-one	DMVGC7H	Investigative	Small molecular drug	[1646]
6-Thiophen-2-yl-imidazo[2,1-b]thiazole	DMC013U	Investigative	Small molecular drug	[1729]
6-Thiophen-3-yl-imidazo[2,1-b]thiazole	DM90VJ6	Investigative	Small molecular drug	[1729]
6-tosyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole	DMVL218	Investigative	Small molecular drug	[1730]
6-[(E)-2-(4-Fluoro-phenyl)-vinyl]-9H-purine	DMDNG8F	Investigative	Small molecular drug	[183]
6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	DMNJPCD	Investigative	Small molecular drug	[22]
6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol	DM40LQ9	Investigative	Small molecular drug	[1276]
6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	DM1G7P9	Investigative	Small molecular drug	[22]
677T	DM7D52Z	Investigative	Antisense drug	[1731]
6beta-naltrexol HCl	DMZ8PBE	Investigative	Small molecular drug	[1732]
6H05	DM44WF1	Investigative	Small molecular drug	[1733]
6s-5,6,7,8-Tetrahydrobiopterin	DMIA7ND	Investigative	Small molecular drug	[12]
7,12-Dihydro-5,7,12-triaza-indeno[1,2-a]fluorene	DM3FXRC	Investigative	Small molecular drug	[1734]
7,12-Dihydro-7,12-diaza-indeno[1,2-a]fluorene	DMTZ943	Investigative	Small molecular drug	[1264]
7,3',4'-trihydroxyisoflavone	DM5JV8G	Investigative	Small molecular drug	[1735]
7,4'-Dihydroxyflavone	DMXQ1K0	Investigative	Small molecular drug	[549]
7,8,3',4'-tetrahydroxyflavone	DMOBEL9	Investigative	Small molecular drug	[414]
7,8,4'-trihydroxyisoflavone	DM80GFL	Investigative	Small molecular drug	[1735]
7,8,9,10-tetrahydro-6H-furo-[2,3-g][3]benzazepine	DMIMLUO	Investigative	Small molecular drug	[1662]
7,8,9,10-tetrahydro-6H-furo-[3,2-g][3]benzazepine	DMVZA27	Investigative	Small molecular drug	[1662]
7,8-dichloroquinoline-4-one-3-carboxylic acid	DMKNQW4	Investigative	Small molecular drug	[1555]
7,8-dihydrobiopterin	DMQU4XM	Investigative	Small molecular drug	[107]
7,8-Dihydroneopterin	DM5TXY1	Investigative	Small molecular drug	[12]
7,8-dihydroxy-4-phenyl-2H-chromen-2-one	DMUB5E8	Investigative	Small molecular drug	[22]
7,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one	DMPF6MD	Investigative	Small molecular drug	[428]
7,9-octadecadiynoic acid	DMO8GEI	Investigative	Small molecular drug	[233]
7,9-tetradecadiynoic acid	DMPEXTB	Investigative	Small molecular drug	[233]
7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	DM2UTEA	Investigative	Small molecular drug	[469]
7-((1H-imidazol-1-yl)methyl)-4H-chromen-4-one	DMOS4ZQ	Investigative	Small molecular drug	[469]
7-((1H-imidazol-1-yl)methyl)isoquinoline	DM9ID4T	Investigative	Small molecular drug	[469]
7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol	DMRPFNU	Investigative	Small molecular drug	[443]
7-(1H-indol-5-yloxy)-N-hydroxyheptanamide	DMOZV9W	Investigative	Small molecular drug	[1736]
7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	DM4HUO1	Investigative	Small molecular drug	[1737]
7-(2-Amino-ethyl)-4-hydroxy-3H-benzothiazol-2-one	DMPV674	Investigative	Small molecular drug	[1738]
7-(2-Dipropylamino-ethyl)-3H-benzothiazol-2-one	DMWXGLE	Investigative	Small molecular drug	[1738]
7-(2-Hydroxyethyl)-3-O-rhamnosylicariin	DMBIY98	Investigative	Small molecular drug	[1159]
7-(2-methoxyphenyl)-2-methylquinoline	DMO8DYW	Investigative	Small molecular drug	[161]
7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine	DMK28IS	Investigative	Small molecular drug	[36]
7-(3,5-dihydroxyphenyl)naphthalene-1,3-diol	DM9BS5L	Investigative	Small molecular drug	[1428]
7-(3,5-dimethoxyphenyl)-1,6-naphthyridine	DM2RFOB	Investigative	Small molecular drug	[868]
7-(3,6,9,12-tetraoxatricos-22-enyl)theophylline	DMNQW2B	Investigative	Small molecular drug	[1739]
7-(3-(methoxymethyl)phenyl)-2-methylquinoline	DMYNLOI	Investigative	Small molecular drug	[161]
7-(3-Benzoyl-ureido)-heptanoic acid hydroxyamide	DMCFV0X	Investigative	Small molecular drug	[1676]
7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	DM762G3	Investigative	Small molecular drug	[1740]
7-(3-chlorophenyl)-2-methylquinoline	DM0Q56N	Investigative	Small molecular drug	[161]
7-(3-fluoro-5-methylphenyl)-1,6-naphthyridine	DME2VD7	Investigative	Small molecular drug	[868]
7-(3-fluorophenyl)-2-methylquinoline	DMDXOBH	Investigative	Small molecular drug	[161]
7-(3-Hydroxy-phenyl)-naphthalen-2-ol	DM2I91C	Investigative	NA	[441]
7-(3-methoxyphenyl)-2-methyl-1,6-naphthyridine	DMEC9YK	Investigative	Small molecular drug	[868]
7-(3-methoxyphenyl)-2-methylquinoline	DMW6LCH	Investigative	Small molecular drug	[161]
7-(4,6-dimethoxypyrimidin-2-yl)-2-methylquinoline	DMHXMY5	Investigative	Small molecular drug	[1192]
7-(4,6-dimethylpyrimidin-2-yl)-2-methylquinoline	DMQFBTW	Investigative	Small molecular drug	[1192]
7-(4-(dimethylamino)phenoxy)-N-hydroxyheptanamide	DM2TNCK	Investigative	Small molecular drug	[1736]
7-(4-Hydroxy-phenyl)-naphthalen-2-ol	DMM9IXB	Investigative	Small molecular drug	[441]
7-(4-methoxyphenyl)-2-methylquinoline	DMBT1KS	Investigative	Small molecular drug	[161]
7-(4-methoxyphenyl)pteridine-2,4-diol	DMLIYUJ	Investigative	Small molecular drug	[134]
7-(4-methoxypyrimidin-2-yl)-2-methylquinoline	DMSRKF0	Investigative	Small molecular drug	[1192]
7-(benzyloxy)-2H-chromen-2-one	DMTKFPW	Investigative	Small molecular drug	[1069]
7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one	DMLCGSY	Investigative	Small molecular drug	[235]
7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one	DM28GZ7	Investigative	Small molecular drug	[1741]
7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one	DMY027P	Investigative	Small molecular drug	[235]
7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide	DMO4YLA	Investigative	Small molecular drug	[1742]
7-(naphthalen-2-yl)benzo[e][1,2,4]triazin-3-amine	DMU74R8	Investigative	Small molecular drug	[1199]
7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one	DM4VQN8	Investigative	Small molecular drug	[235]
7-(piperidin-4-ylmethoxy)-2-naphthonitrile	DM6I5K1	Investigative	Small molecular drug	[59]
7-(trifluoromethyl)-1H-indole-2,3-dione	DM46VT2	Investigative	Small molecular drug	[475]
7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	DMQCDT1	Investigative	Small molecular drug	[1138]
7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	DMQMTSX	Investigative	Small molecular drug	[1138]
7-acetonyloxy-3-acetylamino-8-methoxycoumarin	DMYSNQO	Investigative	Small molecular drug	[1240]
7-Allyl-1,3-dimethyl-3,7-dihydro-purine-2,6-dione	DMPRBO1	Investigative	Small molecular drug	[411]
7-Allyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione	DMHJ6TU	Investigative	Small molecular drug	[411]
7-Allyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	DMSRQ1L	Investigative	Small molecular drug	[847]
7-amino-4-hydroxy-2-naphthalenesulfonic acid	DMDUB63	Investigative	Small molecular drug	[1612]
7-AMINO-4-METHYL-CHROMEN-2-ONE	DMC8O3Z	Investigative	Small molecular drug	[22]
7-benzoyloxy-2-(morpholin-4-yl)-chromen-4-one	DMZDP5S	Investigative	Small molecular drug	[957]
7-benzylidenenaltrexone	DMCJED6	Investigative	Small molecular drug	[1743]
7-benzyloxy-2-(morpholin-4-yl)-chromen-4-one	DMMXAEN	Investigative	Small molecular drug	[957]
7-Biphenyl-4-yl-heptanoic acid hydroxyamide	DMV54MT	Investigative	Small molecular drug	[1744]
7-bromo-1H-indazole	DMYBNCO	Investigative	Small molecular drug	[1469]
7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMVTH0Q	Investigative	Small molecular drug	[760]
7-Bromo-2-(4-hydroxy-phenyl)-benzofuran-5-ol	DMA8DXG	Investigative	Small molecular drug	[916]
7-Bromo-2-phenyl-[1,8]naphthyridin-4-ol	DMG8ZJA	Investigative	Small molecular drug	[1745]
7-Bromo-4,9-dihydro-3H-beta-carboline	DMCWYT7	Investigative	Small molecular drug	[760]
7-bromo-6H-chromeno[4,3-b]quinoline-3,9-diol	DMX85IF	Investigative	Small molecular drug	[1746]
7-bromo-N-(3-bromophenyl)isoquinolin-1-amine	DML8PH7	Investigative	Small molecular drug	[1228]
7-bromoindirubin-3-acetoxime	DM3G8I7	Investigative	Small molecular drug	[1747]
7-bromoindirubin-3-oxime	DM07QD3	Investigative	Small molecular drug	[1747]
7-butoxy-2H-chromen-2-one	DM78C5A	Investigative	Small molecular drug	[1069]
7-Butyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	DMQ8BIX	Investigative	Small molecular drug	[847]
7-Butyl-azepan-(2Z)-ylideneamine	DMVTK0A	Investigative	Small molecular drug	[36]
7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	DM1SEXA	Investigative	Small molecular drug	[1596]
7-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	DMP5JF8	Investigative	Small molecular drug	[135]
7-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DMWUS5Q	Investigative	Small molecular drug	[413]
7-chloro-1,3-dihydroxyacridone	DMPJWIB	Investigative	NA	[410]
7-chloro-1H-indazole	DMX8DZM	Investigative	Small molecular drug	[1469]
7-chloro-1H-indole-2,3-dione	DMCZLKA	Investigative	Small molecular drug	[475]
7-Chloro-2-(4-hydroxy-phenyl)-benzofuran-5-ol	DM38HKE	Investigative	Small molecular drug	[916]
7-Chloro-2-phenyl-[1,8]naphthyridin-4-ol	DM9TZH4	Investigative	Small molecular drug	[1745]
7-chloro-3-hydroxyquinazoline-2,4-dione	DM3OMLU	Investigative	Small molecular drug	[1748]
7-Chloro-3-pyridin-4-yl-quinoline	DM53A1R	Investigative	Small molecular drug	[1328]
7-chloro-6H-chromeno[4,3-b]quinoline-3,9-diol	DMRNZYQ	Investigative	Small molecular drug	[1746]
7-chloroindirubin-3-oxime	DM28NAB	Investigative	Small molecular drug	[1747]
7-Cyclopentyloxy-3-(4-hydroxyphenyl)chromen-4-one	DM2MIJY	Investigative	Small molecular drug	[1218]
7-Diazonium-naphthalene-1-sulfonic acid anion	DMANYSO	Investigative	Small molecular drug	[1749]
7-Dimethylamino-2-phenyl-[1,8]naphthyridin-4-ol	DMNEAU0	Investigative	Small molecular drug	[1745]
7-Dimethylamino-3-methyl-hept-5-yn-2-one	DMDY2PQ	Investigative	Small molecular drug	[1054]
7-Dimethylamino-hept-5-yn-2-one	DMH782V	Investigative	Small molecular drug	[1054]
7-epi-ginkgolide C	DMRAZDW	Investigative	Small molecular drug	[1750]
7-Ethoxy-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DMI16MD	Investigative	Small molecular drug	[413]
7-ethoxy-8-propionyl-2H-chromen-2-one	DMYJBPI	Investigative	Small molecular drug	[1686]
7-Ethyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	DMUMN4B	Investigative	Small molecular drug	[847]
7-ethyl-6H-chromeno[4,3-b]quinoline-3,9-diol	DMSFODU	Investigative	Small molecular drug	[1746]
7-ethyloxyethoxy-2-morpholin-4-yl-chromen-4-one	DMXM2G7	Investigative	Small molecular drug	[957]
7-Ethynyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	DM92EG5	Investigative	Small molecular drug	[847]
7-ethynyl-6H-chromeno[4,3-b]quinoline-3,9-diol	DMJWCAH	Investigative	Small molecular drug	[1746]
7-Fluoro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DMNRCDI	Investigative	Small molecular drug	[413]
7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione	DM4HJZI	Investigative	Small molecular drug	[56]
7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one	DMUPXBJ	Investigative	Small molecular drug	[56]
7-fluoro-2-p-tolyl-4H-chromen-4-one	DMFOU8G	Investigative	Small molecular drug	[56]
7-fluoro-2-p-tolyl-4H-chromene-4-thione	DMJFXKA	Investigative	Small molecular drug	[56]
7-Fluoro-3-thiophen-3-yl-quinoline	DM0QI8V	Investigative	Small molecular drug	[1168]
7-fluorochromone-2-carboxamide	DMQ2ZTJ	Investigative	Small molecular drug	[1751]
7-fluoroindirubin-3-acetoxime	DM70I3V	Investigative	Small molecular drug	[1747]
7-fluoroindirubin-3-oxime	DMQD34N	Investigative	Small molecular drug	[1747]
7-hydroxy-1,2,9,9a-tetrahydrofluoren-3-one	DMKSJE3	Investigative	Small molecular drug	[1752]
7-hydroxy-2-(3-hydroxyphenyl)chroman-4-one	DMXBUNV	Investigative	Small molecular drug	[884]
7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	DMCB2IM	Investigative	Small molecular drug	[866]
7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one	DM2BV6P	Investigative	Small molecular drug	[866]
7-hydroxy-2-(morpholin-4-yl)chromen-4-one	DMIKSTL	Investigative	Small molecular drug	[957]
7-hydroxy-2-phenylchroman-4-one	DM4UW65	Investigative	Small molecular drug	[884]
7-Hydroxy-3-(3-hydroxyphenyl)-1-naphthonitrile	DMS2NZA	Investigative	Small molecular drug	[600]
7-hydroxy-3-(4-hydroxyphenyl)-3H-quinazolin-4-one	DM46J2H	Investigative	Small molecular drug	[1562]
7-hydroxy-3-phenyl-2H-chromen-2-one	DM2ZE8U	Investigative	Small molecular drug	[920]
7-Hydroxy-4-phenylcoumarin	DM3T612	Investigative	Small molecular drug	[1753]
7-Hydroxy-6-nitro-2-phenyl-chromen-4-one	DM49RWY	Investigative	Small molecular drug	[866]
7-hydroxy-6-propionyl-2H-chromen-2-one	DMQ3RVK	Investigative	Small molecular drug	[1686]
7-hydroxy-8-propionyl-2H-chromen-2-one	DMFKSMW	Investigative	Small molecular drug	[1686]
7-Hydroxy-Pyrazolo[4,3-D]Pyrimidine	DMV39XT	Investigative	Small molecular drug	[107]
7-hydroxycholesterol	DMZXMB7	Investigative	Small molecular drug	[1754]
7-hydroxycostunolide	DMV0PT8	Investigative	Small molecular drug	[703]
7-hydroxycoumarin	DMTMNO7	Investigative	Small molecular drug	[1755]
7-Iodo-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one	DM6K5NF	Investigative	Small molecular drug	[436]
7-iodoindirubin-3-oxime	DMNFI02	Investigative	Small molecular drug	[1747]
7-Isopropyl-7H-adenine	DMVSF0O	Investigative	Small molecular drug	[338]
7-m-tolyl-1,6-naphthyridine	DMBDFP2	Investigative	Small molecular drug	[868]
7-Mercapto-heptanoic acid benzothiazol-2-ylamide	DMPYTHV	Investigative	Small molecular drug	[1480]
7-Mercapto-heptanoic acid biphenyl-3-ylamide	DMEQKPO	Investigative	Small molecular drug	[1480]
7-Mercapto-heptanoic acid biphenyl-4-ylamide	DMJMOUK	Investigative	Small molecular drug	[1480]
7-Mercapto-heptanoic acid phenylamide	DM4912P	Investigative	Small molecular drug	[1480]
7-Mercapto-heptanoic acid pyridin-3-ylamide	DMQ9PLA	Investigative	Small molecular drug	[1480]
7-Mercapto-heptanoic acid quinolin-3-ylamide	DMTAGJ1	Investigative	Small molecular drug	[1480]
7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide	DM03XYF	Investigative	Small molecular drug	[320]
7-methoxy-1-naphthylpiperazine	DM3MXI5	Investigative	Small molecular drug	[1756]
7-Methoxy-1H-indazole	DMTFBCU	Investigative	Small molecular drug	[1757]
7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMQ1BE8	Investigative	Small molecular drug	[1021]
7-Methoxy-2-morpholin-4-yl-chromen-4-one	DMR713M	Investigative	Small molecular drug	[627]
7-methoxy-2-oxo-2H-chromene-4-carboxylic acid	DMJITU0	Investigative	Small molecular drug	[1069]
7-methoxy-2-p-tolyl-4H-chromen-4-one	DME5WZQ	Investigative	Small molecular drug	[56]
7-methoxy-2-p-tolyl-4H-chromene-4-thione	DM4WMGK	Investigative	Small molecular drug	[56]
7-Methoxy-3-pyridin-4-yl-quinoline	DMUZIDT	Investigative	Small molecular drug	[1328]
7-Methoxy-3-thiophen-3-yl-quinoline	DM9QKLC	Investigative	Small molecular drug	[1168]
7-Methoxy-4-morpholin-4-yl-chromen-2-one	DMNFIZD	Investigative	Small molecular drug	[627]
7-methoxy-8-propionyl-2H-chromen-2-one	DMH0UVE	Investigative	Small molecular drug	[1686]
7-Methoxy-9H-beta-carboline	DMHKMU1	Investigative	Small molecular drug	[760]
7-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DM5EQJU	Investigative	Small molecular drug	[413]
7-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one	DM7LGDC	Investigative	Small molecular drug	[881]
7-methyl-2-m-tolylpyrido[2,3-d]pyrimidine	DMCV891	Investigative	Small molecular drug	[869]
7-methyl-2-p-tolyl-4H-chromene-4-thione	DMB9YA8	Investigative	Small molecular drug	[56]
7-methyl-2-phenylpyrido[2,3-d]pyrimidine	DMJ4G27	Investigative	Small molecular drug	[869]
7-Methyl-2-propyl-[1,8]naphthyridin-4-ol	DMGB9IE	Investigative	Small molecular drug	[1745]
7-Methyl-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine	DMZKO14	Investigative	Small molecular drug	[1758]
7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (3,5-BIS-TRIFLUOROMETHYL-BENZYL)-METHYL-AMIDE (STRUCTURAL MIX)	DMMENDC	Investigative	Small molecular drug	[1759]
7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(R)-1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYL-AMIDE (ENANTIOMERIC MIX)	DMO0RGL	Investigative	Small molecular drug	[1759]
7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(S)-1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYL-AMIDE (ENANTIOMERIC MIX)	DMOAJ0E	Investigative	Small molecular drug	[1759]
7-Methyl-Gpppa	DME39U2	Investigative	Small molecular drug	[12]
7-Methyl-Guanosine-5'-Triphosphate	DMCGNUO	Investigative	Small molecular drug	[12]
7-Methyl-[1,4]thiazepan-(5E)-ylideneamine	DMUCJA6	Investigative	Small molecular drug	[196]
7-Nitro-1,2,3,4-tetrahydro-isoquinoline	DMX3UV1	Investigative	Small molecular drug	[1308]
7-nitro-1H-indazole	DMW4XKQ	Investigative	Small molecular drug	[1760]
7-Nitroindazole-2-Carboxamidine	DMGLWOM	Investigative	Small molecular drug	[22]
7-O-b-D-Glucopyranosyl-a-homonojirimycin	DM8IY3D	Investigative	Small molecular drug	[435]
7-Oxo-7H-dibenzo[de,g]quinoline	DMJZR0A	Investigative	Small molecular drug	[1761]
7-phenethoxy-2H-chromen-2-one	DM8Q267	Investigative	Small molecular drug	[1069]
7-Phenoxy-heptanoic acid hydroxyamide	DM1FL5G	Investigative	Small molecular drug	[1744]
7-Phenyl-1-(1,3,4-thiadiazol-2-yl)-heptan-1-one	DMQMRGD	Investigative	Small molecular drug	[445]
7-Phenyl-1-(2H-tetrazol-5-yl)-heptan-1-one	DMEABGI	Investigative	Small molecular drug	[445]
7-phenyl-1-(4-phenyloxazol-2-yl)heptan-1-one	DM62PAU	Investigative	Small molecular drug	[530]
7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one	DM9SGBW	Investigative	Small molecular drug	[445]
7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one	DMG1PNX	Investigative	Small molecular drug	[445]
7-Phenyl-1-(thiazol-2-yl)-heptan-1-one	DMLHI5T	Investigative	Small molecular drug	[445]
7-Phenyl-naphthalen-2-ol	DM1WJFR	Investigative	Small molecular drug	[441]
7-phenylethoxy-2-morpholin-4-yl-chromen-4-one	DMEDOFB	Investigative	Small molecular drug	[957]
7-phenyloxyethoxy-2-morpholin-4-yl-chromen-4-one	DMSBJ4M	Investigative	Small molecular drug	[957]
7-Phloroethol	DM19I62	Investigative	Small molecular drug	[1762]
7-propoxy-2-(morpholin-4-yl)-chromen-4-one	DMO8WB2	Investigative	Small molecular drug	[957]
7-propoxy-2H-chromen-2-one	DMD5CB6	Investigative	Small molecular drug	[1069]
7-Propyl-7H-adenine	DM4I0B1	Investigative	Small molecular drug	[338]
7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one	DMW8XME	Investigative	Small molecular drug	[1181]
7-Pyrrolidin-1-yl-hept-5-yn-2-one	DMQJ26K	Investigative	Small molecular drug	[1054]
7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30)	DMSU06X	Investigative	Small molecular drug	[1763]
7-tert-butyl-9H-carbazole-3-carboxylic acid	DMD7Q1R	Investigative	Small molecular drug	[548]
7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline	DMMU5SO	Investigative	Small molecular drug	[1168]
7-trans-OH-PIPAT	DMOQMA0	Investigative	Small molecular drug	[1764]
7-vinyl-6H-chromeno[4,3-b]quinoline-3,9-diol	DM14OHR	Investigative	Small molecular drug	[1746]
7-[1,2,4]Triazol-4-ylmethyl-chromen-4-one	DMNGLM1	Investigative	Small molecular drug	[599]
7alpha,25-dihydroxycholesterol	DM2N8TW	Investigative	Small molecular drug	[1765]
7alpha,27-dihydroxycholesterol	DM52UOM	Investigative	Small molecular drug	[1766]
7alpha-Cl-ginkgolide B	DMD6UC9	Investigative	Small molecular drug	[1767]
7alpha-F-ginkgolide B	DMRQ24A	Investigative	Small molecular drug	[1768]
7alpha-hydroxycholesterol	DMH6LD0	Investigative	Small molecular drug	[1769]
7alpha-N3-ginkgolide B	DMGNWBV	Investigative	Small molecular drug	[1770]
7alpha-NH2-ginkgolide B	DMZUYX1	Investigative	Small molecular drug	[1771]
7alpha-NHEt-ginkgolide B	DMWAB7F	Investigative	Small molecular drug	[1772]
7alpha-NHMe-ginkgolide B	DMSPLYF	Investigative	Small molecular drug	[1773]
7alpha-OAc-ginkgolide B	DMN1U56	Investigative	Small molecular drug	[1774]
7alpha-OCOCH2Ph-ginkgolide B	DMGAPCD	Investigative	Small molecular drug	[1775]
7beta, 25-dihydroxycholesterol	DMYKXWE	Investigative	Small molecular drug	[1776]
7beta, 27-dihydroxycholesterol	DMSDINR	Investigative	Small molecular drug	[1777]
7beta-hydroxycholesterol	DMPHJZU	Investigative	Small molecular drug	[1778]
7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine	DMEGSZD	Investigative	Small molecular drug	[1758]
7n-Methyl-8-Hydroguanosine-5'-Diphosphate	DM2403T	Investigative	Small molecular drug	[12]
8(S)-amino-2(R)-methyl-7-oxononanoic acid	DMT1NW2	Investigative	Small molecular drug	[1779]
8-(1,2-Dimethyl-propoxy)-quinolin-2-ylamine	DMUE15B	Investigative	Small molecular drug	[1780]
8-(1,3,3-Trimethyl-butoxy)-quinolin-2-ylamine	DMGS7CE	Investigative	Small molecular drug	[1781]
8-(1-Ethyl-propoxy)-quinolin-2-ylamine	DMYERNW	Investigative	Small molecular drug	[1780]
8-(1-Methyl-butoxy)-quinolin-2-ylamine	DM7VT3P	Investigative	Small molecular drug	[1780]
8-(1H-indol-5-yl)-2-morpholin-4-ylchromen-4-one	DMMBH9N	Investigative	Small molecular drug	[957]
8-(2,2-dimethylpropyl)naringenin	DMV5FZO	Investigative	Small molecular drug	[1782]
8-(2,3,4-trimethoxyphenyl)-9H-purine-2,6-diamine	DM3QV95	Investigative	Small molecular drug	[1390]
8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	DM4KP5M	Investigative	Small molecular drug	[1390]
8-(2,4,6-trimethoxyphenyl)-9H-purine-2,6-diamine	DM5TSJF	Investigative	Small molecular drug	[1390]
8-(2,4-dimethoxyphenyl)-9H-purine-2,6-diamine	DMJPYIZ	Investigative	Small molecular drug	[1390]
8-(2,5-dimethoxyphenyl)-9H-purine-2,6-diamine	DM0MIGU	Investigative	Small molecular drug	[1390]
8-(2,6-Dichloro-phenyl)-9H-purine-2,6-diamine	DMECWL1	Investigative	Small molecular drug	[1783]
8-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one	DM8SRM0	Investigative	Small molecular drug	[957]
8-(2-Cyclopropyl-ethoxy)-quinolin-2-ylamine	DMJKL3Z	Investigative	Small molecular drug	[1780]
8-(2-Ethoxy-1-methyl-ethoxy)-quinolin-2-ylamine	DMOB8XT	Investigative	Small molecular drug	[1780]
8-(2-Ethyl-1-methyl-butoxy)-quinolin-2-ylamine	DMSKTVW	Investigative	Small molecular drug	[1780]
8-(2-Methoxy-1-methyl-ethoxy)-quinolin-2-ylamine	DMA5K04	Investigative	Small molecular drug	[1780]
8-(2-Methyl-butoxy)-quinolin-2-ylamine	DMVBRMF	Investigative	Small molecular drug	[1780]
8-(2-Methyl-cyclohexyloxy)-quinolin-2-ylamine	DMUIFJY	Investigative	Small molecular drug	[1780]
8-(2-methylpropyl)naringenin	DMQUZSJ	Investigative	Small molecular drug	[1782]
8-(3,3,3-trifluoropropoxy)quinolin-2-amine	DMRUP0A	Investigative	Small molecular drug	[1780]
8-(3,3-Dimethyl-butoxy)-quinolin-2-ylamine	DM72EM9	Investigative	Small molecular drug	[1780]
8-(3,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	DMV63G1	Investigative	Small molecular drug	[1390]
8-(3,4-dichlorophenyl)-9H-purine-2,6-diamine	DMZU0YF	Investigative	Small molecular drug	[1390]
8-(3,4-dimethoxyphenyl)-9H-purine-2,6-diamine	DMYZC3I	Investigative	Small molecular drug	[1390]
8-(3,5-dimethoxyphenyl)-9H-purine-2,6-diamine	DM920XR	Investigative	Small molecular drug	[1390]
8-(3-Azido-phenyl)-6-iodo-quinoline	DM9J2LT	Investigative	Small molecular drug	[1694]
8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline	DMON7RZ	Investigative	Small molecular drug	[1694]
8-(3-Benzoyl-ureido)-octanoic acid hydroxyamide	DMW2NJR	Investigative	Small molecular drug	[1676]
8-(3-Bromobenzyloxy)caffeine	DM2RA4N	Investigative	Small molecular drug	[1784]
8-(3-Chlorobenzyloxy)caffeine	DM7HMNP	Investigative	Small molecular drug	[1784]
8-(3-Fluoro-phenyl)-9-methyl-9H-purin-6-ylamine	DMLQPVH	Investigative	Small molecular drug	[1785]
8-(3-Fluorobenzyloxy)caffeine	DME85GS	Investigative	Small molecular drug	[1784]
8-(3-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one	DM15LVG	Investigative	Small molecular drug	[957]
8-(3-Methoxy-3-methyl-butoxy)-quinolin-2-ylamine	DM3WEQA	Investigative	Small molecular drug	[1780]
8-(3-Methoxybenzyloxy)caffeine	DMLY46X	Investigative	Small molecular drug	[1784]
8-(3-Methyl-butoxy)-quinolin-2-ylamine	DMNYPCQ	Investigative	Small molecular drug	[1780]
8-(3-Methyl-cyclohexyloxy)-quinolin-2-ylamine	DMPMJHV	Investigative	Small molecular drug	[1780]
8-(3-Methyl-cyclopentyloxy)-quinolin-2-ylamine	DM8N314	Investigative	Small molecular drug	[1780]
8-(3-Methylbenzyloxy)caffeine	DMB9645	Investigative	Small molecular drug	[1784]
8-(3-methylbutyl)naringenin	DM2VAJE	Investigative	Small molecular drug	[1782]
8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine	DMP6Z3R	Investigative	Small molecular drug	[1786]
8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline	DM0N68L	Investigative	Small molecular drug	[1694]
8-(4-acetylphenyl)-2-morpholin-4-ylchromen-4-one	DMAK0P3	Investigative	Small molecular drug	[957]
8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide	DMVOCWY	Investigative	Small molecular drug	[1787]
8-(4-chlorophenyl)-2-morpholin-4-ylchromen-4-one	DM4186A	Investigative	Small molecular drug	[957]
8-(4-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one	DMLANGY	Investigative	Small molecular drug	[957]
8-(4-Methyl-cyclohexyloxy)-quinolin-2-ylamine	DMPVQN3	Investigative	Small molecular drug	[1780]
8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one	DMH3SDO	Investigative	Small molecular drug	[376]
8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide	DMD6VSY	Investigative	Small molecular drug	[1787]
8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one	DM23XGW	Investigative	Small molecular drug	[235]
8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid	DMDIGPW	Investigative	Small molecular drug	[1742]
8-acetyl-7-(benzyloxy)-2H-chromen-2-one	DM4R2EX	Investigative	Small molecular drug	[1686]
8-acetyl-7-butoxy-2H-chromen-2-one	DMCTWBL	Investigative	Small molecular drug	[1686]
8-acetyl-7-ethoxy-2H-chromen-2-one	DMDV8UT	Investigative	Small molecular drug	[1686]
8-Acetyl-7-hydroxy-2H-chromen-2-one	DMAMJW2	Investigative	Small molecular drug	[1686]
8-acetyl-7-methoxy-2H-chromen-2-one	DMZSJRC	Investigative	Small molecular drug	[1686]
8-acetyl-7-propoxy-2H-chromen-2-one	DMGRK3V	Investigative	Small molecular drug	[1686]
8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione	DM84D9W	Investigative	Small molecular drug	[12]
8-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	DMTRBDP	Investigative	Small molecular drug	[1788]
8-AMINOGUANINE	DMYXJG7	Investigative	Small molecular drug	[1789]
8-aminoguanosine	DM0JEA6	Investigative	Small molecular drug	[1790]
8-aminoquinolines	DMN8QAF	Investigative	Small molecular drug	[1791]
8-aza-11-deoxyprostaglandin E1	DMYBPGA	Investigative	Small molecular drug	[1792]
8-aza-DADMe-ImmH	DMBVFKR	Investigative	Small molecular drug	[1793]
8-azabicyclo[3.2.1]octan-3-yloxy-benzamide	DMQMSZR	Investigative	Small molecular drug	[1794]
8-Azaguanine	DM7VP90	Investigative	Small molecular drug	[12]
8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	DMT8QAP	Investigative	Small molecular drug	[22]
8-benzyl-9H-purine-2,6-diamine	DM32OQB	Investigative	Small molecular drug	[1390]
8-benzylnaringenin	DMKHF87	Investigative	Small molecular drug	[1782]
8-Benzyloxycaffeine	DMJQ8AP	Investigative	Small molecular drug	[1784]
8-biphenyl-2-yl-2-morpholin-4-ylchromen-4-one	DMMCAZG	Investigative	Small molecular drug	[957]
8-Br-adenine	DMVPIYG	Investigative	Small molecular drug	[338]
8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMALRU4	Investigative	Small molecular drug	[760]
8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione	DMPVU7H	Investigative	Small molecular drug	[1281]
8-Bromo-4,9-dihydro-3H-beta-carboline	DM4V5RU	Investigative	Small molecular drug	[760]
8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin	DM51FL9	Investigative	Small molecular drug	[1189]
8-Bromo-6-methyl-3-phenylcoumarin	DMD1LM8	Investigative	Small molecular drug	[1189]
8-Bromo-6-styryl-naphthalene-2-carboxamidine	DMKU06T	Investigative	Small molecular drug	[1727]
8-Bromo-9-(2,3-dihydroxypropyl)-9H-adenine	DMMQ79W	Investigative	Small molecular drug	[338]
8-Bromo-9-(2-butyl)-9H-adenine	DM5DCPF	Investigative	Small molecular drug	[338]
8-Bromo-9-(2-hydroxypropyl)-9H-adenine	DMKW2PE	Investigative	Small molecular drug	[338]
8-Bromo-9-(3-hydroxypropyl)-9H-adenine	DMA258T	Investigative	Small molecular drug	[338]
8-Bromo-9-(but-3-enyl)-9H-adenine	DMXNF3V	Investigative	Small molecular drug	[338]
8-Bromo-9-(sec-butyl)-9H-adenine	DMSQPFM	Investigative	Small molecular drug	[338]
8-Bromo-9-cyclobutyl-9H-adenine	DMUTV76	Investigative	Small molecular drug	[338]
8-Bromo-9-cyclohexyl-9H-adenine	DMLVCON	Investigative	Small molecular drug	[338]
8-Bromo-9-cyclopentyl-9H-adenine	DMCK0O1	Investigative	Small molecular drug	[338]
8-Bromo-9-ethyl-9H-adenine	DM4YAD6	Investigative	Small molecular drug	[338]
8-bromo-9-isobutyl-9H-purin-6-amine	DMZF3UN	Investigative	Small molecular drug	[935]
8-Bromo-9-isopropyl-9H-adenine	DMIN9HC	Investigative	Small molecular drug	[338]
8-Bromo-9-methyl-9H-adenine	DM1DS3B	Investigative	Small molecular drug	[338]
8-Bromo-9-phenylethyl-9H-adenine	DMB7EWZ	Investigative	Small molecular drug	[338]
8-Bromo-9-propyl-9H-adenine	DMRIPU5	Investigative	Small molecular drug	[338]
8-Bromo-Adenosine-5'-Monophosphate	DM4CV1E	Investigative	Small molecular drug	[107]
8-Butoxy-quinolin-2-ylamine	DM5RFCN	Investigative	Small molecular drug	[1780]
8-carboxamidocyclazocine	DMD18V5	Investigative	Small molecular drug	[1795]
8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	DMS7DA3	Investigative	Small molecular drug	[1596]
8-Chloro-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole	DMFW6Q0	Investigative	Small molecular drug	[135]
8-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DM5IGOL	Investigative	Small molecular drug	[413]
8-chloro-3,4-dihydroquinazolin-2-amine	DM61VJO	Investigative	Small molecular drug	[1146]
8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione	DM842L6	Investigative	Small molecular drug	[1281]
8-Chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	DMB76ZN	Investigative	Small molecular drug	[441]
8-chloro-quinoline-3-carbonitrile	DMFNUHQ	Investigative	Small molecular drug	[1796]
8-Cyclobutylmethoxy-quinolin-2-ylamine	DM4VTM2	Investigative	Small molecular drug	[1780]
8-Cycloheptyloxy-quinolin-2-ylamine	DMEBYRW	Investigative	Small molecular drug	[1780]
8-cyclohexyl-6-(4-tolyl)-2-phenyl-9H-purine	DM79VQM	Investigative	Small molecular drug	[798]
8-Cyclohexyloxy-quinolin-2-ylamine	DMKT0YQ	Investigative	Small molecular drug	[1780]
8-Cyclopentylmethoxy-quinolin-2-ylamine	DM16KZS	Investigative	Small molecular drug	[1780]
8-cyclopentyltheophylline	DMMITAJ	Investigative	Small molecular drug	[1797]
8-deoxy-neodysiherbaine	DM7YW3B	Investigative	Small molecular drug	[1798]
8-DEOXYGARTANIN	DMEOP4J	Investigative	Small molecular drug	[1799]
8-Diazonium-naphthalene-1-sulfonic acid anion	DMQJA4F	Investigative	Small molecular drug	[1749]
8-dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one	DMUR97N	Investigative	Small molecular drug	[957]
8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione	DMY8W0K	Investigative	Small molecular drug	[1281]
8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione	DMBZSAO	Investigative	Small molecular drug	[1281]
8-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	DMGJ3L6	Investigative	Small molecular drug	[441]
8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	DMKPMFJ	Investigative	Small molecular drug	[1788]
8-furan-2-yl-2-morpholin-4-ylchromen-4-one	DMPY9OI	Investigative	Small molecular drug	[957]
8-Furan-3-yl-6-styryl-naphthalene-2-carboxamidine	DMFNCG8	Investigative	Small molecular drug	[1727]
8-Hexyloxy-quinolin-2-ylamine	DM7PJN9	Investigative	Small molecular drug	[1780]
8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	DMNE52B	Investigative	Small molecular drug	[807]
8-Hydroxy-2-phenyl-3H-quinazolin-4-one	DMKD2Q4	Investigative	Small molecular drug	[807]
8-Hydroxy-5,7,9-trimethyl-delta-carboline	DMG4W2C	Investigative	Small molecular drug	[1559]
8-Hydroxy-7,9-dimethyl-delta-carboline	DMFL46R	Investigative	Small molecular drug	[1559]
8-hydroxyguanine	DMT9BPN	Investigative	Small molecular drug	[1800]
8-Imidazol-1-ylmethyl-5-nitro-chromen-4-one	DMA26L4	Investigative	Small molecular drug	[599]
8-Iodo-Guanine	DM3K1EO	Investigative	Small molecular drug	[12]
8-Isopropoxy-quinolin-2-ylamine	DMBIAGJ	Investigative	Small molecular drug	[1780]
8-Mercapto-octanoic acid phenylamide	DMD3FWU	Investigative	Small molecular drug	[1480]
8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline	DMY50UR	Investigative	Small molecular drug	[389]
8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylamine	DMFOM10	Investigative	Small molecular drug	[1013]
8-Methoxy-1,4-dimethylquinolin-2(1H)-one	DM0Y52J	Investigative	Small molecular drug	[428]
8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMHE7J5	Investigative	Small molecular drug	[760]
8-Methoxy-2-(4-methyl-piperazin-1-yl)-quinoline	DMQIFZC	Investigative	Small molecular drug	[391]
8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	DMSN0ZE	Investigative	Small molecular drug	[807]
8-Methoxy-2-methyl-3H-quinazolin-4-one	DMOPN4K	Investigative	Small molecular drug	[807]
8-Methoxy-2-morpholin-4-yl-chromen-4-one	DMYE1X2	Investigative	Small molecular drug	[627]
8-methoxy-2-oxo-2H-chromene-3-carboxylic acid	DMHCWY8	Investigative	Small molecular drug	[1069]
8-Methoxy-2-phenyl-3H-quinazolin-4-one	DM56EW7	Investigative	Small molecular drug	[807]
8-Methoxy-2-piperazin-1-yl-quinoline	DMNWC29	Investigative	Small molecular drug	[391]
8-Methoxy-4,9-dihydro-3H-beta-carboline	DM8MBSN	Investigative	Small molecular drug	[760]
8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine	DMK6U2V	Investigative	Small molecular drug	[1146]
8-Methoxy-4-morpholin-4-yl-chromen-2-one	DMHLKAE	Investigative	Small molecular drug	[627]
8-Methoxy-quinolin-2-ylamine	DMHZ5SB	Investigative	Small molecular drug	[391]
8-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one	DM92XPO	Investigative	Small molecular drug	[413]
8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one	DM7FSZM	Investigative	Small molecular drug	[807]
8-Methyl-2-morpholin-4-yl-chromen-4-one	DMLQ90D	Investigative	Small molecular drug	[627]
8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one	DMWZ27A	Investigative	Small molecular drug	[1060]
8-methyl-2-morpholino-7-phenyl-4H-chromen-4-one	DMUI1YZ	Investigative	Small molecular drug	[1060]
8-Methyl-2-phenyl-3H-quinazolin-4-one	DMEM6Q0	Investigative	Small molecular drug	[807]
8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane	DMOM4VS	Investigative	Small molecular drug	[1319]
8-Methyl-4-morpholin-4-yl-chromen-2-one	DMVAOIG	Investigative	Small molecular drug	[627]
8-methyl-4H,7H-indolo[6,5,4-cd]indol-5-one	DMA28OL	Investigative	Small molecular drug	[1166]
8-methylnaringenin	DMK63P2	Investigative	Small molecular drug	[1782]
8-n-heptylnaringenin	DMWMVI3	Investigative	Small molecular drug	[1782]
8-n-nonylnaringenin	DMC2JLQ	Investigative	Small molecular drug	[1782]
8-n-pentylnaringenin	DMRDOP0	Investigative	Small molecular drug	[1782]
8-n-propylnaringenin	DMDOW5S	Investigative	Small molecular drug	[1782]
8-n-undecylnaringenin	DMXURM8	Investigative	Small molecular drug	[1782]
8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one	DM5L40C	Investigative	Small molecular drug	[1788]
8-O-(4-bromobenzenesulfonyl)manzamine F	DMDRPLA	Investigative	Small molecular drug	[672]
8-O-(4-chlorobenzenesulfonyl)manzamine F	DM48JMC	Investigative	Small molecular drug	[672]
8-O-(4-toluenesulfonyl)manzamine A	DM249GI	Investigative	Small molecular drug	[672]
8-Octyl-benzolactam-V9	DM4Z15M	Investigative	Small molecular drug	[1801]
8-OH-MANZAMINE A	DM4QYEF	Investigative	Small molecular drug	[1802]
8-Oxo-8-phenyl-octanoic acid	DMXDQ25	Investigative	Small molecular drug	[1474]
8-Oxo-8-phenyl-octanoic acid hydroxyamide	DMWM1UL	Investigative	Small molecular drug	[1741]
8-pCPT-2'-O-Me-cAMP	DMK2DUX	Investigative	Small molecular drug	[1803]
8-Pentyloxy-quinolin-2-ylamine	DME8S0R	Investigative	Small molecular drug	[1780]
8-PHENYL THEOPHYLLINE	DMFGUCY	Investigative	Small molecular drug	[111]
8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dione	DMHQGOC	Investigative	Small molecular drug	[1804]
8-Phenyl-2-piperidin-1-yl-chromen-4-one	DM29L4D	Investigative	Small molecular drug	[627]
8-Phenyl-2-thiomorpholin-4-yl-chromen-4-one	DMJMWOE	Investigative	Small molecular drug	[627]
8-Phenyl-3,7-dihydro-purine-2,6-dione	DMJB1NI	Investigative	Small molecular drug	[1804]
8-Phenyl-octanoic acid hydroxyamide	DM516NE	Investigative	Small molecular drug	[1744]
8-Phenyloctylcarbamic Acid Biphenyl-3-yl Ester	DM4TWRJ	Investigative	Small molecular drug	[1011]
8-Piperazin-1-yl-imidazo[1,2-a]pyrazine	DM958EN	Investigative	Small molecular drug	[1592]
8-prenylapigenin	DM2VC0E	Investigative	Small molecular drug	[1159]
8-prenylquercetin	DMZC1SV	Investigative	Small molecular drug	[1159]
8-Propionyl-7-propoxy-2H-chromen-2-one	DMKWYJX	Investigative	Small molecular drug	[1686]
8-Propoxy-quinolin-2-ylamine	DM0TVL5	Investigative	Small molecular drug	[1780]
8-propyl-2,6-diphenyl-9H-purine	DMT6YUF	Investigative	Small molecular drug	[798]
8-Pyridin-4-yl-9H-purine-2,6-diamine	DM1I25F	Investigative	Small molecular drug	[1783]
8-sec-Butoxy-quinolin-2-ylamine	DMFPWJL	Investigative	Small molecular drug	[1780]
8-sulfophenyl theophylline	DMOHB3Z	Investigative	Small molecular drug	[1805]
8-[(3-Trifluoromethyl)benzyloxy]caffeine	DMT3IOB	Investigative	Small molecular drug	[1784]
8alpha,19-dihydroxylabd-13 E-en-15-oic acid	DM7K2DN	Investigative	Small molecular drug	[1806]
8R-hydroxylobel-9-ene	DML9HDA	Investigative	Small molecular drug	[1807]
8R-hydroxylobelane	DMJ82TO	Investigative	Small molecular drug	[660]
8R-Lisuride	DMLK4WO	Investigative	Small molecular drug	[1808]
8S-HETE	DMT9SAC	Investigative	Small molecular drug	[1809]
8S-hydroxylobel-9-ene	DMRL3BK	Investigative	Small molecular drug	[660]
8S-hydroxylobelane	DMLONTS	Investigative	Small molecular drug	[660]
9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide	DMVBCID	Investigative	Small molecular drug	[1741]
9-(2-aminoethyl)-9,10-dihydroanthracene	DM4Y9U3	Investigative	Small molecular drug	[937]
9-(2-aminopropyl)-9,10-dihydroanthracene	DMND39P	Investigative	Small molecular drug	[937]
9-(2-Hydroxyethyl)-9H-adenine	DMYUMHG	Investigative	Small molecular drug	[338]
9-(2-Hydroxypropyl)-9H-adenine	DM2UQ0R	Investigative	Small molecular drug	[338]
9-(3-aminobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	DMDYZCH	Investigative	Small molecular drug	[978]
9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one	DM51MRV	Investigative	Small molecular drug	[1240]
9-(3-Hydroxypropyl)-9H-adenine	DM80MTI	Investigative	Small molecular drug	[338]
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	DMOP5AJ	Investigative	Small molecular drug	[22]
9-(3-n-Pentylureido)non-4(Z)-enoic acid	DMUIRS1	Investigative	Small molecular drug	[675]
9-(3-n-Pentylureido)non-4-ynoic acid	DMJYMFE	Investigative	Small molecular drug	[675]
9-(3-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	DM4X18V	Investigative	Small molecular drug	[978]
9-(4-Fluoro-benzyl)-6-phenylsulfanyl-9H-purine	DMW2NY9	Investigative	Small molecular drug	[183]
9-(4-Hydroxybutyl)-N2-Phenylguanine	DMLKJD9	Investigative	Small molecular drug	[12]
9-(4-Hydroxyphenyl)-2,7-Phenanthroline	DMOL01E	Investigative	Small molecular drug	[12]
9-(4-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	DMURKL9	Investigative	Small molecular drug	[978]
9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	DMGFQLE	Investigative	Small molecular drug	[12]
9-(Aminomethyl)-9,10-dihydroanthracene	DM6QDNH	Investigative	Small molecular drug	[937]
9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one	DMIY3D6	Investigative	Small molecular drug	[1741]
9-(N-benzylaminomethyl)-9,10-dihydroanthracene	DMA2RCD	Investigative	Small molecular drug	[1810]
9-(sec-Butyl)-9H-adenine	DMFKVPA	Investigative	Small molecular drug	[338]
9-Allyl-8-bromo-9H-adenine	DM8VZIY	Investigative	Small molecular drug	[338]
9-Amino-1,2,3,4-tetrahydro-acridine-1,7-diol	DMNHZFG	Investigative	Small molecular drug	[1811]
9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	DMUL6QR	Investigative	Small molecular drug	[1788]
9-amino-7H-dibenzo[de,h]quinolin-7-one	DMNMVCZ	Investigative	Small molecular drug	[1761]
9-Aminomethyl-9H-fluorene-2,5,6-triol	DM9123M	Investigative	Small molecular drug	[1667]
9-Aminomethyl-9H-fluorene-3,4-diol	DMNG6O7	Investigative	Small molecular drug	[1667]
9-anthroic acid	DMGCVT2	Investigative	Small molecular drug	[1812]
9-Benzyl-6-(4-fluoro-phenylsulfanyl)-9H-purine	DM8Q0D9	Investigative	Small molecular drug	[183]
9-benzyl-6-(4-methylpiperazin-1-yl)-9H-purine	DM4JG60	Investigative	Small molecular drug	[1681]
9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine	DMNY5P1	Investigative	Small molecular drug	[1682]
9-benzyl-6-(benzylamino)-9H-purine-2-carbonitrile	DMUMOE2	Investigative	Small molecular drug	[1685]
9-benzyl-6-(furan-2-yl)-9H-purin-2-amine	DMO6CB7	Investigative	Small molecular drug	[978]
9-Benzyl-6-phenylsulfanyl-9H-purine	DMNCL5G	Investigative	Small molecular drug	[183]
9-Benzyl-8-bromo-9H-adenine	DMMWGVI	Investigative	Small molecular drug	[338]
9-BENZYL-9H-ADENINE	DMONCUL	Investigative	Small molecular drug	[338]
9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	DMQEO7F	Investigative	Small molecular drug	[1551]
9-But-3-enyl-9H-adenine	DMSWQY7	Investigative	Small molecular drug	[338]
9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	DMXU90T	Investigative	Small molecular drug	[22]
9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	DMKHPAE	Investigative	Small molecular drug	[22]
9-Butyl-9H-adenine	DMZQLBD	Investigative	Small molecular drug	[338]
9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	DMK5DUA	Investigative	Small molecular drug	[977]
9-chlorobenzo[h]isoquinolin-1(2H)-one	DM6EFN2	Investigative	Small molecular drug	[1675]
9-cis-retinal	DM5QAJS	Investigative	Small molecular drug	[1813]
9-Cyclobutyl-9H-adenine	DM04QWX	Investigative	Small molecular drug	[338]
9-Cycloheptyl-9H-adenine	DMP8VM2	Investigative	Small molecular drug	[338]
9-Cyclopentyl-9H-adenine	DMSGU2L	Investigative	Small molecular drug	[104]
9-Cyclopropyl-9H-adenine	DMAFCZL	Investigative	Small molecular drug	[338]
9-Deazaguanine	DM68IPZ	Investigative	Small molecular drug	[12]
9-Deazahypoxanthine	DM3G6LY	Investigative	Small molecular drug	[12]
9-Deazainosine	DME7ONQ	Investigative	Small molecular drug	[12]
9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	DM9BCDT	Investigative	Small molecular drug	[22]
9-Ethyl-2-methyl-beta-carboline-2-ium iodide	DM70MPJ	Investigative	Small molecular drug	[1057]
9-Ethyl-8-phenylethynyl-9H-purin-6-ylamine	DMRVS2D	Investigative	Small molecular drug	[1814]
9-Ethyl-9H-adenine	DMWV8YX	Investigative	Small molecular drug	[338]
9-Ethyl-beta-carboline	DMHKUO9	Investigative	Small molecular drug	[1057]
9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	DMLK0TX	Investigative	Small molecular drug	[977]
9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	DMGAE9Z	Investigative	Small molecular drug	[1788]
9-hydrazino-1,2,3,4-tetrahydroacridine	DMOX21P	Investigative	Small molecular drug	[1815]
9-Hydroxy-7,8-benzoflavone	DMH72MU	Investigative	Small molecular drug	[549]
9-hydroxyoctadecadienoic acid	DM0FWNJ	Investigative	Small molecular drug	[1816]
9-Hydroxypropyladenine, R-Isomer	DMB9FCK	Investigative	Small molecular drug	[12]
9-Hydroxypropyladenine, S-Isomer	DM8QJUH	Investigative	Small molecular drug	[12]
9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	DMGCX7E	Investigative	Small molecular drug	[1817]
9-Isopropyl-9H-adenine	DMBQLAI	Investigative	Small molecular drug	[338]
9-mercapto-8-oxo-N-phenylnonanamide	DMW905K	Investigative	Small molecular drug	[1671]
9-Mercaptomethyl-10-oxo-azecane-2-carboxylic acid	DMM2GQC	Investigative	Small molecular drug	[1818]
9-Methoxy-1,2,3,4-tetrahydro-anthracen-2-ylamine	DM1YK42	Investigative	Small molecular drug	[1013]
9-Methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	DMDW267	Investigative	Small molecular drug	[1551]
9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	DMF7QS5	Investigative	Small molecular drug	[760]
9-methyl-2-(trifluoromethyl)-9H-carbazole	DMKLTD5	Investigative	Small molecular drug	[548]
9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide	DMKD0ZP	Investigative	Small molecular drug	[977]
9-Methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine	DMO4CSP	Investigative	Small molecular drug	[1819]
9-Methyl-9H-adenine	DM6DOVL	Investigative	Small molecular drug	[1820]
9-Methylguanine	DM54FRI	Investigative	Small molecular drug	[12]
9-N-ETHYL-8-ETHOXY-MANZAMINE A	DMPXLEU	Investigative	Small molecular drug	[672]
9-N-METHYL-8-METHOXY-MANZAMINE A	DM1YUBX	Investigative	Small molecular drug	[672]
9-N-Phenylmethylamino-Tacrine	DMGMD1K	Investigative	Small molecular drug	[12]
9-Nitropaullone	DM8LUYM	Investigative	Small molecular drug	[1821]
9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide	DMYXEJ8	Investigative	Small molecular drug	[1822]
9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide	DM081G2	Investigative	Small molecular drug	[1822]
9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide	DMHRV2A	Investigative	Small molecular drug	[400]
9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide	DM4JG9S	Investigative	Small molecular drug	[400]
9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide	DMWVSPH	Investigative	Small molecular drug	[400]
9-O-[3-(Phenylamino)propyl]-berberine bromide	DMKPUWX	Investigative	Small molecular drug	[400]
9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide	DM0FNUX	Investigative	Small molecular drug	[1822]
9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide	DM58XF6	Investigative	Small molecular drug	[1822]
9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide	DMPZTG9	Investigative	Small molecular drug	[1822]
9-octadecynoic acid	DM1DYU4	Investigative	Small molecular drug	[233]
9-OH-risperidone	DMGORXQ	Investigative	Small molecular drug	[1823]
9-phenanthrol	DMJFBQ1	Investigative	Small molecular drug	[1824]
9-Phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine	DMRCM7Q	Investigative	Small molecular drug	[1825]
9-Phenyl-9H-purin-6-ylamine	DM73O2A	Investigative	Small molecular drug	[104]
9-Phenylethyl-9H-adenine	DMO17J0	Investigative	Small molecular drug	[338]
9-Propyl-9H-adenine	DMQTEPY	Investigative	Small molecular drug	[338]
9-[2-(1-Phosphonobutan-2-yloxy)ethyl]guanine	DMOGD42	Investigative	Small molecular drug	[1826]
9-[2-(1-Phosphonobutan-2-yloxy)ethyl]hypoxanthine	DMKHXT9	Investigative	Small molecular drug	[1826]
9-[2-(1-Phosphonopropan-2-yloxy)ethyl]guanine	DMCXN6R	Investigative	Small molecular drug	[1826]
9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline	DMFR3SD	Investigative	Small molecular drug	[1057]
9-[9-(beta-Carboline-9-yl)nonyl]-beta-carboline	DM6M5A4	Investigative	Small molecular drug	[1057]
9alpha,11beta-prostaglandin F2alpha	DMV7LEJ	Investigative	Small molecular drug	[1827]
9alpha-acetoxy-miller-1(10)Z-enolide	DMO9R6T	Investigative	Small molecular drug	[703]
9H-beta-Carbolin-3-ol	DMBWAMR	Investigative	Small molecular drug	[1264]
9H-beta-Carbolin-6-ylamine	DMBLEI7	Investigative	Small molecular drug	[204]
9H-beta-Carboline-3-carboxylic acid ethyl ester	DMK459I	Investigative	Small molecular drug	[1828]
9H-beta-Carboline-3-carboxylic acid propyl ester	DMMUH98	Investigative	Small molecular drug	[1828]
9H-carbazole-2-carbaldehyde	DM6WHIA	Investigative	Small molecular drug	[548]
9H-carbazole-3-carbaldehyde	DM0HNU3	Investigative	Small molecular drug	[548]
9H-purine derivative	DMF1XLZ	Investigative	NA	[1819]
A 137491	DM1H3FJ	Investigative	Small molecular drug	[1829]
A-119637	DM1DWRN	Investigative	Small molecular drug	[1830]
A-123189	DMZ51UJ	Investigative	Small molecular drug	[1831]
A-192558	DMV03NS	Investigative	Small molecular drug	[815]
A-224940	DM5VQ8E	Investigative	Small molecular drug	[1832]
A-286982	DM98VFW	Investigative	Small molecular drug	[1833]
A-304121	DMPI0YX	Investigative	Small molecular drug	[1834]
A-313326	DML4P6O	Investigative	Small molecular drug	[1835]
A-315456	DMV8MKP	Investigative	Small molecular drug	[92]
A-315675	DMSQLZF	Investigative	Small molecular drug	[815]
A-317567	DMGWO9J	Investigative	Small molecular drug	[1836]
A-357300	DMZHDWN	Investigative	Small molecular drug	[1837]
A-381393	DMI4TVB	Investigative	Small molecular drug	[1838]
A-395	DMSTZ14	Investigative	Small molecular drug	[31]
A-420983	DM7HSCI	Investigative	Small molecular drug	[1839]
A-425444	DMM5XD6	Investigative	Small molecular drug	[1840]
A-432411	DMQHKIA	Investigative	Small molecular drug	[1841]
A-443654	DMLMU63	Investigative	Small molecular drug	[1842]
A-582941	DM7R8DJ	Investigative	Small molecular drug	[1843]
A-62824	DMJ6IMZ	Investigative	Small molecular drug	[1844]
A-641359	DM5JSXI	Investigative	Small molecular drug	[1845]
A-674563	DMJ83LK	Investigative	Small molecular drug	[1846]
A-706149	DMXOPFU	Investigative	Small molecular drug	[1847]
A-740003	DMI7J1L	Investigative	Small molecular drug	[1848]
A-770041	DMP78JY	Investigative	Small molecular drug	[1845]
A-794278	DM6BRTF	Investigative	Small molecular drug	[1849]
A-794282	DMU965M	Investigative	Small molecular drug	[1849]
A-795614	DM2W4IQ	Investigative	Small molecular drug	[1850]
A-80040	DML20N9	Investigative	Small molecular drug	[1851]
A-846714	DM5TDEW	Investigative	Small molecular drug	[1852]
A-850002	DMJCPSD	Investigative	Small molecular drug	[1849]
A-867744	DM96F8U	Investigative	Small molecular drug	[1853]
A-935142	DMBF1OY	Investigative	Small molecular drug	[1854]
A-943931	DMROD7Q	Investigative	Small molecular drug	[1852]
A-987306	DMU34BK	Investigative	Small molecular drug	[1855]
A192621	DMV8AH6	Investigative	Small molecular drug	[1856]
A2P5P	DMK4OD7	Investigative	Small molecular drug	[1857]
A3P5PS	DM82Q7F	Investigative	Small molecular drug	[1858]
A412997	DMKY9G5	Investigative	Small molecular drug	[1859]
A438079	DMUBM8X	Investigative	Small molecular drug	[1860]
A61603	DM7W2ME	Investigative	Small molecular drug	[1861]
A778317	DMG6ZHO	Investigative	Small molecular drug	[1862]
A839977	DMPXKOE	Investigative	Small molecular drug	[1863]
AAE-M-PBP-amine	DMNO51B	Investigative	Small molecular drug	[1864]
AAL-993	DM35RFH	Investigative	Small molecular drug	[1865]
AB-1101	DMELZTH	Investigative	NA	[1866]
AB-MECA	DMQPHFU	Investigative	Small molecular drug	[1867]
AB-NECA	DME8G7F	Investigative	Small molecular drug	[1868]
Abbott 14c	DMDBWT6	Investigative	Small molecular drug	[1869]
Abietic acid	DMW1Y2G	Investigative	Small molecular drug	[1870]
ABL127	DMRC3A5	Investigative	Small molecular drug	[1871]
abnormal cannabidiol	DMV6DAO	Investigative	Small molecular drug	[1872]
ABT-341	DMZ3YTO	Investigative	Small molecular drug	[63]
ABT-670	DM6J57N	Investigative	Small molecular drug	[1873]
Abyssinin I	DMC02FP	Investigative	Small molecular drug	[1602]
Abyssinin II	DMR7IGZ	Investigative	Small molecular drug	[1602]
Abyssinoflavanone VI	DMEYQF9	Investigative	Small molecular drug	[1602]
Abyssinoflavanone VII	DMTVQSL	Investigative	Small molecular drug	[1602]
ABYSSINONE V	DMH3CK2	Investigative	Small molecular drug	[1163]
Abyssinone-IV	DM9YAVX	Investigative	Small molecular drug	[1874]
Abyssinone-VI-4-O-methyl ether	DMZUY93	Investigative	Small molecular drug	[1874]
AC-(D)PHE-PRO-BOROHOMOLYS-OH	DMZ0RP5	Investigative	Small molecular drug	[22]
AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	DMPHV7K	Investigative	Small molecular drug	[22]
AC-(D)PHE-PRO-BOROLYS-OH	DM2YWRL	Investigative	Small molecular drug	[22]
AC-7954	DM367MF	Investigative	Small molecular drug	[1875]
Ac-Ala-Pro-Val-(2-benzoxazole)	DMJ3C20	Investigative	Small molecular drug	[359]
Ac-Asp-Arg-Leu-Asp-Ser-OH	DMYHADT	Investigative	Small molecular drug	[1876]
Ac-Asp-Glu-Val-Asp-CHO	DM4KQUS	Investigative	Small molecular drug	[1877]
Ac-bhg-F-N-Y-Y-W	DM1KDJV	Investigative	NA	[1878]
Ac-Bth-Thr(PO3H2)-Pip-Nal-Gln-NH2	DMSE29N	Investigative	Small molecular drug	[1879]
Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr	DMH0SQC	Investigative	NA	[1880]
Ac-Cys-Ile-Phe(4-NO2)-Lys-Phe(4-NO2)-Tyr	DMG19LW	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Phe(4-NO2)	DMORPDV	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Tyr	DMK7YIG	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-Cl)-Tyr	DMUWI2F	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-CN)-Tyr	DMNW7GR	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-I)-Tyr	DMO4MYI	Investigative	NA	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-N3)-Tyr	DME4FZD	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Phe(4-NO2)	DM856JM	Investigative	Small molecular drug	[1880]
Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Tyr-Phe	DMU2PT1	Investigative	NA	[1880]
Ac-Cys-Ile-Tyr-Lys-Tyr-Phe(4-NO2)	DM4MP69	Investigative	Small molecular drug	[1880]
Ac-D-pro-L-Phe-D-trp-L-Phe-NH2	DMVDH4I	Investigative	Small molecular drug	[1881]
Ac-DEVD-CHO	DMW02H7	Investigative	Small molecular drug	[1882]
Ac-dR[CEHdFRWC]-NH2	DM7XY41	Investigative	NA	[1883]
Ac-FWKY-NH2	DM3XHIY	Investigative	Small molecular drug	[1884]
Ac-Glu-Cha-Cys	DM6T09B	Investigative	Small molecular drug	[1885]
Ac-His-D-Phe-Arg-2-Nal-NHCH3	DMAQR29	Investigative	Small molecular drug	[1886]
Ac-His-DNal(2)-Arg-Trp-NH2	DMUEBRN	Investigative	Small molecular drug	[1887]
Ac-His-DPhe(3,4-diCl)-Arg-Trp-NH2	DMR31Z9	Investigative	Small molecular drug	[1887]
Ac-His-DPhe(pBr)-Arg-Trp-NH2	DMXU5ZP	Investigative	Small molecular drug	[1887]
Ac-His-DPhe(pCF3)-Arg-Trp-NH2	DMTA6I5	Investigative	Small molecular drug	[1887]
Ac-His-DPhe(pI)-Arg-Trp-NH2	DM3GSPX	Investigative	Small molecular drug	[1887]
Ac-His-DPhe-Arg-Trp-NH2	DMMP0D8	Investigative	Small molecular drug	[1888]
Ac-His-Trp-Ala-Val-Ala-His-Leu-Met-NH2	DMCA4QR	Investigative	NA	[213]
Ac-His-Trp-Ala-Val-D-Ala-His-Leu-Met-NH2	DMUINVT	Investigative	NA	[213]
Ac-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2	DMUGO9M	Investigative	Small molecular drug	[213]
Ac-hPhe-Leu-Ala-LeuVSMe	DMU7SBD	Investigative	Small molecular drug	[1889]
Ac-hPhe-Leu-Gly-LeuVSMe	DMH2SU4	Investigative	Small molecular drug	[1889]
Ac-hPhe-Leu-Phe-LeuVSMe	DMMDJPC	Investigative	Small molecular drug	[1889]
Ac-HSDAVFTDQYTRLRKQVAAKKYLQSIKQKRYC	DMV58GQ	Investigative	NA	[1890]
Ac-ICV(1MeW)QDWGAHRCT-NH2	DM351NL	Investigative	NA	[1891]
Ac-ICV(5fW)QDWGAHRCT-NH2	DMQLPGA	Investigative	NA	[1891]
Ac-ICV(5MeW)QDWGAHRCT-NH2	DM52T90	Investigative	NA	[1891]
Ac-ICVWQD(5fW)GAHRCT-NH2	DMPK9LG	Investigative	NA	[1891]
Ac-ICVWQDWGAHRCT-NH2	DMPSI26	Investigative	NA	[1891]
Ac-I[CV(1Nal)QDWGAHRC]T	DMJVRPD	Investigative	NA	[1892]
Ac-I[CV(2Igl)QDWGAHRC]T	DM14DEL	Investigative	NA	[1892]
Ac-I[CV(2Igl)QDWGAHRC]T-NH2	DMQISG6	Investigative	NA	[1892]
Ac-I[CV(2Nal)QDWGAHRC]T	DM20PEO	Investigative	NA	[1892]
Ac-I[CV(2Nal)QDWGAHRC]T-NH2	DMX2IRY	Investigative	NA	[1892]
Ac-I[CV(Bpa)QDWGAHRC]T	DMDFKU3	Investigative	NA	[1892]
Ac-I[CV(Bpa)QDWGAHRC]T-NH2	DMZG46O	Investigative	NA	[1892]
Ac-I[CV(Bta)QDWGAHRC]T	DM5NMVP	Investigative	NA	[1892]
Ac-I[CV(Bta)QDWGAHRC]T-NH2	DMFLA5T	Investigative	NA	[1892]
Ac-I[CV(Dht)QDWGAHRC]T	DMO9VWH	Investigative	NA	[1892]
Ac-I[CV(Yphs)QDWGAHRC]I-NH2	DMY18ET	Investigative	NA	[1892]
Ac-I[CVFQDWGHHRC]T-NH2	DMFOTYQ	Investigative	NA	[1892]
Ac-I[CVHQDWGHHRC]T-NH2	DMLU3PZ	Investigative	NA	[1892]
Ac-I[CVSQDWGHHRC]T-NH2	DMDPSBQ	Investigative	NA	[1892]
Ac-I[CVTQDWGHHRC]T-NH2	DMNVMB5	Investigative	NA	[1892]
Ac-I[CVVQDWGAHRC]T-NH2	DMRSKIY	Investigative	NA	[1892]
Ac-I[CVWQDWG(Abu)HRC]T-NH2	DMUW3T4	Investigative	NA	[1892]
Ac-I[CVWQDWGAHRC]dT	DML5ZSJ	Investigative	NA	[1892]
Ac-I[CVWQDWGAHRC]T	DMV3PC7	Investigative	NA	[1892]
Ac-I[CVWQDWGHHRC]T-NH2	DMBA1LS	Investigative	NA	[1892]
Ac-I[CVWQDWGWHRC]T-NH2	DMDIUK6	Investigative	NA	[1892]
Ac-I[CVYQDWGAHRC]T-NH2	DM3Q5SU	Investigative	NA	[1892]
Ac-L-Phe-D-trp-L-Phe-D-pro-NH2	DMKVU8P	Investigative	Small molecular drug	[1881]
Ac-Lys-[Leu(8)]-des-Arg(9)-BK	DMIAYTP	Investigative	Small molecular drug	[1893]
Ac-Nle-c[Asp-His-DNaI(2')-Pro-Trp-Lys]-NH2	DMLYGPW	Investigative	NA	[1894]
Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2	DMOVI7Y	Investigative	NA	[1894]
AC-Nle-c[Asp-His-DPhe-Pro-Trp-Lys]-NH2	DMG418C	Investigative	Small molecular drug	[1894]
Ac-Phe-D-Thr(PO3H2)-Pip-Nal-Gln-NH2	DM6ONY7	Investigative	Small molecular drug	[1879]
Ac-Phe-Phe-NH2	DMDXBQA	Investigative	Small molecular drug	[216]
Ac-Phe-Thr(PO3H2)-Pip-Nal-Gln-NH2	DMSWTPX	Investigative	Small molecular drug	[1879]
Ac-RYYRIK-GGG-K-(NH2)-YAFGYPS-GG	DM512OP	Investigative	NA	[1895]
Ac-RYYRIK-GGG-K-(NH2)-YRFB-GGGGG	DMAHQIV	Investigative	NA	[1895]
Ac-RYYRIK-K-(NH2)-YAFGYPS	DM2ND3U	Investigative	NA	[1895]
Ac-RYYRIK-K-(NH2)-YRFB	DMNA3F4	Investigative	NA	[1895]
Ac-RYYRIK-NH2	DMI87UE	Investigative	Small molecular drug	[1896]
Ac-R[CEHdFRWC]-NH2	DMBFUD0	Investigative	NA	[1883]
Ac-SFWKYS-NH2	DM8XBR1	Investigative	Small molecular drug	[1884]
Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3	DMIH5CD	Investigative	Small molecular drug	[1886]
Ac-VEID-CHO	DMWOYCZ	Investigative	Small molecular drug	[1897]
Ac-VTHRLAGLLSRSGGVVKNNFVPTDVGPFAF-NH2	DMO0W9V	Investigative	NA	[1898]
Ac-VTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	DMWJ2M5	Investigative	NA	[1898]
Ac-w-F-F-N-Y-Y-W	DMP89K4	Investigative	NA	[1878]
Ac-WKY-NH2	DM7J9O6	Investigative	Small molecular drug	[1884]
Ac-WVEHRLKGELSRKGGVV[hArg]KNFVPTDVGPFAF-NH2	DM9W21L	Investigative	NA	[1898]
Ac-WVTHQLAGLLSQSGGVVRKNFVPTDVGPFAF-NH2	DM3BUP6	Investigative	NA	[1898]
Ac-WVTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	DMSMVK4	Investigative	NA	[1898]
Ac-WVTHRLAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2	DMKO982	Investigative	NA	[1898]
Ac-WVTH[Cit]LAGLLSRSGGVVRKNFVPTDVGPFAF-NH2	DMR1N53	Investigative	NA	[1898]
Ac-WVTH[Cit]LAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2	DMJU4AM	Investigative	NA	[1898]
Ac-WVTH[hArg]LAGLLS[hArg]SGGVVRKNFVPTDVGPFAF-NH2	DM19NMF	Investigative	NA	[1898]
Ac-YCit[CEHdFRWC]-NH2	DMAVPXL	Investigative	NA	[1883]
Ac-YGGFL-NH2	DMC0TU5	Investigative	Small molecular drug	[1899]
Ac-YK[CEHdFRWC]-NH2	DM5SJX8	Investigative	NA	[1883]
Ac-YRC(Me)*EHdFRWC(Me)NH2	DMWJ8UR	Investigative	NA	[1883]
Ac-YRMEHdFRWG-NH2	DMN2UKC	Investigative	NA	[1883]
Ac-YRMEHdFRWGSPPKD-NH2	DMDH5B3	Investigative	NA	[1883]
Ac-YR[CE(1-Me-H)dFRWC]-NH2	DMJK8QZ	Investigative	NA	[1883]
Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2	DMVQ4KG	Investigative	NA	[1883]
Ac-YR[CEH(pCl-dF)RWC]-NH2	DM25JXM	Investigative	NA	[1883]
Ac-YR[CEH(pF-dF)RWC]-NH2	DMXCF9T	Investigative	NA	[1883]
Ac-YR[CEHdFRWC]-NH2	DMBMY73	Investigative	NA	[1883]
Ac-YR[CEHdFRWC]SPPKD-NH2	DMDO468	Investigative	NA	[1883]
Ac-YR[CEHFRWC]-NH2	DMH0EAI	Investigative	NA	[1883]
Ac-[CEHdFRWC]-NH2	DMRLOGP	Investigative	NA	[1883]
Ac-[CFWKFC]-NH2	DM9IN4T	Investigative	Small molecular drug	[1884]
Ac-[CFWkYC]-NH2	DMW24UH	Investigative	Small molecular drug	[1884]
AC1LG8KT	DMFKV97	Investigative	Small molecular drug	[1900]
AC261066	DMSKE1I	Investigative	Small molecular drug	[1901]
AC265347	DM4G60V	Investigative	Small molecular drug	[1902]
AC45594	DM5WBYX	Investigative	Small molecular drug	[1903]
AC55649	DM4JNY9	Investigative	Small molecular drug	[1904]
ACAA	DMACYPW	Investigative	Small molecular drug	[1905]
ACACETIN	DMQOB0X	Investigative	Small molecular drug	[1906]
Acanthus ilicifolius Linn	DMZDFRI	Investigative	Small molecular drug	[1907]
Acarbose Derived Hexasaccharide	DMS9COH	Investigative	Small molecular drug	[12]
AcAsp-D-Gla-Leu-Ile-Cha-Cys	DMT74F5	Investigative	Small molecular drug	[779]
AcAsp-D-Glu-Leu-Glu-Cha-Cys	DMDC71B	Investigative	Small molecular drug	[1885]
AcAsp-Gla-Leu-Ile-Cha-Cys	DMXQATR	Investigative	Small molecular drug	[1885]
AcAsp-Glu-Cha-Val-Prb-Cpg	DMHZ5W3	Investigative	Small molecular drug	[779]
AcAsp-Glu-Cha-Val-Prb-Cys	DMDH5EJ	Investigative	Small molecular drug	[779]
AcAsp-Glu-Dif-Glu-Cha-Cys	DMEB8UA	Investigative	Small molecular drug	[779]
AcAsp-Glu-Dif-Glu-Cha-Fab	DMPQ8Z9	Investigative	Small molecular drug	[779]
AcAsp-Glu-Dif-Ile-Cha-Cys	DM6IP17	Investigative	Small molecular drug	[1885]
AcAsp-Glu-Dif-Ile-Cha-Cys-Iqc-Nle-Thr-TyrNH2	DM3W68X	Investigative	NA	[779]
AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Cha-Asp-ValNH2	DMCIJ6Q	Investigative	NA	[779]
AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Nle-Asp-ValNH2	DMA7ZSY	Investigative	NA	[779]
AcAsp-Glu-Dif-Lys-Cha-Cys	DM6PZ45	Investigative	Small molecular drug	[1885]
AcAsp-Glu-Leu-Glu-Cha-Cys	DMKDZH4	Investigative	Small molecular drug	[1885]
AcAsp-Glu-Met-Glu-Cha-Cys	DMOMI91	Investigative	Small molecular drug	[1885]
AcAsp-Glu-Met-Glu-Glu-Cys	DMIVFZE	Investigative	Small molecular drug	[779]
AcAsp-Glu-Met-Glu-Nal-Cyse	DMBGHX7	Investigative	Small molecular drug	[1885]
AcDif-Glu-Cha-Cys	DMKDEWH	Investigative	Small molecular drug	[1885]
AcDif-Ile-Cha-Cys	DM1DWCP	Investigative	Small molecular drug	[1885]
ACDPP	DMPMH7Z	Investigative	Small molecular drug	[1908]
AcDRGDS	DM9MDBO	Investigative	Small molecular drug	[1909]
ACEA	DMWX3HT	Investigative	Small molecular drug	[1910]
Acenanthrene-9,10-dione	DMU9O7K	Investigative	Small molecular drug	[385]
ACENAPHTHOQUINONE	DMU3DMH	Investigative	Small molecular drug	[385]
Acerogenin A	DM4BWMO	Investigative	Small molecular drug	[1911]
ACEROGENIN B	DMVQ30P	Investigative	Small molecular drug	[1911]
Acerogenin C	DMNETSX	Investigative	Small molecular drug	[1911]
ACET	DMB2463	Investigative	Small molecular drug	[1912]
acetaldehyde	DMJFKG4	Investigative	Small molecular drug	[1913]
acetamide	DM3OM0X	Investigative	Small molecular drug	[1914]
Acetate Ion	DMD08RH	Investigative	Small molecular drug	[12]
Acetic	DMQPF5G	Investigative	Small molecular drug	[1866]
Acetic acid 2,6-diisopropyl-phenyl ester	DMBP5L4	Investigative	Small molecular drug	[802]
Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester	DM97DJL	Investigative	Small molecular drug	[1915]
Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester	DMD89A1	Investigative	Small molecular drug	[1915]
Acetic acid 2-heptylselanyl-phenyl ester	DM50BTA	Investigative	Small molecular drug	[1915]
Acetic acid 2-heptylsulfanyl-phenyl ester	DMLPRIG	Investigative	Small molecular drug	[1915]
Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester	DMFQE1C	Investigative	Small molecular drug	[1915]
Acetic acid 2-hexylsulfanyl-phenyl ester	DMAKNUH	Investigative	Small molecular drug	[1915]
Acetic acid 2-pentylsulfanyl-phenyl ester	DMFKRIH	Investigative	Small molecular drug	[1915]
Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester	DMUYKIE	Investigative	Small molecular drug	[922]
Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester	DM95QEA	Investigative	Small molecular drug	[922]
Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	DMVEH40	Investigative	Small molecular drug	[1916]
Acetic Acid Salicyloyl-Amino-Ester	DMLTNHY	Investigative	Small molecular drug	[22]
acetoacetic acid	DMU1EWA	Investigative	Small molecular drug	[1917]
Acetoacetyl-Coenzyme A	DM3HYU8	Investigative	Small molecular drug	[1918]
acetyl CoA	DMH65Q8	Investigative	Small molecular drug	[1919]
Acetyl-Ala-Ala-Pro-Ala-trifluromethane	DMFZJRN	Investigative	Small molecular drug	[1920]
Acetyl-Ile-Glu-Thr-Asp-aldehyde	DM1VE6S	Investigative	Small molecular drug	[1921]
acetyl-L-carnitine	DM74HGJ	Investigative	Small molecular drug	[1922]
acetyl-podocarpic dimer	DMGTPFY	Investigative	Small molecular drug	[1923]
Acetyl-Pro-Ala-Pro-Ala-trifluoro methane	DMN5Z0F	Investigative	Small molecular drug	[1920]
ACETYLSULFANILAMIDE	DMG8P24	Investigative	Small molecular drug	[749]
AcGlu-Asp-Val-Val-Leu-Cys-Iqc-Nle-Thr-TyrNH2	DMAI43O	Investigative	NA	[779]
AcGlu-Dif-Glu-Cha-Cys	DM0BV9I	Investigative	Small molecular drug	[1885]
AcGlu-Dif-Ile-Cha-Cys	DMK6HGI	Investigative	Small molecular drug	[1885]
Acid blue 25	DMCU6XV	Investigative	Small molecular drug	[1924]
Acid-activated omeprazole	DMTOEJX	Investigative	Small molecular drug	[1925]
AcNPY(25-36)	DMZBOQW	Investigative	NA	[1926]
Aconitate Ion	DMJ5U8C	Investigative	Small molecular drug	[12]
aconitine	DMFOZ60	Investigative	Small molecular drug	[1927]
ACPT-I	DM264XN	Investigative	Small molecular drug	[1928]
AcPYY(22-36)	DMDEFPS	Investigative	NA	[1926]
AcPYY(25-36)	DMRSU2K	Investigative	NA	[1926]
AcPYY(26-36)	DM7RELC	Investigative	NA	[1926]
acrolein	DMAMCSR	Investigative	Small molecular drug	[1929]
acrylamide	DMCK6KL	Investigative	Small molecular drug	[1930]
ACTINOPLANIC ACID A	DMXIDS9	Investigative	Small molecular drug	[363]
ACULEACIN A	DMR2MUG	Investigative	NA	[1931]
Acurea	DMMQKCV	Investigative	Small molecular drug	[1932]
Acylated Ceftazidime	DMIZ5VO	Investigative	Small molecular drug	[12]
Acylureido penicillin mezlocillin	DM4CYKE	Investigative	NA	[1933]
AD-5061	DM5WV13	Investigative	Small molecular drug	[1934]
Ada-RYYRIK-NH2	DM1MAVU	Investigative	NA	[754]
Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester	DMKDRVZ	Investigative	Small molecular drug	[1011]
Adamantan-1-yl-(4-ethyl-piperazin-1-yl)-methanone	DM4S279	Investigative	Small molecular drug	[539]
Adamantan-1-yl-piperazin-1-yl-methanone	DM5K0EI	Investigative	Small molecular drug	[539]
Adamantan-1-yl-piperidin-1-yl-methanone	DMTUL9J	Investigative	Small molecular drug	[539]
Adamantan-1-yl-pyrrolidin-1-yl-methanone	DMAEN9Y	Investigative	Small molecular drug	[539]
Adamantan-2-yl-piperidin-1-yl-methanone	DMBRAV5	Investigative	Small molecular drug	[539]
AdcAhxArg4Lys(biotin)-PEG-OMe	DMZYJHV	Investigative	NA	[1935]
AdcAhxArg4Lys-PEGOMe	DMQ2C8X	Investigative	NA	[1935]
AdcAhxArg4NH(CH2)6NH2	DMSYMRJ	Investigative	NA	[1935]
AdcAhxArg6	DM7J3K0	Investigative	NA	[1935]
ADENOPHOSTIN A	DMV39AW	Investigative	Small molecular drug	[1936]
Adenosine Monotungstate	DMJZPSX	Investigative	Small molecular drug	[12]
adenosine-3'-5'-bisphosphate	DMSOVFD	Investigative	Small molecular drug	[1937]
Adenosine-5'-O-(2-thiodiphosphate)	DMJDO2F	Investigative	Small molecular drug	[1938]
Adenosine-5'-Rp-Alpha-Thio-Triphosphate	DMKY7T8	Investigative	Small molecular drug	[107]
Adenosine-5-Diphosphoribose	DM96LBV	Investigative	Small molecular drug	[12]
ADIPATE	DM2XI09	Investigative	Small molecular drug	[1939]
Ado-P-Ch2-P-Ps-Ado	DM9IBHU	Investigative	Small molecular drug	[12]
AdoC(Ahx)Arg6	DMW5HO0	Investigative	NA	[1940]
AdoC(Aoc)Arg6	DMRSCO2	Investigative	NA	[1940]
AdoC(Aun)Arg6	DMDLHAB	Investigative	NA	[1940]
AdoC(beta-Ala)2AlaArg6	DMPUAFC	Investigative	NA	[1940]
AdoC(beta-Ala)Arg6	DMO8D4V	Investigative	NA	[1940]
AdoC(betaAsp)2AlaArg6	DM65B7Y	Investigative	NA	[1940]
AdoC(Dpr)2AlaArg6	DM2TWSZ	Investigative	NA	[1940]
AdoC(GABA)Arg6	DMMWNPT	Investigative	NA	[1940]
AdoCGlyArg6	DMVQJP0	Investigative	NA	[1940]
ADOCIAQUINONE B	DMPOU86	Investigative	Small molecular drug	[1661]
Adociasulfate-2	DM6MRSC	Investigative	Small molecular drug	[1941]
ADP ribose	DMQ1F7J	Investigative	Small molecular drug	[1942]
Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2	DMVWM75	Investigative	NA	[1943]
ADRENOGLOMERULOTROPIN	DMP8NSU	Investigative	Small molecular drug	[197]
ADS-100380	DM7U4OT	Investigative	Small molecular drug	[1944]
ADS-102550	DMEU6MH	Investigative	Small molecular drug	[1944]
ADS-102891	DMXD0C3	Investigative	Small molecular drug	[1945]
ADS-103168	DMMYUB9	Investigative	Small molecular drug	[1945]
ADS-103214	DMUMF0B	Investigative	Small molecular drug	[1945]
ADS-103253	DMH9A4S	Investigative	Small molecular drug	[1945]
ADS-103254	DMLIOV2	Investigative	Small molecular drug	[1945]
ADS-103274	DMBN6IE	Investigative	Small molecular drug	[1945]
ADS-103293	DM0C4QD	Investigative	Small molecular drug	[1945]
ADS-103294	DMM2Q9L	Investigative	Small molecular drug	[1945]
ADS-103316	DMKCOYE	Investigative	Small molecular drug	[1945]
ADX71743	DM3WAG6	Investigative	Small molecular drug	[1946]
AEKKDEGPYRMEHFRWGSPPKD	DMZ8SV3	Investigative	NA	[1883]
Aerophobin-1	DME0I6U	Investigative	Small molecular drug	[1947]
AF-DX-384	DMNY8H7	Investigative	Small molecular drug	[1948]
AF150(S)	DMOYADT	Investigative	Small molecular drug	[1949]
AF353	DMXQ3MO	Investigative	Small molecular drug	[1950]
AFD(R)	DME9Y8Q	Investigative	Small molecular drug	[1951]
AFLATREME	DM2R5F9	Investigative	Small molecular drug	[1952]
AFP-07	DM4WVMU	Investigative	Small molecular drug	[1953]
AG 1024	DMF0SPB	Investigative	Small molecular drug	[1954]
AG 112	DMDYS0L	Investigative	Small molecular drug	[1955]
AG 1296	DMJ6R70	Investigative	Small molecular drug	[1956]
AG 9	DMSOUI0	Investigative	Small molecular drug	[1955]
AG-014376	DMHFYNE	Investigative	Small molecular drug	[1957]
AG-09/1	DMW7H28	Investigative	Small molecular drug	[1958]
AG-11/03	DMZINUY	Investigative	Small molecular drug	[1959]
AG-14	DMVR9G0	Investigative	Small molecular drug	[1960]
AG-213	DMT3ML6	Investigative	Small molecular drug	[1425]
AG-26	DMMFQR2	Investigative	Small molecular drug	[1961]
AG-538	DM9KIS8	Investigative	Small molecular drug	[334]
AG-E-85378	DM83951	Investigative	Small molecular drug	[1962]
AG-L-66494	DMD7MND	Investigative	Small molecular drug	[1963]
agatoxin 489	DMAUJOM	Investigative	Small molecular drug	[1964]
AGELADINE A	DMOJ3CW	Investigative	Small molecular drug	[1965]
AGK2	DM26AMU	Investigative	Small molecular drug	[1966]
AGL 2043	DMM9A5N	Investigative	Small molecular drug	[1967]
agmatine	DMSBZ29	Investigative	Small molecular drug	[1968]
AGN 191976	DMTPV4Y	Investigative	Small molecular drug	[1969]
AGN 211334	DMC9VH0	Investigative	Small molecular drug	[1970]
AGN-190383	DM53R94	Investigative	Small molecular drug	[1971]
AGN-190744	DMIKDAR	Investigative	NA	[1972]
AGN-192172	DM946RA	Investigative	Small molecular drug	[1973]
AGN-34	DM5ECDM	Investigative	Small molecular drug	[1974]
AGN192093	DMISJXB	Investigative	Small molecular drug	[1975]
AGN193109	DMC0YOE	Investigative	Small molecular drug	[1976]
AGN193836	DMEB93D	Investigative	Small molecular drug	[1977]
AGROCLAVINE	DMT9FJZ	Investigative	Small molecular drug	[1978]
AGTAD[CFWKYC]V	DMMO9YR	Investigative	NA	[1884]
AH 11110	DMF7ZYQ	Investigative	Small molecular drug	[1979]
AH13205	DM2VEHG	Investigative	Small molecular drug	[1980]
AH23848	DM4S1Y6	Investigative	Small molecular drug	[1981]
AH6809	DMKN3R9	Investigative	Small molecular drug	[1982]
AHPN	DM8G6O4	Investigative	Small molecular drug	[1983]
AIDA	DM3LCDK	Investigative	Small molecular drug	[1984]
AK198	DMWKPJH	Investigative	Small molecular drug	[1985]
AKNADILACTAM	DM4E6H1	Investigative	Small molecular drug	[1705]
Akt inhibitor VIII	DMDVIT1	Investigative	Small molecular drug	[1986]
AKUAMMIGINE	DMJW4I5	Investigative	Small molecular drug	[3]
AKUAMMINE	DM8DYWN	Investigative	Small molecular drug	[70]
AL-37350A	DMRJ2GK	Investigative	Small molecular drug	[1987]
AL-43	DMLEDHR	Investigative	Small molecular drug	[1988]
AL-8810	DMRWLQM	Investigative	Small molecular drug	[1989]
AL12180	DM0JE4N	Investigative	Small molecular drug	[1990]
AL4623	DMHG54F	Investigative	Small molecular drug	[12]
AL5300	DM1QJIV	Investigative	Small molecular drug	[12]
AL5424	DMSD2U1	Investigative	Small molecular drug	[12]
AL5927	DM624WO	Investigative	Small molecular drug	[12]
AL6528	DM1JIVR	Investigative	Small molecular drug	[12]
Al7089a	DMTXPJI	Investigative	Small molecular drug	[12]
AL7099A	DMRI08C	Investigative	Small molecular drug	[107]
AL7182	DMG2D4S	Investigative	Small molecular drug	[12]
Ala(1-naph)-Pro-CN	DMRWUQ5	Investigative	Small molecular drug	[1871]
Ala-Pro-Glu	DMTWB54	Investigative	Small molecular drug	[215]
Ala11-SRIF-14-amide	DMZH4NQ	Investigative	NA	[1991]
Ala6-SRIF-14-amide	DM9RQ7E	Investigative	NA	[1991]
Ala7-SRIF-14-amide	DMWF8GN	Investigative	NA	[1991]
ALBAFURAN A	DMO1ZC2	Investigative	Small molecular drug	[1992]
ALBANOL A	DMHIW2L	Investigative	Small molecular drug	[152]
ALDISIN	DMS80DF	Investigative	Small molecular drug	[1365]
Alexa-488-telenzepine	DM83CDK	Investigative	Small molecular drug	[1993]
ALFAXALONE	DMI4OTW	Investigative	Small molecular drug	[1994]
alkyl glycerol phosphate 18:1	DM3DERI	Investigative	Small molecular drug	[1995]
alkyl OMPT	DMM19AO	Investigative	Small molecular drug	[1996]
alkylbenzene sulfonate	DMQH481	Investigative	Small molecular drug	[1997]
all-trans-4-oxo-retinoic acid	DMM2R1N	Investigative	Small molecular drug	[1998]
all-trans-retinal	DM6CEVB	Investigative	Small molecular drug	[1999]
ALLICIN	DMSOJ6H	Investigative	Small molecular drug	[2000]
alloswitch-1	DM05AYE	Investigative	Small molecular drug	[2001]
Alloxazine	DM7U2BE	Investigative	Small molecular drug	[2002]
Allyl 4-(2-oxohexadecanamido)butanoate	DM8R5AS	Investigative	Small molecular drug	[341]
Allyl 4-(aminosulfonyl)benzoate	DMYNKLR	Investigative	Small molecular drug	[633]
Allyl-trimethyl-ammonium	DM1VHCL	Investigative	Small molecular drug	[131]
Allylamines	DMNFGRV	Investigative	NA	[2003]
Allylcarbamic Acid Biphenyl-3-yl Ester	DMJWZB3	Investigative	Small molecular drug	[1011]
Aloe-emodin	DMPTY8S	Investigative	Small molecular drug	[2004]
aloisine	DM7HGX8	Investigative	Small molecular drug	[2005]
aloisine A	DM5U1LN	Investigative	Small molecular drug	[2006]
Alpha,beta-methylene-dATP	DMHRME4	Investigative	Small molecular drug	[2007]
Alpha,beta-methylene-dCTP	DMJI8TX	Investigative	Small molecular drug	[2007]
Alpha,beta-methylene-dGTP	DMPZS80	Investigative	Small molecular drug	[2007]
Alpha,beta-methylene-dTTP	DMPAHJF	Investigative	Small molecular drug	[2007]
Alpha-7-Deoxyhomonojirimycin	DMND5EU	Investigative	Small molecular drug	[2008]
Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen	DMHV14R	Investigative	Small molecular drug	[2009]
Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen	DM4IXUQ	Investigative	NA	[2009]
Alpha-Aminobutyric Acid	DMW1LF0	Investigative	Small molecular drug	[12]
Alpha-Aminoisobutyric Acid	DM9GXFJ	Investigative	Small molecular drug	[22]
alpha-conotoxin AuIB	DM96EJ1	Investigative	Small molecular drug	[2010]
alpha-conotoxin GI	DMHO634	Investigative	Small molecular drug	[2011]
alpha-conotoxin PnIA	DM1QOY0	Investigative	Small molecular drug	[2012]
Alpha-D-Fucose	DM6VH7A	Investigative	Small molecular drug	[12]
Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	DMD2TPA	Investigative	Small molecular drug	[12]
Alpha-D-Glucose-1-Phosphate	DMU36HT	Investigative	Small molecular drug	[12]
Alpha-D-Glucose-6-Phosphate	DMR0EVN	Investigative	Small molecular drug	[12]
Alpha-D-Mannose	DMF5DLW	Investigative	Small molecular drug	[12]
Alpha-D-Mannose-6-Phosphate	DM3NCM1	Investigative	Small molecular drug	[12]
alpha-Emtbl	DMULXO3	Investigative	Small molecular drug	[2013]
alpha-ergocryptine	DMMPOEK	Investigative	Small molecular drug	[2014]
Alpha-eudesmol	DMYSCQU	Investigative	Small molecular drug	[2015]
alpha-fluoromethylenephosphonate	DM4GLZU	Investigative	Small molecular drug	[2016]
Alpha-Homonojirimycin	DMT17H0	Investigative	Small molecular drug	[435]
Alpha-Hydroxy-Midazolam	DMAQBKX	Investigative	Small molecular drug	[2017]
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	DMIH38V	Investigative	Small molecular drug	[22]
alpha-ketoglutaric acid	DM5LFYN	Investigative	Small molecular drug	[2018]
alpha-ketoisocaproate	DMT7KBZ	Investigative	Small molecular drug	[2019]
Alpha-ketoisovalerate	DMBZTS5	Investigative	Small molecular drug	[12]
alpha-linolenic acid	DMY64HE	Investigative	Small molecular drug	[2020]
alpha-MDG	DMO4XOH	Investigative	Small molecular drug	[2021]
alpha-methyl-5-HT	DMCAYXF	Investigative	Small molecular drug	[2022]
Alpha-methyl-alpha-phenylsuccinimide (MPS)	DM892JF	Investigative	Small molecular drug	[2023]
Alpha-methylalanyl-L-proline butylamide	DM7DBTZ	Investigative	Small molecular drug	[153]
Alpha-methylcubebin	DM0C4GP	Investigative	Small molecular drug	[80]
Alpha-Methylisocitric Acid	DM3YGWL	Investigative	Small molecular drug	[12]
alpha-methylphenylalanine	DMAUH96	Investigative	Small molecular drug	[2024]
alpha-methylserine-O-phosphate	DMCIH1X	Investigative	Small molecular drug	[2025]
Alpha-monofluoromethyl-3,4-dehydroornithine	DML7SU3	Investigative	NA	[149]
Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester	DMJTGZV	Investigative	Small molecular drug	[149]
Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester	DMGI9SM	Investigative	Small molecular drug	[149]
ALPHA-NAPHTHOFLAVONE	DMELOIQ	Investigative	Small molecular drug	[627]
alpha-oxoadipic acid	DM0KXN4	Investigative	Small molecular drug	[2026]
Alpha-Phosphoribosylpyrophosphoric Acid	DMT6KI7	Investigative	Small molecular drug	[22]
alpha-propyldopacetamide	DMQKMX3	Investigative	Small molecular drug	[2027]
Alpha-Sulfanyl(2,4-dichlorobenzyl)phosphonic acid	DMWL172	Investigative	Small molecular drug	[961]
Alpha-Sulfanyl(2-methoxybenzyl)phosphonic acid	DM42M6I	Investigative	Small molecular drug	[961]
Alpha-Sulfanyl(4-bromobenzyl)phosphonic acid	DMRIWDV	Investigative	Small molecular drug	[961]
Alpha-Sulfanyl(4-chlorobenzyl)phosphonic acid	DMP6GXU	Investigative	Small molecular drug	[961]
Alpha-Sulfanyl(4-fluorobenzyl)phosphonic acid	DMP9V42	Investigative	Small molecular drug	[961]
Alpha-Sulfanylbenzylphosphonic acid	DMWB07I	Investigative	Small molecular drug	[961]
Alpha-Sulfanylpropylphosphonic acid	DM19NAI	Investigative	Small molecular drug	[961]
alpha.beta-methylene-2-thio-UDP	DMLGMTQ	Investigative	Small molecular drug	[2028]
alpha3IA	DM257WX	Investigative	Small molecular drug	[2029]
alpha5IA	DMTU5QR	Investigative	Small molecular drug	[2030]
alphabeta-methyleneADP	DMRGFEM	Investigative	Small molecular drug	[2031]
alsterpaullone 2-cyanoethyl	DMDI2KH	Investigative	Small molecular drug	[2032]
Alstiphyllanine D	DM2FLDJ	Investigative	Small molecular drug	[654]
Alstiphyllanine E	DMTNQ5E	Investigative	Small molecular drug	[654]
Alstiphyllanine F	DMKRAEW	Investigative	Small molecular drug	[654]
ALTANSERIN	DMBGAWI	Investigative	Small molecular drug	[2033]
ALTENUSIN	DMYCS0B	Investigative	Small molecular drug	[2034]
ALX 1393	DMP26K9	Investigative	Small molecular drug	[2035]
AM-1241	DMFVGXW	Investigative	Small molecular drug	[2036]
AM-1710	DMO7QUP	Investigative	Small molecular drug	[2037]
AM-1714	DMW9ERM	Investigative	Small molecular drug	[2037]
AM-1715	DMKJQZ4	Investigative	Small molecular drug	[2037]
AM-281	DMOKN27	Investigative	Small molecular drug	[2038]
AM-2S	DMZ46GI	Investigative	Small molecular drug	[2039]
AM-404	DMBK9PS	Investigative	Small molecular drug	[2040]
AM-411	DMU3Y4J	Investigative	Small molecular drug	[2041]
AM-4768	DMETXA8	Investigative	Small molecular drug	[2037]
AM-630	DM7R605	Investigative	Small molecular drug	[2042]
AM251	DMTAWHL	Investigative	Small molecular drug	[2043]
AM7	DMYVQFN	Investigative	Small molecular drug	[2044]
AMA	DM5JZUB	Investigative	Small molecular drug	[2045]
AMA37	DMIZQOG	Investigative	Small molecular drug	[2046]
amanitin	DM59IT4	Investigative	Small molecular drug	[2047]
AMD3101	DM75UK8	Investigative	Small molecular drug	[2048]
AMENTOFLAVONE	DMLRNV2	Investigative	Small molecular drug	[2049]
Ametantrone	DMDRSFE	Investigative	Small molecular drug	[2050]
AMG 9810	DM589XV	Investigative	Small molecular drug	[2051]
amg-1	DMUONK5	Investigative	Small molecular drug	[2052]
AMG-126737	DM9H7AZ	Investigative	Small molecular drug	[2053]
AMG-2504	DMRD83Q	Investigative	Small molecular drug	[1051]
AMG-5445	DMNEVXT	Investigative	Small molecular drug	[1051]
AMG-7160	DMEVNZI	Investigative	Small molecular drug	[1051]
AMG-837	DMNHM1B	Investigative	Small molecular drug	[2054]
AMG-9090	DM1J46S	Investigative	Small molecular drug	[1051]
AMG7703	DMJ6L9U	Investigative	Small molecular drug	[2055]
AMI-1	DM4MXOB	Investigative	Small molecular drug	[2056]
amidephrine	DMST5VW	Investigative	Small molecular drug	[2057]
AMIFLAMINE	DMJ0BEG	Investigative	Small molecular drug	[464]
amino-propylphosphinic acid	DMT5HOA	Investigative	Small molecular drug	[2058]
Aminobenzolamide derivative	DMWYS0Z	Investigative	Small molecular drug	[2059]
aminobenzovesamicol	DMCILV7	Investigative	Small molecular drug	[2060]
AMINOBENZTROPINE	DMT13EW	Investigative	Small molecular drug	[2061]
Aminocarbonyl dihydrogen phosphate	DMCLVOZ	Investigative	Small molecular drug	[2062]
Aminodeoxykanamycin	DM79E2K	Investigative	Small molecular drug	[782]
AMINOFENTANYL	DM7Y6AL	Investigative	Small molecular drug	[2063]
AMINOHIPPURIC ACID	DMUN54G	Investigative	Small molecular drug	[2064]
Aminomethylcyclohexane	DMNX9FC	Investigative	Small molecular drug	[12]
aminooxyacetic acid	DMHNDTW	Investigative	Small molecular drug	[2065]
Aminopyridine deriv. 2	DM94KQP	Investigative	Small molecular drug	[2066]
Aminothiazoline	DMGEVBH	Investigative	Small molecular drug	[2067]
ammonium carbonate	DMM2MFL	Investigative	Small molecular drug	[2068]
AMMTC	DMM5K9X	Investigative	Small molecular drug	[2069]
AMN082	DMXDUCP	Investigative	Small molecular drug	[2070]
AMP-PNP	DMTOK1D	Investigative	Small molecular drug	[2071]
AMTB	DM4OCAH	Investigative	Small molecular drug	[2072]
amthamine	DMBAX3P	Investigative	Small molecular drug	[2073]
Amythiamicin	DM7SHQ1	Investigative	NA	[2074]
ANA-06	DMJ51XA	Investigative	NA	[1866]
ANA-502	DMWE51C	Investigative	NA	[1866]
ANA-504	DMAA11E	Investigative	NA	[1866]
ANA-505	DMRV8HW	Investigative	NA	[1866]
anacardic acid	DMAS5BI	Investigative	Small molecular drug	[2075]
analog 3 (Vlattas et al., 1996)	DMMKGT4	Investigative	Small molecular drug	[2076]
ANALOG OF DYNORPHIN A	DMYW5JX	Investigative	NA	[2077]
ANALOGUE A	DM5JN3P	Investigative	Small molecular drug	[2078]
Anandamide	DMCKH3P	Investigative	Small molecular drug	[2079]
andarine	DMX4P5A	Investigative	Small molecular drug	[2080]
androstanol	DMPXF5I	Investigative	Small molecular drug	[2081]
ANDROSTENEDONE	DMPL0BA	Investigative	Small molecular drug	[2082]
androstenol	DM7RXQ6	Investigative	Small molecular drug	[2083]
angiotensin I	DMTBY1S	Investigative	Small molecular drug	[2084]
angiotensin III	DMYK0Z9	Investigative	Small molecular drug	[2085]
Angiotensin IV	DMR9OD1	Investigative	Small molecular drug	[2086]
ANHYDRORYANIDINE	DMGRWA3	Investigative	Small molecular drug	[249]
ANIBAMINE	DMJX1G9	Investigative	Small molecular drug	[2087]
ANISOCOUMARIN H	DMHA9S3	Investigative	Small molecular drug	[2088]
ANNULIN A	DM0RUQ8	Investigative	Small molecular drug	[1033]
ANNULIN B	DMDQXJ2	Investigative	Small molecular drug	[1033]
ANNULIN C	DMTYQDO	Investigative	Small molecular drug	[1033]
ANOLOBINE	DM6DYZ0	Investigative	Small molecular drug	[335]
ANONAINE	DMM5PEV	Investigative	Small molecular drug	[335]
Antanal 1	DMGDZ6Q	Investigative	Small molecular drug	[2089]
Antanal 2	DMZSUHY	Investigative	Small molecular drug	[2089]
ANTAQ	DMA7LUR	Investigative	Small molecular drug	[2090]
antarelix	DM7TOGW	Investigative	Small molecular drug	[2091]
Anthoptilide C	DMRQVW9	Investigative	Small molecular drug	[2092]
Anthracen-10-yl(10H-phenothiazin-10-yl)methanone	DMGEMQX	Investigative	Small molecular drug	[105]
Anthracene-2-carboxylic acid hydroxyamide	DMRC3OU	Investigative	Small molecular drug	[742]
Anthramycin	DMNEGHJ	Investigative	NA	[2093]
ANTHRAQUINONE	DM29I0Y	Investigative	Small molecular drug	[1482]
ANTHRONE	DMWZ093	Investigative	Small molecular drug	[407]
anti-BrP-LPA	DM3IOR0	Investigative	Small molecular drug	[2094]
Anti-CD-20 mab	DMCYOPR	Investigative	Monoclonal antibody	[2095]
Anti-cMET mab	DM2X1SG	Investigative	Monoclonal antibody	[2096]
Anti-EGFR mab	DMW85FP	Investigative	Antibody	[2097]
Anti-EpCAM mab	DMSZ61O	Investigative	Monoclonal antibody	[1866]
Anti-GnRH Spiegelmer	DM4HKC8	Investigative	NA	[2098]
Anti-IGFR 1 mab	DMS4ASS	Investigative	Monoclonal antibody	[1866]
Anti-TNF mab	DMEFGTM	Investigative	Monoclonal antibody	[1866]
Anti-VEGFR 1 mab	DMBMF5F	Investigative	Monoclonal antibody	[1866]
Anti-VEGFR 3 mab	DMAJ6TC	Investigative	Monoclonal antibody	[2099]
Antileukoprotease (ALP)	DMVF2YH	Investigative	NA	[2100]
Antimycin A	DM2EMCW	Investigative	Small molecular drug	[2101]
ANTIOQUINE	DMUESP8	Investigative	Small molecular drug	[2102]
Antiproliferative Agent A771726	DM9THZE	Investigative	Small molecular drug	[12]
AP-21967	DMCNG74	Investigative	NA	[2103]
AP-2238	DMQWIEL	Investigative	Small molecular drug	[2104]
AP-2243	DMRYL9X	Investigative	Small molecular drug	[2105]
AP-24163	DMVT6Y3	Investigative	Small molecular drug	[2106]
AP-24226	DMGTEXD	Investigative	Small molecular drug	[2106]
AP-7	DMBU942	Investigative	Small molecular drug	[2107]
AP-Cav	DMT9Z5A	Investigative	Small molecular drug	[2108]
AP18	DMI97AJ	Investigative	Small molecular drug	[2109]
Ap3a	DM1C0WT	Investigative	Small molecular drug	[2110]
Ap5a	DMLG20P	Investigative	Small molecular drug	[2111]
AP811	DMILA4P	Investigative	Small molecular drug	[2112]
APA	DMVG3K1	Investigative	Small molecular drug	[2113]
apamin	DMYNBK5	Investigative	Small molecular drug	[2114]
apelin-13	DM2CKUZ	Investigative	Small molecular drug	[2115]
APIGENIN	DMI3491	Investigative	Small molecular drug	[2116]
Apigenin-7-O-beta-D-glucuronide	DMIQOXH	Investigative	Small molecular drug	[2117]
Apigenin-7-O-beta-D-glucuronide methyl ester	DMP7J0I	Investigative	Small molecular drug	[2117]
APLYSAMINE	DM6NM8V	Investigative	Small molecular drug	[2118]
Aplysinopsin	DMUPL3J	Investigative	Small molecular drug	[300]
APNEA	DMW45GK	Investigative	Small molecular drug	[2119]
Apomorphine SL	DMPH7EO	Investigative	Small molecular drug	[2120]
Aprophen	DM0VBUL	Investigative	Small molecular drug	[2121]
AR-129330	DMUSYKG	Investigative	Small molecular drug	[2122]
AR-534	DMNJ632	Investigative	Small molecular drug	[2123]
AR-C102222	DMWVULN	Investigative	Small molecular drug	[1503]
AR-C118925XX	DMQCPXL	Investigative	Small molecular drug	[2124]
AR-C126313	DMP1EWV	Investigative	Small molecular drug	[2125]
AR-C133057XX	DM71WQT	Investigative	Small molecular drug	[1503]
AR-C70484XX	DMU3A57	Investigative	Small molecular drug	[613]
AR-HO29953XX	DM2PRHX	Investigative	Small molecular drug	[2126]
AR231453	DMN8W46	Investigative	Small molecular drug	[2127]
AR234960	DMTN10D	Investigative	Small molecular drug	[2128]
AR244555	DM68QY0	Investigative	Small molecular drug	[2129]
Arabinose-5-Phosphate	DMAM619	Investigative	Small molecular drug	[12]
Arachidonic Acid	DMUOQZD	Investigative	Small molecular drug	[2130]
ARACHIDONYL TRIFLUOROMETHYLKETONE	DMHL48F	Investigative	Small molecular drug	[2131]
arachidonylcyclopropylamide	DMZM5KE	Investigative	Small molecular drug	[2132]
ARC-1028	DM0KDTG	Investigative	NA	[2133]
arcaine	DMXOYK0	Investigative	Small molecular drug	[2134]
arecaidine propargyl ester	DMSA6IY	Investigative	Small molecular drug	[2135]
Arg-Pro-Lys-Pro-Ala-Gln-Phe-Phe-Gly-Leu-Met-NH2	DM6PA1S	Investigative	NA	[2136]
Arg-Pro-Lys-Pro-Ala-Ser-Phe-Phe-Gly-Leu-Met-NH2	DMYM91S	Investigative	NA	[2136]
Arg-Pro-Lys-Pro-Gln-Ser-Phe-Phe-Gly-Leu-Met-NH2	DMA318X	Investigative	NA	[2136]
ARGENINE VASOPRESSIN	DM8KN0Q	Investigative	NA	[2137]
Argiotoxin-636	DMQ1DWU	Investigative	Small molecular drug	[2138]
ARI-3099	DMIMD0T	Investigative	Small molecular drug	[1871]
ARI-3531	DMEO82V	Investigative	Small molecular drug	[2139]
ARL66096	DMNPEM4	Investigative	Small molecular drug	[2140]
ARN34	DMMCFEX	Investigative	NA	[2141]
ARP100	DM6KQXF	Investigative	Small molecular drug	[2142]
ARPFAQK-FAM	DMU70YP	Investigative	NA	[2143]
arpromidine	DMB9PDA	Investigative	Small molecular drug	[2144]
Arsenite	DMBCO4Q	Investigative	Small molecular drug	[2145]
Arteminolide	DM8SP4X	Investigative	Small molecular drug	[2146]
artepillin C	DMWCDM8	Investigative	Small molecular drug	[2147]
ARTOBILOXANTHONE	DMB9AR7	Investigative	Small molecular drug	[2148]
ARTORIGIDIN A	DMHUXRP	Investigative	Small molecular drug	[2148]
arvanil	DMO5LUF	Investigative	Small molecular drug	[2149]
AS-01	DMNY319	Investigative	NA	[1866]
AS-03	DMT21GH	Investigative	NA	[1866]
AS-1397	DMPX5SJ	Investigative	Small molecular drug	[1815]
AS-19	DMASE5O	Investigative	Small molecular drug	[2150]
AS-601245	DMQ95EB	Investigative	Small molecular drug	[2151]
AS-602704	DMANU3W	Investigative	NA	[2152]
AS-604850	DM9IUSM	Investigative	Small molecular drug	[2153]
AS04	DMAWJPE	Investigative	NA	[2154]
AS100	DMXZ8S9	Investigative	Small molecular drug	[2155]
AS1269574	DM170G5	Investigative	Small molecular drug	[2156]
AS16	DMP0A17	Investigative	Small molecular drug	[2157]
AS604872	DM9V5GS	Investigative	Small molecular drug	[2158]
AS70	DM9CIJP	Investigative	Small molecular drug	[2155]
AS74	DMZPHKG	Investigative	Small molecular drug	[2159]
AS94	DM7WJ6F	Investigative	Small molecular drug	[2160]
AS95	DMN3E9Q	Investigative	Small molecular drug	[2161]
AS96	DML6I8J	Investigative	Small molecular drug	[2162]
AS99	DMZ7FJN	Investigative	Small molecular drug	[2155]
ASIATIC ACID	DMT8Y65	Investigative	Small molecular drug	[1106]
ASKENDOSIDE B	DMTBZUC	Investigative	Small molecular drug	[2163]
ASKH95	DM2DPYQ	Investigative	NA	[2164]
ASN-11124542	DMFNZOI	Investigative	Small molecular drug	[2165]
ASN02563583	DMEO3Y4	Investigative	Small molecular drug	[2166]
ASN04421891	DMC82XN	Investigative	Small molecular drug	[2167]
ASN04450772	DMKR69T	Investigative	Small molecular drug	[2168]
ASN04885796	DMQ0VZ8	Investigative	Small molecular drug	[2169]
ASN06917370	DMA20JP	Investigative	Small molecular drug	[2170]
Asp-BrPmp-Leu	DMJEZ62	Investigative	Small molecular drug	[2171]
Asp-D-Glu-Leu-Glu-Cha-Cys	DMEW37R	Investigative	Small molecular drug	[1885]
Asp-Tyr(OSO3H)-Met-Gly-Trp-Met-Asp-Phe	DMKAHYQ	Investigative	NA	[2172]
Aspartate Semialdehyde	DMGB90V	Investigative	Small molecular drug	[12]
aspirin triggered lipoxin A4	DMLBSNP	Investigative	Small molecular drug	[2173]
aspirin-triggered resolvin D1	DMOP941	Investigative	Small molecular drug	[2174]
ASS234	DM4VO6A	Investigative	Small molecular drug	[2175]
AST-487	DME76KU	Investigative	Small molecular drug	[2176]
Asterric acid	DMJAPFH	Investigative	Small molecular drug	[2177]
ASTRAGALIN	DMZHWPG	Investigative	Small molecular drug	[2178]
astressin	DMSFLTK	Investigative	Small molecular drug	[2179]
ATC-120	DMIA2F1	Investigative	Small molecular drug	[2180]
ATC0065	DMJNQ5G	Investigative	Small molecular drug	[2181]
ATF-HI-8	DMPJRHX	Investigative	NA	[2182]
ATL802	DMYMCQA	Investigative	Small molecular drug	[2183]
ATLa2	DMA632U	Investigative	Small molecular drug	[2184]
ATPA	DM2DAFS	Investigative	Small molecular drug	[2185]
ATPgammaS	DMXHQIN	Investigative	Small molecular drug	[2186]
ATPO	DMXLS78	Investigative	Small molecular drug	[2187]
ATRIPLICIOLIDTIGLATE	DML2MAI	Investigative	Small molecular drug	[697]
Atropisomer 1	DML3R5Z	Investigative	Small molecular drug	[2188]
Augustic acid	DMKVDAN	Investigative	Small molecular drug	[1273]
AURASPERONE A	DMDKH8N	Investigative	Small molecular drug	[2189]
Auryntricarboxylic acid (ATA)	DMOIQ4K	Investigative	Small molecular drug	[2190]
Autoantibody LKM-3	DMFS4RD	Investigative	NA	[2191]
AUY954	DMVGIO5	Investigative	Small molecular drug	[2192]
AVE 0991	DM9R3WT	Investigative	Small molecular drug	[2193]
AVE-1876	DMC0PY5	Investigative	NA	[2194]
AVPIAQKSEK-FAM	DMNQ9R4	Investigative	NA	[2143]
AVVYPWT	DMK9BMQ	Investigative	Small molecular drug	[2195]
AW-00430	DMG6LJ8	Investigative	Small molecular drug	[2034]
AwFwLL-NH2	DMIWMJP	Investigative	Small molecular drug	[2196]
AX-006	DMDWCY7	Investigative	Small molecular drug	[2197]
AX-048	DMIDXSN	Investigative	Small molecular drug	[2197]
AZ10417808	DMNO6PL	Investigative	Small molecular drug	[2198]
AZ11645373	DMDRXCP	Investigative	Small molecular drug	[2199]
AZ11657312 (salt free)	DMVX8LO	Investigative	Small molecular drug	[2200]
AZ12216052	DM1IN35	Investigative	Small molecular drug	[2201]
AZ12260493	DMQ5H2V	Investigative	Small molecular drug	[2202]
AZ12419304	DM0MIVD	Investigative	Small molecular drug	[2203]
AZ13483342	DMYDWH1	Investigative	Small molecular drug	[2204]
AZ20	DMNQ3HV	Investigative	Small molecular drug	[2205]
AZ3971	DMVMW9S	Investigative	Small molecular drug	[2206]
AZ4800	DMATC5P	Investigative	Small molecular drug	[2207]
AZ960	DM95Y82	Investigative	Small molecular drug	[2208]
Aza-C-nucleosides	DMOSI4U	Investigative	Small molecular drug	[2209]
aza-THIP	DML70NC	Investigative	Small molecular drug	[2210]
AZAKENPAULLONE	DM61H07	Investigative	Small molecular drug	[2211]
AZALINE B	DMN861Q	Investigative	NA	[2212]
Azapeptide	DM3BXUJ	Investigative	NA	[2213]
Azaperone	DMKI2GJ	Investigative	Small molecular drug	[2214]
AZD-7806	DM34W56	Investigative	Small molecular drug	[2215]
AZD1332	DM0PVD9	Investigative	Small molecular drug	[2216]
AZD3463	DMAX9C3	Investigative	Small molecular drug	[2217]
AZD5582	DMPIHN6	Investigative	Small molecular drug	[2218]
AZD8542	DM0HTXO	Investigative	Small molecular drug	[2219]
Azelaic bishydroxamic acid	DMKSQY1	Investigative	Small molecular drug	[2220]
azelaoyl-PAF	DMTU62D	Investigative	Small molecular drug	[2221]
Azepan-(2Z)-ylideneamine	DMZHV39	Investigative	Small molecular drug	[36]
Azide	DM5XZYB	Investigative	Small molecular drug	[2222]
azidopine	DMD0LCA	Investigative	Small molecular drug	[2223]
Azithromycin-N-benzyltriazolyldecahydroxamic Acid	DMDQ2VN	Investigative	NA	[2224]
Azithromycin-N-benzyltriazolylhexahydroxamic Acid	DM7KD5Y	Investigative	NA	[2224]
Azithromycin-N-benzyltriazolylnonahydroxamic Acid	DMW0HXO	Investigative	NA	[2224]
Azithromycin-N-benzyltriazolyloctahydroxamic Acid	DMAJ4LI	Investigative	NA	[2224]
Azithromycinarylalkylhydroxamic Acid	DM8ZQG3	Investigative	NA	[2224]
Azocan-(2Z)-ylideneamine	DMQ13PZ	Investigative	Small molecular drug	[36]
Azonan-(2Z)-ylideneamine	DMTQSNK	Investigative	Small molecular drug	[318]
AZUMAMIDE B	DMXOGE8	Investigative	Small molecular drug	[2225]
AZUMAMIDE C	DMEBA61	Investigative	Small molecular drug	[2225]
AZUMAMIDE E	DMAX06G	Investigative	Small molecular drug	[2225]
B-10	DMD7HFT	Investigative	Small molecular drug	[1866]
B-2-Octylglucoside	DMEGX8H	Investigative	Small molecular drug	[12]
B-623	DMIUD0L	Investigative	NA	[2226]
B-Nonylglucoside	DM48VJR	Investigative	Small molecular drug	[22]
B-Octylglucoside	DMMO75G	Investigative	Small molecular drug	[12]
B173	DMN2XTQ	Investigative	Small molecular drug	[2227]
B3C	DMV3H0C	Investigative	Small molecular drug	[2228]
BADGE	DMCK5DG	Investigative	Small molecular drug	[2229]
bag-1	DMSWQED	Investigative	Small molecular drug	[2230]
bantag-1	DM4OT8M	Investigative	Small molecular drug	[2231]
banyu (I)	DM9JXIZ	Investigative	Small molecular drug	[2232]
Banyu Compound-24	DMD26XN	Investigative	Small molecular drug	[2233]
Barbituric acid derivative	DM2I19P	Investigative	Small molecular drug	[2234]
BARETTIN	DMU3D2O	Investigative	Small molecular drug	[2235]
BAS-00387275	DMZPKGS	Investigative	Small molecular drug	[2236]
BAS-00387328	DM4OSFD	Investigative	Small molecular drug	[2236]
BAS-00387347	DMUF28Q	Investigative	Small molecular drug	[2236]
BAS-00672722	DM6R4X8	Investigative	Small molecular drug	[2236]
BAS-01047341	DMNB7CW	Investigative	Small molecular drug	[2236]
BAS-01047655	DMC0FLB	Investigative	Small molecular drug	[2236]
BAS-01373578	DMZBIC3	Investigative	Small molecular drug	[2236]
BAS-0338868	DMZGLHJ	Investigative	Small molecular drug	[2237]
BAS-0338872	DMZK0SC	Investigative	Small molecular drug	[2237]
BAS-0338876	DMBS8N9	Investigative	Small molecular drug	[2237]
BAS-09534324	DMFMBZ9	Investigative	Small molecular drug	[2236]
BAS-450225	DMTH1JQ	Investigative	Small molecular drug	[2236]
BAS-4844343	DMFNAKU	Investigative	Small molecular drug	[2236]
Batimistat	DMTQX1G	Investigative	NA	[2238]
batrachotoxin	DMYH9SU	Investigative	Small molecular drug	[2239]
BAY 367620	DMVP74I	Investigative	Small molecular drug	[2240]
BAY 50-7952	DM743XB	Investigative	Small molecular drug	[2241]
Bay K 8644	DMRWSGO	Investigative	Small molecular drug	[2242]
BAY-60-7550	DMQZ7JD	Investigative	Small molecular drug	[2243]
BAY-73-1449	DM5CPJ2	Investigative	Small molecular drug	[2244]
BAY412272	DM0M59T	Investigative	Small molecular drug	[2245]
BayCysLT2	DMKFTZA	Investigative	Small molecular drug	[2246]
BAYu9773	DMXQ14V	Investigative	Small molecular drug	[2247]
BAZ2-ICR	DMKDZLG	Investigative	Small molecular drug	[2248]
Bb-3497	DM5SDV9	Investigative	Small molecular drug	[12]
BB-78484	DMFBN9O	Investigative	Small molecular drug	[2249]
BB-78485	DMJKA3F	Investigative	Small molecular drug	[2249]
BB-823	DMZPL63	Investigative	Small molecular drug	[2250]
Bbs-Arg-(D-Pip)-Gly-(EQKLISEEDL)-Gly-Hir	DMMJ4I5	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-(SPH(pY)EKVS)-Gly-Hir	DM8TH4B	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-(SPHYEKVS)-Gly-Hir	DMQVRHG	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)1-Gly-Hir	DMTU0HR	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)11-Gly-Hir	DMXECFJ	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)13-Gly-Hir	DM5N6YE	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)3-Gly-Hir	DMEL2GK	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)5-Gly-Hir	DMCN48J	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)7-Gly-Hir	DMLK5I0	Investigative	NA	[2251]
Bbs-Arg-(D-Pip)-Gly-S-(GS)9-Gly-Hir	DMLZ5R6	Investigative	NA	[2251]
BC-264	DMQWOZ5	Investigative	Small molecular drug	[2252]
BC11-38	DMQNA7V	Investigative	Small molecular drug	[2253]
BCEAB	DM047DQ	Investigative	Small molecular drug	[2254]
BCH	DM9IN0U	Investigative	Small molecular drug	[2255]
BCX-1827	DMVOS2C	Investigative	Small molecular drug	[815]
BCX-1898	DM6JB32	Investigative	Small molecular drug	[815]
BCX-1923	DM8G4HS	Investigative	NA	[815]
BD-1047	DMFIDA0	Investigative	Small molecular drug	[2256]
BED	DM5USUX	Investigative	Small molecular drug	[2257]
befetupitant	DMZX57Y	Investigative	Small molecular drug	[2258]
BELFOSDIL	DM0WOS6	Investigative	Small molecular drug	[2259]
Benzaldehyde O-4-(decyloxy)phenylcarbamoyl oxime	DMFPSOQ	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime	DMU7INH	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-(hexyloxy)phenylcarbamoyl oxime	DMOK0U8	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime	DMIV3S8	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-(octyloxy)phenylcarbamoyl oxime	DMBW7PX	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime	DMWEXOY	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-butoxyphenylcarbamoyl oxime	DMHUQWN	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-ethoxyphenylcarbamoyl oxime	DMD98YP	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-methoxyphenylcarbamoyl oxime	DMLHKQS	Investigative	Small molecular drug	[787]
Benzaldehyde O-4-propoxyphenylcarbamoyl oxime	DMARBF9	Investigative	Small molecular drug	[787]
Benzaldehyde O-benzoyloxime	DMB7DFT	Investigative	Small molecular drug	[1145]
Benzamidine	DM37GWL	Investigative	Small molecular drug	[2260]
benzamil	DM57SVW	Investigative	Small molecular drug	[2261]
BENZENEMETHANETHIOL	DMK5QYW	Investigative	Small molecular drug	[786]
BENZENESULFONAMIDE	DM3I8A1	Investigative	Small molecular drug	[2262]
Benzenesulfonyl	DMMBYGE	Investigative	Small molecular drug	[12]
BENZIL	DM5Y2M8	Investigative	Small molecular drug	[375]
Benzofuran-2-yl(indolin-1-yl)methanone	DMF1ZE6	Investigative	Small molecular drug	[920]
Benzofuran-2-ylboronic acid	DMQ7I06	Investigative	Small molecular drug	[1019]
Benzofuran-3-yl-(indol-3-yl)maleimides	DMNVG1M	Investigative	Small molecular drug	[2263]
Benzoic acid 2,6-diisopropyl-phenyl ester	DMAQK0G	Investigative	Small molecular drug	[802]
Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	DM6T8YM	Investigative	Small molecular drug	[2264]
Benzoin	DM50QMB	Investigative	Small molecular drug	[396]
BENZOLAMIDE	DME5QPX	Investigative	Small molecular drug	[2265]
Benzomate	DMRE96F	Investigative	Small molecular drug	[2266]
benzoquinazolinone 12	DMMKBFN	Investigative	Small molecular drug	[2267]
BENZOQUINONE	DMNBA0G	Investigative	Small molecular drug	[2268]
BENZOTHIAZOLE	DMV7MPL	Investigative	Small molecular drug	[22]
Benzothiazole-2-sulfonic acid amide	DMROP5Q	Investigative	Small molecular drug	[2269]
Benzoyl-Arginine-Alanine-Methyl Ketone	DMC7TNF	Investigative	Small molecular drug	[12]
BENZOYL-TYROSINE-ALANINE-METHYL KETONE	DMIRD8S	Investigative	Small molecular drug	[22]
BENZOYLENUREA	DMY5O1U	Investigative	Small molecular drug	[1188]
Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine	DM067NL	Investigative	Small molecular drug	[2270]
Benzo[b]thiophen-2-ylboronic acid	DMJQSLW	Investigative	Small molecular drug	[12]
Benzo[c][1,2]oxaborol-1(3H)-ol	DMZR02J	Investigative	Small molecular drug	[1254]
Benzo[c][1,5]naphthyridin-6(5H)-one	DMMYGB9	Investigative	Small molecular drug	[238]
Benzo[g]quinazolin-4-yl-(3-bromo-phenyl)-amine	DMISHTB	Investigative	Small molecular drug	[166]
Benzyl 2-hydroxyiminoolean-12-en-28-oate	DMT3JYE	Investigative	Small molecular drug	[1034]
Benzyl 4-aminobutyl(3-aminopropyl)carbamate	DMOKVAT	Investigative	Small molecular drug	[2271]
benzyl bromide	DM857X2	Investigative	Small molecular drug	[2272]
Benzyl derivative of M6G	DMX8W4G	Investigative	Small molecular drug	[2273]
Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine	DM6I5MU	Investigative	Small molecular drug	[2274]
Benzyl-(2-phenyl-quinazolin-4-yl)-amine	DM3X50C	Investigative	Small molecular drug	[2274]
Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine	DMYDGCI	Investigative	Small molecular drug	[2274]
Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine	DMESVWC	Investigative	Small molecular drug	[2274]
Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine	DMH318X	Investigative	Small molecular drug	[2274]
Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine	DMFTIMS	Investigative	Small molecular drug	[1168]
Benzyl-(9-isopropyl-9H-purin-6-yl)-amine	DMNE1M3	Investigative	Small molecular drug	[2275]
Benzyl-(9H-beta-carbolin-6-yl)-amine	DMW167A	Investigative	Small molecular drug	[1264]
Benzyl-biphenyl-4-ylmethyl-imidazol-1-yl-amine	DMFB4M5	Investigative	Small molecular drug	[456]
Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine	DMQAEOL	Investigative	Small molecular drug	[2276]
Benzyl-quinazolin-4-yl-amine	DMRW5J4	Investigative	Small molecular drug	[165]
Benzyl-[2-(1H-indazol-4-yloxy)-ethyl]-amine	DMTC4G0	Investigative	Small molecular drug	[1395]
Benzyl-[2-(1H-indol-4-yloxy)-ethyl]-amine	DMV6DY7	Investigative	Small molecular drug	[1395]
Benzylcarbamic Acid Biphenyl-3-yl Ester	DM7M9O2	Investigative	Small molecular drug	[1011]
Benzylcysteine	DMTCYHM	Investigative	Small molecular drug	[2277]
BENZYLIMIDAZOLE	DMNRHSO	Investigative	Small molecular drug	[160]
Benzyloxycarbonyl-glycylryanodine	DMLJMOD	Investigative	Small molecular drug	[249]
benzylserine	DMHIGDM	Investigative	Small molecular drug	[2278]
Benzylsulfinic Acid	DM7XK28	Investigative	Small molecular drug	[22]
BERGAPTOL	DMDITNB	Investigative	Small molecular drug	[2279]
Beta,beta-dimethylmelatonin	DM6FHQD	Investigative	Small molecular drug	[2280]
Beta-(2-Naphthyl)-Alanine	DMP21ZO	Investigative	Small molecular drug	[22]
Beta-1-C-butenyl-1-deoxygalactonojirimycin	DM6GTBC	Investigative	Small molecular drug	[793]
Beta-1-C-Butyl-1-deoxygalactonojirimycin	DMMKDEZ	Investigative	Small molecular drug	[793]
Beta-Alanine	DMC64EI	Investigative	Small molecular drug	[2281]
BETA-CCM	DM1MFTZ	Investigative	Small molecular drug	[1309]
Beta-D-Glucopyranose Spirohydantoin	DMZ2BR9	Investigative	Small molecular drug	[12]
Beta-D-Glucose	DM5IHYP	Investigative	Small molecular drug	[12]
beta-D-hydroxybutyric acid	DMNE4C6	Investigative	Small molecular drug	[2282]
Beta-D-Mannose	DMHIG9K	Investigative	Small molecular drug	[12]
Beta-endorphin	DM7XC6B	Investigative	Small molecular drug	[2283]
beta-ergocriptine	DMU3YXR	Investigative	Small molecular drug	[2284]
Beta-funaltrexamine	DMJORFK	Investigative	Small molecular drug	[2285]
beta-guanidinopropionic acid	DM130M5	Investigative	Small molecular drug	[2286]
Beta-Hydroxy Aspartic Acid	DMO8LPZ	Investigative	Small molecular drug	[22]
BETA-HYDROXYETHYL THEOPHYLLINE	DMGP9MN	Investigative	Small molecular drug	[935]
Beta-L-fucose	DM3BOQA	Investigative	Small molecular drug	[107]
beta-L-hydroxybutyric acid	DM8003R	Investigative	Small molecular drug	[2287]
Beta-methoxyamphetamine	DMA9CSG	Investigative	Small molecular drug	[2288]
Beta-methylmelatonin	DMKH32S	Investigative	Small molecular drug	[2280]
Beta-naphthylboronic acid	DMZ8Y67	Investigative	Small molecular drug	[942]
Beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	DMQXMKB	Investigative	Small molecular drug	[22]
beta3-tetrapeptide	DMBAN5P	Investigative	Small molecular drug	[2289]
BetaARKct	DMN7DJ5	Investigative	NA	[2290]
BETP	DM4MZQW	Investigative	Small molecular drug	[2291]
BETULIN	DMGQRON	Investigative	Small molecular drug	[1106]
BH4	DM4XMZW	Investigative	Small molecular drug	[2292]
Bhg-F-N-Y-Y-W	DMVH4LK	Investigative	NA	[1878]
BHH-0492	DM86EDJ	Investigative	NA	[1866]
BHQ	DM1BWF1	Investigative	Small molecular drug	[2293]
BI-32169	DMN052T	Investigative	NA	[2294]
BI6015	DMRXK5G	Investigative	Small molecular drug	[2295]
BIBF-1202	DMDTLSP	Investigative	Small molecular drug	[2296]
BIBO3304	DML7HFP	Investigative	Small molecular drug	[2297]
BIC1	DMFS2V9	Investigative	Small molecular drug	[2298]
BICARBONATE	DMT5E36	Investigative	Small molecular drug	[2299]
Bicine	DMTRDPI	Investigative	Small molecular drug	[12]
Bicuculline	DMA6VQW	Investigative	Small molecular drug	[2300]
BIFENOX	DM4MUXT	Investigative	Small molecular drug	[887]
BIIE0246	DMR2SEB	Investigative	Small molecular drug	[2301]
BIIL 260	DMU09E4	Investigative	Small molecular drug	[2302]
bilirubin	DMI0V4O	Investigative	Small molecular drug	[2303]
bilobalide	DM09Z35	Investigative	Small molecular drug	[2304]
biochanin A	DM0HPWY	Investigative	Small molecular drug	[2305]
BIOO-4	DME3M7V	Investigative	NA	[1866]
BIOO-7	DMP5S6U	Investigative	NA	[1866]
Biopterin	DMLNQ2F	Investigative	Small molecular drug	[12]
biotin	DMKMCE1	Investigative	Small molecular drug	[2306]
Bip-tyr(3bzl)-thr-pro-lys-thr	DM4FSXK	Investigative	NA	[2307]
Bip-tyr-ala-pro-lys-thr(obzl)-gly	DM0VKA2	Investigative	NA	[2307]
Bip-tyr-thr-ala-pro-phe	DMUWE81	Investigative	Small molecular drug	[2307]
Bip-tyr-thr-pro-ala-thr(obzl)-gly	DMN38JC	Investigative	NA	[2307]
Bip-tyr-thr-pro-lys-thr	DM7EKH3	Investigative	Small molecular drug	[2307]
Bip-tyr-thr-pro-lys-thr(obzl)-gly	DMAPX9G	Investigative	NA	[2307]
Bip-tyr-thr-pro-thr(obzl)-gly	DM4CZ5B	Investigative	Small molecular drug	[2307]
Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine	DM4D7V6	Investigative	Small molecular drug	[2308]
Biphenyl-3-carboxylic acid hydroxyamide	DMROG71	Investigative	Small molecular drug	[742]
Biphenyl-3-ylboronic acid	DMIAUB1	Investigative	Small molecular drug	[1019]
Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester	DMYCKGH	Investigative	Small molecular drug	[1011]
Biphenyl-3-ylcarbamic acid cyclohexyl ester	DM10AUP	Investigative	Small molecular drug	[382]
Biphenyl-4-carboxylic acid hydroxyamide	DMK5VYG	Investigative	Small molecular drug	[742]
BIPHENYL-4-YL-ACETALDEHYDE	DM5DPHO	Investigative	Small molecular drug	[22]
Biphenyl-4-ylboronic acid	DMIHMP5	Investigative	Small molecular drug	[942]
biphenylindanone A	DM2MYKC	Investigative	Small molecular drug	[2309]
BIS(12)-HUPERZINE B	DMWAS4Q	Investigative	Small molecular drug	[2310]
Bis(14)-Huperzine B	DM58YDV	Investigative	NA	[2310]
BIS(16)-HUPERZINE B	DMYQM3B	Investigative	Small molecular drug	[2310]
BIS(18)-HUPERZINE B	DM3W1T4	Investigative	Small molecular drug	[2310]
Bis(2,3-dibromo-4,5-dihydroxyphenyl)ether	DMQ7KR1	Investigative	Small molecular drug	[745]
Bis(2,4-dinitrophenyl)sulfane	DMEW49T	Investigative	Small molecular drug	[1367]
BIS(20)-HUPERZINE B	DMHQKCJ	Investigative	Small molecular drug	[2310]
Bis(3-bromo-4,5-dihydroxyphenyl)methanone	DMUN50H	Investigative	Small molecular drug	[745]
Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone	DM784AU	Investigative	Small molecular drug	[167]
Bis(3-bromophenyl)(5-hydroxy)thiosemicarbazone	DMASNGX	Investigative	Small molecular drug	[167]
Bis(3-Fluorophenyl)-ketone]thiosemicarbazone	DMMJ635	Investigative	Small molecular drug	[2311]
Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]	DMKANOH	Investigative	Small molecular drug	[2312]
Bis(4-fluorophenyl)-2-fluorophenylacetamide	DMO6HWJ	Investigative	Small molecular drug	[132]
Bis(5-acetoxybenzo[b]furan-2-yl)methanone	DM36VKH	Investigative	Small molecular drug	[210]
Bis(5-aminobenzo[b]furan-2-yl)methanone	DMHRGTY	Investigative	Small molecular drug	[210]
Bis(5-hydroxybenzo[b]furan-2-yl)methanone	DMGRKDP	Investigative	Small molecular drug	[210]
Bis(5-methoxybenzo[b]furan-2-yl)methanone	DM9XC6A	Investigative	Small molecular drug	[210]
Bis(6-hydroxybenzo[b]furan-2-yl)methanone	DMRGNSQ	Investigative	Small molecular drug	[210]
BIS(8)-HUPERZINE B	DMER5GT	Investigative	Small molecular drug	[2310]
BIS(9)-HUPERZINE B	DM5WFQM	Investigative	Small molecular drug	[2310]
Bis(benzo[b]furan-2-yl)methanone	DMK2ZG4	Investigative	Small molecular drug	[210]
Bis-((-)-N-propargylmorphinan-3-yl) sebacoylate	DM0WKNI	Investigative	Small molecular drug	[81]
Bis-(5-hydroxy-1H-indol-2-yl)-methanone	DMTSEXB	Investigative	Small molecular drug	[112]
Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine	DMQ98H5	Investigative	Small molecular drug	[1650]
Bis-7-tacrine	DMVNC1R	Investigative	Small molecular drug	[1062]
Bis-cyclosal-d4TMP	DMF4AHD	Investigative	Small molecular drug	[1293]
BIS-IMIDE A	DM0MK6D	Investigative	Small molecular drug	[2313]
Bis-Napthyl Beta-Ketophosphonic Acid	DM0K6QH	Investigative	Small molecular drug	[12]
Bis-{[R-(-)-apomorphine-2-oxy]ethyl} ether	DMYSQ2B	Investigative	Small molecular drug	[399]
bisandrographolide	DMRSKGC	Investigative	Small molecular drug	[2314]
Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	DMVRXH3	Investigative	Small molecular drug	[12]
Bisindolylmaleimide-I	DMOQJZC	Investigative	Small molecular drug	[2315]
bisphenol A	DM2ZLD7	Investigative	Small molecular drug	[2316]
BIX 02188	DMFHY04	Investigative	Small molecular drug	[2317]
BIX 02565	DMNAX1Q	Investigative	Small molecular drug	[2318]
BM-573	DMD2H7L	Investigative	Small molecular drug	[2319]
BMS compound 4c	DMR82WI	Investigative	Small molecular drug	[2320]
BMS pyrazole inhibitor 7f	DMJM8OQ	Investigative	Small molecular drug	[2321]
BMS-1	DM4D6ZB	Investigative	Small molecular drug	[2322]
BMS-187308	DMJ218E	Investigative	Small molecular drug	[2323]
BMS-189323	DM7GUDC	Investigative	Small molecular drug	[2324]
BMS-193885	DM1ZBU3	Investigative	Small molecular drug	[2325]
BMS-245782	DM5SNMQ	Investigative	Small molecular drug	[2324]
BMS-262084	DMETNA3	Investigative	Small molecular drug	[2326]
BMS-265246	DM6LPIG	Investigative	Small molecular drug	[2327]
BMS-269223	DMZLE0U	Investigative	Small molecular drug	[2328]
BMS-279700	DMOLCFQ	Investigative	Small molecular drug	[2329]
BMS-316810	DM21CYI	Investigative	Small molecular drug	[2330]
BMS-344577	DM9WRUG	Investigative	Small molecular drug	[2328]
BMS-404683	DM1ZDFG	Investigative	Small molecular drug	[2331]
BMS-480404	DMTPNI4	Investigative	Small molecular drug	[827]
BMS-536924	DMXJB4N	Investigative	Small molecular drug	[2332]
BMS-564929	DMILMHZ	Investigative	Small molecular drug	[2333]
BMS-645737	DMBTMO9	Investigative	Small molecular drug	[2334]
BMS-687453	DMYAPG5	Investigative	Small molecular drug	[2335]
BMS-740808	DMQ24TI	Investigative	Small molecular drug	[2336]
BMS184394	DMGE82R	Investigative	Small molecular drug	[12]
BMS270394	DM82SJP	Investigative	Small molecular drug	[2337]
BMS309403	DM86ISD	Investigative	Small molecular drug	[2338]
BMS614	DMZWNO9	Investigative	Small molecular drug	[2339]
BMS641	DMRT7G3	Investigative	Small molecular drug	[2340]
BMS753	DMSX1NF	Investigative	Small molecular drug	[2341]
BMY 45778	DMT02B8	Investigative	Small molecular drug	[2342]
BMY-27709	DMAMYWL	Investigative	Small molecular drug	[1093]
BN-81,644	DM1CNU5	Investigative	Small molecular drug	[2343]
BN-81,674	DM7RPQ4	Investigative	Small molecular drug	[2344]
BN-82685	DMZME4N	Investigative	Small molecular drug	[2345]
Bo(15)PZ	DMCUJH5	Investigative	Small molecular drug	[2346]
Boc-Agly-Val-Agly-OEt	DMDX8M3	Investigative	Small molecular drug	[2347]
Boc-Asp-Tyr(So3-)-Nle-Gly-Trp-Asp-Phe-NH2	DMPJR98	Investigative	NA	[2348]
Boc-cyclo-(Glu-Tyr-Nle-D-Lys)-Trp-Nle-Asp-Phe-NH2	DMRQVME	Investigative	NA	[2349]
Boc-D-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2	DMBCPKF	Investigative	NA	[2349]
Boc-D-Glu-Tyr(SO3H)-Nle-D-Nle-Trp-Nle-Asp-Phe-NH2	DM1IXOG	Investigative	NA	[2349]
Boc-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2	DMN3EU9	Investigative	NA	[2349]
Boc-Ile-Leu-L-(difluoro)aminobutyric aid	DMG35MJ	Investigative	Small molecular drug	[779]
Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-Phe-NH2	DMAYWTI	Investigative	NA	[2349]
BODIPY-pirenzepine	DMY7CN3	Investigative	Small molecular drug	[2350]
BOHEMINE	DMLCMA3	Investigative	Small molecular drug	[2351]
Boldenone	DM0EKO5	Investigative	Small molecular drug	[12]
BOLDINE	DMMVB5P	Investigative	Small molecular drug	[2352]
BOLINAQUINONE	DMVB6UG	Investigative	Small molecular drug	[2353]
BOMA	DMAW40Y	Investigative	Small molecular drug	[2354]
bombesin	DMDFQ0Y	Investigative	Small molecular drug	[2355]
BOMPPA	DMI75A3	Investigative	Small molecular drug	[2356]
bongkrek acid	DMWALXQ	Investigative	Small molecular drug	[2357]
borneol	DMWBV1P	Investigative	Small molecular drug	[2358]
Bornyl (3,4,5-trihydroxy)-cinnamate	DMR70ZO	Investigative	Small molecular drug	[2359]
Borrelidin	DMBSQTR	Investigative	Small molecular drug	[2360]
BPH-252	DMUOS3G	Investigative	Small molecular drug	[2361]
BPH-608	DM0NQLI	Investigative	Small molecular drug	[2362]
BPH-628	DM0TJ6R	Investigative	Small molecular drug	[2363]
BPH-629	DM49BFM	Investigative	Small molecular drug	[2364]
BPH-675	DM3IPYV	Investigative	Small molecular drug	[2365]
BPH-676	DMPKAEW	Investigative	Small molecular drug	[2366]
BPH-715	DMTHW3F	Investigative	Small molecular drug	[2367]
BPH-742	DMD0XEO	Investigative	Small molecular drug	[2368]
BPH-830	DM15L2J	Investigative	Small molecular drug	[2369]
BPIQ-I	DMNHEUT	Investigative	Small molecular drug	[166]
BQ 3020	DMQBRSM	Investigative	Small molecular drug	[2370]
Br-5MPEPy	DMBTC23	Investigative	Small molecular drug	[2371]
bradyzide	DM0DWSR	Investigative	Small molecular drug	[2372]
BRD4770	DMFSJ9O	Investigative	Small molecular drug	[2373]
BRD9539	DMFAVB5	Investigative	Small molecular drug	[2373]
BREMAZOCINE	DM3EIBU	Investigative	Small molecular drug	[2374]
BRL 43694A	DMTM7W0	Investigative	Small molecular drug	[2375]
BRL 44408	DM3WPO4	Investigative	Small molecular drug	[2376]
BRL 52537 hydrochloride	DM16GUV	Investigative	Small molecular drug	[2377]
BRL 52974	DM6XO72	Investigative	Small molecular drug	[2378]
BRL-15572	DMM61Y2	Investigative	Small molecular drug	[2379]
BRL-24682	DMSB4EW	Investigative	Small molecular drug	[2380]
BRL-25594	DMD0YL1	Investigative	NA	[2380]
BRL-26175	DMQ4MFY	Investigative	Small molecular drug	[2381]
BRL-36378	DMRI49D	Investigative	Small molecular drug	[2382]
BRL-48482	DMT4NM5	Investigative	Small molecular drug	[2383]
BRL-54504AX	DM2J1FA	Investigative	Small molecular drug	[2384]
BRL-55473	DMEMZ6Q	Investigative	Small molecular drug	[2385]
BRL50481	DMV2XUM	Investigative	Small molecular drug	[2386]
BRL54443	DM3TWBU	Investigative	Small molecular drug	[2387]
Brocresine	DM9UF02	Investigative	Small molecular drug	[2388]
Brodimoprim-4,6-Dicarboxylate	DM7OF6N	Investigative	Small molecular drug	[12]
Brolamfetamine	DMC4PF0	Investigative	Small molecular drug	[2389]
Brominide tartrate	DMMC4BY	Investigative	Small molecular drug	[2390]
bromo-deaza-SAH	DMX2U7G	Investigative	Small molecular drug	[2391]
Bromo-WR99210	DMKFTW8	Investigative	Small molecular drug	[12]
bromoacetone	DMTBO7F	Investigative	Small molecular drug	[2392]
bromocresol green	DMXTVZ8	Investigative	Small molecular drug	[2393]
BROMODEOXYURIDINE	DM0D7LA	Investigative	Small molecular drug	[2394]
bromoenol lactone	DMKQ0CA	Investigative	Small molecular drug	[2395]
bromosporine	DMLKK6Q	Investigative	Small molecular drug	[2396]
Broussoflavonol F	DMB9SEI	Investigative	Small molecular drug	[152]
BROUSSONIN A	DMXFN6H	Investigative	Small molecular drug	[2397]
Broussonin C	DMKM9F0	Investigative	Small molecular drug	[2398]
BrP-LPA	DMPGEO1	Investigative	Small molecular drug	[2399]
brucine	DM50RUD	Investigative	Small molecular drug	[2400]
BS 7581	DM1VF6H	Investigative	Small molecular drug	[2401]
BS 7840	DMDYNBT	Investigative	Small molecular drug	[2401]
BS 9106	DMQ2FDA	Investigative	Small molecular drug	[2401]
BTP2	DMNM63G	Investigative	Small molecular drug	[2402]
BU-E 47	DM1D47I	Investigative	Small molecular drug	[2403]
Bu-RYYRIK-NH2	DMDC7MT	Investigative	Small molecular drug	[754]
BUDDLEDIN A	DMGFY4X	Investigative	Small molecular drug	[2404]
BUDLEIN A	DMQVL2U	Investigative	Small molecular drug	[697]
bufotenine	DMD1SY9	Investigative	Small molecular drug	[2405]
BUFROLIN	DM61F5W	Investigative	Small molecular drug	[2406]
bufrudin	DMWQ3RH	Investigative	NA	[2407]
burimamide	DMZ2VYG	Investigative	Small molecular drug	[2408]
Burnamine-17-O-3',4',5'-trimethoxybenzoate	DMBO0WI	Investigative	Small molecular drug	[654]
BURTTINONE	DMJP0QT	Investigative	Small molecular drug	[2409]
But-3-enyl-trimethyl-ammonium bromide	DMMHGIN	Investigative	NA	[131]
Butanoic Acid	DMTAJP7	Investigative	Small molecular drug	[2410]
butaprost (free acid form)	DM5MZHP	Investigative	Small molecular drug	[2411]
BUTEIN	DM8E54P	Investigative	Small molecular drug	[2412]
Butirosin B	DMR6GJK	Investigative	Small molecular drug	[782]
BUTORPHAN	DM82KPQ	Investigative	Small molecular drug	[2413]
Butoxamine	DM7XN2J	Investigative	Small molecular drug	[2414]
Butyl 10H-phenothiazine-10-carboxylate	DMGHEQV	Investigative	Small molecular drug	[1050]
Butyl-indol-1-yl-pyridin-4-yl-amine	DM1CX9Y	Investigative	Small molecular drug	[137]
Butyl-methyl-prop-2-ynyl-amine hydrochloride	DMJUTWG	Investigative	NA	[2415]
Butylphosphonate	DMF5D1N	Investigative	Small molecular drug	[12]
Butyrylthiocholine	DMOBYVL	Investigative	Small molecular drug	[107]
BV-6	DMDTV7A	Investigative	Small molecular drug	[2416]
BVDU-MP	DMI1H3Y	Investigative	Small molecular drug	[2417]
BVT173187	DMULZOP	Investigative	Small molecular drug	[2418]
BW 245C	DMA0FO5	Investigative	Small molecular drug	[2419]
BW A360C	DMNSLGC	Investigative	Small molecular drug	[2420]
BW B218C	DMHQP84	Investigative	Small molecular drug	[2420]
BW-202W92	DMFKXMT	Investigative	Small molecular drug	[2421]
BW-A137C	DM7SNU0	Investigative	Small molecular drug	[2422]
BW284C51	DMQ3AC0	Investigative	Small molecular drug	[2423]
BW723C86	DME15JU	Investigative	Small molecular drug	[2424]
BWA868C	DMU9LQW	Investigative	Small molecular drug	[2425]
BX 048	DMA2B1C	Investigative	Small molecular drug	[2426]
BX 471	DM5CGXB	Investigative	Small molecular drug	[2427]
BX 667	DMBKVN9	Investigative	Small molecular drug	[2428]
BX-201	DMGK7U5	Investigative	Small molecular drug	[364]
BX-517	DMBQIEF	Investigative	Small molecular drug	[364]
BX-795	DMRIMLJ	Investigative	Small molecular drug	[2429]
BX-912	DMZA45C	Investigative	Small molecular drug	[2430]
Bz--RYYRIK-NH2	DMUW87A	Investigative	Small molecular drug	[754]
BZ3	DMN5X17	Investigative	Small molecular drug	[2431]
BZ5	DMRXPFM	Investigative	NA	[2431]
BzATP	DM37GYA	Investigative	Small molecular drug	[2432]
BzT-7	DMU13BY	Investigative	Small molecular drug	[2433]
C(-GRGDfL-)	DMTMJAI	Investigative	Small molecular drug	[2434]
C(Arg-Gly-Asp-D-Phe-Val)	DMHNZGP	Investigative	Small molecular drug	[2435]
C(his-D-phe-arg-trp-Abu)	DMSLYHQ	Investigative	Small molecular drug	[2436]
C(his-D-phe-arg-trp-Ahp)	DM0IJFZ	Investigative	Small molecular drug	[2436]
C(his-D-phe-arg-trp-Ahx)	DMJKHAB	Investigative	Small molecular drug	[2436]
C(his-D-phe-arg-trp-Aoc)	DM5NQUA	Investigative	Small molecular drug	[2436]
C(his-L-phe-arg-trp-Aoc)	DMEC2PH	Investigative	Small molecular drug	[2436]
C(RGDfF)	DMMBESU	Investigative	Small molecular drug	[2437]
C(RGDfMeF)	DM8DU42	Investigative	Small molecular drug	[2437]
C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	DMMPXHQ	Investigative	NA	[107]
C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	DM3VF9M	Investigative	Small molecular drug	[12]
C-(1H-Indol-3-yl)-methylamine	DMDLK9G	Investigative	Small molecular drug	[760]
C-(2'-Chloro-biphenyl-2-yl)-methylamine	DMNMYWI	Investigative	Small molecular drug	[115]
C-(5-bromo-4,7-dimethoxyindan-1-yl)methylamine	DM0VKFO	Investigative	Small molecular drug	[797]
C-(5H-Dibenzo[a,d]cyclohepten-5-yl)-methylamine	DMDHVY0	Investigative	Small molecular drug	[756]
C-(6-Methoxy-naphthalen-1-yl)-methylamine	DMJ6SYI	Investigative	Small molecular drug	[389]
C-(9H-Thioxanthen-9-yl)-methylamine	DMDMA4Z	Investigative	Small molecular drug	[756]
C-(9H-Xanthen-9-yl)-methylamine	DMN5YOR	Investigative	Small molecular drug	[756]
C-014C	DMD7OQA	Investigative	Small molecular drug	[2438]
C-16-(S)-3-methylindolerapamycin	DMZXE6O	Investigative	NA	[2103]
C-Naphthalen-1-yl-methylamine	DMFW1JC	Investigative	Small molecular drug	[389]
C-[-Arg-Gly-Asp-Acpca30-]	DML0U8B	Investigative	Small molecular drug	[2439]
C-[-Arg-Gly-Asp-Acpca31-]	DMKENFU	Investigative	Small molecular drug	[2439]
C-[-Arg-Gly-Asp-Acpca32-]	DMVM7B2	Investigative	Small molecular drug	[2439]
C-[-Arg-Gly-Asp-Acpca33-]	DMIBGWO	Investigative	Small molecular drug	[2439]
C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine	DMY2NU8	Investigative	Small molecular drug	[1099]
C1-BODIPY-C12	DMCKZSZ	Investigative	Small molecular drug	[2440]
C16-Fatty-Acyl-Substrate-Mimic	DM23KNC	Investigative	Small molecular drug	[12]
C2-MAD	DMS87IF	Investigative	Small molecular drug	[2441]
C3	DMTCOY9	Investigative	Small molecular drug	[2442]
C4-MAD	DMGA9U7	Investigative	Small molecular drug	[2441]
C646	DMCOQKH	Investigative	Small molecular drug	[2443]
C6S	DM4LIHQ	Investigative	Small molecular drug	[2444]
C7/3-phth	DM7MNOX	Investigative	Small molecular drug	[2445]
Ca(2+) chelator	DMX85E7	Investigative	NA	[2446]
CAA0225	DMQATPN	Investigative	Small molecular drug	[2447]
CACA	DMPKFYZ	Investigative	Small molecular drug	[2448]
Cacodylate Ion	DMK4XLD	Investigative	Small molecular drug	[12]
CACOSPONGIONOLIDE	DMIPJUS	Investigative	Small molecular drug	[2449]
CACOSPONGIONOLIDE B	DMCSXNW	Investigative	Small molecular drug	[2449]
Cacospongionolide E	DM2DYAV	Investigative	Small molecular drug	[2449]
cADPR	DMLKZQH	Investigative	Small molecular drug	[2450]
Caffeic acid phenethyl ester	DMRJKIV	Investigative	Small molecular drug	[2451]
CALCEOLARIOSIDE A	DM6NPUM	Investigative	Small molecular drug	[2452]
CALCEOLARIOSIDE B	DMEAUK5	Investigative	Small molecular drug	[2452]
calcitriol-26,23-lactone	DMZ45M6	Investigative	Small molecular drug	[2453]
calhex 231	DMJXZD5	Investigative	Small molecular drug	[2454]
calindol	DMY9P6E	Investigative	Small molecular drug	[2455]
CALOPOCARPIN	DMVXKLF	Investigative	Small molecular drug	[2456]
Calpastatin	DMR0CNQ	Investigative	Small molecular drug	[2457]
Calusterone	DMBK2S8	Investigative	Small molecular drug	[2458]
Calyculin-A	DMY29Q8	Investigative	Small molecular drug	[2459]
CALYSTEGINE B2	DMMBA70	Investigative	Small molecular drug	[2460]
camonagrel	DMJHNZD	Investigative	Small molecular drug	[2461]
Canaline	DMNLTGF	Investigative	Small molecular drug	[12]
cannabinol	DMM6A7P	Investigative	Small molecular drug	[2462]
CANTHARIDIC_ACID	DME32XU	Investigative	Small molecular drug	[2463]
CAPROCTAMINE	DMDZE8N	Investigative	Small molecular drug	[2464]
Caprylic acid	DMLGS82	Investigative	Small molecular drug	[2465]
CAPSAZEPINE	DM4ATCI	Investigative	Small molecular drug	[2466]
CARAMIPEN	DMJFPA9	Investigative	Small molecular drug	[2467]
Carazolol	DMEKI1J	Investigative	Small molecular drug	[2468]
Carba-Nicotinamide-Adenine-Dinucleotide	DMGP4M3	Investigative	Small molecular drug	[12]
carbacyclin	DMMBQYE	Investigative	Small molecular drug	[2469]
Carbamic Acid	DMJQ3LN	Investigative	Small molecular drug	[12]
Carbamoyl phosphate disodium	DMZYK1W	Investigative	NA	[2470]
Carbaphosphonate	DMGFLI7	Investigative	Small molecular drug	[12]
Carbenoxolone	DMO648T	Investigative	Small molecular drug	[2471]
Carbocyclic Peptidomimetic	DM87SOX	Investigative	Small molecular drug	[2472]
carbocyclic thromboxane A2	DMGKSVF	Investigative	Small molecular drug	[2473]
Carbodine	DMA3FZR	Investigative	Small molecular drug	[2474]
Carboron Cluster with phenol	DMCNV68	Investigative	NA	[2475]
Carboxyatractyloside	DMEORTQ	Investigative	Small molecular drug	[2476]
CARBOXYFENTANYL	DMI7Q61	Investigative	Small molecular drug	[2477]
Carboxylated glucosamine	DM105YR	Investigative	Small molecular drug	[2478]
Carboxylic PRPP	DMCTUR1	Investigative	Small molecular drug	[12]
CARCININE	DMQUKBG	Investigative	Small molecular drug	[2118]
Cardiolipin	DMCSMX4	Investigative	Small molecular drug	[107]
Carinatumins B (2)	DMUSGYQ	Investigative	Small molecular drug	[2479]
carnosine	DMFYCB4	Investigative	Small molecular drug	[2480]
Carpropamid	DMBKQ03	Investigative	Small molecular drug	[2481]
Cartazolate	DMSKT8G	Investigative	Small molecular drug	[2482]
carvacrol	DMINM2D	Investigative	Small molecular drug	[2483]
carveol	DMGIZ5U	Investigative	Small molecular drug	[2484]
Carzenide	DMVD481	Investigative	Small molecular drug	[788]
casp 4 inhib	DMW6P4A	Investigative	Small molecular drug	[2485]
CASUARIIN	DM5E21C	Investigative	Small molecular drug	[387]
CATECHIN	DMY38SB	Investigative	Small molecular drug	[1032]
CATECHOL	DML0YEK	Investigative	Small molecular drug	[21]
CATPB	DMF7TBW	Investigative	Small molecular drug	[2486]
CAULERPIN	DM4QKVN	Investigative	Small molecular drug	[2487]
CAY10583	DMT3MBD	Investigative	Small molecular drug	[2488]
CB-676475	DMXON4L	Investigative	Small molecular drug	[2489]
CBDMB	DM3ZDC0	Investigative	Small molecular drug	[2490]
CBiPES	DMALVY7	Investigative	Small molecular drug	[2491]
CBIQ	DMDIW1M	Investigative	Small molecular drug	[2492]
CBOBNEA	DMITY0H	Investigative	Small molecular drug	[2493]
Cbz-Glu(OtBu)-Ala-LeuVSMe	DM21JVF	Investigative	Small molecular drug	[1889]
Cbz-Ile-hPhe-Ala-LeuVSMe	DMV8CJK	Investigative	Small molecular drug	[1889]
Cbz-Ile-Leu-Ala-LeuVSMe	DMBFLHD	Investigative	Small molecular drug	[1889]
Cbz-Ile-Leu-L-(difluoro)aminobutyric acid	DMI53WR	Investigative	Small molecular drug	[779]
Cbz-Ile-MetO2-Ala-LeuVSMe	DMY4M3J	Investigative	Small molecular drug	[1889]
Cbz-Ile-Phe-Ala-LeuVSMe	DM1OAW3	Investigative	Small molecular drug	[1889]
Cbz-Ile-Pro-Ala-LeuVSMe	DM1KDWE	Investigative	Small molecular drug	[1889]
Cbz-Ile-t-ButylGln-Ala-LeuVSMe	DMGTFON	Investigative	Small molecular drug	[1889]
Cbz-Ile-t-ButylhomoGlu-Ala-LeuVSMe	DMNKC9J	Investigative	Small molecular drug	[1889]
Cbz-Val-Pro-Val-(2-benzoxazole)	DM6TYRA	Investigative	Small molecular drug	[359]
CCACSSKWCRDHSRCC	DMSE20Y	Investigative	NA	[2494]
CCG-100602	DM6R3YK	Investigative	Small molecular drug	[2495]
CCG-1423	DMG1T63	Investigative	Small molecular drug	[2496]
CCG-203971	DMFUCAG	Investigative	Small molecular drug	[2497]
CCG-50014	DMUQJ6X	Investigative	Small molecular drug	[2498]
CCG-977	DMO4PUP	Investigative	Small molecular drug	[2496]
CCK-33	DM1N0ED	Investigative	Small molecular drug	[2499]
CCNCASKWCRDHSRCC	DMRFA5O	Investigative	NA	[2494]
CCNCSAKWCRDHSRCC	DMZKJ37	Investigative	NA	[2494]
CCNCSSKWCRAHSRCC	DM96YR2	Investigative	NA	[2494]
CCNCSSKWCRDHARCC	DMP0C7B	Investigative	NA	[2494]
CCNCSSKWCRDHSRCC	DMBGHTW	Investigative	NA	[2494]
CCP	DM2UJM8	Investigative	Small molecular drug	[2500]
CCT244747	DMSDH3A	Investigative	Small molecular drug	[2501]
CD-832.HCL	DMFYWE3	Investigative	Small molecular drug	[2502]
CD154	DM9BMDO	Investigative	NA	[2503]
CD2665	DM05M9X	Investigative	Small molecular drug	[2504]
CD3254	DM38MU1	Investigative	Small molecular drug	[2505]
CD4 red blood cell electroinsertion	DMIV82T	Investigative	NA	[2506]
CD564	DMZ2LPO	Investigative	Small molecular drug	[12]
CD666	DMC8X9Y	Investigative	Small molecular drug	[2507]
CDC	DMRRZHH	Investigative	Small molecular drug	[2508]
CDDO	DM03NUV	Investigative	Small molecular drug	[2509]
Cdk1 inhibitor	DMNW12R	Investigative	Small molecular drug	[2510]
Cdk1/2 inhibitor III	DMS62T0	Investigative	Small molecular drug	[2511]
Cdk4 inhibitor III	DMNZJAX	Investigative	Small molecular drug	[2512]
CDKN1A	DMEEA01	Investigative	NA	[1866]
CDKN2C	DMX4WUA	Investigative	NA	[1866]
Cebutolol	DMUKGEA	Investigative	NA	[2513]
CENTAUREIDIN	DMCLXO0	Investigative	Small molecular drug	[2514]
Centratherin	DMOHELX	Investigative	Small molecular drug	[703]
CEP-5104	DMV43GY	Investigative	Small molecular drug	[2515]
CEP-6331	DMNXBTD	Investigative	Small molecular drug	[2515]
CEP-6800	DMS16BD	Investigative	Small molecular drug	[2516]
CEP1348	DMA7JO4	Investigative	NA	[2517]
CEP1349	DMOAZX5	Investigative	NA	[2517]
Cephalosporin C	DMYW3ZG	Investigative	Small molecular drug	[107]
CEPHARANTINE	DMCE3NA	Investigative	Small molecular drug	[2518]
CFGGFTCARKSARK	DMSL4FQ	Investigative	NA	[2519]
CFGGFTGARKCARK	DM2B0RX	Investigative	NA	[2519]
CFMMC	DMN8B1S	Investigative	Small molecular drug	[2520]
CFMTI	DM9HMP4	Investigative	Small molecular drug	[2521]
CFTRinh-172	DM8TJW3	Investigative	Small molecular drug	[2522]
CGK733	DM8OAN9	Investigative	Small molecular drug	[2523]
CGNLSTCBLGTYTQDFNKFHZYPQTAIGVGAP-amide	DMLA384	Investigative	NA	[2524]
CGNLSTCBLGTYTQDF[DKFHO]YPQTAIGVGAP-amide	DMQ3SAY	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFc[DKFHK]FPQTAIGVGAP-amide	DMUGAYT	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFc[DKFHO]FPQTAIGVGAP-amide	DM3FP47	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-amide	DMJ9Z31	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFNKPHTFPQTAIGVGAP-amide	DME84PN	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFNPFHTFPQTAIGVGAP-amide	DMV7TE4	Investigative	NA	[2524]
CGNLSTCMLGTYTQDFNPKHTFPQTAIGVGAP-amide	DMMO8A2	Investigative	NA	[2524]
CGP 20712A	DML79NU	Investigative	Small molecular drug	[2525]
CGP 23996	DMTECXA	Investigative	Small molecular drug	[2526]
CGP 40336A	DMEA5BZ	Investigative	Small molecular drug	[782]
CGP 46381	DMXV6RD	Investigative	Small molecular drug	[2527]
CGP 47656	DME39UQ	Investigative	Small molecular drug	[2528]
CGP 54626A	DMEHYVS	Investigative	Small molecular drug	[2529]
CGP 55845	DMNMG0I	Investigative	Small molecular drug	[2530]
CGP 56999A	DMR708D	Investigative	Small molecular drug	[2531]
CGP 62349	DMYXE39	Investigative	Small molecular drug	[2532]
CGP 64213	DMR8U1M	Investigative	Small molecular drug	[2533]
CGP 71872	DMJWED7	Investigative	Small molecular drug	[2534]
CGP 77675	DMXH2R3	Investigative	Small molecular drug	[2535]
CGP-029482	DMNUQAG	Investigative	Small molecular drug	[2536]
CGP-191	DMCE6WJ	Investigative	Small molecular drug	[1471]
CGP-34938	DM84TSH	Investigative	Small molecular drug	[37]
CGP-35024	DMHKETG	Investigative	Small molecular drug	[2537]
CGP-35582	DM3J6HM	Investigative	Small molecular drug	[37]
CGP-36216	DM9U8TO	Investigative	Small molecular drug	[164]
CGP-49870	DM5SATN	Investigative	NA	[2538]
CGP-57380	DMFPOUC	Investigative	Small molecular drug	[2539]
CGP-57698	DMYZ72J	Investigative	Small molecular drug	[2540]
CGP-62464	DMZ34P1	Investigative	Small molecular drug	[1471]
CGP61594	DM8KFZH	Investigative	Small molecular drug	[2541]
CGP74514A	DMU5984	Investigative	Small molecular drug	[2542]
CGS 21680	DMZ0TGY	Investigative	Small molecular drug	[2543]
CGS 24012	DMRU8G7	Investigative	Small molecular drug	[2544]
CGS 35066	DMCHT27	Investigative	Small molecular drug	[2545]
CGS-13767	DM4DSE7	Investigative	Small molecular drug	[2546]
CGS-15943	DMFJ139	Investigative	Small molecular drug	[1866]
CGS-18320B	DM2CS5A	Investigative	Small molecular drug	[549]
CGS-19281A	DMDB2KJ	Investigative	Small molecular drug	[392]
CGS-23885	DM5P7TR	Investigative	Small molecular drug	[2547]
CGS-314447	DM514L0	Investigative	Small molecular drug	[2548]
CGS-7181	DMZKS6Q	Investigative	Small molecular drug	[2549]
CGS-9895	DMKY6CU	Investigative	Small molecular drug	[2550]
CH4474	DMP9UHT	Investigative	Small molecular drug	[2551]
chaetocin	DMBK86L	Investigative	Small molecular drug	[2552]
CHALCONE	DM16QTM	Investigative	Small molecular drug	[2553]
Chebulagic acid	DM0H7AV	Investigative	Small molecular drug	[2554]
Chebulinic acid	DMR8HKC	Investigative	Small molecular drug	[372]
chelerythrine	DMCP1G9	Investigative	Small molecular drug	[2555]
Chemosensitizers	DMYSG9J	Investigative	Small molecular drug	[2556]
CHF-2819	DMLJGVX	Investigative	Small molecular drug	[2557]
Chimeric small nucleolar RNA-TAR decoy	DMJATBL	Investigative	Small molecular drug	[2558]
CHIR-98014	DMVEBT6	Investigative	Small molecular drug	[2559]
CHIR-98023	DMFBW1H	Investigative	Small molecular drug	[1424]
Chk2 inhibitor II	DMNSPFG	Investigative	Small molecular drug	[2560]
CHLORANIL	DMCHGF1	Investigative	Small molecular drug	[397]
chlordane	DMMHU8G	Investigative	Small molecular drug	[2561]
chlorobenzylidene malononitrile	DMLF7MK	Investigative	Small molecular drug	[2562]
CHLOROCYCLINONE A	DMZA394	Investigative	Small molecular drug	[2563]
CHLOROCYCLINONE B	DMO78QB	Investigative	Small molecular drug	[2563]
CHLOROCYCLINONE C	DMX2DQ5	Investigative	Small molecular drug	[2563]
CHLOROCYCLINONE D	DMK7VS1	Investigative	Small molecular drug	[2563]
CHLORODEOXYURIDINE	DMQT3WJ	Investigative	Small molecular drug	[2394]
CHLORODYSINOSIN A	DMGS3FI	Investigative	Small molecular drug	[2564]
Chloroethylclonidine	DMKZIES	Investigative	Small molecular drug	[2565]
Chlorogenic acid	DM2Y3P4	Investigative	Small molecular drug	[2566]
CHLOROPHENYLPIPERAZINE	DMOA8L2	Investigative	NA	[2567]
chloropicrin	DMSGBQA	Investigative	Small molecular drug	[2568]
CHLOROPUUPEHENONE	DM8B0VZ	Investigative	Small molecular drug	[39]
Chloropyramine	DM1OJ3S	Investigative	Small molecular drug	[1866]
Chlorphrifos oxon	DMGBT68	Investigative	Small molecular drug	[1476]
CHLORPYRIFOS	DMKPUI6	Investigative	Small molecular drug	[2569]
CHO793076	DMZHO3S	Investigative	Small molecular drug	[2570]
Cholecystokinin-9	DMVJMG8	Investigative	NA	[2571]
cholesten	DMKM3WJ	Investigative	Small molecular drug	[2572]
Cholesterol	DMR3J6S	Investigative	Small molecular drug	[2573]
CHOLINE	DM5D9YK	Investigative	Small molecular drug	[2574]
CHOLINE IODIDE	DMW6U7K	Investigative	Small molecular drug	[131]
CHPG	DMZ956E	Investigative	Small molecular drug	[2575]
chroman 28	DMVDB7S	Investigative	Small molecular drug	[2576]
CHROMOTROPATE	DM5JHUN	Investigative	Small molecular drug	[2577]
Chrysamine -G	DMLEXN0	Investigative	Small molecular drug	[2578]
Chrysin	DM7V2LG	Investigative	Small molecular drug	[1906]
CHRYSOERIOL	DM96ECL	Investigative	Small molecular drug	[1906]
CHYMOSTATIN	DMT27QD	Investigative	Small molecular drug	[2579]
CI-1015	DMQ5CE1	Investigative	Small molecular drug	[2580]
CI-1031	DMTKVDZ	Investigative	Small molecular drug	[2581]
CI-1040	DMF3DZX	Investigative	Small molecular drug	[2517]
CI-1044	DMG5D6B	Investigative	Small molecular drug	[2582]
CI-218872	DM0RH3S	Investigative	Small molecular drug	[1309]
Cibacron blue	DMWE1N8	Investigative	Small molecular drug	[2583]
cicaprost	DM7ZJ4H	Investigative	Small molecular drug	[2584]
cicloprolol	DM27S6E	Investigative	Small molecular drug	[2585]
CID1172084	DMK6YOP	Investigative	Small molecular drug	[2586]
CID16020046	DMLWZRT	Investigative	Small molecular drug	[2587]
CID16197121	DMP6I98	Investigative	Small molecular drug	[2588]
CID1792197	DMEGZY7	Investigative	Small molecular drug	[2589]
CID2440433	DMA3F7S	Investigative	Small molecular drug	[2590]
CIFEA	DMP35OM	Investigative	Small molecular drug	[2591]
Cilostamide	DMBVIKY	Investigative	Small molecular drug	[2592]
CINANSERIN	DM6TJFU	Investigative	Small molecular drug	[2593]
Cinchoninic acid	DMOJ917	Investigative	Small molecular drug	[430]
cinnamaldehyde	DMZDUXG	Investigative	Small molecular drug	[2594]
cinnamic acid	DM340FH	Investigative	Small molecular drug	[2595]
cirazoline	DMU6JOK	Investigative	Small molecular drug	[2596]
Cirsimarin	DMM10TG	Investigative	Small molecular drug	[2597]
CIRSIMARITIN	DMA3N9R	Investigative	Small molecular drug	[1554]
Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	DMWX6J0	Investigative	Small molecular drug	[2598]
Cis-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea	DMP3F0D	Investigative	Small molecular drug	[570]
Cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea	DM8NX3Q	Investigative	Small molecular drug	[570]
Cis-2,6-dimethyl-1-methyl sulfonyl piperidine	DMJ3HG9	Investigative	Small molecular drug	[580]
Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine	DMVRF9H	Investigative	Small molecular drug	[2598]
Cis-2-(para-fluorophenyl)cyclopropylamine	DMPZ1LY	Investigative	Small molecular drug	[2598]
Cis-2-aminocyclohexylcarbamoylphosphonic acid	DMF10WT	Investigative	Small molecular drug	[2599]
Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine	DMNG9B2	Investigative	Small molecular drug	[2598]
Cis-2-fluoro-2-phenylcyclopropanamine	DMFSPHE	Investigative	Small molecular drug	[2598]
Cis-2-phenylcyclopropylamine	DMKZ32J	Investigative	Small molecular drug	[2598]
cis-3-ACPBPA	DMQ0EA7	Investigative	Small molecular drug	[2600]
Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine	DMTH4BG	Investigative	Small molecular drug	[2601]
Cis-4-hydroxynipecotic acid	DMX07BG	Investigative	NA	[2602]
Cis-H-Tyr-c[D-AllylGly-Gly-Phe-D-Allylgly]-OH	DMQUB19	Investigative	Small molecular drug	[2603]
cis-JB253	DMXACKH	Investigative	Small molecular drug	[2604]
Cis-N,5-dibenzyl-6-oxomorpholine-3-carboxamide	DM75SO4	Investigative	Small molecular drug	[2605]
Cis-[PtCl(NH3)2(N7-acyclovir)]+	DMV3RYK	Investigative	Small molecular drug	[2606]
CITCO	DM0N634	Investigative	Small molecular drug	[2607]
Citraconic acid	DMCIM9A	Investigative	Small molecular drug	[107]
citral	DM53ZGY	Investigative	Small molecular drug	[2608]
citric acid	DM80YI7	Investigative	Small molecular drug	[2609]
CL 385319	DML8MSC	Investigative	Small molecular drug	[1093]
CL-385004	DMLQZGJ	Investigative	Small molecular drug	[2610]
CL-387785	DMLKFZC	Investigative	Small molecular drug	[2611]
Cl-amidine	DMRV89X	Investigative	Small molecular drug	[2612]
CL82198	DMP3MDS	Investigative	Small molecular drug	[2613]
CLAVARINONE	DMIX347	Investigative	Small molecular drug	[2614]
CLEBOPRIDE	DMTLOU6	Investigative	Small molecular drug	[2380]
CLEMATOMANDSHURICA SAPONIN A	DM4SKYA	Investigative	NA	[2615]
CLEMATOMANDSHURICA SAPONIN B	DMNWXOC	Investigative	NA	[2615]
Clik60	DM9WUHD	Investigative	NA	[2616]
Clinopodic acid C	DMS58P1	Investigative	Small molecular drug	[2617]
Clobenpropit	DM537OH	Investigative	Small molecular drug	[2618]
Clocinnamox	DMZLMJH	Investigative	Small molecular drug	[693]
Clodinafop	DMALRU9	Investigative	Small molecular drug	[2074]
clofilium	DMQ37OP	Investigative	Small molecular drug	[2619]
cloprostenol	DMH01JV	Investigative	Small molecular drug	[2620]
Clorobiocin	DMD5FIU	Investigative	Small molecular drug	[2621]
Clorsulon	DMU6FOG	Investigative	Small molecular drug	[2622]
Clostridial collagenase	DMWTBG8	Investigative	NA	[2623]
CM-352	DMXA8K1	Investigative	Small molecular drug	[2624]
CMI-1145	DMYPG01	Investigative	Small molecular drug	[2625]
CMI-489	DM4PWDJ	Investigative	Small molecular drug	[1659]
CMI-936	DMT9YKG	Investigative	Small molecular drug	[2625]
Cmp-2-Keto-3-Deoxy-Octulosonic Acid	DMM9K5S	Investigative	Small molecular drug	[12]
CMP-3	DMDLDTF	Investigative	NA	[1866]
CMP-6	DM241YW	Investigative	Small molecular drug	[2626]
CMP-sialic acid	DMH48YE	Investigative	Small molecular drug	[2627]
cmp5	DMBT2ZW	Investigative	Small molecular drug	[2628]
CMPD1	DMKNUYF	Investigative	Small molecular drug	[2629]
CNICIN	DMEVM0J	Investigative	Small molecular drug	[2630]
CNTO-607	DM329EX	Investigative	NA	[1866]
Cobalt Hexammine Ion	DMTB965	Investigative	Small molecular drug	[107]
COCAINE.HCL	DMJRSIF	Investigative	Small molecular drug	[598]
COCHINCHINENENE B	DMCSAIJ	Investigative	Small molecular drug	[2631]
COCHINCHINENIN B	DMIGB7N	Investigative	Small molecular drug	[2631]
Cochliobolic acid	DMOUSWN	Investigative	Small molecular drug	[2632]
COCLAURINE	DMZ1VSI	Investigative	Small molecular drug	[2102]
CODEINONE	DM08WPL	Investigative	Small molecular drug	[2633]
Coenzyme A	DM1I8LU	Investigative	Small molecular drug	[2634]
Coformycin	DM0ACL9	Investigative	Small molecular drug	[2635]
COLCHINOL	DM326VN	Investigative	Small molecular drug	[2636]
COMBETASTATIN	DMIKD8X	Investigative	Small molecular drug	[2637]
Conantokin-G	DMC2IYH	Investigative	Small molecular drug	[2638]
Conantokin-R	DMN4KJI	Investigative	NA	[2639]
Conantokins G	DMLHF3E	Investigative	NA	[2640]
Conantokins T	DMV6H5S	Investigative	NA	[2640]
Concatameric CD2Ig	DMKVQQF	Investigative	NA	[1866]
Concatameric CTLA4Ig	DMC5RKY	Investigative	NA	[2641]
Concatameric LAG3Ig	DMRPV0A	Investigative	NA	[2642]
CONESSINE	DM4VYP0	Investigative	Small molecular drug	[2518]
Conotoxin	DMQG2MC	Investigative	NA	[2643]
COOH	DM5DTZR	Investigative	Small molecular drug	[2644]
cooling agent 10	DMFH5J9	Investigative	Small molecular drug	[2645]
CORDOIN	DMT5SED	Investigative	Small molecular drug	[2553]
cordycepin	DM72Y01	Investigative	Small molecular drug	[2646]
CORILAGIN	DMAC698	Investigative	Small molecular drug	[372]
CORONARIDINE	DMZBUE7	Investigative	Small molecular drug	[2647]
Corosolic acid	DM563PZ	Investigative	Small molecular drug	[669]
Correloid	DM5ISQK	Investigative	Small molecular drug	[2648]
correolide	DMACH7K	Investigative	Small molecular drug	[2649]
CORYMBONE B	DM463S2	Investigative	Small molecular drug	[2650]
CORYNANTHEINE	DM18CUZ	Investigative	Small molecular drug	[92]
corynanthine	DMOC1ZJ	Investigative	Small molecular drug	[2651]
Cosalane derivative	DMSFXJ8	Investigative	NA	[2652]
Costunolide	DMU6OB4	Investigative	Small molecular drug	[2653]
COUMARIN	DM0N8ZM	Investigative	Small molecular drug	[1069]
Coumermycin	DMAJNPS	Investigative	Small molecular drug	[2654]
COUMESTROL	DM40TBU	Investigative	Small molecular drug	[1217]
CP 4010	DMT2RHV	Investigative	NA	[2655]
CP 93129	DMSNVKP	Investigative	Small molecular drug	[2656]
CP-126998	DM3ZIDT	Investigative	NA	[2657]
CP-226269	DMGLO2X	Investigative	Small molecular drug	[2658]
CP-271485	DMGN38F	Investigative	Small molecular drug	[12]
CP-294838	DM6BRLA	Investigative	Small molecular drug	[2659]
CP-305202	DMME6K2	Investigative	Small molecular drug	[2660]
CP-320626	DMY8O0B	Investigative	Small molecular drug	[2078]
CP-339818	DMTJOWH	Investigative	Small molecular drug	[2661]
CP-376395	DM93CA4	Investigative	Small molecular drug	[2662]
CP-394531	DMDPH3W	Investigative	Small molecular drug	[2663]
CP-409069	DM1U6P7	Investigative	Small molecular drug	[2663]
CP-409092	DMROYD7	Investigative	NA	[1866]
CP-4497	DMTHVCA	Investigative	NA	[2664]
CP-470,711	DMS2RHE	Investigative	Small molecular drug	[2665]
CP-481,715	DMZT7C1	Investigative	Small molecular drug	[2666]
CP-640186	DMO0PS9	Investigative	Small molecular drug	[2667]
CP-673451	DMVBPRO	Investigative	Small molecular drug	[2668]
CP-775146	DMANV7R	Investigative	Small molecular drug	[2669]
CP-810123	DMXDG13	Investigative	Small molecular drug	[1460]
CP-94,253	DMHN2LT	Investigative	Small molecular drug	[2670]
CP-99,994	DMVJX21	Investigative	Small molecular drug	[2671]
CP55,244	DMKWB31	Investigative	Small molecular drug	[2672]
CP55,667	DMNLD6E	Investigative	Small molecular drug	[2673]
CP608,039	DMTKO7P	Investigative	Small molecular drug	[2674]
CP734432	DM9LYJT	Investigative	Small molecular drug	[2675]
CPCCOEt	DMI4WVE	Investigative	Small molecular drug	[2676]
CPFPX	DMFE5GX	Investigative	Small molecular drug	[2677]
CPI-203	DMXSYTA	Investigative	Small molecular drug	[2678]
CPPG	DMVHX5T	Investigative	Small molecular drug	[2679]
CPPHA	DMDG2Y9	Investigative	Small molecular drug	[2680]
CPPZ	DM9OWG5	Investigative	Small molecular drug	[2681]
CPS125	DMG2NI9	Investigative	Small molecular drug	[2682]
CPSI-306	DM2K1P8	Investigative	NA	[1866]
CR-2345	DMFG0XS	Investigative	Small molecular drug	[2683]
CRA_10655	DM70YRT	Investigative	Small molecular drug	[22]
CRA_1144	DMK54RM	Investigative	Small molecular drug	[22]
CRA_8696	DM3IZOP	Investigative	Small molecular drug	[22]
Cremastrine	DMLJOGK	Investigative	Small molecular drug	[2684]
CRISNATOL MESILATE	DMY0GXM	Investigative	Small molecular drug	[1866]
Cristacarpin	DMYPLZ8	Investigative	Small molecular drug	[2456]
Crocusatin-K	DMELUG5	Investigative	Small molecular drug	[2685]
crotylaldehyde	DMTWRQI	Investigative	Small molecular drug	[2686]
CRX-526	DMW61UK	Investigative	NA	[2687]
CRYPTADINE B	DM92IK8	Investigative	Small molecular drug	[2688]
CSNLSTCVLGKLSQELc[DKLHK]YPRTNTGSGTP-amide	DMYDTO8	Investigative	NA	[2524]
CSNLSTCVLGKLSQELc[DKLHO]YPRTNTGSGTP-amide	DMQXEHJ	Investigative	NA	[2524]
CSNLSTCVLGKLSQELc[DKLQK]YPRTNTGSGTP-amide	DMMZK89	Investigative	NA	[2524]
CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-amide	DMTL2BA	Investigative	NA	[2524]
CSNLSTCVLGKLSQELNKLHBYPRTNTGSGTP-amide	DM61V5W	Investigative	NA	[2524]
CT-5357	DM6W9LA	Investigative	NA	[1866]
CT-98024	DM6F8DM	Investigative	Small molecular drug	[2689]
CT301	DMUVQFW	Investigative	NA	[2690]
CTAP	DMLON9K	Investigative	Small molecular drug	[2691]
CTOP	DM7VAJX	Investigative	Small molecular drug	[2692]
CTP	DM4T62U	Investigative	Small molecular drug	[2693]
CU201 (B9870)	DMDPJWF	Investigative	NA	[2694]
CUDRATRICUSXANTHONE	DMBL46A	Investigative	Small molecular drug	[2695]
Cudratricusxanthone F	DM10BOC	Investigative	Small molecular drug	[2695]
Cudraxanthone D	DMBQ1VO	Investigative	Small molecular drug	[2695]
Cudraxanthone L	DMP1D5Q	Investigative	Small molecular drug	[2695]
Cudraxanthone M	DMIQFAU	Investigative	Small molecular drug	[2695]
CV-11194	DMEB0FX	Investigative	Small molecular drug	[2696]
CV-1674	DM9AL7W	Investigative	Small molecular drug	[2697]
CV-1808	DM07VRS	Investigative	Small molecular drug	[2698]
CV-3988	DMM7RAD	Investigative	Small molecular drug	[2699]
CV-4093	DM983QP	Investigative	Small molecular drug	[2700]
CV-6504.HCL	DMO9WZN	Investigative	Small molecular drug	[2701]
CVS-1578	DMO9UMK	Investigative	Small molecular drug	[2702]
CVS-2139	DMT5R1Q	Investigative	Small molecular drug	[2703]
CVS-2359	DM3KB4H	Investigative	Small molecular drug	[2703]
CVT-313	DMSEK5W	Investigative	Small molecular drug	[2704]
CVT-6694	DMYC1DW	Investigative	Small molecular drug	[935]
CVT-7124	DM53VA8	Investigative	Small molecular drug	[935]
CX4	DMCNEXF	Investigative	Small molecular drug	[2705]
Cy3B-telenzepine	DMBKTHI	Investigative	Small molecular drug	[2706]
cyamemazine	DMZ6YPV	Investigative	Small molecular drug	[2707]
CYANATE	DM6HQDL	Investigative	Small molecular drug	[2222]
Cyanide	DMJE4HK	Investigative	Small molecular drug	[2101]
CYANIDIN	DMZBDO1	Investigative	Small molecular drug	[2708]
Cyanopindolol	DMIBLGH	Investigative	Small molecular drug	[2709]
cyanotriphenylborate	DMEZJOU	Investigative	Small molecular drug	[2710]
CYCLAZOCINE	DMC6DAZ	Investigative	Small molecular drug	[2711]
Cyclazosin	DMPXHO8	Investigative	Small molecular drug	[2712]
cyclic CMP	DMVJL8H	Investigative	Small molecular drug	[2713]
Cyclic Guanosine Monophosphate	DMOU93V	Investigative	Small molecular drug	[2714]
Cyclic LVVYPWT	DM2JE5F	Investigative	Small molecular drug	[2195]
Cyclo(-D-Ala-D-Arg-L-Arg-L-Nal-Gly-)	DMLY8CU	Investigative	Small molecular drug	[2715]
Cyclo(-D-MeTyr-D-Arg-L-Arg-L-Nal-Gly-)	DMBKRQ9	Investigative	Small molecular drug	[2715]
Cyclo(-D-MeTyr-L-Arg-L-Arg-L-Nal-Gly-)	DMHI0UL	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)	DM82C6Q	Investigative	Small molecular drug	[2716]
Cyclo(-D-Tyr-D-Ala-L-Arg-L-Nal-Gly-)	DM8RKT1	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-MeNal-Gly-)	DM8XVAW	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-beta-Ala-)	DMWFITM	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-D-Ala-)	DMSA0IW	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Gly-)	DMGOW1E	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Ala-)	DM3PRHF	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Pic-)	DMS9QHI	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Sar-)	DM3Y1TZ	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-Arg-L-MeArg-L-Nal-Gly-)	DMUWC5O	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-D-MeArg-L-Arg-L-Nal-Gly-)	DM8F5DY	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Ala-L-Arg-L-Nal-Gly-)	DMPW9SD	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-Ala-Sar-)	DMOWT4H	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-MeNal-Gly-)	DMPZ316	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-beta-Ala-)	DMNQWBS	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-D-Ala-)	DMV6C9N	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-Gly-)	DMH9VMO	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-L-Ala-)	DM72HW3	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-Arg-L-MeArg-L-Nal-Gly-)	DMSPKWD	Investigative	Small molecular drug	[2715]
Cyclo(-D-Tyr-L-MeArg-L-Arg-L-Nal-Gly-)	DMIUVQ6	Investigative	Small molecular drug	[2715]
Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)	DMZF35W	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)	DMIVREK	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)	DMLBECR	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)	DMA76KW	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)	DMLNJ0O	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)	DMTVMWA	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)	DMUSEDF	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)	DMSEQ0W	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)	DMBKP48	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)	DMVY89X	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)	DMTDIM9	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)	DMV23XD	Investigative	Small molecular drug	[2717]
Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)	DM0VIH4	Investigative	Small molecular drug	[2717]
Cyclo(1,10)EIYDPGDDIK	DMFUG05	Investigative	NA	[2718]
Cyclo(1,10)H-EIYDPGDDIK-OH	DM5CBQ9	Investigative	NA	[2718]
Cyclo(1,11)H-ESIYDPGDDIK-OH	DM4A1TF	Investigative	NA	[2718]
Cyclo(1,12)PenIYDTKGKNVLC-OH	DMVDS8B	Investigative	NA	[2719]
Cyclo(RGDfV) (control)	DM3QVOB	Investigative	Small molecular drug	[2720]
Cyclo-[-Arg-Gly-Asp-Amp21-]	DMVXPUB	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp22-]	DMBELJK	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp23-]	DMT29VJ	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp24-]	DM35ZLK	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp25-]	DMEIXUQ	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp26-]	DME5HRW	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp27-]	DMBNJZ0	Investigative	Small molecular drug	[2721]
Cyclo-[-Arg-Gly-Asp-Amp28-]	DMJMHAV	Investigative	Small molecular drug	[2721]
Cyclo-[Asp6,Lys10]N/OFQ(1-13)NH2	DMWD5RK	Investigative	NA	[2722]
Cyclobutyl	DM35PIJ	Investigative	Small molecular drug	[2723]
Cyclobutylcarbamic Acid Biphenyl-3-yl Ester	DMYLA7F	Investigative	Small molecular drug	[1011]
cycloheximide	DMGDA3C	Investigative	Small molecular drug	[2724]
Cyclohexyl biphenyl-4-ylcarbamate	DMZKH4R	Investigative	Small molecular drug	[1376]
Cyclohexyl-(2-phenoxy-9H-purin-6-yl)-amine	DM84ZX5	Investigative	Small molecular drug	[2725]
Cyclohexyl-(2-phenylsulfanyl-9H-purin-6-yl)-amine	DMLREDJ	Investigative	Small molecular drug	[2725]
Cyclohexyl-(3,4-dichloro-phenyl)-acetonitrile	DMJEN45	Investigative	Small molecular drug	[2726]
Cyclohexyl-(9-ethyl-9H-purin-6-yl)-amine	DM1F7I5	Investigative	Small molecular drug	[104]
Cyclohexyl-(9-methyl-9H-purin-6-yl)-amine	DMIUCSW	Investigative	Small molecular drug	[104]
cyclohexylamine	DM5MMV3	Investigative	Small molecular drug	[2727]
Cyclohexylammonium Ion	DMYQH2N	Investigative	Small molecular drug	[12]
Cyclohexylcarbamic acidbiphenyl-3-yl ester	DM06OLY	Investigative	Small molecular drug	[1011]
Cyclohexylglycine-(2S)-cyanopyrrolidine	DMNG4B1	Investigative	Small molecular drug	[2728]
Cyclohexylmethylcarbamic Acid Biphenyl-3-yl Ester	DMEW7AY	Investigative	Small molecular drug	[1011]
Cycloleucine	DM0L6E1	Investigative	Small molecular drug	[2729]
CYCLOPAMINE	DMEM2SW	Investigative	Small molecular drug	[2730]
Cyclopentane amide derivatives 1	DM78PR5	Investigative	Small molecular drug	[815]
Cyclopentane amide derivatives 2	DMGU97P	Investigative	Small molecular drug	[815]
Cyclopentane amide derivatives 3	DMHTVRL	Investigative	Small molecular drug	[815]
Cyclopentane amide derivatives 4	DMOA7EP	Investigative	Small molecular drug	[815]
Cyclopentyl 10H-phenothiazine-10-carboxylate	DMMV2LN	Investigative	Small molecular drug	[1050]
Cyclopentyl(5-(pyridin-2-yl)oxazol-2-yl)methanone	DM0J9I5	Investigative	Small molecular drug	[1000]
Cyclopentyl-(3,4-dichloro-phenyl)-acetonitrile	DMAKT65	Investigative	Small molecular drug	[2726]
Cyclopentyl-(9-cyclopentyl-9H-purin-6-yl)-amine	DMBDTFQ	Investigative	Small molecular drug	[104]
Cyclopentyl-(9-ethyl-9H-purin-6-yl)-amine	DMQ6BS2	Investigative	Small molecular drug	[104]
Cyclopentyl-(9-methyl-9H-purin-6-yl)-amine	DM9DHNZ	Investigative	Small molecular drug	[104]
Cyclopentyl-(9-phenyl-9H-purin-6-yl)-amine	DMBJV90	Investigative	Small molecular drug	[104]
Cyclopentylcarbamic Acid Biphenyl-3-yl Ester	DMQLGFH	Investigative	Small molecular drug	[1011]
Cyclopentylcytosine	DM4KZ1W	Investigative	Small molecular drug	[2731]
Cyclopiazonic acid	DMPJ08G	Investigative	Small molecular drug	[2732]
Cyclopropyl	DMGFEPJ	Investigative	Small molecular drug	[2723]
CYCLORPHAN	DMB1U8V	Investigative	Small molecular drug	[2413]
Cyclosal-d4TMP	DMLC041	Investigative	Small molecular drug	[1293]
Cyclostellettamine derivative	DMFTDPQ	Investigative	Small molecular drug	[2733]
Cyclotheonamide E	DM8HG0K	Investigative	Small molecular drug	[2734]
Cyclotheonamide E4	DM2E5VZ	Investigative	Small molecular drug	[2734]
Cyclotheonamide E5	DMCA76M	Investigative	Small molecular drug	[2734]
Cyclo[(6-bromotryptophan)arginine]	DM9ZCWV	Investigative	Small molecular drug	[2235]
Cyclo[Ac-Cys-Ile-Phe]-Lys-Tyr-Tyr	DM67CAY	Investigative	Small molecular drug	[1880]
Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Phe]	DMB2DV1	Investigative	Small molecular drug	[1880]
Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Tyr]	DMO5V9M	Investigative	Small molecular drug	[1880]
Cyclo[Cys6,Cys10]N/OFQ(1-13)NH2	DMSMH6T	Investigative	NA	[2722]
Cyclo[Cys7,Cys10]N/OFQ(1-13)NH2	DMI9C57	Investigative	NA	[2722]
Cyclo[DAsp7,Lys10]N/OFQ(1-13)NH2	DM39UMT	Investigative	NA	[2722]
Cyclo[RGDfK(cypate)]	DMWYFLD	Investigative	NA	[2720]
CYLINDOL A	DMTS8D5	Investigative	Small molecular drug	[2735]
CYLINDROL A	DMCRU4H	Investigative	Small molecular drug	[363]
Cylopentenyl cytosine	DMQWLIC	Investigative	NA	[2736]
CYM2503	DM5NFEA	Investigative	Small molecular drug	[2737]
CYM5181	DMGTZ9Q	Investigative	Small molecular drug	[2738]
CYM5442	DMURD2E	Investigative	Small molecular drug	[2739]
CYNAROPICRIN	DMG0PHU	Investigative	Small molecular drug	[2630]
Cynooxide anion	DMZCA15	Investigative	Small molecular drug	[2740]
Cypate-[(RGD)2-NH2]1	DMBTU7G	Investigative	NA	[2720]
Cypate-[(RGD)2-NH2]2	DMJNW9P	Investigative	NA	[2720]
Cypate-[(RGD)3-NH2]1	DMWINK5	Investigative	NA	[2720]
Cypate-[(RGD)3-NH2]2	DM1SAIX	Investigative	NA	[2720]
Cypate-[(RGD)4-NH2]1	DM3GLMP	Investigative	NA	[2720]
Cypate-[(RGD)4-NH2]2	DMR74OM	Investigative	NA	[2720]
CyPPA	DM64L9I	Investigative	Small molecular drug	[2741]
cyPPTS	DME9LPO	Investigative	Small molecular drug	[2742]
CYPRODIME	DMJXCVA	Investigative	Small molecular drug	[2743]
Cystamine	DMS5DHY	Investigative	Small molecular drug	[2744]
cystathionine	DMT4IXS	Investigative	Small molecular drug	[2745]
Cysteinesulfonic Acid	DMXI8FP	Investigative	Small molecular drug	[12]
cytidine	DMK0W8E	Investigative	Small molecular drug	[2746]
Cytidine-5'-Diphosphate	DMA5FGS	Investigative	Small molecular drug	[12]
Cytidine-5'-Monophosphate	DM6PAXD	Investigative	Small molecular drug	[107]
cytosine	DMS9S5H	Investigative	Small molecular drug	[2747]
Cytosine Arabinose-5'-Phosphate	DMPT4WM	Investigative	Small molecular drug	[12]
cytosporone B	DMGC5AT	Investigative	Small molecular drug	[2748]
Cytotoxin Peptide Conjugate	DM7SVLZ	Investigative	NA	[2749]
CZC 24832	DMLBYFG	Investigative	Small molecular drug	[2750]
C[-Arg-Gly-Asp-Acpca19-]	DMPOIDK	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca20-]	DMJVW1N	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca21-]	DMXCUDV	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca22-]	DM6DV90	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca34-]	DMKHSAV	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca35-]	DMQOY3J	Investigative	Small molecular drug	[2439]
C[-Arg-Gly-Asp-Acpca36-]	DM7LCPW	Investigative	Small molecular drug	[2439]
C[Asp22-Lys26][Gly8]GLP-1(7-37)-NH2	DMISP20	Investigative	NA	[2751]
C[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2	DMHARQX	Investigative	Small molecular drug	[2752]
C[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2	DMI3CSJ	Investigative	Small molecular drug	[2752]
C[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	DMYPHVC	Investigative	Small molecular drug	[2752]
C[CO-(CH2)3-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2	DM0VP79	Investigative	Small molecular drug	[2752]
C[CO-2,3-pyrazine-CO-D-Nal(2)-Arg-Trp-Lys]-NH2	DM1VCJP	Investigative	Small molecular drug	[2752]
C[CO-2,3-pyrazine-CO-D-Phe-Arg-Trp-Lys]-NH2	DM8AMGF	Investigative	Small molecular drug	[2752]
C[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	DMD6OW4	Investigative	Small molecular drug	[2752]
C[CO-o-C6H4-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2	DMNKT8J	Investigative	Small molecular drug	[2752]
C[Cpa19-Lys26][Gly8]GLP-1(7-37)-NH2	DMYIJT1	Investigative	NA	[2751]
C[Glu18-Lys22][Gly8]GLP-1(7-37)-NH2	DMJR5UD	Investigative	NA	[2751]
C[Glu19-Lys23][Gly8]GLP-1(7-37)-NH2	DM6O4EZ	Investigative	NA	[2751]
C[Glu21-Lys25][Gly8]GLP-1(7-37)-NH2	DMA3ZRJ	Investigative	NA	[2751]
C[Glu21-Lys26][Gly8]GLP-1(7-37)-NH2	DMPK74W	Investigative	NA	[2751]
C[Glu22-Lys26][Gly8]GLP-1(7-37)-NH2	DM8I0CZ	Investigative	NA	[2751]
C[Glu22-Orn26][Gly8]GLP-1(7-37)-NH2	DMMA9GE	Investigative	NA	[2751]
C[Glu23-Lys27][Gly8]GLP-1(7-37)-NH2	DMWYN87	Investigative	NA	[2751]
C[Glu24-Lys28][Gly8]GLP-1(7-37)-NH2	DMKZXV3	Investigative	NA	[2751]
C[Glu26-Lys30][Gly8]GLP-1(7-37)-NH2	DMX2WCZ	Investigative	NA	[2751]
C[hGlu22-Lys26][Gly8]GLP-1(7-37)-NH2	DMTP5YZ	Investigative	NA	[2751]
C[homoPhe-Hca-Glu-Gly-Leu-Glu-Glu]-NH2	DM8HK0J	Investigative	Small molecular drug	[2753]
C[L-Ala-D-pro-L-Phe-D-trp]	DMHXTWK	Investigative	Small molecular drug	[1881]
C[L-mTyr-D-pro-L-Phe-D-trp]	DMNHSR0	Investigative	Small molecular drug	[1881]
C[L-Phe-D-pro-L-mTyr-D-trp]	DM82ZOM	Investigative	Small molecular drug	[1881]
C[L-Phe-D-pro-L-Phe-D-trp]	DM0NTU5	Investigative	Small molecular drug	[1881]
C[L-Phe-D-pro-L-Phe-L-trp]	DMCY4L0	Investigative	Small molecular drug	[1881]
C[L-Phe-D-pro-L-Tyr(OMe)-D-trp]	DM4M3OP	Investigative	Small molecular drug	[1881]
C[L-Phe-D-pro-L-Tyr-D-trp]	DMADSBT	Investigative	Small molecular drug	[1881]
C[L-Tyr(OMe)-D-pro-L-Phe-D-trp]	DMLB6UA	Investigative	Small molecular drug	[1881]
C[L-Tyr-D-pro-L-Phe-D-trp]	DM7OIY8	Investigative	Small molecular drug	[1881]
C[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2	DMX7IVO	Investigative	Small molecular drug	[2754]
C[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2	DMUESCH	Investigative	Small molecular drug	[2754]
C[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2	DM8SXLR	Investigative	Small molecular drug	[2754]
C[Nle-Asp-D-Phe-Arg-Trp-Glu]-NH2	DMXJAOI	Investigative	Small molecular drug	[2754]
C[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2	DMM19SJ	Investigative	Small molecular drug	[2754]
C[Nle-Gln-D-Phe-Arg-Trp-Glu]-NH2	DMSGWZE	Investigative	Small molecular drug	[2754]
C[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2	DMHNCAG	Investigative	Small molecular drug	[2754]
C[Nle-Glu-D-Phe-Arg-Trp-Glu]-NH2	DMVWOPG	Investigative	Small molecular drug	[2754]
C[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2	DM36HBK	Investigative	Small molecular drug	[2754]
C[Nle-His-D-Phe-Arg-Trp-Glu]-NH2	DM5HRNM	Investigative	Small molecular drug	[2754]
C[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2	DM73ZMG	Investigative	Small molecular drug	[2754]
C[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2	DMDPBVS	Investigative	Small molecular drug	[2754]
C[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2	DMPZ4VB	Investigative	Small molecular drug	[2754]
C[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2	DMZWMV0	Investigative	Small molecular drug	[2754]
C[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2	DMSIGJW	Investigative	Small molecular drug	[2754]
C[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2	DM45ZLW	Investigative	Small molecular drug	[2754]
C[RGD-(R)-alpha-TfmfV]	DMF091Y	Investigative	Small molecular drug	[2437]
C[RGD-(S)-alpha-TfmfV]	DMC9G2Y	Investigative	Small molecular drug	[2437]
C[RGDf-(3R)-Carboxymorpholine]	DM1DMR2	Investigative	Small molecular drug	[2755]
C[RGDf-(3S)-Carboxymorpholine]	DM0ULZM	Investigative	Small molecular drug	[2755]
C[RGDf-(R)-alpha-TfmF]	DMXA0JB	Investigative	Small molecular drug	[2437]
C[RGDf-(R)-alpha-TfmV]	DM8FGMA	Investigative	Small molecular drug	[2437]
C[RGDf-(R)-N-Me-alpha-TfmF]	DM4ZWOD	Investigative	Small molecular drug	[2437]
C[RGDf-(S)-alpha-TfmF]	DMCXJOL	Investigative	Small molecular drug	[2437]
C[RGDf-(S)-alpha-TfmV]	DMLRYXK	Investigative	Small molecular drug	[2437]
C[RGDf-(S)-N-Me-alpha-TfmF]	DMNS3HC	Investigative	Small molecular drug	[2437]
C[RGDf-(S,R)-alpha-Dfm-F]	DMAILK8	Investigative	Small molecular drug	[2437]
C[Ser-Tyr-Thr-His-Dphe-Arg-Trp-Thr-Ile-Pro]	DMO7BMZ	Investigative	NA	[2756]
C[Thr-Tyr-Thr-His-DNaf-Arg-Trp-Thr-Ile-Pro]	DMRY95I	Investigative	NA	[2756]
C[YYAEGLEE]-NH2	DM0YLPV	Investigative	Small molecular drug	[2757]
C[YYDEGLEE]-NH2	DMSKW8H	Investigative	Small molecular drug	[2757]
C[YYDEKLEE]-NH2	DMTHGMR	Investigative	NA	[2757]
D 2343	DM1E5C4	Investigative	Small molecular drug	[2758]
d(CH2)5[D-Ile2,Ile4]AVP	DMAX7LW	Investigative	Small molecular drug	[2759]
D(CH2)5[Tyr(Me)2,Thr4,Orn8(5/6C-Flu),Tyr-NH29]VT	DMVHMGA	Investigative	NA	[2760]
D(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT	DM1BMT7	Investigative	NA	[2760]
d(CH2)5[Tyr(Me)2]AVP	DMHTSAX	Investigative	Small molecular drug	[2761]
D-166A	DMQJD4P	Investigative	Small molecular drug	[2762]
D-189	DMU8BJH	Investigative	Small molecular drug	[2763]
D-190	DMUMNSW	Investigative	Small molecular drug	[2763]
D-192	DM8D26T	Investigative	Small molecular drug	[2763]
D-193	DMU83T7	Investigative	Small molecular drug	[2763]
D-203	DMKPIH0	Investigative	Small molecular drug	[2763]
D-210	DMNLE4S	Investigative	Small molecular drug	[2763]
D-211A	DMIBOAK	Investigative	Small molecular drug	[2762]
D-211B	DM54CKZ	Investigative	Small molecular drug	[2762]
D-218	DMQLT84	Investigative	Small molecular drug	[2763]
D-219	DMQ2U4G	Investigative	Small molecular drug	[2763]
D-220	DMTUJWN	Investigative	Small molecular drug	[2763]
D-237	DMGA48T	Investigative	Small molecular drug	[2764]
D-254C	DM6KFCO	Investigative	Small molecular drug	[2762]
D-257A	DMN7E6Y	Investigative	Small molecular drug	[2762]
D-257C	DM5GLJ2	Investigative	Small molecular drug	[2762]
D-264	DMWLHBQ	Investigative	Small molecular drug	[2765]
D-315	DMG1CD5	Investigative	Small molecular drug	[2766]
D-366	DMZAM3G	Investigative	Small molecular drug	[2767]
D-65476	DM0A54V	Investigative	Small molecular drug	[2768]
D-Alanine	DMVIDQL	Investigative	Small molecular drug	[2769]
D-AP4	DM2WS8B	Investigative	Small molecular drug	[2770]
d-AP5	DMY5OTN	Investigative	Small molecular drug	[2771]
D-arginine	DM77YU0	Investigative	Small molecular drug	[2772]
D-ascorbic acid	DMQ53JD	Investigative	Small molecular drug	[2773]
D-aspartic acid	DM7Z892	Investigative	Small molecular drug	[2774]
d-CCPene	DM36D0F	Investigative	Small molecular drug	[2775]
D-citrulline	DMVQK6G	Investigative	Small molecular drug	[2776]
D-cysteine	DMYBPCR	Investigative	Small molecular drug	[2777]
D-fucose	DMLXNGP	Investigative	Small molecular drug	[2778]
D-Gluconhydroximo-1,5-Lactam	DM527XP	Investigative	Small molecular drug	[22]
D-glucose	DMMG2TO	Investigative	Small molecular drug	[2779]
D-glutamic acid	DMZN4RR	Investigative	Small molecular drug	[2780]
D-histidine	DMOZ9PP	Investigative	Small molecular drug	[2781]
D-kynurenine	DM0QZ6I	Investigative	Small molecular drug	[2782]
D-lactic acid	DMBNFQ8	Investigative	Small molecular drug	[2783]
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	DMVN93B	Investigative	Small molecular drug	[22]
D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	DMIFCHL	Investigative	Small molecular drug	[22]
D-lysine	DM16TM9	Investigative	Small molecular drug	[2784]
D-mannose	DMT6X03	Investigative	Small molecular drug	[2785]
D-Mannose 1-Phosphate	DM7O1IW	Investigative	Small molecular drug	[12]
D-myo-inositol 1,4,5-trisphosphate	DMNUKIX	Investigative	Small molecular drug	[107]
D-ornithine	DMHVF91	Investigative	Small molecular drug	[2786]
D-Phe-Arg-2-Nal-NHCH3	DMLK428	Investigative	NA	[2787]
D-Phe-Cys-Tyr--Trp-Lys-Thr-Pen-Thr-NH2	DMUJC97	Investigative	NA	[2788]
D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(CTAP)	DM2EFLA	Investigative	NA	[2788]
D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2(CTP)	DMPQHRC	Investigative	NA	[2788]
D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2(CTOP)	DMX1IYO	Investigative	NA	[2788]
D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Asp-NH2	DM0YQHM	Investigative	NA	[2789]
D-Phenylalanine	DMTUHFX	Investigative	Small molecular drug	[2790]
D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	DMGD7JM	Investigative	Small molecular drug	[22]
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	DM5XHA6	Investigative	Small molecular drug	[22]
D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	DMV9RAN	Investigative	Small molecular drug	[22]
D-phenylalanyl-N-benzyl-L-prolinamide	DMHNR63	Investigative	Small molecular drug	[22]
D-PhGly-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2	DMMXA5K	Investigative	NA	[2788]
D-Pro-Phe-Arg chloromethyl ketone	DMRJQ8X	Investigative	Small molecular drug	[2791]
D-proline	DMRFQU8	Investigative	Small molecular drug	[2792]
D-tartaric acid	DM376J2	Investigative	Small molecular drug	[12]
D-Trp8-SRIF-14	DM1JL5W	Investigative	NA	[1991]
D-tryptophan	DMKIML1	Investigative	Small molecular drug	[2793]
D-Val-L-boroPro	DML4G6K	Investigative	Small molecular drug	[2794]
D609	DM0M81E	Investigative	Small molecular drug	[2795]
DAB-486-IL-2	DM54T8J	Investigative	NA	[2796]
DABCO	DMHZKMG	Investigative	Small molecular drug	[2797]
DABCO-C16	DMN3GTF	Investigative	Small molecular drug	[2798]
DADLE	DMRM0OW	Investigative	Small molecular drug	[2799]
DADMe-ImmG	DMJIFY3	Investigative	NA	[1793]
DAEDALIN A	DMWR3XL	Investigative	Small molecular drug	[66]
daidzein	DMRFTJX	Investigative	Small molecular drug	[2800]
Daio-Orengedokuto (DOT)	DM3M652	Investigative	Small molecular drug	[2801]
DAMGO	DMS1DVA	Investigative	Small molecular drug	[2802]
daminozide	DMXM7JR	Investigative	Small molecular drug	[2803]
Dansylamide	DMQ4L1I	Investigative	Small molecular drug	[12]
dATP	DMMXFBJ	Investigative	Small molecular drug	[2804]
dATPalphaS	DMRDX8U	Investigative	Small molecular drug	[2805]
DAU-5750	DMT14A7	Investigative	Small molecular drug	[2806]
DAU-5884	DMEZVGK	Investigative	NA	[2807]
DAU-6202	DMM5SI1	Investigative	NA	[2808]
DC-EBIO	DM2T5OV	Investigative	Small molecular drug	[2809]
DC6S	DMX9FOB	Investigative	Small molecular drug	[2444]
DCB-3503	DMPRYTW	Investigative	Small molecular drug	[2810]
DCDPC	DMG9BFR	Investigative	Small molecular drug	[2811]
DCG IV	DM9HG1Y	Investigative	Small molecular drug	[2812]
Dcp-c[D-Cys-Gly-Phe(pNO2)-D-Cys]NH2	DMU287Q	Investigative	Small molecular drug	[2813]
DCPIB	DM9NMIY	Investigative	Small molecular drug	[2814]
DDATHF	DM6GWAC	Investigative	Small molecular drug	[12]
DdCTP SODIUM	DMHLNA2	Investigative	Small molecular drug	[2815]
De-O-sulfonated kotalanol	DMNWRV9	Investigative	Small molecular drug	[2816]
Debio-0721	DM0AYYF	Investigative	NA	[1866]
DEBROMOHYMENIALDISINE	DMDLER8	Investigative	Small molecular drug	[2817]
Decane-1,10-diyl disulfamate	DM1ESVR	Investigative	Small molecular drug	[2818]
Decanoic Acid	DM8FMYL	Investigative	Small molecular drug	[2819]
decavanadate	DMLT1N3	Investigative	Small molecular drug	[2820]
DECIDIUM	DM4SWYX	Investigative	Small molecular drug	[86]
Decoyinine	DMHO3N1	Investigative	Small molecular drug	[2821]
decyl dihydrogen phosphate	DMNKDT5	Investigative	Small molecular drug	[2822]
Decyl sulfamate	DMIERWO	Investigative	Small molecular drug	[2818]
DECYL(DIMETHYL)PHOSPHINE OXIDE	DMQMR3P	Investigative	Small molecular drug	[22]
Decyl-phosphonic acid	DMFT3J2	Investigative	Small molecular drug	[96]
Decylamine-N,N-Dimethyl-N-Oxide	DM2WEB9	Investigative	Small molecular drug	[12]
Decyltrimethylammonium	DM1ITJ5	Investigative	Small molecular drug	[1763]
decynium 22	DMWCTZ7	Investigative	Small molecular drug	[2823]
Degraded Cephaloridine	DMKRT20	Investigative	Small molecular drug	[12]
dehydroascorbic acid	DMKYQO4	Investigative	Small molecular drug	[2824]
dehydroepiandrosterone sulphate	DMGYXQ6	Investigative	Small molecular drug	[2825]
DEHYDROLEUCODIN	DM0V1NH	Investigative	Small molecular drug	[549]
Dehydropipernonaline	DMIOA9M	Investigative	Small molecular drug	[2826]
DEHYDROZINGERONE	DM9TWR7	Investigative	Small molecular drug	[2578]
DELTA 8-TETRAHYDROCANNOBINOL	DM5ARHI	Investigative	Small molecular drug	[2827]
Delta-Amino Valeric Acid	DMV7IAK	Investigative	Small molecular drug	[12]
Delta1-dihydrotestosterone	DML6MVH	Investigative	Small molecular drug	[2828]
Delta12-PGJ2	DMB6ADI	Investigative	Small molecular drug	[2829]
DELTORPHIN	DMHOT9P	Investigative	Small molecular drug	[2830]
DELTORPHIN-II	DM9ZWRK	Investigative	Small molecular drug	[2831]
DEMETHOXYCURCUMIN	DMO5UGV	Investigative	Small molecular drug	[2832]
DEMETHYLDEBROMOFLUSTRAMINE B	DMJBAEP	Investigative	Small molecular drug	[82]
DEMETHYLMEDICARPIN	DMUVR5T	Investigative	Small molecular drug	[2456]
DEMETHYLZEYLASTERONE	DMAMS7R	Investigative	Small molecular drug	[2833]
Demotensin 1	DMRICV6	Investigative	NA	[2834]
Demotensin 2	DMW2GA4	Investigative	NA	[2834]
Demotensin 3	DMS0V84	Investigative	NA	[2834]
Demotensin 4	DMB2HXM	Investigative	NA	[2834]
DEOXY SALVINORIN A	DM5JFKX	Investigative	Small molecular drug	[2835]
Deoxy-Bigchap	DMYAJCG	Investigative	Small molecular drug	[12]
deoxycorticosterone	DMW6YLS	Investigative	Small molecular drug	[2836]
deoxycortisone	DMX42WW	Investigative	Small molecular drug	[2837]
Deoxyfluorothymidine	DMKFMRY	Investigative	NA	[1129]
Deoxythymidine	DMR90HY	Investigative	Small molecular drug	[12]
Deoxyuridine-5'-Diphosphate	DMIFMDC	Investigative	Small molecular drug	[107]
Deoxyuridine-5'-Triphosphate	DMCG5V2	Investigative	Small molecular drug	[12]
Dephospho Coenzyme A	DMGHM1L	Investigative	Small molecular drug	[107]
Deprenyl	DMRFBD0	Investigative	Small molecular drug	[2838]
Deprotected cogener of M6G	DMH340E	Investigative	Small molecular drug	[2273]
DEPX	DM4JM50	Investigative	Small molecular drug	[2839]
DERMORPHIN	DMCYQHO	Investigative	Small molecular drug	[2840]
Des-AA1,2,4,12,13-[D-Trp8]SRIF	DMMWDC5	Investigative	NA	[2841]
Des-AA1,2,4,13-[D-Trp8]SRIF	DMR6Z2N	Investigative	NA	[2841]
Des-AA1,2,4,5,10,12,13-[D-Trp8]SRIF	DMEVOD2	Investigative	Small molecular drug	[2841]
Des-AA1,2,4,5,11,12,13-[D-Trp8]SRIF	DMJI6BK	Investigative	Small molecular drug	[2841]
Des-AA1,2,4,5,13-[D-Trp8]-SRIF	DMYZXEO	Investigative	NA	[2841]
Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF	DM6HZ8D	Investigative	Small molecular drug	[2841]
Des-AA1,2,4,5-[D-Trp8]SRIF	DMEN4G8	Investigative	NA	[2841]
Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF	DMZPXGY	Investigative	NA	[2841]
Des-AA1,2,5,12,13-[D-Trp8]SRIF	DM1KJAE	Investigative	NA	[2842]
Des-AA1,2,5-[(NalphaMe)Cys3,D-Nal8,IAmp9]SRIF	DMVYHGI	Investigative	NA	[2843]
Des-AA1,2,5-[(NalphaMe)Cys3,D-Trp8,IAmp9]SRIF	DMY6NID	Investigative	NA	[2843]
Des-AA1,2,5-[(NalphaMe)D-Nal8,IAmp9]SRIF	DMQPVGO	Investigative	NA	[2843]
Des-AA1,2,5-[(NalphaMe)Lys4,D-Nal8,IAmp9]SRIF	DM478XZ	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9,Tyr11]SRIF	DMQOL73	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9]SRIF	DMN4ZYO	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Cys14]SRIF	DMXD60K	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Phe11]SRIF	DM0574W	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Ser13]SRIF	DMOZ9WC	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Thr12]SRIF	DMYFCB0	Investigative	NA	[2843]
Des-AA1,2,5-[D-Nal8,IAmp9]SRIF	DM6JAFM	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9,Tyr11]SRIF	DMLHUPY	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF	DMX2I4P	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Cys14]SRIF	DMFXKRO	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Ser13]SRIF	DM9EN01	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Thr12]SRIF	DMB10GV	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9,m-I-Tyr11]Cbm-SRIF	DMH0DLZ	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9,Tyr11]Cbm-SRIF	DMXWF2Z	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,IAmp9]SRIF CH-275	DMSXILZ	Investigative	NA	[2843]
Des-AA1,2,5-[D-Trp8,Tyr11]SRIF	DM7MZ2V	Investigative	NA	[2843]
Des-AA1,2,5-[IAmp9,Tyr11]-SRIF	DMQRUF6	Investigative	NA	[2843]
Des-AA1,4,5,13-[Tyr2,D-Trp8]-SRIF	DMPMAXI	Investigative	NA	[2841]
Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]Cbm-SRIF	DMFCA05	Investigative	NA	[2843]
Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]SRIF	DMW56NI	Investigative	NA	[2843]
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]Cbm-SRIF	DMV8EWF	Investigative	NA	[2843]
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF CH-288	DMLY7DC	Investigative	NA	[2841]
Des-AA5-[D-Trp8]SRIF	DMO3CFV	Investigative	NA	[2844]
Des-Arg10-Kallidin	DMZ5Y94	Investigative	Small molecular drug	[2845]
Des-Arg10-Leu9-Kallidin	DMWO4EI	Investigative	Small molecular drug	[2846]
Des-bromoaplysamine-1	DMIKUBY	Investigative	Small molecular drug	[2847]
Des-His1[Glu9]glucagon-NH2	DMGTAZ4	Investigative	NA	[2848]
Deschloroflavopiridol	DMQER8D	Investigative	Small molecular drug	[2849]
Desclasinose Azithromycinarylalkyl Hydroxamate	DMAB9KG	Investigative	Small molecular drug	[2224]
Desethyl isoquine	DM47JFS	Investigative	Small molecular drug	[2850]
DesGly-NH2,d(CH2)5[D-Tyr2,Thr4,Orn8(5/6C-Flu)]VT	DMJK0H5	Investigative	NA	[2760]
Desirudine	DMB07WE	Investigative	NA	[2851]
Desmethylastemizole	DM58XJN	Investigative	Small molecular drug	[2852]
Desmethylclomipramine	DMIESYM	Investigative	Small molecular drug	[2853]
DESMETHYLOLANZAPINE	DMLKBNR	Investigative	Small molecular drug	[118]
desmosterol	DMV8SUM	Investigative	Small molecular drug	[2854]
desulfated cholecystokinin-8	DMW740T	Investigative	Small molecular drug	[2855]
detirelix	DMFWDNJ	Investigative	Small molecular drug	[2856]
Detrothyronine	DMPCRSY	Investigative	Small molecular drug	[2857]
Deuterium-substituted L-DOPA	DMCSTC4	Investigative	Small molecular drug	[2858]
DFGYVAE	DMR8M19	Investigative	Small molecular drug	[2859]
DH97	DM7UVOD	Investigative	Small molecular drug	[2860]
DHbetaE	DMPVQ79	Investigative	Small molecular drug	[2861]
Dhp-c[D-Cys-Gly-Phe(pNO2)-D-Cys]NH2	DMSN87T	Investigative	Small molecular drug	[2813]
Di(1H-indol-2-yl)methanone	DM3DR6J	Investigative	Small molecular drug	[112]
Di(2,6-di-t-butylphenol)	DMO6Z02	Investigative	Small molecular drug	[799]
Di(2,6-diisopropylphenol)	DMG21PZ	Investigative	Small molecular drug	[799]
Di(2,6-dimethylphenol)	DMZ3EML	Investigative	Small molecular drug	[799]
Di-Benzyloxycarbonyl-guanidino acetylryanodine	DMAYSGI	Investigative	Small molecular drug	[249]
Di-imidazole lexitropsin	DME4NH1	Investigative	Small molecular drug	[2862]
DI-O-METHYLENDIANDRIN A	DM5G4O7	Investigative	Small molecular drug	[2863]
Di-Stearoyl-3-Sn-Phosphatidylcholine	DM0GQJ2	Investigative	Small molecular drug	[12]
Diamide	DMOCQ9J	Investigative	Small molecular drug	[2864]
diamide 7	DM4EX8Y	Investigative	Small molecular drug	[2865]
Diaminopropyl sulfate	DMDGIT6	Investigative	NA	[2866]
diarylpropionitril	DM14X29	Investigative	Small molecular drug	[2867]
DIASTEREOMER 2	DM3CQV6	Investigative	Small molecular drug	[2868]
Diazaborines	DM5UFZX	Investigative	Small molecular drug	[2869]
Diazacholesterol	DM5DPM4	Investigative	NA	[2870]
diBA-(5)-C4	DM9KPHZ	Investigative	Small molecular drug	[2871]
Dibenzo-p-dioxin-2-carboxylic acid	DMOKNXE	Investigative	Small molecular drug	[1612]
dibenzoxazepine	DMD8TWC	Investigative	Small molecular drug	[2872]
Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate	DM2G8ON	Investigative	Small molecular drug	[2873]
dibutyl phthalate	DMEDGKO	Investigative	Small molecular drug	[2874]
Dichloroally-lawsone	DMAU5VM	Investigative	NA	[430]
Dichloroallyl lawsone	DMXGV63	Investigative	Small molecular drug	[2875]
Dichloroisoproterenol	DMSZ7UE	Investigative	Small molecular drug	[2876]
Diclosan	DMO3KU5	Investigative	Small molecular drug	[12]
Dideazaacyclotetrahydrofolic acid	DM9WU3R	Investigative	Small molecular drug	[2877]
Dideazafolate	DMAIOC9	Investigative	Small molecular drug	[2878]
DIDODECANOYLPHLOROGLUCINOL	DM2FLRQ	Investigative	Small molecular drug	[2879]
DIDS	DMKSQUB	Investigative	Small molecular drug	[2880]
DIECKOL	DMBCK4G	Investigative	Small molecular drug	[1762]
DIETHOXYFLOURESCEIN	DMK7QXA	Investigative	Small molecular drug	[1506]
Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate	DMDJ9QA	Investigative	Small molecular drug	[2873]
Diethyl 2-((biphenyl-3-ylamino)methylene)malonate	DM7YHBR	Investigative	Small molecular drug	[2881]
Diethylphosphono Group	DMM4QFL	Investigative	Small molecular drug	[12]
difluoroagomelatine	DM8AZQ3	Investigative	Small molecular drug	[2882]
Difluorobenztropine	DM8ABD6	Investigative	Small molecular drug	[1341]
Difluoromethionine	DM8TG41	Investigative	Small molecular drug	[12]
digeranyl bisphosphonate	DMXK8BH	Investigative	Small molecular drug	[2883]
DIGITOXIGENIN	DM5AOFW	Investigative	Small molecular drug	[2884]
Diheptan-3-yl 5-(hydroxymethyl)isophthalate	DMBAY7P	Investigative	Small molecular drug	[2885]
Dihexan-3-yl 5-(hydroxymethyl)isophthalate	DM8TBQ9	Investigative	Small molecular drug	[2885]
Dihydro-quinolinone	DM9UK6D	Investigative	Small molecular drug	[2886]
DIHYDROAKUAMMINE	DMW1ALX	Investigative	Small molecular drug	[70]
dihydrocarveol	DMS4U68	Investigative	Small molecular drug	[2887]
DIHYDROCUBEBIN	DMZL7R6	Investigative	Small molecular drug	[80]
dihydroergocryptine	DMDW2NL	Investigative	Small molecular drug	[2888]
Dihydrofolic Acid	DM1BDM8	Investigative	Small molecular drug	[12]
DIHYDROKAEMPFEROL	DM73OTF	Investigative	Small molecular drug	[1317]
DIHYDROKAINATE	DM9NO6F	Investigative	Small molecular drug	[2889]
dihydrolipoic acid	DMMAK9J	Investigative	Small molecular drug	[2890]
Dihydromorphine	DM4TR0D	Investigative	Small molecular drug	[2891]
Dihydroorotate	DM76BGZ	Investigative	Small molecular drug	[12]
Dihydropyridines	DM0W64U	Investigative	Small molecular drug	[2892]
DIHYDRORALOXIFENE	DM70OIC	Investigative	Small molecular drug	[2893]
DIHYDROXANTHOHUMOL	DMFKWRM	Investigative	Small molecular drug	[2034]
Diisopropyl 1-mercaptopropylphosphonate	DMNR439	Investigative	Small molecular drug	[961]
Diisopropyl 2-(sulfanylmethyl)phenylphosphonate	DMVFJAH	Investigative	Small molecular drug	[961]
Diisopropyl mercapto(phenyl)methylphosphonate	DMHKE3M	Investigative	Small molecular drug	[961]
Diisopropylphosphono Group	DMND2AS	Investigative	Small molecular drug	[12]
Diketonitrile	DMPKQER	Investigative	NA	[2894]
Dilazep	DMOD5Y0	Investigative	Small molecular drug	[2895]
Dimaprit	DMA4NI2	Investigative	Small molecular drug	[2896]
DIMEBOLIN	DMV8ZQG	Investigative	Small molecular drug	[2897]
Dimemorfan	DM2Q3CL	Investigative	Small molecular drug	[2898]
Dimepheptanol	DMRMHE8	Investigative	Small molecular drug	[1684]
Dimethyl	DM1SJ0Q	Investigative	Small molecular drug	[1866]
Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate	DMTVA49	Investigative	Small molecular drug	[2873]
Dimethyl-pent-4-enyl-ammonium bromide	DMO0UI8	Investigative	NA	[131]
Dimethylallyl Diphosphate	DMP5I47	Investigative	Small molecular drug	[2899]
dimethylamine	DM9Q0QI	Investigative	Small molecular drug	[2900]
dimethylethylamine	DM2HYEN	Investigative	Small molecular drug	[2901]
Dimethylformamide	DML6O4N	Investigative	Small molecular drug	[2902]
DIMETHYLGRISABINE	DMW0MTV	Investigative	Small molecular drug	[2102]
dimethylhistaprodifen	DMY0FVU	Investigative	Small molecular drug	[2903]
Dimethylnordihydroguarierate acid	DMG3WTE	Investigative	Small molecular drug	[39]
Dimethylthiambutene	DM7EKAF	Investigative	Small molecular drug	[12]
Diminazene	DM2Y0AI	Investigative	Small molecular drug	[12]
DIOA	DMBKJL8	Investigative	Small molecular drug	[2904]
dioctanoylglycerol pyrophosphate	DM0QY1V	Investigative	Small molecular drug	[2905]
dioleoylphosphatidic acid	DM7D6JV	Investigative	Small molecular drug	[2906]
DIOSMETIN	DM4KXIM	Investigative	Small molecular drug	[1906]
DIOXINODEHYDROECKOL	DML2B04	Investigative	Small molecular drug	[1762]
Dioxothiomolybdenum(VI) ion	DM93MAB	Investigative	Small molecular drug	[107]
Diphenyl(piperidin-4-yl)methanol	DMO4XUC	Investigative	Small molecular drug	[545]
Diphenylacetic Acid	DMP6IHR	Investigative	Small molecular drug	[12]
diphenylamine-2-carboxylic acid	DMBV19T	Investigative	Small molecular drug	[2907]
diphenylboronic anhydride	DMRQZTS	Investigative	Small molecular drug	[2908]
diphenyleneiodonium chloride	DMB75PV	Investigative	Small molecular drug	[2909]
diphenyltetrahydrofuran	DMK8T61	Investigative	Small molecular drug	[2910]
Diphosphate	DMHY30B	Investigative	Small molecular drug	[12]
diphosphoglycolyl proline	DM28NIU	Investigative	Small molecular drug	[2911]
diphosphoric acid	DMYWL89	Investigative	Small molecular drug	[2912]
Diphthamide	DMRWD9M	Investigative	Small molecular drug	[107]
Diprenorphine	DMIXPU6	Investigative	Small molecular drug	[2913]
dipropyl-5-CT	DM9VKXC	Investigative	Small molecular drug	[2914]
DIPROTIN A	DMGBCP0	Investigative	Small molecular drug	[2915]
DIRLOTAPIDE	DM2MV9O	Investigative	Small molecular drug	[2916]
Distamycin A	DMPVNDK	Investigative	Small molecular drug	[2917]
Disulergine	DM6TVAX	Investigative	Small molecular drug	[2918]
dithiipin-1,1,4,4-tetroxide analogue 7	DMK0VFS	Investigative	Small molecular drug	[2919]
DL-benzylsuccinic acid	DMHI9ZJ	Investigative	Small molecular drug	[902]
DL-guanidinoethylmercaptosuccinic acid	DMM1GXI	Investigative	Small molecular drug	[902]
DL-TBOA	DM2HGNU	Investigative	Small molecular drug	[2920]
DL-threo-beta-hydroxyaspartate	DMGRYOH	Investigative	Small molecular drug	[2921]
DLX-521	DMPD2XF	Investigative	Antibody	[2922]
DLX-903/1008	DMKFRXF	Investigative	NA	[1866]
DM-1451	DMM0VDK	Investigative	Small molecular drug	[2923]
DM-PPP	DMUGPD1	Investigative	Small molecular drug	[2924]
DM3A6S	DM7YXKL	Investigative	Small molecular drug	[2444]
DM3B6S	DML68UF	Investigative	Small molecular drug	[2444]
DM6S	DMAJ0Q8	Investigative	Small molecular drug	[2444]
DMCM	DMK3WY4	Investigative	Small molecular drug	[2925]
DMPP	DM9H45U	Investigative	Small molecular drug	[2926]
Dmt-Pro-3,5Dmp-Phe-NH2	DM5WEFK	Investigative	Small molecular drug	[2927]
Dmt-Pro-Dmp-Phe-NH2	DMGUIR1	Investigative	Small molecular drug	[2927]
Dmt-Pro-Dmt-Phe-NH2	DM4VEU2	Investigative	Small molecular drug	[2927]
Dmt-Pro-Emp-Phe-NH2	DM06VGY	Investigative	Small molecular drug	[2927]
Dmt-Pro-Imp-Phe-NH2	DMXUI1J	Investigative	Small molecular drug	[2927]
Dmt-Pro-Mmp-Phe-NH2	DM78PFN	Investigative	Small molecular drug	[2927]
Dmt-Pro-Phe-D-1-Nal-NH2	DM0VCWA	Investigative	Small molecular drug	[2928]
Dmt-Pro-Phe-D-2-Nal-NH2	DMRJVE8	Investigative	NA	[2928]
Dmt-Pro-Phe-Phe-NH2	DMM8BIE	Investigative	Small molecular drug	[2927]
Dmt-Pro-Tmp-Phe-NH2	DMEMQAK	Investigative	Small molecular drug	[2927]
Dmt-Pro-Trp-D-2-Nal-NH2	DMKEV5U	Investigative	Small molecular drug	[2928]
Dmt-Sar-Phe-D-2-Nal-NH	DMHRT0F	Investigative	Small molecular drug	[2929]
DNQX	DMQXPA5	Investigative	Small molecular drug	[2930]
Docosapentaenoic acid	DMVCP6X	Investigative	Small molecular drug	[2931]
Dodeca-2E,4E-dienoic acid isobutylamide	DMEKU71	Investigative	Small molecular drug	[2932]
Dodecane-1-sulfonyl fluoride	DME9CGK	Investigative	Small molecular drug	[1476]
Dodecane-Trimethylamine	DMUPMCZ	Investigative	Small molecular drug	[12]
Dodecanesulfonate ion	DMCNFEL	Investigative	Small molecular drug	[22]
Dodecanoic acid adamantan-1-ylamide	DM6TIQX	Investigative	Small molecular drug	[517]
Dodecyl-Alpha-D-Maltoside	DMMDG92	Investigative	Small molecular drug	[107]
Dodecyl-phosphonic acid	DMLHKI9	Investigative	Small molecular drug	[96]
dodecyl-thiophosphate	DMAJVPI	Investigative	Small molecular drug	[2933]
dodecylphosphate	DMPCLTW	Investigative	Small molecular drug	[2934]
dolichol phosphate	DM1YCQF	Investigative	Small molecular drug	[2935]
DOM	DM53KZX	Investigative	Small molecular drug	[2936]
DOM-0215	DMXJOYH	Investigative	NA	[1866]
domoic acid	DMYPVO0	Investigative	Small molecular drug	[2937]
Domoric acid	DMOJF6D	Investigative	Small molecular drug	[157]
Dorsomorphin	DMKYXJW	Investigative	Small molecular drug	[2938]
DOTA	DM4RW8Q	Investigative	Small molecular drug	[2939]
Double Oxidized Cysteine	DM6TU84	Investigative	Small molecular drug	[12]
DOV 102677	DMR397P	Investigative	Small molecular drug	[1866]
Doxorubicin-Formaldehyde Conjugate	DMJF6AQ	Investigative	NA	[2940]
doxorubicin-LL2 conjugate	DMNJBF8	Investigative	NA	[1866]
doxorubicin-peptide-PEG conjugate	DM2OCZ8	Investigative	NA	[1866]
DPDPE	DMIRSNA	Investigative	Small molecular drug	[2941]
DPI59	DMTHZ3B	Investigative	Small molecular drug	[22]
DprwFwLL-NH2	DM35CKE	Investigative	NA	[2196]
DQP-1105	DMQLJ3Y	Investigative	Small molecular drug	[2942]
DR-4004	DMW8ORN	Investigative	Small molecular drug	[2943]
DRF 2519	DMTFQG3	Investigative	Small molecular drug	[2944]
droxinostat	DM5IA9W	Investigative	Small molecular drug	[2945]
Drug 311383	DM5QUJV	Investigative	NA	[2946]
Drug 311440	DMOIFBK	Investigative	NA	[2946]
Drug 311951	DMXTCJ1	Investigative	NA	[2946]
Drug 311952	DM27ILS	Investigative	NA	[2946]
Drug 7684380	DML4V73	Investigative	NA	[2947]
DS-437	DME3WBQ	Investigative	Small molecular drug	[2948]
DS1	DMFE2B9	Investigative	Small molecular drug	[2949]
DS2	DMX42IW	Investigative	Small molecular drug	[2950]
DSLET	DMSTOB0	Investigative	Small molecular drug	[2951]
DSTBULET	DMSVP1K	Investigative	Small molecular drug	[2952]
DTD	DMPKTB4	Investigative	Small molecular drug	[2953]
DTPA Conjugate	DMNS265	Investigative	NA	[246]
Duo3	DMUKPO3	Investigative	Small molecular drug	[2954]
Duocarmycin	DM0CQIP	Investigative	Small molecular drug	[2955]
Durhamycin A	DM29PTO	Investigative	Small molecular drug	[2956]
Duroquinone	DML7YPS	Investigative	Small molecular drug	[12]
DVDAVP	DM53079	Investigative	Small molecular drug	[2957]
DwFwLL-NH2	DMEUVIP	Investigative	Small molecular drug	[2196]
DY131	DMFJ3VC	Investigative	Small molecular drug	[2958]
dynorphin B	DMSPVLM	Investigative	Small molecular drug	[2959]
Dynorphin(1-8)	DMM92LG	Investigative	Small molecular drug	[2960]
DYSIDENIN	DMIZQTX	Investigative	Small molecular drug	[2961]
DYSIDINE	DMNYQL9	Investigative	Small molecular drug	[2962]
dysiherbaine	DM0EBAF	Investigative	Small molecular drug	[2963]
DYSINOSIN A	DMU42C1	Investigative	Small molecular drug	[2564]
DZNep	DM0JXBK	Investigative	Small molecular drug	[2964]
D[Arg4,Dab8]VP	DMCU8HK	Investigative	NA	[2137]
D[Arg4,Lys8]VP	DM69OVM	Investigative	NA	[2137]
D[Arg4,Orn8]VP	DM8D4QT	Investigative	NA	[2137]
D[Arg4]AVP	DM76Q2B	Investigative	NA	[2137]
D[Cha4,Dab8]VP	DMCLUXI	Investigative	NA	[2965]
D[Cha4,Dap8]VP	DMAPZKB	Investigative	NA	[2137]
D[Cha4,Lys8]VP	DM0GO7U	Investigative	NA	[2137]
D[Cha4,Orn8]VP	DMZWTJK	Investigative	NA	[2137]
D[Cha4]AVP	DM8FCX5	Investigative	NA	[2966]
D[D-3-Pal2]AVP	DMD4V6U	Investigative	NA	[2967]
D[Leu4,Dab8]VP	DMNSXG9	Investigative	Small molecular drug	[2137]
D[Leu4,Dap8]VP	DME3HK8	Investigative	Small molecular drug	[2968]
D[Leu4,Lys8]VP	DMDBU7Q	Investigative	NA	[2969]
D[Leu4,Orn8]VP	DMJCW8Y	Investigative	NA	[2137]
D[Leu4]AVP	DMREZT7	Investigative	NA	[2970]
D[Lys8(5/6-Flu)]VT	DME2PKB	Investigative	NA	[2760]
D[Orn4,Lys8]VP	DMNQTBU	Investigative	NA	[2137]
D[Orn4,Orn8]VP	DMONV0M	Investigative	NA	[2137]
D[Orn4]AVP	DMJNT95	Investigative	NA	[2137]
D[Orn8(5/6C-Flu)]VT	DMH791N	Investigative	NA	[2760]
d[Pen1,Tyr(Me)2]AVP	DMT8KI6	Investigative	Small molecular drug	[2971]
D[Thr4,Lys8(5/6C-Flu)]VT	DMS4F8O	Investigative	NA	[2760]
D[Thr4,Orn8(5/6C-Flu)]VT	DMBDZQA	Investigative	NA	[2760]
D[Val4]AVP	DM3GM8E	Investigative	NA	[2137]
E coli toxin-based adjuvants	DM2HDK1	Investigative	NA	[1866]
E-3024	DME5JBH	Investigative	NA	[2972]
E-6-O-p-methoxycinnamoyl scandoside methyl ester	DM7ROJI	Investigative	Small molecular drug	[2973]
E-64	DMMOPAK	Investigative	Small molecular drug	[2974]
E-6837	DMJ2P0N	Investigative	Small molecular drug	[816]
E-EBU-dM	DMN8JKX	Investigative	Small molecular drug	[2975]
E-pentenylbutanedioic acid 32	DMT7RXZ	Investigative	Small molecular drug	[2976]
E339-3D6	DMGPRT7	Investigative	Small molecular drug	[2977]
E55888	DM0O8KR	Investigative	Small molecular drug	[2978]
E5700	DM8LPBF	Investigative	Small molecular drug	[2979]
E6801	DM7LGAF	Investigative	Small molecular drug	[2980]
EB-47	DM4UZ6V	Investigative	Small molecular drug	[2981]
EBIO	DMPKI0N	Investigative	Small molecular drug	[2982]
EC-SOD	DMYZVLN	Investigative	NA	[2983]
EC18	DM61FB0	Investigative	Small molecular drug	[2984]
EC33	DM67549	Investigative	NA	[2985]
Eckol	DMIVY0Q	Investigative	Small molecular drug	[1762]
ECOPLADIB	DMWKS29	Investigative	Small molecular drug	[2986]
Edatrexate	DM32O0L	Investigative	Small molecular drug	[2987]
Edetic	DMQM81S	Investigative	NA	[1866]
Edetic acid	DM10D85	Investigative	Small molecular drug	[2988]
EDMT	DMS3AXK	Investigative	Small molecular drug	[2989]
Edoxudine	DMC7DYX	Investigative	Small molecular drug	[1085]
EFFUSOL	DMXZRND	Investigative	Small molecular drug	[1162]
Efomycine M	DMOKX76	Investigative	NA	[2990]
EFPPEA	DMZ2XOH	Investigative	Small molecular drug	[2991]
EGFR inhibitor	DM7AYH4	Investigative	Small molecular drug	[2992]
EGIS-7625	DMLK4X5	Investigative	Small molecular drug	[2993]
eGlu	DMKW0Q3	Investigative	Small molecular drug	[2994]
EGTA	DMW9MRO	Investigative	Small molecular drug	[2446]
EHNA	DM014WS	Investigative	Small molecular drug	[2995]
EI1	DMBQCMU	Investigative	Small molecular drug	[2996]
eicosatetranoic acid	DMAKP20	Investigative	Small molecular drug	[2997]
EISAI-1	DM03X7D	Investigative	Small molecular drug	[2998]
ELAEOCARPENINE	DMRHSCQ	Investigative	Small molecular drug	[2999]
Elaidoylamide	DMP8VDT	Investigative	Small molecular drug	[12]
eledoisin	DMEOJ9W	Investigative	Small molecular drug	[3000]
Eleutherobin	DMMVZU0	Investigative	Small molecular drug	[3001]
ELLAGIC ACID	DMX8BS5	Investigative	Small molecular drug	[372]
Ellipticine	DMHPYSM	Investigative	Small molecular drug	[3002]
EM-1424	DMSLHDN	Investigative	Small molecular drug	[3003]
EM-1745	DM3RSYO	Investigative	Small molecular drug	[12]
EM-523	DMC4XJ6	Investigative	Small molecular drug	[3004]
EM1396	DMZ2EL1	Investigative	Small molecular drug	[3003]
EMATE	DMFQX1U	Investigative	Small molecular drug	[910]
EMD 56551	DM4SEMA	Investigative	NA	[3005]
EMD-386088	DM3AGUQ	Investigative	Small molecular drug	[1015]
EMPA	DM6O2BR	Investigative	Small molecular drug	[3006]
EnacyloxinIia	DMHYGEB	Investigative	NA	[1866]
enantio PAF C-16	DMASQWV	Investigative	Small molecular drug	[3007]
ENDIANDRIN A	DM7RDGH	Investigative	Small molecular drug	[2863]
Endo-CD	DM4AI91	Investigative	NA	[3008]
ENDOMORPHIN 2	DMOQWBU	Investigative	Small molecular drug	[3009]
ENDOMORPHIN-1	DMBJUEM	Investigative	Small molecular drug	[3010]
Endothelin-2	DMOEIYQ	Investigative	Small molecular drug	[3011]
Endothelin-3	DM0DM6X	Investigative	Small molecular drug	[3012]
ENHYDRIN	DM0STFR	Investigative	Small molecular drug	[703]
Enoxaprin	DMYJ8ZB	Investigative	NA	[3013]
EP 157	DMSPIF2	Investigative	Small molecular drug	[3014]
EP 171	DM7YION	Investigative	Small molecular drug	[3015]
EPALRESTATE	DM01MW7	Investigative	Small molecular drug	[2117]
Epibatidine	DMAGZD8	Investigative	Small molecular drug	[3016]
EPIDEPRIDE	DMGKIYE	Investigative	Small molecular drug	[3017]
Epierenone	DMVZW92	Investigative	Small molecular drug	[3018]
EPIMER A	DMQAEU8	Investigative	Small molecular drug	[3019]
epipregnanolone sulphate	DMW271Q	Investigative	Small molecular drug	[3020]
EPLIVANSERIN MESILATE	DMDOR0L	Investigative	NA	[3021]
EPO	DMDPF2C	Investigative	Small molecular drug	[1866]
EPPTB	DMK3VID	Investigative	Small molecular drug	[3022]
EPZ005687	DMYISTE	Investigative	Small molecular drug	[3023]
EPZ015666	DM3INX7	Investigative	Small molecular drug	[3024]
Equilenin	DMHO56W	Investigative	Small molecular drug	[12]
ER-119884	DMIQ801	Investigative	Small molecular drug	[3025]
ER819762	DMSG91J	Investigative	Small molecular drug	[3026]
ERIODICTYOL	DMD3BEQ	Investigative	Small molecular drug	[1906]
ERK inhibitor III	DMB3ROZ	Investigative	Small molecular drug	[3027]
Erybreadin b	DM27FRY	Investigative	Small molecular drug	[1164]
Erybreadin C	DMNS976	Investigative	Small molecular drug	[1164]
Erybreadin D	DMYG7BM	Investigative	Small molecular drug	[1164]
ERYSTAGALLIN A	DMCHVIG	Investigative	Small molecular drug	[2456]
Erysubin D	DMVA9F7	Investigative	Small molecular drug	[2456]
Erysubin E	DMXWK1A	Investigative	Small molecular drug	[1164]
Erythose-4-Phosphate	DMLT7FQ	Investigative	Small molecular drug	[12]
ERYTHRIBYSSIN A	DM5GEUN	Investigative	Small molecular drug	[1164]
Erythribyssin D	DMBVSKZ	Investigative	Small molecular drug	[2456]
Erythribyssin L	DMUL4AP	Investigative	Small molecular drug	[2456]
Erythribyssin M	DMWEK8I	Investigative	Small molecular drug	[2456]
Erythribyssin O	DM8LEJ4	Investigative	Small molecular drug	[2456]
Erythro-3,4-dichloromethylphenidate hydrochloride	DM8UVI3	Investigative	Small molecular drug	[598]
Erythromycin salnacedin	DM0PHEW	Investigative	Small molecular drug	[1866]
Eryvarin D	DM8BS5C	Investigative	Small molecular drug	[2456]
ES-936	DMIVZ3W	Investigative	Small molecular drug	[3028]
ESCHOLTZINE	DMPTDHC	Investigative	Small molecular drug	[3029]
esculetin	DMS2V2H	Investigative	Small molecular drug	[3030]
ESI-09	DMTJDXY	Investigative	Small molecular drug	[3031]
Estradiol 17-O-sulfamate	DM7K14V	Investigative	Small molecular drug	[1016]
Estradiol 3,17-O,O-bis-sulfamate	DMPM8I5	Investigative	Small molecular drug	[1016]
ET bromodomain inhibitor	DMH4MBW	Investigative	Small molecular drug	[3032]
EtBut-RYYRIK-NH2	DM0IYLS	Investigative	Small molecular drug	[754]
ethcathinone	DMEMI7N	Investigative	Small molecular drug	[3033]
Ethidium	DMMEQUR	Investigative	Small molecular drug	[3034]
ETHIOFENCARB	DMQTEDP	Investigative	Small molecular drug	[887]
ETHIONINE	DMGESUH	Investigative	Small molecular drug	[317]
ETHISTERONE	DMDXRP1	Investigative	Small molecular drug	[3035]
ETHOXYCLUSIN	DM1MGTX	Investigative	Small molecular drug	[80]
ETHOXYCOUMARIN	DMSKU4M	Investigative	Small molecular drug	[1069]
ethyketazocine	DM7390Y	Investigative	Small molecular drug	[3036]
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	DM0O4A2	Investigative	Small molecular drug	[22]
Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate	DM3FH02	Investigative	Small molecular drug	[3037]
Ethyl 1-[(1H-benzimidazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate	DMQ0XYH	Investigative	Small molecular drug	[3037]
Ethyl 1-[(1H-benzotriazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate	DM82X3J	Investigative	NA	[3037]
Ethyl 2-(2-oxohexadecanamido)acetate	DM762HQ	Investigative	Small molecular drug	[341]
Ethyl 2-amino-4,5-diphenylthiophene-3-carboxylate	DM2MX4P	Investigative	Small molecular drug	[3038]
Ethyl 2-cyano-2-(quinoxalin-2(1H)-ylidene)acetate	DM06AQZ	Investigative	Small molecular drug	[1388]
Ethyl 2beta-hydroxyolean-12-en-28-oate	DMPUCMV	Investigative	Small molecular drug	[1034]
Ethyl 3-(biphenyl-3-ylamino)-2-cyanoacrylate	DM5XYFN	Investigative	Small molecular drug	[2881]
Ethyl 3-(pyridin-4-yl)-1H-indole-6-carboxylate	DM4UWYF	Investigative	Small molecular drug	[519]
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	DMKJGLO	Investigative	Small molecular drug	[22]
Ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate	DM5GLP7	Investigative	Small molecular drug	[3039]
Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate	DMQ3LMF	Investigative	Small molecular drug	[1070]
Ethyl 4-(2-oxohexadecanamido)benzoate	DMB12M7	Investigative	Small molecular drug	[341]
Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate	DMK4T5Y	Investigative	Small molecular drug	[3040]
Ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate	DM5G91Z	Investigative	Small molecular drug	[1231]
Ethyl 7-hydroxy-2-oxo-2H-chromene-3-carboxylate	DM7FPX8	Investigative	Small molecular drug	[920]
Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate	DMWIB0V	Investigative	Small molecular drug	[1069]
Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate	DMJQTIK	Investigative	Small molecular drug	[988]
Ethyl Dihydrogen Phosphate	DMW0J3D	Investigative	Small molecular drug	[12]
Ethyl estrone-16-methylcarboxylate	DMXTLJE	Investigative	Small molecular drug	[708]
ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	DMT4XJM	Investigative	Small molecular drug	[22]
Ethyl octylfluorophosphonate	DMXMRK7	Investigative	Small molecular drug	[3041]
Ethyl Oxo(Piperidin-1-Yl)Acetate	DM9KF0H	Investigative	Small molecular drug	[22]
Ethyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine	DMYFK4L	Investigative	Small molecular drug	[3042]
Ethyl-indol-1-yl-pyridin-4-yl-amine	DM3CWFR	Investigative	Small molecular drug	[137]
ETHYLGALLATE	DMJ6PB8	Investigative	Small molecular drug	[372]
ethylketocyclazocine	DM9YRCU	Investigative	Small molecular drug	[3043]
Ethylmorphine	DM0YROF	Investigative	Small molecular drug	[3044]
ETHYLPHENSERINE	DMT51QD	Investigative	Small molecular drug	[3045]
ETICLOPRIDE	DM4FW3H	Investigative	Small molecular drug	[3046]
etifoxine	DMNKSD9	Investigative	Small molecular drug	[3047]
ETIOCHOLANOLONE	DMVI9DM	Investigative	Small molecular drug	[3048]
Etisulergine	DMKH8TC	Investigative	Small molecular drug	[3049]
Etoloxamine	DMDOX1Z	Investigative	Small molecular drug	[128]
ETONITAZENE	DMFR1SE	Investigative	Small molecular drug	[3050]
Etorphine	DM79YZN	Investigative	Small molecular drug	[3051]
eucalyptol	DME5CK3	Investigative	Small molecular drug	[3052]
EUGENIIN	DMUA485	Investigative	Small molecular drug	[372]
EUPAFOLIN	DMLXKZH	Investigative	Small molecular drug	[2034]
EUPATORIOPICRIN	DM068CY	Investigative	Small molecular drug	[2630]
EUSYNSTYELAMIDE B	DMXBGSL	Investigative	NA	[3053]
Eusynstyelamide C	DM6ODAS	Investigative	NA	[3053]
evans blue dye	DM7FJCE	Investigative	Small molecular drug	[3054]
EVP4593	DM03RD2	Investigative	Small molecular drug	[3055]
EX5	DMNI6YU	Investigative	Antisense drug	[1731]
example 131 [WO2009133348]	DMSG8RI	Investigative	Small molecular drug	[3056]
example 166 (WO2014154727)	DMY3CKG	Investigative	Small molecular drug	[3057]
example 2 (WO2013004676)	DMU25HZ	Investigative	Small molecular drug	[3058]
example 20 (WO2010128058)	DMF9W41	Investigative	Small molecular drug	[3059]
example 373 [WO2012093101]	DMP8A5R	Investigative	Small molecular drug	[3060]
example 41 (WO2012028563)	DM2N9Y8	Investigative	Small molecular drug	[3061]
example 8 [WO1999033801A1]	DMFSHXW	Investigative	Small molecular drug	[3062]
example 92 (WO2012095521)	DMU42CR	Investigative	Small molecular drug	[3063]
Exiguamine A	DMMZH3Q	Investigative	Small molecular drug	[726]
EXIGUAMINE B	DME1TGM	Investigative	Small molecular drug	[3064]
exo-THPO	DMVMTJQ	Investigative	Small molecular drug	[3065]
EXP3174	DMWIBFM	Investigative	Small molecular drug	[3066]
Ezetimibe-glucuronide	DM5V3S7	Investigative	Small molecular drug	[3067]
E[c(RGDyK)]2	DM76UJY	Investigative	NA	[3068]
E[c(RGDyK)]2-PTX conjugate	DMS1LZI	Investigative	NA	[3068]
F(4-Fluoro)VAE	DMTW571	Investigative	Small molecular drug	[3069]
F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-CONH2	DMKLSBN	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-COOH	DMPDMFA	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-CONH2	DMD9SOF	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-COOH	DMCSN9M	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-CONH2	DM9H80P	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-COOH	DMPRZ8N	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-CONH2	DMV3ZF1	Investigative	NA	[3070]
F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-COOH	DMZI6RD	Investigative	NA	[3070]
F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-CONH2	DMN7501	Investigative	NA	[3070]
F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-COOH	DMU3IJL	Investigative	NA	[3070]
F-G-G-F-T-G-Aib-R-K-S-Aib-R-K-L-A-N-Q-CONH2	DMMV061	Investigative	NA	[3070]
F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-CONH2	DMPHIBZ	Investigative	NA	[3070]
F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-COOH	DMXH2D8	Investigative	NA	[3070]
F3	DM69MKU	Investigative	Small molecular drug	[3071]
FAICAR	DMJFKSU	Investigative	Small molecular drug	[3072]
FALCARINDIOL	DMLOV18	Investigative	Small molecular drug	[3073]
FAMOXADONE	DMJYNMC	Investigative	Small molecular drug	[22]
FANA	DM45K8W	Investigative	Small molecular drug	[815]
Farnesol	DMV2X1B	Investigative	Small molecular drug	[3074]
FARNESYL	DMXYWD7	Investigative	Small molecular drug	[22]
Fascaplysin	DMG5OZP	Investigative	Small molecular drug	[3075]
fasidotrilat	DMC8G7X	Investigative	Small molecular drug	[3076]
Fasudil	DMTCNOM	Investigative	Small molecular drug	[22]
FAUC 113	DMC6J3B	Investigative	Small molecular drug	[3077]
FAUC213	DM1LMFG	Investigative	Small molecular drug	[3078]
FD-1	DM7IEL2	Investigative	Small molecular drug	[3079]
FdG	DMYXA7E	Investigative	NA	[3080]
FE 999011	DMKVA6Z	Investigative	Small molecular drug	[3081]
fenclonine	DMUBO3E	Investigative	Small molecular drug	[3082]
FETAV	DMO1N2T	Investigative	Small molecular drug	[3083]
Fexaramine	DMWCLQ5	Investigative	Small molecular drug	[3084]
FG-5893	DM1NL3Z	Investigative	Small molecular drug	[3085]
FGGFTCARKCARK	DML9IGY	Investigative	NA	[2519]
FGGFTGARKCARKC	DMTEO35	Investigative	NA	[2519]
FGGFTGARKRKRKLANQ	DMIFKPE	Investigative	NA	[3086]
FGGFTGARKSARKAANQ	DM5W1VF	Investigative	NA	[3086]
FGGFTGARKSARKFANQ	DMYJTZ7	Investigative	NA	[3086]
FGGFTGARKSARKKANQ	DMHG2TB	Investigative	NA	[3086]
FGGFTGARKSARKKKNQ	DMY347Q	Investigative	NA	[3086]
FGGFTGARKSARKKRNQ	DMPG8NC	Investigative	NA	[3086]
FGGFTGARKSARKKWNQ	DMHD6N7	Investigative	NA	[3087]
FGGFTGARKSARKL	DM78I2W	Investigative	NA	[2519]
FGGFTGARKSARKLADE	DMS5AH4	Investigative	NA	[2519]
FGGFTGARKSARKLARK	DMSMK70	Investigative	NA	[3086]
FGGFTGARKSARKLFNQ	DMLDWFE	Investigative	NA	[3086]
FGGFTGARKSARKLKNQ	DMIA2XJ	Investigative	NA	[3086]
FGGFTGARKSARKLLNQ	DMRVSXG	Investigative	NA	[3086]
FGGFTGARKSARKLRNQ	DMCSTP5	Investigative	NA	[3086]
FGGFTGARKSARKLVNQ	DMDEJS6	Investigative	NA	[3086]
FGGFTGARKSARKLWNQ	DMV34KQ	Investigative	NA	[3087]
FGGFTGARKSARKLYNQ	DMG5LXT	Investigative	NA	[3086]
FGGFTGARKSARKRANQ	DM21XBO	Investigative	NA	[3086]
FGGFTGARKSARKRKNQ	DM9RHXC	Investigative	NA	[3087]
FGGFTGARKSARKRKRK	DMWK0Z6	Investigative	NA	[3086]
FGGFTGARKSARKRRNQ	DMDMT5U	Investigative	NA	[3086]
FGGFTGARKSARKRWNQ	DMEGW7F	Investigative	NA	[3087]
FGGFTGARKSARKVANQ	DM1QTN5	Investigative	NA	[3086]
FGGFTGARKSARKWANQ	DMM17AO	Investigative	NA	[3087]
FGGFTGARKSARKWKNQ	DM1YN0F	Investigative	NA	[3087]
FGGFTGARKSARKWRNQ	DMRLZKJ	Investigative	NA	[3087]
FGGFTGARKSARKYANQ	DM5FRXN	Investigative	NA	[3086]
FGGFTGCRKSARKC	DM2PYE7	Investigative	NA	[2519]
FGGFTGCRKSCRK	DMQX2GK	Investigative	NA	[2519]
FGGFTRKRKSARKLANQ	DMD9UQN	Investigative	NA	[3086]
FGIN-1-27	DM4T5DY	Investigative	Small molecular drug	[3088]
FHT-1206	DMGALDA	Investigative	NA	[1866]
FHT-2107	DMH7LDX	Investigative	siRNA drug	[2097]
Fibronectin extra domain A	DMUX702	Investigative	Vaccine	[2154]
Fidarestat(Stereoisomer)	DMETVLB	Investigative	Small molecular drug	[12]
FIG 1	DM29TVC	Investigative	Small molecular drug	[3089]
Fipronil	DMHUNFB	Investigative	Small molecular drug	[3090]
Firocoxib	DMP6GNY	Investigative	Small molecular drug	[3091]
FITC-LMNNAEHINQFYMFI	DMW2VOX	Investigative	NA	[3092]
FKB-001	DM9K834	Investigative	Small molecular drug	[12]
FL104	DMO7U62	Investigative	Small molecular drug	[3093]
Flavanone	DMNWIYM	Investigative	Small molecular drug	[56]
flavin mononucleotide	DM97Z4C	Investigative	Small molecular drug	[3094]
Flavin-Adenine Dinucleotide	DM5S4GK	Investigative	Small molecular drug	[3095]
flavone	DMEQH6J	Investigative	Small molecular drug	[3096]
Flourouracil	DMUEOVZ	Investigative	NA	[1866]
FLUANISONE	DMQSDM7	Investigative	Small molecular drug	[3097]
flufenamate	DMN8AP0	Investigative	Small molecular drug	[3098]
FLUMEZAPINE	DMW0HOG	Investigative	Small molecular drug	[3099]
Fluoro loxoprofen	DMJS62X	Investigative	Small molecular drug	[3100]
FLUORO-NEPLANOCIN A	DM0LR7G	Investigative	Small molecular drug	[3101]
Fluoro-Phosphite Ion	DMIRBYE	Investigative	Small molecular drug	[12]
FLUPENTIXOLE	DMELB5S	Investigative	Small molecular drug	[648]
FLUPERAMIDE	DMEGL84	Investigative	Small molecular drug	[3102]
fluperlapine	DM9KIPU	Investigative	Small molecular drug	[3103]
fluprostenol	DM9Q2PG	Investigative	Small molecular drug	[3104]
FLUTROLINE	DMUOHVL	Investigative	Small molecular drug	[3105]
FM1-10	DM5782Z	Investigative	Small molecular drug	[3106]
FM1-43	DMAP8VY	Investigative	Small molecular drug	[3106]
FMS586	DMQBTL3	Investigative	Small molecular drug	[3107]
Folate gamma-hydroxamic acid	DMJ4F3Q	Investigative	Small molecular drug	[3108]
Folate gamma-L-phenylalaninehydroxamic acid	DM76AUO	Investigative	Small molecular drug	[3108]
Folate gamma-L-proline-hydroxamic acid	DMH5SQV	Investigative	Small molecular drug	[3108]
folipastatin	DMEPZ2I	Investigative	Small molecular drug	[3109]
FOLITENOL	DMSBQL0	Investigative	Small molecular drug	[1164]
For-RYYRIK-NH2	DMVBGAT	Investigative	Small molecular drug	[754]
Formaldehyde	DM7Q6M0	Investigative	Small molecular drug	[3110]
formamide	DM2Z2I4	Investigative	Small molecular drug	[3111]
Formic Acid	DMNFZC6	Investigative	Small molecular drug	[3112]
FORMONONETIN	DM7WFZ8	Investigative	Small molecular drug	[3113]
Formycin	DMWG0P3	Investigative	Small molecular drug	[12]
Formycin B	DMHLYUM	Investigative	Small molecular drug	[3114]
FORMYLCHROMONE	DMFOU92	Investigative	Small molecular drug	[3115]
FORSYTHIASIDE	DMPC568	Investigative	Small molecular drug	[2452]
FP-0240	DMURUC4	Investigative	NA	[1866]
FP0429	DMYBQN9	Investigative	Small molecular drug	[3116]
FPL64176	DMB8U4F	Investigative	Small molecular drug	[3117]
FPTQ	DMR2NBK	Investigative	Small molecular drug	[3118]
FPYVAE peptide	DMDUR4C	Investigative	Small molecular drug	[3119]
FR-122788	DMNMO83	Investigative	NA	[3120]
FR-166124	DMPCBXT	Investigative	Small molecular drug	[3121]
FR-175985	DMQDP23	Investigative	Small molecular drug	[3122]
FR-180204	DM051PI	Investigative	Small molecular drug	[3123]
FR-181157	DM2V7U1	Investigative	Small molecular drug	[3124]
FR-193262	DM9BS3W	Investigative	Small molecular drug	[3125]
FR-226928	DMBY3T5	Investigative	Small molecular drug	[3126]
FR-230481	DMKJQWR	Investigative	Small molecular drug	[3126]
FR-233118	DMPD16N	Investigative	Small molecular drug	[3126]
FR-73966	DMV0UM2	Investigative	Small molecular drug	[3126]
FR-900452	DMMGWXQ	Investigative	Small molecular drug	[3127]
FR117016	DM6UWVB	Investigative	Small molecular drug	[22]
FR122047	DMAYTWN	Investigative	Small molecular drug	[3128]
FR161282	DMZSFEP	Investigative	Small molecular drug	[2610]
FR167344	DM2W5VA	Investigative	Small molecular drug	[3129]
FR190997	DM0G4HP	Investigative	Small molecular drug	[3130]
FR191413	DM75VHN	Investigative	Small molecular drug	[3131]
FR194921	DMISP7G	Investigative	Small molecular drug	[3132]
FR221647	DM70UQR	Investigative	Small molecular drug	[22]
FR230513	DM3V0HA	Investigative	Small molecular drug	[22]
FR233623	DMR251H	Investigative	Small molecular drug	[22]
FR236913	DMLH546	Investigative	Small molecular drug	[22]
FR239087	DMMJDXT	Investigative	Small molecular drug	[22]
FR260010	DMSQ6CV	Investigative	Small molecular drug	[3133]
frescolat MGA	DMEYNGP	Investigative	Small molecular drug	[3134]
frescolat ML	DMIBCZJ	Investigative	Small molecular drug	[3135]
Fructose-6-Phosphate	DMU5SAF	Investigative	Small molecular drug	[12]
FTI 276	DMN2Q7Y	Investigative	Small molecular drug	[3136]
FTIDC	DM65VLB	Investigative	Small molecular drug	[3137]
FTY720-phosphate	DMDZBQH	Investigative	Small molecular drug	[3138]
FUB 349	DMUAYWX	Investigative	Small molecular drug	[3139]
FUKUGETIN	DMWF82O	Investigative	Small molecular drug	[1317]
Fumagillin	DMA3Y8C	Investigative	Small molecular drug	[3140]
Fumarate	DM9VLS2	Investigative	Small molecular drug	[12]
furan-1	DMCFEBW	Investigative	Small molecular drug	[3141]
Furan-2-ylmethylcarbamic Acid Biphenyl-3-yl Ester	DM9XPUN	Investigative	Small molecular drug	[1011]
Furan-3-yl(4-(methylsulfonyl)phenyl)methanone	DMPC6YL	Investigative	Small molecular drug	[528]
furin inhibitor peptide	DM78NOM	Investigative	Small molecular drug	[3142]
FUROSIN	DMVT0JO	Investigative	Small molecular drug	[372]
Furo[2,3d]Pyrimidine Antifolate	DMVYEZ1	Investigative	Small molecular drug	[12]
furtrethonium	DM4M3C8	Investigative	Small molecular drug	[3143]
FUTOENONE	DMFBP7C	Investigative	Small molecular drug	[3144]
FV-Aib-TDVGPFAF	DMEI890	Investigative	NA	[1898]
FV-Hyp-TDVGPFAF	DMXQC6H	Investigative	NA	[3145]
FV-Tic-TDVGPFAF	DMBOE1U	Investigative	NA	[3145]
FVATDVGPFAF	DMDG1ZX	Investigative	NA	[3145]
FVPTDVG-Tic-FAF-Tic	DM58JFR	Investigative	NA	[3145]
FVPTDVGAFAF	DMSD7B1	Investigative	NA	[3145]
FVPTDVGPFAF	DMUVXZQ	Investigative	NA	[3145]
G(D-Pen)-G-H-R-G-D-L-R-C-A	DMUC0F5	Investigative	NA	[3146]
G-25	DMADOK6	Investigative	Small molecular drug	[1763]
G15	DMMEC9D	Investigative	Small molecular drug	[3147]
G36	DMDJCIP	Investigative	Small molecular drug	[3148]
G418	DMKTJBU	Investigative	Small molecular drug	[12]
G749	DMC7HIS	Investigative	Small molecular drug	[3149]
Gababutin	DMDEAWS	Investigative	Small molecular drug	[813]
Gabaculine	DMH17MU	Investigative	Small molecular drug	[3150]
Gal-B5	DM7PR5E	Investigative	NA	[3151]
Galangin	DM5TQ2O	Investigative	Small molecular drug	[3152]
GALANIN	DMHPV8A	Investigative	NA	[3153]
Galanthamine derivative	DMAFE24	Investigative	Small molecular drug	[86]
GALANTIDE	DMDZHEO	Investigative	Small molecular drug	[3154]
GalB2	DMGX6UH	Investigative	NA	[3155]
Gallic acid 5,6-dihydroxy-3-carboxyphenylester	DMNWU83	Investigative	Small molecular drug	[3156]
GALLICACID	DM6Y3A0	Investigative	Small molecular drug	[3157]
GALLOCATECHIN GALLATE	DMX2084	Investigative	Small molecular drug	[1160]
galmic	DML9DH8	Investigative	Small molecular drug	[3158]
Galnon	DMB8HCW	Investigative	Small molecular drug	[3159]
GalR3ant	DMI7RPT	Investigative	Small molecular drug	[3160]
Gamma-acetylenic GABA	DMFSXOM	Investigative	Small molecular drug	[3161]
gamma-butyrolactone	DMDCZWY	Investigative	Small molecular drug	[3162]
Gamma-Carboxy-Glutamic Acid	DMZMCT0	Investigative	Small molecular drug	[12]
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	DMHNJDE	Investigative	Small molecular drug	[12]
Gamma-mangostin	DMC0OVP	Investigative	Small molecular drug	[1799]
Ganoderic acid A	DM42EVG	Investigative	Small molecular drug	[669]
GANSTIGMINE	DMFT4GU	Investigative	Small molecular drug	[86]
garcinol	DM6B9ZG	Investigative	Small molecular drug	[3163]
GARCINONE D	DMQDV3U	Investigative	Small molecular drug	[1799]
GARTANIN	DMZ5AD8	Investigative	Small molecular drug	[1799]
GARVEATIN A	DM7GX1S	Investigative	Small molecular drug	[1033]
Garveatin C	DMXNQ15	Investigative	Small molecular drug	[1033]
Garveatin E	DMUFZ18	Investigative	Small molecular drug	[1033]
GB-12819	DM7B5HA	Investigative	Small molecular drug	[2401]
GB110	DMWFYJ4	Investigative	Small molecular drug	[3164]
GB88	DMLDVFM	Investigative	Small molecular drug	[3165]
GBR 12530	DMPOML4	Investigative	Small molecular drug	[2401]
GBR-12289	DM2CUNP	Investigative	Small molecular drug	[2401]
GC-14	DMYMGBA	Investigative	Small molecular drug	[3166]
GCCSHPACAGNNQHIC*	DM4BZEC	Investigative	NA	[3167]
GCCSNPVCHLEHSNLC*	DMJ0ICN	Investigative	NA	[3167]
GDP-fucose	DMZMULS	Investigative	Small molecular drug	[3168]
GE-137	DMB813H	Investigative	Small molecular drug	[3169]
GEA 3162	DMBGWEK	Investigative	Small molecular drug	[3170]
Geldanamycin-estradiol hybrid	DMUSJ96	Investigative	NA	[3171]
Gelsolin	DML0OUY	Investigative	Antibody	[3172]
gemini	DMETRIS	Investigative	Small molecular drug	[3173]
GENESERINE	DMAUFLQ	Investigative	Small molecular drug	[3174]
Genz-10850	DMB70WC	Investigative	Small molecular drug	[12]
GERANIIN	DMB5I03	Investigative	Small molecular drug	[372]
geraniol	DMS3CBD	Investigative	Small molecular drug	[3175]
Geranyl Diphosphate	DMB9LE1	Investigative	Small molecular drug	[3176]
Geranylcoumarin	DMRPWGL	Investigative	Small molecular drug	[2279]
GERANYLGERANYL DIPHOSPHATE	DMJZ0AM	Investigative	Small molecular drug	[3177]
GFPDGG	DMLM02I	Investigative	Small molecular drug	[3069]
GFPEGG	DMGZTQW	Investigative	Small molecular drug	[3069]
GFPTGG	DM9D8VH	Investigative	Small molecular drug	[3069]
gingerol	DMNXYSM	Investigative	Small molecular drug	[3178]
GINKGOLIDE A	DMKZJ7T	Investigative	Small molecular drug	[3179]
Ginkgolide C	DMVN374	Investigative	Small molecular drug	[3180]
Ginkgolide J	DMUOMP1	Investigative	Small molecular drug	[3181]
Ginkgolide M	DMHWIG6	Investigative	Small molecular drug	[653]
ginkgolide X	DMK543E	Investigative	Small molecular drug	[3182]
ginsenoside Rg3	DMFN58T	Investigative	Small molecular drug	[3183]
GKA1	DM9P62Y	Investigative	Small molecular drug	[3184]
GLAUCINE	DMSP7V8	Investigative	Small molecular drug	[335]
Glaxo-11p	DM4QJPU	Investigative	Small molecular drug	[3185]
GlaxoSmithKline compound 5h	DMNEML0	Investigative	Small molecular drug	[3186]
GlaxoSmithKline compound 6i	DM1UAWP	Investigative	Small molecular drug	[3187]
GLP-17-(7-36) derivative	DMBH18C	Investigative	NA	[3188]
GLPDGG peptide	DMGTPDA	Investigative	Small molecular drug	[3119]
GLPTGG	DME2YL6	Investigative	Small molecular drug	[3069]
Glu-Leu-Asp-Leu-(CHOH-CH2)-Ala-Ala-Glu-Phe	DMXBQRJ	Investigative	Small molecular drug	[3189]
Glu-Pro-Gln-F2Pmp-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	DM6EA9B	Investigative	NA	[3190]
Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	DMYZO37	Investigative	NA	[3190]
Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro	DM1Q83B	Investigative	NA	[3191]
Glu20-Lys24][Gly8][GLP-1(7-37)-NH2	DM0HWB1	Investigative	NA	[2751]
glucagon-(1-6)	DMVWDHM	Investigative	Small molecular drug	[3192]
gluconate	DMU3MCO	Investigative	Small molecular drug	[3193]
Gluconolactone	DMO071E	Investigative	Small molecular drug	[22]
Glucosamine 6-Phosphate	DMY590Q	Investigative	Small molecular drug	[12]
glucuronic acid	DMIUQPC	Investigative	Small molecular drug	[3194]
Glutamine Hydroxamate	DMT7K0U	Investigative	Small molecular drug	[12]
GLUTARATE	DMPUFDS	Investigative	Small molecular drug	[1939]
Glutathionylspermidine Disulfide	DMPX7FR	Investigative	Small molecular drug	[12]
Gly-Amp-Glu	DMO8LAC	Investigative	Small molecular drug	[215]
Gly-Arg-Gly-Asp-Ser	DMACT8D	Investigative	Small molecular drug	[3195]
Gly-Arg-Gly-Asp-Ser-Pro-Lys	DMGOIME	Investigative	Small molecular drug	[3196]
Gly-b7Pro-Glu	DM8L09J	Investigative	Small molecular drug	[215]
Gly-Hyp-Glu	DM8XR4Y	Investigative	Small molecular drug	[215]
Gly-Pip-Glu	DMM0JA4	Investigative	Small molecular drug	[215]
glycerol 3-phosphate	DMKABUE	Investigative	Small molecular drug	[3197]
Glycerol-2-Phosphate	DM0J5KF	Investigative	Small molecular drug	[12]
Glycinamid	DMTCEFV	Investigative	Small molecular drug	[12]
Glycinamide Ribonucleotide	DMW180Y	Investigative	Small molecular drug	[12]
glycochenodeoxycholic acid	DMB7XQL	Investigative	Small molecular drug	[3198]
glycocholic acid	DM0SXNM	Investigative	Small molecular drug	[3199]
glycodeoxycholic acid	DM1XEJV	Investigative	Small molecular drug	[3200]
glycoursodeoxycholic acid	DMQLDGX	Investigative	Small molecular drug	[3201]
Glycyl-H 1152	DM0SCK8	Investigative	Small molecular drug	[3202]
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine	DM8FTJN	Investigative	Small molecular drug	[12]
GLYCYLRYANODINE	DMTOCXZ	Investigative	Small molecular drug	[249]
GlyH-101	DM67FQ1	Investigative	Small molecular drug	[3203]
Glyoxalate, Glyoxylate	DMQUP7O	Investigative	Small molecular drug	[12]
GM-109	DMMDU0K	Investigative	Small molecular drug	[3204]
GM2-n	DMP6V0C	Investigative	NA	[1866]
GMQ	DMM0ZKQ	Investigative	Small molecular drug	[3205]
GNE-7915	DMYWM56	Investigative	Small molecular drug	[3206]
GNE-9605	DMLXR90	Investigative	Small molecular drug	[3207]
GNF-2	DM4CNSS	Investigative	Small molecular drug	[3208]
GNF-5	DMGLIPV	Investigative	Small molecular drug	[3209]
GNF-5837	DMYJO13	Investigative	Small molecular drug	[3210]
GNF-PF-117	DM3INUK	Investigative	Small molecular drug	[3211]
GNF-PF-1399	DM183RV	Investigative	Small molecular drug	[2034]
GNF-PF-1550	DMVUBGF	Investigative	Small molecular drug	[3212]
GNF-PF-1591	DMHCGBZ	Investigative	Small molecular drug	[2034]
GNF-PF-1694	DM4JZ9A	Investigative	Small molecular drug	[3213]
GNF-PF-173	DMUSAYG	Investigative	Small molecular drug	[3214]
GNF-PF-1967	DMGSRLA	Investigative	Small molecular drug	[3215]
GNF-PF-2094	DM9J35R	Investigative	Small molecular drug	[3216]
GNF-PF-2224	DM26UKN	Investigative	Small molecular drug	[1805]
GNF-PF-2272	DMONK0F	Investigative	Small molecular drug	[2034]
GNF-PF-2307	DMP6DBX	Investigative	Small molecular drug	[2034]
GNF-PF-2322	DMW93IO	Investigative	Small molecular drug	[3212]
GNF-PF-254	DMJBLP2	Investigative	Small molecular drug	[3217]
GNF-PF-2700	DMC56YJ	Investigative	Small molecular drug	[935]
GNF-PF-2812	DMD1QOH	Investigative	Small molecular drug	[2034]
GNF-PF-2857	DML5QFZ	Investigative	Small molecular drug	[3218]
GNF-PF-2893	DMLP241	Investigative	Small molecular drug	[2034]
GNF-PF-3037	DM4RZSB	Investigative	Small molecular drug	[2034]
GNF-PF-3464	DMWAKHD	Investigative	Small molecular drug	[2034]
GNF-PF-3645	DM17GIV	Investigative	Small molecular drug	[1260]
GNF-PF-3832	DMIY79U	Investigative	Small molecular drug	[2034]
GNF-PF-3878	DM7BXHQ	Investigative	Small molecular drug	[3218]
GNF-PF-3955	DMOJL61	Investigative	Small molecular drug	[2034]
GNF-PF-4292	DMXWYMH	Investigative	Small molecular drug	[3219]
GNF-PF-4421	DMV10UH	Investigative	Small molecular drug	[1260]
GNF-PF-4453	DMPYIA3	Investigative	Small molecular drug	[2034]
GNF-PF-4478	DMCDU8K	Investigative	Small molecular drug	[2034]
GNF-PF-4599	DM1ZMUN	Investigative	Small molecular drug	[3215]
GNF-PF-5134	DM7850H	Investigative	Small molecular drug	[2034]
GNF-PF-5188	DMVI4JG	Investigative	Small molecular drug	[3220]
GNF-PF-5411	DMZNAEQ	Investigative	Small molecular drug	[3219]
GNF-PF-5434	DMP9AIH	Investigative	Small molecular drug	[3221]
GNF-PF-5618	DMT8VUS	Investigative	Small molecular drug	[3222]
GNF-PF-600	DMWGXBF	Investigative	Small molecular drug	[3223]
GNF-PF-607	DMJXE6K	Investigative	Small molecular drug	[3224]
GNF-PF-67	DM3SYH5	Investigative	Small molecular drug	[2034]
GNF-PF-78	DM7SPRJ	Investigative	Small molecular drug	[2034]
GNF-PF-826	DM37ORC	Investigative	Small molecular drug	[2034]
GNF-PF-85	DMB6FN7	Investigative	Small molecular drug	[3225]
Go 6983	DMKVTZN	Investigative	Small molecular drug	[3226]
Go-Y022	DMZNUAD	Investigative	Small molecular drug	[434]
Go-Y026	DMUNSLJ	Investigative	Small molecular drug	[434]
Go7874	DMS91OR	Investigative	Small molecular drug	[3227]
Gold trichloride sodium chloride	DMS97A1	Investigative	NA	[3228]
GOSSYPETIN	DMMT05U	Investigative	Small molecular drug	[3229]
GP515	DMRUIX3	Investigative	Small molecular drug	[3230]
GPI 18214	DMAY48N	Investigative	NA	[3231]
GPYRMEHFRWGSPPKD-NH2	DMLRTPH	Investigative	NA	[1883]
GR 125,743	DMMX7KL	Investigative	Small molecular drug	[3232]
GR 125487	DM72B86	Investigative	Small molecular drug	[3233]
GR 128107	DMAI9Y0	Investigative	Small molecular drug	[3234]
GR 196429	DMHAWYJ	Investigative	Small molecular drug	[3235]
GR-113808	DMFU9VH	Investigative	Small molecular drug	[3236]
GR-133686	DMQH8PK	Investigative	NA	[3237]
GR-38414	DMIY9UF	Investigative	NA	[3238]
GR-45809	DM5UOYM	Investigative	Small molecular drug	[3239]
GR-86014	DMEO7CP	Investigative	NA	[3240]
GR-91272	DM9WY1D	Investigative	NA	[3240]
GR100679	DMP1DO4	Investigative	Small molecular drug	[3241]
GR138676	DMW8YDR	Investigative	Small molecular drug	[3242]
GR55562	DM8L1Z2	Investigative	Small molecular drug	[3243]
GR94800	DMBYK0X	Investigative	Small molecular drug	[3244]
Grandisine C	DMVLQUP	Investigative	Small molecular drug	[88]
Grandisine D	DM0JHYF	Investigative	Small molecular drug	[88]
Grandisine F	DM04S2P	Investigative	Small molecular drug	[88]
GRANULATIMIDE	DM65SQK	Investigative	Small molecular drug	[2313]
Grassystatin a	DM1PWX2	Investigative	Small molecular drug	[3245]
grayanotoxin III	DMXSWF6	Investigative	Small molecular drug	[3246]
Green tea	DMQHJTF	Investigative	Small molecular drug	[3247]
GRI977143	DM3A0TE	Investigative	Small molecular drug	[3248]
grifolic acid	DMGTRZE	Investigative	Small molecular drug	[3249]
GRL-7234	DMR93MK	Investigative	Small molecular drug	[3250]
group E 1682-2106	DMO6IM1	Investigative	Small molecular drug	[3251]
GS4071	DMG0OUD	Investigative	Small molecular drug	[815]
GSK-0660	DMNIVOX	Investigative	Small molecular drug	[3252]
GSK-1564023A	DMKN76P	Investigative	Small molecular drug	[3253]
GSK-1838705A	DM4HLK3	Investigative	Small molecular drug	[3254]
GSK-188909	DMMWBU6	Investigative	Small molecular drug	[3255]
GSK-325971A	DM1865H	Investigative	Small molecular drug	[3253]
GSK-3787	DMKDLB7	Investigative	Small molecular drug	[3256]
GSK-3beta inhibitor II	DMQR7TZ	Investigative	Small molecular drug	[3257]
GSK-3beta inhibitor XI	DM734QB	Investigative	Small molecular drug	[3258]
GSK-5182	DMNGEAY	Investigative	Small molecular drug	[3259]
GSK-8062	DMGW42V	Investigative	Small molecular drug	[3260]
GSK-9578	DMW9AN1	Investigative	Small molecular drug	[3261]
GSK-9772	DM4WS3R	Investigative	Small molecular drug	[3262]
GSK-J1	DMY3SEN	Investigative	Small molecular drug	[3263]
GSK-LSD1	DMHJU7A	Investigative	Small molecular drug	[3264]
GSK1016790A	DMDHZR1	Investigative	Small molecular drug	[3265]
GSK1331268	DMIWY7Q	Investigative	Small molecular drug	[3266]
GSK1511931	DMZUTXW	Investigative	Small molecular drug	[3267]
GSK1614343	DMG6TL7	Investigative	Small molecular drug	[3268]
GSK2033	DM9GPAU	Investigative	Small molecular drug	[3269]
GSK2193874	DMY2XV3	Investigative	Small molecular drug	[3270]
GSK2194069	DMZ2TD9	Investigative	Small molecular drug	[3271]
GSK2606414	DMLASOF	Investigative	Small molecular drug	[3272]
GSK2801	DMDSK9N	Investigative	Small molecular drug	[3273]
GSK312948	DMOYM03	Investigative	Small molecular drug	[3274]
GSK343	DM9QU5Y	Investigative	Small molecular drug	[3275]
GSK4716	DMHUMP9	Investigative	Small molecular drug	[3276]
GSK484	DM93BGA	Investigative	Small molecular drug	[3277]
GSK494581A	DMMIWHV	Investigative	Small molecular drug	[3278]
GSK575594A	DM1I0AN	Investigative	Small molecular drug	[3279]
GSK579289A	DMJXHU8	Investigative	Small molecular drug	[3280]
GSK931145	DMIDQ8B	Investigative	Small molecular drug	[3281]
GT2394	DMH3PDG	Investigative	Small molecular drug	[3282]
GTP-14564	DMW23Y9	Investigative	Small molecular drug	[3283]
GTPgammaS	DMJUXKY	Investigative	Small molecular drug	[3284]
GTPL8662	DMZQETV	Investigative	Small molecular drug	[3285]
guanidinoethane sulfonic acid	DMA3TW9	Investigative	Small molecular drug	[3286]
guanidoacetic acid	DMX2AUR	Investigative	Small molecular drug	[3287]
GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	DMCN56S	Investigative	Small molecular drug	[22]
GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	DMRITFU	Investigative	Small molecular drug	[22]
Guanosine-5',3'-Tetraphosphate	DMG2ZFV	Investigative	Small molecular drug	[12]
Guanosine-5'-Diphosphate	DM0MUKQ	Investigative	Small molecular drug	[3288]
Guanosine-5'-Monophosphate	DM3SLZK	Investigative	Small molecular drug	[3289]
Guanosine-5'-Triphosphate	DMV2OJX	Investigative	Small molecular drug	[3290]
guanylpirenzepine	DMOUQLB	Investigative	Small molecular drug	[3291]
Gue1654	DM89KNT	Investigative	Small molecular drug	[3292]
Guttiferone I	DMBXGVH	Investigative	Small molecular drug	[3293]
GW 627368	DM78KYC	Investigative	Small molecular drug	[3294]
GW-2331	DMM8V9E	Investigative	Small molecular drug	[3295]
GW-2580	DMTW9GM	Investigative	Small molecular drug	[3296]
GW-5074	DMIHOYF	Investigative	Small molecular drug	[3297]
GW-5823	DMCOYF9	Investigative	Small molecular drug	[3298]
GW-637185X	DMX59A0	Investigative	Small molecular drug	[3299]
GW-8510	DML4UMT	Investigative	Small molecular drug	[3300]
GW0072	DM3D2R4	Investigative	Small molecular drug	[3301]
GW0742X	DMGKEO5	Investigative	Small molecular drug	[3302]
GW1100	DM3DXM0	Investigative	Small molecular drug	[3303]
GW1929	DMOV980	Investigative	Small molecular drug	[3304]
GW2433	DMEAIQC	Investigative	Small molecular drug	[3305]
GW4065	DMFRP7H	Investigative	NA	[3306]
GW441756	DMAS4TV	Investigative	Small molecular drug	[3307]
GW583340	DMQNUGD	Investigative	Small molecular drug	[3308]
GW7604	DMCA4RM	Investigative	Small molecular drug	[3309]
GW7647	DM9RD0C	Investigative	Small molecular drug	[3310]
GW7845	DMEK2I4	Investigative	Small molecular drug	[3311]
GW803430	DMWAEJ3	Investigative	Small molecular drug	[3312]
GW841819X	DMRL9IN	Investigative	Small molecular drug	[3313]
GW848687X	DMXA5M9	Investigative	Small molecular drug	[3314]
GW853606	DMITKX8	Investigative	Small molecular drug	[3315]
GW9508	DMVKZ5I	Investigative	Small molecular drug	[3316]
GWTLNSAGYLLGPHAV-NH2	DMZPRIG	Investigative	NA	[3317]
GwTLNSAGYLLGPHAVGNHRSFSDKNGLTS-CONH2	DMPIRE0	Investigative	NA	[3318]
GWTLNSAGYLLGPPPALALA-CONH2	DMKFMQ5	Investigative	NA	[3318]
GWTLNSAGYLLGPPPGFSPFR-CONH2	DMVWGM2	Investigative	NA	[3318]
GWTLNSAGYLLGPRHYINLITRQRY-CONH2	DM5YR4S	Investigative	NA	[3318]
GWTLNSAGYLLGPrPKPQQwFwLL-CONH2	DM48AV3	Investigative	NA	[3318]
Gymnochrome E	DM7SLAM	Investigative	Small molecular drug	[3319]
H-2',6'-dimethyltyrosine-Tic-Phe-Phe-OH	DM7IEU2	Investigative	Small molecular drug	[3320]
H-8	DM80QF9	Investigative	Small molecular drug	[3321]
H-89	DM4RVGO	Investigative	Small molecular drug	[3322]
H-Aba-ala-Gly-Phe-leu-OH	DM61G0I	Investigative	Small molecular drug	[3323]
H-Aba-ala-Gly-Phe-Met-OH	DMKD94Q	Investigative	Small molecular drug	[3323]
H-Aba-Gly-Gly-Phe-Leu-OH	DMH1L3P	Investigative	Small molecular drug	[3323]
H-Aba-ser-Gly-Phe-Leu-Thr-OH	DMFE3J4	Investigative	Small molecular drug	[3323]
H-Ala-Pro-Phe-Phe-NH2	DM5S4AO	Investigative	Small molecular drug	[216]
H-Apa-ala-Gly-Phe-leu-OH	DM5SUYP	Investigative	Small molecular drug	[3323]
H-Arg-Arg-Pro-Tyr-Ile-Aac-OH	DMENVKA	Investigative	Small molecular drug	[3324]
H-Arg-Arg-Pro-Tyr-Ile-N-Me-Leu-OH	DM4FKR1	Investigative	Small molecular drug	[3324]
H-Arg-Arg-Pro-Tyr-N-Me-Ile-Leu-OH	DM107RT	Investigative	Small molecular drug	[3324]
H-Arg-N-Me-Arg-Pro-Tyr-Ile-Leu-OH	DMSXLKJ	Investigative	Small molecular drug	[3324]
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH	DMJ6N1X	Investigative	Small molecular drug	[216]
H-Cdp-ala-Gly-Phe-leu-OH	DMV751G	Investigative	Small molecular drug	[3323]
H-Cdp-Gly-Gly-Phe-Leu-OH	DMVEB8C	Investigative	Small molecular drug	[3323]
H-Cdp-ser-Gly-Phe-Leu-Thr-OH	DMCDLTV	Investigative	Small molecular drug	[3323]
H-Cpa-c[pen-Gly-Phe-pen]OH	DM3V4XG	Investigative	Small molecular drug	[3323]
H-Cpa-Gly-Gly-Phe-Met-NH2	DMU6PV8	Investigative	Small molecular drug	[3323]
H-Cpa-Gly-Gly-Phe-Met-OH	DM154G2	Investigative	Small molecular drug	[3323]
H-Cxp-ala-Gly-Phe-leu-OH	DMPL0BR	Investigative	Small molecular drug	[3323]
H-c[Cys-Phe-DTrp-Lys-Thr-Cys]-OH	DMCQH23	Investigative	Small molecular drug	[3325]
H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2	DM1EGC3	Investigative	NA	[2789]
H-D-Phe-c[Cys-Ala-D-Trp-Lys-Thr-Cys]-Thr-NH2	DML8S7J	Investigative	Small molecular drug	[3325]
H-D-Tca-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	DMY4QE6	Investigative	NA	[3326]
H-D-Tic-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	DM8GC36	Investigative	NA	[3326]
H-D-Trp-c[Cys-Tyr-D-Trp-Arg-Thr-Pen]-Thr-NH2	DMNAE6J	Investigative	NA	[3326]
H-DArg-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1638)	DM6839G	Investigative	NA	[3327]
H-Dmt-Aba-Gly-NH-CH2-Bid	DM9WJZK	Investigative	Small molecular drug	[3328]
H-Dmt-Aba-Gly-NH-CH2-Ph	DM61CMS	Investigative	Small molecular drug	[3328]
H-Dmt-Aba-Gly-NH-Ph	DMCQYIJ	Investigative	Small molecular drug	[3328]
H-Dmt-D-Arg(NO2)-Phe-Lys(Z)-NH2	DMHK70B	Investigative	Small molecular drug	[3329]
H-Dmt-D-Arg(NO2)-Phe-Lys(Z)-OH	DMM9EPQ	Investigative	Small molecular drug	[3329]
H-Dmt-Tic-(2R,3R)-beta-MeCha-Phe-NH2	DM1ZDJ6	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2R,3R)-beta-MeCha-Phe-OH	DMC3APN	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2R,3S)-beta-MeCha-Phe-NH2	DMY97TN	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2R,3S)-beta-MeCha-Phe-OH	DMGPAM0	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2S,3R)-beta-MeCha-Phe-NH2	DMOI1U5	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2S,3R)-beta-MeCha-Phe-OH	DMZBFJ5	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2S,3S)-beta-MeCha-Phe-NH2	DMNS1GX	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-(2S,3S)-beta-MeCha-Phe-OH	DMM9TUR	Investigative	Small molecular drug	[3330]
H-Dmt-Tic-Asp-N(Me)-Ph	DM4JP8L	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Asp-NH-Bzl	DMBKOJG	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Asp-NH-Ph	DM3W9FQ	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-D-Asp-N(Me)-Ph	DM483BG	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-D-Asp-NH-Ph	DMUG7X1	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Glu-Dap(6DMN)-NH(2)	DMQSRPD	Investigative	Small molecular drug	[244]
H-Dmt-Tic-Glu-NH-(CH2)5-NH2	DMF52SH	Investigative	Small molecular drug	[3332]
H-Dmt-Tic-Glu-NH2	DM8A573	Investigative	Small molecular drug	[3332]
H-Dmt-Tic-Gly-N(Me)-Ph	DMHYKBC	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Gly-NH-Bzl	DMM39YW	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Gly-NH-CH2-Bid	DMH6JOU	Investigative	Small molecular drug	[3328]
H-Dmt-Tic-Gly-NH-Ph	DMIZ28H	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-Lys(Ac)-NH-CH2-Ph	DM2TY43	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-Lys(Ac)-NH-Ph	DMZH9P5	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-Lys(Z)-NH-CH2-Ph	DMP8HFA	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-Lys(Z)-NH-Ph	DMBXGLA	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-Lys-NH-CH2-Ph	DMDJ9PE	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-Lys-NH-Ph	DMT3Y6E	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-NH-(CH2)6-NH-Dmt-H	DMMJ9YN	Investigative	Small molecular drug	[3334]
H-Dmt-Tic-NH-(CH2)6-NH-Phe-H	DM0BGNE	Investigative	Small molecular drug	[3334]
H-Dmt-Tic-NH-(CH2)6-NH-Tic-H	DMQ586T	Investigative	Small molecular drug	[3334]
H-Dmt-Tic-NH-(D)-CH[(CH2)4-NH-Z]-Bid	DMAU2H6	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid	DM5TZ1J	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid(N1-Me)	DMIDLPT	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(N1-Me)	DMNEAQ9	Investigative	Small molecular drug	[3331]
H-Dmt-Tic-NH-CH2-Boa	DM4IUCW	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH2-Bta	DMZ8C0U	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH2-CH2-NH2	DMYJAW4	Investigative	Small molecular drug	[3336]
H-Dmt-Tic-NH-CH2-Imid	DMJ2F8M	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH2-ImidPh	DMKGIQJ	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH2-Indl	DMNY3A1	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH2-Indn	DMZWUFK	Investigative	Small molecular drug	[3335]
H-Dmt-Tic-NH-CH[(CH2)4-NH-Ac]-Bid	DM8PJ92	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-NH-CH[(CH2)4-NH-Z]-Bid	DMQ4ILK	Investigative	Small molecular drug	[3333]
H-Dmt-Tic-NH-CH[(CH2)4-NH2]-Bid	DMQEDP5	Investigative	Small molecular drug	[3333]
H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2	DMLCIZ8	Investigative	NA	[3325]
H-Gly-D-dmP-Glu-OH	DMX2TGD	Investigative	Small molecular drug	[3337]
H-Gly-dmP-Glu-OH	DMOYQPM	Investigative	Small molecular drug	[3337]
H-KPPR-OH	DMDINX9	Investigative	Small molecular drug	[3338]
H-Leu-Phe-NH2	DMAPWC2	Investigative	Small molecular drug	[216]
H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1645)	DMDXIS7	Investigative	NA	[3327]
H-Lys-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1669)	DMTGU0L	Investigative	NA	[3327]
H-mCpa-ala-Gly-Phe-leu-OH	DM17QMV	Investigative	Small molecular drug	[3323]
H-mCpa-Gly-Gly-Phe-Leu-OH	DMKAEQP	Investigative	Small molecular drug	[3323]
H-mCpa-ser-Gly-Phe-Leu-Thr-OH	DM8OUHV	Investigative	Small molecular drug	[3323]
H-Phe-NH2	DM9IODG	Investigative	Small molecular drug	[216]
H-Phe-Phe-NH2	DM0KFW2	Investigative	Small molecular drug	[216]
H-Poa-ser-Gly-Phe-Leu-Thr-OH	DME1CT9	Investigative	Small molecular drug	[3323]
H-Pro-Phe-Phe-NH2	DMXKPQR	Investigative	Small molecular drug	[216]
H-RYYRIK-NH2	DMSTV96	Investigative	Small molecular drug	[754]
H-SMGLPCVVM-OH	DMA91T4	Investigative	Small molecular drug	[3339]
H-Tyr(OMe)-Phe(2-Me)-NH2	DMX08FL	Investigative	Small molecular drug	[216]
H-Tyr-Ala-Phe-Phe-NH2	DMUHBGC	Investigative	Small molecular drug	[216]
H-Tyr-c[cys-Gly-Phe(p-NO2)-cys]NH2	DMP8KMV	Investigative	Small molecular drug	[3323]
H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]-OH	DMA2CZL	Investigative	Small molecular drug	[2603]
H-Tyr-c[D-Allylgly-Gly-Phe-D-Allylgly]NH2	DM48XV0	Investigative	Small molecular drug	[3340]
H-Tyr-c[D-Allylgly-Gly-Phe-L-Allylgly]NH2	DMXPJHB	Investigative	Small molecular drug	[3340]
H-Tyr-c[D-Cys-Gly-Phe-D-Cys]NH2	DM7QAES	Investigative	Small molecular drug	[3340]
H-Tyr-c[D-Cys-Gly-Phe-L-Cys]NH2	DMZSTL5	Investigative	Small molecular drug	[3340]
H-Tyr-c[D-Orn-(D or L)Atc-Glu]-NH2	DMI7CR9	Investigative	Small molecular drug	[3341]
H-Tyr-c[D-Orn-Aic-Glu]-NH2	DMOTI0P	Investigative	Small molecular drug	[3341]
H-Tyr-c[pen-Gly-Phe-pen]OH	DMAKPM1	Investigative	Small molecular drug	[3323]
H-Tyr-D-Ala-(R or S)Atc-Asp-Val-Val-Gly-NH2	DMN2AQO	Investigative	Small molecular drug	[3342]
H-Tyr-D-Ala-Aic-Asp-Val-Val-Gly-NH2	DM6ZHWS	Investigative	Small molecular drug	[3342]
H-Tyr-D-Ala-Gly Phe-Pro-Leu-Trp-O-3,5-Bzl(CF3)2	DMDF9AS	Investigative	NA	[3343]
H-Tyr-D-Ala-Gly-Phe-NH-NH-(NMe)Phe-Asp-Nle-Trp-Ac	DM4VBDW	Investigative	NA	[3344]
H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Phe-D-Asp-D-Nle-Trp-H	DM0J8P6	Investigative	NA	[3345]
H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-Bo	DMW50ZQ	Investigative	NA	[3345]
H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-H	DMF82C1	Investigative	NA	[3345]
H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-Boc	DM6UWKL	Investigative	NA	[3344]
H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-H	DMSXD63	Investigative	NA	[3344]
H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Ac	DMRUD37	Investigative	NA	[3344]
H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Boc	DMIPXCZ	Investigative	NA	[3344]
H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-H	DMFSKDM	Investigative	NA	[3345]
H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-3,5-Bzl(CF3)2	DM2K16M	Investigative	NA	[3343]
H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-Bzl	DMRE4ZI	Investigative	Small molecular drug	[3343]
H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-3,5-Bzl(CF3)2	DM1ESMZ	Investigative	NA	[3343]
H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-Bzl	DM56KDV	Investigative	Small molecular drug	[3343]
H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-O-Bzl	DMH3YKR	Investigative	Small molecular drug	[3343]
H-Tyr-D-Ala-Tic-Asp-Val-Val-Gly-NH2	DMSX8CH	Investigative	Small molecular drug	[3342]
H-Tyr-Gly-Gly-Phe-Met-NH2	DM6D0ZS	Investigative	Small molecular drug	[3323]
H-Tyr-NMe-D-Ala-Phe-Sar-NH2	DM1NT5G	Investigative	Small molecular drug	[3346]
H-Tyr-Pro-Ala-Phe-NH2	DMP0CRD	Investigative	NA	[1899]
H-Tyr-Pro-Dap(6DMN)-Phe-NH2	DMQUNGC	Investigative	Small molecular drug	[244]
H-Tyr-Pro-Phe-Ala-NH2	DM2F6L9	Investigative	Small molecular drug	[216]
H-Tyr-Pro-Phe-Phe-NH-(CH2)5-(C=O)-Dap(6DMN)-NH2	DM326GJ	Investigative	Small molecular drug	[244]
H-Tyr-Pro-Phe-Phe-NH-CH2-CH2-NH Tic Dmt-H	DMXQUKJ	Investigative	Small molecular drug	[3336]
H-Tyr-Pro-Phe-Phe-OH	DMUQLRN	Investigative	Small molecular drug	[216]
H-Tyr-Tic-Cha-Phe-OH	DM1VFLG	Investigative	Small molecular drug	[3330]
H-Tyr-Tic-OH	DMIU52O	Investigative	Small molecular drug	[3320]
H-Tyr-Tic-Phe-Phe-OH	DMI0U87	Investigative	Small molecular drug	[3347]
H-[Trp-Arg-Nva-Arg-Tyr]2-NH2	DM9XK05	Investigative	NA	[1943]
H-[Trp-Arg-Nva-Arg-Tyr]3-NH2	DMKH8PF	Investigative	NA	[1943]
H22xKi-4	DMOJI0N	Investigative	Antibody	[3348]
H2L5186303	DMYL029	Investigative	Small molecular drug	[3349]
H87/07	DM43ODJ	Investigative	Small molecular drug	[3350]
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-NH2	DMQCGRI	Investigative	NA	[2751]
HAEGTFTSDVSSYLEGQAAKEIFAWLVKGR	DMN54LS	Investigative	NA	[3351]
Halisulfate 1	DMJB87Q	Investigative	Small molecular drug	[39]
HALOPEMIDE	DMF6V8W	Investigative	Small molecular drug	[3352]
Haloxyfop	DM5SULN	Investigative	Small molecular drug	[2074]
HALOXYSTEROL A	DM4AEGQ	Investigative	Small molecular drug	[139]
HALOXYSTEROL B	DMD8O7S	Investigative	Small molecular drug	[139]
Haloxysterol C	DMU1DHM	Investigative	Small molecular drug	[139]
Haloxysterol D	DMWCZLT	Investigative	Small molecular drug	[139]
HAMI3379	DMJN0BL	Investigative	Small molecular drug	[3353]
HBR-985	DMKDBFL	Investigative	Small molecular drug	[3354]
HC-056456	DMOG1Q4	Investigative	Small molecular drug	[3355]
HC067047	DMIXY1O	Investigative	Small molecular drug	[3356]
HCGRPalpha	DM415ZX	Investigative	NA	[1855]
HDS-029	DMLRUVA	Investigative	Small molecular drug	[3357]
Heberkinasa	DM9I5Y0	Investigative	NA	[3358]
Helenalin-2-methylbutyrate	DMQPCDG	Investigative	Small molecular drug	[703]
HELENALINMETHACRYLATE	DMPOALD	Investigative	Small molecular drug	[703]
HELENAQUINONE	DM5MOLY	Investigative	Small molecular drug	[3359]
helodermin	DMIUABO	Investigative	Small molecular drug	[3360]
Heme	DMGC287	Investigative	Small molecular drug	[3361]
Hemi-Babim	DMXP276	Investigative	Small molecular drug	[22]
Hemoparatide	DMF7X31	Investigative	NA	[1866]
Heparin Pentasaccharide	DMY16VG	Investigative	Small molecular drug	[12]
Heparin-Cantithrombin III	DM7U491	Investigative	Small molecular drug	[3362]
hepoxilin A3	DMAK1W7	Investigative	Small molecular drug	[3363]
HEPT	DMK846H	Investigative	Small molecular drug	[3364]
Heptane-1,2,3-Triol	DMV4GDI	Investigative	Small molecular drug	[12]
Heptane-2,3-dione	DMCFTB8	Investigative	Small molecular drug	[397]
HEPTANOATE	DMGEO8N	Investigative	Small molecular drug	[1939]
Heptanoic Acid	DM4NY9H	Investigative	Small molecular drug	[22]
Heptulose-2-Phosphate	DMIAQX4	Investigative	Small molecular drug	[12]
Heptyl 1-Thiohexopyranoside	DMKF762	Investigative	Small molecular drug	[22]
Heptyl-Beta-D-Glucopyranoside	DMPQBN0	Investigative	Small molecular drug	[107]
Heptyl-methyl-prop-2-ynyl-amine hydrochloride	DM1NUO5	Investigative	NA	[2415]
HERBACETIN	DM8MD52	Investigative	Small molecular drug	[3229]
HERKINORIN	DMJXBWV	Investigative	Small molecular drug	[3365]
HERNIARIN	DM9UASM	Investigative	Small molecular drug	[1069]
HESPERADIN	DM2CK7B	Investigative	Small molecular drug	[3366]
Hex-RYYRIK-NH2	DMHTWN9	Investigative	Small molecular drug	[754]
Hexadecanal	DMJCHE1	Investigative	Small molecular drug	[3367]
Hexadecanoic acid	DMWUXDZ	Investigative	Small molecular drug	[3368]
Hexahydro-cyclopenta[b]pyrrol-(2Z)-ylideneamine	DMNZLD6	Investigative	Small molecular drug	[1150]
Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine	DMG0UVT	Investigative	Small molecular drug	[1150]
Hexahydro-pyrrolizin-(3E)-ylideneamine	DMIB3J2	Investigative	Small molecular drug	[1150]
hexahydrodifenidol	DMH25OD	Investigative	Small molecular drug	[3369]
hexahydrosiladifenidol	DM6UAV7	Investigative	Small molecular drug	[3370]
Hexane-1,6-diamine	DMSHF0K	Investigative	Small molecular drug	[3371]
Hexane-1,6-Diol	DMWAPGI	Investigative	Small molecular drug	[12]
Hexanoic Acid (2,6-diphenylpyrimidin-4-yl)amide	DMJOZYG	Investigative	Small molecular drug	[3372]
Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester	DM4U0L1	Investigative	Small molecular drug	[922]
hexocyclium	DM0HS7L	Investigative	Small molecular drug	[3373]
Hexyl-trimethyl-ammonium	DM9EW7V	Investigative	Small molecular drug	[131]
HG-1384	DMDQLTL	Investigative	NA	[1866]
HG-1387	DMA8ZNU	Investigative	NA	[1866]
HG-9-91-01	DM8FD3Z	Investigative	Small molecular drug	[3374]
hGCGR antagonist	DMOIPYD	Investigative	Small molecular drug	[3375]
HI-172	DMCKAWY	Investigative	Small molecular drug	[3376]
HI-236	DM3R4ZF	Investigative	Small molecular drug	[3377]
HI-240	DMQK5RM	Investigative	Small molecular drug	[3378]
HI-241	DMTKCW6	Investigative	Small molecular drug	[3377]
HI-242	DM0QYLP	Investigative	Small molecular drug	[3377]
HI-244	DMG36BD	Investigative	Small molecular drug	[458]
HI-280	DME4SML	Investigative	Small molecular drug	[3376]
HI-281	DM7K0PH	Investigative	Small molecular drug	[3376]
HI-443	DMSUWD8	Investigative	Small molecular drug	[3378]
HI-445	DMYP0DE	Investigative	NA	[3376]
HINOKININ	DMD6NZO	Investigative	Small molecular drug	[80]
HINOKITIOL	DMHL9Y6	Investigative	Small molecular drug	[1030]
His-DPhe-Arg-Trp	DMRJGOP	Investigative	Small molecular drug	[3379]
histaprodifen	DMA9YIB	Investigative	Small molecular drug	[3380]
HJC 0350	DMNI5FW	Investigative	Small molecular drug	[3381]
hK2p01 derivative KLK2 inhibitor	DME13RQ	Investigative	Small molecular drug	[3382]
HL-034	DMMW0OF	Investigative	NA	[3383]
HL-036	DMBHBOE	Investigative	NA	[1866]
HL-142	DMAQPPG	Investigative	NA	[1866]
HL-144	DM1H2SM	Investigative	NA	[1866]
HL-157	DMOE3VJ	Investigative	NA	[1866]
HMR-1556	DMXMTA9	Investigative	Small molecular drug	[3384]
HMR1883	DMNXR17	Investigative	Small molecular drug	[3385]
HMS3229G08	DMW11IX	Investigative	Small molecular drug	[3386]
HMS3229G13	DMUPS48	Investigative	Small molecular drug	[3387]
HNHA	DMOTEGL	Investigative	Small molecular drug	[3388]
HO-LVA	DMJQI7A	Investigative	NA	[3389]
HOE-33258	DMKOMP2	Investigative	Small molecular drug	[3390]
homo-AMPA	DMH96AI	Investigative	Small molecular drug	[3391]
HOMOAROMOLINE	DMIHFQY	Investigative	Small molecular drug	[2102]
Homocamptothecins (hCPTs)	DMCIRY0	Investigative	NA	[3392]
HOMOERIODICTYOL	DM1SDN8	Investigative	Small molecular drug	[1906]
HOMOPHENYLALANINYLMETHANE	DMVBTHA	Investigative	NA	[22]
homoquinolinic acid	DMBW5DU	Investigative	Small molecular drug	[3393]
Homorisedronate	DMX8DC2	Investigative	Small molecular drug	[3394]
Homoserine Lactone	DMTKN4A	Investigative	Small molecular drug	[12]
HONOKIOL	DMJWT3X	Investigative	Small molecular drug	[774]
Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2	DMHW2DU	Investigative	Small molecular drug	[3395]
Howiinol A (GHM-10)	DM2OZBL	Investigative	Small molecular drug	[3396]
HPTE	DMRPZD4	Investigative	Small molecular drug	[3397]
HQL-79	DMSHYQ3	Investigative	Small molecular drug	[3398]
HS-173	DM0A2UF	Investigative	Small molecular drug	[3399]
HS014	DMM3FD2	Investigative	NA	[3400]
HT1042	DMZRPM5	Investigative	Small molecular drug	[3401]
HTMT	DMPT8JN	Investigative	Small molecular drug	[3402]
HTS-00213	DMQ8ADE	Investigative	Small molecular drug	[1663]
HTS-00798	DMXV379	Investigative	Small molecular drug	[1441]
HTS-02876	DMVUTJ5	Investigative	Small molecular drug	[1663]
HTS-05058	DM3F4IQ	Investigative	Small molecular drug	[3403]
HTS-466284	DM70YTF	Investigative	Small molecular drug	[22]
HTS01037	DM2SQ2A	Investigative	Small molecular drug	[3404]
HTyr-Gly-Gly-Phe-Leu-Arg-Arg-lle-Arg-Pro-LysNH2	DM25KZE	Investigative	NA	[3405]
HU210	DM48F3D	Investigative	Small molecular drug	[3406]
Human CD40 agonist ligand	DM8FLVH	Investigative	NA	[3407]
Human growth hormone	DM3NRWE	Investigative	NA	[1866]
human monoclonal antibodies (GM-CSF)	DMFV5UL	Investigative	NA	[1866]
Huprine X	DMTPXB6	Investigative	Small molecular drug	[3408]
Huprine-Tacrine Heterodimer	DMJ4ME7	Investigative	NA	[3409]
HwFwLL-NH2	DM1D5F0	Investigative	Small molecular drug	[2196]
HX 531	DMG8MK1	Investigative	Small molecular drug	[3410]
Hyacinthacine B3	DMJ9KNU	Investigative	Small molecular drug	[2008]
Hydantocidin-5'-Monophosphate	DMOTXP1	Investigative	Small molecular drug	[12]
HYDRAZINECARBOXAMIDE	DMARWG5	Investigative	Small molecular drug	[1081]
Hydrohalisulfate 1	DM0HQF6	Investigative	Small molecular drug	[39]
Hydrolyzed Cephalothin	DMWH92F	Investigative	Small molecular drug	[12]
HYDROSULFIDE	DMO32HN	Investigative	Small molecular drug	[2222]
Hydroxyacetic Acid	DMQFBH6	Investigative	Small molecular drug	[12]
Hydroxyalanine	DM5HWZY	Investigative	NA	[107]
Hydroxyaminovaline	DMUVCRQ	Investigative	Small molecular drug	[12]
Hydroxycitric acid	DMY0A9E	Investigative	Small molecular drug	[3411]
hydroxycitronellal	DMFHCV9	Investigative	Small molecular drug	[3412]
Hydroxyclemastine	DM5DOEC	Investigative	Small molecular drug	[3413]
Hydroxydimethylarsine Oxide	DMPS2B1	Investigative	Small molecular drug	[12]
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	DMA4SIN	Investigative	Small molecular drug	[22]
HYG-104	DMRXD65	Investigative	NA	[1866]
HYG-112	DMD9IO9	Investigative	NA	[1866]
HYG-113	DMOPBBZ	Investigative	NA	[1866]
HYG-114	DMLFARG	Investigative	NA	[1866]
HYG-201	DMIRRQ8	Investigative	NA	[1866]
HYG-202	DMWT52L	Investigative	NA	[1866]
HYG-301	DM1I741	Investigative	NA	[1866]
HYG-302	DMS906N	Investigative	NA	[1866]
Hygromycin B	DMEZ92A	Investigative	Small molecular drug	[782]
HYNIC Analogue	DMETS37	Investigative	NA	[246]
hyp 9	DM0U8IV	Investigative	Small molecular drug	[3414]
Hyperforin	DM2L3PE	Investigative	Small molecular drug	[3415]
hypoglaucin A	DMJKIUX	Investigative	Small molecular drug	[3416]
Hypoxanthine	DMLSABI	Investigative	Small molecular drug	[3417]
Hyrtiosulawesine	DMWLJ5S	Investigative	Small molecular drug	[3418]
I-309	DM7QE51	Investigative	Small molecular drug	[3419]
I-5	DM1TQ7N	Investigative	Small molecular drug	[12]
I-ABA	DMIJ2GV	Investigative	Small molecular drug	[3420]
I-ABOPX	DM5X0JS	Investigative	Small molecular drug	[3421]
I-BET151	DMYRUH2	Investigative	Small molecular drug	[3422]
I-BOP	DMJAPML	Investigative	Small molecular drug	[3423]
I-BRD9	DM9C8FP	Investigative	Small molecular drug	[3424]
I-CBP112	DMQX3W6	Investigative	Small molecular drug	[3425]
I-SAP	DMJ2FQA	Investigative	Small molecular drug	[3426]
IAA-94	DMFSAK3	Investigative	Small molecular drug	[3427]
IBC 293	DM8J24A	Investigative	Small molecular drug	[3428]
iberiotoxin	DMRIG3O	Investigative	Small molecular drug	[3429]
Ibogaine	DM3HJX7	Investigative	Small molecular drug	[3430]
ibotenate	DM8RZE0	Investigative	Small molecular drug	[3431]
IBZM	DMUSRJ8	Investigative	Small molecular drug	[3017]
IC86621	DMWRVGE	Investigative	Small molecular drug	[3432]
IC87114	DMM50ED	Investigative	Small molecular drug	[3433]
IC980033	DM8L6WB	Investigative	Small molecular drug	[3433]
ICA-105574	DMS9H2P	Investigative	Small molecular drug	[3434]
ICA-27243	DMO0N3Q	Investigative	Small molecular drug	[3435]
Icariside II	DM3DB8X	Investigative	Small molecular drug	[1159]
ICI 154129	DMN6UET	Investigative	Small molecular drug	[3436]
ICI 200,355	DMLPZ3N	Investigative	Small molecular drug	[3437]
ICI 200,880	DM0PQ37	Investigative	Small molecular drug	[3438]
ICI-174864	DM1D6CQ	Investigative	Small molecular drug	[3439]
ICI-198583	DMW4L3K	Investigative	Small molecular drug	[3440]
ICI-199441	DMEWZ80	Investigative	Small molecular drug	[3441]
ICI-204448	DMNA8RS	Investigative	Small molecular drug	[3442]
ICI-211965	DMYRILU	Investigative	Small molecular drug	[3443]
icilin	DMYVOL9	Investigative	Small molecular drug	[3444]
ICR 62	DMH4KGX	Investigative	Antibody	[3445]
ICRF-154	DM9DXRL	Investigative	Small molecular drug	[3446]
IDD552	DM3P7W5	Investigative	Small molecular drug	[12]
IDD594	DMDHLG3	Investigative	Small molecular drug	[22]
IDN-1965	DMRQSN2	Investigative	Small molecular drug	[3447]
IGERNELLIN	DMFMY1L	Investigative	Small molecular drug	[39]
IIK7	DMLYIBO	Investigative	Small molecular drug	[3448]
IK-862	DMJA4UE	Investigative	Small molecular drug	[3449]
IkappaB-alphaM	DM2X3EV	Investigative	NA	[3450]
IKs124	DMLY5IF	Investigative	Small molecular drug	[3451]
IL-2 antibody (anti-tumor)	DMU6AMP	Investigative	NA	[3452]
IL-28B immunoadjuvant	DMLEDCT	Investigative	NA	[1866]
Il-8((3-73))K11R	DM10Z5W	Investigative	NA	[3453]
Il-94	DMPNQ27	Investigative	Small molecular drug	[3454]
IM-023911	DMZW0YO	Investigative	Small molecular drug	[1420]
IM-094261	DMTFV65	Investigative	Small molecular drug	[1420]
IM-094882	DMO18YN	Investigative	Small molecular drug	[1434]
IM-12	DM58DGY	Investigative	Small molecular drug	[3455]
IM-491	DMUQO86	Investigative	Small molecular drug	[3456]
imbutamine	DMPKWUO	Investigative	Small molecular drug	[3457]
Imetit	DMMJ6NS	Investigative	Small molecular drug	[3458]
Imidazolidin-2-ylidene-o-tolyl-amine	DMTGRAF	Investigative	Small molecular drug	[1973]
Imidazolidin-2-ylidene-quinoxalin-6-yl-amine	DMZ5ISH	Investigative	Small molecular drug	[1973]
imiloxan	DMS4D96	Investigative	Small molecular drug	[3459]
Immepip	DMDM3Y1	Investigative	Small molecular drug	[3460]
Immethridine	DM7YQ26	Investigative	Small molecular drug	[3461]
Immucillin-G	DMX2NKO	Investigative	Small molecular drug	[2209]
impentamine	DMPJXZN	Investigative	Small molecular drug	[3462]
IMPERATORIN	DMVLW6R	Investigative	Small molecular drug	[3073]
improgan	DMQ4ICU	Investigative	Small molecular drug	[3463]
impromidine	DMTDRPM	Investigative	Small molecular drug	[3464]
IN-1130	DM3YJXF	Investigative	Small molecular drug	[3465]
IN-1166	DMMS6D3	Investigative	Small molecular drug	[3465]
IN-3	DMENHMU	Investigative	Small molecular drug	[3466]
IN1479	DM4JNUH	Investigative	Small molecular drug	[3467]
IN1535	DMKFE6X	Investigative	Small molecular drug	[3468]
incensole acetate	DMONMHK	Investigative	Small molecular drug	[3469]
Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester	DMVZMBU	Investigative	Small molecular drug	[1011]
indanidine	DM4S81A	Investigative	Small molecular drug	[3470]
Indatraline	DMIP9DN	Investigative	Small molecular drug	[3471]
indirubin deriv. 8a	DMYLVQF	Investigative	Small molecular drug	[3472]
indirubin derivative E804	DMFP1C5	Investigative	Small molecular drug	[3473]
Indirubin-3'-monoxime	DMLRQH0	Investigative	Small molecular drug	[3474]
Indirubin-3-acetoxime	DM3UR1E	Investigative	Small molecular drug	[1747]
Indirubin-3-methoxime	DMZ5ODC	Investigative	Small molecular drug	[1747]
Indirubin-5-sulfonate	DM08VHZ	Investigative	Small molecular drug	[12]
Indol-1-yl-methyl-pyridin-4-yl-amine	DMJB876	Investigative	Small molecular drug	[137]
Indol-1-yl-prop-2-ynyl-pyridin-4-yl-amine	DMR9GNW	Investigative	Small molecular drug	[137]
Indol-1-yl-pyridin-4-yl-amine	DM1F53L	Investigative	Small molecular drug	[137]
INDOLACTUM	DMP543H	Investigative	Small molecular drug	[3475]
Indole Naphthyridinone	DMB4ZNW	Investigative	Small molecular drug	[12]
indole-3-propionic acid	DMF0VAG	Investigative	Small molecular drug	[3476]
Indolin-2-one deriv. 4b	DMML9AY	Investigative	Small molecular drug	[3477]
Infractopicrin	DMV6UJ5	Investigative	Small molecular drug	[651]
Ingenol-3-bezoate	DM487FU	Investigative	Small molecular drug	[3478]
Inhibitor 1 [Colombo et al., 2012]	DMUQHMP	Investigative	Small molecular drug	[3479]
inhibitor 19	DMWIHRX	Investigative	Small molecular drug	[3480]
Inhibitor Idd 384	DMBQY3C	Investigative	Small molecular drug	[12]
Inosinic Acid	DMLR86H	Investigative	Small molecular drug	[3481]
Inositol 1,3,4,5-Tetrakisphosphate	DMIFD35	Investigative	Small molecular drug	[3482]
inositol 1-phosphate	DMQWI6B	Investigative	Small molecular drug	[3483]
inositol 2,4,5-trisphosphate	DM43G5Z	Investigative	Small molecular drug	[3484]
inositol 3-phosphate	DMZXXW9	Investigative	Small molecular drug	[3485]
inositol 4-phosphate	DMX6UOH	Investigative	Small molecular drug	[3486]
Ins(3,4,5,6)P4	DMAQU71	Investigative	Small molecular drug	[3487]
INS48823	DMLZFTH	Investigative	Small molecular drug	[3488]
INS49266	DM95BL8	Investigative	Small molecular drug	[3489]
Insulin molecules, Novo	DMFU92Z	Investigative	NA	[3490]
Interleukin-1-alpha - Amgen/Roche	DMB9AIX	Investigative	NA	[3491]
interleukin-2, Roussel Uclaf	DM3D9XY	Investigative	NA	[3492]
IODIDE	DM3FZ6P	Investigative	Small molecular drug	[3493]
Iodo-Phenylalanine	DMF8EJ6	Investigative	Small molecular drug	[12]
Iodoacetamide	DMM4XVL	Investigative	Small molecular drug	[3494]
iodoaminopotentidine	DM7AHNF	Investigative	Small molecular drug	[3495]
iodocyanopindolol	DMOA2J8	Investigative	Small molecular drug	[3496]
IODOINDOMETHACIN	DM3BL0G	Investigative	Small molecular drug	[2886]
IODOPRIDE	DM0749Z	Investigative	Small molecular drug	[3017]
IODOPROXYFAN	DMDA6VL	Investigative	Small molecular drug	[3497]
IODOSULPIRIDE	DMXYFMB	Investigative	Small molecular drug	[3017]
IODOSUPROFEN	DMOE8LT	Investigative	Small molecular drug	[2886]
Iodotubercidin	DMQMH6S	Investigative	Small molecular drug	[1731]
Iodyl-benzene	DMO73M9	Investigative	Small molecular drug	[614]
IOX1	DMYG0M5	Investigative	Small molecular drug	[3498]
IOX2	DMQ0X7I	Investigative	Small molecular drug	[3499]
Ip5I	DMB2YXN	Investigative	Small molecular drug	[3500]
iperoxo	DM6OHVU	Investigative	Small molecular drug	[3501]
IPRONIAZIDE	DM42ENF	Investigative	Small molecular drug	[999]
IQM-97423	DM2MXIK	Investigative	Small molecular drug	[3502]
IRAK-1/4 inhibitor	DMOQBGP	Investigative	Small molecular drug	[3503]
IRAK4 inhibitor 4b	DMC80TA	Investigative	Small molecular drug	[3504]
IRAK4 inhibitor rac-45	DM1XHNW	Investigative	Small molecular drug	[3505]
IRL-1722	DMMGQZ8	Investigative	Small molecular drug	[3506]
IRL-1841	DML0S7V	Investigative	Small molecular drug	[3506]
IS1	DMNF70P	Investigative	Small molecular drug	[3507]
IS20	DMQ5GA9	Investigative	Small molecular drug	[3508]
IS20I	DMXPMA6	Investigative	NA	[3509]
ISA-2011B	DMU6QXV	Investigative	Small molecular drug	[3510]
ISAINDIGOTONE	DMD6U4F	Investigative	Small molecular drug	[3511]
ischemin	DMM2I9G	Investigative	Small molecular drug	[3512]
ISIS 100742	DMIB6JL	Investigative	Antisense drug	[3513]
ISIS 100743	DMI7PGZ	Investigative	Antisense drug	[3513]
ISIS 100748	DMFW5VK	Investigative	Antisense drug	[3513]
ISIS 100749	DMSMJ37	Investigative	Antisense drug	[3513]
ISIS 100750	DMFJES5	Investigative	Antisense drug	[3513]
ISIS 100913	DMZV5A7	Investigative	Antisense drug	[3514]
ISIS 100929	DMUMVIF	Investigative	Antisense drug	[3514]
ISIS 100935	DMHUC1X	Investigative	Antisense drug	[3514]
ISIS 100939	DM67Q3C	Investigative	Antisense drug	[3514]
ISIS 101952	DMS6JD4	Investigative	Antisense drug	[3515]
ISIS 101960	DMEWXR2	Investigative	Antisense drug	[3515]
ISIS 101983	DMV9PI7	Investigative	Antisense drug	[3515]
ISIS 101984	DMYZ5CX	Investigative	Antisense drug	[3515]
ISIS 101985	DM8CN2M	Investigative	Antisense drug	[3515]
ISIS 101986	DM5PTQX	Investigative	Antisense drug	[3515]
ISIS 101987	DMWCK8Q	Investigative	Antisense drug	[3515]
ISIS 101995	DM3EMLB	Investigative	Antisense drug	[3515]
ISIS 101996	DM5APGL	Investigative	Antisense drug	[3515]
ISIS 101997	DMUZJCD	Investigative	Antisense drug	[3515]
ISIS 101998	DMEH6G1	Investigative	Antisense drug	[3515]
ISIS 10228	DMESKQX	Investigative	Antisense drug	[3516]
ISIS 102450	DML40N3	Investigative	Antisense drug	[3517]
ISIS 102454	DMNSEH1	Investigative	Antisense drug	[3517]
ISIS 102458	DMBUTFN	Investigative	Antisense drug	[3517]
ISIS 102462	DMXNC0B	Investigative	Antisense drug	[3517]
ISIS 102466	DMAG8QO	Investigative	Antisense drug	[3517]
ISIS 102478	DMU70ND	Investigative	Antisense drug	[3517]
ISIS 102482	DMMBJWK	Investigative	Antisense drug	[3517]
ISIS 102486	DMTMBEX	Investigative	Antisense drug	[3517]
ISIS 102490	DMMWVCH	Investigative	Antisense drug	[3517]
ISIS 102558	DMYJO7T	Investigative	Antisense drug	[3517]
ISIS 102563	DMTHMF0	Investigative	Antisense drug	[3517]
ISIS 102584	DMEDFLA	Investigative	Antisense drug	[3517]
ISIS 102599	DM3RVUY	Investigative	Antisense drug	[3517]
ISIS 102604	DMZ6X9B	Investigative	Antisense drug	[3517]
ISIS 102609	DM60LT9	Investigative	Antisense drug	[3517]
ISIS 102614	DMEB36I	Investigative	Antisense drug	[3517]
ISIS 102619	DMXH9IT	Investigative	Antisense drug	[3517]
ISIS 102624	DMGO4TZ	Investigative	Antisense drug	[3517]
ISIS 102629	DMNSZPX	Investigative	Antisense drug	[3517]
ISIS 102633	DMWT7BK	Investigative	Antisense drug	[3517]
ISIS 102660	DM6KUV9	Investigative	Antisense drug	[3517]
ISIS 102664	DMKI6L5	Investigative	Antisense drug	[3517]
ISIS 102668	DMY87QX	Investigative	Antisense drug	[3517]
ISIS 102676	DMFP598	Investigative	Antisense drug	[3517]
ISIS 10303	DM205TE	Investigative	Antisense drug	[3518]
ISIS 10310	DMT6H9S	Investigative	Antisense drug	[3518]
ISIS 10311	DMQ3KUV	Investigative	Antisense drug	[3518]
ISIS 103375	DMX835E	Investigative	Antisense drug	[3519]
ISIS 103386	DMBAM5K	Investigative	Antisense drug	[3519]
ISIS 103387	DMW8GIT	Investigative	Antisense drug	[3519]
ISIS 103471	DM86KWU	Investigative	Antisense drug	[3520]
ISIS 103473	DMQRP32	Investigative	Antisense drug	[3520]
ISIS 103486	DM5BSVQ	Investigative	Antisense drug	[3520]
ISIS 103489	DM6ZME7	Investigative	Antisense drug	[3520]
ISIS 103582	DME9Q8L	Investigative	Antisense drug	[3521]
ISIS 103601	DM6BH7K	Investigative	Antisense drug	[3521]
ISIS 103612	DM298KT	Investigative	Antisense drug	[3521]
ISIS 103613	DMNPMW4	Investigative	Antisense drug	[3521]
ISIS 103615	DMGTX6O	Investigative	Antisense drug	[3521]
ISIS 103616	DM3PK2G	Investigative	Antisense drug	[3521]
ISIS 103619	DMERJAV	Investigative	Antisense drug	[3521]
ISIS 103620	DM61FYM	Investigative	Antisense drug	[3521]
ISIS 103621	DMP7VJL	Investigative	Antisense drug	[3521]
ISIS 103622	DM9J4I3	Investigative	Antisense drug	[3521]
ISIS 103624	DMST2QW	Investigative	Antisense drug	[3521]
ISIS 103629	DMJLHE7	Investigative	Antisense drug	[3521]
ISIS 103631	DMOK9FA	Investigative	Antisense drug	[3521]
ISIS 103635	DMVW7N5	Investigative	Antisense drug	[3521]
ISIS 103669	DM3TIJD	Investigative	Antisense drug	[3521]
ISIS 103671	DMF9JAH	Investigative	Antisense drug	[3521]
ISIS 103701	DMQ48YZ	Investigative	Antisense drug	[3521]
ISIS 103708	DMLVPOA	Investigative	Antisense drug	[3521]
ISIS 10373	DM60CBI	Investigative	Antisense drug	[3522]
ISIS 103736	DMKI6JF	Investigative	Antisense drug	[3521]
ISIS 103747	DM7DOY3	Investigative	Antisense drug	[3521]
ISIS 103752	DMBZVW0	Investigative	Antisense drug	[3521]
ISIS 103771	DM8HDW6	Investigative	Antisense drug	[3521]
ISIS 103803	DMVL8O0	Investigative	Antisense drug	[3521]
ISIS 103806	DMA0D8I	Investigative	Antisense drug	[3521]
ISIS 103819	DMFQ10R	Investigative	Antisense drug	[3521]
ISIS 104211	DMPKQ61	Investigative	Antisense drug	[3523]
ISIS 104253	DMME8JP	Investigative	Antisense drug	[3523]
ISIS 104254	DMDEI9X	Investigative	Antisense drug	[3523]
ISIS 104255	DMAI5B8	Investigative	Antisense drug	[3523]
ISIS 104256	DMHUX9A	Investigative	Antisense drug	[3523]
ISIS 104257	DMSDCGV	Investigative	Antisense drug	[3523]
ISIS 104258	DMUC3L0	Investigative	Antisense drug	[3523]
ISIS 10582	DMB5F9H	Investigative	Antisense drug	[3524]
ISIS 105987	DMIGV0H	Investigative	Antisense drug	[3525]
ISIS 105989	DMFOSYU	Investigative	Antisense drug	[3525]
ISIS 105990	DM8FY3H	Investigative	Antisense drug	[3526]
ISIS 106008	DMTY6O9	Investigative	Antisense drug	[3525]
ISIS 10639	DM4YJQG	Investigative	Antisense drug	[3524]
ISIS 10707	DMYG5IO	Investigative	Antisense drug	[3516]
ISIS 107612	DMBWCZR	Investigative	Antisense drug	[3527]
ISIS 107642	DMPR7OD	Investigative	Antisense drug	[3527]
ISIS 107652	DMOX8JF	Investigative	Antisense drug	[3527]
ISIS 107676	DMUE64H	Investigative	Antisense drug	[3527]
ISIS 107681	DMB9VFS	Investigative	Antisense drug	[3527]
ISIS 107772	DM37VYR	Investigative	Antisense drug	[3528]
ISIS 107773	DMA3ZGH	Investigative	Antisense drug	[3528]
ISIS 107774	DMFOTQY	Investigative	Antisense drug	[3528]
ISIS 107775	DMLBX9Z	Investigative	Antisense drug	[3528]
ISIS 107776	DMNHBGJ	Investigative	Antisense drug	[3528]
ISIS 107791	DMVTU63	Investigative	Antisense drug	[3528]
ISIS 107792	DMV87MP	Investigative	Antisense drug	[3528]
ISIS 109110	DM83TLC	Investigative	Antisense drug	[3529]
ISIS 109111	DM0UOL3	Investigative	Antisense drug	[3529]
ISIS 109112	DM6R5YW	Investigative	Antisense drug	[3529]
ISIS 109113	DM58XT1	Investigative	Antisense drug	[3529]
ISIS 109114	DMUDFZN	Investigative	Antisense drug	[3529]
ISIS 109115	DMBMDG7	Investigative	Antisense drug	[3529]
ISIS 109116	DMQ8K9J	Investigative	Antisense drug	[3529]
ISIS 109351	DM508BS	Investigative	Antisense drug	[3530]
ISIS 109352	DMWK1XC	Investigative	Antisense drug	[3530]
ISIS 109353	DM6AJMC	Investigative	Antisense drug	[3530]
ISIS 109354	DM1REKQ	Investigative	Antisense drug	[3530]
ISIS 109355	DMFIQGW	Investigative	Antisense drug	[3530]
ISIS 109490	DMDVE6A	Investigative	Antisense drug	[3531]
ISIS 109491	DMISNWV	Investigative	Antisense drug	[3531]
ISIS 109502	DMRPMN6	Investigative	Antisense drug	[3531]
ISIS 109524	DMJ7EDV	Investigative	Antisense drug	[3531]
ISIS 109525	DMB28D3	Investigative	Antisense drug	[3531]
ISIS 109526	DMZN60F	Investigative	Antisense drug	[3531]
ISIS 110064	DMXNG1S	Investigative	Antisense drug	[3532]
ISIS 110065	DMBOU16	Investigative	Antisense drug	[3532]
ISIS 110066	DM4B35Y	Investigative	Antisense drug	[3532]
ISIS 110067	DM0EFHM	Investigative	Antisense drug	[3532]
ISIS 110068	DMSLOKM	Investigative	Antisense drug	[3532]
ISIS 110073	DMUG4HJ	Investigative	Antisense drug	[3532]
ISIS 110074	DM2KECW	Investigative	Antisense drug	[3532]
ISIS 11061	DMNKY2R	Investigative	Antisense drug	[3516]
ISIS 111084	DMF4V58	Investigative	Antisense drug	[3533]
ISIS 111085	DMJQS5O	Investigative	Antisense drug	[3533]
ISIS 111086	DMJ86U4	Investigative	Antisense drug	[3533]
ISIS 111105	DM2VNUW	Investigative	Antisense drug	[3533]
ISIS 111117	DMAVQK3	Investigative	Antisense drug	[3533]
ISIS 111118	DM2N8JX	Investigative	Antisense drug	[3533]
ISIS 111119	DM019LA	Investigative	Antisense drug	[3533]
ISIS 111120	DM3W8R0	Investigative	Antisense drug	[3533]
ISIS 111121	DMIHTPC	Investigative	Antisense drug	[3533]
ISIS 11155	DMB31GR	Investigative	Antisense drug	[3534]
ISIS 11158	DMX1OI8	Investigative	Antisense drug	[3535]
ISIS 11159	DM9V6FW	Investigative	Antisense drug	[3535]
ISIS 111992	DMNIBTG	Investigative	Antisense drug	[3536]
ISIS 111993	DMVMDAZ	Investigative	Antisense drug	[3536]
ISIS 111997	DMSXTRI	Investigative	Antisense drug	[3536]
ISIS 112000	DM1NHJ8	Investigative	Antisense drug	[3536]
ISIS 112001	DM2K74C	Investigative	Antisense drug	[3536]
ISIS 112002	DMPROW5	Investigative	Antisense drug	[3536]
ISIS 112003	DMHRLYJ	Investigative	Antisense drug	[3536]
ISIS 112004	DMRJ1L6	Investigative	Antisense drug	[3536]
ISIS 112005	DMDZY8F	Investigative	Antisense drug	[3536]
ISIS 112019	DMN6IBS	Investigative	Antisense drug	[3536]
ISIS 112020	DMO2FY8	Investigative	Antisense drug	[3536]
ISIS 112021	DM0E1SH	Investigative	Antisense drug	[3536]
ISIS 112022	DM7R53M	Investigative	Antisense drug	[3536]
ISIS 112023	DM5F4Q6	Investigative	Antisense drug	[3536]
ISIS 112024	DMVLHN9	Investigative	Antisense drug	[3536]
ISIS 11219	DMW3145	Investigative	Antisense drug	[3537]
ISIS 11220	DMNJS0K	Investigative	Antisense drug	[3537]
ISIS 11221	DMDUIG3	Investigative	Antisense drug	[3537]
ISIS 11223	DM7LPI4	Investigative	Antisense drug	[3537]
ISIS 11224	DMMGA6K	Investigative	Antisense drug	[3537]
ISIS 112580	DMXHQSG	Investigative	Antisense drug	[3538]
ISIS 112590	DMU5QRX	Investigative	Antisense drug	[3538]
ISIS 112592	DM9OPJW	Investigative	Antisense drug	[3538]
ISIS 112599	DMIYCMF	Investigative	Antisense drug	[3538]
ISIS 112690	DM6PO0N	Investigative	Antisense drug	[3538]
ISIS 112694	DMA4635	Investigative	Antisense drug	[3538]
ISIS 112696	DMXZS4Y	Investigative	Antisense drug	[3538]
ISIS 112699	DMIE0GJ	Investigative	Antisense drug	[3538]
ISIS 112711	DM52UGS	Investigative	Antisense drug	[3538]
ISIS 112724	DMB2O1Y	Investigative	Antisense drug	[3538]
ISIS 113019	DMVCYBG	Investigative	Antisense drug	[3539]
ISIS 113020	DMUXN8P	Investigative	Antisense drug	[3539]
ISIS 113021	DMQ4GL6	Investigative	Antisense drug	[3539]
ISIS 113022	DMOQ0XD	Investigative	Antisense drug	[3539]
ISIS 113048	DMKTNVJ	Investigative	Antisense drug	[3539]
ISIS 113131	DM063XM	Investigative	Antisense drug	[3526]
ISIS 113176	DM5QEP4	Investigative	Antisense drug	[3540]
ISIS 113187	DM4E6Y8	Investigative	Antisense drug	[3540]
ISIS 113209	DMGVN7A	Investigative	Antisense drug	[3540]
ISIS 113210	DMZWH6E	Investigative	Antisense drug	[3540]
ISIS 113858	DM9D3F1	Investigative	Antisense drug	[3541]
ISIS 113871	DMTEUDL	Investigative	Antisense drug	[3541]
ISIS 113872	DMR05YO	Investigative	Antisense drug	[3541]
ISIS 113873	DMHUC3Q	Investigative	Antisense drug	[3541]
ISIS 113874	DMEMSW1	Investigative	Antisense drug	[3541]
ISIS 113902	DMI8NYF	Investigative	Antisense drug	[3541]
ISIS 113903	DM56A89	Investigative	Antisense drug	[3541]
ISIS 113904	DMBM7HD	Investigative	Antisense drug	[3541]
ISIS 113905	DMPRDXO	Investigative	Antisense drug	[3541]
ISIS 113906	DMPJAB5	Investigative	Antisense drug	[3541]
ISIS 113907	DMP6WE0	Investigative	Antisense drug	[3541]
ISIS 113908	DMKLZ2H	Investigative	Antisense drug	[3541]
ISIS 113909	DM0B9V5	Investigative	Antisense drug	[3541]
ISIS 114170	DMUVS0E	Investigative	Antisense drug	[3542]
ISIS 114184	DM60V4N	Investigative	Antisense drug	[3542]
ISIS 114197	DMVJN4B	Investigative	Antisense drug	[3542]
ISIS 114232	DM2GH8X	Investigative	Antisense drug	[3542]
ISIS 114371	DMBO3YT	Investigative	Antisense drug	[3543]
ISIS 114372	DMNTRKI	Investigative	Antisense drug	[3543]
ISIS 114388	DMIZH16	Investigative	Antisense drug	[3543]
ISIS 114390	DM1H428	Investigative	Antisense drug	[3543]
ISIS 114397	DMCBXQK	Investigative	Antisense drug	[3543]
ISIS 114399	DMZVE0S	Investigative	Antisense drug	[3543]
ISIS 114404	DMIOWBH	Investigative	Antisense drug	[3543]
ISIS 114442	DMCVP5G	Investigative	Antisense drug	[3543]
ISIS 114527	DM1OVSW	Investigative	Antisense drug	[3544]
ISIS 114530	DMSEQ61	Investigative	Antisense drug	[3544]
ISIS 114531	DMZSUA9	Investigative	Antisense drug	[3544]
ISIS 114532	DMJ7BOL	Investigative	Antisense drug	[3544]
ISIS 114537	DMD9O2H	Investigative	Antisense drug	[3544]
ISIS 114559	DMMOPUK	Investigative	Antisense drug	[3544]
ISIS 114563	DMD2J3Q	Investigative	Antisense drug	[3544]
ISIS 116359	DM280AE	Investigative	Antisense drug	[3545]
ISIS 116360	DMFEZHM	Investigative	Antisense drug	[3545]
ISIS 116361	DMWBQHS	Investigative	Antisense drug	[3545]
ISIS 116362	DM7M1UB	Investigative	Antisense drug	[3545]
ISIS 116363	DMXKAJP	Investigative	Antisense drug	[3545]
ISIS 116414	DM4Q3JO	Investigative	Antisense drug	[3545]
ISIS 116505	DMVE5UH	Investigative	Antisense drug	[3546]
ISIS 116507	DM76CYG	Investigative	Antisense drug	[3546]
ISIS 116508	DM3XHBR	Investigative	Antisense drug	[3546]
ISIS 116625	DMIJES1	Investigative	Antisense drug	[3547]
ISIS 116631	DM2X5RT	Investigative	Antisense drug	[3547]
ISIS 116632	DMW2Q4T	Investigative	Antisense drug	[3547]
ISIS 116648	DMUOB3S	Investigative	Antisense drug	[3547]
ISIS 11665	DMYWINR	Investigative	Antisense drug	[3535]
ISIS 116654	DMBJU2X	Investigative	Antisense drug	[3547]
ISIS 116670	DM9R51M	Investigative	Antisense drug	[3547]
ISIS 119262	DMIS715	Investigative	Antisense drug	[3548]
ISIS 119263	DMD3M9J	Investigative	Antisense drug	[3548]
ISIS 119264	DM0P3R5	Investigative	Antisense drug	[3548]
ISIS 119281	DMFPM5S	Investigative	Antisense drug	[3548]
ISIS 119282	DMLND5S	Investigative	Antisense drug	[3548]
ISIS 119283	DMKJ57H	Investigative	Antisense drug	[3548]
ISIS 119284	DM7CTVE	Investigative	Antisense drug	[3548]
ISIS 119285	DMYQR3A	Investigative	Antisense drug	[3548]
ISIS 119286	DM42LSO	Investigative	Antisense drug	[3548]
ISIS 11929	DMZYOPD	Investigative	Antisense drug	[3535]
ISIS 122970	DM0LMQH	Investigative	Antisense drug	[3549]
ISIS 122971	DM4NBX0	Investigative	Antisense drug	[3549]
ISIS 122974	DMLHA6K	Investigative	Antisense drug	[3549]
ISIS 122975	DM4Y8EQ	Investigative	Antisense drug	[3549]
ISIS 122976	DM7OSZI	Investigative	Antisense drug	[3549]
ISIS 122984	DMVZS1D	Investigative	Antisense drug	[3549]
ISIS 122985	DM6JVOP	Investigative	Antisense drug	[3549]
ISIS 122986	DMU79FD	Investigative	Antisense drug	[3549]
ISIS 122990	DMLN8XS	Investigative	Antisense drug	[3549]
ISIS 122991	DMHAWMV	Investigative	Antisense drug	[3549]
ISIS 12659	DMZGKHO	Investigative	Antisense drug	[3550]
ISIS 12660	DMNOPWB	Investigative	Antisense drug	[3550]
ISIS 12882	DMAXB8T	Investigative	Antisense drug	[3551]
ISIS 12883	DMND0JL	Investigative	Antisense drug	[3551]
ISIS 12884	DMS15A3	Investigative	Antisense drug	[3551]
ISIS 133206	DMKY5LI	Investigative	Antisense drug	[3552]
ISIS 133207	DMR3KLF	Investigative	Antisense drug	[3552]
ISIS 133208	DMTSKQZ	Investigative	Antisense drug	[3552]
ISIS 133211	DMCGF2P	Investigative	Antisense drug	[3552]
ISIS 133242	DMP60XE	Investigative	Antisense drug	[3552]
ISIS 133243	DM2PIAZ	Investigative	Antisense drug	[3552]
ISIS 133244	DMTGFXI	Investigative	Antisense drug	[3552]
ISIS 133245	DMO09DU	Investigative	Antisense drug	[3552]
ISIS 133712	DMDZ3FU	Investigative	Antisense drug	[3526]
ISIS 133726	DMJ56XU	Investigative	Antisense drug	[3526]
ISIS 134499	DM90TOR	Investigative	Antisense drug	[3553]
ISIS 134524	DMFCOA5	Investigative	Antisense drug	[3553]
ISIS 134528	DMYZNIW	Investigative	Antisense drug	[3553]
ISIS 134532	DMRFMVL	Investigative	Antisense drug	[3553]
ISIS 134563	DMWRYA1	Investigative	Antisense drug	[3553]
ISIS 134564	DM8J24F	Investigative	Antisense drug	[3553]
ISIS 134565	DM9FR3A	Investigative	Antisense drug	[3553]
ISIS 134566	DMCM2S4	Investigative	Antisense drug	[3553]
ISIS 134583	DM0HWRN	Investigative	Antisense drug	[3553]
ISIS 134601	DMNP8HG	Investigative	Antisense drug	[3553]
ISIS 134602	DMDS4BP	Investigative	Antisense drug	[3553]
ISIS 134603	DM01UDZ	Investigative	Antisense drug	[3553]
ISIS 134604	DM32XGR	Investigative	Antisense drug	[3553]
ISIS 134605	DMCPKV9	Investigative	Antisense drug	[3553]
ISIS 134606	DM4OF6C	Investigative	Antisense drug	[3553]
ISIS 134607	DMZDJF3	Investigative	Antisense drug	[3553]
ISIS 134608	DMVX9IT	Investigative	Antisense drug	[3553]
ISIS 134609	DMYODMN	Investigative	Antisense drug	[3553]
ISIS 13727	DMCDW4H	Investigative	Antisense drug	[3554]
ISIS 13730	DMRJBH4	Investigative	Antisense drug	[3554]
ISIS 13740	DM5Q12D	Investigative	Antisense drug	[3554]
ISIS 13741	DMC7Q38	Investigative	Antisense drug	[3554]
ISIS 13743	DMO6R1I	Investigative	Antisense drug	[3554]
ISIS 13805	DMLVKPD	Investigative	Antisense drug	[3522]
ISIS 13812	DMPXCZ7	Investigative	Antisense drug	[3522]
ISIS 138612	DMLE7YQ	Investigative	Antisense drug	[3555]
ISIS 138613	DMN3L0Y	Investigative	Antisense drug	[3555]
ISIS 138616	DM1FX7N	Investigative	Antisense drug	[3555]
ISIS 138647	DM73NIE	Investigative	Antisense drug	[3555]
ISIS 138648	DMSUKAO	Investigative	Antisense drug	[3555]
ISIS 138649	DMNFYZL	Investigative	Antisense drug	[3555]
ISIS 138678	DMB7E4X	Investigative	Antisense drug	[3555]
ISIS 140148	DMKYWQ2	Investigative	Antisense drug	[3556]
ISIS 140153	DMD60BA	Investigative	Antisense drug	[3556]
ISIS 140157	DMG2P7B	Investigative	Antisense drug	[3556]
ISIS 140158	DMO87PG	Investigative	Antisense drug	[3556]
ISIS 140161	DMRHSY6	Investigative	Antisense drug	[3556]
ISIS 140180	DMP9WOZ	Investigative	Antisense drug	[3526]
ISIS 14144	DMWIKD5	Investigative	Antisense drug	[3554]
ISIS 144368	DMJW4C5	Investigative	Antisense drug	[3557]
ISIS 144379	DM1QLB0	Investigative	Antisense drug	[3557]
ISIS 144396	DMY34RB	Investigative	Antisense drug	[3557]
ISIS 14548	DMHWGL0	Investigative	Antisense drug	[3544]
ISIS 147483	DMNMXKC	Investigative	Antisense drug	[3558]
ISIS 147788	DM1Z5W8	Investigative	Antisense drug	[3558]
ISIS 147919	DMTE3FJ	Investigative	Antisense drug	[3559]
ISIS 148715	DMSB27R	Investigative	Antisense drug	[3526]
ISIS 150450	DMMBW13	Investigative	Antisense drug	[3560]
ISIS 150451	DM1DCFP	Investigative	Antisense drug	[3560]
ISIS 150452	DMQE7BH	Investigative	Antisense drug	[3560]
ISIS 150453	DMKCG41	Investigative	Antisense drug	[3560]
ISIS 150454	DMW0Y75	Investigative	Antisense drug	[3560]
ISIS 150463	DMFUM62	Investigative	Antisense drug	[3560]
ISIS 150464	DM1IC54	Investigative	Antisense drug	[3560]
ISIS 156449	DMPB3FH	Investigative	Antisense drug	[3561]
ISIS 156451	DMPH2W7	Investigative	Antisense drug	[3561]
ISIS 156452	DMCU6RF	Investigative	Antisense drug	[3561]
ISIS 156453	DMQ9018	Investigative	Antisense drug	[3561]
ISIS 156471	DMM9ARP	Investigative	Antisense drug	[3561]
ISIS 156472	DM3U0Z6	Investigative	Antisense drug	[3561]
ISIS 156473	DMDFUS8	Investigative	Antisense drug	[3561]
ISIS 156474	DMCXP9T	Investigative	Antisense drug	[3561]
ISIS 156475	DMNB4UJ	Investigative	Antisense drug	[3561]
ISIS 15998	DMAQ9EB	Investigative	Antisense drug	[3537]
ISIS 15999	DMMEP6J	Investigative	Antisense drug	[3537]
ISIS 16005	DMDORHA	Investigative	Antisense drug	[3537]
ISIS 16009	DMBRKFC	Investigative	Antisense drug	[3537]
ISIS 16010	DMZID0W	Investigative	Antisense drug	[3537]
ISIS 16108	DM7VQH8	Investigative	Antisense drug	[3562]
ISIS 16112	DMS7HQN	Investigative	Antisense drug	[3562]
ISIS 16121	DM71H65	Investigative	Antisense drug	[3562]
ISIS 16123	DM0AC3S	Investigative	Antisense drug	[3562]
ISIS 16124	DMYGOT7	Investigative	Antisense drug	[3562]
ISIS 16179	DMOTMVP	Investigative	Antisense drug	[3563]
ISIS 17020	DMXMHJV	Investigative	Antisense drug	[3563]
ISIS 17148	DMPZ9D3	Investigative	Antisense drug	[3540]
ISIS 17152	DME7VZG	Investigative	Antisense drug	[3540]
ISIS 17252	DMW40NK	Investigative	Antisense drug	[3564]
ISIS 173813	DM8ITFJ	Investigative	Antisense drug	[3565]
ISIS 173831	DM9Y5NX	Investigative	Antisense drug	[3565]
ISIS 173840	DMIU0QJ	Investigative	Antisense drug	[3565]
ISIS 173848	DMSG1NI	Investigative	Antisense drug	[3565]
ISIS 1751	DMBFK8A	Investigative	Antisense drug	[3566]
ISIS 1753	DMKWT6F	Investigative	Antisense drug	[3566]
ISIS 175510	DMPAXR4	Investigative	Antisense drug	[3567]
ISIS 1820	DMQ5A4Y	Investigative	Antisense drug	[3568]
ISIS 1821	DMUG2PN	Investigative	Antisense drug	[3568]
ISIS 1822	DMLJBU8	Investigative	Antisense drug	[3568]
ISIS 1827	DMPHWMO	Investigative	Antisense drug	[3568]
ISIS 1831	DM1LWGI	Investigative	Antisense drug	[3568]
ISIS 183881	DMOU9EP	Investigative	Antisense drug	[3558]
ISIS 183882	DMT3YI5	Investigative	Antisense drug	[3569]
ISIS 183883	DMA46S1	Investigative	Antisense drug	[3569]
ISIS 183897	DMS172K	Investigative	Antisense drug	[3569]
ISIS 183901	DMSEJZK	Investigative	Antisense drug	[3569]
ISIS 183910	DMMQ2L7	Investigative	Antisense drug	[3569]
ISIS 183911	DMTB350	Investigative	Antisense drug	[3569]
ISIS 183912	DM5QWED	Investigative	Antisense drug	[3569]
ISIS 18473	DMR6QNA	Investigative	Antisense drug	[3563]
ISIS 188755	DM0BAX4	Investigative	Antisense drug	[3570]
ISIS 188757	DMFTJD5	Investigative	Antisense drug	[3570]
ISIS 188759	DMM8G03	Investigative	Antisense drug	[3570]
ISIS 188761	DMTY3N6	Investigative	Antisense drug	[3570]
ISIS 188763	DMOJBHC	Investigative	Antisense drug	[3570]
ISIS 188778	DMP9YD3	Investigative	Antisense drug	[3570]
ISIS 188780	DMVZTU0	Investigative	Antisense drug	[3570]
ISIS 188781	DMOYINM	Investigative	Antisense drug	[3570]
ISIS 188782	DM5O4L8	Investigative	Antisense drug	[3570]
ISIS 191729	DMOQ27M	Investigative	Antisense drug	[3571]
ISIS 191731	DM52ZWB	Investigative	Antisense drug	[3571]
ISIS 191755	DMHWMFP	Investigative	Antisense drug	[3571]
ISIS 191756	DMQRZX8	Investigative	Antisense drug	[3571]
ISIS 191759	DMHPENR	Investigative	Antisense drug	[3571]
ISIS 191761	DM0VAUR	Investigative	Antisense drug	[3571]
ISIS 19211	DMKFCD5	Investigative	Antisense drug	[3572]
ISIS 19212	DMLQT5F	Investigative	Antisense drug	[3572]
ISIS 19213	DMD1JVZ	Investigative	Antisense drug	[3572]
ISIS 19217	DMQK0AL	Investigative	Antisense drug	[3572]
ISIS 19218	DMX4I5A	Investigative	Antisense drug	[3572]
ISIS 19219	DMFAWGX	Investigative	Antisense drug	[3572]
ISIS 19220	DMIKEXD	Investigative	Antisense drug	[3572]
ISIS 19221	DMKOFNX	Investigative	Antisense drug	[3572]
ISIS 1931	DMBMQNI	Investigative	Antisense drug	[3573]
ISIS 196103	DM1NJD7	Investigative	Antisense drug	[3526]
ISIS 19634	DMVOSN1	Investigative	Antisense drug	[3574]
ISIS 19639	DMAW4OE	Investigative	Antisense drug	[3574]
ISIS 19647	DMS5PZ0	Investigative	Antisense drug	[3574]
ISIS 19649	DMBEPGU	Investigative	Antisense drug	[3574]
ISIS 19650	DMCZLK1	Investigative	Antisense drug	[3574]
ISIS 19651	DM8O7EM	Investigative	Antisense drug	[3574]
ISIS 19657	DMGIMH8	Investigative	Antisense drug	[3574]
ISIS 19658	DM8WC4A	Investigative	Antisense drug	[3574]
ISIS 19659	DMQ5UA3	Investigative	Antisense drug	[3574]
ISIS 19675	DMB5LNC	Investigative	Antisense drug	[3574]
ISIS 19676	DMYEMST	Investigative	Antisense drug	[3574]
ISIS 19677	DMN0DR2	Investigative	Antisense drug	[3574]
ISIS 20577	DM76H35	Investigative	Antisense drug	[3575]
ISIS 20579	DM6X9RQ	Investigative	Antisense drug	[3575]
ISIS 20585	DMJRNWK	Investigative	Antisense drug	[3575]
ISIS 20586	DMHVQ0S	Investigative	Antisense drug	[3575]
ISIS 20990	DMLWO70	Investigative	Antisense drug	[3575]
ISIS 20993	DMFYDE4	Investigative	Antisense drug	[3575]
ISIS 20994	DM85EV7	Investigative	Antisense drug	[3575]
ISIS 20995	DMCXVPG	Investigative	Antisense drug	[3575]
ISIS 2177	DM4VZPU	Investigative	Antisense drug	[3568]
ISIS 222001	DMD7HA3	Investigative	Antisense drug	[3567]
ISIS 222035	DMQY2EA	Investigative	Antisense drug	[3567]
ISIS 222039	DMVL1SN	Investigative	Antisense drug	[3567]
ISIS 222041	DMS03TR	Investigative	Antisense drug	[3567]
ISIS 222043	DM26M7E	Investigative	Antisense drug	[3567]
ISIS 2324	DMREFCY	Investigative	Antisense drug	[3576]
ISIS 232828	DMYEPV8	Investigative	Antisense drug	[3577]
ISIS 23412	DMJ0LB1	Investigative	Antisense drug	[3578]
ISIS 23414	DMOC0DT	Investigative	Antisense drug	[3578]
ISIS 23416	DMHQD76	Investigative	Antisense drug	[3578]
ISIS 23452	DM17G39	Investigative	Antisense drug	[3578]
ISIS 23454	DM7FPZV	Investigative	Antisense drug	[3578]
ISIS 23459	DM4PGRU	Investigative	Antisense drug	[3578]
ISIS 23544	DMDHY37	Investigative	Antisense drug	[3579]
ISIS 23559	DM7NKRO	Investigative	Antisense drug	[3579]
ISIS 23705	DM5LBQM	Investigative	Antisense drug	[3580]
ISIS 23707	DMIK0GR	Investigative	Antisense drug	[3580]
ISIS 23718	DM1SDN3	Investigative	Antisense drug	[3580]
ISIS 24448	DMLHQ2J	Investigative	Antisense drug	[3581]
ISIS 24453	DM45WUZ	Investigative	Antisense drug	[3581]
ISIS 24454	DMDE3J1	Investigative	Antisense drug	[3581]
ISIS 24475	DMBKZOQ	Investigative	Antisense drug	[3581]
ISIS 24477	DMCNBIL	Investigative	Antisense drug	[3581]
ISIS 2490	DMYEC3M	Investigative	Antisense drug	[3576]
ISIS 2491	DMVI1D0	Investigative	Antisense drug	[3576]
ISIS 2502	DMYTXBS	Investigative	Antisense drug	[3582]
ISIS 25073	DMUMEST	Investigative	Antisense drug	[3583]
ISIS 25074	DMM0GUN	Investigative	Antisense drug	[3583]
ISIS 25075	DM1EPLC	Investigative	Antisense drug	[3583]
ISIS 25078	DMSZRY0	Investigative	Antisense drug	[3583]
ISIS 25079	DMAKTCH	Investigative	Antisense drug	[3583]
ISIS 25080	DMEI28S	Investigative	Antisense drug	[3583]
ISIS 25081	DM4AZG9	Investigative	Antisense drug	[3583]
ISIS 25082	DM04CUL	Investigative	Antisense drug	[3583]
ISIS 25113	DM3IR7W	Investigative	Antisense drug	[3583]
ISIS 25114	DMG6SYP	Investigative	Antisense drug	[3583]
ISIS 25115	DMDH943	Investigative	Antisense drug	[3583]
ISIS 25116	DM8AHJC	Investigative	Antisense drug	[3583]
ISIS 25117	DMAN94P	Investigative	Antisense drug	[3583]
ISIS 25118	DMA7KV8	Investigative	Antisense drug	[3583]
ISIS 25123	DMFQO21	Investigative	Antisense drug	[3583]
ISIS 25124	DMEI8L2	Investigative	Antisense drug	[3583]
ISIS 25125	DML2F3N	Investigative	Antisense drug	[3583]
ISIS 25126	DM8K4DP	Investigative	Antisense drug	[3583]
ISIS 25127	DM6AQ2X	Investigative	Antisense drug	[3583]
ISIS 25128	DMH3C01	Investigative	Antisense drug	[3583]
ISIS 25237	DMD75MP	Investigative	Antisense drug	[3526]
ISIS 25544	DMB9DWH	Investigative	Antisense drug	[3584]
ISIS 25547	DM4P15C	Investigative	Antisense drug	[3584]
ISIS 25549	DMWXQPG	Investigative	Antisense drug	[3584]
ISIS 25551	DM41B62	Investigative	Antisense drug	[3584]
ISIS 25552	DMO8IVA	Investigative	Antisense drug	[3584]
ISIS 25554	DM5PXN4	Investigative	Antisense drug	[3584]
ISIS 25563	DMBI2PH	Investigative	Antisense drug	[3584]
ISIS 25564	DMMZW8J	Investigative	Antisense drug	[3584]
ISIS 25565	DMB0CJ4	Investigative	Antisense drug	[3584]
ISIS 25566	DMUR2TH	Investigative	Antisense drug	[3584]
ISIS 25567	DMX72T6	Investigative	Antisense drug	[3584]
ISIS 2674	DMRUEM8	Investigative	Antisense drug	[3585]
ISIS 2678	DMZP5VG	Investigative	Antisense drug	[3585]
ISIS 2686	DM78BDU	Investigative	Antisense drug	[3585]
ISIS 28405	DMGMKH3	Investigative	Antisense drug	[3586]
ISIS 28407	DMXKRWN	Investigative	Antisense drug	[3586]
ISIS 28425	DMR24BS	Investigative	Antisense drug	[3586]
ISIS 28465	DMQ5JNT	Investigative	Antisense drug	[3586]
ISIS 28466	DMH96UP	Investigative	Antisense drug	[3586]
ISIS 28472	DMA4U2P	Investigative	Antisense drug	[3586]
ISIS 28477	DMMOV9U	Investigative	Antisense drug	[3586]
ISIS 29112	DMECMA6	Investigative	Antisense drug	[3587]
ISIS 29135	DMGJURC	Investigative	Antisense drug	[3587]
ISIS 29136	DMAMTLR	Investigative	Antisense drug	[3587]
ISIS 29137	DMAR1D6	Investigative	Antisense drug	[3587]
ISIS 29138	DMBY1RS	Investigative	Antisense drug	[3587]
ISIS 29139	DM2K0RD	Investigative	Antisense drug	[3587]
ISIS 29154	DMT9F15	Investigative	Antisense drug	[3587]
ISIS 29155	DMSVN1B	Investigative	Antisense drug	[3587]
ISIS 29156	DMD8KXB	Investigative	Antisense drug	[3587]
ISIS 29159	DMLE1IJ	Investigative	Antisense drug	[3587]
ISIS 29160	DM9NB1A	Investigative	Antisense drug	[3587]
ISIS 29161	DMPS6OQ	Investigative	Antisense drug	[3587]
ISIS 29176	DMVLU5J	Investigative	Antisense drug	[3587]
ISIS 29177	DMSUWVE	Investigative	Antisense drug	[3587]
ISIS 29178	DMTE7BJ	Investigative	Antisense drug	[3587]
ISIS 2918	DMJTHXY	Investigative	Antisense drug	[3588]
ISIS 2919	DMVMF5X	Investigative	Antisense drug	[3588]
ISIS 2920	DMJFLK0	Investigative	Antisense drug	[3588]
ISIS 29200	DMN1LHI	Investigative	Antisense drug	[3587]
ISIS 29201	DMSKVWG	Investigative	Antisense drug	[3587]
ISIS 29202	DMDR8V9	Investigative	Antisense drug	[3587]
ISIS 2921	DMDZAKS	Investigative	Antisense drug	[3588]
ISIS 29219	DM37R5F	Investigative	Antisense drug	[3589]
ISIS 29223	DMMQPFE	Investigative	Antisense drug	[3589]
ISIS 29224	DM9UNWE	Investigative	Antisense drug	[3589]
ISIS 29232	DMLES7J	Investigative	Antisense drug	[3589]
ISIS 29233	DMGV4O7	Investigative	Antisense drug	[3589]
ISIS 29234	DM1XAPO	Investigative	Antisense drug	[3589]
ISIS 29236	DMAXD7P	Investigative	Antisense drug	[3589]
ISIS 29237	DMPYJEB	Investigative	Antisense drug	[3589]
ISIS 29239	DMHQF1J	Investigative	Antisense drug	[3589]
ISIS 29243	DMZ7UM2	Investigative	Antisense drug	[3589]
ISIS 29244	DMTHVEL	Investigative	Antisense drug	[3589]
ISIS 29246	DM0DG1K	Investigative	Antisense drug	[3589]
ISIS 29255	DMK2QPU	Investigative	Antisense drug	[3589]
ISIS 29256	DMF1MJ2	Investigative	Antisense drug	[3589]
ISIS 29257	DMUM2H1	Investigative	Antisense drug	[3589]
ISIS 29469	DMVCFQ5	Investigative	Antisense drug	[3589]
ISIS 29470	DMPCK7Y	Investigative	Antisense drug	[3589]
ISIS 29471	DMG4RMZ	Investigative	Antisense drug	[3589]
ISIS 29475	DMEBQUN	Investigative	Antisense drug	[3589]
ISIS 29477	DMKQMXV	Investigative	Antisense drug	[3589]
ISIS 2974	DM7K19L	Investigative	Antisense drug	[3573]
ISIS 298697	DM0WH1L	Investigative	Antisense drug	[3567]
ISIS 298699	DMB28JW	Investigative	Antisense drug	[3567]
ISIS 298700	DM3DE98	Investigative	Antisense drug	[3567]
ISIS 298701	DMVIXND	Investigative	Antisense drug	[3567]
ISIS 298702	DM4L7NE	Investigative	Antisense drug	[3567]
ISIS 298711	DMCDWSG	Investigative	Antisense drug	[3567]
ISIS 298712	DMGJ4AO	Investigative	Antisense drug	[3567]
ISIS 298743	DMD3NSQ	Investigative	Antisense drug	[3567]
ISIS 298744	DM8VMQ4	Investigative	Antisense drug	[3567]
ISIS 298745	DM9YMPI	Investigative	Antisense drug	[3567]
ISIS 298746	DMHOJ0Z	Investigative	Antisense drug	[3567]
ISIS 3067	DMC9OL7	Investigative	Antisense drug	[3535]
ISIS 31963	DMOHZKW	Investigative	Antisense drug	[3590]
ISIS 31982	DMP9IR2	Investigative	Antisense drug	[3590]
ISIS 31996	DM21ZCQ	Investigative	Antisense drug	[3590]
ISIS 32000	DM0O9WM	Investigative	Antisense drug	[3590]
ISIS 32002	DMEAXV3	Investigative	Antisense drug	[3590]
ISIS 32003	DM7EVQX	Investigative	Antisense drug	[3590]
ISIS 32004	DME7VX6	Investigative	Antisense drug	[3590]
ISIS 32005	DMT8GWX	Investigative	Antisense drug	[3590]
ISIS 32006	DMFKLUS	Investigative	Antisense drug	[3590]
ISIS 32008	DME1KXM	Investigative	Antisense drug	[3590]
ISIS 32010	DM8PBCA	Investigative	Antisense drug	[3590]
ISIS 32014	DMF5SK8	Investigative	Antisense drug	[3590]
ISIS 32015	DMMV4WX	Investigative	Antisense drug	[3590]
ISIS 32020	DMXL9IY	Investigative	Antisense drug	[3590]
ISIS 32021	DMISB5V	Investigative	Antisense drug	[3590]
ISIS 32024	DMPKGIU	Investigative	Antisense drug	[3590]
ISIS 32028	DMATWDO	Investigative	Antisense drug	[3590]
ISIS 32035	DM47B2O	Investigative	Antisense drug	[3590]
ISIS 32039	DMY1R0Q	Investigative	Antisense drug	[3590]
ISIS 3224	DMAFEYG	Investigative	Antisense drug	[3535]
ISIS 3246	DM56EZC	Investigative	Antisense drug	[3588]
ISIS 329956	DMA96KW	Investigative	Antisense drug	[3526]
ISIS 3300	DM2TIO1	Investigative	Antisense drug	[3550]
ISIS 330012	DMWIVS9	Investigative	Antisense drug	[3526]
ISIS 330031	DM35WFL	Investigative	Antisense drug	[3526]
ISIS 3303	DM0W47U	Investigative	Antisense drug	[3591]
ISIS 3304	DM1K6DX	Investigative	Antisense drug	[3591]
ISIS 3306	DMWD1XH	Investigative	Antisense drug	[3591]
ISIS 3307	DMXRL2J	Investigative	Antisense drug	[3591]
ISIS 3308	DMSIBWP	Investigative	Antisense drug	[3591]
ISIS 3309	DMDSMJU	Investigative	Antisense drug	[3591]
ISIS 341881	DMOYBFQ	Investigative	siRNA drug	[3592]
ISIS 343867	DMO7492	Investigative	siRNA drug	[3592]
ISIS 347573	DMAFEX8	Investigative	Antisense drug	[3577]
ISIS 347577	DM36SRT	Investigative	Antisense drug	[3577]
ISIS 3792	DMBE1T8	Investigative	Antisense drug	[3585]
ISIS 3801	DMJDWX5	Investigative	Antisense drug	[3585]
ISIS 3804	DM7VAT0	Investigative	Antisense drug	[3585]
ISIS 3805	DMX927V	Investigative	Antisense drug	[3585]
ISIS 4189	DMN8OHG	Investigative	Antisense drug	[3518]
ISIS 4719	DMXNBGP	Investigative	Antisense drug	[3585]
ISIS 4729	DMD67YO	Investigative	Antisense drug	[3585]
ISIS 4730	DMKU1PN	Investigative	Antisense drug	[3585]
ISIS 4756	DMCZK1U	Investigative	Antisense drug	[3585]
ISIS 4759	DM3PZUX	Investigative	Antisense drug	[3585]
ISIS 4764	DMLA5I9	Investigative	Antisense drug	[3535]
ISIS 5874	DMYVST6	Investigative	Antisense drug	[3585]
ISIS 5875	DM8T1Z4	Investigative	Antisense drug	[3585]
ISIS 5876	DMRATOH	Investigative	Antisense drug	[3585]
ISIS 5884	DME7698	Investigative	Antisense drug	[3585]
ISIS 6186	DMH7LPO	Investigative	Antisense drug	[3582]
ISIS 6431	DMEUCI2	Investigative	Antisense drug	[3518]
ISIS 6432	DMQHN43	Investigative	Antisense drug	[3518]
ISIS 6434	DMNVLE2	Investigative	Antisense drug	[3518]
ISIS 6435	DMI7JQG	Investigative	Antisense drug	[3518]
ISIS 6442	DM7KSRG	Investigative	Antisense drug	[3518]
ISIS 6443	DMGN051	Investigative	Antisense drug	[3518]
ISIS 6445	DMXJ4SO	Investigative	Antisense drug	[3518]
ISIS 6553	DM5L387	Investigative	Antisense drug	[3518]
ISIS 6581	DMEAVPQ	Investigative	Antisense drug	[3518]
ISIS 6603	DMVXC7W	Investigative	Antisense drug	[3518]
ISIS 6717	DM5KGQO	Investigative	Antisense drug	[3516]
ISIS 6720	DMJS6B0	Investigative	Antisense drug	[3516]
ISIS 6729	DMWZOQJ	Investigative	Antisense drug	[3516]
ISIS 6739	DM0B4RD	Investigative	Antisense drug	[3593]
ISIS 6748	DMQONPU	Investigative	Antisense drug	[3593]
ISIS 6755	DM4LD1Y	Investigative	Antisense drug	[3593]
ISIS 6756	DMRM5QH	Investigative	Antisense drug	[3593]
ISIS 6957	DMTHO4A	Investigative	Antisense drug	[3594]
ISIS 6958	DM83EK9	Investigative	Antisense drug	[3582]
ISIS 7453	DMOX7FJ	Investigative	Antisense drug	[3582]
ISIS 7847	DMTN1D7	Investigative	Antisense drug	[3516]
ISIS 7848	DMOXBDT	Investigative	Antisense drug	[3516]
ISIS 7849	DMQYB7A	Investigative	Antisense drug	[3516]
ISIS 7851	DMJKC45	Investigative	Antisense drug	[3516]
ISIS 7853	DM12E76	Investigative	Antisense drug	[3516]
ISIS 7855	DMKAQ6U	Investigative	Antisense drug	[3516]
ISIS 7942	DMN0A1R	Investigative	Antisense drug	[3518]
ISIS 7948	DMYZE8R	Investigative	Antisense drug	[3518]
ISIS 9002	DMLIRKY	Investigative	Antisense drug	[3551]
ISIS 9003	DMBL2CG	Investigative	Antisense drug	[3551]
ISIS 9005	DM3PVGC	Investigative	Antisense drug	[3551]
ISIS 9007	DMGK2TQ	Investigative	Antisense drug	[3518]
ISIS 9008	DMQDZF2	Investigative	Antisense drug	[3518]
ISIS 9022	DM7TRSB	Investigative	Antisense drug	[3518]
ISIS 9023	DMO2V5C	Investigative	Antisense drug	[3518]
ISIS 9025	DMAQ7XH	Investigative	Antisense drug	[3518]
ISIS 9058	DMD1MEZ	Investigative	Antisense drug	[3516]
ISIS 9060	DMZL7SW	Investigative	Antisense drug	[3595]
ISIS 9061	DMFAL2E	Investigative	Antisense drug	[3595]
ISIS 9062	DM5ZGSO	Investigative	Antisense drug	[3595]
ISIS 9063	DM8E5RO	Investigative	Antisense drug	[3595]
ISIS 9064	DMBMTGP	Investigative	Antisense drug	[3595]
ISIS 9065	DMH50RX	Investigative	Antisense drug	[3595]
ISIS 9066	DMB8MH0	Investigative	Antisense drug	[3595]
ISIS 9067	DML8HCZ	Investigative	Antisense drug	[3595]
ISIS 9068	DM953VY	Investigative	Antisense drug	[3595]
ISIS 9069	DM5C86M	Investigative	Antisense drug	[3595]
ISIS 9070	DMU0HQF	Investigative	Antisense drug	[3595]
ISIS 9071	DMWY2XB	Investigative	Antisense drug	[3595]
ISIS 9133	DMDKB1I	Investigative	Antisense drug	[3522]
ISIS 9139	DMGOPHN	Investigative	Antisense drug	[3522]
ISIS 9606	DM052M3	Investigative	Antisense drug	[3596]
ISIS 9984	DM054SL	Investigative	Antisense drug	[3535]
ISIS-1939	DMGN4OQ	Investigative	NA	[3597]
Iso-caffeine	DM861DU	Investigative	Small molecular drug	[3598]
Iso-OMPA	DMFX16H	Investigative	Small molecular drug	[3599]
ISO24	DMU64W8	Investigative	Small molecular drug	[22]
isoamyl-agomelatine	DMGNFXY	Investigative	Small molecular drug	[3600]
isoamylamine	DMTEDHP	Investigative	Small molecular drug	[3601]
IsoBu-RYYRIK-NH2	DMV8OCF	Investigative	Small molecular drug	[754]
Isobutyl-(4-methyl-benzyl)-piperidin-4-yl-amine	DM293XH	Investigative	Small molecular drug	[3602]
isobutylmethylxanthine	DM46F5X	Investigative	Small molecular drug	[3603]
isobutyric acid	DMX4VY9	Investigative	Small molecular drug	[3604]
isocarbacyclin	DMZR7W6	Investigative	Small molecular drug	[3605]
Isochroman mono-carboxylic acid	DMUB187	Investigative	Small molecular drug	[3115]
Isocitric Acid	DMJKW4S	Investigative	Small molecular drug	[12]
ISOCLOZAPINE	DM52CPU	Investigative	Small molecular drug	[3606]
ISOCONAZOLE	DMMF1HX	Investigative	Small molecular drug	[3607]
ISODISPAR B	DM7ZSVD	Investigative	Small molecular drug	[3608]
Isoelaeocarpine	DMSLO71	Investigative	Small molecular drug	[3609]
isoferulic acid	DMN23KT	Investigative	Small molecular drug	[3610]
ISOFORMONENTIN	DM5CMA8	Investigative	Small molecular drug	[3611]
Isogemichalcone C	DM31AXO	Investigative	Small molecular drug	[152]
ISOGOIAZENSOLIDE	DMCF1ZD	Investigative	Small molecular drug	[697]
Isogranulatimide	DMI6NJ1	Investigative	Small molecular drug	[3612]
Isoguanosine	DMAFLCJ	Investigative	Small molecular drug	[3613]
Isohelenin	DMZH9PW	Investigative	Small molecular drug	[3614]
Isoindolinone Urea derivative	DMQC4HV	Investigative	Small molecular drug	[3615]
Isojaspic acid	DMHTBDN	Investigative	Small molecular drug	[3616]
ISOLICOFLAVONOL	DMYEGBC	Investigative	Small molecular drug	[152]
ISOLONGIFOLOL	DMXWOBE	Investigative	Small molecular drug	[3617]
ISOLOXAPINE	DMH1BN4	Investigative	Small molecular drug	[3618]
ISOMER A	DMOJ52F	Investigative	NA	[3019]
ISONEORAUTENOL	DM69XT3	Investigative	Small molecular drug	[2456]
ISONICOTINIC ACID	DMUVAIF	Investigative	Small molecular drug	[727]
ISONIPECOTAMIDE	DM5DKUY	Investigative	Small molecular drug	[3619]
isonipecotic acid	DMO1ZHE	Investigative	Small molecular drug	[3620]
ISOPENTENYL PYROPHOSPHATE	DMTU05Y	Investigative	Small molecular drug	[3621]
Isopentyl Pyrophosphate	DM9J5IS	Investigative	Small molecular drug	[12]
ISOPILINE	DM9ERD6	Investigative	Small molecular drug	[2102]
ISOPPADS	DMWI0M8	Investigative	Small molecular drug	[2195]
Isopropyl 10H-phenothiazine-10-carboxylate	DMH67J2	Investigative	Small molecular drug	[1050]
Isopropyl 3-(phenylthio)-1H-indole-2-carboxylate	DMS8MBI	Investigative	Small molecular drug	[3622]
Isopropyl 4-nitrophenyl dodecylphosphonate	DM2VJF4	Investigative	Small molecular drug	[1476]
Isopropyl dodecylfluorophosphonate	DML54EA	Investigative	Small molecular drug	[3041]
Isopropyl-methyl-prop-2-ynyl-amine hydrochloride	DM92F6Z	Investigative	NA	[2415]
Isopropylcarbamic Acid Biphenyl-3-yl Ester	DMBR8P1	Investigative	Small molecular drug	[1011]
isopulegol	DMPYAMU	Investigative	Small molecular drug	[3623]
Isoquinolin-1-yl-(3-phenyl-propyl)-amine	DMDF26N	Investigative	Small molecular drug	[171]
Isoquinoline-1,3,4(2H)-trione	DMT4RI2	Investigative	Small molecular drug	[913]
Isoquinoline-3-carboxylic acid methyl ester	DMWIMUZ	Investigative	Small molecular drug	[1264]
ISORHAMNETIN	DMQ4Z6E	Investigative	Small molecular drug	[1906]
Isorhamnetin 3,7-disulfate	DMFKQ0B	Investigative	Small molecular drug	[3624]
Isorhamnetin 3-O-rhamnoside	DMZQUY4	Investigative	Small molecular drug	[3625]
ISOSAKUTANETIN	DMJS7MV	Investigative	Small molecular drug	[1906]
ISOSCOPOLETIN	DMNM2SQ	Investigative	Small molecular drug	[40]
Isosorbide-2-(benzylcarbamate)-5-benzoate	DMTRCSV	Investigative	Small molecular drug	[3599]
Isosorbide-2-(benzylcarbamate)-5-mononitrate	DMG0TW2	Investigative	Small molecular drug	[3599]
Isosorbide-2-(butylcarbamate)-5-benzoate	DM1ZH2U	Investigative	Small molecular drug	[3599]
Isosorbide-2-(butylcarbamate)-5-mononitrate	DMUDS12	Investigative	Small molecular drug	[3599]
Isosorbide-2-(cyclohexylcarbamate)-5-mononitrate	DM4ZYRP	Investigative	Small molecular drug	[3599]
Isosorbide-2-(ethylcarbamate)-5-mononitrate	DMMH70I	Investigative	Small molecular drug	[3599]
Isosorbide-2-(methylcarbamate)-5-benzoate	DMC7MLN	Investigative	Small molecular drug	[3599]
Isosorbide-2-(methylcarbamate)-5-mononitrate	DMEKMOF	Investigative	Small molecular drug	[3599]
Isosorbide-2-(propylcarbamate)-5-mononitrate	DMQAEZP	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzyl carbamate	DM6FVDO	Investigative	Small molecular drug	[3626]
Isosorbide-2-benzylcarbamate-5-(o-toluate)	DM5XEZI	Investigative	Small molecular drug	[3626]
Isosorbide-2-benzylcarbamate-5-acetate	DMD4WRH	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-cyclopentanoate	DMWDQ90	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-cyclopropanoate	DM8E2L6	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-isonicotinate	DMQ3Z17	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-nicotinate	DMY49DN	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-pentanoate	DMSQ538	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-propionate	DMP6E34	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-tosylate	DMCHSWQ	Investigative	Small molecular drug	[3599]
Isosorbide-2-benzylcarbamate-5-triflate	DMG69IX	Investigative	Small molecular drug	[3599]
Isosorbide-di-(4-nitrophenyl carbamate)	DMPA2ON	Investigative	Small molecular drug	[3627]
Isosorbide-di-(benzylcarbamate)	DMFVN71	Investigative	Small molecular drug	[3627]
Isosorbide-di-(butylcarbamate)	DMNSTKD	Investigative	Small molecular drug	[3627]
Isosorbide-di-(ethylcarbamate)	DMTHWXO	Investigative	Small molecular drug	[3627]
Isosorbide-di-(propylcarbamate)	DMV1GLP	Investigative	Small molecular drug	[3627]
Isosorbide-di-phenylcarbamate	DMT1ZGM	Investigative	Small molecular drug	[3627]
ISOTETRANDRINE	DM21K0E	Investigative	Small molecular drug	[2102]
ISOTHIAZOLIDINONE ANALOG	DMKTBEH	Investigative	Small molecular drug	[22]
isothiourea-1a	DMAYOTF	Investigative	Small molecular drug	[3628]
isothiourea-1t	DMBX4WR	Investigative	Small molecular drug	[3628]
IsoVa-RYYRIK-NH2	DMNL0BK	Investigative	Small molecular drug	[754]
isovelleral	DMTRGAP	Investigative	Small molecular drug	[3629]
Isoxazol	DMXAD8E	Investigative	Small molecular drug	[430]
isoxazole azepine compound 3	DMAFC3R	Investigative	Small molecular drug	[3630]
Isoxazolecarboxylic acid	DMPZURH	Investigative	Small molecular drug	[3115]
ITdU	DMA8F4N	Investigative	Small molecular drug	[3631]
ITP	DMVFITX	Investigative	Small molecular drug	[3632]
Iva-His-Pro-Phe-His-ACHPA-Leu-Phe-NH2	DMFMYIH	Investigative	NA	[3633]
Iva-His-Pro-Phe-His-AHPPA-Leu-Phe-NH2	DMZTIU3	Investigative	NA	[3633]
Iva-His-Pro-Phe-His-Sta-Leu-Phe-NH2	DM92QIW	Investigative	Peptide	[3633]
J-104118	DMQ8J3M	Investigative	Small molecular drug	[3634]
J-104123	DMWF7RO	Investigative	Small molecular drug	[3635]
J-104870	DMCS4BL	Investigative	Small molecular drug	[3636]
J-109,390	DM9SFGB	Investigative	NA	[3637]
JASPAQUINOL	DMJAEMT	Investigative	Small molecular drug	[3616]
Jaspic acid	DMOF0TB	Investigative	Small molecular drug	[39]
JATRORRHIZINE	DMYFNW9	Investigative	Small molecular drug	[3638]
JB 98064	DMPRTVX	Investigative	Small molecular drug	[3639]
JCF 109	DMYF7AE	Investigative	Small molecular drug	[3640]
JDTic	DMINR6E	Investigative	Small molecular drug	[3641]
JG-365	DMQP4VG	Investigative	Small molecular drug	[3642]
JL-18	DM0LD3F	Investigative	Small molecular drug	[3643]
JMV 1535	DMP1B9D	Investigative	NA	[218]
JMV 1693	DMARTN3	Investigative	Small molecular drug	[218]
JMV 1719	DM82HW9	Investigative	Small molecular drug	[218]
JMV 1799	DMX3P68	Investigative	Small molecular drug	[218]
JMV 1801	DMTX694	Investigative	NA	[218]
JMV 1802	DMGT6DN	Investigative	NA	[218]
JMV 1803	DM248HC	Investigative	NA	[218]
JMV 1813	DMSICYK	Investigative	Small molecular drug	[218]
JMV1431	DMAR3M2	Investigative	Small molecular drug	[3644]
JMV180	DM5G0IM	Investigative	Small molecular drug	[3645]
JMV3008	DMB9U17	Investigative	Small molecular drug	[3646]
JMV449	DME9GF8	Investigative	Small molecular drug	[3647]
JMV458	DMC1ARG	Investigative	Small molecular drug	[3648]
JNJ-10191584	DM6P1UA	Investigative	Small molecular drug	[113]
JNJ-10198409	DM9GDP5	Investigative	Small molecular drug	[3649]
JNJ-10392980	DMZH0K8	Investigative	Small molecular drug	[453]
JNJ-16567083	DMXNFU5	Investigative	Small molecular drug	[3650]
JNJ-1661010	DM3ZNF9	Investigative	Small molecular drug	[3651]
JNJ-17148066	DMJ1DE9	Investigative	Small molecular drug	[3652]
JNJ-17156516	DMIXUNB	Investigative	Small molecular drug	[3653]
JNJ-19398990	DM94IJC	Investigative	Small molecular drug	[3652]
JNJ-26529126	DMK6TVN	Investigative	Small molecular drug	[3652]
JNJ-26529152	DMBZ7MA	Investigative	Small molecular drug	[3652]
JNJ-28312141	DMCMH7O	Investigative	Small molecular drug	[3654]
JNJ-28318706	DM84PWI	Investigative	Small molecular drug	[3655]
JNJ-28583867	DM5LEOR	Investigative	Small molecular drug	[3656]
JNJ-42153605	DMLOQ92	Investigative	Small molecular drug	[3657]
JNJ-5207787	DMWYU5C	Investigative	Small molecular drug	[3658]
JNJ-7706621	DMHTYBS	Investigative	Small molecular drug	[3659]
JNK-IN-8	DMLWYJB	Investigative	Small molecular drug	[3660]
joro toxin	DMYBJ4K	Investigative	Small molecular drug	[3661]
JP1302	DMMVBK6	Investigative	Small molecular drug	[3662]
JT-2724	DMD9W0B	Investigative	NA	[1866]
JWH-120	DM7JQDS	Investigative	Small molecular drug	[3220]
JWH-133	DM1DEYU	Investigative	Small molecular drug	[3663]
JWH-145	DMZQ31O	Investigative	Small molecular drug	[3664]
JWH-146	DMU7E6A	Investigative	Small molecular drug	[3664]
JWH-147	DMEX9GV	Investigative	Small molecular drug	[3664]
JWH-150	DM86OZD	Investigative	Small molecular drug	[3664]
JWH-151	DMGPN61	Investigative	Small molecular drug	[3220]
JWH-156	DMWGSQO	Investigative	Small molecular drug	[3664]
JWH-167	DMLDOYV	Investigative	Small molecular drug	[3665]
JWH-201	DMC2XSU	Investigative	Small molecular drug	[3665]
JWH-202	DMQU2SV	Investigative	Small molecular drug	[3665]
JWH-203	DMEJ8YA	Investigative	Small molecular drug	[3665]
JWH-204	DMDTILC	Investigative	Small molecular drug	[3665]
JWH-205	DMKIR63	Investigative	Small molecular drug	[3665]
JWH-206	DMGFSQB	Investigative	Small molecular drug	[3665]
JWH-207	DMF70IM	Investigative	Small molecular drug	[3665]
JWH-208	DMLYHUN	Investigative	Small molecular drug	[3665]
JWH-209	DMDXCIV	Investigative	Small molecular drug	[3665]
JWH-229	DMMKYGP	Investigative	Small molecular drug	[3220]
JWH-237	DMRQOL5	Investigative	Small molecular drug	[3665]
JWH-243	DMGD73A	Investigative	Small molecular drug	[3664]
JWH-244	DMETAOU	Investigative	Small molecular drug	[3664]
JWH-245	DMC5RZ9	Investigative	Small molecular drug	[3664]
JWH-246	DMGTEYB	Investigative	Small molecular drug	[3664]
JWH-248	DMURL8D	Investigative	Small molecular drug	[3665]
JWH-249	DMTOUCL	Investigative	Small molecular drug	[3665]
JWH-250	DMWVS5X	Investigative	Small molecular drug	[3665]
JWH-251	DMOJAUI	Investigative	Small molecular drug	[3665]
JWH-252	DM6IWCZ	Investigative	Small molecular drug	[3665]
JWH-253	DML1UMX	Investigative	Small molecular drug	[3665]
JWH-268	DM07XBG	Investigative	Small molecular drug	[3220]
JWH-292	DM5FAUY	Investigative	Small molecular drug	[3664]
JWH-293	DMCK1XR	Investigative	Small molecular drug	[3664]
JWH-294	DMTMF8X	Investigative	Small molecular drug	[3666]
JWH-295	DMUMJGD	Investigative	Small molecular drug	[3666]
JWH-296	DMNRXJU	Investigative	Small molecular drug	[3666]
JWH-297	DM4A761	Investigative	Small molecular drug	[3666]
JWH-302	DMI7LF1	Investigative	Small molecular drug	[3665]
JWH-303	DMCLAHR	Investigative	Small molecular drug	[3665]
JWH-305	DM36W9M	Investigative	Small molecular drug	[3665]
JWH-306	DMPDJKG	Investigative	Small molecular drug	[3665]
JWH-307	DM23RUZ	Investigative	Small molecular drug	[3664]
JWH-308	DMV5ASE	Investigative	Small molecular drug	[3664]
JWH-309	DMTV1B9	Investigative	Small molecular drug	[3664]
JWH-311	DMLABGW	Investigative	Small molecular drug	[3665]
JWH-312	DMYIGCU	Investigative	Small molecular drug	[3665]
JWH-313	DMWBHZL	Investigative	Small molecular drug	[3665]
JWH-314	DMCEKNJ	Investigative	Small molecular drug	[3665]
JWH-315	DMWHN56	Investigative	Small molecular drug	[3665]
JWH-323	DM63LOX	Investigative	Small molecular drug	[3666]
JWH-324	DMJ2EI9	Investigative	Small molecular drug	[2664]
JWH-325	DMHNTZ8	Investigative	Small molecular drug	[3666]
JWH-337	DMK3DUZ	Investigative	Small molecular drug	[3666]
JWH-342	DMTSZFB	Investigative	Small molecular drug	[3666]
JWH-343	DMEU1NS	Investigative	Small molecular drug	[3666]
JWH-344	DM6VZ3T	Investigative	Small molecular drug	[3666]
JWH-345	DML53SK	Investigative	Small molecular drug	[3666]
JWH-346	DMHNILP	Investigative	Small molecular drug	[3664]
JWH-347	DMK2NQ1	Investigative	Small molecular drug	[3664]
JWH-348	DMQIVPK	Investigative	Small molecular drug	[3664]
JWH-363	DMFLB1Z	Investigative	Small molecular drug	[3664]
JWH-364	DMP6C4D	Investigative	Small molecular drug	[3664]
JWH-365	DM2ZXBR	Investigative	Small molecular drug	[3664]
JWH-366	DMSNLFJ	Investigative	Small molecular drug	[3664]
JWH-367	DM7ZF2K	Investigative	Small molecular drug	[3664]
JWH-368	DMK0FNX	Investigative	Small molecular drug	[3664]
JWH-369	DMPDTWY	Investigative	Small molecular drug	[3664]
JWH-370	DM6IG7P	Investigative	Small molecular drug	[3664]
JWH-371	DME0URP	Investigative	Small molecular drug	[3664]
JWH-372	DM9D3GM	Investigative	Small molecular drug	[3664]
JWH-373	DMWP84R	Investigative	Small molecular drug	[3664]
JWH-385	DMU1HA7	Investigative	Small molecular drug	[3666]
JWH-392	DMMUBIF	Investigative	Small molecular drug	[3666]
JWH-401	DMFL6B9	Investigative	Small molecular drug	[3666]
JWH-402	DM8TQIF	Investigative	Small molecular drug	[3666]
JWH-403	DMRG1VI	Investigative	Small molecular drug	[3666]
JWH-404	DM3KWER	Investigative	Small molecular drug	[3666]
JWH-405	DM57TN3	Investigative	Small molecular drug	[3666]
JWH-406	DMNP7GD	Investigative	Small molecular drug	[3666]
JWH-407	DMZQ0V9	Investigative	Small molecular drug	[3666]
JWH-440	DM89602	Investigative	Small molecular drug	[2664]
JWH-441	DM7R1XS	Investigative	Small molecular drug	[2664]
JWH-442	DMX6F1L	Investigative	Small molecular drug	[2664]
JY-0691	DMYY3UZ	Investigative	NA	[1866]
JZL184	DMWA8B0	Investigative	Small molecular drug	[3667]
JZL195	DMEOCKZ	Investigative	Small molecular drug	[1871]
K-252a analogue	DMCZPH4	Investigative	Small molecular drug	[3668]
K-777	DMIFCMW	Investigative	Small molecular drug	[3669]
K-Ras(G12C) inhibitor 12	DM20EL1	Investigative	Small molecular drug	[1733]
K-Ras(G12C) inhibitor 6	DMMM2YQ	Investigative	Small molecular drug	[1733]
K-Ras(G12C) inhibitor 9	DM3E8XE	Investigative	Small molecular drug	[1733]
K00024	DMP8M9Q	Investigative	Small molecular drug	[3670]
K00244	DM2BKU8	Investigative	Small molecular drug	[3671]
K00248	DMWZJG6	Investigative	Small molecular drug	[3672]
K00592a	DM1RP5Q	Investigative	Small molecular drug	[3673]
K185	DME65H8	Investigative	Small molecular drug	[3674]
KAEMPFERIDE	DMUWA2G	Investigative	Small molecular drug	[1906]
KAEMPFEROL	DMHEMUB	Investigative	Small molecular drug	[40]
Kaempferol-3-O-(2''-O-galloyl)-glucoside	DMUCZ3F	Investigative	Small molecular drug	[2178]
Kaempferol-3-O-methyl ether	DMBG7X1	Investigative	Small molecular drug	[3675]
kallidin	DMRT6OP	Investigative	Small molecular drug	[3676]
kallstroemin D	DM7YAE0	Investigative	Small molecular drug	[3677]
kassinin	DMMIA38	Investigative	Small molecular drug	[3678]
KATSUMADAIN A	DM513QY	Investigative	Small molecular drug	[241]
Kazinol C	DMS527J	Investigative	Small molecular drug	[2398]
Kazinol F	DMFVT81	Investigative	Small molecular drug	[2398]
KAZINOL S	DMEV2AL	Investigative	Small molecular drug	[2398]
KB-130015	DMO72XF	Investigative	Small molecular drug	[3679]
KB-74935	DM0JN5I	Investigative	Small molecular drug	[3680]
KB-R7943	DMMD5W3	Investigative	Small molecular drug	[3681]
KC-12291	DMY6QOR	Investigative	Small molecular drug	[3682]
KDOAM25	DMPCW5Z	Investigative	Small molecular drug	[3683]
KELATORPHAN	DMOX8FD	Investigative	Small molecular drug	[3684]
KETOCYCLAZOCINE	DM0RC8M	Investigative	Small molecular drug	[3685]
KF 17837S	DM7W9MT	Investigative	Small molecular drug	[3686]
KF-A5	DMFBMYG	Investigative	Small molecular drug	[3687]
KF-A6	DMQJ3T5	Investigative	Small molecular drug	[3687]
KF24345	DMK6SMW	Investigative	Small molecular drug	[3688]
KF26777	DMPBDW0	Investigative	Small molecular drug	[3689]
KH-164	DMCE8Q9	Investigative	Small molecular drug	[3690]
KH-CB19	DMSOB3U	Investigative	Small molecular drug	[3691]
Ki-11502	DMLG2EA	Investigative	Small molecular drug	[3692]
Ki-20227	DM9M3VC	Investigative	Small molecular drug	[3693]
Ki16425	DMJTDK9	Investigative	Small molecular drug	[3694]
kisspeptin-10	DMDL21W	Investigative	Small molecular drug	[3695]
KKHT-10318	DMAU1SZ	Investigative	Small molecular drug	[3696]
KKHT-10608	DMYT381	Investigative	Small molecular drug	[3696]
KKHT-10609	DMMI1H0	Investigative	Small molecular drug	[3696]
KKHT-10613	DM1H5TO	Investigative	Small molecular drug	[3696]
KKHT-10618	DMW704S	Investigative	Small molecular drug	[3696]
KKHT-11018	DM4F96I	Investigative	Small molecular drug	[3696]
KKHT-20718	DMLB4TU	Investigative	Small molecular drug	[3696]
KKHT-20818	DMP1A3C	Investigative	Small molecular drug	[3696]
KKHT-20918	DMTW4Q1	Investigative	Small molecular drug	[3696]
KL044	DMG3FDE	Investigative	Small molecular drug	[3697]
KLH/IMG	DMVSLND	Investigative	NA	[1866]
KM-233	DMZSYKC	Investigative	Small molecular drug	[3698]
KM-233-M	DMK4IBO	Investigative	Small molecular drug	[3698]
KM11060	DMOQJ6Q	Investigative	Small molecular drug	[3699]
KMI-172	DMLRVEJ	Investigative	NA	[3700]
KMI-494	DMQ4WNB	Investigative	Small molecular drug	[3700]
KMI-538	DMX9EA7	Investigative	Small molecular drug	[3700]
KMI-596	DMXUETW	Investigative	Small molecular drug	[3701]
KML110	DMFVS16	Investigative	Small molecular drug	[3702]
KN-62	DMLZ89P	Investigative	Small molecular drug	[3703]
KN-93	DMPTMKH	Investigative	Small molecular drug	[3704]
KNI-10006	DMMISH6	Investigative	Small molecular drug	[3705]
KNI-10033	DMLOXMQ	Investigative	Small molecular drug	[3706]
KNI-10061	DMMZ6AO	Investigative	Small molecular drug	[3706]
KNI-10062	DMYSDN4	Investigative	Small molecular drug	[3706]
KNI-10074	DMM5SDT	Investigative	Small molecular drug	[3707]
KNI-10079	DMCZOX9	Investigative	Small molecular drug	[3707]
KNI-10080	DMEN4DZ	Investigative	Small molecular drug	[3707]
KNI-10081	DM1Z7QK	Investigative	Small molecular drug	[3707]
KNI-10087	DMYN2U4	Investigative	Small molecular drug	[3707]
KNI-10088	DM4GASE	Investigative	Small molecular drug	[3707]
KNI-10092	DMV1KI2	Investigative	Small molecular drug	[3707]
KNI-10093	DMGY5Z0	Investigative	Small molecular drug	[3707]
KNI-10094	DMJIQG2	Investigative	Small molecular drug	[3707]
KNI-10095	DMEHPVF	Investigative	Small molecular drug	[3707]
KNI-10106	DMBTRHG	Investigative	Small molecular drug	[3707]
KNI-10113	DM78A6F	Investigative	Small molecular drug	[3707]
KNI-10124	DMA9104	Investigative	Small molecular drug	[3707]
KNI-10125	DMDBERC	Investigative	Small molecular drug	[3707]
KNI-10152	DMNBUS4	Investigative	Small molecular drug	[3707]
KNI-10155	DM1PKWA	Investigative	Small molecular drug	[3707]
KNI-10216	DM64NBG	Investigative	Small molecular drug	[3707]
KNI-10217	DMHLFAE	Investigative	Small molecular drug	[3707]
KNI-10232	DMQY1ST	Investigative	Small molecular drug	[3706]
KNI-10255	DMV3U9Z	Investigative	Small molecular drug	[3707]
KNI-10256	DMZFVHT	Investigative	Small molecular drug	[3707]
KNI-10260	DMZXI6U	Investigative	Small molecular drug	[3707]
KNI-10265	DMQLB3T	Investigative	Small molecular drug	[3707]
KNI-10266	DMP2E3I	Investigative	Small molecular drug	[3707]
KNI-10282	DMAR35H	Investigative	Small molecular drug	[3707]
KNI-10283	DMGVBIT	Investigative	Small molecular drug	[3707]
KNI-10313	DMP7M8O	Investigative	Small molecular drug	[3706]
KNI-10314	DMYGNZA	Investigative	Small molecular drug	[3706]
KNI-10315	DM1OPYT	Investigative	Small molecular drug	[3706]
KNI-10316	DMMIDCG	Investigative	Small molecular drug	[3706]
KNI-10332	DMKVPMS	Investigative	Small molecular drug	[3706]
KNI-10341	DMF9P25	Investigative	Small molecular drug	[3706]
KNI-10342	DMDM5BL	Investigative	Small molecular drug	[3706]
KNI-10368	DM8SIRL	Investigative	Small molecular drug	[3706]
KNI-10369	DM97STY	Investigative	Small molecular drug	[3707]
KNI-10372	DM4AUCE	Investigative	Small molecular drug	[3706]
KNI-10526	DMEN2L3	Investigative	Small molecular drug	[3707]
KNI-10527	DMU4K7O	Investigative	Small molecular drug	[3707]
KNI-10529	DMDRWYG	Investigative	Small molecular drug	[3707]
KNI-10538	DM7XEIY	Investigative	Small molecular drug	[3708]
KNI-10539	DMLWOFY	Investigative	Small molecular drug	[3707]
KNI-10541	DMP87U4	Investigative	Small molecular drug	[3707]
KNI-10737	DMGUABP	Investigative	Small molecular drug	[3708]
KNI-10740	DMPWY6H	Investigative	Small molecular drug	[3708]
KNI-10741	DM7TW4C	Investigative	Small molecular drug	[3708]
KNI-10742	DM4D9T3	Investigative	Small molecular drug	[3708]
KNI-10743	DM0VSPE	Investigative	Small molecular drug	[3708]
KNI-10758	DMM2A5Q	Investigative	Small molecular drug	[3708]
KNI-10759	DMAF1W3	Investigative	Small molecular drug	[3708]
KNI-10760	DMT5FIP	Investigative	Small molecular drug	[3708]
KNI-10761	DMXUTWZ	Investigative	Small molecular drug	[3708]
KNI-10762	DM73WB2	Investigative	Small molecular drug	[3708]
KNI-10763	DMKAY5G	Investigative	Small molecular drug	[3708]
KNI-1293	DMZX430	Investigative	Small molecular drug	[3707]
KNI-227	DMS61DB	Investigative	Small molecular drug	[3706]
KNI-727	DM105NU	Investigative	Small molecular drug	[3709]
KNT-5	DMZF3E9	Investigative	Small molecular drug	[3710]
KNT-62	DM9M5HC	Investigative	Small molecular drug	[3711]
KNT-63	DM0U5N9	Investigative	Small molecular drug	[3711]
KO-286011	DMVGNZJ	Investigative	Small molecular drug	[3712]
Kodaistatin A	DMAJKRX	Investigative	Small molecular drug	[3713]
Kodaistatin C	DM72WQ3	Investigative	NA	[3713]
KOJIC ACID	DMP84CS	Investigative	Small molecular drug	[3714]
Kojic acid-phenylalanine amide	DMRB1AT	Investigative	Small molecular drug	[3715]
KOS1326	DMYDGA7	Investigative	Small molecular drug	[3716]
KOTALANOL	DMT1H9Z	Investigative	Small molecular drug	[2816]
KP772	DMUZSJ2	Investigative	NA	[3717]
KR61639	DMIEKJ4	Investigative	Small molecular drug	[3718]
KRP 203-phosphate	DMLIK7X	Investigative	Small molecular drug	[3719]
KRP-100	DMJX9E1	Investigative	NA	[3720]
KRP-109	DMHWO4J	Investigative	NA	[1866]
KSG-LDTKNYKQTSV	DM5DTMQ	Investigative	NA	[3083]
KSG-YEKLSSIESDV	DMPLFRC	Investigative	NA	[3083]
KSP-BCS-1-alpha-CHF2-1624F2-2	DMXBITO	Investigative	Small molecular drug	[3721]
KSP-BCS-1-alpha-CHF2-20-epi-22-oxabishomo-26-OH	DMJV3R7	Investigative	Small molecular drug	[3721]
KT 5823	DMOBYU3	Investigative	Small molecular drug	[3722]
KT-5720	DM9J50F	Investigative	Small molecular drug	[3723]
KT6006	DMXIUO5	Investigative	Small molecular drug	[3724]
KT6528	DMRDZ7I	Investigative	Small molecular drug	[3724]
KU-0060648	DMQWS6U	Investigative	Small molecular drug	[3725]
KU-58684	DMVGY6K	Investigative	Small molecular drug	[238]
Kuanoniamine D	DMAVM94	Investigative	Small molecular drug	[3726]
KUR-CXCR4	DMPKDJ4	Investigative	NA	[3727]
KURAIDIN	DMLDUJ1	Investigative	Small molecular drug	[3728]
KURARINOL	DMRV5YE	Investigative	Small molecular drug	[3728]
KURARINONE	DMH0G8W	Investigative	Small molecular drug	[3113]
KUSHENOL A	DMCFHPD	Investigative	Small molecular drug	[151]
Kushenol N	DMY13UR	Investigative	Small molecular drug	[3113]
kuwanon H	DMVQDNR	Investigative	Small molecular drug	[3729]
Kuwanon J	DMFSUJB	Investigative	Small molecular drug	[1992]
Kuwanon L	DMX4D1Q	Investigative	Small molecular drug	[3730]
Kuwanon R	DMEZOT9	Investigative	Small molecular drug	[1992]
Kuwanon V	DM84M20	Investigative	Small molecular drug	[1992]
KwFwLL-NH2	DM7RFUC	Investigative	Small molecular drug	[2196]
KYS-05001	DM3MID9	Investigative	Small molecular drug	[3731]
KYS-05040	DM1JU8F	Investigative	Small molecular drug	[3732]
KYS-05041	DMVA6LH	Investigative	NA	[3215]
KYS-05042	DMM6G4H	Investigative	NA	[3733]
KYS-05055	DMRVOT7	Investigative	Small molecular drug	[3733]
KYS-05056	DMP6S0L	Investigative	Small molecular drug	[3733]
KYS-05057	DM7BYG8	Investigative	Small molecular drug	[3733]
KYS-05064	DM61GPQ	Investigative	Small molecular drug	[3215]
KYS-05065	DMA8LFD	Investigative	Small molecular drug	[3733]
KYS-05070	DMRJQY3	Investigative	Small molecular drug	[3734]
KYS-05071	DM7K5Z3	Investigative	Small molecular drug	[3734]
KYS-05074	DMYRWQ3	Investigative	Small molecular drug	[3734]
KYS-05077	DMHW40F	Investigative	Small molecular drug	[3735]
KYS-05080	DM57BXZ	Investigative	Small molecular drug	[3733]
KYS-05090	DM92RHP	Investigative	Small molecular drug	[3733]
L 691121	DMB73Y4	Investigative	Small molecular drug	[3736]
L-(cis)-diltiazem	DMK07MI	Investigative	Small molecular drug	[3737]
L-054,522	DMQR6ZX	Investigative	Small molecular drug	[3738]
L-136662	DMWNJV0	Investigative	Small molecular drug	[3739]
L-152,804	DMVGX7Z	Investigative	Small molecular drug	[3740]
L-159093	DMOX8JE	Investigative	Small molecular drug	[3741]
L-162313	DMZOW96	Investigative	Small molecular drug	[3742]
L-162782	DMWSP6H	Investigative	Small molecular drug	[3743]
L-163,101	DMYC7AK	Investigative	Small molecular drug	[3744]
L-165041	DMZP7YM	Investigative	Small molecular drug	[3745]
L-165461	DMKBSGN	Investigative	Small molecular drug	[3746]
L-2-Amino-4-(Guanidinooxy)Butyric Acid	DMWQCRD	Investigative	Small molecular drug	[12]
L-249313	DMEK65F	Investigative	Small molecular drug	[1785]
L-269,289	DMV6018	Investigative	Small molecular drug	[3637]
L-365,209	DM1WMHO	Investigative	Small molecular drug	[3747]
L-366,509	DMGQE1B	Investigative	Small molecular drug	[3748]
L-366,682	DMAS5P8	Investigative	Small molecular drug	[3749]
L-366,948	DM31NXF	Investigative	Small molecular drug	[3750]
L-367,773	DMQ369D	Investigative	Small molecular drug	[3751]
L-370,518	DMC1Z0L	Investigative	Small molecular drug	[3752]
L-372662	DMQV974	Investigative	Small molecular drug	[3753]
L-375378	DMQWKPM	Investigative	Small molecular drug	[3754]
L-454560	DM0P4V6	Investigative	Small molecular drug	[3755]
L-5-(bromovinyl)deoxyuridine	DMHL901	Investigative	Small molecular drug	[1085]
L-5-iodo-2'-deoxyuridine	DM3Q0JL	Investigative	Small molecular drug	[1085]
L-644,698	DMENUOD	Investigative	Small molecular drug	[3756]
L-652,343	DMA23LP	Investigative	Small molecular drug	[3757]
L-652731	DM360VU	Investigative	Small molecular drug	[3758]
L-655708	DM4CDIB	Investigative	Small molecular drug	[3759]
L-658,758	DMY0IQ6	Investigative	Small molecular drug	[3760]
L-659,699	DMDF0KZ	Investigative	Small molecular drug	[3761]
L-671,480	DMP4QCJ	Investigative	NA	[3762]
L-685,818	DMJUQT1	Investigative	Small molecular drug	[2947]
L-689,037	DMCH3ZK	Investigative	Small molecular drug	[3763]
L-689065	DM42BGX	Investigative	Small molecular drug	[3764]
L-692289	DMAB1RW	Investigative	NA	[3765]
L-702-539	DM92X5T	Investigative	Small molecular drug	[3766]
L-703,606	DMUOPRT	Investigative	Small molecular drug	[3767]
L-708,906	DMWYIJ3	Investigative	Small molecular drug	[3768]
L-708474	DM3QUCS	Investigative	Small molecular drug	[3769]
L-708568	DMLMV9P	Investigative	Small molecular drug	[3770]
L-709,587	DM9KCYQ	Investigative	Small molecular drug	[12]
L-731,988	DM7YVUT	Investigative	Small molecular drug	[3768]
L-731120	DM8WCUY	Investigative	Small molecular drug	[3771]
L-731128	DMTHLUN	Investigative	Small molecular drug	[3772]
L-734115	DMDNVTF	Investigative	Small molecular drug	[3773]
L-735,821	DMY60MG	Investigative	Small molecular drug	[3774]
L-735021	DM8BVJQ	Investigative	Small molecular drug	[3775]
L-736281	DMJNLSI	Investigative	Small molecular drug	[3776]
L-736380	DMM5AYL	Investigative	Small molecular drug	[3777]
L-739750	DMAHC9Z	Investigative	Small molecular drug	[3778]
L-739758	DM5IAXN	Investigative	Small molecular drug	[3773]
L-740093	DMVA2D0	Investigative	Small molecular drug	[3779]
L-741626	DMCYQJF	Investigative	Small molecular drug	[3780]
L-741742	DMP75YK	Investigative	Small molecular drug	[3781]
L-746233	DMRC8MT	Investigative	Small molecular drug	[3773]
L-746530	DMUY8MP	Investigative	Small molecular drug	[3782]
L-747201	DMBPWSJ	Investigative	Small molecular drug	[3783]
L-748337	DM7CPBU	Investigative	Small molecular drug	[3784]
L-748780	DMJZXAF	Investigative	Small molecular drug	[3785]
L-750,667	DM2WUKF	Investigative	Small molecular drug	[3786]
L-750034	DM9QAP4	Investigative	Small molecular drug	[3787]
L-756568	DMEQWSB	Investigative	Small molecular drug	[3773]
L-759,633	DMQJNDX	Investigative	Small molecular drug	[3788]
L-759,656	DM5SOR4	Investigative	Small molecular drug	[3789]
L-760790	DMA9VDN	Investigative	Small molecular drug	[3790]
L-761000	DM0A2MG	Investigative	Small molecular drug	[3785]
L-764406	DMG5KVS	Investigative	Small molecular drug	[3791]
L-765314	DMH0TUZ	Investigative	Small molecular drug	[3792]
L-767679	DM96SPJ	Investigative	Small molecular drug	[3773]
L-772,405	DM5O0CM	Investigative	Small molecular drug	[3793]
L-779,976	DMMUAW5	Investigative	Small molecular drug	[3794]
L-779450	DM51B74	Investigative	Small molecular drug	[3795]
L-783483	DM6OTGE	Investigative	Small molecular drug	[3796]
L-791943	DM5D892	Investigative	Small molecular drug	[3797]
L-796,778	DMINOFE	Investigative	Small molecular drug	[3798]
L-796449	DMWTGQM	Investigative	Small molecular drug	[3799]
L-797,591	DM96ASN	Investigative	Small molecular drug	[3800]
L-798,106	DM4FMGJ	Investigative	Small molecular drug	[3801]
L-803,087	DMWBRDK	Investigative	Small molecular drug	[3802]
L-817,818	DM8YT7X	Investigative	Small molecular drug	[3803]
L-826266	DMYJ6QZ	Investigative	Small molecular drug	[3804]
L-869298	DMKEDU6	Investigative	Small molecular drug	[3805]
L-888,291	DMMAIQ2	Investigative	Small molecular drug	[3806]
L-888607	DMJCTWO	Investigative	Small molecular drug	[3807]
L-Ala-L-boroPro	DMH6XTP	Investigative	Small molecular drug	[2794]
L-AP4	DMPJFGI	Investigative	Small molecular drug	[3808]
L-argininosuccinic acid	DMT91Q4	Investigative	Small molecular drug	[3809]
L-asparagine	DM8HBUW	Investigative	Small molecular drug	[3810]
L-azetidine-2-carboxylate	DMZWKVQ	Investigative	Small molecular drug	[3811]
L-beta-BA	DMENM1B	Investigative	Small molecular drug	[3812]
L-betagamma-meATP	DMTNQCE	Investigative	Small molecular drug	[12]
L-CCG-I	DMPZ8XH	Investigative	Small molecular drug	[3813]
L-cysteate	DMD6JBU	Investigative	Small molecular drug	[3814]
L-cystine	DMTOIW1	Investigative	Small molecular drug	[3815]
L-glucose	DMCGWRU	Investigative	Small molecular drug	[3816]
L-Homoarginine	DML83XP	Investigative	Small molecular drug	[12]
L-homocysteine	DMOHLFZ	Investigative	Small molecular drug	[3817]
L-Iso-Aspartate	DM26AB4	Investigative	Small molecular drug	[12]
L-Isofagomine	DM6RKOC	Investigative	Small molecular drug	[435]
L-isoleucine	DM4B6H3	Investigative	Small molecular drug	[3818]
L-isoleucyl-L-prolinamide	DMVSAUL	Investigative	Small molecular drug	[153]
L-lactic acid	DMO1Z5Q	Investigative	Small molecular drug	[3819]
L-leucine	DMQHN7I	Investigative	Small molecular drug	[3820]
L-leucinol	DMJF6W5	Investigative	Small molecular drug	[3821]
L-leucyl-L-prolinamide	DM41MS3	Investigative	Small molecular drug	[153]
L-lysine	DMOD5CK	Investigative	Small molecular drug	[3822]
L-mannitol derivative	DMK12C0	Investigative	Small molecular drug	[3823]
L-methionine	DME8G1U	Investigative	Small molecular drug	[3824]
L-Myo-Inositol-1-Phosphate	DM8LVQF	Investigative	Small molecular drug	[12]
L-NIO	DME9FAV	Investigative	Small molecular drug	[107]
L-norleucyl-L-prolinamide	DM7V30L	Investigative	Small molecular drug	[153]
L-norvalyl-L-prolinamide	DMIXFGC	Investigative	Small molecular drug	[153]
L-ornithine	DMHKGCM	Investigative	Small molecular drug	[3825]
L-phenylalaninol	DMGB1T3	Investigative	Small molecular drug	[3826]
L-serine	DM6WPIS	Investigative	Small molecular drug	[3827]
L-serine-O-phosphate	DMTJ1NH	Investigative	Small molecular drug	[12]
L-Thiocitrulline	DMP8O6R	Investigative	Small molecular drug	[12]
L-threonine	DMFHTBX	Investigative	Small molecular drug	[3828]
L-trans-2,4-pyrolidine dicarboxylate	DMW9HAL	Investigative	Small molecular drug	[3829]
L-Tryptophan-L-2-aminoadipic acid	DMYLONS	Investigative	Small molecular drug	[3830]
L-Tryptophan-L-arginine	DMYU65F	Investigative	Small molecular drug	[3830]
L-Tryptophan-L-asparagine	DMWZMCA	Investigative	Small molecular drug	[3830]
L-Tryptophan-L-aspartic acid	DMVFAD5	Investigative	Small molecular drug	[3830]
L-Tryptophan-L-glutamine	DMNMRHX	Investigative	Small molecular drug	[3830]
L-Tryptophan-L-leucine	DMPV5D0	Investigative	Small molecular drug	[3830]
L-Tyrosinamide	DMGVELK	Investigative	Small molecular drug	[22]
L-Val-L-boroPro	DMPGT80	Investigative	Small molecular drug	[2794]
L-valine	DM68RPD	Investigative	Small molecular drug	[3831]
L-valinol	DMPIAHH	Investigative	Small molecular drug	[3832]
L-valyl-L-prolinamide	DMH7TNA	Investigative	Small molecular drug	[153]
L-valyl-L-proline benzylamide	DMQZ13A	Investigative	Small molecular drug	[153]
L-valyl-L-proline hexylamide	DMX4DRV	Investigative	Small molecular drug	[153]
L-xylose	DMLWZUB	Investigative	Small molecular drug	[3833]
L000021649	DMYWD6C	Investigative	Small molecular drug	[1157]
L023103	DM9KWUR	Investigative	Small molecular drug	[3834]
L17	DMZ4KO0	Investigative	Small molecular drug	[3768]
L690330	DMYX0TY	Investigative	Small molecular drug	[3835]
L748328	DMEGU5J	Investigative	Small molecular drug	[3836]
L902688	DMIORW9	Investigative	Small molecular drug	[3837]
Laevulinic Acid	DMTZ17V	Investigative	Small molecular drug	[12]
Lanosterol	DMHN74V	Investigative	Small molecular drug	[3838]
LARGAZOLE	DMSYLIJ	Investigative	Small molecular drug	[3839]
Lauric Acid	DM9C8KQ	Investigative	Small molecular drug	[3840]
Lauryl Dimethylamine-N-Oxide	DM3W2OE	Investigative	Small molecular drug	[12]
LAVENDUSTIN A	DMH3X06	Investigative	Small molecular drug	[3841]
LAVYPWT	DMOK6IP	Investigative	Small molecular drug	[2195]
LAWSARITOL	DM5GNFO	Investigative	Small molecular drug	[139]
LB30812	DM3H9ZY	Investigative	Small molecular drug	[3842]
LB42708	DMOOK7D	Investigative	Small molecular drug	[3843]
LB42908	DM6RH19	Investigative	Small molecular drug	[3844]
LBQ657	DMQ2DFN	Investigative	Small molecular drug	[3845]
Lck inhibitor	DME4TUQ	Investigative	Small molecular drug	[3846]
LDC1267	DMH7R6L	Investigative	Small molecular drug	[3847]
LDN-214117	DM57Z8J	Investigative	Small molecular drug	[3848]
LDN-91946	DMTSLGF	Investigative	Small molecular drug	[3849]
LE135	DMVFGSI	Investigative	Small molecular drug	[3850]
LEACHIANONE A	DMZ21HU	Investigative	Small molecular drug	[151]
Lead acetate	DML0GZ2	Investigative	Small molecular drug	[3851]
Lecanindole D	DMZ7OHP	Investigative	Small molecular drug	[3852]
Lefaxin	DM0CEY3	Investigative	Small molecular drug	[2190]
Lerdelimumab	DME91CG	Investigative	Antibody	[3853]
lergotrile	DMDV67S	Investigative	Small molecular drug	[3854]
leualacin	DMV40XH	Investigative	Small molecular drug	[3855]
Leucettamidine	DM94JXH	Investigative	Small molecular drug	[3856]
LEUCETTAMINE A	DMIZVA6	Investigative	Small molecular drug	[3856]
LEUCETTAMINE B	DMFQEWM	Investigative	Small molecular drug	[3857]
leucettine L41	DMBYND6	Investigative	Small molecular drug	[3858]
Leucine-enkephalin	DMT2CZK	Investigative	Small molecular drug	[3859]
LEUCOSCEPTOSIDE A	DM6W27F	Investigative	Small molecular drug	[2452]
levetimide	DMPYSIT	Investigative	Small molecular drug	[3860]
LEVONORDEFRIN	DMWDJ0H	Investigative	Small molecular drug	[3861]
LF-160335	DMOEQTN	Investigative	NA	[1866]
LFA703	DM5G307	Investigative	Small molecular drug	[12]
LFM-A13	DMTXWCZ	Investigative	Small molecular drug	[3403]
LG-120838	DMG1UOR	Investigative	Small molecular drug	[3862]
LG-121071	DMMHYQ4	Investigative	Small molecular drug	[3863]
LG100754	DMEK4FY	Investigative	Small molecular drug	[3864]
LG190178	DMO1FCU	Investigative	Small molecular drug	[3865]
LGD-2226	DMKRSZY	Investigative	Small molecular drug	[3866]
LGD-5552	DM67KWM	Investigative	Small molecular drug	[3867]
LICOAGROCHACONE A	DMWY0TN	Investigative	Small molecular drug	[3868]
LICOAGROCHALCONE A	DMY65ZP	Investigative	Small molecular drug	[1602]
linalool	DMGZQ5P	Investigative	Small molecular drug	[3869]
Linear peptide of RES-701-1	DMD3AJH	Investigative	NA	[3870]
LINOLEIC ACID	DMDGPY9	Investigative	Small molecular drug	[3871]
Lipid Fragment	DMW9Z7N	Investigative	Small molecular drug	[12]
LIPOCRINE	DMUIVCX	Investigative	Small molecular drug	[3872]
Lipoic	DMUG4N6	Investigative	NA	[1866]
LIQUIRTIGENIN	DM6YSG3	Investigative	Small molecular drug	[1317]
lisinopril-tryptophan	DMQ42KU	Investigative	Small molecular drug	[3873]
Lithium chloride	DMHYLQ2	Investigative	Small molecular drug	[3874]
lithocholylcholine	DME76CQ	Investigative	Small molecular drug	[3875]
Lithospermic acid	DMPAKQV	Investigative	Small molecular drug	[2617]
LIVIDOMYCIN A	DM6J1BY	Investigative	Small molecular drug	[3390]
LK 204-545	DMLVTXM	Investigative	Small molecular drug	[3876]
LLZ16406	DMOGZLU	Investigative	Small molecular drug	[2517]
LLZ16407	DM783BP	Investigative	NA	[2517]
LM-4108	DMWLMTD	Investigative	Small molecular drug	[3877]
Lobatamide A	DM2GBEW	Investigative	Small molecular drug	[3878]
Lobatamide B	DMD91RI	Investigative	Small molecular drug	[3878]
Lobatamide C	DMFIDJS	Investigative	Small molecular drug	[3878]
Lobatamide D	DMG706J	Investigative	Small molecular drug	[3878]
Lobatamide F	DM6BWGQ	Investigative	Small molecular drug	[3878]
LOFENTANIL	DMR2WQE	Investigative	Small molecular drug	[3879]
LONCHOCARPUSONE	DMWFAPJ	Investigative	Small molecular drug	[1302]
LONGANINE	DMH106Y	Investigative	Small molecular drug	[1705]
Lophocladine a	DM5OHVN	Investigative	Small molecular drug	[3880]
LORNEIC ACID A	DM0ECUK	Investigative	Small molecular drug	[3881]
LP-12	DM8ZR17	Investigative	Small molecular drug	[3882]
LP-211	DMKDGLA	Investigative	Small molecular drug	[3883]
LP-403812	DMIWMZY	Investigative	Small molecular drug	[3884]
LP-44	DM0C3SF	Investigative	Small molecular drug	[3882]
LP-661438	DMGMO3Q	Investigative	NA	[3885]
LP99	DMTZYQ3	Investigative	Small molecular drug	[3886]
LPA	DMI5XR1	Investigative	Small molecular drug	[3887]
Lpc-Ether	DM1JGDM	Investigative	Small molecular drug	[12]
LRHYLNLLTRQRY-NH2	DMY1807	Investigative	NA	[3888]
LS-192629	DMUBF53	Investigative	Small molecular drug	[3889]
LSN2463359	DMWVTS3	Investigative	Small molecular drug	[3890]
LSN2814617	DMV9NP6	Investigative	Small molecular drug	[3891]
LSP1-2111	DM74J10	Investigative	Small molecular drug	[3892]
LSP4-2022	DMBWHGP	Investigative	Small molecular drug	[3893]
LTA4	DMGM1L2	Investigative	Small molecular drug	[3894]
LTC4	DM702WR	Investigative	Small molecular drug	[3895]
LTD4	DMIUZX3	Investigative	Small molecular drug	[3896]
LTE4	DMCPB0Q	Investigative	Small molecular drug	[3897]
LTERHKILHRLLQEGSPSD	DMDU6F4	Investigative	NA	[3898]
LTK-14	DMW09LB	Investigative	Small molecular drug	[3899]
Lu AF21934	DMH693E	Investigative	Small molecular drug	[3900]
LU-53439	DMGYBSC	Investigative	Small molecular drug	[3901]
LU302872	DM7F3SE	Investigative	Small molecular drug	[3902]
LU32-176B	DM2YOVC	Investigative	Small molecular drug	[3903]
LuAE51090	DM2L0E2	Investigative	Small molecular drug	[3904]
LUDARTIN	DMI9VNO	Investigative	Small molecular drug	[549]
LUF-5417	DMUPQED	Investigative	Small molecular drug	[3040]
LUF-5433	DME4O5D	Investigative	Small molecular drug	[3040]
LUF-5437	DM0DRO8	Investigative	Small molecular drug	[637]
LUF-5735	DM89FBX	Investigative	Small molecular drug	[3372]
LUF-5737	DMXFD3S	Investigative	Small molecular drug	[3372]
LUF-5764	DMQ3VHR	Investigative	Small molecular drug	[3372]
LUF-5767	DMP08QO	Investigative	Small molecular drug	[3372]
LUF-5816	DMQZDMH	Investigative	Small molecular drug	[803]
LUF-5853	DMZQU90	Investigative	Small molecular drug	[804]
LUF-5956	DMG4YWM	Investigative	Small molecular drug	[798]
LUF-5957	DMJFMH9	Investigative	Small molecular drug	[798]
LUF-5962	DMR6LIE	Investigative	Small molecular drug	[798]
LUF-5978	DMCTM3L	Investigative	Small molecular drug	[803]
LUF-5980	DMGOIF5	Investigative	Small molecular drug	[803]
LUF-5981	DMHO3XL	Investigative	Small molecular drug	[3905]
LUF-6258	DM0K75N	Investigative	Small molecular drug	[3906]
LUF5831	DMYZGIK	Investigative	Small molecular drug	[3907]
LUF6200	DMWQ1LH	Investigative	Small molecular drug	[3908]
LUFFARIELLOLIDE	DMYRCHV	Investigative	Small molecular drug	[3909]
LUPEOL	DM4ZLUH	Investigative	Small molecular drug	[3910]
LVAYPWT	DMIO405	Investigative	Small molecular drug	[2195]
LVVAPWT	DM78Z9D	Investigative	Small molecular drug	[2195]
LVVYPWT	DM1QPG7	Investigative	Small molecular drug	[3911]
LXA4	DMGSVL0	Investigative	Small molecular drug	[3912]
LXB4	DMBHQV0	Investigative	Small molecular drug	[3913]
LY 165,163	DM9IU21	Investigative	Small molecular drug	[3914]
LY-2183240	DM8SU6N	Investigative	Small molecular drug	[1127]
LY-2318912	DMPV6N9	Investigative	Small molecular drug	[3915]
LY-266111	DMX5H3T	Investigative	Small molecular drug	[624]
LY-282210	DMBSFDE	Investigative	Small molecular drug	[3916]
LY-292223	DML36ZE	Investigative	Small molecular drug	[3917]
LY-314657	DMD2J97	Investigative	NA	[1866]
LY-326449	DMN53M4	Investigative	Small molecular drug	[3918]
LY-3390334	DMUXFZQ	Investigative	NA	[3919]
LY-379268	DMME40U	Investigative	Small molecular drug	[3920]
LY-389795	DM6Y2XG	Investigative	Small molecular drug	[3921]
LY-465608	DMK64AZ	Investigative	Small molecular drug	[3922]
LY-593039	DMQVF41	Investigative	NA	[3923]
LY063518	DMNB82L	Investigative	Small molecular drug	[3924]
LY108742	DMYNCQR	Investigative	Small molecular drug	[3925]
LY134046	DMT0JXC	Investigative	Small molecular drug	[3926]
LY178002	DMI01YM	Investigative	Small molecular drug	[3927]
LY2033298	DMVHQGF	Investigative	Small molecular drug	[3928]
LY2087101	DMIS82X	Investigative	Small molecular drug	[3929]
LY2109761	DMAWTG3	Investigative	Small molecular drug	[3930]
LY2119620	DM4IELQ	Investigative	Small molecular drug	[3931]
LY214352	DMKZJVA	Investigative	Small molecular drug	[3932]
LY215840	DM5RG7J	Investigative	Small molecular drug	[3933]
Ly231514 Tetra Glu	DM5VWCI	Investigative	Small molecular drug	[12]
LY233053	DMC82DA	Investigative	Small molecular drug	[3934]
LY233536	DMHJOGI	Investigative	Small molecular drug	[3935]
LY2365109	DMBFLOJ	Investigative	Small molecular drug	[3936]
LY256548	DM1KCHN	Investigative	Small molecular drug	[3927]
LY266500	DMHC853	Investigative	Small molecular drug	[3937]
LY301875	DM2HQ9O	Investigative	Small molecular drug	[3938]
LY303336	DMY9WTE	Investigative	Small molecular drug	[3939]
LY307452	DM4C3T4	Investigative	Small molecular drug	[3940]
LY314228	DMWAHYX	Investigative	Small molecular drug	[3941]
LY320135	DMK3Y5U	Investigative	Small molecular drug	[3942]
LY320954	DM3DOI7	Investigative	Small molecular drug	[3943]
LY334362	DMFHT3U	Investigative	Small molecular drug	[3944]
LY339434	DM8S7AO	Investigative	Small molecular drug	[3945]
LY341770	DMS7KW8	Investigative	Small molecular drug	[12]
LY344864	DM8LSQP	Investigative	Small molecular drug	[3946]
LY382884	DMWKYFO	Investigative	Small molecular drug	[3947]
LY456066	DM86Y1V	Investigative	Small molecular drug	[3948]
LY456236	DMROFX8	Investigative	Small molecular drug	[3949]
LY466195	DM97NBO	Investigative	Small molecular drug	[3950]
LY593093	DMQE89J	Investigative	Small molecular drug	[3951]
LY86057	DM5TYMG	Investigative	Small molecular drug	[3952]
LY97241	DMTNVP4	Investigative	Small molecular drug	[3953]
LYCOGARUBIN B	DMVX19Q	Investigative	Small molecular drug	[3954]
Lys-thiol	DME15MN	Investigative	Small molecular drug	[3955]
lysergic acid	DM4MGAQ	Investigative	Small molecular drug	[3956]
lysergol	DM1OHF8	Investigative	Small molecular drug	[3957]
LYSICAMINE	DMIZQW6	Investigative	Small molecular drug	[3958]
Lysine Nz-Carboxylic Acid	DMW1YK3	Investigative	Small molecular drug	[12]
lysophosphatidylcholine	DMOGFVH	Investigative	Small molecular drug	[3959]
lysophosphatidylethanolamine	DMI4FKH	Investigative	Small molecular drug	[3960]
lysophosphatidylinositol	DMETM3R	Investigative	Small molecular drug	[3961]
lysophosphatidylserine	DMKG7J2	Investigative	Small molecular drug	[3962]
Lysophosphotidylserine	DMIG3FX	Investigative	Small molecular drug	[12]
Lys[Z(NO2)]-Lys[Z(NO2)]	DMH0Q9V	Investigative	Small molecular drug	[3963]
Lys[Z(NO2)]-Pro	DMJX4GA	Investigative	Small molecular drug	[3964]
M&B 28767	DMJQG82	Investigative	Small molecular drug	[3965]
M-5MPEP	DMFS7QK	Investigative	Small molecular drug	[3966]
M-Aminophenylboronic Acid	DM213MD	Investigative	Small molecular drug	[12]
m-chlorophenylpiperazine	DMM1J2D	Investigative	Small molecular drug	[3967]
M-Phenoxybenzoic Acid For Cis-Isomer	DMJRK47	Investigative	Small molecular drug	[1096]
M-tolyl 10H-phenothiazine-10-carboxylate	DMXPIKT	Investigative	Small molecular drug	[1050]
M372049	DMYU3Z7	Investigative	Small molecular drug	[3968]
M3A6S	DMJK1RE	Investigative	Small molecular drug	[2444]
M3B6S	DMAHGBF	Investigative	Small molecular drug	[2444]
M3IBu6S	DM0UOF1	Investigative	Small molecular drug	[2444]
m3M3FBS	DMKGNXT	Investigative	Small molecular drug	[3969]
M3P6S	DMXT87E	Investigative	Small molecular drug	[2444]
M3Pr6S	DMMC8RN	Investigative	Small molecular drug	[2444]
M3S	DMWADOY	Investigative	NA	[2444]
M55113	DMM5X8Z	Investigative	Small molecular drug	[3970]
M6G thiosaccharide analogue	DMRB4YV	Investigative	NA	[2273]
M6S	DMFCUN4	Investigative	NA	[2444]
M8-B	DM8I0TY	Investigative	Small molecular drug	[3971]
M826	DM9NPE4	Investigative	Small molecular drug	[3972]
MA-2029	DMKWQ52	Investigative	Small molecular drug	[3973]
MAACKIAIN	DMDHGM2	Investigative	Small molecular drug	[3113]
MACLURAXANTHONE	DMOMG7S	Investigative	Small molecular drug	[2695]
Macrocyclic tripeptide motif	DMFULZO	Investigative	Small molecular drug	[3974]
MAGGIEMYCIN	DMSQL19	Investigative	Small molecular drug	[3975]
Mahureone D	DM5WNH8	Investigative	Small molecular drug	[2815]
Makaluvamine N	DMKE03Q	Investigative	Small molecular drug	[3976]
Malate Like Intermediate	DM4OQWZ	Investigative	Small molecular drug	[107]
Maleic Acid	DM4L0R7	Investigative	Small molecular drug	[22]
malic acid	DMU3O5H	Investigative	Small molecular drug	[3977]
Mallotinic acid	DM9ECWN	Investigative	Small molecular drug	[372]
Mallotusinic acid	DMHX9P8	Investigative	Small molecular drug	[372]
Malonate sodium	DMAJDU7	Investigative	NA	[3978]
malonyl-CoA	DM9ZY2A	Investigative	Small molecular drug	[3979]
Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam	DMMY542	Investigative	Small molecular drug	[107]
MANGIFERIN	DMWAF5Z	Investigative	Small molecular drug	[2695]
MANGOSTANIN	DMOWZUB	Investigative	Small molecular drug	[1799]
MANGOSTANOL	DMG3DUE	Investigative	Small molecular drug	[1799]
MANGOSTENONE F	DMNRZ3S	Investigative	Small molecular drug	[1799]
MANGOSTENONE G	DM4I2NR	Investigative	Small molecular drug	[1799]
MANGOSTIN	DMYQGDV	Investigative	Small molecular drug	[2961]
MANZAMINE A	DMB3GNC	Investigative	Small molecular drug	[3980]
Manzamine E	DMOI9RT	Investigative	Small molecular drug	[1802]
MAP4	DMUCE93	Investigative	Small molecular drug	[3981]
MASLINIC ACID	DMN9UX3	Investigative	Small molecular drug	[1273]
mast cell degranulating peptide	DMDZIHT	Investigative	Small molecular drug	[3982]
MB-3	DMNRMKA	Investigative	Small molecular drug	[3983]
MC-1301	DM5RVO0	Investigative	Small molecular drug	[3984]
MC-CAM	DMAHN4L	Investigative	Small molecular drug	[3985]
MCC950	DM6J2UZ	Investigative	Small molecular drug	[3986]
MCCG	DMKTX1A	Investigative	Small molecular drug	[3987]
MCI	DMZ1YGI	Investigative	Small molecular drug	[3988]
MCL-117	DMQIGZ7	Investigative	Small molecular drug	[81]
MCL-129	DMQZC0U	Investigative	Small molecular drug	[3989]
MCL-139	DMQ1BDZ	Investigative	Small molecular drug	[81]
MCL-144	DMW7ZF8	Investigative	Small molecular drug	[3990]
MCL-145	DMJXU67	Investigative	Small molecular drug	[81]
MCL-147	DMH5SMT	Investigative	Small molecular drug	[3991]
MCL-149	DMTWY94	Investigative	Small molecular drug	[3991]
MCL-153	DMCPW5F	Investigative	Small molecular drug	[3992]
MCL-154	DM3PIHV	Investigative	Small molecular drug	[3992]
MCL-182	DM39YW1	Investigative	Small molecular drug	[3991]
MCL-183	DMVR51Z	Investigative	Small molecular drug	[3991]
MCL-428	DMXBHE4	Investigative	Small molecular drug	[3993]
MCL-429	DM1XH04	Investigative	Small molecular drug	[3993]
MCL-431	DMISHCW	Investigative	Small molecular drug	[3993]
MCL-432	DMPOFAR	Investigative	Small molecular drug	[3993]
MCL-433	DMD3OAQ	Investigative	Small molecular drug	[3993]
MCL-434	DMR31VO	Investigative	Small molecular drug	[3993]
MCL-435	DMLSYD9	Investigative	Small molecular drug	[3993]
MCL-443	DM8LTQ4	Investigative	Small molecular drug	[3993]
MCL-444	DM8HALS	Investigative	Small molecular drug	[3993]
MCL-445	DMR2K4F	Investigative	Small molecular drug	[3991]
MCL-446	DMXF73G	Investigative	Small molecular drug	[3991]
MCL-447	DMSTGNH	Investigative	Small molecular drug	[3991]
MCL-448	DMSJGA9	Investigative	Small molecular drug	[3991]
MCL-449	DMQ890N	Investigative	Small molecular drug	[3993]
MCL-450	DM7I6U8	Investigative	Small molecular drug	[3994]
MCL-451	DMP523A	Investigative	Small molecular drug	[3994]
MCL-457	DMORMGU	Investigative	Small molecular drug	[3991]
MCL-458	DMZN93Y	Investigative	Small molecular drug	[3991]
MCL-515	DMTB8D4	Investigative	Small molecular drug	[3995]
MCL-516	DMQA7ZI	Investigative	Small molecular drug	[260]
MCL0129	DMFTPMX	Investigative	Small molecular drug	[3996]
McN-A-343	DML3AZG	Investigative	Small molecular drug	[3997]
MDL 100,453	DMLI5VH	Investigative	Small molecular drug	[3998]
MDL-18962	DMTVOWC	Investigative	Small molecular drug	[3999]
MDL-28163	DMUHJ2C	Investigative	Small molecular drug	[3741]
MDL-28618	DMF76M8	Investigative	Small molecular drug	[34]
MDL-74156	DMF8VX3	Investigative	Small molecular drug	[2852]
ME bromodomain inhibitor	DMMFYP9	Investigative	Small molecular drug	[3032]
ME0328	DMCLT1V	Investigative	Small molecular drug	[4000]
ME36	DMOZAQ6	Investigative	Small molecular drug	[4001]
ME4	DMO5E2L	Investigative	Small molecular drug	[4002]
ME67	DM3C6X2	Investigative	Small molecular drug	[4003]
MeAIB	DMCT4UW	Investigative	Small molecular drug	[4004]
MEBUDIPINE	DM0P59E	Investigative	Small molecular drug	[4005]
MeBut-RYYRIK-NH2	DMYQOKX	Investigative	Small molecular drug	[754]
MEDI-552	DMQ5S9C	Investigative	NA	[4006]
medica 16	DML2GFB	Investigative	Small molecular drug	[4007]
Medicor	DMVHP3X	Investigative	NA	[1866]
MEDIORESINOL	DMDJ6RE	Investigative	Small molecular drug	[80]
MEK inhibitor I	DMYJI90	Investigative	Small molecular drug	[4008]
MEL57A	DM08SVH	Investigative	Small molecular drug	[4009]
melanin	DM5CS5Y	Investigative	Small molecular drug	[4010]
melanin-concentrating hormone	DMY57L0	Investigative	Small molecular drug	[4011]
Melogatran	DME54M7	Investigative	NA	[3362]
MELOSMINE	DM3492O	Investigative	Small molecular drug	[335]
MEMOQUIN	DM9S30P	Investigative	Small molecular drug	[3872]
Mepacrine	DMU8L7C	Investigative	Small molecular drug	[4012]
mercaptoacrylate inhibitor of calpain 1	DMZIA1R	Investigative	Small molecular drug	[4013]
MERCK-544	DMD25I6	Investigative	Small molecular drug	[4014]
Mercuribenzoic Acid	DMT56ER	Investigative	Small molecular drug	[12]
MERIOLIN 1	DMJT93H	Investigative	Small molecular drug	[4015]
MERIOLIN 2	DM413XJ	Investigative	Small molecular drug	[4015]
MERIOLIN 3	DMVE95S	Investigative	Small molecular drug	[4015]
MERIOLIN 4	DMIJMZQ	Investigative	Small molecular drug	[4015]
MERIOLIN 5	DMGVLR0	Investigative	Small molecular drug	[4015]
MERIOLIN 6	DMW5AXC	Investigative	Small molecular drug	[4015]
MERIOLIN 7	DM8D3NY	Investigative	Small molecular drug	[4015]
MERIOLIN 8	DM0E95B	Investigative	Small molecular drug	[4015]
mersalyl	DMUQZZ0	Investigative	Small molecular drug	[4016]
MESCALINE	DMYVUCE	Investigative	Small molecular drug	[459]
meso-DAP	DM86WRO	Investigative	Small molecular drug	[4017]
MESUAGENIN A	DMZ12GE	Investigative	Small molecular drug	[4018]
MESUAGENIN B	DMKXG3V	Investigative	Small molecular drug	[4018]
Mesuagenin D	DMLZGO7	Investigative	Small molecular drug	[4018]
MESULERGINE	DMKGWAH	Investigative	Small molecular drug	[4019]
Met-Lys-bradykinin	DMZBLQD	Investigative	Small molecular drug	[4020]
meta-chlorphenylbiguanide	DMEA8GP	Investigative	Small molecular drug	[4021]
Meta-Nitro-Tyrosine	DMITMN9	Investigative	Small molecular drug	[12]
Meta-sirtinol	DMSK0QX	Investigative	Small molecular drug	[296]
Meta-Tyrosine	DM0748C	Investigative	Small molecular drug	[12]
Metanephrine	DMTGMB1	Investigative	Small molecular drug	[4022]
Metazamide	DMQBGH9	Investigative	Small molecular drug	[4023]
METAZOCINE	DMB6T23	Investigative	Small molecular drug	[3685]
Methanandamide	DMZVF6M	Investigative	Small molecular drug	[4024]
Methimepip	DMVQSEH	Investigative	Small molecular drug	[4025]
methionine benzimidazole 6	DMEIP6H	Investigative	Small molecular drug	[4026]
Methionine Phosphonate	DMOUTNA	Investigative	Small molecular drug	[12]
Methionine Sulfoxide	DMKE18W	Investigative	Small molecular drug	[22]
METHIOTHEPIN	DMMC0I7	Investigative	Small molecular drug	[4027]
METHOCTRAMINE	DMH2CKX	Investigative	Small molecular drug	[4028]
methoprene acid	DM58A0W	Investigative	Small molecular drug	[4029]
Methotrexate gamma-hydroxamic acid	DM8P526	Investigative	Small molecular drug	[3108]
Methotrexate gamma-L-phenylalaninehydroxamic acid	DMELK2A	Investigative	Small molecular drug	[3108]
Methotrexate gamma-L-proline-hydroxamic acid	DMPYJLA	Investigative	Small molecular drug	[3108]
Methoxy arachidonyl fluorophosphonate	DMX8QK0	Investigative	Small molecular drug	[12]
METHOXYUNDECYLPHOSPHINIC ACID	DMY0O7X	Investigative	Small molecular drug	[22]
Methyl 10H-phenothiazine-10-carboxylate	DMGYZHU	Investigative	Small molecular drug	[1050]
Methyl 14-(3-n-butylureido)tetradec-8(Z)-enoate	DMV1AL5	Investigative	Small molecular drug	[675]
Methyl 2-(2-oxo-8-phenyloctanamido)acetate	DMBKU9M	Investigative	Small molecular drug	[341]
Methyl 2-(2-oxohexadecanamido)acetate	DMVYGBU	Investigative	Small molecular drug	[341]
Methyl 2-(4-chloro-2-cyclohexylphenoxy)acetate	DMA82IQ	Investigative	Small molecular drug	[839]
Methyl 2-(7-phenylheptanoyl)oxazole-4-carboxylate	DMP06I3	Investigative	Small molecular drug	[530]
Methyl 2-(7-phenylheptanoyl)oxazole-5-carboxylate	DM9FA26	Investigative	Small molecular drug	[445]
Methyl 2-(Benzylamino)-1H-indole-3-carboxylate	DMB1PXR	Investigative	Small molecular drug	[248]
Methyl 2-(Diallylamino)-1H-indole-3-carboxylate	DMB74WP	Investigative	Small molecular drug	[248]
Methyl 2-(naphthalen-2-yl)benzoate	DMF6MRS	Investigative	Small molecular drug	[4030]
Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate	DMWM814	Investigative	Small molecular drug	[160]
Methyl 3beta-hydroxyolean-12-en-28-oate	DMWG9BE	Investigative	Small molecular drug	[718]
Methyl 4-(3-cyclohexylureido)butanoate	DM9S210	Investigative	Small molecular drug	[4031]
Methyl 4-(4-hydroxybenzylideneamino)benzoate	DMUROGX	Investigative	Small molecular drug	[917]
Methyl 4-(4-tert-butylbenzylideneamino)benzoate	DMSBCL6	Investigative	Small molecular drug	[917]
Methyl 6-(3-cyclohexylureido)hexanoate	DM9BPQ1	Investigative	Small molecular drug	[4031]
Methyl 7-methoxy-4-phenylbenzofuran-2-ylcarbamate	DMBLW1A	Investigative	Small molecular drug	[4032]
Methyl 7-tert-butyl-9H-carbazole-3-carboxylate	DM9HLXD	Investigative	Small molecular drug	[548]
Methyl 9H-carbazole-2-carboxylate	DM4DIS3	Investigative	Small molecular drug	[548]
methyl arachidonate	DMO7NGP	Investigative	Small molecular drug	[4033]
Methyl arachidonyl fluorophosphonate	DMAXEH3	Investigative	Small molecular drug	[4034]
Methyl estradiol-16-beta-carboxylate	DMG8XD1	Investigative	Small molecular drug	[708]
Methyl icosylphosphonofluoridate	DM9O5S6	Investigative	Small molecular drug	[1476]
methyl isocyanate	DME4JGF	Investigative	Small molecular drug	[4035]
Methyl L-phenylalaninate	DMBHUKV	Investigative	Small molecular drug	[22]
Methyl Mercury Ion	DM6YEW4	Investigative	Small molecular drug	[12]
Methyl Methylsulfinylmethyl Sulfide	DMOCXLW	Investigative	Small molecular drug	[12]
methyl p-hydroxybenzoate	DMO58UW	Investigative	Small molecular drug	[4036]
Methyl Phosphinic Acid	DM096SI	Investigative	Small molecular drug	[12]
Methyl piperate	DMW2R3M	Investigative	Small molecular drug	[4037]
methyl salicylate	DMKCG8H	Investigative	Small molecular drug	[4038]
Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine	DM9Y4FL	Investigative	Small molecular drug	[390]
Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine	DMQU9VD	Investigative	Small molecular drug	[1650]
Methyl-pentyl-prop-2-ynyl-amine oxalic acid	DMQ7THK	Investigative	NA	[2415]
METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	DMR7HV3	Investigative	Small molecular drug	[22]
methyl-piperidino-pyrazole	DMKTOPJ	Investigative	Small molecular drug	[4039]
Methyl3beta-hydroxyolean-12-en-27-oate	DMOA54M	Investigative	Small molecular drug	[718]
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	DM9JECY	Investigative	Small molecular drug	[22]
Methylcarbamic Acid Biphenyl-3-yl Ester	DMDP84X	Investigative	Small molecular drug	[1011]
methylcarbamyl PAF	DMV865Q	Investigative	Small molecular drug	[4040]
METHYLENEDIOXYAMPHETAMINE	DMP204G	Investigative	Small molecular drug	[4041]
METHYLENEDIOXYMETHAMPHETAMINE	DMYVU47	Investigative	Small molecular drug	[4042]
methylfurmethide	DMZ318I	Investigative	Small molecular drug	[4043]
methylglyoxal	DMRC3OZ	Investigative	Small molecular drug	[12]
methylhistaprodifen	DM7PRDY	Investigative	Small molecular drug	[4044]
METHYLHONOKIOL	DM9YE6K	Investigative	Small molecular drug	[774]
methylmalonyl-CoA	DMS4EAM	Investigative	Small molecular drug	[4045]
METHYLNORADRENALINE	DMOWMPL	Investigative	Small molecular drug	[4046]
methylurea	DMAEQB6	Investigative	Small molecular drug	[4047]
Methyl[4'-(trifluoromethyl)-4-biphenylyl]amine	DMZVBLT	Investigative	Small molecular drug	[1349]
Metiamide	DMO7JGS	Investigative	Small molecular drug	[4048]
Metrenperone	DM70RDZ	Investigative	Small molecular drug	[4049]
MeTRH	DMGH8WV	Investigative	Small molecular drug	[4050]
METYRAPOL	DMHTGCR	Investigative	Small molecular drug	[635]
MEZILAMINE	DMVYWJS	Investigative	Small molecular drug	[4051]
MF-152	DMBLUSA	Investigative	Small molecular drug	[4052]
MF-8623	DM1FEVB	Investigative	NA	[1498]
MF266-1	DMSYQP9	Investigative	Small molecular drug	[4053]
MG-101	DM3RUT8	Investigative	Small molecular drug	[4054]
MG-1101	DM710KZ	Investigative	NA	[4055]
MG-111	DMG56EU	Investigative	NA	[4056]
MG149	DM7V58G	Investigative	Small molecular drug	[4057]
MGS0028	DMIMKFZ	Investigative	Small molecular drug	[4058]
MHL cyclohexylthiosemicarbazone	DMZ9MCR	Investigative	Small molecular drug	[910]
MI-1148	DMCN91V	Investigative	Small molecular drug	[4059]
MI-3	DM449LS	Investigative	Small molecular drug	[4060]
Micrococcin	DMJ4D1P	Investigative	Small molecular drug	[2074]
MICROCYSTIN-LR	DMTMLRN	Investigative	Small molecular drug	[4061]
Miller-9E-enolide	DM6BANS	Investigative	Small molecular drug	[703]
Miller-9Z-enolide	DMFMOX5	Investigative	Small molecular drug	[703]
minaxolone	DM8YWNM	Investigative	Small molecular drug	[4062]
MiR-375	DM4P9LJ	Investigative	NA	[4063]
MJ-451	DMMP6YH	Investigative	NA	[4064]
MJN228	DMRSBWT	Investigative	Small molecular drug	[4065]
MK-0343	DMTFRLO	Investigative	NA	[4066]
MK-0668	DMVBFJP	Investigative	Small molecular drug	[4067]
MK-10	DMI7859	Investigative	Small molecular drug	[4068]
MK-11	DM4FG32	Investigative	Small molecular drug	[4068]
MK-1925	DM3NDWK	Investigative	Small molecular drug	[4069]
MK-212	DMYO8T6	Investigative	Small molecular drug	[4070]
MK-5046	DMS7C6R	Investigative	Small molecular drug	[4071]
MK-5435	DMU8VRB	Investigative	Small molecular drug	[4072]
MK-771	DM4YQV0	Investigative	Small molecular drug	[4073]
MK-9	DMKEG2B	Investigative	NA	[2752]
ML 10375	DM4ZNOU	Investigative	Small molecular drug	[4074]
ML-10302	DMM5P8Q	Investigative	Small molecular drug	[4075]
ML-18	DMHJCN6	Investigative	Small molecular drug	[4076]
ML-253764	DMK6YC1	Investigative	Small molecular drug	[2756]
ML-3163	DM3S5UC	Investigative	Small molecular drug	[4077]
ML-3375	DMXJY6W	Investigative	Small molecular drug	[4078]
ML-3403	DMTQWI8	Investigative	Small molecular drug	[4079]
ML169	DMPB7EL	Investigative	Small molecular drug	[4080]
ML204	DM15YL0	Investigative	Small molecular drug	[4081]
ML213	DMFAUGP	Investigative	Small molecular drug	[4082]
ML218	DM3D21X	Investigative	Small molecular drug	[4083]
ML221	DM3OEP4	Investigative	Small molecular drug	[4084]
ML233	DM8CIE4	Investigative	Small molecular drug	[4085]
ML277	DMQ98RS	Investigative	Small molecular drug	[4086]
ML290	DMPOX4Q	Investigative	Small molecular drug	[4087]
ML297	DMY40UG	Investigative	Small molecular drug	[4088]
ML315	DMNOREK	Investigative	Small molecular drug	[4089]
ML321	DMVELYW	Investigative	Small molecular drug	[4090]
ML347	DMR8N36	Investigative	Small molecular drug	[4091]
ML375	DMXJASC	Investigative	Small molecular drug	[4092]
ML380	DMQROC3	Investigative	Small molecular drug	[4093]
ML381	DMKCIP0	Investigative	Small molecular drug	[4094]
ML398	DMA0E2Q	Investigative	Small molecular drug	[4095]
ML9	DMP13VE	Investigative	Small molecular drug	[4096]
MLN-120B	DMYKNSP	Investigative	Small molecular drug	[4097]
MLS1547	DMPTBJZ	Investigative	Small molecular drug	[4098]
MM 11253	DMT1NP8	Investigative	Small molecular drug	[4099]
MM3A6S	DMB74MS	Investigative	Small molecular drug	[2444]
MM3B6S	DM9PGQI	Investigative	Small molecular drug	[2444]
MMDA	DMUWVGP	Investigative	Small molecular drug	[12]
MMI-175	DMH1YN6	Investigative	Small molecular drug	[12]
MMI270	DM38N2K	Investigative	Small molecular drug	[268]
MMPIP	DMWMZL7	Investigative	Small molecular drug	[4100]
MNI-135	DMBJFH9	Investigative	Small molecular drug	[4101]
MNI-136	DM5C9VI	Investigative	Small molecular drug	[4102]
MNI-137	DMKRI1J	Investigative	Small molecular drug	[4103]
modified HA14-1 compounds (cancer)	DMB5OG8	Investigative	NA	[4104]
moexiprilat	DMPYBHI	Investigative	Small molecular drug	[4105]
MOL 6131	DMSF8UC	Investigative	Small molecular drug	[2053]
MOLASSAMIDE	DM0OWTS	Investigative	Small molecular drug	[4106]
Molecule 11	DMZ6H1X	Investigative	Small molecular drug	[4107]
MOLEPHANTIN	DM4OLAZ	Investigative	Small molecular drug	[697]
MOLEPHANTININ	DMGNX6M	Investigative	Small molecular drug	[697]
Monastrol	DMLSEJN	Investigative	Small molecular drug	[12]
Monoctanoin component C	DM31YGM	Investigative	Small molecular drug	[4108]
MONODICTYOCHROMONE B	DM59CR0	Investigative	Small molecular drug	[4109]
Monoisopropyl Ester Phosphonic Acid Group	DMNJXHF	Investigative	Small molecular drug	[12]
Monoisopropylphosphorylserine	DM0OFT6	Investigative	Small molecular drug	[12]
monomethylfumarate	DMU4JWM	Investigative	Small molecular drug	[4110]
Monothioglycerol	DMENSOZ	Investigative	Small molecular drug	[12]
MORACHALCONE A	DMWR0J1	Investigative	Small molecular drug	[152]
MORIN	DM2OGZ5	Investigative	Small molecular drug	[4111]
morphanthridine	DMB91UL	Investigative	Small molecular drug	[4112]
MORPHICEPTIN	DM9A1RY	Investigative	Small molecular drug	[4113]
Morphinan Cyclic Imine analogue	DMTHFSE	Investigative	NA	[4114]
MORPHINONE	DM9LQIA	Investigative	Small molecular drug	[2633]
Morpholino(1'H-phenothiazin-1'-yl)methanone	DM05L3S	Investigative	Small molecular drug	[95]
MPA	DMTM91V	Investigative	Small molecular drug	[4115]
MPC-MECA	DMONDP1	Investigative	Small molecular drug	[4116]
MPDT	DMYX31S	Investigative	Small molecular drug	[4117]
MPP+	DM86RN7	Investigative	Small molecular drug	[4118]
MPPG	DMJHQ9T	Investigative	Small molecular drug	[4119]
MPrP	DMWUK9G	Investigative	Small molecular drug	[4120]
MQ1	DMQ357C	Investigative	Small molecular drug	[4121]
MR-1029	DMS7FC6	Investigative	Small molecular drug	[4122]
MR-1526	DM5WMXJ	Investigative	Small molecular drug	[4122]
MR-16089	DMM2WG7	Investigative	Small molecular drug	[549]
MR-2034	DMF04AG	Investigative	Small molecular drug	[3685]
MR-20492	DMEBQLK	Investigative	Small molecular drug	[549]
MR-20494	DMC79YF	Investigative	Small molecular drug	[549]
MR-20496	DMTCG8M	Investigative	Small molecular drug	[4123]
MR-20814	DMSR3OI	Investigative	NA	[4123]
MR-22388	DMIQ8GL	Investigative	Small molecular drug	[4124]
MR-2266	DMXWSIU	Investigative	Small molecular drug	[4122]
MRE 2029F20	DMUK1PA	Investigative	Small molecular drug	[4125]
MRE 3008F20	DM72US0	Investigative	Small molecular drug	[4126]
MRE 3010F20	DMMFJA8	Investigative	Small molecular drug	[4127]
MRK016	DM7VQTO	Investigative	Small molecular drug	[4128]
MRS 2219	DM7IK68	Investigative	Small molecular drug	[4129]
MRS-1220	DMT6JH9	Investigative	Small molecular drug	[4130]
MRS-2160	DMHJ47A	Investigative	Small molecular drug	[4131]
MRS-2179	DMIVGHB	Investigative	Small molecular drug	[4132]
MRS1041	DMBXKYR	Investigative	Small molecular drug	[4133]
MRS1042	DMVT865	Investigative	Small molecular drug	[4134]
MRS1062	DM50QBR	Investigative	Small molecular drug	[4135]
MRS1065	DMYAHU3	Investigative	Small molecular drug	[4136]
MRS1067	DMAEW9M	Investigative	Small molecular drug	[4137]
MRS1084	DMKELWG	Investigative	Small molecular drug	[4138]
MRS1086	DM1K5E2	Investigative	Small molecular drug	[4139]
MRS1088	DMSKWL7	Investigative	Small molecular drug	[4140]
MRS1093	DM801AO	Investigative	Small molecular drug	[4141]
MRS1097	DMLOHAZ	Investigative	Small molecular drug	[4142]
MRS1132	DMY4C0G	Investigative	Small molecular drug	[4143]
MRS1177	DMBXTPU	Investigative	Small molecular drug	[4144]
MRS1186	DMGJ0IE	Investigative	Small molecular drug	[4145]
MRS1191	DM9WX3C	Investigative	Small molecular drug	[4146]
MRS1476	DMLQYN7	Investigative	Small molecular drug	[4147]
MRS1486	DMFJHMQ	Investigative	Small molecular drug	[4148]
MRS1505	DM3Q5NO	Investigative	Small molecular drug	[4149]
MRS1523	DM4AONZ	Investigative	Small molecular drug	[4150]
MRS1706	DM5I7PL	Investigative	Small molecular drug	[4151]
MRS2211	DM2G5ZE	Investigative	Small molecular drug	[4152]
MRS2279	DM0QGF3	Investigative	Small molecular drug	[4153]
MRS2298	DMZ6EGA	Investigative	Small molecular drug	[4154]
MRS2365	DM0CS3V	Investigative	Small molecular drug	[4155]
MRS2496	DM0CAKS	Investigative	Small molecular drug	[4156]
MRS2500	DMNGTOY	Investigative	Small molecular drug	[4157]
MRS2567	DMUJEA9	Investigative	Small molecular drug	[4158]
MRS2578	DMKMPS6	Investigative	Small molecular drug	[4159]
MRS2603	DMNGC79	Investigative	Small molecular drug	[4160]
MRS2690	DMNS3RT	Investigative	Small molecular drug	[4161]
MRS2693	DM2L3CJ	Investigative	Small molecular drug	[4162]
MRS2698	DM7EZBU	Investigative	Small molecular drug	[4163]
MRS2768	DMO5J39	Investigative	Small molecular drug	[4164]
MRS2782	DMZSO4R	Investigative	Small molecular drug	[4165]
MRS2802	DMWKZCY	Investigative	Small molecular drug	[4166]
MRS2905	DMGCPHO	Investigative	Small molecular drug	[4167]
MRS2927	DMB2A7Q	Investigative	Small molecular drug	[4168]
MRS2950	DMDSB1F	Investigative	Small molecular drug	[4169]
MRS2957	DMROQP6	Investigative	Small molecular drug	[4170]
MRS4062	DMWKXGP	Investigative	Small molecular drug	[4171]
MRS5151	DM1GUTC	Investigative	Small molecular drug	[4172]
MRS5698	DMDF6WG	Investigative	Small molecular drug	[4173]
MRS923	DMMN42V	Investigative	Small molecular drug	[4174]
MRS928	DMKJ9WM	Investigative	Small molecular drug	[4175]
MRT67307	DMYRCHG	Investigative	Small molecular drug	[4176]
MS417	DMXC30P	Investigative	Small molecular drug	[4177]
MS436	DMNBFX0	Investigative	Small molecular drug	[4178]
MS453	DMBTPDL	Investigative	Small molecular drug	[31]
MS7972	DM9WQSA	Investigative	Small molecular drug	[4179]
MSC2032964A	DMS3O9H	Investigative	Small molecular drug	[4180]
MSOPPE	DMU67CE	Investigative	Small molecular drug	[4181]
MSVIII-19	DM4KM91	Investigative	Small molecular drug	[4182]
MT-Immucillin-H	DMK2FOX	Investigative	Small molecular drug	[4183]
MTNF-K90R	DMBC4CK	Investigative	NA	[1866]
MTSEA	DM8KPWM	Investigative	Small molecular drug	[4184]
Mulberrofuran C	DMYV49C	Investigative	Small molecular drug	[3730]
Mulberrofuran D	DMMKH72	Investigative	Small molecular drug	[1992]
Mulberrofuran W	DMTV9P3	Investigative	Small molecular drug	[1992]
Mumbaistatin	DM6SYMH	Investigative	Small molecular drug	[4185]
muramyl dipeptide	DM4FR71	Investigative	Small molecular drug	[4186]
Muscarine	DMNDUJ5	Investigative	Small molecular drug	[4187]
Muscimol	DMNTF2O	Investigative	Small molecular drug	[4188]
MVP-009	DM9CXZ2	Investigative	NA	[1866]
Mycophenolic bis(sulfonamide)	DMUQP3J	Investigative	Small molecular drug	[4189]
Mycophenolic hydroxamic acid	DM4YRAH	Investigative	Small molecular drug	[4190]
MYOSEVERIN	DMX1POR	Investigative	Small molecular drug	[4191]
Myricetin	DMTV4L0	Investigative	Small molecular drug	[12]
MYRIOCIN	DMVXW4L	Investigative	Small molecular drug	[4192]
MYRISTIC ACID	DMYX0BL	Investigative	Small molecular drug	[4193]
Myristoyl-Coa	DMV7NGS	Investigative	Small molecular drug	[12]
Myxopyronin B	DM16SVM	Investigative	Small molecular drug	[22]
N',2-diphenylquinoline-4-carbohydrazide	DMWKRJX	Investigative	Small molecular drug	[1303]
N',2-diphenylquinoline-4-carbohydrazide 8m	DMNJA3C	Investigative	Small molecular drug	[4194]
N'-(2-fluorobenzoyl)-2-naphthohydrazide	DM7BKUQ	Investigative	Small molecular drug	[792]
N'-(2-phenylallyl)hydrazine hydrochloride	DMBR1MX	Investigative	Small molecular drug	[4195]
N'-(phenylsulfonyl)benzofuran-2-carbohydrazide	DMJO3B1	Investigative	Small molecular drug	[4196]
N'-(phenylsulfonyl)quinoline-6-carbohydrazide	DMQETUY	Investigative	Small molecular drug	[4196]
N'-Acridin-9-yl-N,N-diethyl-butane-1,4-diamine	DM1XH8D	Investigative	Small molecular drug	[4197]
N'-Pyridoxyl-Lysine-5'-Monophosphate	DM3ZHBO	Investigative	Small molecular drug	[12]
N(6)-cyclohexyladenosine	DMHINE0	Investigative	Small molecular drug	[4198]
N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine	DM8JQEO	Investigative	Small molecular drug	[4199]
N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine	DME8KXT	Investigative	Small molecular drug	[890]
N*2*-Benzyl-N*6*-cyclohexyl-9H-purine-2,6-diamine	DM41TQB	Investigative	Small molecular drug	[2725]
N*4*-(3-Bromo-phenyl)-quinazoline-4,6,7-triamine	DMFWN5U	Investigative	Small molecular drug	[166]
N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine	DMUI8RC	Investigative	Small molecular drug	[4200]
N*4*-(3-Bromo-phenyl)-quinazoline-4,7-diamine	DMO56XY	Investigative	Small molecular drug	[165]
N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine	DMNGSQK	Investigative	Small molecular drug	[975]
N*4*-Benzyl-pyrido[4,3-d]pyrimidine-4,7-diamine	DMK674I	Investigative	Small molecular drug	[4201]
N*6*-Benzyl-quinazoline-2,4,6-triamine	DMRNGV0	Investigative	Small molecular drug	[3224]
N*6*-Cyclohexyl-N*2*-ethyl-9H-purine-2,6-diamine	DM1K2A4	Investigative	Small molecular drug	[2725]
N*6*-Cyclohexyl-N*2*-phenyl-9H-purine-2,6-diamine	DM3C8PJ	Investigative	Small molecular drug	[2725]
N*6*-Cyclooctyl-N*2*-phenyl-9H-purine-2,6-diamine	DMCOPR3	Investigative	Small molecular drug	[2725]
N,4-dibenzhydrylpiperazine-1-carboxamide	DMOG37L	Investigative	Small molecular drug	[585]
N,4-dimethyl-3,4-dihydroquinazolin-2-amine	DMMTQ3N	Investigative	Small molecular drug	[1504]
N,8-dihydroxy-8-(naphthalen-2-yl)octanamide	DM8G0WX	Investigative	Small molecular drug	[1787]
N,8-diphenyl-9H-purin-6-amine	DMZXF36	Investigative	Small molecular drug	[1226]
N,N'-(1',10'-decylene)-bis-(-)-nor-MEP	DMIX0CT	Investigative	Small molecular drug	[4202]
N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP	DM5NVIO	Investigative	Small molecular drug	[4202]
N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP	DMWI06H	Investigative	Small molecular drug	[4202]
N,N'-(1',2'-ethylene)-bis-(-)-nor-MEP	DM1LKEP	Investigative	Small molecular drug	[4202]
N,N'-(1',3'-propylene)-bis-(-)-nor-MEP	DM4G6BT	Investigative	Small molecular drug	[4202]
N,N'-(1',4'-butylene)-bis-(-)-nor-MEP	DMZHBTA	Investigative	Small molecular drug	[4202]
N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP	DMBPC0K	Investigative	Small molecular drug	[4202]
N,N'-(1',6-hexylene)-bis-(-)-nor-MEP	DMU4BIW	Investigative	Small molecular drug	[4202]
N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP	DMSORHA	Investigative	Small molecular drug	[4202]
N,N'-(1',8'-octylene)-bis-(-)-nor-MEP	DMHFYK2	Investigative	Small molecular drug	[4202]
N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP	DMIWF7U	Investigative	Small molecular drug	[4202]
N,N'-Bis(4-Amino-2-Methylquinolin-6-Yl)Urea	DMT4USP	Investigative	Small molecular drug	[12]
N,N'-Bis-(4-butoxy-phenyl)-guanidine	DMLOP2B	Investigative	Small molecular drug	[4203]
N,N'-Bis-(4-butyl-phenyl)-guanidine	DMOS2GH	Investigative	Small molecular drug	[4203]
N,N'-Bis-(4-ethyl-phenyl)-guanidine	DM0CTG7	Investigative	Small molecular drug	[4203]
N,N'-Bis-(4-hexyl-phenyl)-guanidine	DM0RQGU	Investigative	Small molecular drug	[4203]
N,N'-Bis-(4-isopropyl-phenyl)-guanidine	DMM38BC	Investigative	Small molecular drug	[4203]
N,N'-Bis-(4-sec-butyl-phenyl)-guanidine	DMFDXLB	Investigative	Small molecular drug	[4203]
N,N'-Di-acenaphthen-5-yl-guanidine	DM8TA0M	Investigative	Small molecular drug	[4204]
N,N'-dicyclohexyl-urea	DMLVMJH	Investigative	Small molecular drug	[570]
N,N,N-Triisobutyl-pyrimidine-2,4,6-triamine	DMLU27Y	Investigative	Small molecular drug	[783]
N,N-bis(cyanomethyl)-3,4-dimethoxybenzamide	DMBQ0TY	Investigative	Small molecular drug	[114]
N,N-bis(tosylmethyl)hexan-1-amine	DMM678B	Investigative	Small molecular drug	[1082]
N,N-diallyl[D-Pro-10]Dyn A-(1-11)	DMSY571	Investigative	NA	[4205]
N,N-dibenzyl[D-Pro-10]Dyn A-(1-11)	DMILJUE	Investigative	NA	[4205]
N,N-diCPM[D-Pro-10]Dyn A-(1-11)	DM1UCZ9	Investigative	NA	[4205]
N,N-diethyl estrone-16-methyl carboxamide	DMZ3EA1	Investigative	Small molecular drug	[708]
N,N-Diethyl-1'H-phenothiazine-1'-carboxamide	DM5K3D2	Investigative	Small molecular drug	[95]
N,N-diethyl-2-(1H-indol-3-yl)ethanamine	DM0UBI9	Investigative	Small molecular drug	[4206]
N,N-Diethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	DMBFASY	Investigative	Small molecular drug	[862]
N,N-Dihexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	DMV8QTR	Investigative	Small molecular drug	[862]
N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide	DM4E8C9	Investigative	Small molecular drug	[95]
N,N-dimethyl(2-phenoxyphenyl)methanamine	DMWK91T	Investigative	Small molecular drug	[4207]
N,N-dimethyl(pyridin-3-yl)methanamine	DM41C8E	Investigative	Small molecular drug	[4208]
N,N-Dimethyl-1'H-phenothiazine-1'-carboxamide	DM4CDYG	Investigative	Small molecular drug	[95]
N,N-dimethyl-2,2,2-triphenylacetamide	DM9XZJN	Investigative	Small molecular drug	[132]
N,N-dimethyl-2,2-diphenylethanamine	DMJDQGR	Investigative	Small molecular drug	[937]
N,N-dimethyl-2-(1-tosyl-1H-indol-3-yl)ethanamine	DMYUQDK	Investigative	Small molecular drug	[1373]
N,N-dimethyl-2-(2'-methylbiphenyl-3-yl)ethanamine	DM1DZEL	Investigative	Small molecular drug	[282]
N,N-Dimethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	DM73PXI	Investigative	Small molecular drug	[862]
N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine	DMMD9A0	Investigative	Small molecular drug	[4208]
N,N-Dimethyl-3,3-diphenylpropan-1-amine	DMIP5K7	Investigative	Small molecular drug	[937]
N,N-dimethyl-3,4-dihydroquinazolin-2-amine	DMI3CUZ	Investigative	Small molecular drug	[1146]
N,N-dimethyl-4,4-diphenylbutan-1-amine	DMX9U7S	Investigative	Small molecular drug	[937]
N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine	DMLX0PI	Investigative	Small molecular drug	[4208]
N,N-Dimethylaminoethyl 18-methoxycoronaridinate	DMWJ2PM	Investigative	Small molecular drug	[705]
N,N-dimethylarginine	DM0Y8OW	Investigative	Small molecular drug	[4209]
N,N-dimethylhistamine	DM8WPD2	Investigative	Small molecular drug	[4210]
N,N-Dipropyl-1'H-phenothiazine-1'-carboxamide	DM8769D	Investigative	Small molecular drug	[95]
N,Ndimethyl milnacipran	DMTWK7L	Investigative	Small molecular drug	[4211]
N,N`-bis-alkyl butylimmidazole 12b	DMNZKCL	Investigative	Small molecular drug	[4212]
N,O-Didansyl-L-Tyrosine	DM7FT8D	Investigative	Small molecular drug	[12]
N,O6-Disulfo-Glucosamine	DMYCV7U	Investigative	Small molecular drug	[12]
N-((1H-indol-2-yl)methyl)(phenyl)methanamine	DM093GO	Investigative	Small molecular drug	[4213]
N-((1H-indol-2-yl)methyl)-2-phenylethanamine	DMYUAXR	Investigative	Small molecular drug	[4213]
N-(1'-Phenyl-ethyl) estradiol-16-carboxamide	DM6DEZ4	Investigative	Small molecular drug	[708]
N-(1,3,4-thiadiazol-2-yl)benzamide	DMWP6OZ	Investigative	Small molecular drug	[543]
N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide	DMDW8VX	Investigative	Small molecular drug	[1270]
N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide	DMEDJ7X	Investigative	Small molecular drug	[1270]
N-(1-((cyanomethyl)carbamoyl)cyclohexyl)benzamide	DMBQ5NS	Investigative	Small molecular drug	[4214]
N-(1-(1-phenylethyl)piperidin-4-yl)-1-naphthamide	DMJWTH9	Investigative	Small molecular drug	[4215]
N-(1-(1-phenylethyl)piperidin-4-yl)-2-naphthamide	DMMCGL3	Investigative	Small molecular drug	[4215]
N-(1-(3-bromobenzyl)piperidin-4-yl)-1-naphthamide	DMGYLC1	Investigative	Small molecular drug	[4216]
N-(1-(3-bromobenzyl)piperidin-4-yl)-2-naphthamide	DMRQKYC	Investigative	Small molecular drug	[4216]
N-(1-(4-bromobenzyl)piperidin-4-yl)-2-naphthamide	DMS9RDW	Investigative	Small molecular drug	[4216]
N-(1-(4-nitrobenzyl)piperidin-4-yl)-2-naphthamide	DMAP4R8	Investigative	Small molecular drug	[4216]
N-(1-(4-phenylbutyl)piperidin-4-yl)-1-naphthamide	DMQSLJI	Investigative	Small molecular drug	[4215]
N-(1-(4-phenylbutyl)piperidin-4-yl)-2-naphthamide	DMZ84JH	Investigative	Small molecular drug	[4215]
N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	DMD6N8V	Investigative	Small molecular drug	[12]
N-(1-adamantyl)-N'-propylsulfamide	DM29QT4	Investigative	Small molecular drug	[4217]
N-(1-benzofuran-3-ylmethyl)sulfamide	DM3WBZP	Investigative	Small molecular drug	[4218]
N-(1-Benzyl-2-oxo-ethyl)-benzamide	DMP9A7L	Investigative	Small molecular drug	[100]
N-(1-benzylpiperidin-4-yl)-3,5-dimethoxybenzamide	DM4HB7S	Investigative	Small molecular drug	[4219]
N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	DMEKSHG	Investigative	Small molecular drug	[22]
N-(1-benzylpiperidine-4-yl)-2-naphthamide	DMUQ6P4	Investigative	Small molecular drug	[4216]
N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine	DMY3UZH	Investigative	Small molecular drug	[4213]
N-(1-oxobutan-2-yl)-3-(trifluoromethyl)benzamide	DMI1HBR	Investigative	Small molecular drug	[4220]
N-(1-phenethylpiperidin-4-yl)-1-naphthamide	DMU9YF6	Investigative	Small molecular drug	[4215]
N-(1-phenethylpiperidin-4-yl)-2-naphthamide	DM9QA7Z	Investigative	Small molecular drug	[4215]
N-(1-PHENYL-PROPYL)-FORMAMIDE	DMSHWYU	Investigative	Small molecular drug	[22]
N-(14-methylallyl)norgalanthamine	DMW460V	Investigative	Small molecular drug	[4221]
N-(17-Methylmorphinan-3-yl)-N'-phenylurea	DMFRQ2U	Investigative	Small molecular drug	[712]
N-(1H-benzo[d]imidazol-2-yl)-3-cyanobenzamide	DM054NF	Investigative	Small molecular drug	[3503]
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide	DM0CWPX	Investigative	Small molecular drug	[3503]
N-(1H-indazol-5-yl)acetamide	DMIMJNU	Investigative	Small molecular drug	[4222]
N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide	DM63YJV	Investigative	Small molecular drug	[4222]
N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine	DMHAGSW	Investigative	Small molecular drug	[4213]
N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	DMCM51R	Investigative	Small molecular drug	[4213]
N-(1H-Indol-2-ylmethyl)-N-phenylamine	DMXD592	Investigative	Small molecular drug	[4213]
N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)-acetamide	DMWC70I	Investigative	Small molecular drug	[4223]
N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	DMUZL3J	Investigative	Small molecular drug	[22]
N-(2,3-dihydro-1H-inden-2-yl)isoquinolin-1-amine	DMTLPDZ	Investigative	Small molecular drug	[1431]
N-(2,3-dihydro-1H-inden-2-yl)quinazolin-4-amine	DMJ6LI8	Investigative	Small molecular drug	[1431]
N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide	DMPL26K	Investigative	Small molecular drug	[4224]
N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide	DM5R3ZG	Investigative	Small molecular drug	[4225]
N-(2,4-Dichloro-benzoyl)-benzenesulfonamide	DMHI4Y6	Investigative	Small molecular drug	[1473]
N-(2,4-dichlorophenyl)-2-nitrobenzamide	DM5COQ9	Investigative	Small molecular drug	[997]
N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide	DMHJOBQ	Investigative	Small molecular drug	[997]
N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide	DMNT3JV	Investigative	Small molecular drug	[4226]
N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide	DM3IMXF	Investigative	Small molecular drug	[4226]
N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide	DM6U8SL	Investigative	Small molecular drug	[4226]
N-(2,4-Dimethoxy-phenyl)-3,5-dimethoxy-benzamide	DME0YBF	Investigative	Small molecular drug	[1100]
N-(2,4-dimethoxyphenethyl)docos-13-enamide	DM3QWZU	Investigative	Small molecular drug	[236]
N-(2,4-dimethoxyphenethyl)oleamide	DMRQSD2	Investigative	Small molecular drug	[236]
N-(2,4-dimethylphenyl)-2-nitrobenzamide	DMFZAS9	Investigative	Small molecular drug	[997]
N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide	DMXA9MR	Investigative	Small molecular drug	[4225]
N-(2,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide	DMUVSM1	Investigative	Small molecular drug	[997]
N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide	DMOL79W	Investigative	Small molecular drug	[4225]
N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	DM9ATQ6	Investigative	Small molecular drug	[12]
N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide	DMTBAPH	Investigative	Small molecular drug	[4225]
N-(2,6-diphenylpyrimidin-4-yl)-2-ethylbutyramide	DMK5AU4	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)-3-methylbutyramide	DM6HGK4	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)acetamide	DMQ0DMU	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)benzamide	DMBW752	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)butyramide	DM5EF71	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)isobutyramide	DMWPZCS	Investigative	Small molecular drug	[3372]
N-(2,6-diphenylpyrimidin-4-yl)propionamide	DM89NGE	Investigative	Small molecular drug	[3372]
N-(2-(1H-Indol-3-yl)ethyl)biphenyl-4-carboxamide	DM6NC8G	Investigative	Small molecular drug	[4227]
N-(2-(4-chlorobenzyloxy)-5-bromobenzyl)ethanamine	DM97Q6T	Investigative	Small molecular drug	[126]
N-(2-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	DM57GQN	Investigative	Small molecular drug	[842]
N-(2-(5-methoxybenzofuran-3-yl)ethyl)acetamide	DM4V7AS	Investigative	Small molecular drug	[4228]
N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide	DMLTROU	Investigative	Small molecular drug	[4229]
N-(2-Acetamido)Iminodiacetic Acid	DM7D3GL	Investigative	Small molecular drug	[12]
N-(2-adamantyl)-N'-propylsulfamide	DM6QZPH	Investigative	Small molecular drug	[4217]
N-(2-amino-5-(benzofuran-2-yl)phenyl)benzamide	DM7VN9P	Investigative	Small molecular drug	[4230]
N-(2-amino-5-(furan-2-yl)phenyl)benzamide	DMY9HO8	Investigative	Small molecular drug	[4230]
N-(2-amino-5-(furan-3-yl)phenyl)benzamide	DMI7W9N	Investigative	Small molecular drug	[4230]
N-(2-amino-5-(pyridin-4-yl)phenyl)benzamide	DM1KVPG	Investigative	Small molecular drug	[4230]
N-(2-amino-5-(thiazol-2-yl)phenyl)benzamide	DM2K0AJ	Investigative	Small molecular drug	[4230]
N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide	DMFYG79	Investigative	Small molecular drug	[4231]
N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide	DM7SUTQ	Investigative	Small molecular drug	[1070]
N-(2-aminoethyl)-p-chlorobenzamide	DMLSFQI	Investigative	NA	[22]
N-(2-aminoethyl)isoquinoline-5-sulfonamide	DMG2MSX	Investigative	Small molecular drug	[4232]
N-(2-aminophenyl)-4-(chroman-3-ylmethyl)benzamide	DMT7JUC	Investigative	Small molecular drug	[4233]
N-(2-aminophenyl)-4-methoxybenzamide	DMTKWUM	Investigative	Small molecular drug	[4234]
N-(2-aminophenyl)benzamide	DM8PB90	Investigative	Small molecular drug	[4230]
N-(2-aminophenyl)nicotinamide	DMRDQ1B	Investigative	Small molecular drug	[4231]
N-(2-aminophenyl)quinoxaline-6-carboxamide	DMJXV7C	Investigative	Small molecular drug	[4234]
N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine	DM72BSO	Investigative	Small molecular drug	[302]
N-(2-benzyloxy-4-nitrophenyl)methanesulfonamide	DMW5XLG	Investigative	Small molecular drug	[4235]
N-(2-bromobenzoyloxy)-4-chlorobenzamide	DMFC564	Investigative	Small molecular drug	[479]
N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide	DM4IEWG	Investigative	Small molecular drug	[1573]
N-(2-chloroethyl)icosa-5,8,11,14-tetraenamide	DMU5R2O	Investigative	Small molecular drug	[4236]
N-(2-Diethylamino-ethyl)-4-hexyloxy-benzamide	DMZ4A2X	Investigative	Small molecular drug	[4237]
N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	DMMDXEO	Investigative	Small molecular drug	[1598]
N-(2-Ethylphenyl)-N'-hydroxyoctanediamide	DMDM50P	Investigative	Small molecular drug	[4225]
N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	DM3CZVW	Investigative	Small molecular drug	[12]
N-(2-hexyloxy-4-nitrophenyl)methanesulfonamide	DM27L53	Investigative	Small molecular drug	[4238]
N-(2-hydroxyethyl)linoleoylamide	DM97MGE	Investigative	Small molecular drug	[4239]
N-(2-iodethyl)arachidonylamide	DM8ORQ4	Investigative	Small molecular drug	[4239]
N-(2-iodoethyl)linoleoylamide	DMV84PQ	Investigative	Small molecular drug	[4239]
N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide	DM0GOPV	Investigative	Small molecular drug	[4240]
N-(2-Mercapto-ethyl)-N'-phenyl-succinamide	DMJLFOQ	Investigative	Small molecular drug	[4240]
N-(2-methoxybenzyl)cinnamamidine	DM06S5Z	Investigative	Small molecular drug	[4241]
N-(2-Methyl-1H-indol-5-yl)benzamide	DMH42YF	Investigative	Small molecular drug	[1142]
N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	DM3SF5M	Investigative	Small molecular drug	[1142]
N-(2-methyl-2-phenylpropyl)pyrazine-2-carboxamide	DMXRSM1	Investigative	Small molecular drug	[4242]
N-(2-morpholinophenyl)-5-nitrofuran-2-carboxamide	DMI4KNB	Investigative	Small molecular drug	[4243]
N-(2-naphthylsulfonyl)-glycyl-glycine-nitrile	DMF5N4O	Investigative	Small molecular drug	[4244]
N-(2-nonyloxy-4-nitrophenyl)methanesulfonamide	DMU6FPL	Investigative	Small molecular drug	[4238]
N-(2-oxazolemethyl)milnacipran	DMVGP02	Investigative	Small molecular drug	[4211]
N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	DM1ADE5	Investigative	Small molecular drug	[302]
N-(2-Phenylethyl)-1H-indole-2-carboxamide	DMJCO7F	Investigative	Small molecular drug	[4213]
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide	DMUILX8	Investigative	Small molecular drug	[1270]
N-(2-phenylpropyl)quinoxaline-2-carboxamide	DMA1LRF	Investigative	Small molecular drug	[4242]
N-(2-Propyloxy-4-nitrophenyl)methanesulfonamide	DMAQMXJ	Investigative	Small molecular drug	[4238]
N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	DME9HNO	Investigative	Small molecular drug	[12]
N-(3'-acetyl-4-aminobiphenyl-3-yl)benzamide	DMYJB1A	Investigative	Small molecular drug	[4230]
N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide	DM2Y5AP	Investigative	Small molecular drug	[4237]
N-(3,3-Dimethyl-butyl)-4-indol-1-yl-benzamide	DMEUXOQ	Investigative	Small molecular drug	[4237]
N-(3,3-Dimethyl-cyclopentyl)-4-hexyloxy-benzamide	DM6EJQ4	Investigative	Small molecular drug	[4237]
N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide	DMAXLVQ	Investigative	Small molecular drug	[4245]
N-(3,3-Diphenyl)propyl-2-phenylacetamide	DMBX0K1	Investigative	Small molecular drug	[4245]
N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide	DM4PTR3	Investigative	Small molecular drug	[1354]
N-(3,3-Diphenyl-propyl)-isonicotinamide	DMOXR4K	Investigative	Small molecular drug	[1354]
N-(3,3-diphenyl-propyl)-nicotinamide	DMDYZ9K	Investigative	Small molecular drug	[1354]
N-(3,4,5-trihydroxyphenethyl)oleamide	DMQ5USA	Investigative	Small molecular drug	[4246]
N-(3,4-Dichlorophenyl)propyl-ETAV	DMTERF6	Investigative	Small molecular drug	[3083]
N-(3,4-Difluorophenyl)propyl-ETAV	DMF2D4O	Investigative	Small molecular drug	[3083]
N-(3,4-dihydroxybenzyl)oleamide	DM67XSW	Investigative	Small molecular drug	[4247]
N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide	DMEP2VM	Investigative	Small molecular drug	[4225]
N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide	DM9B1ID	Investigative	Small molecular drug	[2881]
N-(3,5-dichlorophenyl)-2-nitrobenzamide	DMDNUCL	Investigative	Small molecular drug	[997]
N-(3,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide	DM8DAGL	Investigative	Small molecular drug	[997]
N-(3,5-dichlorophenyl)imidodicarbonimidic diamide	DMQ0LF2	Investigative	Small molecular drug	[4248]
N-(3,5-dimethoxyphenethyl)docos-13-enamide	DM95SJU	Investigative	Small molecular drug	[236]
N-(3,5-dimethoxyphenethyl)oleamide	DM1C40H	Investigative	Small molecular drug	[236]
N-(3,5-dimethoxyphenyl)-4-methyl-2-nitrobenzamide	DM43QHV	Investigative	Small molecular drug	[997]
N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide	DM1L3FM	Investigative	Small molecular drug	[4225]
N-(3-(1H-indol-4-yloxy)propyl)cyclohexanamine	DM0JE7H	Investigative	Small molecular drug	[1384]
N-(3-(1H-indol-4-yloxy)propyl)cyclopentanamine	DM2URTK	Investigative	Small molecular drug	[1384]
N-(3-(2,5-dimethoxyphenyl)propyl)acetamide	DM4ZTF1	Investigative	Small molecular drug	[4249]
N-(3-(2-aminoethyl)phenyl)benzenesulfonamide	DMP8547	Investigative	Small molecular drug	[876]
N-(3-(2-ethoxy-5-methoxyphenyl)propyl)acetamide	DMLWGPC	Investigative	Small molecular drug	[4249]
N-(3-(2-hydroxy-5-methoxyphenyl)propyl)acetamide	DMI452E	Investigative	Small molecular drug	[4249]
N-(3-(3-aminopropyl)phenyl)benzenesulfonamide	DMW59AY	Investigative	Small molecular drug	[876]
N-(3-(3-cyanobenzamido)phenyl)-2-methoxybenzamide	DMXL70A	Investigative	Small molecular drug	[1004]
N-(3-(3-methoxyphenyl)-3-phenylallyl)acetamide	DMH0LOT	Investigative	Small molecular drug	[4250]
N-(3-(3-methoxyphenyl)propyl)acetamide	DMSZ03N	Investigative	Small molecular drug	[4249]
N-(3-(3-methoxyphenyl)propyl)propionamide	DMKSM5A	Investigative	Small molecular drug	[4249]
N-(3-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	DMOCZVB	Investigative	Small molecular drug	[842]
N-(3-(4-hydroxy-3-methoxyphenyl)propyl)acetamide	DMILWPS	Investigative	Small molecular drug	[4249]
N-(3-(5-methoxy-2-propoxyphenyl)propyl)acetamide	DMHM0WI	Investigative	Small molecular drug	[4249]
N-(3-(aminomethyl)phenyl)benzenesulfonamide	DMSC862	Investigative	Small molecular drug	[876]
N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide	DMSJX1H	Investigative	Small molecular drug	[4251]
N-(3-(trifluoromethoxy)benzyl)-4-phenoxybenzamide	DM6UC8Y	Investigative	Small molecular drug	[4252]
N-(3-(trifluoromethyl)benzyl)-4-phenoxybenzamide	DMSMRF9	Investigative	Small molecular drug	[4252]
N-(3-acetamidophenyl)-3-chlorobenzamide	DMH3R21	Investigative	Small molecular drug	[1004]
N-(3-aminophenyl)benzenesulfonamide	DMJ6FP7	Investigative	Small molecular drug	[876]
N-(3-Benzooxazol-7-yl-propyl)-acetamide	DMYSURL	Investigative	Small molecular drug	[4253]
N-(3-Benzooxazol-7-yl-propyl)-butyramide	DMKMESD	Investigative	Small molecular drug	[4253]
N-(3-Benzooxazol-7-yl-propyl)-propionamide	DMEMYS1	Investigative	Small molecular drug	[4253]
N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide	DMOQ08F	Investigative	Small molecular drug	[1473]
N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine	DM0Z1HJ	Investigative	Small molecular drug	[1598]
N-(3-bromophenyl)-6-chloroquinazolin-4-amine	DMEWQCN	Investigative	Small molecular drug	[1228]
N-(3-bromophenyl)-6-fluoroquinazolin-4-amine	DMRIK7P	Investigative	Small molecular drug	[1228]
N-(3-Chloro-phenyl)-2-cyclohexyl-acetamide	DME6IKT	Investigative	Small molecular drug	[517]
N-(3-chlorophenyl)-3-cyano-5-fluorobenzamide	DM3RQHG	Investigative	Small molecular drug	[1268]
N-(3-chlorophenyl)-6-fluoroquinazolin-4-amine	DM3AGJH	Investigative	Small molecular drug	[1228]
N-(3-chlorophenyl)-6-methoxyquinazolin-4-amine	DMQEPV0	Investigative	Small molecular drug	[1228]
N-(3-chlorophenyl)-6-nitroquinazolin-4-amine	DMIKP5Y	Investigative	Small molecular drug	[1228]
N-(3-Ethylphenyl)-N'-hydroxyoctanediamide	DMC5G6Y	Investigative	Small molecular drug	[4225]
N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine	DM0H8CK	Investigative	Small molecular drug	[4254]
N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine	DMSVQJP	Investigative	Small molecular drug	[4254]
N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE	DM2D4KY	Investigative	Small molecular drug	[22]
N-(3-phenethoxybenzyl)-4-hydroxybenzamide	DMHZU8K	Investigative	Small molecular drug	[4255]
N-(3-phenoxy-4-pyridinyl)ethanesulfonamide	DMXF46V	Investigative	Small molecular drug	[4256]
N-(3-phenoxy-4-pyridinyl)propanesulfonamide	DMN1DPJ	Investigative	Small molecular drug	[4256]
N-(3-phenoxypyridin-4-yl)methanesulfonamide	DM7CM3F	Investigative	Small molecular drug	[4251]
N-(3-Phenyl)propyl-2,2-diphenylacetamide	DM9XH18	Investigative	Small molecular drug	[4245]
N-(3-Phenyl)propyl-2-(4-bromophenylacetamide)	DMSNF7W	Investigative	Small molecular drug	[4245]
N-(3-Phenyl-propyl)-nicotinamide	DMA7X62	Investigative	Small molecular drug	[1354]
N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide	DM4IA92	Investigative	Small molecular drug	[637]
N-(3-phenylamino-4-pyridinyl)methanesulfonamide	DMJB7SE	Investigative	Small molecular drug	[4251]
N-(3-Phenylpropyl)-1H-indole-2-carboxamide	DMKAX3Q	Investigative	Small molecular drug	[4213]
N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide	DMZ3I6U	Investigative	Small molecular drug	[302]
N-(4'-acetyl-4-aminobiphenyl-3-yl)benzamide	DMIJLX6	Investigative	Small molecular drug	[4230]
N-(4'-bromo-3,3'-difluoro-4-biphenylyl)urea	DMWHYOJ	Investigative	Small molecular drug	[1349]
N-(4'-chloro-4-biphenylyl)methanesulfonamide	DM0ARP8	Investigative	Small molecular drug	[1349]
N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide	DM2N3TG	Investigative	Small molecular drug	[1276]
N-(4'-isopropyl-4-biphenylyl)urea	DM2MGSO	Investigative	Small molecular drug	[1349]
N-(4'-methyl-4-biphenylyl)urea	DMO8L57	Investigative	Small molecular drug	[1349]
N-(4'-methyl-piperazinyl) estradiol-16-carboxamide	DMXNMTD	Investigative	Small molecular drug	[708]
N-(4'-pentanonyl)-4-(4''-dimethylamino-styryl)pyridinium	DMKNBFM	Investigative	Small molecular drug	[4257]
N-(4'-t-butyl-4-biphenylyl)urea	DMHX4F2	Investigative	Small molecular drug	[1349]
N-(4,4-Diphenyl-butyl)-nicotinamide	DM086VJ	Investigative	Small molecular drug	[1354]
N-(4,5-diphenylpyrimidin-2-yl)acetamide	DM34R10	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)-2-ethylbutyramide	DMDP1QG	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)-3-chlorobenzamide	DMQVPK9	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)-3-methylbutyramide	DMOAPJ1	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)-4-chlorobenzamide	DM1PSR7	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)benzamide	DMA214F	Investigative	Small molecular drug	[3372]
N-(4,6-diphenylpyrimidin-2-yl)propionamide	DMJZ2IP	Investigative	Small molecular drug	[3372]
N-(4-(2-aminoethyl)phenyl)benzenesulfonamide	DM1V83P	Investigative	Small molecular drug	[876]
N-(4-(3-(pyridin-2-yl)acryloyl)phenyl)acetamide	DMRH987	Investigative	Small molecular drug	[4258]
N-(4-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide	DMQDI5H	Investigative	Small molecular drug	[842]
N-(4-(benzyloxy)phenethyl)pyridin-4-amine	DMIPKNQ	Investigative	Small molecular drug	[4259]
N-(4-(diethylamino)phenyl)-2-nitrobenzamide	DMZAOVG	Investigative	Small molecular drug	[997]
N-(4-(trifluoromethyl)benzyl)-4-phenoxybenzamide	DMZ0V8O	Investigative	Small molecular drug	[4252]
N-(4-amino-2-propylquinolin-6-yl)cinnamamide	DMCLRBK	Investigative	Small molecular drug	[4260]
N-(4-amino-3'-methoxybiphenyl-3-yl)benzamide	DMV6154	Investigative	Small molecular drug	[4230]
N-(4-amino-3'-methylbiphenyl-3-yl)benzamide	DM910BF	Investigative	Small molecular drug	[4230]
N-(4-amino-4'-bromobiphenyl-3-yl)benzamide	DMIAGS8	Investigative	Small molecular drug	[4230]
N-(4-amino-4'-fluorobiphenyl-3-yl)benzamide	DMR5D16	Investigative	Small molecular drug	[4230]
N-(4-amino-4'-methoxybiphenyl-3-yl)benzamide	DM93PDA	Investigative	Small molecular drug	[4230]
N-(4-amino-4'-vinylbiphenyl-3-yl)benzamide	DMSUJDH	Investigative	Small molecular drug	[4230]
N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide	DMY1FMG	Investigative	Small molecular drug	[4261]
N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide	DMUFVM6	Investigative	Small molecular drug	[2066]
N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide	DMSAD87	Investigative	Small molecular drug	[2066]
N-(4-aminobiphenyl-3-yl)benzamide	DMLA92O	Investigative	Small molecular drug	[4230]
N-(4-aminobiphenyl-3-yl)nicotinamide	DMXVZIY	Investigative	Small molecular drug	[4231]
N-(4-bromo-2-methylphenyl)-2-naphthamide	DMSNZV1	Investigative	Small molecular drug	[2881]
N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine	DMC28SN	Investigative	Small molecular drug	[4254]
N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine	DMFG6MU	Investigative	Small molecular drug	[4254]
N-(4-Chloro-7-p-tolyl-isoquinolin-1-yl)-guanidine	DMNO46U	Investigative	Small molecular drug	[4262]
N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine	DMGI9EA	Investigative	Small molecular drug	[4254]
N-(4-cyanophenyl)sulfamide	DMW8S2D	Investigative	Small molecular drug	[4263]
N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide	DMB3E7H	Investigative	Small molecular drug	[1054]
N-(4-Dipropylaminobutyl)-4-biphenylcarboxamide	DMU1ATH	Investigative	Small molecular drug	[4264]
N-(4-Ethoxybutyl)-2-oxohexadecanamide	DM012TN	Investigative	Small molecular drug	[341]
N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	DMWTVJH	Investigative	Small molecular drug	[1070]
N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	DMIWNAY	Investigative	Small molecular drug	[1598]
N-(4-Ethylphenyl)-N'-hydroxyoctanediamide	DMKN8U6	Investigative	Small molecular drug	[4225]
N-(4-Ethylphenyl)benzo[d]oxazol-2-amine	DMJ73T6	Investigative	Small molecular drug	[1598]
N-(4-fluorobenzyl)-N-(pyridin-4-yl)-2-naphthamide	DMP1ICB	Investigative	Small molecular drug	[4265]
N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide	DM7O5WS	Investigative	Small molecular drug	[4222]
N-(4-hydroxybiphenyl-3-yl)benzamide	DMC5H8G	Investigative	Small molecular drug	[4231]
N-(4-hydroxyphenylpropanyl)-spermine	DM4QR2C	Investigative	Small molecular drug	[4266]
N-(4-iodophenyl)-4-(trifluoromethoxy)benzamide	DM6GFRP	Investigative	Small molecular drug	[4267]
N-(4-iodophenyl)-4-(trifluoromethyl)benzamide	DMK9FQG	Investigative	Small molecular drug	[4267]
N-(4-Iodophenyl)-N'-(17-methylmorphinan-3-yl)urea	DMHANU5	Investigative	Small molecular drug	[712]
N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide	DMEBGF1	Investigative	Small molecular drug	[4268]
N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide	DMG6RTJ	Investigative	Small molecular drug	[4268]
N-(4-methoxybenzyl)oleamide	DMHM3LC	Investigative	Small molecular drug	[236]
N-(4-methoxyphenethyl)oleamide	DM5NOSM	Investigative	Small molecular drug	[236]
N-(4-methoxyphenyl)oleamide	DMJVPK6	Investigative	Small molecular drug	[236]
N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine	DMCZD37	Investigative	Small molecular drug	[4269]
N-(4-methyl-benzyl)-4-phenoxy-benzamide	DMZX2BH	Investigative	Small molecular drug	[4252]
N-(4-methylthiazol-2-yl)-2-phenylacetamide	DM03VXN	Investigative	Small molecular drug	[543]
N-(4-methylthiazol-2-yl)benzamide	DMTCA2Z	Investigative	Small molecular drug	[543]
N-(4-morpholinophenyl)docos-13-enamide	DMGRFYV	Investigative	Small molecular drug	[236]
N-(4-Phenyl-pyridin-2-yl)-guanidine	DMYD4PC	Investigative	Small molecular drug	[4270]
N-(4-Phenyl-thiazol-2-yl)-benzamide	DMPA91F	Investigative	Small molecular drug	[785]
N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile	DMUJS4Y	Investigative	Small molecular drug	[4244]
N-(4-Phenylbutyl)-1H-indole-2-carboxamide	DMTCMUG	Investigative	Small molecular drug	[4213]
N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide	DMSREW5	Investigative	Small molecular drug	[302]
N-(4-phenylsulfamoyl-naphthalen-1-yl)-benzamide	DMQS9OH	Investigative	Small molecular drug	[4271]
N-(4-Phenylthiazol-2-yl)isonicotinamide	DM2OHVJ	Investigative	Small molecular drug	[238]
N-(4-Propylaminobutyl)-4-biphenylcarboxamide	DMG9D7A	Investigative	Small molecular drug	[4264]
N-(4-Pyridin-2-yl-thiazol-2-yl)-benzamide	DMHBWM9	Investigative	Small molecular drug	[637]
N-(4-Sulfamoyl-phenyl)-benzamide	DMZDACT	Investigative	Small molecular drug	[749]
N-(4-Sulfamoyl-phenyl)-butyramide	DM3FW9Q	Investigative	Small molecular drug	[749]
N-(4-Sulfamoyl-phenyl)-isobutyramide	DMJCXYQ	Investigative	Small molecular drug	[749]
N-(4-Sulfamoyl-phenyl)-propionamide	DM7MHQD	Investigative	Small molecular drug	[749]
N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	DMOMYDV	Investigative	Small molecular drug	[22]
N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide	DM7QX03	Investigative	Small molecular drug	[4272]
N-(4-tert-butylphenyl)-4-(pyridin-2-yl)benzamide	DMN6DAZ	Investigative	Small molecular drug	[1409]
N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine	DMFUBQ8	Investigative	Small molecular drug	[1497]
N-(4-tert-butylthiazol-2-yl)isoquinolin-5-amine	DMMUX86	Investigative	Small molecular drug	[1497]
N-(4-tert-butylthiazol-2-yl)quinolin-5-amine	DMBMAKG	Investigative	Small molecular drug	[1497]
N-(5'-Phosphopyridoxyl)-D-Alanine	DM3FCAI	Investigative	Small molecular drug	[12]
N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	DMEW3L0	Investigative	Small molecular drug	[22]
N-(5-Amino-6-oxo-heptyl)-acetamidine	DM47XR8	Investigative	Small molecular drug	[1150]
N-(5-Benzoyl-4-phenylthiazol-2-yl)benzamide	DMTF8US	Investigative	Small molecular drug	[3040]
N-(5-Benzyloxy-isoquinolin-1-yl)-guanidine	DMGAITY	Investigative	Small molecular drug	[4262]
N-(5-Bromo-quinoxalin-6-yl)-guanidine	DMD5E8G	Investigative	Small molecular drug	[1973]
N-(5-chloro-2-(phenylthio)phenyl)butyramide	DMHZ256	Investigative	Small molecular drug	[4273]
N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamide	DM2TFJE	Investigative	Small molecular drug	[4274]
N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	DM9JCD3	Investigative	Small molecular drug	[12]
N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide	DMNQDLC	Investigative	Small molecular drug	[4275]
N-(5-Hydroxycarbamoyl-pentyl)-4-methoxy-benzamide	DMUHKYW	Investigative	Small molecular drug	[4276]
N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide	DMSUW7M	Investigative	Small molecular drug	[1474]
N-(5-Hydroxycarbamoyl-pentyl)-benzamide	DMZSGPB	Investigative	Small molecular drug	[4276]
N-(5-m-Tolyl-furan-2-carbonyl)-guanidine	DMS2X69	Investigative	Small molecular drug	[4277]
N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide	DMSQEXP	Investigative	Small molecular drug	[1584]
N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine	DM91463	Investigative	Small molecular drug	[4254]
N-(5-methylthiazol-2-yl)-2-phenylacetamide	DM8PNKC	Investigative	Small molecular drug	[543]
N-(5-methylthiazol-2-yl)benzamide	DMFI057	Investigative	Small molecular drug	[543]
N-(5-o-Tolyl-furan-2-carbonyl)-guanidine	DMFNZSL	Investigative	Small molecular drug	[4277]
N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide	DMA21WB	Investigative	Small molecular drug	[4275]
N-(5-Phenyl-furan-2-carbonyl)-guanidine	DMNU68D	Investigative	Small molecular drug	[4277]
N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide	DMDZ9BY	Investigative	Small molecular drug	[1088]
N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide	DM5E7OC	Investigative	Small molecular drug	[4275]
N-(6)-methyl-2'-deoxyadenosine-3',5'-bisphosphate	DMKWYMP	Investigative	NA	[4278]
N-(6-(2-chlorophenyl)-1H-indazol-3-yl)butyramide	DMDCX5O	Investigative	Small molecular drug	[239]
N-(6-(3-hydroxyphenyl)-1H-indazol-3-yl)butyramide	DMKGBZA	Investigative	Small molecular drug	[239]
N-(6-(4-aminophenyl)-1H-indazol-3-yl)butyramide	DMDQEZG	Investigative	Small molecular drug	[239]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	DMP7UZB	Investigative	Small molecular drug	[143]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX)	DMDPXUA	Investigative	Small molecular drug	[143]
N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	DMSX5DI	Investigative	Small molecular drug	[143]
N-(6-(4-fluorophenyl)-1H-indazol-3-yl)butyramide	DM4M12J	Investigative	Small molecular drug	[239]
N-(6-(4-hydroxyphenyl)-1H-indazol-3-yl)butyramide	DM8JLR4	Investigative	Small molecular drug	[239]
N-(6-(furan-3-yl)-1H-indazol-3-yl)butyramide	DMRGQTM	Investigative	Small molecular drug	[239]
N-(6-(pyridin-3-yl)-1H-indazol-3-yl)butyramide	DM3FOKL	Investigative	Small molecular drug	[4279]
N-(6-(pyridin-4-yl)-1H-indazol-3-yl)butyramide	DM4GRK8	Investigative	Small molecular drug	[239]
N-(6-(thiophen-3-yl)-1H-indazol-3-yl)butyramide	DMNRSYP	Investigative	Small molecular drug	[239]
N-(6-(trifluoromethyl)-1H-indazol-3-yl)butyramide	DMMHD9Z	Investigative	Small molecular drug	[239]
N-(6-benzyl-1H-indazol-3-yl)butyramide	DM0OCLU	Investigative	Small molecular drug	[239]
N-(6-bromo-1H-indazol-3-yl)butyramide	DMJPL7E	Investigative	Small molecular drug	[239]
N-(6-chloro-1H-indazol-3-yl)butyramide	DMHGXPY	Investigative	Small molecular drug	[239]
N-(6-chloro-5-p-tolyl-1H-indazol-3-yl)butyramide	DMIN128	Investigative	Small molecular drug	[239]
N-(6-chloro-5-phenyl-1H-indazol-3-yl)butyramide	DMJV3UO	Investigative	Small molecular drug	[4279]
N-(6-ethoxypyridin-2-yl)acetamide	DM90KGB	Investigative	Small molecular drug	[2066]
N-(6-Hydroxycarbamoyl-hexyl)-benzamide	DMIZVMT	Investigative	Small molecular drug	[1474]
N-(6-Mercapto-hexyl)-benzamide	DM01Y37	Investigative	Small molecular drug	[1480]
N-(6-methylpyridin-2-yl)-5-phenylpicolinamide	DMQRE5D	Investigative	Small molecular drug	[4280]
N-(6-methylpyridin-2-yl)-6-phenylnicotinamide	DMQZMRG	Investigative	Small molecular drug	[1080]
N-(6-methylpyridin-2-yl)biphenyl-3-carboxamide	DMBNJ2L	Investigative	Small molecular drug	[1080]
N-(6-phenethyl-1H-indazol-3-yl)butyramide	DM9K4WP	Investigative	Small molecular drug	[239]
N-(6-phenoxypyridin-3-yl)-1H-indole-3-carboxamide	DM2E5OX	Investigative	Small molecular drug	[4281]
N-(6-phenyl-1H-indazol-3-yl)butyramide	DMVCPLU	Investigative	Small molecular drug	[4279]
N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX)	DM5F27T	Investigative	Small molecular drug	[143]
N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	DMO3Y0B	Investigative	Small molecular drug	[143]
N-(7-Benzyloxy-isoquinolin-1-yl)-guanidine	DMPMBC2	Investigative	Small molecular drug	[4262]
N-(7-methoxy-4-phenylbenzofuran-2-yl)acetamide	DMH42L8	Investigative	Small molecular drug	[4032]
N-(8-(3-cyanophenyl)-9H-purin-6-yl)pentanamide	DMHFPE3	Investigative	Small molecular drug	[1226]
N-(9H-beta-Carbolin-3-yl)-acetamide	DMBD52I	Investigative	Small molecular drug	[208]
N-(9H-beta-Carbolin-3-yl)-formamide	DM3KNSY	Investigative	Small molecular drug	[208]
N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide	DMFONC1	Investigative	Small molecular drug	[95]
N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM87YJW	Investigative	Small molecular drug	[302]
N-(benzyloxycarbonyl)-leucyl-glycine-nitrile	DMR18YI	Investigative	Small molecular drug	[4244]
N-(biphenyl-3-yl)-6-(sulfamoylamino)hexanamide	DMRCYB8	Investigative	Small molecular drug	[4282]
N-(biphenyl-3-yl)benzo[d]isoxazol-3-amine	DM2ZQBS	Investigative	Small molecular drug	[4283]
N-(Biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	DMSO7FW	Investigative	Small molecular drug	[4284]
N-(biphenyl-4-yl)benzo[d]isoxazol-3-amine	DML10NT	Investigative	Small molecular drug	[4283]
N-(biphenyl-4-ylsulfonyl)-D-leucine	DMHPITZ	Investigative	Small molecular drug	[22]
N-(Chlorophenyl)-N'-Hydroxyguanidine	DMFGSLO	Investigative	Small molecular drug	[22]
N-(cis-9-cis-12-octadecadienyl)sulfamide	DM1TA5R	Investigative	Small molecular drug	[4217]
N-(cyanomethyl)cyclohex-1-ene-1-carboxamide	DMTKREZ	Investigative	Small molecular drug	[4214]
N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine	DMI245K	Investigative	Small molecular drug	[22]
N-(Ethylphosphoryl)-L-isoleucyl-L-Trp-NHCH3	DMJ6U4H	Investigative	Small molecular drug	[4285]
N-(furan-2-ylmethyl)-estrone-16-methyl carboxamide	DM0DZ9J	Investigative	Small molecular drug	[708]
N-(furan-2-ylmethyl)estradiol-16-carboxamide	DMLJZGD	Investigative	Small molecular drug	[708]
N-(naphthalen-1-yl)-4-neopentylthiazol-2-amine	DMW378C	Investigative	Small molecular drug	[1497]
N-(naphthalen-1-yl)-4-phenylthiazol-2-amine	DMFZPCD	Investigative	Small molecular drug	[1497]
N-(naphthalen-1-yl)benzo[d]isoxazol-3-amine	DM2CBNG	Investigative	Small molecular drug	[4283]
N-(naphthalen-2-yl)benzo[d]isoxazol-3-amine	DM2NHVX	Investigative	Small molecular drug	[4283]
N-(Naphthalene-2-yl)ethyl-ETAV	DMG8KXR	Investigative	Small molecular drug	[3083]
N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide	DMULBO9	Investigative	Small molecular drug	[4286]
N-(pentafluorophenyl)sulfamide	DME45J8	Investigative	Small molecular drug	[4263]
N-(phosphonacetyl)-L-aspartate	DMGHQJ8	Investigative	Small molecular drug	[12]
N-(piperidin-4-yl)-N-propyl-2-naphthamide	DM9QIH4	Investigative	Small molecular drug	[289]
N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMTJ5WL	Investigative	Small molecular drug	[302]
N-(Propylamide-acetophenone)-1-deoxynojirimycin	DMXI4V8	Investigative	Small molecular drug	[4287]
N-(Propylamide-benzophenone)-1-deoxynojirimycin	DMCZHBI	Investigative	Small molecular drug	[4287]
N-(pyridin-3-yl)indoline-1-carboxamide	DMTHJL4	Investigative	Small molecular drug	[300]
N-(pyridin-3-ylmethyl) estradiol-16-carboxamide	DMBJKH1	Investigative	Small molecular drug	[708]
N-(pyridin-3-ylmethyl)aniline	DMIN60B	Investigative	Small molecular drug	[22]
N-(pyridin-4-ylmethyl) estradiol-16-carboxamide	DMYFAQV	Investigative	Small molecular drug	[708]
N-(quinolin-3-yl)-6-(sulfamoylamino)hexanamide	DMYEQXH	Investigative	Small molecular drug	[4282]
N-(quinolin-6-yl)-6-(sulfamoylamino)hexanamide	DMFC3XI	Investigative	Small molecular drug	[4282]
N-(quinolin-8-yl)-6-(sulfamoylamino)hexanamide	DML8EVA	Investigative	Small molecular drug	[4282]
N-(quinolin-8-yl)thiophene-2-sulfonamide	DM7O1F3	Investigative	Small molecular drug	[977]
N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)	DM2SNXB	Investigative	Small molecular drug	[12]
N-(Sulfanylacetyl)Tyrosylprolylmethioninamide	DMWJDYZ	Investigative	Small molecular drug	[12]
N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile	DMJ0S5C	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile	DMXYQWG	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile	DM3I0WZ	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile	DMGF4XC	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile	DMOP5N7	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-tyrosyl-glycine-nitrile	DMP9JVT	Investigative	Small molecular drug	[4244]
N-(tert-butoxycarbonyl)-valyl-glycine-nitrile	DMUQBOP	Investigative	Small molecular drug	[4244]
N-(thiazol-2-yl)benzamide	DM1N7AG	Investigative	Small molecular drug	[543]
N-1,3,4-thiadiazol-2-ylsulfamide	DMJ10WH	Investigative	Small molecular drug	[4275]
N-1-isopropyl-5-MeOT	DM5LC3D	Investigative	Small molecular drug	[4288]
N-1-isopropyltryptamine	DM25NLH	Investigative	Small molecular drug	[4289]
N-2-phenylethyl-1H-pyrrole-2-carboxamide	DM3WTDL	Investigative	Small molecular drug	[302]
N-2-Thiophen-2-Yl-Acetamide Boronic Acid	DMLK0J8	Investigative	Small molecular drug	[12]
N-3'-ethylaplysinopsin	DMWZTKD	Investigative	Small molecular drug	[1700]
N-3-(4-bromophenyl)propyl imidazole	DMFRD09	Investigative	Small molecular drug	[509]
N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	DMUNCFQ	Investigative	Small molecular drug	[107]
N-acetyl-phenylalanyl-glycine-nitrile	DME8O69	Investigative	Small molecular drug	[4244]
N-Acetylalanine	DMZW9AC	Investigative	Small molecular drug	[12]
N-Acetylmethionine	DM9WQ6V	Investigative	Small molecular drug	[22]
N-acetyloxyethyl-exo-THPO	DMXR527	Investigative	Small molecular drug	[4290]
N-acetylserotonin	DMJ4SBM	Investigative	Small molecular drug	[4291]
N-adamantanemethyloxypentyl-1-deoxynojirimycin	DMSR4A6	Investigative	Small molecular drug	[4292]
N-adamantyl-N'-cyclohexylurea	DMZ43N1	Investigative	Small molecular drug	[570]
N-alkyl urea hydroxamic acids	DM9T0OK	Investigative	Small molecular drug	[4293]
N-allyl-4-hydroxy-N-phenylbenzenesulfonamide	DMZQUMB	Investigative	Small molecular drug	[1492]
N-ALLYLNORGALANTHAMINE	DMRXA8N	Investigative	Small molecular drug	[4221]
N-allylnorlitebamine	DM5W2VK	Investigative	Small molecular drug	[4294]
N-allyl[D-Pro-10]Dyn A-(1-11)	DM30LI6	Investigative	NA	[4205]
N-alpha-amidino-Tyr(Me)-D-Pro-Gly-Trp-Phe-NH2	DMFNCQ1	Investigative	Small molecular drug	[4295]
N-alpha-amidino-Tyr(Me)-Pro-Trp-p-Cl-Phe-NH2	DM8QTSU	Investigative	Small molecular drug	[4295]
N-alpha-amidino-Tyr(Me)-Pro-Trp-Phe-NH2	DMSC9FV	Investigative	Small molecular drug	[4295]
N-Aminoethylmorpholine	DMWXBYC	Investigative	Small molecular drug	[12]
N-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	DMF9U2O	Investigative	Small molecular drug	[4296]
N-arachidonoyl-O-(2-hydroxyethyl)hydroxylamine	DM49HIO	Investigative	Small molecular drug	[4296]
N-arachidonoylglycine	DM85RJ1	Investigative	Small molecular drug	[4297]
N-arachidonyl-D-alanine	DMAELS7	Investigative	Small molecular drug	[4298]
N-arachidonyl-gamma-aminobutyric acid	DMC1I8Z	Investigative	Small molecular drug	[4299]
N-arachidonyl-glycine	DMAA7K4	Investigative	Small molecular drug	[4300]
N-arachidonylmaleimide	DMLVGT8	Investigative	Small molecular drug	[382]
N-BENZOYL-D-ALANINE	DMX0Y79	Investigative	Small molecular drug	[22]
N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	DM7U81L	Investigative	Small molecular drug	[12]
N-benzoyl-phenylalanyl-glycine-nitrile	DMRJ4B1	Investigative	Small molecular drug	[4244]
N-benzyl brucine	DMOQMEU	Investigative	Small molecular drug	[4301]
N-Benzyl,N-methyl-1H-indole-2-carboxamide	DMHVRFM	Investigative	Small molecular drug	[4213]
N-benzyl,N-methyl-1H-pyrrole-2-carboxamide	DM8I7N2	Investigative	Small molecular drug	[302]
N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane	DMN9WZ3	Investigative	Small molecular drug	[205]
N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane	DMKJ6F8	Investigative	Small molecular drug	[205]
N-Benzyl-1'H-phenothiazine-1'-carboxamide	DMC7XST	Investigative	Small molecular drug	[95]
N-Benzyl-17-(cyclobutylmethyl)morphinan-3-amine	DM7SEM1	Investigative	Small molecular drug	[712]
N-Benzyl-17-(cyclopropylmethyl)morphinan-3-amine	DMLP9VM	Investigative	Small molecular drug	[712]
N-Benzyl-1H-indole-2-carboxamide	DMA3YWU	Investigative	Small molecular drug	[4213]
N-benzyl-1H-pyrrole-2-carboxamide	DM73ZHV	Investigative	Small molecular drug	[302]
N-Benzyl-2-(1H-indol-3-yl)-2-oxo-acetamide	DM8A23B	Investigative	Small molecular drug	[4286]
N-benzyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide	DMMT65J	Investigative	Small molecular drug	[4286]
N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	DM0ZXBQ	Investigative	Small molecular drug	[1062]
N-Benzyl-2-(toluene-4-sulfonylamino)-benzamide	DM3C0P2	Investigative	Small molecular drug	[4302]
N-benzyl-2-morpholinopyrimidin-4-amine	DMQCGFL	Investigative	Small molecular drug	[1062]
N-benzyl-2-oxo-2H-chromene-3-carboxamide	DMJ29MN	Investigative	Small molecular drug	[1070]
N-benzyl-2-thiomorpholinopyrimidin-4-amine	DMRJMGK	Investigative	Small molecular drug	[1062]
N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide	DMUD85N	Investigative	Small molecular drug	[4303]
N-Benzyl-4-(2-diphenyl)-1-piperazinehexanamide	DMCJWQT	Investigative	Small molecular drug	[3883]
N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide	DMUNL5Q	Investigative	Small molecular drug	[4304]
N-benzyl-4-cyclopentylpiperazine-1-carboxamide	DMUFR62	Investigative	Small molecular drug	[4305]
N-benzyl-4-hydroxy-N-phenylbenzenesulfonamide	DM5TPEJ	Investigative	Small molecular drug	[1492]
N-Benzyl-4-Sulfamoyl-Benzamide	DMCIJU0	Investigative	Small molecular drug	[12]
N-benzyl-5-(4-chlorophenyl)nicotinamide	DM2XLHY	Investigative	Small molecular drug	[1573]
N-benzyl-6-(3,3,3-trifluoropropoxy)nicotinamide	DM7NHRV	Investigative	Small molecular drug	[1692]
N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide	DMDRE64	Investigative	Small molecular drug	[4306]
N-Benzyl-ETAV	DMNPS4R	Investigative	Small molecular drug	[3083]
N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	DM0NJAL	Investigative	Small molecular drug	[4213]
N-benzyl-N-(phenylsulfonyl)benzamide	DMT2GSI	Investigative	Small molecular drug	[381]
N-benzyl-N-isobutylpiperidin-4-amine	DM6QK7E	Investigative	Small molecular drug	[3602]
N-benzylacetimidamide hydrobromide	DM26R4P	Investigative	Small molecular drug	[58]
N-Benzylmethylphenidate	DMDZ5XI	Investigative	Small molecular drug	[69]
N-benzylnorlitebamine	DMVEZH1	Investigative	Small molecular drug	[4294]
N-benzyl[D-Pro-10]Dyn A-(1-11)	DM2YZC5	Investigative	NA	[4205]
N-biphenyl-3-ylmethyl-N'-hydroxy-malonamide	DMJF9VA	Investigative	Small molecular drug	[979]
N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide	DMWSDZ9	Investigative	Small molecular drug	[4307]
N-Butyl 2beta-hydroxyolean-12-en-28-oate	DMAQT6S	Investigative	Small molecular drug	[1034]
N-butyl-2-(1H-indol-3-yl)-2-oxoacetamide	DM157LQ	Investigative	Small molecular drug	[4286]
N-butyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide	DMH7Z4L	Investigative	Small molecular drug	[4286]
N-butyl-4-hydroxy-N-phenylbenzenesulfonamide	DMH5GW6	Investigative	Small molecular drug	[1492]
N-butyl-4-methyl-3,4-dihydroquinazolin-2-amine	DMMI8X4	Investigative	Small molecular drug	[1504]
N-Butyl-ETAV	DMY3HEF	Investigative	Small molecular drug	[3083]
N-Butyl-N'-(4-methyl-benzoyl)-guanidine	DM8U70E	Investigative	Small molecular drug	[4269]
N-Butyl-N'-Hydroxyguanidine	DMKCX5N	Investigative	Small molecular drug	[12]
N-Butylcarbamic Acid Biphenyl-3-yl Ester	DMW7BZT	Investigative	Small molecular drug	[1011]
N-butylgalactonojirimycin	DMB06TA	Investigative	Small molecular drug	[4308]
N-butylnorlitebamine	DMNFTO6	Investigative	Small molecular drug	[4294]
N-butylresorcinol	DM8STQA	Investigative	Small molecular drug	[1443]
N-Carbamoyl-L-Aspartate	DMJ13TR	Investigative	Small molecular drug	[12]
N-Carboxymethionine	DMX80JF	Investigative	Small molecular drug	[12]
N-Carboxymethyl-N-cyclopentyl-phthalamic acid	DME9U7Y	Investigative	Small molecular drug	[4309]
N-cetylgallate	DM5KNCX	Investigative	Small molecular drug	[372]
N-chloromethyl-brucine	DM6VEON	Investigative	Small molecular drug	[4310]
N-CPM[D-Pro-10]Dyn A-(1-11)	DM1K64F	Investigative	NA	[4205]
N-Cyclobutyl-1'H-phenothiazine-1'-carboxamide	DM5T23S	Investigative	Small molecular drug	[95]
N-cyclobutyl-N-(piperidin-4-yl)-2-naphthamide	DM1GTVW	Investigative	Small molecular drug	[289]
N-Cyclohexyl-1'H-phenothiazine-1'-carboxamide	DMMW8J1	Investigative	Small molecular drug	[95]
N-Cyclohexyl-2-(4-methoxy-phenyl)-acetamide	DM8HS0B	Investigative	Small molecular drug	[517]
N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide	DMRA548	Investigative	Small molecular drug	[1070]
N-Cyclohexyl-2-phenyl-acetamide	DM15MQT	Investigative	Small molecular drug	[517]
N-cyclohexyl-4-hydroxy-N-phenylbenzenesulfonamide	DMCDBM5	Investigative	Small molecular drug	[1492]
N-Cyclohexyl-4-phenyl-butyramide	DM2COR5	Investigative	Small molecular drug	[517]
N-Cyclohexyl-N'-(4-Iodophenyl)Urea	DMPSYRW	Investigative	Small molecular drug	[12]
N-Cyclohexyl-N'-(Propyl)Phenyl Urea	DMYF243	Investigative	Small molecular drug	[22]
N-Cyclohexyl-N'-Decylurea	DM17G82	Investigative	Small molecular drug	[22]
N-Cyclohexylethyl-ETAV	DMCH5M1	Investigative	Small molecular drug	[3083]
N-Cyclohexylmethyl-ETAV	DMIC8Z6	Investigative	Small molecular drug	[3083]
N-cyclohexylquinazolin-4-amine	DMJ0T3W	Investigative	Small molecular drug	[1431]
N-cyclohexylquinolin-4-amine	DMJY2PA	Investigative	Small molecular drug	[1431]
N-Cyclopentyl-1'H-phenothiazine-1'-carboxamide	DM0KDSA	Investigative	Small molecular drug	[95]
N-cyclopentyl-6-(2-phenylethynyl)nicotinamide	DMDPKCM	Investigative	Small molecular drug	[4311]
N-desalkylquetiapine	DMBFC1U	Investigative	Small molecular drug	[4312]
N-docosatetra-7,10,13,16-enoylethanolamine	DMW2ORH	Investigative	Small molecular drug	[4313]
N-dodecylgallate	DMV5RZM	Investigative	Small molecular drug	[372]
N-ethyl estradiol-16-methyl carboxamide	DM1W2GZ	Investigative	Small molecular drug	[708]
N-ethyl estrone-16-methyl carboxamide	DMM9526	Investigative	Small molecular drug	[708]
N-ethyl-1-deoxynojirimycin	DMGYAOD	Investigative	Small molecular drug	[4314]
N-ethyl-2,2,2-triphenylacetamide	DMQ3184	Investigative	NA	[132]
N-Ethyl-2-methylnorapomorphine hydrochloride	DMWLI4U	Investigative	Small molecular drug	[4315]
N-Ethyl-2-phenylnorapomorphine hydrochloride	DM6HMBW	Investigative	Small molecular drug	[4315]
N-ethyl-4-hydroxy-N-phenylbenzenesulfonamide	DMHY35A	Investigative	Small molecular drug	[1492]
N-ethyl-5,6-dip-tolylpyrazine-2-carboxamide	DM873WR	Investigative	Small molecular drug	[4316]
N-Ethyl-ETAV	DMPTNI8	Investigative	Small molecular drug	[3083]
N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine	DMMKSGL	Investigative	Small molecular drug	[4208]
N-ethylhistamine	DMYI87T	Investigative	Small molecular drug	[4317]
N-ethylmaleimide	DMV4JJW	Investigative	Small molecular drug	[4318]
N-Formylmethionine	DM7GBDX	Investigative	Small molecular drug	[12]
N-glycylglycinehydroxamic acid	DMPEZHC	Investigative	Small molecular drug	[4319]
N-guanyl-1,7-diaminoheptane	DMBG3ZF	Investigative	Small molecular drug	[4320]
N-Hexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide	DMM0F2G	Investigative	Small molecular drug	[862]
N-Hexylcarbamic Acid Biphenyl-3-yl Ester	DML27CG	Investigative	Small molecular drug	[1011]
N-homo-gamma-linolenoylethanolamine	DMJVFXV	Investigative	Small molecular drug	[4321]
N-hydroxy-1-naphthamide	DMZ2T59	Investigative	Small molecular drug	[4322]
N-hydroxy-2,2'-bithiophene-5-carboxamide	DMWIMR4	Investigative	Small molecular drug	[1944]
N-hydroxy-2,2-diphenylacetamide	DMX3KRQ	Investigative	Small molecular drug	[751]
N-hydroxy-2,2-diphenylpropanamide	DM7I2TD	Investigative	Small molecular drug	[751]
N-hydroxy-2,3-bis(phenylsulfonamido)propanamide	DMZWIVJ	Investigative	Small molecular drug	[4323]
N-Hydroxy-2-(4-methoxy-benzenesulfonyl)benzamide	DM56P1I	Investigative	Small molecular drug	[943]
N-hydroxy-2-(4-methoxyphenylsulfonamido)acetamide	DM50NKS	Investigative	Small molecular drug	[905]
N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide	DM4VADN	Investigative	Small molecular drug	[943]
N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide	DMISXUM	Investigative	Small molecular drug	[4324]
N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide	DME96RF	Investigative	Small molecular drug	[742]
N-Hydroxy-2-naphthalen-2-yl-acetamide	DMYDX34	Investigative	Small molecular drug	[742]
N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide	DMWXUCT	Investigative	Small molecular drug	[4325]
N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)	DMA6EPH	Investigative	Small molecular drug	[4325]
N-hydroxy-3-(naphthalen-1-yl)acrylamide	DMY6Z0U	Investigative	Small molecular drug	[4322]
N-Hydroxy-3-naphthalen-2-yl-acrylamide	DMZ3INJ	Investigative	Small molecular drug	[742]
N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide	DMKBACJ	Investigative	Small molecular drug	[742]
N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide	DMVOPXE	Investigative	Small molecular drug	[742]
N-Hydroxy-3-naphthalen-2-yl-propionamide	DMPIMRC	Investigative	Small molecular drug	[742]
N-hydroxy-3-phenoxybenzamide	DMTZ8RQ	Investigative	Small molecular drug	[4322]
N-Hydroxy-3-phenyl-acrylamide	DM9IPTV	Investigative	Small molecular drug	[742]
N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide	DMCN91A	Investigative	Small molecular drug	[1461]
N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide	DMVK2Y3	Investigative	Small molecular drug	[1461]
N-hydroxy-4-(2-oleamidoethyl)benzamide	DMKELRB	Investigative	Small molecular drug	[4246]
N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide	DMHEQ41	Investigative	Small molecular drug	[1461]
N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide	DMUOCQB	Investigative	NA	[1461]
N-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-butyramide	DMQN6CL	Investigative	Small molecular drug	[1416]
N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide	DMVEOBY	Investigative	Small molecular drug	[1461]
N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide	DMISRMT	Investigative	Small molecular drug	[1461]
N-hydroxy-4-(naphthalen-1-yl)benzamide	DMSHQE3	Investigative	Small molecular drug	[4322]
N-hydroxy-4-(oleamidomethyl)benzamide	DMUSHZK	Investigative	Small molecular drug	[4247]
N-Hydroxy-4-(pentanoylamino-methyl)-benzamide	DMGTNQY	Investigative	Small molecular drug	[1470]
N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide	DMDUOH4	Investigative	Small molecular drug	[1470]
N-Hydroxy-4-iodo-benzamide	DMEO7L5	Investigative	Small molecular drug	[742]
N-Hydroxy-4-isobutyl-benzamide	DM16G80	Investigative	Small molecular drug	[742]
N-Hydroxy-4-naphthalen-2-yl-benzamide	DMMHQE8	Investigative	Small molecular drug	[742]
N-Hydroxy-4-oxo-4-(4-phenoxy-phenyl)-butyramide	DMQSWO8	Investigative	Small molecular drug	[1416]
N-Hydroxy-4-phenylacetylamino-benzamide	DMCRU17	Investigative	Small molecular drug	[1461]
N-hydroxy-5-(pyridin-2-yl)thiophene-2-carboxamide	DMYKJZ2	Investigative	Small molecular drug	[1944]
N-hydroxy-5-(pyridin-3-yl)thiophene-2-carboxamide	DMK98LE	Investigative	Small molecular drug	[1944]
N-hydroxy-5-(pyridin-4-yl)thiophene-2-carboxamide	DM653RM	Investigative	Small molecular drug	[1944]
N-hydroxy-5-phenylthiophene-2-carboxamide	DMA2WUQ	Investigative	Small molecular drug	[1944]
N-hydroxy-6-oxo-6-phenylhexanamide	DM0JNO2	Investigative	Small molecular drug	[1787]
N-hydroxy-7-(4-methoxyphenyl)-7-oxoheptanamide	DMUXZL1	Investigative	Small molecular drug	[1787]
N-hydroxy-7-(naphthalen-2-yl)-7-oxoheptanamide	DM8Z4L0	Investigative	Small molecular drug	[1787]
N-hydroxy-7-(naphthalen-2-yloxy)heptanamide	DMBUNAP	Investigative	Small molecular drug	[1736]
N-hydroxy-7-oxo-7-phenylheptanamide	DMQW7JZ	Investigative	Small molecular drug	[1787]
N-hydroxy-8-(2-methoxyphenyl)-8-oxooctanamide	DMSIMNR	Investigative	Small molecular drug	[1787]
N-hydroxy-8-(4-methoxyphenyl)-8-oxooctanamide	DMD2K4T	Investigative	Small molecular drug	[1787]
N-hydroxy-8-(naphthalen-2-yl)non-8-enamide	DMRN1C6	Investigative	Small molecular drug	[1787]
N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide	DMGZY1Q	Investigative	Small molecular drug	[1787]
N-hydroxy-8-(naphthalen-2-yl)octanamide	DMXQICK	Investigative	Small molecular drug	[1787]
N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide	DMO4CR7	Investigative	Small molecular drug	[1787]
N-hydroxy-9,10-dihydroanthracene-9-carboxamide	DMID3BF	Investigative	Small molecular drug	[751]
N-hydroxy-9-oxo-9-phenylnonanamide	DMIC2A8	Investigative	Small molecular drug	[1787]
N-hydroxy-9H-xanthene-9-carboxamide	DM0DRHP	Investigative	Small molecular drug	[751]
N-Hydroxy-E-3-(4'-chlorobiphenyl-4-yl)-acrylamide	DM3J5MR	Investigative	Small molecular drug	[1581]
N-Hydroxy-E-3-(4'-cyanobiphenyl-4-yl)-acrylamide	DMVFKO4	Investigative	Small molecular drug	[1581]
N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide	DMQCK5G	Investigative	Small molecular drug	[1581]
N-Hydroxy-N'-(2-methylphenyl)octanediamide	DM865Y2	Investigative	Small molecular drug	[4225]
N-Hydroxy-N'-(3-methylphenyl)octanediamide	DMYRC2M	Investigative	Small molecular drug	[4225]
N-Hydroxy-N'-(4-methoxyphenyl)octanediamide	DMELB07	Investigative	Small molecular drug	[4225]
N-Hydroxy-N'-(4-methylphenyl)octanediamide	DM3DPZ8	Investigative	Small molecular drug	[4225]
N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide	DMQ4ST2	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide	DMNVD8I	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide	DMSRPI8	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide	DMANTW0	Investigative	Small molecular drug	[4326]
N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide	DMMYV34	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide	DMAN57F	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide	DMV8UCK	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide	DMQBD27	Investigative	Small molecular drug	[742]
N-Hydroxy-N-methyl-benzamide	DMDQWOB	Investigative	Small molecular drug	[742]
N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea	DM4E8NJ	Investigative	Small molecular drug	[4327]
N-hydroxybenzo[b]thiophene-2-carboxamide	DMR4J8G	Investigative	Small molecular drug	[1671]
N-Hydroxycarbamoylmethyl-4-methoxy-benzamide	DM41JIB	Investigative	Small molecular drug	[1416]
N-Hydroxycarbamoylmethyl-4-phenoxy-benzamide	DMDTX4L	Investigative	Small molecular drug	[1416]
N-hydroxysulfamide	DMTDBMU	Investigative	Small molecular drug	[4328]
N-hydroxysulfonamides	DMJBC03	Investigative	NA	[4329]
N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide	DM8ZMB5	Investigative	Small molecular drug	[4330]
N-isobutyl-2-oxo-2H-chromene-3-carboxamide	DMO4E9U	Investigative	Small molecular drug	[1070]
N-isobutylnorlitebamine	DM9Z6VP	Investigative	Small molecular drug	[4294]
N-isobutylnoroxymorphone	DMN1FIU	Investigative	Small molecular drug	[4331]
N-isoleucylthiazolidine	DM53AS0	Investigative	Small molecular drug	[2728]
N-isopentyl-5,6-dip-tolylpyrazine-2-carboxamide	DMC8L4J	Investigative	Small molecular drug	[4316]
N-isopropyl estradiol-16-carboxamide	DMFSW5M	Investigative	Small molecular drug	[708]
N-isopropyl estradiol-16-methyl carboxamide	DMHJMTI	Investigative	Small molecular drug	[708]
N-isopropyl estrone-16-methyl carboxamide	DMZGMQJ	Investigative	Small molecular drug	[708]
N-Isopropyl-1'H-phenothiazine-1'-carboxamide	DM14L7O	Investigative	Small molecular drug	[95]
N-isopropyl-5,6-dip-tolylpyrazine-2-carboxamide	DMRPUCA	Investigative	Small molecular drug	[4316]
N-Isopropyl-N'-Hydroxyguanidine	DMIVO8P	Investigative	Small molecular drug	[12]
N-isopropylnorlitebamine	DMG8NB0	Investigative	Small molecular drug	[4294]
N-isopropylnorlitebamineN-methoiodide	DMDVO9T	Investigative	Small molecular drug	[4294]
N-Me-aminopyrimidinone 9	DMM731A	Investigative	Small molecular drug	[4332]
N-mesityl-4,6-dimethyl-3-tosylpyridin-2-amine	DMI065U	Investigative	Small molecular drug	[4333]
N-mesityl-6-methyl-3-tosylpyridin-2-amine	DMEUI8C	Investigative	Small molecular drug	[4333]
N-methoxyethyl estrone-16-methyl carboxamide	DMI9QRO	Investigative	Small molecular drug	[708]
N-methoxyquinuclidine-3-carboximidoyl chloride	DMMB3PG	Investigative	Small molecular drug	[2385]
N-methoxyquinuclidine-3-carboximidoyl fluoride	DMF8IA6	Investigative	Small molecular drug	[2385]
N-methyl estradiol-16-methyl carboxamide	DM32YID	Investigative	Small molecular drug	[708]
N-methyl estrone-16-methyl carboxamide	DM7XIK5	Investigative	Small molecular drug	[708]
N-methyl LTC4	DM6XYCU	Investigative	Small molecular drug	[4334]
N-methyl ryanodine-succinamidate	DMXGY4F	Investigative	Small molecular drug	[249]
N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM83AEM	Investigative	Small molecular drug	[302]
N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMZ24XT	Investigative	Small molecular drug	[302]
N-Methyl,N-phenyl-1H-indole-2-carboxamide	DMM3B21	Investigative	Small molecular drug	[4213]
N-Methyl-1'H-phenothiazine-1'-carboxamide	DMK8VZM	Investigative	Small molecular drug	[95]
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	DMUJ18P	Investigative	Small molecular drug	[22]
N-methyl-2,2,2-triphenylacetamide	DMQGRMO	Investigative	NA	[132]
N-methyl-2-(pyridin-2-yl)ethanamine	DM8LNMY	Investigative	Small molecular drug	[947]
N-methyl-2-(pyridin-3-yloxy)ethanamine	DMXS43P	Investigative	Small molecular drug	[4208]
N-methyl-3,3-diphenylpropan-1-amine	DM8IHQP	Investigative	Small molecular drug	[937]
N-methyl-4,4-diphenylbutan-1-amine	DMO3PNF	Investigative	Small molecular drug	[937]
N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine	DMMNIRC	Investigative	Small molecular drug	[4208]
N-methyl-4-pentyl-N-(pyridin-3-yl)benzamide	DMA0YGE	Investigative	Small molecular drug	[926]
N-methyl-5,6-dip-tolylpyrazine-2-carboxamide	DMD621E	Investigative	Small molecular drug	[4316]
N-Methyl-ETAV	DMP1EF6	Investigative	Small molecular drug	[3083]
N-methyl-exo-THPO	DMLYORU	Investigative	Small molecular drug	[4335]
N-Methyl-N-(Methylbenzyl)Formamide	DMYPEX3	Investigative	Small molecular drug	[22]
N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide	DM796AX	Investigative	Small molecular drug	[302]
N-methyl-N-(pyridin-3-ylmethyl)ethanamine	DMOP128	Investigative	Small molecular drug	[4208]
N-methyl-N-ethyl estradiol-16-carboxamide	DM6DM4L	Investigative	Small molecular drug	[708]
N-methyl-N-ethyl estrone-16-methyl carboxamide	DM2CUEB	Investigative	NA	[708]
N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide	DMDB7ZM	Investigative	Small molecular drug	[1070]
N-Methyl-N-Propargyl-1(R)-Aminoindan	DMB9OGI	Investigative	Small molecular drug	[22]
N-methyl-Pip-F-homoF-vinyl sulfonyl phenyl (N-methyl-Pip-F-hF-VS phi)	DMDAN0K	Investigative	Small molecular drug	[4336]
N-methyl-pyridinium-2-aldoxime	DMXPEDA	Investigative	Small molecular drug	[4337]
N-methylbicuculline	DM5GXIS	Investigative	Small molecular drug	[4338]
N-methylhistamine	DMCFH5W	Investigative	Small molecular drug	[4339]
N-methyllaurotetanine	DMWPBKU	Investigative	Small molecular drug	[3029]
N-Methylleucine	DM9AGCV	Investigative	Small molecular drug	[12]
N-Methylmesoporphyrin	DM4FMZP	Investigative	Small molecular drug	[12]
N-Methylmesoporphyrin Containing Copper	DMKZL5H	Investigative	Small molecular drug	[12]
N-Methylnaloxonium	DMXSJH0	Investigative	Small molecular drug	[107]
N-methylpiperidine	DM362XR	Investigative	Small molecular drug	[4340]
N-methylstephisoferulin	DMZYSM1	Investigative	Small molecular drug	[1705]
N-methylstephuline	DM5CR2E	Investigative	Small molecular drug	[1705]
N-N-diethyl estradiol-16-methyl carboxamide	DMUHZ23	Investigative	Small molecular drug	[708]
N-n-dodecyl-7-methoxytacrine hydrochloride	DM8FOSR	Investigative	Small molecular drug	[4341]
N-n-heptyl-7-methoxytacrine hydrochloride	DMA8R47	Investigative	Small molecular drug	[4341]
N-n-hexyl-7-methoxytacrine hydrochloride	DM4ZMG6	Investigative	Small molecular drug	[4341]
N-n-nonyl-7-methoxytacrine hydrochloride	DMLH23M	Investigative	Small molecular drug	[4341]
N-n-octyl-7-methoxytacrine hydrochloride	DMLC257	Investigative	Small molecular drug	[4341]
N-n-pentyl-7-methoxytacrine hydrochloride	DMWAK5V	Investigative	Small molecular drug	[4341]
N-n-propyl-7-methoxytacrine hydrochloride	DMCN78A	Investigative	Small molecular drug	[4341]
N-Neopentyl-1'H-phenothiazine-1'-carboxamide	DMSUK2A	Investigative	Small molecular drug	[95]
N-o-Tolyl-1'H-phenothiazine-1'-carboxamide	DMLVFUY	Investigative	Small molecular drug	[95]
N-octadecyl-N'-propylsulfamide	DMKTE5V	Investigative	Small molecular drug	[4217]
N-Octylcarbamic Acid Biphenyl-3-yl Ester	DM95JEW	Investigative	Small molecular drug	[1011]
N-oleoyl-dopamine	DM1AVCZ	Investigative	Small molecular drug	[4342]
N-oleoyl-N-(2-hydroxyethyl)hydroxylamine	DMRU21X	Investigative	Small molecular drug	[4296]
N-oleoyl-O-(2-hydroxyethyl)hydroxylamine	DMZM3CH	Investigative	Small molecular drug	[4296]
N-oleoylethanolamide	DMJQ4L7	Investigative	Small molecular drug	[117]
N-omega-allyl-L-arginine	DM0BPCT	Investigative	Small molecular drug	[4343]
N-Omega-Hydroxy-L-Arginine	DMOXQ3N	Investigative	Small molecular drug	[12]
N-omega-propargyl-L-arginine	DM9X3B7	Investigative	Small molecular drug	[4343]
N-Omega-Propyl-L-Arginine	DM4X0WY	Investigative	Small molecular drug	[4344]
N-oxo-2-(phenylsulfonylamino)ethanamide	DMQ84J7	Investigative	Small molecular drug	[22]
N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide	DMHTI5X	Investigative	Small molecular drug	[22]
N-p-Tolyl-1'H-phenothiazine-1'-carboxamide	DMMR7DI	Investigative	Small molecular drug	[95]
N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	DMJQZMH	Investigative	Small molecular drug	[1062]
N-Phenethyl-2-(toluene-4-sulfonylamino)-benzamide	DM1BU5P	Investigative	Small molecular drug	[4302]
N-phenethyl-2-phenylquinoline-4-carboxamide	DM4G6LJ	Investigative	Small molecular drug	[1083]
N-phenethylquinoxaline-2-carboxamide	DM1ZPGY	Investigative	Small molecular drug	[4242]
N-Phenyl-1'H-phenothiazine-1'-carboxamide	DM1LHD3	Investigative	Small molecular drug	[95]
N-Phenyl-1-methyl-1H-indole-2-carboxamide	DM1XV0O	Investigative	Small molecular drug	[4213]
N-Phenyl-1H-indole-2-carboxamide	DM7V025	Investigative	Small molecular drug	[4213]
N-phenyl-1H-pyrazole-3-carboxamide	DMP5E1G	Investigative	Small molecular drug	[22]
N-phenyl-1H-pyrrole-2-carboxamide	DMBGIUE	Investigative	Small molecular drug	[302]
N-phenyl-2,3,4-trihydroxy-5-benzyl-benzamide	DM0JI2L	Investigative	Small molecular drug	[763]
N-phenyl-3-(2-aminoethyl)benzenesulfonamide	DMWH86J	Investigative	Small molecular drug	[876]
N-phenyl-5,6-dip-tolylpyrazine-2-carboxamide	DM7XER1	Investigative	Small molecular drug	[4316]
N-Phenyl-5-phenylimidazo[1,5-a]pyrazin-8-amine	DMGVJBD	Investigative	Small molecular drug	[2329]
N-phenyl-6-(sulfamoylamino)hexanamide	DMRHKF8	Investigative	Small molecular drug	[4282]
N-Phenylbenzo[d]oxazol-2-amine	DMXANES	Investigative	Small molecular drug	[1598]
N-Phenylethyl-ETAV	DM1VSO9	Investigative	Small molecular drug	[3083]
N-Phenylpropyl-ETAV	DM90GNC	Investigative	Small molecular drug	[3083]
N-Propargyl-1(S)-Aminoindan	DMHZCLV	Investigative	Small molecular drug	[22]
N-propargyl-1H-pyrrole-2-carboxamide	DMNYQ28	Investigative	Small molecular drug	[302]
N-Propyl-2-methylnorapomorphine hydrochloride	DMKBG1F	Investigative	Small molecular drug	[4315]
N-Propyl-2-phenylnorapomorphine hydrochloride	DML6SAG	Investigative	Small molecular drug	[4315]
N-Propyl-ETAV	DMUTDNV	Investigative	Small molecular drug	[3083]
N-propylnorlitebamine	DM3JQYD	Investigative	Small molecular drug	[4294]
N-propynyl amidebenzenesulphonide	DMWTPJH	Investigative	Small molecular drug	[4345]
N-Pyridoxyl-Glycine-5-Monophosphate	DMMV1YN	Investigative	Small molecular drug	[12]
N-tert-Butyl-1'H-phenothiazine-1'-carboxamide	DMOPSJU	Investigative	Small molecular drug	[95]
N-Tridecanoic Acid	DMNZ37C	Investigative	Small molecular drug	[22]
N-Trimethyllysine	DMZQXLS	Investigative	Small molecular drug	[12]
N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide	DMLTYPS	Investigative	Small molecular drug	[4218]
N-[(4-methoxyphenyl)sulfonyl]-D-alanine	DMVOJFW	Investigative	Small molecular drug	[22]
N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide	DMYJHRV	Investigative	Small molecular drug	[4218]
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	DMHNR36	Investigative	Small molecular drug	[22]
N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine	DMI9GQV	Investigative	Small molecular drug	[4346]
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	DMM7T13	Investigative	Small molecular drug	[12]
N-[2-(4'-Nitrophenyl)ethyl]-imidazole	DMPKBT1	Investigative	Small molecular drug	[549]
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]lauramide	DM5FQH8	Investigative	Small molecular drug	[4347]
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]linoleamide	DMG5PL7	Investigative	Small molecular drug	[4347]
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]undecanamide	DMC1GYH	Investigative	Small molecular drug	[4347]
N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate	DMJ8W6F	Investigative	Small molecular drug	[4348]
N-[3'-(trifluoromethyl)-4-biphenylyl]urea	DM7OA4R	Investigative	Small molecular drug	[1349]
N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide	DMKPYEU	Investigative	Small molecular drug	[1354]
N-[3,3-Bis-(4-fluorophenyl)-propyl]-nicotinamide	DMIP8AK	Investigative	Small molecular drug	[1354]
N-[3-(2-Ethyl-benzooxazol-7-yl)-propyl]-acetamide	DMU89FH	Investigative	Small molecular drug	[4253]
N-[3H]alpha-methylhistamine	DMWDCV1	Investigative	Small molecular drug	[4349]
N-[3H]methylhistamine	DM0CI4L	Investigative	Small molecular drug	[4350]
N-[4'-(ethylsulfonyl)-3-fluoro-4-biphenylyl]urea	DMD5F6Z	Investigative	Small molecular drug	[1349]
N-[4'-(trifluoromethyl)-4-biphenylyl]sulfamide	DMCTZFP	Investigative	Small molecular drug	[1349]
N-[4'-(trifluoromethyl)-4-biphenylyl]thiourea	DMPVKWG	Investigative	Small molecular drug	[1349]
N-[4'-(trifluoromethyl)-4-biphenylyl]urea	DMMHQRT	Investigative	Small molecular drug	[1349]
N-[4-(1,3-benzodioxol-5-yl)phenyl]sulfamide	DMITN82	Investigative	Small molecular drug	[1349]
N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine	DMT6LX9	Investigative	Small molecular drug	[4346]
N-[4-(3-amino-1H-indazol-4-yl)phenyl]benzamide	DMLV18K	Investigative	Small molecular drug	[1414]
N-[4-(3-pyridylethynyl)-2-thiazolyl]acetamide	DMC62K1	Investigative	Small molecular drug	[228]
N-[4-(4-Phenyl-piperazin-1-yl)-butyl]-benzamide	DMA4L5P	Investigative	Small molecular drug	[4351]
N-[4-(trifluoromethyl)phenyl]sulfamide	DMMX65T	Investigative	Small molecular drug	[4263]
N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine	DMP5A8K	Investigative	Small molecular drug	[4277]
N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine	DMZ9V18	Investigative	Small molecular drug	[4277]
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide	DMSI4PE	Investigative	Small molecular drug	[4275]
N-[5-(Formyl-hydroxy-amino)-pentyl]-benzamide	DMH7QOF	Investigative	Small molecular drug	[4352]
N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide	DMXLJGR	Investigative	Small molecular drug	[4275]
N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)	DMVY7RX	Investigative	Small molecular drug	[4353]
N-[O-Phosphono-Pyridoxyl]-Isoleucine	DM6EICU	Investigative	Small molecular drug	[12]
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	DMN493F	Investigative	Small molecular drug	[12]
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	DMX4QKU	Investigative	Small molecular drug	[22]
N-{4'-[(trifluoromethyl)sulfonyl]-4-biphenyl}urea	DM90U5P	Investigative	Small molecular drug	[1349]
N-{4'-[(trifluoromethyl)thio]-4-biphenyl}urea	DMEIB69	Investigative	Small molecular drug	[1349]
N-{4-[(benzylamino)sulfonyl]-1-naphthyl}benzamide	DM74KHG	Investigative	Small molecular drug	[4271]
N-{4-[2-(3-Hydroxyphenyl)ethyl]phenyl}phthalimide	DMO3VLJ	Investigative	Small molecular drug	[861]
N-{4-[2-(3-Methoxyphenyl)ethyl]phenyl}phthalimide	DMZ4N7Q	Investigative	Small molecular drug	[861]
N-{4-[2-(4-Hydroxyphenyl)ethyl]phenyl}phthalimide	DMXU5IS	Investigative	Small molecular drug	[861]
N-{4-[2-(4-Methoxyphenyl)ethyl]phenyl}phthalimide	DM0S71O	Investigative	Small molecular drug	[861]
N/OFQ-(1-13)-NH2	DMCGVAB	Investigative	Small molecular drug	[4354]
N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide	DM1L89K	Investigative	Small molecular drug	[979]
N1,2-dibenzyl-N3-hydroxymalonamide	DMM59IS	Investigative	Small molecular drug	[979]
N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	DMVIGCJ	Investigative	Small molecular drug	[12]
N1,N2-bis(dihydrocaffeoyl)spermine	DMSDVGQ	Investigative	Small molecular drug	[2518]
N1,N3-bis(3-methoxybenzyl)isophthalamide	DMA5Z7P	Investigative	Small molecular drug	[4355]
N1,N4-bis(5-chloro-2-methylphenyl)succinamide	DMRO7JX	Investigative	Small molecular drug	[1238]
N1-(2-aminoethyl)ethane-1,2-diamine	DM6HM5S	Investigative	Small molecular drug	[3371]
N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide	DM5F04D	Investigative	Small molecular drug	[979]
N1-(3-phenoxybenzyl)-N3-hydroxymalonamide	DMSRHJA	Investigative	Small molecular drug	[979]
N1-(4-bromophenyl)-N2,N2-dipentylphthalamide	DMCH7GO	Investigative	Small molecular drug	[3220]
N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide	DMJ025O	Investigative	Small molecular drug	[979]
N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide	DMTMDZ4	Investigative	Small molecular drug	[979]
N1-(4-fluorobenzyl)-2-benzyl-N3-hydroxymalonamide	DMS1P85	Investigative	Small molecular drug	[979]
N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide	DMMQXON	Investigative	Small molecular drug	[4282]
N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide	DMZA8NC	Investigative	Small molecular drug	[4356]
N1-(naphthalen-1-yl)ethane-1,2-diamine	DMYGCSV	Investigative	Small molecular drug	[3371]
N1-benzyl-N3-hydroxy-2-isobutylmalonamide	DMXSFWK	Investigative	Small molecular drug	[4357]
N1-dansyl-spermine	DM76CLF	Investigative	Small molecular drug	[4358]
N1-guanyl-1,7-diaminoheptane	DMXE8CB	Investigative	NA	[4359]
N1-hydroxy-2-isobutyl-N3-phenethylmalonamide	DMF6RVS	Investigative	Small molecular drug	[4357]
N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide	DMOZARM	Investigative	Small molecular drug	[4356]
N1-Methyl-1,9-pyrazoloanthrone	DMXI4JB	Investigative	Small molecular drug	[4360]
N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine	DM4Q86B	Investigative	Small molecular drug	[1538]
N1-[4-(Phenylmethoxy)phenyl]-D-glutamine	DMK10WX	Investigative	Small molecular drug	[1538]
N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine	DMLEMUX	Investigative	Small molecular drug	[1538]
N1-[4-(Phenylmethoxy)phenyl]-L-glutamine	DM9XCZS	Investigative	Small molecular drug	[1538]
N2-(3-trifluoromethylphenyl)guanine	DMGJEH9	Investigative	Small molecular drug	[1085]
N2-[4-(benzyloxy)benzyl]glycinamide	DMOZ1IY	Investigative	Small molecular drug	[291]
N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide	DMHJ2IP	Investigative	Small molecular drug	[291]
N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	DMEWP9L	Investigative	Small molecular drug	[291]
N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	DMLPJGX	Investigative	Small molecular drug	[291]
N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide	DMAVB0G	Investigative	Small molecular drug	[291]
N3-GHQMFYYPra-NH2	DMQEGJU	Investigative	NA	[4361]
N4,N6-dibenzylpyrimidine-4,6-dicarboxamide	DMCR13E	Investigative	Small molecular drug	[4362]
N4-(3-chlorophenyl)quinazoline-4,6-diamine	DM561Z7	Investigative	Small molecular drug	[4363]
N4-(3-methylphenyl)-4,6-quinazolinediamine	DMDRYJ7	Investigative	Small molecular drug	[4364]
N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine	DMARZHU	Investigative	Small molecular drug	[4365]
N4-(N,N-diphenylcarbamoyl)-aminoguanidine	DMYPZMO	Investigative	NA	[22]
N4-Butyl-2-cinnamamido-N1-hydroxysuccinamide	DM1N73J	Investigative	Small molecular drug	[1008]
N4-phenylethoxycytidine-5'-triphosphate	DM7KX2V	Investigative	Small molecular drug	[4168]
N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine	DMV7ORJ	Investigative	Small molecular drug	[1538]
N5-(1-Imino-3-Butenyl)-L-Ornithine	DMY3O6N	Investigative	Small molecular drug	[12]
N5-(1-iminobut-3-enyl)-L-ornithine	DMB62OI	Investigative	Small molecular drug	[4343]
N5-(1-iminobutyl)-L-ornithine	DMT893N	Investigative	Small molecular drug	[4343]
N5-(1-iminopent-3-enyl)-L-ornithine	DM0TS21	Investigative	Small molecular drug	[4343]
N5-(1-iminopropyl)-L-ornithine	DM05O7J	Investigative	Small molecular drug	[4343]
N5-(4-Phenoxyphenyl)-L-glutamine	DMNVK6T	Investigative	Small molecular drug	[1538]
N5-methylfolate	DML0R9M	Investigative	Small molecular drug	[4366]
N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide	DMXUODT	Investigative	Small molecular drug	[1538]
N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide	DMJT4UR	Investigative	Small molecular drug	[1538]
N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide	DMR2C94	Investigative	Small molecular drug	[1538]
N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine	DM97H52	Investigative	Small molecular drug	[1538]
N5-[4-(2-phenylethoxy)phenyl]-L-glutamine	DMR1XJN	Investigative	Small molecular drug	[1538]
N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide	DMTO8KS	Investigative	Small molecular drug	[1538]
N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine	DMINK9Q	Investigative	Small molecular drug	[1538]
N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide	DM6PXMJ	Investigative	Small molecular drug	[1538]
N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide	DMMV1CB	Investigative	Small molecular drug	[1538]
N5-[4-(N-Phenylamino)phenyl]-L-glutamine	DMH8VYM	Investigative	Small molecular drug	[1538]
N5-[4-(Phenylmethoxy)phenyl]-D-glutamine	DMUVP5L	Investigative	Small molecular drug	[1538]
N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide	DMMYIJ0	Investigative	Small molecular drug	[1538]
N5-[4-(Phenylmethoxy)phenyl]-L-glutamine	DMCG26A	Investigative	Small molecular drug	[1538]
N5-[4-Benzylphenyl]-L-glutamamide	DMH6O4G	Investigative	Small molecular drug	[1538]
N6 benzyl-cAMP	DMXSZ1A	Investigative	Small molecular drug	[4367]
N6-((+/-)-endo-norborn-2-yl)adenosine	DM30KXV	Investigative	Small molecular drug	[790]
N6-(3-Iodobenzyl)-2'-O-methyladenosine	DM2W9NO	Investigative	Small molecular drug	[4368]
N6-(4-hydroxybenzyl)adenine riboside	DM5Q71U	Investigative	Small molecular drug	[4369]
N6-Benzyl Adenosine-5'-Diphosphate	DM71MO2	Investigative	Small molecular drug	[12]
N6-CYCLOPENTYLADENOSINE	DMD6AJO	Investigative	Small molecular drug	[4370]
N6-methoxy-2-phenylethynyladenosine	DMDG59X	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(2-pyridinyl)ethynyl]adenosine	DMSEL5W	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(3-pyridinyl)ethynyl]-adenosine	DMP7246	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(4-methoxyphenyl)ethynyl]adenosine	DM8LR62	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(4-methylphenyl)ethynyl]adenosine	DM1KA9R	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(4-pentylphenyl)ethynyl]adenosine	DMQ5K8R	Investigative	Small molecular drug	[919]
N6-methoxy-2-[(4-pyridinyl)ethynyl]adenosine	DM9H3W8	Investigative	Small molecular drug	[919]
N6-methoxy-2-[2-(trimethylsilyl)ethynyl]adenosine	DMRBS50	Investigative	Small molecular drug	[919]
N6-[(4-Amino)-phenyl]-9-benzyl-2-phenyladenine	DM0WMKJ	Investigative	Small molecular drug	[4371]
N6-[(4-Nitro)-phenyl]-9-benzyl-2-phenyladenine	DMVNLPF	Investigative	Small molecular drug	[4371]
N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine	DMBT2HW	Investigative	Small molecular drug	[1538]
N7-hydroxy-2-methoxy-N1-phenylheptanediamide	DM6XDZA	Investigative	Small molecular drug	[939]
N7-hydroxy-N1-phenyl-2-propoxyheptanediamide	DMDJUZX	Investigative	Small molecular drug	[939]
N8,2-dihydroxy-N1-phenyloctanediamide	DMHC32M	Investigative	Small molecular drug	[939]
N8-hydroxy-2-methoxy-N1-phenyloctanediamide	DM7OZ2T	Investigative	Small molecular drug	[939]
NAADP	DM51DW6	Investigative	Small molecular drug	[4372]
NAAG	DMFGOW0	Investigative	Small molecular drug	[4373]
NADA	DM3ORGM	Investigative	Small molecular drug	[4374]
NADP+	DMX5EJ5	Investigative	Small molecular drug	[4375]
NADPH	DM75Q34	Investigative	Small molecular drug	[4376]
NAEPA	DM38XWZ	Investigative	Small molecular drug	[4377]
nafadotride	DM79KLR	Investigative	Small molecular drug	[4378]
Nafoxidine	DM0FROP	Investigative	Small molecular drug	[4379]
nahuoic acid A	DM1LWMU	Investigative	Small molecular drug	[4380]
NalBzOH	DM0CP36	Investigative	Small molecular drug	[4381]
Nalorphine	DM1SCU5	Investigative	Small molecular drug	[4382]
naloxonazine	DM8ZMNH	Investigative	Small molecular drug	[4383]
Naltrexone-6-alpha-ol	DMRAN5O	Investigative	Small molecular drug	[3685]
naltriben	DMNDOLZ	Investigative	Small molecular drug	[4384]
Namn	DM1EZ3N	Investigative	Small molecular drug	[12]
Naphthalen-1-yl 10H-phenothiazine-10-carboxylate	DMYDRB7	Investigative	Small molecular drug	[1050]
Naphthalen-1-yl(10H-phenothiazin-10-yl)methanone	DM93CZW	Investigative	Small molecular drug	[105]
Naphthalen-2-yl 10H-phenothiazine-10-carboxylate	DM08W6U	Investigative	Small molecular drug	[1050]
Naphthalen-2-yl cyclohexylcarbamate	DMDXM2A	Investigative	Small molecular drug	[1127]
Naphthalen-2-yl(10H-phenothiazin-10-yl)methanone	DMW8BXG	Investigative	Small molecular drug	[105]
Naphthalene Trisulfonate	DML6FI3	Investigative	Small molecular drug	[12]
Naphthalene-1,4-diol	DMOQ43W	Investigative	Small molecular drug	[768]
Naphthalene-2,6-disulfonic acid	DMLHWNG	Investigative	Small molecular drug	[22]
Naphthalene-2-carboxylic acid hydroxyamide	DMG8A74	Investigative	Small molecular drug	[742]
Naphthyridinomycin	DMTWEQP	Investigative	NA	[4385]
NAPHTHYRIDINONE	DM0OEGV	Investigative	Small molecular drug	[143]
naringin	DM4DG1Y	Investigative	Small molecular drug	[4386]
NAS181	DMRKE2J	Investigative	Small molecular drug	[4387]
NAVPNLRGDLQVLAQKVART	DM3RP25	Investigative	NA	[4388]
NBBCC	DMTZ1XV	Investigative	Small molecular drug	[4389]
NBI-59159	DM7S5Y4	Investigative	Small molecular drug	[4390]
NBI-74330	DMURC6X	Investigative	Small molecular drug	[4391]
NBTGR	DMVF420	Investigative	Small molecular drug	[4392]
NC-2100	DMJKZUC	Investigative	Small molecular drug	[4393]
NC00075159	DMJCYMW	Investigative	Small molecular drug	[4394]
NCFP	DM0JCN2	Investigative	Small molecular drug	[4395]
NCG21	DMMRWJG	Investigative	Small molecular drug	[4396]
NCGC00167772-01	DMY8RT9	Investigative	Small molecular drug	[4397]
NCI-159878	DMTCBLS	Investigative	Small molecular drug	[887]
NCI-58425	DM9C7GP	Investigative	Small molecular drug	[887]
NCL-1	DMH1BVG	Investigative	Small molecular drug	[4398]
NCX-1067	DMUHXRA	Investigative	NA	[4399]
ND-2110	DMMODRE	Investigative	Small molecular drug	[4400]
ND-2158	DMH7GLE	Investigative	Small molecular drug	[4401]
NDP-alpha-MSH	DMTMHW2	Investigative	NA	[1855]
NDP-SYSMEHFRWGKPVG	DMRV16G	Investigative	NA	[1883]
NDT9520492	DMFKX7Z	Investigative	Small molecular drug	[4402]
NE-10575	DMGSNU4	Investigative	Small molecular drug	[4403]
NE-28345	DMVSRYH	Investigative	Small molecular drug	[1866]
NE10790	DMVESO2	Investigative	Small molecular drug	[4404]
NE11808	DMR92HV	Investigative	Small molecular drug	[4405]
NE21650	DM58O3I	Investigative	Small molecular drug	[4406]
NE58018	DM28ZPT	Investigative	Small molecular drug	[4407]
NE58027	DMU4I8R	Investigative	Small molecular drug	[4408]
NE58043	DMS7UNR	Investigative	Small molecular drug	[4409]
NE58062	DMHIM6N	Investigative	Small molecular drug	[4410]
NE97220	DMDWESP	Investigative	Small molecular drug	[4411]
Neamine	DMNCU6H	Investigative	Small molecular drug	[782]
Nectamazin C	DMO0Q1F	Investigative	Small molecular drug	[738]
Neo-kauluamine	DM6D0JC	Investigative	Small molecular drug	[1802]
NEODYSIDENIN	DM5EWIK	Investigative	Small molecular drug	[2961]
NEOLIGNAN 9-NOR-7,8-DEHYDRO-ISOLICARIN B	DMKFPA9	Investigative	Small molecular drug	[738]
NEORAUTENOL	DM5GMOJ	Investigative	Small molecular drug	[1164]
Neplanocin A	DMXULGK	Investigative	Small molecular drug	[3166]
Netropsin	DMOW2QS	Investigative	Small molecular drug	[4412]
neurokinin A	DM9UXRP	Investigative	Small molecular drug	[4413]
NEUROKININ B	DM5O2MJ	Investigative	Small molecular drug	[4414]
neuromedin B	DMCXJLH	Investigative	Small molecular drug	[4415]
NEUROTENSIN	DM27WCE	Investigative	Small molecular drug	[4416]
Neurotrophic factor companion	DMH51MK	Investigative	NA	[1866]
nexturastat A	DM6NS7H	Investigative	Small molecular drug	[4417]
NF023	DMJ4GO9	Investigative	Small molecular drug	[4418]
NF157	DMGMH8T	Investigative	Small molecular drug	[4419]
NF340	DMPSXR8	Investigative	Small molecular drug	[4420]
NF449	DM816Z2	Investigative	Small molecular drug	[4421]
NF546	DMPZB31	Investigative	Small molecular drug	[4422]
NG-25	DMC48D9	Investigative	Small molecular drug	[4423]
NGB 2904	DMMC42Z	Investigative	Small molecular drug	[4424]
NH-3	DMYAB79	Investigative	Small molecular drug	[4425]
NH-4	DMSUZFO	Investigative	Small molecular drug	[3166]
NI-57	DM52ITO	Investigative	Small molecular drug	[4426]
NIBR-0213	DMH6MVJ	Investigative	Small molecular drug	[4427]
NICARBAZIN	DM4I6MD	Investigative	Small molecular drug	[4428]
Nickel chloride	DMI12Y8	Investigative	Small molecular drug	[4429]
Nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime	DM0DFNJ	Investigative	Small molecular drug	[787]
Nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime	DM957CK	Investigative	Small molecular drug	[787]
Nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime	DMC9WAL	Investigative	Small molecular drug	[787]
NIFEVIROC	DMIK40C	Investigative	Small molecular drug	[4430]
Niflumic	DM431J5	Investigative	NA	[1866]
NIHP	DMDMG1O	Investigative	Small molecular drug	[4431]
NILTUBACIN	DM0QJSO	Investigative	Small molecular drug	[1518]
NIPECOTIC ACID	DMPV450	Investigative	Small molecular drug	[4432]
NIS-62949	DM1R0WC	Investigative	NA	[4433]
NISOXETINE	DMZBNH0	Investigative	Small molecular drug	[4434]
Nitracrine	DMY59KQ	Investigative	Small molecular drug	[4435]
NITRAQUAZONE	DMVDM0Q	Investigative	Small molecular drug	[4436]
NITRATE	DMVFB93	Investigative	Small molecular drug	[3493]
Nitrilotriacetic Acid	DMIOQFU	Investigative	Small molecular drug	[12]
Nitrobenzylthioinosine	DM7F3RY	Investigative	Small molecular drug	[4437]
NITROCEFIN	DM7M5VY	Investigative	NA	[22]
Nitroflurbiprofen	DMWCV48	Investigative	Small molecular drug	[4438]
NK3201	DM9WC1T	Investigative	Small molecular drug	[4439]
NKY80	DMSB2YG	Investigative	Small molecular drug	[4440]
Nle-Pro-Glu	DM0FA6B	Investigative	Small molecular drug	[215]
NM-2023	DM5V4F8	Investigative	NA	[1866]
NM-2026	DM86VSI	Investigative	NA	[1866]
NM-3014	DM87G5J	Investigative	NA	[1866]
NM-4540	DMIB47D	Investigative	NA	[1866]
NM-4654	DM2KVEH	Investigative	NA	[1866]
NM-9505	DMV0SWH	Investigative	NA	[1866]
NM-PP1	DMS8H5Q	Investigative	Small molecular drug	[4441]
NN-dimethyl-D-erythrosphingosine	DMSYOHD	Investigative	Small molecular drug	[4442]
NNC 11-1314	DMSQ4TL	Investigative	Small molecular drug	[4443]
NNC 11-1585	DMMX19B	Investigative	Small molecular drug	[4444]
NNC 11-1607	DMZJSWI	Investigative	Small molecular drug	[4445]
NNC 711	DM0C8N3	Investigative	Small molecular drug	[4446]
NNC 92-1687	DMPQ1HL	Investigative	Small molecular drug	[4447]
NNC-26-0194	DMDCPFJ	Investigative	NA	[4448]
NNC052090	DMCGF3U	Investigative	Small molecular drug	[4449]
NNC269100	DMAQTW3	Investigative	Small molecular drug	[4450]
NNC55-0396	DMID3F7	Investigative	Small molecular drug	[4451]
NOCARDIMICIN A	DMN7GO8	Investigative	Small molecular drug	[3222]
Nocardimicin C	DM4SRL7	Investigative	Small molecular drug	[3222]
Nocardimicin D	DM1SABZ	Investigative	Small molecular drug	[3222]
Nocardimicin F	DMK02YC	Investigative	Small molecular drug	[3222]
Noccardimicin E	DMXOF4Z	Investigative	Small molecular drug	[3222]
Nogalamycin	DM50TCG	Investigative	Small molecular drug	[4452]
Nojirimycine Tetrazole	DMYZRTB	Investigative	Small molecular drug	[22]
Nomega-hydroxyarginine	DMADW4G	Investigative	Small molecular drug	[4453]
Nonanoic acid biphenyl-2-ylamide	DM951PF	Investigative	Small molecular drug	[362]
Nor-binaltorphimine dihydrochloride	DM6HKEC	Investigative	Small molecular drug	[2377]
NOR-ROEFRACTINE	DMSZWGN	Investigative	Small molecular drug	[251]
Noradrenalone (arterenone)	DMFNB40	Investigative	Small molecular drug	[4454]
NORARISTEROMYCIN	DMZ9024	Investigative	Small molecular drug	[4455]
NORBINALTORPHIMINE	DMLYZOG	Investigative	Small molecular drug	[4456]
NORBOLDINE	DM6BNQR	Investigative	Small molecular drug	[2102]
NORCANTHARIDIN	DM9B6Y1	Investigative	Small molecular drug	[2034]
norfenfluramine	DMGI4ZW	Investigative	Small molecular drug	[4457]
norfluoxetine	DMKNUP3	Investigative	Small molecular drug	[4458]
NORHARMANE	DMKYQWG	Investigative	Small molecular drug	[4459]
normetanephrine	DMMUFTK	Investigative	Small molecular drug	[4460]
normorphine	DMYQGFJ	Investigative	Small molecular drug	[4461]
NORSTEPHALAGINE	DM1VIHC	Investigative	Small molecular drug	[2102]
Nortropinyl-arylsulfonylurea 3	DMTY43L	Investigative	Small molecular drug	[4462]
norzotepine	DMS3N4X	Investigative	Small molecular drug	[4463]
NOSTOCARBOLINE	DME5O17	Investigative	Small molecular drug	[4464]
Novo Nordisk a/S Compound	DM3C2VA	Investigative	Small molecular drug	[12]
NP-506	DMVPIF8	Investigative	Small molecular drug	[4465]
NPC-349	DMU426Z	Investigative	Small molecular drug	[4466]
NPPB	DMFIWAN	Investigative	Small molecular drug	[1763]
NPTS	DMAABFU	Investigative	Small molecular drug	[4467]
NQN-1	DMAXHLK	Investigative	Small molecular drug	[4468]
NRT-700	DMV0KZU	Investigative	NA	[1866]
NS 2028	DML0N7D	Investigative	Small molecular drug	[4469]
NS1738	DM2S5ZF	Investigative	Small molecular drug	[4470]
NS3763	DMVL5KS	Investigative	Small molecular drug	[4471]
NS5818	DM629TD	Investigative	Small molecular drug	[4472]
NS9283	DMWN8FU	Investigative	Small molecular drug	[4473]
NSC 665564	DMX4DT7	Investigative	Small molecular drug	[4474]
NSC-106080	DMR6P9S	Investigative	Small molecular drug	[2034]
NSC-106084	DM6ID8P	Investigative	Small molecular drug	[4475]
NSC-106547	DMR2DTI	Investigative	Small molecular drug	[4476]
NSC-106970	DMHK0F6	Investigative	Small molecular drug	[2514]
NSC-115890	DMPLUHT	Investigative	Small molecular drug	[2034]
NSC-119911	DM1MRFW	Investigative	Small molecular drug	[2034]
NSC-119913	DMVE69Y	Investigative	Small molecular drug	[2034]
NSC-122427	DMYMB4A	Investigative	Small molecular drug	[4477]
NSC-125034	DM3NQDW	Investigative	Small molecular drug	[2961]
NSC-126445	DMHGIB1	Investigative	Small molecular drug	[4478]
NSC-12999	DMJAO6Z	Investigative	Small molecular drug	[469]
NSC-131736	DMYJNS9	Investigative	Small molecular drug	[469]
NSC-137546	DMKQYMX	Investigative	Small molecular drug	[4475]
NSC-138419	DMH684Q	Investigative	Small molecular drug	[4475]
NSC-154957	DMW82SA	Investigative	Small molecular drug	[4475]
NSC-158324	DMDR460	Investigative	Small molecular drug	[4475]
NSC-172033	DM9QW8N	Investigative	Small molecular drug	[2961]
NSC-1771	DMNXDGQ	Investigative	Small molecular drug	[2034]
NSC-180246	DMXBRCI	Investigative	Small molecular drug	[2034]
NSC-180969	DMZFHL0	Investigative	Small molecular drug	[2034]
NSC-204996	DMAQGIW	Investigative	Small molecular drug	[2034]
NSC-2113	DMOGV9F	Investigative	Small molecular drug	[4476]
NSC-224124	DMM9PDR	Investigative	Small molecular drug	[4476]
NSC-23180	DMJ91Y7	Investigative	Small molecular drug	[385]
NSC-238146	DMWXNOI	Investigative	Small molecular drug	[2034]
NSC-26699	DM4RPBJ	Investigative	Small molecular drug	[4478]
NSC-26745	DMNX245	Investigative	Small molecular drug	[1627]
NSC-270718	DMUNIWE	Investigative	Small molecular drug	[795]
NSC-27236	DMANZIE	Investigative	Small molecular drug	[1374]
NSC-275420	DMV2D8F	Investigative	Small molecular drug	[4476]
NSC-289311	DMZU1L0	Investigative	Small molecular drug	[469]
NSC-292213	DMNUSKT	Investigative	Small molecular drug	[2961]
NSC-300853	DM6IF8N	Investigative	Small molecular drug	[2034]
NSC-30171	DMFBZEI	Investigative	Small molecular drug	[4478]
NSC-306843	DMZYJU0	Investigative	Small molecular drug	[2034]
NSC-316158	DMTPRXI	Investigative	Small molecular drug	[4476]
NSC-319745	DMF3G06	Investigative	Small molecular drug	[4475]
NSC-324572	DMN50OT	Investigative	Small molecular drug	[4478]
NSC-339580	DMK0H2P	Investigative	Small molecular drug	[4476]
NSC-339583	DMITE1A	Investigative	Small molecular drug	[4476]
NSC-341622	DMVGLH7	Investigative	Small molecular drug	[4479]
NSC-345763	DM2UPSV	Investigative	Small molecular drug	[4475]
NSC-348926	DM3TDEO	Investigative	Small molecular drug	[4475]
NSC-354279	DMVL51I	Investigative	Small molecular drug	[4476]
NSC-356483	DMEK5B2	Investigative	Small molecular drug	[469]
NSC-356781	DM9LI7M	Investigative	Small molecular drug	[469]
NSC-356819	DMXT1EK	Investigative	Small molecular drug	[2034]
NSC-356820	DM9CM5V	Investigative	Small molecular drug	[2034]
NSC-359466	DMHUG1W	Investigative	Small molecular drug	[2034]
NSC-368272	DMR97X3	Investigative	Small molecular drug	[469]
NSC-368280	DMR3IP5	Investigative	Small molecular drug	[469]
NSC-369087	DMAQWM8	Investigative	Small molecular drug	[469]
NSC-37031	DMLY6WX	Investigative	Small molecular drug	[4478]
NSC-37173	DMZFULS	Investigative	Small molecular drug	[4478]
NSC-380292	DMHO40Q	Investigative	Small molecular drug	[4480]
NSC-381864	DMLGWHM	Investigative	Small molecular drug	[2034]
NSC-401077	DM0214E	Investigative	Small molecular drug	[4475]
NSC-40331	DMCFNMK	Investigative	Small molecular drug	[4481]
NSC-407228	DMKJWGP	Investigative	Small molecular drug	[1554]
NSC-45592	DMQ6GBX	Investigative	Small molecular drug	[4478]
NSC-47729	DMRZJL1	Investigative	Small molecular drug	[4478]
NSC-50187	DMTQP3V	Investigative	Small molecular drug	[56]
NSC-527035	DMY689Z	Investigative	Small molecular drug	[4482]
NSC-54162	DMW2Q6N	Investigative	Small molecular drug	[4475]
NSC-56071	DMLEN4X	Investigative	Small molecular drug	[4475]
NSC-57893	DMIRK41	Investigative	Small molecular drug	[4475]
NSC-58046	DMI6WA7	Investigative	Small molecular drug	[4478]
NSC-613604	DMD1XM0	Investigative	Small molecular drug	[4477]
NSC-621351	DMFXEIK	Investigative	Small molecular drug	[2034]
NSC-622444	DMM5UT9	Investigative	Small molecular drug	[4475]
NSC-622445	DME35CB	Investigative	Small molecular drug	[4475]
NSC-623548	DMW437Z	Investigative	Small molecular drug	[4475]
NSC-625409	DM0GWAC	Investigative	Small molecular drug	[469]
NSC-625987	DMLG05U	Investigative	Small molecular drug	[4483]
NSC-637991	DMY7EAF	Investigative	Small molecular drug	[4484]
NSC-637992	DM0U7CK	Investigative	Small molecular drug	[4484]
NSC-637993	DM2HC8L	Investigative	Small molecular drug	[4484]
NSC-637994	DMKA8YT	Investigative	Small molecular drug	[4484]
NSC-640353	DMZCYM1	Investigative	Small molecular drug	[2034]
NSC-640556	DM3DW6A	Investigative	NA	[2034]
NSC-640558	DMPFC5U	Investigative	Small molecular drug	[2034]
NSC-640559	DMMT73G	Investigative	Small molecular drug	[2034]
NSC-640566	DMSJ06G	Investigative	Small molecular drug	[2034]
NSC-640583	DMC4Y0R	Investigative	Small molecular drug	[2034]
NSC-640584	DMY2API	Investigative	Small molecular drug	[2034]
NSC-645808	DMMBAR3	Investigative	Small molecular drug	[4484]
NSC-645811	DMCNIT2	Investigative	Small molecular drug	[4484]
NSC-645812	DM1MPJ9	Investigative	Small molecular drug	[4484]
NSC-645827	DMNJLW2	Investigative	Small molecular drug	[4476]
NSC-645831	DMSO215	Investigative	Small molecular drug	[4484]
NSC-645833	DM1AD8T	Investigative	Small molecular drug	[4484]
NSC-645834	DMY5JFB	Investigative	Small molecular drug	[4484]
NSC-645835	DMKDVP7	Investigative	Small molecular drug	[4484]
NSC-645836	DMQ13SI	Investigative	Small molecular drug	[4484]
NSC-649091	DM6F3HV	Investigative	Small molecular drug	[2034]
NSC-65069	DMFEGYB	Investigative	Small molecular drug	[2034]
NSC-651016	DMWY39L	Investigative	NA	[4485]
NSC-654077	DMW3QAK	Investigative	Small molecular drug	[191]
NSC-656158	DM52NOI	Investigative	Small molecular drug	[4486]
NSC-660838	DMXDNQ6	Investigative	Small molecular drug	[4484]
NSC-660839	DM8LOCA	Investigative	Small molecular drug	[4484]
NSC-660840	DMB5PLD	Investigative	Small molecular drug	[4484]
NSC-660841	DMXHPV0	Investigative	Small molecular drug	[4484]
NSC-66209	DMQ0S4B	Investigative	Small molecular drug	[2034]
NSC-663284	DMEXW31	Investigative	Small molecular drug	[2345]
NSC-664171	DMEF603	Investigative	Small molecular drug	[4487]
NSC-665126	DMNQXE0	Investigative	Small molecular drug	[2034]
NSC-666292	DMNMF0C	Investigative	Small molecular drug	[469]
NSC-66811	DMRVMA5	Investigative	Small molecular drug	[4488]
NSC-669977	DMVFZKQ	Investigative	Small molecular drug	[2034]
NSC-676468	DMY4MPG	Investigative	Small molecular drug	[2034]
NSC-677939	DM35V46	Investigative	Small molecular drug	[2034]
NSC-679036	DMPO2RU	Investigative	Small molecular drug	[881]
NSC-683634	DMZ2KUB	Investigative	Small molecular drug	[469]
NSC-686549	DM0164B	Investigative	Small molecular drug	[4489]
NSC-693571	DMKMTJ9	Investigative	Small molecular drug	[2034]
NSC-720622	DMCP1I6	Investigative	Small molecular drug	[2034]
NSC-73410	DMX0VQN	Investigative	Small molecular drug	[4476]
NSC-73613	DMT6CV5	Investigative	Small molecular drug	[879]
NSC-745794	DM1ETX5	Investigative	Small molecular drug	[772]
NSC-745795	DMI2GFM	Investigative	Small molecular drug	[772]
NSC-745796	DM8JMBI	Investigative	Small molecular drug	[772]
NSC-745797	DM9YAPX	Investigative	Small molecular drug	[772]
NSC-745798	DMSPQYV	Investigative	Small molecular drug	[772]
NSC-745799	DML6OMH	Investigative	Small molecular drug	[772]
NSC-745883	DMVA6R0	Investigative	Small molecular drug	[772]
NSC-745884	DM8W0J3	Investigative	Small molecular drug	[772]
NSC-745885	DMZQ803	Investigative	Small molecular drug	[772]
NSC-745886	DMHBYN5	Investigative	Small molecular drug	[772]
NSC-745887	DMG9BWY	Investigative	Small molecular drug	[772]
NSC-745888	DMWHYND	Investigative	Small molecular drug	[772]
NSC-746457	DM2GO7N	Investigative	Small molecular drug	[4490]
NSC-75308	DM8GZAM	Investigative	Small molecular drug	[469]
NSC-77833	DM82XAU	Investigative	Small molecular drug	[2034]
NSC-78017	DM8R12J	Investigative	Small molecular drug	[2034]
NSC-78021	DM7L3DE	Investigative	Small molecular drug	[2034]
NSC-86715	DMA53YD	Investigative	Small molecular drug	[2034]
NSC-87509	DMSYT0A	Investigative	Small molecular drug	[2034]
NSC-89508	DMGS6HB	Investigative	Small molecular drug	[4481]
NSC-93358	DMTOFS7	Investigative	Small molecular drug	[4477]
NSC-93394	DM2JPD4	Investigative	Small molecular drug	[879]
NSC-93405	DM3BZ7S	Investigative	Small molecular drug	[56]
NSC-94258	DM6VY3P	Investigative	Small molecular drug	[4491]
NSC-94891	DM31CZK	Investigative	Small molecular drug	[4477]
NSC-95397	DMX0TAM	Investigative	Small molecular drug	[1661]
NSC-99495	DM96X2U	Investigative	Small molecular drug	[2034]
NSC-99528	DMXZAIG	Investigative	Small molecular drug	[2034]
NSFQ-105	DMSLA8X	Investigative	NA	[4492]
NTE-1	DMFIE0U	Investigative	Small molecular drug	[4493]
NTE-2	DM4DB0W	Investigative	Small molecular drug	[4493]
nTzDpa	DMTHB2Y	Investigative	Small molecular drug	[4494]
NU-6027	DMELYAX	Investigative	NA	[1708]
NU-6102	DMMOFKD	Investigative	Small molecular drug	[4495]
NU-7432	DMDNUM5	Investigative	Small molecular drug	[4496]
NU-8231	DMEUV5R	Investigative	Small molecular drug	[4497]
NU6140	DMCUSG3	Investigative	Small molecular drug	[4498]
NUTLIN-3	DM5KXFI	Investigative	Small molecular drug	[4499]
NV-31	DM0BNYU	Investigative	Small molecular drug	[4500]
NVP 231	DM6DRFC	Investigative	Small molecular drug	[4501]
NVP ACQ090	DM8R16V	Investigative	Small molecular drug	[4502]
NVP-AAM077	DM9DURZ	Investigative	Small molecular drug	[4503]
NVP-BBT594	DMCCO4E	Investigative	Small molecular drug	[4504]
NVP-PDF386	DMOV0QT	Investigative	NA	[4505]
N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	DML35GB	Investigative	Small molecular drug	[22]
N~3~-BENZYLPYRIDINE-2,3-DIAMINE	DMOCQ9I	Investigative	Small molecular drug	[22]
O-1602	DM9VISB	Investigative	Small molecular drug	[4506]
O-1812	DMCXMQJ	Investigative	Small molecular drug	[4507]
O-Acetylserine	DMAEHFT	Investigative	Small molecular drug	[12]
O-arachidonoyl ethanolamine	DML0P72	Investigative	Small molecular drug	[4508]
O-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	DMWZXH6	Investigative	Small molecular drug	[4296]
O-Benzylsulfonyl-Serine	DMD25HJ	Investigative	Small molecular drug	[12]
O-DESMETHYL TRAMADOL	DM8ZG2I	Investigative	Small molecular drug	[3685]
o-hydroxyatorvastatin	DMN37KO	Investigative	Small molecular drug	[4509]
O-methyldauricine	DMKTA5R	Investigative	Small molecular drug	[2102]
O-oleoyl-N-(2-hydroxyethyl)hydroxylamine	DMDR95N	Investigative	Small molecular drug	[4296]
O-Sialic Acid	DMCAR7B	Investigative	Small molecular drug	[22]
O-spiroketal glucoside	DM3FS62	Investigative	Small molecular drug	[4510]
O-tolyl 10H-phenothiazine-10-carboxylate	DM0R6MT	Investigative	Small molecular drug	[1050]
O2-Sulfo-Glucuronic Acid	DME78MS	Investigative	Small molecular drug	[12]
O5-Acetyl-O7-nitrooxyethyl chrysin	DMKMH2X	Investigative	Small molecular drug	[4511]
O7-Nitrooxyethyl chrysin	DMAUDCW	Investigative	Small molecular drug	[4511]
OAADPR	DM458IH	Investigative	Small molecular drug	[4512]
OAG	DMOP8IJ	Investigative	Small molecular drug	[4513]
OBABERINE	DMY4PMN	Investigative	Small molecular drug	[2102]
OBIDOXIME	DMM98BC	Investigative	Small molecular drug	[2569]
Ochnaflavone	DMGVDR6	Investigative	Small molecular drug	[4514]
OCOPHYLLALS A	DMT59UG	Investigative	Small molecular drug	[738]
Ocophyllals b	DMEUPVF	Investigative	Small molecular drug	[738]
Octahydro-isoindol-(1Z)-ylideneamine	DM4C70S	Investigative	Small molecular drug	[1150]
Octane-1,8-diyl disulfamate	DMBQMGH	Investigative	Small molecular drug	[2818]
Octane-1-sulfonyl fluoride	DMDBI5S	Investigative	Small molecular drug	[1476]
Octanedioic acid bis-hydroxyamide	DMJNQ9K	Investigative	Small molecular drug	[4515]
Octanedioic acid hydroxyamide pyridin-2-ylamide	DMHNWS1	Investigative	Small molecular drug	[1474]
Octanedioic acid hydroxyamide pyridin-4-ylamide	DM945RK	Investigative	Small molecular drug	[1474]
Octanoic acid biphenyl-2-ylamide	DM4RGCX	Investigative	Small molecular drug	[362]
octanol	DMBGHPE	Investigative	Small molecular drug	[4516]
OCTOCLOTHEPIN	DM0UADK	Investigative	Small molecular drug	[4517]
Octyl sulfamate	DM40ZCA	Investigative	Small molecular drug	[2818]
octyl thiophosphatidic acid	DM2RJYO	Investigative	Small molecular drug	[4518]
OCTYL_GALLATE	DMXLGUS	Investigative	Small molecular drug	[372]
ODQ	DMSAJO8	Investigative	Small molecular drug	[4519]
OF-1	DMK8LEC	Investigative	Small molecular drug	[4520]
OG-L002	DM0PMKW	Investigative	Small molecular drug	[4521]
OHIOENSIN A	DMZMTLB	Investigative	Small molecular drug	[4522]
Ohioensin C	DMNUGTL	Investigative	Small molecular drug	[4522]
Ohioensin F	DMCT348	Investigative	Small molecular drug	[4522]
Ohioensin G	DMLJBVP	Investigative	Small molecular drug	[4522]
OICR-9429	DMN7KPQ	Investigative	Small molecular drug	[4523]
Okadaic acid	DM47CO1	Investigative	Small molecular drug	[4524]
OL-92	DM5ZJ3G	Investigative	Small molecular drug	[2322]
Olean-12-en-3beta,15alpha-diol	DMVM78Q	Investigative	Small molecular drug	[3910]
OLEANOLIC_ACID	DMWDMJ3	Investigative	Small molecular drug	[4525]
Oleanonic acid	DMYPJC3	Investigative	Small molecular drug	[1106]
OLEIC ACID	DM54O1Z	Investigative	Small molecular drug	[4526]
Oleic acid anilide	DMXCSVH	Investigative	Small molecular drug	[4527]
oleocanthal	DMI1CAJ	Investigative	Small molecular drug	[4528]
oleoyl-CoA	DMJ1VRU	Investigative	Small molecular drug	[4529]
oleoyl-lysophosphatidylcholine	DMB5KQ4	Investigative	Small molecular drug	[4530]
oleoyl-thiophosphate	DM1TAM9	Investigative	Small molecular drug	[4531]
Olterodine	DMTY63G	Investigative	Small molecular drug	[4532]
OM00-3	DMXJ2SM	Investigative	Small molecular drug	[4533]
omega-chloroacetophenone	DMGMIX3	Investigative	Small molecular drug	[4534]
omega-conotoxin GVIA	DM4BQFW	Investigative	Small molecular drug	[4535]
OMPT	DMGFRSY	Investigative	Small molecular drug	[4536]
ONO-1581	DMSXT0H	Investigative	Small molecular drug	[4537]
ONO-3080573	DM8LKED	Investigative	Small molecular drug	[4538]
ONO-3708	DM84IW9	Investigative	Small molecular drug	[4539]
ONO-8713	DMD2G65	Investigative	Small molecular drug	[4540]
ONO-9780307	DMATXHR	Investigative	Small molecular drug	[4538]
ONO-9910539	DML4DPV	Investigative	Small molecular drug	[4538]
ONO-AE-248	DMA7VP5	Investigative	Small molecular drug	[4541]
ONO-AE1-329	DMS3MZG	Investigative	Small molecular drug	[4542]
ONO-AE2-227	DM78DO6	Investigative	Small molecular drug	[4543]
ONO-AE3-208	DMEY7T4	Investigative	Small molecular drug	[4544]
ONO-AE3-237	DMGA4W5	Investigative	Small molecular drug	[4545]
ONO-AE3-240	DMN3OWP	Investigative	Small molecular drug	[4546]
ONO-AE5-599	DMDA7M9	Investigative	Small molecular drug	[4547]
ONO-AP-324	DMA1NL9	Investigative	Small molecular drug	[4548]
ONO-DI-004	DM81RKT	Investigative	Small molecular drug	[4549]
OPC 4392	DMQOJY2	Investigative	Small molecular drug	[4550]
orexin-B	DM0XT69	Investigative	Small molecular drug	[4551]
Org 12962	DM8JUBG	Investigative	Small molecular drug	[4552]
Org 24598	DMCPX9D	Investigative	Small molecular drug	[4553]
Org-30850	DMXGA56	Investigative	Small molecular drug	[4554]
Org-33201	DMDY38R	Investigative	Small molecular drug	[4555]
Org-36764	DM4SFKW	Investigative	NA	[4556]
Org-37663	DM3EZDG	Investigative	NA	[4557]
ORG2058	DMH1M6N	Investigative	Small molecular drug	[4558]
Org27569	DMRU3H0	Investigative	Small molecular drug	[4559]
ORIPAVINE	DMPQGUL	Investigative	Small molecular drug	[2633]
ORM-10103	DMX292N	Investigative	Small molecular drug	[4560]
OROIDIN	DMA2DQT	Investigative	Small molecular drug	[4561]
Orotate	DMMB29S	Investigative	Small molecular drug	[1589]
Orotic acid	DMP6BSH	Investigative	Small molecular drug	[4562]
Orthovanadate	DMGRXD4	Investigative	Small molecular drug	[4563]
OSCILLARIN	DMK6X5P	Investigative	Small molecular drug	[2564]
OSI-75	DM5IGN7	Investigative	NA	[4564]
OTS964	DMXP72F	Investigative	Small molecular drug	[4565]
Ovalicin	DMM4CE7	Investigative	Small molecular drug	[12]
oxalacetic acid	DMPZSV1	Investigative	Small molecular drug	[4566]
oxalate	DM40SEU	Investigative	Small molecular drug	[4567]
Oxalic Acid	DMLN2GQ	Investigative	Small molecular drug	[12]
Oxalylaminobenzoic acid	DMT7XYE	Investigative	Small molecular drug	[3115]
OXAMATE	DMTYBC9	Investigative	Small molecular drug	[12]
Oxametacin	DMWVLG1	Investigative	Small molecular drug	[4568]
Oxazolidin-(2Z)-ylideneamine	DM8109D	Investigative	Small molecular drug	[192]
OXDEX	DMMEDJT	Investigative	Small molecular drug	[4569]
OXENDLONE	DM6RJOI	Investigative	Small molecular drug	[4570]
Oximidine I	DMG6O0L	Investigative	Small molecular drug	[3878]
Oximidine II	DMW6K80	Investigative	Small molecular drug	[3878]
Oxindole 16 (compound 3)	DMM5208	Investigative	Small molecular drug	[2849]
Oxindole 95	DM4UL1G	Investigative	NA	[2849]
oxo-arpromidine	DMV0KTW	Investigative	Small molecular drug	[4571]
OXYBENZONE	DMMZYX6	Investigative	Small molecular drug	[887]
Oxybutynine	DMJPBAX	Investigative	Small molecular drug	[4572]
OXYMORPHINDOLE	DMTP4S2	Investigative	Small molecular drug	[4573]
Oxymorphone semicarbazone hydrochloride	DMTSM61	Investigative	Small molecular drug	[2960]
OXYQUINOLINE	DMZVS9Y	Investigative	Small molecular drug	[958]
OXYRESVERATROL	DMN7S4L	Investigative	Small molecular drug	[775]
P'-geranyl 2-fluoromevalonate 5-diphosphate	DMNY187	Investigative	Small molecular drug	[4574]
P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate	DMJ4SIA	Investigative	Small molecular drug	[4575]
P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate	DMO9BUR	Investigative	Small molecular drug	[4576]
P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate	DM2395E	Investigative	Small molecular drug	[4577]
P(1)-(6-Hydroxymethylpterin)-P(4)-(5'-adenosyl)tetraphosphate	DMOY627	Investigative	Small molecular drug	[4578]
P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	DMJ0W43	Investigative	Small molecular drug	[22]
P-Anisic Acid	DM8HWS9	Investigative	Small molecular drug	[12]
P-Coumaric Acid	DMGJSVD	Investigative	Small molecular drug	[4579]
p-F-HHSiD	DM9CV6S	Investigative	Small molecular drug	[4580]
p-hydroxyatorvastatin	DMY5DGJ	Investigative	Small molecular drug	[4581]
P-hydroxyphenethyl trans-ferulate	DMPS1Y2	Investigative	Small molecular drug	[3073]
P-IODOAMPHETAMINE	DMHLBZR	Investigative	Small molecular drug	[4582]
P-MPPI	DMHSWT6	Investigative	Small molecular drug	[4583]
p-nitrophenyl glutamyl anilide	DM29RO1	Investigative	Small molecular drug	[4584]
P-toluenesulfonamide	DMPEKTO	Investigative	Small molecular drug	[788]
P-tolyl 10H-phenothiazine-10-carboxylate	DMDGUEK	Investigative	Small molecular drug	[1050]
P-tolylboronic acid	DM8MZF4	Investigative	Small molecular drug	[942]
p-[18F]MPPF	DM9SNFX	Investigative	Small molecular drug	[4585]
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	DMM4VWD	Investigative	Small molecular drug	[107]
P2,P3 Ketoamide derivative	DMETL3Z	Investigative	Small molecular drug	[4586]
PA-640	DMRUHWE	Investigative	NA	[1866]
PA451	DMTGZ3E	Investigative	Small molecular drug	[4587]
PACAP-27	DMB26IK	Investigative	Small molecular drug	[4588]
PAF	DMRZAQW	Investigative	Small molecular drug	[4589]
PALASONIN	DMDTP1R	Investigative	Small molecular drug	[2463]
PALBINONE	DMN97BF	Investigative	Small molecular drug	[4590]
PALMATINE	DMJCOKV	Investigative	Small molecular drug	[3638]
Palmitoleic Acid	DM4W5X8	Investigative	Small molecular drug	[4591]
palmitoyl-CoA	DMU5SQ7	Investigative	Small molecular drug	[4592]
Palodesangren C	DMKLVSO	Investigative	Small molecular drug	[4570]
Palodesangren D	DMY6NRC	Investigative	Small molecular drug	[4570]
Palodesangren E	DMUEK1N	Investigative	Small molecular drug	[4570]
Pam2CSK4	DMJTPKE	Investigative	Small molecular drug	[4593]
pamoic acid	DM7M5AF	Investigative	Small molecular drug	[4594]
PARA-(BENZOYL)-PHENYLALANINE	DM2JUTB	Investigative	Small molecular drug	[22]
Para-chloroamphetamine	DMOH75D	Investigative	Small molecular drug	[4595]
Para-Isopropylaniline	DMZY41U	Investigative	Small molecular drug	[12]
Para-Mercury-Benzenesulfonic Acid	DMQVFWJ	Investigative	Small molecular drug	[12]
Para-sirtinol	DM83C9N	Investigative	Small molecular drug	[296]
PARAOXON	DMN4ZKC	Investigative	Small molecular drug	[1476]
paraquat	DMR8O3X	Investigative	Small molecular drug	[4596]
parathyroid hormone	DMKJY3U	Investigative	NA	[4055]
PAS219	DML8BT7	Investigative	Small molecular drug	[22]
PASBN	DM7Y0G6	Investigative	Small molecular drug	[22]
PAT5A	DMRJ104	Investigative	Small molecular drug	[4597]
Patuletin 3-O-beta-D-galactoside	DMOXNYQ	Investigative	Small molecular drug	[1721]
Patuletin 3-O-beta-D-robinobioside	DMZ5Q7J	Investigative	Small molecular drug	[1721]
PATULIN	DM0RV9C	Investigative	Small molecular drug	[779]
PAULLONE	DMQA8N3	Investigative	Small molecular drug	[2689]
paxilline	DMPF2N1	Investigative	Small molecular drug	[4598]
Paz-PC	DMM6QXZ	Investigative	Small molecular drug	[4599]
PB-1120	DMX7WU9	Investigative	NA	[4600]
PB-27	DMZURA2	Investigative	Small molecular drug	[2331]
PB-28	DMSXZ19	Investigative	Small molecular drug	[4601]
PB-80	DMAOIW5	Investigative	Small molecular drug	[2331]
PB-81	DM9V807	Investigative	Small molecular drug	[2331]
PBC-264	DM39LS5	Investigative	Small molecular drug	[4602]
PBD150	DM1Y2F0	Investigative	Small molecular drug	[4603]
PBIT	DM8Q54I	Investigative	Small molecular drug	[4604]
PBMC	DM8K7C4	Investigative	Small molecular drug	[4605]
PC-25	DMQSOPL	Investigative	Small molecular drug	[4606]
PCCG-4	DMD9KYN	Investigative	Small molecular drug	[4607]
pCMPS	DMGIS5Q	Investigative	Small molecular drug	[4608]
PCNOTAXIME GROUP	DMGS6YH	Investigative	Small molecular drug	[22]
PD 128907	DMYC51H	Investigative	Small molecular drug	[4609]
PD 154740	DM5GTHE	Investigative	Small molecular drug	[4610]
PD 165929	DM5J4NA	Investigative	Small molecular drug	[4611]
PD 168368	DMFNQEA	Investigative	Small molecular drug	[4612]
PD 176252	DM7AY6K	Investigative	Small molecular drug	[4613]
PD-0166326	DMD2CG9	Investigative	Small molecular drug	[4614]
PD-0173952	DMSCQ9U	Investigative	Small molecular drug	[4615]
PD-0173955	DMOZEW9	Investigative	Small molecular drug	[4616]
PD-0173956	DM8RW92	Investigative	Small molecular drug	[4614]
PD-0173958	DMZQ8YV	Investigative	Small molecular drug	[4615]
PD-0179483	DMKO8LE	Investigative	Small molecular drug	[4615]
PD-068235	DM8QMJ1	Investigative	Small molecular drug	[3830]
PD-115199	DMQ4LRZ	Investigative	Small molecular drug	[4617]
PD-117558	DM3KAY5	Investigative	Small molecular drug	[4618]
PD-118057	DM0E4OW	Investigative	Small molecular drug	[4619]
PD-128763	DMV1F7U	Investigative	Small molecular drug	[12]
PD-135111	DMYEFAV	Investigative	Small molecular drug	[4620]
PD-135118	DMUTEWI	Investigative	Small molecular drug	[4621]
PD-135146	DMZ4LDC	Investigative	Small molecular drug	[4620]
PD-135158	DMA7YJV	Investigative	Small molecular drug	[4622]
PD-135188	DMSHBLF	Investigative	Small molecular drug	[4620]
PD-135222	DM0LTNJ	Investigative	Small molecular drug	[4620]
PD-135385	DMX294V	Investigative	Small molecular drug	[4620]
PD-135478	DM56PBI	Investigative	Small molecular drug	[4620]
PD-135540	DMI4MPZ	Investigative	Small molecular drug	[4620]
PD-136621	DM8N3RB	Investigative	Small molecular drug	[4621]
PD-137337	DMJWK0T	Investigative	Small molecular drug	[4621]
PD-137342	DMH2OV9	Investigative	Small molecular drug	[4621]
PD-137789	DM9ZK6L	Investigative	Small molecular drug	[4620]
PD-137821	DMYMFSE	Investigative	Small molecular drug	[4620]
PD-138915	DMLVRU7	Investigative	Small molecular drug	[4621]
PD-138916	DMIAFN5	Investigative	Small molecular drug	[4621]
PD-138917	DMUG2L9	Investigative	Small molecular drug	[4621]
PD-140547	DMF86P3	Investigative	Small molecular drug	[4621]
PD-140548	DMNO2EP	Investigative	Small molecular drug	[4623]
PD-140723	DMWTOJN	Investigative	Small molecular drug	[4621]
PD-144550	DM03526	Investigative	Small molecular drug	[1242]
PD-149164	DMP65EI	Investigative	Small molecular drug	[4624]
PD-151307	DMHD8UL	Investigative	Small molecular drug	[4625]
PD-152255	DMV0EDM	Investigative	NA	[4626]
PD-157672	DMHI8C9	Investigative	Small molecular drug	[4627]
PD-158780	DMQXYE9	Investigative	Small molecular drug	[4628]
PD-160946	DMZYIKR	Investigative	Small molecular drug	[4629]
PD-161182	DM8NV2E	Investigative	Small molecular drug	[4630]
PD-163140	DMBZ09U	Investigative	Small molecular drug	[4631]
PD-167341	DM9LJEP	Investigative	Small molecular drug	[4625]
PD-168077	DMX1AY4	Investigative	Small molecular drug	[4632]
PD-168393	DMN8M5P	Investigative	Small molecular drug	[4268]
PD-169316	DM1Z3D7	Investigative	Small molecular drug	[4633]
PD-169469	DMU3OR1	Investigative	Small molecular drug	[4634]
PD-171729	DMJ3DOI	Investigative	Small molecular drug	[4635]
PD-172938	DM29GUY	Investigative	Small molecular drug	[4636]
PD-172939	DMI8JTE	Investigative	Small molecular drug	[4636]
PD-174265	DMBHIAK	Investigative	Small molecular drug	[4637]
PD-307243	DMLU9P6	Investigative	Small molecular drug	[4638]
PD-32577	DMBA15J	Investigative	Small molecular drug	[4639]
PD-81723	DM5SYTW	Investigative	Small molecular drug	[4640]
PD-83176	DMSIMKZ	Investigative	Small molecular drug	[4641]
PD123177	DM4OQZX	Investigative	Small molecular drug	[4642]
PD159790	DM6RVTO	Investigative	Small molecular drug	[4643]
PD164333	DM5421R	Investigative	Small molecular drug	[4644]
PD182905	DMXLW4F	Investigative	NA	[4645]
PDGF receptor tyrosine kinase inhibitor III	DMORLTH	Investigative	Small molecular drug	[4646]
Pedunculagin	DMKLRCX	Investigative	Small molecular drug	[387]
PEGylated recombinant IFN beta 1b	DMR6DOC	Investigative	NA	[1866]
PELARGONIDIN CHLORIDE	DMAW0R7	Investigative	Small molecular drug	[2708]
Pellitorin	DMYIWBD	Investigative	Small molecular drug	[2826]
Pen(Acm)AQFRKEKETFC(Acm)-OH	DM81AWU	Investigative	NA	[2719]
PENECA	DMIDSJ9	Investigative	Small molecular drug	[4647]
PENICILLIOL A	DMZUES2	Investigative	Small molecular drug	[4648]
Pentane-1,5-diamine	DMVPZG9	Investigative	Small molecular drug	[3371]
pentanoic acid	DM56RAX	Investigative	Small molecular drug	[4649]
Pentanoic acid (4,6-diphenylpyrimidin-2-yl)amide	DM3S790	Investigative	Small molecular drug	[3372]
Pentanoic acid (4-sulfamoyl-phenyl)-amide	DMAZ07T	Investigative	Small molecular drug	[749]
pentylthio-TZTP	DMD8NHB	Investigative	Small molecular drug	[4650]
peptide 18	DMIDP1R	Investigative	Small molecular drug	[4651]
peptide 4	DM45RTZ	Investigative	Small molecular drug	[4652]
Peptide alpha-keto-beta-aldehyde-based inhibitors	DMC6GUA	Investigative	Small molecular drug	[4653]
peptide III-BTD	DMSDFOC	Investigative	Small molecular drug	[4654]
Pergularinine	DM8OC9F	Investigative	Small molecular drug	[4655]
Perillaldehyde	DMZA0VD	Investigative	Small molecular drug	[4656]
PERIPENTADENINE	DMN9W56	Investigative	Small molecular drug	[4657]
PERSICARIN	DM3RGPF	Investigative	Small molecular drug	[1317]
pertechnetate	DMCI63G	Investigative	Small molecular drug	[4658]
Pervanadate	DM873BS	Investigative	Small molecular drug	[2864]
PETCM	DM0N1DH	Investigative	Small molecular drug	[4659]
Petrosamine	DMYIEOJ	Investigative	Small molecular drug	[4660]
Petrosaspongiolide M	DMR8ZBT	Investigative	Small molecular drug	[4661]
Petrosaspongiolide P	DMMVZFN	Investigative	Small molecular drug	[4662]
PF 5208766	DMY45K1	Investigative	NA	[4663]
PF-00356231	DMV43NF	Investigative	Small molecular drug	[107]
PF-06447475	DMEUT0W	Investigative	Small molecular drug	[4664]
PF-06454589	DMWIVM3	Investigative	Small molecular drug	[4665]
PF-0998425	DMBM7LU	Investigative	Small molecular drug	[4666]
PF-18298	DMJMU09	Investigative	NA	[264]
PF-228	DM32FKD	Investigative	Small molecular drug	[4667]
PF-3644022	DM6KVIA	Investigative	Small molecular drug	[4668]
PF-429242	DMB0OZ3	Investigative	Small molecular drug	[4669]
PF-4840154	DMI29ED	Investigative	Small molecular drug	[4670]
PF-526014	DMD8QOZ	Investigative	Small molecular drug	[264]
PF-543	DMC4UHD	Investigative	Small molecular drug	[4671]
PF-592379	DMY93GJ	Investigative	Small molecular drug	[4672]
PF-877423	DM49MYE	Investigative	Small molecular drug	[4673]
PF3845	DMCRXAM	Investigative	Small molecular drug	[4674]
PF750	DMBE24Y	Investigative	Small molecular drug	[4675]
PFFFFF	DM9AZKE	Investigative	Small molecular drug	[4676]
PFI-1	DMVFK3J	Investigative	Small molecular drug	[4677]
PFI-3	DM619EU	Investigative	Small molecular drug	[4678]
PFI-4	DMPKXNZ	Investigative	Small molecular drug	[4679]
PG-01037	DM2TP4Q	Investigative	Small molecular drug	[4680]
PGD2	DMYDW6J	Investigative	Small molecular drug	[4681]
PGD3	DMWNCLJ	Investigative	Small molecular drug	[4682]
PGF1alpha	DMUPWQT	Investigative	Small molecular drug	[4683]
PGF2-1-ethanolamide	DMJSCSR	Investigative	Small molecular drug	[4684]
PGH2	DMZFVGC	Investigative	Small molecular drug	[4685]
PGJ2	DMR2LTC	Investigative	Small molecular drug	[4686]
PGlu-His-Trp-Ser-His-D-Tyr-Leu-Arg-Pro-Gly-NH2	DMLMTIY	Investigative	NA	[4687]
PGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2	DM40PT5	Investigative	NA	[4687]
PH-709829	DM5GY6Z	Investigative	Small molecular drug	[4688]
PHA-767491	DM4H7D5	Investigative	Small molecular drug	[4689]
Phaclofen	DMALRCH	Investigative	Small molecular drug	[4690]
phalloidin	DMPFWP3	Investigative	Small molecular drug	[4691]
PHASEOLIN	DM7H5KY	Investigative	Small molecular drug	[2456]
PHASEOLLIDIN	DMSQ10I	Investigative	Small molecular drug	[2456]
PHCCC	DMNJY79	Investigative	Small molecular drug	[4692]
Phe-Pro-Glu	DMJMLKA	Investigative	Small molecular drug	[215]
PHELLIGRIDIN I	DMAP04X	Investigative	Small molecular drug	[4693]
phenamil	DMJLUFM	Investigative	Small molecular drug	[4694]
Phenanthrene-2-carboxylic acid hydroxyamide	DMYT8UG	Investigative	Small molecular drug	[742]
Phenanthrene-3-carboxylic acid hydroxyamide	DMRYJBA	Investigative	Small molecular drug	[742]
Phenanthrene-9,10-dione	DMG8KS9	Investigative	Small molecular drug	[385]
PHENAZOCINE	DMCTVMI	Investigative	Small molecular drug	[3685]
Phenazone	DMCE985	Investigative	Small molecular drug	[4695]
PHENCYCLIDINE	DMQBEYX	Investigative	Small molecular drug	[4696]
Phenethyl-(3-phenyl-propyl)-amine	DMQWFO1	Investigative	Small molecular drug	[1464]
Phenethyl-(4-phenyl-butyl)-amine	DMFQMHK	Investigative	Small molecular drug	[1464]
PHENETHYLAMINE	DMX0G4F	Investigative	Small molecular drug	[4697]
Phenethylboronic acid	DMPDVG2	Investigative	Small molecular drug	[942]
Phenethylcarbamic Acid Biphenyl-3-yl Ester	DM02PAW	Investigative	Small molecular drug	[1011]
PHENIDONE	DMJD8XN	Investigative	Small molecular drug	[406]
PHENMEDIPHAM	DMYCHTD	Investigative	Small molecular drug	[4428]
Phenoxyarsonous acid	DMZJO5V	Investigative	Small molecular drug	[3493]
PHENSTATIN	DMJ5GY7	Investigative	Small molecular drug	[4698]
Phenyl 1-(4-butoxyphenyl)propylcarbamate	DMSNIBO	Investigative	Small molecular drug	[787]
Phenyl 10H-phenothiazine-10-carboxylate	DM52H1D	Investigative	Small molecular drug	[1050]
Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	DMHDWTS	Investigative	Small molecular drug	[830]
Phenyl 4-(decyloxy)phenylcarbamate	DMZ03DT	Investigative	Small molecular drug	[787]
Phenyl 4-(dodecyloxy)phenylcarbamate	DMR1MQE	Investigative	Small molecular drug	[787]
Phenyl 4-(heptyloxy)phenylcarbamate	DM9UNLH	Investigative	Small molecular drug	[787]
Phenyl 4-(hexyloxy)phenylcarbamate	DMZ07H6	Investigative	Small molecular drug	[787]
Phenyl 4-(octyloxy)phenylcarbamate	DMULMWK	Investigative	Small molecular drug	[787]
Phenyl 4-(undecyloxy)phenylcarbamate	DMSZ2CO	Investigative	Small molecular drug	[787]
Phenyl 7-methoxy-4-phenylbenzofuran-2-ylcarbamate	DMWN9XU	Investigative	Small molecular drug	[4032]
Phenyl Boronic acid	DMFZH49	Investigative	Small molecular drug	[1254]
Phenyl(2-(trifluoromethyl)quinolin-4-yl)methanol	DMDV1SN	Investigative	Small molecular drug	[4699]
Phenyl-(3-phenyl-1H-indazol-6-yl)-amine	DMDCTNU	Investigative	Small molecular drug	[4700]
Phenyl-(5-phenyl-oxazol-2-yl)-amine	DMR2B4O	Investigative	Small molecular drug	[136]
Phenyl-(9-phenyl-9H-purin-6-yl)-amine	DMIQ18W	Investigative	Small molecular drug	[104]
Phenyl-1,4-bismaleimide	DMWEKBD	Investigative	Small molecular drug	[382]
Phenyl-N,N-bis(tosylmethyl)methanamine	DMYTS73	Investigative	Small molecular drug	[1082]
Phenyl-phosphonic acid	DMYMNBL	Investigative	Small molecular drug	[2062]
Phenyl-Uridine-5'-Diphosphate	DM7J0YG	Investigative	Small molecular drug	[12]
phenylacetyl-Ala,DTrp-phenthylamide	DM5A8KR	Investigative	Small molecular drug	[4701]
Phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide	DM16KSA	Investigative	Small molecular drug	[4702]
phenylacetylrinvanil	DM29EFJ	Investigative	Small molecular drug	[4703]
Phenylalanylmethane	DMZNFT2	Investigative	Small molecular drug	[12]
PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	DMHVW61	Investigative	Small molecular drug	[22]
Phenylarsonic acid	DMFRA1Y	Investigative	Small molecular drug	[2222]
Phenylcarbamic Acid Biphenyl-3-yl Ester	DMMNYXK	Investigative	Small molecular drug	[1011]
PHENYLDIFLUOROMETHANESULFONAMIDE	DME75VC	Investigative	Small molecular drug	[130]
phenylglycine-01	DMHT9AR	Investigative	Small molecular drug	[4704]
Phenylmercury	DMJTC2B	Investigative	Small molecular drug	[12]
PHENYLMETHANESULFONAMIDE	DMGLDFI	Investigative	Small molecular drug	[130]
Phenylphosphate	DMQ6P13	Investigative	Small molecular drug	[107]
PHENYLPIPERAZINE	DMWAK1R	Investigative	Small molecular drug	[391]
PHENYLSULFAMATE	DMRLFJV	Investigative	Small molecular drug	[130]
PHENYLSULFAMIDE	DMRTHW1	Investigative	Small molecular drug	[122]
PHENYLTHIOUREA	DMM1IAU	Investigative	Small molecular drug	[526]
Philanthotoxin-343	DMP3MOC	Investigative	Small molecular drug	[4266]
phloretin	DMYA50U	Investigative	Small molecular drug	[4705]
Phlorizin	DMNARGO	Investigative	Small molecular drug	[4706]
PHLOROFUCOFUROECKOL A	DMO1I6G	Investigative	Small molecular drug	[1762]
Phorbol 12,13-butyrate	DMZWTY7	Investigative	Small molecular drug	[4707]
Phorbol 12-myristate	DM096SC	Investigative	Small molecular drug	[4708]
phosphatidyl (3,5) inositol biphosphate	DMMHQYB	Investigative	Small molecular drug	[4709]
phosphatidylethanolamine	DMOPYWF	Investigative	Small molecular drug	[4710]
phosphatidylserine	DM76TSG	Investigative	Small molecular drug	[4711]
Phosphocholine	DMIZLVW	Investigative	Small molecular drug	[12]
Phosphoenolpyruvate	DM2D947	Investigative	Small molecular drug	[4712]
PHOSPHOGLYCOLOHYDROXAMATE	DMAYLNO	Investigative	Small molecular drug	[4713]
Phosphomethylphosphonic Acid Guanylate Ester	DM4IRU5	Investigative	Small molecular drug	[12]
Phosphonothreonine	DMTFHPI	Investigative	Small molecular drug	[12]
Phosphonotyrosine	DM09MY1	Investigative	Small molecular drug	[12]
Phosphoramidon	DM3VL7G	Investigative	Small molecular drug	[4714]
Phosphoric acid mono-((E)-dec-4-enyl) ester	DMS57HX	Investigative	Small molecular drug	[96]
Phosphoric acid mono-((E)-dodec-9-enyl) ester	DMC873V	Investigative	Small molecular drug	[96]
Phosphoric acid mono-((E)-tetradec-11-enyl) ester	DMET9ZC	Investigative	Small molecular drug	[96]
Phosphoric acid mono-((E)-tetradec-9-enyl) ester	DME8APC	Investigative	Small molecular drug	[96]
Phosphoric acid monodec-9-enyl ester	DMANVJY	Investigative	Small molecular drug	[96]
Phosphoric acid monododecyl ester	DMME0VN	Investigative	Small molecular drug	[96]
Phosphoric acid monotetradecyl ester	DMG5MJL	Investigative	Small molecular drug	[96]
PhSO2-Gly-(Me-Gly)-Arg-(2-thiazole)	DMN0D14	Investigative	Small molecular drug	[359]
PHT-427	DMI96Y3	Investigative	Small molecular drug	[4715]
Phthalic Acid	DMF9T64	Investigative	Small molecular drug	[12]
PHTPP	DMBHKAV	Investigative	Small molecular drug	[4716]
physalaemin	DM09T76	Investigative	Small molecular drug	[4717]
phytanic acid	DMSZ1RB	Investigative	Small molecular drug	[4718]
phytosphingosine 1-phosphate	DMWJCST	Investigative	Small molecular drug	[4719]
PI-3065	DMCQUWI	Investigative	Small molecular drug	[4720]
PI1	DM68JNY	Investigative	Small molecular drug	[4721]
PIBTU	DMQBAM6	Investigative	Small molecular drug	[4722]
Piceatannol	DMYOP45	Investigative	Small molecular drug	[4723]
PICROTIN	DMND2QG	Investigative	Small molecular drug	[4724]
Picrotoxinin	DMNC4ZQ	Investigative	Small molecular drug	[4725]
PIK-75	DM9BQTX	Investigative	Small molecular drug	[4726]
PIK-93	DM3JBLK	Investigative	Small molecular drug	[4727]
Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2	DMBERSG	Investigative	NA	[1943]
PIP2	DMOZV7N	Investigative	Small molecular drug	[4728]
PIP3	DMJX39N	Investigative	Small molecular drug	[4729]
Piperidin-(2E)-ylideneamine	DMN8OR2	Investigative	Small molecular drug	[202]
piperidine	DMOM5GH	Investigative	Small molecular drug	[4730]
Piperidine-1-carboxamidine	DMKYF5U	Investigative	Small molecular drug	[4731]
Piperidine-1-carboxylic acid adamantan-2-yl ester	DMF375O	Investigative	Small molecular drug	[4732]
Piperidine-1-carboxylic acid adamantan-2-ylamide	DMHZFK1	Investigative	Small molecular drug	[4732]
piperidine-4-sulphonic acid	DMMIZWE	Investigative	Small molecular drug	[4733]
PIPERNONALINE	DMB3NZA	Investigative	Small molecular drug	[2826]
PIPEROXAN	DMIHO0P	Investigative	Small molecular drug	[4046]
PIPERROLEIN B	DMRVHWZ	Investigative	Small molecular drug	[2826]
Piragliatin	DMOE39X	Investigative	Small molecular drug	[4734]
pirenperone	DM9T2G3	Investigative	Small molecular drug	[4735]
Piretanide	DM0SCDR	Investigative	Small molecular drug	[4736]
piribedil	DMNP6QD	Investigative	Small molecular drug	[4737]
Piridronic acid	DMRDF8Z	Investigative	Small molecular drug	[4738]
Piriqualone	DM7XTHD	Investigative	Small molecular drug	[4739]
Pitrazepine	DMKHZQW	Investigative	Small molecular drug	[4740]
Piv-RYYRIK-NH2	DMVYNTB	Investigative	Small molecular drug	[754]
PK 11195	DMDOZPU	Investigative	Small molecular drug	[661]
PKF-241-466	DM04C9V	Investigative	Small molecular drug	[4741]
PKF-242-484	DMNDLAS	Investigative	Small molecular drug	[4742]
PKR inhibitor, negative control	DMB710J	Investigative	Small molecular drug	[4743]
PKR-A	DMSJCKN	Investigative	Small molecular drug	[4744]
PL017	DMICVXN	Investigative	Small molecular drug	[4745]
Plantainoside D	DMWHNZ4	Investigative	Small molecular drug	[2452]
Platelet factor 4 (PF-4)	DMV34O2	Investigative	Small molecular drug	[4746]
Ploglitazone	DM4MKIX	Investigative	Small molecular drug	[4747]
PLSQETFSDLWKLLPEN-NH2	DMBN4V6	Investigative	NA	[4748]
Plumbagin	DM9BS50	Investigative	Small molecular drug	[4749]
PMBA	DMU6972	Investigative	Small molecular drug	[4750]
PMD38	DMEYHWN	Investigative	Small molecular drug	[4751]
PMEA	DMBKVJY	Investigative	Small molecular drug	[4752]
PMID10395480C6	DM7SDNI	Investigative	Small molecular drug	[4753]
PMID10602705C40	DMLH73O	Investigative	Small molecular drug	[4754]
PMID11934595C2	DMU0AGE	Investigative	Small molecular drug	[4755]
PMID12014956C12	DMFO7UC	Investigative	Small molecular drug	[4756]
PMID12127536C20	DMY7W2U	Investigative	Small molecular drug	[4757]
PMID12238936C3a	DMQZXMF	Investigative	Small molecular drug	[4758]
PMID12238936C3f	DMO5J8N	Investigative	Small molecular drug	[4758]
PMID12372533C20	DMIW5TY	Investigative	Small molecular drug	[4759]
PMID12470711C3	DM1ISJU	Investigative	Small molecular drug	[4760]
PMID12614873C2b-1	DMXFY4P	Investigative	Small molecular drug	[4761]
PMID12723943C12	DMR1MCD	Investigative	Small molecular drug	[4762]
PMID12723954C21b	DM3EZ9Q	Investigative	Small molecular drug	[4763]
PMID12812482C11	DMYXDK5	Investigative	Small molecular drug	[4764]
PMID14640538C3	DMR2L6X	Investigative	Small molecular drug	[4765]
PMID14697765C11a	DMFWCAJ	Investigative	Small molecular drug	[4766]
PMID14697765C16a	DMFT1DO	Investigative	Small molecular drug	[4766]
PMID15027864C8d	DMOQ8PF	Investigative	Small molecular drug	[4767]
PMID15055993C1a	DM9V6YK	Investigative	Small molecular drug	[4768]
PMID15261275C1	DMFI4J6	Investigative	Small molecular drug	[4769]
PMID1527791C29	DM7JKLM	Investigative	Small molecular drug	[4770]
PMID15300839C17	DMWDE9A	Investigative	Small molecular drug	[4771]
PMID15482906C10	DM7T8BE	Investigative	Small molecular drug	[4772]
PMID15482908C8	DMCPIQ4	Investigative	Small molecular drug	[4773]
PMID15546730C2	DMOPUIH	Investigative	Small molecular drug	[4774]
PMID15603962Crac-16	DMN5LZQ	Investigative	Small molecular drug	[4775]
PMID15664838C18	DM93RKC	Investigative	Small molecular drug	[4776]
PMID15686906C17	DM50E6R	Investigative	Small molecular drug	[4777]
PMID15686906C29	DMBZSKJ	Investigative	Small molecular drug	[4777]
PMID15686941C13	DMPB7Z6	Investigative	Small molecular drug	[4778]
PMID15686947C(S)-3h	DMR7UBZ	Investigative	Small molecular drug	[4779]
PMID15724976C1	DMBEHA5	Investigative	Small molecular drug	[4780]
PMID15925511C13	DMHY95J	Investigative	Small molecular drug	[4781]
PMID15955699C24	DMF0ZXU	Investigative	Small molecular drug	[4782]
PMID16099654C3a	DMIRSWL	Investigative	Small molecular drug	[4783]
PMID16099654C4b	DMV8UK1	Investigative	Small molecular drug	[4783]
PMID16242323C15a	DMM4A7P	Investigative	Small molecular drug	[4784]
PMID16242323C15b	DM7U3RM	Investigative	Small molecular drug	[4784]
PMID16242323C16	DM2Q79X	Investigative	Small molecular drug	[4784]
PMID16242323C18a	DMI5WPQ	Investigative	Small molecular drug	[4784]
PMID16242323C18b	DMIS7NT	Investigative	Small molecular drug	[4784]
PMID16242323C22c	DMFDRMH	Investigative	Small molecular drug	[4784]
PMID16242323C22d	DMJICNL	Investigative	Small molecular drug	[4784]
PMID16242323C26a	DMD0Q7K	Investigative	Small molecular drug	[4784]
PMID16242323C26b	DMF0VLX	Investigative	Small molecular drug	[4784]
PMID16242323C26c	DMT3EU2	Investigative	Small molecular drug	[4784]
PMID16250654C37	DMIT4UN	Investigative	Small molecular drug	[4785]
PMID16290936C1b	DMOP8YM	Investigative	Small molecular drug	[312]
PMID16439120C20	DMI8HAV	Investigative	Small molecular drug	[873]
PMID16439120C26	DMVM2XD	Investigative	Small molecular drug	[873]
PMID16451062C46	DMT3RUE	Investigative	Small molecular drug	[4786]
PMID16460935C28	DM8BKI4	Investigative	Small molecular drug	[4787]
PMID16516466C12c	DM2ZYR8	Investigative	Small molecular drug	[4788]
PMID16539403C15b	DMU2X59	Investigative	Small molecular drug	[4789]
PMID1656041C11dd	DMJ8A4I	Investigative	Small molecular drug	[4790]
PMID1656041C11ff	DM20TFH	Investigative	Small molecular drug	[4790]
PMID1656041C11jj	DMLIXJW	Investigative	Small molecular drug	[4790]
PMID1656041C11nn	DMNOMCT	Investigative	Small molecular drug	[4790]
PMID1656041C4ff	DMW90GD	Investigative	Small molecular drug	[4790]
PMID1656041C4rr	DMQGPJE	Investigative	Small molecular drug	[4790]
PMID1656041C74	DMZVK16	Investigative	Small molecular drug	[4790]
PMID16766089C(R)-4d	DMTOX8E	Investigative	Small molecular drug	[4791]
PMID17064898C29	DMITDEB	Investigative	Small molecular drug	[4242]
PMID17125263C17	DMLTXHJ	Investigative	Small molecular drug	[4792]
PMID17189691C42	DMG9ZYP	Investigative	Small molecular drug	[4793]
PMID17276684C22	DMWNYBV	Investigative	Small molecular drug	[4794]
PMID17280833C30	DMXHS4L	Investigative	Small molecular drug	[4795]
PMID17358052C5b	DMR9TYV	Investigative	Small molecular drug	[1630]
PMID1738140C9	DM4BZ2L	Investigative	Small molecular drug	[4796]
PMID17480064C16	DM4IABG	Investigative	Small molecular drug	[4797]
PMID17532216C2f	DMX3CYG	Investigative	Small molecular drug	[4798]
PMID17556356C1a	DM7Z2WV	Investigative	Small molecular drug	[4799]
PMID17560788C29f	DMLX87P	Investigative	Small molecular drug	[4800]
PMID17574411C41	DM6W73A	Investigative	Small molecular drug	[4801]
PMID17574411C42	DM1YLF6	Investigative	Small molecular drug	[4801]
PMID17574412C33	DM7HYPZ	Investigative	Small molecular drug	[4802]
PMID17600705C23	DMJFOGW	Investigative	Small molecular drug	[1210]
PMID17709461C4g	DMMB6NU	Investigative	Small molecular drug	[1332]
PMID17723296C18	DMBP3O7	Investigative	Small molecular drug	[869]
PMID17888661C18	DMLPC17	Investigative	Small molecular drug	[4803]
PMID17888661C19	DMRWTHA	Investigative	Small molecular drug	[4803]
PMID17929793C11c	DMDVW4K	Investigative	Small molecular drug	[4804]
PMID17929793C23c	DMIG308	Investigative	Small molecular drug	[4804]
PMID17929793C23e	DMOB07W	Investigative	Small molecular drug	[4804]
PMID17929793C23h	DM83Z6M	Investigative	Small molecular drug	[4804]
PMID17929793C23i	DM07TVS	Investigative	Small molecular drug	[4804]
PMID17935989C25	DML8ZBR	Investigative	Small molecular drug	[4805]
PMID17936624C36	DMEHC2I	Investigative	Small molecular drug	[868]
PMID17942791C3	DMYH36T	Investigative	Small molecular drug	[4806]
PMID17963374C31	DMTP5OY	Investigative	Small molecular drug	[4807]
PMID17975902C5e	DMS1QM8	Investigative	Small molecular drug	[4808]
PMID18068976C25	DMTZQUJ	Investigative	Small molecular drug	[4809]
PMID18072721C50	DMK5PO8	Investigative	Small molecular drug	[4810]
PMID18078750C1b	DMO21H5	Investigative	Small molecular drug	[4811]
PMID18155906C16f	DM2U4NW	Investigative	Small molecular drug	[4812]
PMID18178086C15	DMA2OWK	Investigative	Small molecular drug	[4813]
PMID18295483C2	DM3GYNM	Investigative	Small molecular drug	[4814]
PMID18324760C28	DMCTFWE	Investigative	Small molecular drug	[4815]
PMID18334293C15b	DM1I6AY	Investigative	Small molecular drug	[4816]
PMID18337095C27	DMEOHLV	Investigative	Small molecular drug	[4817]
PMID18412317C13b	DM6NL2B	Investigative	Small molecular drug	[4818]
PMID18445527C11	DMW7PQ8	Investigative	Small molecular drug	[498]
PMID18445527C67	DM7AXRF	Investigative	Small molecular drug	[498]
PMID18477808CB	DM0G42B	Investigative	Small molecular drug	[4819]
PMID18752940C9n	DMPZSGV	Investigative	Small molecular drug	[4820]
PMID1875346C18	DMTH0PD	Investigative	Small molecular drug	[4821]
PMID18754614C10	DM1JRGI	Investigative	Small molecular drug	[1101]
PMID18754614C17	DMSVB9D	Investigative	Small molecular drug	[1101]
PMID18754614C18	DMF7VZO	Investigative	Small molecular drug	[1101]
PMID18754614C19	DMHSE96	Investigative	Small molecular drug	[1101]
PMID18754614C4	DMQFYM4	Investigative	Small molecular drug	[1101]
PMID18754614C7	DMVTLO0	Investigative	Small molecular drug	[1101]
PMID18754614C8	DM7SCM3	Investigative	Small molecular drug	[1101]
PMID18754614C9	DMPH7A6	Investigative	Small molecular drug	[1101]
PMID18790648C10	DM613NQ	Investigative	Small molecular drug	[3449]
PMID18800762C11	DM4UWKR	Investigative	Small molecular drug	[4822]
PMID18800762C14	DM5T2FR	Investigative	Small molecular drug	[4822]
PMID18800762C16	DM70SEQ	Investigative	Small molecular drug	[4822]
PMID18800762C19	DM1QXFI	Investigative	Small molecular drug	[4822]
PMID18800762C47	DMZDC14	Investigative	Small molecular drug	[4822]
PMID18800762C51	DMWFGY4	Investigative	Small molecular drug	[4822]
PMID1895299C1	DMA5P9Q	Investigative	Small molecular drug	[4823]
PMID1895299C4p	DMAZWHB	Investigative	Small molecular drug	[4823]
PMID1895299C6v	DM384PH	Investigative	Small molecular drug	[4823]
PMID18986805C9b	DMFU6AI	Investigative	Small molecular drug	[4824]
PMID19097784C2	DMH70UC	Investigative	Small molecular drug	[3315]
PMID19111466C7d	DMVTXKI	Investigative	Small molecular drug	[4825]
PMID19115845C89S	DMB9F2L	Investigative	Small molecular drug	[4826]
PMID19191557C14	DMG7D3I	Investigative	Small molecular drug	[4827]
PMID19191557C19	DMXLVEC	Investigative	Small molecular drug	[4827]
PMID19191557C21	DM5RIB0	Investigative	Small molecular drug	[4827]
PMID19191557C3	DM1MEY3	Investigative	Small molecular drug	[4827]
PMID19191557C32	DMH8QRI	Investigative	Small molecular drug	[4827]
PMID19191557C35	DM09IEK	Investigative	Small molecular drug	[4827]
PMID19191557C8	DMUWYA2	Investigative	Small molecular drug	[4827]
PMID19289283C22	DMJRLB5	Investigative	Small molecular drug	[1431]
PMID19289283C32	DMSKGEJ	Investigative	Small molecular drug	[1431]
PMID19309152C2g	DMTASYN	Investigative	Small molecular drug	[4828]
PMID19364658C33	DMSE1C3	Investigative	Small molecular drug	[4829]
PMID19433355C11q	DMPXEIQ	Investigative	Small molecular drug	[4830]
PMID19433355C11s	DMBU0XJ	Investigative	Small molecular drug	[4830]
PMID19456099C13	DMBU9E4	Investigative	Small molecular drug	[4831]
PMID19456099C15	DMPZMS0	Investigative	Small molecular drug	[4831]
PMID19502059C25d	DMTRL0X	Investigative	Small molecular drug	[4832]
PMID19524438C6o	DMK5JB8	Investigative	Small molecular drug	[4833]
PMID19632837C17f	DMRWM24	Investigative	Small molecular drug	[4834]
PMID19743866C51	DMTX0ZJ	Investigative	Small molecular drug	[4835]
PMID19788238C66	DMCVJK9	Investigative	Small molecular drug	[4836]
PMID19800804C12	DMQXK4B	Investigative	Small molecular drug	[4837]
PMID19831390C14	DMIECOF	Investigative	Small molecular drug	[4838]
PMID19831390C22m	DM8T6VG	Investigative	Small molecular drug	[4838]
PMID19854648C27	DMEGPBS	Investigative	Small molecular drug	[4839]
PMID19899765C22	DMBTV20	Investigative	Small molecular drug	[4840]
PMID1992138C8b	DMI3PCZ	Investigative	Small molecular drug	[4841]
PMID1992149C13	DM2X1NY	Investigative	Small molecular drug	[4842]
PMID1992149C9	DM9RENG	Investigative	Small molecular drug	[4843]
PMID19931453C16m	DM3DCR9	Investigative	Small molecular drug	[1679]
PMID19954973C4	DMDYZE5	Investigative	Small molecular drug	[4844]
PMID20005102C1	DMMESBW	Investigative	Small molecular drug	[4845]
PMID20080612C1	DMV8ZFA	Investigative	Small molecular drug	[4846]
PMID20121197C57	DMM49JO	Investigative	Small molecular drug	[4847]
PMID20167483C22e	DM8NGEQ	Investigative	Small molecular drug	[4848]
PMID20299227C12	DMKAZ1O	Investigative	Small molecular drug	[4849]
PMID20299227C20	DM9H6LZ	Investigative	Small molecular drug	[4849]
PMID20346665C24	DMLKFTE	Investigative	Small molecular drug	[4850]
PMID20346665C27	DMDKW6G	Investigative	Small molecular drug	[4850]
PMID20363624C(+)17a	DMCAXNU	Investigative	Small molecular drug	[4851]
PMID20409708C34	DMA2Y74	Investigative	Small molecular drug	[4852]
PMID20462760C22	DMQFKBI	Investigative	Small molecular drug	[4853]
PMID20471253C32	DMBQAKO	Investigative	Small molecular drug	[4854]
PMID20483621C5g	DMQ918T	Investigative	Small molecular drug	[4855]
PMID20483621C5m	DML6OZR	Investigative	Small molecular drug	[4855]
PMID20483621C5n	DM2BUKP	Investigative	Small molecular drug	[4855]
PMID20598884C8	DMS21ZP	Investigative	Small molecular drug	[1268]
PMID20615702C8f	DMN2HXL	Investigative	Small molecular drug	[4856]
PMID20638279C11	DMFHS4V	Investigative	Small molecular drug	[4857]
PMID20638279C7	DMKFJP2	Investigative	Small molecular drug	[4858]
PMID20684603C24dd	DMWZK9U	Investigative	Small molecular drug	[4859]
PMID20684608C35	DMVUEZI	Investigative	Small molecular drug	[4860]
PMID20690647C4b	DMKVONZ	Investigative	Small molecular drug	[4861]
PMID20690647C5a	DMRWZX6	Investigative	Small molecular drug	[4861]
PMID20809633C29b	DM0W6C9	Investigative	Small molecular drug	[4862]
PMID20855207C25	DMNEB6J	Investigative	Small molecular drug	[4863]
PMID20873740C18	DMVHR3Z	Investigative	Small molecular drug	[4864]
PMID20936789C31	DMUGWO6	Investigative	Small molecular drug	[4865]
PMID20947351C16	DM02YSE	Investigative	Small molecular drug	[1683]
PMID21123062C27	DMVPW1G	Investigative	Small molecular drug	[4866]
PMID21155570C14	DM7I341	Investigative	Small molecular drug	[4867]
PMID21185185C21	DM1BQY3	Investigative	Small molecular drug	[4868]
PMID21273063C1	DMEFUZW	Investigative	Small molecular drug	[4869]
PMID21273063C36	DMFYJ6O	Investigative	Small molecular drug	[4869]
PMID21273063C58	DMDCUYB	Investigative	Small molecular drug	[4869]
PMID21277783C7	DMYBV8Q	Investigative	Small molecular drug	[4870]
PMID21295468C47	DM0DNSV	Investigative	Small molecular drug	[4871]
PMID21310611C3	DMTOM3E	Investigative	Small molecular drug	[4872]
PMID21444206C23	DM9YVPU	Investigative	Small molecular drug	[4873]
PMID21444206C3a	DMN50B9	Investigative	Small molecular drug	[4873]
PMID21444206C3j	DMM1YBE	Investigative	Small molecular drug	[4873]
PMID21444206C8g	DMR21YD	Investigative	Small molecular drug	[4873]
PMID21493067C1d	DMFUQIT	Investigative	Small molecular drug	[4874]
PMID2153213C13b	DMUMYTB	Investigative	Small molecular drug	[4875]
PMID2153213C13g	DM5TL2S	Investigative	Small molecular drug	[4875]
PMID2153213C1a	DMVYB6Q	Investigative	Small molecular drug	[4875]
PMID2153213C1e	DMRUJFZ	Investigative	Small molecular drug	[4875]
PMID2153213C1f	DMOLIE1	Investigative	Small molecular drug	[4875]
PMID2153213C2c	DMJ4126	Investigative	Small molecular drug	[4875]
PMID2153213C2d	DMGAY4M	Investigative	Small molecular drug	[4875]
PMID2153213C2f	DM6QXYE	Investigative	Small molecular drug	[4875]
PMID21536437C15c	DM2R94W	Investigative	Small molecular drug	[4876]
PMID21536438C20f	DMHWX2O	Investigative	Small molecular drug	[4877]
PMID21536438C36j	DM06V1Q	Investigative	Small molecular drug	[4877]
PMID21561767C8h	DMABZH6	Investigative	Small molecular drug	[4878]
PMID21571530C5g	DMEF8GV	Investigative	Small molecular drug	[4879]
PMID21571530C7e	DMPBITK	Investigative	Small molecular drug	[4879]
PMID21596927C101	DM7JRHB	Investigative	Small molecular drug	[4880]
PMID21627121C2	DMQHAIK	Investigative	Small molecular drug	[4881]
PMID21688779C22a	DMEBM19	Investigative	Small molecular drug	[4882]
PMID21692504C8	DMXSCEA	Investigative	Small molecular drug	[4883]
PMID21741839C5	DM8PA2V	Investigative	Small molecular drug	[4884]
PMID21742770C1	DME3JMH	Investigative	Small molecular drug	[4885]
PMID21757343C30	DM3ELPS	Investigative	Small molecular drug	[4886]
PMID21802293C66	DM48HR9	Investigative	Small molecular drug	[4887]
PMID21823616C22	DMXF32O	Investigative	Small molecular drug	[4888]
PMID21851057C4d	DMI1FGV	Investigative	Small molecular drug	[4889]
PMID21855335C19a	DMTKJA9	Investigative	Small molecular drug	[4890]
PMID21907142CJ	DMST0IN	Investigative	Small molecular drug	[4891]
PMID21927650C18	DMLGKD3	Investigative	Small molecular drug	[4892]
PMID21939274C1	DMEUQFG	Investigative	Small molecular drug	[4893]
PMID21939274C2	DMRCAEI	Investigative	Small molecular drug	[4893]
PMID21967808CR-16	DMCOHKU	Investigative	Small molecular drug	[4894]
PMID21982499C14k	DM0VOXN	Investigative	Small molecular drug	[4895]
PMID22017539C15	DMWBYNF	Investigative	Small molecular drug	[4896]
PMID22115617C2c	DMX5UKA	Investigative	Small molecular drug	[4897]
PMID22123324C38	DMZ5BHX	Investigative	Small molecular drug	[4898]
PMID22136433C20	DMI8217	Investigative	Small molecular drug	[4899]
PMID22153340C20	DMTGVSU	Investigative	Small molecular drug	[4900]
PMID22266036C12e	DM4NRG5	Investigative	Small molecular drug	[4901]
PMID22266036C9a	DMFQHVL	Investigative	Small molecular drug	[4901]
PMID2231594C3j	DMVI6EX	Investigative	Small molecular drug	[4902]
PMID2231594C3k	DMJYHIM	Investigative	Small molecular drug	[4902]
PMID2231594C3q	DMJQ5B0	Investigative	Small molecular drug	[4902]
PMID2231594C3u	DMJ504Y	Investigative	Small molecular drug	[4902]
PMID22364337C48	DMRLG7Z	Investigative	Small molecular drug	[4903]
PMID22390415C13k	DMHW15S	Investigative	Small molecular drug	[4904]
PMID22420767C42	DM123TU	Investigative	Small molecular drug	[4905]
PMID22464687C15a	DMCDOHA	Investigative	Small molecular drug	[4906]
PMID22465637C1	DMV4ZWD	Investigative	Small molecular drug	[4907]
PMID22490048C(R)-10h	DMQXRCW	Investigative	Small molecular drug	[4908]
PMID22521646C12	DMYQDXO	Investigative	Small molecular drug	[4909]
PMID22533316C1	DMYEMWB	Investigative	Small molecular drug	[4910]
PMID22533316C3	DMOZG0A	Investigative	Small molecular drug	[4910]
PMID22533316C4	DMW3UHO	Investigative	Small molecular drug	[4910]
PMID22545772C42	DMVZQ6U	Investigative	Small molecular drug	[4911]
PMID22564207C25b	DMBMYKQ	Investigative	Small molecular drug	[4912]
PMID22595175C4g	DM9SLUK	Investigative	Small molecular drug	[4913]
PMID22607879CR-(-)-5f	DM7OJ5Q	Investigative	Small molecular drug	[4914]
PMID22686657C(R)-26	DM19D7G	Investigative	Small molecular drug	[4915]
PMID22765894C8h	DMH5RFU	Investigative	Small molecular drug	[4916]
PMID22795084C1	DM0XQZO	Investigative	Small molecular drug	[4917]
PMID22802221C21	DMVK1GT	Investigative	Small molecular drug	[4918]
PMID22861813C8a	DM6RY4F	Investigative	Small molecular drug	[4919]
PMID22873688C3a	DMLUCSB	Investigative	Small molecular drug	[4920]
PMID22902653C30	DMXDTPL	Investigative	Small molecular drug	[4921]
PMID22902653C31	DMWVTAE	Investigative	Small molecular drug	[4921]
PMID22902653C35	DMLVKPG	Investigative	Small molecular drug	[4921]
PMID2296027C25	DMOKZ3R	Investigative	Small molecular drug	[4922]
PMID2296027C29	DMY267E	Investigative	Small molecular drug	[4922]
PMID2296036C2g	DM6VG8K	Investigative	Small molecular drug	[4923]
PMID2296036C2t	DMBXCNA	Investigative	Small molecular drug	[4923]
PMID2296036C4d	DMC6HQL	Investigative	Small molecular drug	[4923]
PMID2296036C4i	DMSJ94N	Investigative	Small molecular drug	[4923]
PMID22984835C20o	DMAW86U	Investigative	Small molecular drug	[4924]
PMID22984835C4	DMMI9JE	Investigative	Small molecular drug	[4924]
PMID23083103C4	DMW579R	Investigative	Small molecular drug	[4925]
PMID23084894C10i	DMURP5Y	Investigative	Small molecular drug	[4926]
PMID23084894C9n	DM4ATLM	Investigative	Small molecular drug	[4926]
PMID23099093C17d	DMWS7O9	Investigative	Small molecular drug	[4927]
PMID23147077C10	DM3Z6F4	Investigative	Small molecular drug	[4928]
PMID23232060C5	DMBT92F	Investigative	Small molecular drug	[4929]
PMID23312943C21	DMOJ8QR	Investigative	Small molecular drug	[4930]
PMID23357634C24d	DM4NAC9	Investigative	Small molecular drug	[4931]
PMID23368907C16	DMPHKJI	Investigative	Small molecular drug	[4932]
PMID23374866C31	DMEZSHI	Investigative	Small molecular drug	[4933]
PMID23374867C24	DMRC14X	Investigative	Small molecular drug	[4934]
PMID23412139C16	DM9O8I7	Investigative	Small molecular drug	[4935]
PMID23414845C30	DMNVQ29	Investigative	Small molecular drug	[4936]
PMID23428964CI3	DMZUQ7X	Investigative	Small molecular drug	[4937]
PMID23434029C41	DMG0XC7	Investigative	Small molecular drug	[4938]
PMID23434029C53	DMG0B4N	Investigative	Small molecular drug	[4938]
PMID23441572C24	DMG4MLA	Investigative	Small molecular drug	[4939]
PMID23489211C20	DMDYC4J	Investigative	Small molecular drug	[4940]
PMID23517011C9	DMFQVNL	Investigative	Small molecular drug	[4941]
PMID23521020C7k	DMPCTED	Investigative	Small molecular drug	[4942]
PMID23589301C1	DMB7TE6	Investigative	Small molecular drug	[4943]
PMID23631440C29e	DMM92IB	Investigative	Small molecular drug	[4944]
PMID23634668C14	DMA8UQM	Investigative	Small molecular drug	[4945]
PMID23639540C13a	DMLXOAQ	Investigative	Small molecular drug	[4091]
PMID23639540C13d	DMSTQGH	Investigative	Small molecular drug	[4091]
PMID23639540C13r	DMHBZ0N	Investigative	Small molecular drug	[4091]
PMID23642479C17	DM4JWMA	Investigative	Small molecular drug	[4089]
PMID23692593C20	DM1T9LJ	Investigative	Small molecular drug	[4946]
PMID23788254C9	DM0QS8F	Investigative	Small molecular drug	[4947]
PMID23788657C1754-31	DM2FDJN	Investigative	Small molecular drug	[4948]
PMID23849879C3	DMUW3MT	Investigative	Small molecular drug	[4949]
PMID23916253C17	DM35FH8	Investigative	Small molecular drug	[4950]
PMID24000170C36	DMHUWZS	Investigative	Small molecular drug	[4951]
PMID24000170C38	DMOLRIY	Investigative	Small molecular drug	[4951]
PMID24044867C8	DML4KMP	Investigative	Small molecular drug	[4952]
PMID24099220C5i	DMWOHAE	Investigative	Small molecular drug	[4953]
PMID24157366C35	DMWUZP1	Investigative	Small molecular drug	[4954]
PMID24210504C1o	DM4LEUT	Investigative	Small molecular drug	[4955]
PMID24359159C19a	DM26JYS	Investigative	Small molecular drug	[4956]
PMID24412111C9f	DM6O7MK	Investigative	Small molecular drug	[4957]
PMID24412111C9g	DM8JQL4	Investigative	Small molecular drug	[4957]
PMID24418773C37	DMG4NQV	Investigative	Small molecular drug	[4958]
PMID24432909C8e	DMEGAZS	Investigative	Small molecular drug	[4959]
PMID24440480C3	DMHQK54	Investigative	Small molecular drug	[4960]
PMID24556381C10f	DMK6GAU	Investigative	Small molecular drug	[4961]
PMID24556381C10l	DMOH45T	Investigative	Small molecular drug	[4961]
PMID24673130C26	DM2HVU8	Investigative	Small molecular drug	[4962]
PMID24749861C34	DMJNQE1	Investigative	Small molecular drug	[4963]
PMID24775305C7u	DMDMU01	Investigative	Small molecular drug	[4964]
PMID24793884C74	DMFSJQC	Investigative	Small molecular drug	[4965]
PMID24793884C77	DMZENGX	Investigative	Small molecular drug	[4965]
PMID24793972C2	DM5G1RP	Investigative	Small molecular drug	[4966]
PMID24809814C31	DMI8T1Y	Investigative	Small molecular drug	[4967]
PMID24825313C7	DM415IX	Investigative	Small molecular drug	[4968]
PMID24900237C15	DM6TFPY	Investigative	Small molecular drug	[4969]
PMID24900283C8a	DM6TYD0	Investigative	Small molecular drug	[4970]
PMID24900311C1a	DMJS0F5	Investigative	Small molecular drug	[4971]
PMID24900428C14	DMU4BL2	Investigative	Small molecular drug	[4972]
PMID24900446C5	DMZ5P2K	Investigative	Small molecular drug	[4973]
PMID24900526C1	DMEWVG8	Investigative	Small molecular drug	[4974]
PMID24900526C3	DMEPK81	Investigative	Small molecular drug	[4974]
PMID24900526C5	DMKTBCM	Investigative	Small molecular drug	[4974]
PMID24900538C2c	DM5PATM	Investigative	Small molecular drug	[4975]
PMID24900608C1	DMCL6H3	Investigative	Small molecular drug	[4976]
PMID24900635C21	DM1QDG0	Investigative	Small molecular drug	[4977]
PMID24900699C68	DM2V4MJ	Investigative	Small molecular drug	[4978]
PMID24900749C1a	DMZPUSO	Investigative	Small molecular drug	[4979]
PMID24900824C2-1-1	DMOSMBZ	Investigative	Small molecular drug	[4980]
PMID24900824C2-13-1	DM2FYUM	Investigative	Small molecular drug	[4980]
PMID24900824C2-3-1	DMC5JAT	Investigative	Small molecular drug	[4980]
PMID24900824C2-3-2	DMVP0Z9	Investigative	Small molecular drug	[4980]
PMID24915291C31	DMN7QB8	Investigative	Small molecular drug	[4981]
PMID24915291C38	DMBXT9J	Investigative	Small molecular drug	[4981]
PMID24946214C3b	DMNPA2C	Investigative	Small molecular drug	[4982]
PMID24997608CA	DML0PFU	Investigative	Small molecular drug	[4983]
PMID24999562C6b	DM5D3SN	Investigative	Small molecular drug	[4984]
PMID24999562C8d	DMD7VOZ	Investigative	Small molecular drug	[4984]
PMID25037917C58	DMJPR8M	Investigative	Small molecular drug	[4985]
PMID25050158C14	DMRFQ1W	Investigative	Small molecular drug	[4986]
PMID25259874C21	DMTCGLY	Investigative	Small molecular drug	[4987]
PMID25259874C4	DMZKEIH	Investigative	Small molecular drug	[4987]
PMID25313322C15	DMDO9AJ	Investigative	Small molecular drug	[4988]
PMID25408830C1	DM5GL23	Investigative	Small molecular drug	[4989]
PMID25408830C2	DM20E13	Investigative	Small molecular drug	[4989]
PMID25408830C3	DM8SBR2	Investigative	Small molecular drug	[4989]
PMID25489658C4d	DMWZJT0	Investigative	Small molecular drug	[4990]
PMID25497965C17c	DMO6NEX	Investigative	Small molecular drug	[4991]
PMID25703523C7d	DM4PZ37	Investigative	Small molecular drug	[4992]
PMID25719566C1	DM7AJER	Investigative	Small molecular drug	[2248]
PMID25719566C7	DMGCAIO	Investigative	Small molecular drug	[2248]
PMID25742366C14b	DMDYT6P	Investigative	Small molecular drug	[4993]
PMID25815140C48	DMUEDBP	Investigative	Small molecular drug	[4994]
PMID25974391C34	DMGWZA3	Investigative	Small molecular drug	[4995]
PMID26061392C2	DMHZOIU	Investigative	Small molecular drug	[4996]
PMID26080733C7r	DM8D6ZL	Investigative	Small molecular drug	[4997]
PMID26155854C57	DM4TN73	Investigative	Small molecular drug	[4998]
PMID26155854C60	DMM5SI4	Investigative	Small molecular drug	[4998]
PMID26161824C70	DMTO95J	Investigative	Small molecular drug	[4999]
PMID2909732C7	DM9J5Q7	Investigative	Small molecular drug	[5000]
PMID3514912C9	DM3J746	Investigative	Small molecular drug	[5001]
PMID3941405C3d	DM6ZOW4	Investigative	Small molecular drug	[5002]
PMID7473541C11	DMB2MQW	Investigative	Small molecular drug	[5003]
PMID7473541C19	DM2CP5J	Investigative	Small molecular drug	[5003]
PMID7473541C20	DMMZ1LR	Investigative	Small molecular drug	[5003]
PMID7473541C21	DMMRSZB	Investigative	Small molecular drug	[5003]
PMID7629799C2d	DMOJ57D	Investigative	Small molecular drug	[5004]
PMID7629799C2e	DMBRH0Q	Investigative	Small molecular drug	[5004]
PMID7629799C6	DMXMF39	Investigative	Small molecular drug	[5004]
PMID7650673C4q	DM5SU6N	Investigative	Small molecular drug	[5005]
PMID7932551C9	DM769YQ	Investigative	Small molecular drug	[5006]
PMID7966163C3f	DMJF7OC	Investigative	Small molecular drug	[5007]
PMID7966163C4e	DMD524S	Investigative	Small molecular drug	[5007]
PMID7966163C6c	DMUEG8O	Investigative	Small molecular drug	[5007]
PMID7966163C6d	DM0XU3C	Investigative	Small molecular drug	[5007]
PMID7966163C6g	DM8T41N	Investigative	Small molecular drug	[5007]
PMID8246233C28	DMRGY2X	Investigative	Small molecular drug	[5008]
PMID8246233C35	DMUJ9F7	Investigative	Small molecular drug	[5008]
PMID8246233C5ab	DMETHN7	Investigative	Small molecular drug	[5008]
PMID8246234C3h	DMJWEXQ	Investigative	Small molecular drug	[5009]
PMID8246237C18t	DMLOR6F	Investigative	Small molecular drug	[5010]
PMID8410973C2	DMEITGU	Investigative	Small molecular drug	[5011]
PMID8410973C3	DM6J5KY	Investigative	Small molecular drug	[5011]
PMID8426367C18	DMTURQZ	Investigative	Small molecular drug	[5012]
PMID8496919C7	DM8PBKQ	Investigative	Small molecular drug	[5013]
PMID8568816C56	DMG3ZD1	Investigative	Small molecular drug	[5014]
PMID8576905C4	DMUJEA4	Investigative	Small molecular drug	[5015]
PMID8709131C15	DMWBPOJ	Investigative	Small molecular drug	[5016]
PMID8709131C17	DM10IQP	Investigative	Small molecular drug	[5016]
PMID8709131C23	DMSKJ53	Investigative	Small molecular drug	[5016]
PMID8709131C2a (+)	DM1OS6M	Investigative	Small molecular drug	[5016]
PMID8709131C4	DMETC8A	Investigative	Small molecular drug	[5016]
PMID8831774C19	DMM08LV	Investigative	Small molecular drug	[5017]
PMID9003518C3	DM1I578	Investigative	Small molecular drug	[5018]
PMID9003518C4	DMYE64O	Investigative	Small molecular drug	[5018]
PMID9216829C5j	DM2F81A	Investigative	Small molecular drug	[5019]
PMID9216829C5m	DM3ARWX	Investigative	Small molecular drug	[5019]
PMID9871507C14	DMY28QM	Investigative	Small molecular drug	[5020]
PNRI-299	DMDBZGP	Investigative	Small molecular drug	[5021]
PNU 101017	DMKBCS2	Investigative	NA	[5022]
PNU-107859	DMS5XRY	Investigative	Small molecular drug	[5023]
PNU-120596	DMYBQM7	Investigative	Small molecular drug	[5024]
PNU-142372	DMEI0S7	Investigative	Small molecular drug	[5025]
PNU-22394	DMHTPSF	Investigative	Small molecular drug	[760]
PNU-87663	DM6SZVE	Investigative	NA	[5026]
PNU177836	DMM0EYR	Investigative	Small molecular drug	[12]
PO3 2-Ile-Trp-O-3K	DMQMDSG	Investigative	Small molecular drug	[5027]
PO3 2-Leu-Nal-O-3K	DMY43FU	Investigative	Small molecular drug	[5027]
PO3 2-Leu-Trp-O-3K	DM3O78D	Investigative	Small molecular drug	[5027]
PO3 2-Nle-Trp-O-3K	DMW1XY4	Investigative	Small molecular drug	[5027]
pobilukast	DMURB4Y	Investigative	Small molecular drug	[5028]
Polybrominated diphenyl ether derivative	DMG7K84	Investigative	Small molecular drug	[758]
POLYGALATENOSIDE B	DMUTV5P	Investigative	Small molecular drug	[5029]
polyIC	DMV486E	Investigative	Small molecular drug	[5030]
Polyporic acid	DMN6Q4E	Investigative	Small molecular drug	[430]
POLYSIN	DMRX9E3	Investigative	Small molecular drug	[5031]
Pomolic acid	DM1GV7K	Investigative	Small molecular drug	[722]
PONKORANOL	DMGRPK8	Investigative	Small molecular drug	[5032]
Posintro	DMSAD8I	Investigative	NA	[1866]
PP-242	DM2348V	Investigative	Small molecular drug	[5033]
PP1-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	DMYA5CB	Investigative	Small molecular drug	[5034]
PP121	DMU8KTO	Investigative	Small molecular drug	[5033]
PP2-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	DM3NUKX	Investigative	NA	[5034]
PP3	DMMRJOO	Investigative	Small molecular drug	[5035]
PPA	DM86ZL2	Investigative	NA	[5036]
PPADS	DMWHN3T	Investigative	Small molecular drug	[5037]
PPAHV	DMWVZFK	Investigative	Small molecular drug	[5038]
PPG	DM5IG4F	Investigative	Small molecular drug	[5039]
PPTN	DML72JT	Investigative	Small molecular drug	[5040]
PQ401	DMVNHTE	Investigative	Small molecular drug	[5041]
Pr-RYYRIK-NH2	DMKRMSP	Investigative	Small molecular drug	[754]
PRAVADOLINE	DM3XRJT	Investigative	Small molecular drug	[5042]
Preclamol	DMHEV75	Investigative	Small molecular drug	[1233]
Predicentrine methiodide	DM2HN4D	Investigative	Small molecular drug	[2352]
pregnenolone-16alpha-carbonitrile	DM0LW7G	Investigative	Small molecular drug	[5043]
Premafloxacin	DMC4W03	Investigative	Small molecular drug	[5044]
PREMETREXED	DMVOGT4	Investigative	Small molecular drug	[5045]
prenalterol	DMV8YHQ	Investigative	Small molecular drug	[5046]
Prenyl pyrophosphate analogue	DM9HSQJ	Investigative	NA	[5047]
presqualene diphosphate	DMTY9R4	Investigative	Small molecular drug	[5048]
PREUSSOMERIN	DM5P1NZ	Investigative	Small molecular drug	[363]
Prifelone	DMLI4RF	Investigative	Small molecular drug	[3741]
Primary alcohol metabolite of celecoxib	DMA8GI6	Investigative	Small molecular drug	[5049]
pristanic acid	DMTJZQK	Investigative	Small molecular drug	[5050]
Pro-His-Pro-His-Leu-Phe-Val-Tyr	DMZH0KY	Investigative	NA	[3191]
Pro-His-Pro-His-Phe-Phe-Val-Tyr	DMD3WVO	Investigative	NA	[3191]
Pro-His-Pro-His-Phe-Phe-Val-Tyr-Lys	DMNDUI3	Investigative	NA	[3191]
Pro-His-Pro-Phe-His-Leu(CH2NH)Val-Ile-His-Lys	DM26VFX	Investigative	NA	[5051]
Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2	DMOTXE3	Investigative	NA	[2136]
Procyanidin B-2 3,3'-di-O-gallate	DMTW82E	Investigative	Small molecular drug	[372]
Prodipine	DMGIF1L	Investigative	Small molecular drug	[3219]
PRONTOCIL	DMIUV25	Investigative	Small molecular drug	[1448]
Prop-2-ynyl 4-sulfamoylbenzoate	DM8O41M	Investigative	Small molecular drug	[4345]
Propan-2-one O-3-butoxyphenylcarbamoyl oxime	DMQZYW6	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(decyloxy)phenylcarbamoyl oxime	DMIQ0DF	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(heptyloxy)phenylcarbamoyl oxime	DM8FXM6	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime	DM5J0H3	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(nonyloxy)phenylcarbamoyl oxime	DMYBH91	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(octyloxy)phenylcarbamoyl oxime	DM6VZ4S	Investigative	Small molecular drug	[787]
Propan-2-one O-4-(pentyloxy)phenylcarbamoyl oxime	DM408U3	Investigative	Small molecular drug	[787]
Propan-2-one O-4-butoxybenzylcarbamoyl oxime	DMV13MO	Investigative	Small molecular drug	[787]
Propan-2-one O-4-butoxyphenylcarbamoyl oxime	DMYJ28G	Investigative	Small molecular drug	[787]
Propan-2-one O-4-ethoxyphenylcarbamoyl oxime	DM573UT	Investigative	Small molecular drug	[787]
Propan-2-one O-4-propoxyphenylcarbamoyl oxime	DMWX5Q6	Investigative	Small molecular drug	[787]
Propanoic Acid	DM9TN2W	Investigative	Small molecular drug	[5052]
propargylglycine	DMVRWL6	Investigative	Small molecular drug	[5053]
Propidium	DMZ1FRS	Investigative	Small molecular drug	[12]
Propionate	DM0O8N6	Investigative	Small molecular drug	[5054]
Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	DMO325J	Investigative	Small molecular drug	[2264]
propionyl-CoA	DMSI7J7	Investigative	Small molecular drug	[5055]
Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine	DMZ40RQ	Investigative	Small molecular drug	[3042]
propylpyrazoletriol	DMTCP8K	Investigative	Small molecular drug	[5056]
prostaglandin A2	DMWC4X8	Investigative	Small molecular drug	[5057]
Prostaglandin G2	DME74SP	Investigative	Small molecular drug	[5058]
PROSTEPHABYSSINE	DMI8SH2	Investigative	Small molecular drug	[1705]
Protoporphyrin IX	DMWYE7A	Investigative	Small molecular drug	[5059]
Protoporphyrin Ix Containing Co	DMJ8TP3	Investigative	Small molecular drug	[12]
PROTOSTEMODIOL	DMI6TKU	Investigative	Small molecular drug	[5060]
Proxyfan	DM72AT8	Investigative	Small molecular drug	[5061]
prunetin	DMPD41Q	Investigative	Small molecular drug	[5062]
PS-015146	DM0N9JV	Investigative	NA	[1866]
PS-154636-1	DMQUG0K	Investigative	Small molecular drug	[5063]
PS-222036	DMQVI5U	Investigative	NA	[5063]
PS-444035	DMH8YMP	Investigative	Small molecular drug	[5063]
PS-662477	DMT4YFR	Investigative	Small molecular drug	[5063]
PS-725074	DM05DOF	Investigative	Small molecular drug	[5063]
PS-777621	DM3F7SD	Investigative	Small molecular drug	[5064]
PS020990	DMK6HMS	Investigative	Small molecular drug	[5065]
PSAB-OFP	DM38JMK	Investigative	Small molecular drug	[5066]
PSAMMAPLIN A	DM6T0IQ	Investigative	Small molecular drug	[5067]
PSB-0702	DMLAFJE	Investigative	Small molecular drug	[5068]
PSB-0739	DM3AZPD	Investigative	Small molecular drug	[5069]
PSB-0788	DM0FKV9	Investigative	Small molecular drug	[5070]
PSB-09120	DMAFHLX	Investigative	Small molecular drug	[5071]
PSB-0952	DMW19LB	Investigative	Small molecular drug	[1924]
PSB-0963	DMBDVJ1	Investigative	Small molecular drug	[1924]
PSB-10	DMXDWO7	Investigative	Small molecular drug	[5072]
PSB-11	DMGK2PC	Investigative	Small molecular drug	[5073]
PSB-1115	DMOH2VC	Investigative	Small molecular drug	[5074]
PSB-601	DMBIK7D	Investigative	Small molecular drug	[5071]
PSB-6426	DMJ9ML8	Investigative	Small molecular drug	[5075]
PSB-716	DMS2V0P	Investigative	Small molecular drug	[5076]
PSB1114	DMR9HYI	Investigative	Small molecular drug	[5077]
PSB36	DMBGM1E	Investigative	Small molecular drug	[5078]
PSB603	DM6QERS	Investigative	Small molecular drug	[5079]
PSEUDOCOCAINE	DMN5AE8	Investigative	Small molecular drug	[5080]
Pseudocolumbamine trifluoroacetate	DM0E5G9	Investigative	Small molecular drug	[3958]
Pseudopalmatine trifluoroacetate	DM4HE1V	Investigative	Small molecular drug	[3958]
PSILOCIN	DMPDO49	Investigative	Small molecular drug	[459]
PSN375963	DM2U9SR	Investigative	Small molecular drug	[5081]
PSN632408	DMJIB8N	Investigative	Small molecular drug	[5082]
PSP-D-BAFF	DMMXIMO	Investigative	NA	[1866]
psychosine	DMDQF3F	Investigative	Small molecular drug	[5083]
PT-101	DM47F9I	Investigative	Small molecular drug	[481]
PT-102	DMD0K61	Investigative	Small molecular drug	[3377]
PT-103	DM0LTB2	Investigative	Small molecular drug	[481]
PT-104	DMABLF7	Investigative	Small molecular drug	[5084]
PT-106	DMPX71O	Investigative	Small molecular drug	[481]
PT-108	DMBLAV4	Investigative	Small molecular drug	[481]
PT-109	DM8PX1T	Investigative	Small molecular drug	[5084]
PT-110	DMEIW5T	Investigative	Small molecular drug	[5084]
PT-113	DMUFC6V	Investigative	Small molecular drug	[5084]
PT-114	DMYE1P8	Investigative	Small molecular drug	[5084]
PT-115	DMS01IN	Investigative	Small molecular drug	[5084]
PT-306	DME0N2Z	Investigative	Small molecular drug	[481]
PT-307	DM45HVR	Investigative	Small molecular drug	[481]
PT-308	DM7FM8V	Investigative	Small molecular drug	[481]
PT-309	DM7TILD	Investigative	Small molecular drug	[481]
PT-310	DMT7G32	Investigative	Small molecular drug	[481]
PT-311	DM9ZCGX	Investigative	Small molecular drug	[481]
PT-312	DM7GN3E	Investigative	Small molecular drug	[481]
PT-313	DMN80XD	Investigative	Small molecular drug	[481]
PT-314	DM5C1ND	Investigative	Small molecular drug	[481]
PT-315	DMUK7IT	Investigative	Small molecular drug	[481]
PT-316	DMXM6NT	Investigative	Small molecular drug	[481]
PT-317	DM14XB7	Investigative	Small molecular drug	[481]
PT-319	DMKEPGN	Investigative	Small molecular drug	[481]
PT-320	DMV940C	Investigative	Small molecular drug	[481]
PT-322	DMIHSEV	Investigative	Small molecular drug	[481]
PTAC	DMEJ6SK	Investigative	Small molecular drug	[4532]
PTBE	DMY02IR	Investigative	Small molecular drug	[5085]
PTeB	DM1NM5F	Investigative	Small molecular drug	[5086]
Pterin-6-Yl-Methyl-Monophosphate	DM98IOX	Investigative	Small molecular drug	[12]
Pteroic Acid	DMT2YNG	Investigative	Small molecular drug	[22]
PTI-221	DMQPDMO	Investigative	NA	[1866]
PTI-301	DMLBGV0	Investigative	NA	[1866]
PTI-303	DM0GRCL	Investigative	NA	[1866]
PTI-320	DMKEBL6	Investigative	NA	[1866]
PTI-421	DMPT5OB	Investigative	NA	[1866]
PTI-DX304	DMSQIK1	Investigative	NA	[1866]
PTosyl-Glu(OtBu)-Ala-LeuVSMe	DMPEVQT	Investigative	Small molecular drug	[1889]
PTR-302	DMYFWF9	Investigative	NA	[1866]
PTR-3046	DMZGFE8	Investigative	NA	[5087]
PUKATEINE	DM4SGVF	Investigative	Small molecular drug	[335]
PUNICAFOLIN	DM7CWQY	Investigative	Small molecular drug	[5088]
Purine Riboside	DMHNS0V	Investigative	Small molecular drug	[12]
Purpurin	DMYWRL6	Investigative	Small molecular drug	[5089]
Purvalanol A	DMNQ7TM	Investigative	Small molecular drug	[5090]
PUUPEHEDIONE	DMF28IU	Investigative	Small molecular drug	[3616]
PUUPEHENONE	DMF3BCK	Investigative	Small molecular drug	[3616]
PXVX-0103	DM2P0I4	Investigative	NA	[5091]
Pycnogenol	DMLFJHE	Investigative	NA	[5092]
Pyr3	DM3VNYQ	Investigative	Small molecular drug	[5093]
Pyrazine-2-carboxylic acid adamantan-1-ylamide	DMIZB81	Investigative	Small molecular drug	[994]
Pyrazofurin	DMVJLSM	Investigative	Small molecular drug	[2731]
pyrazolone, 1	DMLFQKU	Investigative	Small molecular drug	[5094]
PYRAZOLOPYRIDAZINE 1	DMKTB5U	Investigative	Small molecular drug	[5095]
PYRAZOLOPYRIDAZINE 2	DMI7AUJ	Investigative	Small molecular drug	[5095]
Pyrazolo[1,5-a]pyrimidine 3G	DMUB0EJ	Investigative	Small molecular drug	[1157]
Pyrazolo[1,5-a]pyrimidine-3-carboxylate	DM69LKB	Investigative	NA	[5096]
Pyridin-3-yl 4-butoxybenzylcarbamate	DMOCG6M	Investigative	Small molecular drug	[787]
Pyridine-2,4-dicarboxylic acid	DM4G8WX	Investigative	Small molecular drug	[945]
Pyridoxamine-5'-Phosphate	DMQ6POC	Investigative	Small molecular drug	[12]
Pyridoxine-5'-Phosphate	DMFUNL1	Investigative	Small molecular drug	[12]
Pyridoxyl-Alanine-5-Phosphate	DMUVCWY	Investigative	Small molecular drug	[12]
Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate	DM7AW0X	Investigative	Small molecular drug	[12]
Pyrimidinyl acylthiourea	DM7T2VQ	Investigative	NA	[3080]
PYRIPYROPENE A	DMCTJAM	Investigative	Small molecular drug	[5097]
PYROGALLOL	DMG5KDY	Investigative	Small molecular drug	[407]
Pyroglutamic Acid	DMROZUA	Investigative	Small molecular drug	[5098]
Pyrophosphate 2-	DMZQ75M	Investigative	Small molecular drug	[22]
PYROVALERONE	DMV48S2	Investigative	Small molecular drug	[532]
Pyrrolidin-(2Z)-ylideneamine	DMS4ZFU	Investigative	Small molecular drug	[1150]
Pyrrolidin-1-yl-thiourea	DMYNZXC	Investigative	Small molecular drug	[1521]
Pyrrolidin-3-yl-acetic acid	DM0BHCJ	Investigative	Small molecular drug	[5099]
Pyrrolidine dithiocarbamate	DM5ZAS6	Investigative	Small molecular drug	[5100]
pyrrolidine MCHR1 antagonist 1	DME6HCQ	Investigative	Small molecular drug	[5101]
Pyrrolidine-1-carbonitrile	DM906JK	Investigative	Small molecular drug	[5102]
Pyrrolopyrimidine	DMZLFVG	Investigative	NA	[5103]
pyrrolopyrimidine 48	DMUEKB3	Investigative	Small molecular drug	[5104]
Pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	DM1X5JR	Investigative	Small molecular drug	[440]
Pyrrolo[3,4-e]indole-1,3(2H,6H)-dione	DMM4CU9	Investigative	Small molecular drug	[440]
Pyruvic	DMTV32A	Investigative	NA	[1866]
PYY(22-36)	DM725FL	Investigative	NA	[1926]
PYY(25-36)	DMD6ZWV	Investigative	NA	[1926]
Pyz11-D-Trp8-SRIF	DMFUYR1	Investigative	NA	[1991]
Pyz6-D-Trp8-SRIF	DMDB3Q8	Investigative	NA	[1991]
Pyz7-D-Trp8-SRIF	DM9D805	Investigative	NA	[1991]
QA1	DM26GBV	Investigative	Small molecular drug	[5105]
QCP	DM62PI8	Investigative	Small molecular drug	[5106]
QCPac	DMSMQXZ	Investigative	Small molecular drug	[5106]
QEDIIRNIARHLAQVGDSMDR	DMJ38YV	Investigative	NA	[763]
QNEQCPQVSac	DMTY5HP	Investigative	NA	[5106]
QNZ 46	DM01RZX	Investigative	Small molecular drug	[5107]
QO-58	DMYXPF8	Investigative	Small molecular drug	[5108]
QSPac	DMJHTUG	Investigative	Small molecular drug	[5106]
quadazocine	DM2Q6JY	Investigative	Small molecular drug	[5109]
Quercetin 3-O-neohesperidoside	DMXIU6W	Investigative	Small molecular drug	[3625]
QUERCITRIN	DM1DH96	Investigative	Small molecular drug	[2117]
quin-C1	DMVQYWS	Investigative	Small molecular drug	[5110]
quin-C7	DM1CYWB	Investigative	Small molecular drug	[5111]
Quinapril analogue	DM0BEZS	Investigative	Small molecular drug	[5112]
quinazoline deriv. 1	DMJDU5S	Investigative	Small molecular drug	[5113]
Quinizarin	DMRQCK3	Investigative	Small molecular drug	[1612]
quinoline 2	DM1QIPZ	Investigative	Small molecular drug	[5114]
Quinoline-2-carboxylic acid adamantan-1-ylamide	DMDY3I2	Investigative	Small molecular drug	[994]
Quinoline-3-carboxylic acid adamantan-1-ylamide	DM9BIVL	Investigative	Small molecular drug	[994]
Quinoline-8-carboxamide	DMV57OZ	Investigative	Small molecular drug	[924]
Quinoline-8-sulfonamide	DMTPFLU	Investigative	Small molecular drug	[431]
Quinolinic Acid	DM8YGOI	Investigative	Small molecular drug	[12]
Quinoxaline1	DMRWXH4	Investigative	Small molecular drug	[5115]
QUINPIROLE	DMDNHEP	Investigative	Small molecular drug	[5116]
QUIPAZINE	DMPY6IG	Investigative	Small molecular drug	[5117]
Quizalofop	DM9KMEI	Investigative	Small molecular drug	[2074]
QwFwLL-NH2	DMQ7PIL	Investigative	Small molecular drug	[2196]
R(-)amphetamine	DM72ES1	Investigative	Small molecular drug	[5118]
R,R-THC	DM4URMA	Investigative	Small molecular drug	[5119]
R-138727	DML49FI	Investigative	Small molecular drug	[5120]
R-226161	DM4BP7S	Investigative	Small molecular drug	[5121]
R-820	DMHX9CT	Investigative	NA	[5122]
R-87027	DM2QN0S	Investigative	Small molecular drug	[5123]
R-dimethindene	DM6FVZW	Investigative	Small molecular drug	[5124]
R-fadrozole	DMJG4U0	Investigative	Small molecular drug	[160]
R-L3	DMGEDQJ	Investigative	Small molecular drug	[5125]
R-N6-(phenylisopropyl)adenosine	DM2N3BA	Investigative	Small molecular drug	[5126]
R-NORDULOXETINE	DMGV4DS	Investigative	Small molecular drug	[346]
R-PSOP	DM4LTE3	Investigative	Small molecular drug	[5127]
R116031	DM6Y7QM	Investigative	Small molecular drug	[5128]
R214127	DMX80BL	Investigative	Small molecular drug	[5129]
R396	DM1OPZ9	Investigative	Small molecular drug	[5130]
R59949	DMR6JYN	Investigative	Small molecular drug	[5131]
Rac-2-amino-4-phenylbutanoic acid	DMTUR6C	Investigative	Small molecular drug	[317]
Rac-2-amino-5-cyclohexylpentanoic acid	DMU0746	Investigative	Small molecular drug	[317]
Rac-2q	DMD5TPH	Investigative	Small molecular drug	[2579]
Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol	DMTN7IU	Investigative	Small molecular drug	[5132]
Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol	DMQYRAB	Investigative	Small molecular drug	[5132]
Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol	DMH2CX5	Investigative	Small molecular drug	[5132]
Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol	DMUQ6FW	Investigative	Small molecular drug	[5132]
Rac-cis-N-arachidonoylcyclopropanolamide	DMR8L6O	Investigative	Small molecular drug	[117]
Racemic DOI	DM39FSQ	Investigative	Small molecular drug	[5133]
Racemic DOTFM	DMNLCUH	Investigative	Small molecular drug	[459]
Radicicol	DMNZS94	Investigative	Small molecular drug	[5134]
ranatensin	DMI7NAF	Investigative	Small molecular drug	[5135]
RAP-164	DMF190S	Investigative	NA	[1866]
Rapamycin complexed with immunophilin FKBP12	DMLBP3F	Investigative	NA	[4564]
Rapamycin Immunosuppressant Drug	DM678IB	Investigative	Small molecular drug	[12]
rawsonol	DM9XOE6	Investigative	Small molecular drug	[5136]
RAZAXABAN	DMPML15	Investigative	Small molecular drug	[5137]
RB 2	DMCEFUW	Investigative	Small molecular drug	[5076]
RB-400	DMJDE6Y	Investigative	Small molecular drug	[5138]
RBI257	DM9IQXM	Investigative	Small molecular drug	[5139]
Rec 15/2615	DM386JM	Investigative	Small molecular drug	[5140]
recAAT, PPL Therapeutics/Bayer	DM1P830	Investigative	NA	[5141]
Receptor-Fc fusion proteins	DM4B6FO	Investigative	Antibody	[5142]
Redoxal	DM2S496	Investigative	Small molecular drug	[2875]
reglitazar	DMQ3ER0	Investigative	Small molecular drug	[5143]
Relcovaptan	DM3AWPB	Investigative	Small molecular drug	[5144]
remodelin	DMUCNB3	Investigative	Small molecular drug	[5145]
repinotan	DM47TSV	Investigative	Small molecular drug	[5146]
RES-701-1-C-terminal analogue	DMQEBKF	Investigative	NA	[5147]
RESCOVITINE	DM2IBND	Investigative	Small molecular drug	[5148]
resolvin D2	DMLVU6H	Investigative	Small molecular drug	[5149]
RESORCINOL	DMM37C0	Investigative	Small molecular drug	[5150]
Resveratrol Potassium3-Sulfate	DMN1RLA	Investigative	Small molecular drug	[5151]
Resveratrol Potassium4,-Sulfate	DMMFP57	Investigative	Small molecular drug	[5151]
REVERSINE	DMWDNOK	Investigative	Small molecular drug	[2725]
RF9	DM3IXEA	Investigative	Small molecular drug	[5152]
RG-50810	DMUR9LM	Investigative	Small molecular drug	[334]
RGB-286147	DMP08BY	Investigative	Small molecular drug	[5153]
RGD	DMFASRB	Investigative	NA	[5154]
RGDechi	DMX4JN6	Investigative	NA	[2435]
RGFP966	DME9T0A	Investigative	Small molecular drug	[5155]
RGI-4000	DMRTJ2X	Investigative	NA	[1866]
RGS4 inhibitor 13	DM4XVLB	Investigative	Small molecular drug	[5156]
RHC80267	DMC471Z	Investigative	Small molecular drug	[5157]
RHEIN	DMS6IJ0	Investigative	Small molecular drug	[2034]
RHODIOLININ	DMH9QAF	Investigative	Small molecular drug	[3229]
rHuB-D2	DMW1VOB	Investigative	NA	[5158]
RI-TPO	DMJD3WY	Investigative	NA	[1866]
Ribavirin-TP	DM09NGV	Investigative	Small molecular drug	[5159]
Ribose-1-Phosphate	DM7V8DZ	Investigative	Small molecular drug	[12]
Ribose-5-Phosphate	DMRKO49	Investigative	Small molecular drug	[12]
Ribostamycin	DMXWUHA	Investigative	Small molecular drug	[782]
Riccardin C	DM6MYGX	Investigative	Small molecular drug	[673]
Ridine-5-carboxylic acid ethyl ester	DM9HMCS	Investigative	Small molecular drug	[5160]
Rimantadine isomer 1	DMN98U1	Investigative	Small molecular drug	[815]
Rimantadine isomer 2	DM3BEF7	Investigative	NA	[815]
RIP	DM83L5Y	Investigative	Small molecular drug	[5161]
RIPAZEPAM	DMTHVQD	Investigative	Small molecular drug	[5162]
RK-682	DM5CI2P	Investigative	Small molecular drug	[5163]
RKI-1447	DMGTAWC	Investigative	Small molecular drug	[5164]
RM65	DMJU5A9	Investigative	Small molecular drug	[5165]
RN1734	DMA3ZXM	Investigative	Small molecular drug	[5166]
RN1747	DMIPZTM	Investigative	Small molecular drug	[5167]
RN486	DML7SQH	Investigative	Small molecular drug	[5168]
Ro 10-4548	DMXT34V	Investigative	Small molecular drug	[5169]
RO 116 1148	DMMO6PH	Investigative	Small molecular drug	[5170]
RO 244383	DM3FYUM	Investigative	NA	[5171]
Ro 28-2653	DMDC4HY	Investigative	Small molecular drug	[5172]
Ro 40-6055	DMU2EKN	Investigative	Small molecular drug	[5173]
Ro 41-5253	DMSJLWP	Investigative	Small molecular drug	[5174]
Ro 46-8443	DMXMSYB	Investigative	Small molecular drug	[5175]
Ro 8-4304	DMH79BO	Investigative	Small molecular drug	[5176]
Ro-04-6790	DM6H8JM	Investigative	Small molecular drug	[5177]
Ro-0505124	DMLVERQ	Investigative	Small molecular drug	[5178]
RO-054520	DM78B4A	Investigative	Small molecular drug	[5179]
Ro-11-04253	DMOQ0CE	Investigative	Small molecular drug	[92]
RO-145974	DM0ACKJ	Investigative	Small molecular drug	[5180]
RO-145975	DMAJ6BW	Investigative	Small molecular drug	[5180]
RO-147437	DMX4B36	Investigative	Small molecular drug	[5180]
Ro-15-3505	DM4NW3U	Investigative	Small molecular drug	[5180]
RO-194603	DM8C2Z0	Investigative	Small molecular drug	[5181]
Ro-21-7767	DMOE0JX	Investigative	Small molecular drug	[5182]
RO-316233	DMAGLPW	Investigative	Small molecular drug	[5183]
Ro-32-0557	DMPVKEA	Investigative	Small molecular drug	[5184]
Ro-3201195	DM9GXYV	Investigative	Small molecular drug	[5185]
Ro-37-9790	DM83QMZ	Investigative	Small molecular drug	[5186]
Ro-4396686	DM5DMCH	Investigative	Small molecular drug	[5187]
Ro-4938581	DMCB2N9	Investigative	Small molecular drug	[5188]
RO-5267683	DM97VNZ	Investigative	NA	[1866]
Ro-65-7219	DM6S742	Investigative	Small molecular drug	[2660]
Ro-66-1168	DMPT01J	Investigative	Small molecular drug	[5189]
Ro01-6128	DM0AC84	Investigative	Small molecular drug	[5190]
Ro0711401	DMZLUAK	Investigative	Small molecular drug	[5191]
Ro092210	DM2DXHO	Investigative	NA	[2517]
RO1138452	DMAOI51	Investigative	Small molecular drug	[5192]
RO116-4875/608	DMFTW0U	Investigative	Small molecular drug	[5193]
RO116-9132/238	DM6XM1D	Investigative	Small molecular drug	[5194]
Ro26-4550	DMGL7TM	Investigative	Small molecular drug	[5195]
RO3	DMRYNJE	Investigative	Small molecular drug	[5196]
Ro31-8220	DMDJLF0	Investigative	Small molecular drug	[5197]
RO320-2947/001	DM8BLYO	Investigative	Small molecular drug	[5198]
RO3244794	DMBFCKD	Investigative	Small molecular drug	[5199]
RO330-0802/001	DMGOPY1	Investigative	Small molecular drug	[5200]
Ro4491533	DMJLSX0	Investigative	Small molecular drug	[5201]
Ro48-8071	DMVGITD	Investigative	Small molecular drug	[12]
RO4988546	DM6SQ9A	Investigative	Small molecular drug	[5202]
RO5101576	DMPXC9L	Investigative	Small molecular drug	[5203]
RO5166017	DM57UB9	Investigative	Small molecular drug	[5204]
RO5488608	DMHXGCO	Investigative	Small molecular drug	[5205]
Ro64-5229	DMXOTHC	Investigative	Small molecular drug	[5206]
Ro67-4853	DMD93NP	Investigative	Small molecular drug	[5207]
Ro67-7476	DMI95DP	Investigative	Small molecular drug	[5208]
ROBINETIN	DMASOWP	Investigative	Small molecular drug	[1317]
ROCAGLAMIDE	DME9VTX	Investigative	Small molecular drug	[2148]
Roche 28-2653	DMD4JHK	Investigative	Small molecular drug	[5172]
Rockout	DMOTPJD	Investigative	Small molecular drug	[5209]
Rolicyclidine	DM5HV4W	Investigative	Small molecular drug	[5210]
ROLIPRAM	DMJ03UM	Investigative	Small molecular drug	[5211]
ROMe	DMAROW1	Investigative	Small molecular drug	[5212]
rose bengal (photoactivated)	DM3NBQ6	Investigative	Small molecular drug	[5213]
ROSETTACIN	DMN802V	Investigative	Small molecular drug	[4479]
Rotungenic acid	DM751OH	Investigative	Small molecular drug	[722]
ROXIFIBAN	DMWUAMQ	Investigative	Small molecular drug	[3773]
Rp-5-OMe-UDPalphaB	DM03RIT	Investigative	Small molecular drug	[5214]
RP-52770	DM5IXOS	Investigative	Small molecular drug	[5215]
RP-66471	DMR4O3I	Investigative	NA	[5216]
RP-69758	DMXMRVG	Investigative	Small molecular drug	[5217]
RP-71483	DMUFLNT	Investigative	NA	[5218]
RP-72540	DMWIXQS	Investigative	NA	[5218]
Rp-8-CPT-cGMPS	DMJMC43	Investigative	Small molecular drug	[5219]
Rp-adenosine 3',5'-cyclic monophosphothioate triethylamine (Rp-cAMPS)	DM1JWGH	Investigative	Small molecular drug	[5220]
Rp-cAMPS	DMG0S9B	Investigative	Small molecular drug	[5221]
RP73870	DMLKPZ6	Investigative	Small molecular drug	[5222]
RPKPfQwFwLL-NH2	DMAROTU	Investigative	NA	[2196]
RPR-101511	DM0HD3O	Investigative	Small molecular drug	[1168]
RPR-108514A	DM37I92	Investigative	Small molecular drug	[5223]
RPR-108518A	DMJ6RZI	Investigative	Small molecular drug	[1403]
RPR-118071	DM61VHF	Investigative	Small molecular drug	[5224]
RPR-118723	DMLDWCB	Investigative	Small molecular drug	[5225]
RPR-120844	DM1V0MD	Investigative	Small molecular drug	[5224]
RPR121154	DM9DXHM	Investigative	Small molecular drug	[5226]
RPR260243	DM4T2R3	Investigative	Small molecular drug	[5227]
RR(17)PZ	DMP9RLE	Investigative	NA	[2346]
RS 100235	DM32ZIC	Investigative	Small molecular drug	[5228]
RS 116 0086	DMX9W0T	Investigative	Small molecular drug	[5229]
RS 57639	DMD91WS	Investigative	Small molecular drug	[5230]
RS 67333	DMO7G94	Investigative	Small molecular drug	[5231]
RS 93520	DM8SGTQ	Investigative	Small molecular drug	[5232]
RS-100329	DMDKC0J	Investigative	Small molecular drug	[5233]
RS-102,221	DMHDYBN	Investigative	Small molecular drug	[5234]
RS-102895	DMF71B3	Investigative	Small molecular drug	[5235]
RS-136270	DMEHN2L	Investigative	Small molecular drug	[5236]
RS-14491	DMRW57G	Investigative	Small molecular drug	[5237]
RS-1636	DMKQT1Y	Investigative	NA	[5238]
RS-25344	DM0W2IS	Investigative	Small molecular drug	[5239]
RS-30199	DMDC1B4	Investigative	Small molecular drug	[5240]
RS-39066	DM2SCM7	Investigative	Small molecular drug	[5241]
RS-513815	DMLI5U2	Investigative	Small molecular drug	[92]
RS67506	DM89I0L	Investigative	Small molecular drug	[5242]
rT3	DMWDXPN	Investigative	Small molecular drug	[5243]
RTI-118	DMKA7F3	Investigative	Small molecular drug	[5244]
RTI-20	DMD3ST8	Investigative	Small molecular drug	[5245]
RTI-219	DM2QYXN	Investigative	Small molecular drug	[5246]
RTI-5989-23	DMR4TM1	Investigative	Small molecular drug	[5247]
RTI-5989-25	DMQ28L9	Investigative	Small molecular drug	[5247]
RTI-5989-31	DMZO1QC	Investigative	Small molecular drug	[5248]
RU-43044	DMY9P85	Investigative	Small molecular drug	[2663]
RU-5135	DMCASRD	Investigative	Small molecular drug	[5249]
RU-56187	DMO3WEG	Investigative	Small molecular drug	[5250]
RU-59063	DM5D9UT	Investigative	Small molecular drug	[5251]
RU26988	DMA7URH	Investigative	Small molecular drug	[5252]
RU28318	DMN049T	Investigative	Small molecular drug	[5253]
RU28362	DMAOJ0E	Investigative	Small molecular drug	[5254]
RU78191	DMOQE91	Investigative	Small molecular drug	[22]
RU78262	DMR8I03	Investigative	Small molecular drug	[22]
RU78299	DMXAK92	Investigative	Small molecular drug	[22]
RU78300	DM27BKD	Investigative	Small molecular drug	[22]
RU78783	DMU5H4K	Investigative	Small molecular drug	[12]
RU79072	DM9GQP0	Investigative	Small molecular drug	[22]
RU79073	DMWKTYC	Investigative	Small molecular drug	[22]
RU79256	DM06BGV	Investigative	Small molecular drug	[22]
RU81843	DMY3X6I	Investigative	Small molecular drug	[12]
RU82129	DMX7ZI0	Investigative	Small molecular drug	[12]
RU82197	DMJG4RC	Investigative	Small molecular drug	[107]
RU82209	DMR3A2O	Investigative	Small molecular drug	[12]
RU83876	DMNGKYF	Investigative	Small molecular drug	[12]
RU84687	DMWK3LU	Investigative	Small molecular drug	[22]
RU85053	DMOA8FK	Investigative	Small molecular drug	[12]
RU85493	DM97ZHX	Investigative	Small molecular drug	[12]
RU90395	DMHFKUC	Investigative	Small molecular drug	[12]
Ruthenium red	DMOHTC6	Investigative	Small molecular drug	[5255]
Rutin	DMEHRAJ	Investigative	Small molecular drug	[12]
RvD1-ME	DM8EZTM	Investigative	Small molecular drug	[5256]
RwFwLL-NH2	DMAU6FN	Investigative	Small molecular drug	[2196]
RWJ-16979	DME68VT	Investigative	Small molecular drug	[5257]
RWJ-38063	DMPJTLM	Investigative	Small molecular drug	[92]
RWJ-387273	DM28IKN	Investigative	NA	[5258]
RWJ-50353	DMRPYGX	Investigative	Small molecular drug	[359]
RWJ-53419	DMAEWMP	Investigative	Small molecular drug	[5259]
RWJ-56110	DME07AN	Investigative	Small molecular drug	[5260]
RWJ-68141	DMUZW80	Investigative	Small molecular drug	[92]
RWJ-68157	DMUK7LX	Investigative	Small molecular drug	[92]
RWJ-68354	DMNLVRS	Investigative	Small molecular drug	[5261]
RWJ-69736	DM2EOBM	Investigative	Small molecular drug	[92]
RXP-407	DMM5O30	Investigative	Small molecular drug	[5262]
RXP470.1	DMB7EGU	Investigative	Small molecular drug	[5263]
RY-066	DMGUX16	Investigative	Small molecular drug	[5264]
RY024	DM9KXV0	Investigative	Small molecular drug	[5265]
RY796	DMW4850	Investigative	Small molecular drug	[5266]
Ryanodine	DM2K6I8	Investigative	Small molecular drug	[5267]
S 0957	DM9HA8G	Investigative	NA	[5268]
S 1743	DMA5GOX	Investigative	NA	[5268]
S 18204	DM2FC5V	Investigative	Small molecular drug	[5269]
S 202 791	DMGEHNX	Investigative	Small molecular drug	[5270]
S 3025	DMZN0RW	Investigative	Small molecular drug	[5271]
S,S-(2-Hydroxyethyl)Thiocysteine	DMLPAD8	Investigative	Small molecular drug	[12]
S-(-)-enantiomer of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP)	DMQG4L2	Investigative	Small molecular drug	[3598]
S-(-)-sulpiride	DM1D7KY	Investigative	Small molecular drug	[5272]
S-(-)CPB	DMXUBIK	Investigative	Small molecular drug	[5273]
S-(-)CPP	DME9QR0	Investigative	Small molecular drug	[5274]
S-(2,4-Dichlorobenzyl)isothiourea hydrobromide	DMO1R69	Investigative	Small molecular drug	[786]
S-(2-boronoethyl)-L-cysteine	DMMZQB5	Investigative	Small molecular drug	[5275]
S-(2-Chlorobenzyl)isothiourea hydrochloride	DMN62KP	Investigative	Small molecular drug	[786]
S-(3,4-Dichlorobenzyl)isothiourea hydrochloride	DMNMCQJ	Investigative	Small molecular drug	[786]
S-(3-Chlorobenzyl)isothiourea hydrochloride	DMNG6JB	Investigative	Small molecular drug	[786]
S-(4-Bromobenzyl)isothiourea hydrobromide	DM0XDFG	Investigative	Small molecular drug	[786]
S-(4-Chlorobenzyl)isothiourea hydrochloride	DMWJE2X	Investigative	Small molecular drug	[786]
S-(4-Cyanobenzyl)isothiourea hydrobromide	DMYGULD	Investigative	Small molecular drug	[786]
S-(4-Ethylbenzyl)isothiourea hydrochloride	DMNXDWV	Investigative	Small molecular drug	[786]
S-(4-Fluorobenzyl)isothiourea hydrochloride	DM10MET	Investigative	Small molecular drug	[786]
S-(4-Methoxybenzyl)isothiourea hydrochloride	DM4XWAU	Investigative	Small molecular drug	[786]
S-(4-Methylbenzyl)isothiourea hydrochloride	DMAGLI8	Investigative	Small molecular drug	[786]
S-(4-Nitrobenzyl)isothiourea hydrochloride	DMYRBO0	Investigative	Small molecular drug	[786]
S-(Dimethylarsenic)Cysteine	DMSCHL0	Investigative	Small molecular drug	[12]
S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione	DM3FXPV	Investigative	Small molecular drug	[5276]
S-(N-4chlorophenyl-N-hydroxycarbamoyl)glutathione	DMPURE8	Investigative	Small molecular drug	[5276]
S-(N-butyl-N-hydroxycarbamoyl)glutathione	DMU7EQV	Investigative	Small molecular drug	[5276]
S-(N-ethyl-N-hydroxycarbamoyl)glutathione	DMMETC2	Investigative	Small molecular drug	[5276]
S-(N-heptyl-N-hydroxycarbamoyl)glutathione	DMV6T1Q	Investigative	Small molecular drug	[5276]
S-(N-hexyl-N-hydroxycarbamoyl)glutathione	DMSWHMI	Investigative	Small molecular drug	[5276]
S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione	DM1AHIW	Investigative	Small molecular drug	[107]
S-(N-methyl-N-hydroxycarbamoyl)glutathione	DM1C9W3	Investigative	Small molecular drug	[5276]
S-(N-pentyl-N-hydroxycarbamoyl)glutathione	DM4E9J2	Investigative	Small molecular drug	[5276]
S-(N-phenyl-N-hydroxycarbamoyl)glutathione	DMECAS0	Investigative	Small molecular drug	[5276]
S-(N-propyl-N-hydroxycarbamoyl)glutathione	DMRFKZ6	Investigative	Small molecular drug	[5276]
S-14671	DMHVEJF	Investigative	Small molecular drug	[5277]
S-2,9-dioxo-9-(phenylamino)nonyl ethanethioate	DMTH15E	Investigative	Small molecular drug	[1671]
S-2-(o-toluidino)-2-oxoethyl carbamothioate	DMU9F7K	Investigative	Small molecular drug	[5278]
S-21007	DMOJ9N6	Investigative	NA	[5279]
S-2238	DM3GS2X	Investigative	Small molecular drug	[5280]
S-34324	DMZLQ5W	Investigative	Small molecular drug	[5281]
S-36212	DMSO8MM	Investigative	NA	[1866]
S-4048	DME5HIR	Investigative	Small molecular drug	[5282]
S-adenosyl-L-methioninamine	DMO3W8H	Investigative	Small molecular drug	[5283]
s-allylglycine	DMUPCA6	Investigative	Small molecular drug	[5284]
S-ATPO	DMJQVAG	Investigative	Small molecular drug	[5285]
S-benzo[d]oxazol-2-yl O-butyl carbonothioate	DMCRQ29	Investigative	Small molecular drug	[479]
S-benzyl phenylmethanesulfinothioate	DMDUC2X	Investigative	Small molecular drug	[5286]
S-Benzyl-brassinin	DM2RLXF	Investigative	Small molecular drug	[4348]
S-Benzyl-Glutathione	DMIQU8D	Investigative	Small molecular drug	[12]
S-Ethyl-N-Phenyl-Isothiourea	DM6DT9Z	Investigative	Small molecular drug	[22]
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	DM49AYM	Investigative	Small molecular drug	[22]
S-hexyl hexane-1-sulfinothioate	DMODS9A	Investigative	Small molecular drug	[5286]
S-hexylglutathione	DMNWP02	Investigative	Small molecular drug	[5287]
S-isopentyl 3-methylbutane-1-sulfinothioate	DM1NXFL	Investigative	Small molecular drug	[5286]
S-Isopropyl-Isothiourea	DMZ30AM	Investigative	Small molecular drug	[12]
S-methyl 4-methyl-4-morpholinopent-2-ynethioate	DM79QC2	Investigative	Small molecular drug	[5288]
S-Methylcysteine	DMAMRKS	Investigative	Small molecular drug	[12]
S-OOPP	DMH6JI8	Investigative	Small molecular drug	[5289]
S-p-bromobenzyl glutatione	DMFXJKB	Investigative	Small molecular drug	[5290]
S-P-Nitrobenzyloxycarbonylglutathione	DMYBCEG	Investigative	Small molecular drug	[12]
S-propyl propane-1-sulfinothioate	DMFTLY9	Investigative	Small molecular drug	[5286]
S-sulpho-L-cysteine	DMDIYWV	Investigative	Small molecular drug	[5291]
S-tubercidinylhomocysteine	DM9UHCY	Investigative	Small molecular drug	[5292]
S136492	DMN6HE3	Investigative	Small molecular drug	[5293]
S1627	DMD4KLQ	Investigative	Small molecular drug	[5294]
S22153	DM4S5TQ	Investigative	Small molecular drug	[5295]
S24014	DM9RU46	Investigative	Small molecular drug	[5296]
S24773	DM1HAD0	Investigative	Small molecular drug	[5297]
S26131	DMCJ86U	Investigative	Small molecular drug	[5298]
S26284	DMLJITC	Investigative	Small molecular drug	[5299]
S3969	DM84DMW	Investigative	Small molecular drug	[5300]
S6-nitrobenzyl mercaptopurine riboside	DMIKJNL	Investigative	Small molecular drug	[5301]
S6716	DMML1HC	Investigative	Small molecular drug	[5302]
Sabadinine	DM5MBX7	Investigative	Small molecular drug	[5303]
SACCHARIN	DMRA736	Investigative	Small molecular drug	[5304]
saclofen	DM3TO27	Investigative	Small molecular drug	[5305]
Saframycin A	DMZWGVP	Investigative	Small molecular drug	[5306]
SAG	DMHOG7W	Investigative	Small molecular drug	[5307]
sakuranetin	DMUAQYZ	Investigative	Small molecular drug	[5308]
Salicyclic	DMWHC63	Investigative	NA	[1866]
Salicylhydroxamic acid	DMGLSPC	Investigative	Small molecular drug	[2101]
salicylidene salicylhydrazide	DME9LEO	Investigative	Small molecular drug	[5309]
Salvinicin A	DM8T1Y4	Investigative	Small molecular drug	[5310]
SALVINICIN B	DMB70T3	Investigative	Small molecular drug	[5310]
Salvinorin A (ester)	DMYH9Q5	Investigative	Small molecular drug	[2835]
SALVINORIN B	DMBR7O0	Investigative	Small molecular drug	[3365]
Salvinorin B 1-ethoxyethyl ether	DM5ZE7F	Investigative	Small molecular drug	[5311]
Salvinorin B 2,2,2-trifluoroethoxymethyl ether	DM1DE3F	Investigative	Small molecular drug	[5311]
Salvinorin B 2-fluoroethoxymethyl ether	DMBAXDU	Investigative	Small molecular drug	[5311]
Salvinorin B 2-methoxy-2-propyl ether	DMD9A08	Investigative	Small molecular drug	[5311]
Salvinorin B 2-methoxyethoxymethyl ether	DM8UATD	Investigative	Small molecular drug	[5311]
Salvinorin B benzyloxymethyl ether	DMKXEQ6	Investigative	Small molecular drug	[5311]
Salvinorin B butoxymethyl ether	DM7Q12B	Investigative	Small molecular drug	[5311]
Salvinorin B ethoxymethyl ether	DMP5WNL	Investigative	Small molecular drug	[5311]
Salvinorin B fluoromethyl ether	DM01WOF	Investigative	Small molecular drug	[5311]
Salvinorin B isopropoxymethyl ether	DMSFXA3	Investigative	Small molecular drug	[5311]
Salvinorin B methoxymethyl ether	DMZ51IE	Investigative	Small molecular drug	[5311]
Salvinorin B methylthiomethyl ether	DMKDMPL	Investigative	Small molecular drug	[5311]
Salvinorin B propoxymethyl ether	DMKCUY6	Investigative	Small molecular drug	[5311]
Salvinorin B tert-butoxymethyl ether	DM8H6AT	Investigative	Small molecular drug	[5311]
Salvinorin B tetrahydropyran-2-yl ether	DM3UPAE	Investigative	Small molecular drug	[5311]
Sanfetrinem cilexetil	DMTRMX8	Investigative	Small molecular drug	[5312]
Sanggenon C	DMSF5DW	Investigative	Small molecular drug	[3730]
Sanggenon G	DMNHUOD	Investigative	Small molecular drug	[3730]
Sanguiin H-6	DM9XV16	Investigative	NA	[372]
santacruzamate A	DMFAM7P	Investigative	Small molecular drug	[5313]
Sar-Arg-Val-Tyr-Ile-His-Pro-Ala	DMCNOJV	Investigative	Small molecular drug	[5314]
Sar-Arg-Val-Tyr-Ile-His-Pro-Ile	DMS0FQC	Investigative	Small molecular drug	[5314]
Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH	DMD6SJT	Investigative	NA	[5315]
Sarafotoxin 6C	DM0RDC4	Investigative	Small molecular drug	[5316]
sarafotoxin S6b	DMR6PJ5	Investigative	Small molecular drug	[5317]
Sarcodictyin A	DMZR4FX	Investigative	Small molecular drug	[5318]
sarcosine	DMIVGOR	Investigative	Small molecular drug	[5319]
Saxitoxin	DMLX8RW	Investigative	Small molecular drug	[5320]
SB 202474	DMAIYYC	Investigative	Small molecular drug	[5321]
SB 203106	DMQAO5B	Investigative	NA	[5322]
SB 204070	DM43K85	Investigative	Small molecular drug	[5323]
SB 204741	DM3LQF4	Investigative	Small molecular drug	[5324]
SB 215505	DMCM4LT	Investigative	Small molecular drug	[5325]
SB 216641	DMB3R4Z	Investigative	Small molecular drug	[5326]
SB 218078	DMN1G5S	Investigative	Small molecular drug	[5327]
SB 221284	DM8DVY2	Investigative	Small molecular drug	[5328]
SB 224289	DMIS8JQ	Investigative	Small molecular drug	[5329]
SB 227122	DM7S63O	Investigative	Small molecular drug	[2378]
SB 228357	DMKA8R4	Investigative	Small molecular drug	[5330]
SB 242084	DMISBDC	Investigative	Small molecular drug	[5331]
SB 243213	DMAFWRT	Investigative	Small molecular drug	[5332]
SB 258585	DM2QJKZ	Investigative	Small molecular drug	[5333]
SB 269970-A	DMFHUGC	Investigative	Small molecular drug	[4336]
SB 272183	DMOLNQX	Investigative	Small molecular drug	[5334]
SB 272844	DMVO8P5	Investigative	Small molecular drug	[5335]
SB 649915	DM21Z6H	Investigative	Small molecular drug	[5336]
SB 699551	DM82GH9	Investigative	Small molecular drug	[5337]
SB 714786	DMGHRY0	Investigative	Small molecular drug	[5338]
SB-0304	DMOZX0D	Investigative	Small molecular drug	[3346]
SB-13	DM9O0AR	Investigative	Small molecular drug	[437]
SB-201076	DMKLWSG	Investigative	Small molecular drug	[5339]
SB-202235	DM09UIS	Investigative	Small molecular drug	[5340]
SB-203347	DM3AWMF	Investigative	NA	[5341]
SB-207043	DM704TL	Investigative	NA	[5342]
SB-207710	DMVQKMC	Investigative	Small molecular drug	[5343]
SB-210313	DM5EWQN	Investigative	Small molecular drug	[5344]
SB-213068	DMUCHNP	Investigative	Small molecular drug	[2383]
SB-214111	DMH1CFX	Investigative	Small molecular drug	[5345]
SB-216995	DMOH9TA	Investigative	Small molecular drug	[2886]
SB-218655	DMJKE4M	Investigative	Small molecular drug	[2886]
SB-227931	DMO1WI8	Investigative	Small molecular drug	[5346]
SB-258719	DMO01AG	Investigative	Small molecular drug	[5347]
SB-258741	DM0HK6L	Investigative	Small molecular drug	[2918]
SB-265123	DM8UKH7	Investigative	Small molecular drug	[5348]
SB-271046	DM5VJAF	Investigative	Small molecular drug	[5349]
SB-298	DMU2J3K	Investigative	Small molecular drug	[5071]
SB-328872	DMT1KFL	Investigative	Small molecular drug	[5350]
SB-334867	DMDZKWJ	Investigative	Small molecular drug	[5351]
SB-357134	DMFTO8R	Investigative	Small molecular drug	[5352]
SB-381320	DM3BV5S	Investigative	Small molecular drug	[220]
SB-408124	DMB8XZP	Investigative	Small molecular drug	[5353]
SB-410220	DMQLHE8	Investigative	Small molecular drug	[5354]
SB-415286	DMMAL3I	Investigative	Small molecular drug	[5355]
SB-416	DMJW72O	Investigative	Small molecular drug	[5076]
SB-505124	DM4G09S	Investigative	Small molecular drug	[5356]
SB-525334	DM0PETL	Investigative	Small molecular drug	[5357]
SB-568849	DMBIF42	Investigative	Small molecular drug	[5358]
SB-611812	DMASQV4	Investigative	Small molecular drug	[5359]
SB-633825	DM9QGBT	Investigative	Small molecular drug	[5360]
SB-656104	DMVOIL5	Investigative	Small molecular drug	[5361]
SB-699551-A	DMLW8BI	Investigative	NA	[5362]
SB-706375	DM9ZYNJ	Investigative	Small molecular drug	[5363]
SB-731489	DMO2EXW	Investigative	Small molecular drug	[1349]
SB-747651A	DM20Q5O	Investigative	Small molecular drug	[5364]
SB-782443	DMYL56F	Investigative	Small molecular drug	[5365]
SB216763	DMIYFQ5	Investigative	Small molecular drug	[5366]
SB236057	DMYQDPM	Investigative	Small molecular drug	[5367]
SB251023	DMLZDK6	Investigative	Small molecular drug	[5368]
SB269652	DMEGNJK	Investigative	Small molecular drug	[5369]
SB290157	DM28K0E	Investigative	Small molecular drug	[5370]
SB399885	DMFMK89	Investigative	Small molecular drug	[5371]
SB452533	DMUFV4O	Investigative	Small molecular drug	[5372]
SBB007833	DMU8KGB	Investigative	Small molecular drug	[5373]
SBTI	DMDBLGQ	Investigative	NA	[5374]
SC-0030	DMD2WEQ	Investigative	Small molecular drug	[5375]
SC-19220	DMU2C9W	Investigative	Small molecular drug	[5376]
SC-41661A	DMCWZ84	Investigative	Small molecular drug	[5377]
Sc-43076	DMVZ9Q0	Investigative	siRNA drug	[5378]
Sc-43077	DMYDS5Z	Investigative	siRNA drug	[5378]
SC-5003	DM2DU80	Investigative	Small molecular drug	[5379]
SC-50073	DMU2WIS	Investigative	Small molecular drug	[5380]
SC-50135	DMI2KE7	Investigative	Small molecular drug	[5380]
SC-50676	DM8RJ0V	Investigative	Small molecular drug	[5380]
SC-50998	DMBQ16F	Investigative	Small molecular drug	[5381]
SC-51322	DM0LWUV	Investigative	Small molecular drug	[5382]
SC-514	DMAWI4M	Investigative	Small molecular drug	[5383]
SC-52073	DM0E2SM	Investigative	Small molecular drug	[5380]
SC-52491	DMJ576C	Investigative	Small molecular drug	[5384]
SC-52569	DMLOJ42	Investigative	Small molecular drug	[5380]
SC-52892	DMXA6LU	Investigative	Small molecular drug	[5385]
SC-53229	DMYH12X	Investigative	Small molecular drug	[5380]
SC-54701A	DM3BEKV	Investigative	Small molecular drug	[5386]
SC-54750	DMEUTXG	Investigative	NA	[5384]
SC-55634	DMLJ8T7	Investigative	Small molecular drug	[5385]
SC-558	DMAZLKX	Investigative	Small molecular drug	[2886]
SC-560	DMT1GJL	Investigative	Small molecular drug	[5387]
SC-58272	DMZJQ1D	Investigative	Small molecular drug	[355]
SC-68376	DMBFIUX	Investigative	Small molecular drug	[5388]
SC-74020	DMNI91Z	Investigative	Small molecular drug	[12]
SC-79407	DMD71VB	Investigative	Small molecular drug	[5389]
SC-795	DMZN7YT	Investigative	Small molecular drug	[4481]
SC-83157	DM96ATK	Investigative	Small molecular drug	[5389]
SC46275	DM6AS0P	Investigative	Small molecular drug	[5390]
SC66	DM3MT49	Investigative	NA	[1866]
SCANDENOLIDE	DMX40NM	Investigative	Small molecular drug	[697]
Sch 202596	DMRC4LE	Investigative	Small molecular drug	[5391]
SCH 206272	DMD1M24	Investigative	Small molecular drug	[5392]
SCH 44643	DMNLD6W	Investigative	Small molecular drug	[5393]
SCH-12679	DMP8OKA	Investigative	Small molecular drug	[5394]
SCH-210971	DM42A1F	Investigative	Small molecular drug	[5395]
SCH-225336	DMH7EWZ	Investigative	Small molecular drug	[5396]
SCH-24518	DM6SC5K	Investigative	Small molecular drug	[5397]
SCH-356036	DMOEB8M	Investigative	Small molecular drug	[5398]
SCH-48375	DM0J937	Investigative	Small molecular drug	[5399]
SCH-57726	DMDK8TR	Investigative	Small molecular drug	[5400]
SCH-63390	DMAUB9F	Investigative	Small molecular drug	[5401]
SCH-68631	DM4CI57	Investigative	Small molecular drug	[779]
SCH-725737	DM9YJI8	Investigative	NA	[5402]
SCH-725739	DMYKB0S	Investigative	NA	[5402]
SCH-900931	DMDTUQP	Investigative	NA	[1866]
SCH51866	DMCWSJP	Investigative	Small molecular drug	[5403]
SCH772984	DMWVH62	Investigative	Small molecular drug	[5404]
schisandrin A	DMWQ480	Investigative	Small molecular drug	[5405]
SCOPOLETIN	DM645FP	Investigative	Small molecular drug	[40]
SCUTELLAREIN	DMJD03I	Investigative	Small molecular drug	[1317]
SD-208	DMQXUYH	Investigative	Small molecular drug	[5406]
SDMA	DMS2EQ9	Investigative	Small molecular drug	[5407]
SDZ-205-557	DMP3EXG	Investigative	Small molecular drug	[5408]
SDZ-PDI-747	DM3GJ07	Investigative	NA	[1866]
SDZ-PTS-893	DMBYSEM	Investigative	NA	[5409]
Se-Ethyl-Isoselenourea	DM9BJ27	Investigative	Small molecular drug	[12]
SEA	DMSB4WO	Investigative	Small molecular drug	[5410]
SEBACIC ACID	DM3VOPQ	Investigative	Small molecular drug	[22]
Sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate	DM9QSDC	Investigative	Small molecular drug	[1231]
Seco-exiguamine	DMY7IVZ	Investigative	Small molecular drug	[3064]
SECOCULARIDINE	DM76CUP	Investigative	Small molecular drug	[2102]
Selenazofurin	DMKSIVL	Investigative	Small molecular drug	[5411]
Selenazole-4-Carboxyamide-Adenine Dinucleotide	DMXERWD	Investigative	Small molecular drug	[12]
SEMIPLENAMIDE A	DMW5SIQ	Investigative	Small molecular drug	[5412]
SEMIPLENAMIDE B	DMHWCFJ	Investigative	Small molecular drug	[5412]
Semiplenamide G	DM4RP0A	Investigative	Small molecular drug	[5412]
Semorphone	DM1C5GZ	Investigative	Small molecular drug	[5413]
Septide	DMRJIP4	Investigative	Small molecular drug	[5414]
Ser-Tyr-Ser-Nle-Glu-His-Dphe-Arg	DMS509U	Investigative	NA	[3379]
sergliflozin	DMF8GAX	Investigative	Small molecular drug	[5415]
SERGLIFLOZIN A	DM6FVCE	Investigative	Small molecular drug	[5416]
SEROTONIN	DMOFCRY	Investigative	Small molecular drug	[5417]
SEW2871	DMJBW7X	Investigative	Small molecular drug	[5418]
SF-11	DMVI2H9	Investigative	Small molecular drug	[5419]
SF-21	DMI6SNQ	Investigative	Small molecular drug	[5420]
SF-51	DMXNZ8V	Investigative	Small molecular drug	[5421]
SF303	DMH36A9	Investigative	Small molecular drug	[5422]
SGC-CBP30	DMTLRGZ	Investigative	Small molecular drug	[5423]
SGC0946	DMP35VS	Investigative	Small molecular drug	[5424]
SGC707	DMGINBT	Investigative	Small molecular drug	[5425]
SHA 68	DMW7E32	Investigative	Small molecular drug	[5426]
Shikimate-3-Phosphate	DMBE0CT	Investigative	Small molecular drug	[12]
SHU9119	DMT62LS	Investigative	Small molecular drug	[5427]
SIB-1533A	DMR5FD9	Investigative	Small molecular drug	[5428]
SIB-1757	DMFOGE2	Investigative	Small molecular drug	[5429]
SIB-1893	DMAVBKP	Investigative	Small molecular drug	[5430]
SID7969543	DMPS22J	Investigative	Small molecular drug	[5431]
SIDEROXYLONAL A	DMEIBTY	Investigative	Small molecular drug	[5432]
SIDEROXYLONAL B	DMDP7Y5	Investigative	Small molecular drug	[5432]
Sideroxylonal C	DMSGNM1	Investigative	Small molecular drug	[5432]
SIGMOIDIN A	DMB70NK	Investigative	Small molecular drug	[1602]
SIGMOIDIN B	DMVH5WK	Investigative	Small molecular drug	[1602]
Sigmoidin F	DM8E62L	Investigative	Small molecular drug	[1602]
silahexocyclium	DM4VDMP	Investigative	Small molecular drug	[5433]
Simoctocog alfa	DM3LDFB	Investigative	NA	[5434]
Sinefungin	DMNWM8H	Investigative	Small molecular drug	[5435]
SITS	DMCMIUG	Investigative	Small molecular drug	[5436]
SK&F 107649	DMU1P3T	Investigative	Small molecular drug	[5437]
SK&F-105854	DMYRKEJ	Investigative	Small molecular drug	[5438]
SK&F-106686	DMHETY7	Investigative	Small molecular drug	[3]
SK&F-29661	DM2KFQ5	Investigative	Small molecular drug	[1308]
SK&F-64139	DM60Y3Q	Investigative	Small molecular drug	[393]
SK&F-86466	DM4RHEZ	Investigative	Small molecular drug	[3]
SK&F-89626	DM3SUKX	Investigative	NA	[5439]
SK-683	DMM32CF	Investigative	Small molecular drug	[5440]
SK1-I	DMMYX7C	Investigative	Small molecular drug	[5441]
SK509	DM73SC6	Investigative	Small molecular drug	[3937]
SK549	DMK1OP2	Investigative	NA	[5442]
SK554	DMUTBZ8	Investigative	NA	[2190]
SKA-121	DMBL7YN	Investigative	Small molecular drug	[5443]
SKA-31	DMX34F1	Investigative	Small molecular drug	[5444]
SKF 89748	DMWODHR	Investigative	Small molecular drug	[5445]
SKF-75670	DMQ6YXF	Investigative	Small molecular drug	[5446]
SKF-83556	DMCMQH8	Investigative	Small molecular drug	[5447]
SKF-83959	DMWC6RU	Investigative	Small molecular drug	[5448]
SKF-89124A	DMNUQ9P	Investigative	Small molecular drug	[1738]
SKF89976A	DM0WNHQ	Investigative	Small molecular drug	[5449]
SKS-927	DMGQ9Z5	Investigative	Small molecular drug	[5450]
SL-3111	DM0UE28	Investigative	Small molecular drug	[5451]
SL-327	DMYJV4I	Investigative	Small molecular drug	[5452]
SL422	DM3I2US	Investigative	Small molecular drug	[5453]
SLG	DMEBPCO	Investigative	Small molecular drug	[5454]
slotoxin	DMBD6TC	Investigative	Small molecular drug	[5455]
SLV-314	DMPETL7	Investigative	Small molecular drug	[5456]
SM 21	DM7MSGK	Investigative	Small molecular drug	[5457]
SM-122	DMC7YQE	Investigative	Small molecular drug	[5458]
SM-130,686	DMKZVEQ	Investigative	Small molecular drug	[5459]
SM-131	DMP8VO6	Investigative	Small molecular drug	[5460]
SM-337	DMOSTP9	Investigative	Small molecular drug	[5461]
Small molecule 34	DMWJ70Q	Investigative	Small molecular drug	[12]
SMEATHXANTHONE A	DMZC2BT	Investigative	Small molecular drug	[1799]
SMP-797	DMSI95J	Investigative	Small molecular drug	[4784]
SN-1	DMWCSQH	Investigative	Small molecular drug	[5462]
SN-11	DMA0JZM	Investigative	Small molecular drug	[5463]
SN-2	DMYVIBW	Investigative	Small molecular drug	[5464]
SN-23	DM6O0PD	Investigative	Small molecular drug	[5463]
SN-28	DMB8TJC	Investigative	Small molecular drug	[5465]
SN6	DMPD5FP	Investigative	Small molecular drug	[5466]
SNAP 398299	DMS1AFL	Investigative	Small molecular drug	[5467]
SNAP-5036	DMEJ5CP	Investigative	Small molecular drug	[92]
SNAP-5114	DMFM19S	Investigative	Small molecular drug	[5468]
SNAP-5150	DM2OLGQ	Investigative	Small molecular drug	[5469]
SNAP-7915	DM3KN2F	Investigative	Small molecular drug	[92]
SNAP-8719	DMCHPMA	Investigative	Small molecular drug	[5470]
SNAP-94847	DMMHQDX	Investigative	Small molecular drug	[5471]
SNC-80	DMJI5H0	Investigative	Small molecular drug	[5472]
SNEWIQPRLPQH	DMYUH62	Investigative	NA	[5473]
SNX-2112	DMB5A80	Investigative	Small molecular drug	[713]
Sodium 2,3,5,6-tetrafluorobenzoate	DMSRM49	Investigative	Small molecular drug	[5474]
SODIUM CITRATE	DMHPD2Y	Investigative	Small molecular drug	[3978]
Sodium maleate	DM2WUZA	Investigative	Small molecular drug	[5474]
Sodium N-methylphenylaminomethanesulfonate	DMBVQI4	Investigative	Small molecular drug	[1167]
Sodium orthovanadate	DM8CLG2	Investigative	Small molecular drug	[5475]
SODIUM PERFLUOROHEXANESULFONAMIDE	DMESHV2	Investigative	Small molecular drug	[5476]
Sodium phenylaminomethanesulfonate	DMJ7I4U	Investigative	Small molecular drug	[1167]
Sodium phenylarsonate	DMXELBI	Investigative	Small molecular drug	[5477]
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	DM1G4S9	Investigative	Small molecular drug	[2470]
Sodium sulfamate	DMAMV6T	Investigative	Small molecular drug	[5477]
Sodium trithiocarbonate	DM6WYGC	Investigative	Small molecular drug	[5478]
Sodium valproate	DMX6PLV	Investigative	Small molecular drug	[5479]
SODIUM ZINC DIHYDROLIPOYLHISTIDINATE	DMEZAPR	Investigative	Small molecular drug	[5480]
SOMATOSTATIN	DMIOFQE	Investigative	NA	[2789]
SOPHOFLAVESCENOL	DM8Y1S7	Investigative	Small molecular drug	[3728]
SOPHORAFLAVANONE B	DMUVKX5	Investigative	Small molecular drug	[1782]
Sophoraflavanone G	DMBTMN5	Investigative	Small molecular drug	[3113]
SOPHORICOSIDE	DM4A0NP	Investigative	Small molecular drug	[5481]
Soraphen A	DM18IKZ	Investigative	Small molecular drug	[12]
SP-650003	DM4SXIT	Investigative	NA	[5482]
Sp-722	DMV1W4M	Investigative	Small molecular drug	[12]
Sp-876	DMJZKEH	Investigative	Small molecular drug	[12]
Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	DM1VQ4K	Investigative	Small molecular drug	[12]
SP203	DM6VQZ7	Investigative	Small molecular drug	[5483]
SP2456	DM5HUY0	Investigative	Small molecular drug	[12]
SP4160	DMLA3WY	Investigative	Small molecular drug	[12]
Sp7343-Sp7964	DML2V1I	Investigative	Small molecular drug	[12]
SPANTIDE	DMV63IP	Investigative	NA	[5484]
spantide II	DMKC6IX	Investigative	Small molecular drug	[5485]
Spathodic acid	DMJ6WNK	Investigative	Small molecular drug	[722]
sphinganine	DM9ZBLE	Investigative	Small molecular drug	[5486]
sphingosylphosphorylcholine	DM7ZIMS	Investigative	Small molecular drug	[5487]
spiradoline	DMDZIV5	Investigative	Small molecular drug	[5488]
spiramide	DM5KNMD	Investigative	Small molecular drug	[5489]
SPIROINDANYLOXYMORPHONE	DMNJVZU	Investigative	Small molecular drug	[5490]
spiroxatrine	DMPHRXQ	Investigative	Small molecular drug	[5491]
Spiro[cyclopropane-1,2-adamantan]-2-amine	DMGFC8D	Investigative	Small molecular drug	[815]
Spiro[piperidine-2,2-adamantane]	DMWU9PV	Investigative	Small molecular drug	[815]
Spiro[pyrrolidine-2,2-adamantane]	DMW48JD	Investigative	Small molecular drug	[815]
splitomicin	DMCLHZ5	Investigative	Small molecular drug	[5492]
SPONGIADIOXIN A	DM0GJVS	Investigative	Small molecular drug	[758]
SPT	DM94RJW	Investigative	Small molecular drug	[5493]
SQ 26655	DMRP42B	Investigative	Small molecular drug	[5494]
SQ-14603	DMJW8NV	Investigative	Small molecular drug	[62]
SQ-24798	DMW7Y9L	Investigative	Small molecular drug	[5495]
SQ-27986	DMLPN95	Investigative	Small molecular drug	[5496]
SQ-29548	DM9G3UD	Investigative	Small molecular drug	[5497]
SQ32,910	DML6SIE	Investigative	Small molecular drug	[5270]
squalene	DMYF78I	Investigative	Small molecular drug	[5498]
SR-59026	DMCRVM2	Investigative	NA	[5499]
SR-973	DMU48OD	Investigative	Small molecular drug	[5500]
SR11254	DMBA297	Investigative	Small molecular drug	[12]
SR142948A	DMMXU6R	Investigative	Small molecular drug	[5501]
SR144528	DMBRVXY	Investigative	Small molecular drug	[5502]
SR48527	DMUHQS9	Investigative	Small molecular drug	[5503]
SR9238	DM2WIGO	Investigative	Small molecular drug	[5504]
SRA880	DM37YJH	Investigative	Small molecular drug	[5505]
Src kinase inhibitor I	DMUZP9V	Investigative	Small molecular drug	[5383]
SRI-224	DM35NF6	Investigative	Small molecular drug	[1147]
SRI-63-675	DM8GDZS	Investigative	Small molecular drug	[5506]
Sri-9439	DM5GILS	Investigative	Small molecular drug	[107]
Sri-9662	DMYO4A3	Investigative	Small molecular drug	[12]
SRIF-14	DMDY1M7	Investigative	Small molecular drug	[5507]
SRIF-28	DM0OM9L	Investigative	Small molecular drug	[5508]
SRT1720	DMUKVHQ	Investigative	Small molecular drug	[5509]
SRTCX1003	DMIGACW	Investigative	Small molecular drug	[5510]
SSR126768A	DMF0X2S	Investigative	Small molecular drug	[5511]
SSR128129E	DMYGB1L	Investigative	Small molecular drug	[5512]
ST-1025	DM14PLC	Investigative	Small molecular drug	[1645]
ST-1093	DMKZJWV	Investigative	Small molecular drug	[1645]
ST-1535	DMUTC9Z	Investigative	Small molecular drug	[5513]
ST-1646	DMR1G40	Investigative	Small molecular drug	[2721]
ST-2741	DM73E0G	Investigative	Small molecular drug	[5514]
ST-2986	DMNERM6	Investigative	Small molecular drug	[5515]
ST-3050	DM19K2D	Investigative	Small molecular drug	[5515]
ST-5732	DM9FYPM	Investigative	Small molecular drug	[5514]
ST074946	DMO7WRU	Investigative	Small molecular drug	[5516]
STA2	DMIYJ2M	Investigative	Small molecular drug	[5517]
Stachyflin	DMIZESL	Investigative	Small molecular drug	[1093]
Staurosporine	DM0E9BR	Investigative	Small molecular drug	[1]
STAUROSPORINONE	DMU2H4K	Investigative	NA	[5518]
stearic acid	DMOJHGN	Investigative	Small molecular drug	[5519]
STEPHOLIDINE	DMGMXQC	Investigative	Small molecular drug	[5520]
Sterculic acid	DM1PMR3	Investigative	Small molecular drug	[1]
STO609	DMZSOG2	Investigative	Small molecular drug	[5521]
streptonigrin	DM0HOEA	Investigative	Small molecular drug	[5522]
STYLISSADINE A	DMO9VWJ	Investigative	NA	[5523]
STYLISSADINE B	DMNAYEP	Investigative	NA	[5523]
Styrylboronic acid	DMJ4Z7W	Investigative	Small molecular drug	[942]
SU 6656	DMF1P6W	Investigative	Small molecular drug	[5524]
SU-11652	DMGQXN7	Investigative	Small molecular drug	[5525]
SU-6689	DMDNA23	Investigative	Small molecular drug	[364]
SU11274	DMASP9Z	Investigative	Small molecular drug	[5526]
SU4984	DMWVN8R	Investigative	Small molecular drug	[5527]
SU5403	DMV1408	Investigative	Small molecular drug	[5527]
SU9516	DMQHG0R	Investigative	Small molecular drug	[5528]
subalin	DMKH9IE	Investigative	NA	[5529]
Suberic bishydroxamic acid	DM235XH	Investigative	NA	[2220]
Subersic acid	DM8BLXT	Investigative	Small molecular drug	[39]
Substance P	DMQ6W4I	Investigative	Small molecular drug	[5530]
Sub[-Trp-Arg-Nva-Arg-Tyr-NH2]2	DM4SWQA	Investigative	NA	[1943]
Sub[-Tyr-Arg-Leu-Arg-Tyr-NH2]2	DM56MOV	Investigative	NA	[1943]
Succinic	DMWHOPH	Investigative	NA	[1866]
Sucrose	DMVWUCF	Investigative	Small molecular drug	[5531]
Sucrose Octasulfate	DMET64R	Investigative	Small molecular drug	[12]
Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp	DMTEU0L	Investigative	NA	[5034]
Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	DMQB2CN	Investigative	NA	[5034]
SULFAMATE	DMF1589	Investigative	NA	[2299]
Sulfamic acid 12-sulfamoyloxy-dodecyl ester	DM9XNSK	Investigative	Small molecular drug	[5532]
Sulfamic acid 16-sulfamoyloxy-hexadecyl ester	DM7VBSY	Investigative	Small molecular drug	[5532]
Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester	DMM70K1	Investigative	Small molecular drug	[5533]
Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester	DMSZ50N	Investigative	Small molecular drug	[1338]
Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester	DMIQWAH	Investigative	Small molecular drug	[1338]
Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester	DMH71N6	Investigative	Small molecular drug	[1338]
Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester	DMFVE3N	Investigative	Small molecular drug	[1338]
Sulfamic acid 3-benzoyl-phenyl ester	DMLXHAI	Investigative	Small molecular drug	[1338]
Sulfamic acid 3-sulfamoyloxy-phenyl ester	DMA0MEV	Investigative	Small molecular drug	[5532]
Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester	DMSYXHF	Investigative	Small molecular drug	[1338]
Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester	DM8LWM3	Investigative	Small molecular drug	[1338]
Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester	DMK97WC	Investigative	Small molecular drug	[1338]
Sulfamic acid 4-benzoyl-phenyl ester	DMDUW9F	Investigative	Small molecular drug	[1338]
Sulfamic acid 4-sulfamoyloxy-butyl ester	DMQZGNJ	Investigative	Small molecular drug	[5532]
Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester	DMFJR0S	Investigative	Small molecular drug	[5532]
Sulfamic acid 6-sulfamoyloxy-hexyl ester	DMT3U2D	Investigative	Small molecular drug	[5532]
Sulfamic acid 7-sulfamoyloxy-heptyl ester	DMVWEN3	Investigative	Small molecular drug	[5532]
Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester	DMFVQYI	Investigative	Small molecular drug	[5534]
Sulfamic acid chroman-2-ylmethyl ester	DMN0Q71	Investigative	Small molecular drug	[5534]
SULFATE	DMW0ZBF	Investigative	Small molecular drug	[3493]
SULFOARECOLINE	DM8KYUE	Investigative	Small molecular drug	[5535]
sulfonamide-01	DMU0BW9	Investigative	Small molecular drug	[5536]
Sulfonylthioureas	DMBG0H1	Investigative	Small molecular drug	[3354]
SULFURETIN	DMYPM2D	Investigative	Small molecular drug	[2034]
SUN-C8257	DM26KQG	Investigative	NA	[5537]
super cinnamaldehyde	DMVZWCI	Investigative	Small molecular drug	[5538]
SX-517	DMZGX48	Investigative	Small molecular drug	[5539]
SYM2081	DM30WDL	Investigative	Small molecular drug	[5540]
SYMBIOPOLYOL	DM28TXP	Investigative	NA	[5541]
SYN-1327	DMFNR75	Investigative	NA	[5542]
syn-BrP-LPA	DMM5PVL	Investigative	Small molecular drug	[5543]
Syringic Acid	DM802V7	Investigative	Small molecular drug	[21]
SZ(+)-(S)-202-791	DM8L6ZF	Investigative	Small molecular drug	[5544]
T-0509	DMSVLXQ	Investigative	Small molecular drug	[5545]
T-1105	DMGPQ0Y	Investigative	Small molecular drug	[3080]
T-98475	DMFKQ1W	Investigative	Small molecular drug	[5546]
T-BuAc-RYYRIK-NH2	DMKAX76	Investigative	Small molecular drug	[754]
T-kinin	DMYGXHK	Investigative	Small molecular drug	[5547]
T0070907	DMTKSVO	Investigative	Small molecular drug	[5548]
T0156	DMZE9TW	Investigative	Small molecular drug	[5549]
T0901317	DMZQVDI	Investigative	Small molecular drug	[5550]
T1117	DMSA3U4	Investigative	Small molecular drug	[5551]
T13	DMVRJEL	Investigative	Small molecular drug	[5552]
T134	DM6HZVC	Investigative	Small molecular drug	[5553]
T140	DMIHBC5	Investigative	Small molecular drug	[5554]
T22	DMBIH8A	Investigative	Small molecular drug	[5555]
T2328	DMCWE90	Investigative	Small molecular drug	[5556]
TA1-RTA	DMP2016	Investigative	Small molecular drug	[5557]
TACRINE(8)-4-AMINOQUINOLINE	DMOWHER	Investigative	Small molecular drug	[22]
TAD	DMCIEQO	Investigative	Small molecular drug	[5558]
Tagetitoxin	DM3B8R1	Investigative	Small molecular drug	[5559]
tagitinin A	DM2RN0S	Investigative	Small molecular drug	[5560]
TALAROFLAVONE	DMW24JP	Investigative	Small molecular drug	[5561]
talinolol	DMRTD16	Investigative	Small molecular drug	[5562]
Talmapimod	DMMTSL2	Investigative	Small molecular drug	[5563]
TAM-67	DM26SE7	Investigative	Small molecular drug	[5564]
TAMARIXETIN	DM0EP51	Investigative	Small molecular drug	[1906]
Tamarixetin 3-glucoside-7-sulfate	DM17JFO	Investigative	Small molecular drug	[3624]
Tamoxifen butyl bromide	DMBKL5O	Investigative	Small molecular drug	[5565]
Tamoxifen ethyl bromide	DM76BXY	Investigative	Small molecular drug	[5565]
Tamoxifen isopropyl bromide	DMBKWUZ	Investigative	Small molecular drug	[5565]
tannic acid	DM52WGH	Investigative	Small molecular drug	[5566]
TANNIN	DMTFHRI	Investigative	NA	[5088]
TASPINE	DM9S5DV	Investigative	Small molecular drug	[5567]
taurine	DMVW7N3	Investigative	Small molecular drug	[5568]
taurochenodeoxycholic acid	DMEL9UT	Investigative	Small molecular drug	[5569]
taurolithocholic acid-3-sulphate	DMWKJLT	Investigative	Small molecular drug	[5570]
tauroursodeoxycholic acid	DMFKRQE	Investigative	Small molecular drug	[5571]
TAUTOMYCIN	DMC92DQ	Investigative	Small molecular drug	[2463]
TBI-4000	DMM3JK1	Investigative	NA	[1866]
TBPS	DMFC3XP	Investigative	Small molecular drug	[5572]
TC-2559	DMLNVH8	Investigative	Small molecular drug	[5573]
TCI15	DM06DI1	Investigative	Small molecular drug	[5574]
TCN-201	DMMT2GP	Investigative	Small molecular drug	[5575]
TCPA	DMTF4VI	Investigative	Small molecular drug	[5576]
TCPOBOP	DMKVF5Q	Investigative	Small molecular drug	[5577]
TCS 2510	DMOLJRH	Investigative	Small molecular drug	[5578]
TCS 5861528	DMMUFSQ	Investigative	Small molecular drug	[5579]
TCS-359	DMH6UN8	Investigative	Small molecular drug	[867]
TCS-OX2-29	DML8RTO	Investigative	Small molecular drug	[5580]
TCS2314	DMBVYQR	Investigative	Small molecular drug	[5581]
tedisamil	DM0HJD4	Investigative	Small molecular drug	[5582]
TEFLUDAZINE	DMRPFCS	Investigative	Small molecular drug	[5583]
TEI-8362	DMBNYJW	Investigative	Small molecular drug	[3438]
TEI-9063	DMGQLYR	Investigative	Small molecular drug	[5584]
TEI-9647	DMLDAR4	Investigative	Small molecular drug	[5585]
Teijin-lead_cmp_5	DMSMLRB	Investigative	Small molecular drug	[5586]
Tellimagrandin II	DM60HU5	Investigative	Small molecular drug	[387]
Tellurium	DMGD0HT	Investigative	Small molecular drug	[5587]
Tendamistat	DML53GP	Investigative	Small molecular drug	[5588]
TENELLONE A	DM1S209	Investigative	Small molecular drug	[5589]
TENELLONE B	DM9ZVJ7	Investigative	Small molecular drug	[5589]
Tenocyclidine	DMRM1QV	Investigative	Small molecular drug	[5590]
Tensirolimus	DM2UI7Y	Investigative	NA	[1866]
TEPA (possesses cytotoxic activity)	DMROS5K	Investigative	Small molecular drug	[386]
TERRITREM B	DMPX7QS	Investigative	Small molecular drug	[5591]
Tert-butyl (2S)-1-cyanopyrrolidine-2-carboxylate	DM8LI1K	Investigative	Small molecular drug	[5102]
Tert-butyl 10H-phenothiazine-10-carboxylate	DMW2X5V	Investigative	Small molecular drug	[1050]
Tert-Butyl 2-(2-oxohexadecanamido)acetate	DMWQFY6	Investigative	Small molecular drug	[341]
TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE	DMZG5I7	Investigative	Small molecular drug	[22]
Tert-Butyl 3-(2-oxo-8-phenyloctanamido)propanoate	DMNU9WV	Investigative	Small molecular drug	[341]
Tert-Butyl 3-(2-oxohexadecanamido)propanoate	DMYQXPB	Investigative	Small molecular drug	[341]
Tert-Butyl 5-(2-oxohexadecanamido)pentanoate	DM1ALTR	Investigative	Small molecular drug	[341]
Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate	DM42WFH	Investigative	Small molecular drug	[22]
Tert-butyloxy carbonyl-D-Phe-pro-Arg-H	DMQKOUZ	Investigative	Small molecular drug	[5592]
Tetrabromocinnamic acid	DMKLIXZ	Investigative	Small molecular drug	[5593]
Tetrabutylammonium Ion	DMX5MAU	Investigative	Small molecular drug	[12]
Tetradecane	DMK8P61	Investigative	Small molecular drug	[12]
Tetradecyl-phosphonic acid	DMABITD	Investigative	Small molecular drug	[96]
Tetraethylene Glycol	DMH4AGL	Investigative	Small molecular drug	[12]
Tetragastrin	DMDWUCX	Investigative	Small molecular drug	[5594]
Tetrahydro-pyrimidin-2-ylideneamine	DMMU6WQ	Investigative	Small molecular drug	[318]
TETRAHYDROBENXIMIDAZOLE	DMNURE0	Investigative	Small molecular drug	[5595]
tetrahydrocannabivarin	DMDY1MZ	Investigative	Small molecular drug	[5596]
tetrahydrodeoxycorticosterone	DMF8M0W	Investigative	Small molecular drug	[5597]
Tetrahydroimidazo[4,5,1-jk]-[1,4]benzodiazepin-2(1H)-one	DMNH3ST	Investigative	NA	[5598]
TETRAHYDROQUINOLINE A	DMWRZJX	Investigative	Small molecular drug	[5599]
TETRAHYDROQUINOLINE B	DMHT61V	Investigative	Small molecular drug	[5599]
tetralin_urea analogue (7o)	DMWOBAE	Investigative	Small molecular drug	[5600]
Tetramethylammonium Ion	DMLEPYN	Investigative	Small molecular drug	[12]
tetronothiodin	DM8T7CG	Investigative	Small molecular drug	[5601]
TFMPP	DMAC8TP	Investigative	Small molecular drug	[5602]
TG-100435	DMIR3X2	Investigative	Small molecular drug	[5603]
TG-1031	DM5VJQP	Investigative	NA	[5604]
TG-2001	DMRFAVG	Investigative	NA	[5605]
TG4-155	DM862TI	Investigative	Small molecular drug	[5606]
TG7-171	DM0OHL3	Investigative	Small molecular drug	[5607]
TGX-221	DMM0LRE	Investigative	Small molecular drug	[5608]
THEASINENSIN A	DMG6S2V	Investigative	Small molecular drug	[372]
THEBAINE	DMRCD3O	Investigative	Small molecular drug	[2633]
Thenoyltrifluoroacetone	DM54OKX	Investigative	Small molecular drug	[5609]
THI	DMDSSHW	Investigative	Small molecular drug	[5610]
thiadiazolidinone (TDZD) deriv. 6	DM9CF45	Investigative	Small molecular drug	[5611]
Thiadiazolo[2,3-a]pyrimidine	DMKRG2C	Investigative	NA	[3080]
Thiamin Diphosphate	DM3F25L	Investigative	Small molecular drug	[12]
thiamine monophosphate	DMWE5EJ	Investigative	Small molecular drug	[5612]
Thieno analogue of kenpaullone	DMIOTHG	Investigative	Small molecular drug	[5613]
Thieno[2,3-B]Pyridine-2-Carboxamidine	DMUL2FW	Investigative	Small molecular drug	[22]
Thieno[3,2-e][1]benzothiophene-4,5-dione	DMT74N6	Investigative	Small molecular drug	[385]
THIIC	DM3KU46	Investigative	Small molecular drug	[5614]
thio-BCTC	DM76EPH	Investigative	Small molecular drug	[5615]
Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester	DMBOKSF	Investigative	Small molecular drug	[1480]
Thiocarbamate	DMP7LJH	Investigative	Small molecular drug	[5616]
thiochrome	DML4TQ5	Investigative	Small molecular drug	[5617]
THIOCITRULLINE	DM7X8MH	Investigative	Small molecular drug	[5618]
Thiocolchicine	DMJSKIP	Investigative	Small molecular drug	[5619]
Thiocoumarin	DMPTSN0	Investigative	Small molecular drug	[22]
THIOCTIC ACID	DMNFCXW	Investigative	Small molecular drug	[1362]
THIOGENISTEIN	DMK2J5L	Investigative	Small molecular drug	[1562]
Thiophene-2-ylboronic acid	DML3OHW	Investigative	Small molecular drug	[1617]
Thiophosphoric acid (E)-dodec-9-enyl ester	DMZ4FCB	Investigative	Small molecular drug	[96]
Thiophosphoric acid (E)-tetradec-9-enyl ester	DMYOXJ4	Investigative	Small molecular drug	[96]
Thiophosphoric acid dec-9-enyl ester	DM12NGE	Investigative	Small molecular drug	[96]
Thiophosphoric acid decyl ester	DM36KW9	Investigative	Small molecular drug	[96]
Thiorphan	DM86LFB	Investigative	Small molecular drug	[5620]
Thiostrepton	DML7Y1R	Investigative	Small molecular drug	[2074]
Thioureido sulfonamide	DM8WYEM	Investigative	NA	[5621]
THPG	DMD1G6R	Investigative	Small molecular drug	[5622]
THPO	DMJD479	Investigative	Small molecular drug	[5623]
Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride	DM4W1E8	Investigative	Small molecular drug	[598]
threo-3-methylglutamate	DMOE3IJ	Investigative	Small molecular drug	[5624]
thromboxane A2	DMXCA0U	Investigative	Small molecular drug	[5625]
THRX160209	DMY07CA	Investigative	Small molecular drug	[3997]
THYMELEATOXIN	DMUDGSN	Investigative	Small molecular drug	[3478]
Thymidine-5'-Phosphate	DMKM6NQ	Investigative	Small molecular drug	[12]
Thymine	DMKGXB9	Investigative	Small molecular drug	[5626]
TI3	DMGXSTB	Investigative	Small molecular drug	[2431]
TI4	DMOXINT	Investigative	Small molecular drug	[2431]
Tiazofurin adenine dinucleotide	DMEFVPH	Investigative	Small molecular drug	[5627]
Tic-D-Phe-Arg-2-Nal-NHCH3	DMMFCHU	Investigative	Small molecular drug	[5628]
tifluadom	DM4QK0T	Investigative	Small molecular drug	[5629]
TILIROSIDE	DMLNTB5	Investigative	Small molecular drug	[5630]
Tin protoporphyrin	DMTXJ5S	Investigative	Small molecular drug	[5631]
tin protoporphyrin IX	DMJO1VQ	Investigative	Small molecular drug	[5632]
TINGENIN B	DMEV7FY	Investigative	Small molecular drug	[5633]
TINGENONE	DMH3NTP	Investigative	Small molecular drug	[5633]
tiotidine	DM81KD2	Investigative	Small molecular drug	[5634]
TIP	DMZO1FJ	Investigative	Small molecular drug	[3347]
TIPPpsi	DM9FNQ6	Investigative	Small molecular drug	[5635]
tirotundin	DMQ4GBO	Investigative	Small molecular drug	[5560]
TL-77	DMSIM4Y	Investigative	Small molecular drug	[5636]
TMB-8	DMCN2B8	Investigative	Small molecular drug	[5637]
TMP269	DMSMQE7	Investigative	Small molecular drug	[5638]
TNK-651	DMC958O	Investigative	Small molecular drug	[5639]
TNP-ATP	DMVZY0X	Investigative	Small molecular drug	[5640]
TOLOXATONE	DMHV5NK	Investigative	Small molecular drug	[5641]
TOLSERINE	DMPTM6V	Investigative	Small molecular drug	[5642]
toluene	DMNK7ZU	Investigative	Small molecular drug	[5643]
Toluene-1-diazonium-3-sulfonic acid anion	DMAYUV6	Investigative	Small molecular drug	[1749]
Tonazocine mesylate	DMROZL8	Investigative	Small molecular drug	[5644]
TOPOSTATIN	DMNZQO9	Investigative	Small molecular drug	[5645]
torin 1	DMZD0NA	Investigative	Small molecular drug	[5646]
Tormentic acid methyl ester	DMDG0HK	Investigative	Small molecular drug	[669]
Tosyl-D-Proline	DMNC2A5	Investigative	Small molecular drug	[12]
toxaphene	DM4R657	Investigative	Small molecular drug	[5647]
TOXIFERINE	DMJHTQK	Investigative	Small molecular drug	[5648]
TP-680	DMM41O9	Investigative	Small molecular drug	[5649]
TP003	DMRHDGN	Investigative	Small molecular drug	[5650]
TPCA-1	DMA14PR	Investigative	Small molecular drug	[5651]
Tpl2 kinase inhibitor	DMHATCZ	Investigative	Small molecular drug	[5652]
TPMPA	DMBF6KS	Investigative	Small molecular drug	[5653]
TPP+	DM2NZPY	Investigative	Small molecular drug	[5654]
TQX-173	DMZA6X3	Investigative	Small molecular drug	[5655]
tracazolate	DMFC0VR	Investigative	Small molecular drug	[5656]
TRACIZOLINE	DM18CV3	Investigative	Small molecular drug	[1021]
Tramazoline	DM3ML0N	Investigative	Small molecular drug	[4046]
Trans,trans-1,3-bis-(4-hydroxycyclohexyl)urea	DMHD1XM	Investigative	Small molecular drug	[570]
Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	DM27TPM	Investigative	Small molecular drug	[2598]
Trans-(1S(R),2S(R))-2-Hydroxycyclooctyl nitrate	DMYVJHN	Investigative	Small molecular drug	[5657]
Trans-(R(S))-2-Hydroxy-1-phenylethyl nitrate	DMXC98D	Investigative	Small molecular drug	[5657]
Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	DMH1S57	Investigative	Small molecular drug	[2598]
Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	DMO01T8	Investigative	Small molecular drug	[2598]
Trans-2-fluoro-2-p-tolylcyclopropanamine	DM392QT	Investigative	Small molecular drug	[2598]
Trans-2-fluoro-2-phenylcyclopropylamin	DMVGAFR	Investigative	Small molecular drug	[2598]
trans-2-methylcrotonic acid	DMHJM0B	Investigative	Small molecular drug	[5658]
Trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine	DMEDC5I	Investigative	Small molecular drug	[2601]
trans-3-ACPBPA	DM6HI8W	Investigative	Small molecular drug	[5659]
trans-4-hydroxy-proline	DMZLV5D	Investigative	Small molecular drug	[5660]
Trans-dimethyl gababutin	DM8E9YS	Investigative	Small molecular drug	[5661]
Trans-H-Tyr-c[D-AllylGly-Gly-Phe-D-Allylgly]-OH	DMBU4KJ	Investigative	Small molecular drug	[2603]
Trans-hydroxytamoxifen	DMXS8LN	Investigative	NA	[5662]
TRANSTORINE	DMP4T87	Investigative	Small molecular drug	[5663]
Trapoxin	DMXZAH6	Investigative	Small molecular drug	[5664]
Trecadrine	DMDX0VI	Investigative	Small molecular drug	[5665]
Triazine	DM8LYSB	Investigative	Small molecular drug	[430]
triazine compound PC10	DMCLA2D	Investigative	Small molecular drug	[5666]
Triazolopyridine	DM1F2K0	Investigative	Small molecular drug	[22]
TRIAZOLOPYRIMIDINE	DM5ZBF3	Investigative	Small molecular drug	[22]
Tribenzyl 2-aminopropane-1,2,3-tricarboxylate	DMYSX0K	Investigative	Small molecular drug	[578]
Tributylstannanyl	DMHN7CB	Investigative	Small molecular drug	[22]
Tricarballylic Acid	DMLKWTG	Investigative	Small molecular drug	[12]
trichloroethanol	DMNALMF	Investigative	Small molecular drug	[5667]
Triethyl 2-aminopropane-1,2,3-tricarboxylate	DM5Q7K8	Investigative	Small molecular drug	[578]
triethylcholine	DMUPK6G	Investigative	Small molecular drug	[5668]
Trifluoroethanol	DMAWTUL	Investigative	Small molecular drug	[107]
Trifluoromethionine	DM4IKBV	Investigative	Small molecular drug	[5669]
Trifluoromethylketone	DMEPFAB	Investigative	NA	[2220]
trihydroxycholestane	DMSP56N	Investigative	Small molecular drug	[5670]
TRIM	DMNHU4M	Investigative	Small molecular drug	[5671]
TRIMEDOXIME	DMPXHTY	Investigative	Small molecular drug	[2569]
Trimethyl-(3-nitro-phenyl)-ammonium iodide	DMQXPMB	Investigative	NA	[131]
Trimethyl-(4-oxo-pentyl)-ammonium iodide	DMJ4I98	Investigative	NA	[131]
trimethylamine	DM8LJ3C	Investigative	Small molecular drug	[5672]
Trimetoquinol	DMK9743	Investigative	Small molecular drug	[5673]
Triphenylacetic acid methyl ester	DM2VIDK	Investigative	Small molecular drug	[132]
TRIPHENYLMETHANAMINE	DM3CQIZ	Investigative	Small molecular drug	[132]
TRIPHLOROETHOL A	DMF8QR6	Investigative	Small molecular drug	[1762]
tripitramine	DMWZ5FB	Investigative	Small molecular drug	[5674]
TRIPTOCALLINE A	DMBYV3M	Investigative	Small molecular drug	[5633]
TRISMETHOXYRESVERATROL	DM6USPC	Investigative	Small molecular drug	[1100]
Trisnorsqualene alcohol	DMQVH3J	Investigative	Small molecular drug	[372]
Trisnorsqualene cyclopropylamine	DM0G2IR	Investigative	Small molecular drug	[372]
Trisnorsqualene difluoromethylidene	DMQA7ZS	Investigative	Small molecular drug	[372]
Trisodium phosphate	DMPVI3A	Investigative	Small molecular drug	[2470]
TROPOLONE	DMOMXP7	Investigative	Small molecular drug	[1147]
TROX-1	DMIF6NS	Investigative	Small molecular drug	[5675]
Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Ser-Val-Tyr-Phe-Cys)	DM48QTG	Investigative	NA	[5676]
Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Val-Tyr-Phe-Cys)	DMOZX8M	Investigative	NA	[5676]
Trypanothione	DMDUGQ1	Investigative	Small molecular drug	[12]
tryptanthrin	DMTRYCI	Investigative	Small molecular drug	[4953]
TRYPTOLINE	DMV19K7	Investigative	Small molecular drug	[1021]
TTNPB	DMSABD0	Investigative	Small molecular drug	[5677]
Tu-514	DMUR0TF	Investigative	Small molecular drug	[12]
tubercidin	DMHICK8	Investigative	Small molecular drug	[5678]
TUG-424	DM2H0PQ	Investigative	Small molecular drug	[5679]
TUG-770	DM487HF	Investigative	Small molecular drug	[5680]
TUG-891	DMJRGZT	Investigative	Small molecular drug	[5681]
TUPICHINOL C	DMAUTRP	Investigative	Small molecular drug	[2397]
TURBINATINE	DMLDYVB	Investigative	Small molecular drug	[5682]
TVX-006	DMDW1L1	Investigative	NA	[1866]
TVX-007	DM5OD2G	Investigative	NA	[1866]
TVX-008	DMD7LOQ	Investigative	NA	[1866]
TVX-009	DMWT0C6	Investigative	NA	[1866]
TVX-010	DM4CUUE	Investigative	NA	[1866]
TVX-011	DM2HWWF	Investigative	NA	[1866]
TW-37	DMDE8YS	Investigative	Small molecular drug	[763]
TWS-119	DMS29M4	Investigative	Small molecular drug	[5683]
Tylophorinidine	DMHFCZA	Investigative	Small molecular drug	[4655]
Tyr-(NMe)Ala-L-Phe-D-Pro-NH2	DMIWPKB	Investigative	Small molecular drug	[5684]
Tyr-(R)-Aba-Gly-Phe-NH2	DMDQJUO	Investigative	Small molecular drug	[5685]
Tyr-(R)-spiro-Aba-Gly-Phe-NH2	DMHNM3K	Investigative	Small molecular drug	[5685]
Tyr-(S)-Aba-Gly-Phe-NH2	DMYZ792	Investigative	Small molecular drug	[5685]
Tyr-(S)-spiro-Aba-Gly-Phe-NH2	DMT316S	Investigative	Small molecular drug	[5685]
Tyr-D-Ala-Gly-D-Trp-Nle-Asp-Phe-NH2	DM0D1Z5	Investigative	Small molecular drug	[5686]
Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2	DMPH1G0	Investigative	Small molecular drug	[5686]
Tyr-D-Ala-Gly-NMePhe	DM2XRZL	Investigative	Small molecular drug	[5687]
Tyr-D-Ala-Gly-Phe-Met-NH2	DMC7LND	Investigative	Small molecular drug	[5688]
Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-Bzl	DMWOP9N	Investigative	NA	[5689]
Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-NMeNle-D-Trp-Boc	DMB2TCF	Investigative	NA	[3344]
Tyr-D-Ala-Gly-Trp-Nle-Asp-Phe-NH2	DMUXMVQ	Investigative	Small molecular drug	[5686]
Tyr-D-Ala-Gly-Trp-NMeNle-Asp-Phe-NH2	DMREJ69	Investigative	Small molecular drug	[5686]
Tyr-D-Ala-Phe-Asp-Val-Val-Thr[Beta-D-Glc]-Gly-NH2	DMTPLNZ	Investigative	NA	[5690]
Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2	DMC4NO5	Investigative	Small molecular drug	[5691]
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr(Beta-D-Glc)-Gly-NH2	DM4FASR	Investigative	NA	[5690]
Tyr-D-Ala-Phe-Thr(-D-Glc)-Tyr-Pro-Ser-NH2	DMB9A46	Investigative	NA	[5690]
Tyr-D-Ala-Phe-Thr[-D-Glc(OAc)4]-Tyr-Pro-Ser-NH2	DMLC0NW	Investigative	NA	[5690]
Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2	DM4YTFP	Investigative	Small molecular drug	[5691]
Tyr-D-Nle-Gly-D-Trp-Nle-Asp-Phe-NH2	DMY9NIJ	Investigative	Small molecular drug	[5686]
Tyr-D-Nle-Gly-D-Trp-NMeNle-Asp-Phe-NH2	DMQREP2	Investigative	Small molecular drug	[5686]
Tyr-D-Nle-Gly-Trp-Nle-Asp-Phe-NH2	DMZ24LN	Investigative	Small molecular drug	[5686]
Tyr-D-Nle-Gly-Trp-NMeNle-Asp-Phe-NH2	DMPSJ72	Investigative	Small molecular drug	[5686]
Tyr-D-Phe-Gly-D-Trp-Nle-Asp-Phe-NH2	DMIWMN6	Investigative	Small molecular drug	[5686]
Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2	DM2CEWT	Investigative	Small molecular drug	[5686]
Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2	DMKM81A	Investigative	Small molecular drug	[5686]
Tyr-D-Phe-Gly-Trp-NMeNle-Asp-Phe-NH2	DMZOTGM	Investigative	Small molecular drug	[5686]
Tyr-D-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	DMM9H07	Investigative	Small molecular drug	[5686]
Tyr-Gly-Gly-Phe-c(Cys-Arg-Arg-Ile-Cys)-Arg-lys	DMKND2R	Investigative	NA	[2077]
Tyr-Gly-Gly-Phe-leu-c(Cys-Arg-Ile-Arg-Cys)-lys	DMG6NDA	Investigative	NA	[2077]
Tyr-Gly-Gly-Trp-NMeNle-Asp-Phe-NH2	DMN7290	Investigative	Small molecular drug	[5686]
Tyr-Pro-3,5Dmp-Phe-NH2	DMDCJWU	Investigative	Small molecular drug	[2927]
Tyr-Pro-D-(NMe)Phe-D-Pro-NH2	DMH08O3	Investigative	Small molecular drug	[5684]
Tyr-Pro-D-Phe-D-Pro-NH2	DM4ZJR5	Investigative	Small molecular drug	[5684]
Tyr-Pro-D-Phe-Pro-NH2	DMCTSNE	Investigative	Small molecular drug	[5684]
Tyr-Pro-D-Phg-Phe-NH2	DMEDVRN	Investigative	Small molecular drug	[5692]
Tyr-Pro-Dmp-Phe-NH2	DMNXCHT	Investigative	Small molecular drug	[2927]
Tyr-Pro-Dmt-Phe-NH2	DMOU43H	Investigative	Small molecular drug	[2927]
Tyr-Pro-Emp-Phe-NH2	DMUKE43	Investigative	Small molecular drug	[2927]
Tyr-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	DM8THU2	Investigative	Small molecular drug	[5686]
Tyr-Pro-Hfe-Phe-NH2	DME5HIS	Investigative	Small molecular drug	[5692]
Tyr-Pro-Hfe-Pro-NH2	DMJBR75	Investigative	Small molecular drug	[5692]
Tyr-Pro-Imp-Phe-NH2	DMUV3ZW	Investigative	Small molecular drug	[2927]
Tyr-Pro-L-(NMe)Phe-D-Pro-NH2	DMI65GV	Investigative	Small molecular drug	[5684]
Tyr-Pro-L-(NMe)Phe-Pro-NH2	DM1NITL	Investigative	Small molecular drug	[5684]
Tyr-Pro-L-Phe-D-Pro-NH2	DMUVHGS	Investigative	Small molecular drug	[5684]
Tyr-Pro-L-Phe-Pro-NH2	DM8VW3Z	Investigative	Small molecular drug	[5684]
Tyr-Pro-Mmp-Phe-NH	DMRE7G3	Investigative	Small molecular drug	[2927]
Tyr-Pro-Phe-Ala-Bn	DMIE4U5	Investigative	Small molecular drug	[5693]
Tyr-Pro-Phe-D-2-Nal-NH2	DMLQ3PR	Investigative	Small molecular drug	[2929]
Tyr-Pro-Phe-D-Ala-Bn	DMLEUF6	Investigative	Small molecular drug	[5693]
Tyr-Pro-Phe-D-Phg-NH2	DM6YRVT	Investigative	Small molecular drug	[5692]
Tyr-Pro-Phe-D-Val-Bn	DM1QZ9X	Investigative	Small molecular drug	[5693]
Tyr-Pro-Phe-Hfe-NH2	DM71P2O	Investigative	Small molecular drug	[5692]
Tyr-Pro-Phe-Phe-N(CH3)2	DM5DRIZ	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-NHCH3	DM2U4VI	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-NHNH2	DMY6V9R	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-OC(CH3)3	DMS4P1E	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-OCH2CH3	DMZNHEC	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-OCH2OH	DMFV7NI	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phe-OCH3	DMRQXHO	Investigative	Small molecular drug	[5694]
Tyr-Pro-Phe-Phg-NH2	DM70HYT	Investigative	Small molecular drug	[5692]
Tyr-Pro-Phg-Phe-NH2	DMVDM73	Investigative	Small molecular drug	[5692]
Tyr-Pro-Phg-Pro-NH2	DMSGMPU	Investigative	Small molecular drug	[5692]
Tyr-Pro-Tmp-Phe-NH	DMR3IVB	Investigative	Small molecular drug	[2927]
Tyr-Pro-Trp-D-Ala-Bn	DMFIPXA	Investigative	Small molecular drug	[5693]
Tyr-Pro-Trp-D-Val-Bn	DMY5HX6	Investigative	Small molecular drug	[5693]
Tyr-Pro-Trp-Gly-Bn	DMKLDWF	Investigative	Small molecular drug	[5693]
Tyr-Sar-Phe-D-2-Nal-NH2	DMIZB25	Investigative	Small molecular drug	[2929]
tyramine	DM4UXT1	Investigative	Small molecular drug	[5695]
Tyrphostin ag-1478	DM87ZIH	Investigative	Small molecular drug	[5696]
TZD18	DMVCHOX	Investigative	Small molecular drug	[5697]
TZI-41127	DMSI0HE	Investigative	Small molecular drug	[5698]
U-44069	DM0DMNS	Investigative	Small molecular drug	[1855]
U-89267	DMQT6AH	Investigative	Small molecular drug	[5699]
U0126	DM31OGF	Investigative	Small molecular drug	[5700]
U101958	DM9GOAV	Investigative	Small molecular drug	[5701]
U46619	DM13FX4	Investigative	Small molecular drug	[5702]
U50,488H	DMYW1VP	Investigative	Small molecular drug	[5703]
U73122	DMTZ0C5	Investigative	Small molecular drug	[5704]
U92016A	DM7CJNE	Investigative	Small molecular drug	[5705]
UBIQUINONE-2	DMLUP30	Investigative	Small molecular drug	[22]
UBP-302	DMSJLX0	Investigative	Small molecular drug	[5706]
UBP141	DM6IG5J	Investigative	Small molecular drug	[5707]
UBP310	DMVQL3J	Investigative	Small molecular drug	[5708]
UCB-101333-3	DMHYORU	Investigative	Small molecular drug	[5709]
UCB35625	DMQB8C3	Investigative	Small molecular drug	[5710]
UCCF-029	DMO9S5P	Investigative	Small molecular drug	[5711]
UCCF-339	DM3I9JG	Investigative	Small molecular drug	[5712]
UCCF-853	DMN9QO4	Investigative	Small molecular drug	[5713]
UCL-2138	DM15CJZ	Investigative	Small molecular drug	[5714]
UCL1684	DMZNJFU	Investigative	Small molecular drug	[5715]
UCL1848	DM2CN0A	Investigative	Small molecular drug	[5716]
UCL1972	DM0P5Z9	Investigative	Small molecular drug	[5717]
UCM 549	DM9JG1L	Investigative	Small molecular drug	[5718]
UCM 724	DMCKSYQ	Investigative	Small molecular drug	[5719]
UCM 765	DMD16MH	Investigative	Small molecular drug	[5720]
UCM 793	DM8J41W	Investigative	Small molecular drug	[5721]
UCM-454	DMSVJFG	Investigative	Small molecular drug	[5722]
UCM-5600	DMOJ4TG	Investigative	Small molecular drug	[5723]
UCPH-101	DMTQEDA	Investigative	Small molecular drug	[5724]
UDP-beta-S	DMMWHAV	Investigative	Small molecular drug	[5725]
UDP-glucose	DMLT4JA	Investigative	Small molecular drug	[12]
UDP-glucuronic acid	DMW16X2	Investigative	Small molecular drug	[5726]
UDP-xylose	DMVE7MZ	Investigative	Small molecular drug	[5727]
UFP-101	DMKZF01	Investigative	Small molecular drug	[5728]
UFP-112	DMENTMP	Investigative	Small molecular drug	[5729]
UFP-502	DMD8BRG	Investigative	Small molecular drug	[5730]
UFP-512	DMYPVSJ	Investigative	Small molecular drug	[5730]
UH-232	DM5K6ZE	Investigative	Small molecular drug	[5731]
UH-AH 37	DMT5UMG	Investigative	Small molecular drug	[5732]
Uinagolide	DMOVY6L	Investigative	Small molecular drug	[5733]
UK-129485	DM6GLSF	Investigative	Small molecular drug	[5734]
UK-356618	DM02FGH	Investigative	Small molecular drug	[5735]
UK-383367	DME7VG6	Investigative	Small molecular drug	[5736]
UltraBAFF	DMD55I2	Investigative	NA	[1866]
UMI-77	DM54XJO	Investigative	Small molecular drug	[5737]
UNC0006	DMXSTF2	Investigative	Small molecular drug	[5738]
UNC0321	DMCVU1T	Investigative	Small molecular drug	[5739]
UNC0638	DM4A1KJ	Investigative	Small molecular drug	[5740]
UNC0642	DM7Y1SO	Investigative	Small molecular drug	[5741]
UNC1215	DMWMRLS	Investigative	Small molecular drug	[5742]
UNC1999	DMOPCBD	Investigative	Small molecular drug	[5743]
UNC9975	DM4RDVO	Investigative	Small molecular drug	[5738]
UNC9994	DMDK86V	Investigative	Small molecular drug	[5738]
undecanoic acid	DMFOIPL	Investigative	Small molecular drug	[5744]
Undecyl-Phosphinic Acid Butyl Ester	DMD9KEB	Investigative	NA	[22]
Undecylamine-n,n-dimethyl-n-oxide	DM4AYC2	Investigative	Small molecular drug	[22]
UNIFLORINE B	DMFH79T	Investigative	Small molecular drug	[94]
Up3U	DMKQWSB	Investigative	Small molecular drug	[5745]
UR-10324	DMPF1VU	Investigative	NA	[5746]
UR-11353	DM8G9NY	Investigative	Small molecular drug	[5746]
UR-12519	DMVZQ47	Investigative	Small molecular drug	[5747]
UR-PG131A	DM2C6GB	Investigative	Small molecular drug	[5748]
UR-PG146	DMQCL6Y	Investigative	Small molecular drug	[5749]
UR-PG153	DM3VTLG	Investigative	Small molecular drug	[5750]
UR-PG55B	DM6SM4N	Investigative	Small molecular drug	[5751]
Uracil	DMNPO9Q	Investigative	Small molecular drug	[1866]
uric acid	DMA1MKT	Investigative	Small molecular drug	[5752]
Uridine Diphosphate Galactose	DMPA0BJ	Investigative	Small molecular drug	[5753]
Uridine-5'-Diphosphate	DMDQKJB	Investigative	Small molecular drug	[5754]
Uridine-5'-Diphosphate-Mannose	DMAYCQU	Investigative	Small molecular drug	[12]
Uridine-5'-Monophosphate	DMG1NM7	Investigative	Small molecular drug	[5755]
Uridine-Diphosphate-N-Acetylglucosamine	DMEQSTP	Investigative	Small molecular drug	[5756]
URMC-099	DMCJXWK	Investigative	Small molecular drug	[4952]
urotensin II-related peptide	DMCE3PJ	Investigative	Small molecular drug	[5757]
USIMINE A	DMCQ8AL	Investigative	Small molecular drug	[5758]
USNIC ACID	DMGOURX	Investigative	Small molecular drug	[5758]
USTILOXIN A	DMZP32O	Investigative	Small molecular drug	[1718]
Ustiloxin D	DMA8JH7	Investigative	Small molecular drug	[1718]
Ustiloxin F	DMT1LS0	Investigative	Small molecular drug	[1718]
UTPgammaS	DMKLB4O	Investigative	Small molecular drug	[5759]
UVAOL	DMAFQE1	Investigative	Small molecular drug	[722]
UVI3003	DM95UI1	Investigative	Small molecular drug	[5760]
V-165	DM8SWVN	Investigative	Small molecular drug	[5761]
Va-RYYRIK-NH2	DM3K8PT	Investigative	Small molecular drug	[754]
vacquinol-1	DMDANYG	Investigative	Small molecular drug	[5762]
VAGANINE D	DMEOJ89	Investigative	Small molecular drug	[5763]
valerenic acid amide	DME7OTF	Investigative	Small molecular drug	[5764]
VALIOLAMINE	DM2VQN5	Investigative	Small molecular drug	[435]
vanillylmandelic acid	DMZ0VBX	Investigative	Small molecular drug	[5765]
VARIECOLIN	DMVBO78	Investigative	Small molecular drug	[5766]
Vaxfectin	DMQ9SXU	Investigative	NA	[1866]
VCP-28	DMG1YZQ	Investigative	Small molecular drug	[5767]
VEGF receptor 2 kinase inhibitor I	DMWXCYA	Investigative	Small molecular drug	[5768]
VER-156085	DMCRHOA	Investigative	Small molecular drug	[5769]
VER-2692	DM5WAM8	Investigative	Small molecular drug	[5770]
VER-3323	DM7O2K1	Investigative	Small molecular drug	[5771]
VER-49009	DMF1KDX	Investigative	Small molecular drug	[5772]
VER-5384	DMC2EO9	Investigative	Small molecular drug	[5773]
VER-5593	DMZ2V0A	Investigative	Small molecular drug	[5773]
VERAGUENSIN	DMJRVBS	Investigative	Small molecular drug	[3758]
veratridine	DMUF8JZ	Investigative	Small molecular drug	[5774]
Verdoheme	DM7NRK5	Investigative	Small molecular drug	[107]
Verongamine	DMD1C6S	Investigative	Small molecular drug	[1947]
vesamicol	DMHKUBG	Investigative	Small molecular drug	[5775]
vinburnine	DMO4GBK	Investigative	Small molecular drug	[5776]
viral macrophage inflammatory protein-II	DMAXOPS	Investigative	Small molecular drug	[5777]
visnagin	DMCSHE8	Investigative	Small molecular drug	[5778]
Vitamin K	DMN6EZY	Investigative	Small molecular drug	[5779]
VITAMIN K2	DMJB3E1	Investigative	Small molecular drug	[5780]
VL-0395	DMKW5YL	Investigative	Small molecular drug	[5781]
VL-0494	DM2XAUY	Investigative	Small molecular drug	[5782]
VL-0699	DMCZNB3	Investigative	Small molecular drug	[5783]
VL-1499	DMU9VQJ	Investigative	Small molecular drug	[5784]
VL-2799	DMBEV4W	Investigative	Small molecular drug	[5785]
VLTS-582	DMYH3A0	Investigative	NA	[5786]
Voacangine	DMA106W	Investigative	Small molecular drug	[2647]
VP-343	DMT03VB	Investigative	Small molecular drug	[2610]
VPC03090-P	DMIXUM3	Investigative	Small molecular drug	[5787]
VPC12249	DM6F0VR	Investigative	Small molecular drug	[5788]
VPC23019	DMVQFY4	Investigative	Small molecular drug	[5789]
VPC32179	DMARFCR	Investigative	Small molecular drug	[5790]
VPC32183	DMLK3I9	Investigative	Small molecular drug	[5791]
VPC44116	DMQ4OTJ	Investigative	Small molecular drug	[5792]
VRC3375	DM1QKVL	Investigative	Small molecular drug	[5793]
VRS-XXX	DMS9J4B	Investigative	NA	[1866]
VRX-03011	DMCXZGU	Investigative	NA	[5794]
VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2	DMJ2PG1	Investigative	NA	[1898]
VTX-11e	DMDPN6X	Investigative	NA	[1866]
VTX-744	DMEVAIF	Investigative	NA	[5795]
VU-1545	DMCRF48	Investigative	Small molecular drug	[5796]
VU-29	DM29FTF	Investigative	Small molecular drug	[5797]
VU-71	DMHX1KJ	Investigative	Small molecular drug	[5798]
VU0001171	DMDF2U3	Investigative	Small molecular drug	[5799]
VU0010010	DMXD3T7	Investigative	Small molecular drug	[5800]
VU0029767	DMRNLGW	Investigative	Small molecular drug	[5801]
VU0080241	DMUMOV1	Investigative	Small molecular drug	[5802]
VU0090157	DMGFTVI	Investigative	Small molecular drug	[5803]
VU0092145	DMVMXKP	Investigative	Small molecular drug	[5804]
VU0092273	DMT76JS	Investigative	Small molecular drug	[5805]
VU0119498	DMPSI10	Investigative	Small molecular drug	[5806]
VU0152099	DM1UAQT	Investigative	Small molecular drug	[5807]
VU0152100	DM04HUC	Investigative	Small molecular drug	[5808]
VU0155041	DMPKSTD	Investigative	Small molecular drug	[5809]
VU0238429	DMOPLQI	Investigative	Small molecular drug	[5810]
VU0240382	DMH720P	Investigative	Small molecular drug	[5811]
VU0240551	DMU3YRH	Investigative	Small molecular drug	[5812]
VU0255035	DMRKE6W	Investigative	Small molecular drug	[5813]
VU0285683	DM7VCDF	Investigative	Small molecular drug	[5814]
VU0357121	DMETUHS	Investigative	Small molecular drug	[5815]
VU0359516	DM9V01W	Investigative	Small molecular drug	[5816]
VU0360172	DM3NXMB	Investigative	Small molecular drug	[5817]
VU0361737	DME71ON	Investigative	Small molecular drug	[5818]
VU0361747	DM3ZUH2	Investigative	Small molecular drug	[5819]
VU0364289	DM8TR1Y	Investigative	Small molecular drug	[5820]
VU0364770	DMXY980	Investigative	Small molecular drug	[5821]
VU0366058	DMA6CLO	Investigative	Small molecular drug	[5822]
VU0400195	DM7L51U	Investigative	Small molecular drug	[5823]
VU0404251	DMZRE6X	Investigative	Small molecular drug	[5824]
VU0405601	DMLPMAY	Investigative	Small molecular drug	[5825]
VU0424465	DMZDIVL	Investigative	Small molecular drug	[5826]
VU0463597	DM96FQ2	Investigative	Small molecular drug	[5827]
VU0463841	DMDW9MS	Investigative	Small molecular drug	[5828]
VU0469650	DM1H5DL	Investigative	Small molecular drug	[5829]
VU10007	DM31V7K	Investigative	Small molecular drug	[5830]
VU10010	DM2HGCB	Investigative	Small molecular drug	[5830]
VU591	DMX9ED1	Investigative	Small molecular drug	[5831]
VUF 4904	DMFPNRD	Investigative	Small molecular drug	[5832]
VUF 5207	DMMNVGJ	Investigative	Small molecular drug	[5833]
VUF 5681	DMVFJR4	Investigative	Small molecular drug	[5717]
VUF 8328	DMI6GD0	Investigative	Small molecular drug	[5834]
VUF 8430	DMJC0UH	Investigative	Small molecular drug	[5835]
VUF-10148	DM89PMC	Investigative	Small molecular drug	[5836]
VUF-10214	DMADEOQ	Investigative	Small molecular drug	[5836]
VUF-5297	DM3G6OK	Investigative	Small molecular drug	[1099]
VUF-8504	DM8OTAG	Investigative	Small molecular drug	[5837]
VUF-8507	DMQFWV7	Investigative	Small molecular drug	[5838]
VUF5391	DMF1O0Z	Investigative	NA	[5717]
VUF5574	DMUA751	Investigative	Small molecular drug	[5839]
W-84	DMMBI9Y	Investigative	Small molecular drug	[5840]
W-F-F-N--Y-Y-W	DMAXOIS	Investigative	NA	[1878]
W146	DMDYTSW	Investigative	Small molecular drug	[5841]
W54011	DMQI7BA	Investigative	Small molecular drug	[5842]
WA-8242-A1	DMNRBDP	Investigative	NA	[5843]
waixenicin A	DMB6H35	Investigative	Small molecular drug	[5844]
WAY 100135	DMC6KYF	Investigative	Small molecular drug	[5845]
WAY-125971	DMCSZG0	Investigative	Small molecular drug	[5846]
WAY-151693	DMRWG0C	Investigative	Small molecular drug	[12]
WAY-163909	DMNMO4Q	Investigative	Small molecular drug	[5847]
WAY-169916	DM94KWA	Investigative	Small molecular drug	[1378]
WAY-196025	DMNH0CM	Investigative	Small molecular drug	[2986]
WAY-207024	DMJ14NE	Investigative	Small molecular drug	[5848]
WAY-208466	DM9K2LU	Investigative	Small molecular drug	[5849]
WAY-213613	DMMXL4E	Investigative	Small molecular drug	[5850]
WAY-214950	DM8ODI7	Investigative	Small molecular drug	[990]
WAY-254011	DMC83HA	Investigative	NA	[5851]
WAY-466	DMMOH51	Investigative	Small molecular drug	[5852]
WAY-855	DM06ASD	Investigative	Small molecular drug	[5853]
WAY170523	DMZT8LI	Investigative	Small molecular drug	[5854]
WAY200070	DMBHXTL	Investigative	Small molecular drug	[5855]
WDuo3	DMWU5PK	Investigative	Small molecular drug	[5856]
WEDELOLACTONE	DMHL3YV	Investigative	Small molecular drug	[5857]
WFwGG-NH2	DMQS7BT	Investigative	Small molecular drug	[2196]
WFwLL-NH2	DMOBXVL	Investigative	Small molecular drug	[2196]
WH-4-023	DMJS8VQ	Investigative	Small molecular drug	[5858]
WHI-P131	DMAGTQP	Investigative	Small molecular drug	[1866]
WIN 51,708	DMY5LOB	Investigative	Small molecular drug	[5859]
WIN 62,577	DMGOQY2	Investigative	Small molecular drug	[5860]
WIN 64338	DMTE0YJ	Investigative	Small molecular drug	[5861]
WIN-35065	DM6IH4F	Investigative	Small molecular drug	[5246]
WIN-63395	DMNM50K	Investigative	Small molecular drug	[5862]
WIN-64745	DMQ1B2Y	Investigative	NA	[5863]
WIN-66306	DMUM5LV	Investigative	Small molecular drug	[5864]
WIN-68577	DMJHG1O	Investigative	NA	[5864]
WK-X-34	DMX0ZBC	Investigative	NA	[3717]
WO2012007375C1	DMOZATX	Investigative	Small molecular drug	[5865]
WO2012007375C7	DMPI2MA	Investigative	Small molecular drug	[5866]
WO2013026806C72	DM21WOP	Investigative	Small molecular drug	[5867]
WO2013110309CA127	DMDPN4E	Investigative	Small molecular drug	[5868]
Wogonin	DMGCF51	Investigative	Small molecular drug	[484]
WR-080539	DMUCGK8	Investigative	Small molecular drug	[5869]
WR-089120	DMT9WPJ	Investigative	Small molecular drug	[5869]
WR-190706	DM3TI6L	Investigative	Small molecular drug	[5869]
WR-203581	DM9M1UO	Investigative	Small molecular drug	[5869]
WR-289009	DM5W9GR	Investigative	Small molecular drug	[5869]
WR-289010	DMS2QUL	Investigative	Small molecular drug	[5869]
WR-289012	DMG2LVM	Investigative	Small molecular drug	[5869]
WR-289016	DMT08ZH	Investigative	Small molecular drug	[5869]
WR85915	DM9V0KP	Investigative	Small molecular drug	[5870]
WRC-0571	DM1U29V	Investigative	Small molecular drug	[5871]
WRR-112	DMP761U	Investigative	Small molecular drug	[12]
WRR-204	DMRVAH1	Investigative	Small molecular drug	[12]
WRR-99	DM8ZA6K	Investigative	Small molecular drug	[12]
WS-12	DM48MHL	Investigative	Small molecular drug	[5872]
WS-23	DMT5SXR	Investigative	Small molecular drug	[5873]
WS-3	DM1R8MW	Investigative	Small molecular drug	[5874]
WS-5	DMX1JR0	Investigative	Small molecular drug	[5875]
WTLNSAGYLL-CONH2	DMF9SOV	Investigative	NA	[3318]
WTLNSAGYLLGPHAVGNHPSFSDKNGLTS-CONH2	DMB3567	Investigative	NA	[3318]
WVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2	DMVZB8U	Investigative	NA	[1898]
WWL70	DM3SVG0	Investigative	Small molecular drug	[5876]
WY-46016	DM0AZLE	Investigative	Small molecular drug	[5877]
WZ4003	DMP9RBK	Investigative	Small molecular drug	[5878]
XAC-BY630	DMFS06E	Investigative	Small molecular drug	[5879]
xamoterol	DMOVJP3	Investigative	Small molecular drug	[5880]
xanthine amine congener	DMGYVFD	Investigative	Small molecular drug	[5881]
Xanthosine-5'-monophosphate disodium salt	DM1GJX8	Investigative	Small molecular drug	[5882]
XANTHOSTIGMINE	DM38TLN	Investigative	Small molecular drug	[5883]
XAP044	DMLTVI6	Investigative	Small molecular drug	[5884]
XCC	DM8PADV	Investigative	Small molecular drug	[5885]
XCT790	DMZ7N8D	Investigative	Small molecular drug	[5886]
XD1	DMS3TZ5	Investigative	Small molecular drug	[5887]
XD14	DMUMACD	Investigative	Small molecular drug	[5888]
XE991	DMLH1PK	Investigative	Small molecular drug	[5889]
xenin	DMAPRNO	Investigative	Small molecular drug	[5890]
xestospongin C	DM4YQR2	Investigative	Small molecular drug	[5891]
XMD8-92	DMZIHKY	Investigative	Small molecular drug	[5892]
XMT-1191	DM5TR49	Investigative	Small molecular drug	[5893]
XNT	DMPOGXU	Investigative	Small molecular drug	[5894]
XR-9456	DMTUFI1	Investigative	Small molecular drug	[5895]
XR-9504	DMIQP69	Investigative	Small molecular drug	[5895]
XR-9544	DM1OZPN	Investigative	Small molecular drug	[5895]
XR-9577	DMIZV6T	Investigative	Small molecular drug	[5895]
XV454	DML1K07	Investigative	NA	[5896]
xylazine	DMSXJUW	Investigative	Small molecular drug	[5897]
Y-26763	DMZKPSQ	Investigative	Small molecular drug	[5898]
Y-39041	DMC95YB	Investigative	Small molecular drug	[5899]
Y-40613	DM412IV	Investigative	Small molecular drug	[5900]
Y-c[D-Pen-(2')Nal-GSFC]KR-NH2	DMAC65P	Investigative	NA	[5901]
Y-c[D-Pen-(2R,3R)-2-Me-(2')Nal-GSFC]KR-NH2	DMEL4UN	Investigative	NA	[5901]
Y-c[D-Pen-(2R,3S)-2-Me-(2')Nal-GSFC]KR-NH2	DM7P0H6	Investigative	NA	[5901]
Y-c[D-Pen-(2S,3R)-2-Me-(2')Nal-GSFC]KR-NH2	DMBNM85	Investigative	NA	[5901]
Y-c[D-Pen-(2S,3S)-2-Me-(2')Nal-GSFC]KR-NH2	DME1BGO	Investigative	NA	[5901]
Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2	DMF7S54	Investigative	NA	[5901]
Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2	DMW1PSO	Investigative	NA	[5901]
Y-c[D-Pen-D-(2')Nal-GSFC]KR-NH2	DM2ILAH	Investigative	NA	[5901]
Y134	DMI4RPK	Investigative	Small molecular drug	[5902]
YAWF-NH2	DMUW4KG	Investigative	Small molecular drug	[1899]
YGGWL-NH2	DM5LYKW	Investigative	Small molecular drug	[1899]
YGRKKRRQRRR-KLSSIESDV	DMV89B4	Investigative	NA	[3083]
YGWFL-NH2	DMQ2EYJ	Investigative	Small molecular drug	[1899]
YH-1238	DM6FEMV	Investigative	NA	[5903]
YIL781	DML1JY4	Investigative	Small molecular drug	[5904]
YM 218	DMPYM3J	Investigative	Small molecular drug	[5905]
YM 471	DM5BFL4	Investigative	Small molecular drug	[5906]
YM-175735	DMMW3L1	Investigative	Small molecular drug	[5907]
YM-202074	DM3IOLR	Investigative	Small molecular drug	[5908]
YM-348	DM38F9T	Investigative	Small molecular drug	[5909]
YM-35278	DMXRZ6N	Investigative	Small molecular drug	[5910]
YM-75440	DMMCXWQ	Investigative	Small molecular drug	[5911]
YM-96765	DMPU5TC	Investigative	Small molecular drug	[5912]
YM298198	DMUYDXT	Investigative	Small molecular drug	[5913]
YM44778	DMDOR2L	Investigative	Small molecular drug	[5914]
YM44781	DM73AEL	Investigative	Small molecular drug	[5915]
YM49598	DMTYSUN	Investigative	Small molecular drug	[5916]
YM90709	DML5DU0	Investigative	Small molecular drug	[5917]
YPAA-NH2	DMC3DK5	Investigative	Small molecular drug	[1899]
YPWA-NH2	DMOTHAC	Investigative	Small molecular drug	[1899]
YRFB	DMXOJIB	Investigative	Small molecular drug	[1895]
YS121	DM854XX	Investigative	Small molecular drug	[5918]
YVAD	DM24LNB	Investigative	Small molecular drug	[5919]
Z 944	DMFT51X	Investigative	NA	[5920]
Z-Ala-Leu-His-Agly-Ile-Val-OMe	DMMP0DT	Investigative	Small molecular drug	[2347]
Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl	DM7IGRT	Investigative	Small molecular drug	[2347]
Z-Ala-Leu-lle-Agly-Ile-Val-OMe	DMVEUOL	Investigative	Small molecular drug	[2347]
Z-Ala-Leu-Nal-Agly-Ile-Val-OMe	DM3209T	Investigative	Small molecular drug	[2347]
Z-Ala-Leu-Phe-Agly-Ile-Val-OMe	DML16BT	Investigative	Small molecular drug	[2347]
Z-Ala-Leu-Tyr(Me)-Agly-Ile-Val-OMe	DMIB5O3	Investigative	Small molecular drug	[2347]
Z-Arg-Leu-Val-Agly-Ala-Gly-NH2	DM69FKN	Investigative	Small molecular drug	[2347]
Z-Arg-Leu-Val-Agly-Ile-Val-OMe	DM9SXMB	Investigative	Small molecular drug	[5921]
Z-Arg-Leu-Val-Agly-Ile-Val-Trp-NH2	DMZDGJO	Investigative	Small molecular drug	[2347]
Z-Arg-Leu-Val-Agly-Ileu-Val-OMe	DMT0UZ1	Investigative	Small molecular drug	[2347]
Z-Arg-Leu-Val-Agly-Trp-Val-Ala-NH2	DMM5O2V	Investigative	Small molecular drug	[2347]
Z-Arg-Leu-Val-Agly-Val-Ala-NH2	DMTWNH7	Investigative	Small molecular drug	[2347]
Z-LEHD-fmk	DMEFHQI	Investigative	Small molecular drug	[5922]
Z-leu-Val-Agly-Val-OBzl	DM6OGR9	Investigative	Small molecular drug	[2347]
Z-Pro-Prolinal	DM43O2U	Investigative	Small molecular drug	[22]
Z-VAD-CHO	DMCE8K1	Investigative	Small molecular drug	[5923]
Z-YVAD-CHO	DM0TP2R	Investigative	Small molecular drug	[5923]
Z-YVAD-FMK	DMFTBPI	Investigative	Small molecular drug	[5924]
ZAPOTIN	DMM4ZKU	Investigative	Small molecular drug	[5925]
ZARAGOZIC ACID B	DMYRLA0	Investigative	Small molecular drug	[5926]
Zaragozic Acid C	DMUQWP1	Investigative	Small molecular drug	[5927]
Zaragozic Acid D	DMMTJE3	Investigative	Small molecular drug	[5928]
Zaragozic Acid D2	DML4WQJ	Investigative	Small molecular drug	[5928]
ZD-6021	DM8MXS6	Investigative	Small molecular drug	[5929]
ZD1604	DMLI8GZ	Investigative	NA	[5930]
ZEARALANONE	DMI5WF1	Investigative	Small molecular drug	[2034]
zebularine	DM734V4	Investigative	Small molecular drug	[5931]
zinc pyrithione	DMF0CRA	Investigative	Small molecular drug	[5932]
zinterol	DMKETL5	Investigative	Small molecular drug	[5933]
ZK 756326	DMP089G	Investigative	Small molecular drug	[5934]
ZK-112993	DM8JN45	Investigative	Small molecular drug	[5935]
ZK-114043	DMBCPKE	Investigative	Small molecular drug	[5936]
ZK-136798	DMCQYBE	Investigative	NA	[5937]
ZK-158252	DMNMD0J	Investigative	Small molecular drug	[5938]
ZK-164015	DMROWV8	Investigative	Small molecular drug	[5939]
ZK-810388	DMNOWAQ	Investigative	Small molecular drug	[5940]
ZK-813039	DMIC4HJ	Investigative	Small molecular drug	[5940]
ZK-814048	DMCBV5F	Investigative	Small molecular drug	[5940]
ZK110841	DMY3SUZ	Investigative	Small molecular drug	[5941]
ZK159222	DMYRHK6	Investigative	Small molecular drug	[5942]
ZM 253270	DMA3M9H	Investigative	Small molecular drug	[5943]
ZM 325802	DMC46RQ	Investigative	NA	[5944]
ZM-274773	DMD0NFL	Investigative	Small molecular drug	[5945]
ZM-336372	DMD5JYQ	Investigative	Small molecular drug	[5383]
ZM-39923	DMTMVYH	Investigative	Small molecular drug	[5946]
ZM-447439	DMFP8WE	Investigative	Small molecular drug	[5947]
Zn2+	DMEC1I9	Investigative	Small molecular drug	[5948]
ZNCCNCSSKWCRDHSRCC	DMY2V37	Investigative	NA	[2494]
ZRCCNCSSKWCRDHSRCC	DM1YZJ3	Investigative	NA	[2494]
ztz240	DM60N3C	Investigative	Small molecular drug	[5949]
ZY H2	DMN9UCI	Investigative	NA	[1866]
ZYKLOPHIN	DM0S5PE	Investigative	NA	[3405]
[(125)I] RB129	DMX0G7E	Investigative	Small molecular drug	[5950]
[(1e)-4-Phenylbut-1-Enyl]Benzene	DMG1ATX	Investigative	Small molecular drug	[22]
[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine	DM3WDOY	Investigative	Small molecular drug	[1543]
[(3-Bromophenyl)-m-tolyl-ketone]thiosemicarbazone	DMTK9V7	Investigative	Small molecular drug	[2311]
[(3-Bromophenyl)-p-tolyl-ketone]thiosemicarbazone	DMZG7TH	Investigative	Small molecular drug	[2311]
[(40-OH) MeLeu]4-CsA derivatives	DM9YHA7	Investigative	NA	[5951]
[(40-OH)MeLeu]4-Cyclosporin A	DM1ZM5R	Investigative	NA	[5951]
[(D)MeSer]3-[(40-OH) MeLeu]4-Cyclosporin A	DMV30N2	Investigative	NA	[5951]
[(N4-Bzdig)0,Nle14]BB(7-14)	DMVWCTL	Investigative	NA	[5952]
[(N4-Bzdig)0]BB(7-14)	DMD4BSJ	Investigative	NA	[5952]
[(R)-(+)-deoxytylophorinidine	DMPFUBE	Investigative	Small molecular drug	[2810]
[1,1':2',1'']-terphenyl-4,3'',5''-triol	DMVOY4D	Investigative	Small molecular drug	[1123]
[1,1':2',1'']Terphenyl-4'-carbaldehyde oxime	DMFXA8P	Investigative	Small molecular drug	[5953]
[1,2,4]triazolo[1,5-a]quinoxalin-4(5H)-one	DMPV0QN	Investigative	Small molecular drug	[5954]
[1,3]Oxazinan-(2E)-ylideneamine	DMDX6W4	Investigative	Small molecular drug	[318]
[1,3]Thiazinan-(2E)-ylideneamine	DMOEIHC	Investigative	Small molecular drug	[318]
[1,4]Oxazepan-(3E)-ylideneamine	DMX58NK	Investigative	Small molecular drug	[196]
[1,4]Oxazepan-(5E)-ylideneamine	DMMUZVS	Investigative	Small molecular drug	[196]
[1,4]Thiazepan-(3E)-ylideneamine	DMCBFJQ	Investigative	Small molecular drug	[196]
[1,4]Thiazepan-(5E)-ylideneamine	DMFQ0Z4	Investigative	Small molecular drug	[196]
[1,5]Thiazocan-(4E)-ylideneamine	DMF62JR	Investigative	Small molecular drug	[36]
[1-(4-p-Tolyl-butyl)-piperidin-4-yl]-methanol	DMAGW3R	Investigative	Small molecular drug	[545]
[1-Benzyl-1H-quinolin-(4E)-ylidene]-hexyl-amine	DMH3BG5	Investigative	Small molecular drug	[596]
[1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate	DMS1YN3	Investigative	Small molecular drug	[5955]
[11C]AZ10419369	DMMZUPX	Investigative	Small molecular drug	[5956]
[11C]butylthio-TZTP	DMQP03A	Investigative	Small molecular drug	[5957]
[11C]DTBZ	DM4ZANH	Investigative	Small molecular drug	[5958]
[11C]GlySar	DM5Q08F	Investigative	Small molecular drug	[5959]
[11C]MMTP	DMQRSP7	Investigative	Small molecular drug	[5960]
[11C]SB207145	DMOZ8E3	Investigative	Small molecular drug	[5961]
[11C]volinanserin	DMCQTYW	Investigative	Small molecular drug	[5962]
[11C]WAY100635	DMXIEA1	Investigative	Small molecular drug	[5963]
[11C]xanomeline	DM742L9	Investigative	Small molecular drug	[5964]
[123I]AM251	DMCJQ0P	Investigative	Small molecular drug	[5965]
[123I]iodobenzovesamicol	DMOZGLM	Investigative	Small molecular drug	[5966]
[123I]iodoproxyfan	DM5SRT1	Investigative	Small molecular drug	[5967]
[123I]SB 207710	DMMG1TA	Investigative	Small molecular drug	[5968]
[125I]-BDZ2	DMYBQOG	Investigative	Small molecular drug	[5969]
[125I]7-azido-8-iodoketanserine	DMFT5N9	Investigative	Small molecular drug	[5970]
[125I]AB-MECA	DM8EQFL	Investigative	Small molecular drug	[5971]
[125I]ABOPX	DMZBNK9	Investigative	Small molecular drug	[5972]
[125I]APNEA	DM95A4Z	Investigative	Small molecular drug	[5973]
[125I]BE-2254	DM7GVYF	Investigative	Small molecular drug	[5974]
[125I]BOP	DMV6I7H	Investigative	Small molecular drug	[5975]
[125I]cetrorelix	DM0X824	Investigative	Small molecular drug	[5976]
[125I]CGP 64213	DMIAO4V	Investigative	Small molecular drug	[5977]
[125I]CGP 71872	DMQVW4E	Investigative	Small molecular drug	[5978]
[125I]CGP42112	DM1NXDA	Investigative	Small molecular drug	[5979]
[125I]DIV880	DMEPT8H	Investigative	Small molecular drug	[5980]
[125I]DOI	DMQUY08	Investigative	Small molecular drug	[5981]
[125I]epibatidine	DMZWQH3	Investigative	Small molecular drug	[5982]
[125I]EXP985	DMEKGZS	Investigative	Small molecular drug	[5983]
[125I]GR231118	DMFWE4H	Investigative	Small molecular drug	[5984]
[125I]GTI	DMSYT5P	Investigative	Small molecular drug	[5985]
[125I]HEAT	DMTFP5Q	Investigative	Small molecular drug	[5986]
[125I]ICYP	DM3BQHO	Investigative	Small molecular drug	[5987]
[125I]iodoaminopotentidine	DMHJL58	Investigative	Small molecular drug	[5988]
[125I]iodophenpropit	DMN4ABU	Investigative	Small molecular drug	[5989]
[125I]IRL1620	DMVEHI7	Investigative	Small molecular drug	[5990]
[125I]L703,606	DMKSI80	Investigative	Small molecular drug	[5991]
[125I]L750667	DMO7VRJ	Investigative	Small molecular drug	[5992]
[125I]LSD	DMP69QG	Investigative	Small molecular drug	[5993]
[125I]PD142308	DMEHK9M	Investigative	Small molecular drug	[5994]
[125I]PD151242	DM4HLO5	Investigative	Small molecular drug	[5995]
[125I]PTA-OH	DMROKJP	Investigative	Small molecular drug	[5996]
[125I]resiniferatoxin	DMUD3A8	Investigative	Small molecular drug	[5997]
[125I]RTI55	DMY6BI9	Investigative	Small molecular drug	[5998]
[125I]S70254	DMHC6KX	Investigative	Small molecular drug	[5999]
[125I]SAP	DM1DXHG	Investigative	Small molecular drug	[6000]
[125I]SB-236636	DM0XUPK	Investigative	Small molecular drug	[6001]
[125I]SB-258585	DMXWZCB	Investigative	Small molecular drug	[6002]
[125I]SCH23982	DM06S9X	Investigative	Small molecular drug	[6003]
[125I]SD6	DM285MQ	Investigative	Small molecular drug	[6004]
[125I]SQ-29548	DM0GKMA	Investigative	Small molecular drug	[6005]
[125I]ZM-241385	DME53D6	Investigative	Small molecular drug	[6006]
[14C]acetylCoA	DM42B5D	Investigative	Small molecular drug	[6007]
[14C]GlySar	DMGLQ72	Investigative	Small molecular drug	[6008]
[14C]histidine	DMVUF71	Investigative	Small molecular drug	[6009]
[14C]methylamine	DMRBZ3X	Investigative	Small molecular drug	[6010]
[14C]MTEP	DMG17IU	Investigative	Small molecular drug	[6011]
[14C]TEA	DM6SFYH	Investigative	Small molecular drug	[6012]
[18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate	DMZJQC0	Investigative	Small molecular drug	[6013]
[18F]altanserin	DM65BDN	Investigative	Small molecular drug	[6014]
[18F]FITM	DM4VQNE	Investigative	Small molecular drug	[6015]
[18F]fluoroethylflumazenil	DMPWART	Investigative	Small molecular drug	[6016]
[18F]FP-TZTP	DMM2YU9	Investigative	Small molecular drug	[6017]
[18F]FPIT	DMRQ6XD	Investigative	Small molecular drug	[6018]
[18F]MK-1312	DMQ6AR5	Investigative	Small molecular drug	[6019]
[18F]SPA-RQ	DMXIO84	Investigative	Small molecular drug	[6020]
[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	DMI9RLZ	Investigative	Small molecular drug	[2431]
[2,2':5',2'']Terthiophen-4-yl-methanol	DMRQC1F	Investigative	Small molecular drug	[6021]
[2,2':5',2'']Terthiophene-4,5''-dicarbaldehyde	DMWDNLI	Investigative	Small molecular drug	[6021]
[2,2':5',2'']Terthiophene-4-carbaldehyde	DM2S5EJ	Investigative	Small molecular drug	[6021]
[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-benzyl-amine	DMSPMHE	Investigative	Small molecular drug	[1395]
[2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine	DMAJCVL	Investigative	Small molecular drug	[1381]
[2-(3-Benzyl-3H-indol-1-yl)-ethyl]-dimethyl-amine	DMU5P8O	Investigative	Small molecular drug	[6022]
[2-(3-Benzyl-indol-1-yl)-ethyl]-dimethyl-amine	DMBTRN6	Investigative	Small molecular drug	[1381]
[2-(3H-Indol-1-yl)-ethyl]-dimethyl-amine	DM1RW4U	Investigative	Small molecular drug	[6022]
[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine	DMDIH96	Investigative	Small molecular drug	[480]
[2-(5-Ethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine	DMOZ73L	Investigative	Small molecular drug	[1604]
[2-(6-Chloro-purin-9-yl)ethyl]-bisphosphonic acid	DM5LVIR	Investigative	Small molecular drug	[6023]
[2-(6-Methoxy-indol-1-yl)-ethyl]-dimethyl-amine	DMHPBQC	Investigative	Small molecular drug	[135]
[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid	DM98MXT	Investigative	Small molecular drug	[6023]
[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid	DM37C25	Investigative	Small molecular drug	[943]
[2-(Imidazol-1-yl)ethyl]-bisphosphonic acid	DMQZUD9	Investigative	Small molecular drug	[6023]
[2-(Imidazol-2-yl-thio)ethyl]-bisphosphonic acid	DMBVDY5	Investigative	Small molecular drug	[6023]
[2-(Purin-9-yl)ethyl]-bisphosphonic acid	DM3VT8M	Investigative	Small molecular drug	[6023]
[2-(Pyrazol-1-yl)ethyl]-bisphosphonic acid	DMJN8XK	Investigative	Small molecular drug	[6023]
[2-Phenylacetophenone]thiosemicarbazone	DM4WXD2	Investigative	Small molecular drug	[167]
[3,4''']biflavone	DMHU4NS	Investigative	Small molecular drug	[6024]
[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine	DM4BYEQ	Investigative	Small molecular drug	[496]
[3-(4-Nonyl-benzylamino)-propyl]-phosphonic acid	DMGD487	Investigative	Small molecular drug	[172]
[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol	DMD0LCU	Investigative	Small molecular drug	[136]
[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine	DMRBJ4V	Investigative	Small molecular drug	[6025]
[32P]MRS2500	DMEMVY5	Investigative	Small molecular drug	[6026]
[32P]S1P	DMV1UD6	Investigative	Small molecular drug	[6027]
[33P]2MeSADP	DM218VZ	Investigative	Small molecular drug	[6028]
[35S]-non-peptide OT antagonist	DMSHOQ8	Investigative	Small molecular drug	[6029]
[35S]ACPPB	DMVUEYM	Investigative	Small molecular drug	[6030]
[35S]ADPbetaS	DMAYPTO	Investigative	Small molecular drug	[6031]
[35S]ATPalphaS	DMEP4KW	Investigative	Small molecular drug	[6032]
[35S]ATPgammaS	DM0IRQA	Investigative	Small molecular drug	[6033]
[35S]ibutamoren	DMQ0NK8	Investigative	Small molecular drug	[6034]
[35S]TBPS	DMSD51L	Investigative	Small molecular drug	[6035]
[3H](+)-cis-diltiazem	DMP6XL9	Investigative	Small molecular drug	[6036]
[3H](+)-isradipine	DM7QE1J	Investigative	Small molecular drug	[6037]
[3H](-)CGP 12177	DMN35BY	Investigative	Small molecular drug	[6038]
[3H](-)devapamil	DM0KGHP	Investigative	Small molecular drug	[6039]
[3H](R)-NPTS	DMRPS2X	Investigative	Small molecular drug	[6040]
[3H](S)-zacopride	DM0B54M	Investigative	Small molecular drug	[6041]
[3H]2,2,2-TEMPS	DMQO8AF	Investigative	Small molecular drug	[6042]
[3H]4NMPB	DM5SWI1	Investigative	Small molecular drug	[6043]
[3H]5-CT	DMEAHFZ	Investigative	Small molecular drug	[6044]
[3H]5-HT	DMYJXV7	Investigative	Small molecular drug	[6045]
[3H]5-oxo-ETE	DM50WFM	Investigative	Small molecular drug	[6046]
[3H]7-OH-DPAT	DM2PW8T	Investigative	Small molecular drug	[6047]
[3H]8-OH-DPAT	DM4KCYU	Investigative	Small molecular drug	[6048]
[3H]A-585539	DMSDY2Z	Investigative	Small molecular drug	[6049]
[3H]A317491	DMTBAXD	Investigative	Small molecular drug	[6050]
[3H]A778317	DMVJKCH	Investigative	Small molecular drug	[6051]
[3H]alphabeta-meATP	DMWV5C3	Investigative	Small molecular drug	[6052]
[3H]AZ11637326	DMPVG5Y	Investigative	Small molecular drug	[6053]
[3H]azietomidate	DM4ZHI8	Investigative	Small molecular drug	[6054]
[3H]bag-2	DMKL9X7	Investigative	Small molecular drug	[2231]
[3H]BQ123	DMG8T3W	Investigative	Small molecular drug	[6055]
[3H]cAMP	DMZRQU7	Investigative	Small molecular drug	[6056]
[3H]CCPA	DMHDGB3	Investigative	Small molecular drug	[6057]
[3H]CGP12177	DMZN1A3	Investigative	Small molecular drug	[6058]
[3H]CGP27492	DMQTBRM	Investigative	Small molecular drug	[6059]
[3H]CGP39653	DMITR7A	Investigative	Small molecular drug	[6060]
[3H]CGS19755	DM7H3JN	Investigative	Small molecular drug	[6061]
[3H]CNQX	DMIFKUX	Investigative	Small molecular drug	[6062]
[3H]CP55940	DMU7FC5	Investigative	Small molecular drug	[6063]
[3H]CPP	DMR5UBF	Investigative	Small molecular drug	[6064]
[3H]cytisine	DMVLRHW	Investigative	Small molecular drug	[6065]
[3H]devazepide	DM4NXRO	Investigative	Small molecular drug	[6066]
[3H]dihydroalprenolol	DM14QKZ	Investigative	Small molecular drug	[6067]
[3H]dimethyl-W84	DMBWAIE	Investigative	Small molecular drug	[6068]
[3H]diprenorphine	DMBMS1U	Investigative	Small molecular drug	[6069]
[3H]dizocilpine	DMEC2PF	Investigative	Small molecular drug	[6070]
[3H]DPCPX	DM9GY7O	Investigative	Small molecular drug	[6071]
[3H]eletriptan	DMDTYRV	Investigative	Small molecular drug	[6072]
[3H]EM-TBPC	DMM1KBW	Investigative	Small molecular drug	[6073]
[3H]estradiol-17beta-glucuronide	DM3KJ45	Investigative	Small molecular drug	[6074]
[3H]estrone-3-sulphate	DMGPF0N	Investigative	Small molecular drug	[6075]
[3H]ETB-TBOA	DMWGY61	Investigative	Small molecular drug	[6076]
[3H]folinic acid	DME0XHN	Investigative	Small molecular drug	[6077]
[3H]GABA	DMH24GL	Investigative	Small molecular drug	[6078]
[3H]GBR12935	DMGQDLU	Investigative	Small molecular drug	[6079]
[3H]GlySar	DMFEYLS	Investigative	Small molecular drug	[6080]
[3H]GR 125,743	DM4URBO	Investigative	Small molecular drug	[6044]
[3H]GR65630	DMMHSYA	Investigative	Small molecular drug	[6081]
[3H]granisetron	DMB9VGW	Investigative	Small molecular drug	[6082]
[3H]GSK931145	DMU6A3W	Investigative	Small molecular drug	[6083]
[3H]GW2331	DMJT6D3	Investigative	Small molecular drug	[6084]
[3H]HEMADO	DMEO6AH	Investigative	Small molecular drug	[6085]
[3H]HU-243	DM8YUW6	Investigative	Small molecular drug	[6086]
[3H]JB-93182	DMJCI2A	Investigative	Small molecular drug	[6087]
[3H]JNJ-40068782	DMSE56B	Investigative	Small molecular drug	[6088]
[3H]kainate	DMMK7XU	Investigative	Small molecular drug	[6089]
[3H]L655708	DMUZ9LX	Investigative	Small molecular drug	[6090]
[3H]LSD	DM0YJHS	Investigative	Small molecular drug	[6091]
[3H]LTB4	DMDOJVX	Investigative	Small molecular drug	[6092]
[3H]LTC4	DMD09BO	Investigative	Small molecular drug	[6093]
[3H]LY341495	DMGX0Y8	Investigative	Small molecular drug	[6094]
[3H]M-MPEP	DMF7VX9	Investigative	Small molecular drug	[6095]
[3H]MDL105519	DMPKGHB	Investigative	Small molecular drug	[6096]
[3H]meclinertant	DMEX6GT	Investigative	Small molecular drug	[6097]
[3H]mesulergine	DM8K6VF	Investigative	Small molecular drug	[6098]
[3H]methoxy-PEPy	DMZ2R1O	Investigative	Small molecular drug	[6099]
[3H]methoxymethyl-MTEP	DMONI13	Investigative	Small molecular drug	[6100]
[3H]methyllycaconitine	DMYWGCS	Investigative	Small molecular drug	[6101]
[3H]methyltrienolone	DMTSGOW	Investigative	Small molecular drug	[6102]
[3H]mibolerone	DM6HDKQ	Investigative	Small molecular drug	[6103]
[3H]MK-912	DMO89N0	Investigative	Small molecular drug	[6104]
[3H]N-methyl-SSR504734	DMX4RJ8	Investigative	Small molecular drug	[6105]
[3H]N-methylspiperone	DM5176Y	Investigative	Small molecular drug	[6106]
[3H]N5-methylfolate	DM0THB9	Investigative	Small molecular drug	[6107]
[3H]naltrindole	DMQW3A9	Investigative	Small molecular drug	[6108]
[3H]NECA	DMAO9SH	Investigative	Small molecular drug	[6109]
[3H]nelivaptan	DM0163O	Investigative	Small molecular drug	[6110]
[3H]NFPS	DM6PO49	Investigative	Small molecular drug	[6111]
[3H]nicotine	DM9E2YI	Investigative	Small molecular drug	[6112]
[3H]nisoxetine	DMS3WNG	Investigative	Small molecular drug	[6113]
[3H]nitrobenzylmercaptopurine ribonucleoside	DM5TDFQ	Investigative	Small molecular drug	[6114]
[3H]NLX-112	DMG1TIV	Investigative	Small molecular drug	[6115]
[3H]OSIP339391	DM4BY5J	Investigative	Small molecular drug	[6116]
[3H]oxotremorine-M	DM5L7D3	Investigative	Small molecular drug	[6117]
[3H]p-MPPF	DM2LA9X	Investigative	Small molecular drug	[6118]
[3H]PBC-264	DMK46C7	Investigative	Small molecular drug	[6119]
[3H]PD140376	DMWAT5S	Investigative	Small molecular drug	[6120]
[3H]pentazocine	DMF4TWE	Investigative	Small molecular drug	[6121]
[3H]PGF2alpha	DMPE1B2	Investigative	Small molecular drug	[6122]
[3H]pirenzepine	DMAMD5H	Investigative	Small molecular drug	[6123]
[3H]pregnenolone sulphate	DM15DX2	Investigative	Small molecular drug	[6124]
[3H]PSB-0413	DMP98AQ	Investigative	Small molecular drug	[6125]
[3H]PSB-11	DMFDCJK	Investigative	Small molecular drug	[6126]
[3H]QNB	DMC1WHR	Investigative	Small molecular drug	[6127]
[3H]quisqualate	DMDQBTX	Investigative	Small molecular drug	[6128]
[3H]ramosetron	DM21B46	Investigative	Small molecular drug	[6129]
[3H]rauwolscine	DMBQZ2H	Investigative	Small molecular drug	[6130]
[3H]resolvin D1	DMFT0HU	Investigative	Small molecular drug	[6131]
[3H]Ro 63-0563	DM5XSMN	Investigative	Small molecular drug	[6132]
[3H]Ro154513	DMMBWKL	Investigative	Small molecular drug	[6133]
[3H]robalzotan	DMK1TRG	Investigative	Small molecular drug	[6134]
[3H]RX821002	DM6IRN4	Investigative	Small molecular drug	[6135]
[3H]RY80	DMJKWNY	Investigative	Small molecular drug	[6136]
[3H]S0139	DM32IAB	Investigative	Small molecular drug	[6137]
[3H]SB-674042	DMO9L38	Investigative	Small molecular drug	[6138]
[3H]SB-733993	DMUS7EH	Investigative	Small molecular drug	[6139]
[3H]SNAP-7941	DM0MLU9	Investigative	Small molecular drug	[6140]
[3H]spiperone	DMWHEV8	Investigative	Small molecular drug	[6141]
[3H]strychnine	DM0Y2SC	Investigative	Small molecular drug	[6142]
[3H]sumatriptan	DM3MBGV	Investigative	Small molecular drug	[6143]
[3H]thiamine	DMSHW2E	Investigative	Small molecular drug	[6144]
[3H]U69593	DM6RSZ9	Investigative	Small molecular drug	[6145]
[3H]vesamicol	DM3MK8S	Investigative	Small molecular drug	[6146]
[3H]WIN35428	DMI8RU0	Investigative	Small molecular drug	[6147]
[3H]WIN55212-2	DM0TRAZ	Investigative	Small molecular drug	[6148]
[3H]ZM 241385	DMKU4YQ	Investigative	Small molecular drug	[6149]
[4',4''']-biflavone	DM7JSQL	Investigative	Small molecular drug	[6024]
[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid	DMNCAE9	Investigative	Small molecular drug	[569]
[4Aph(CO-(C2H4O)3-C2H4-NH-CO-NH-OCH3)5]degarelix	DM86Z4H	Investigative	NA	[6150]
[4Aph(CO-NH-(C2H4O)2-C2H5)5]degarelix	DM4IXJA	Investigative	NA	[6150]
[4Aph(CO-NH-OCH3)5,D-4Aph(CO-NH-OCH3)6]degarelix	DM57TIU	Investigative	NA	[6150]
[4Aph(CO-NH-OCH3)5]degarelix	DM6C8K1	Investigative	NA	[6150]
[4Aph(CO-NH-OH)5]degarelix	DMFMB31	Investigative	NA	[6150]
[6,3''']biflavone	DMA9PW7	Investigative	Small molecular drug	[6024]
[6,4''']biflavone	DMVOX4L	Investigative	Small molecular drug	[6024]
[Aib7]OT	DMUCAXT	Investigative	Small molecular drug	[6151]
[Asp6,Lys10]N/OFQ(1-13)NH2	DMHJEQL	Investigative	NA	[2722]
[Au(CN)2]-	DMN70VT	Investigative	NA	[6152]
[Bpa1]AngII	DMB78GP	Investigative	NA	[6153]
[Cu(CN)2]-	DMV6NP1	Investigative	NA	[6152]
[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid	DMQ8CD3	Investigative	Small molecular drug	[4309]
[Cys-Trp-Arg-Nva-Arg-Tyr-NH2]2	DMWFGBC	Investigative	NA	[1943]
[D-4Aph(CO-NH-(C2H4O)2-C2H5)6]degarelix	DMFKTJ8	Investigative	NA	[6150]
[D-4Aph(CO-NH-OCH3)6]degarelix	DMR7TEQ	Investigative	NA	[6150]
[D-4Aph(CO-NH-OH)6]degarelix	DMMVIX7	Investigative	NA	[6150]
[D-Ala2]Met-enkephalinamide	DM18ZNJ	Investigative	Small molecular drug	[6154]
[D-Asp7,Lys10]N/OFQ(1-13)NH2	DMSGW51	Investigative	NA	[2722]
[D-Dab(CO-NH-OCH3)3]degarelix	DMEZKX0	Investigative	NA	[6150]
[D-Dab(CO-NH-OH)3]degarelix	DMRVPN1	Investigative	NA	[6150]
[D-Dap(CO-NH-OCH3)3]degarelix	DM5ZR4S	Investigative	NA	[6150]
[D-Dap(CO-NH-OH)3]degarelix	DMS0LFT	Investigative	NA	[6150]
[D-Gln3,D-Ncy(isopropyl)7]acyline	DMP1D7Q	Investigative	NA	[2212]
[D-Gln3,D-Ncy(SO,isopropyl)7]acyline	DMFAX1Q	Investigative	NA	[2212]
[D-Gln3,D-Ncy(SO2,isopropyl)7]acyline	DM3H0CX	Investigative	NA	[2212]
[D-Gln3,Ncy(isopropyl)7]acyline	DMMEQ3R	Investigative	NA	[2212]
[D-Gln3,Ncy(SO,isopropyl)7]acyline	DM2QDXW	Investigative	NA	[2212]
[D-Gln3,Ncy(SO2,isopropyl)7]acyline	DMJSCO7	Investigative	NA	[2212]
[D-Ncy(2-naphthyl)1]acyline	DMAFNTL	Investigative	NA	[2212]
[D-Ncy(isopropyl)7]acyline	DMVBTAM	Investigative	NA	[2212]
[D-Ncy(methyl)10] acyline	DM9TORW	Investigative	NA	[2212]
[D-Ncy(methyl)4]acyline	DM63FN5	Investigative	NA	[2212]
[D-Ncy(SO,isopropyl)7]acyline	DME9AN4	Investigative	NA	[2212]
[D-Ncy(SO,methyl)10]acyline	DMT2X98	Investigative	NA	[2212]
[D-Ncy(SO,methyl)4]acyline	DM6HEXG	Investigative	NA	[2212]
[D-Tic7]OT	DME8W3R	Investigative	NA	[6151]
[Dcp1]Dyn A(1-11)-NH2	DM23GCK	Investigative	NA	[2813]
[des-Arg9]bradykinin	DMEL0SZ	Investigative	Small molecular drug	[6155]
[des-His1,Tyr5,Glu9,D-Ala10]glucagon-NH2	DM1EPZB	Investigative	NA	[6156]
[des-His1,Tyr5,Glu9,D-Phe10]glucagon-NH2	DM06Q2V	Investigative	NA	[6156]
[des-His1,Tyr5,Glu9,D-Tyr10]glucagon-NH2	DMFLVED	Investigative	NA	[6156]
[des-His1,Tyr5,Glu9]glucagon-NH2	DM93I0B	Investigative	NA	[6156]
[Fe(CN)6]4-	DMWGADP	Investigative	Small molecular drug	[6152]
[Gly(But)7]OT	DMZM3GB	Investigative	NA	[6151]
[Gly8, aib22]GLP-1(7-37)-NH2	DM9SP2U	Investigative	NA	[2751]
[Gly8,Glu22]GLP-1(7,37)-NH2	DMO8U3S	Investigative	NA	[2751]
[Gly8]GLP-1(7-37)-NH2	DM1SOT4	Investigative	NA	[2751]
[HO1][Lys8(5/6C-Flu)]VT	DMLZNK6	Investigative	NA	[2760]
[HO1][Orn8(5/6C-Flu)]VT	DMFK9V5	Investigative	NA	[2760]
[HO1][Orn8(5/6C-Rhm)]VT	DM7COAM	Investigative	NA	[2760]
[HO1][Thr4,Lys8(5/6C-Flu)]VT	DMT2UYR	Investigative	NA	[2760]
[HO1][Thr4,Orn8(5/6C-Flu)]VT	DM81B4W	Investigative	NA	[2760]
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	DM7NXMB	Investigative	Small molecular drug	[22]
[L-Tic7]OT	DMHUMDR	Investigative	NA	[6151]
[Leu13]motilin (human)	DMXTY6L	Investigative	Small molecular drug	[6157]
[Leu5]enkephalin	DMA0N32	Investigative	Small molecular drug	[6158]
[Leu8,des-Arg9]bradykinin	DM3JHRC	Investigative	Small molecular drug	[6159]
[Lys8(Alexa 488) ]PVA	DM7STF6	Investigative	NA	[3389]
[Lys8(Alexa 546) ]PVA	DM38L6U	Investigative	NA	[3389]
[Mpa1, D-Tic2, Aib7]OT	DM27LNU	Investigative	Small molecular drug	[6151]
[Mpa1, D-Tic7]OT	DMPT1ME	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, Aib7, D-Tic9]OT	DMBPVSD	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, Aib7]OT	DMQSG6Y	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, D-Tic7, Aib9]OT	DM5GSXC	Investigative	NA	[6160]
[Mpa1, D-Tyr(Et)2, D-Tic7, D-Tic9]OT	DMI9MBO	Investigative	NA	[6161]
[Mpa1, D-Tyr(Et)2, D-Tic7]OT	DM3T4JF	Investigative	NA	[6162]
[Mpa1, D-Tyr(Et)2, Gly(But)3, Gly(But)7]OT	DML8V4F	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, Gly(But)7]OT	DMX2SU9	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, L-Tic7]OT	DM0H3NV	Investigative	NA	[6151]
[Mpa1, D-Tyr(Et)2, Pip7]OT	DM6W4LR	Investigative	NA	[6151]
[Mpa1, L-Tic7]OT	DMB4J3N	Investigative	NA	[6151]
[N-Ac,des-Sar]Gal-B2	DMW6LIJ	Investigative	NA	[3318]
[N-Me,des-Sar]Gal-B2	DM4XFOH	Investigative	NA	[6163]
[N-[2-[(3'-N'-PROPYL-3''ALPHA-(BIS(4-FLUORORPHENYL)METHOXY)TROPANE-2''BETA-CARBOXYLIC ACID METHYL ESTER)(2-MERCAPTOETHYL)AMINO]ACETYL]-2-AMINOETHANETHIOLATO]RHENIUM(V) OXIDE (DIASTEREOMERIC MIX)	DMW9AST	Investigative	NA	[6164]
[N40,Pro1,Tyr4,Nle 14]BB	DM6EAHF	Investigative	NA	[5952]
[N40,Pro1,Tyr4]BB	DMVFHNM	Investigative	NA	[5952]
[Ncy(2-naphthyl)1]acyline	DME6LKY	Investigative	NA	[2212]
[Ncy(isopropyl)7]acyline	DM5CS8U	Investigative	NA	[2212]
[Ncy(methyl)10]acyline	DM9RC3O	Investigative	NA	[2212]
[Ncy(methyl)4]acyline	DMLK8YQ	Investigative	NA	[2212]
[Ncy(SO,isopropyl)7]acyline	DMEFIQ9	Investigative	NA	[2212]
[Ncy(SO,methyl)10]acyline	DMT8X45	Investigative	NA	[2212]
[Ncy(SO,methyl)4]acyline	DM057MP	Investigative	NA	[2212]
[Nphe(1)]-nociceptin (1-13)-NH(2)	DMTG17Q	Investigative	Small molecular drug	[6165]
[Phe3]OT	DMK18CS	Investigative	Small molecular drug	[6166]
[Pip7]OT	DMXJDEA	Investigative	NA	[6151]
[Pterin-6-Yl Methanyl]-Phosphonophosphate	DM4ZY79	Investigative	Small molecular drug	[12]
[R-(-)-Apomorphine-2-yl]-(2'-hydroxy-ethyl)ether	DM8YF3V	Investigative	Small molecular drug	[399]
[Sar,D-Phe8,des-Arg9]bradykinin	DMUF7DP	Investigative	Small molecular drug	[6167]
[Sar1,Bpa2]AngII	DM1HQ3D	Investigative	NA	[6153]
[Sar1,Bpa3]AngII	DMP64XH	Investigative	NA	[6153]
[Sar1,Bpa8]AngII	DMWC10R	Investigative	NA	[6153]
[Sar1,Tdf2]AngII	DM4AUFR	Investigative	NA	[6153]
[Sar1,Tdf3]AngII	DMWCS4Y	Investigative	NA	[6153]
[Sar1,Tdf8]AngII	DMTNGCW	Investigative	NA	[6153]
[Sar1Ala]GAL-B2	DMUD0LA	Investigative	NA	[3318]
[Sar1Gly]GAL-B2	DMUI0XV	Investigative	NA	[3318]
[Sar9,Met(O2)11]-SP	DMYF85Q	Investigative	NA	[6168]
[Tdf1]AngII	DMN0BT3	Investigative	NA	[6153]
[Thr4,Gly7]OT	DM7QAKB	Investigative	Small molecular drug	[6169]
[Tyr-Pro-Phe-NH-CH2-]2	DMZTRQ0	Investigative	Small molecular drug	[6170]
[Tyr-Pro-Phe-NH-]2	DM61RG2	Investigative	Small molecular drug	[6170]
[Tyr-Pro-Phe-Phe-NH-CH2-]2	DMFGO4W	Investigative	NA	[6170]
[Tyr-Pro-Phe-Phe-NH-]2	DME6TNL	Investigative	NA	[6170]
[Tyr4]Bombesin	DMA6VNI	Investigative	NA	[5952]
[U-13C]ascomycin	DMP3I6E	Investigative	NA	[6171]
[Val4]AVP	DMW82ZT	Investigative	Small molecular drug	[6172]
[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	DMU9F2P	Investigative	Small molecular drug	[12]
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	DM86305	Investigative	Small molecular drug	[12]
{2-[3-(Phenylsulfonyl)-1H-indol-4-yl]ethyl}amine	DM3FBAZ	Investigative	Small molecular drug	[6173]
{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid	DMX53OY	Investigative	Small molecular drug	[170]
{[(9Z)-octadec-9-en-1-yl]sulfamoyl}amine	DMMB4US	Investigative	Small molecular drug	[4217]

This Disease is Treated as An Indication in 1 Investigative Agents

Drug Name	Drug ID	Highest Status	Drug Type	REF
Equilin	DM2Q19U	Investigative	Small molecular drug	[12]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Curr Pharm Des. 1998 Oct;4(5):381-96.
• [3] Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J Med Chem. 1995 Sep 15;38(19):3681-716.
• [4] Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov;108(5):913-22.
• [5] Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
• [6] Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats
• [7] Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gen... Biol Pharm Bull. 2010;33(2):216-22.
• [8] ClinicalTrials.gov (NCT05307978) A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of Subcutaneously and Intravenously Administered ALXN1910 in Healthy Adult Participants. U.S.National Institutes of Health.
• [9] ClinicalTrials.gov (NCT05501717) A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Subcutaneous ALXN2030 in Healthy Participants. U.S.National Institutes of Health.
• [10] ClinicalTrials.gov (NCT05428696) A Randomized, Double-blind, Placebo-controlled First-in-Human Study of Single and Multiple Doses of ALXN2080 in Healthy Participants. U.S.National Institutes of Health.
• [11] Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5718-21.
• [12] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
• [13] Clinical pipeline report, company report or official report of Roche
• [14] Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent RH1
• [15] Clinical pipeline report, company report or official report of Sanofi
• [16] Clinical pipeline report, company report or official report of Teva Pharmaceutical
• [17] Inactivation of GABA transaminase by 3-chloro-1-(4-hydroxyphenyl)propan-1-one. Bioorg Med Chem Lett. 2009 Feb 1;19(3):731-4.
• [18] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3379).
• [19] Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity. J Med Chem. 2009 May 14;52(9):2673-82.
• [20] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2425).
• [21] Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
• [22] The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
• [23] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2917).
• [24] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6000).
• [25] Benzoyl 2-methyl indoles as selective PPARgamma modulators. Bioorg Med Chem Lett. 2005 Jan 17;15(2):357-62.
• [26] Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds. J Med Chem. 2008 Aug 28;51(16):4948-56.
• [27] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6412).
• [28] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7828).
• [29] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5942).
• [30] Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.Haemophilia.2012 Nov;18(6):881-7.
• [31] Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discov. 2021 Apr;20(4):265-286.
• [32] Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948.
• [33] Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014 Jan;124(1):6-12.
• [34] Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4495-8.
• [35] Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships. J Med Chem. 2008 Jul 10;51(13):3825-40.
• [36] Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase. Bioorg Med Chem Lett. 2001 Oct 8;11(19):2651-3.
• [37] Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J Med Chem. 1995 Aug 18;38(17):3297-312.
• [38] Displacement activity of bisbenzylisoquinoline alkaloids at striatal 3H-SCH 23390 and 3H-raclopride binding sites. J Nat Prod. 1992 Sep;55(9):1281-6.
• [39] Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases. J Nat Prod. 2003 Feb;66(2):230-5.
• [40] Lipoxygenase inhibitory constituents of the fruits of noni (Morinda citrifolia) collected in Tahiti. J Nat Prod. 2007 May;70(5):859-62.
• [41] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1589).
• [42] Flexible synthesis and biological evaluation of novel 5-deoxyadenophorine analogues. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3262-7.
• [43] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 932).
• [44] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 970).
• [45] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5504).
• [46] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 62).
• [47] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1208).
• [48] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4066).
• [49] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1373).
• [50] (+)-Myristinins A and D from Knema elegans, which inhibit DNA polymerase beta and cleave DNA. J Nat Prod. 2005 Nov;68(11):1625-8.
• [51] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 216).
• [52] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 955).
• [53] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6677).
• [54] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1209).
• [55] 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1388-95.
• [56] A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. Bioorg Med Chem. 2010 Feb;18(3):1273-9.
• [57] Regiospecific and conformationally restrained analogs of melphalan and DL-2-NAM-7 and their affinities for the large neutral amino acid transporter... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3688-91.
• [58] N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6495-9.
• [59] Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32.
• [60] 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7.
• [61] Immucillins in custom catalytic-site cavities. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5900-3.
• [62] Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis. J Med Chem. 2007 Nov 29;50(24):6095-103.
• [63] Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)... J Med Chem. 2006 Nov 2;49(22):6439-42.
• [64] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4067).
• [65] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1206).
• [66] Asymmetric syntheses of daedalin A and quercinol and their tyrosinase inhibitory activity. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1063-4.
• [67] Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. Bioorg Med Chem Lett. 2010 Jan 15;20(2):628-31.
• [68] Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. J Med Chem. 2007 Oct 4;50(20):5012-23.
• [69] Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38.
• [70] Akuammine and dihydroakuammine, two indolomonoterpene alkaloids displaying affinity for opioid receptors. J Nat Prod. 1992 Mar;55(3):380-4.
• [71] The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5760-3.
• [72] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2519).
• [73] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4065).
• [74] Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists. J Med Chem. 1993 Oct 15;36(21):3188-96.
• [75] Lipoperoxidation and cyclooxygenase enzyme inhibitory piperidine alkaloids from Cassia spectabilis green fruits. J Nat Prod. 2007 Dec;70(12):2026-8.
• [76] An analysis of phakellin and oroidin structures stimulated by further study of an Agelas sponge. J Nat Prod. 2004 Aug;67(8):1256-61.
• [77] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5344).
• [78] Green tea catechins as a BACE1 (beta-secretase) inhibitor. Bioorg Med Chem Lett. 2003 Nov 17;13(22):3905-8.
• [79] (-)-Cercosporamide derivatives as novel antihyperglycemic agents. Bioorg Med Chem Lett. 2009 Feb 1;19(3):724-6.
• [80] Potent CYP3A4 inhibitory constituents of Piper cubeba. J Nat Prod. 2005 Jan;68(1):64-8.
• [81] Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opio... J Med Chem. 2006 Jan 12;49(1):256-62.
• [82] Synthesis and biological evaluation of (-)- and (+)-debromoflustramine B and its analogues as selective butyrylcholinesterase inhibitors. J Med Chem. 2008 Sep 11;51(17):5271-84.
• [83] Discorhabdins from the Korean marine sponge Sceptrella sp. J Nat Prod. 2010 Feb 26;73(2):258-62.
• [84] Enantioselective synthesis of (-)-englerins A and B. Angew Chem Int Ed Engl. 2010 May 3;49(20):3517-9.
• [85] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5328).
• [86] Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely... J Med Chem. 2008 Jun 12;51(11):3154-70.
• [87] 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3208-11.
• [88] Grandisines C-G, indolizidine alkaloids from the Australian rainforest tree Elaeocarpus grandis. J Nat Prod. 2006 Sep;69(9):1295-9.
• [89] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 217).
• [90] Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93.
• [91] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5571).
• [92] Pharmacophore identification of alpha(1A)-adrenoceptor antagonists. Bioorg Med Chem Lett. 2005 Feb 1;15(3):657-64.
• [93] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1212).
• [94] Total synthesis of (-)-uniflorine A. J Nat Prod. 2009 Nov;72(11):2058-60.
• [95] Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-2244.
• [96] Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activ... J Med Chem. 2005 Jul 28;48(15):4919-30.
• [97] 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferas... J Med Chem. 1999 Jun 3;42(11):1982-90.
• [98] Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor. Bioorg Med Chem Lett. 1999 Jun 7;9(11):1511-6.
• [99] Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2. Bioorg Med Chem Lett. 2001 Jun 4;11(11):1401-5.
• [100] Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. J Med Chem. 1990 Jan;33(1):11-3.
• [101] Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl... Bioorg Med Chem. 2008 Mar 15;16(6):3283-90.
• [102] Current and novel approaches to the drug treatment of schizophrenia. J Med Chem. 2001 Feb 15;44(4):477-501.
• [103] Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2225-8.
• [104] N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor. J Med Chem. 1991 Sep;34(9):2877-82.
• [105] Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78.
• [106] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2869).
• [107] DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
• [108] Synthesis and antiinflammatory/analgesic activities of 11H-dibenzo[b, e,][1,4]dioxepinacetic acids. J Med Chem. 1986 Aug;29(8):1436-41.
• [109] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4072).
• [110] Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonists. J Med Chem. 1997 Jan 3;40(1):18-23.
• [111] 1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists. J Med Chem. 1991 Mar;34(3):1202-6.
• [112] Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase. J Med Chem. 2006 Jun 1;49(11):3101-15.
• [113] Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists. J Med Chem. 2005 Dec 29;48(26):8289-98.
• [114] N-benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase. J Med Chem. 2007 Oct 4;50(20):4928-38.
• [115] In silico fragment-based discovery of DPP-IV S1 pocket binders. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1405-9.
• [116] A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist. J Med Chem. 1995 May 12;38(10):1593-9.
• [117] Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. J Med Chem. 2009 May 14;52(9):3001-9.
• [118] Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new ... J Med Chem. 2009 Jul 23;52(14):4266-76.
• [119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1365).
• [120] 5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity. J Med Chem. 2010 May 13;53(9):3696-706.
• [121] Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore. J Nat Prod. 2009 Dec;72(12):2199-202.
• [122] Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. J Med Chem. 2006 Jun 15;49(12):3496-500.
• [123] (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad ant... J Med Chem. 2005 Dec 29;48(26):8163-73.
• [124] Substituted furans as inhibitors of the PDE4 enzyme. Bioorg Med Chem Lett. 1999 Feb 8;9(3):323-6.
• [125] 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation. Bioorg Med Chem Lett. 2005 May 2;15(9):2221-4.
• [126] CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives. Bioorg Med Chem Lett. 2007 Apr 1;17(7):1883-7.
• [127] ( )-2-amino-2-thiazoline-4-ethanoic acid; a novel, specific GABAA receptor agonist. Bioorg. Med. Chem. Lett. 1(5):247-248 (1991).
• [128] Dopamine/serotonin receptor ligands. 9. Oxygen-containing midsized heterocyclic ring systems and nonrigidized analogues. A step toward dopamine D5 ... J Med Chem. 2004 Aug 12;47(17):4155-8.
• [129] Novel aminoethylbiphenyls as 5-HT7 receptor ligands. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3018-22.
• [130] Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6.
• [131] Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors. J Med Chem. 1996 Dec 20;39(26):5064-71.
• [132] Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem. 2008 Feb 28;51(4):976-82.
• [133] A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3816-20.
• [134] Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J Med Chem. 2008 Aug 14;51(15):4553-62.
• [135] Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors. Bioorg Med Chem Lett. 2002 Jan 21;12(2):155-8.
• [136] Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9.
• [137] Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeu... J Med Chem. 1996 Jan 19;39(2):570-81.
• [138] A new 7,8-euphadien-type triterpenoid from Brackenridgea nitida and Bleasdalea bleasdalei that inhibits DNA polymerase beta. J Nat Prod. 2000 Oct;63(10):1356-60.
• [139] Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum. Bioorg Med Chem Lett. 2006 Feb;16(3):573-80.
• [140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3200).
• [141] gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83.
• [142] Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis. Bioorg Med Chem. 2003 Jul 17;11(14):3205-14.
• [143] Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3750-4.
• [144] New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4940-3.
• [145] Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter. Bioorg Med Chem Lett. 2009 Sep 1;19(17):4996-8.
• [146] The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. J Med Chem. 2005 May 19;48(10):3449-62.
• [147] Synthesis of new beta-1-C-alkylated imino-L-iditols: A comparative study of their activity as beta-glucocerebrosidase inhibitors. Bioorg Med Chem. 2010 Apr 1;18(7):2645-50.
• [148] Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behav Neurosci. 2002 Dec;116(6):1075-83.
• [149] Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. Exp Parasitol. 1987 Oct;64(2):237-43.
• [150] Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor a... Bioorg Med Chem. 2008 Feb 15;16(4):1966-82.
• [151] BACE1 inhibitory effects of lavandulyl flavanones from Sophora flavescens. Bioorg Med Chem. 2008 Jul 15;16(14):6669-74.
• [152] Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod. 2001 Oct;64(10):1286-93.
• [153] Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach ... J Med Chem. 2005 Nov 17;48(23):7333-42.
• [154] Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first clas... Bioorg Med Chem. 2007 May 1;15(9):3161-70.
• [155] Novel gamma-secretase inhibitors discovered by library screening of in-house synthetic natural product intermediates. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3813-6.
• [156] Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. J Med Chem. 2010 Jun 24;53(12):4731-48.
• [157] Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotr... J Med Chem. 2008 Jul 24;51(14):4093-103.
• [158] Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate recepto... Bioorg Med Chem. 2009 Aug 1;17(15):5708-15.
• [159] Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor. J Med Chem. 2005 May 5;48(9):3114-7.
• [160] Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2). J Med Chem. 2010 Feb 25;53(4):1712-25.
• [161] Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4415-8.
• [162] Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem. 2010 Feb 25;53(4):1799-809.
• [163] Phosphorus analogues of gamma-aminobutyric acid, a new class of anticonvulsants. J Med Chem. 1984 May;27(5):654-9.
• [164] Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABAB agonist with CNS activity, Bioorg. Med. Chem. Lett. 3(4):515-518 (1993).
• [165] Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as poten... J Med Chem. 1995 Sep 1;38(18):3482-7.
• [166] Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase acti... J Med Chem. 1996 Feb 16;39(4):918-28.
• [167] Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6610-5.
• [168] Synthesis and evaluation of phenyl- and benzoylpiperazines as potential serotonergic agents. J Med Chem. 1986 May;29(5):630-4.
• [169] Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonists. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4350-3.
• [170] Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids. J Med Chem. 2006 Jan 26;49(2):748-59.
• [171] A diazine heterocycle replaces a six-membered hydrogen-bonded array in the active site of scytalone dehydratase, Bioorg. Med. Chem. Lett. 3(8):1605-1608 (1993).
• [172] Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) rec... Bioorg Med Chem Lett. 2004 Oct 4;14(19):4861-6.
• [173] Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A. 1999 Nov23;96(24):13989-94.
• [174] Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones. Eur J Med Chem. 2010 Feb;45(2):526-35.
• [175] A kinetic study on the stereospecific inhibition of KCNQ1 and I(Ks) by the chromanol 293B. Br J Pharmacol. 2001 Dec;134(8):1647-54.
• [176] 3-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor, Bioorg. Med. Chem. Lett. 7(17):2307-2312 (1997).
• [177] 1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2966-70.
• [178] Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett. 2003 Oct 20;13(20):3527-30.
• [179] Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorg Med Chem Lett. 2010 Jan 15;20(2):636-9.
• [180] Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach. Eur J Med Chem. 2010 Mar;45(3):1133-9.
• [181] Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorg Med Chem. 2007 Nov 1;15(21):6649-58.
• [182] Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonis... J Med Chem. 2000 Feb 24;43(4):756-62.
• [183] Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem. 2005 Feb 10;48(3):710-22.
• [184] Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties. J Med Chem. 2007 Dec 27;50(26):6638-46.
• [185] Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80.
• [186] Design, synthesis, and evaluation of postulated transient intermediate and substrate analogues as inhibitors of 4-hydroxyphenylpyruvate dioxygenase. Bioorg Med Chem Lett. 2002 Jul 8;12(13):1709-13.
• [187] The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4563-5.
• [188] Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives. J Med Chem. 1986 Oct;29(10):2024-8.
• [189] Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I. Bioorg Med Chem Lett. 2000 Oct 2;10(19):2167-70.
• [190] Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. J Med Chem. 2009 Jun 11;52(11):3548-62.
• [191] Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J Med Chem. 2008 Jun 12;51(11):3051-6.
• [192] 4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):313-6.
• [193] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5291).
• [194] Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 2006 Nov 30;49(24):6987-7001.
• [195] Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highl... J Med Chem. 2006 Mar 9;49(5):1562-75.
• [196] Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5907-11.
• [197] Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify no... J Med Chem. 2010 Nov 11;53(21):7573-86.
• [198] 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure... J Med Chem. 1996 Oct 11;39(21):4285-98.
• [199] Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2362-7.
• [200] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2759).
• [201] The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination. J Med Chem. 2005 Jul 14;48(14):4663-9.
• [202] Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inh... Bioorg Med Chem Lett. 2005 Apr 15;15(8):1997-2001.
• [203] Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I. J Nat Prod. 2002 Nov;65(11):1715-8.
• [204] Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists. J Med Chem. 1987 Apr;30(4):750-3.
• [205] Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors. Bioorg Med Chem. 2009 Mar 15;17(6):2452-60.
• [206] Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)ox... J Med Chem. 2009 Nov 12;52(21):6685-706.
• [207] Benzodiazepine receptor binding activity of 6,9-disubstituted purines. J Med Chem. 1989 May;32(5):1020-4.
• [208] 3-Amino-beta-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam. J Med Chem. 1985 Jun;28(6):824-8.
• [209] Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree ... J Med Chem. 2009 Aug 13;52(15):4631-9.
• [210] Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorg Med Chem. 2007 Mar 1;15(5):2187-97.
• [211] Benzodiazepine receptor affinity and interaction of some N-(indol-3-ylglyoxylyl)amine derivatives. J Med Chem. 1992 Jun 12;35(12):2214-20.
• [212] Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR i... Bioorg Med Chem. 2008 Oct 1;16(19):8959-67.
• [213] Gastrin releasing peptide antagonists with improved potency and stability. J Med Chem. 1991 Jul;34(7):2102-7.
• [214] Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. Bioorg Med Chem Lett. 2008 Jul 1;18(13):3682-6.
• [215] New Gly-Pro-Glu (GPE) analogues: expedite solid-phase synthesis and biological activity. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1392-6.
• [216] Discovery of dipeptides with high affinity to the specific binding site for substance P1-7. J Med Chem. 2010 Mar 25;53(6):2383-9.
• [217] Design and conformational analysis of several highly potent bradykinin receptor antagonists. J Med Chem. 1991 Mar;34(3):1230-3.
• [218] Synthesis and biological evaluation of bombesin constrained analogues. J Med Chem. 2000 Jun 15;43(12):2356-61.
• [219] Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 2004 Apr 1;18(7):830-50.
• [220] (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors. Bioorg Med Chem Lett. 2005 Mar 1;15(5):1525-7.
• [221] A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different class... J Med Chem. 2004 Oct 21;47(22):5418-26.
• [222] Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitors. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3350-3.
• [223] Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 production. Bioorg Med Chem Lett. 2010 Dec 1;20(23):6938-41.
• [224] 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands. Bioorg Med Chem Lett. 2007 May 1;17(9):2643-8.
• [225] 3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists. J Med Chem. 2006 Jun 29;49(13):3757-8.
• [226] Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1482-96.
• [227] Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides. J Med Chem. 2005 Jan 13;48(1):71-90.
• [228] Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic g... J Med Chem. 2006 Feb 9;49(3):1080-100.
• [229] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2681).
• [230] Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fl... J Med Chem. 2009 Apr 23;52(8):2443-53.
• [231] Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13.
• [232] 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Eur J Med Chem. 2009 Sep;44(9):3471-9.
• [233] Novel Acetylenic Acids from the Root Bark of Paramacrolobium caeruleum: Inhibitors of 3-Hydroxy-3-methyl-glutaryl Coenzyme A Reductase J. Nat. Prod. 52(1):153-161 (1989).
• [234] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5609).
• [235] Heterocyclic ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2003 Nov 17;13(22):3909-13.
• [236] New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41.
• [237] Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter. J Pharmacol Exp Ther. 1999 Nov;291(2):648-54.
• [238] Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem. 2009 Feb 12;52(3):718-25.
• [239] Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1985-9.
• [240] Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas. Bioorg Med Chem Lett. 2004 Aug 16;14(16):4277-80.
• [241] Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J Med Chem. 2010 Jan 28;53(2):778-86.
• [242] Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues. Bioorg Med Chem. 2008 Sep 15;16(18):8676-84.
• [243] Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. J Med Chem. 1987 Oct;30(10):1729-37.
• [244] 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem. 2006 Jun 15;49(12):3653-8.
• [245] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7922).
• [246] Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci. J Med Chem. 2005 Oct 6;48(20):6442-53.
• [247] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1740).
• [248] Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase. J Med Chem. 2009 Jun 11;52(11):3474-83.
• [249] Amino- and guanidinoacylryanodines: basic ryanodine esters with enhanced affinity for the sarcoplasmic reticulum Ca(2+)-release channel. J Med Chem. 1993 May 14;36(10):1319-23.
• [250] C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. J Med Chem. 2006 Jul 13;49(14):4269-74.
• [251] Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine. J Nat Prod. 1998 Jun 26;61(6):709-12.
• [252] R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4128-30.
• [253] Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selec... J Med Chem. 2008 Feb 28;51(4):983-7.
• [254] Synthesis and neuropharmacological evaluation of 2-aryl- and alkylapomorphines. Bioorg Med Chem. 2008 Apr 1;16(7):3773-9.
• [255] Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter. Bioorg Med Chem Lett. 2006 Apr 1;16(7):2022-5.
• [256] Alpha-methylation at benzylic fragment of N-aryl-N'-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher effic... Bioorg Med Chem Lett. 2007 Jul 15;17(14):3894-9.
• [257] Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety. J Med Chem. 2008 Oct 9;51(19):6005-13.
• [258] In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series. Bioorg Med Chem Lett. 2008 Jan 1;18(1):355-9.
• [259] Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2998-3002.
• [260] Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines. Bioorg Med Chem. 2008 Jul 15;16(14):6675-81.
• [261] Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. J Med Chem. 1998 Jul 2;41(14):2565-71.
• [262] Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds. Bioorg Med Chem Lett. 2010 May 1;20(9):2851-4.
• [263] Structure-based design of novel human Pin1 inhibitors (II). Bioorg Med Chem Lett. 2010 Apr 1;20(7):2210-4.
• [264] Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reduc... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92.
• [265] Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of ... J Med Chem. 2010 Jan 28;53(2):573-85.
• [266] 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. J Med Chem. 2005 Jun 30;48(13):4312-31.
• [267] Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybri... J Med Chem. 2003 Oct 9;46(21):4377-92.
• [268] Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors. Bioorg Med Chem Lett. 2006 Jan 15;16(2):311-6.
• [269] Discovery of novel sphingosine kinase 1 inhibitors. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6119-21.
• [270] Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. J Med Chem. 2005 Apr 7;48(7):2627-37.
• [271] Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors. J Med Chem. 2009 Jun 11;52(11):3591-5.
• [272] Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6682-5.
• [273] Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6691-6.
• [274] Heteroaromatic side-chain analogs of pregabalin. Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32.
• [275] Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-meth... J Med Chem. 1996 Aug 30;39(18):3539-46.
• [276] Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):402-4.
• [277] Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther. 2004 Jun;309(3):1148-53.
• [278] Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorop... J Med Chem. 1999 Jun 3;42(11):2053-9.
• [279] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3047).
• [280] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3046).
• [281] In vitro studies on a class of quinoline containing histamine H3 antagonists. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3295-300.
• [282] SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling. Bioorg Med Chem. 2010 Mar 1;18(5):1958-67.
• [283] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1237).
• [284] 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors. Bioorg Med Chem Lett. 2009 Jan 1;19(1):58-61.
• [285] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6512).
• [286] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 65).
• [287] Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem. 2002 Nov 21;45(24):5260-79.
• [288] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3042).
• [289] Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. Epub 2009 Aug 21.Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
• [290] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5720).
• [291] Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16.
• [292] GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. Curr Pharm Des. 2000 Aug;6(12):1193-209.
• [293] Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression. Bioorg Med Chem. 2009 Jan 1;17(1):337-43.
• [294] A binary QSAR model for classification of hERG potassium channel blockers. Bioorg Med Chem. 2008 Apr 1;16(7):4107-19.
• [295] PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L959-69.
• [296] Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors. J Med Chem. 2005 Dec 1;48(24):7789-95.
• [297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2288).
• [298] [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). Bioorg Med Chem Lett. 2003 Jan 20;13(2):201-4.
• [299] Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor. J Med Chem. 2007 Jun 14;50(12):2903-15.
• [300] Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes. Bioorg Med Chem. 2010 Jul 1;18(13):4783-92.
• [301] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1406).
• [302] New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. J Med Chem. 2007 Mar 8;50(5):922-31.
• [303] N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands. J Med Chem. 2002 Jul 18;45(15):3271-9.
• [304] 3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. J Med Chem. 2002 Mar 14;45(6):1180-3.
• [305] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4583).
• [306] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4068).
• [307] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3055).
• [308] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3056).
• [309] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6676).
• [310] Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter. J Med Chem. 2007 Jan 25;50(2):219-32.
• [311] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3421).
• [312] Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors Bioorg Med Chem Lett. 2006 Feb 15;16(4):978-83.
• [313] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6551).
• [314] Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies. Bioorg Med Chem. 2007 Aug 1;15(15):5198-206.
• [315] New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4770-3.
• [316] Development of potent and selective dipeptidyl peptidase II inhibitors. Bioorg Med Chem Lett. 2002 Oct 21;12(20):2825-8.
• [317] Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41.
• [318] 2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms. J Med Chem. 1996 Feb 2;39(3):669-72.
• [319] Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3614-7.
• [320] Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhib... J Med Chem. 2007 Nov 1;50(22):5425-38.
• [321] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1407).
• [322] Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acety... Bioorg Med Chem. 2009 Jul 1;17(13):4367-77.
• [323] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6610).
• [324] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3040).
• [325] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1366).
• [326] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4069).
• [327] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3420).
• [328] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1374).
• [329] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1418).
• [330] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4070).
• [331] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4071).
• [332] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1238).
• [333] Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. J Med Chem. 2005 Dec 1;48(24):7867-81.
• [334] Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. J Nat Prod. 1992 Nov;55(11):1529-60.
• [335] Advances in development of dopaminergic aporphinoids. J Med Chem. 2007 Jan 25;50(2):171-81.
• [336] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1215).
• [337] Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature. 2014 Apr 10;508(7495):222-7.
• [338] 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands. Bioorg Med Chem. 2009 Apr 1;17(7):2812-22.
• [339] Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol. J Med Chem. 2010 Aug 12;53(15):5676-83.
• [340] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6513).
• [341] Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes. Bioorg Med Chem. 2008 Dec 15;16(24):10257-69.
• [342] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 66).
• [343] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5448).
• [344] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5721).
• [345] The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels. Neuropharmacology. 2006 Nov;51(6):1068-77.
• [346] Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression. Bioorg Med Chem. 2009 Oct 1;17(19):6890-7.
• [347] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 415).
• [348] Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates: synthesis, in vitro pharmacology, and modeling. J Med Chem. 2004 Nov 4;47(23):5620-9.
• [349] Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group. Bioorg Med Chem. 2008 Feb 15;16(4):1613-31.
• [350] [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors. Bioorg Med Chem Lett. 2007 May 1;17(9):2618-21.
• [351] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3419).
• [352] Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J Med Chem. 1997 Oct 24;40(22):3645-50.
• [353] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2289).
• [354] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8285).
• [355] Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-... J Biol Chem. 2007 Jul 27;282(30):22185-94.
• [356] Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues. J Med Chem. 2009 Mar 12;52(5):1310-6.
• [357] Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. J Med Chem. 2010 May 13;53(9):3602-10.
• [358] Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56.
• [359] Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95.
• [360] The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3271-4.
• [361] alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1517-20.
• [362] Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors. J Med Chem. 2008 Mar 13;51(5):1474-7.
• [363] Ras farnesyltransferase: a new therapeutic target. J Med Chem. 1997 Sep 12;40(19):2971-90.
• [364] Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3814-8.
• [365] Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors. Bioorg Med Chem. 2003 May 29;11(11):2403-14.
• [366] Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse a... Bioorg Med Chem. 2009 Jan 15;17(2):905-18.
• [367] Adrenoceptor and tetrabenazine antagonism activities of some pyridinyltetrahydropyridines. J Med Chem. 1984 Sep;27(9):1182-5.
• [368] Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays. Eur J Med Chem. 2007 Nov-Dec;42(11-12):1370-81.
• [369] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6298).
• [370] Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem. 1989 May;32(5):1057-62.
• [371] Oral oxytocin antagonists. J Med Chem. 2010 Sep 23;53(18):6525-38.
• [372] Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. J Nat Prod. 2001 Aug;64(8):1010-4.
• [373] New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxyst... J Med Chem. 2009 Nov 12;52(21):6724-43.
• [374] Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes. J Med Chem. 2008 Dec 25;51(24):8027-37.
• [375] Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hy... Bioorg Med Chem. 2008 Feb 15;16(4):2114-30.
• [376] Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3443-7.
• [377] The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases. Curr Pharm Des. 2001 Mar;7(4):231-59.
• [378] Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1845-8.
• [379] Alpha-spirocyclopentyl- and alpha-spirocyclopropyl-gamma-butyrolactones: conformationally constrained derivatives of anticonvulsant and convulsant ... J Med Chem. 1994 Jan 21;37(2):275-86.
• [380] Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylch... Bioorg Med Chem Lett. 2009 Aug 15;19(16):4560-2.
• [381] beta-Keto sulfones as inhibitors of 11beta-hydroxysteroid dehydrogenase type I and the mechanism of action. Bioorg Med Chem. 2007 Jul 1;15(13):4396-405.
• [382] Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20.
• [383] Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for My... Bioorg Med Chem Lett. 2010 Mar 1;20(5):1763-6.
• [384] Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists. J Med Chem. 2005 Dec 15;48(25):8035-44.
• [385] Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1. J Med Chem. 2007 Nov 15;50(23):5727-34.
• [386] N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies. J Med Chem. 1998 Oct 8;41(21):4165-70.
• [387] Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. J Nat Prod. 1998 Nov;61(11):1356-60.
• [388] Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor. J Nat Prod. 2010 Sep 24;73(9):1578-81.
• [389] Examination of the role of the acidic hydrogen in imparting selectivity of 7-(aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) toward inh... J Med Chem. 1997 Dec 5;40(25):3997-4005.
• [390] Stereoisomers of allenic amines as inactivators of monoamine oxidase type B. Stereochemical probes of the active site. J Med Chem. 1988 Aug;31(8):1558-66.
• [391] 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues. J Med Chem. 1986 Nov;29(11):2375-80.
• [392] Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands. Bioorg Med Chem Lett. 2004 Feb 23;14(4):1003-5.
• [393] Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phen... J Med Chem. 2006 Sep 7;49(18):5424-33.
• [394] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4701).
• [395] Benzo[c]quinolizin-3-ones: a novel class of potent and selective nonsteroidal inhibitors of human steroid 5alpha-reductase 1. J Med Chem. 2000 Oct 5;43(20):3718-35.
• [396] Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorg Med Chem. 2007 Jun 1;15(11):3801-17.
• [397] Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. J Med Chem. 2005 Apr 21;48(8):2906-15.
• [398] Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands. J Med Chem. 2005 Sep 22;48(19):5989-6003.
• [399] Synthesis and neuropharmacological characterization of 2-O-substituted apomorphines. Bioorg Med Chem. 2008 Apr 15;16(8):4563-8.
• [400] Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Bioorg Med Chem. 2010 Jun 15;18(12):4475-84.
• [401] Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and t... J Med Chem. 2005 Aug 25;48(17):5543-50.
• [402] Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3233-7.
• [403] Identification of the brominated flame retardant 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane as an androgen agonist. J Med Chem. 2006 Dec 14;49(25):7366-72.
• [404] Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine sk... J Med Chem. 2007 Dec 27;50(26):6596-606.
• [405] 'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors. Bioorg Med Chem. 2007 Sep 15;15(18):6109-18.
• [406] Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity. J Med Chem. 1991 Mar;34(3):1028-36.
• [407] Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. J Med Chem. 1997 Nov 7;40(23):3773-80.
• [408] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2435).
• [409] Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cann... J Med Chem. 2006 Feb 9;49(3):872-82.
• [410] 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication. Antiviral Res. 2000 Feb;45(2):123-34.
• [411] Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J Med Chem. 1986 Jul;29(7):1305-8.
• [412] 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors. J Med Chem. 1985 Apr;28(4):487-92.
• [413] 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation. J Med Chem. 1991 Sep;34(9):2906-16.
• [414] Catecholic flavonoids acting as telomerase inhibitors. J Med Chem. 2004 Dec 16;47(26):6466-75.
• [415] Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evalu... Bioorg Med Chem Lett. 2009 Jun 1;19(11):3014-8.
• [416] Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors. J Med Chem. 2004 Sep 23;47(20):4818-28.
• [417] Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1691-4.
• [418] Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists. J Med Chem. 1988 Oct;31(10):2034-9.
• [419] Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents. Eur J Med Chem. 2009 Jan;44(1):432-6.
• [420] Synthesis, binding studies, and structure-activity relationships of 1-aryl-and 2-aryl[1]benzopyranopyrazol-4-ones, central benzodiazepine receptor ... J Med Chem. 1988 Jan;31(1):1-3.
• [421] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6685).
• [422] Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs. J Med Chem. 2010 Sep 23;53(18):6539-49.
• [423] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5098).
• [424] Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo. Eur J Pharmacol. 2003 Jul 25;473(2-3):149-52.
• [425] New sugar-mimic alkaloids from the pods of Angylocalyx pynaertii. J Nat Prod. 2002 Feb;65(2):198-202.
• [426] Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the... Eur J Med Chem. 2010 Sep;45(9):3656-61.
• [427] Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichl... J Med Chem. 2005 Nov 17;48(23):7351-62.
• [428] Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J Med Chem. 2009 Apr 9;52(7):1873-84.
• [429] Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4438-46.
• [430] Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Chem Biol Interact. 2000 Jan 3;124(1):61-76.
• [431] Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorg Med Chem. 2009 Jan 15;17(2):553-7.
• [432] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5099).
• [433] Synthesis and CB1 cannabinoid receptor affinity of 4-alkoxycarbonyl-1,5-diaryl-1,2,3-triazoles. Bioorg Med Chem Lett. 2009 Feb 1;19(3):891-3.
• [434] Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. Eur J Med Chem. 2008 Aug;43(8):1621-31.
• [435] In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. Bioorg Med Chem. 2008 Aug 1;16(15):7330-6.
• [436] Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoim... J Med Chem. 1988 Nov;31(11):2136-45.
• [437] Synthesis of biphenyltrienes as probes for beta-amyloid plaques. J Med Chem. 2006 May 4;49(9):2841-4.
• [438] Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors. J Med Chem. 2010 Jun 24;53(12):4803-7.
• [439] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6291).
• [440] Synthesis and structure-activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitors. Bioorg Med Chem Lett. 2006 Feb 15;16(4):938-42.
• [441] ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity. J Med Chem. 2005 Jun 16;48(12):3953-79.
• [442] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4100).
• [443] Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxyl... Bioorg Med Chem. 2008 Aug 15;16(16):7715-27.
• [444] 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem. 2006 Jan 12;49(1):318-28.
• [445] Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403.
• [446] Bioorg Med Chem Lett. 2007 Jun 1;17(11):3023-7. Epub 2007 Mar 23.Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.
• [447] N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8.
• [448] Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4349-53.
• [449] Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB. Bioorg Med Chem Lett. 2008 May 1;18(9):2883-5.
• [450] 1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. Bioorg Med Chem. 2008 Feb 1;16(3):1096-102.
• [451] Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4405-9.
• [452] Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxyla... Bioorg Med Chem. 2008 Feb 15;16(4):1992-2010.
• [453] Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. J Med Chem. 2008 Jul 24;51(14):4150-69.
• [454] 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, a... J Med Chem. 2010 Oct 14;53(19):7067-75.
• [455] Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-bin... J Med Chem. 1993 Apr 30;36(9):1188-93.
• [456] CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors. Bioorg Med Chem. 2008 Sep 15;16(18):8349-58.
• [457] Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3265-71.
• [458] Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds. Bioorg Med Chem Lett. 2001 Feb 26;11(4):523-8.
• [459] The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands. Bioorg Med Chem. 2008 Apr 15;16(8):4661-9.
• [460] Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. J Med Chem. 2001 Dec 20;44(26):4615-27.
• [461] Synthesis and beta-adrenergic receptor blocking potency of 1-(substituted amino)-3-(4-indolyloxy)propan-2-ols. J Med Chem. 1986 Aug;29(8):1524-7.
• [462] Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate. J Med Chem. 2005 Nov 17;48(23):7400-10.
• [463] 5-Functionalized indazoles as glucocorticoid receptor agonists. Bioorg Med Chem Lett. 2010 May 15;20(10):3017-20.
• [464] Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-... J Med Chem. 1986 Aug;29(8):1406-12.
• [465] 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem. 1986 Feb;29(2):194-9.
• [466] A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds. Eur J Med Chem. 2009 Apr;44(4):1773-8.
• [467] Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7.
• [468] Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agon... Bioorg Med Chem Lett. 2010 Feb 1;20(3):1114-7.
• [469] Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors. J Med Chem. 2009 Jan 8;52(1):143-50.
• [470] Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models. J Med Chem. 2006 Jul 13;49(14):4085-97.
• [471] Discovery of orally active butyrolactam 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5555-60.
• [472] A vHTS approach for the identification of beta-adrenoceptor ligands. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3399-404.
• [473] Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors. Bioorg Med Chem Lett. 2007 May 1;17(9):2540-4.
• [474] Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleuki... Bioorg Med Chem Lett. 2004 Aug 16;14(16):4307-11.
• [475] Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. J Med Chem. 2007 Apr 19;50(8):1876-85.
• [476] Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptor. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1713-7.
• [477] Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy. J Med Chem. 1989 May;32(5):1052-6.
• [478] Pyrimido[5,4-b]indole derivatives. 1. A new class of potent and selective alpha 1 adrenoceptor ligands. J Med Chem. 1991 Jun;34(6):1850-4.
• [479] An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40.
• [480] SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4555-9.
• [481] Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relati... J Med Chem. 1995 Dec 8;38(25):4929-36.
• [482] Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor. J Med Chem. 2004 Mar 11;47(6):1319-21.
• [483] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 834).
• [484] Inhibitory activity of prostaglandin E2 production by the synthetic 2'-hydroxychalcone analogues: Synthesis and SAR study. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1650-3.
• [485] Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4708-12.
• [486] Structure-activity relationship studies of central nervous system agents. 13. 4-[3-(Benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)piperazine, a new ... J Med Chem. 1994 Aug 19;37(17):2754-60.
• [487] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 280).
• [488] Identification of a red-emitting fluorescent ligand for in vitro visualization of human serotonin 5-HT(1A) receptors. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6628-32.
• [489] 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem. 2006 Feb 23;49(4):1420-32.
• [490] Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. Eur J Med Chem. 2008 Mar;43(3):513-39.
• [491] Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorg Med Chem Lett. 2009 May 15;19(10):2780-4.
• [492] Parallel synthesis of isatin-based serine protease inhibitors. Bioorg Med Chem Lett. 2000 Nov 20;10(22):2501-4.
• [493] Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles. J Med Chem. 1985 Oct;28(10):1427-32.
• [494] Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation. J Med Chem. 2010 Jul 22;53(14):5347-51.
• [495] Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718. J Med Chem. 1992 Mar 20;35(6):1042-9.
• [496] Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters. J Med Chem. 2004 May 6;47(10):2624-34.
• [497] Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hy... Bioorg Med Chem Lett. 2006 Aug 1;16(15):4011-5.
• [498] P2Y1 receptor antagonists as novel antithrombotic agents. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3338-43.
• [499] N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4316-20.
• [500] 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem. 2010 Jul 8;53(13):4989-5001.
• [501] Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B... J Med Chem. 2006 Apr 6;49(7):2222-31.
• [502] Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferase. J Med Chem. 2005 Dec 15;48(25):8070-8.
• [503] Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase. J Med Chem. 2004 Dec 2;47(25):6207-17.
• [504] Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands. Bioorg Med Chem. 2009 Apr 15;17(8):3037-42.
• [505] Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4259-63.
• [506] Piperidine variations in search for non-imidazole histamine H(3) receptor ligands. Bioorg Med Chem. 2008 Sep 15;16(18):8729-36.
• [507] Fluorinated non-imidazole histamine H3 receptor antagonists. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2172-5.
• [508] Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6.
• [509] Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitor... Bioorg Med Chem Lett. 2006 Sep 15;16(18):4752-6.
• [510] Synthesis and SAR of tolylamine 5-HT6 antagonists. Bioorg Med Chem Lett. 2009 May 1;19(9):2409-12.
• [511] The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. Bioorg Med Chem. 2007 Nov 1;15(21):6659-66.
• [512] Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1708-12.
• [513] Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin... J Med Chem. 1983 Feb;26(2):294-8.
• [514] Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J Med Chem. 2006 Feb 9;49(3):900-10.
• [515] A structure-based design approach to the development of novel, reversible AChE inhibitors. J Med Chem. 2001 Sep 27;44(20):3203-15.
• [516] Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. J Med Chem. 2010 Mar 11;53(5):2204-14.
• [517] Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. J Med Chem. 2005 May 19;48(10):3621-9.
• [518] Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). Bioorg Med Chem Lett. 2008 Jun 15;18(12):3513-6.
• [519] Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships. Bioorg Med Chem Lett. 2006 May 1;16(9):2539-42.
• [520] Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. Bioorg Med Chem Lett. 2001 Apr 9;11(7):879-82.
• [521] Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabi... J Med Chem. 2010 Mar 25;53(6):2510-20.
• [522] Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart fa... J Med Chem. 2005 Oct 20;48(21):6632-42.
• [523] Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. J Med Chem. 2006 Jul 13;49(14):4183-95.
• [524] Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2955-9.
• [525] Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D(4)-selective ligand. Bioorg Med Chem. 2007 Sep 1;15(17):5811-8.
• [526] Analogues of N-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitors of tyrosinase and melanin formation. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3607-10.
• [527] Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors. J Med Chem. 2009 Jul 9;52(13):3892-901.
• [528] Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones. J Med Chem. 2010 Sep 23;53(18):6560-71.
• [529] Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1336-9.
• [530] Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hyd... Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6.
• [531] Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer. Bioorg Med Chem. 2010 Jul 15;18(14):5352-66.
• [532] A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone. Bioorg Med Chem. 2009 Jun 1;17(11):3770-4.
• [533] Synthesis and cyclooxygenase inhibitory activities of linear 1-(methanesulfonylphenyl or benzenesulfonamido)-2-(pyridyl)acetylene regioisomers. Bioorg Med Chem. 2008 Feb 15;16(4):1948-56.
• [534] Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents. Eur J Med Chem. 2009 Dec;44(12):4862-88.
• [535] Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quin... J Med Chem. 2005 Feb 10;48(3):744-52.
• [536] Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):333-6.
• [537] Probing the cannabinoid CB1/CB2 receptor subtype selectivity limits of 1,2-diarylimidazole-4-carboxamides by fine-tuning their 5-substitution pattern. Bioorg Med Chem Lett. 2010 May 1;20(9):2770-5.
• [538] Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors. J Med Chem. 2006 Mar 23;49(6):1855-66.
• [539] Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2007 May 15;17(10):2838-43.
• [540] Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives. Bioorg Med Chem Lett. 2006 Feb;16(3):592-5.
• [541] Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as pote... Bioorg Med Chem Lett. 2010 Sep 1;20(17):5345-8.
• [542] Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols. Bioorg Med Chem Lett. 1999 Apr 5;9(7):943-8.
• [543] Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6.
• [544] A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 re... J Med Chem. 2004 Dec 30;47(27):6662-5.
• [545] Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5043-7.
• [546] Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5215-8.
• [547] 5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine. J Med Chem. 1997 Nov 21;40(24):3974-8.
• [548] Kinesin spindle protein (KSP) inhibitors with 2,3-fused indole scaffolds. J Med Chem. 2010 Jul 8;53(13):5054-8.
• [549] Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorg Med Chem Lett. 2010 May 15;20(10):3050-64.
• [550] Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. J Med Chem. 1992 Oct 30;35(22):4001-10.
• [551] Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition. J Med Chem. 2006 Nov 2;49(22):6607-13.
• [552] Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. J Med Chem. 2010 Mar 11;53(5):2155-70.
• [553] Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and... J Med Chem. 2010 Jun 10;53(11):4379-89.
• [554] 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists. J Med Chem. 2005 Nov 17;48(23):7486-90.
• [555] 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase. J Med Chem. 2006 Sep 7;49(18):5562-70.
• [556] In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 ... J Med Chem. 2007 Jul 26;50(15):3651-60.
• [557] Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Feb 28;51(4):937-47.
• [558] Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorg Med Chem Lett. 2008 Mar 15;18(6):2109-13.
• [559] Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6549-52.
• [560] Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5298-302.
• [561] Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity. Bioorg Med Chem Lett. 2010 Jan 1;20(1):266-71.
• [562] Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity. J Med Chem. 2006 May 4;49(9):2673-6.
• [563] Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privil... Bioorg Med Chem Lett. 2009 Apr 15;19(8):2240-3.
• [564] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5482).
• [565] Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9.
• [566] Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5773-7.
• [567] Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6.
• [568] 1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic prope... J Med Chem. 2007 Oct 18;50(21):5217-26.
• [569] Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9.
• [570] Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem. 2007 Aug 9;50(16):3825-40.
• [571] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3136).
• [572] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3135).
• [573] Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J Med Chem. 2002 May 23;45(11):2131-8.
• [574] Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4364-6.
• [575] New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13. Bioorg Med Chem. 2010 Apr 15;18(8):2930-6.
• [576] Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands. J Med Chem. 1991 Oct;34(10):2946-53.
• [577] (1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist. J Med Chem. 1990 Nov;33(11):2948-50.
• [578] Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3593-7.
• [579] Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5478-82.
• [580] Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylc... Eur J Med Chem. 2009 Oct;44(10):4057-62.
• [581] 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. J Med Chem. 2001 Jun 7;44(12):1866-82.
• [582] Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4780-5.
• [583] N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists. Bioorg Med Chem Lett. 2005 Jan 17;15(2):379-83.
• [584] Bioorg Med Chem Lett. 2007 Jun 1;17(11):3028-33. Epub 2007 Mar 21.Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2.
• [585] Scaffold-based design and synthesis of potent N-type calcium channel blockers. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72.
• [586] The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety. Bioorg Med Chem Lett. 2009 May 1;19(9):2519-23.
• [587] Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists. J Med Chem. 2002 Aug 1;45(16):3337-44.
• [588] N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8.
• [589] 4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase. J Med Chem. 2010 Jan 14;53(1):241-53.
• [590] Progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton. Bioorg Med Chem. 2008 Jul 15;16(14):7046-54.
• [591] Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibito... Bioorg Med Chem Lett. 2007 Apr 1;17(7):2005-12.
• [592] Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands. Bioorg Med Chem Lett. 1999 Nov 1;9(21):3143-6.
• [593] 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity. J Med Chem. 2009 Jul 9;52(13):3954-68.
• [594] Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands. J Med Chem. 2005 Jan 13;48(1):266-73.
• [595] Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4973-8.
• [596] Novel inhibitors of potassium ion channels on human T lymphocytes. J Med Chem. 1995 May 26;38(11):1877-83.
• [597] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1436).
• [598] Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. J Med Chem. 2007 May 31;50(11):2718-31.
• [599] A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. J Med Chem. 2001 Mar 1;44(5):672-80.
• [600] Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design,... J Med Chem. 2008 Aug 14;51(15):4685-98.
• [601] Effects of alkyl substitutions of xanthine skeleton on bronchodilation. J Med Chem. 1992 Oct 30;35(22):4039-44.
• [602] Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic... J Med Chem. 2004 Feb 12;47(4):1031-43.
• [603] Aryl sulfones: a new class of gamma-secretase inhibitors. Bioorg Med Chem Lett. 2005 May 16;15(10):2685-8.
• [604] Facile one-pot synthesis of thio and selenourea derivatives: a new class of potent urease inhibitors. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6387-91.
• [605] 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modellin... Bioorg Med Chem. 2010 May 15;18(10):3413-25.
• [606] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4744).
• [607] Affinity of 10-(4-methylpiperazino)dibenz[b,f]oxepins for clozapine and spiroperidol binding sites in rat brain. J Med Chem. 1982 Jul;25(7):855-8.
• [608] Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues. J Med Chem. 1986 Mar;29(3):342-6.
• [609] New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indoles. Bioorg Med Chem Lett. 1999 Feb 8;9(3):333-6.
• [610] The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced ... Vascul Pharmacol. 2009 Mar-Apr;50(3-4):123-31.
• [611] Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines. J Med Chem. 2007 May 17;50(10):2341-51.
• [612] Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):972-5.
• [613] 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase. Bioorg Med Chem. 2010 Jan 15;18(2):945-52.
• [614] Periodinates: a new class of protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett. 1999 Feb 8;9(3):353-6.
• [615] Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues. Eur J Med Chem. 2010 Sep;45(9):4221-8.
• [616] Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists. Bioorg Med Chem Lett. 2004 May 3;14(9):2079-82.
• [617] Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5268-71.
• [618] D4 dopamine receptor-selective compounds from the Chinese plant Phoebe chekiangensis, Bioorg. Med. Chem. Lett. 7(9):1207-1212 (1997).
• [619] Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity. Bioorg Med Chem Lett. 2001 May 7;11(9):1229-31.
• [620] Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. J Med Chem. 1992 Aug 21;35(17):3270-9.
• [621] Low molecular weight indole fragments as IMPDH inhibitors. Bioorg Med Chem Lett. 2006 May 1;16(9):2535-8.
• [622] Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine. Bioorg Med Chem Lett. 1999 Dec 6;9(23):3273-6.
• [623] Further explorations of unnatural alkaloids. J Nat Prod. 1985 Nov-Dec;48(6):878-93.
• [624] Simple bi- and tricyclic inhibitors of human steroid 5alpha-reductase. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1909-11.
• [625] Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-,... J Med Chem. 1989 Jun;32(6):1231-7.
• [626] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6500).
• [627] Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and... J Med Chem. 2005 Jan 27;48(2):569-85.
• [628] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3).
• [629] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1944).
• [630] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5756).
• [631] The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem. 2005 Aug 11;48(16):5059-87.
• [632] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5650).
• [633] Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5429-33.
• [634] Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor. J Med Chem. 1998 Dec 31;41(27):5457-65.
• [635] Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues. J Med Chem. 1984 Jan;27(1):15-9.
• [636] Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorg Med Chem. 2007 Oct 15;15(20):6574-95.
• [637] Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. J Med Chem. 2001 Mar 1;44(5):749-62.
• [638] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2284).
• [639] Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies. J Med Chem. 2008 Feb 14;51(3):603-11.
• [640] Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: pharmacological evaluation for central dopaminergic and serotonergic activity, Bioorg. Med. Chem. Lett. 7(3):241-246 (1997).
• [641] New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor. J Med Chem. 2003 Jan 2;46(1):161-8.
• [642] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5651).
• [643] Stereoselective synthesis of desloratadine derivatives as antagonist of histamine. Bioorg Med Chem. 2010 Feb 15;18(4):1626-32.
• [644] N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors. J Med Chem. 2006 Dec 28;49(26):7766-73.
• [645] Discovery of novel triazole-based opioid receptor antagonists. J Med Chem. 2006 Jul 13;49(14):4044-7.
• [646] Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain. Bioorg Med Chem. 2008 Jun 15;16(12):6379-86.
• [647] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6069).
• [648] Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. Eur J Med Chem. 2009 Jun;44(6):2667-72.
• [649] Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones. J Med Chem. 1992 May 15;35(10):1887-97.
• [650] Anthraquinones and betaenone derivatives from the sponge-associated fungus Microsphaeropsis species: novel inhibitors of protein kinases. J Nat Prod. 2000 Jun;63(6):739-45.
• [651] Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorg Med Chem. 2010 Mar 15;18(6):2173-2177.
• [652] Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Int J Oncol. 1998 Apr;12(4):793-804.
• [653] Probing the pharmacophore of ginkgolides as glycine receptor antagonists. J Med Chem. 2007 Apr 5;50(7):1610-7.
• [654] Alstiphyllanines E-H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter. Bioorg Med Chem. 2010 Mar 15;18(6):2152-2158.
• [655] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1835).
• [656] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1838).
• [657] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1836).
• [658] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1837).
• [659] Discovery of a potent, nonpolyglutamatable inhibitor of glycinamide ribonucleotide transformylase. J Med Chem. 2006 May 18;49(10):2998-3002.
• [660] Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5018-21.
• [661] DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.
• [662] N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands. Bioorg Med Chem. 2008 Sep 15;16(18):8335-8.
• [663] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6669).
• [664] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6670).
• [665] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4484).
• [666] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1925).
• [667] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1945).
• [668] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5100).
• [669] 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational a... Bioorg Med Chem. 2010 Feb 15;18(4):1507-15.
• [670] Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3233-7.
• [671] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2879).
• [672] Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for ... J Nat Prod. 2007 Sep;70(9):1397-405.
• [673] Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. Bioorg Med Chem. 2008 Apr 15;16(8):4272-85.
• [674] Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement. J Med Chem. 2009 Aug 27;52(16):5009-12.
• [675] 14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxi... J Med Chem. 2009 Aug 27;52(16):5069-75.
• [676] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6160).
• [677] Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor. Bioorg Med Chem. 2009 Feb 1;17(3):1370-80.
• [678] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6159).
• [679] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6922).
• [680] Scalarane sesterterpenes from a marine sponge of the genus Spongia and their FXR antagonistic activity. J Nat Prod. 2007 Nov;70(11):1691-5.
• [681] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3405).
• [682] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5101).
• [683] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5508).
• [684] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2481).
• [685] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1900).
• [686] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1901).
• [687] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1955).
• [688] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1946).
• [689] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6671).
• [690] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6672).
• [691] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5426).
• [692] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8343).
• [693] 14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. J Med Chem. 2009 Mar 26;52(6):1553-7.
• [694] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5102).
• [695] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1902).
• [696] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1903).
• [697] Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB. J Med Chem. 2004 Nov 18;47(24):6042-54.
• [698] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2692).
• [699] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1904).
• [700] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1877).
• [701] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3402).
• [702] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5865).
• [703] Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem. 2006 Apr 6;49(7):2241-52.
• [704] Preview of potential therapeutic applications of leukotriene B4 inhibitors in dermatology. Skin Pharmacol Appl Skin Physiol. 2000 Sep-Oct;13(5):235-45.
• [705] Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents. J Med Chem. 2003 Jun 19;46(13):2716-30.
• [706] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5864).
• [707] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2482).
• [708] Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45.
• [709] Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum. Bioorg Med Chem Lett. 2006 Jun 1;16(11):3061-4.
• [710] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6923).
• [711] Inhibition of 3 beta-hydroxysteroid-dehydrogenase: an approach for prostate cancer treatment Anticancer Res. 1995 Jul-Aug;15(4):1349-54.
• [712] Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors. J Med Chem. 2010 Jan 14;53(1):402-18.
• [713] Heat shock protein 90: inhibitors in clinical trials. J Med Chem. 2010 Jan 14;53(1):3-17.
• [714] Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorp... J Med Chem. 2006 Aug 24;49(17):5333-8.
• [715] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1912).
• [716] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5103).
• [717] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6924).
• [718] Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3273-6.
• [719] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3400).
• [720] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5105).
• [721] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1947).
• [722] Triterpenoids from the leaves of Diospyros kaki (persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B. J Nat Prod. 2008 Oct;71(10):1775-8.
• [723] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1477).
• [724] Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem Pharmacol. 2009 Jul 15;78(2):203-10.
• [725] Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett. 2001 Dec 3;11(23):2993-5.
• [726] Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A. J Med Chem. 2008 May 8;51(9):2634-7.
• [727] Pyrazole derivatives as partial agonists for the nicotinic acid receptor. J Med Chem. 2003 Aug 28;46(18):3945-51.
• [728] Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropath... J Med Chem. 2008 Nov 27;51(22):7265-72.
• [729] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1709).
• [730] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5108).
• [731] Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcript... J Med Chem. 2005 Apr 7;48(7):2695-700.
• [732] 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. J Med Chem. 2006 Oct 19;49(21):6412-5.
• [733] Biaryl cannabinoid mimetics--synthesis and structure-activity relationship. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3652-6.
• [734] Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: inhibitors of the angiogenic enzyme thymidine phosphorylase. J Med Chem. 2003 Jan 16;46(2):207-9.
• [735] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5122).
• [736] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5110).
• [737] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5505).
• [738] COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6922-5.
• [739] Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen recepto... J Med Chem. 2008 Nov 13;51(21):7010-4.
• [740] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5591).
• [741] 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 ... Bioorg Med Chem. 2008 Jan 1;16(1):336-53.
• [742] Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8.
• [743] The synthesis of 2'-O-methyl G-clamp containing oligonucleotides and their inhibition of the HIV-1 Tat-TAR interaction. Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):1259-62.
• [744] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5107).
• [745] Bromophenols as Candida albicans isocitrate lyase inhibitors. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6644-8.
• [746] Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg Med Chem. 2007 Mar 15;15(6):2396-402.
• [747] New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triaz... Bioorg Med Chem. 2010 Jun 1;18(11):4042-8.
• [748] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1729).
• [749] Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4862-6.
• [750] Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore. J Med Chem. 1998 Aug 27;41(18):3461-6.
• [751] Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5684-8.
• [752] New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3. Eur J Med Chem. 2009 Jun;44(6):2563-71.
• [753] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3213).
• [754] Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist. Bioorg Med Chem. 2008 Mar 1;16(5):2635-44.
• [755] Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J Med Chem. 2008 Mar 27;51(6):1706-18.
• [756] Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin rec... Bioorg Med Chem Lett. 2001 Feb 26;11(4):563-6.
• [757] Multivariate analysis by the minimum spanning tree method of the structural determinants of diphenylethylenes and triphenylacrylonitriles implicate... J Med Chem. 1992 Feb 7;35(3):573-83.
• [758] Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase. J Med Chem. 2004 Jul 29;47(16):4060-5.
• [759] Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis. J Med Chem. 1990 Sep;33(9):2452-5.
• [760] Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation. Bioorg Med Chem Lett. 2004 Feb 23;14(4):999-1002.
• [761] Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem. 2005 Dec 15;48(25):8045-54.
• [762] Enzyme inhibitors: new and known polybrominated phenols and diphenyl ethers from four Indo-Pacific Dysidea sponges. J Nat Prod. 1995 Sep;58(9):1384-91.
• [763] Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem. 2006 Oct 19;49(21):6139-42.
• [764] Rational design of novel, potent small molecule pan-selectin antagonists. J Med Chem. 2007 Mar 22;50(6):1101-15.
• [765] Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells. Biochem J. 2003 Jul 15;373(Pt 2):523-9.
• [766] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3486).
• [767] Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorg Med Chem Lett. 2010 Jan 15;20(2):448-52.
• [768] Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem. 2010 Feb 11;53(3):1172-89.
• [769] Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. J Med Chem. 2006 Sep 7;49(18):5411-3.
• [770] Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9.
• [771] 2,3-Dimethoxybenzo[i]phenanthridines: topoisomerase I-targeting anticancer agents. Bioorg Med Chem. 2003 Feb 20;11(4):521-8.
• [772] Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,1... Bioorg Med Chem. 2009 Nov 1;17(21):7418-28.
• [773] Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5562-6.
• [774] Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxyge... Bioorg Med Chem. 2009 Jul 1;17(13):4459-65.
• [775] Chemical transformations of oxyresveratrol (trans-2,4,3',5'-tetrahydroxystilbene) into a potent tyrosinase inhibitor and a strong cytotoxic agent. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5650-3.
• [776] Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1670-4.
• [777] 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis, Bioorg. Med. Chem. Lett. 5(11):1171-1176 (1995).
• [778] The purification and properties of glutathione reductase from the cestode Moniezia expansa. Int J Biochem Cell Biol. 1995 Apr;27(4):393-401.
• [779] Control of hepatitis C: a medicinal chemistry perspective. J Med Chem. 2005 Jan 13;48(1):1-20.
• [780] 2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2791-5.
• [781] Glycine antagonists. Synthesis, structure, and biological effects of some bicyclic 5-isoxazolol zwitterions. J Med Chem. 1986 Feb;29(2):224-9.
• [782] RNA as a target for small molecules. Curr Opin Chem Biol. 2000 Dec;4(6):678-86.
• [783] Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. J Med Chem. 2008 Oct 23;51(20):6512-30.
• [784] Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Bioorg Med Chem. 2010 Jan 15;18(2):930-8.
• [785] Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor. Bioorg Med Chem Lett. 2001 Aug 6;11(15):2017-9.
• [786] S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9.
• [787] Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7.
• [788] Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
• [789] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4102).
• [790] N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine recept... J Med Chem. 2009 Apr 23;52(8):2393-406.
• [791] Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1350-2.
• [792] Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases, Bioorg. Med. Chem. Lett. 20(13):3863-3867 (2010).
• [793] 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease. Bioorg Med Chem. 2010 Jun 1;18(11):3790-4.
• [794] Nitrogen-containing furanose and pyranose analogues from Hyacinthus orientalis. J Nat Prod. 1998 May;61(5):625-8.
• [795] Structure-based development of novel adenylyl cyclase inhibitors. J Med Chem. 2008 Aug 14;51(15):4456-64.
• [796] Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
• [797] 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agoni... J Med Chem. 2006 Sep 21;49(19):5794-803.
• [798] 2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists. J Med Chem. 2006 May 18;49(10):2861-7.
• [799] Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem. 2009 Apr 15;17(8):3207-11.
• [800] Structural studies of pterin-based inhibitors of dihydropteroate synthase. J Med Chem. 2010 Jan 14;53(1):166-77.
• [801] Selective cyclooxygenase-2 inhibitors from Calophyllum membranaceum. J Nat Prod. 2005 Oct;68(10):1514-8.
• [802] Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological p... J Med Chem. 1998 May 21;41(11):1846-54.
• [803] 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists. J Med Chem. 2007 Feb 22;50(4):828-34.
• [804] A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines. Bioorg Med Chem. 2008 Mar 15;16(6):2741-52.
• [805] Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives. Bioorg Med Chem. 2008 Jul 15;16(14):6976-86.
• [806] Synthesis and modeling studies of a potent conformationally rigid muscarinic agonist: 1-azabicyclo[2.2.1]heptanespirofuranone. J Med Chem. 1998 Oct 22;41(22):4181-5.
• [807] Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeras... J Med Chem. 1998 Dec 17;41(26):5247-56.
• [808] Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain. J Med Chem. 2010 Sep 9;53(17):6445-56.
• [809] 2-Aryloxymethylmorpholine histamine H(3) antagonists. Bioorg Med Chem Lett. 2008 Nov 1;18(21):5796-9.
• [810] Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorg Med Chem Lett. 2007 Jan 15;17(2):533-7.
• [811] 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J Med Chem. 2006 Nov 2;49(22):6500-9.
• [812] Synthesis and structure-activity relationships of 2-(1,4'-bipiperidin-1'-yl)thiazolopyridine as H3 receptor antagonists. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6176-80.
• [813] Synthesis and in vivo evaluation of 3-substituted gababutins. Bioorg Med Chem Lett. 2010 Jan 1;20(1):362-5.
• [814] Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist. J Med Chem. 2007 Nov 15;50(23):5535-8.
• [815] Antiviral agents active against influenza A viruses. Nat Rev Drug Discov. 2006 Dec;5(12):1015-25.
• [816] Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists. J Med Chem. 2009 Feb 12;52(3):675-87.
• [817] 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.
• [818] Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-... J Med Chem. 1986 May;29(5):816-9.
• [819] Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists. J Med Chem. 2008 Mar 27;51(6):1764-70.
• [820] Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase. J Med Chem. 2008 Aug 28;51(16):4968-77.
• [821] Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists. J Med Chem. 1990 Jan;33(1):13-6.
• [822] 2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database search... J Med Chem. 2005 Dec 29;48(26):8253-60.
• [823] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 141).
• [824] Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependen... J Med Chem. 2007 Apr 19;50(8):1958-72.
• [825] Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor. J Med Chem. 2007 Apr 19;50(8):1810-27.
• [826] 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors. Bioorg Med Chem. 2009 Mar 1;17(5):2047-68.
• [827] NMR structure of a potent small molecule inhibitor bound to human keratinocyte fatty acid-binding protein. J Med Chem. 2006 Aug 10;49(16):5013-7.
• [828] Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier pr... Eur J Med Chem. 2009 Jul;44(7):3009-19.
• [829] X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalar... J Biol Chem. 2007 Aug 31;282(35):25436-44.
• [830] Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):546-9.
• [831] Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 1. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1177-80.
• [832] 2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4697-9.
• [833] Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan der... Bioorg Med Chem Lett. 2006 Apr 15;16(8):2163-9.
• [834] Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4026-30.
• [835] Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib. J Biol Chem. 2007 Jun 1;282(22):16379-90.
• [836] Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4963-7.
• [837] Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies. Bioorg Med Chem Lett. 2007 Feb 1;17(3):668-72.
• [838] Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem. 2006 Nov 16;49(23):6638-41.
• [839] 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4347-50.
• [840] Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor. J Med Chem. 2002 Sep 12;45(19):4188-201.
• [841] Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer... Bioorg Med Chem. 2010 Jun 1;18(11):3974-84.
• [842] Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors. Bioorg Med Chem Lett. 2008 May 15;18(10):3029-33.
• [843] Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1181-5.
• [844] The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg Med Chem Lett. 2006 Jan 1;16(1):88-92.
• [845] SAR studies of 2-o-substituted-benzoyl- and 2-alkanoyl-cyclohexane-1,3-diones as inhibitors of 4-hydroxyphenylpyruvate dioxygenase. Bioorg Med Chem Lett. 2000 May 1;10(9):843-5.
• [846] Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. J Med Chem. 2006 May 18;49(10):2876-85.
• [847] Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J Med Chem. 2004 Oct 7;47(21):5021-40.
• [848] Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor effica... J Med Chem. 2009 Nov 26;52(22):7170-85.
• [849] The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6056-61.
• [850] Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Jul 15;18(14):5063-70.
• [851] Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. J Med Chem. 2008 Feb 14;51(3):400-6.
• [852] Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasmi... J Med Chem. 2001 Aug 16;44(17):2753-71.
• [853] Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2097-100.
• [854] 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease. J Med Chem. 1998 Mar 26;41(7):1060-7.
• [855] Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor. J Med Chem. 2003 May 8;46(10):1989-96.
• [856] Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. Bioorg Med Chem. 2009 Apr 1;17(7):2842-51.
• [857] Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6083-7.
• [858] 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist... Bioorg Med Chem Lett. 2004 Aug 2;14(15):3993-6.
• [859] Anti-inflammatory acylphloroglucinol derivatives from Hops (Humulus lupulus). J Nat Prod. 2005 Oct;68(10):1545-8.
• [860] Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic ... Bioorg Med Chem. 2009 Aug 15;17(16):5782-90.
• [861] Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LX... Bioorg Med Chem. 2009 Jul 15;17(14):5001-14.
• [862] Chemistry, binding affinities, and behavioral properties of a new class of "antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. J Med Chem. 1993 Oct 1;36(20):2908-20.
• [863] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1193).
• [864] Structure-based design of COX-2 selectivity into flurbiprofen. Bioorg Med Chem Lett. 1999 Feb 8;9(3):307-12.
• [865] Tyrphostins. 3. Structure-activity relationship studies of alpha-substituted benzylidenemalononitrile 5-S-aryltyrphostins. J Med Chem. 1993 Nov 12;36(23):3556-64.
• [866] 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. J Med Chem. 1999 Jun 3;42(11):1881-93.
• [867] Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3282-6.
• [868] Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8.
• [869] Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5396-9.
• [870] Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1981-4.
• [871] Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5. J Med Chem. 2004 Dec 30;47(27):6948-57.
• [872] A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5). Bioorg Med Chem Lett. 2006 Sep 15;16(18):4792-5.
• [873] Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1892-7.
• [874] Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists. Bioorg Med Chem. 2009 Jul 15;17(14):5153-63.
• [875] 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorg Med Chem Lett. 2007 Mar 1;17(5):1349-54.
• [876] Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors. J Med Chem. 2006 Aug 24;49(17):5217-25.
• [877] Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisoste... Bioorg Med Chem. 2010 Mar 15;18(6):2107-2114.
• [878] Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor. J Med Chem. 2007 Dec 13;50(25):6303-6.
• [879] Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor, Bioorg. Med. Chem. Lett. 7(15):2003-2008 (1997).
• [880] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1194).
• [881] Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubul... J Med Chem. 1997 Sep 12;40(19):3049-56.
• [882] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1195).
• [883] 2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs). Bioorg Med Chem Lett. 2003 Feb 10;13(3):479-83.
• [884] New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation. Bioorg Med Chem. 2008 Feb 1;16(3):1474-80.
• [885] Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors... J Med Chem. 2008 Apr 10;51(7):2158-69.
• [886] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1196).
• [887] Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of n... J Med Chem. 2008 Oct 23;51(20):6478-94.
• [888] New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine. Bioorg Med Chem Lett. 1998 May 19;8(10):1133-8.
• [889] Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
• [890] Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1. Bioorg Med Chem Lett. 2000 Jul 17;10(14):1559-62.
• [891] Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial age... J Med Chem. 2005 Mar 10;48(5):1596-609.
• [892] Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase. J Med Chem. 2004 Aug 12;47(17):4151-4.
• [893] Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3096-100.
• [894] Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine... J Med Chem. 1991 Jun;34(6):1896-907.
• [895] Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGl... Bioorg Med Chem Lett. 2006 Sep 15;16(18):4788-91.
• [896] A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase. Bioorg Med Chem. 2009 Jun 1;17(11):3916-22.
• [897] Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors. Bioorg Med Chem. 2010 Feb;18(3):1029-33.
• [898] Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. ... Bioorg Med Chem Lett. 2005 Dec 1;15(23):5247-52.
• [899] Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines. Bioorg Med Chem Lett. 2002 Mar 11;12(5):787-90.
• [900] Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors. Bioorg Med Chem. 2008 Apr 1;16(7):3926-32.
• [901] Thiazole analog as stearoyl-CoA desaturase 1 inhibitor. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5214-7.
• [902] A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases. Eur J Med Chem. 2009 Aug;44(8):3266-71.
• [903] Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties. J Med Chem. 1994 Apr 29;37(9):1320-5.
• [904] Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides. J Med Chem. 2007 Mar 8;50(5):901-14.
• [905] Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule sheddi... J Med Chem. 2010 Mar 25;53(6):2622-35.
• [906] 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4794-8.
• [907] Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. J Med Chem. 1996 Jul 5;39(14):2844-51.
• [908] Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with su... Bioorg Med Chem. 2007 Mar 15;15(6):2298-311.
• [909] Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6402-5.
• [910] Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase. J Med Chem. 2007 Jul 26;50(15):3661-6.
• [911] 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem. 2005 Jan 13;48(1):306-11.
• [912] Design of dual acting anticonvulsant-antimuscarinic succinimide and hydantoin derivatives, Bioorg. Med. Chem. Lett. 7(8):979-984 (1997).
• [913] Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. J Med Chem. 2006 Mar 9;49(5):1613-23.
• [914] Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3574-7.
• [915] ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4520-5.
• [916] 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4925-9.
• [917] Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6014-7.
• [918] Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor. Eur J Pharmacol. 2009 Jun 2;611(1-3):100-6.
• [919] N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor. J Med Chem. 2007 Mar 22;50(6):1222-30.
• [920] Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. J Med Chem. 2009 Jan 22;52(2):416-24.
• [921] Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization. J Med Chem. 1998 Dec 3;41(25):4965-72.
• [922] 4-hydroxythiazole inhibitors of 5-lipoxygenase. J Med Chem. 1991 Jul;34(7):2158-65.
• [923] Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study. Bioorg Med Chem. 2009 Feb 1;17(3):1101-8.
• [924] Design, synthesis, and evaluation in vitro of quinoline-8-carboxamides, a new class of poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) inhi... J Med Chem. 2009 Feb 12;52(3):868-77.
• [925] 4-(3-furyl)-2-(4-methylpiperazino)pyrimidines: Potent 5-HT2A receptor antagonists, Bioorg. Med. Chem. Lett. 7(13):1635-1638 (1997).
• [926] N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1). Bioorg Med Chem Lett. 2008 Apr 15;18(8):2730-4.
• [927] NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles. J Med Chem. 2004 Apr 8;47(8):2089-96.
• [928] Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005 Mar 24;48(6):1873-85.
• [929] Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. J Med Chem. 2008 Dec 25;51(24):7882-8.
• [930] Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5426-30.
• [931] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 146).
• [932] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 106).
• [933] 3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J Med Chem. 2006 Sep 7;49(18):5578-86.
• [934] 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine. Bioorg Med Chem Lett. 2000 May 1;10(9):903-5.
• [935] Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods. Eur J Med Chem. 2010 Aug;45(8):3459-71.
• [936] 5-benzyloxytryptamine as an antagonist of TRPM8. Bioorg Med Chem Lett. 2010 Dec 1;20(23):7076-9.
• [937] Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity. Bioorg Med Chem. 2009 Sep 15;17(18):6496-504.
• [938] Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Bioorg Med Chem Lett. 2007 Sep 1;17(17):4837-40.
• [939] Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6261-5.
• [940] Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead. J Med Chem. 2006 Jan 12;49(1):407-16.
• [941] Bioactivity-guided mapping and navigation of chemical space. Nat Chem Biol. 2009 Aug;5(8):585-92.
• [942] Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett. 2009 May 15;19(10):2642-5.
• [943] Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhib... J Med Chem. 2009 Oct 22;52(20):6347-61.
• [944] Kojyl thioether derivatives having both tyrosinase inhibitory and anti-inflammatory properties. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6569-71.
• [945] Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone de... J Med Chem. 2010 Aug 12;53(15):5629-38.
• [946] Divergent modes of enzyme inhibition in a homologous structure-activity series. J Med Chem. 2009 Aug 27;52(16):5005-8.
• [947] 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity. J Med Chem. 2009 Jul 9;52(13):3855-68.
• [948] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7782).
• [949] Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a... J Med Chem. 2009 Jul 23;52(14):4103-6.
• [950] New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1893-7.
• [951] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamide... J Med Chem. 2005 Mar 24;48(6):2121-5.
• [952] Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem. 2009 Nov 12;52(21):6768-81.
• [953] Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system. Bioorg Med Chem. 2007 Jul 15;15(14):4876-90.
• [954] 2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure an... J Med Chem. 2008 May 22;51(10):2933-43.
• [955] 4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluation. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3266-70.
• [956] A diverse series of substituted benzenesulfonamides as aldose reductase inhibitors with antioxidant activity: design, synthesis, and in vitro activ... J Med Chem. 2010 Nov 11;53(21):7756-66.
• [957] Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005 Dec 1;48(24):7829-46.
• [958] Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors, Bioorg. Med. Chem. Lett. 20(14):4038-4044 (2010).
• [959] Structure-activity relationship of thiopyrimidines as mGluR5 antagonists. Bioorg Med Chem Lett. 2006 May 1;16(9):2467-9.
• [960] Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1146-50.
• [961] Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases. J Med Chem. 2010 Jul 8;53(13):4862-76.
• [962] Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruz... J Med Chem. 2002 Jun 20;45(13):2695-707.
• [963] Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation. Eur J Med Chem. 2008 Dec;43(12):2853-60.
• [964] Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced conformation-restricted cyclopropanecarbonyl deri... Bioorg Med Chem Lett. 2006 Dec 1;16(23):6024-7.
• [965] Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5781-6.
• [966] Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4999-5002.
• [967] Non-classical antifolates. Part 2: synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Bioorg Med Chem. 2010 Apr 15;18(8):2849-63.
• [968] Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2493-6.
• [969] 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological charact... J Med Chem. 2010 May 27;53(10):4110-8.
• [970] 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists. J Med Chem. 2008 Aug 14;51(15):4449-55.
• [971] L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors. J Med Chem. 2009 Jul 23;52(14):4533-7.
• [972] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5111).
• [973] (2S,1'S,2'R,3'R)-2(2'-Carboxy-3'-hydroxymethylcyclopropyl)glycine-[3H], a potent and selective radioligand for labeling group 2 and 3 metabotropic ... Bioorg Med Chem Lett. 2005 Jan 17;15(2):349-51.
• [974] Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategies. J Med Chem. 2006 May 18;49(10):2898-908.
• [975] Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. J Med Chem. 1986 May;29(5):676-81.
• [976] Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches. Bioorg Med Chem Lett. 2006 Dec 1;16(23):5993-7.
• [977] Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput s... Bioorg Med Chem Lett. 2008 Jan 1;18(1):329-35.
• [978] Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpu... Bioorg Med Chem Lett. 2008 May 1;18(9):2924-9.
• [979] Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J Med Chem. 2007 Mar 22;50(6):1322-34.
• [980] Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors. J Med Chem. 2011 Apr 28;54(8):2878-90.
• [981] Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors. Bioorg Med Chem Lett. 2001 Sep 17;11(18):2489-93.
• [982] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2433).
• [983] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 729).
• [984] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4029).
• [985] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5545).
• [986] 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists. J Med Chem. 2006 Dec 14;49(25):7373-83.
• [987] Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic gluta... Bioorg Med Chem. 2010 May 1;18(9):3026-35.
• [988] Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1). J Med Chem. 2009 Nov 26;52(22):7142-56.
• [989] New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluati... J Med Chem. 2007 Aug 23;50(17):4061-74.
• [990] Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic tr... J Med Chem. 2008 Nov 27;51(22):7161-8.
• [991] Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3957-61.
• [992] Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation. J Med Chem. 2010 Feb 11;53(3):1357-69.
• [993] Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1273-6.
• [994] Positive and negative modulation of group I metabotropic glutamate receptors. J Med Chem. 2008 Feb 14;51(3):634-47.
• [995] Pyrimidine thioethers: a novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIV. J Med Chem. 1998 Sep 24;41(20):3793-803.
• [996] Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett. 2000 Mar 20;10(6):605-7.
• [997] Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30.
• [998] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 272).
• [999] Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64.
• [1000] Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2007 Jul 12;50(14):3359-68.
• [1001] Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2176-8.
• [1002] Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives. Bioorg Med Chem Lett. 2008 May 1;18(9):2920-3.
• [1003] The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors. Bioorg Med Chem. 2007 May 15;15(10):3450-6.
• [1004] Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6502-6.
• [1005] Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitors. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2949-52.
• [1006] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 372).
• [1007] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1716).
• [1008] Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13. Bioorg Med Chem. 2009 Oct 15;17(20):7398-404.
• [1009] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8447).
• [1010] Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4589-93.
• [1011] Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98.
• [1012] 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K. J Med Chem. 2007 Feb 22;50(4):591-4.
• [1013] Synthesis of new derivatives of 8-OH-DPAT: Influence of substitution on the aromatic ring on the pharmacological profile, Bioorg. Med. Chem. Lett. 3(10):2035-2038 (1993).
• [1014] Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2229-32.
• [1015] 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4230-4.
• [1016] 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem. 2006 Dec 28;49(26):7683-96.
• [1017] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3204).
• [1018] Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines. Bioorg Med Chem. 2009 Dec 1;17(23):7987-92.
• [1019] Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60.
• [1020] Design, new synthesis, and calcilytic activity of substituted 3H-pyrimidin-4-ones. Bioorg Med Chem Lett. 2005 May 16;15(10):2537-40.
• [1021] Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):527-9.
• [1022] Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. J Med Chem. 1996 Jul 19;39(15):2915-21.
• [1023] Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem. 1999 Oct 7;42(20):4081-7.
• [1024] Acetylcholinesterase inhibition by alkaloids of the ant's venom Monomorium minutum, Bioorg. Med. Chem. Lett. 5(11):1131-1132 (1995).
• [1025] 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. Bioorg Med Chem. 2010 Nov 1;18(21):7475-85.
• [1026] New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A ... Bioorg Med Chem. 2009 Jan 15;17(2):675-89.
• [1027] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5847).
• [1028] Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. J Med Chem. 1999 May 6;42(9):1537-45.
• [1029] Allosteric inhibition of endothelin ETA receptors by 3, 5-dibromosalicylic acid. Mol Pharmacol. 2000 Dec;58(6):1461-9.
• [1030] Structural insights into the hot spot amino acid residues of mushroom tyrosinase for the bindings of thujaplicins. Bioorg Med Chem. 2010 Nov 15;18(22):8112-8.
• [1031] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1068).
• [1032] Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
• [1033] Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata. J Nat Prod. 2006 Oct;69(10):1496-9.
• [1034] Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase. J Nat Prod. 2009 Aug;72(8):1414-8.
• [1035] RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information. J Med Chem. 2009 Oct 8;52(19):5781-4.
• [1036] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5849).
• [1037] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5796).
• [1038] Synthetic tyrosyl gallate derivatives as potent melanin formation inhibitors. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5462-4.
• [1039] Synthesis and characterization of azole isoflavone inhibitors of aromatase. Bioorg Med Chem. 2005 Jun 2;13(12):4063-70.
• [1040] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1343).
• [1041] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5396).
• [1042] Phenolic compounds from the roots of Lindera fruticosa. J Nat Prod. 2006 May;69(5):853-5.
• [1043] 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production. Bioorg Med Chem Lett. 2009 Mar 1;19(5):1310-3.
• [1044] Synthesis of alkoxy-substituted diaryl compounds and correlation of ring separation with inhibition of tubulin polymerization: differential enhance... J Med Chem. 1992 Mar 20;35(6):1058-67.
• [1045] Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers. Bioorg Med Chem Lett. 2001 Jan 8;11(1):51-4.
• [1046] The synthesis and evaluation of temperature sensitive tubulin toxins. Bioorg Med Chem Lett. 1999 Feb 8;9(3):407-12.
• [1047] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7775).
• [1048] Benzamide derivatives as blockers of Kv1.3 ion channel. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1161-4.
• [1049] Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents. J Med Chem. 2008 Mar 13;51(5):1295-308.
• [1050] Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem. 2008 Jul 24;51(14):4200-12.
• [1051] Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem. 2010 Jul 22;53(14):5085-107.
• [1052] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6611).
• [1053] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1426).
• [1054] Cholinergic agents: aldehyde, ketone, and oxime analogues of the muscarinic agonist UH5, Bioorg. Med. Chem. Lett. 2(8):803-808 (1992).
• [1055] Synthesis and evaluation of 1,2,3,4-tetrahydro[1]benzothieno[2,3-h]isoquinolines as dopamine antagonists. J Med Chem. 1981 Sep;24(9):1107-10.
• [1056] Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. J Med Chem. 2007 Nov 1;50(22):5364-71.
• [1057] Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem. 2010 May 13;53(9):3611-7.
• [1058] 2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents. J Med Chem. 1990 Oct;33(10):2772-7.
• [1059] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1268).
• [1060] Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity. Bioorg Med Chem Lett. 2006 Feb 15;16(4):969-73.
• [1061] Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic... Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72.
• [1062] Design, synthesis and evaluation of 2,4-disubstituted pyrimidines as cholinesterase inhibitors. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3606-9.
• [1063] Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT upt... J Med Chem. 1997 Mar 28;40(7):1049-62.
• [1064] Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase. J Med Chem. 2006 Jul 13;49(14):4116-26.
• [1065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1829).
• [1066] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1830).
• [1067] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5112).
• [1068] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2936).
• [1069] Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
• [1070] Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem. 2009 Apr 9;52(7):1935-42.
• [1071] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4521).
• [1072] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2417).
• [1073] Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias. Bioorg Med Chem Lett. 2007 Jan 1;17(1):282-4.
• [1074] New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. J Med Chem. 2005 Jul 28;48(15):5001-8.
• [1075] 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into ... J Med Chem. 2009 Dec 10;52(23):7640-52.
• [1076] 3-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution, Bioorg. Med. Chem. Lett. 7(23):2959-2962 (1997).
• [1077] 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists. Bioorg Med Chem Lett. 2000 Dec 18;10(24):2701-3.
• [1078] 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. J Med Chem. 2001 May 10;44(10):1603-14.
• [1079] New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1059-61.
• [1080] Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-met... J Med Chem. 2009 Jun 11;52(11):3563-75.
• [1081] Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxi... J Med Chem. 2004 Nov 18;47(24):5860-71.
• [1082] Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem. 2008 Feb 14;51(3):581-8.
• [1083] Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor. J Med Chem. 2010 Nov 25;53(22):8080-8.
• [1084] Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2277-81.
• [1085] Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate anal... Antimicrob Agents Chemother. 2007 Jun;51(6):2028-34.
• [1086] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5600).
• [1087] Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer. Bioorg Med Chem. 2008 Feb 15;16(4):1648-57.
• [1088] Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem. 2002 Jan 17;45(2):312-20.
• [1089] Epibatidine structure-activity relationships. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1889-96.
• [1090] Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions. 1991 Mar;32(3-4):289-94.
• [1091] 4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor an... Bioorg Med Chem Lett. 2003 May 19;13(10):1759-62.
• [1092] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1197).
• [1093] Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41.
• [1094] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6202).
• [1095] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3398).
• [1096] Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of ant... Bioorg Med Chem Lett. 2005 Dec 1;15(23):5170-5.
• [1097] Phenylpyrroles, a new chemolibrary virtual screening class of 5-HT7 receptor ligands. Bioorg Med Chem Lett. 2005 Aug 15;15(16):3753-7.
• [1098] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1344).
• [1099] Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist f... J Med Chem. 2003 May 8;46(10):1980-8.
• [1100] Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J Med Chem. 2002 Jan 3;45(1):160-4.
• [1101] Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity. J Med Chem. 2008 Sep 25;51(18):5861-5.
• [1102] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4103).
• [1103] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3399).
• [1104] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3434).
• [1105] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2742).
• [1106] Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystal... J Med Chem. 2008 Jun 26;51(12):3540-54.
• [1107] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2751).
• [1108] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2750).
• [1109] Inactivation of soybean sterol 24-C-methyltransferase by elongated sterol side chains at C26. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5902-6.
• [1110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2885).
• [1111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2752).
• [1112] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6719).
• [1113] Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase. J Nat Prod. 2008 Nov;71(11):1877-80.
• [1114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8688).
• [1115] Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specif... J Med Chem. 2010 Feb 11;53(3):1407-11.
• [1116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2776).
• [1117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1710).
• [1118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1764).
• [1119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1711).
• [1120] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5931).
• [1121] 9-Dihydroerythromycin ethers as motilin agonists--developing structure-activity relationships for potency and safety. Bioorg Med Chem. 2010 Nov 1;18(21):7651-8.
• [1122] Nitrogen-containing phorbol esters from Croton ciliatoglandulifer and their effects on cyclooxygenases-1 and -2. J Nat Prod. 2006 Jun;69(6):887-90.
• [1123] Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. J Med Chem. 2006 May 18;49(10):3012-8.
• [1124] Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents. Bioorg Med Chem. 2010 Nov 15;18(22):7826-35.
• [1125] 3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase. J Med Chem. 2010 Apr 8;53(7):2902-12.
• [1126] Novel estrone mimetics with high 17beta-HSD1 inhibitory activity. Bioorg Med Chem. 2010 May 15;18(10):3494-505.
• [1127] Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. J Med Chem. 2008 Dec 11;51(23):7327-43.
• [1128] Phenolic metabolites of clomiphene: [(E,Z)-2-[4-(1,2-diphenyl-2-chlorovinyl)phenoxy]ethyl]diethylamine. Preparation, electrophilicity, and effects ... J Med Chem. 1989 Jan;32(1):192-7.
• [1129] Current use of anti-HIV drugs in AIDS. J Antimicrob Chemother. 1993 Jul;32 Suppl A:133-8.
• [1130] Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5529-32.
• [1131] Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as p... J Med Chem. 2008 Nov 13;51(21):6725-39.
• [1132] Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl ... Bioorg Med Chem. 2010 May 1;18(9):3066-77.
• [1133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1424).
• [1134] Classification of chemical compounds by protein-compound docking for use in designing a focused library. J Med Chem. 2006 Jan 26;49(2):523-33.
• [1135] 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6666-9.
• [1136] Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [... Bioorg Med Chem Lett. 2009 Nov 1;19(21):6225-9.
• [1137] Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. Bioorg Med Chem Lett. 2005 Jun 15;15(12):3137-42.
• [1138] Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008 Nov 13;51(21):6740-51.
• [1139] Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure. Bioorg Med Chem Lett. 1998 May 5;8(9):1019-22.
• [1140] Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. J Med Chem. 2006 Feb 23;49(4):1271-81.
• [1141] Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4794-8.
• [1142] Inhibition of monoamine oxidase by indole and benzofuran derivatives. Eur J Med Chem. 2010 Oct;45(10):4458-66.
• [1143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4597).
• [1144] Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and G... Antimicrob Agents Chemother. 2007 Feb;51(2):543-50.
• [1145] Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde O-heterocycle-4-carbonyloxime. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5576-9.
• [1146] Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation. Bioorg Med Chem Lett. 2008 Jan 1;18(1):256-61.
• [1147] Discovery of 4-functionalized phenyl-O-beta-D-glycosides as a new class of mushroom tyrosinase inhibitors. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6157-60.
• [1148] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6633).
• [1149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6632).
• [1150] Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4539-44.
• [1151] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1367).
• [1152] Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase. Bioorg Med Chem. 2009 Feb 1;17(3):1244-50.
• [1153] Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3593-6.
• [1154] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5783).
• [1155] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6651).
• [1156] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3397).
• [1157] Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharm... Bioorg Med Chem Lett. 2002 Dec 16;12(24):3537-41.
• [1158] Spirocyclic NK(1) antagonists II: [4.5]-spiroethers. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2719-22.
• [1159] Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod. 2008 Sep;71(9):1513-7.
• [1160] Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem. 2006 Jun 1;49(11):3345-53.
• [1161] Halogenated boldine derivatives with enhanced monoamine receptor selectivity. J Nat Prod. 2000 Apr;63(4):480-4.
• [1162] 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1468-72.
• [1163] Phospholipase A2 Inhibitors from an Erythrina Species from Samoa J. Nat. Prod. 60(6):537-539 (1997).
• [1164] Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6745-9.
• [1165] Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase. Eur J Med Chem. 2010 Nov;45(11):5140-9.
• [1166] Pharmacophore modeling and in silico screening for new KDR kinase inhibitors. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2126-33.
• [1167] Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the... Bioorg Med Chem. 2009 Oct 15;17(20):7093-9.
• [1168] A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem. 1994 Jul 8;37(14):2129-37.
• [1169] 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic a... J Med Chem. 1990 Aug;33(8):2087-93.
• [1170] Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2). Bioorg Med Chem Lett. 2006 Jan 1;16(1):25-30.
• [1171] 3-(4-Piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as ligands for the ORL-1 receptor. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3524-8.
• [1172] Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5847-52.
• [1173] Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J Med Chem. 2004 Sep 9;47(19):4645-8. Letter
• [1174] Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6067-70.
• [1175] Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmaco... Bioorg Med Chem Lett. 2004 Jan 19;14(2):351-5.
• [1176] Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5171-4.
• [1177] Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5647-51.
• [1178] Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6062-6.
• [1179] Synthesis of cystamidin a (pyrrole-3-propanamide), a reported calpain inhibitor, Bioorg. Med. Chem. Lett. 6(13):1541-1542 (1996).
• [1180] Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitor... J Med Chem. 2005 Mar 10;48(5):1563-75.
• [1181] In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-... J Med Chem. 2008 Dec 25;51(24):8077-87.
• [1182] N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and rece... J Med Chem. 1998 Dec 3;41(25):4933-8.
• [1183] Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. J Med Chem. 2007 May 31;50(11):2676-81.
• [1184] Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening. J Med Chem. 2006 Aug 24;49(17):5232-44.
• [1185] Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives. Bioorg Med Chem Lett. 2003 May 19;13(10):1825-7.
• [1186] Comparison between two classes of selective EP(3) antagonists and their biological activities. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5639-42.
• [1187] New generation dopaminergic agents. 2. Discovery of 3-OH-phenoxyethylamine and 3-OH-N1-phenylpiperazine dopaminergic templates. Bioorg Med Chem Lett. 1998 Feb 3;8(3):295-300.
• [1188] CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example. Eur J Med Chem. 2008 Jul;43(7):1349-59.
• [1189] New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5157-60.
• [1190] Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors. Eur J Med Chem. 2010 Apr;45(4):1415-23.
• [1191] Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity. J Med Chem. 1992 May 1;35(9):1521-5.
• [1192] Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2987-91.
• [1193] Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5384-9.
• [1194] Synthesis, in vitro, and in silico evaluation of organometallic technetium and rhenium thymidine complexes with retained substrate activity toward ... J Med Chem. 2008 Nov 13;51(21):6689-98.
• [1195] Designing active template molecules by combining computational de novo design and human chemist's expertise. J Med Chem. 2007 Apr 19;50(8):1925-32.
• [1196] Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-... J Med Chem. 2008 Mar 27;51(6):1861-73.
• [1197] Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8.
• [1198] Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5294-7.
• [1199] Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitors. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5546-50.
• [1200] Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors. J Med Chem. 2010 Nov 11;53(21):7564-72.
• [1201] Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach. J Med Chem. 2008 Oct 9;51(19):6138-49.
• [1202] Synthesis and pharmacological evaluation of phenylethynyl[1,2,4]methyltriazines as analogues of 3-methyl-6-(phenylethynyl)pyridine. J Med Chem. 2007 Jul 12;50(14):3388-91.
• [1203] Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones. J Med Chem. 1999 Mar 25;42(6):1018-26.
• [1204] Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5053-5.
• [1205] Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem. 2002 May 23;45(11):2213-21.
• [1206] Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and int... Eur J Med Chem. 2009 Oct;44(10):4179-91.
• [1207] Selective inhibition of matrix metalloproteinase isozymes and in vivo protection against emphysema by substituted gamma-keto carboxylic acids. J Med Chem. 2006 Jan 26;49(2):456-8.
• [1208] Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure. Bioorg Med Chem. 2008 Jan 1;16(1):284-92.
• [1209] Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity. Bioorg Med Chem Lett. 2007 Apr 1;17(7):2018-21.
• [1210] N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4363-8.
• [1211] Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione. J Med Chem. 1986 Apr;29(4):520-3.
• [1212] Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones. J Med Chem. 1986 Aug;29(8):1362-9.
• [1213] Thienopyridine urea inhibitors of KDR kinase. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1246-9.
• [1214] Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues. Bioorg Med Chem. 2008 Sep 1;16(17):8011-21.
• [1215] New generation dopaminergic agents. 5. Heterocyclic bioisosteres that exploit the 3-OH-N1-phenylpiperazine dopaminergic template. Bioorg Med Chem Lett. 1998 Oct 6;8(19):2675-80.
• [1216] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5958).
• [1217] Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative ... J Med Chem. 2005 May 19;48(10):3463-6.
• [1218] Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. J Med Chem. 2010 Aug 26;53(16):6153-63.
• [1219] Synthesis and biological evaluation of 1,3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipoxygenases. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4842-5.
• [1220] Synthesis and identification of conformationally constrained selective MMP inhibitors. Bioorg Med Chem Lett. 1999 Jul 5;9(13):1757-60.
• [1221] 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4... J Med Chem. 1996 May 10;39(10):1941-2.
• [1222] Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem. 2007 Sep 1;15(17):5837-44.
• [1223] 3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. J Med Chem. 2004 Mar 11;47(6):1547-52.
• [1224] Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors. Bioorg Med Chem Lett. 2003 Sep 15;13(18):2973-6.
• [1225] A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation, Bioorg. Med. Chem. Lett. 7(23):2935-2940 (1997).
• [1226] Novel 8-arylated purines as inhibitors of glycogen synthase kinase. Eur J Med Chem. 2010 Aug;45(8):3389-93.
• [1227] Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R... J Med Chem. 2000 Nov 30;43(24):4694-700.
• [1228] Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6623-6.
• [1229] Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on pote... J Med Chem. 2008 Aug 28;51(16):5064-74.
• [1230] Crystallization and preliminary X-ray analysis of anti-cancer agent 3-(9-acridinylamino)-5-(hydroxymethyl)aniline complexed with the DNA hexamer d(CGTACG)2. Biochim Biophys Acta. 2003 Jan 3;1625(1):27-9.
• [1231] Design, synthesis, and subtype selectivity of 3,6-disubstituted -carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents f... Bioorg Med Chem. 2010 Nov 1;18(21):7548-64.
• [1232] Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. J Med Chem. 2006 Jul 27;49(15):4777-80.
• [1233] Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). ... J Med Chem. 1990 Mar;33(3):1015-22.
• [1234] 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1657-60.
• [1235] 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7.
• [1236] Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some sulfonamidobenzoylglutamate and related de... J Med Chem. 1993 Oct 29;36(22):3464-71.
• [1237] S1P receptor mediated activity of FTY720 phosphate mimics. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1485-7.
• [1238] Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem. 2010 Jan 14;53(1):37-51.
• [1239] Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3828-33.
• [1240] A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J Med Chem. 2006 Feb 9;49(3):1149-56.
• [1241] Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med. 2001 Jan;7(1):108-13.
• [1242] Enantioselective synthesis of PD144723: a potent stereospecific anticonvulsant, Bioorg. Med. Chem. Lett. 4(6):823-826 (1994).
• [1243] A study of 3-amino-N-hydroxypropanesulfonamide derivatives as potential GABAB agonists and their fragmentation to 3-aminopropanesulfinic acid, Bioorg. Med. Chem. Lett. 6(14):1709-1714 (1996).
• [1244] Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore. J Med Chem. 2007 Aug 9;50(16):3777-85.
• [1245] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3199).
• [1246] Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. J Med Chem. 2000 Jun 15;43(12):2324-31.
• [1247] Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor... J Med Chem. 2009 Jan 22;52(2):278-92.
• [1248] Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequence... J Med Chem. 2007 Nov 1;50(22):5471-84.
• [1249] Amino acid bioisosteres: design of 2-quinolone derivatives as glycine-site N-methyl-D-aspartate receptor antagonists, Bioorg. Med. Chem. Lett. 3(2):299-304 (1993).
• [1250] Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF). Bioorg Med Chem Lett. 2010 Oct 1;20(19):5811-4.
• [1251] 1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4604-10.
• [1252] Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one. J Med Chem. 1992 Oct 16;35(21):3792-802.
• [1253] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2569).
• [1254] Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors. J Med Chem. 2009 Oct 8;52(19):6097-106.
• [1255] Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: particular potency of 1H-indazole-7-carbonitrile. Bioorg Med Chem. 2008 Jun 1;16(11):5962-73.
• [1256] Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20... J Med Chem. 2009 May 28;52(10):3259-64.
• [1257] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5113).
• [1258] Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3371-5.
• [1259] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4517).
• [1260] 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore mod... J Med Chem. 2006 Apr 20;49(8):2526-33.
• [1261] 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists. J Med Chem. 1992 Oct 30;35(22):3984-90.
• [1262] 2-carboxy indolines and indoles as potential glycine/NMDA antagonists: effect of five-membered ring conformation on affinity. Bioorg. Med. Chem. Lett. 2(12):1627-1630 (1992).
• [1263] Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta. J Med Chem. 2008 Mar 13;51(5):1344-51.
• [1264] Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore. J Med Chem. 1988 Sep;31(9):1854-61.
• [1265] 3,6-disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa. J Med Chem. 2005 Dec 1;48(24):7592-603.
• [1266] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5114).
• [1267] DNA polymerase beta inhibitors from Tetracera boiviniana. J Nat Prod. 1999 Dec;62(12):1660-3.
• [1268] 3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure ... Bioorg Med Chem Lett. 2010 Aug 1;20(15):4390-4.
• [1269] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1422).
• [1270] Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat... J Med Chem. 2006 Jun 1;49(11):3332-44.
• [1271] Inhibition of human sputum elastase by substituted 2-pyrones. J Med Chem. 1987 Jun;30(6):1017-23.
• [1272] Syntheses of novel high affinity ligands for opioid receptors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2289-94.
• [1273] Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6618-22.
• [1274] Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) a... J Med Chem. 1998 Jul 2;41(14):2537-52.
• [1275] Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors. J Med Chem. 2010 Jul 8;53(13):5049-53.
• [1276] Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prosta... J Med Chem. 2010 Aug 12;53(15):5749-58.
• [1277] 3-hydroxymethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline inhibitors of phenylethanolamine N-methyltransferase that display re... J Med Chem. 2005 Jan 13;48(1):134-40.
• [1278] Mechanism-based inactivation of alanine racemase by 3-halovinylglycines. J Biol Chem. 1991 Nov 15;266(32):21657-65.
• [1279] Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schis... J Med Chem. 2009 Oct 22;52(20):6474-83.
• [1280] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5848).
• [1281] Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. J Med Chem. 1996 Nov 8;39(23):4643-53.
• [1282] Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists. J Med Chem. 2007 Jan 11;50(1):21-39.
• [1283] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3202).
• [1284] Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Bioorg Med Chem. 2008 Aug 1;16(15):7450-6.
• [1285] Hydroxy- and amino-substituted piperidinecarboxylic acids as gamma-aminobutyric acid agonists and uptake inhibitors. J Med Chem. 1982 Oct;25(10):1157-62.
• [1286] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5116).
• [1287] Comparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase. BMC Biochem. 2003 Sep 24;4:13.
• [1288] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5850).
• [1289] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2933).
• [1290] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2145).
• [1291] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5117).
• [1292] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 447).
• [1293] Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides. J Med Chem. 2007 Mar 22;50(6):1335-46.
• [1294] Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1905-8.
• [1295] Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. J Med Chem. 1990 Sep;33(9):2343-57.
• [1296] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2766).
• [1297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6654).
• [1298] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3396).
• [1299] Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J Med Chem. 2006 Sep 7;49(18):5544-51.
• [1300] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5118).
• [1301] Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line. Toxicol In Vitro. 2002 Apr;16(2):113-21.
• [1302] New bioactive flavonoids and stilbenes in cub resin insecticide. J Nat Prod. 1999 Feb;62(2):205-10.
• [1303] N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5748-51.
• [1304] N-2 methylated quaternary derivatives of beta-carboline-3-carboxylates inhibit acetylcholinesterase in vitroO, Bioorg. Med. Chem. Lett. 3(12):2831-2836 (1993).
• [1305] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6642).
• [1306] Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors. Bioorg Med Chem Lett. 2006 Jan 1;16(1):96-9.
• [1307] Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor. Bioorg Med Chem Lett. 2010 Jan 1;20(1):276-9.
• [1308] Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoqui... Bioorg Med Chem Lett. 2005 Feb 15;15(4):1143-7.
• [1309] Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. J Med Chem. 1994 Dec 23;37(26):4576-80.
• [1310] Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM: Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem. 2000 Feb 10;43(3):381-91.
• [1311] You HJ, Colpaert FC, Arendt-Nielsen L: The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes. Exp Neurol. 2005 Jan;191(1):174-83.
• [1312] 4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4221-5.
• [1313] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1401).
• [1314] Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5703-7.
• [1315] Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol. 2000 Aug;7(8):663-8.
• [1316] Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists. J Med Chem. 2006 Nov 30;49(24):7119-31.
• [1317] Inhibition of cow's milk xanthine oxidase by flavonoids. J Nat Prod. 1988 Mar-Apr;51(2):345-8.
• [1318] DNA polymerase beta inhibitors from Sandoricum koetjape. J Nat Prod. 1999 Aug;62(8):1110-3.
• [1319] 3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporter. Bioorg Med Chem Lett. 2000 Nov 6;10(21):2445-7.
• [1320] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1745).
• [1321] 3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1557-60.
• [1322] Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4371-5.
• [1323] Novel GSK-3beta inhibitors from sequential virtual screening. Bioorg Med Chem. 2008 Jan 15;16(2):636-43.
• [1324] Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor. J Med Chem. 2006 Feb 9;49(3):864-71.
• [1325] Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem. 2009 Jul 9;52(13):4063-7.
• [1326] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4104).
• [1327] New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. J Med Chem. 1995 Nov 24;38(24):4739-59.
• [1328] 5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular beta-type platelet-derived growth factor receptor tyro... J Med Chem. 1994 Aug 19;37(17):2627-9.
• [1329] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1590).
• [1330] Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. J Med Chem. 1992 Apr 3;35(7):1280-90.
• [1331] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1428).
• [1332] Quinuclidine derivatives as potential antiparasitics. Antimicrob Agents Chemother. 2007 Nov;51(11):4049-61.
• [1333] Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxypheny... J Med Chem. 1986 Sep;29(9):1668-74.
• [1334] Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. Bioorg Med Chem. 2007 Jan 1;15(1):575-85.
• [1335] A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition. J Med Chem. 2004 Oct 21;47(22):5492-500.
• [1336] Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4283-6.
• [1337] Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid ... Bioorg Med Chem. 2008 Jun 15;16(12):6423-35.
• [1338] 4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2093-5.
• [1339] Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30. Curr Top Med Chem. 2009;9(13):1227-36.
• [1340] Synthesis of heteroaromatic tropeines and heterogeneous binding to glycine receptors. Bioorg Med Chem. 2009 Oct 1;17(19):6872-8.
• [1341] Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogue... J Med Chem. 2006 Oct 19;49(21):6391-9.
• [1342] Harbinatic acid, a novel and potent DNA polymerase beta inhibitor from Hardwickia binata. J Nat Prod. 1999 Jul;62(7):1000-2.
• [1343] DNA polymerase beta inhibitors from Baeckea gunniana. J Nat Prod. 1999 Dec;62(12):1624-6.
• [1344] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4672).
• [1345] Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. Eur J Med Chem. 2010 May;45(5):2010-7.
• [1346] Isolation and structure elucidation of an isoflavone and a sesterterpenoic acid from Henriettella fascicularis. J Nat Prod. 2002 Dec;65(12):1749-53.
• [1347] Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. Bioorg Med Chem. 2009 Apr 1;17(7):2658-72.
• [1348] Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5514-6.
• [1349] Novel ATP-competitive kinesin spindle protein inhibitors. J Med Chem. 2007 Oct 4;50(20):4939-52.
• [1350] Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4'-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II. J Nat Prod. 1989 May-Jun;52(3):606-13.
• [1351] Synthesis of 5'-functionalized nucleosides: S-Adenosylhomocysteine analogues with the carbon-5' and sulfur atoms replaced by a vinyl or halovinyl u... Bioorg Med Chem. 2008 May 15;16(10):5424-33.
• [1352] Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5252-4.
• [1353] Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associa... Eur J Med Chem. 2010 Jun;45(6):2396-404.
• [1354] Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95.
• [1355] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5119).
• [1356] Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2. Bioorg Med Chem. 2009 Feb 15;17(4):1573-8.
• [1357] Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. J Med Chem. 2004 Dec 2;47(25):6239-47.
• [1358] Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation. Bioorg Med Chem. 2009 Sep 1;17(17):6180-7.
• [1359] Reduction in potency of selective gamma-aminobutyric acidA agonists and diazepam in CA1 region of in vitro hippocampal slices from chronic flurazepam-treated rats. J Pharmacol Exp Ther. 1992 Jul;262(1):204-11.
• [1360] A phthalide with in vitro growth inhibitory activity from an oidiodendron strain. J Nat Prod. 2004 Dec;67(12):2086-9.
• [1361] 3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptor, Bioorg. Med. Chem. Lett. 6(5):499-504 (1996).
• [1362] Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles. Eur J Med Chem. 2008 Jun;43(6):1152-9.
• [1363] Diaryl-dithiolanes and -isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, *OH scavenging and anti-adhesive activities. Bioorg Med Chem. 2009 Jan 15;17(2):558-68.
• [1364] Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. J Med Chem. 2010 May 27;53(10):3899-906.
• [1365] Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1). J Med Chem. 2002 Jan 17;45(2):529-32.
• [1366] In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem. 2008 Oct 15;16(20):9101-5.
• [1367] Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2283-92.
• [1368] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5730).
• [1369] Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and pros... J Med Chem. 2004 Dec 30;47(27):6716-29.
• [1370] Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold. Bioorg Med Chem Lett. 2006 Jan 15;16(2):395-9.
• [1371] Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorg Med Chem. 2010 Jul 15;18(14):5441-8.
• [1372] ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents. Eur J Pharmacol. 2007 May 7;562(1-2):1-11.
• [1373] Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1691-4.
• [1374] Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4440-3.
• [1375] Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene deriva... J Med Chem. 1996 Jul 19;39(15):3001-13.
• [1376] The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors. Eur J Med Chem. 2009 Jul;44(7):2994-3008.
• [1377] Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphen... J Med Chem. 2002 Nov 21;45(24):5358-64.
• [1378] Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid ... J Med Chem. 2004 Dec 16;47(26):6435-8.
• [1379] Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds. J Med Chem. 1993 May 14;36(10):1393-400.
• [1380] A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic recep... J Med Chem. 1994 Jul 22;37(15):2328-33.
• [1381] Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorg Med Chem Lett. 2005 Apr 15;15(8):1987-91.
• [1382] Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling. Bioorg Med Chem Lett. 2007 May 1;17(9):2414-20.
• [1383] Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3099-104.
• [1384] Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5600-4.
• [1385] First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5829-32.
• [1386] Discovery of a new series of Aurora inhibitors through truncation of GSK1070916. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2552-5.
• [1387] Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5536-40.
• [1388] High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate. Bioorg Med Chem. 2009 Feb 1;17(3):990-1005.
• [1389] Optimisation of a pyrazole series of progesterone antagonists; Part 1. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3384-6.
• [1390] CoMFA analysis of tgDHFR and rlDHFR based on antifolates with 6-5 fused ring system using the all-orientation search (AOS) routine and a modified c... Bioorg Med Chem. 2010 Feb 15;18(4):1684-701.
• [1391] Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4018-21.
• [1392] Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active hi... J Med Chem. 2010 May 13;53(9):3840-4.
• [1393] CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives. Bioorg Med Chem Lett. 2007 Jan 1;17(1):231-4.
• [1394] Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and pharmacological characterization of ga... J Med Chem. 2006 Jul 13;49(14):4442-6.
• [1395] New generation dopaminergic agents. 7. Heterocyclic bioisosteres that exploit the 3-OH-phenoxyethylamine D2 template. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2593-8.
• [1396] Discovery and development of aryl-fused imidazole-based angiotensin II antagonists, Bioorg. Med. Chem. Lett. 4(1):213-218 (1994).
• [1397] Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (T... J Med Chem. 2005 Sep 22;48(19):5966-79.
• [1398] Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha. J Med Chem. 2007 Mar 22;50(6):1380-400.
• [1399] Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inh... Bioorg Med Chem. 2009 Jul 15;17(14):4894-9.
• [1400] Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1168-72.
• [1401] Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):817-22.
• [1402] The rational design of a novel potent analogue of the 5'-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular a... Bioorg Med Chem Lett. 2010 Nov 15;20(22):6394-9.
• [1403] he preparation and sar of 4-(anilino), 4-(phenoxy), and 4-(thiophenoxy)-quinazolines: Inhibitors of p56lck and EGF-R tyrosine kinase activity, Bioorg. Med. Chem. Lett. 7(4):417-420 (1997).
• [1404] Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6237-40.
• [1405] Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides. Bioorg Med Chem. 2008 Mar 1;16(5):2697-706.
• [1406] Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of alpha- and beta-adrenergic rece... J Med Chem. 1992 Mar 20;35(6):1009-18.
• [1407] Isoxazolidine-3,5-diones as lens aldose reductase inhibitors. J Med Chem. 1982 Jun;25(6):745-7.
• [1408] 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1707-11.
• [1409] From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonist. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5217-21.
• [1410] 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. J Med Chem. 2008 May 22;51(10):2944-53.
• [1411] Different antagonist binding properties of human and rat histamine H3 receptors. Bioorg Med Chem Lett. 2001 Apr 9;11(7):951-4.
• [1412] Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase. Bioorg Med Chem. 2007 Feb 1;15(3):1533-8.
• [1413] Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5349-52.
• [1414] Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted ... J Med Chem. 2007 Apr 5;50(7):1584-97.
• [1415] Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett. 2010 Dec 1;20(23):7033-6.
• [1416] Receptor flexibility in de novo ligand design and docking. J Med Chem. 2005 Oct 20;48(21):6585-96.
• [1417] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 289).
• [1418] Vasorelaxant activity of phthalazinones and related compounds. Bioorg Med Chem Lett. 2006 May 15;16(10):2786-90.
• [1419] Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding. J Med Chem. 1992 Dec 25;35(26):4903-10.
• [1420] Arylphthalazines: identification of a new phthalazine chemotype as inhibitors of VEGFR kinase. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4696-8.
• [1421] Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3793-6.
• [1422] Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potent... J Med Chem. 1997 Sep 12;40(19):3014-24.
• [1423] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2554).
• [1424] Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models. Eur J Med Chem. 2009 Jun;44(6):2361-71.
• [1425] Syntheses of 4-(indole-3-yl)quinazolines: a new class of epidermal growth factor receptor tyrosine kinase inhibitors. Eur J Med Chem. 2008 Jul;43(7):1478-88.
• [1426] Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor. J Med Chem. 1999 Jul 1;42(13):2373-82.
• [1427] Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dith... J Med Chem. 1995 Jul 7;38(14):2663-71.
• [1428] Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase. Bioorg Med Chem Lett. 2007 Jan 15;17(2):461-4.
• [1429] Novel 4-(piperidin-4-yl)-1-hydroxypyrazoles as gamma-aminobutyric acid(A) receptor ligands: synthesis, pharmacology, and structure-activity relatio... J Med Chem. 2010 Apr 22;53(8):3417-21.
• [1430] Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. Bioorg Med Chem. 2010 Jan 15;18(2):880-6.
• [1431] In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2190-4.
• [1432] Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines. J Med Chem. 2009 Jan 8;52(1):33-47.
• [1433] 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. Bioorg Med Chem Lett. 2010 Jan 1;20(1):42-7.
• [1434] Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1579-81.
• [1435] Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglauc... Bioorg Med Chem Lett. 2005 Feb 15;15(4):963-9.
• [1436] 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6619-22.
• [1437] Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-pipe... J Med Chem. 2008 Oct 9;51(19):5893-6.
• [1438] 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists. J Med Chem. 2010 Nov 11;53(21):7639-46.
• [1439] Synthesis and cytotoxic activity of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidine derivatives. Eur J Med Chem. 2010 Jan;45(1):379-86.
• [1440] Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) b... J Med Chem. 2009 Sep 24;52(18):5685-702.
• [1441] Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem. 2006 Jul 27;49(15):4650-6.
• [1442] Acryloylamino-salicylanilides as EGFR PTK inhibitors. Bioorg Med Chem Lett. 2006 Jan 15;16(2):469-72.
• [1443] Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety. Bioorg Med Chem Lett. 2009 Mar 1;19(5):1532-3.
• [1444] Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines. Bioorg Med Chem Lett. 2002 Mar 11;12(5):811-5.
• [1445] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4702).
• [1446] Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma mo... J Med Chem. 2009 Dec 10;52(23):7364-7.
• [1447] Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human panc... J Med Chem. 2007 Dec 13;50(25):6316-25.
• [1448] Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem. 2007 Dec 1;15(23):7229-36.
• [1449] 3-Thienyl- and 3-furylaminobutyric acids. Synthesis and binding GABAB receptor studies. J Med Chem. 1991 Aug;34(8):2557-60.
• [1450] Synthesis and pharmacological evaluation of gamma-aminobutyric acid analogues. New ligand for GABAB sites. J Med Chem. 1987 Apr;30(4):743-6.
• [1451] GABA agonists. Resolution, absolute stereochemistry, and enantioselectivity of (S)-(+)- and (R)-(-)-dihydromuscimol. J Med Chem. 1985 Nov;28(11):1612-7.
• [1452] Analgesic agents without gastric damage: design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors. Bioorg Med Chem. 2007 Jan 15;15(2):1014-21.
• [1453] Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. J Pharmacol Exp Ther. 2010 Nov;335(2):389-400.
• [1454] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6606).
• [1455] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6258).
• [1456] 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1). Bioorg Med Chem Lett. 2012 Jan 1;22(1):427-30.
• [1457] Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2273-6.
• [1458] 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists. J Med Chem. 2002 Jan 17;45(2):492-503.
• [1459] Design and synthesis of a novel class of histone deacetylase inhibitors. Bioorg Med Chem Lett. 2001 Nov 5;11(21):2847-50.
• [1460] Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor ag... J Med Chem. 2010 Feb 11;53(3):1222-37.
• [1461] Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. J Med Chem. 2005 Aug 25;48(17):5530-5.
• [1462] alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a ... J Med Chem. 2000 Mar 9;43(5):765-8.
• [1463] 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist. J Med Chem. 1999 Jul 29;42(15):2993-3000.
• [1464] Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors. J Med Chem. 1998 Aug 27;41(18):3499-506.
• [1465] Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology. J Med Chem. 2006 Feb 23;49(4):1388-96.
• [1466] Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. J Med Chem. 2005 Jan 27;48(2):427-39.
• [1467] Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis. J Med Chem. 2010 Feb 25;53(4):1465-72.
• [1468] Synthesis and inhibitory activity of 4-alkynyl and 4-alkenylquinazolines: identification of new scaffolds for potent EGFR tyrosine kinase inhibitors. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5863-7.
• [1469] 4-substituted indazoles as new inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3177-80.
• [1470] Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. J Med Chem. 2004 Jan 15;47(2):467-74.
• [1471] Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-Src. Bioorg Med Chem Lett. 2000 May 1;10(9):945-9.
• [1472] A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives. J Med Chem. 2000 Jul 27;43(15):2814-23.
• [1473] Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents. J Med Chem. 2004 Oct 21;47(22):5367-80.
• [1474] Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. J Med Chem. 2002 Feb 14;45(4):753-7.
• [1475] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5500).
• [1476] Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875-8.
• [1477] Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1524-7.
• [1478] Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies. J Med Chem. 1988 May;31(5):893-7.
• [1479] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 307).
• [1480] Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxama... J Med Chem. 2005 Feb 24;48(4):1019-32.
• [1481] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 396).
• [1482] Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases. Bioorg Med Chem. 2009 Mar 15;17(6):2276-81.
• [1483] Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropy... Bioorg Med Chem Lett. 2002 Sep 2;12(17):2291-4.
• [1484] A novel class of potent 3-isoxazolol GABA(A) antagonists: design, synthesis, and pharmacology. J Med Chem. 2000 Dec 28;43(26):4930-3.
• [1485] Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. J Med Chem. 2008 Mar 27;51(6):1945-53.
• [1486] Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. J Med Chem. 2008 Dec 11;51(23):7645-9.
• [1487] Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors. Eur J Med Chem. 2008 Jan;43(1):166-73.
• [1488] PEG-immobilization of cardol and soluble polymer-supported synthesis of some cardol-coumarin derivatives: preliminary evaluation of their inhibitor... Bioorg Med Chem Lett. 2009 Jan 1;19(1):36-9.
• [1489] Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies. J Med Chem. 2000 Feb 10;43(3):351-60.
• [1490] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6274).
• [1491] 3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4620-3.
• [1492] Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands. Bioorg Med Chem Lett. 2006 Feb 15;16(4):854-8.
• [1493] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6635).
• [1494] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6629).
• [1495] Bioactive abietane and seco-abietane diterpenoids from Salvia prionitis. J Nat Prod. 2002 Jul;65(7):1016-20.
• [1496] Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett. 2006 Jan 1;16(1):123-8.
• [1497] Optimization of 2-aminothiazole derivatives as CCR4 antagonists. Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3.
• [1498] A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin. 2001;17(3):159-65.
• [1499] Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. J Med Chem. 2004 Oct 7;47(21):5224-9.
• [1500] Activity and inhibition of 3-beta-hydroxysteroid dehydrogenase/delta-5-4-isomerase in human skin. Skin Pharmacol. 1997;10(3):160-8.
• [1501] A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affi... J Med Chem. 1995 Nov 10;38(23):4730-8.
• [1502] N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases. J Med Chem. 1988 Feb;31(2):370-4.
• [1503] Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase. Nat Chem Biol. 2008 Nov;4(11):700-7.
• [1504] Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration. Bioorg Med Chem Lett. 2008 Jan 1;18(1):262-6.
• [1505] Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives. J Med Chem. 1981 Oct;24(10):1149-55.
• [1506] Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists. J Med Chem. 2010 Oct 14;53(19):7129-39.
• [1507] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1269).
• [1508] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5449).
• [1509] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1402).
• [1510] Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases. J Med Chem. 2010 Feb 25;53(4):1830-42.
• [1511] Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of - but not of -, - and -carbonic anhydrases. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6208-12.
• [1512] Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12.
• [1513] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6283).
• [1514] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6608).
• [1515] Design, synthesis, and 5-lipoxygenase-inhibiting properties of 1-thio-substituted butadienes. J Med Chem. 1990 Apr;33(4):1163-70.
• [1516] 4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists. Bioorg Med Chem Lett. 2006 Jan 1;16(1):146-9.
• [1517] 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4447-50.
• [1518] Chemical phylogenetics of histone deacetylases. Nat Chem Biol. 2010 Mar;6(3):238-243.
• [1519] Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase. Bioorg Med Chem. 2010 Jul 15;18(14):5056-62.
• [1520] Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J Med Chem. 2004 Aug 26;47(18):4494-506.
• [1521] N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands. Bioorg Med Chem Lett. 2004 Apr 5;14(7):1693-6.
• [1522] Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob Agents Chemother. 1996 May;40(5):1304-7.
• [1523] Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid. Bioorg Med Chem Lett. 2004 Feb 9;14(3):605-9.
• [1524] Design of novel histone deacetylase inhibitors. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4619-24.
• [1525] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1730).
• [1526] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6604).
• [1527] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6605).
• [1528] Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity. J Med Chem. 2003 Apr 10;46(8):1484-91.
• [1529] Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists. Bioorg Med Chem Lett. 2000 Oct 16;10(20):2379-82.
• [1530] Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-... Bioorg Med Chem Lett. 1999 Jun 7;9(11):1619-24.
• [1531] Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abe... Bioorg Med Chem. 2007 Oct 15;15(20):6596-607.
• [1532] Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activ... J Med Chem. 2008 Jul 24;51(14):4226-38.
• [1533] Structure and anti-acetylcholinesterase activity of 4 alpha-(hydroxymethyl)-4 alpha-demethylterritrem B. J Nat Prod. 1997 Aug;60(8):842-3.
• [1534] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2500).
• [1535] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4105).
• [1536] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3962).
• [1537] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1358).
• [1538] Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase. Bioorg Med Chem. 2008 May 1;16(9):4963-83.
• [1539] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4186).
• [1540] S-adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992 Dec;56(3):359-77.
• [1541] Rational design of 5'-thiourea-substituted alpha-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacteri... J Med Chem. 2007 Nov 1;50(22):5281-92.
• [1542] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5120).
• [1543] New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues ... J Med Chem. 2009 Mar 12;52(5):1388-407.
• [1544] Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands. J Med Chem. 2006 Sep 21;49(19):5750-8.
• [1545] Design, synthesis, and molecular modeling studies of 5'-deoxy-5'-ureidoadenosine: 5'-ureido group as multiple hydrogen bonding donor in the active ... Bioorg Med Chem Lett. 2007 Aug 15;17(16):4456-9.
• [1546] Thymidylate kinase as target enzyme for 5'-deoxythymidine and various 5'-deoxy-5'-halogeno pyrimidine nucleosides. Acta Biol Med Ger. 1969;23(6):Suppl:K 19+.
• [1547] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4855).
• [1548] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4109).
• [1549] Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism. Osteoarthritis Cartilage. 2005 Mar;13(3):250-7.
• [1550] Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem. 2001 Dec 6;44(25):4313-24.
• [1551] Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases. J Med Chem. 2005 Oct 6;48(20):6194-201.
• [1552] Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and... J Med Chem. 2010 Feb 11;53(3):951-65.
• [1553] 1-Hydroxy-1,4-dihydroquinoxaline-2,3-diones: Novel antagonists at NMDA receptor glycine sites, Bioorg. Med. Chem. Lett. 6(4):439-440 (1996).
• [1554] Interactions of flavonoids and other phytochemicals with adenosine receptors. J Med Chem. 1996 Feb 2;39(3):781-8.
• [1555] Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J Med Chem. 2006 Nov 2;49(22):6443-50.
• [1556] Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. J Med Chem. 1994 Apr 1;37(7):1015-27.
• [1557] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5178).
• [1558] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6304).
• [1559] Synthesis of eudistomin D analogues and its effects on adenosine receptors. Bioorg Med Chem. 2008 Apr 1;16(7):3825-30.
• [1560] 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists. Bioorg Med Chem Lett. 2004 May 3;14(9):2345-9.
• [1561] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2361).
• [1562] Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. J Med Chem. 2006 Apr 20;49(8):2440-55.
• [1563] 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dih... J Med Chem. 1995 Mar 3;38(5):745-52.
• [1564] 6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3237-40.
• [1565] Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5... Bioorg Med Chem Lett. 2008 Jul 15;18(14):4098-101.
• [1566] Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands. J Med Chem. 1992 Nov 13;35(23):4408-14.
• [1567] Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal m... J Med Chem. 2008 Feb 14;51(3):449-69.
• [1568] 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthas... J Med Chem. 2000 May 4;43(9):1841-51.
• [1569] Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and... J Biol Chem. 1996 Oct 18;271(42):26157-64.
• [1570] 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression, Bioorg. Med. Chem. Lett. 20(13):3941-3945 (2010).
• [1571] NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding s... J Med Chem. 2007 Apr 19;50(8):1865-75.
• [1572] Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. Bioorg Med Chem Lett. 2004 May 17;14(10):2477-81.
• [1573] Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6812-5.
• [1574] Aza-stilbenes as potent and selective c-RAF inhibitors. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5378-83.
• [1575] Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2485-8.
• [1576] Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors. Bioorg Med Chem Lett. 2001 Apr 23;11(8):969-72.
• [1577] Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol. 2004 Jun;65(6):1364-74.
• [1578] 5-Oxo-ETE receptor antagonists. J Med Chem. 2013 May 9;56(9):3725-32.
• [1579] A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4882-4.
• [1580] Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach. Bioorg Med Chem. 2009 Aug 15;17(16):6040-7.
• [1581] Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. Eur J Med Chem. 2009 May;44(5):1900-12.
• [1582] Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists. Bioorg Med Chem Lett. 2006 Feb 15;16(4):960-3.
• [1583] Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-pip... J Med Chem. 2008 Jun 26;51(12):3609-16.
• [1584] Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-th... Bioorg Med Chem Lett. 2005 May 2;15(9):2347-52.
• [1585] Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase. J Med Chem. 2007 Nov 29;50(24):6016-23.
• [1586] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 265).
• [1587] New tetrazole-based selective anandamide uptake inhibitors. Bioorg Med Chem Lett. 2008 May 1;18(9):2820-4.
• [1588] Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. J Pharmacol Exp Ther. 2011 Jun;337(3):860-7.
• [1589] Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase. Biochem Pharmacol. 1992 Mar 17;43(6):1295-301.
• [1590] Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1335-7.
• [1591] Novel IKK inhibitors: beta-carbolines. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2419-22.
• [1592] Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines. J Med Chem. 1992 Oct 16;35(21):3845-57.
• [1593] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1591).
• [1594] Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands. Bioorg Med Chem Lett. 2004 May 17;14(10):2443-6.
• [1595] The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. Eur J Med Chem. 2012 Sep;55:358-74.
• [1596] The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex ) derivaties, Bioorg. Med. Chem. Lett. 2(8):861-864 (1992).
• [1597] Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. Bioorg Med Chem Lett. 2003 May 19;13(10):1829-35.
• [1598] Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors. Bioorg Med Chem. 2010 Nov 1;18(21):7580-5.
• [1599] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6560).
• [1600] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4).
• [1601] Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei. Bioorg Med Chem. 2003 Apr 3;11(7):1207-14.
• [1602] Isoprenylated flavonoids from the stem bark of Erythrina abyssinica. J Nat Prod. 2007 Jun;70(6):1039-42.
• [1603] Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal. J Med Chem. 2004 Sep 23;47(20):4881-90.
• [1604] 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists. Bioorg Med Chem Lett. 2000 Aug 7;10(15):1707-9.
• [1605] Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models. J Med Chem. 1989 Jul;32(7):1577-80.
• [1606] Binding dynamics of two water molecules constrained within the scytalone dehydratase binding pocket. Bioorg Med Chem Lett. 2000 Jan 3;10(1):23-6.
• [1607] Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents. J Med Chem. 2009 Mar 26;52(6):1648-58.
• [1608] The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1648-51.
• [1609] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4614).
• [1610] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1345).
• [1611] A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies. Bioorg Med Chem. 2010 Jun 15;18(12):4468-74.
• [1612] Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking. FEMS Microbiol Lett. 1996 May 1;138(2-3):105-11.
• [1613] Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains. J Med Chem. 2006 May 4;49(9):2725-30.
• [1614] Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones. Bioorg Med Chem Lett. 2007 Jan 1;17(1):118-22.
• [1615] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4671).
• [1616] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2295).
• [1617] Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy. J Med Chem. 2007 Nov 15;50(23):5644-54.
• [1618] Structure of yeast 5-aminolaevulinic acid dehydratase complexed with the inhibitor 5-hydroxylaevulinic acid. Acta Crystallogr D Biol Crystallogr. 2005 Sep;61(Pt 9):1222-6.
• [1619] Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase. J Med Chem. 2005 Mar 24;48(6):1796-805.
• [1620] Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes. J Med Chem. 2006 Nov 16;49(23):6726-31.
• [1621] Total synthesis and biological evaluation of structural analogues of compactin and dihydromevinolin. J Med Chem. 1987 Oct;30(10):1858-73.
• [1622] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4107).
• [1623] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 145).
• [1624] Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors. Bioorg Med Chem. 2009 Jul 15;17(14):5312-7.
• [1625] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1364).
• [1626] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3393).
• [1627] Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4706-10.
• [1628] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 107).
• [1629] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1592).
• [1630] Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b. J Med Chem. 2007 Apr 5;50(7):1445-8.
• [1631] Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase. Bioorg Med Chem. 2008 Apr 1;16(7):3809-15.
• [1632] Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitors. Bioorg Med Chem Lett. 2002 Feb 11;12(3):491-5.
• [1633] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 489).
• [1634] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1419).
• [1635] Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem. 2008 May 8;51(9):2606-12.
• [1636] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 128).
• [1637] Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect. Bioorg Med Chem. 2012 Apr 15;20(8):2747-61.
• [1638] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6171).
• [1639] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6167).
• [1640] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6169).
• [1641] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3392).
• [1642] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6164).
• [1643] 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo. J Med Chem. 2005 Sep 8;48(18):5644-7.
• [1644] X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of ... J Med Chem. 2001 Aug 30;44(18):2928-32.
• [1645] Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5883-6.
• [1646] Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activ... J Med Chem. 1994 May 13;37(10):1427-38.
• [1647] Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from plat... J Med Chem. 1989 Aug;32(8):1836-42.
• [1648] Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors. Bioorg Med Chem Lett. 2006 Aug 1;16(15):3975-80.
• [1649] Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides. JMed Virol. 1988 Dec;26(4):353-62.
• [1650] 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. J Med Chem. 2005 Jan 13;48(1):224-39.
• [1651] Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod. 2001 Jun;64(6):745-9.
• [1652] Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2299-304.
• [1653] Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod. 1994 Apr;57(4):545-51.
• [1654] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1731).
• [1655] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6414).
• [1656] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3390).
• [1657] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2483).
• [1658] Halogenation of 4-hydroxy/amino-3-methoxyphenyl acetamide TRPV1 agonists showed enhanced antagonism to capsaicin. Bioorg Med Chem. 2010 Nov 15;18(22):8092-105.
• [1659] Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. J Med Chem. 2007 Dec 13;50(25):6383-91.
• [1660] Synthesis of biflavones having a 6-O-7'' linkage and effects on cyclooxygenase-2 and inducible nitric oxide synthase. Bioorg Med Chem Lett. 2009 Jan 1;19(1):74-6.
• [1661] Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. Bioorg Med Chem. 2008 Oct 1;16(19):9040-9.
• [1662] Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists. Bioorg Med Chem. 2008 Mar 15;16(6):3309-20.
• [1663] Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship anal... J Med Chem. 2009 Feb 26;52(4):964-75.
• [1664] Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three ... J Med Chem. 2003 Apr 24;46(9):1726-36.
• [1665] Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1779-82.
• [1666] A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3... J Med Chem. 2005 Oct 6;48(20):6326-39.
• [1667] Synthesis and dopaminergic binding of 2-aryldopamine analogues: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes. J Med Chem. 1986 Oct;29(10):1904-12.
• [1668] Small molecule modulators of toll-like receptors. J Med Chem. 2008 Nov 13;51(21):6621-6.
• [1669] Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6841-6.
• [1670] 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. J Med Chem. 1992 Feb 21;35(4):620-8.
• [1671] Histone deacetylase inhibitors: from bench to clinic. J Med Chem. 2008 Mar 27;51(6):1505-29.
• [1672] Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17. Bioorg Med Chem Lett. 2008 Jan 1;18(1):267-73.
• [1673] 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4507-10.
• [1674] Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. J Med Chem. 2002 Aug 1;45(16):3381-93.
• [1675] Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6280-5.
• [1676] Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3314-21.
• [1677] Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. J Med Chem. 1980 Jan;23(1):34-8.
• [1678] Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading... J Med Chem. 2005 Aug 11;48(16):5092-5.
• [1679] Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity. Bioorg Med Chem Lett. 2010 Jan 1;20(1):184-8.
• [1680] Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ... J Med Chem. 1999 May 6;42(9):1556-75.
• [1681] 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization. Bioorg Med Chem. 2009 Oct 15;17(20):7186-96.
• [1682] Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups. J Med Chem. 2004 Oct 21;47(22):5441-50.
• [1683] Inhibitors selective for HDAC6 in enzymes and cells. Bioorg Med Chem Lett. 2010 Dec 1;20(23):7067-70.
• [1684] Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists. J Med Chem. 1981 Jul;24(7):903-6.
• [1685] Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB. J Med Chem. 2008 Feb 14;51(3):545-52.
• [1686] 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and X... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8.
• [1687] Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)gua... J Med Chem. 2000 Nov 2;43(22):4071-83.
• [1688] Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group. Bioorg Med Chem Lett. 2004 May 3;14(9):2141-5.
• [1689] Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. J Med Chem. 2006 Oct 19;49(21):6143-6.
• [1690] Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors. Eur J Med Chem. 2008 Jun;43(6):1248-60.
• [1691] Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides co... J Med Chem. 1999 Jul 15;42(14):2641-50.
• [1692] Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5864-8.
• [1693] Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics. J Med Chem. 2006 Aug 10;49(16):4937-45.
• [1694] Hunting the emesis and efficacy targets of PDE4 inhibitors: identification of the photoaffinity probe 8-(3-azidophenyl)-6- [(4-iodo-1H-1-imidazolyl... J Med Chem. 2000 Oct 19;43(21):3820-3.
• [1695] Aromatic sulfide inhibitors of histone deacetylase based on arylsulfinyl-2,4-hexadienoic acid hydroxyamides. J Med Chem. 2006 Jan 26;49(2):800-5.
• [1696] Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines. J Med Chem. 1995 Aug 18;38(17):3258-63.
• [1697] 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine d... J Med Chem. 1999 Feb 25;42(4):619-27.
• [1698] Inhibition of human O6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)-(benzyloxy)-2,6(4)-... J Med Chem. 1998 Feb 12;41(4):503-8.
• [1699] Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase. Bioorg Med Chem. 2010 May 15;18(10):3403-12.
• [1700] New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod. 2002 Apr;65(4):476-80.
• [1701] 6-Bromo-3 nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).
• [1702] Stable generation of serum- and feeder-free embryonic stem cell-derived mice with full germline-competency by using a GSK3 specific inhibitor. Genesis. 2009 Jun;47(6):414-22.
• [1703] 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and... J Med Chem. 1997 Oct 24;40(22):3679-86.
• [1704] Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. J Med Chem. 2009 Sep 10;52(17):5365-79.
• [1705] Hasubanan alkaloids with delta-opioid binding affinity from the aerial parts of Stephania japonica. J Nat Prod. 2010 May 28;73(5):988-91.
• [1706] High performance liquid chromatography analysis of hypoxanthine metabolism in mouse oocyte-cumulus cell complexes: effects of purine metabolic perturbants. Biol Reprod. 1994 Jun;50(6):1403-12.
• [1707] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1346).
• [1708] 4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2. Bioorg Med Chem Lett. 2003 Jan 20;13(2):217-22.
• [1709] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 510).
• [1710] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3205).
• [1711] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7996).
• [1712] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5126).
• [1713] 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists. Bioorg Med Chem Lett. 2005 Apr 15;15(8):2119-22.
• [1714] 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5840-3.
• [1715] Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg Med Chem Lett. 2006 Jan 15;16(2):257-61.
• [1716] Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors Bioorg Med Chem Lett. 2008 Jul 15;18(14):3938-41.
• [1717] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1347).
• [1718] Total synthesis and biological evaluation of ustiloxin natural products and two analogs. Bioorg Med Chem Lett. 2006 Sep 15;16(18):4804-7.
• [1719] Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain. J Med Chem. 2005 Nov 17;48(23):7253-60.
• [1720] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4110).
• [1721] Flavonoids with anti-cataract activity from Brickellia arguta. J Nat Prod. 1984 Mar-Apr;47(2):316-9.
• [1722] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5846).
• [1723] 6,3'-Dinitroflavone, a novel high affinity ligand for the benzodiazepine receptor with potent anxiolytic properties, Bioorg. Med. Chem. Lett. 5(22):2717-2720 (1995).
• [1724] Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity. J Med Chem. 2006 Sep 21;49(19):5671-86.
• [1725] Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model. J Med Chem. 2003 Jul 31;46(16):3455-62.
• [1726] Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gon... J Med Chem. 1996 Apr 26;39(9):1836-45.
• [1727] Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.
• [1728] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4111).
• [1729] Thienylimidazo[2,1-b]thiazoles as inhibitors of mitochondrial NADH dehydrogenase. J Med Chem. 1995 Mar 31;38(7):1090-7.
• [1730] A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3929-31.
• [1731] Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36.
• [1732] Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes. Bioorg Med Chem Lett. 2009 May 15;19(10):2811-4.
• [1733] K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013 Nov 28;503(7477):548-51.
• [1734] Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b']diindoles. A novel class of rigid, planar benzodiazepine receptor ligands. J Med Chem. 1987 Mar;30(3):456-8.
• [1735] Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1162-4.
• [1736] Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2007 Jan 1;17(1):136-41.
• [1737] Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors. J Med Chem. 2004 Dec 30;47(27):6792-803.
• [1738] Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent benzot... J Med Chem. 1987 Jul;30(7):1166-76.
• [1739] Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors. Bioorg Med Chem. 2010 Mar 15;18(6):2081-2088.
• [1740] Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem. 2007 Nov 15;50(23):5848-52.
• [1741] Histone deacetylase inhibitors. J Med Chem. 2003 Nov 20;46(24):5097-116.
• [1742] Alpha-keto amides as inhibitors of histone deacetylase. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3331-5.
• [1743] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1634).
• [1744] A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3817-20.
• [1745] Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives. J Med Chem. 2004 Jun 3;47(12):3019-31.
• [1746] ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands. Bioorg Med Chem Lett. 2007 Jul 15;17(14):4053-6.
• [1747] An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted in... J Med Chem. 2007 Aug 23;50(17):4027-37.
• [1748] Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Syn... J Med Chem. 2006 Oct 5;49(20):6015-26.
• [1749] Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptor. J Med Chem. 1987 Dec;30(12):2222-7.
• [1750] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1848).
• [1751] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1303).
• [1752] The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3489-94.
• [1753] 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5630-3.
• [1754] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3432).
• [1755] Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer. 2001 Nov;34(2):185-94.
• [1756] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6).
• [1757] Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles. Bioorg Med Chem Lett. 2001 May 7;11(9):1153-6.
• [1758] High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines w... J Med Chem. 1996 Feb 16;39(4):892-903.
• [1759] Axially chiral N-benzyl-N,7-dimethyl-5-phenyl-1, 7-naphthyridine-6-carboxamide derivatives as tachykinin NK1 receptor antagonists: determination of... J Med Chem. 1998 Oct 22;41(22):4232-9.
• [1760] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5127).
• [1761] Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinester... Eur J Med Chem. 2009 Jun;44(6):2523-32.
• [1762] Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3211-5.
• [1763] Novel molecular targets for antimalarial drug development. Chem Biol Drug Des. 2008 Apr;71(4):287-97.
• [1764] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 951).
• [1765] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4350).
• [1766] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4353).
• [1767] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1840).
• [1768] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1841).
• [1769] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4351).
• [1770] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1842).
• [1771] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1843).
• [1772] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1844).
• [1773] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1845).
• [1774] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1846).
• [1775] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1847).
• [1776] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4355).
• [1777] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4354).
• [1778] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4352).
• [1779] Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus. J Nat Prod. 1996 Oct;59(10):962-4.
• [1780] Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4873-7.
• [1781] Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4879-82.
• [1782] Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen re... J Med Chem. 2006 Dec 14;49(25):7357-65.
• [1783] Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneum... J Med Chem. 1997 Sep 12;40(19):3032-9.
• [1784] Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem. 2010 Feb;18(3):1018-28.
• [1785] 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic gluc... J Med Chem. 2001 Jan 18;44(2):170-9.
• [1786] Palladium-catalyzed cross-coupling reactions for the synthesis of 6, 8-disubstituted 1,7-naphthyridines: a novel class of potent and selective phos... J Med Chem. 2000 Feb 24;43(4):675-82.
• [1787] 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76.
• [1788] Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone. J Med Chem. 2005 Aug 11;48(16):5100-3.
• [1789] Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J Med Chem. 1993 Apr 16;36(8):1024-31.
• [1790] Differential metabolism of guanine nucleosides by human lymphoid cell lines. Proc Soc Exp Biol Med. 1985 Sep;179(4):427-31.
• [1791] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3963).
• [1792] Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agents. J Med Chem. 2004 Dec 2;47(25):6124-7.
• [1793] Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J Biol Chem. 2003 Aug 22;278(34):31465-8.
• [1794] SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5405-10.
• [1795] Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-c... Bioorg Med Chem. 2008 May 15;16(10):5653-64.
• [1796] Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood. J Biol Chem. 2007 Nov 16;282(46):33295-304.
• [1797] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 385).
• [1798] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4112).
• [1799] Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana. Bioorg Med Chem. 2010 Sep 1;18(17):6258-64.
• [1800] GTP cyclohydrolase I feedback regulatory protein-dependent and -independent inhibitors of GTP cyclohydrolase I. Arch Biochem Biophys. 2001 Apr 1;388(1):67-73.
• [1801] Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta. J Med Chem. 2006 May 4;49(9):2681-8.
• [1802] Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical p... J Nat Prod. 2006 Jul;69(7):1034-40.
• [1803] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5172).
• [1804] Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationshi... J Med Chem. 1993 Oct 29;36(22):3341-9.
• [1805] Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol. 2001 Dec;117(6):1594-600.
• [1806] Cyclooxygenase (COX)-1 and -2 inhibitory labdane diterpenes from Crassocephalum mannii. J Nat Prod. 2008 Jun;71(6):1070-3.
• [1807] Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters. Bioorg Med Chem. 2010 Jan 15;18(2):640-9.
• [1808] 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist. Mol Pharmacol. 2004 Mar;65(3):538-49.
• [1809] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2679).
• [1810] 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites. Bioorg Med Chem Lett. 2010 Feb 1;20(3):935-8.
• [1811] Synthesis and biological activity of putative mono-hydroxylated metabolites of velnacrine, Bioorg. Med. Chem. Lett. 2(8):865-870 (1992).
• [1812] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4113).
• [1813] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6673).
• [1814] Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1931-4.
• [1815] Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. J Med Chem. 2006 Dec 14;49(25):7540-4.
• [1816] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5567).
• [1817] Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Eur J Med Chem. 2009 Apr;44(4):1383-95.
• [1818] Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor. J Med Chem. 1993 Nov 26;36(24):3821-8.
• [1819] 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacolog... J Med Chem. 2005 Nov 3;48(22):6887-96.
• [1820] Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique aden... J Med Chem. 2004 Apr 22;47(9):2243-55.
• [1821] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5925).
• [1822] Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorg Med Chem. 2010 Feb;18(3):1244-51.
• [1823] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 67).
• [1824] The TRPM4 channel inhibitor 9-phenanthrol. Br J Pharmacol. 2014 Apr;171(7):1600-13.
• [1825] Conformationally-restricted ligands for the histamine H1 receptor. Bioorg Med Chem Lett. 2000 Jun 5;10(11):1277-9.
• [1826] Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum h... Bioorg Med Chem. 2009 Sep 1;17(17):6218-32.
• [1827] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5129).
• [1828] beta-Carbolines as benzodiazepine receptor ligands. 1. Synthesis and benzodiazepine receptor interaction of esters of beta-carboline-3-carboxylic a... J Med Chem. 1983 Apr;26(4):499-503.
• [1829] The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. J Pharmacol Exp Ther. 1998 Jan;284(1):83-8.
• [1830] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 490).
• [1831] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 491).
• [1832] Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 3. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4883-6.
• [1833] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6592).
• [1834] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1258).
• [1835] Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase. Bioorg Med Chem Lett. 2005 Jan 3;15(1):153-8.
• [1836] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4116).
• [1837] Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res. 2003 Nov 15;63(22):7861-9.
• [1838] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8441).
• [1839] A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection. Bioorg Med Chem Lett. 2004 May 17;14(10):2613-6.
• [1840] Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 ago... J Med Chem. 2006 Dec 14;49(25):7450-65.
• [1841] Synthesis of selenophene derivatives as novel CHK1 inhibitors. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5065-8.
• [1842] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8204).
• [1843] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3995).
• [1844] Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent anti... Bioorg Med Chem Lett. 2006 Mar 1;16(5):1272-6.
• [1845] Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection. Bioorg Med Chem Lett. 2006 Jan 1;16(1):118-22.
• [1846] Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther. 2005 Jun;4(6):977-86.
• [1847] Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.genes... Bioorg Med Chem Lett. 2006 Feb;16(3):658-62.
• [1848] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4119).
• [1849] Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists. J Med Chem. 2005 Nov 17;48(23):7374-88.
• [1850] Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists. Bioorg Med Chem. 2008 Sep 15;16(18):8516-25.
• [1851] Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acet... J Med Chem. 2006 Jun 29;49(13):3770-3.
• [1852] Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and... J Med Chem. 2008 Oct 23;51(20):6547-57.
• [1853] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3986).
• [1854] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7661).
• [1855] cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain... J Med Chem. 2008 Nov 27;51(22):7094-8.
• [1856] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1009).
• [1857] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1717).
• [1858] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1719).
• [1859] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3301).
• [1860] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4118).
• [1861] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 480).
• [1862] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4120).
• [1863] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4122).
• [1864] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8289).
• [1865] Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors. J Med Chem. 2002 Dec 19;45(26):5687-93.
• [1866] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [1867] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 416).
• [1868] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 434).
• [1869] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5871).
• [1870] A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity. Mol Cell Endocrinol. 2003 Dec 30;212(1-2):41-9.
• [1871] A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity. Nat Chem Biol. 2014 Aug;10(8):656-63.
• [1872] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5526).
• [1873] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8439).
• [1874] Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii. J Nat Prod. 2006 Nov;69(11):1572-6.
• [1875] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2151).
• [1876] Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one sc... Bioorg Med Chem. 2007 Dec 1;15(23):7380-90.
• [1877] Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3. J Med Chem. 2004 Dec 16;47(26):6455-8.
• [1878] Res-701-1, synthesis and a reevaluation of its effects on the endothelin receptors, Bioorg. Med. Chem. Lett. 5(6):621-626 (1995).
• [1879] Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J Med Chem. 2006 Apr 6;49(7):2147-50.
• [1880] Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibi... J Med Chem. 2006 Jun 1;49(11):3395-401.
• [1881] Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3647-50.
• [1882] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6527).
• [1883] Discovery of a beta-MSH-derived MC-4R selective agonist. J Med Chem. 2005 May 5;48(9):3095-8.
• [1884] Urotensin-II receptor modulators as potential drugs. J Med Chem. 2010 Apr 8;53(7):2695-708.
• [1885] Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain. Bioorg Med Chem Lett. 2001 Jan 22;11(2):203-6.
• [1886] Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4668-73.
• [1887] Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-... J Med Chem. 2008 Sep 25;51(18):5585-93.
• [1888] Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J Med Chem. 1997 Jul 4;40(14):2133-9.
• [1889] Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and c... J Med Chem. 2006 May 18;49(10):2953-68.
• [1890] Engineering of a VPAC2 receptor peptide agonist to impart dipeptidyl peptidase IV stability and enhance in vivo glucose disposal. J Med Chem. 2006 Dec 14;49(25):7545-8.
• [1891] Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem. 2006 Jul 27;49(15):4616-22.
• [1892] Design and NMR characterization of active analogues of compstatin containing non-natural amino acids. J Med Chem. 2005 Jan 13;48(1):274-86.
• [1893] Non-competitive pharmacological antagonism at the rabbit B(1) receptor. Br J Pharmacol. 2000 Nov;131(5):885-92.
• [1894] Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 rece... J Med Chem. 2009 Jun 25;52(12):3627-35.
• [1895] Synthesis and receptor binding properties of chimeric peptides containing a mu-opioid receptor ligand and nociceptin/orphanin FQ receptor ligand Ac... Bioorg Med Chem Lett. 2006 Sep 15;16(18):4839-41.
• [1896] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1679).
• [1897] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8566).
• [1898] Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor. J Med Chem. 2008 Dec 25;51(24):7889-97.
• [1899] Internalisation of the mu-opioid receptor by endomorphin-1 and leu-enkephalin is dependant on aromatic amino acid residues. Bioorg Med Chem. 2008 Apr 15;16(8):4341-6.
• [1900] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5996).
• [1901] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4054).
• [1902] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3947).
• [1903] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5422).
• [1904] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4055).
• [1905] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2443).
• [1906] Selective inhibition of methoxyflavonoids on human CYP1B1 activity. Bioorg Med Chem. 2010 Sep 1;18(17):6310-5.
• [1907] Anti-inflammatory activity of Acanthus ilicifolius. J Ethnopharmacol. 2008 Oct 30;120(1):7-12.
• [1908] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3388).
• [1909] Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2329-33.
• [1910] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 738).
• [1911] Cyclic diarylheptanoids as Na+-glucose cotransporter (SGLT) inhibitors from Acer nikoense. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1070-4.
• [1912] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4123).
• [1913] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6277).
• [1914] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4661).
• [1915] Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators. J Med Chem. 1998 Nov 19;41(24):4800-18.
• [1916] 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors. J Med Chem. 1998 Jun 4;41(12):2047-55.
• [1917] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4522).
• [1918] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3039).
• [1919] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3038).
• [1920] Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, ... J Med Chem. 1990 Jan;33(1):394-407.
• [1921] The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure. 1999 Sep 15;7(9):1135-43.
• [1922] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4520).
• [1923] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2753).
• [1924] Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. J Med Chem. 2010 Mar 11;53(5):2076-86.
• [1925] ClC-2 Cl- channels in human lung epithelia: activation by arachidonic acid, amidation, and acid-activated omeprazole. Am J Physiol Cell Physiol. 2001 Jul;281(1):C46-54.
• [1926] Identification of selective neuropeptide Y2 peptide agonists. Bioorg Med Chem Lett. 2007 Jan 15;17(2):538-41.
• [1927] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2617).
• [1928] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1408).
• [1929] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2418).
• [1930] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4553).
• [1931] Synthesis, anti-fungal and 1,3--D-glucan synthase inhibitory activities of caffeic and quinic acid derivatives. Bioorg Med Chem. 2010 Oct 1;18(19):7009-14.
• [1932] Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies. Eur J Biochem. 2002 Mar;269(6):1684-96.
• [1933] Microbiology, pharmacology, and clinical use of mezlocillin sodium. Pharmacotherapy. 1982 Nov-Dec;2(6):300-12.
• [1934] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2663).
• [1935] Liquid-phase synthesis of a pegylated adenosine-oligoarginine conjugate, cell-permeable inhibitor of cAMP-dependent protein kinase. Bioorg Med Chem Lett. 2003 Sep 15;13(18):3035-9.
• [1936] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4124).
• [1937] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1718).
• [1938] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1755).
• [1939] Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem. 2007 Aug 17;282(33):23841-53.
• [1940] Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinases. Bioorg Med Chem Lett. 1999 May 17;9(10):1447-52.
• [1941] Inhibition of kinesin motor proteins by adociasulfate-2. J Med Chem. 2006 Aug 10;49(16):4857-60.
• [1942] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2444).
• [1943] Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar a... J Med Chem. 2006 Apr 20;49(8):2661-5.
• [1944] Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibit... Bioorg Med Chem Lett. 2007 Jan 15;17(2):363-9.
• [1945] Quinazoline and benzimidazole MCH-1R antagonists. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1403-7.
• [1946] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6217).
• [1947] Verongamine, a novel bromotyrosine-derived histamine H3-antagonist from the marine sponge Verongula gigantea. J Nat Prod. 1994 Jan;57(1):175-7.
• [1948] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 368).
• [1949] M1 muscarinic agonists target major hallmarks of Alzheimer's disease--an update. Curr Alzheimer Res. 2007 Dec;4(5):577-80.
• [1950] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4125).
• [1951] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2937).
• [1952] Partial structures of the fungal toxin aflatrem, methyl-substituted 6,8-dioxabicyclo[3.2.1]octan-2-ones have anticonvulsant activity, Bioorg. Med. Chem. Lett. 5(3):265-270 (1995).
• [1953] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1962).
• [1954] Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology. 1997 Apr;138(4):1427-33.
• [1955] Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem. 1989 Oct;32(10):2344-52.
• [1956] Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 1994 Dec 1;54(23):6106-14.
• [1957] Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J Med Chem. 2004 Oct 21;47(22):5467-81.
• [1958] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5833).
• [1959] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5832).
• [1960] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5835).
• [1961] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6268).
• [1962] Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr. Bioorg Med Chem Lett. 2007 Nov 1;17(21):6003-8.
• [1963] The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer. 2005 May 23;92(10):1899-905.
• [1964] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2484).
• [1965] Synthesis of novel ageladine A analogs showing more potent matrix metalloproteinase (MMP)-12 inhibitory activity than the natural product. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5461-3.
• [1966] The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004;73:417-35.
• [1967] Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorg Med Chem. 2003 May 1;11(9):2007-18.
• [1968] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4127).
• [1969] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6071).
• [1970] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5455).
• [1971] AGN 190383, a novel phospholipase inhibitor with topical anti-inflammatory activity. Agents Actions. 1991 Sep;34(1-2):70-2.
• [1972] The antiinflammatory activity of topically applied novel calcium-channel antagonists. Inflammation. 1995 Apr;19(2):261-75.
• [1973] Analogs of UK 14,304: Structural features responsible for alpha2 adrenoceptor activity, Bioorg. Med. Chem. Lett. 5(15):1745-1750 (1995).
• [1974] Farnesoid X receptor: from structure to potential clinical applications. J Med Chem. 2005 Aug 25;48(17):5383-403.
• [1975] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3387).
• [1976] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2640).
• [1977] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2649).
• [1978] Ergolines as selective 5-HT1 agonists. J Med Chem. 1988 Aug;31(8):1512-9.
• [1979] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8461).
• [1980] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1928).
• [1981] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1949).
• [1982] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1896).
• [1983] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3431).
• [1984] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1376).
• [1985] The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition. ACS Chem Biol. 2015 Jul 17;10(7):1637-42.
• [1986] Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):761-4.
• [1987] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 160).
• [1988] Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dih... J Med Chem. 2003 Mar 13;46(6):1016-30.
• [1989] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1956).
• [1990] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3386).
• [1991] Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSS... J Med Chem. 2005 Jun 16;48(12):4025-30.
• [1992] Protein tyrosine phosphatase 1B inhibitors isolated from Morus bombycis. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6759-61.
• [1993] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8600).
• [1994] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5461).
• [1995] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6994).
• [1996] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2913).
• [1997] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2362).
• [1998] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2741).
• [1999] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2350).
• [2000] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2419).
• [2001] An allosteric modulator to control endogenous G protein-coupled receptors with light. Nat Chem Biol. 2014 Oct;10(10):813-5.
• [2002] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 456).
• [2003] Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine. Arch Biochem Biophys. 1997 Apr 15;340(2):265-9.
• [2004] Elgonica-Dimers A and B, Two Potent Alcohol Metabolism Inhibitory Constituents of Aloe arborescens J. Nat. Prod. 60(11):1180-1182 (1997).
• [2005] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5923).
• [2006] Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem. 2003 Jan 16;46(2):222-36.
• [2007] Alpha,beta-methylene-2'-deoxynucleoside 5'-triphosphates as noncleavable substrates for DNA polymerases: isolation, characterization, and stability... J Med Chem. 2008 Oct 23;51(20):6460-70.
• [2008] New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica. J Nat Prod. 2002 Dec;65(12):1875-81.
• [2009] Enzymatic synthesis of a selective inhibitor for alpha-glucosidases: alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen. J Agric Food Chem. 2008 Jul 9;56(13):5324-30.
• [2010] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3973).
• [2011] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3983).
• [2012] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3982).
• [2013] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2363).
• [2014] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 271).
• [2015] Alpha-eudesmol, a P/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res. 2000 Aug 4;873(1):94-101.
• [2016] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2915).
• [2017] Design and synthesis of a new fluorescent probe for cytochrome P450 3A4 (CYP 3A4). Bioorg Med Chem Lett. 2003 Nov 3;13(21):3643-5.
• [2018] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3636).
• [2019] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4656).
• [2020] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1049).
• [2021] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4640).
• [2022] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 152).
• [2023] Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001 Nov;60(5):1121-32.
• [2024] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5093).
• [2025] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1398).
• [2026] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4657).
• [2027] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5095).
• [2028] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6203).
• [2029] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4094).
• [2030] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4095).
• [2031] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5092).
• [2032] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5926).
• [2033] Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET. Bioorg Med Chem. 2009 Apr 15;17(8):2989-3002.
• [2034] In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
• [2035] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4622).
• [2036] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3316).
• [2037] Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity. J Med Chem. 2007 Dec 27;50(26):6493-500.
• [2038] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 741).
• [2039] Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1970-6.
• [2040] Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. J Med Chem. 1996 Oct 25;39(22):4515-9.
• [2041] Heteroadamantyl cannabinoids. J Med Chem. 2010 Aug 12;53(15):5656-66.
• [2042] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 750).
• [2043] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3317).
• [2044] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8292).
• [2045] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5134).
• [2046] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5961).
• [2047] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4632).
• [2048] Opportunities and challenges in targeting HIV entry. Curr Opin Pharmacol. 2002 Oct;2(5):529-33.
• [2049] Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4.
• [2050] Interactions of antitumor agents Ametantrone and Mitoxantrone (Novatrone) with double-stranded DNA. Biochem Pharmacol. 1985 Dec 15;34(24):4203-13.
• [2051] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6347).
• [2052] Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochim Biophys Acta. 2011 Dec;1814(12):1947-54.
• [2053] Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol. 2002 Feb 15;168(4):1992-2000.
• [2054] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6485).
• [2055] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5803).
• [2056] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7028).
• [2057] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 514).
• [2058] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1065).
• [2059] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides d... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5775-80.
• [2060] Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor. Biochem Pharmacol. 1995 Mar 15;49(6):791-7.
• [2061] 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. J Med Chem. 1997 Mar 14;40(6):851-7.
• [2062] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1683-6.
• [2063] Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity. Bioorg Med Chem Lett. 2006 Sep 15;16(18):4946-50.
• [2064] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4810).
• [2065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5136).
• [2066] Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity. J Med Chem. 2006 Jun 15;49(12):3563-80.
• [2067] The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6206-9.
• [2068] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4509).
• [2069] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3385).
• [2070] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1441).
• [2071] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2456).
• [2072] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4132).
• [2073] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4025).
• [2074] The apicoplast as an antimalarial drug target. Drug Resist Updat. 2001 Jun;4(3):145-51.
• [2075] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6999).
• [2076] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7994).
• [2077] Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs. J Med Chem. 1993 Mar 19;36(6):750-7.
• [2078] Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. Drug Metab Dispos. 2007 Mar;35(3):493-500.
• [2079] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2364).
• [2080] Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem. 2009 Jun 25;52(12):3597-617.
• [2081] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2760).
• [2082] Effects of steroid D-ring modification on suicide inactivation and competitive inhibition of aromatase by analogues of androsta-1,4-diene-3,17-dione. J Med Chem. 1989 Mar;32(3):651-8.
• [2083] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2761).
• [2084] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 583).
• [2085] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 585).
• [2086] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5368).
• [2087] Isolation and structure of antagonists of chemokine receptor (CCR5). J Nat Prod. 2004 Jun;67(6):1036-8.
• [2088] Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors. Bioorg Med Chem. 2008 Mar 15;16(6):3218-23.
• [2089] Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp]. J Med Chem. 2008 Sep 25;51(18):5866-70.
• [2090] Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells. Bioorg Med Chem Lett. 2003 Jan 6;13(1):83-6.
• [2091] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1189).
• [2092] Anthoptilides A-E, new Briarane diterpenes from the Australian sea pen Anthoptilum cf. kukenthali. J Nat Prod. 2000 Mar;63(3):318-21.
• [2093] Crystal structure of a covalent DNA-drug adduct: anthramycin bound to C-C-A-A-C-G-T-T-G-G and a molecular explanation of specificity. Biochemistry. 1994 Nov 22;33(46):13593-610.
• [2094] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6987).
• [2095] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2628).
• [2096] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1815).
• [2097] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1797).
• [2098] In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8898-902.
• [2099] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1814).
• [2100] Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors. Int J Gynecol Cancer. 2001 Nov-Dec;11(6):454-61.
• [2101] Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob Agents Chemother. 1995 Feb;39(2):325-8.
• [2102] Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes. J Nat Prod. 1995 Oct;58(10):1475-84.
• [2103] The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain. J Biol Chem. 2007 May 4;282(18):13395-401.
• [2104] Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238. Bioorg Med Chem. 2010 Mar 1;18(5):1749-60.
• [2105] Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Bioorg Med Chem Lett. 2008 Jan 1;18(1):423-6.
• [2106] 9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluation. J Med Chem. 2009 Aug 13;52(15):4743-56.
• [2107] Bioisosteric replacement of the alpha-amino carboxylic acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3,4-diamino-3-cyclobut... J Med Chem. 1992 Dec 11;35(25):4720-6.
• [2108] Endothelial nitric oxide synthase: the Cinderella of inflammation Trends Pharmacol Sci. 2003 Feb;24(2):91-5.
• [2109] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4134).
• [2110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5454).
• [2111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5453).
• [2112] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4870).
• [2113] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5139).
• [2114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2311).
• [2115] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 605).
• [2116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4136).
• [2117] Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity. J Nat Prod. 2008 Apr;71(4):713-5.
• [2118] The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. J Med Chem. 2008 Sep 11;51(17):5423-30.
• [2119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 417).
• [2120] Dopamine and sexual function. Int J Impot Res. 2001 Aug;13 Suppl 3:S18-28.
• [2121] The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor. Mol Pharmacol. 1987 Nov;32(5):678-85.
• [2122] Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3853-6.
• [2123] A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest. 2009 May;119(5):1382-95.
• [2124] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5907).
• [2125] Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Curr Top Med Chem. 2004;4(8):805-19.
• [2126] Synthesis and SAR of 2-carboxylic acid indoles as inhibitors of plasminogen activator inhibitor-1. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3514-8.
• [2127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5653).
• [2128] Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection. Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H299-311.
• [2129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7042).
• [2130] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2391).
• [2131] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5142).
• [2132] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 739).
• [2133] Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhi... J Med Chem. 2009 Jan 22;52(2):308-21.
• [2134] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4137).
• [2135] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 295).
• [2136] Conformational comparisons of a series of tachykinin peptide analogs. J Med Chem. 2007 Dec 27;50(26):6501-6.
• [2137] Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasop... J Med Chem. 2007 Feb 22;50(4):835-47.
• [2138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4138).
• [2139] Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase. J Med Chem. 2013 May 9;56(9):3467-77.
• [2140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3384).
• [2141] Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth. Mol Cell Endocrinol. 2004 Feb 12;214(1-2):175-87.
• [2142] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5140).
• [2143] Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional... J Med Chem. 2004 May 6;47(10):2430-40.
• [2144] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1221).
• [2145] Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem. 2000 Nov 17;275(46):36062-6.
• [2146] Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. J Med Chem. 2002 Mar 28;45(7):1460-5.
• [2147] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6302).
• [2148] Cytotoxic and NF-kappaB inhibitory constituents of Artocarpus rigida. J Nat Prod. 2010 May 28;73(5):949-55.
• [2149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2485).
• [2150] The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation. Behav Brain Res. 2008 Dec 16;195(1):112-9.
• [2151] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5997).
• [2152] Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa. Drug Dev Ind Pharm. 2007 Jan;33(1):71-7.
• [2153] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6024).
• [2154] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1754).
• [2155] Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors. Biochem Pharmacol. 2005 Nov 25;70(11):1601-12.
• [2156] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4027).
• [2157] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 438).
• [2158] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3424).
• [2159] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 439).
• [2160] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 440).
• [2161] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 441).
• [2162] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 442).
• [2163] New tyrosinase inhibitors selected by atomic linear indices-based classification models. Bioorg Med Chem Lett. 2006 Jan 15;16(2):324-30.
• [2164] Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest. 2003 Jan;111(1):35-41.
• [2165] Small molecule inhibitors of the RNA-dependent protein kinase. Biochem Biophys Res Commun. 2003 Aug 15;308(1):50-7.
• [2166] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5517).
• [2167] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5518).
• [2168] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5519).
• [2169] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5520).
• [2170] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5524).
• [2171] A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors. Bioorg Med Chem. 2010 Dec 15;18(24):8679-86.
• [2172] Toward developing peptidomimetics: Successful replacement of backbone amide bonds in tetrapeptide-based CCK-A receptor agonists, Bioorg. Med. Chem. Lett. 3(5):855-860 (1993).
• [2173] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3933).
• [2174] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6239).
• [2175] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7369).
• [2176] Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells. Blood. 2008 Dec 15;112(13):5161-70.
• [2177] New chlorinated diphenyl ethers from an Aspergillus species. J Nat Prod. 2002 Jan;65(1):7-10.
• [2178] Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity. J Nat Prod. 1987 Jul-Aug;50(4):680-3.
• [2179] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 925).
• [2180] Silicon switch approach in TRPV1 antagonist MK-056 and its analogues. Bioorg Med Chem. 2010 Jan 1;18(1):111-6.
• [2181] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1304).
• [2182] Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro. J Biol Chem. 1995 Apr 7;270(14):8361-6.
• [2183] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5616).
• [2184] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3383).
• [2185] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4140).
• [2186] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1714).
• [2187] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4141).
• [2188] Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole. J Med Chem. 2009 Dec 24;52(24):7938-41.
• [2189] New dimeric naphthopyrones from Aspergillus niger. J Nat Prod. 2003 Jan;66(1):136-9.
• [2190] Novel approaches to the treatment of thrombosis. Trends Pharmacol Sci. 2002 Jan;23(1):25-32.
• [2191] Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases. Hepatology. 2001 May;33(5):1053-9.
• [2192] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2925).
• [2193] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5579).
• [2194] Company report (Sanofi)
• [2195] Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist. J Med Chem. 2007 Sep 6;50(18):4543-7.
• [2196] Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J Biol Chem. 2007 May 25;282(21):15799-811.
• [2197] 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides. Bioorg Med Chem. 2009 Jul 1;17(13):4833-43.
• [2198] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5143).
• [2199] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4142).
• [2200] The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond). 2007 Mar 16;4:5.
• [2201] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6216).
• [2202] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7725).
• [2203] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7734).
• [2204] Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4232-41.
• [2205] Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity. J Med Chem. 2013 Mar 14;56(5):2125-38.
• [2206] Combining an amyloid-beta (Abeta) cleaving enzyme inhibitor with a gamma-secretase modulator results in an additive reduction of Abeta production. FEBS J. 2015 Jan;282(1):65-73.
• [2207] First and second generation gamma-secretase modulators (GSMs) modulate amyloid-beta (Abeta) peptide production through different mechanisms. J Biol Chem. 2012 Apr 6;287(15):11810-9.
• [2208] Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2. J Biol Chem. 2008 Nov 21;283(47):32334-43.
• [2209] Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase. J Med Chem. 2003 Jul 17;46(15):3412-23.
• [2210] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4143).
• [2211] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8018).
• [2212] Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized deriv... J Med Chem. 2007 May 3;50(9):2067-77.
• [2213] Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1005-8.
• [2214] Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors. J Med Chem. 1993 Nov 26;36(24):3929-36.
• [2215] Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013 Feb;22(2):277-84.
• [2216] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7700).
• [2217] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7706).
• [2218] Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582). J Med Chem. 2013 Dec 27;56(24):9897-919.
• [2219] Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol Cancer Res. 2012 Sep;10(9):1147-57.
• [2220] Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84.
• [2221] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5428).
• [2222] Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5769-73.
• [2223] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6980).
• [2224] Non-peptide macrocyclic histone deacetylase inhibitors. J Med Chem. 2009 Jan 22;52(2):456-68.
• [2225] Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. Bioorg Med Chem Lett. 2008 May 1;18(9):2982-4.
• [2226] Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator. Oncol Rep. 1999 May-Jun;6(3):523-6.
• [2227] The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res. 2007 Jan;31(1):11-8.
• [2228] Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5895-9.
• [2229] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2708).
• [2230] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6188).
• [2231] Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity. Cell Metab. 2010 Feb 3;11(2):101-12.
• [2232] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 795).
• [2233] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7361).
• [2234] Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel. 2003 Sep;6(5):648-57.
• [2235] Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands. J Nat Prod. 2006 Oct;69(10):1421-4.
• [2236] A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors. J Med Chem. 2006 Jun 1;49(11):3278-86.
• [2237] Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1207-11.
• [2238] The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase. FEBS Lett. 1998 Jul 10;431(1):63-5.
• [2239] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2619).
• [2240] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1381).
• [2241] seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties. J Med Chem. 2001 Feb 15;44(4):619-26.
• [2242] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2511).
• [2243] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5147).
• [2244] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5851).
• [2245] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5146).
• [2246] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6196).
• [2247] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3381).
• [2248] Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B. J Med Chem. 2015 Mar 12;58(5):2553-9.
• [2249] Antibacterial activities and characterization of novel inhibitors of LpxC. Antimicrob Agents Chemother. 2002 Jun;46(6):1793-9.
• [2250] Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis. Br J Pharmacol. 1995 Feb;114(4):895-901.
• [2251] Transforming bivalent ligands into retractable enzyme inhibitors through polypeptide-protein interactions. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5120-3.
• [2252] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 897).
• [2253] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6559).
• [2254] Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis. Jpn J Pharmacol. 2002 Nov;90(3):206-9.
• [2255] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4700).
• [2256] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6680).
• [2257] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8438).
• [2258] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5759).
• [2259] Determination of belfosdil, a new calcium channel blocker, in human plasma by capillary gas chromatography with nitrogen-phosphorus detection. J Chromatogr. 1990 May 18;527(2):343-50.
• [2260] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7566).
• [2261] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4145).
• [2262] Ligand-directed tosyl chemistry for protein labeling in vivo. Nat Chem Biol. 2009 May;5(5):341-3.
• [2263] From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells. J Med Chem. 2009 Apr 9;52(7):1853-63.
• [2264] 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors. J Med Chem. 2000 Jun 29;43(13):2514-22.
• [2265] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6920).
• [2266] Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Bioorg Med Chem. 2004 May 15;12(10):2759-72.
• [2267] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8549).
• [2268] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6307).
• [2269] Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6.
• [2270] Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity. J Med Chem. 1994 Jun 24;37(13):2106-11.
• [2271] Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2837-41.
• [2272] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6294).
• [2273] Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1583-6.
• [2274] Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and th... J Med Chem. 1995 Sep 1;38(18):3547-57.
• [2275] Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2. J Med Chem. 2000 Jun 29;43(13):2506-13.
• [2276] Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B. J Med Chem. 2003 Mar 13;46(6):917-20.
• [2277] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4501).
• [2278] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4500).
• [2279] Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit. Bioorg Med Chem. 2007 Jun 1;15(11):3684-91.
• [2280] Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-me... J Med Chem. 2006 Jun 15;49(12):3509-19.
• [2281] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2365).
• [2282] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1593).
• [2283] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3723).
• [2284] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 988).
• [2285] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1631).
• [2286] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4707).
• [2287] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4699).
• [2288] Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):955-77.
• [2289] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2078).
• [2290] Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure. Minerva Cardioangiol. 2001 Dec;49(6):389-94.
• [2291] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7585).
• [2292] Company report of BioMarin
• [2293] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5486).
• [2294] BI-32169, a bicyclic 19-peptide with strong glucagon receptor antagonist activity from Streptomyces sp. J Nat Prod. 2004 Sep;67(9):1528-31.
• [2295] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6695).
• [2296] Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers. Xenobiotica. 2011 Apr;41(4):297-311.
• [2297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1528).
• [2298] Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors. Chem Biol. 2011 Apr 22;18(4):495-507.
• [2299] Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbo... Bioorg Med Chem Lett. 2005 Feb 1;15(3):567-71.
• [2300] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2312).
• [2301] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1547).
• [2302] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6154).
• [2303] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4577).
• [2304] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2366).
• [2305] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2829).
• [2306] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4787).
• [2307] Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction. J Med Chem. 2006 Jul 13;49(14):4048-51.
• [2308] Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modu... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4355-9.
• [2309] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3954).
• [2310] Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors. J Med Chem. 2005 Feb 10;48(3):655-7.
• [2311] Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors. Bioorg Med Chem Lett. 2010 Feb 15;20(4):1415-9.
• [2312] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 892).
• [2313] Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of pyrrolo[3,4-a]carbazole-1,3-diones, pyrrolo[3,4-c]carbazole-1,3... Eur J Med Chem. 2008 Feb;43(2):282-92.
• [2314] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2502).
• [2315] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5193).
• [2316] Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol Sci. 2003 Sep;75(1):40-6.
• [2317] Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem Biophys Res Commun. 2008 Dec 5;377(1):120-5.
• [2318] Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. Bioorg Med Chem Lett. 2012 Jan 1;22(1):738-42.
• [2319] Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta iso... J Med Chem. 2006 Jun 15;49(12):3701-9.
• [2320] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5901).
• [2321] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7030).
• [2322] Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors. J Med Chem. 2009 Jan 8;52(1):170-80.
• [2323] Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of t... J Med Chem. 1998 Dec 17;41(26):5198-218.
• [2324] Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists. Bioorg Med Chem Lett. 2004 Dec 20;14(24):5975-8.
• [2325] Dihydropyridine neuropeptide Y Y(1) receptor antagonists. Bioorg Med Chem Lett. 2002 Feb 11;12(3):379-82.
• [2326] Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3229-33.
• [2327] A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulators. Mol Cancer Ther. 2011 Feb;10(2):242-54.
• [2328] Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6882-9.
• [2329] Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke. Bioorg Med Chem. 2007 Jan 15;15(2):868-85.
• [2330] Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1895-9.
• [2331] Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. J Med Chem. 2005 Jun 2;48(11):3704-13.
• [2332] Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitum... J Med Chem. 2005 Sep 8;48(18):5639-43.
• [2333] N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation. J Med Chem. 2009 May 14;52(9):2794-8.
• [2334] Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]t... Bioorg Med Chem Lett. 2008 May 1;18(9):2985-9.
• [2335] Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol... J Med Chem. 2010 Apr 8;53(7):2854-64.
• [2336] Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors. Bioorg Med Chem Lett. 2008 Jan 15;18(2):749-54.
• [2337] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2653).
• [2338] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6735).
• [2339] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2643).
• [2340] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2651).
• [2341] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2650).
• [2342] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1963).
• [2343] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2070).
• [2344] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2071).
• [2345] Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. Bioorg Med Chem Lett. 2006 Jan 1;16(1):171-5.
• [2346] On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies. J Med Chem. 2005 Dec 1;48(24):7847-59.
• [2347] Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J Med Chem. 2002 Sep 12;45(19):4202-11.
• [2348] Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide ... J Med Chem. 1987 Aug;30(8):1366-73.
• [2349] Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. J Med Chem. 1989 Jun;32(6):1184-90.
• [2350] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8604).
• [2351] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5938).
• [2352] Aporphine metho salts as neuronal nicotinic acetylcholine receptor blockers. Bioorg Med Chem. 2007 May 15;15(10):3368-72.
• [2353] New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte... J Nat Prod. 2001 May;64(5):612-5.
• [2354] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1421).
• [2355] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 616).
• [2356] Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability. Bioorg Med Chem. 2013 Jan 15;21(2):547-52.
• [2357] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4689).
• [2358] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6413).
• [2359] Bornyl (3,4,5-trihydroxy)-cinnamate--an optimized human neutrophil elastase inhibitor designed by free energy calculations. Bioorg Med Chem. 2008 Mar 1;16(5):2385-90.
• [2360] Borrelidin inhibits a cyclin-dependent kinase (CDK), Cdc28/Cln2, of Saccharomyces cerevisiae. J Antibiot (Tokyo). 2001 Jan;54(1):84-90.
• [2361] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3198).
• [2362] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7977).
• [2363] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3188).
• [2364] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7976).
• [2365] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7975).
• [2366] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7978).
• [2367] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3196).
• [2368] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3189).
• [2369] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3121).
• [2370] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3859).
• [2371] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6397).
• [2372] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 680).
• [2373] A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem Biol. 2012 Jul 20;7(7):1152-7.
• [2374] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1603).
• [2375] BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy. Schweiz Med Wochenschr. 1989 Jun 10;119(23):831-4.
• [2376] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 525).
• [2377] Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats. Anesth Analg. 2003 Dec;97(6):1776-83.
• [2378] The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther. 2000 Feb;292(2):803-9.
• [2379] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 10).
• [2380] Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotoni... J Med Chem. 2003 Feb 27;46(5):702-15.
• [2381] 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J Med Chem. 1993 Nov 12;36(23):3707-20.
• [2382] Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue. Arzneimittelforschung. 1988 Apr;38(4):531-6.
• [2383] Non thiazolidinedione antihyperglycaemic agents. 2: alpha-Carbon substituted beta-phenylpropanoic acids1, Bioorg. Med. Chem. Lett. 6(17):2127-2130 (1996).
• [2384] Isosteric replacement of the indole nucleus by benzothiophene in a series of pyrido[2,3-b]indoles with potential anxiolytic activity, Bioorg. Med. Chem. Lett. 5(22):2589-2592 (1995).
• [2385] A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality, Bioorg. Med. Chem. Lett. 2(8):791-796 (1992).
• [2386] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5154).
• [2387] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3927).
• [2388] Histamine in brain--its role in regulation of seizure susceptibility. Epilepsy Res. 1991 Nov-Dec;10(2-3):111-8.
• [2389] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 163).
• [2390] Alpha(2A)-adrenoceptor: G(alphai1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway. Biochem Pharmacol. 2000 Jun 15;59(12):1531-8.
• [2391] DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Blood. 2011 Jun 23;117(25):6912-22.
• [2392] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6293).
• [2393] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4530).
• [2394] Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial ac... Bioorg Med Chem. 2008 Jun 1;16(11):6075-85.
• [2395] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5149).
• [2396] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8234).
• [2397] New estrogenic compounds isolated from Broussonetia kazinoki. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3764-7.
• [2398] Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. Bioorg Med Chem. 2009 Jan 1;17(1):35-41.
• [2399] Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 2009 Jul 1;69(13):5441-9.
• [2400] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 342).
• [2401] Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking. J Med Chem. 2006 Apr 20;49(8):2417-30.
• [2402] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2438).
• [2403] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1219).
• [2404] Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation. J Nat Prod. 1999 Sep;62(9):1241-5.
• [2405] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 144).
• [2406] A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem. 1985 May;28(5):537-45.
• [2407] Leech therapeutic applications.Indian J Pharm Sci.2013 Mar;75(2):127-37.
• [2408] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1229).
• [2409] Flavanones from the stem bark of Erythrina abyssinica. Bioorg Med Chem. 2008 Dec 15;16(24):10356-62.
• [2410] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1059).
• [2411] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1892).
• [2412] The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1990-3.
• [2413] Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pha... J Med Chem. 2000 Jan 13;43(1):114-22.
• [2414] Partial agonistic effects of carteolol on atypical beta-adrenoceptors in the guinea pig gastric fundus. Jpn J Pharmacol. 2000 Nov;84(3):287-92.
• [2415] Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem. 1992 Oct 2;35(20):3705-13.
• [2416] IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007 Nov 16;131(4):669-81.
• [2417] Crystal structure of varicella zoster virus thymidine kinase. J Biol Chem. 2003 Jul 4;278(27):24680-7.
• [2418] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5825).
• [2419] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1878).
• [2420] Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99.
• [2421] Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones. J Med Chem. 2009 May 14;52(9):2694-707.
• [2422] Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Br J Pharmacol. 1988 Jun;94(2):540-6.
• [2423] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6600).
• [2424] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 161).
• [2425] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1899).
• [2426] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1766).
• [2427] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 767).
• [2428] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1767).
• [2429] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8006).
• [2430] Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002 Jun 28;90(12):1243-50.
• [2431] Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. Clin Cancer Res. 2003 Jul;9(7):2711-8.
• [2432] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1757).
• [2433] Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. Bioorg Med Chem. 2012 Mar 15;20(6):1878-86.
• [2434] Multiple N-methylation by a designed approach enhances receptor selectivity. J Med Chem. 2007 Nov 29;50(24):5878-81.
• [2435] Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. J Med Chem. 2006 Jun 1;49(11):3416-20.
• [2436] Design of cyclic peptides with agonist activity at melanocortin receptor-4. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3723-6.
• [2437] Incorporation of the unusual C(alpha)-fluoroalkylamino acids into cyclopeptides: synthesis of arginine-glycine-aspartate (RGD) analogues and study ... J Med Chem. 2006 Mar 9;49(5):1808-17.
• [2438] Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines. Bioorg Med Chem. 2008 Jul 15;16(14):7021-32.
• [2439] Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders. J Med Chem. 2005 Dec 1;48(24):7675-87.
• [2440] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5496).
• [2441] Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia. J Med Chem. 2002 Jan 31;45(3):703-12.
• [2442] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1291).
• [2443] Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov Today. 2014 May;19(5):654-60.
• [2444] Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4291-5.
• [2445] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7634).
• [2446] Sulfur mustard-stimulated protease: a target for antivesicant drugs. J Appl Toxicol. 2002 Mar-Apr;22(2):139-40.
• [2447] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6532).
• [2448] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4148).
• [2449] A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration... J Nat Prod. 1998 Jul;61(7):931-5.
• [2450] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2445).
• [2451] Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury. Br J Pharmacol. 2002 Jun;136(3):353-60.
• [2452] Phenylethanoid glycosides from Digitalis purpurea and Penstemon linarioides with PKCalpha-inhibitory activity. J Nat Prod. 1998 Nov;61(11):1410-2.
• [2453] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2786).
• [2454] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 714).
• [2455] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 719).
• [2456] Prenylated pterocarpans as bacterial neuraminidase inhibitors. Bioorg Med Chem. 2010 May 1;18(9):3335-44.
• [2457] Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 2003 May;42(2):169-85.
• [2458] MR appearance of intra-abdominal metastatic melanoma. Magn Reson Imaging. 1992;10(4):705-8.
• [2459] Involvement of K(+)-Cl(-)-cotransport in the apoptosis induced by N-ethylmaleimide in HepG2 human hepatoblastoma cells. Eur J Pharmacol. 2001 Apr 20;418(1-2):1-5.
• [2460] Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86.
• [2461] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5157).
• [2462] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 740).
• [2463] Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem. 2002 Mar 14;45(6):1151-75.
• [2464] Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inne... J Med Chem. 2008 Nov 27;51(22):7308-12.
• [2465] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4585).
• [2466] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2461).
• [2467] Muscarinic receptor binding profile of para-substituted caramiphen analogues. J Med Chem. 1991 Oct;34(10):2984-9.
• [2468] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 569).
• [2469] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1893).
• [2470] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral dru... Bioorg Med Chem Lett. 2004 Dec 6;14(23):5763-7.
• [2471] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4151).
• [2472] Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics. J Med Chem. 2005 Aug 11;48(16):5175-90.
• [2473] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1970).
• [2474] Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. Mol Pharmacol. 1987 Aug;32(1):286-92.
• [2475] Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types ... Bioorg Med Chem Lett. 2003 Nov 17;13(22):4089-92.
• [2476] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4572).
• [2477] Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors. J Med Chem. 2007 Nov 1;50(22):5528-32.
• [2478] Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3105-10.
• [2479] Carinatumins A-C, new alkaloids from Lycopodium carinatum inhibiting acetylcholinesterase. Bioorg Med Chem. 2007 Feb 15;15(4):1703-7.
• [2480] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4559).
• [2481] Enzymatic characterization of scytalone dehydratase Val75Met variant found in melanin biosynthesis dehydratase inhibitor (MBI-D) resistant strains of the rice blast fungus. Biosci Biotechnol Biochem.2004 Mar;68(3):615-21.
• [2482] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction. J Med Chem. 2001 Mar 29;44(7):1025-7.
• [2483] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2497).
• [2484] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6417).
• [2485] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8635).
• [2486] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6487).
• [2487] Two novel aromatic valerenane-type sesquiterpenes from the Chinese green alga Caulerpa taxifolia. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2947-50.
• [2488] Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem. 2005 Jul 1;280(26):24816-23.
• [2489] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8245).
• [2490] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4593).
• [2491] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3372).
• [2492] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4152).
• [2493] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7778).
• [2494] Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels. J Biol Chem. 2007 Oct 19;282(42):30699-706.
• [2495] Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423. Bioorg Med Chem Lett. 2010 Jan 15;20(2):665-72.
• [2496] CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007 Aug;6(8):2249-60.
• [2497] Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3826-32.
• [2498] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7784).
• [2499] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 860).
• [2500] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5161).
• [2501] Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. J Med Chem. 2012 Nov 26;55(22):10229-40.
• [2502] Actions of a new Ca2+ channel antagonist, CD832, on two types of Ca2+ channels in smooth muscle. Eur J Pharmacol. 1994 Feb 11;252(3):267-74.
• [2503] Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res. 2001 Mar;7(3):691-703.
• [2504] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2654).
• [2505] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2810).
• [2506] Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120. J Acquir Immune Defic Syndr. 1990;3(11):1041-5.
• [2507] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2652).
• [2508] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5162).
• [2509] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2717).
• [2510] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5944).
• [2511] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5946).
• [2512] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5952).
• [2513] Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol. 1998 Feb;53(6):389-404.
• [2514] Structure-activity requirements for flavone cytotoxicity and binding to tubulin. J Med Chem. 1998 Jun 18;41(13):2333-8.
• [2515] Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-linea... J Med Chem. 2008 Sep 25;51(18):5680-9.
• [2516] Novel poly(ADP-ribose) polymerase-1 inhibitors. Bioorg Med Chem Lett. 2007 Jan 15;17(2):542-5.
• [2517] Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.
• [2518] The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors. Bioorg Med Chem. 2008 Jul 15;16(14):6689-95.
• [2519] Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nocic... J Med Chem. 2001 Nov 8;44(23):4015-8.
• [2520] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6340).
• [2521] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6341).
• [2522] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4153).
• [2523] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5929).
• [2524] Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept fo... J Med Chem. 2002 Feb 28;45(5):1108-21.
• [2525] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 541).
• [2526] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2005).
• [2527] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1086).
• [2528] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1066).
• [2529] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1090).
• [2530] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1088).
• [2531] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1071).
• [2532] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3429).
• [2533] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1073).
• [2534] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1074).
• [2535] A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone. 1999 May;24(5):437-49.
• [2536] Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2920-3.
• [2537] Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists. Am J Physiol. 1999 Oct;277(4 Pt 1):G867-74.
• [2538] Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
• [2539] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6010).
• [2540] A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lun... Mol Pharmacol. 2000 Jun;57(6):1182-9.
• [2541] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4079).
• [2542] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5945).
• [2543] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 424).
• [2544] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 418).
• [2545] The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system. Expert Opin Investig Drugs. 2002 Nov;11(11):1537-52.
• [2546] Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones. J Med Chem. 1991 Jan;34(1):281-90.
• [2547] Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an exp... Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):470-4.
• [2548] Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11, Bioorg. Med. Chem. Lett. 7(8):1059-1064 (1997).
• [2549] Molecular mechanism of pharmacological activation of BK channels
• [2550] 1,3-Diarylpyrazolo[4,5-c]- and -[5,4-c]quinolin-4-ones. 4. Synthesis and specific inhibition of benzodiazepine receptor binding. J Med Chem. 1987 Oct;30(10):1737-42.
• [2551] Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol. 2004 Jan;135(1):146-53.
• [2552] Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. Nat Chem Biol. 2013 Mar;9(3):136-7.
• [2553] Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem. 2009 May 14;52(9):2818-24.
• [2554] Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009 Jul 30;124(3):506-12.
• [2555] Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor. Br J Pharmacol. 2004 Jul;142(6):1015-9.
• [2556] P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets. 2000 Jul;1(1):85-99.
• [2557] Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. J Med Chem. 2005 Feb 24;48(4):986-94.
• [2558] A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14047-52.
• [2559] Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes. 1999 Aug;48(8):1662-6.
• [2560] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5954).
• [2561] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2831).
• [2562] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4158).
• [2563] Chlorocyclinones A-D, chlorinated angucyclinones from Streptomyces sp. strongly antagonizing rosiglitazone-induced PPAR-gamma activation. J Nat Prod. 2007 Dec;70(12):1934-8.
• [2564] From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5429-32.
• [2565] Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes. Mol Pharmacol. 1993 Dec;44(6):1165-70.
• [2566] Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med Chem. 1997 Jan 17;40(2):137-45.
• [2567] Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1128-33.
• [2568] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6292).
• [2569] Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpy... Bioorg Med Chem Lett. 2006 Feb;16(3):622-7.
• [2570] Synthesis of new camptothecin analogs with improved antitumor activities. Bioorg Med Chem Lett. 2009 Apr 1;19(7):2018-21.
• [2571] 5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectiv... J Med Chem. 2004 Oct 7;47(21):5318-29.
• [2572] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2802).
• [2573] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2718).
• [2574] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4551).
• [2575] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1417).
• [2576] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 664).
• [2577] Evans Blue and other dyes as protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1923-6.
• [2578] Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J Med Chem. 2006 Oct 5;49(20):6111-9.
• [2579] Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitors. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3431-4.
• [2580] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 872).
• [2581] Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits. J Cardiovasc Pharmacol. 2000 May;35(5):796-805.
• [2582] Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indol... J Med Chem. 2000 Dec 14;43(25):4850-67.
• [2583] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1739).
• [2584] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1917).
• [2585] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 552).
• [2586] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5564).
• [2587] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6577).
• [2588] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8579).
• [2589] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5563).
• [2590] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5565).
• [2591] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7780).
• [2592] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5167).
• [2593] Central serotonin receptors as targets for drug research. J Med Chem. 1987 Jan;30(1):1-12.
• [2594] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2423).
• [2595] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3203).
• [2596] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 515).
• [2597] Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis. J Nat Prod. 1997 Jun;60(6):638-41.
• [2598] Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases... Bioorg Med Chem. 2008 Aug 1;16(15):7148-66.
• [2599] Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic mat... J Med Chem. 2008 Mar 13;51(5):1406-14.
• [2600] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4096).
• [2601] Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). Bioorg Med Chem Lett. 2008 Jul 15;18(14):4224-7.
• [2602] GABA uptake inhibitors. Synthesis and effects on audiogenic seizures of ester prodrugs of nipecotic acid, guvacine and cis-4-hydroxynipecotic acid. Drug Des Deliv. 1987 Sep;2(1):9-21.
• [2603] Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis. J Med Chem. 2007 Jun 28;50(13):3138-42.
• [2604] Multiple forms of "kiss-and-run" exocytosis revealed by evanescent wave microscopy. Curr Biol. 2003 Apr 1;13(7):563-7.
• [2605] Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5244-8.
• [2606] DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+. Mol Pharmacol. 1998 May;53(5):846-55.
• [2607] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2758).
• [2608] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6327).
• [2609] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2478).
• [2610] Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res. 2002;139:197-210.
• [2611] Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB... J Med Chem. 2006 Feb 23;49(4):1475-85.
• [2612] The development of N-alpha-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-alpha-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors. J Med Chem. 2011 Oct 13;54(19):6919-35.
• [2613] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5170).
• [2614] Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase. J Med Chem. 1998 Nov 5;41(23):4492-501.
• [2615] Triterpene saponins from clematis mandshurica. J Nat Prod. 2006 Nov;69(11):1591-5.
• [2616] Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest. 2002 Aug;110(3):361-9.
• [2617] Matrix metalloproteinase-2 inhibitors from Clinopodium chinense var. parviflorum. J Nat Prod. 2009 Aug;72(8):1379-84.
• [2618] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1223).
• [2619] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2507).
• [2620] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1894).
• [2621] The high-resolution crystal structure of a 24-kDa gyrase B fragment from E.coli complexed with one of the most potent coumarin inhibitors, clorobiocin. Proteins. 1997 May;28(1):41-52.
• [2622] Modes of action of anthelmintic drugs. Vet J. 1997 Jul;154(1):11-34.
• [2623] Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002 Sep;27(5):788-98.
• [2624] proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke. J Thromb Haemost. 2013 Aug;11(8):1464-73.
• [2625] Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol. 2002 Nov;62(5):1084-93.
• [2626] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5992).
• [2627] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4663).
• [2628] Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015 Apr 16;125(16):2530-43.
• [2629] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6009).
• [2630] Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5605-9.
• [2631] Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis. J Nat Prod. 2007 Oct;70(10):1570-7.
• [2632] Cochliobolic acid, a novel metabolite produced by Cochliobolus lunatus, inhibits binding of TGF-alpha to the EGF receptor in a SPA assay. J Nat Prod. 1997 Jan;60(1):6-8.
• [2633] Live cell monitoring of mu-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors. J Biol Chem. 2007 Sep 14;282(37):27126-32.
• [2634] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3044).
• [2635] Mechanisms of cell death induced by 2-chloroadenosine in leukemic B-cells. Biochem Pharmacol. 2008 Apr 1;75(7):1451-60.
• [2636] Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5154-9.
• [2637] Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. Bioorg Med Chem Lett. 1998 Aug 4;8(15):1997-2000.
• [2638] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4161).
• [2639] Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors. J Biol Chem. 2007 Dec 21;282(51):36905-13.
• [2640] Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain. 2003 Jan;101(1-2):109-16.
• [2641] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2743).
• [2642] IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study. J Immune Based Ther Vaccines. 2007 Mar 29;5:5.
• [2643] Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res. 1990 Dec 24;537(1-2):256-62.
• [2644] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2715).
• [2645] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2463).
• [2646] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4630).
• [2647] Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6185-7.
• [2648] Potent Kv1.3 inhibitors from correolide-modification of the C18 position. Bioorg Med Chem Lett. 2005 Jan 17;15(2):447-51.
• [2649] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2555).
• [2650] Corymbones A and B, phloroglucinols with thyrotropin releasing hormone receptor 2 binding affinity from the flowers of Corymbia peltata. J Nat Prod. 2008 May;71(5):881-3.
• [2651] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5345).
• [2652] Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds. Bioorg Med Chem Lett. 2001 Jan 8;11(1):59-62.
• [2653] A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chem Biol Interact. 2004 Jan 15;147(1):79-86.
• [2654] Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones. Antimicrob Agents Chemother. 1989 May;33(5):705-9.
• [2655] Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem. 1989 May 5;264(13):7405-11.
• [2656] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 11).
• [2657] PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor. Synapse. 2002 Jul;45(1):1-9.
• [2658] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 973).
• [2659] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3058).
• [2660] Direct renin inhibitors as a new therapy for hypertension. J Med Chem. 2010 Nov 11;53(21):7490-520.
• [2661] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2558).
• [2662] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3496).
• [2663] Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists. J Med Chem. 2002 Jun 6;45(12):2417-24.
• [2664] Synthesis and pharmacology of 1-methoxy analogs of CP-47,497. Bioorg Med Chem. 2010 Aug 1;18(15):5475-82.
• [2665] Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. FASEB J. 2003 Dec;17(15):2331-3.
• [2666] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3497).
• [2667] Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2383-8.
• [2668] Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 2005 Feb 1;65(3):957-66.
• [2669] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6691).
• [2670] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3221).
• [2671] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2102).
• [2672] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5568).
• [2673] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5570).
• [2674] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5598).
• [2675] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4039).
• [2676] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1382).
• [2677] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5603).
• [2678] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7513).
• [2679] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1413).
• [2680] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1423).
• [2681] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6416).
• [2682] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6369).
• [2683] Biological properties of (R)-4-benzamido-5-oxopentanoic basic derivatives as CCK-antagonists, Bioorg. Med. Chem. Lett. 3(5):861-866 (1993).
• [2684] Cremastrine, a pyrrolizidine alkaloid from Cremastra appendiculata. J Nat Prod. 2005 Apr;68(4):572-3.
• [2685] Antityrosinase principles and constituents of the petals of Crocus sativus. J Nat Prod. 2004 Mar;67(3):437-40.
• [2686] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6288).
• [2687] The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5350-4.
• [2688] Cryptadines A and B, novel C27N3-type pentacyclic alkaloids from Lycopodium cryptomerinum. Bioorg Med Chem. 2007 Dec 15;15(24):7803-8.
• [2689] Discovery of potent and bioavailable GSK-3beta inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1693-6.
• [2690] Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin. J Neuroimmunol. 2002 Oct;131(1-2):147-59.
• [2691] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1635).
• [2692] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1674).
• [2693] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1741).
• [2694] Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clin Cancer Res. 2002 May;8(5):1280-7.
• [2695] Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata. Bioorg Med Chem. 2009 Apr 1;17(7):2744-50.
• [2696] Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisoste... J Med Chem. 1996 Dec 20;39(26):5228-35.
• [2697] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 419).
• [2698] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 420).
• [2699] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6079).
• [2700] Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity. J Med Chem. 1989 Oct;32(10):2399-406.
• [2701] Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Int. 1991 May;39(5):920-9.
• [2702] Design and construction of novel thrombin inhibitors featuring P3-P4 quaternary lactam dipeptide surrogates. Bioorg Med Chem Lett. 1998 Sep 22;8(18):2501-6.
• [2703] Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates. Bioorg Med Chem Lett. 2002 Apr 22;12(8):1203-8.
• [2704] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5948).
• [2705] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7663).
• [2706] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8598).
• [2707] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 84).
• [2708] Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I. Bioorg Med Chem. 2010 Oct 1;18(19):7029-33.
• [2709] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 132).
• [2710] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2368).
• [2711] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1604).
• [2712] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 486).
• [2713] cCMP and cUMP: emerging second messengers. Trends Biochem Sci. 2015 Jan;40(1):8-15.
• [2714] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2347).
• [2715] Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone... J Med Chem. 2007 Jan 25;50(2):192-8.
• [2716] Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4124-9.
• [2717] Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. Bioorg Med Chem. 2007 Dec 15;15(24):7830-9.
• [2718] Design of beta-hairpin peptides for modulation of cell adhesion by beta-turn constraint. J Med Chem. 2009 Feb 12;52(3):726-36.
• [2719] Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation. J Med Chem. 2005 Oct 6;48(20):6236-49.
• [2720] Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem. 2006 Apr 6;49(7):2268-75.
• [2721] Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues. J Med Chem. 2008 Mar 27;51(6):1771-82.
• [2722] High affinity conformationally constrained nociceptin/orphanin FQ(1-13) amide analogues. J Med Chem. 2008 Aug 14;51(15):4385-7.
• [2723] Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents. J Antimicrob Chemother. 2004 Jul;54(1):56-9.
• [2724] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5433).
• [2725] Reversine and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem. 2005 Jul 28;48(15):4910-8.
• [2726] Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. J Med Chem. 2003 Apr 10;46(8):1538-45.
• [2727] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5507).
• [2728] 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioava... J Med Chem. 2006 Jan 12;49(1):373-80.
• [2729] Effects of D-cycloserine and cycloleucine, ligands for the NMDA-associated strychnine-insensitive glycine site, on brain-stimulation reward and spontaneous locomotion. Pharmacol Biochem Behav. 1990 Aug;36(4):735-8.
• [2730] Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signali... Bioorg Med Chem Lett. 2009 Jan 15;19(2):328-31.
• [2731] Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Res. 1993 Sep;22(1):45-75.
• [2732] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5350).
• [2733] Three new cyclostellettamines, which inhibit histone deacetylase, from a marine sponge of the genus Xestospongia. Bioorg Med Chem Lett. 2004 May 17;14(10):2617-20.
• [2734] Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge. J Nat Prod. 2002 Mar;65(3):259-61.
• [2735] Cylindol A, a novel biphenyl ether with 5-lipoxygenase inhibitory activity, and a related compound from Imperata Cylindrica. J Nat Prod. 1994 Sep;57(9):1290-3.
• [2736] Comments on: cylopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy. A.C. Verschuur et al. Eur J Cancer 2000, 36, 627-635. Eur J Cancer. 2001 Jan;37(2):290.
• [2737] GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15229-34.
• [2738] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2927).
• [2739] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2928).
• [2740] Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4563-7.
• [2741] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2323).
• [2742] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6257).
• [2743] Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonis... J Med Chem. 2004 Jun 3;47(12):3242-7.
• [2744] The gamma-glutamylcysteine synthetase of Onchocerca volvulus. Mol Biochem Parasitol. 2000 Dec;111(2):243-51.
• [2745] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5173).
• [2746] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4728).
• [2747] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8490).
• [2748] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5424).
• [2749] An adjustable release rate linking strategy for cytotoxin-peptide conjugates. Bioorg Med Chem Lett. 2003 Mar 10;13(5):799-803.
• [2750] A selective inhibitor reveals PI3Kgamma dependence of T(H)17 cell differentiation. Nat Chem Biol. 2012 Apr 29;8(6):576-82.
• [2751] Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo acti... J Med Chem. 2008 May 8;51(9):2758-65.
• [2752] Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 ... J Med Chem. 2008 Jan 24;51(2):187-95.
• [2753] Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor. J Med Chem. 2007 Oct 18;50(21):5135-46.
• [2754] Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities. J Med Chem. 2006 Mar 23;49(6):1946-52.
• [2755] Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. Bioorg Med Chem. 2009 Feb 15;17(4):1542-9.
• [2756] Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for... J Med Chem. 2006 Feb 9;49(3):911-22.
• [2757] Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist. J Med Chem. 2010 Jun 10;53(11):4428-40.
• [2758] A new beta 2-adrenoceptor agonist--D 2343--with long duration. Inhalation comparison with terbutaline in asthmatics. Allergy. 1984 Aug;39(6):485-9.
• [2759] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2236).
• [2760] Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors. J Med Chem. 2002 Jun 6;45(12):2579-88.
• [2761] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2223).
• [2762] Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an ex... Bioorg Med Chem. 2008 Mar 15;16(6):2769-78.
• [2763] Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly... J Med Chem. 2008 May 22;51(10):3005-19.
• [2764] Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding character... J Med Chem. 2008 Dec 25;51(24):7806-19.
• [2765] Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-... Bioorg Med Chem. 2009 Jun 1;17(11):3923-33.
• [2766] Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template... Bioorg Med Chem. 2010 Aug 1;18(15):5661-74.
• [2767] Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a... J Med Chem. 2010 Feb 11;53(3):1023-37.
• [2768] Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase. J Med Chem. 2002 Feb 28;45(5):1002-18.
• [2769] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4678).
• [2770] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1443).
• [2771] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4168).
• [2772] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4680).
• [2773] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4651).
• [2774] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4698).
• [2775] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4170).
• [2776] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4683).
• [2777] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4537).
• [2778] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4722).
• [2779] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4536).
• [2780] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4708).
• [2781] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4679).
• [2782] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5799).
• [2783] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2934).
• [2784] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4681).
• [2785] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4650).
• [2786] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4682).
• [2787] Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic ap... J Med Chem. 2006 Jul 27;49(15):4745-61.
• [2788] Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J Med Chem. 1986 Nov;29(11):2370-5.
• [2789] Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from ... J Med Chem. 2005 Oct 20;48(21):6643-52.
• [2790] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5797).
• [2791] Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors. J Med Chem. 2008 Jun 12;51(11):3077-80.
• [2792] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4676).
• [2793] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5798).
• [2794] Synthesis and characterization of constrained peptidomimetic dipeptidyl peptidase IV inhibitors: amino-lactam boroalanines. J Med Chem. 2007 May 17;50(10):2391-8.
• [2795] Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. J Exp Med. 1996 Aug 1;184(2):725-33.
• [2796] Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice. Eur J Immunol. 1992 Mar;22(3):697-702.
• [2797] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2577).
• [2798] 1,4-Diazabicyclo[2.2.2]octane derivatives: a novel class of voltage-gated potassium channel blockers. Mol Pharmacol. 2006 Mar;69(3):718-26.
• [2799] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1607).
• [2800] The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res. 2004 May;19(5):853-61.
• [2801] Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol Pharm Bull. 2002 Nov;25(11):1442-5.
• [2802] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1647).
• [2803] Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. J Med Chem. 2012 Jul 26;55(14):6639-43.
• [2804] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1760).
• [2805] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1715).
• [2806] Synthesis, absolute configuration, conformational analysis and binding affinity properties of enantiomeric forms of DAU 5750, a novel M1-M3 muscari... Bioorg Med Chem. 1994 Dec;2(12):1375-83.
• [2807] Doi: 10.1038/bjp.2008.208
• [2808] Characterization of muscarinic receptors in guinea-pig uterus. Eur J Pharmacol. 1993 Dec 7;250(2):223-30.
• [2809] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2324).
• [2810] Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4338-42.
• [2811] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4173).
• [2812] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1377).
• [2813] Replacement of the N-terminal tyrosine residue in opioid peptides with 3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid (Dcp) results in novel opio... J Med Chem. 2006 Aug 24;49(17):5382-5.
• [2814] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4174).
• [2815] Acylphloroglucinol derivatives from Mahurea palustris. J Nat Prod. 2005 Jul;68(7):979-84.
• [2816] Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membe... Bioorg Med Chem. 2010 Nov 15;18(22):7794-8.
• [2817] Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine. Bioorg Med Chem Lett. 2004 Aug 16;14(16):4319-21.
• [2818] Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-bi... J Med Chem. 2009 Oct 8;52(19):5990-8.
• [2819] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5532).
• [2820] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2459).
• [2821] High-level production from a baculovirus expression system and biochemical characterization of human GMP synthetase. Protein Expr Purif. 1995 Aug;6(4):487-95.
• [2822] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4030).
• [2823] Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am J Physiol Renal Physiol. 2009 Jun;296(6):F1307-13.
• [2824] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4733).
• [2825] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5577).
• [2826] Alkamides from the fruits of Piper longum and Piper nigrum displaying potent cell adhesion inhibition. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4544-6.
• [2827] Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands. J Med Chem. 2008 Oct 23;51(20):6393-9.
• [2828] 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Toxicol Lett. 2006 Aug 20;165(2):149-55.
• [2829] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1876).
• [2830] Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptors. J Med Chem. 1994 Jan 7;37(1):146-50.
• [2831] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1615).
• [2832] Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammator... Bioorg Med Chem Lett. 2005 Apr 1;15(7):1793-7.
• [2833] Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica. J Nat Prod. 2001 Oct;64(10):1294-6.
• [2834] Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc. J Med Chem. 2006 Jul 27;49(15):4767-76.
• [2835] Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18). Bioorg Med Chem Lett. 2006 Sep 1;16(17):4679-85.
• [2836] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2871).
• [2837] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3450).
• [2838] The effect of deprenyl washout in patients with long-standing Parkinson's disease. J Neural Transm. 2002 May;109(5-6):797-803.
• [2839] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 445).
• [2840] Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). J Med Chem. 2005 Dec 29;48(26):8112-4.
• [2841] Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides. J Med Chem. 2005 Jan 27;48(2):515-22.
• [2842] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2009).
• [2843] Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan. J Med Chem. 2005 Jan 27;48(2):507-14.
• [2844] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2012).
• [2845] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 644).
• [2846] Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6045-8.
• [2847] Aplysamine-1 and related analogs as histamine H3 receptor antagonists. Bioorg Med Chem Lett. 2006 Feb 15;16(4):897-900.
• [2848] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1150).
• [2849] Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci. 2002 Sep;23(9):417-25.
• [2850] Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for ... J Med Chem. 2009 Mar 12;52(5):1408-15.
• [2851] New antithrombotic drugs (excluding plasminogen activators. Arch Mal Coeur Vaiss. 2001 Nov;94(11 Suppl):1225-32.
• [2852] Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2773-5.
• [2853] Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds Eur J Pharmacol. 1999 Aug 6;378(2):161-8.
• [2854] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2748).
• [2855] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3725).
• [2856] Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix). J Clin Endocrinol Metab. 1991 Apr;72(4):927-33.
• [2857] Thyroid receptor ligands. Part 5: novel bicyclic agonist ligands selective for the thyroid hormone receptor beta. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1240-4.
• [2858] Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias. Exp Neurol. 2010 Oct;225(2):408-15.
• [2859] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3023).
• [2860] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3366).
• [2861] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4006).
• [2862] Defining GC-specificity in the minor groove: side-by-side binding of the di-imidazole lexitropsin to C-A-T-G-G-C-C-A-T-G. Structure. 1997 Aug 15;5(8):1033-46.
• [2863] Endiandrin A, a potent glucocorticoid receptor binder isolated from the Australian plant Endiandra anthropophagorum. J Nat Prod. 2007 Jul;70(7):1118-21.
• [2864] Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. Eur J Immunol. 1997 Sep;27(9):2172-9.
• [2865] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5830).
• [2866] Reactions of glutamate 1-semialdehyde aminomutase with R- and S-enantiomers of a novel, mechanism-based inhibitor, 2,3-diaminopropyl sulfate. Biochemistry. 2000 Mar 21;39(11):3091-6.
• [2867] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2825).
• [2868] Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydroc... J Med Chem. 2007 Feb 22;50(4):794-806.
• [2869] Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry. 2001 Dec 25;40(51):15612-23.
• [2870] Antilipemic drug-induced skin manifestations. Hautarzt. 1995 Feb;46(2):76-80.
• [2871] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4176).
• [2872] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6472).
• [2873] Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5528-30.
• [2874] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6295).
• [2875] Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity. J Biol Chem. 2002 Nov 1;277(44):41827-34.
• [2876] The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists. J Med Chem. 1994 May 13;37(10):1518-25.
• [2877] Asymmetric synthesis of inhibitors of glycinamide ribonucleotide transformylase. J Med Chem. 2008 Sep 11;51(17):5441-8.
• [2878] N10-substituted 5,8-dideazafolate inhibitors of glycinamide ribonucleotide transformylase. J Med Chem. 1987 Jul;30(7):1254-6.
• [2879] Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5415-9.
• [2880] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4177).
• [2881] Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase. J Med Chem. 2007 Jan 25;50(2):186-91.
• [2882] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7776).
• [2883] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3187).
• [2884] 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity r... J Med Chem. 2000 Jun 15;43(12):2332-49.
• [2885] Design, synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C. J Med Chem. 2009 Jul 9;52(13):3969-81.
• [2886] In silico search for multi-target anti-inflammatories in Chinese herbs and formulas. Bioorg Med Chem. 2010 Mar 15;18(6):2204-2218.
• [2887] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6415).
• [2888] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 282).
• [2889] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4571).
• [2890] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6738).
• [2891] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1616).
• [2892] Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review). Int J Mol Med. 1999 May;3(5):455-66.
• [2893] Synthesis and biological activity of trans-2,3-dihydroraloxifene. Bioorg Med Chem Lett. 1999 Apr 19;9(8):1137-40.
• [2894] 4-Hydroxyphenylpyruvate dioxygenase as a drug discovery target. Drug News Perspect. 2003 Oct;16(8):493-6.
• [2895] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4717).
• [2896] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1248).
• [2897] Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles. Bioorg Med Chem Lett. 2010 Jan 1;20(1):78-82.
• [2898] Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation. J Neurochem. 2008 Jan;104(2):558-72.
• [2899] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3049).
• [2900] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5177).
• [2901] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5523).
• [2902] Liver disease associated with occupational exposure to the solvent dimethylformamide. Ann Intern Med. 1988 May;108(5):680-6.
• [2903] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1203).
• [2904] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4589).
• [2905] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2916).
• [2906] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5512).
• [2907] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4182).
• [2908] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2494).
• [2909] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7802).
• [2910] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2498).
• [2911] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3206).
• [2912] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3151).
• [2913] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1617).
• [2914] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 122).
• [2915] Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Bioorg Med Chem Lett. 2008 Jan 15;18(2):479-84.
• [2916] In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlota... Bioorg Med Chem Lett. 2007 Apr 1;17(7):1996-9.
• [2917] Development of distamycin-related DNA binding anticancer drugs. Expert Opin Investig Drugs. 2001 Sep;10(9):1703-14.
• [2918] Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). J Med Chem. 2003 Jul 3;46(14):2795-812.
• [2919] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6124).
• [2920] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4631).
• [2921] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4497).
• [2922] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1839).
• [2923] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 267).
• [2924] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1383).
• [2925] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4179).
• [2926] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3967).
• [2927] Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mi... J Med Chem. 2007 Jun 14;50(12):2753-66.
• [2928] Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D... J Med Chem. 2007 Feb 8;50(3):512-20.
• [2929] Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1350-3.
• [2930] Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antago... J Med Chem. 1991 Apr;34(4):1243-52.
• [2931] Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J Nat Prod. 2006 Apr;69(4):700-3.
• [2932] Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. J Nat Prod. 2007 Jun;70(6):1010-5.
• [2933] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6990).
• [2934] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4031).
• [2935] A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Genet. 2007 Mar;80(3):433-40.
• [2936] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 164).
• [2937] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4181).
• [2938] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4907).
• [2939] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5538).
• [2940] Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells. J Med Chem. 2004 Feb 26;47(5):1193-206.
• [2941] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1608).
• [2942] Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol. 2011 Nov;80(5):782-95.
• [2943] Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. J Med Chem. 1999 Feb 25;42(4):533-5.
• [2944] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2671).
• [2945] Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligands. Mol Cancer Ther. 2010 Jan;9(1):246-56.
• [2946] Discovery of a Subnanomolar helical D-tridecapeptide inhibitor of gamma-secretase. J Med Chem. 2004 Jul 29;47(16):3931-3.
• [2947] FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. J Biol Chem. 1993 May 25;268(15):11335-9.
• [2948] PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer. Cancer Res. 2014 Oct 1;74(19):5656-67.
• [2949] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4183).
• [2950] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4184).
• [2951] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1609).
• [2952] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3873).
• [2953] A new ditriazine inhibitor of NF-kappaB modulates chronic inflammation and angiogenesis. Naunyn Schmiedebergs Arch Pharmacol. 2002 May;365(5):357-64.
• [2954] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7635).
• [2955] Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol Ther. 1999 Sep;83(3):181-215.
• [2956] Durhamycin A, a potent inhibitor of HIV Tat transactivation. J Nat Prod. 2002 Aug;65(8):1091-5.
• [2957] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2183).
• [2958] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2834).
• [2959] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1622).
• [2960] Peptides as receptor selectivity modulators of opiate pharmacophores. J Med Chem. 1986 Jul;29(7):1222-5.
• [2961] Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg Med Chem. 2007 Nov 15;15(22):6900-8.
• [2962] A novel sesquiterpene quinone from Hainan sponge Dysidea villosa. Bioorg Med Chem Lett. 2009 Jan 15;19(2):390-2.
• [2963] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4185).
• [2964] 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Commun. 1986 Mar 13;135(2):688-94.
• [2965] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2186).
• [2966] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2187).
• [2967] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2184).
• [2968] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2189).
• [2969] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2191).
• [2970] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2190).
• [2971] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2225).
• [2972] E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-o ne tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor.Eur J Pharmacol.2006 Oct 24;548(1-3):181-7.
• [2973] Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa. Bioorg Med Chem Lett. 2010 Jan 15;20(2):513-5.
• [2974] Baculoviral expression and characterization of rodent cathepsin S. Protein Expr Purif. 2001 Oct;23(1):45-54.
• [2975] Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor. Microbiol Immunol. 1998;42(3):195-202.
• [2976] Synthesis and biological activity of isopentenyl diphosphate analogues. Bioorg Med Chem. 2004 Feb 15;12(4):763-70.
• [2977] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6187).
• [2978] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3929).
• [2979] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3104).
• [2980] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3217).
• [2981] Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. 2005 May;4(5):421-40.
• [2982] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2314).
• [2983] Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.Transl Res.2008 Feb;151(2):68-78.
• [2984] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6262).
• [2985] Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans. 2000;28(4):435-40.
• [2986] Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitors. J Med Chem. 2009 Feb 26;52(4):1156-71.
• [2987] Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer. 2003 Feb 20;103(5):587-99.
• [2988] Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity. Biochem J. 2006 Apr 15;395(2):443-8.
• [2989] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 12).
• [2990] Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders Trends Pharmacol Sci. 2003 Feb;24(2):49-52.
• [2991] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7774).
• [2992] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5963).
• [2993] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 176).
• [2994] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1400).
• [2995] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5179).
• [2996] Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21360-5.
• [2997] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2669).
• [2998] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1566).
• [2999] Synthesis and evaluation of opioid receptor-binding affinity of elaeocarpenine and its analogs. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1601-3.
• [3000] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2086).
• [3001] Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). Cancer Res. 1998 Mar 15;58(6):1111-5.
• [3002] In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors. Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):118-22.
• [3003] Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase. J Biol Chem. 2007 Mar 16;282(11):8368-79.
• [3004] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1445).
• [3005] Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
• [3006] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4037).
• [3007] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1834).
• [3008] Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.Mol Cancer Ther.2011 Aug;10(8):1327-36.
• [3009] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3668).
• [3010] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1623).
• [3011] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 990).
• [3012] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1004).
• [3013] Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv. 1994 Jun;49(6):424-31.
• [3014] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5853).
• [3015] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1971).
• [3016] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5348).
• [3017] Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT. J Med Chem. 1993 Jan 22;36(2):221-8.
• [3018] (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mine... J Med Chem. 2007 Dec 27;50(26):6443-5.
• [3019] The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4740-2.
• [3020] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4188).
• [3021] Role of 5-HT2A receptor antagonists in the treatment of insomnia
• [3022] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5457).
• [3023] A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol. 2012 Nov;8(11):890-6.
• [3024] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8287).
• [3025] Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives. Antimicrob Agents Chemother. 2007 Jun;51(6):2123-9.
• [3026] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4040).
• [3027] Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure. Bioorg Med Chem Lett. 2006 Dec 15;16(24):6281-7.
• [3028] Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) ... J Med Chem. 2007 Nov 15;50(23):5780-9.
• [3029] Alkaloids from Eschscholzia californica and their capacity to inhibit binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A receptors in ... J Nat Prod. 2006 Mar;69(3):432-5.
• [3030] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5180).
• [3031] Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18613-8.
• [3032] Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. Science. 2014 Oct 31;346(6209):638-41.
• [3033] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7398).
• [3034] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4569).
• [3035] TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-b... Bioorg Med Chem. 2007 Feb 1;15(3):1483-503.
• [3036] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1610).
• [3037] Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitors. Bioorg Med Chem. 2000 Sep;8(9):2305-9.
• [3038] Substituted 2-aminothiopen-derivatives: a potential new class of GluR6-antagonists. Eur J Med Chem. 2010 Jan;45(1):69-77.
• [3039] Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives. Bioorg Med Chem. 2008 Feb 1;16(3):1262-78.
• [3040] 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists. Bioorg Med Chem. 2010 Mar 15;18(6):2195-2203.
• [3041] Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol. 2008 Jun;4(6):373-8.
• [3042] Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity. J Med Chem. 1989 Oct;32(10):2388-96.
• [3043] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1602).
• [3044] Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. Br J Clin Pharmacol. 1995 Jun;39(6):611-20.
• [3045] Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based vi... J Med Chem. 2010 Sep 9;53(17):6490-505.
• [3046] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 966).
• [3047] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5468).
• [3048] Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes. J Med Chem. 2006 Jul 27;49(15):4595-605.
• [3049] Resolution and absolute configuration of the potent dopamine agonist N,N-diethyl-N'-[(3 alpha, 4a alpha, 10a beta)-1,2,3,4,4a,5,10,10a- -octahydro-... J Med Chem. 1985 Oct;28(10):1540-2.
• [3050] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1624).
• [3051] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1625).
• [3052] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2464).
• [3053] Eusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius. J Nat Prod. 2009 Jun;72(6):1115-20.
• [3054] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4579).
• [3055] Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem Biol. 2011 Jun 24;18(6):777-93.
• [3056] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8489).
• [3057] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7892).
• [3058] Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors. ACS Med Chem Lett. 2013 Mar 15;4(4):379-80.
• [3059] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7853).
• [3060] Factor D Inhibitors for the Treatment of AMD: Patent Highlight. ACS Med Chem Lett. 2012 Aug 27;3(10):781-2.
• [3061] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7855).
• [3062] Structure and function of tripeptidyl peptidase II, a giant cytosolic protease. Biochim Biophys Acta. 2012 Jan;1824(1):237-45.
• [3063] BACE2 as a new diabetes target: a patent review (2010 - 2012). Expert Opin Ther Pat. 2013 May;23(5):649-63.
• [3064] Biomimetic synthesis of the IDO inhibitors exiguamine A and B. Nat Chem Biol. 2008 Sep;4(9):535-7.
• [3065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5418).
• [3066] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 586).
• [3067] Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2965-8.
• [3068] Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J Med Chem. 2005 Feb 24;48(4):1098-106.
• [3069] Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone. Bioorg Med Chem. 2008 Feb 1;16(3):1309-18.
• [3070] Novel, potent ORL-1 receptor agonist peptides containing alpha-Helix-promoting conformational constraints. J Med Chem. 2002 Nov 21;45(24):5280-6.
• [3071] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2400).
• [3072] Structure-based design, synthesis, evaluation, and crystal structures of transition state analogue inhibitors of inosine monophosphate cyclohydrolase. J Biol Chem. 2007 Apr 27;282(17):13033-46.
• [3073] Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis. J Nat Prod. 2006 Apr;69(4):536-41.
• [3074] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3215).
• [3075] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5969).
• [3076] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6502).
• [3077] Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine. J Med Chem. 2001 Apr 12;44(8):1151-7.
• [3078] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 974).
• [3079] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1182).
• [3080] Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrob Agents Chemother. 2009 Jan;53(1):202-9.
• [3081] Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes. 2002 May;51(5):1461-9.
• [3082] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5240).
• [3083] Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction. J Med Chem. 2008 Oct 23;51(20):6450-9.
• [3084] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2744).
• [3085] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 13).
• [3086] Synergistic effect of basic residues at positions 14-15 of nociceptin on binding affinity and receptor activation. Bioorg Med Chem. 2008 Oct 15;16(20):9261-7.
• [3087] Discriminatory synergistic effect of Trp-substitutions in superagonist [(Arg/Lys)(14), (Arg/Lys)(15)]nociceptin on ORL1 receptor binding and activa... Bioorg Med Chem. 2009 Aug 1;17(15):5683-7.
• [3088] Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer. 2001 Nov 30;85(11):1771-80.
• [3089] 4-Methyl-5-phenyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3405-11.
• [3090] RdlDv, a novel GABA-gated chloride channel gene from the American dog tick Dermacentor variabilis. Insect Biochem Mol Biol. 2003 Jun;33(6):595-9.
• [3091] SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor. Bioorg Med Chem Lett. 1999 Aug 2;9(15):2207-12.
• [3092] A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development. J Med Chem. 2008 Jun 12;51(11):3116-23.
• [3093] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3501).
• [3094] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5185).
• [3095] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5184).
• [3096] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 409).
• [3097] 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1. J Med Chem. 1987 Nov;30(11):2099-104.
• [3098] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4191).
• [3099] Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics. J Med Chem. 1989 Dec;32(12):2573-82.
• [3100] Properties and synthesis of 2-{2-fluoro (or bromo)-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low... J Med Chem. 2010 Nov 11;53(21):7879-82.
• [3101] Synthesis of 5'-substituted fluoro-neplanocin A analogues: importance of a hydrogen bonding donor at 5'-position for the inhibitory activity of S-a... Bioorg Med Chem Lett. 2004 Nov 15;14(22):5641-4.
• [3102] Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5275-9.
• [3103] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 279).
• [3104] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1940).
• [3105] Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines. J Med Chem. 1980 Jun;23(6):635-43.
• [3106] Design and synthesis of a fluorescent muscarinic antagonist. Bioorg Med Chem Lett. 2008 Jan 15;18(2):825-7.
• [3107] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1563).
• [3108] Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs. Bioorg Med Chem. 2007 Feb 1;15(3):1266-74.
• [3109] Folipastatin, a new depsidone compound from Aspergillus unguis as an inhibitor of phospholipase A2.Taxonomy, fermentation, isolation, structure determination and biological properties.J Antibiot (Tokyo).1992 Aug;45(8):1195-201.
• [3110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4196).
• [3111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4739).
• [3112] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4540).
• [3113] Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens. Bioorg Med Chem. 2007 May 15;15(10):3445-9.
• [3114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4737).
• [3115] Synthesis and evaluation of some novel dibenzo[b,d]furan carboxylic acids as potential anti-diabetic agents. Eur J Med Chem. 2010 Sep;45(9):3709-18.
• [3116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1409).
• [3117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2518).
• [3118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6353).
• [3119] Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase. Bioorg Med Chem. 2010 Jun 15;18(12):4300-9.
• [3120] Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives. Chem Pharm Bull (Tokyo). 1998 Jun;46(6):966-72.
• [3121] Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist. Bioorg Med Chem Lett. 1999 Jul 19;9(14):1979-84.
• [3122] Dual CCK-A and -B receptor antagonists (I) C9-methyl-1,4-benzodiazepines, Bioorg. Med. Chem. Lett. 7(2):169-174 (1997).
• [3123] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5966).
• [3124] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5854).
• [3125] Discovery of new diphenyloxazole derivatives containing a pyrrolidine ring: orally active prostacyclin mimetics. Part 2. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3279-83.
• [3126] Novel potent antagonists of human neuropeptide Y Y5 receptors. Part 3: 7-methoxy-1-hydroxy-1-substituted tetraline derivatives. Bioorg Med Chem Lett. 2002 Mar 11;12(5):799-802.
• [3127] FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, a... J Antibiot (Tokyo). 1986 Feb;39(2):198-204.
• [3128] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5191).
• [3129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 673).
• [3130] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 668).
• [3131] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 669).
• [3132] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 387).
• [3133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3223).
• [3134] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2465).
• [3135] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2466).
• [3136] Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003 Jan;3(1):11-22.
• [3137] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6363).
• [3138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2924).
• [3139] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1259).
• [3140] Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design. Biophys Chem. 2003 Aug 1;105(1):29-43.
• [3141] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1179).
• [3142] Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. J Biol Chem. 2007 Jul 20;282(29):20847-53.
• [3143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 299).
• [3144] Inhibition of metalloproteinase by futoenone derivatives, Bioorg. Med. Chem. Lett. 5(15):1637-1642 (1995).
• [3145] Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. J Med Chem. 2006 Jan 26;49(2):616-24.
• [3146] Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists. J Med Chem. 1994 Jan 7;37(1):1-8.
• [3147] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3320).
• [3148] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6480).
• [3149] G-749, a novel FLT3 kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia. Blood. 2014 Apr 3;123(14):2209-19.
• [3150] A suicide vector for allelic recombination involving the gene for glutamate 1-semialdehyde aminotransferase in the cyanobacterium Synechococcus PCC 7942. Mol Gen Genet. 1997 Jul;255(4):392-9.
• [3151] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6107).
• [3152] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 410).
• [3153] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6129).
• [3154] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3896).
• [3155] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6105).
• [3156] Differential inhibition of reverse transcriptase and various DNA polymerases by digallic acid and its derivatives. J Nat Prod. 1990 Sep-Oct;53(5):1234-40.
• [3157] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5549).
• [3158] Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10470-5.
• [3159] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6118).
• [3160] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6127).
• [3161] Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Neurology. 1981 Feb;31(2):207-11.
• [3162] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5462).
• [3163] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7001).
• [3164] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6657).
• [3165] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6658).
• [3166] Design of thyroid hormone receptor antagonists from first principles. J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):59-73.
• [3167] Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 2005 Jul 28;48(15):4705-45.
• [3168] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4578).
• [3169] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8585).
• [3170] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4200).
• [3171] Synthesis and evaluation of geldanamycin-estradiol hybrids. Bioorg Med Chem Lett. 1999 May 3;9(9):1233-8.
• [3172] Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci. 2003 Jan 1;23(1):29-33.
• [3173] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2782).
• [3174] Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug g... J Med Chem. 2006 Aug 24;49(17):5051-8.
• [3175] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2467).
• [3176] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3051).
• [3177] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3052).
• [3178] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2428).
• [3179] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1861).
• [3180] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1863).
• [3181] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1864).
• [3182] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4201).
• [3183] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7658).
• [3184] Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes. 2004 Mar;53(3):535-41.
• [3185] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 866).
• [3186] Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4104-7.
• [3187] Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6222-6.
• [3188] Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4395-8.
• [3189] Efficient evaluation of binding free energy using continuum electrostatics solvation. J Med Chem. 2004 Nov 4;47(23):5791-7.
• [3190] The Role of 4-phosphonodifluoromethyl- and 4-phosphono-phenylalanine in the selectivity and cellular uptake of SH2 domain ligands, Bioorg. Med. Chem. Lett. 7(14):1909-1914 (1997).
• [3191] Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. J Med Chem. 1981 Apr;24(4):355-61.
• [3192] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1147).
• [3193] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4519).
• [3194] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4723).
• [3195] alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers. J Med Chem. 2009 Nov 26;52(22):7029-43.
• [3196] N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem. 1999 Aug 12;42(16):3033-40.
• [3197] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4740).
• [3198] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4545).
• [3199] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4544).
• [3200] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4714).
• [3201] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4715).
• [3202] Development of specific Rho-kinase inhibitors and their clinical application. Biochim Biophys Acta. 2005 Dec 30;1754(1-2):245-52.
• [3203] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4202).
• [3204] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1466).
• [3205] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4203).
• [3206] Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2012 Nov 26;55(22):9416-33.
• [3207] Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2014 Feb 13;57(3):921-36.
• [3208] Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nat Chem Biol. 2006 Feb;2(2):95-102.
• [3209] Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature. 2010 Jan 28;463(7280):501-6.
• [3210] Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. ACS Med Chem Lett. 2012 Jan 1;3(2):140-5.
• [3211] Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agent... J Med Chem. 1993 Apr 30;36(9):1146-56.
• [3212] 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and ... J Med Chem. 2005 Sep 8;48(18):5684-97.
• [3213] Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5391-5.
• [3214] Synthesis and biological evaluation of poly-gamma-glutamyl metabolites of 10-deazaaminopterin and 10-ethyl-10-deazaaminopterin. J Med Chem. 1988 Jan;31(1):181-5.
• [3215] 3D pharmacophore based virtual screening of T-type calcium channel blockers. Bioorg Med Chem. 2007 Jan 15;15(2):1091-105.
• [3216] Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines. Bioorg Med Chem Lett. 2010 Jan 1;20(1):228-31.
• [3217] Akt inhibitor Akt-IV blocks virus replication through an Akt-independent mechanism. J Virol. 2009 Nov;83(22):11665-72.
• [3218] Structure-activity relationship of quinoline derivatives as potent and selective alpha(2C)-adrenoceptor antagonists. J Med Chem. 2006 Oct 19;49(21):6351-63.
• [3219] Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J Med Chem. 1993 Apr 30;36(9):1136-45.
• [3220] Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow. J Med Chem. 2009 Jan 22;52(2):369-78.
• [3221] Substrate optimization for monitoring cathepsin C activity in live cells. Bioorg Med Chem. 2009 Feb 1;17(3):1064-70.
• [3222] Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674. J Nat Prod. 2005 Jul;68(7):1061-5.
• [3223] Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. J Med Chem. 2006 Jan 12;49(1):27-30.
• [3224] CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate r... J Med Chem. 2005 Mar 10;48(5):1448-69.
• [3225] Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falcipa... J Med Chem. 2008 Jun 26;51(12):3649-53.
• [3226] Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 1996 Aug 26;392(2):77-80.
• [3227] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 335).
• [3228] Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I). Bioorg Med Chem Lett. 2004 Oct 18;14(20):5113-6.
• [3229] Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem. 2009 Oct 1;17(19):6816-23.
• [3230] 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2. J Med Chem. 1997 Mar 28;40(7):1112-29.
• [3231] Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit Care Med. 2004 Jun;32(6):1365-74.
• [3232] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 69).
• [3233] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 248).
• [3234] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1348).
• [3235] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1349).
• [3236] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 259).
• [3237] 5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitor. Bioorg Med Chem Lett. 1998 Nov 3;8(21):2955-60.
• [3238] A series of novel, highly potent and selective agonists for the kappa-opioid receptor. Br J Pharmacol. 1990 Dec;101(4):944-8.
• [3239] J. Med. Chem. 1993,36, 2075-2083
• [3240] Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
• [3241] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3880).
• [3242] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2128).
• [3243] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 113).
• [3244] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3882).
• [3245] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8674).
• [3246] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2628).
• [3247] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 302).
• [3248] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6580).
• [3249] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5588).
• [3250] Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands. J Med Chem. 2007 May 17;50(10):2399-407.
• [3251] Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol Pharmacol. 2005 Nov;68(5):1301-10.
• [3252] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3441).
• [3253] The identification a novel, selective, non-steroidal, functional glucocorticoid receptor antagonist. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2340-3.
• [3254] GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2009 Oct;8(10):2811-20.
• [3255] Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3664-8.
• [3256] Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversibl... J Med Chem. 2010 Feb 25;53(4):1857-61.
• [3257] Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1525-8.
• [3258] Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitors. Bioorg Med Chem. 2004 Jun 15;12(12):3167-85.
• [3259] Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg Med Chem Lett. 2006 Feb 15;16(4):821-4.
• [3260] Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4339-43.
• [3261] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2673).
• [3262] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8693).
• [3263] A miniaturized screen for inhibitors of Jumonji histone demethylases. Mol Biosyst. 2010 Feb;6(2):357-64.
• [3264] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8241).
• [3265] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4205).
• [3266] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6253).
• [3267] Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway. Bioorg Med Chem Lett. 2009 Jan 15;19(2):373-7.
• [3268] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5870).
• [3269] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8690).
• [3270] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6465).
• [3271] A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site. Nat Chem Biol. 2014 Sep;10(9):774-9.
• [3272] Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 2012 Aug 23;55(16):7193-207.
• [3273] The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats. EMBO J. 2010 Jul 7;29(13):2135-46.
• [3274] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8647).
• [3275] Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. ACS Med Chem Lett. 2012 Oct 19;3(12):1091-6.
• [3276] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2835).
• [3277] Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015 Mar;11(3):189-91.
• [3278] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5562).
• [3279] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5561).
• [3280] Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1694-7.
• [3281] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4598).
• [3282] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1261).
• [3283] Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosin... J Biol Chem. 2003 Aug 29;278(35):32892-8.
• [3284] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4207).
• [3285] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8662).
• [3286] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5492).
• [3287] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5325).
• [3288] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2410).
• [3289] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5123).
• [3290] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1742).
• [3291] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3276).
• [3292] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6173).
• [3293] Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. J Nat Prod. 2005 Apr;68(4):617-9.
• [3294] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1953).
• [3295] PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independe... Br J Pharmacol. 2003 May;139(1):163-71.
• [3296] Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16078-83.
• [3297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8072).
• [3298] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 865).
• [3299] Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhib... Bioorg Med Chem Lett. 2009 Aug 1;19(15):4504-8.
• [3300] Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles. Bioorg Med Chem Lett. 2004 Feb 23;14(4):953-7.
• [3301] Nuclear receptors and their selective pharmacologic modulators. Pharmacol Rev. 2013 Mar 1;65(2):710-78.
• [3302] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2686).
• [3303] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1057).
• [3304] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2703).
• [3305] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2716).
• [3306] Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem. 2002 Aug 30;277(35):31441-7.
• [3307] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4946).
• [3308] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4947).
• [3309] Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. Endocrinology. 2001 Feb;142(2):838-46.
• [3310] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2674).
• [3311] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2704).
• [3312] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4033).
• [3313] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7514).
• [3314] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3360).
• [3315] Discovery of thiophene inhibitors of polo-like kinase. Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21.
• [3316] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1050).
• [3317] Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. J Med Chem. 2008 Dec 25;51(24):8038-47.
• [3318] Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic de... J Med Chem. 2010 Feb 25;53(4):1871-5.
• [3319] Gymnochromes E and F, cytotoxic phenanthroperylenequinones from a deep-water crinoid, Holopus rangii. J Nat Prod. 2010 Apr 23;73(4):712-5.
• [3320] Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1). J Med Chem. 2009 Nov 12;52(21):6941-5.
• [3321] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2348).
• [3322] Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990 Mar 25;265(9):5267-72.
• [3323] Further studies of tyrosine surrogates in opioid receptor peptide ligands. Bioorg Med Chem Lett. 2007 May 1;17(9):2656-60.
• [3324] Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensi... Bioorg Med Chem. 2008 Oct 15;16(20):9359-68.
• [3325] Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. J Med Chem. 2006 Jul 27;49(15):4487-96.
• [3326] Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biologi... J Med Chem. 2000 Feb 24;43(4):569-80.
• [3327] Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists. J Med Chem. 2000 Jun 15;43(12):2382-6.
• [3328] New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands. J Med Chem. 2006 Jun 29;49(13):3990-3.
• [3329] From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH. J Med Chem. 2005 Aug 25;48(17):5608-11.
• [3330] Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists. J Med Chem. 2007 Jan 25;50(2):328-33.
• [3331] Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. J Med Chem. 2008 Aug 28;51(16):5109-17.
• [3332] Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic. J Med Chem. 2004 Dec 16;47(26):6541-6.
• [3333] Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. J Med Chem. 2006 Sep 7;49(18):5610-7.
• [3334] New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5517-20.
• [3335] Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502). Bioorg Med Chem. 2008 Mar 15;16(6):3032-8.
• [3336] A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic. Bioorg Med Chem. 2007 Nov 15;15(22):6876-81.
• [3337] The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3396-400.
• [3338] Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J Med Chem. 2010 Mar 11;53(5):2215-26.
• [3339] Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2583-6.
• [3340] Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity. J Med Chem. 2007 Mar 22;50(6):1414-7.
• [3341] Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity. J Med Chem. 1991 Oct;34(10):3125-32.
• [3342] Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors. J Med Chem. 1993 Nov 26;36(24):3748-56.
• [3343] A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid ... J Med Chem. 2008 Mar 13;51(5):1369-76.
• [3344] Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists. J Med Chem. 2006 Mar 9;49(5):1773-80.
• [3345] Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors. J Med Chem. 2007 Jan 11;50(1):165-8.
• [3346] Blood-brain barrier penetration by two dermorphin tetrapeptide analogues: role of lipophilicity vs structural flexibility. J Med Chem. 2008 Apr 24;51(8):2571-4.
• [3347] The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists. Biopolymers. 1999;51(6):411-25.
• [3348] Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma. Blood. 2002 Nov 1;100(9):3101-7.
• [3349] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6579).
• [3350] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 542).
• [3351] Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1. Bioorg Med Chem. 2008 Dec 1;16(23):10106-12.
• [3352] Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.
• [3353] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6197).
• [3354] Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureas. J Med Chem. 2001 Mar 29;44(7):1085-98.
• [3355] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4212).
• [3356] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4213).
• [3357] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5965).
• [3358] Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay
• [3359] New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia. Bioorg Med Chem. 2010 Aug 15;18(16):6006-11.
• [3360] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2280).
• [3361] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4349).
• [3362] Thrombin inhibitors in acute coronary artery disease. Eur Heart J. 2002 Aug;23(15):1142-4.
• [3363] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6305).
• [3364] 5-Alkyl-2-[(aryl and alkyloxylcarbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones as an unique HIV reverse transcriptase inhibitors of S... Bioorg Med Chem Lett. 2004 Jun 21;14(12):3173-6.
• [3365] Herkinorin analogues with differential beta-arrestin-2 interactions. J Med Chem. 2008 Apr 24;51(8):2421-31.
• [3366] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8354).
• [3367] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6627).
• [3368] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1055).
• [3369] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 322).
• [3370] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 310).
• [3371] Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
• [3372] 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. J Med Chem. 2004 Dec 16;47(26):6529-40.
• [3373] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 323).
• [3374] Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16986-91.
• [3375] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1148).
• [3376] Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistan... Bioorg Med Chem Lett. 1999 Jun 7;9(11):1593-8.
• [3377] Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity. Bioorg Med Chem Lett. 2000 Jan 3;10(1):87-90.
• [3378] N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency vi... Bioorg Med Chem Lett. 1999 Dec 20;9(24):3411-6.
• [3379] Squalene-derived flexible linkers for bioactive peptides. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3310-3.
• [3380] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4026).
• [3381] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6556).
• [3382] Novel peptide inhibitors of human kallikrein 2. J Biol Chem. 2006 May 5;281(18):12555-60.
• [3383] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1722).
• [3384] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2590).
• [3385] Clamikalant (Aventis). IDrugs. 2000 Nov;3(11):1353-7.
• [3386] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5967).
• [3387] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5995).
• [3388] Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun. 2007 Apr 27;356(1):233-8.
• [3389] Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands. J Med Chem. 2007 Oct 4;50(20):4976-85.
• [3390] Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3467-71.
• [3391] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3359).
• [3392] Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs. Crit Rev Oncol Hematol. 2003 Jan;45(1):91-108.
• [3393] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4216).
• [3394] Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. J Biol Chem. 2001 Sep 7;276(36):33930-7.
• [3395] Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92.
• [3396] Anticancer effect of Howiinol A and its mechanism of action. J Asian Nat Prod Res. 1999;2(1):1-19.
• [3397] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2827).
• [3398] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6662).
• [3399] HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep. 2013 Dec 11;3:3470.
• [3400] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1321).
• [3401] Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol. 2011 Dec 25;13(2):129-35.
• [3402] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1273).
• [3403] A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8.
• [3404] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6736).
• [3405] The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues. J Med Chem. 2009 Nov 12;52(21):6814-21.
• [3406] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 731).
• [3407] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1874).
• [3408] Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites. J Med Chem. 2006 Jun 1;49(11):3421-5.
• [3409] Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors. J Med Chem. 2005 Mar 24;48(6):1701-4.
• [3410] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8079).
• [3411] Chemistry, physiological properties, and microbial production of hydroxycitric acid. Appl Microbiol Biotechnol. 2007 Jul;75(5):977-82.
• [3412] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2468).
• [3413] Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol. 2008 Dec;128(12):2783-91.
• [3414] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4101).
• [3415] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2764).
• [3416] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 842).
• [3417] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4555).
• [3418] Hyrtiazepine, an azepino-indole-type alkaloid from the Red Sea marine sponge Hyrtios erectus. J Nat Prod. 2006 Dec;69(12):1676-9.
• [3419] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 812).
• [3420] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 458).
• [3421] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 446).
• [3422] Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011 Oct 2;478(7370):529-33.
• [3423] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1938).
• [3424] Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition. J Med Chem. 2016 Feb 25;59(4):1425-39.
• [3425] CBP and p300: HATs for different occasions. Biochem Pharmacol. 2004 Sep 15;68(6):1145-55.
• [3426] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3332).
• [3427] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4217).
• [3428] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1597).
• [3429] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4218).
• [3430] Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol. 2002 Mar 1;438(1-2):99-105.
• [3431] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1371).
• [3432] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5960).
• [3433] Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun. 2003 Sep 5;308(4):764-9.
• [3434] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7656).
• [3435] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7667).
• [3436] In vivo evidence for the selectivity of ICI 154129 for the delta-opioid receptor. Neuropharmacology. 1985 Feb;24(2):107-10.
• [3437] Role of neutrophil elastase in hypersecretion in asthma. Eur Respir J. 1999 Jan;13(1):190-6.
• [3438] Neutrophil elastase inhibitors as treatment for COPD. Expert Opin Investig Drugs. 2002 Jul;11(7):965-80.
• [3439] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1636).
• [3440] The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583). Biochem Pharmacol. 1991 Oct 24;42(10):1885-95.
• [3441] Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of kappa opioid receptors in mouse micr... J Med Chem. 1996 Apr 12;39(8):1729-35.
• [3442] ICI 204448: a kappa-opioid agonist with limited access to the CNS.
• [3443] DOI: 10.1517/13543776.2.11.1817
• [3444] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2429).
• [3445] Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer. 2002 Mar 1;94(5):1593-611.
• [3446] The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia. Exp Hematol. 2002 Nov;30(11):1273-82.
• [3447] Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic ... Circulation. 2003 Dec 16;108(24):3036-41.
• [3448] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1350).
• [3449] Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge. Bioorg Med Chem. 2008 Oct 1;16(19):8781-94.
• [3450] An IkappaB-alpha mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res. 2002 Feb;102(2):198-206.
• [3451] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2591).
• [3452] An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2. Immunopharmacology. 1994 Nov-Dec;28(3):223-32.
• [3453] Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Biochem Biophys Res Commun. 2001 Aug 24;286(3):595-600.
• [3454] PAK1: A Therapeutic Target for Cancer Treatment. ACS Med Chem Lett. 2013 Mar 19;4(5):431-2.
• [3455] The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature. 2001 May 17;411(6835):325-30.
• [3456] Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):241-6.
• [3457] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1249).
• [3458] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1250).
• [3459] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3470).
• [3460] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1251).
• [3461] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4024).
• [3462] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1252).
• [3463] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1276).
• [3464] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1226).
• [3465] Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4006-10.
• [3466] Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity. Bioorg Med Chem Lett. 2001 Oct 8;11(19):2597-602.
• [3467] Aromatic interactions with phenylalanine 691 and cysteine 828: a concept for FMS-like tyrosine kinase-3 inhibition. Application to the discovery of a new class of potential antileukemia agents. J MedChem. 2006 Jul 27;49(15):4451-4.
• [3468] M-phase regulation of the recruitment of mRNAs onto polysomes using the CDK1/cyclin B inhibitor aminopurvalanol. Biochem Biophys Res Commun. 2003 Jul 11;306(4):880-6.
• [3469] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4220).
• [3470] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 512).
• [3471] Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. Neuropsychopharmacology. 2001 Jul;25(1):104-17.
• [3472] Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J Med Chem. 2004 Feb 12;47(4):935-46.
• [3473] Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett. 2011 Jul 1;21(13):4108-14.
• [3474] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5989).
• [3475] Structural basis of RasGRP binding to high-affinity PKC ligands. J Med Chem. 2002 Feb 14;45(4):853-60.
• [3476] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4709).
• [3477] Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and P... J Med Chem. 1999 Dec 16;42(25):5120-30.
• [3478] Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method a... J Med Chem. 2001 May 24;44(11):1690-701.
• [3479] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8624).
• [3480] The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. J Renin Angiotensin Aldosterone Syst. 2008 Dec;9(4):226-37.
• [3481] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5124).
• [3482] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5202).
• [3483] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5203).
• [3484] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4223).
• [3485] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5204).
• [3486] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5205).
• [3487] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4224).
• [3488] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1746).
• [3489] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1769).
• [3490] Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia. 1995 May;38(5):592-8.
• [3491] Identification of regions in interleukin-1 alpha important for activity. J Biol Chem. 1993 Oct 15;268(29):22105-11.
• [3492] Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. Eur Cytokine Netw. 2000 Mar;11(1):91-8.
• [3493] Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9.
• [3494] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6271).
• [3495] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1232).
• [3496] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7583).
• [3497] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1253).
• [3498] A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem. 2014 Mar;9(3):566-71.
• [3499] Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases. ACS Chem Biol. 2013 Jul 19;8(7):1488-96.
• [3500] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4225).
• [3501] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6937).
• [3502] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 876).
• [3503] Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5.
• [3504] IRAK-4 inhibitors. Part 1: a series of amides. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4.
• [3505] IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3656-60.
• [3506] IRL 2500: A potent ETB selective endothelin antagonist, Bioorg. Med. Chem. Lett. 6(19):2323-2328 (1996).
• [3507] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8517).
• [3508] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8518).
• [3509] IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo. Neurosurgery. 2003 Jan;52(1):177-85; discussion 185-6.
• [3510] Type I phosphatidylinositol-4-phosphate 5-kinases are distinct members of this novel lipid kinase family. J Biol Chem. 1996 Dec 20;271(51):32937-43.
• [3511] Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives. J Nat Prod. 2001 Oct;64(10):1297-300.
• [3512] A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem Biol. 2011 Apr 22;18(4):531-41.
• [3513] US patent application no. 6,228,648, Antisense modulation of ADAM10 expression.
• [3514] US patent application no. 6,168,950, Antisense modulation of MEKK1 expression.
• [3515] US patent application no. 6,277,636, Antisense inhibition of MADH6 expression.
• [3516] US patent application no. 5,952,229, Antisense oligonucleotide modulation of raf gene expression.
• [3517] US patent application no. 6,248,586, Antisense modulation of PKA catalytic subunit C-alpha expression.
• [3518] US patent application no. 5,959,096, Antisense oligonucleotides against human protein kinase C.
• [3519] US patent application no. 6,482,644, Antisense modulation of dual specific phosphatase 8 expression.
• [3520] US patent application no. 6,566,133, Antisense inhibition of dual specific phosphatase 9 expression.
• [3521] US patent application no. 6,258,601, Antisense modulation of ubiquitin protein ligase expression.
• [3522] US patent application no. 6,319,906, Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.
• [3523] US patent application no. 6,426,221, Antisense modulation of RIP2 expression.
• [3524] US patent application no. 6,312,900, Antisense oligonucleotide compositions and methods for the modulation of activating protein 1.
• [3525] US patent application no. 6,159,734, Antisense modulation of peroxisome proliferator-activated receptor gamma expression.
• [3526] US patent application no. 7,425,545, Modulation of C-reactive protein expression.
• [3527] US patent application no. 6,258,600, Antisense modulation of caspase 8 expression.
• [3528] US patent application no. 6,261,840, Antisense modulation of PTP1B expression.
• [3529] US patent application no. 6,372,492, Antisense modulation of talin expression.
• [3530] US patent application no. 6,190,869, Antisense inhibition of protein kinase C-theta expression.
• [3531] US patent application no. 6,171,860, Antisense inhibition of rank expression.
• [3532] US patent application no. 6,165,786, Antisense modulation of nucleolin expression.
• [3533] US patent application no. 6,271,029, Antisense inhibition of cytohesin-2 expression.
• [3534] US patent application no. 6,391,542, Compositions and methods for treatment of Hepatitis C virus-associated diseases.
• [3535] US patent application no. 5,789,573, Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2.
• [3536] US patent application no. 6,165,789, Antisense modulation of hnRNP A1 expression.
• [3537] US patent application no. 7,148,204, Antisense modulation of bcl-x expression.
• [3538] US patent application no. 6,268,151, Antisense modulation of macrophage migration inhibitory factor expression.
• [3539] US patent application no. 6,187,587, Antisense inhibition of e2f transcription factor 1 expression.
• [3540] US patent application no. 7,098,192, Antisense oligonucleotide modulation of STAT3 expression.
• [3541] US patent application no. 6,287,860, Antisense inhibition of MEKK2 expression.
• [3542] US patent application no. 6,165,791, Antisense inhibition of E2F transcription factor 3 expression.
• [3543] US patent application no. 6,255,110, Antisense modulation of ARA70 expression.
• [3544] US patent application no. 6,242,590, Antisense modulation of zinc finger protein-217 expression.
• [3545] US patent application no. 6,265,216, Antisense modulation of cot oncogene expression.
• [3546] US patent application no. 6,271,030, Antisense inhibition of C/EBP beta expression.
• [3547] US patent application no. 6,316,259, Antisense inhibition of glycogen synthase kinase 3 alpha expression.
• [3548] US patent application no. 6,503,756, Antisense modulation of syntaxin 4 interacting protein expression.
• [3549] US patent application no. 6,498,035, Antisense modulation of MEKK3 expression.
• [3550] US patent application no. 5,767,102, Antisense composition and method for treatment of CMV infection.
• [3551] US patent application no. 5,968,748, Antisense oligonucleotide modulation of human HER-2 expression.
• [3552] US patent application no. 6,867,039, Antisense modulation of dual specific phosphatase 5 expression.
• [3553] US patent application no. 6,566,135, Antisense modulation of caspase 6 expression.
• [3554] US patent application no. 5,981,731, Antisense oligonucleotide modulation of B-raf gene expression.
• [3555] US patent application no. 7,427,470, Antisense modulation of helicase-moi expression.
• [3556] US patent application no. 7,202,357, Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression.
• [3557] US patent application no. 7,259,150, Modulation of apolipoprotein (a) expression.
• [3558] US patent application no. 7,407,943, Antisense modulation of apolipoprotein B expression.
• [3559] US patent application no. 7,132,529, Antisense modulation of stearoyl-CoA desaturase expression.
• [3560] US patent application no. 7,132,530, Antisense modulation of superoxide dismutase 1, soluble expression.
• [3561] US patent application no. 6,692,959, Antisense modulation of IL-1 receptor-associated kinase-4 expression.
• [3562] US patent application no. 6,607,915, Antisense inhibition of E2A-Pbx1 expression.
• [3563] US patent application no. 6,204,055, Antisense inhibition of Fas mediated signaling.
• [3564] US patent application no. 6,235,723, Antisense oligonucleotide modulation of human protein kinase C-.delta. expression.
• [3565] US patent application no. 7,375,212, Modulation of Aurora B expression.
• [3566] US patent application no. 5,665,580, Antisense oligonucleotide inhibition of papillomavirus transformed cells.
• [3567] US patent application no. 7,217,572, Modulation of HIF1.alpha. and HIF2.alpha. expression.
• [3568] US patent application no. 5,530,114, Oligonucleotide modulation of arachidonic acid metabolism.
• [3569] US patent application no. 7,163,927, Antisense modulation of kinesin-like 1 expression.
• [3570] US patent application no. 7,229,976, Modulation of forkhead box O1A expression.
• [3571] US patent application no. 7,414,033, Modulation of diacylglycerol acyltransferase 1 expression.
• [3572] US patent application no. 6,197,584, Antisense modulation of CD40 expression.
• [3573] US patent application no. 6,300,491, Oligonucleotide inhibition of cell adhesion.
• [3574] US patent application no. 6,255,111, Antisense modulation of Her-4 expression.
• [3575] US patent application no. 5,951,455, Antisense modulation of G-alpha-11 expression.
• [3576] US patent application no. 5,457,189, Antisense oligonucleotide inhibition of papillomavirus.
• [3577] US patent application no. 7,468,431, Modulation of eIF4E-BP2 expression.
• [3578] US patent application no. 5,958,771, Antisense modulation of cellular inhibitor of Apoptosis-2 expression.
• [3579] US patent application no. 6,395,545, Antisense modulation of inhibitor-kappa B kinase-alpha expression.
• [3580] US patent application no. 6,165,788, Antisense modulation of Survivin expression.
• [3581] US patent application no. 6,258,790, Antisense modulation of integrin .alpha.4 expression.
• [3582] US patent application no. 5,965,722, Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
• [3583] US patent application no. 5,959,097, Antisense modulation of MEK2 expression.
• [3584] US patent application no. 5,945,290, Antisense modulation of RhoA expression.
• [3585] US patent application no. 5,843,738, Oligonucleotide modulation of cell adhesion.
• [3586] US patent application no. 6,159,697, Antisense modulation of Smad7 expression.
• [3587] US patent application no. 6,187,586, Antisense modulation of AKT-3 expression.
• [3588] US patent application no. 5,442,049, Oligonucleotides for modulating the effects of cytomegalovirus infections.
• [3589] US patent application no. 6,124,272, Antisense modulation of PDK-1 expression.
• [3590] US patent application no. 6,133,032, Antisense modulation of PI3 kinase p110 beta expression.
• [3591] US patent application no. 5,580,767, Inhibition of influenza viruses by antisense oligonucleotides.
• [3592] US patent application no. 7,541,344, Modulation of survivin expression.
• [3593] US patent application no. 5,814,619, Oligonucleotide inhibition of P120.
• [3594] Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J Biol Chem. 1996 Nov 8;271(45):28259-65.
• [3595] US patent application no. 5,563,255, Antisense oligonucleotide modulation of raf gene expression.
• [3596] US patent application no. 6,300,320, Modulation of c-jun using inhibitors of protein kinase C.
• [3597] Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem. 1991 Sep 25;266(27):18162-71.
• [3598] Ocular hypotension induced by topical dopaminergic drugs and phosphodiesterase inhibitors. Eur J Pharmacol. 1994 Jun 2;258(1-2):85-94.
• [3599] Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. J Med Chem. 2008 Oct 23;51(20):6400-9.
• [3600] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7781).
• [3601] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5506).
• [3602] N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake. Bioorg Med Chem Lett. 2006 May 15;16(10):2714-8.
• [3603] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 388).
• [3604] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1060).
• [3605] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1934).
• [3606] Synthesis and pharmacological evaluation of triflate-substituted analogues of clozapine: identification of a novel atypical neuroleptic. J Med Chem. 1997 Dec 5;40(25):4146-53.
• [3607] Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy. J Med Chem. 2003 Jun 5;46(12):2345-51.
• [3608] 4-Phenylcoumarins as HIV transcription inhibitors. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4447-50.
• [3609] Indolizidine alkaloids with delta-opioid receptor binding affinity from the leaves of Elaeocarpus fuscoides. J Nat Prod. 2007 May;70(5):872-5.
• [3610] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7980).
• [3611] Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. J Med Chem. 2008 Aug 14;51(15):4482-7.
• [3612] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5991).
• [3613] High selectivity of novel isoguanosine analogues for the adenosine A1 receptor. Bioorg. Med. Chem. Lett. 1(9):481-486 (1991).
• [3614] Protective effects of isohelenin, an inhibitor of nuclear factor kappaB, in endotoxic shock in rats. J Endotoxin Res. 2002;8(2):99-107.
• [3615] Isoindolinone ureas: a novel class of KDR kinase inhibitors. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4505-9.
• [3616] Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes. J Nat Prod. 2009 Oct;72(10):1857-63.
• [3617] Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives. J Med Chem. 2007 May 31;50(11):2655-64.
• [3618] Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain. J Med Chem. 1981 Sep;24(9):1021-6.
• [3619] Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5227-32.
• [3620] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4227).
• [3621] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3048).
• [3622] New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies. J Med Chem. 2006 Feb 9;49(3):947-54.
• [3623] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2462).
• [3624] Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. J Nat Prod. 1996 Apr;59(4):443-5.
• [3625] New flavonol oligoglycosides and polyacylated sucroses with inhibitory effects on aldose reductase and platelet aggregation from the flowers of Pru... J Nat Prod. 2002 Aug;65(8):1151-5.
• [3626] Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor. J Med Chem. 2010 Feb 11;53(3):1190-9.
• [3627] Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability. Bioorg Med Chem. 2010 Feb;18(3):1045-53.
• [3628] Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo. J Med Chem. 2008 Dec 25;51(24):7915-20.
• [3629] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6287).
• [3630] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7527).
• [3631] Trichomonas vaginalis thymidine kinase: purification, characterization and search for inhibitors. Biochem J. 1998 Aug 15;334 ( Pt 1):15-22.
• [3632] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1743).
• [3633] Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. J Med Chem. 1985 Dec;28(12):1779-90.
• [3634] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3070).
• [3635] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3110).
• [3636] The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability. Biochem Biophys Res Commun. 1999 Dec 9;266(1):88-91.
• [3637] Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes. J Bacteriol. 2000 Feb;182(3):704-13.
• [3638] Cytochrome P3A4 inhibitors and other constituents of Fibraurea tinctoria. J Nat Prod. 2007 Dec;70(12):1930-3.
• [3639] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1262).
• [3640] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1564).
• [3641] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7362).
• [3642] [Mechanism of action of aspartic proteases. III. Conformational characteristics of HIV-1 protease inhibitor JG-365]. Bioorg Khim. 1999 Jun;25(6):418-22.
• [3643] (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist. J Med Chem. 1996 Jun 21;39(13):2435-7.
• [3644] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 656).
• [3645] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3888).
• [3646] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5872).
• [3647] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1570).
• [3648] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1572).
• [3649] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6020).
• [3650] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7442).
• [3651] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5206).
• [3652] Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symp... J Med Chem. 2009 Dec 10;52(23):7544-69.
• [3653] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 877).
• [3654] JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. Mol Cancer Ther. 2009 Nov;8(11):3151-61.
• [3655] Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits. J Med Chem. 2009 Dec 10;52(23):7432-45.
• [3656] Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):39-43.
• [3657] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6317).
• [3658] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3504).
• [3659] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5932).
• [3660] Discovery of potent and selective covalent inhibitors of JNK. Chem Biol. 2012 Jan 27;19(1):140-54.
• [3661] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4229).
• [3662] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3930).
• [3663] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 747).
• [3664] 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5432-5.
• [3665] 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg Med Chem Lett. 2005 Sep 15;15(18):4110-3.
• [3666] Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorg Med Chem. 2008 Jan 1;16(1):322-35.
• [3667] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5207).
• [3668] Synthesis, modeling, and in vitro activity of (3'S)-epi-K-252a analogues. Elucidating the stereochemical requirements of the 3'-sugar alcohol on tr... J Med Chem. 2005 Jun 2;48(11):3776-83.
• [3669] Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6218-21.
• [3670] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5950).
• [3671] The discovery of the potent aurora inhibitor MK-0457 (VX-680). Bioorg Med Chem Lett. 2009 Jul 1;19(13):3586-92.
• [3672] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6025).
• [3673] Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives. Bioorg Med Chem. 2005 Aug 15;13(16):4936-51.
• [3674] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1359).
• [3675] Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities. J Nat Prod. 2004 Jul;67(7):1079-83.
• [3676] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 650).
• [3677] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 843).
• [3678] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2088).
• [3679] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7659).
• [3680] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7370).
• [3681] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4232).
• [3682] Sodium late current blockers in ischemia reperfusion: is the bullet magic J Med Chem. 2008 Jul 10;51(13):3856-66.
• [3683] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8576).
• [3684] Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes. J Med Chem. 1988 Sep;31(9):1825-31.
• [3685] Syntheses and opioid receptor binding properties of carboxamido-substituted opioids. Bioorg Med Chem Lett. 2009 Jan 1;19(1):203-8.
• [3686] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 428).
• [3687] Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum. Antimicrob Agents Chemother. 2007 Nov;51(11):4133-40.
• [3688] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4734).
• [3689] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5618).
• [3690] Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases. J Acquir Immune Defic Syndr. 1993 Jan;6(1):24-31.
• [3691] Liver X receptors as regulators of macrophage inflammatory and metabolic pathways. Biochim Biophys Acta. 2011 Aug;1812(8):982-94.
• [3692] Identification of potent and selective inhibitors of PDGF receptor autophosphorylation. J Med Chem. 2006 Apr 6;49(7):2186-92.
• [3693] A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol Cancer Ther. 2006 Nov;5(11):2634-43.
• [3694] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2907).
• [3695] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1283).
• [3696] Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives. Bioorg Med Chem. 2007 Jan 1;15(1):365-73.
• [3697] Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock. ChemMedChem. 2015 Sep;10(9):1489-97.
• [3698] Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs. Bioorg Med Chem. 2008 Jul 1;16(13):6489-500.
• [3699] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4234).
• [3700] Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1629-33.
• [3701] Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions. Bioorg Med Chem. 2010 May 1;18(9):3175-86.
• [3702] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8702).
• [3703] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6001).
• [3704] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6002).
• [3705] alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases. Bioorg Med Chem. 2009 Aug 15;17(16):5933-49.
• [3706] Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3048-52.
• [3707] Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin. Bioorg Med Chem. 2008 Dec 1;16(23):10049-60.
• [3708] Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9.
• [3709] Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. Biochemistry. 2002 Feb 19;41(7):2273-80.
• [3710] Investigation of Beckett-Casy model 1: synthesis of novel 16,17-seco-naltrexone derivatives and their pharmacology. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1055-8.
• [3711] Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology. Bioorg Med Chem Lett. 2010 Jan 1;20(1):121-4.
• [3712] Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):713-8.
• [3713] Kodaistatins, novel inhibitors of glucose-6-phosphate translocase T1 from Aspergillus terreus thom DSM 11247. Isolation and structural elucidation. J Antibiot (Tokyo). 2000 Jul;53(7):677-86.
• [3714] A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antio... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7393-6.
• [3715] Kojic acid-amino acid conjugates as tyrosinase inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5586-9.
• [3716] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1446).
• [3717] Thiazolides: a new class of antiviral drugs. Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):667-74.
• [3718] Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent. Eur J Pharmacol. 2004 Feb 6;485(1-3):333-9.
• [3719] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2923).
• [3720] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 319).
• [3721] Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, an... J Med Chem. 2006 Dec 14;49(25):7513-7.
• [3722] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 338).
• [3723] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 337).
• [3724] Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Biochemistry. 1992 Dec 8;31(48):12069-75.
• [3725] Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K. Mol Cancer Ther. 2012 Aug;11(8):1789-98.
• [3726] Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp. J Nat Prod. 1998 Feb;61(2):301-5.
• [3727] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 71).
• [3728] A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2313-6.
• [3729] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 622).
• [3730] Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1426-9.
• [3731] Discovery of potent T-type calcium channel blocker. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5740-3.
• [3732] 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3379-84.
• [3733] T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3899-901.
• [3734] Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5014-7.
• [3735] Synthesis and biological evaluation of novel T-type calcium channel blockers. Bioorg Med Chem Lett. 2007 Jan 15;17(2):471-5.
• [3736] Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats. Arch Toxicol. 1994;69(1):65-71.
• [3737] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2349).
• [3738] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2046).
• [3739] Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5295-8.
• [3740] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1565).
• [3741] Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005 Oct 20;48(21):6523-43.
• [3742] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3936).
• [3743] Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships. Bioorg Med Chem. 2008 Jul 15;16(14):6841-9.
• [3744] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6895).
• [3745] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2691).
• [3746] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2690).
• [3747] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2241).
• [3748] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2242).
• [3749] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2243).
• [3750] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2245).
• [3751] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2246).
• [3752] Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost. 1998 Mar;79(3):656-62.
• [3753] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2253).
• [3754] Small, low nanomolar, noncovalent thrombin inhibitors lacking a group to fill the 'distal binding pocket'. Bioorg Med Chem Lett. 2003 Jan 20;13(2):161-4.
• [3755] The discovery and synthesis of highly potent subtype selective phosphodiesterase 4D inhibitors. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5502-5.
• [3756] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1879).
• [3757] Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide. Arzneimittelforschung. 1988 Mar;38(3):372-8.
• [3758] Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,... J Med Chem. 1992 Sep 18;35(19):3474-82.
• [3759] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4238).
• [3760] Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol. 1998 Aug;275(2 Pt 2):H385-92.
• [3761] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5886).
• [3762] 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors. Mol Pharmacol. 1991 Jul;40(1):22-7.
• [3763] 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors. Mol Pharmacol. 1992 Feb;41(2):267-72.
• [3764] Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation ... J Med Chem. 1993 Sep 17;36(19):2771-87.
• [3765] Antifungal lipopeptides: Structure-activity relationships of 3-hydroxyglutamine-modified pneumocandin B0 derivatives, Bioorg. Med. Chem. Lett. 5(20):2357-2362 (1995).
• [3766] Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics... J Med Chem. 1997 Aug 29;40(18):2866-75.
• [3767] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2104).
• [3768] Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob Agents Chemother. 2001 Sep;45(9):2510-6.
• [3769] High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group. J Med Chem. 1994 Mar 18;37(6):719-21.
• [3770] N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists. J Med Chem. 1993 Jul 9;36(14):2044-5.
• [3771] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3069).
• [3772] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3068).
• [3773] Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. J Med Chem. 2000 Sep 21;43(19):3453-73.
• [3774] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2592).
• [3775] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3117).
• [3776] N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. J Med Chem. 1996 Jul 19;39(15):2907-14.
• [3777] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 880).
• [3778] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8030).
• [3779] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 881).
• [3780] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 177).
• [3781] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3302).
• [3782] Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorg Med Chem Lett. 2006 May 1;16(9):2528-31.
• [3783] Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents. J Med Chem. 1997 Oct 24;40(22):3501-3.
• [3784] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3932).
• [3785] From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors, Bioorg. Med. Chem. Lett. 6(6):725-730 (1996).
• [3786] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 978).
• [3787] Molecular model of the alpha(IIb)beta(3) integrin. J Med Chem. 2003 Dec 4;46(25):5316-25.
• [3788] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 748).
• [3789] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 749).
• [3790] 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. J Med Chem. 1999 Feb 25;42(4):691-705.
• [3791] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2696).
• [3792] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 506).
• [3793] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 16).
• [3794] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2050).
• [3795] The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorg Med Chem Lett. 2006 Jan 15;16(2):378-81.
• [3796] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2688).
• [3797] Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1457-61.
• [3798] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2073).
• [3799] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2689).
• [3800] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2015).
• [3801] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1941).
• [3802] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2082).
• [3803] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2016).
• [3804] Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor. Bioorg Med Chem. 2001 Aug;9(8):1977-84.
• [3805] Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase. J Med Chem. 2006 Mar 23;49(6):1867-73.
• [3806] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1880).
• [3807] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1907).
• [3808] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1412).
• [3809] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5324).
• [3810] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4533).
• [3811] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4686).
• [3812] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4625).
• [3813] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1368).
• [3814] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5329).
• [3815] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5413).
• [3816] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4719).
• [3817] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5198).
• [3818] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3311).
• [3819] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2932).
• [3820] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3312).
• [3821] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4751).
• [3822] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 724).
• [3823] Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations. J Med Chem. 2005 Sep 22;48(19):6090-106.
• [3824] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4814).
• [3825] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 725).
• [3826] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4752).
• [3827] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 726).
• [3828] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4785).
• [3829] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4516).
• [3830] Tryptophan-containing dipeptide derivatives as potent PPARgamma antagonists: design, synthesis, biological evaluation, and molecular modeling. Eur J Med Chem. 2008 Dec;43(12):2699-716.
• [3831] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4794).
• [3832] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4750).
• [3833] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4720).
• [3834] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2194).
• [3835] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5208).
• [3836] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3463).
• [3837] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3357).
• [3838] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2746).
• [3839] Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues. J Med Chem. 2010 Jun 24;53(12):4654-67.
• [3840] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5534).
• [3841] Novel antiproliferative agents derived from lavendustin A. J Med Chem. 1994 Nov 25;37(24):4079-84.
• [3842] Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide. J Med Chem. 2003 Aug 14;46(17):3612-22.
• [3843] The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways. Mol Pharmacol. 2010 Jul;78(1):142-50.
• [3844] A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase). Bioorg Med Chem Lett. 2001 Dec 3;11(23):3069-72.
• [3845] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7858).
• [3846] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6003).
• [3847] The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature. 2014 Mar 27;507(7493):508-12.
• [3848] ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Am J Med Genet A. 2014 Jan;164A(1):220-4.
• [3849] Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3729-32.
• [3850] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3433).
• [3851] Ferrochelatase, a novel target for photodynamic therapy of cancer. Oncol Rep. 1999 Nov-Dec;6(6):1439-42.
• [3852] The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144. J Nat Prod. 2009 Nov;72(11):1944-8.
• [3853] A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology. 2007 Oct;114(10):1822-30.
• [3854] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 270).
• [3855] Leualacin, a novel calcium blocker from Hapsidospora irregularis. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo). 1992 Jun;45(6):899-905.
• [3856] New leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge Leucetta microraphis. J Nat Prod. 1993 Jan;56(1):116-21.
• [3857] Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors. Eur J Med Chem. 2010 Feb;45(2):805-10.
• [3858] Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing. J Med Chem. 2011 Jun 23;54(12):4172-86.
• [3859] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1613).
• [3860] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 358).
• [3861] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 508).
• [3862] 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists. J Med Chem. 1998 Oct 22;41(22):4354-9.
• [3863] Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. J Med Chem. 2007 May 17;50(10):2486-96.
• [3864] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2814).
• [3865] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2787).
• [3866] Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1527-31.
• [3867] Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19244-9.
• [3868] Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5155-7.
• [3869] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2469).
• [3870] RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor, Bioorg. Med. Chem. Lett. 7(13):1715-1720 (1997).
• [3871] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1052).
• [3872] Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks. J Med Chem. 2009 Dec 10;52(23):7883-6.
• [3873] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7893).
• [3874] Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar;2(1):93-6.
• [3875] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 326).
• [3876] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 544).
• [3877] Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also ... Bioorg Med Chem. 2010 Jan 15;18(2):597-604.
• [3878] Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. J Pharmacol Exp Ther. 2001 Apr;297(1):114-20.
• [3879] Potential affinity labels for the opiate receptor based on fentanyl and related compounds. J Med Chem. 1982 Aug;25(8):913-9.
• [3880] Lophocladines, bioactive alkaloids from the red alga Lophocladia sp. J Nat Prod. 2006 Apr;69(4):640-4.
• [3881] Lorneic acids, trialkyl-substituted aromatic acids from a marine-derived actinomycete. J Nat Prod. 2009 Nov;72(11):2046-8.
• [3882] Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2. J Med Chem. 2007 Aug 23;50(17):4214-21.
• [3883] Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor act... J Med Chem. 2008 Sep 25;51(18):5813-22.
• [3884] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4576).
• [3885] 236th ACS National Meeting
• [3886] LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angew Chem Int Ed Engl. 2015 May 18;54(21):6217-21.
• [3887] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5395).
• [3888] A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice. Bioorg Med Chem Lett. 2007 Apr 1;17(7):1916-9.
• [3889] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2192).
• [3890] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6394).
• [3891] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6395).
• [3892] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6739).
• [3893] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6706).
• [3894] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5214).
• [3895] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3354).
• [3896] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3412).
• [3897] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5863).
• [3898] Bicyclo[2.2.2]octanes: close structural mimics of the nuclear receptor-binding motif of steroid receptor coactivators. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4118-22.
• [3899] Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol. 2007 Jun;14(6):645-57.
• [3900] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6237).
• [3901] Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. J Pharmacol Exp Ther. 1999 Mar;288(3):984-92.
• [3902] Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy. Clin Sci (Lond). 2002 Aug;103 Suppl 48:276S-279S.
• [3903] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4756).
• [3904] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5435).
• [3905] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5607).
• [3906] Hybrid ortho/allosteric ligands for the adenosine A(1) receptor. J Med Chem. 2010 Apr 22;53(8):3028-37.
• [3907] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 376).
• [3908] Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs. Toxicol Appl Pharmacol. 2014 Jan 1;274(1):78-86.
• [3909] Phospholipase A2 inhibitors from marine organisms. J Nat Prod. 1992 Dec;55(12):1701-17.
• [3910] Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. J Nat Prod. 2001 Dec;64(12):1545-7.
• [3911] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1026).
• [3912] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3411).
• [3913] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5216).
• [3914] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 18).
• [3915] Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. Eur J Med Chem. 2008 Jan;43(1):62-72.
• [3916] Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists. J Med Chem. 1993 Nov 26;36(24):3982-4.
• [3917] LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family. Bioorg Med Chem Lett. 2001 Apr 9;11(7):909-13.
• [3918] (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H... J Med Chem. 1996 Jul 5;39(14):2664-71.
• [3919] Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagon... Neurosci Lett. 2002 Sep 20;330(2):127-30.
• [3920] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1394).
• [3921] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3349).
• [3922] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2659).
• [3923] Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur J Pharmacol. 2009 Mar 1;605(1-3):53-6.
• [3924] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 178).
• [3925] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 179).
• [3926] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6631).
• [3927] The anti-inflammatory effects of LY178002 and LY256548. Agents Actions. 1989 Jun;27(3-4):300-2.
• [3928] Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects. Mol Pharmacol. 2012 Jan;81(1):41-52.
• [3929] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3992).
• [3930] LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther. 2008 Apr;7(4):829-40.
• [3931] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6938).
• [3932] Identification of a new antifungal target site through a dual biochemical and molecular-genetics approach. Curr Genet. 1996 Jul 31;30(2):159-65.
• [3933] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 180).
• [3934] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4243).
• [3935] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4244).
• [3936] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4712).
• [3937] Histidine kinases as targets for new antimicrobial agents. Bioorg Med Chem. 2002 Apr;10(4):855-67.
• [3938] Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors. Pharm Res. 2000 Dec;17(12):1482-8.
• [3939] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6910).
• [3940] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3350).
• [3941] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 181).
• [3942] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 742).
• [3943] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 182).
• [3944] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 231).
• [3945] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4246).
• [3946] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 21).
• [3947] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4247).
• [3948] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3347).
• [3949] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3346).
• [3950] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4250).
• [3951] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5441).
• [3952] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 184).
• [3953] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2606).
• [3954] New cytotoxic bisindole alkaloids with protein tyrosine kinase inhibitory activity from a myxomycete Lycogala epidendrum. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2776-80.
• [3955] L-lysinethiol: a subnanomolar inhibitor of aminopeptidase B. Biochem Biophys Res Commun. 1987 Jun 30;145(3):1038-42.
• [3956] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 139).
• [3957] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 123).
• [3958] Characterization of Acetylcholinesterase Inhibitory Constituents from Annona glabra Assisted by HPLC Microfractionation. J Nat Prod. 2010 Oct 22;73(10):1632-5.
• [3959] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2508).
• [3960] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5652).
• [3961] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4028).
• [3962] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4064).
• [3963] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4499).
• [3964] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4498).
• [3965] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1913).
• [3966] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6396).
• [3967] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 142).
• [3968] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5020).
• [3969] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5097).
• [3970] Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor. Chem Pharm Bull (Tokyo). 2001 Oct;49(10):1237-44.
• [3971] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6376).
• [3972] Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1173-80.
• [3973] Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits. Eur J Pharmacol. 2008 Mar10;581(3):296-305.
• [3974] Novel thrombin inhibitors that are based on a macrocyclic tripeptide motif, Bioorg. Med. Chem. Lett. 6(24):2947-2952 (1996).
• [3975] Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. J Med Chem. 2007 May 31;50(11):2742-6.
• [3976] Makaluvamine N: a new pyrroloiminoquinone from Zyzzya fuliginosa. J Nat Prod. 1997 Apr;60(4):408-10.
• [3977] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2480).
• [3978] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):573-8.
• [3979] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5219).
• [3980] 2-N-Methyl modifications and SAR studies of manzamine A. Bioorg Med Chem. 2008 Jul 15;16(14):6702-6.
• [3981] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1414).
• [3982] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2548).
• [3983] Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5. Angew Chem Int Ed Engl. 2004 Jul 26;43(30):3974-6.
• [3984] Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiati... Br J Pharmacol. 1997 Mar;120(6):1119-27.
• [3985] 14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid rece... J Med Chem. 2009 Nov 12;52(21):6926-30.
• [3986] A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015 Mar;21(3):248-55.
• [3987] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1439).
• [3988] Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. Chest. 2001 Feb;119(2):554-61.
• [3989] Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor. Bioorg Med Chem. 2007 Mar 1;15(5):1989-2005.
• [3990] Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands. J Med Chem. 2009 Dec 10;52(23):7389-96.
• [3991] In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors. Bioorg Med Chem. 2007 Jun 15;15(12):4106-12.
• [3992] Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1507-9.
• [3993] High-affinity carbamate analogues of morphinan at opioid receptors. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1508-11.
• [3994] New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores. J Med Chem. 2006 Sep 7;49(18):5640-3.
• [3995] Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines. Bioorg Med Chem Lett. 2009 Jan 1;19(1):51-3.
• [3996] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1340).
• [3997] International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands. Pharmacol Rev. 2014 Oct;66(4):918-47.
• [3998] Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. J Pharmacol Exp Ther. 1999 Sep;290(3):1034-40.
• [3999] 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase. J Med Chem. 1997 Sep 26;40(20):3263-70.
• [4000] Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3. J Med Chem. 2013 Dec 12;56(23):9556-68.
• [4001] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1447).
• [4002] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1448).
• [4003] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1449).
• [4004] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4697).
• [4005] Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels Ca V 1.3 and Ca V 1.2. Bioorg Med Chem. 2010 May 1;18(9):3147-58.
• [4006] Anti CD37 antibodies
• [4007] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1053).
• [4008] Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors. Bioorg Med Chem Lett. 2004 Mar 22;14(6):1483-6.
• [4009] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6260).
• [4010] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5415).
• [4011] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1298).
• [4012] Involvement of protein kinase C activation in L-leucine-induced stimulation of protein synthesis in l6 myotubes. Cytotechnology. 2003 Nov;43(1-3):97-103.
• [4013] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8570).
• [4014] Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1551-4.
• [4015] Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin com... J Med Chem. 2008 Feb 28;51(4):737-51.
• [4016] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5331).
• [4017] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5021).
• [4018] 4-Phenylcoumarins from Mesua elegans with acetylcholinesterase inhibitory activity. Bioorg Med Chem. 2010 Nov 15;18(22):7873-7.
• [4019] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 206).
• [4020] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 638).
• [4021] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2304).
• [4022] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6644).
• [4023] Glucose utilization and activity of glucose-6-phosphate dehydrogenase, isocitrate dehydrogenase and malate dehydrogenase in rat erythrocytes after treatment with tuberculostatic agents. Vopr Med Khim. 1986 Sep-Oct;32(5):32-5.
• [4024] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2506).
• [4025] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1254).
• [4026] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5829).
• [4027] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 89).
• [4028] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 327).
• [4029] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2812).
• [4030] Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters. Bioorg Med Chem. 2007 Jun 15;15(12):4159-74.
• [4031] Peptidyl-urea based inhibitors of soluble epoxide hydrolases. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5439-44.
• [4032] Synthetic studies on selective adenosine A2A receptor antagonists: synthesis and structure-activity relationships of novel benzofuran derivatives. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1090-3.
• [4033] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5222).
• [4034] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5218).
• [4035] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6290).
• [4036] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6273).
• [4037] Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorg Med Chem Lett. 2010 Jan 15;20(2):537-40.
• [4038] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2431).
• [4039] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3459).
• [4040] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3427).
• [4041] Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioampheta... Bioorg Med Chem. 2010 Jun 1;18(11):4009-31.
• [4042] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4574).
• [4043] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 300).
• [4044] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1205).
• [4045] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5223).
• [4046] alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem. 1982 Dec;25(12):1389-401.
• [4047] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4662).
• [4048] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1233).
• [4049] Cardiovascular response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves. Vet J. 1999 Jan;157(1):31-7.
• [4050] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2141).
• [4051] 4-Amino-6-chloro-2-piperazinopyrimidines with selective affinity for alpha 2-adrenoceptors. J Med Chem. 1986 Aug;29(8):1394-8.
• [4052] SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1593-7.
• [4053] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6068).
• [4054] Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.J Mol Model.2009 Dec;15(12):1481-90.
• [4055] Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.J Bone Miner Res.2012 Aug;27(8):1811-20.
• [4056] Effects of hEGF (MG111) on gastric mucosal potential difference in rats. Scand J Gastroenterol Suppl. 1989;162:198-201.
• [4057] Basic nuclear processes affected by histone acetyltransferases and histone deacetylase inhibitors. Epigenomics. 2013 Aug;5(4):379-96.
• [4058] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1395).
• [4059] Novel Furin Inhibitors with Potent Anti-infectious Activity. ChemMedChem. 2015 Jul;10(7):1218-31.
• [4060] Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol. 2012 Jan 29;8(3):277-84.
• [4061] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4735).
• [4062] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5478).
• [4063] miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 2008 Oct;57(10):2708-17.
• [4064] Pharmacological characteristics of MJ-451, a new benzopyran- derived ATP-sensitive potassium channel opener, in guinea pig isolated trachea. Pharmacology. 1998 Dec;57(6):314-22.
• [4065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8515).
• [4066] Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.J Psychopharmacol.2008 Jan;22(1):24-32.
• [4067] Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalan... Bioorg Med Chem Lett. 2009 Oct 1;19(19):5803-6.
• [4068] Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. J Med Chem. 2002 Jun 6;45(12):2644-50.
• [4069] Identification of MK-1925: a selective, orally active and brain-penetrable opioid receptor-like 1 (ORL1) antagonist. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4729-32.
• [4070] [Agonists of 5HT2C-receptors SCH 23390 and MK 212 incresase the force of rat aorta contraction in the presence of vasopressin and angiotensin II].Patol Fiziol Eksp Ter.2014 Oct-Dec;(4):17-29.
• [4071] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6170).
• [4072] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6335).
• [4073] TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides. 1989 Jan-Feb;10(1):121-4.
• [4074] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 249).
• [4075] Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel ... Neurogastroenterol Motil. 2001 Dec;13(6):543-53.
• [4076] ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth. Peptides. 2015 Feb;64:55-61.
• [4077] From imidazoles to pyrimidines: new inhibitors of cytokine release. J Med Chem. 2002 Jun 20;45(13):2733-40.
• [4078] Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem. 2003 Jul 17;46(15):3230-44.
• [4079] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6014).
• [4080] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5437).
• [4081] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4255).
• [4082] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7665).
• [4083] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7720).
• [4084] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6282).
• [4085] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6314).
• [4086] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7666).
• [4087] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8322).
• [4088] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7768).
• [4089] Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun15;23(12):3654-61.
• [4090] Discovery, optimization, and characterization of a novel series of dopamine D2 versus D3 receptor selective antagonists. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010.
• [4091] Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52.
• [4092] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7631).
• [4093] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8687).
• [4094] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8591).
• [4095] Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo Activity. ACS Med Chem Lett. 2014 Jul 9;5(9):1060-4.
• [4096] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4256).
• [4097] Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta. Blood. 2006 Jun 1;107(11):4266-73.
• [4098] Discovery and characterization of a G protein-biased agonist that inhibits beta-arrestin recruitment to the D2 dopamine receptor. Mol Pharmacol. 2014 Jul;86(1):96-105.
• [4099] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4062).
• [4100] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3341).
• [4101] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6219).
• [4102] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6220).
• [4103] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6221).
• [4104] The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. Mol Cancer Ther. 2004 Dec;3(12):1513-24.
• [4105] Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther. 1995 Nov;275(2):854-63.
• [4106] Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis. J Nat Prod. 2010 Mar 26;73(3):459-62.
• [4107] Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation. Cardiovasc Drug Rev. 2002 Winter;20(1):67-80.
• [4108] Synthesis and characterization of the second cysteine-rich region of mouse skin PKCGh, Bioorg. Med. Chem. Lett. 6(4):353-356 (1996).
• [4109] Monodictyochromes A and B, dimeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J Nat Prod. 2008 Nov;71(11):1793-9.
• [4110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5786).
• [4111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 411).
• [4112] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6473).
• [4113] Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2. Eur J Med Chem. 2010 Oct;45(10):4594-600.
• [4114] Morphinan cyclic imines and pyrrolidines containing a constrained phenyl group: High affinity opioid agonists, Bioorg. Med. Chem. Lett. 5(24):2969-2974 (1995).
• [4115] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4595).
• [4116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 460).
• [4117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 71).
• [4118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4568).
• [4119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1415).
• [4120] Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity. Bioorg Med Chem Lett. 2009 Jan 1;19(1):108-10.
• [4121] The MCH(1) receptor, an anti-obesity target, is allosterically inhibited by 8-methylquinoline derivatives possessing subnanomolar binding and long residence times. Br J Pharmacol. 2014 Mar;171(5):1287-98.
• [4122] Electrophilic gamma-lactone kappa-opioid receptor probes. Analogues of 2'-hydroxy-2-tetrahydrofurfuryl-5,9-dimethyl-6,7-benzomorphan diastereomers. J Med Chem. 1991 Aug;34(8):2438-44.
• [4123] Design and synthesis of a new type of non steroidal human aromatase inhibitors. Bioorg Med Chem Lett. 1998 May 5;8(9):1041-4.
• [4124] Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents. J Med Chem. 2004 Mar 11;47(6):1448-64.
• [4125] Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. J Med Chem. 2004 Mar 11;47(6):1434-47.
• [4126] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 477).
• [4127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 465).
• [4128] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4257).
• [4129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6496).
• [4130] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 448).
• [4131] Purine and pyrimidine (P2) receptors as drug targets. J Med Chem. 2002 Sep 12;45(19):4057-93.
• [4132] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1720).
• [4133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 392).
• [4134] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 393).
• [4135] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 394).
• [4136] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 395).
• [4137] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 466).
• [4138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 397).
• [4139] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 398).
• [4140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 429).
• [4141] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 399).
• [4142] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 467).
• [4143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 400).
• [4144] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 468).
• [4145] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 469).
• [4146] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 470).
• [4147] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 471).
• [4148] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 472).
• [4149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 473).
• [4150] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 474).
• [4151] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3287).
• [4152] Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochem Pharmacol. 2005 Jul 15;70(2):266-74.
• [4153] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1727).
• [4154] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1722).
• [4155] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3338).
• [4156] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1723).
• [4157] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1724).
• [4158] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1752).
• [4159] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1753).
• [4160] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1778).
• [4161] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3337).
• [4162] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1747).
• [4163] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1733).
• [4164] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4043).
• [4165] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1748).
• [4166] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5909).
• [4167] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5908).
• [4168] Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate delta-ester modifications as selective agonists of the P2Y(4) receptor. J Med Chem. 2011 Jun 23;54(12):4018-33.
• [4169] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5809).
• [4170] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5903).
• [4171] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4044).
• [4172] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5622).
• [4173] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8421).
• [4174] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 401).
• [4175] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 402).
• [4176] Novel cross-talk within the IKK family controls innate immunity. Biochem J. 2011 Feb 15;434(1):93-104.
• [4177] Down-regulation of NF- B transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem. 2012 Aug 17;287(34):28840-51.
• [4178] Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. J Med Chem. 2013 Nov 27;56(22):9251-64.
• [4179] Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol. 2006 Jan;13(1):81-90.
• [4180] Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway. EMBO Mol Med. 2010 Dec;2(12):504-15.
• [4181] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1440).
• [4182] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4258).
• [4183] Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem. 2004 Apr 30;279(18):18103-6.
• [4184] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6272).
• [4185] Studies toward the total synthesis of mumbaistatin, a highly potent glucose-6-phosphate translocase inhibitor. Synthesis of a mumbaistatin analogue. J Org Chem. 2002 Dec 27;67(26):9248-56.
• [4186] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5024).
• [4187] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3996).
• [4188] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4090).
• [4189] Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase. Bioorg Med Chem. 2008 Aug 1;16(15):7462-9.
• [4190] Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycoph... Bioorg Med Chem. 2010 Nov 15;18(22):8106-11.
• [4191] Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors. J Med Chem. 2001 Dec 20;44(26):4497-500.
• [4192] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6664).
• [4193] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2806).
• [4194] N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5752-6.
• [4195] Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J Med Chem. 2006 Apr 6;49(7):2166-73.
• [4196] The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40.
• [4197] N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the alpha2delta subunit of voltage gated calcium channels. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1913-6.
• [4198] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 423).
• [4199] Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase. J Med Chem. 1998 Jul 2;41(14):2636-42.
• [4200] Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a n... J Med Chem. 2003 Dec 4;46(25):5546-51.
• [4201] Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinas... J Med Chem. 1996 Apr 26;39(9):1823-35.
• [4202] Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. J Med Chem. 2008 Apr 10;51(7):2027-36.
• [4203] Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents. J Med Chem. 1998 Aug 13;41(17):3298-302.
• [4204] Synthesis and characterization of N-(acenaphth-5-yl)-N'-(4-methoxynaphth-1-yl)guanidine as a glutamate release inhibitor and potential anti-ischemic agent, Bioorg. Med. Chem. Lett. 5(19):2259-2262 (1995).
• [4205] Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution. J Med Chem. 1997 Aug 15;40(17):2733-9.
• [4206] Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5832-5.
• [4207] 1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity. Bioorg Med Chem Lett. 2008 Jan 15;18(2):596-9.
• [4208] Synthesis and analgesic activity of secondary amine analogues of pyridylmethylamine and positional isomeric analogues of ABT-594. Bioorg Med Chem Lett. 2006 Apr 1;16(7):2013-6.
• [4209] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5229).
• [4210] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1270).
• [4211] Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1346-9.
• [4212] Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem. 2013 Apr;62:352-70.
• [4213] Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. Bioorg Med Chem. 2008 Nov 15;16(22):9729-40.
• [4214] Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K. J Med Chem. 2006 Feb 9;49(3):1066-79.
• [4215] Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the ... Bioorg Med Chem Lett. 2007 Mar 15;17(6):1565-9.
• [4216] Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the a... Bioorg Med Chem Lett. 2007 Mar 15;17(6):1570-4.
• [4217] Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. Eur J Med Chem. 2009 Dec;44(12):4889-95.
• [4218] Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into huma... J Med Chem. 2009 Dec 10;52(23):7528-36.
• [4219] Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5445-50.
• [4220] Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors. Bioorg Med Chem Lett. 2010 Dec 1;20(23):6890-4.
• [4221] N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2263-6.
• [4222] New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide. J Med Chem. 2008 Dec 25;51(24):7800-5.
• [4223] Mapping the melatonin receptor. 2. synthesis and biological activity of indole derived melatonin analogues with restricted conformations of the C-3 amidoethane side chain, Bioorg. Med. Chem. Lett. 4(13):1559-1564 (1994).
• [4224] Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors. J Med Chem. 1996 Aug 2;39(16):3089-95.
• [4225] Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short al... J Med Chem. 2010 Mar 11;53(5):1937-50.
• [4226] N-Benzylbenzamides: a new class of potent tyrosinase inhibitors. Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4.
• [4227] Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4. Bioorg Med Chem. 2008 Aug 15;16(16):7728-39.
• [4228] Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3. Bioorg Med Chem. 2008 May 1;16(9):4954-62.
• [4229] Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1697-700.
• [4230] Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg Med Chem Lett. 2010 May 15;20(10):3142-5.
• [4231] Bioorg Med Chem Lett. 2008 Dec 1;18(23):6104-9. Epub 2008 Oct 14.SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2).
• [4232] Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk. Bioorg Med Chem Lett. 2007 Sep 1;17(17):4961-6.
• [4233] N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6729-33.
• [4234] Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity. J Med Chem. 2007 Nov 15;50(23):5543-6.
• [4235] Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. J Med Chem. 2007 Apr 5;50(7):1635-44.
• [4236] New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6505-10.
• [4237] Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers. J Med Chem. 2001 Nov 8;44(23):3764-7.
• [4238] Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition. J Med Chem. 2006 Feb 23;49(4):1413-9.
• [4239] Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH. Bioorg Med Chem. 2009 Jan 1;17(1):49-56.
• [4240] Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors. Bioorg Med Chem Lett. 2005 Apr 15;15(8):1969-72.
• [4241] Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5439-41.
• [4242] Structure-activity relationships of novel non-competitive mGluR1 antagonists: a potential treatment for chronic pain. Bioorg Med Chem Lett. 2007 Jan 15;17(2):486-90.
• [4243] Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6070-4.
• [4244] Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. J Med Chem. 2005 Dec 1;48(24):7688-707.
• [4245] Novel sterically hindered cannabinoid CB1 receptor ligands. Bioorg Med Chem. 2008 Aug 1;16(15):7510-5.
• [4246] Inhibitors of anthrax lethal factor. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4575-8.
• [4247] Inhibitors of anthrax lethal factor based upon N-oleoyldopamine. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2467-70.
• [4248] Emerging targets in osteoporosis disease modification. J Med Chem. 2010 Jun 10;53(11):4332-53.
• [4249] Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2582-5.
• [4250] 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists. J Med Chem. 2009 Feb 12;52(3):826-33.
• [4251] Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibi... J Med Chem. 2009 Oct 8;52(19):5864-71.
• [4252] Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5274-9.
• [4253] Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3799-802.
• [4254] (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors. J Med Chem. 1997 Jun 20;40(13):2017-34.
• [4255] Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5537-42.
• [4256] Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors. J Med Chem. 2004 Dec 30;47(27):6749-59.
• [4257] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4773).
• [4258] Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. J Med Chem. 2006 Sep 21;49(19):5664-70.
• [4259] Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetr... J Med Chem. 2007 Feb 22;50(4):807-19.
• [4260] 4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5275-9.
• [4261] Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors. J Med Chem. 2006 Jul 27;49(15):4455-8.
• [4262] Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3227-30.
• [4263] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxy... Bioorg Med Chem Lett. 2005 May 2;15(9):2353-8.
• [4264] Novel D3 selective dopaminergics incorporating enyne units as nonaromatic catechol bioisosteres: synthesis, bioactivity, and mutagenesis studies. J Med Chem. 2008 Nov 13;51(21):6829-38.
• [4265] Amide-based inhibitors of p38alpha MAP kinase. Part 2: design, synthesis and SAR of potent N-pyrimidyl amides. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2560-3.
• [4266] Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands. Bioorg Med Chem. 2010 Feb 15;18(4):1381-7.
• [4267] Synthesis of benzamide derivatives as TRPV1 antagonists. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1072-8.
• [4268] Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP... J Med Chem. 1999 May 20;42(10):1803-15.
• [4269] Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers. Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.
• [4270] Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines. Bioorg Med Chem Lett. 2002 Jan 21;12(2):181-4.
• [4271] Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. J Med Chem. 2007 Feb 8;50(3):566-84.
• [4272] Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity. Bioorg Med Chem. 2010 Jul 15;18(14):5081-9.
• [4273] Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class ... J Med Chem. 2005 Dec 15;48(25):8087-97.
• [4274] Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1807-10.
• [4275] Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes ... Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5.
• [4276] Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J Med Chem. 1999 Nov 4;42(22):4669-79.
• [4277] (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1. J Med Chem. 2005 Apr 21;48(8):2882-91.
• [4278] Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation. 2001 Feb 6;103(5):718-23.
• [4279] Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2344-9.
• [4280] Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Apr 1;17(7):2074-9.
• [4281] Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3844-7.
• [4282] Sulfamides as novel histone deacetylase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):336-40.
• [4283] A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5716-21.
• [4284] Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases. J Med Chem. 2009 May 14;52(9):2683-93.
• [4285] Phosphoramidate peptide inhibitors of human skin fibroblast collagenase. J Med Chem. 1990 Jan;33(1):263-73.
• [4286] Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-... J Med Chem. 2007 Apr 5;50(7):1627-34.
• [4287] Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase. Bioorg Med Chem. 2010 Jan 1;18(1):267-73.
• [4288] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 158).
• [4289] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 159).
• [4290] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5420).
• [4291] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5451).
• [4292] Synthesis and evaluation of D-gluco-pyranocyclopropyl amines as potential glucosidase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6600-3.
• [4293] N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob Agents Chemother. 2002 Sep;46(9):2752-64.
• [4294] Litebamine N-homologues: preparation and anti-acetylcholinesterase activity. J Nat Prod. 1998 Jan;61(1):46-50.
• [4295] Endomorphin-1 analogs with enhanced metabolic stability and systemic analgesic activity: design, synthesis, and pharmacological characterization. Bioorg Med Chem. 2007 Feb 15;15(4):1694-702.
• [4296] Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. J Med Chem. 2006 Apr 6;49(7):2333-8.
• [4297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3635).
• [4298] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5495).
• [4299] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5494).
• [4300] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5493).
• [4301] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 332).
• [4302] Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2823-7.
• [4303] Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin ... J Med Chem. 2001 Feb 1;44(3):441-52.
• [4304] CB2 selective sulfamoyl benzamides: optimization of the amide functionality. Bioorg Med Chem Lett. 2009 Jan 15;19(2):309-13.
• [4305] Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5303-8.
• [4306] Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1... J Med Chem. 2007 Jul 26;50(15):3730-42.
• [4307] Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 2003 Jul 18;978(1-2):99-103.
• [4308] Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. J Biol Chem. 2007 Nov 9;282(45):32655-64.
• [4309] Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids. J Med Chem. 1985 Mar;28(3):328-32.
• [4310] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 344).
• [4311] Discovery of a potent and brain penetrant mGluR5 positive allosteric modulator. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3275-8.
• [4312] Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms. Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):190-201.
• [4313] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5445).
• [4314] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4586).
• [4315] N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists. Bioorg Med Chem. 2009 Jul 1;17(13):4756-62.
• [4316] Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy... Bioorg Med Chem Lett. 2007 Jul 15;17(14):3978-82.
• [4317] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1271).
• [4318] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5335).
• [4319] Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases. J Med Chem. 2008 Sep 25;51(18):5736-44.
• [4320] Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme w... Bioorg Med Chem. 2007 Sep 15;15(18):6200-7.
• [4321] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5444).
• [4322] Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8.
• [4323] Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3333-7.
• [4324] N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity. Bioorg Med Chem Lett. 2005 Jan 3;15(1):181-3.
• [4325] Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem. 2008 Jan 1;16(1):530-5.
• [4326] In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase. J Med Chem. 1987 Nov;30(11):2121-6.
• [4327] Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. J Med Chem. 1997 Feb 28;40(5):819-24.
• [4328] Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5.
• [4329] Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents. J Enzyme Inhib. 1998 Jul;13(4):267-84.
• [4330] Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular mo... J Med Chem. 2001 Jul 5;44(14):2286-97.
• [4331] Synthesis of N-isobutylnoroxymorphone from naltrexone by a selective cyclopropane ring opening reaction. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4978-81.
• [4332] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5733).
• [4333] Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands. Bioorg Med Chem Lett. 2006 Feb 15;16(4):934-7.
• [4334] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6194).
• [4335] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5419).
• [4336] 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):81-90.
• [4337] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4652).
• [4338] GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol. 2001 Oct;134(4):896-904.
• [4339] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1242).
• [4340] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5522).
• [4341] Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. Bioorg Med Chem Lett. 2010 Oct 15;20(20):6093-5.
• [4342] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5552).
• [4343] Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads. Bioorg Med Chem. 2008 Dec 15;16(24):10205-9.
• [4344] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6525).
• [4345] A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". J Med Chem. 2006 Nov 2;49(22):6539-48.
• [4346] Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-... Bioorg Med Chem Lett. 2007 May 1;17(9):2430-3.
• [4347] New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. J Med Chem. 2007 Dec 27;50(26):6554-69.
• [4348] Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. J Med Chem. 2006 Jan 26;49(2):684-92.
• [4349] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1239).
• [4350] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1241).
• [4351] Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands. J Med Chem. 1988 Oct;31(10):1968-71.
• [4352] Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group. Bioorg Med Chem Lett. 2004 Jan 19;14(2):449-53.
• [4353] Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carbox... J Med Chem. 2010 May 27;53(10):4028-37.
• [4354] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1682).
• [4355] Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment ... Bioorg Med Chem Lett. 2010 Jan 15;20(2):576-80.
• [4356] Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3023-6.
• [4357] A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening. Bioorg Med Chem. 2007 Jan 1;15(1):63-76.
• [4358] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4260).
• [4359] Effects of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on the growth of tumorigenic cell lines in culture. Biochim Biophys Acta. 1996 Jan 10;1310(1):119-26.
• [4360] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5999).
• [4361] On-resin cyclization of peptide ligands of the Vascular Endothelial Growth Factor Receptor 1 by copper(I)-catalyzed 1,3-dipolar azide-alkyne cycloa... Bioorg Med Chem Lett. 2007 Oct 15;17(20):5590-4.
• [4362] Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13. Bioorg Med Chem Lett. 2009 Jan 1;19(1):47-50.
• [4363] Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discover... J Med Chem. 2007 May 31;50(11):2605-8.
• [4364] The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR). J Med Chem. 2006 Jun 15;49(12):3544-52.
• [4365] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6538).
• [4366] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4684).
• [4367] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5228).
• [4368] Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands. Bioorg Med Chem. 2007 Aug 15;15(16):5440-7.
• [4369] Neuroprotective principles from Gastrodia elata. J Nat Prod. 2007 Apr;70(4):571-4.
• [4370] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 380).
• [4371] N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A... Eur J Med Chem. 2008 Aug;43(8):1639-47.
• [4372] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2450).
• [4373] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1405).
• [4374] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4261).
• [4375] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3045).
• [4376] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3041).
• [4377] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6982).
• [4378] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 44).
• [4379] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4263).
• [4380] Nahuoic acid A produced by a Streptomyces sp. isolated from a marine sediment is a selective SAM-competitive inhibitor of the histone methyltransferase SETD8. Org Lett. 2013 Jan 18;15(2):414-7.
• [4381] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1664).
• [4382] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1629).
• [4383] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1677).
• [4384] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3828).
• [4385] Naphthyridinomycin-DNA adducts: a molecular modeling study. J Antibiot (Tokyo). 1991 Aug;44(8):885-94.
• [4386] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4738).
• [4387] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3226).
• [4388] Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem. 2007 Mar 30;282(13):9657-65.
• [4389] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2374).
• [4390] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4626).
• [4391] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 839).
• [4392] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4513).
• [4393] A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes. 2000 May;49(5):759-67.
• [4394] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7664).
• [4395] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6471).
• [4396] Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists. J Med Chem. 2008 Dec 11;51(23):7640-4.
• [4397] Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. J Biol Chem. 2005 Sep 9;280(36):31924-35.
• [4398] Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 2009 Mar 1;69(5):2065-71.
• [4399] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 639).
• [4400] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8082).
• [4401] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8083).
• [4402] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 578).
• [4403] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3184).
• [4404] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3165).
• [4405] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3160).
• [4406] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3167).
• [4407] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3168).
• [4408] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3154).
• [4409] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3179).
• [4410] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3166).
• [4411] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3171).
• [4412] Drug-DNA binding specificity: binding of netropsin and distamycin to poly(d2NH2A-dT). Biopolymers. 1990;30(1-2):223-7.
• [4413] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2089).
• [4414] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2090).
• [4415] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 613).
• [4416] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1579).
• [4417] Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. J Med Chem. 2012 Nov 26;55(22):9891-9.
• [4418] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4266).
• [4419] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1761).
• [4420] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1762).
• [4421] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4267).
• [4422] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4046).
• [4423] Discovery of type II inhibitors of TGFbeta-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2). J Med Chem. 2015 Jan 8;58(1):183-96.
• [4424] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6674).
• [4425] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2633).
• [4426] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8573).
• [4427] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6997).
• [4428] Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inh... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6793-6.
• [4429] T-type calcium channels facilitate insulin secretion by enhancing general excitability in the insulin-secreting beta-cell line, INS-1. Endocrinology. 1997 Sep;138(9):3735-40.
• [4430] Determination of nifeviroc, a novel CCR5 antagonist: application to a pharmacokinetic study. J Pharm Biomed Anal. 2011 Nov 1;56(3):637-40.
• [4431] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 545).
• [4432] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4564).
• [4433] Pharmacology of a novel, orally active PDE4 inhibitor. Pharmacology. 2009;83(5):275-86.
• [4434] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4637).
• [4435] Crosslinking of cellular DNA by nitracrine and furocoumarin derivatives. Neoplasma. 1999;46(1):50-3.
• [4436] Synthesis and biological evaluation of 2,5-dihydropyrazol. Bioorg Med Chem Lett. 2000 Dec 4;10(23):2661-4.
• [4437] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4512).
• [4438] The cyclooxygenase inhibitor flurbiprofen reduces radiation-induced angiogenic growth factor secretion of squamous cell carcinoma cell lines. Ann N Y Acad Sci. 2004 Dec;1030:37-42.
• [4439] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6503).
• [4440] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5233).
• [4441] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6028).
• [4442] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2454).
• [4443] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 291).
• [4444] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 292).
• [4445] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 293).
• [4446] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4669).
• [4447] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3515).
• [4448] Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption. Xenobiotica. 1998 Nov;28(11):1083-92.
• [4449] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4610).
• [4450] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3513).
• [4451] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4269).
• [4452] Structure, dynamics and hydration of the nogalamycin-d(ATGCAT)2Complex determined by NMR and molecular dynamics simulations in solution. J Mol Biol. 1999 Jul 16;290(3):699-716.
• [4453] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5227).
• [4454] Activation of an adrenergic pro-drug through sequential stereoselective action of tandem target enzymes. Biochem Biophys Res Commun. 1992 Nov 30;189(1):33-9.
• [4455] Synthesis of 4'-modified noraristeromycins to clarify the effect of the 4'-hydroxyl groups for inhibitory activity against S-adenosyl-L-homocystein... Bioorg Med Chem Lett. 2008 Apr 15;18(8):2615-8.
• [4456] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1642).
• [4457] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 215).
• [4458] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 208).
• [4459] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8222).
• [4460] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6643).
• [4461] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1630).
• [4462] Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3673-7.
• [4463] Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake. J Pharmacol Exp Ther. 2010 Jun;333(3):772-81.
• [4464] Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A. J Nat Prod. 2005 Dec;68(12):1793-5.
• [4465] 5-Substituted pyrido[2,3-d]pyrimidine, an inhibitor against three receptor tyrosine kinases. Bioorg Med Chem Lett. 2009 Feb 1;19(3):745-50.
• [4466] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 675).
• [4467] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4601).
• [4468] A novel class of small molecule inhibitors of HDAC6. ACS Chem Biol. 2012 Feb 17;7(2):331-9.
• [4469] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6554).
• [4470] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4000).
• [4471] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4274).
• [4472] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4275).
• [4473] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3993).
• [4474] Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar. Biochem Biophys Res Commun. 1996 Jun 25;223(3):654-9.
• [4475] Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem. 2010 Jan 15;18(2):822-9.
• [4476] In silico identification and biochemical characterization of novel inhibitors of NQO1. Bioorg Med Chem Lett. 2006 Dec 15;16(24):6246-54.
• [4477] An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. Eur J Med Chem. 2009 Oct;44(10):4121-7.
• [4478] Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identif... J Med Chem. 2004 Dec 30;47(27):6681-90.
• [4479] Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of share... Bioorg Med Chem. 2009 Oct 15;17(20):7145-55.
• [4480] New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: synthesis, resolution, and inhibitory activity. Bioorg Med Chem Lett. 2006 Jun 1;16(11):3034-8.
• [4481] Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic expl... Eur J Med Chem. 2010 Apr;45(4):1598-617.
• [4482] Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast... J Med Chem. 2010 Apr 8;53(7):2757-65.
• [4483] The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4. Clin Cancer Res. 1999 Dec;5(12):4279-86.
• [4484] Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2. Bioorg Med Chem Lett. 2010 May 1;20(9):2832-6.
• [4485] Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemo... J Med Chem. 1998 Jun 18;41(13):2184-93.
• [4486] Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumo... J Med Chem. 2010 Feb 25;53(4):1616-26.
• [4487] Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of a... J Med Chem. 1998 Mar 26;41(7):1155-62.
• [4488] Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening str... J Med Chem. 2006 Jun 29;49(13):3759-62.
• [4489] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6007).
• [4490] Histone deacetylase inhibitors through click chemistry. J Med Chem. 2008 Dec 11;51(23):7417-27.
• [4491] Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries. J Med Chem. 2008 Jul 24;51(14):4188-99.
• [4492] Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target i... Antimicrob Agents Chemother. 2000 Feb;44(2):320-5.
• [4493] Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo. J Biol Chem. 2015 Aug 14;290(33):20044-59.
• [4494] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2699).
• [4495] Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity. J Med Chem. 2006 Sep 7;49(18):5470-7.
• [4496] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8010).
• [4497] Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold. J Med Chem. 2006 Oct 19;49(21):6209-21.
• [4498] Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol Cancer Ther. 2005 Sep;4(9):1328-37.
• [4499] Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein intera... J Med Chem. 2009 Nov 26;52(22):7044-53.
• [4500] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2375).
• [4501] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6668).
• [4502] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2076).
• [4503] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4276).
• [4504] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7584).
• [4505] Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor. J Antimicrob Chemother. 2003 Jan;51(1):157-61.
• [4506] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5525).
• [4507] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 732).
• [4508] The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007 Dec;152(7):1092-101.
• [4509] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6705).
• [4510] ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. Bioorg Med Chem. 2010 Jun 15;18(12):4422-32.
• [4511] Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin. Bioorg Med Chem. 2010 May 1;18(9):3020-5.
• [4512] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6333).
• [4513] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2436).
• [4514] Synthesis of phospholipase A2 inhibitory biflavonoids. Bioorg Med Chem Lett. 2006 May 1;16(9):2373-5.
• [4515] Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differenti... J Med Chem. 2002 Jul 18;45(15):3296-309.
• [4516] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4278).
• [4517] Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for (1)-adre... J Med Chem. 2010 Oct 14;53(19):7021-34.
• [4518] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6995).
• [4519] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5234).
• [4520] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8574).
• [4521] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7023).
• [4522] Ohioensins F and G: protein tyrosine phosphatase 1B inhibitory benzonaphthoxanthenones from the Antarctic moss Polytrichastrum alpinum. Bioorg Med Chem Lett. 2008 Jan 15;18(2):772-5.
• [4523] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8231).
• [4524] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5349).
• [4525] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3306).
• [4526] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1054).
• [4527] Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5580-3.
• [4528] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6308).
• [4529] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2386).
• [4530] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3623).
• [4531] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6983).
• [4532] Which muscarinic receptor is important in the bladder World J Urol. 2001 Nov;19(5):299-306.
• [4533] Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human beta-secretase (BACE1). Bioorg Med Chem. 2007 Jun 15;15(12):4136-43.
• [4534] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6285).
• [4535] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2535).
• [4536] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2912).
• [4537] Pharmacological evaluation of combined PGI2 agonists/thromboxane synthase inhibitors, Bioorg. Med. Chem. Lett. 5(10):1087-1090 (1995).
• [4538] Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1. Cell. 2015 Jun 18;161(7):1633-43.
• [4539] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1978).
• [4540] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1921).
• [4541] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1931).
• [4542] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1933).
• [4543] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5824).
• [4544] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1942).
• [4545] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8537).
• [4546] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1943).
• [4547] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5823).
• [4548] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5821).
• [4549] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1914).
• [4550] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 268).
• [4551] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1699).
• [4552] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 170).
• [4553] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4600).
• [4554] In vivo effects of a potent GnRH antagonist ORG 30850: physiologic evidence that down-regulation of GnRH receptors does not occur. J Soc Gynecol Investig. 1994 Oct-Dec;1(4):290-6.
• [4555] Org 33201: a new highly selective orally active aromatase inhibitor. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):681-2.
• [4556] Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities. Thromb Haemost. 2000 Oct;84(4):611-20.
• [4557] The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.Arthritis Rheum.2010 Feb;62(2):351-8.
• [4558] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3454).
• [4559] A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569. J Biol Chem. 2012 Sep 28;287(40):33873-82.
• [4560] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6481).
• [4561] Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tubercul... Bioorg Med Chem. 2007 Nov 1;15(21):6834-45.
• [4562] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4690).
• [4563] Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates. J Bone Miner Res. 1996 Apr;11(4):535-43.
• [4564] Selected novel anticancer treatments targeting cell signaling proteins. Oncologist. 2001;6(6):517-37.
• [4565] Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci. 2010 Feb;101(2):403-11.
• [4566] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5236).
• [4567] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4538).
• [4568] Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donors. J Med Chem. 2007 Dec 13;50(25):6367-82.
• [4569] Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides. J Med Chem. 2009 Aug 13;52(15):4604-12.
• [4570] Antiandrogenic natural Diels--Alder-type adducts from Brosimum rubescens. J Nat Prod. 1997 Oct;60(10):997-1002.
• [4571] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1199).
• [4572] Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor. Biochem J. 2008 May 15;412(1):103-12.
• [4573] Ligand binding to nucleic acids and proteins: Does selectivity increase with strength Eur J Med Chem. 2008 Nov;43(11):2307-15.
• [4574] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3207).
• [4575] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3208).
• [4576] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3210).
• [4577] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5621).
• [4578] Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: synthesis and biochemical and crystallographic studies. J Med Chem. 2001 Apr 26;44(9):1364-71.
• [4579] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5787).
• [4580] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 308).
• [4581] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7359).
• [4582] Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective a... J Med Chem. 1992 Oct 30;35(22):4143-9.
• [4583] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 68).
• [4584] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4508).
• [4585] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3227).
• [4586] Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4897-902.
• [4587] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2815).
• [4588] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2257).
• [4589] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1833).
• [4590] Inhibitors of aldose reductase and formation of advanced glycation end-products in moutan cortex (Paeonia suffruticosa). J Nat Prod. 2009 Aug;72(8):1465-70.
• [4591] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5547).
• [4592] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6765).
• [4593] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8560).
• [4594] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2920).
• [4595] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4592).
• [4596] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4552).
• [4597] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2709).
• [4598] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2309).
• [4599] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5427).
• [4600] Company report (PhaseBio)
• [4601] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6681).
• [4602] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3948).
• [4603] Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta. Biochemistry. 2008 Jul 15;47(28):7405-13.
• [4604] Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J Biol Chem. 2013 Mar 29;288(13):9408-17.
• [4605] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6370).
• [4606] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8519).
• [4607] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3335).
• [4608] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1773).
• [4609] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3298).
• [4610] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5766).
• [4611] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 620).
• [4612] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 621).
• [4613] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 626).
• [4614] Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors. Bioorg Med Chem Lett. 2009 Dec 15;19(24):6872-6.
• [4615] Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors. Biochem Pharmacol. 2000 Oct 1;60(7):885-98.
• [4616] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5699).
• [4617] (E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists. J Med Chem. 1992 Jun 12;35(12):2342-5.
• [4618] 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.New quantitative structure-activity relationships at N1 for the quinolone antibacterials.J Med Chem.1988 May;31(5):991-1001.
• [4619] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7676).
• [4620] Synthesis and pharmacological evaluation of the enantiomers of the dopamine autoreceptor agonist PD 135385, Bioorg. Med. Chem. Lett. 3(4):639-644 (1993).
• [4621] Selective ligands for cholecystokinin receptor subtypes CCK-A and CCK-B within a single structural class, Bioorg. Med. Chem. Lett. 3(5):881-884 (1993).
• [4622] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 882).
• [4623] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 904).
• [4624] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 905).
• [4625] Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic proper... J Med Chem. 1999 Oct 7;42(20):4239-49.
• [4626] Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist. Pharmacol Biochem Behav. 1998 Feb;59(2):487-93.
• [4627] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2125).
• [4628] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6015).
• [4629] The development of a novel series of non-peptide tachykinin NK3 receptor selective antagonists, Bioorg. Med. Chem. Lett. 5(16):1773-1778 (1995).
• [4630] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5767).
• [4631] gamma-Carbamate butenolide analogues as potent ETA selective endothelin receptor antagonists and prodrugs, Bioorg. Med. Chem. Lett. 7(3):297-302 (1997).
• [4632] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 975).
• [4633] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6016).
• [4634] Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J Med Chem. 2006 Feb 9;49(3):923-31.
• [4635] Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2067-70.
• [4636] Isoindolinone enantiomers having affinity for the dopamine D4 receptor. Bioorg Med Chem Lett. 1998 Jun 16;8(12):1499-502.
• [4637] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6017).
• [4638] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7677).
• [4639] Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers. Bioorg Med Chem Lett. 1999 Aug 16;9(16):2447-52.
• [4640] Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of t... J Med Chem. 2008 Sep 25;51(18):5875-9.
• [4641] Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase. J Med Chem. 1997 Jan 17;40(2):192-200.
• [4642] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 596).
• [4643] Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res. 1999 Apr 30;84(8):891-6.
• [4644] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1002).
• [4645] Growth factors and their receptors: new targets for prostate cancer therapy. Urology. 2001 Aug;58(2 Suppl 1):114-22.
• [4646] Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. J Med Chem. 2003 Nov 6;46(23):4910-25.
• [4647] 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):103-8.
• [4648] Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases. Bioorg Med Chem. 2009 Mar 1;17(5):1811-6.
• [4649] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1061).
• [4650] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 304).
• [4651] Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor. J Med Chem. 2014 Jan 9;57(1):98-109.
• [4652] Use of lantibiotic synthetases for the preparation of bioactive constrained peptides. Bioorg Med Chem Lett. 2008 May 15;18(10):3025-8.
• [4653] Synthesis and kinetic evaluation of peptide alpha-keto-beta-aldehyde-based inhibitors of trypsin-like serine proteases. J Pharm Pharmacol. 2001 Apr;53(4):473-80.
• [4654] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1696).
• [4655] Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents. Toxicol In Vitro. 2000 Feb;14(1):53-9.
• [4656] Taste-guided identification of high potency TRPA1 agonists from Perilla frutescens. Bioorg Med Chem. 2009 Feb 15;17(4):1636-9.
• [4657] Alkaloids with human delta-opioid receptor binding affinity from the Australian rainforest tree Peripentadenia mearsii. J Nat Prod. 2007 Dec;70(12):1946-50.
• [4658] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4515).
• [4659] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5242).
• [4660] Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp. Bioorg Med Chem. 2008 Jul 1;16(13):6560-7.
• [4661] Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffo... J Med Chem. 2007 May 3;50(9):2176-84.
• [4662] Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra. J Nat Prod. 1998 May;61(5):571-5.
• [4663] Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor... J Med Chem. 2005 Feb 24;48(4):1107-31.
• [4664] Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J Med Chem. 2015 Jan 8;58(1):419-32.
• [4665] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8295).
• [4666] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6698).
• [4667] Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem. 2007 May 18;282(20):14845-52.
• [4668] A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J Pharmacol Exp Ther. 2010 Jun;333(3):797-807.
• [4669] Aminopyrrolidineamide inhibitors of site-1 protease. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4411-4.
• [4670] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6309).
• [4671] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6623).
• [4672] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7683).
• [4673] The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors. Bioorg Med Chem Lett. 2010 May 1;20(9):2897-902.
• [4674] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5243).
• [4675] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5244).
• [4676] Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg Med Chem Lett. 2007 Feb 1;17(3):793-8.
• [4677] Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hit. J Med Chem. 2012 Nov 26;55(22):9831-7.
• [4678] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7915).
• [4679] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8575).
• [4680] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6675).
• [4681] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1891).
• [4682] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1908).
• [4683] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5412).
• [4684] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5456).
• [4685] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4483).
• [4686] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1885).
• [4687] Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor. J Med Chem. 2006 Jan 26;49(2):637-47.
• [4688] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3997).
• [4689] Drug design with Cdc7 kinase: a potential novel cancer therapy target. Drug Des Devel Ther. 2009 Feb 6;2:255-64.
• [4690] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1091).
• [4691] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4736).
• [4692] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1416).
• [4693] Structures, biogenesis, and biological activities of pyrano[4,3-c]isochromen-4-one derivatives from the Fungus Phellinus igniarius. J Nat Prod. 2007 Feb;70(2):296-9.
• [4694] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4281).
• [4695] Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective. Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S51-7.
• [4696] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4282).
• [4697] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2144).
• [4698] Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. J Med Chem. 2002 Jun 6;45(12):2534-42.
• [4699] Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives. Bioorg Med Chem Lett. 2008 May 1;18(9):2916-9.
• [4700] Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3. Bioorg Med Chem Lett. 2005 Nov 15;15(22):5095-9.
• [4701] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6192).
• [4702] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6564).
• [4703] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4283).
• [4704] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4284).
• [4705] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4285).
• [4706] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4757).
• [4707] Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of ... J Med Chem. 2007 Jul 26;50(15):3465-81.
• [4708] Protein kinase epsilon dampens the secretory response of model intestinal epithelia during ischemia. Surgery. 2001 Aug;130(2):310-8.
• [4709] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2794).
• [4710] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2796).
• [4711] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3638).
• [4712] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4692).
• [4713] N-Sulfonyl hydroxamate derivatives as inhibitors of class II fructose-1,6-diphosphate aldolase. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5375-7.
• [4714] In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. Biochem Pharmacol. 1998 Mar 1;55(5):697-701.
• [4715] Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem. 2009 Oct 1;17(19):6983-92.
• [4716] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3461).
• [4717] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2094).
• [4718] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2813).
• [4719] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2922).
• [4720] Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 2014 Jun 19;510(7505):407-11.
• [4721] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5814).
• [4722] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5246).
• [4723] Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes. Shock. 2004 May;21(5):470-5.
• [4724] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4286).
• [4725] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2291).
• [4726] Isoform-selective inhibition of phosphoinositide 3-kinase: identification of a new region of nonconserved amino acids critical for p110alpha inhibition. Mol Pharmacol. 2011 Oct;80(4):657-64.
• [4727] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6062).
• [4728] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2387).
• [4729] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2353).
• [4730] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5477).
• [4731] GRID/CPCA: a new computational tool to design selective ligands. J Med Chem. 2000 Aug 10;43(16):3033-44.
• [4732] Discovery and optimization of adamantyl carbamate inhibitors of 11-HSD1. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6725-9.
• [4733] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4287).
• [4734] Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study.J Clin Endocrinol Metab.2010 Nov;95(11):5028-36.
• [4735] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 283).
• [4736] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4742).
• [4737] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 49).
• [4738] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3183).
• [4739] Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antag... Bioorg Med Chem Lett. 2001 Jan 22;11(2):177-81.
• [4740] Structure and molecular modeling of GABAA receptor antagonists. J Med Chem. 1992 May 29;35(11):1969-77.
• [4741] Current perspective of TACE inhibitors: a review. Bioorg Med Chem. 2009 Jan 15;17(2):444-59.
• [4742] A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors. Bioorg Med Chem Lett. 2006 May 15;16(10):2632-6.
• [4743] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6027).
• [4744] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6066).
• [4745] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1671).
• [4746] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3685).
• [4747] Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. J Med Chem. 2004 Aug 12;47(17):4118-27.
• [4748] Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. J Med Chem. 2006 Jun 15;49(12):3432-5.
• [4749] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7003).
• [4750] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4289).
• [4751] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2472).
• [4752] Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine. J Biol Chem. 1991 Jan 5;266(1):238-44.
• [4753] Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J Med Chem. 1999 Jul 1;42(13):2394-402.
• [4754] Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme. J Med Chem. 1999 Dec 16;42(25):5197-211.
• [4755] Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains. Bioorg Med Chem Lett. 2002 Apr 22;12(8):1233-5.
• [4756] Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents. J Med Chem. 2002 May 23;45(11):2185-96.
• [4757] Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2197-200.
• [4758] Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis. J Med Chem. 2002 Sep 26;45(20):4571-80.
• [4759] P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3199-202.
• [4760] Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists. Bioorg Med Chem. 2003 Jan 17;11(2):171-83.
• [4761] Structure-activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists. Bioorg Med Chem. 2003 Mar 20;11(6):875-84.
• [4762] Benzodiazepines as potent and selective bradykinin B1 antagonists. J Med Chem. 2003 May 8;46(10):1803-6.
• [4763] Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. J Med Chem. 2003 May 8;46(10):1918-30.
• [4764] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist. J Am Chem Soc. 2003 Jun 25;125(25):7516-7.
• [4765] Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics. J Med Chem. 2003 Dec 4;46(25):5294-7.
• [4766] Discovery of novel modulators of metabotropic glutamate receptor subtype-5. Bioorg Med Chem. 2004 Jan 2;12(1):17-21.
• [4767] Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents. J Med Chem. 2004 Mar 25;47(7):1729-38.
• [4768] Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents. J Med Chem. 2004 Apr 8;47(8):1930-8.
• [4769] Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists. Bioorg Med Chem Lett. 2004 Aug 16;14(16):4225-9.
• [4770] Synthesis and biological evaluation of dihydroeptastatin, a novel inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Med Chem. 1992 Sep 4;35(18):3388-93.
• [4771] N(1)-Arylsulfonyl-N(2)-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor. Chembiochem. 2004 Aug 6;5(8):1131-6.
• [4772] 2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5473-6.
• [4773] Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity. Bioorg Med Chem Lett. 2004Nov 15;14(22):5481-4.
• [4774] Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56(Lck). Bioorg Med Chem Lett. 2003 Nov 17;13(22):4007-10.
• [4775] IKCa-channel blockers. Part 2: discovery of cyclohexadienes. Bioorg Med Chem Lett. 2005 Jan 17;15(2):401-4.
• [4776] Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8. Bioorg Med Chem Lett. 2005 Feb 1;15(3):687-91.
• [4777] Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparativemolecular similarity indices analysis (CoMSIA). Bioorg Med Chem Lett. 2005 Feb 15;15(4):1027-32.
• [4778] Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1197-200.
• [4779] Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1225-8.
• [4780] Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Am Chem Soc. 2005 Mar 2;127(8):2376-7.
• [4781] Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives. Bioorg Med Chem Lett. 2005 Jul 1;15(13):3241-6.
• [4782] (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3407-11.
• [4783] 9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers. Bioorg Med Chem Lett. 2005 Oct 15;15(20):4628-31.
• [4784] Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor wit... Bioorg Med Chem Lett. 2006 Jan 1;16(1):44-8.
• [4785] 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics. J Med Chem. 2005 Nov 3;48(22):6956-69.
• [4786] Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors. J Med Chem. 2006 Feb 9;49(3):955-70.
• [4787] A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2200-4.
• [4788] Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors. Bioorg Med Chem Lett. 2006 May 15;16(10):2699-704.
• [4789] Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity vers... J Med Chem. 2006 Mar 23;49(6):2138-42.
• [4790] Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids. J Med Chem. 1991 Oct;34(10):2962-83.
• [4791] New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids. Eur J Med Chem. 2006 Jul;41(7):809-24.
• [4792] 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist. J Med Chem. 2006 Nov 30;49(24):7108-18.
• [4793] Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mglu5 receptor antagonists based on the fenobam struc... Bioorg Med Chem Lett. 2007 Mar 1;17(5):1302-6.
• [4794] From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2254-9.
• [4795] Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and prelimin... Bioorg Med Chem Lett. 2007 Apr 15;17(8):2305-9.
• [4796] Alpha-Keto amide inhibitors of aminopeptidases. J Med Chem. 1992 Feb 7;35(3):451-6.
• [4797] Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem. 2007 May 31;50(11):2647-54.
• [4798] Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4303-7.
• [4799] Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism. J Biol Chem. 2007 Aug 10;282(32):23231-9.
• [4800] Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase. Bioorg Med Chem. 2007 Aug 15;15(16):5576-89.
• [4801] Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4531-7.
• [4802] Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4538-44.
• [4803] Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6164-8.
• [4804] Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain. J Med Chem. 2007 Nov 15;50(23):5550-3.
• [4805] Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and prelimina... Bioorg Med Chem Lett. 2007 Dec 1;17(23):6593-601.
• [4806] Small-molecule inhibitors of the Rce1p CaaX protease. J Biomol Screen. 2007 Oct;12(7):983-93.
• [4807] Activity of sulfonium bisphosphonates on tumor cell lines. J Med Chem. 2007 Nov 29;50(24):6067-79.
• [4808] Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate. J Med Chem. 2007 Nov 29;50(24):5967-75.
• [4809] Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations. Bioorg Med Chem Lett. 2008 Jan 15;18(2):560-4.
• [4810] Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylca... J Med Chem. 2008 Jan 10;51(1):31-45.
• [4811] Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite. Bioorg Med Chem Lett. 2008 Jan 15;18(2):732-7.
• [4812] Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1151-6.
• [4813] Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1037-41.
• [4814] Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones. Bioorg Med Chem Lett.2008 Mar 15;18(6):1840-4.
• [4815] Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J Med Chem. 2008 Apr 10;51(7):2216-26.
• [4816] Pyrimidine-based inhibitors of CaMKIIdelta. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2404-8.
• [4817] Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2399-403.
• [4818] (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. J Med Chem. 2008 May 8;51(9):2722-33.
• [4819] Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes. 2008 Aug;57(8):2211-9.
• [4820] Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4948-51.
• [4821] 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives. J Med Chem. 1991 Aug;34(8):2489-95.
• [4822] Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation. J Med Chem. 2008 Sep 25;51(18):5594-607.
• [4823] Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety. J Med Chem. 1991 Sep;34(9):2804-15.
• [4824] Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6486-9.
• [4825] Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):688-92.
• [4826] First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery. J Med Chem. 2009 Jan 22;52(2):293-307.
• [4827] Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem. 2009 Feb 26;52(4):976-88.
• [4828] Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats. J Med Chem. 2009 Apr 23;52(8):2587-602.
• [4829] Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg Med Chem. 2009 May 1;17(9):3342-51.
• [4830] Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3199-203.
• [4831] Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results. J Med Chem. 2009 Jul 9;52(13):3869-80.
• [4832] Application of a 3,3-diphenylpentane skeleton as a multi-template for creation of HMG-CoA reductase inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4228-31.
• [4833] 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4207-9.
• [4834] Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5063-6.
• [4835] Structure-activity relationships for substrate-based inhibitors of human complement factor B. J Med Chem. 2009 Oct 8;52(19):6042-52.
• [4836] Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). J Med Chem. 2009 Oct 22;52(20):6433-46.
• [4837] Structure-based drug design identifies novel LPA3 antagonists. Bioorg Med Chem. 2009 Nov 1;17(21):7457-64.
• [4838] Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12;52(21):6515-8.
• [4839] Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6548-51.
• [4840] Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors. J Med Chem. 2010 Jan 14;53(1):208-20.
• [4841] Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors. J Med Chem. 1991 Jan;34(1):367-73.
• [4842] Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase. J Med Chem. 1991 Jan;34(1):463-6.
• [4843] Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones. J Med Chem. 1992 May 29;35(11):2095-103.
• [4844] Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor. Bioorg Med Chem Lett. 2010 Jan 1;20(1):92-6.
• [4845] 2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles. Bioorg Med Chem Lett. 2010 Jan 15;20(2):679-83.
• [4846] Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2307-12.
• [4847] Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors. J Med Chem. 2010 Feb 25;53(4):1473-82.
• [4848] Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1913-7.
• [4849] Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs). Bioorg Med Chem. 2010 Apr 1;18(7):2428-38.
• [4850] A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2474-7.
• [4851] Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a). Bioorg Med Chem Lett. 2010 May 1;20(9):2797-800.
• [4852] 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts. Bioorg Med Chem Lett. 2010 May 15;20(10):3129-33.
• [4853] Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account. Bioorg Med Chem Lett. 2010 Jun 1;20(11):3235-9.
• [4854] Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3746-9.
• [4855] Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorg Med Chem. 2010 Jun 15;18(12):4351-62.
• [4856] GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4472-4.
• [4857] An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4901-5.
• [4858] mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455. Expert Opin Ther Pat. 2010 Mar;20(3):441-5.
• [4859] Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors. J Med Chem. 2010 Aug 12;53(15):5620-8.
• [4860] Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors. J Med Chem. 2010 Aug 12;53(15):5727-37.
• [4861] Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors. J Med Chem. 2010 Sep 9;53(17):6326-36.
• [4862] Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5. J Med Chem. 2010 Oct 14;53(19):7107-18.
• [4863] Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6739-43.
• [4864] Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding. J Med Chem. 2010 Oct 28;53(20):7296-315.
• [4865] Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization. J Med Chem. 2010 Nov 11;53(21):7682-98.
• [4866] Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors. Bioorg Med Chem Lett. 2011 Jan 1;21(1):164-7.
• [4867] Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats. J Med Chem. 2011 Jan 13;54(1):342-53.
• [4868] The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties. Bioorg Med Chem Lett. 2011 May 1;21(9):2721-4.
• [4869] Design of potent and selective GPR119 agonists for type II diabetes. Bioorg Med Chem Lett. 2011 May 1;21(9):2665-9.
• [4870] Acridone alkaloids as potent inhibitors of cathepsin V. Bioorg Med Chem. 2011 Feb 15;19(4):1477-81.
• [4871] Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Bioorg Med Chem Lett. 2011 Mar 1;21(5):1402-6.
• [4872] Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1306-9.
• [4873] Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control. Bioorg Med Chem Lett. 2011 May 15;21(10):3134-41.
• [4874] In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors. Bioorg Med Chem Lett. 2011 May 15;21(10):2958-61.
• [4875] Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids. J Med Chem. 1990 Jan;33(1):61-70.
• [4876] Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3301-6.
• [4877] Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3290-6.
• [4878] Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3743-8.
• [4879] Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3596-602.
• [4880] Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol Pharmacol. 2011 Aug;80(2):294-303.
• [4881] Irreversible Nek2 kinase inhibitors with cellular activity. J Med Chem. 2011 Jun 23;54(12):4133-46.
• [4882] Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators. J Med Chem. 2011 Jul 28;54(14):5070-81.
• [4883] A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors. J Am Chem Soc. 2011 Aug 3;133(30):11665-74.
• [4884] Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4860-4.
• [4885] STK33 kinase activity is nonessential in KRAS-dependent cancer cells. Cancer Res. 2011 Sep 1;71(17):5818-26.
• [4886] 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4891-9.
• [4887] Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5533-7.
• [4888] Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma. PLoS One. 2011 Feb 9;6(2):e16984.
• [4889] 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J Med Chem. 2011 Oct 13;54(19):6761-70.
• [4890] Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5870-5.
• [4891] Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab. 2011 Sep 7;14(3):365-77.
• [4892] (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction. ACS Chem Neurosci. 2011 Aug 17;2(8):471-482.
• [4893] Oxidative metabolism of a quinoxaline derivative by xanthine oxidase in rodent plasma. Chem Res Toxicol. 2011 Dec 19;24(12):2207-16.
• [4894] Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group. Bioorg Med Chem. 2011 Nov 1;19(21):6274-84.
• [4895] 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity. Bioorg Med Chem Lett. 2011 Nov 15;21(22):6687-92.
• [4896] Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13. J Med Chem. 2011 Dec 8;54(23):8174-87.
• [4897] CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50.
• [4898] Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorg Med Chem Lett. 2012 Jan 1;22(1):363-6.
• [4899] 7,8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. J Med Chem. 2012 Jan 12;55(1):403-13.
• [4900] Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD). Bioorg Med Chem Lett. 2012 Jan 1;22(1):138-43.
• [4901] Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1575-8.
• [4902] Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis. J Med Chem. 1990 Nov;33(11):2952-6.
• [4903] Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor. J Med Chem. 2012 Mar 8;55(5):2388-405.
• [4904] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7579).
• [4905] Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A). J Med Chem. 2012 Apr 12;55(7):3563-7.
• [4906] Discovery of novel tricyclic compounds as squalene synthase inhibitors. Bioorg Med Chem. 2012 May 1;20(9):3072-93.
• [4907] 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators. Bioorg Med Chem Lett. 2012 May 1;22(9):3235-9.
• [4908] Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities. J Med Chem. 2012 May 10;55(9):4336-51.
• [4909] Novel triazolopyridylbenzamides as potent and selective p38alpha inhibitors. Bioorg Med Chem Lett. 2012 May 15;22(10):3431-6.
• [4910] Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. J Med Chem. 2012 Jun 14;55(11):4990-5002.
• [4911] Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation. J Med Chem. 2012 Jun 14;55(11):5361-79.
• [4912] Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase. J Med Chem. 2012 May 24;55(10):4580-93.
• [4913] N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases. Bioorg Med Chem Lett. 2012 Jun 15;22(12):3993-7.
• [4914] Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. Bioorg Med Chem. 2012 Jun 15;20(12):3781-92.
• [4915] Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F. J Med Chem. 2012 Jun 28;55(12):5982-6.
• [4916] The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett. 2012 Aug 1;22(15):4979-85.
• [4917] An allosteric inhibitor of protein arginine methyltransferase 3. Structure. 2012 Aug 8;20(8):1425-35.
• [4918] Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism. Hypertension. 2012 Sep;60(3):722-9.
• [4919] Novel beta-amino acid derivatives as inhibitors of cathepsin A. J Med Chem. 2012 Sep 13;55(17):7636-49.
• [4920] Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist. J Med Chem. 2012 Sep 13;55(17):7623-35.
• [4921] Cofilin phosphorylation and actin reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli cells. J Biol Chem. 2001 Aug 17;276(33):31449-58.
• [4922] Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazoles. J Med Chem. 1990 Jan;33(1):31-8.
• [4923] Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids. J Med Chem. 1990 Jan;33(1):52-60.
• [4924] Identification of high-affinity P2Y antagonists based on a phenylpyrazole glutamic acid piperazine backbone. J Med Chem. 2012 Oct 25;55(20):8615-29.
• [4925] Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation. J Thromb Haemost. 2012 Dec;10(12):2573-80.
• [4926] Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7223-6.
• [4927] Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKepsilon kinases. Bioorg Med Chem Lett. 2012 Dec 1;22(23):7169-73.
• [4928] Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7326-9.
• [4929] Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors. Bioorg Med Chem Lett. 2013 Jan 15;23(2):569-73.
• [4930] Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase. Bioorg Med Chem Lett. 2013 Feb 15;23(4):1051-5.
• [4931] Discovery and structure-activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators. Bioorg Med Chem Lett. 2013 Mar 1;23(5):1398-406.
• [4932] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5808).
• [4933] Inhibiting NF- B-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures. Bioorg Med Chem Lett. 2013 Mar 1;23(5):1238-44.
• [4934] Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator. Bioorg Med Chem Lett. 2013 Mar 1;23(5):1249-52.
• [4935] Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor that Affords Robust CNS A Reduction. ACS Med Chem Lett. 2012 Nov 8;3(11):897-902.
• [4936] Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res. 2006 Aug 15;12(16):4916-24.
• [4937] Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Bioorg Med Chem. 2013 Apr 1;21(7):2135-44.
• [4938] Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators. Bioorg Med Chem Lett. 2013 Apr 1;23(7):2134-9.
• [4939] Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform. J Med Chem. 2013 Apr 11;56(7):3033-47.
• [4940] Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. J Med Chem. 2013 Apr 11;56(7):2936-47.
• [4941] Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J Med Chem. 2013 Apr 25;56(8):3217-27.
• [4942] Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J Med Chem. 2013 Apr 25;56(8):3281-95.
• [4943] Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. J Biol Chem. 2013 Jun 14;288(24):17296-312.
• [4944] Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core. J Med Chem. 2013 Jun 13;56(11):4357-73.
• [4945] Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells. J Med Chem. 2013 May 23;56(10):3996-4016.
• [4946] Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors. J Med Chem. 2013 Jun 13;56(11):4224-35.
• [4947] 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors. Chembiochem. 2013 Jul 8;14(10):1248-54.
• [4948] Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries. Mol Pharmacol. 2013 Sep;84(3):314-24.
• [4949] 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4547-51.
• [4950] Novel selective inhibitors of aminopeptidases that generate antigenic peptides. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4832-6.
• [4951] Naphthyridines as novel BET family bromodomain inhibitors. ChemMedChem. 2014 Mar;9(3):580-9.
• [4952] Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem. 2013 Oct 24;56(20):8032-48.
• [4953] Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice. J Med Chem. 2013 Nov 14;56(21):8321-31.
• [4954] Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6228-33.
• [4955] Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. Bioorg Med Chem Lett. 2013 Dec 15;23(24):6711-6.
• [4956] Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors. J Med Chem. 2014 Jan 9;57(1):144-58.
• [4957] Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration. Bioorg Med Chem Lett. 2014 Feb 1;24(3):750-5.
• [4958] Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia. Bioorg Med Chem Lett. 2014 Feb 1;24(3):821-7.
• [4959] Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib. J Med Chem.> 2014 Feb 27;57(4):1170-87.
• [4960] Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. Bioorg Med Chem. 2014 Feb 15;22(4):1362-9.
• [4961] Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase. Bioorg Med Chem Lett. 2014 Mar 15;24(6):1545-9.
• [4962] Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. J Med Chem. 2014 Apr 24;57(8):3484-93.
• [4963] Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J Med Chem. 2014 May 22;57(10):4289-301.
• [4964] P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. Bioorg Med Chem Lett. 2014 Jun 1;24(11):2521-4.
• [4965] Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors. Eur J Med Chem. 2014 Jun 10;80:364-82.
• [4966] Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor. ACS Chem Neurosci. 2014 Jul 16;5(7):576-87.
• [4967] Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis. J MedChem. 2014 Jun 26;57(12):5074-84.
• [4968] Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin. ACS Chem Neurosci. 2014 Aug 20;5(8):690-9.
• [4969] Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity. ACS Med Chem Lett. 2010 Sep 1;1(9):493-8.
• [4970] Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality. ACS Med Chem Lett. 2011 Oct 3;2(12):933-7.
• [4971] Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139. ACS Med Chem Lett. 2011 Feb 28;2(4):303-6.
• [4972] Structure-Based Design of Potent and Selective CK1gamma Inhibitors. ACS Med Chem Lett. 2012 Oct 18;3(12):1059-64.
• [4973] Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. ACS Med Chem Lett. 2012 Jan 11;3(2):159-64.
• [4974] Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12. ACS Med Chem Lett. 2012 Jul 14;3(8):653-7.
• [4975] Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. ACS Med Chem Lett. 2012 Jul 26;3(9):705-9.
• [4976] Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example. ACS Med Chem Lett. 2013 Sep 16;4(11):1079-84.
• [4977] Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21695-700.
• [4978] Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis. 2005 Nov;20(2):392-400.
• [4979] Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo. ACS Med Chem Lett. 2013 Jul 3;4(8):800-5.
• [4980] Novel cycloalkenepyrazoles as inhibitors of bub1 kinase. ACS Med Chem Lett. 2014 Feb 12;5(4):280-1.
• [4981] Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity. J Med Chem. 2014 Jun 26;57(12):5112-28.
• [4982] Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors. Eur J Med Chem. 2014 Aug 18;83:1-14.
• [4983] A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med. 2014 Aug;20(8):942-7.
• [4984] Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2. J Med Chem. 2014 Aug 14;57(15):6583-93.
• [4985] Novel inhibitors of the high-affinity L-proline transporter as potential therapeutic agents for the treatment of cognitive disorders. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3886-90.
• [4986] Discovery of a Negative Allosteric Modulator of GABAB Receptors. ACS Med Chem Lett. 2014 May 27;5(7):742-7.
• [4987] Potent heterocyclic ligands for human complement c3a receptor. J Med Chem. 2014 Oct 23;57(20):8459-70.
• [4988] Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8.
• [4989] 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain. ACS Med Chem Lett. 2014 Sep 10;5(11):1190-5.
• [4990] Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2000 Jun;25(2):141-2.
• [4991] Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach. Bioorg Med Chem. 2015 Jan 1;23(1):89-104.
• [4992] 9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain. J Med Chem. 2015 Mar 26;58(6):2718-36.
• [4993] Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method. J Am Chem Soc. 2015 Mar 18;137(10):3616-21.
• [4994] Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors. ACS Med Chem Lett. 2015 Jan 28;6(3):244-8.
• [4995] Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF. J Med Chem. 2016 Feb 25;59(4):1642-7.
• [4996] Photoactivatable Prodrugs of Antimelanoma Agent Vemurafenib. ACS Chem Biol. 2015 Sep 18;10(9):2099-107.
• [4997] Design, synthesis and biological evaluation of novel FGFR inhibitors bearing an indazole scaffold. Org Biomol Chem. 2015 Jul 28;13(28):7643-54.
• [4998] Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors. J Med Chem. 2015 Jul 23;58(14):5649-73.
• [4999] A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. Expert Opin Ther Pat. 2015 Oct;25(10):1093-116.
• [5000] Synthesis and biological evaluation of a monocyclic, fully functional analogue of compactin. J Med Chem. 1989 Jan;32(1):197-202.
• [5001] Synthesis and inhibition of human acrosin and trypsin and acute toxicity of aryl 4-guanidinobenzoates. J Med Chem. 1986 Apr;29(4):514-9.
• [5002] Carboxyl-modified amino acids and peptides as protease inhibitors. J Med Chem. 1986 Jan;29(1):104-11.
• [5003] Phenoxypropylamines: a new series of squalene synthase inhibitors. J Med Chem. 1995 Oct 13;38(21):4157-60.
• [5004] 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate. J Med Chem. 1995 Jul 7;38(14):2596-605.
• [5005] (Aryloxy)methylsilane derivatives as new cholesterol biosynthesis inhibitors: synthesis and hypocholesterolemic activity of a new class of squalene epoxidase inhibitors. J Med Chem. 1995 Aug 18;38(17):3207-16.
• [5006] Synthesis and biological activity of bile acid-derived HMG-CoA reductase inhibitors. The role of 21-methyl in recognition of HMG-CoA reductase and the ileal bile acid transport system. J Med Chem. 1994 Sep 30;37(20):3240-6.
• [5007] Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. J Med Chem. 1994 Nov 11;37(23):4031-51.
• [5008] Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors. J Med Chem. 1993 Nov 12;36(23):3646-57.
• [5009] Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. J Med Chem. 1993 Nov 12;36(23):3658-62.
• [5010] HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts. J Med Chem. 1993 Nov 12;36(23):3674-85.
• [5011] Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation. J Med Chem. 1993 Sep 3;36(18):2614-20.
• [5012] 32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis. J Med Chem. 1993 Feb 5;36(3):410-6.
• [5013] N-(arylalkyl)farnesylamines: new potent squalene synthetase inhibitors. J Med Chem. 1993 May 14;36(10):1501-4.
• [5014] Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem. 1996 Jan 5;39(1):267-76.
• [5015] Alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase. J Med Chem. 1996 Feb 2;39(3):657-60.
• [5016] Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors. J Med Chem. 1996 Jul 19;39(15):2971-9.
• [5017] Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases. J Med Chem. 1996 Sep 27;39(20):4089-98.
• [5018] Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase. J Med Chem. 1997 Jan 17;40(2):201-9.
• [5019] (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent ... J Med Chem. 1997 Jul 4;40(14):2123-5.
• [5020] Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation. Bioorg Med Chem Lett. 1998 Apr 21;8(8):891-6.
• [5021] Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1169-73.
• [5022] Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats. Neurosci Lett. 1997 May 30;228(1):45-9.
• [5023] A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics s... J Med Chem. 2004 Jun 3;47(12):3065-74.
• [5024] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3991).
• [5025] Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole ... Bioorg Med Chem Lett. 2002 Oct 7;12(19):2667-72.
• [5026] List of drugs in development for neurodegenerative diseases.Update June 2004.Neurodegener Dis.2004;1(2-3):113-52.
• [5027] Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).
• [5028] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3334).
• [5029] Antidepressant principles of the roots of Polygala tenuifolia. J Nat Prod. 2006 Sep;69(9):1305-9.
• [5030] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5047).
• [5031] Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): their effects on three selected glycolytic enzymes of Trypanosoma brucei. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3495-8.
• [5032] Probing the active-site requirements of human intestinal N-terminal maltase glucoamylase: the effect of replacing the sulfate moiety by a methyl et... Bioorg Med Chem Lett. 2010 Oct 1;20(19):5686-9.
• [5033] Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9.
• [5034] Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in ... J Med Chem. 1991 Feb;34(2):633-42.
• [5035] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6029).
• [5036] Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology. 2004 May;126(5):1337-46.
• [5037] Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal. 2009 Mar;5(1):75-89.
• [5038] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2490).
• [5039] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1438).
• [5040] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5802).
• [5041] Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr;5(4):1079-86.
• [5042] Morpholinoalkylindenes as antinociceptive agents: Novel cannabinoid receptor agonists, Bioorg. Med. Chem. Lett. 5(4):381-386 (1995).
• [5043] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2762).
• [5044] Alteration of Escherichia coli topoisomerase IV to novobiocin resistance. Antimicrob Agents Chemother. 2003 Mar;47(3):941-7.
• [5045] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6688).
• [5046] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 537).
• [5047] Synthesis and evaluation of benzophenone-based photoaffinity labeling analogs of prenyl pyrophosphates containing stable amide linkages, Bioorg. Med. Chem. Lett. 7(16):2125-2130 (1997).
• [5048] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3053).
• [5049] Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole an... Bioorg Med Chem. 2008 Nov 15;16(22):9694-8.
• [5050] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2676).
• [5051] Synthesis and biological activity of some transition-state inhibitors of human renin. J Med Chem. 1988 Sep;31(9):1839-46.
• [5052] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1062).
• [5053] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5247).
• [5054] Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers. 2003 Oct;70(2):186-200.
• [5055] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5248).
• [5056] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2819).
• [5057] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6279).
• [5058] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5245).
• [5059] Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic bene... Parasitol Res. 2008 Mar;102(4):805-7.
• [5060] Alkaloids from stems and leaves of Stemona japonica and their insecticidal activities. J Nat Prod. 2008 Jan;71(1):112-6.
• [5061] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1255).
• [5062] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6919).
• [5063] Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg Med Chem Lett. 1998 Sep 8;8(17):2315-20.
• [5064] High antiplasmodial activity of novel plasmepsins I and II inhibitors. J Med Chem. 2006 Dec 14;49(25):7440-9.
• [5065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 660).
• [5066] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3968).
• [5067] Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5744-7.
• [5068] High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. J Med Chem. 2009 Jun 25;52(12):3784-93.
• [5069] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5904).
• [5070] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6561).
• [5071] 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with... J Med Chem. 2009 Jul 9;52(13):3994-4006.
• [5072] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5619).
• [5073] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5620).
• [5074] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3286).
• [5075] Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide. J Med Chem. 2008 Aug 14;51(15):4518-28.
• [5076] Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. Bioorg Med Chem Lett. 2008 Jan 1;18(1):223-7.
• [5077] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5902).
• [5078] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3285).
• [5079] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5728).
• [5080] Synthesis of 8-Oxa analogues of norcocaine endowed with interesting cocaine-like activity. Bioorg Med Chem Lett. 1999 Jul 5;9(13):1831-6.
• [5081] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3318).
• [5082] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3319).
• [5083] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5548).
• [5084] Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity r... J Med Chem. 1996 Oct 11;39(21):4261-74.
• [5085] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1403).
• [5086] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1430).
• [5087] Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivities. J Med Chem. 2009 Jan 8;52(1):95-104.
• [5088] Tannins as selective inhibitors of protein kinase C, Bioorg. Med. Chem. Lett. 2(3):239-244 (1992).
• [5089] Identification of HIV-1 integrase inhibitors based on a four-point pharmacophore. Antivir Chem Chemother. 1998 Nov;9(6):461-72.
• [5090] Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem. 2004 May 7;279(19):20267-76.
• [5091] Company report (PaxVax)
• [5092] Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Ann N Y Acad Sci. 2001 Apr;928:141-56.
• [5093] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4293).
• [5094] Functional characterization of three mouse formyl peptide receptors. Mol Pharmacol. 2013 Feb;83(2):389-98.
• [5095] N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular effi... J Med Chem. 2004 Sep 9;47(19):4716-30.
• [5096] Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 May 15;19(10):2735-8.
• [5097] Saucerneol B derivatives as human acyl-CoA: cholesterol acyltransferase inhibitors. Bioorg Med Chem Lett. 2005 Jan 17;15(2):385-8.
• [5098] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4703).
• [5099] Orally active and potent inhibitors of gamma-aminobutyric acid uptake. J Med Chem. 1985 May;28(5):653-60.
• [5100] Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol. 2002 Jul;168(1):248-52.
• [5101] Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2460-7.
• [5102] Acyclic cyanamide-based inhibitors of cathepsin K. Bioorg Med Chem Lett. 2005 Jun 15;15(12):3039-43.
• [5103] Topological model for the prediction of MRP1 inhibitory activity of pyrrolopyrimidines and templates derived from pyrrolopyrimidine. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4967-72.
• [5104] Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists. Bioorg Med Chem Lett. 2012 Mar 1;22(5):2052-62.
• [5105] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5815).
• [5106] Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity. J Biol Chem. 2007 Sep 28;282(39):28501-13.
• [5107] Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci. 2011 Mar 9;31(10):3650-61.
• [5108] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7669).
• [5109] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1633).
• [5110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6265).
• [5111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1039).
• [5112] Ace inhibitors as a template for the design of bradykinin B2 receptor antagonists, Bioorg. Med. Chem. Lett. 5(4):367-370 (1995).
• [5113] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5930).
• [5114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8599).
• [5115] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5947).
• [5116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2).
• [5117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 173).
• [5118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2146).
• [5119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2822).
• [5120] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1771).
• [5121] Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-a... Bioorg Med Chem. 2007 Jun 1;15(11):3649-60.
• [5122] Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br J Pharmacol. 2003 Feb;138(4):554-63.
• [5123] Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method. J Med Chem. 1998 Dec 17;41(26):5272-86.
• [5124] Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia. J Med Chem. 2009 Sep 10;52(17):5307-10.
• [5125] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2595).
• [5126] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 414).
• [5127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3524).
• [5128] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5754).
• [5129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1391).
• [5130] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2118).
• [5131] The role of endogenously formed diacylglycerol in the propagation and termination of platelet activation. A biochemical and functional analysis using the novel diacylglycerol kinase inhibitor, R 59 949. J Biol Chem. 1989 Feb 25;264(6):3274-85.
• [5132] Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyl... Eur J Med Chem. 2009 Jul;44(7):2765-75.
• [5133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 157).
• [5134] High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity. Anal Biochem. 2004 Apr 15;327(2):176-83.
• [5135] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 618).
• [5136] Bromophenols in Marine Algae and Their Bioactivities
• [5137] Phenyltriazolinones as potent factor Xa inhibitors. Bioorg Med Chem Lett. 2010 Feb 15;20(4):1373-7.
• [5138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 900).
• [5139] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 981).
• [5140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8459).
• [5141] Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic ... Br J Biomed Sci. 2004;61(3):146-7.
• [5142] BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders. Expert Opin Ther Targets. 2003 Feb;7(1):115-23.
• [5143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2670).
• [5144] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3482).
• [5145] Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014 May 2;344(6183):527-32.
• [5146] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 95).
• [5147] Analogs of an endothelin antagonist RES-701-1: substitutions of C-terminal amino acid, Bioorg. Med. Chem. Lett. 6(7):775-778 (1996).
• [5148] Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors. Eur J Med Chem. 2010 Mar;45(3):1158-66.
• [5149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5417).
• [5150] Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study. J Nat Prod. 2004 Nov;67(11):1777-82.
• [5151] Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem. 2010 Jul 8;53(13):5033-43.
• [5152] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1486).
• [5153] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5943).
• [5154] AlphaIIbbeta3 and its antagonism at the new millennium. Thromb Haemost. 2001 Jul;86(1):34-40.
• [5155] HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2647-52.
• [5156] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8034).
• [5157] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5255).
• [5158] Bioactive coating of titanium surfaces with recombinant human -defensin-2 (rHuD2) may prevent bacterial colonization in orthopaedic surgery.J Bone Joint Surg Am.2011 May 4;93(9):840-6.
• [5159] ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol. 2000;47(1):173-80.
• [5160] Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents. J Med Chem. 1989 Dec;32(12):2561-73.
• [5161] Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors. J Med Chem. 1985 Nov;28(11):1553-5.
• [5162] Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in r... J Med Chem. 1985 May;28(5):683-5.
• [5163] Prenylflavonoids from Glycyrrhiza uralensis and their protein tyrosine phosphatase-1B inhibitory activities. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5398-401.
• [5164] Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). Medchemcomm. 2012 Jun 1;3(6):699-709.
• [5165] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7029).
• [5166] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4294).
• [5167] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4295).
• [5168] RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. J Pharmacol Exp Ther. 2012 Apr;341(1):90-103.
• [5169] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 982).
• [5170] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 252).
• [5171] Mechanisms of resistance to cephalosporin antibiotics.Drugs.1987;34 Suppl 2:64-88.
• [5172] The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene. 2002 Mar 27;21(13):2089-96.
• [5173] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2647).
• [5174] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2642).
• [5175] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1011).
• [5176] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4300).
• [5177] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 274).
• [5178] Inhibition of S/G2 phase CDK4 reduces mitotic fidelity. J Biol Chem. 2006 Apr 14;281(15):9987-95.
• [5179] Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem. 1988 Dec;31(12):2235-46.
• [5180] Synthesis and evaluation of imidazo[1,5-a][1,4]benzodiazepine esters with high affinities and selectivities at "diazepam-insensitive" benzodiazepin... J Med Chem. 1993 Apr 16;36(8):1001-6.
• [5181] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4297).
• [5182] Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine recepto... J Med Chem. 1995 Jan 20;38(2):318-27.
• [5183] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5937).
• [5184] Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain, Bioorg. Med. Chem. Lett. 4(11):1303-1308 (1994).
• [5185] Microwave-assisted synthesis of 5-aminopyrazol-4-yl ketones and the p38(MAPK) inhibitor RO3201195 for study in Werner syndrome cells. Bioorg Med Chem Lett. 2008 Jul 1;18(13):3745-8.
• [5186] 11,21-Bisphenyl-19-norpregnane derivatives are selective antiglucocorticoids, Bioorg. Med. Chem. Lett. 7(17):2299-2302 (1997).
• [5187] Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1950-3.
• [5188] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4299).
• [5189] Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors. J Med Chem. 2009 Jun 25;52(12):3689-702.
• [5190] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1386).
• [5191] Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1666-9.
• [5192] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1969).
• [5193] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 789).
• [5194] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 790).
• [5195] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5052).
• [5196] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4298).
• [5197] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5259).
• [5198] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 791).
• [5199] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4042).
• [5200] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 792).
• [5201] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6226).
• [5202] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6324).
• [5203] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6158).
• [5204] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5862).
• [5205] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6325).
• [5206] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3955).
• [5207] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1387).
• [5208] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1388).
• [5209] Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996 Aug 23;271(34):20246-9.
• [5210] 4-Acetoxy-7-chloro-3-(3-(-4-[11C]methoxybenzyl)phenyl)-2(1H)-quinolone Molecular Imaging and Contrast Agent Database (MICAD) [Internet].
• [5211] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5313).
• [5212] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6625).
• [5213] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2393).
• [5214] UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety. Bioorg Med Chem. 2012 Sep 15;20(18):5483-95.
• [5215] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1858).
• [5216] Potassium channel opener, RP 66471, induces membrane depolarization of rat liver mitochondria. Biochem Biophys Res Commun. 1995 Feb 6;207(1):126-32.
• [5217] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 906).
• [5218] Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. Eur J Pharmacol. 1994 Sep 12;262(3):233-45.
• [5219] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5261).
• [5220] Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions. Behav Neurosci. 2002 Dec;116(6):1070-4.
• [5221] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5262).
• [5222] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3523).
• [5223] The synthesis and SAR of new 4-(N-alkyl-N-phenyl)amino-6,7-dimethoxyquinazolines and 4-(N-alkyl-N-phenyl)aminopyrazolo[3,4-d]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity, Bioorg. Med. Chem. Lett. 7(4):421-424 (1997).
• [5224] Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa. J Med Chem. 1999 Sep 9;42(18):3557-71.
• [5225] Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. J Med Chem. 2000 Jun 15;43(12):2371-81.
• [5226] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 580).
• [5227] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7657).
• [5228] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 250).
• [5229] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 251).
• [5230] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 239).
• [5231] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 237).
• [5232] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1886).
• [5233] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7381).
• [5234] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 187).
• [5235] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 779).
• [5236] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 780).
• [5237] Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors. J Med Chem. 1997 May 9;40(10):1417-21.
• [5238] Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility. Jpn J Pharmacol. 2002 Feb;88(2):174-82.
• [5239] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6557).
• [5240] Interaction of the anxiogenic agent, RS-30199, with 5-HT1A receptors: modulation of sexual activity in the male rat. Neuropharmacology. 1998 Jun;37(6):769-80.
• [5241] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8567).
• [5242] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3230).
• [5243] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2636).
• [5244] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7929).
• [5245] Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. J Med Chem. 1991 Jul;34(7):2231-41.
• [5246] Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-... J Med Chem. 2007 Jul 26;50(15):3686-95.
• [5247] Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)p... J Med Chem. 1998 May 21;41(11):1980-90.
• [5248] Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an ... J Med Chem. 2007 Aug 9;50(16):3765-76.
• [5249] Complex interactions between the steroid derivative RU 5135 and the GABAA-receptor complex. Eur J Pharmacol. 1992 Oct 1;227(2):147-51.
• [5250] Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists. Bioorg Med Chem. 2010 May 1;18(9):3159-68.
• [5251] Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile... J Med Chem. 2000 Aug 24;43(17):3344-7.
• [5252] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3446).
• [5253] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3451).
• [5254] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3445).
• [5255] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2432).
• [5256] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5555).
• [5257] Potential anxiolytic agents. Pyrido[1,2-a]benzimidazoles: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors. J Med Chem. 1995 Jan 6;38(1):16-20.
• [5258] DOI: 10.1021/op060099f
• [5259] 1,2,4-triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonists. Bioorg Med Chem Lett. 2001 Oct 8;11(19):2619-22.
• [5260] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3525).
• [5261] Imidazopyrimidines, potent inhibitors of p38 MAP kinase. Bioorg Med Chem Lett. 2003 Feb 10;13(3):347-50.
• [5262] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7894).
• [5263] Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies. J Med Chem. 2013 Feb 14;56(3):1149-59.
• [5264] Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines a... J Med Chem. 1998 Oct 8;41(21):4130-42.
• [5265] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4301).
• [5266] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7759).
• [5267] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4303).
• [5268] Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling. Biochem J. 1999 May 1;339 ( Pt 3):629-38.
• [5269] Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist. J Thromb Haemost. 2004 Mar;2(3):492-8.
• [5270] Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol. 1997;37:361-96.
• [5271] Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphate translocase inhibitor S 3025. Biochim Biophys Acta. 2002 Jan 15;1569(1-3):105-10.
• [5272] The treatment of Tourette's syndrome: current opinions. Expert Opin Pharmacother. 2002 Jul;3(7):899-914.
• [5273] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4097).
• [5274] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4098).
• [5275] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5264).
• [5276] Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. J Med Chem. 2000 Oct 19;43(21):3981-6.
• [5277] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 25).
• [5278] Discovery of small-molecule inhibitors of tyrosinase. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6871-5.
• [5279] Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxiety. Zhongguo Yao Li Xue Bao. 1999 Sep;20(9):805-12.
• [5280] Screening for selective thrombin inhibitors in mushrooms. Blood Coagul Fibrinolysis. 2001 Mar;12(2):123-8.
• [5281] Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking... J Med Chem. 2005 Mar 24;48(6):2054-71.
• [5282] Glucose release from GLUT2-null hepatocytes: characterization of a major and a minor pathway. Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E794-801.
• [5283] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5121).
• [5284] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5267).
• [5285] 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands. Bioorg Med Chem. 2009 Sep 1;17(17):6390-401.
• [5286] Allicin and derivates are cysteine protease inhibitors with antiparasitic activity. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5541-3.
• [5287] Purification and catalytic properties of glutathione transferase from the hepatopancreas of crayfish macrobrachium vollenhovenii (herklots). J Biochem Mol Toxicol. 2004;18(6):332-44.
• [5288] Aldehyde dehydrogenase inhibitors: alpha,beta-acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but i... Eur J Med Chem. 2008 May;43(5):906-16.
• [5289] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6493).
• [5290] Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors. J Med Chem. 2009 Aug 13;52(15):4650-6.
• [5291] Petrosamine B, an inhibitor of the Helicobacter pylori enzyme aspartyl semialdehyde dehydrogenase from the Australian sponge Oceanapia sp. J Nat Prod. 2005 May;68(5):804-6.
• [5292] SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorg Med Chem Lett. 2009 May 15;19(10):2747-51.
• [5293] Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol. 2015 Jan;172(2):704-19.
• [5294] Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 2004 Feb 18;24(7):1637-45.
• [5295] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1361).
• [5296] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1353).
• [5297] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1354).
• [5298] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1362).
• [5299] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1355).
• [5300] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4305).
• [5301] Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):917-21.
• [5302] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2163).
• [5303] Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. J Med Chem. 2004 Feb 26;47(5):1079-80.
• [5304] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5432).
• [5305] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1078).
• [5306] Identification of GAPDH as a protein target of the saframycin antiproliferative agents. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5862-6.
• [5307] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2437).
• [5308] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 412).
• [5309] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5465).
• [5310] Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues. J Med Chem. 2007 Jul 26;50(15):3596-603.
• [5311] Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers. Bioorg Med Chem. 2008 Feb 1;16(3):1279-86.
• [5312] Entry of Sanfetrinem into Human Polymorphonuclear Granulocytes and Its Cell-Associated Activity against Intracellular, Penicillin-Resistant Streptococcus pneumoniae
• [5313] Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. J Nat Prod. 2013 Nov 22;76(11):2026-33.
• [5314] Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 sub... J Med Chem. 1991 Nov;34(11):3248-60.
• [5315] 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. J Med Chem. 1991 Apr;34(4):1514-7.
• [5316] Human optic nerve head astrocytes as a target for endothelin-1. Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2704-13.
• [5317] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 995).
• [5318] The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry. 1999 Apr 27;38(17):5490-8.
• [5319] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4713).
• [5320] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2625).
• [5321] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6036).
• [5322] 5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist. J Vet Pharmacol Ther. 2002 Feb;25(1):49-58.
• [5323] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 256).
• [5324] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 221).
• [5325] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 190).
• [5326] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 28).
• [5327] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6037).
• [5328] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 191).
• [5329] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 130).
• [5330] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 192).
• [5331] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 193).
• [5332] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 194).
• [5333] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3232).
• [5334] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 75).
• [5335] The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis. Pulm Pharmacol Ther. 2002;15(2):103-10.
• [5336] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 76).
• [5337] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 264).
• [5338] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 77).
• [5339] The biology and chemistry of hyperlipidemia. Bioorg Med Chem. 2007 Jul 15;15(14):4674-99.
• [5340] Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma. J Pharmacol Exp Ther. 1995 Jun;273(3):1147-55.
• [5341] SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine... J Pharmacol Exp Ther. 1995 Sep;274(3):1254-62.
• [5342] Preparation and Properties of a fibrinogen receptor antagonist containing the Arg-Gly-Asp sequence and nitroxide radicals, Bioorg. Med. Chem. Lett. 3(6):1179-1184 (1993).
• [5343] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 257).
• [5344] Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg Med Chem Lett. 1998 Nov 17;8(22):3111-6.
• [5345] The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]S... Brain Res. 2002 Apr 26;934(1):49-57.
• [5346] The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold. Bioorg Med Chem Lett. 2005 Nov 1;15(21):4666-70.
• [5347] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 281).
• [5348] 1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailability. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5937-41.
• [5349] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 276).
• [5350] Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3950-4.
• [5351] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1703).
• [5352] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3235).
• [5353] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1704).
• [5354] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1705).
• [5355] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8019).
• [5356] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6049).
• [5357] Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors, Bioorg. Med. Chem. Lett. 20(14):4228-4232 (2010).
• [5358] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1312).
• [5359] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3531).
• [5360] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8642).
• [5361] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3237).
• [5362] 5-ht5A receptors as a therapeutic target. Pharmacol Ther. 2006 Sep;111(3):707-14.
• [5363] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2165).
• [5364] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8130).
• [5365] Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5609-13.
• [5366] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8015).
• [5367] SB-236057-A: a selective 5-HT1B receptor inverse agonist. CNS Drug Rev. 2001 Winter;7(4):433-44.
• [5368] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3468).
• [5369] Bridging the gap: bitopic ligands of G-protein-coupled receptors. Trends Pharmacol Sci. 2013 Jan;34(1):59-66.
• [5370] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3529).
• [5371] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3241).
• [5372] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4310).
• [5373] Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Biochem Pharmacol. 2007 Aug 15;74(4):601-11.
• [5374] Expression and characterization of human tissue kallikrein variants. Protein Expr Purif. 1998 Apr;12(3):361-70.
• [5375] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4230).
• [5376] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1922).
• [5377] Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase. Prostaglandins Leukot Essent Fatty Acids. 1993 Apr;48(4):323-6.
• [5378] Connexin Antibodies. Report from santa cruz biotechnology, inc. Santa cruz biotechnology. 2009.
• [5379] Protease inhibitors: current status and future prospects. J Med Chem. 2000 Feb 10;43(3):305-41.
• [5380] Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity, Bioorg. Med. Chem. Lett. 4(6):811-816 (1994).
• [5381] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 883).
• [5382] Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest. 2007 Sep;117(9):2496-505.
• [5383] The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297-315.
• [5384] Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5509-12.
• [5385] N1-sterically hindered 2H-imidazol-2-one angiotensin II receptor antagonists: The conversion of surmountable antagonists to insurmountable antagonists, Bioorg. Med. Chem. Lett. 3(6):1055-1060 (1993).
• [5386] Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists. J Med Chem. 1997 Aug 29;40(18):2843-57.
• [5387] Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem. 2005 Oct 6;48(20):6400-8.
• [5388] p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. J Biol Chem. 1997 Mar 21;272(12):8083-9.
• [5389] Pharmacological intervention at disparate sites in the coagulation cascade: comparison of anti-thrombotic efficacy vs bleeding propensity in a rat model of acute arterial thrombosis. J Thromb Thrombolysis. 2002 Oct;14(2):113-21.
• [5390] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3331).
• [5391] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6128).
• [5392] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2106).
• [5393] Determination of plasma concentrations of SCH 44643 by a GC method and correlation of plasma concentration and anti-PAF activity in cynomolgus monkeys. J Pharm Biomed Anal. 1996 Dec;15(3):343-7.
• [5394] Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]ben... J Med Chem. 1998 Nov 5;41(23):4486-91.
• [5395] Chemokine receptor CCR-5 inhibitors produced by Chaetomium globosum. J Nat Prod. 2006 Jul;69(7):1025-8.
• [5396] Radiosynthesis of novel carbon-11-labeled triaryl ligands for cannabinoid-type 2 receptor. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1565-8.
• [5397] Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands. J Med Chem. 1988 Oct;31(10):1941-6.
• [5398] Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1084-9.
• [5399] 2-Azetidinones as inhibitors of cholesterol absorption. J Med Chem. 1994 Jun 10;37(12):1733-6.
• [5400] The Gif system as a tool in medicinal chemistry: The oxidation of Sch 57726 under GoAggIII conditions, Bioorg. Med. Chem. Lett. 7(11):1381-1386 (1997).
• [5401] Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A... J Med Chem. 1998 Jun 4;41(12):2126-33.
• [5402] Novel steroidal saponins, Sch 725737 and Sch 725739, from a marine starfish, Novodinia antillensis. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5543-7.
• [5403] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5270).
• [5404] Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov. 2013 Jul;3(7):742-50.
• [5405] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2769).
• [5406] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8246).
• [5407] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5271).
• [5408] SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol. 1991 Aug 6;200(2-3):373-4.
• [5409] Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats. Bone. 1999 Nov;25(5):561-9.
• [5410] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3621).
• [5411] In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog. Anticancer Res. 1998 Jul-Aug;18(4A):2623-30.
• [5412] Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J Nat Prod. 2003 Oct;66(10):1364-8.
• [5413] Respiratory effects and tolerability of Mr 2264 Cl.A new opiate partial agonist in comparison with morphine and placebo.Eur J Clin Pharmacol.1994;46(4):301-4.
• [5414] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2095).
• [5415] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4587).
• [5416] Novel C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents: 1,3,4-Thiadiazolylmethylphenyl glucoside congeners. Bioorg Med Chem. 2010 Mar 15;18(6):2178-2194.
• [5417] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5).
• [5418] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2926).
• [5419] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6404).
• [5420] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6405).
• [5421] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6387).
• [5422] The design and synthesis of noncovalent factor Xa inhibitors. Curr Top Med Chem. 2001 Jun;1(2):137-49.
• [5423] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7529).
• [5424] Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun. 2012;3:1288.
• [5425] A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase (PRMT3). Angew Chem Int Ed Engl. 2015 Apr 20;54(17):5166-70.
• [5426] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5813).
• [5427] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1325).
• [5428] Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res. 2000 Mar-Apr;31(2):131-44.
• [5429] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1431).
• [5430] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1432).
• [5431] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5423).
• [5432] Sideroxylonal C, a new inhibitor of human plasminogen activator inhibitor type-1, from the flowers of Eucalyptus albens. J Nat Prod. 1999 Feb;62(2):324-6.
• [5433] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 331).
• [5434] A new recombinant factor VIII: from genetics to clinical use
• [5435] The effect of sinefungin and synthetic analogues on RNA and DNA methyltransferases from Streptomyces. J Antibiot (Tokyo). 1991 Oct;44(10):1141-7.
• [5436] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4314).
• [5437] Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat. Kidney Int. 1994 May;45(5):1301-10.
• [5438] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 518).
• [5439] trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. J Med Chem. 1990 Jun;33(6):1756-64.
• [5440] On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. J Med Chem. 2004 Jun 17;47(13):3409-17.
• [5441] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6622).
• [5442] Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2. J Med Chem. 1999 Jul 29;42(15):2760-73.
• [5443] New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1. Mol Pharmacol. 2014 Sep;86(3):342-57.
• [5444] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2335).
• [5445] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 511).
• [5446] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 936).
• [5447] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 944).
• [5448] Identification of G protein-biased agonists that fail to recruit beta-arrestin or promote internalization of the D1 dopamine receptor. ACS Chem Neurosci. 2015 Apr 15;6(4):681-92.
• [5449] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4705).
• [5450] Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1358-61.
• [5451] Exploring the structure-activity relationships of [1-(4-tert-butyl-3'-hydroxy)benzhydryl-4-benzylpiperazine] (SL-3111), a high-affinity and selecti... J Med Chem. 1999 Dec 30;42(26):5359-68.
• [5452] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6008).
• [5453] Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo. J Med Chem. 2001 Aug 2;44(16):2636-60.
• [5454] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2442).
• [5455] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2310).
• [5456] Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential a... J Med Chem. 2005 Nov 3;48(22):6855-69.
• [5457] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6682).
• [5458] Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. J Med Chem. 2010 Sep 9;53(17):6361-7.
• [5459] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5866).
• [5460] Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of ca... J Med Chem. 2008 Dec 11;51(23):7352-5.
• [5461] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7732).
• [5462] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6401).
• [5463] Design and synthesis of novel delta opioid receptor agonists and their pharmacologies. Bioorg Med Chem Lett. 2009 May 15;19(10):2792-5.
• [5464] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6402).
• [5465] Design and synthesis of KNT-127, a -opioid receptor agonist effective by systemic administration. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6302-5.
• [5466] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4666).
• [5467] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6125).
• [5468] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4677).
• [5469] Design and synthesis of novel dihydropyridine alpha-1a antagonists. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2843-8.
• [5470] Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione ... J Med Chem. 2005 Apr 21;48(8):3076-9.
• [5471] Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key frag... J Med Chem. 2007 Aug 9;50(16):3883-90.
• [5472] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1611).
• [5473] Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. J Biol Chem. 2007 Dec 14;282(50):36505-13.
• [5474] Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with ali... Bioorg Med Chem. 2009 Apr 1;17(7):2654-7.
• [5475] Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett. 2004 May 7;565(1-3):181-7.
• [5476] Synthesis and investigation of inhibition effect of fluorinated sulfonamide derivatives on carbonic anhydrase. Eur J Med Chem. 2010 Mar;45(3):1225-9.
• [5477] Carbonic anhydrase inhibitors: the membrane-associated isoform XV is highly inhibited by inorganic anions. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1155-8.
• [5478] Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1855-7.
• [5479] Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity. Aviat Space Environ Med. 1978 Jul;49(7):877-9.
• [5480] Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products. Bioorg Med Chem. 2007 Mar 1;15(5):1967-75.
• [5481] Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity. Bioorg Med Chem. 2010 Jul 1;18(13):4625-9.
• [5482] Book (Current Pharmaceutical Design)
• [5483] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6434).
• [5484] Synthesis and substance P antagonist activity of naphthimidazolium derivatives. J Med Chem. 1992 Apr 3;35(7):1273-9.
• [5485] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2097).
• [5486] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2453).
• [5487] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4032).
• [5488] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1653).
• [5489] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 175).
• [5490] Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl-C-normo... Bioorg Med Chem. 2009 Aug 15;17(16):5983-8.
• [5491] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 53).
• [5492] Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15113-8.
• [5493] Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 1995 Mar;27(3):883-92.
• [5494] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6070).
• [5495] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8656).
• [5496] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1887).
• [5497] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1985).
• [5498] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3054).
• [5499] Effect of SR 59026A, a new 5-HT(1A) receptor agonist, on sexual activity in male rats. Behav Pharmacol. 1995 Apr;6(3):276-282.
• [5500] Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors. Bioorg Med Chem Lett. 2006 May 1;16(9):2357-63.
• [5501] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1580).
• [5502] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 751).
• [5503] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1581).
• [5504] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8692).
• [5505] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2030).
• [5506] The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction. J Lipid Mediat Cell Signal. 1994 Sep;10(3):229-42.
• [5507] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2019).
• [5508] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2020).
• [5509] Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007 Nov 29;450(7170):712-6.
• [5510] SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF- B activity. PLoS One. 2012;7(9):e46364.
• [5511] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2201).
• [5512] Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling. Cancer Cell. 2013 Apr 15;23(4):489-501.
• [5513] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5613).
• [5514] Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors. Bioorg Med Chem Lett. 2009 May 15;19(10):2840-3.
• [5515] N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9.
• [5516] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6539).
• [5517] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1939).
• [5518] Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105.
• [5519] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3377).
• [5520] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8370).
• [5521] STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002 May 3;277(18):15813-8.
• [5522] A fluopol-ABPP HTS assay to identify PAD inhibitors. Chem Commun (Camb). 2010 Oct 14;46(38):7175-7.
• [5523] Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screening. Bioorg Med Chem. 2009 Jul 15;17(14):4861-5.
• [5524] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6044).
• [5525] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6043).
• [5526] Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. Curr Drug Targets. 2001 Mar;2(1):41-55.
• [5527] Tumor angiogenesis as a therapeutic target. Drug Discov Today. 2001 Oct 1;6(19):1005-1024.
• [5528] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6045).
• [5529] [Adjuvant properties of subalin, a recombinant interferon-producing probiotic].Zh Mikrobiol Epidemiol Immunobiol.2001 Nov-Dec;(6):77-82.
• [5530] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2098).
• [5531] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5411).
• [5532] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):579-84.
• [5533] Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J Med Chem. 2003 Nov 6;46(23):5091-4.
• [5534] Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. J Med Chem. 2005 Mar 24;48(6):1941-7.
• [5535] Heterocyclic muscarinic agonists. Synthesis and biological activity of some bicyclic sulfonium arecoline bioisosteres. J Med Chem. 1988 Jul;31(7):1312-6.
• [5536] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4313).
• [5537] Chymase inhibitor ameliorates eosinophilia in mice infected with Nippostrongylus brasiliensis. Int Arch Allergy Immunol. 2002 Jul;128(3):235-9.
• [5538] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6270).
• [5539] Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2. J Med Chem. 2014 Oct 23;57(20):8378-97.
• [5540] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4075).
• [5541] Symbiopolyol, a VCAM-1 inhibitor from a symbiotic dinoflagellate of the jellyfish Mastigias papua. J Nat Prod. 2010 Jul 23;73(7):1318-22.
• [5542] Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. Bioorg Med Chem. 2008 Jun 15;16(12):6394-405.
• [5543] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6986).
• [5544] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4318).
• [5545] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 533).
• [5546] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1184).
• [5547] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 639).
• [5548] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3444).
• [5549] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5275).
• [5550] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2755).
• [5551] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5560).
• [5552] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6984).
• [5553] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 852).
• [5554] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 853).
• [5555] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 854).
• [5556] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5746).
• [5557] Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Clin Cancer Res.2000 Aug;6(8):3334-41.
• [5558] Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis. Biochemistry. 2002 Nov 5;41(44):13309-17.
• [5559] Synthesis of the bicyclic core of tagetitoxin. Chem Commun (Camb). 2006 Mar 21;(11):1197-9.
• [5560] Sesquiterpene lactones from Tithonia diversifolia act as peroxisome proliferator-activated receptor agonists. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2954-8.
• [5561] 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Bioorg Med Chem. 2008 Mar 15;16(6):2939-44.
• [5562] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4664).
• [5563] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7817).
• [5564] AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene. 2001 May 17;20(22):2771-80.
• [5565] Genomic action of permanently charged tamoxifen derivatives via estrogen receptor-alpha. Bioorg Med Chem. 2010 Aug 1;18(15):5593-601.
• [5566] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4319).
• [5567] Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. J Nat Prod. 2006 Sep;69(9):1341-6.
• [5568] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2379).
• [5569] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4747).
• [5570] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4548).
• [5571] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4746).
• [5572] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4320).
• [5573] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3987).
• [5574] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6582).
• [5575] Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J Neurosci. 2012 May 2;32(18):6197-208.
• [5576] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5590).
• [5577] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2756).
• [5578] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5859).
• [5579] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6276).
• [5580] N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4497-9.
• [5581] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6590).
• [5582] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2567).
• [5583] Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans. J Med Chem. 1983 Jul;26(7):935-47.
• [5584] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1965).
• [5585] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2788).
• [5586] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 785).
• [5587] Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003 Jan;42(1):37-50.
• [5588] Influence of Specific Signal Peptide Mutations on the Expression and Secretion of the alpha -Amylase Inhibitor Tendamistat in Streptomyces lividans. J Biol Chem. 1996 Jun 21;271(25):15244-52.
• [5589] Tenellones A and B from a Diaporthe sp.: two highly substituted benzophenone inhibitors of parasite cGMP-dependent protein kinase activity. J Nat Prod. 2005 Apr;68(4):611-3.
• [5590] The binding of [3H]thienyl cyclohexylpiperidine ([3H]TCP) to the NMDA-phencyclidine receptor complex. Neuropharmacology. 1989 Jan;28(1):1-7.
• [5591] Acetylcholinesterase inhibition by territrem B derivatives. J Nat Prod. 1995 Jun;58(6):857-62.
• [5592] Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitu... J Med Chem. 1995 Oct 27;38(22):4446-53.
• [5593] Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem. 2007 Jan 2;8(1):129-39.
• [5594] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 861).
• [5595] Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazi... J Med Chem. 1989 Feb;32(2):342-50.
• [5596] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6418).
• [5597] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4321).
• [5598] Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9878-82.
• [5599] Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform. Bioorg Med Chem Lett. 2009 May 1;19(9):2456-60.
• [5600] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1319).
• [5601] Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line. Eur J Pharmacol. 1992 Oct 6;221(1):99-105.
• [5602] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 115).
• [5603] Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinas... Bioorg Med Chem Lett. 2007 Feb 1;17(3):602-8.
• [5604] Technology evaluation: TG-1031, Transgene SA.Curr Opin Mol Ther.2000 Feb;2(1):106-11.
• [5605] Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose le... Cancer Gene Ther. 2002 Mar;9(3):289-95.
• [5606] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5818).
• [5607] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8546).
• [5608] PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med. 2005 May;11(5):507-14.
• [5609] Zhang JG, Fariss MW: Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity. Biochem Pharmacol. 2002 Feb 15;63(4):751-4.
• [5610] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6626).
• [5611] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8033).
• [5612] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4580).
• [5613] 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. Bioorg Med Chem Lett. 2004 Jan 19;14(2):413-6.
• [5614] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6259).
• [5615] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2473).
• [5616] Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob Agents Chemother. 1996 Feb;40(2):443-7.
• [5617] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 348).
• [5618] Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2881-5.
• [5619] Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-(acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)me... J Med Chem. 1993 Mar 5;36(5):544-51.
• [5620] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5278).
• [5621] Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowe... Bioorg Med Chem Lett. 2005 Sep 1;15(17):3821-7.
• [5622] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3326).
• [5623] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4727).
• [5624] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4573).
• [5625] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4482).
• [5626] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4581).
• [5627] Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment. J Med Chem. 2007 Dec 27;50(26):6685-91.
• [5628] Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1721-5.
• [5629] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1667).
• [5630] Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa. J Nat Prod. 2004 Nov;67(11):1839-41.
• [5631] Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001 Nov 27;104(22):2710-5.
• [5632] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5279).
• [5633] Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis. J Nat Prod. 2003 Sep;66(9):1191-6.
• [5634] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3959).
• [5635] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1637).
• [5636] Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities. J Med Chem. 2014 Mar 27;57(6):2275-91.
• [5637] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4323).
• [5638] Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group. Nat Chem Biol. 2013 May;9(5):319-25.
• [5639] Synthesis and Antiviral Evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) Analogues of HIV Drugs Emivirine and TNK-651.Drug Res (Stuttg).2016 Apr;66(4):181-8.
• [5640] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4324).
• [5641] Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and ... J Nat Prod. 2006 Jun;69(6):945-9.
• [5642] Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. J Med Chem. 2006 Apr 6;49(7):2174-85.
• [5643] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5481).
• [5644] Antiparkinson potential of delta-opioid receptor agonists. Eur J Pharmacol. 2000 May 19;396(2-3):101-7.
• [5645] Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba. J Nat Prod. 2001 Feb;64(2):204-7.
• [5646] An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem. 2009 Mar 20;284(12):8023-32.
• [5647] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2830).
• [5648] Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine re... J Med Chem. 2007 Sep 20;50(19):4616-29.
• [5649] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 885).
• [5650] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4326).
• [5651] Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbo... J Pharmacol Exp Ther. 2005 Jan;312(1):373-81.
• [5652] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6051).
• [5653] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4328).
• [5654] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4558).
• [5655] Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,... J Med Chem. 2001 Sep 13;44(19):3157-65.
• [5656] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5467).
• [5657] In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3661-3.
• [5658] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6499).
• [5659] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4099).
• [5660] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4704).
• [5661] Synthesis and in vivo evaluation of bicyclic gababutins. Bioorg Med Chem Lett. 2010 Jan 15;20(2):461-4.
• [5662] Antagonists selective for estrogen receptor alpha. Endocrinology. 2002 Mar;143(3):941-7.
• [5663] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2918).
• [5664] Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S20-6.
• [5665] Sulfenamido-sulfonamides as inhibitors of carbonic anhydrase isozymes I, II and IV. J Enzyme Inhib. 1997 Aug;12(3):175-90.
• [5666] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6433).
• [5667] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2293).
• [5668] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4760).
• [5669] Kinetic characterization of methionine gamma-lyases from the enteric protozoan parasite Entamoeba histolytica against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis. FEBS J. 2008 Feb;275(3):548-60.
• [5670] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2803).
• [5671] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4331).
• [5672] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5521).
• [5673] Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro. J Med Chem. 2000 Feb 24;43(4):591-8.
• [5674] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 361).
• [5675] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7766).
• [5676] Structure-activity relationships in a series of monocyclic endothelin analogues, Bioorg. Med. Chem. Lett. 4(4):567-572 (1994).
• [5677] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2646).
• [5678] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4755).
• [5679] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3952).
• [5680] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6483).
• [5681] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6490).
• [5682] Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors. J Nat Prod. 2004 Nov;67(11):1882-5.
• [5683] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5980).
• [5684] A topochemical approach to explain morphiceptin bioactivity. J Med Chem. 1993 Mar 19;36(6):708-19.
• [5685] Endomorphin-2 with a beta-turn backbone constraint retains the potent micro-opioid receptor agonist properties. J Med Chem. 2008 Jan 10;51(1):173-7.
• [5686] Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors. J Med Chem. 2006 May 18;49(10):2868-75.
• [5687] Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. J Med Chem. 2009 Dec 10;52(23):7372-5.
• [5688] The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor anta... Bioorg Med Chem. 2009 Oct 15;17(20):7337-43.
• [5689] The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokin... J Med Chem. 2008 Oct 23;51(20):6334-47.
• [5690] Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides. J Med Chem. 1997 Aug 29;40(18):2948-52.
• [5691] Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptors. J Med Chem. 1994 Jan 7;37(1):141-5.
• [5692] Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3... Bioorg Med Chem Lett. 2006 Jul 15;16(14):3688-92.
• [5693] Molecular modeling studies to predict the possible binding modes of endomorphin analogs in mu opioid receptor. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5387-91.
• [5694] Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling. Bioorg Med Chem. 2008 Jun 15;16(12):6415-22.
• [5695] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2148).
• [5696] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4862).
• [5697] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2665).
• [5698] Design of pyrrolo-1,4-benzoxazine derivatives as inhibitors of 5-lipoxygenase and PAF antagonists with anthihistaminic properties, Bioorg. Med. Chem. Lett. 4(20):2383-2388 (1994).
• [5699] Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptor. J Med Chem. 1994 Mar 18;37(6):758-68.
• [5700] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5282).
• [5701] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5781).
• [5702] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1974).
• [5703] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1652).
• [5704] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5283).
• [5705] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 30).
• [5706] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4333).
• [5707] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4332).
• [5708] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4092).
• [5709] Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3077-80.
• [5710] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3536).
• [5711] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4335).
• [5712] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4337).
• [5713] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4338).
• [5714] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1257).
• [5715] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2320).
• [5716] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2321).
• [5717] The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov. 2005 Feb;4(2):107-20.
• [5718] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7772).
• [5719] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7773).
• [5720] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7923).
• [5721] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7777).
• [5722] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7783).
• [5723] Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. J Med Chem. 2009 Apr 23;52(8):2384-92.
• [5724] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4609).
• [5725] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1750).
• [5726] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1784).
• [5727] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4730).
• [5728] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1694).
• [5729] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3917).
• [5730] Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds. Bioorg Med Chem. 2010 Aug 15;18(16):6024-30.
• [5731] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 957).
• [5732] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8583).
• [5733] Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD. Br J Pharmacol. 2002 Jun;136(4):620-8.
• [5734] Imidazo[2 3 :6,5]dipyrido[3,2-b:2 3 e]-1,4-diazepines: non-nucleoside HIV-1 reverse transcriptase inhibitors with greater enzyme affinity than nevirapine, Bioorg. Med. Chem. Lett. 2(12):1745-1750(1992).
• [5735] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6528).
• [5736] Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically a... Bioorg Med Chem Lett. 2008 Dec 15;18(24):6562-7.
• [5737] A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther. 2014 Mar;13(3):565-75.
• [5738] Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18488-93.
• [5739] G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002 Jul 15;16(14):1779-91.
• [5740] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7015).
• [5741] Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP. J Med Chem. 2013 Nov 14;56(21):8931-42.
• [5742] Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat Chem Biol. 2013 Mar;9(3):184-91.
• [5743] An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chem Biol. 2013;8(6):1324-34.
• [5744] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5533).
• [5745] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1751).
• [5746] Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents. Br J Pharmacol. 1991 Dec;104(4):990-4.
• [5747] Evidence for the autocrine induction of capacitation of mammalian spermatozoa.J Biol Chem.2001 Jul 20;276(29):26962-8.
• [5748] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1198).
• [5749] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1200).
• [5750] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1201).
• [5751] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1202).
• [5752] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4731).
• [5753] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1782).
• [5754] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1749).
• [5755] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5125).
• [5756] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1779).
• [5757] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2156).
• [5758] Usimines A-C, bioactive usnic acid derivatives from the Antarctic lichen Stereocaulon alpinum. J Nat Prod. 2008 Apr;71(4):710-2.
• [5759] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1735).
• [5760] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2816).
• [5761] New class of HIV integrase inhibitors that block viral replication in cell culture. Curr Biol. 2002 Jul 23;12(14):1169-77.
• [5762] Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell. 2014 Apr 10;157(2):313-28.
• [5763] Steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin. J Nat Prod. 2001 Jun;64(6):842-4.
• [5764] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5470).
• [5765] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6645).
• [5766] Inhibition of the human chemokine receptor CCR5 by variecolin and variecolol and isolation of four new variecolin analogues, emericolins A-D, from ... J Nat Prod. 2004 Oct;67(10):1681-4.
• [5767] Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists. Bioorg Med Chem. 2010 May 1;18(9):3078-87.
• [5768] Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem. 1998 Jul 2;41(14):2588-603.
• [5769] Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4241-4.
• [5770] Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists. Bioorg Med Chem Lett. 2006 Feb;16(3):677-80.
• [5771] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 168).
• [5772] Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design. J Med Chem. 2005 Jun 30;48(13):4212-5.
• [5773] Indoline derivatives as 5-HT(2C) receptor agonists. Bioorg Med Chem Lett. 2004 May 3;14(9):2367-70.
• [5774] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2626).
• [5775] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4759).
• [5776] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 345).
• [5777] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 768).
• [5778] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 433).
• [5779] Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy. Tohoku J Exp Med. 1986 Aug;149(4):351-7.
• [5780] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2771).
• [5781] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 886).
• [5782] Synthesis and evaluation of novel benzimidazole derivative [Bz-Im] and its radio/biological studies. Bioorg Med Chem Lett. 2007 May 15;17(10):2749-55.
• [5783] Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their "receptor desmodynamic processes". J Med Chem. 2006 Apr 20;49(8):2456-62.
• [5784] 2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK(1) receptor antagonists: 'Hic Rhodus, hic saltus'. Bioorg Med Chem. 2009 Jul 15;17(14):5198-206.
• [5785] Anthranilic acid based CCK1 receptor antagonists: blocking the receptor with the same 'words' of the endogenous ligand. Bioorg Med Chem. 2009 Mar 15;17(6):2336-50.
• [5786] A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer
• [5787] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6992).
• [5788] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2909).
• [5789] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3324).
• [5790] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5450).
• [5791] Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist. Bioorg Med Chem Lett. 2004 Jun 7;14(11):2735-40.
• [5792] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2930).
• [5793] Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob Agents Chemother. 2004 Jan;48(1):250-61.
• [5794] VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.Neuropharmacology.2007 Sep;53(4):563-73.
• [5795] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1758).
• [5796] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4059).
• [5797] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6403).
• [5798] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6207).
• [5799] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6228).
• [5800] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7633).
• [5801] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3261).
• [5802] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6227).
• [5803] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3259).
• [5804] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6229).
• [5805] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6421).
• [5806] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7632).
• [5807] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3256).
• [5808] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3263).
• [5809] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3323).
• [5810] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3257).
• [5811] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6422).
• [5812] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4665).
• [5813] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3274).
• [5814] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6398).
• [5815] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6399).
• [5816] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6230).
• [5817] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6400).
• [5818] Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs). J Med Chem. 2009 Jul 23;52(14):4115-8.
• [5819] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6423).
• [5820] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6424).
• [5821] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6234).
• [5822] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6438).
• [5823] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6233).
• [5824] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6410).
• [5825] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7662).
• [5826] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6411).
• [5827] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6225).
• [5828] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6393).
• [5829] N-Acyl-N'-arylpiperazines as negative allosteric modulators of mGlu1: identification of VU0469650, a potent and selective tool compound with CNS exposure in rats. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3713-8.
• [5830] An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. Nat Chem Biol. 2008 Jan;4(1):42-50.
• [5831] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7696).
• [5832] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1263).
• [5833] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1245).
• [5834] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1246).
• [5835] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1274).
• [5836] Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem. 2008 Apr 24;51(8):2457-67.
• [5837] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 475).
• [5838] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 476).
• [5839] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3280).
• [5840] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 362).
• [5841] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2931).
• [5842] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 581).
• [5843] WA8242A1, A2 and B, novel secretary phospholipase A2 inhibitors produced by Streptomyces violaceusniger. III. Structure elucidation and total synth... J Antibiot (Tokyo). 1998 Jul;51(7):655-64.
• [5844] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6359).
• [5845] Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol Biochem Behav. 1997 Oct;58(2):593-603.
• [5846] Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives. J Med Chem. 1991 Nov;34(11):3212-28.
• [5847] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 229).
• [5848] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5582).
• [5849] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8429).
• [5850] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4531).
• [5851] Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta. Bioorg Med Chem. 2009 May 15;17(10):3519-27.
• [5852] Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists. J Med Chem. 2005 Jan 27;48(2):353-6.
• [5853] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5327).
• [5854] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5288).
• [5855] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4052).
• [5856] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 363).
• [5857] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5551).
• [5858] Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity. J Med Chem. 2006 Aug 10;49(16):4981-91.
• [5859] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 339).
• [5860] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 340).
• [5861] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 677).
• [5862] A comparative SAR and computer modeling study of benzisothiazolone, mechanism-based inhibitors with porcine pancreatic and human leukocyte elastase, Bioorg. Med. Chem. Lett. 6(24):2941-2946 (1996).
• [5863] DOI: 10.1021/jo00074a031
• [5864] WIN 66306, a new neurokinin antagonist produced by an Aspergillus species: fermentation, isolation and physico-chemical properties. J Antibiot (Tokyo). 1994 Nov;47(11):1182-7.
• [5865] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8084).
• [5866] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8085).
• [5867] Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II. Molecules. 2014 Sep 26;19(10):15411-39.
• [5868] The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 2010 Jun 16;29(12):2082-96.
• [5869] Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1982-5.
• [5870] Cellular effects of leishmanial tubulin inhibitors on L. donovani. Mol Biochem Parasitol. 2000 Oct;110(2):223-36.
• [5871] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8419).
• [5872] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4343).
• [5873] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2474).
• [5874] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2475).
• [5875] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6368).
• [5876] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5289).
• [5877] N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides.Potent orally active leukotriene D4 antagonists of novel structure.J Med Chem.1990 Jan;33(1):240-5.
• [5878] Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases. Biochem J. 2014 Jan 1;457(1):215-25.
• [5879] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3279).
• [5880] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 538).
• [5881] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 432).
• [5882] Structural diversity and plasticity associated with nucleotides targeting orotidine monophosphate decarboxylase. J Med Chem. 2008 Feb 14;51(3):432-8.
• [5883] Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkox... J Med Chem. 1998 Oct 8;41(21):3976-86.
• [5884] Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior. J Biol Chem. 2014 Apr 18;289(16):10975-87.
• [5885] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 451).
• [5886] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2832).
• [5887] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7525).
• [5888] 4-Acyl pyrroles: mimicking acetylated lysines in histone code reading. Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14055-9.
• [5889] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2596).
• [5890] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1587).
• [5891] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4344).
• [5892] Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010 Sep 14;18(3):258-67.
• [5893] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6486).
• [5894] Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension. 2008 May;51(5):1312-7.
• [5895] Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem. 2008 Mar 1;16(5):2448-62.
• [5896] Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost. 2003 Sep;90(3):549-54.
• [5897] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 523).
• [5898] Y-26763: ATP-sensitive K+ channel activation and the inhibition of insulin release from human pancreatic beta-cells. Eur J Pharmacol. 2004 Feb 20;486(2):133-9.
• [5899] A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats. Eur J Pharmacol. 2000 Dec 15;409(3):331-5.
• [5900] Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol. 2002 Nov;90(3):214-7.
• [5901] Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographica... J Med Chem. 1998 Jun 18;41(13):2252-60.
• [5902] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5430).
• [5903] Compositions for improving gastrointestinal nutrient and drug absorption
• [5904] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3538).
• [5905] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2204).
• [5906] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2205).
• [5907] (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally po... J Med Chem. 2006 Jan 26;49(2):716-26.
• [5908] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6361).
• [5909] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 230).
• [5910] Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists. Bioorg Med Chem. 2008 Nov 1;16(21):9524-35.
• [5911] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3137).
• [5912] Synthesis and biological activity of novel 1,4-diazepane derivatives as factor Xa inhibitor with potent anticoagulant and antithrombotic activity. Bioorg Med Chem. 2004 May 1;12(9):2179-91.
• [5913] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5392).
• [5914] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2120).
• [5915] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2121).
• [5916] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2122).
• [5917] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5090).
• [5918] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5293).
• [5919] Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol. 1999 Nov;277(5 Pt 2):R1435-43.
• [5920] Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model.PLoS One.2015 Aug 14;10(8):e0130012.
• [5921] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6534).
• [5922] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5298).
• [5923] Tethering identifies fragment that yields potent inhibitors of human caspase-1. Bioorg Med Chem Lett. 2006 Feb;16(3):559-62.
• [5924] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5302).
• [5925] Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. J Med Chem. 2007 Jan 25;50(2):350-5.
• [5926] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6061).
• [5927] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3073).
• [5928] Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. J Nat Prod. 1993 Nov;56(11):1923-9.
• [5929] Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. J Pharmacol Exp Ther. 2001 Jul;298(1):307-15.
• [5930] Acquisition of resistance to anticancer agents by overproduction of target enzymes. Nippon Rinsho. 1997 May;55(5):1030-7.
• [5931] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4729).
• [5932] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2597).
• [5933] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3466).
• [5934] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 813).
• [5935] Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.Anticancer Res.1990 May-Jun;10(3):683-7.
• [5936] Progesterone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J Endocrinol. 1998 Sep;158(3):401-7.
• [5937] The antiovulatory activity of progesterone antagonists is not correlated to their antiprogestational potency in the rat. J Steroid Biochem Mol Biol. 1996 Sep;59(1):75-82.
• [5938] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6162).
• [5939] Synthesis and biological evaluation of stilbene-based pure estrogen antagonists. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4659-63.
• [5940] Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors. J Med Chem. 2007 Jun 28;50(13):2967-80.
• [5941] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1889).
• [5942] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2789).
• [5943] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5771).
• [5944] Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol. 2001 Nov;134(6):1296-302.
• [5945] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5778).
• [5946] Naphthyl ketones: a new class of Janus kinase 3 inhibitors. Bioorg Med Chem Lett. 2000 Mar 20;10(6):575-9.
• [5947] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8353).
• [5948] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 566).
• [5949] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7668).
• [5950] Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, a... J Biol Chem. 2004 Apr 30;279(18):18415-24.
• [5951] Synthesis of non-immunosuppressive cyclophilin-Binding cyclosporin A derivatives as potential anti-HIV-1 drugs. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4415-9.
• [5952] Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. J Med Chem. 2005 Jan 13;48(1):100-10.
• [5953] Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process. J Med Chem. 2003 Sep 11;46(19):4032-42.
• [5954] 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological eva... J Med Chem. 2005 Dec 15;48(25):7932-45.
• [5955] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6991).
• [5956] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3926).
• [5957] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3268).
• [5958] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4608).
• [5959] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4489).
• [5960] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6212).
• [5961] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3244).
• [5962] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3249).
• [5963] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3252).
• [5964] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3278).
• [5965] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 744).
• [5966] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4762).
• [5967] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1264).
• [5968] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3243).
• [5969] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6667).
• [5970] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4763).
• [5971] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 436).
• [5972] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 452).
• [5973] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 462).
• [5974] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 500).
• [5975] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1973).
• [5976] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1186).
• [5977] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1076).
• [5978] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1077).
• [5979] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 594).
• [5980] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7771).
• [5981] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 169).
• [5982] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3976).
• [5983] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3942).
• [5984] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1531).
• [5985] Direct visualization of serotonin1D receptors in the human brain using a new iodinated radioligand. Brain Res Mol Brain Res. 1992 Mar;13(1-2):175-8.
• [5986] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 482).
• [5987] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 562).
• [5988] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1230).
• [5989] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3960).
• [5990] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1007).
• [5991] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3471).
• [5992] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3295).
• [5993] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 261).
• [5994] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3472).
• [5995] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1001).
• [5996] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1981).
• [5997] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2492).
• [5998] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5409).
• [5999] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7779).
• [6000] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1982).
• [6001] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2710).
• [6002] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3245).
• [6003] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 945).
• [6004] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7770).
• [6005] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1983).
• [6006] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 430).
• [6007] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4541).
• [6008] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4599).
• [6009] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4623).
• [6010] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4624).
• [6011] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1429).
• [6012] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4575).
• [6013] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3275).
• [6014] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3242).
• [6015] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6213).
• [6016] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4368).
• [6017] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3266).
• [6018] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6392).
• [6019] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6334).
• [6020] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3473).
• [6021] Novel protein kinase C inhibitors: synthesis and PKC inhibition of beta-substituted polythiophene derivatives. Bioorg Med Chem Lett. 1999 Aug 2;9(15):2279-82.
• [6022] Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4569-73.
• [6023] Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocy... J Med Chem. 2008 Nov 13;51(21):6800-7.
• [6024] Inhibitory effect of synthetic C-C biflavones on various phospholipase A(2)s activity. Bioorg Med Chem. 2007 Nov 15;15(22):7138-43.
• [6025] Oxidosqualene cyclase inhibitors as antimicrobial agents. J Med Chem. 2003 Sep 25;46(20):4240-3.
• [6026] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1726).
• [6027] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5402).
• [6028] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1774).
• [6029] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3484).
• [6030] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4584).
• [6031] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3408).
• [6032] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3407).
• [6033] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5406).
• [6034] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1097).
• [6035] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4369).
• [6036] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2512).
• [6037] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2733).
• [6038] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 531).
• [6039] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2515).
• [6040] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4602).
• [6041] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4074).
• [6042] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6329).
• [6043] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 352).
• [6044] Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett. 1999 Jul 30;456(1):63-7.
• [6045] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3248).
• [6046] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3391).
• [6047] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 950).
• [6048] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 31).
• [6049] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3974).
• [6050] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5407).
• [6051] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4076).
• [6052] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5405).
• [6053] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3971).
• [6054] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5404).
• [6055] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1003).
• [6056] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5096).
• [6057] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 379).
• [6058] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5387).
• [6059] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5381).
• [6060] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4078).
• [6061] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4080).
• [6062] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4081).
• [6063] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 734).
• [6064] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4082).
• [6065] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3979).
• [6066] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3476).
• [6067] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5388).
• [6068] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 364).
• [6069] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1612).
• [6070] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4089).
• [6071] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 406).
• [6072] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 118).
• [6073] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1390).
• [6074] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4687).
• [6075] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4748).
• [6076] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4492).
• [6077] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6690).
• [6078] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5410).
• [6079] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4638).
• [6080] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4659).
• [6081] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2303).
• [6082] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2292).
• [6083] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4490).
• [6084] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2706).
• [6085] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5599).
• [6086] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 735).
• [6087] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 908).
• [6088] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6331).
• [6089] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4085).
• [6090] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4363).
• [6091] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 219).
• [6092] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3413).
• [6093] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6195).
• [6094] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1399).
• [6095] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1425).
• [6096] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4088).
• [6097] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1583).
• [6098] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 232).
• [6099] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6425).
• [6100] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5394).
• [6101] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3980).
• [6102] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3457).
• [6103] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3456).
• [6104] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 527).
• [6105] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4603).
• [6106] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 196).
• [6107] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6689).
• [6108] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3829).
• [6109] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 425).
• [6110] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3483).
• [6111] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4619).
• [6112] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3978).
• [6113] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4636).
• [6114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4511).
• [6115] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3925).
• [6116] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 454).
• [6117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8595).
• [6118] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 81).
• [6119] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 899).
• [6120] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3478).
• [6121] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6683).
• [6122] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1957).
• [6123] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3272).
• [6124] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6504).
• [6125] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6147).
• [6126] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5729).
• [6127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3260).
• [6128] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1370).
• [6129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2305).
• [6130] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 223).
• [6131] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4356).
• [6132] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3246).
• [6133] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4365).
• [6134] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 82).
• [6135] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 528).
• [6136] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4364).
• [6137] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3479).
• [6138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1706).
• [6139] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4491).
• [6140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1318).
• [6141] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3300).
• [6142] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2360).
• [6143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 119).
• [6144] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4628).
• [6145] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1656).
• [6146] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4758).
• [6147] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4605).
• [6148] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 736).
• [6149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 455).
• [6150] Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III. J Med Chem. 2006 Jun 15;49(12):3536-43.
• [6151] Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7. Eur J Med Chem. 2007 Jun;42(6):799-806.
• [6152] Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1909-13.
• [6153] The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. J Med Chem. 2010 Mar 11;53(5):2063-75.
• [6154] Synthesis and biological evaluation of a metazocine-containing enkephalinamide. Evidence for nonidentical roles of the tyramine moiety in opiates a... J Med Chem. 1982 Dec;25(12):1423-7.
• [6155] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 646).
• [6156] Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences. J Med Chem. 1996 Jun 21;39(13):2449-55.
• [6157] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1453).
• [6158] Carba-analogues of fentanyl are opioid receptor agonists. J Med Chem. 2010 Apr 8;53(7):2875-81.
• [6159] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 641).
• [6160] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2255).
• [6161] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2254).
• [6162] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2256).
• [6163] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6109).
• [6164] A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. J Med Chem. 1997 Jun 6;40(12):1835-44.
• [6165] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1695).
• [6166] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2178).
• [6167] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 643).
• [6168] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3850).
• [6169] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2179).
• [6170] Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2. Bioorg Med Chem Lett. 2005 Apr 1;15(7):1847-50.
• [6171] NMR studies of an FK-506 analog, [U-13C]ascomycin, bound to FK-506-binding protein. J Med Chem. 1992 Jun 26;35(13):2467-73.
• [6172] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2180).
• [6173] Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(p... Bioorg Med Chem. 2009 Nov 15;17(22):7802-15.